PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	GILLMAN, SA; HADDAD, ZH				GILLMAN, SA; HADDAD, ZH			HISTAMINE-RELEASE FROM RAT PERITONEAL MAST-CELLS AFTER PASSIVE SENSITIZATION WITH HUMAN REAGINIC SERUM OR E MYELOMA PROTEIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		AMOS B, 1971, P PROGRESS IMMUNOLOG, P1301; HADDAD Z H, 1971, Journal of Allergy, V47, P88; HADDAD ZH, 1972, J ALLERGY CLIN IMMUN, V49, P210, DOI 10.1016/0091-6749(72)90084-X; HADDAD ZH, 1971, INT ARCH ALLER A IMM, V41, P72, DOI 10.1159/000230489; HADDAD ZH, 1971, 1 INT C IMM WASH; HUMPHREY JH, 1963, IMMUNOLOGY, V6, P226; JOHNSON AR, 1969, AM J PHYSIOL, V216, P453, DOI 10.1152/ajplegacy.1969.216.3.453; KANYEREZI B, 1971, J IMMUNOL, V106, P1411; KOROTZER J, 1970, J ALLERGY, V45, P126; KOROTZER JL, 1971, IMMUNOLOGY, V20, P545; LIAKOPOULOU A, 1971, J IMMUNOL, V107, P131; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; PERELMUTTER L, 1971, INT ARCH ALLER A IMM, V40, P481, DOI 10.1159/000230432; PERELMUTTER L, 1969, LANCET, V1, P1269; PERELMUTTER L, 1971, J ALLERGY, V47, P88; VIJAYANAGAR HM, 1972, J ALLERGY CLIN IMMUN, V49, P119	17	18	18	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	50	3					131	&		10.1016/0091-6749(72)90043-7	http://dx.doi.org/10.1016/0091-6749(72)90043-7			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N4708	4115105				2022-12-18	WOS:A1972N470800001
J	Silverberg, JI; De Bruin-Weller, M; Bieber, T; Soong, W; Kabashima, K; Costanzo, A; Rosmarin, D; Lynde, C; Liu, J; Gamelli, A; Zeng, JW; Ladizinski, B; Chu, AD; Reich, K				Silverberg, Jonathan, I; De Bruin-Weller, Marjolein; Bieber, Thomas; Soong, Weily; Kabashima, Kenji; Costanzo, Antonio; Rosmarin, David; Lynde, Charles; Liu, John; Gamelli, Amy; Zeng, Jiewei; Ladizinski, Barry; Chu, Alvina D.; Reich, Kristian			Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; randomized clinical trial; upadacitinib; topical corticosteroids; Janus kinase inhibitors	DAILY PRACTICE COHORT; ADULT PATIENTS; DRUG SURVIVAL; BURDEN; PLACEBO; PERSISTENCE; PREVALENCE; MANAGEMENT; DUPILUMAB; FEATURES	Background: Primary (week 16) results from the ongoing phase 3, double-blind AD Up study (NCT03568318) demonstrate a positive benefit-risk profile for upadacitinib + topical corticosteroid (TCS) in patients with moderate-to-severe atopic dermatitis. Objective: We evaluated the efficacy and safety of upadacitinib + TCS through 52 weeks. Methods: Patients aged 12 to 75 years with chronic moderate-to-severe atopic dermatitis >= 10% of body surface area affected, Eczema Area and Severity Index [EASI] >= 16, Validated Investigator's Global Assessment for atopic dermatitis [vIGA-AD] >= 3, and Worst Pruritus Numerical Rating Scale[WP-NRS] score >= 4) were randomized 1:1:1 to once-daily upadacitinib 15 mg + TCS, upadacitinib 30 mg+TCS, or placebo (PBO) + TCS(rerandomized at week 16 to upadacitinib 1 TCS). Safety and efficacy, including proportion of patients experiencing >= 75% improvement in EASI (EASI-75), vIGA-AD of clear/almost clear with improvement >= 2 grades (vIGA-AD 0/1), and WP-NRS improvement >= 4, were assessed through week 52. Missing data were primarily handled by nonresponse imputation incorporating multiple imputation for missing values due to coronavirus disease 2019 (COVID-19). Results: Of 901 patients, 300 were randomized to upadacitinib 15 mg + TCS, 297 to upadacitinib 30 mg + TCS, and 304 to PBO + TCS. For all end points, efficacy for upadacitinib 15 mg + TCS and upadacitinib 30 mg + TCS at week 16 was maintained through week 52. At week 52, the proportions of patients treated with upadacitinib 15 mg + TCS and upadacitinib 30 mg + TCS who experienced EASI-75 were 50.8% and 69.0%, respectively; 33.5% and 45.2%, respectively, experienced vIGA-AD 0/1; and 45.3% and 57.5%, respectively, experienced WP-NRS improvement >= 4. Upadacitinib + TCS was well tolerated through 52 weeks; no new important safety risks beyond the current label were observed. No deaths were reported; major adverse cardiovascular events and venous thromboembolic events were infrequent (<= 0.2/100 patient-years). Conclusions: Results through 52 weeks demonstrate long-term maintenance of efficacy and a favorable safety profile of upadacitinib + TCS in patients with moderate-to-severe AD.	[Silverberg, Jonathan, I] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, 2150 Penn Ave NW, Washington, DC 20037 USA; [De Bruin-Weller, Marjolein] Univ Med Ctr Utrecht, Natl Expertise Ctr Atop Dermatitis, Dept Dermatol & Allergol, Utrecht, Netherlands; [Bieber, Thomas] Univ Hosp Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Soong, Weily] Alabama Allergy & Asthma Ctr, Birmingham, AL USA; [Soong, Weily] Clin Res Ctr Alabama, Birmingham, AL USA; [Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Costanzo, Antonio] Humanitas Univ, Dept Biomed Sci, Dermatol Unit, Milan, Italy; [Rosmarin, David] Tufts Univ, Sch Med, Dept Dermatol, Boston, MA 02111 USA; [Lynde, Charles] Prob Med Res, Lynde Dermatol, Markham, ON, Canada; [Lynde, Charles] Univ Toronto, Dept Med, Toronto, ON, Canada; [Liu, John; Gamelli, Amy; Zeng, Jiewei; Ladizinski, Barry; Chu, Alvina D.] AbbVie Inc, N Chicago, IL USA; [Reich, Kristian] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, Hamburg, Germany	George Washington University; Utrecht University; Utrecht University Medical Center; University of Bonn; Kyoto University; Humanitas University; Tufts University; University of Toronto; AbbVie; University of Hamburg; University Medical Center Hamburg-Eppendorf	Silverberg, JI (corresponding author), George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, 2150 Penn Ave NW, Washington, DC 20037 USA.	jonathanisilverberg@gmail.com	Costanzo, Antonio/GZG-2433-2022; silverberg, jonathan/ABH-2765-2021	Costanzo, Antonio/0000-0001-9697-2557; silverberg, jonathan/0000-0003-3686-7805	AbbVie Inc.	AbbVie Inc.(AbbVie)	Supported by AbbVie Inc. The design, study conduct, analysis, and financial support for AD Up were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the manuscript. All authors had full access to all the data in the study and had final responsibility for the decision to submit the manuscript for publication.	[Anonymous], 2019, RINVOQ UPDACITINIB E; Blauvelt A, 2017, LANCET, V389, P2287, DOI 10.1016/S0140-6736(17)31191-1; Drucker AM, 2017, ALLERGY ASTHMA PROC, V38, P3, DOI 10.2500/aap.2017.38.4005; Drucker AM, 2017, J INVEST DERMATOL, V137, P26, DOI 10.1016/j.jid.2016.07.012; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Guttman-Yassky E, 2021, LANCET; Guttman-Yassky E, 2020, J ALLERGY CLIN IMMUN, V145, P877, DOI 10.1016/j.jaci.2019.11.025; Hanifin IM, 2007, DERMATITIS, V18, P82, DOI 10.2310/6620.2007.06034; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; He H, 2019, AM J CLIN DERMATOL, V20, P181, DOI 10.1007/s40257-018-0413-2; Kim JP, 2016, J AM ACAD DERMATOL, V75, P681, DOI 10.1016/j.jaad.2016.05.028; Langan SM, 2020, LANCET, V396, P345, DOI 10.1016/S0140-6736(20)31286-1; Lyons JJ, 2015, IMMUNOL ALLERGY CLIN, V35, P161, DOI 10.1016/j.iac.2014.09.008; Margolis JS, 2014, JAMA DERMATOL, V150, P593, DOI 10.1001/jamadermatol.2013.10271; Parmentier JM, 2018, BMC RHEUMATOL, V2, DOI 10.1186/s41927-018-0031-x; Reich K, 2021, LANCET, V397, P2169, DOI 10.1016/S0140-6736(21)00589-4; Reich K, 2020, JAMA DERMATOL, V156, P1333, DOI 10.1001/jamadermatol.2020.3260; Ronnstad ATM, 2018, J AM ACAD DERMATOL, V79, P448, DOI 10.1016/j.jaad.2018.03.017; Silverberg JI, 2021, BRIT J DERMATOL, V184, P450, DOI 10.1111/bjd.19573; Silverberg JI, 2017, DERMATOL CLIN, V35, P283, DOI 10.1016/j.det.2017.02.002; Simpson EL, 2020, BRIT J DERMATOL, V183, P242, DOI 10.1111/bjd.18898; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Simpson E, 2020, J AM ACAD DERMATOL, V83, P839, DOI 10.1016/j.jaad.2020.04.104; Simpson EL, 2021, J AM ACAD DERMATOL, V85, P62, DOI 10.1016/j.jaad.2021.02.028; van der Schaft J, 2016, BRIT J DERMATOL, V175, P199, DOI 10.1111/bjd.14398; van der Schaft J, 2015, BRIT J DERMATOL, V172, P1621, DOI 10.1111/bjd.13730; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wollenberg A, 2021, BRIT J DERMATOL, V184, P437, DOI 10.1111/bjd.19574	29	17	18	5	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					977	+		10.1016/j.jaci.2021.07.036	http://dx.doi.org/10.1016/j.jaci.2021.07.036			25	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34403658				2022-12-18	WOS:000765938100027
J	Winter, NA; Qin, L; Gibson, PG; McDonald, VM; Baines, KJ; Faulkner, J; Evans, TJ; Fricker, M				Winter, Natasha A.; Qin, Ling; Gibson, Peter G.; McDonald, Vanessa M.; Baines, Katherine J.; Faulkner, Jack; Evans, Tiffany-Jane; Fricker, Michael			Sputum mast cell/basophil gene expression relates to inflammatory and clinical features of severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mast cells; basophils; asthma; gene expression; inflammation	CELL DIFFERENTIATION; AIRWAY INFLAMMATION; ACTIVATION; BASOPHILS; SUBTYPES; T(H)2-HIGH; VALIDATION; PROMOTE; IL-13; KIT	Background: Mast cells (MCs) and basophils are important in asthma pathophysiology, however direct measurement is difficult, and clinical and inflammatory associations in severe asthma are poorly understood. Transcriptomic hallmarks of MCs/basophils may allow their measurement in sputum using gene expression. Objectives: This study sought to develop and validate a sputum MC/basophil gene signature and investigate its relationship to inflammatory and clinical characteristics of severe asthma. Methods: A total of 134 candidate MC/basophil genes (identified by the Immunological Genome Project Consortium) were screened in sputum microarray for differential expression among control subjects (n = 18), patients with eosinophilic (n = 29), and patients with noneosinophilic asthma (n = 30). Candidate genes were validated by confirming correlation of gene expression with flow cytometry-quantified sputum MCs and basophils in a separate asthma cohort (n = 20). The validated gene signature was measured in a severe asthma cohort (n = 81), and inflammatory and clinical associations were tested. Results: Through microarray screening and subsequent validation, we found quantitative PCR gene expression of 8 targets correlated with sputum MCs/basophils: TPSAB1/ TPSB2, CPA3, ENO2, GATA2, KIT, GPR56, HDC, SOCS2. In severe asthma, MC/basophil genes were associated with eosinophilic airway inflammation (GATA2, TPSB2, CPA3, GPR56, HDC, SOCS2), blood eosinophils (TPSB2, CPA3, GATA2, SOCS2, FCER1A, HDC), fractional exhaled NO (GATA2, SOCS2), decreased lung function (KIT, ENO2), and moderate exacerbation history (GATA2, SOCS2). Conclusions: Quantitative PCR-based measures reflect varying sputum MC/basophil abundance, demonstrating associations of MCs/basophils with eosinophilic inflammation, spirometry and exacerbation history in severe asthma.	[Winter, Natasha A.; Gibson, Peter G.; McDonald, Vanessa M.; Fricker, Michael] Univ Newcastle, Natl Hlth & Med Res Council, Ctr Res Excellence Severe Asthma, Newcastle, NSW, Australia; [Winter, Natasha A.; Gibson, Peter G.; McDonald, Vanessa M.; Baines, Katherine J.; Fricker, Michael] Univ Newcastle, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia; [Winter, Natasha A.; Gibson, Peter G.; Fricker, Michael] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [McDonald, Vanessa M.] Univ Newcastle, Sch Nursing & Midwifery, Newcastle, NSW, Australia; [Gibson, Peter G.] John Hunter Hosp, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Faulkner, Jack; Evans, Tiffany-Jane] Hunter Med Res Inst, Clin Res Design IT & Stat Support Unit, Newcastle, NSW, Australia; [Qin, Ling] Cent South Univ, Dept Resp Med, Dept Pulm & Crit Care Med, Changsha, Peoples R China	University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; Central South University	Fricker, M (corresponding author), Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Lot 1 Kookaburra Circuit, New Lambton Hts, NSW 2305, Australia.	Michael.Fricker@newcastle.edu.au	FRICKER, MICHAEL/ABE-2316-2021; MCDONALD, VANESSA/AAQ-1845-2020	MCDONALD, VANESSA/0000-0001-9890-3408; Fricker, Michael/0000-0002-8587-1774; Winter, Natasha/0000-0001-5797-0073	National Health and Medical Research Council [G1400017]; University of Newcastle [G1101050]; Hunter Medical Research Institute [G1101169]; John Hunter Hospital Charitable Trust [G1200211]; Thoracic Society of Australia; New Zealand/AstraZeneca Respiratory Research Fellowship; Lung Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital Charitable Trust; Thoracic Society of Australia; New Zealand/AstraZeneca Respiratory Research Fellowship; Lung Foundation	This work was supported by grants from the National Health and Medical Research Council (G1400017); University of Newcastle (G1101050); Hunter Medical Research Institute (G1101169); and John Hunter Hospital Charitable Trust (G1200211). M.F. received funding from a Thoracic Society of Australia and New Zealand/AstraZeneca Respiratory Research Fellowship. K.J.B. was supported by a Lung Foundation Australia chronic obstructive pulmonary disease research fellowship. Sponsors had no role in study design, analysis or interpretation of results, or preparation of manuscript.	Baines KJ, 2014, J ALLERGY CLIN IMMUN, V133, P997, DOI 10.1016/j.jaci.2013.12.1091; Baines KJ, 2011, J ALLERGY CLIN IMMUN, V127, P153, DOI 10.1016/j.jaci.2010.10.024; Berry MA, 2005, CLIN EXP ALLERGY, V35, P1175, DOI 10.1111/j.1365-2222.2005.02314.x; Berthon BS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00180-2017; Borriello F, 2015, EUR J IMMUNOL, V45, P2042, DOI 10.1002/eji.201445303; Boulet LP, 2003, RESP MED, V97, P739, DOI 10.1053/rmed.2003.1491; Bradding P, 2016, CLIN EXP ALLERGY, V46, P194, DOI 10.1111/cea.12675; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Brightling CE, 2020, ALLERGY, V75, P761, DOI 10.1111/all.14001; Brooks CR, 2017, ALLERGY, V72, P1583, DOI 10.1111/all.13185; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; Caughey GH, 2016, EUR J PHARMACOL, V778, P44, DOI 10.1016/j.ejphar.2015.04.045; Chachi L, 2018, CLIN EXP IMMUNOL, V194, P253, DOI 10.1111/cei.13191; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; D'silva L, 2007, CAN RESPIR J, V14, P281, DOI 10.1155/2007/190618; de Meer G, 2005, EUR RESPIR J, V25, P153, DOI 10.1183/09031936.04.00008004; Desai A, 2019, J ALLERGY CLIN IMMUN, V144, P613, DOI 10.1016/j.jaci.2019.05.007; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Dweik RA, 2010, AM J RESP CRIT CARE, V181, P1033, DOI 10.1164/rccm.200905-0695OC; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; Erjefalt JS, 2014, EUR RESPIR REV, V23, P299, DOI 10.1183/09059180.00005014; Fricker M, 2020, RESPIROLOGY, V25, P87, DOI 10.1111/cea.13609; Fricker M, 2019, J ALLERGY CLIN IMMUN, V144, P51, DOI 10.1016/j.jaci.2018.12.1020; Galli SJ, 2017, NEW ENGL J MED, V376, P1983, DOI 10.1056/NEJMe1702653; Gauthier M, 2015, AM J RESP CRIT CARE, V192, P660, DOI 10.1164/rccm.201504-0763PP; Hekking PP, 2018, J ALLERGY CLIN IMMUN, V141, P1280, DOI 10.1016/j.jaci.2017.06.037; Hekking PPW, 2015, J ALLERGY CLIN IMMUN, V135, P896, DOI 10.1016/j.jaci.2014.08.042; Huang H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01392; Jiang J, 2020, CLIN EXP ALLERGY, V50, P1428, DOI 10.1111/cea.13732; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Karasuyama H, 2018, J ALLERGY CLIN IMMUN, V142, P370, DOI 10.1016/j.jaci.2017.10.042; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Kuo CHS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02135-2016; Lewis RJ, 2016, J IMMUNOL, V196, P55, DOI 10.4049/jimmunol.1402232; Li YP, 2015, J IMMUNOL, V194, P4328, DOI 10.4049/jimmunol.1500018; Lommatzsch M, 2020, CLIN EXP ALLERGY, V50, P1267, DOI 10.1111/cea.13720; McDonald VM, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01509-2019; McLeod JJA, 2015, CYTOKINE, V75, P57, DOI 10.1016/j.cyto.2015.05.019; Modena BD, 2016, TRANSL RES, V174, P98, DOI 10.1016/j.trsl.2016.02.011; Nagarkar DR, 2015, J ALLERGY CLIN IMMUN, V136, P202, DOI 10.1016/j.jaci.2015.01.036; Naveed SUN, 2017, AM J RESP CRIT CARE, V195, P1000, DOI 10.1164/rccm.201604-0822OC; Peters MC, 2019, AM J RESP CRIT CARE, V199, P465, DOI 10.1164/rccm.201807-1291OC; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Price DB, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0282-7; Rao TN, 2015, STEM CELL RES, V14, P307, DOI 10.1016/j.scr.2015.02.001; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Roufosse F, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00049; Salter BM, 2015, J ALLERGY CLIN IMMUN, V136, P1636, DOI 10.1016/j.jaci.2015.03.039; Shaw DE, 2015, EUR RESPIR J, V46, P1308, DOI 10.1183/13993003.00779-2015; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Sridhar S, 2019, RESP RES, V20, DOI 10.1186/s12931-018-0968-8; Suzuki Y, 2016, J ALLERGY CLIN IMMUN, V72, P1532; Wagener AH, 2015, THORAX, V70, P115, DOI 10.1136/thoraxjnl-2014-205634; Wang G, 2016, EUR RESPIR J, V47, P1123, DOI 10.1183/13993003.01098-2015; Woodman L, 2008, J IMMUNOL, V181, P5001, DOI 10.4049/jimmunol.181.7.5001; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Xie GG, 2018, CELL PHYSIOL BIOCHEM, V46, P2401, DOI 10.1159/000489646; Xu CM, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20192732	60	17	17	3	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					428	438		10.1016/j.jaci.2021.01.033	http://dx.doi.org/10.1016/j.jaci.2021.01.033		AUG 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	33609626				2022-12-18	WOS:000684625700020
J	Marschall, P; Wei, RC; Segaud, J; Yao, WJ; Hener, P; German, BF; Meyer, P; Hugel, C; Da Silva, GA; Braun, R; Kaplan, DH; Li, M				Marschall, Pierre; Wei, Ruicheng; Segaud, Justine; Yao, Wenjin; Hener, Pierre; German, Beatriz Falcon; Meyer, Pierre; Hugel, Cecile; Da Silva, Grace Ada; Braun, Reinhard; Kaplan, Daniel H.; Li, Mei			Dual function of Langerhans cells in skin TSLP-promoted T-FH differentiation in mouse atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; TSLP; dendritic cells; Langerhans cells; T-FH; T(H)2; allergen sensitization; mouse	THYMIC STROMAL LYMPHOPOIETIN; FOLLICULAR HELPER-CELLS; DERMAL DENDRITIC CELLS; GERMINAL CENTER FORMATION; ANTIGEN-PRESENTING CELLS; MEDIATED-IMMUNITY; IN-VIVO; EXPRESSION; INDUCE; INFLAMMATION	Background: Atopic dermatitis (AD) is among the most common chronic inflammatory skin diseases, usually occurring early in life, and often preceding other atopic diseases such as asthma. T(H)2 has been believed to play a crucial role in cellular and humoral response in AD, but accumulating evidence has shown that follicular helper T cell (TFH), a critical player in humoral immunity, is associated with disease severity and plays an important role in AD pathogenesis. Objectives: This study aimed at investigating how TFHs are generated during the pathogenesis of AD, particularly what is the role of keratinocyte-derived cytokine TSLP and Langerhans cells (LCs). Methods: Two experimental AD mouse models were employed: (1) triggered by the overproduction of TSLP through topical application of MC903, and (2) induced by epicutaneous allergen ovalbumin (OVA) sensitization. Results: This study demonstrated that the development of TFHs and germinal center (GC) response were crucially dependent on TSLP in both the MC903 model and the OVA sensitization model. Moreover, we found that LCs promoted T-FH differentiation and GC response in the MC903 model, and the depletion of Langerin(+) dendritic cells (DCs) or selective depletion of LCs diminished the T-FH/GC response. By contrast, in the model with OVA sensitization, LCs inhibited T-FH/GC response and suppressed T(H)2 skin inflammation and the subsequent asthma. Transcriptomic analysis of Langerin(+) and Langerin(-) migratory DCs revealed that Langerin(+) DCs became activated in the MC903 model, whereas these cells remained inactivated in OVA sensitization model. Conclusions: Together, these studies revealed a dual functionality of LCs in TSLP-promoted TFH and T(H)2 differentiation in AD pathogenesis.	[Marschall, Pierre; Wei, Ruicheng; Segaud, Justine; Yao, Wenjin; Hener, Pierre; German, Beatriz Falcon; Meyer, Pierre; Hugel, Cecile; Da Silva, Grace Ada; Li, Mei] Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, INSERM,U1258,Unite Mixte Rech 7104, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France; [Braun, Reinhard] Pantec Biosolut AG, Ruggell, Liechtenstein; [Kaplan, Daniel H.] Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15260 USA; [Kaplan, Daniel H.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, M (corresponding author), Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, INSERM,U1258,Unite Mixte Rech 7104, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	mei@igbmc.fr		MEYER, Pierre/0000-0001-9547-7976; Li, Mei/0000-0003-4225-6699; Hugel, Cecile/0000-0002-5472-0906; Segaud, Justine/0000-0003-4687-7046; MARSCHALL, Pierre/0000-0001-6718-149X	l'Agence Nationale de la Recherche [ANR17CE140025, ANR19CE170017, ANR19CE170021]; Fondation Recherche Medicale; first joint programme of the Freiburg Institute for Advanced Studies; University of Strasbourg Institute for Advanced Study; Agence Nationale de la Recherche under the frame program Investissements d'Avenir [ANR10IDEX000202]; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite de Strasbourg; Region Alsace; Association pourla Recherche a` l'Institut de Genetique et de Biologie Moleculaire et Cellulaire; PhD fellowship from Equipes-FRM 2018;  [ANR10LABX0030INRT]	l'Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Recherche Medicale; first joint programme of the Freiburg Institute for Advanced Studies; University of Strasbourg Institute for Advanced Study; Agence Nationale de la Recherche under the frame program Investissements d'Avenir(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg; Region Alsace(Region Grand-Est); Association pourla Recherche a` l'Institut de Genetique et de Biologie Moleculaire et Cellulaire; PhD fellowship from Equipes-FRM 2018; 	M.L. received funding support from l'Agence Nationale de la Recherche (ANR17CE140025; ANR19CE170017; ANR19CE170021) , Fondation Recherche Medicale (EquipesFRM 2018) , and the first joint programme of the Association pourla Recherche a` l'Institut de Genetique et de Biologie Moleculaire et CellulaireFreiburg Institute for Advanced Studies and the University of Strasbourg Institute for Advanced Study. The study was also supported by the grant ANR10LABX0030INRT, a French State fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir ANR10IDEX000202; the Centre National de la Recherche Scientifique; the Institut National de la Sante et de la Recherche Medicale, and the Universite de Strasbourg. P.M. was supported by PhD fellowship from Region Alsace. R.W. and W.Y. were supported by PhD fellowships from the Association pourla Recherche a` l'Institut de Genetique et de Biologie Moleculaire et Cellulaire. J.S. was supported by a PhD fellowship from EquipesFRM 2018.	Altan-Bonnet G, 2019, NAT REV IMMUNOL, V19, P205, DOI 10.1038/s41577-019-0131-x; Angelova-Fischer I, 2010, J INVEST DERMATOL, V130, P2505, DOI 10.1038/jid.2010.143; Bagnall J, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaf3998; Ballesteros-Tato A, 2016, IMMUNITY, V44, P259, DOI 10.1016/j.immuni.2015.11.017; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Barington L, 2018, J LEUKOCYTE BIOL, V104, P313, DOI 10.1002/JLB.2VMR1217-510R; Bell BD, 2013, NAT IMMUNOL, V14, P364, DOI 10.1038/ni.2541; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Calabro S, 2016, J EXP MED, V213, P887, DOI 10.1084/jem.20151720; Chakarov S, 2014, EMBO MOL MED, V6, P590, DOI 10.1002/emmm.201403841; CHAPMAN MD, 1983, J ALLERGY CLIN IMMUN, V72, P27, DOI 10.1016/0091-6749(83)90048-9; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Deckers J, 2017, J ALLERGY CLIN IMMUN, V140, P1364, DOI 10.1016/j.jaci.2016.12.970; Dharmage SC, 2014, ALLERGY, V69, P17, DOI 10.1111/all.12268; Dolence JJ, 2018, J ALLERGY CLIN IMMUN, V142, P1144, DOI 10.1016/j.jaci.2017.11.020; Ebner S, 2007, J ALLERGY CLIN IMMUN, V119, P982, DOI 10.1016/j.jaci.2007.01.003; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fernandez MI, 2011, BLOOD, V118, P3862, DOI 10.1182/blood-2010-12-323089; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jiang WB, 2019, J IMMUNOL METHODS, V467, P48, DOI 10.1016/j.jim.2019.02.008; Karnekura R, 2015, CLIN IMMUNOL, V158, P204, DOI 10.1016/j.clim.2015.02.016; Kashem SW, 2017, ANNU REV IMMUNOL, V35, P469, DOI 10.1146/annurev-immunol-051116-052215; Kemeny DM, 2012, CELL MOL IMMUNOL, V9, P386, DOI 10.1038/cmi.2012.31; Kim TG, 2015, J ALLERGY CLIN IMMUN, V136, P713, DOI 10.1016/j.jaci.2015.03.033; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kitashima DY, 2018, EBIOMEDICINE, V27, P293, DOI 10.1016/j.ebiom.2017.12.022; Krishnaswamy JK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02169; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Levin C, 2017, J INVEST DERMATOL, V137, P1905, DOI 10.1016/j.jid.2017.04.016; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Leyva-Castillo JM, 2013, J INVEST DERMATOL, V133, P154, DOI 10.1038/jid.2012.239; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li M, 2009, J INVEST DERMATOL, V129, P498, DOI 10.1038/jid.2008.232; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lu E, 2019, IMMUNOL REV, V289, P158, DOI 10.1111/imr.12743; Luo Y, 2019, ALLERGY, V74, P1738, DOI 10.1111/all.13813; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Pattarini L, 2017, J EXP MED, V214, P1529, DOI 10.1084/jem.20150402; Polak ME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00651-5; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Qin L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01884; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Roy S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01228; Sahoo A, 2016, CYTOKINE GROWTH F R, V30, P29, DOI 10.1016/j.cytogfr.2016.03.011; Scheiblhofer S, 2013, EXPERT OPIN DRUG DEL, V10, P761, DOI 10.1517/17425247.2013.773970; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Shaker M, 2014, CURR OPIN PEDIATR, V26, P516, DOI 10.1097/MOP.0000000000000120; Simpson EL, 2019, J AM ACAD DERMATOL, V80, P1013, DOI 10.1016/j.jaad.2018.11.059; Simpson EL, 2017, NEW ENGL J MED, V376, P1090, DOI 10.1056/NEJMc1700366; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Szabo K, 2017, IMMUNOL LETT, V189, P101, DOI 10.1016/j.imlet.2017.04.010; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; van Rijn A, 2016, J IMMUNOL, V196, P459, DOI 10.4049/jimmunol.1403096; Varricchi G, 2016, ALLERGY, V71, P1086, DOI 10.1111/all.12878; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Watanabe M, 2017, J EXP MED, V214, P2795, DOI 10.1084/jem.20161955; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Weiss R, 2012, J CONTROL RELEASE, V162, P391, DOI 10.1016/j.jconrel.2012.06.031; Werfel T, 2016, J ALLERGY CLIN IMMUN, V138, P336, DOI 10.1016/j.jaci.2016.06.010; West HC, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01941; Yao C, 2018, J INVEST DERMATOL, V138, P1665, DOI 10.1016/j.jid.2018.02.005; Yao C, 2015, J ALLERGY CLIN IMMUN, V136, P1387, DOI 10.1016/j.jaci.2015.04.001; Yao WG, 2013, IMMUNITY, V38, P360, DOI 10.1016/j.immuni.2013.01.007; Yao Y, 2018, J ALLERGY CLIN IMMUN, V142, P321, DOI 10.1016/j.jaci.2018.03.008; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhong J, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau007; Zimara N, 2014, EUR J IMMUNOL, V44, P2955, DOI 10.1002/eji.201344263	81	17	17	3	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1778	1794		10.1016/j.jaci.2020.10.006	http://dx.doi.org/10.1016/j.jaci.2020.10.006		MAY 2021	17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33068561				2022-12-18	WOS:000647680800026
J	Dreskin, SC; Koppelman, SJ; Andorf, S; Nadeau, KC; Kalra, A; Braun, W; Negi, SS; Chen, XN; Schein, CH				Dreskin, Stephen C.; Koppelman, Stef J.; Andorf, Sandra; Nadeau, Kari C.; Kalra, Anjeli; Braun, Werner; Negi, Surendra S.; Chen, Xueni; Schein, Catherine H.			The importance of the 2S albumins for allergenicity and cross-reactivity of peanuts, tree nuts, and sesame seeds	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Peanuts; tree nuts; 2S albumins; food allergy; IgE		Allergies to peanuts, tree nuts, and sesame seeds are among the most important food-related causes of anaphylaxis. Important clinical questions include: Why is there a variable occurrence of coallergy among these foods and Is this immunologically mediated? The clinical and immunologic data summarized here suggest an immunologic basis for these coallergies that is based on similarities among the 2S albumins. Data from component resolved diagnostics have highlighted the relationship between IgE binding to these allergens and the presence of IgE-mediated food allergy. Furthermore, in vitro and in vivo experiments provide strong evidence that the 2S albumins are the most important allergens in peanuts for inducing an allergic effector response. Although the 2S albumins are diverse, they have a common disulfide-linked core with similar physicochemical properties that make them prime candidates to explain much of the observed coallergy among peanuts, tree nuts, and sesame seeds. The well-established frequency of cashew and pistachio nut coallergy (64%-100%) highlights how the structural similarities among their 2S albumins may account for observed clinical cross-reactivity. A complete understanding of the physicochemical properties of the 2S albumins in peanuts, tree nuts, and sesame seeds will enhance our ability to diagnose, treat, and ultimately prevent these allergies.	[Dreskin, Stephen C.; Kalra, Anjeli; Chen, Xueni] Univ Colorado Denver, Div Allergy & Clin Immunol, Dept Med, Aurora, CO USA; [Koppelman, Stef J.] Univ Nebraska, Dept Food Sci & Technol, Food Allergy Res & Resource Program, Lincoln, NE 68583 USA; [Andorf, Sandra] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Andorf, Sandra] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Andorf, Sandra] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Andorf, Sandra; Nadeau, Kari C.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Braun, Werner; Negi, Surendra S.] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Braun, Werner; Negi, Surendra S.; Schein, Catherine H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Schein, Catherine H.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Nebraska System; University of Nebraska Lincoln; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Stanford University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Schein, CH (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.; Dreskin, SC (corresponding author), Univ Colorado Denver, Div Allergy & Clin Immunol, Campus Box B164,12700 E 19th Ave,Room 10002, Aurora, CO 80045 USA.	stephen.dreskin@cuanschutz.edu; chschein@utmb.edu		Andorf, Sandra/0000-0002-3093-2568	National Institutes of Health [R01AI099029, R21AI135397, R21AI137881, R21 AI109090, R01 AI 137332]; EPA Star [RE-83406601]; National Institute of Allergy and Infectious Diseases [5R01 AI140134]; Myra Reinhard Family Foundation; US Department of Agriculture [ARS 58-6435-6-40]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA Star(United States Environmental Protection Agency); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Myra Reinhard Family Foundation; US Department of Agriculture(United States Department of Agriculture (USDA))	Supported by National Institutes of Health grants R01AI099029 (to S.C.D.), R21AI135397 (to S.C.D.), R21AI137881 (to X.C.), R21 AI109090 and R01 AI 137332 (to W.B.),EPA Star RE-83406601 and US Department of Agriculture -ARS 58-6435-6-40 (to C.H.S.) and a National Institute of Allergy and Infectious Diseases R01 grant (5R01 AI140134 [to K.N.]), as well as a grant from the Myra Reinhard Family Foundation (to K.N.). The contents are the sole responsibility of the authors and do not necessarily represent official National Institutes of Health views.	Albrecht M, 2009, J ALLERGY CLIN IMMUN, V124, P328, DOI 10.1016/j.jaci.2009.05.031; ALTENBACH SB, 1992, PLANT MOL BIOL, V18, P235, DOI 10.1007/BF00034952; Andorf S, 2019, ECLINICALMEDICINE, V7, P27, DOI 10.1016/j.eclinm.2018.12.006; Andorf S, 2018, LANCET GASTROENTEROL, V3, P85, DOI 10.1016/S2468-1253(17)30392-8; Andorf S, 2017, J ALLER CL IMM-PRACT, V5, P1325, DOI 10.1016/j.jaip.2017.01.016; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; [Anonymous], 2020, PD SCORES; Apostolovic D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29249; Apostolovic D, 2013, BBA-PROTEINS PROTEOM, V1834, P2832, DOI 10.1016/j.bbapap.2013.10.004; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; Baroux C, 2019, CURR TOP DEV BIOL, V131, P605, DOI 10.1016/bs.ctdb.2018.11.017; Baumert JL, 2018, J ALLER CL IMM-PRACT, V6, P457, DOI 10.1016/j.jaip.2017.05.006; Bencharitiwong R, 2015, ALLERGY ASTHMA PROC, V36, P185, DOI 10.2500/aap.2015.36.3840; Bernard H, 2015, J ALLERGY CLIN IMMUN, V135, P1267, DOI 10.1016/j.jaci.2014.10.025; Beyer K, 2015, ALLERGY, V70, P90, DOI 10.1111/all.12530; Braun BA, 2021, BIOINFORM BIOL INSIG, V15, DOI [10.1177/11779322211020316, 10.1101/2020.08.13.249649]; Breiteneder H, 2005, J ALLERGY CLIN IMMUN, V115, P14, DOI 10.1016/j.jaci.2004.10.022; Cabanillas B, 2015, J INVEST ALLERG CLIN, V25, P329; Cabanillas B, 2016, FOOD CHEM, V210, P70, DOI 10.1016/j.foodchem.2016.04.068; Chen X, 2016, CLIN EXP ALLERGY, V46, P1120, DOI 10.1111/cea.12764; Chen XN, 2011, J IMMUNOL METHODS, V372, P65, DOI 10.1016/j.jim.2011.06.031; de Jong GAH, 2018, J AGR FOOD CHEM, V66, P10855, DOI 10.1021/acs.jafc.8b03140; de Leon MP, 2007, MOL IMMUNOL, V44, P463, DOI 10.1016/j.molimm.2006.02.016; de Leon MP, 2003, CLIN EXP ALLERGY, V33, P1273, DOI 10.1046/j.1365-2222.2003.01761.x; Deak PE, 2019, P NATL ACAD SCI USA, V116, P8966, DOI 10.1073/pnas.1820417116; Downs ML, 2014, J AGR FOOD CHEM, V62, P11767, DOI 10.1021/jf504672m; Dreskin SC, 2019, PEDIAT ALLERG IMM-UK, DOI 10.1111/pai.13117; Du XY, 2016, GENE, V591, P27, DOI 10.1016/j.gene.2016.06.040; Dunlop JH, 2018, IMMUNOL ALLERGY CLIN, V38, P13, DOI 10.1016/j.iac.2017.09.002; Elizur A, 2018, ALLERGY, V73, P593, DOI 10.1111/all.13353; Elizur A, 2020, J ALLER CL IMM-PRACT, V8, P157, DOI 10.1016/j.jaip.2019.08.038; Elizur A, 2019, LANCET CHILD ADOLESC, V3, P312, DOI 10.1016/S2352-4642(19)30029-X; Fisher Amanda, 2015, Aliso, V33, P91, DOI 10.5642/aliso.20153302.03; Geiselhart S, 2018, MOL IMMUNOL, V100, P71, DOI 10.1016/j.molimm.2018.03.011; Grabenhenrich L, 2020, ALLERGY, V75, P2294, DOI 10.1111/all.14290; Han YS, 2016, MOLECULES, V21, DOI 10.3390/molecules21050622; Hazebrouck S, 2019, CLIN EXP ALLERGY, V49, P1107, DOI 10.1111/cea.13432; Ivanciuc O, 2003, J AGR FOOD CHEM, V51, P4830, DOI 10.1021/jf034218r; Ivanciuc O, 2009, MOL IMMUNOL, V46, P873, DOI 10.1016/j.molimm.2008.09.004; Ivanciuc O, 2009, MOL IMMUNOL, V46, P559, DOI 10.1016/j.molimm.2008.07.034; Ivanciuc O, 2009, REGUL TOXICOL PHARM, V54, pS11, DOI 10.1016/j.yrtph.2008.11.007; JanssenDuijghuijsen LM, 2017, J IMMUNOL METHODS, V440, P52, DOI 10.1016/j.jim.2016.11.002; Kim JF, 2018, ALLERGY, V73, P1609, DOI 10.1111/all.13399; Klemans RJB, 2014, ALLERGY, V69, P1112, DOI 10.1111/all.12424; Koid AE, 2014, J AGR FOOD CHEM, V62, P206, DOI 10.1021/jf4022509; Koplin JJ, 2015, CURR OPIN ALLERGY CL, V15, P409, DOI 10.1097/ACI.0000000000000196; Koppelman SJ, 2004, CLIN EXP ALLERGY, V34, P583, DOI 10.1111/j.1365-2222.2004.1923.x; Koppelman SJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091281; Koppelman SJ, 2010, MOL NUTR FOOD RES, V54, P1711, DOI 10.1002/mnfr.201000011; Korte R, 2017, J PROTEOME RES, V16, P988, DOI 10.1021/acs.jproteome.6b00924; Kukkonen AK, 2015, ALLERGY, V70, P1239, DOI 10.1111/all.12671; Kulis M, 2012, CLIN EXP ALLERGY, V42, P326, DOI 10.1111/j.1365-2222.2011.03934.x; Lange L, 2017, ALLERGY, V72, P598, DOI 10.1111/all.13050; Lehmann K, 2006, BIOCHEM J, V395, P463, DOI 10.1042/BJ20051728; Li J, 2020, J ALLER CL IMM-PRACT, V8, P1349, DOI 10.1016/j.jaip.2019.11.042; Liao SM, 2019, CLIN EXP ALLERGY, V49, P1154, DOI 10.1111/cea.13442; Lu WZ, 2018, MOL IMMUNOL, V99, P1, DOI 10.1016/j.molimm.2018.03.022; Lyons SA, 2020, J ALLERGY, V8, P2726; Lyons SA, 2019, J ALLER CL IMM-PRACT, V7, P1920, DOI 10.1016/j.jaip.2019.02.044; Maleki SJ, 2011, ALLERGY, V66, P1522, DOI 10.1111/j.1398-9995.2011.02692.x; Maloney JM, 2008, J ALLERGY CLIN IMMUN, V122, P145, DOI 10.1016/j.jaci.2008.04.014; Maruyama N, 2016, CLIN EXP ALLERGY, V46, P163, DOI 10.1111/cea.12626; Masthoff LJ, 2015, ALLERGY, V70, P265, DOI 10.1111/all.12554; Masthoff LJN, 2013, J ALLERGY CLIN IMMUN, V132, P393, DOI 10.1016/j.jaci.2013.02.024; McWilliam V, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0555-8; Midoro-Horiuti T, 2006, MOL IMMUNOL, V43, P509, DOI 10.1016/j.molimm.2005.05.006; Moreno F Javier, 2008, Open Biochem J, V2, P16, DOI 10.2174/1874091X00802010016; Mueller GA, 2011, ALLERGY, V66, P878, DOI 10.1111/j.1398-9995.2010.02532.x; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Muraro A, 2019, ANN ALLERG ASTHMA IM, V122, P586, DOI 10.1016/j.anai.2019.03.026; Murtagh GJ, 2002, BIOCHEM SOC T, V30, P913, DOI 10.1042/BST0300913; Negi SS, 2017, BIOINFORMATICS, V33, P1014, DOI 10.1093/bioinformatics/btw767; Nesbit JB, 2020, MOL IMMUNOL, V122, P223, DOI 10.1016/j.molimm.2020.03.017; Noorbakhsh Reihaneh, 2011, Allergology International, V60, P425, DOI 10.2332/allergolint.10-OA-0222; Otsu K, 2015, CLIN EXP ALLERGY, V45, P471, DOI 10.1111/cea.12407; Pajno GB, 2018, ALLERGY, V73, P799, DOI 10.1111/all.13319; Palladino C, 2018, MOL IMMUNOL, V100, P58, DOI 10.1016/j.molimm.2018.04.005; Palmer GW, 2005, CLIN IMMUNOL, V115, P302, DOI 10.1016/j.clim.2005.02.011; Pantoja-Uceda D, 2003, BIOCHEMISTRY-US, V42, P13839, DOI 10.1021/bi0352217; Patel A, 2016, ALLERGY, V71, P1405, DOI 10.1111/all.12962; Pedrosa M, 2015, ANN ALLERG ASTHMA IM, V115, P108, DOI 10.1016/j.anai.2015.05.015; Peeters KABM, 2007, CLIN EXP ALLERGY, V37, P108, DOI 10.1111/j.1365-2222.2006.02628.x; Pitt TJ, 2018, J ALLERGY CLIN IMMUN, V141, P620, DOI 10.1016/j.jaci.2017.06.024; Polk BI, 2016, ANN ALLERG ASTHMA IM, V117, P412, DOI 10.1016/j.anai.2016.07.023; Pouessel G, 2018, CLIN EXP ALLERGY, V48, P1584, DOI 10.1111/cea.13287; Prodic I, 2018, CLIN EXP ALLERGY, V48, P731, DOI 10.1111/cea.13113; Reitsma M, 2016, J AGR FOOD CHEM, V64, P1191, DOI 10.1021/acs.jafc.5b04401; Robotham JM, 2005, J ALLERGY CLIN IMMUN, V115, P1284, DOI 10.1016/j.jaci.2005.02.028; Rundqvist L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046435; Santos AF, 2020, ALLERGY, V75, P2309, DOI 10.1111/all.14301; Sato S, 2018, CURR OPIN ALLERGY CL, V18, P214, DOI 10.1097/ACI.0000000000000441; Sato S, 2017, J ALLER CL IMM-PRACT, V5, P1784, DOI 10.1016/j.jaip.2017.04.025; Savage J, 2016, J ALLER CL IMM-PRACT, V4, P196, DOI 10.1016/j.jaip.2015.11.024; Savvatianos S, 2015, J ALLERGY CLIN IMMUN, V136, P192, DOI 10.1016/j.jaci.2015.03.037; Scala E, 2018, EUR ANN ALLERGY CLIN, V50, P148, DOI 10.23822/EurAnnACI.1764-1489.54; Schein CH, 2007, IMMUNOL ALLERGY CLIN, V27, P1, DOI 10.1016/j.iac.2006.11.005; Schein CH, 2019, MOL NEUROBIOL, V56, P3664, DOI 10.1007/s12035-018-1269-4; Schein CH, 2005, J AGR FOOD CHEM, V53, P8752, DOI 10.1021/jf051148a; Schein CH, 2005, PROTEINS, V58, P200, DOI 10.1002/prot.20253; Schocker F, 2017, INT ARCH ALLERGY IMM, V174, P17, DOI 10.1159/000479388; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Sicherer SH, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0194; Smeekens JM, 2018, CLIN EXP ALLERGY, V48, P762, DOI 10.1111/cea.13163; Stanley JS, 1997, ARCH BIOCHEM BIOPHYS, V342, P244, DOI 10.1006/abbi.1997.9998; Stiefel G, 2017, CLIN EXP ALLERGY, V47, P719, DOI 10.1111/cea.12957; Tscheppe A, 2020, J ALLERGY CLIN IMMUN, V145, P229, DOI 10.1016/j.jaci.2019.08.036; Turner PJ, 2015, J ALLERGY CLIN IMMUN, V135, P956, DOI 10.1016/j.jaci.2014.10.021; Valcour A, 2019, ANN ALLERG ASTHMA IM, V122, P111, DOI 10.1016/j.anai.2018.09.466; Villalta D, 2019, INT ARCH ALLERGY IMM, V178, P89, DOI 10.1159/000492399	110	17	17	4	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1154	1163		10.1016/j.jaci.2020.11.004	http://dx.doi.org/10.1016/j.jaci.2020.11.004		APR 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	33217410	Green Accepted			2022-12-18	WOS:000637368900004
J	Scott, WC; Cahill, KN; Milne, GL; Li, P; Sheng, QH; Huang, LC; Dennis, S; Snyder, J; Bauer, AM; Chandra, RK; Chowdhury, NI; Turner, JH				Scott, William C.; Cahill, Katherine N.; Milne, Ginger L.; Li, Ping; Sheng, Quanhu; Huang, Li Ching; Dennis, Spencer; Snyder, Jacob; Bauer, Ashley M.; Chandra, Rakesh K.; Chowdhury, Naweed I.; Turner, Justin H.			Inflammatory heterogeneity in aspirin-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cytokine; endotype; leukotriene; prostaglandin; aspirin; nonsteroidal anti-inflammatory drug; rhinosinusitis; eicosanoid; asthma	CHRONIC RHINOSINUSITIS; AIRWAY INFLAMMATION; LUNG LAVAGES; LEUKOTOXIN; RECEPTOR; ASTHMA; METABOLITES; INHIBITION; CONVERSION; PLATELETS	Background: Aspirin-exacerbated respiratory disease (AERD) is a mechanistically distinct subtype of chronic rhinosinusitis with nasal polyps (CRSwNP). Although frequently associated with type 2 inflammation, literature characterizing the milieu of inflammatory cytokines and lipid mediators in AERD has been conflicting. Objective: We sought to identify differences in the upper airway inflammatory signature between CRSwNP and AERD and determine whether endotypic subtypes of AERD may exist. Methods: Levels of 7 cytokines representative of type 1, type 2, and type 3 inflammation, and 21 lipid mediators were measured in nasal mucus from 109 patients with CRSwNP, 30 patients with AERD, and 64 non-CRS controls. Differences in inflammatory mediators were identified between groups, and patterns of inflammation among patients with AERD were determined by hierarchical cluster analysis. Results: AERD could be distinguished from CRSwNP by profound elevations in IL-5, IL-6, IL-13, and IFN-gamma; however, significant heterogeneity existed between patients. Hierarchical cluster analysis identified 3 inflammatory subendotypes of AERD characterized by (1) low inflammatory burden, (2) high type 2 cytokines, and (3) comparatively low type 2 cytokines and high levels of type 1 and type 3 cytokines. Several lipid mediators were associated with asthma and sinonasal disease severity; however, lipid mediators showed less variability than cytokines. Conclusions: AERD is associated with elevations in type 2 cytokines (IL-5 and IL-13) and the type 1 cytokine, IFN-gamma. Among patients with AERD, the inflammatory signature is heterogeneous, supporting subendotypes of the disease. Variability in AERD immune signatures should be further clarified because this may predict clinical response to biologic medications that target type 2 inflammation.	[Scott, William C.; Li, Ping; Dennis, Spencer; Snyder, Jacob; Bauer, Ashley M.; Chandra, Rakesh K.; Chowdhury, Naweed I.; Turner, Justin H.] Vanderbilt Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 1215 21st Ave South,Ste 7209, Nashville, TN 37232 USA; [Cahill, Katherine N.; Milne, Ginger L.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Sheng, Quanhu; Huang, Li Ching] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Turner, JH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 1215 21st Ave South,Ste 7209, Nashville, TN 37232 USA.	justin.h.turner@vumc.org		Cahill, Katherine/0000-0002-8549-1835	National Institutes of Health [R21 AI142321, R01 AG065550, K23 AI118804]; Clinical Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences [UL1TR000445]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences	This project was supported by the National Institutes of Health (grant nos. R21 AI142321 and R01 AG065550 to J.H.T. and grant no. K23 AI118804 to K.N.C.) and Clinical Translational Science Award (CTSA) award UL1TR000445 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	Archambault AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202424; Askari AA, 2014, BIOCHEM BIOPH RES CO, V446, P633, DOI 10.1016/j.bbrc.2014.03.020; Bankova LG, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9453; Bankova LG, 2016, P NATL ACAD SCI USA, V113, P6242, DOI 10.1073/pnas.1605957113; Bochenek G, 2014, J ALLERGY CLIN IMMUN, V133, P98, DOI 10.1016/j.jaci.2013.07.004; Carter BZ, 1997, J BIOL CHEM, V272, P12305, DOI 10.1074/jbc.272.19.12305; Celejewska-Wojcik N, 2020, ALLERGY, V75, P831, DOI 10.1111/all.14141; Chang JE, 2012, ALLERGY ASTHMA PROC, V33, P117, DOI 10.2500/aap.2012.33.3541; CROSET M, 1983, BIOCHEM BIOPH RES CO, V112, P878, DOI 10.1016/0006-291X(83)91699-6; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; FONLUPT P, 1991, THROMB RES, V63, P239, DOI 10.1016/0049-3848(91)90287-7; Gorsuch RL, 1997, J PERS ASSESS, V68, P532, DOI 10.1207/s15327752jpa6803_5; HAYAKAWA M, 1986, BIOCHEM BIOPH RES CO, V137, P424, DOI 10.1016/0006-291X(86)91227-1; Kato A, 2015, ALLERGOL INT, V64, P121, DOI 10.1016/j.alit.2014.12.006; Kennedy JL, 2013, ANN ALLERG ASTHMA IM, V111, P246, DOI 10.1016/j.anai.2013.06.033; KEPPLER D, 1989, ADV ENZYME REGUL, V28, P307, DOI 10.1016/0065-2571(89)90078-2; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; Lazarinis N, 2018, J ALLERGY CLIN IMMUN, V142, P1080, DOI 10.1016/j.jaci.2018.02.024; LEE CW, 1983, IMMUNOLOGY, V48, P27; Liu T, 2015, J IMMUNOL, V194, P5061, DOI 10.4049/jimmunol.1402959; Liu T, 2013, P NATL ACAD SCI USA, V110, P16987, DOI 10.1073/pnas.1313185110; Massoud AH, 2016, NAT MED, V22, P1013, DOI 10.1038/nm.4147; Meltzer EO, 2011, MAYO CLIN PROC, V86, P427, DOI 10.4065/mcp.2010.0392; Mitsui C, 2016, J ALLERGY CLIN IMMUN, V137, P400, DOI 10.1016/j.jaci.2015.05.041; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Morse JC, 2019, INT FORUM ALLERGY RH, V9, P255, DOI 10.1002/alr.22249; Morse JC, 2019, J ALLERGY CLIN IMMUN, V143, P990, DOI 10.1016/j.jaci.2018.10.056; O'Rourke N, 2013, STEP BY STEP APPROAC; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS3, DOI 10.1002/alr.21694; ORNING L, 1980, J BIOL CHEM, V255, P8023; OZAWA T, 1986, BIOCHEM BIOPH RES CO, V134, P1071, DOI 10.1016/0006-291X(86)90360-8; OZAWA T, 1988, AM REV RESPIR DIS, V137, P535, DOI 10.1164/ajrccm/137.3.535; Perez-Novo CA, 2005, J ALLERGY CLIN IMMUN, V115, P1189, DOI 10.1016/j.jaci.2005.02.029; Peters AT, 2010, J ALLERGY CLIN IMMUN, V125, P397, DOI 10.1016/j.jaci.2009.10.072; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; PLAZA V, 1995, THORAX, V50, P490, DOI 10.1136/thx.50.5.490; Poposki JA, 2017, IMMUN INFLAMM DIS, V5, P233, DOI 10.1002/iid3.161; Porro B, 2014, J CHROMATOGR B, V964, P26, DOI 10.1016/j.jchromb.2014.03.015; Sandig H, 2006, FEBS LETT, V580, P373, DOI 10.1016/j.febslet.2005.11.052; Sandig H, 2007, J LEUKOCYTE BIOL, V81, P372, DOI 10.1189/jlb.0706424; Steinke JW, 2013, J ALLERGY CLIN IMMUN, V132, P856, DOI 10.1016/j.jaci.2013.05.008; Stevens WW, 2017, J ALLER CL IMM-PRACT, V5, P1061, DOI 10.1016/j.jaip.2016.12.027; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Stevens WW, 2014, J ALLERGY CLIN IMMUN, V133, P1503, DOI 10.1016/j.jaci.2014.03.022; Succar EF, 2020, ALLERGY, V75, P713, DOI 10.1111/all.14071; Takeda T, 2016, J ALLERGY CLIN IMMUN, V138, P1395, DOI 10.1016/j.jaci.2016.01.032; Tan BK, 2013, J ALLERGY CLIN IMMUN, V131, P1350, DOI 10.1016/j.jaci.2013.02.002; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Toth E, 2018, RHINOLOGY, V56, P245, DOI 10.4193/Rhin17.108; Turner JH, 2018, INT FORUM ALLERGY RH, V8, P1175, DOI 10.1002/alr.22160; Turner JH, 2018, J ALLERGY CLIN IMMUN, V141, P1895, DOI 10.1016/j.jaci.2018.02.002; TURNER SR, 1975, NATURE, V257, P680, DOI 10.1038/257680a0; Ullah MA, 2015, J ALLERGY CLIN IMMUN, V136, P1065, DOI 10.1016/j.jaci.2015.02.032; Wu J, 2018, LARYNGOSCOPE, V128, pE304, DOI 10.1002/lary.27112; Zhao JM, 2017, AM J RESP CELL MOL, V57, P692, DOI 10.1165/rcmb.2017-0031OC	55	17	17	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1318	+		10.1016/j.jaci.2020.11.001	http://dx.doi.org/10.1016/j.jaci.2020.11.001		APR 2021	16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	33189729	Green Accepted			2022-12-18	WOS:000637368900021
J	Zhang, Y; Do, DC; Hu, XY; Wang, J; Zhao, YL; Mishra, S; Zhang, X; Wan, M; Gao, PS				Zhang, Yan; Do, Danh C.; Hu, Xinyue; Wang, Ji; Zhao, Yilin; Mishra, Sumita; Zhang, Xin; Wan, Mei; Gao, Peisong			CaMKII oxidation regulates cockroach allergen-induced mitophagy in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; cockroach allergen; ROS; CaMKII; autophagy; mitophagy; mitochandira	AUTOPHAGY; AIRWAY; PINK1; LUNG; INFLAMMATION; ACTIVATION; STRESS; CELLS; PHOSPHORYLATION; DEGRADATION	Background: Autophagy plays an important role in causing inflammatory responses initiated by environmental pollutants and respiratory tract infection. Objective: We sought to investigate the role of cockroach allergen-induced excessive activation of autophagy in allergic airway inflammation and its underlying molecular mechanisms. Methods: Environmental allergen-induced autophagy was investigated in the primary human bronchial epithelial cells (HBECs) and lung tissues of asthmatic mouse model and patients. The role of autophagy in asthma development was examined by using autophagy inhibitor 3-methyladenine in an asthma mouse model. Furthermore, the involvements of reactive oxygen species (ROS) and oxidized Ca2+ /calmodulin-dependent protein kinase II (ox-CaMKII) signaling in regulating autophagy during asthma were examined in allergen-treated HBECs and mouse model. Results: Cockroach allergen activated autophagy in HBECs and in the lung tissues from asthmatic patients and mice. Autophagy inhibitor 3-methyladenine significantly attenuated airway hyperresponsiveness, T(H)2-associated lung inflammation, and ROS generation. Mechanistically, we demonstrated a pathological feedforward circuit between cockroach allergen-induced ROS and autophagy that is mediated through CaMKII oxidation. Furthermore, transgenic mice with ROS-resistant CaMKII MM-VVd showed attenuation of T(H)2-associated lung inflammation and autophagy. Mitochondrial ox-CaMKII inhibition induced by adenovirus carrying mitochondrial-targeted inhibitor peptide CaMKIIN suppresses cockroach allergen-induced autophagy, mitochondrial dysfunction, mitophagy, and cytokine production in HBECs. Finally, mitochondrial CaMKII inhibition suppressed the expression of one of the key ubiquitin-binding autophagy receptors, optineurin, and its recruitment to fragmented mitochondria. Optineurin knockdown inhibited cockroach allergy-induced mitophagy. Conclusions: Our data suggest a previously uncovered axis of allergen-ROS-ox-CaMKII-mitophagy in the development of allergic airway inflammation and asthma.	[Zhang, Yan; Do, Danh C.; Hu, Xinyue; Gao, Peisong] Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Zhang, Yan; Hu, Xinyue] Cent South Univ, Xiangya Hosp, Dept Resp Med, Changsha, Peoples R China; [Wang, Ji; Zhang, Xin] Sichuan Univ, West China Sch Med, Dept Integrated Tradit Chinese & Western Med, Chengdu, Peoples R China; [Zhao, Yilin] Fourth Mil Med Univ, Dept Resp Med, Xian, Peoples R China; [Mishra, Sumita] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Wan, Mei] Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Central South University; Sichuan University; Air Force Military Medical University; Johns Hopkins University; Johns Hopkins University	Gao, PS (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle,Rm 3B-71, Baltimore, MD 21224 USA.	pgao1@jhmi.edu		Mishra, Sumita/0000-0002-6455-4075	US National Institutes of Health [R56 AI143668, 2R56ES021739, R21 AI137547, R01AI141642]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported by grants from the US National Institutes of Health (grant nos. R56 AI143668, 2R56ES021739, R21 AI137547, and R01AI141642 to P.G.) .	Baek SH, 2017, MOL CELL, V65, P781, DOI 10.1016/j.molcel.2016.12.027; Ban GY, 2016, CLIN EXP ALLERGY, V46, P48, DOI 10.1111/cea.12585; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Cho IH, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0211-9; Choubey V, 2014, AUTOPHAGY, V10, P1105, DOI 10.4161/auto.28615; Dickinson JD, 2018, REDOX BIOL, V14, P272, DOI 10.1016/j.redox.2017.09.013; Do DC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126832; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fattah EA, 2015, J IMMUNOL, V194, P5407, DOI 10.4049/jimmunol.1402277; Ghosh R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8602041; Gkikas I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01283; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Inoue D, 2011, BIOCHEM BIOPH RES CO, V405, P13, DOI 10.1016/j.bbrc.2010.12.092; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jang JE, 2017, CLIN CANCER RES, V23, P2781, DOI 10.1158/1078-0432.CCR-16-1903; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaushal GP, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153791; Ke X, 2019, J ALLERGY CLIN IMMUN, V143, P1560, DOI 10.1016/j.jaci.2018.08.023; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Lee J, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e5; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01272-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luczak ED, 2014, J MOL CELL CARDIOL, V73, P112, DOI 10.1016/j.yjmcc.2014.02.004; Matsuda N, 2010, AUTOPHAGY, V6, P952, DOI 10.4161/auto.6.7.13039; McAlinden KD, 2019, AM J RESP CELL MOL, V60, P541, DOI 10.1165/rcmb.2018-0169OC; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Poon A, 2012, AUTOPHAGY, V8, P694, DOI 10.4161/auto.19315; Pu QQ, 2017, J IMMUNOL, V198, P3205, DOI 10.4049/jimmunol.1601196; Qiu LP, 2018, J IMMUNOL, V201, P916, DOI 10.4049/jimmunol.1701167; Qu JJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90139; Racanelli AC, 2018, AUTOPHAGY, V14, P221, DOI 10.1080/15548627.2017.1389823; Rogers Lynette K., 2018, Current Opinion in Toxicology, V7, P37, DOI 10.1016/j.cotox.2017.09.001; Roy SJ, 2020, FREE RADICAL BIO MED, V146, P287, DOI 10.1016/j.freeradbiomed.2019.11.012; Sachdeva K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02787; Saito T, 2015, CIRC RES, V116, P1477, DOI 10.1161/CIRCRESAHA.116.303790; Sanders PN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006135; Sebag SC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88297; Silveira JS, 2020, J CELL PHYSIOL, V235, P267, DOI 10.1002/jcp.28966; Suzuki Y, 2016, J ALLERGY CLIN IMMUN, V137, P1382, DOI 10.1016/j.jaci.2015.09.033; Tsubouchi K, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0077-6; Uchida M, 2017, ALLERGY, V72, P1521, DOI 10.1111/all.13158; Vargas JNS, 2019, MOL CELL, V74, P347, DOI 10.1016/j.molcel.2019.02.010; Wang EY, 2019, ALLERGY, V74, P1675, DOI 10.1111/all.13784; Wible Daric J., 2018, Current Opinion in Toxicology, V7, P28, DOI 10.1016/j.cotox.2017.10.006; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xia FC, 2018, AUTOPHAGY, V14, P450, DOI 10.1080/15548627.2017.1421884; Xu T, 2015, J IMMUNOL, V195, P5539, DOI 10.4049/jimmunol.1501198; Zeki AA, 2016, ALLERGY, V71, P5, DOI 10.1111/all.12761; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	55	17	18	6	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1464	+		10.1016/j.jaci.2020.08.033	http://dx.doi.org/10.1016/j.jaci.2020.08.033		APR 2021	25	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RX3VK	32920093	Green Accepted			2022-12-18	WOS:000647154500011
J	Currier, R; Puck, JM				Currier, Robert; Puck, Jennifer M.			SCID newborn screening: What we've learned	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Primary immunodeficiency; T-cell receptor excision circle (TREC); severe combined immunodeficiency (SCID); lymphopenia; dried blood spot; newborn screening		Newborn screening for severe combined immunodeficiency, the most profound form of primary immune system defects, has long been recognized as a measure that would decrease morbidity and improve outcomes by helping patients avoid devastating infections and receive prompt immune-restoring therapy. The T-cell receptor excision circle test, developed in 2005, proved to be successful in pilot studies starting in the period 2008 to 2010, and by 2019 all states in the United States had adopted versions of it in their public health programs. Introduction of newborn screening for severe combined immunodeficiency, the first immune disorder accepted for population-based screening, has drastically changed the presentation of this disorder while providing important lessons for public health programs, immunologists, and transplanters.	Univ Calif San Francisco, Dept Pediat, Sch Med, Div Allergy Immunol & Blood & Marrow Transplantat, San Francisco, CA 94143 USA; UCSF Benioff Childrens Hosp San Francisco, San Francisco, CA USA	University of California System; University of California San Francisco	Puck, JM (corresponding author), Univ Calif San Francisco, Smith Cardiovasc Res Inst, Div Allergy Immunol & Blood & Marrow Transplantat, Dept Pediat,Sch Med, Box 3118,555 Mission Bay Blvd South,Rm SC-252K, San Francisco, CA 94143 USA.	Jennifer.Puck@ucsf.edu			Primary Immune Deficiency Treatment Consortium [U54-AI082973]; National Institute of Allergy and Infectious Diseases [U54-AI082973]; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland [U54-AI082973]; Jeffrey Modell Foundation; Lisa and Douglas Goldman Fund; Michelle Platt-Ross Foundation	Primary Immune Deficiency Treatment Consortium; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland; Jeffrey Modell Foundation; Lisa and Douglas Goldman Fund; Michelle Platt-Ross Foundation	J. M. Puck received support from the Primary Immune Deficiency Treatment Consortium, the National Institute of Allergy and Infectious Diseases and the National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland (cooperative agreement no. U54-AI082973); the Jeffrey Modell Foundation; the Lisa and Douglas Goldman Fund; and the Michelle Platt-Ross Foundation.	Adhikari AN, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0966-5; Albin-Leeds S, 2017, CLIN IMMUNOL, V183, P36, DOI 10.1016/j.clim.2017.07.002; Amatuni GS, 2019, J ALLERGY CLIN IMMUN, V144, P1674, DOI 10.1016/j.jaci.2019.05.038; Amatuni GS, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2300; Argudo-Ramirez A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02406; Barbaro M, 2017, J CLIN IMMUNOL, V37, P51, DOI 10.1007/s10875-016-0347-5; Barry JC, 2017, J CLIN IMMUNOL, V37, P476, DOI 10.1007/s10875-017-0403-9; Bifsha P, 2020, BLOOD ADV, V4, P2606, DOI 10.1182/bloodadvances.2020001736; Blom M, 2017, CLIN IMMUNOL, V180, P106, DOI 10.1016/j.clim.2017.05.007; Bosticardo M, 2019, AM J HUM GENET, V105, P549, DOI 10.1016/j.ajhg.2019.07.014; Buckley RH, 2012, J ALLERGY CLIN IMMUN, V129, P597, DOI 10.1016/j.jaci.2011.12.964; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Chan A, 2011, CLIN IMMUNOL, V138, P3, DOI 10.1016/j.clim.2010.09.010; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Chrzanowska KH, 1998, CLIN GENET, V53, P308; D'Assante R, 2016, INT REV IMMUNOL, V35, P25, DOI 10.3109/08830185.2015.1010724; Dasouki M, 2011, CLIN IMMUNOL, V141, P128, DOI 10.1016/j.clim.2011.06.003; Davey BT, 2019, J PEDIATR-US, V213, P96, DOI 10.1016/j.jpeds.2019.05.061; Dorna MB, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00122; Du QM, 2019, J CLIN INVEST, V129, P4724, DOI 10.1172/JCI127565; Dvorak CC, 2019, BIOL BLOOD MARROW TR, V25, P1355, DOI 10.1016/j.bbmt.2019.03.008; Dvorak CC, 2019, J ALLERGY CLIN IMMUN, V143, P405, DOI 10.1016/j.jaci.2018.08.027; Fischer A, 2020, J EXP MED, V217, DOI 10.1084/jem.20190607; Fischer A, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.61; Framme JL, 2014, J CLIN IMMUNOL, V34, P514, DOI 10.1007/s10875-014-0002-y; Fullerton BS, 2018, JPEN-PARENTER ENTER, V42, P239, DOI 10.1002/jpen.1013; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Haddad E, 2018, BLOOD, V132, P1737, DOI 10.1182/blood-2018-03-840702; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Heimall J, 2017, BIOL BLOOD MARROW TR, V23, P379, DOI 10.1016/j.bbmt.2016.12.619; Hsu AP, 2019, BLOOD, V133, P1977, DOI 10.1182/blood-2018-11-886028; Jyonouchi S, 2013, PEDIATRICS, V132, pE484, DOI 10.1542/peds.2012-3815; Kemper AR, 2018, EVIDENCE BASED REV N; Kohn DB, 2019, J ALLERGY CLIN IMMUN, V143, P852, DOI 10.1016/j.jaci.2018.08.024; Ktuan A, 2015, SEMIN PERINATOL, V39, P194, DOI 10.1053/j.semperi.2015.03.004; Kuo CY, 2017, J ALLER CL IMM-PRACT, V5, P198, DOI 10.1016/j.jaip.2016.09.028; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; la Marca G, 2013, J ALLERGY CLIN IMMUN, V131, P1604, DOI 10.1016/j.jaci.2012.08.054; Mallott J, 2013, J CLIN IMMUNOL, V33, P540, DOI 10.1007/s10875-012-9846-1; Mamcarz E, 2019, NEW ENGL J MED, V380, P1525, DOI 10.1056/NEJMoa1815408; Michael Pulsipher, COND SCID INF DIAGN; Miggelbrink AM, 2018, BLOOD, V131, P2967, DOI 10.1182/blood-2017-10-809822; Nourizadeh M, 2018, SCAND J IMMUNOL, V88, DOI 10.1111/sji.12699; Pai SY, 2020, J ALLERGY CLIN IMMUN, V146, P258, DOI 10.1016/j.jaci.2020.05.055; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Patel JP, 2015, J CLIN IMMUNOL, V35, P227, DOI 10.1007/s10875-015-0136-6; Patel NC, 2010, NEW ENGL J MED, V362, P314, DOI 10.1056/NEJMoa0904485; Punwani D, 2016, NEW ENGL J MED, V375, P2165, DOI 10.1056/NEJMoa1509164; Rechavi E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01448; Richards S, 2018, J PAEDIATR CHILD H, V54, P14, DOI 10.1111/jpc.13659; Savic RM, 2013, BIOL BLOOD MARROW TR, V19, P1608, DOI 10.1016/j.bbmt.2013.08.014; Schoenaker MHD, 2020, EUR J PEDIATR, V179, P251, DOI 10.1007/s00431-019-03479-5; Schorling DC, 2020, J NEUROMUSCULAR DIS, V7, P1, DOI 10.3233/JND-190424; Somech R, 2013, ISR MED ASSOC J, V15, P404; Tangsinmankong N, 1999, J ALLERGY CLIN IMMUN, V103, P1222, DOI 10.1016/S0091-6749(99)70207-1; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Thomas C, 2019, CLIN IMMUNOL, V202, P33, DOI 10.1016/j.clim.2019.03.012; Truck J., 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.2020.20254, DOI 10.4414/SMW.2020.20254]; Volpi S, 2017, J EXP MED, V214, P623, DOI 10.1084/jem.20161525; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Yamashita M, 2019, INT J HEMATOL, V109, P603, DOI 10.1007/s12185-019-02619-9	61	17	18	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					417	426		10.1016/j.jaci.2020.10.020	http://dx.doi.org/10.1016/j.jaci.2020.10.020		FEB 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	33551023	Green Accepted			2022-12-18	WOS:000616665800001
J	Koh, B; Ulrich, BJ; Nelson, AS; Panangipalli, G; Kharwadkar, R; Wu, WT; Xie, MM; Fu, YY; Turner, MJ; Paczesny, S; Janga, SC; Dent, AL; Kaplan, MH				Koh, Byunghee; Ulrich, Benjamin J.; Nelson, Andrew S.; Panangipalli, Gayathri; Kharwadkar, Rakshin; Wu, Wenting; Xie, Markus M.; Fu, Yongyao; Turner, Matthew J.; Paczesny, Sophie; Janga, Sarath Chandra; Dent, Alexander L.; Kaplan, Mark H.			Bcl6 and Blimp1 reciprocally regulate ST2(+) Treg-cell development in the context of allergic airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Interleukin-33; ST2; Bcl6; Blimp1; T follicular regulatory T cells; ST2-expressing regulatory T cells; allergy; asthma	HELPER T-CELLS; GERMINAL-CENTER FORMATION; FOLLICULAR HELPER; DENDRITIC CELLS; EXPRESSION; IL-33; DIFFERENTIATION; INTERLEUKIN-2; RESPONSES; HOMEOSTASIS	Background: Bcl6 is required for the development of T follicular helper cells and T follicular regulatory (Tfr) cells that regulate germinal center responses. Bcl6 also affects the function of regulatory T (Treg) cells. Objective: The goal of this study was to define the functions of Bcl6 in Treg cells, including Tfr cells, in the context of allergic airway inflammation. Methods: We used a model of house dust mite sensitization to challenge wild-type, Bcl6(fl/fl) Foxp3-Cre, and Prdm1 (Blimp1)(fl/fl) Foxp3-Cre mice to study the reciprocal roles of Bcl6 and Blimp1 in allergic airway inflammation. Results: In the house dust mite model, Tfr cells repress the production of IgE and Bcl6(+) Treg cells suppress the generation of type 2 cytokine-producing cells in the lungs. In mice with Bcl6-deficient Treg cells, twice as many ST2(+) (IL-33R(+)) Treg cells develop as are observed in wild-type mice. ST2(+) Treg cells in the context of allergic airway inflammation are Blimp1 dependent, express type 2 cytokines, and share features of visceral adipose tissue Treg cells. Bcl6-deficient Treg cells are more susceptible, and Blimp1-deficient Treg cells are resistant, to acquiring the ST2(+) Treg-cell phenotype in vitro and in vivo in response to IL-33. Bcl6-deficient ST2(+) Treg cells, but not Bcl6- deficient ST2(+) conventional T cells, strongly promote allergic airway inflammation when transferred into recipient mice. Lastly, ST2 is required for the exacerbated allergic airway inflammation in Bcl6(fl/fl) Foxp3-Cre mice. Conclusions: During allergic airway inflammation, Bcl6 and Blimp1 play dual roles in regulating Tfr-cell activity in the germinal center and in the development of ST2(+) Treg cells that promote type 2 cytokine responses.	[Koh, Byunghee; Nelson, Andrew S.; Paczesny, Sophie; Kaplan, Mark H.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Koh, Byunghee; Nelson, Andrew S.; Paczesny, Sophie; Kaplan, Mark H.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Koh, Byunghee; Ulrich, Benjamin J.; Xie, Markus M.; Fu, Yongyao; Paczesny, Sophie; Dent, Alexander L.; Kaplan, Mark H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, 635 Barnhill Dr,Room 420, Indianapolis, IN 46202 USA; [Kharwadkar, Rakshin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Wu, Wenting] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Panangipalli, Gayathri; Janga, Sarath Chandra] Indiana Univ Purdue Univ, Sch Informat & Comp, Dept Biohlth Informat, Indianapolis, IN 46202 USA; [Turner, Matthew J.] Richard L Roudebush VA Med Ctr, Dept Dermatol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Kaplan, MH (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, 635 Barnhill Dr,Room 420, Indianapolis, IN 46202 USA.	mkaplan2@iu.edu	Koh, Byunghee/AAL-5372-2021; Ulrich, Benjamin/AAK-9510-2020; Paczesny, Sophie/AAR-5119-2021	Koh, Byunghee/0000-0003-3554-4449; Ulrich, Benjamin/0000-0002-2729-1798; Paczesny, Sophie/0000-0001-5571-2775; Xie, Markus/0000-0003-1350-7364	Public Health Service from the National Institutes of Health [R01 AI057459, R01 AI132771]; American Association of Immunologists; Department of Veterans Affairs [IK2 CX001019]; Indiana University Simon Cancer Center [P30 CA082709, U54 DK106846]; Herman B. Wells Center from the Riley Children's Foundation;  [T32 AI060519];  [F30 HL147515];  [T32 HL007910]	Public Health Service from the National Institutes of Health; American Association of Immunologists; Department of Veterans Affairs(US Department of Veterans Affairs); Indiana University Simon Cancer Center; Herman B. Wells Center from the Riley Children's Foundation; ; ; 	This work was supported by Public Health Service grants from the National Institutes of Health (grant R01 AI057459 to M.H.K. and grant R01 AI132771 to A.L.D.). B.J.U. was supported by grants T32 AI060519 and F30 HL147515. A.S.N. was supported by grant T32 HL007910. M.M.X. was supported by a Careers in Immunology Fellowship from the American Association of Immunologists. M.J.T. was supported by the Department of Veterans Affairs (grant IK2 CX001019 [VA CDA2]). Core facility use was also supported by Indiana University Simon Cancer Center Support Grant (P30 CA082709 and U54 DK106846). Support provided by the Herman B. Wells Center was obtained in part from the Riley Children's Foundation.	Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen CC, 2017, J ALLERGY CLIN IMMUN, V140, P1351, DOI 10.1016/j.jaci.2017.01.015; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Clement RL, 2019, NAT IMMUNOL, V20, P1360, DOI 10.1038/s41590-019-0472-4; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Delacher M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09276-w; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fu WW, 2018, J EXP MED, V215, P815, DOI 10.1084/jem.20170901; Garg G, 2019, CELL REP, V26, P1854, DOI 10.1016/j.celrep.2019.01.070; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Hollister K, 2014, HUM VACC IMMUNOTHER, V10, P1985, DOI 10.4161/hv.28659; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim EH, 2014, J IMMUNOL, V192, P985, DOI 10.4049/jimmunol.1302378; Kobayashi T, 2017, J ALLERGY CLIN IMMUN, V139, P300, DOI 10.1016/j.jaci.2016.04.021; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Laidlaw BJ, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan4767; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu Q, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123919; MacDonald KG, 2015, J ALLERGY CLIN IMMUN, V135, P946, DOI 10.1016/j.jaci.2014.12.1932; Matta BM, 2016, BLOOD, V128, P427, DOI 10.1182/blood-2015-12-684142; Matta BM, 2014, J IMMUNOL, V193, P4010, DOI 10.4049/jimmunol.1400481; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Page K, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-91; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reubsaet L, 2013, J ALLERGY CLIN IMMUN, V132, P1440, DOI 10.1016/j.jaci.2013.06.028; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sage PT, 2014, J CLIN INVEST, V124, P5191, DOI 10.1172/JCI76861; Sawant DV, 2015, IMMUNOLOGY, V145, P11, DOI 10.1111/imm.12393; Sawant DV, 2012, J IMMUNOL, V189, P4759, DOI 10.4049/jimmunol.1201794; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Siede J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161507; Singh B, 2005, CLIN EXP IMMUNOL, V141, P223, DOI 10.1111/j.1365-2249.2005.02841.x; Starruy J, 2014, BIOINFORMATICS, V30, P1331, DOI 10.1093/bioinformatics/btt772; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vannella KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1938; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Verma M, 2018, J ALLERGY CLIN IMMUN, V142, P793, DOI 10.1016/j.jaci.2017.10.020; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu H, 2016, EUR J IMMUNOL, V46, P1152, DOI 10.1002/eji.201546094; Wu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155040; Xie MM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128076; Xie Markus M, 2019, Immunohorizons, V3, P306, DOI 10.4049/immunohorizons.1900034; Xie MM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01536; Xie MM, 2017, EUR J IMMUNOL, V47, P1136, DOI 10.1002/eji.201747034; Yang JF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122014; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu RYL, 2005, BLOOD, V105, P1777, DOI 10.1182/blood-2004-08-3171; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zoltowska AM, 2016, CLIN EXP ALLERGY, V46, P479, DOI 10.1111/cea.12683	74	17	18	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					1121	+		10.1016/j.jaci.2020.03.002	http://dx.doi.org/10.1016/j.jaci.2020.03.002			25	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	32179158	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000588153700016
J	Assan, F; Gottlieb, J; Tubach, F; Lebbah, S; Guigue, N; Hickman, G; Pape, E; Madrange, M; Delaporte, E; Sendid, B; Aubin, F; Derouin, F; Bretagne, S; Richette, P; Smahi, A; Sbidian, E; Bachelez, H				Assan, Florence; Gottlieb, Jeremy; Tubach, Florence; Lebbah, Said; Guigue, Nicolas; Hickman, Geoffroy; Pape, Emeline; Madrange, Marine; Delaporte, Emmanuel; Sendid, Boualem; Aubin, Francois; Derouin, Francis; Bretagne, Stephane; Richette, Pascal; Smahi, Asma; Sbidian, Emilie; Bachelez, Herve			Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							BOWEL-DISEASE; PREVALENCE; ASCA		[Assan, Florence; Gottlieb, Jeremy; Guigue, Nicolas; Hickman, Geoffroy; Madrange, Marine; Derouin, Francis; Bretagne, Stephane; Richette, Pascal; Smahi, Asma; Bachelez, Herve] Univ Paris, Paris, France; [Assan, Florence; Bachelez, Herve] INSERM UMR 1163, Inst Imagine, Lab Genet Skin Dis, Paris, France; [Gottlieb, Jeremy; Hickman, Geoffroy; Bachelez, Herve] Hop St Louis, APHP, Dept Dermatol, Paris, France; [Tubach, Florence; Lebbah, Said] Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, Hop Pitie Salpetriere,AP HP,Dept Sante Publ, CIC-1422, F-75013 Paris, France; [Guigue, Nicolas; Derouin, Francis; Bretagne, Stephane] Hop St Louis, APHP, Dept Mycol & Parasitol, Paris, France; [Pape, Emeline; Delaporte, Emmanuel] CHRU Lille, Dept Dermatol, Lille, France; [Pape, Emeline; Delaporte, Emmanuel; Sendid, Boualem] Univ Lille, LIRIC Inserm UMR 995 Team 2, Lille, France; [Madrange, Marine; Smahi, Asma] INSERM UMR 1163, Lab Genet Monogen Autoinflammatory Dis, Imagine Inst, Paris, France; [Sendid, Boualem] CHRU Lille, Dept Mycol & Parasitol, Lille, France; [Aubin, Francois] Hop Besancon, Dept Dermatol, Besancon, France; [Richette, Pascal] Hop Lariboisiere, Dept Rheumatol, Paris, France; [Richette, Pascal] INSERM U1132 Bioscar, Paris, France; [Sbidian, Emilie] Hop Henri Mondor, APHP, Dept Dermatol, Creteil, France; [Sbidian, Emilie] INSERM, Ctr Invest Clin 1430, Creteil, France; [Sbidian, Emilie] Paris Est Creteil Univ UPEC, Creteil, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Bachelez, H (corresponding author), Univ Paris, Paris, France.; Bachelez, H (corresponding author), INSERM UMR 1163, Inst Imagine, Lab Genet Skin Dis, Paris, France.; Bachelez, H (corresponding author), Hop St Louis, APHP, Dept Dermatol, Paris, France.	herve.bachelez@aphp.fr	BRETAGNE, Stephane/GLT-8879-2022; Aubin, François/ABE-1236-2021; Sbidian, Emilie/ABH-5714-2020; Aubin, François/AAB-5824-2022; Sendid, Boualem/ABE-9870-2020	Aubin, François/0000-0002-1421-4996; Aubin, François/0000-0002-1421-4996; Sendid, Boualem/0000-0003-1577-7325	Janssen; Boehringer-Ingelheim; Amgen	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer-Ingelheim(Boehringer Ingelheim); Amgen(Amgen)	J. Gottlieb has potential competing interests as follows: clinical research sponsored by Janssen, Boehringer-Ingelheim, and Amgen, as well as consultant arrangements with UCB, Janssen, Novartis, AbbVie, Celgene, Lilly, and Sanofi. H. Bachelez has participated in paid consulting activities for AbbVie, Almirall, Amgen, Biocad, Biogen, Boehringer-Ingelheim, Celgene, Janssen, Leo Pharma, Lilly, Mylan, Novartis, Pfizer, UCB, and Sun Pharmaceuticals. The rest of the authors declare that they have no relevant conflicts of interest.	Egeberg A, 2017, J INVEST DERMATOL, V137, P1060, DOI 10.1016/j.jid.2016.11.040; Frew JW, 2017, BRIT J DERMATOL, V177, P987, DOI 10.1111/bjd.15441; Gottlieb J, 2019, BRIT J DERMATOL, V181, P866, DOI 10.1111/bjd.18003; Kim BC, 2007, DIGEST LIVER DIS, V39, P610, DOI 10.1016/j.dld.2007.03.006; Maillet J, 2016, JOINT BONE SPINE, V83, P665, DOI 10.1016/j.jbspin.2015.10.011; Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788; Scher JU, 2016, ARTHRITIS RHEUMATOL, V68, P35, DOI 10.1002/art.39259; Standaert-Vitse A, 2009, AM J GASTROENTEROL, V104, P1745, DOI 10.1038/ajg.2009.225; Vossen ARJV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02965	9	17	18	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					452	+		10.1016/j.jaci.2020.01.045	http://dx.doi.org/10.1016/j.jaci.2020.01.045			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32061710	Bronze			2022-12-18	WOS:000558835000036
J	Kimura, H; Kurusu, H; Sada, M; Kurai, D; Murakami, K; Kamitani, W; Tomita, H; Katayama, K; Ryo, A				Kimura, Hirokazu; Kurusu, Hiromu; Sada, Mitsuru; Kurai, Daisuke; Murakami, Koichi; Kamitani, Wataru; Tomita, Haruyoshi; Katayama, Kazuhiko; Ryo, Akihide			Molecular pharmacology of ciclesonide against SARS-CoV-2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DOCKING		[Kimura, Hirokazu] Gunma Paz Univ, Grad Hlth Sci, Dept Hlth Sci, Gunma, Japan; [Kurusu, Hiromu; Sada, Mitsuru] Gunma Paz Univ, Adv Med Sci Res Ctr, Gunma, Gunma, Japan; [Kurai, Daisuke] Kyorin Univ, Dept Resp Med, Sch Med, Tokyo, Japan; [Murakami, Koichi] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Kamitani, Wataru] Gunma Univ, Dept Infect Dis & Host Def, Grad Sch Med, Gunma, Japan; [Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Dept Bacteriol, Gunma, Japan; [Katayama, Kazuhiko] Kitasato Univ, Grad Sch Infect Control Sci, Lab Viral Infect I, Kitasato Inst Life Sci, Tokyo, Japan; [Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Yokohama, Kanagawa, Japan	Kyorin University; National Institute of Infectious Diseases (NIID); Gunma University; Gunma University; Kitasato University; Yokohama City University	Kimura, H (corresponding author), Gunma Paz Univ, Grad Hlth Sci, Dept Hlth Sci, Gunma, Japan.	kimhiro@nih.go.jp		Kurai, Daisuke/0000-0001-9492-8798; Katayama, Kazuhiko/0000-0002-7692-1151; Ryo, Akihide/0000-0001-6028-8091	Japan Agency for Medical Research and Development (AMED) [20fk0108103h0202]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was partly supported by a commissioned project for Research on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED, grant no. 20fk0108103h0202).	Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Nave R, 2005, PULM PHARMACOL THER, V18, P390, DOI 10.1016/j.pupt.2005.02.012; Ratner PH, 2006, J ALLERGY CLIN IMMUN, V118, P1142, DOI 10.1016/j.jaci.2006.07.050; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vogelmeier CF, 2011, RESP MED, V105, P186, DOI 10.1016/j.rmed.2010.09.016; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	6	17	17	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					330	331		10.1016/j.jaci.2020.05.029	http://dx.doi.org/10.1016/j.jaci.2020.05.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32593491	Green Published, Bronze			2022-12-18	WOS:000558835000019
J	Hammarstrom, L; Abolhassani, H; Baldanti, F; Marcotte, H; Pan-Hammarstrom, Q				Hammarstrom, Lennart; Abolhassani, Hassan; Baldanti, Fausto; Marcotte, Harold; Pan-Hammarstrom, Qiang			Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						COVID-19; immunodeficiency; passive immunity; plasma therapy; IVIG; mAb			[Hammarstrom, Lennart; Abolhassani, Hassan; Marcotte, Harold] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Immunol & Transfus Med, Stockholm, Sweden; [Baldanti, Fausto] Univ Pavia, IRCCS Policlin San Matteo, Mol Virol Unit, Pavia, Italy; [Pan-Hammarstrom, Qiang] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; IRCCS Fondazione San Matteo; University of Pavia; Karolinska Institutet	Pan-Hammarstrom, Q (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Neo, SE-14183 Huddinge, Sweden.	qiang.pan-hammarstrom@ki.se	hammarstrom, qiang pan/ABA-4589-2021; Marcotte, Harold/P-9375-2017; Abolhassani, Hassan/B-3465-2014; Baldanti, Fausto/J-4924-2018	Marcotte, Harold/0000-0002-7168-349X; Abolhassani, Hassan/0000-0002-4838-0407; Baldanti, Fausto/0000-0002-3358-8969; pan-hammarstrom, qiang/0000-0003-1990-8804	Swedish Research Council [101003650-ATAC]; European Commission Horizon 2020 program [101003650-ATAC]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission Horizon 2020 program	This work was supported by the Swedish Research Council and the European Commission Horizon 2020 program (grant no. 101003650-ATAC).	Amanat F, SEROLOGICAL ASSAY DE, DOI [10.1101/2020.03.17, DOI 10.1101/2020.03.17]; Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Zhang B, 2020, CHEST, V158, pE9, DOI 10.1016/j.chest.2020.03.039	10	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2020	146	1					58	60		10.1016/j.jaci.2020.04.043	http://dx.doi.org/10.1016/j.jaci.2020.04.043			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OC5BB	32413374	Green Published, Bronze			2022-12-18	WOS:000579170500009
J	Lee, YS; Han, SB; Ham, HJ; Park, JH; Lee, JS; Hwang, DY; Jung, YS; Yoon, DY; Hong, JT				Lee, Yong Sun; Han, Sang-Bae; Ham, Hyeon Joo; Park, Ju Ho; Lee, Jong Sung; Hwang, Dae Yeon; Jung, Young Suk; Yoon, Do Young; Hong, Jin Tae			IL-32 gamma suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; IL-32 gamma; miR-205; NF-kappa B	TH2 RESPONSES; UP-REGULATION; MURINE MODEL; INFLAMMATION; CELLS; ACTIVATION; MICRORNAS; CYTOKINES; IL-32; IL-1-BETA	Background: IL-32 is a novel cytokine involved in many inflammatory diseases. However, the role of IL-32 gamma, an isotype of IL-32, in atopic dermatitis (AD) has not been reported. Objective: We investigated the effects of IL-32 gamma on development of AD and its action mechanisms. Methods: We used phthalic anhydride (PA) and an MC903-induced AD model using wild-type and IL-32 gamma transgenic mice. We conducted the therapy experiments by using recombinant IL-32 gamma protein in a reconstructed human skin model and PA-induced model. We conducted a receiver operating characteristic analysis of IL-32 gamma with new AD biomarkers, IL-31 and IL-33, in serum from patients with AD. Results: Dermatitis severity and epidermal thickness were significantly reduced in PA- and MC903-induced IL-32 gamma transgenic mice compared with in wild-type mice. The concentration of AD-related cytokines was reduced in PA- and MC903-induced IL-32 gamma transgenic mice compared with in wild-type mice. Subsequent analysis showed that IL-32 gamma inhibits miR-205 expression in PA- and MC903-induced skin tissue samples and TNF-alpha/IFN-gamma-treated HaCaT cells. IL-32 gamma reduced NF-kappa B activity in skin tissue samples from PA- and MC903-induced mice and TNF-alpha/IFN-gamma-treated HaCaT cells. NF-kappa B inhibitor treatment with IL-32 gamma expression further suppressed expression of inflammatory mediators as well as miR-205 in TNF-alpha/IFN-gamma-treated HaCaT cells. Furthermore, recombinant IL-32 gamma protein alleviated AD-like inflammation in in vivo and reconstructed human skin models. Spearman correlation analysis showed that serum levels of IL-32 gamma and miR-205 were significantly concordant in patients with AD. Conclusion: Our results indicate that IL-32 gamma reduces AD through the inhibition of miR-205 expression via inactivation of NF-kappa B.	[Lee, Yong Sun; Han, Sang-Bae; Ham, Hyeon Joo; Park, Ju Ho; Lee, Jong Sung; Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea; [Lee, Yong Sun; Han, Sang-Bae; Ham, Hyeon Joo; Park, Ju Ho; Lee, Jong Sung; Hong, Jin Tae] Chungbuk Natl Univ, Med Res Ctr, Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea; [Hwang, Dae Yeon] Pusan Natl Univ, Life & Ind Convergence Res Inst, Coll Nat Resources & Life Sci, Dept Biomat Sci, Miryang, South Korea; [Jung, Young Suk] Pusan Natl Univ, Coll Pharm, Busan, South Korea; [Yoon, Do Young] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea	Chungbuk National University; Chungbuk National University; Pusan National University; Pusan National University; Konkuk University	Hong, JT (corresponding author), Chungbuk Natl Univ, Coll Pharm, Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea.; Hong, JT (corresponding author), Chungbuk Natl Univ, Med Res Ctr, Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea.; Yoon, DY (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea.	ydy4218@konkuk.ac.kr; jinthong@chungbuk.ac.kr			National Research Foundation of Korea (Republic of Korea) - Korean government [MRC 2017R1A5A2015541, 2018R1A2B2001225]	National Research Foundation of Korea (Republic of Korea) - Korean government	Supported by a National Research Foundation of Korea (Republic of Korea) grant funded by the Korean government (grants MRC 2017R1A5A2015541 and 2018R1A2B2001225).	Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Bang BR, 2014, AM J RESP CELL MOL, V50, P1021, DOI 10.1165/rcmb.2013-0234OC; Bernard Francois-Xavier, 2012, J Allergy (Cairo), V2012, P718725, DOI 10.1155/2012/718725; Brandt Eric B, 2011, J Clin Cell Immunol, V2; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Chan BCL, 2019, FRONT IMMUNOL, V10; Choi J, 2010, P NATL ACAD SCI USA, V107, P21082, DOI 10.1073/pnas.1015418107; Conti P, 2007, AUTOIMMUN REV, V6, P131, DOI 10.1016/j.autrev.2006.08.015; DAHL CA, 1992, J IMMUNOL, V148, P597; Dajee M, 2006, J INVEST DERMATOL, V126, P1792, DOI 10.1038/sj.jid.5700307; Danso MO, 2014, J INVEST DERMATOL, V134, P1941, DOI 10.1038/jid.2014.83; Di Salvo E, 2018, MEDIAT INFLAMM, V2018; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Fyhrquist N, 2012, J INVEST DERMATOL, V132, P1672, DOI 10.1038/jid.2012.40; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Gu CY, 2017, INT J CLIN EXP PATHO, V10, P10117; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Hong JT, 2017, PHARMACOL THERAPEUT, V174, P127, DOI 10.1016/j.pharmthera.2017.02.025; Huang F, 2015, COPD RES PRAC, V1, P2; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Joosten LAB, 2013, CELL MOL LIFE SCI, V70, P3883, DOI 10.1007/s00018-013-1301-9; Kang JW, 2014, BIOCHIMIE, V101, P248, DOI 10.1016/j.biochi.2014.01.013; Kim S, 2011, ANN DERMATOL, V23, P468, DOI 10.5021/ad.2011.23.4.468; Kosaka S, 2011, IMMUNOBIOLOGY, V216, P811, DOI 10.1016/j.imbio.2010.12.003; Laouini D, 2003, J CLIN INVEST, V112, P1058, DOI 10.1172/JCI200318246; Lee DH, 2015, CLIN SCI, V128, P695, DOI 10.1042/CS20140576; Lee YS, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0943-8; Lee YS, 2018, CANCER LETT, V433, P156, DOI 10.1016/j.canlet.2018.07.007; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Liu CC, 2014, NUCLEIC ACIDS RES, V42, pW137, DOI 10.1093/nar/gku412; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lv YN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Meng JH, 2018, J ALLERGY CLIN IMMUN, V141, P1677, DOI 10.1016/j.jaci.2017.12.1002; Meyer N, 2010, J ALLERGY CLIN IMMUN, V125, P858, DOI 10.1016/j.jaci.2010.01.016; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Moosbrugger-Martinz V, 2017, METHODS MOL BIOL, V1559, P91, DOI 10.1007/978-1-4939-6786-5_8; Nakashima C, 2018, EXP DERMATOL, V27, P327, DOI 10.1111/exd.13533; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Nold-Petry CA, 2009, P NATL ACAD SCI USA, V106, P3883, DOI 10.1073/pnas.0813334106; Oh JH, 2011, ONCOGENE, V30, P3345, DOI 10.1038/onc.2011.52; Ohmatsu H, 2012, ACTA DERM-VENEREOL, V92, P282, DOI 10.2340/00015555-1345; Park JH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040738; Park MH, 2015, ONCOTARGET, V6, P38566, DOI 10.18632/oncotarget.6160; Rebane A, 2014, J ALLERGY CLIN IMMUN, V134, P836, DOI 10.1016/j.jaci.2014.05.022; Rozalski M, 2016, POSTEP DERM ALERGOL, V33, P157, DOI 10.5114/ada.2016.60606; Seo HS, 2019, ANN DERMATOL, V31, P186, DOI 10.5021/ad.2019.31.2.186; Son DJ, 2017, THERANOSTICS, V7, P2186, DOI 10.7150/thno.18407; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126, P581, DOI 10.1016/j.jaci.2010.05.045; Sriram Gopu, 2019, Methods Mol Biol, V1879, P367, DOI 10.1007/7651_2018_163; Tamagawa-Mineoka R, 2014, J AM ACAD DERMATOL, V70, P882, DOI 10.1016/j.jaad.2014.01.867; Tanaka A, 2007, J INVEST DERMATOL, V127, P855, DOI 10.1038/sj.jid.5700603; Tenda Y, 2006, J ALLERGY CLIN IMMUN, V118, P725, DOI 10.1016/j.jaci.2006.05.024; Thomsen Simon Francis, 2014, ISRN Allergy, V2014, P354250, DOI 10.1155/2014/354250; Vennegaard MT, 2012, CONTACT DERMATITIS, V67, P298, DOI 10.1111/j.1600-0536.2012.02083.x; Wang BB, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180497; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Yang ZB, 2017, CELL IMMUNOL, V319, P53, DOI 10.1016/j.cellimm.2017.08.003; Yeh DW, 2016, CELL DEATH DIFFER, V23, P841, DOI 10.1038/cdd.2015.147; Yun HM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.166	63	17	20	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2020	146	1					156	168		10.1016/j.jaci.2019.12.905	http://dx.doi.org/10.1016/j.jaci.2019.12.905			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OC5BB	31931018	hybrid			2022-12-18	WOS:000579170500025
J	Altman, MC; Beigelman, A; Ciaccio, C; Gern, JE; Heymann, PW; Jackson, DJ; Kennedy, JL; Kloepfer, K; Lemanske, RF; McWilliams, LM; Muehling, L; Nance, C; Peebles, RS				Altman, Matthew C.; Beigelman, Avraham; Ciaccio, Christina; Gern, James E.; Heymann, Peter W.; Jackson, Daniel J.; Kennedy, Joshua L.; Kloepfer, Kirsten; Lemanske, Robert F., Jr.; McWilliams, Laurie M.; Muehling, Lyndsey; Nance, Christy; Peebles, R. Stokes, Jr.			Evolving concepts in how viruses impact asthma: A Work Group Report of the Microbes in Allergy Committee of the American Academy of Allergy, Asthma & Immunology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Virus; asthma; genetics; immune; microbiome	RESPIRATORY-SYNCYTIAL-VIRUS; VITAMIN-D SUPPLEMENTATION; FAMILY-MEMBER 3; EARLY-LIFE; RHINOVIRUS INFECTION; MUCOUS METAPLASIA; RECURRENT WHEEZE; CHILDHOOD ASTHMA; 1ST YEAR; NASOPHARYNGEAL MICROBIOTA	Over the past decade, there have been substantial advances in our understanding about how viral infections regulate asthma. Important lessons have been learned from birth cohort studies examining viral infections and subsequent asthma and from understanding the relationships between host genetics and viral infections, the contributions of respiratory viral infections to patterns of immune development, the impact of environmental exposure on the severity of viral infections, and how the viral genome influences host immune responses to viral infections. Further, there has been major progress in our knowledge about how bacteria regulate host immune responses in asthma pathogenesis. In this article, we also examine the dynamics of bacterial colonization of the respiratory tract during viral upper respiratory tract infection, in addition to the relationship of the gut and respiratory microbiomes with respiratory viral infections. Finally, we focus on potential interventions that could decrease virus-induced wheezing and asthma. There are emerging therapeutic options to decrease the severity of wheezing exacerbations caused by respiratory viral infections. Primary prevention is a major goal, and a strategy toward this end is considered.	[Altman, Matthew C.] Univ Washington, Dept Med, Seattle, WA USA; [Beigelman, Avraham] Univ Washington, Dept Med, Div Pediat Allergy Immunol & Pulm Med, Seattle, WA USA; [Beigelman, Avraham] Tel Aviv Univ, Kipper Inst Allergy & Immunol, Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; [Ciaccio, Christina] Univ Chicago, Sch Med, Allergy Immunol & Pediat Pulmonol & Sleep Med, Chicago, IL 60637 USA; [Gern, James E.; Jackson, Daniel J.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Div Pediat Allergy Immunol & Rheumatol, Madison, WI USA; [Heymann, Peter W.] Univ Virginia, Med Ctr, Dept Pediat, Charlottesville, VA USA; [Kennedy, Joshua L.] Univ Virginia, Med Ctr, Dept Med, Charlottesville, VA USA; [Kloepfer, Kirsten] Univ Arkansas Med Sci, Div Allergy Immunol, Dept Pediat, Little Rock, AR 72205 USA; [Kloepfer, Kirsten] Univ Arkansas Med Sci, Div Allergy Immunol, Dept Internal Med, Little Rock, AR 72205 USA; [Lemanske, Robert F., Jr.] Indiana Univ Sch Med, Dept Pediat, Div Pediat Pulmonol Allergy & Sleep Med, Indianapolis, IN 46202 USA; [McWilliams, Laurie M.] Allergy Partners Triangle, Houston, TX USA; [Muehling, Lyndsey] Baylor Coll Med, Dept Pediat, Houston, TX USA; [Nance, Christy] Baylor Coll Med, Dept Immunol Pathol, Houston, TX USA; [Peebles, R. Stokes, Jr.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tel Aviv University; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Virginia; University of Virginia; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Indiana University System; Indiana University Bloomington; Baylor College of Medicine; Baylor College of Medicine; Vanderbilt University	Peebles, RS (corresponding author), Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med3, T-1218 MCN,VUMC,1161 21st Ave South, Nashville, TN 37232 USA.	stokes.peebles@vanderbilt.edu			National Institutes of Health [UG3/UH3OD023282, U19AI104317, UM1AI114271, U01AI100799, K08AI1211345, T32AI007496, U19AI095227, R01AI124456, R01AI145265, R21AI145397]; US Department of Veterans Affairs [I01BX004299]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs)	Supported by the National Institutes of Health grants UG3/UH3OD023282 (J.E.G. and D.J.J.), U19AI104317 (J.E.G.), UM1AI114271 (J.E.G. and D.J.J.), U01AI100799 (P.W.H.), K08AI1211345 (J.L.K.), T32AI007496 (L.M.), U19AI095227 (R.S.P.), R01AI124456 (R.S.P.), R01AI145265 (R.S.P.), R21AI145397 (R.S.P.), and US Department of Veterans Affairs I01BX004299 (R.S.P.).	Altman MC, 2018, J ALLERGY CLIN IMMUN, V142, P451, DOI 10.1016/j.jaci.2017.10.004; Asgari S, 2017, P NATL ACAD SCI USA, V114, P8342, DOI 10.1073/pnas.1704259114; Bacharier LB, 2015, JAMA-J AM MED ASSOC, V314, P2034, DOI 10.1001/jama.2015.13896; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Beigelman A, 2016, CURR OPIN ALLERGY CL, V16, P172, DOI 10.1097/ACI.0000000000000244; Beigelman A, 2015, J ALLERGY CLIN IMMUN, V135, P1171, DOI 10.1016/j.jaci.2014.10.001; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bochkov YA, 2014, J CLIN MICROBIOL, V52, P2461, DOI 10.1128/JCM.00075-14; Bonnelykke K, 2018, AM J RESP CRIT CARE, V197, P589, DOI 10.1164/rccm.201705-1021OC; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Bosch AATM, 2017, AM J RESP CRIT CARE, V196, P1582, DOI 10.1164/rccm.201703-0554OC; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Bufford JD, 2008, CLIN EXP ALLERGY, V38, P1635, DOI 10.1111/j.1365-2222.2008.03018.x; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Carroll KN, 2017, J ALLERGY CLIN IMMUN, V139, P66, DOI 10.1016/j.jaci.2016.01.055; Carroll KN, 2009, J ALLERGY CLIN IMMUN, V123, P1055, DOI 10.1016/j.jaci.2009.02.021; Castro M, 2014, JAMA-J AM MED ASSOC, V311, P2083, DOI 10.1001/jama.2014.5052; Castro-Rodriguez JA, 2016, J ALLER CL IMM-PRACT, V4, P1111, DOI 10.1016/j.jaip.2016.05.003; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; Chiu CY, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100021; Ciaccio CE, 2019, ANN ALLERG ASTHMA IM, V122, P233, DOI 10.1016/j.anai.2018.12.006; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; Contoli M, 2015, ALLERGY, V70, P910, DOI 10.1111/all.12627; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Copenhaver CC, 2004, AM J RESP CRIT CARE, V170, P175, DOI 10.1164/rccm.200312-1647OC; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Custovic A, 2018, AM J RESP CRIT CARE, V197, P1265, DOI 10.1164/rccm.201708-1762OC; Del-Rio-Navarro BE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004974; Denlinger LC, 2016, AM J RESP CRIT CARE, V193, P634, DOI 10.1164/rccm.201506-1169OC; Donovan BM, 2018, PEDIATR RES, V84, P619, DOI 10.1038/s41390-018-0070-4; Esquivel A, 2017, AM J RESP CRIT CARE, V196, P985, DOI 10.1164/rccm.201701-0120OC; Folsgaard NV, 2013, AM J RESP CRIT CARE, V187, P589, DOI 10.1164/rccm.201207-1297OC; Fujimura KE, 2015, CELL HOST MICROBE, V17, P592, DOI 10.1016/j.chom.2015.04.007; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Gern JE, 2017, J ALLERGY CLIN IMMUN, V140, P836, DOI 10.1016/j.jaci.2016.10.052; Gern JE, 2006, J ALLERGY CLIN IMMUN, V117, P72, DOI 10.1016/j.jaci.2005.10.002; Gill MA, 2018, J ALLERGY CLIN IMMUN, V141, P1735, DOI 10.1016/j.jaci.2017.07.035; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Han MY, 2017, J IMMUNOL, V199, P1308, DOI 10.4049/jimmunol.1700216; Hasegawa K, 2016, EUR RESPIR J, V48, P1329, DOI 10.1183/13993003.00152-2016; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Heymann PW, 2004, J ALLERGY CLIN IMMUN, V114, P239, DOI 10.1016/j.jaci.2004.04.006; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Hyde ER, 2014, J ALLERGY CLIN IMMUN, V133, P1220, DOI 10.1016/j.jaci.2013.10.049; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Inouye M, 2018, CELL HOST MICROBE, V24; Jackson DJ, 2018, NEW ENGL J MED, V378, P891, DOI 10.1056/NEJMoa1710988; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Jolliffe DA, 2017, LANCET RESP MED, V5, P881, DOI [10.1016/S2213-2600(17)30306-5, 10.1016/s2213-2600(17)30306-5]; Kantor DB, 2016, AM J RESP CRIT CARE, V194, P1552; Kantor DB, 2016, J ALLERGY CLIN IMMUN, V138, P1467, DOI 10.1016/j.jaci.2016.04.044; Kennedy JL, 2018, J ALLERGY CLIN IMMUN, V141, P1887, DOI 10.1016/j.jaci.2017.11.041; Kennedy JL, 2014, AM J RESP CRIT CARE, V189, P532, DOI 10.1164/rccm.201310-1767OC; Kew K. M., 2016, COCHRANE DB SYST REV, V6; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Kloepfer KM, 2017, J ALLERGY CLIN IMMUN, V140, P312, DOI 10.1016/j.jaci.2017.01.038; Kloepfer KM, 2014, J ALLERGY CLIN IMMUN, V133, P1301, DOI 10.1016/j.jaci.2014.02.030; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Laforest-Lapointe I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00788; Larkin EK, 2015, FUTURE VIROL, V10, P883, DOI 10.2217/FVL.15.55; Laza-Stanca V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002114; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Liu L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013034; Loisel DA, 2016, CLIN EXP ALLERGY, V46, P112, DOI 10.1111/cea.12642; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; Ludka-Gaulke T, 2018, J ALLERGY CLIN IMMUN, V141, P454, DOI 10.1016/j.jaci.2017.07.032; Lukacs NW, 2006, AM J PATHOL, V169, P977, DOI 10.2353/ajpath.2006.051055; Lukkarinen M, 2017, J ALLERGY CLIN IMMUN, V140, P988, DOI 10.1016/j.jaci.2016.12.991; Ly NP, 2007, PEDIATRICS, V119, pE171, DOI 10.1542/peds.2006-0524; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; McAleer JP, 2018, EUR J IMMUNOL, V48, P39, DOI 10.1002/eji.201646721; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Midulla F, 2014, ACTA PAEDIATR, V103, P1094, DOI 10.1111/apa.12720; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Mirzakhani H, 2015, CLIN EXP ALLERGY, V45, P114, DOI 10.1111/cea.12430; Mochizuki H, 2017, AM J RESP CRIT CARE, V196, P29, DOI [10.1164/rccm.201609-1812OC, 10.1164/rccm.201609-1812oc]; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Nakagome K, 2014, J ALLERGY CLIN IMMUN, V134, P332, DOI 10.1016/j.jaci.2014.01.029; Olenec JP, 2010, J ALLERGY CLIN IMMUN, V125, P1001, DOI 10.1016/j.jaci.2010.01.059; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Pelgrom LR, 2017, EUR J IMMUNOL, V47, P1266, DOI 10.1002/eji.201646728; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Rodriguez-Fernandez R, 2018, J INFECT DIS, V217, P24, DOI 10.1093/infdis/jix543; Rosas-Salazar C, 2018, J ALLERGY CLIN IMMUN, V142, P1447, DOI 10.1016/j.jaci.2017.10.049; Rosas-Salazar C, 2016, J INFECT DIS, V214, P1924, DOI 10.1093/infdis/jiw456; Rubner FJ, 2017, J ALLERGY CLIN IMMUN, V139, P501, DOI 10.1016/j.jaci.2016.03.049; Ruotsalainen M, 2013, PEDIATR PULM, V48, P633, DOI 10.1002/ppul.22692; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Scheltema NM, 2018, LANCET RESP MED, V6, P257, DOI 10.1016/S2213-2600(18)30055-9; Schneider D, 2012, J IMMUNOL, V188, P2894, DOI 10.4049/jimmunol.1101391; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Siegle JS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-14; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sokolowska Milena, 2018, Asthma Res Pract, V4, P1, DOI 10.1186/s40733-017-0037-y; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stier MT, 2018, ANN AM THORAC SOC, V15, pS205, DOI 10.1513/AnnalsATS.201806-380AW; Stier MT, 2016, J ALLERGY CLIN IMMUN, V138, P814, DOI 10.1016/j.jaci.2016.01.050; Stokholm J, 2018, J ALLERGY CLIN IMMUN, V141, P1598, DOI 10.1016/j.jaci.2017.07.044; Stokholm J, 2016, LANCET RESP MED, V4, P19, DOI [10.1016/S2213-2600(15)00500-7, 10.1016/S2213-2600(16)00050-3]; Sumino K, 2012, J ALLERGY CLIN IMMUN, V129, P1267, DOI 10.1016/j.jaci.2012.02.033; Tam JS, 2013, J ALLERGY CLIN IMMUN, V132, P1241, DOI 10.1016/j.jaci.2013.07.011; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Thomsen SF, 2009, AM J RESP CRIT CARE, V179, P1091, DOI 10.1164/rccm.200809-1471OC; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201; Vrijheid M, 2014, THORAX, V69, P876, DOI 10.1136/thoraxjnl-2013-204949; Wang HT, 2019, CHILDREN-BASEL, V6, DOI 10.3390/children6020024; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; WELLIVER RC, 1980, NEW ENGL J MED, V303, P1198, DOI 10.1056/NEJM198011203032103; WELLIVER RC, 1981, NEW ENGL J MED, V305, P841, DOI 10.1056/NEJM198110083051501; WELLIVER RC, 1995, LANCET, V346, P789, DOI 10.1016/S0140-6736(95)91615-6; Wolsk HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186657; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Zhou YJ, 2016, J ALLERGY CLIN IMMUN, V138, P1215, DOI 10.1016/j.jaci.2016.03.054	132	17	18	2	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1332	1344		10.1016/j.jaci.2019.12.904	http://dx.doi.org/10.1016/j.jaci.2019.12.904			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	31926183	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000531063400003
J	Lee, JH; An, J; Won, HK; Kang, Y; Kwon, HS; Kim, TB; Cho, YS; Moon, HB; Song, WJ; Hull, JH				Lee, Ji-Hyang; An, Jin; Won, Ha-Kyeong; Kang, Yewon; Kwon, Hyouk-Soo; Kim, Tae-Bum; Cho, You Sook; Moon, Hee-Bom; Song, Woo-Jung; Hull, James H.			Prevalence and impact of comorbid laryngeal dysfunction in asthma: A systematic review and meta-analysis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Laryngeal dysfunction; vocal cord dysfunction; inducible laryngeal obstruction; asthma; treatable traits; prevalence; systematic review	VOCAL-CORD DYSFUNCTION; OBSTRUCTION; DIAGNOSIS; SYMPTOMS; MOVEMENT; QUALITY; MOTION; BIAS; TOOL	Background: Laryngeal or vocal cord dysfunction has long been regarded as a mimic of asthma; however, recent evidence indicates that it may be a significant comorbid condition in patients with asthma. Objective: We aimed to systematically estimate the prevalence of comorbid laryngeal dysfunction (LD) in adults with asthma and characterize its clinical impact on asthma. Methods: Electronic databases were searched for relevant studies published until June 2019. Studies were included if LD was objectively defined by direct visualization of laryngeal movement. Outcomes included the prevalence of LD and its association with clinical asthma indicators, such as severity, control, and quality of life. Random effects meta-analyses were performed to calculate the estimates. Results: A total of 21 studies involving 1637 patients were identified. Overall, the pooled prevalence of LD in adults with asthma was 25% (95% CI = 15%-37%; I-2 = 96%). Prevalence estimates differed according to the diagnostic test utilized, with the lowest overall prevalence (4% [95% CI = 0%-10%; I-2 = 90%]) seen when LD was diagnosed by resting laryngoscopy without external stimuli; however, it was much higher when diagnosed by laryngoscopy studies utilizing an external trigger, such as exercise (38% [95% CI = 24%-53%; I-2 = 90%]) or in studies using a computed tomography-based diagnostic protocol (36% [95% CI = 24%-49%; I-2 = 78%]). Only 7 studies reported the associations between LD and clinical asthma indicators; inconsistencies between studies limited meaningful conclusions. Conclusion: LD may be a common comorbidity in asthma, affecting about 25% of adult patients. Further prospective studies are needed to better characterize its clinical impact and the benefits of detecting and managing LD in patients with asthma.	[Lee, Ji-Hyang; An, Jin; Kwon, Hyouk-Soo; Kim, Tae-Bum; Cho, You Sook; Moon, Hee-Bom; Song, Woo-Jung] Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Asan Med Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea; [Won, Ha-Kyeong] Vet Hlth Serv Med Ctr, Dept Internal Med, Seoul, South Korea; [Kang, Yewon] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Hull, James H.] Imperial Coll London, Natl Heart & Lung Inst, London SW3 6HP, England; [Hull, James H.] Royal Brompton & Harefield NHS Fdn Trust, London SW3 6HP, England	University of Ulsan; Veterans Health Service Medical Center; Pusan National University; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust	Song, WJ (corresponding author), Univ Ulsan, Coll Med, Dept Allergy & Clin Immunol, Asan Med Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.; Hull, JH (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London SW3 6HP, England.; Hull, JH (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, London SW3 6HP, England.	swj0126@amc.seoul.kr; j.hull@rbht.nhs.uk		Song, Woo-Jung/0000-0002-4630-9922				Agusti A, 2016, EUR RESPIR J, V47, P410, DOI 10.1183/13993003.01359-2015; Baxter M, 2019, RESPIROLOGY, V24, P758, DOI 10.1111/resp.13520; Baxter M, 2014, RESPIROLOGY, V19, P531, DOI 10.1111/resp.12271; Bisaccioni C, 2009, CLINICS, V64, P769, DOI 10.1590/S1807-59322009000800010; Chan A, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA5097; Christensen P, 2010, AM J RESP CRIT CARE, V181; Christensen P, 2010, EUR ARCH OTO-RHINO-L, V267, P401, DOI 10.1007/s00405-009-1113-6; Christensen PM, 2011, EUR ARCH OTO-RHINO-L, V268, P1313, DOI 10.1007/s00405-011-1612-0; CHRISTOPHER KL, 1983, NEW ENGL J MED, V308, P1566, DOI 10.1056/NEJM198306303082605; Daley CP, 2019, AM J RESP CRIT CARE, V200, P782, DOI 10.1164/rccm.201902-0396LE; Denton E, 2019, J ALLER CL IMM-PRACT, V7, P1471, DOI 10.1016/j.jaip.2018.11.037; Dogan M, 2007, J VOICE, V21, P224, DOI 10.1016/j.jvoice.2005.11.003; Pinto LHE, 2016, ALLERGOL INT, V65, P180, DOI 10.1016/j.alit.2015.11.001; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Fowler SJ, 2015, CLIN EXP ALLERGY, V45, P1406, DOI 10.1111/cea.12550; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Halvorsen T, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02221-2016; Herth FJF, 2017, LANCET RESP MED, V5, P548, DOI 10.1016/S2213-2600(17)30222-9; Hira HS, 2009, LUNG INDIA, V26, P5, DOI 10.4103/0970-2113.45197; Holmes PW, 2009, RESPIROLOGY, V14, P1106, DOI 10.1111/j.1440-1843.2009.01629.x; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Hull JH, 2019, RESPIROLOGY, V24, P714, DOI 10.1111/resp.13560; Hull JH, 2019, AM J RESP CRIT CARE, V199, P538, DOI 10.1164/rccm.201809-1734LE; Hull JH, 2016, AM J RESP CRIT CARE, V194, P1062, DOI 10.1164/rccm.201606-1249CI; Hull JH, 2019, LARYNGOSCOPE, V129, P1863, DOI 10.1002/lary.27620; Jain S, 2006, J ASTHMA, V43, P207, DOI 10.1080/02770900600566892; Johansson H, 2015, THORAX, V70, P57, DOI 10.1136/thoraxjnl-2014-205738; Kramer S, 2017, LARYNGOSCOPE, V127, P1531, DOI 10.1002/lary.26416; Lee JW, 2018, CLIN EXP ALLERGY, V48, P1622, DOI 10.1111/cea.13185; Lin JY, 2019, IEEE T BIO-MED ENG, V66, P1127, DOI 10.1109/TBME.2018.2867636; Low K, 2017, CLIN EXP ALLERGY, V47, P200, DOI 10.1111/cea.12828; Low K, 2011, AM J RESP CRIT CARE, V184, P50, DOI 10.1164/rccm.201010-1604OC; Maat RC, 2009, EUR ARCH OTO-RHINO-L, V266, P1929, DOI 10.1007/s00405-009-1030-8; McDonald VM, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02058-2018; Mitchell SAFC, 2017, THORAX, V72, P129, DOI 10.1136/thoraxjnl-2016-208843; MOBEIREEK A, 1995, EUR RESPIR J, V8, P1978, DOI 10.1183/09031936.95.08111978; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Morris MJ, 2010, CHEST, V138, P1213, DOI 10.1378/chest.09-2944; NEWMAN KB, 1995, AM J RESP CRIT CARE, V152, P1382, DOI 10.1164/ajrccm.152.4.7551399; OCONNELL MA, 1995, ANN ALLERG ASTHMA IM, V74, P341; Oktay B, 2009, TUBERK TORAK, V57, P401; PACHT ER, 1995, CHEST, V108, P1772, DOI 10.1378/chest.108.6.1772-a; Parsons JP, 2010, RESP MED, V104, P504, DOI 10.1016/j.rmed.2009.11.004; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Porsbjerg C, 2015, THORAX, V70, pA156, DOI 10.1136/thoraxjnl-2015-207770.293; Song WJ, 2019, ALLERGY ASTHMA IMMUN, V11, P763, DOI 10.4168/aair.2019.11.6.763; Taverne J, 2014, PRESSE MED, V43, pE393, DOI 10.1016/j.lpm.2014.05.017; Tay TR, 2016, RESPIROLOGY, V21, P1384, DOI 10.1111/resp.12838; Tiotiu A, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0056-2018; Walsted ES, 2017, J ASTHMA, V54, P77, DOI 10.1080/02770903.2016.1195843; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yelken K, 2009, RESPIROLOGY, V14, P729, DOI 10.1111/j.1440-1843.2009.01568.x	53	17	18	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1165	1173		10.1016/j.jaci.2019.12.906	http://dx.doi.org/10.1016/j.jaci.2019.12.906			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	31940470	Bronze			2022-12-18	WOS:000523633400013
J	Shears, RK; Jacques, LC; Naylor, G; Miyashita, L; Khandaker, S; Lebre, F; Lavelle, EC; Grigg, J; French, N; Neill, DR; Kadioglu, A				Shears, Rebecca K.; Jacques, Laura C.; Naylor, Georgia; Miyashita, Lisa; Khandaker, Shadia; Lebre, Filipa; Lavelle, Ed C.; Grigg, Jonathan; French, Neil; Neill, Daniel R.; Kadioglu, Aras			Exposure to diesel exhaust particles increases susceptibility to invasive pneumococcal disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Streptococcus pneumoniae; pneumococcus; pneumonia; pneumococcal disease; particulates; pollution	AMBIENT AIR-POLLUTION; STREPTOCOCCUS-PNEUMONIAE; ALVEOLAR MACROPHAGES; HOSPITAL ADMISSIONS; IMMUNE-RESPONSE; PULMONARY; CLEARANCE; INFECTION; CHILDREN; RISK	Background: The World Health Organization estimates that air pollution is responsible for 7 million deaths per annum, with 7% of these attributable to pneumonia. Many of these fatalities have been linked to exposure to high levels of airborne particulates, such as diesel exhaust particles (DEPs). Objectives: We sought to determine whether exposure to DEPs could promote the progression of asymptomatic nasopharyngeal carriage of Streptococcus pneumoniae to invasive pneumococcal disease. Methods: We used mouse models and in vitro assays to provide a mechanistic understanding of the link between DEP exposure and pneumococcal disease risk, and we confirmed our findings by using induced sputum macrophages isolated from healthy human volunteers. Results: We demonstrate that inhaled exposure to DEPs disrupts asymptomatic nasopharyngeal carriage of S pneumoniae in mice, leading to dissemination to lungs and blood. Pneumococci are transported from the nasopharynx to the lungs following exposure to DEPs, leading to increased proinflammatory cytokine production, reduced phagocytic function of alveolar macrophages, and consequently, increased pneumococcal loads within the lungs and translocation into blood. These findings were confirmed by using DEP-exposed induced sputum macrophages isolated from healthy volunteers, demonstrating that impaired innate immune mechanisms following DEP exposure are also at play in humans. Conclusion: Lung inhaled DEPs increase susceptibility to pneumococcal disease by leading to loss of immunological control of pneumococcal colonisation, increased inflammation, tissue damage, and systemic bacterial dissemination.	[Shears, Rebecca K.; Jacques, Laura C.; Naylor, Georgia; Khandaker, Shadia; French, Neil; Neill, Daniel R.; Kadioglu, Aras] Univ Liverpool, Inst Infect & Global Hlth, Bacterial Pathogenesis & Immun Grp, Liverpool, Merseyside, England; [Neill, Daniel R.] Univ Liverpool, Inst Infect & Global Hlth, Microbial Evolut Genom & Adaptat Grp, Liverpool, Merseyside, England; [Miyashita, Lisa; Grigg, Jonathan] Queen Mary Univ London, Ctr Genom & Child Hlth, Blizard Inst, London, England; [Lebre, Filipa; Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin, Ireland	University of Liverpool; University of Liverpool; University of London; Queen Mary University London; Trinity College Dublin	Kadioglu, A (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Ronald Ross Bldg,8 West Derby St, Liverpool L69 7BE, Merseyside, England.	A.Kadioglu@liverpool.ac.uk		Shears, Rebecca/0000-0002-0279-2801; French, Neil/0000-0003-4814-8293; Grigg, Jonathan/0000-0003-3109-6028; Lebre, Filipa/0000-0003-3146-269X; Neill, Daniel/0000-0002-7911-8153	UK Medical Research Council Programme Grant [MR/P011284/1]; Sir Henry Dale Fellowship - Wellcome Trust [204457/Z/16/Z]; Sir Henry Dale Fellowship - Royal Society [204457/Z/16/Z]; MRC [MR/P011284/1] Funding Source: UKRI	UK Medical Research Council Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a UK Medical Research Council Programme Grant (MR/P011284/1) awarded to A.K. D.R.N. was supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (204457/Z/16/Z).	Aberdein JD, 2013, CLIN EXP IMMUNOL, V174, P193, DOI 10.1111/cei.12170; Achakulwisut P, 2019, LANCET PLANET HEALTH, V3, pE166, DOI 10.1016/S2542-5196(19)30046-4; Alvarez-Simon D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179569; Bangert M, 2012, J INFECT DIS, V205, P1399, DOI 10.1093/infdis/jis223; Barath S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-19; Barnett AG, 2005, AM J RESP CRIT CARE, V171, P1272, DOI 10.1164/rccm.200411-1586OC; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Brugha R, 2014, PAEDIATR RESPIR REV, V15, P194, DOI 10.1016/j.prrv.2014.03.001; Carlsten C, 2016, THORAX, V71, P35, DOI 10.1136/thoraxjnl-2015-207399; Chang XH, 2015, ARCH ENVIRON OCCUP H, V70, P98, DOI 10.1080/19338244.2013.807763; Chaudhuri N, 2010, AM J PHYSIOL-LUNG C, V299, pL263, DOI 10.1152/ajplung.00297.2009; Chaudhuri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051107; Cole J, 2014, ADV MICROB PHYSIOL, V65, P125, DOI 10.1016/bs.ampbs.2014.08.004; Dagan R, 2011, PEDIATR INFECT DIS J, V30, P1, DOI 10.1097/INF.0b013e3182005389; Das R, 2014, J IMMUNOL, V193, P764, DOI 10.4049/jimmunol.1400133; de Brito JM, 2018, SCI TOTAL ENVIRON, V628-629, P1223, DOI 10.1016/j.scitotenv.2018.02.019; De Grove KC, 2018, CLIN EXP ALLERGY, V48, P1665, DOI 10.1111/cea.13261; Demetriou CA, 2012, OCCUP ENVIRON MED, V69, P619, DOI 10.1136/oemed-2011-100566; El-Zein A, 2007, SCI TOTAL ENVIRON, V384, P134, DOI 10.1016/j.scitotenv.2007.06.005; Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-130; Fiordelisi A, 2017, HEART FAIL REV, V22, P337, DOI 10.1007/s10741-017-9606-7; Franklin BA, 2015, CURR PROB CARDIOLOGY, V40, P207, DOI 10.1016/j.cpcardiol.2015.01.003; Gingles NA, 2001, INFECT IMMUN, V69, P426, DOI 10.1128/IAI.69.1.426-434.2001; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Gunier RB, 2003, J EXPO ANAL ENV EPID, V13, P240, DOI 10.1038/sj.jea.7500276; Harrod KS, 2005, TOXICOL SCI, V83, P155, DOI 10.1093/toxsci/kfi007; Hirayama D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010092; Jacquemin B, 2015, ENVIRON HEALTH PERSP, V123, P613, DOI 10.1289/ehp.1408206; Jaspers I, 2005, TOXICOL SCI, V85, P990, DOI 10.1093/toxsci/kfi141; Jusot JF, 2017, J ALLERGY CLIN IMMUN, V139, P977, DOI 10.1016/j.jaci.2016.04.062; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Lee SL, 2006, CLIN EXP ALLERGY, V36, P1138, DOI 10.1111/j.1365-2222.2006.02555.x; Lensmar C, 1998, EUR RESPIR J, V12, P595, DOI 10.1183/09031936.98.12030595; Li JH, 2016, INT J CHRONIC OBSTR, V11, P3079, DOI 10.2147/COPD.S122282; Lin WW, 2011, ENVIRON HEALTH PERSP, V119, P1507, DOI 10.1289/ehp.1103461; MacIntyre EA, 2014, ENVIRON HEALTH PERSP, V122, P107, DOI 10.1289/ehp.1306755; McLeish JA, 2010, THROMB HAEMOSTASIS, V103, P797, DOI 10.1160/TH09-06-0413; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; Meo SA, 2015, EUR REV MED PHARMACO, V19, P4890; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Moldoveanu B, 2009, J INFLAMM RES, V2, P1; National Institute of Standards Technology, CERT AN STAND REF MA; Neill DR, 2014, AM J RESP CRIT CARE, V189, P1250, DOI 10.1164/rccm.201401-0128OC; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; PRUSS-USTUN A., 2016, PREVENTING DIS HLTH; Qiu H, 2014, THORAX, V69, P1027, DOI 10.1136/thoraxjnl-2014-205429; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Rynning I, 2018, TOXICOL SCI, V166, P51, DOI 10.1093/toxsci/kfy183; Santana FPR, 2019, ECOTOX ENVIRON SAFE, V167, P494, DOI 10.1016/j.ecoenv.2018.10.005; Tabor CM, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0116-x; Tanaka M, 2013, J TOXICOL SCI, V38, P35, DOI 10.2131/jts.38.35; World Health Organization, AMB OUTD AIR QUAL HL; World Health Organization, AMB AIR POLL; World Health Organization, ANN MEAN PM2 5 MAP; Xu Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153099; Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711; Yu XJ, 2015, EBIOMEDICINE, V2, P583, DOI 10.1016/j.ebiom.2015.04.003	65	17	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1272	+		10.1016/j.jaci.2019.11.039	http://dx.doi.org/10.1016/j.jaci.2019.11.039			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	31983527	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000523633400023
J	Mendez-Barbero, N; Yuste-Montalvo, A; Nunez-Borque, E; Jensen, BM; Gutierrez-Munoz, C; Tome-Amat, J; Garrido-Arandia, M; Diaz-Perales, A; Ballesteros-Martinez, C; Laguna, JJ; Beitia, JM; Poulsen, LK; Cuesta-Herranz, J; Blanco-Colio, LM; Esteban, V				Mendez-Barbero, Nerea; Yuste-Montalvo, Alma; Nunez-Borque, Emilio; Jensen, Bettina M.; Gutierrez-Munoz, Carmen; Tome-Amat, Jaime; Garrido-Arandia, Maria; Diaz-Perales, Araceli; Ballesteros-Martinez, Contanza; Julio Laguna, Jose; Beitia, J. M.; Poulsen, Lars K.; Cuesta-Herranz, Javier; Miguel Blanco-Colio, Luis; Esteban, Vanesa			The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Anaphylaxis; TNF-like weak inducer of apoptosis/fibroblast growth factor-inducible molecule 14 axis; vascular permeability; mast cells; endothelial cells	TWEAK/FN14 PATHWAY; APOPTOSIS TWEAK; MURINE MODEL; CELLS; FN14; CYTOKINE; ATHEROSCLEROSIS; PROLIFERATION; SEVERITY; DEPENDS	Background: Anaphylaxis includes mast cell (MC) activation, but less is known about downstream mechanisms (ie, vascular permeability controlled by endothelial cells [ECs]). The TNF-like weak inducer of apoptosis (TWEAK) and its sole receptor, fibroblast growth factor-inducible molecule 14 (Fn14), belong to the TNF superfamily and are involved in proinflammatory responses. Objective: We sought to investigate the role of TWEAK/Fn14 axis in anaphylaxis. Methods: In vivo vascular permeability and mouse models of passive systemic anaphylaxis (PSA) and active systemic anaphylaxis were applied to wild-type (WT), TWEAK- and Fn14-deficient mice (TWEAK(-/-) and Fn14(-/-), respectively). Primary bone marrow-derived mast cells (BMMCs) and ECs from WT and Fn14(-/-) or TWEAK(-/-) mice were studied. The TWEAK/Fn14 axis was also investigated in human samples. Results: Mice with PSA and active systemic anaphylaxis had increased Fn14 and TWEAK expression in lung tissues and increased serum soluble TWEAK concentrations. TWEAK and Fn14 deficiencies prevent PSA-related symptoms, resulting in resistance to decreased body temperature, less severe reactions, and maintained physical activity. Numbers of MCs after PSA are similar between genotypes in different tissue regions, such as ear skin and the trachea, tongue, peritoneum, lungs, and bone marrow. Moreover, in vitro studies revealed no differences in degranulation or mediator release between WT and Fn14(-/-) BMMCs after IgE-FceRI stimulation. In vivo and in vitro histamine and platelet-activating factor administration increases Fn14 receptor expression in lungs and ECs. Moreover, Fn14 deficiency in ECs maintained in vitro impermeability when stimulated by mediators or activated BMMCs but not by TWEAK(-/-) BMMCs, indicating that Fn14 is crucial for endothelial barrier function. TWEAK/Fn14 deletion or TWEAK-blocking antibody prevented histamine/platelet-activating factor-induced vascular subcutaneous permeability. Circulating soluble TWEAK levels were increased in patients with anaphylaxis, and plasma from those patients increased Fn14 expression in ECs. Conclusion: The TWEAK/Fn14 axis participates in anaphylactic reactions. Inhibition of TWEAK/Fn14 interaction could be efficacious in anaphylaxis therapy.	[Mendez-Barbero, Nerea; Gutierrez-Munoz, Carmen; Miguel Blanco-Colio, Luis] IIS Fdn Jimenez Diaz, Vasc Res Lab, Avda Reyes Catolicos 2, Madrid 28040, Spain; [Yuste-Montalvo, Alma; Nunez-Borque, Emilio; Ballesteros-Martinez, Contanza; Esteban, Vanesa] IIS Fdn Jimenez Diaz, Dept Allergy & Immunol, Avda Reyes Catolicos 2, Madrid 28040, Spain; [Cuesta-Herranz, Javier] IIS Fdn Jimenez Diaz, Dept Allergy, Madrid, Spain; [Mendez-Barbero, Nerea; Miguel Blanco-Colio, Luis] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Jensen, Bettina M.; Poulsen, Lars K.] Copenhagen Univ Hosp, Gentofte Hosp, Allergy Clin, Hellerup, Denmark; [Tome-Amat, Jaime; Garrido-Arandia, Maria; Diaz-Perales, Araceli] Univ Politecn Madrid, Ctr Plant Biotechnol & Genom UPM INIA, Madrid, Spain; [Tome-Amat, Jaime; Garrido-Arandia, Maria; Diaz-Perales, Araceli] ARADyAL Network RD16 0006 0003, Madrid, Spain; [Julio Laguna, Jose] Alfonso X El Sabio Univ, Hosp Cent Cruz Roja, Fac Med, Allergy Unit,Allergoanaesthesia Unit, Madrid, Spain; [Julio Laguna, Jose] ARADyAL Network RD16 0006 0033, Madrid, Spain; [Beitia, J. M.] Hosp Univ Guadalajara, Allergy Unit, Guadalajara, Spain; [Beitia, J. M.] ARADyAL Network RD16 0006 0023, Madrid, Spain; [Cuesta-Herranz, Javier; Esteban, Vanesa] ARADyAL Network RD16 0006 0013, Madrid, Spain	Fundacion Jimenez Diaz; Fundacion Jimenez Diaz; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; University of Copenhagen; Herlev & Gentofte Hospital; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP); Universidad Alfonso X el Sabio (UAX)	Blanco-Colio, LM (corresponding author), IIS Fdn Jimenez Diaz, Vasc Res Lab, Avda Reyes Catolicos 2, Madrid 28040, Spain.; Esteban, V (corresponding author), IIS Fdn Jimenez Diaz, Dept Allergy & Immunol, Avda Reyes Catolicos 2, Madrid 28040, Spain.	lblanco@fjd.es; vesteban@fjd.es	Martinez, Jose Julio Laguna/L-6891-2017; Díaz-Perales, Araceli/D-8433-2016; Esteban, Vanesa/J-8075-2012; Mendez-Barbero, Nerea/AAV-4643-2020; Núñez Borque, Emilio/D-5123-2019; Garrido-Arandia, Maria/ABG-9760-2020	Martinez, Jose Julio Laguna/0000-0001-5909-8979; Díaz-Perales, Araceli/0000-0002-1093-3627; Esteban, Vanesa/0000-0002-7500-6277; Mendez-Barbero, Nerea/0000-0003-1620-3067; Núñez Borque, Emilio/0000-0003-2928-410X; TOME-AMAT, JAIME/0000-0003-4442-3649; Garrido Arandia, Maria/0000-0001-6114-5754; Ballesteros Martinez, Constanza/0000-0003-4085-0459; Yuste, Alma/0000-0002-4727-1284	Spanish Council Ministry of Science and Innovation (Ramon y Cajal Program) [RyC-12880-2013]; Fundacion Merck Salud; program LOREAL for women in science 2016; Instituto de Salud Carlos III [PI13/00928, PI16/01419, PI16/00888, PI18/00348]; RETICS ARADyAL [RD16/0006/0003, RD16/0006/0013, RD16/0006/0033, RD16/0006/0023]; FEDER; Consejeria de Educacion, Juventud y Deporte de la Comunidad de Madrid y del Fondo Social Europeo [CAM PEJD-2017-PRE/BMD5007]; Allerscreening project [EU SEP-210415617]	Spanish Council Ministry of Science and Innovation (Ramon y Cajal Program); Fundacion Merck Salud; program LOREAL for women in science 2016; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); RETICS ARADyAL; FEDER(European Commission); Consejeria de Educacion, Juventud y Deporte de la Comunidad de Madrid y del Fondo Social Europeo; Allerscreening project	This work was supported by the Spanish Council Ministry of Science and Innovation (Ramon y Cajal Program RyC-12880-2013), the Fundacion Merck Salud, and the program LOREAL for women in science 2016 (to V.E.). This work was also supported by grants from the Instituto de Salud Carlos III (PI13/00928, PI16/01419, PI16/00888 and PI18/00348) and RETICS ARADyAL (RD16/0006/0003, RD16/0006/0013, RD16/0006/0033, and RD16/0006/0023) and cosupported by FEDER grants. N.M.-B, is a Juan de la Cierva researcher (IJCI-2016-29630). A.Y.-M. is supported by Consejeria de Educacion, Juventud y Deporte de la Comunidad de Madrid y del Fondo Social Europeo (CAM PEJD-2017-PRE/BMD5007). M.G.-A. received fund support from the Allerscreening project (EU SEP-210415617).	Ashina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132367; Ballesteros-Martinez C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01323; Bertin D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00489; Berzal S, 2015, J CELL PHYSIOL, V230, P1580, DOI 10.1002/jcp.24905; Blanco-Colio LM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00003; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Brown SGA, 2013, J ALLERGY CLIN IMMUN, V132, P1141, DOI 10.1016/j.jaci.2013.06.015; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2014, SEMIN IMMUNOL, V26, P229, DOI 10.1016/j.smim.2014.02.006; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, BASIC RES CARDIOL, V105, P301, DOI 10.1007/s00395-009-0046-y; Dahlin JS, 2015, STEM CELLS DEV, V24, P1703, DOI 10.1089/scd.2014.0553; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Fernandez-Laso V, 2017, ATHEROSCLEROSIS, V260, P130, DOI 10.1016/j.atherosclerosis.2017.03.043; Galli SJ, 2016, AM J PATHOL, V186, P212, DOI 10.1016/j.ajpath.2015.07.025; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Henaut L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.220; Inta I, 2008, J NEUROL SCI, V275, P117, DOI 10.1016/j.jns.2008.08.005; Itoigawa Y, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0207-5; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Kim SY, 2018, PEDIAT ALLERG IMM-UK, V29, P42, DOI 10.1111/pai.12827; Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Liu QL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6746870; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Mendez-Barbero N, 2013, EMBO MOL MED, V5, P1901, DOI 10.1002/emmm.201302842; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Muraro A, 2017, ALLERGY, V72, P1006, DOI 10.1111/all.13132; Nakamura T, 2018, BRIT J PHARMACOL, V175, P2538, DOI 10.1111/bph.14332; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Poulsen LK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00871; Radinger M, 2015, METHODS MOL BIOL, V1220, P307, DOI 10.1007/978-1-4939-1568-2_19; Reber LL, 2017, J ALLERGY CLIN IMMUN, V140, P335, DOI 10.1016/j.jaci.2017.06.003; Rodriguez MJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40449; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sastre C, 2014, J CELL MOL MED, V18, P721, DOI 10.1111/jcmm.12221; Schnittler H, 2016, HISTOCHEM CELL BIOL, V146, P651, DOI 10.1007/s00418-016-1501-0; SILVERMAN HJ, 1984, AM J MED, V77, P341, DOI 10.1016/0002-9343(84)90717-4; Stephan D, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-9; Stock AD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00484; Vadas P, 2013, J ALLERGY CLIN IMMUN, V131, P144, DOI 10.1016/j.jaci.2012.08.016; Wawrzyniak M, 2015, J ALLERGY CLIN IMMUN, V135, P1625, DOI 10.1016/j.jaci.2014.11.006; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xia YM, 2015, J AM SOC NEPHROL, V26, P1053, DOI 10.1681/ASN.2014030233; Yepes M, 2005, AM J PATHOL, V166, P511, DOI 10.1016/S0002-9440(10)62273-0; Zamorano P, 2017, AM J PHYSIOL-HEART C, V313, pH66, DOI 10.1152/ajpheart.00135.2017; Zhang XH, 2007, J CEREBR BLOOD F MET, V27, P534, DOI 10.1038/sj.jcbfm.9600368	53	17	17	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					583	+		10.1016/j.jaci.2019.09.019	http://dx.doi.org/10.1016/j.jaci.2019.09.019			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31679818	hybrid			2022-12-18	WOS:000512887400021
J	Abuabara, K; You, Y; Margolis, DJ; Hoffmann, TJ; Risch, N; Jorgenson, E				Abuabara, Katrina; You, Yue; Margolis, David J.; Hoffmann, Thomas J.; Risch, Neil; Jorgenson, Eric			Genetic ancestry does not explain increased atopic dermatitis susceptibility or worse disease control among African American subjects in 2 large US cohorts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; eczema; genetic ancestry; disease control; racial/ethnic disparities	GENOME-WIDE ASSOCIATION; ECZEMA PREVALENCE; EPIDEMIOLOGY RESEARCH; TOPICAL PIMECROLIMUS; GENOTYPE IMPUTATION; DIAGNOSTIC-CRITERIA; LUNG-FUNCTION; ADULT HEALTH; CHILDREN; FILAGGRIN	Background: Atopic dermatitis (AD) is more common among African American children. Whether there are racial/ethnic difference among adults with AD and the causes for those disparities are unclear. Objective: We sought to examine the relationship between self-reported race/ethnicity and AD and determine whether African genetic ancestry is predictive of these outcomes among African American subjects. Methods: We analyzed data from 2 independent multiethnic longitudinal studies: 86,893 subjects aged 18 to 100 years from the Kaiser Permanente Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort and 5467 subjects aged 2 to 26 years from the national Pediatric Eczema Elective Registry (PEER) cohort. The primary outcomes were physician-diagnosed AD in GERA and repeated measures of self-reported disease control among patients with physician-diagnosed AD at 6-month intervals in PEER. We examined whether self-identified African American race/ ethnicity was predictive of these outcomes and then tested whether a continuous measure of African genetic ancestry was associated with outcomes within the African American group. Results: AD was more common among self-identified African American subjects than non-Hispanic white subjects in GERA (4.4% vs 2.1%; odds ratio, 2.06; 95% CI, 1.70-2.48) and less well-controlled in PEER subjects (odds of 1-level worse control, 1.91; 95% CI, 1.64-2.22). However, African genetic ancestry was not associated with AD risk or control among self-identified African American subjects in either cohort, nor did an AD polygenic risk score or genetic skin pigment score explain the AD disparities in patients with AD. Conclusion: Ancestry-related genetic effects do not explain increased AD prevalence or poorer disease control among African American subjects.	[Abuabara, Katrina] Univ Calif San Francisco, Dept Dermatol, Program Clin Res, San Francisco, CA 94115 USA; [You, Yue] Univ Calif Berkeley, Div Biostat & Epidemiol, Berkeley, CA 94720 USA; [Margolis, David J.] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Margolis, David J.] Univ Penn, Ctr Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hoffmann, Thomas J.; Risch, Neil] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94115 USA; [Hoffmann, Thomas J.; Risch, Neil] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94115 USA; [Risch, Neil; Jorgenson, Eric] Kaiser Permanente, Div Res, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente	Abuabara, K (corresponding author), UCSF, Dept Dermatol, 2340 Sutter St,N421, San Francisco, CA 94115 USA.	Katrina.abuabara@ucsf.edu			Robert Wood Johnson Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K23 AR073915]; National Eye Institute [R01 EY027004]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK116738]; National Institute on Aging; National Institute of Mental Health; National Institute of Health Common Fund [RC2 AG036607]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Health Common Fund	K.A. is supported by grants from the Robert Wood Johnson Foundation and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS; K23 AR073915). E.J. is supported by grants from the National Eye Institute (R01 EY027004) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK116738). Support for participant enrollment, survey completion, and biospecimen collection for the GERA was provided by the Robert Wood Johnson Foundation, the Wayne and Gladys Valley Foundation, the Ellison Medical Foundation, and Kaiser Permanente National and Regional Community Benefit programs. Genotyping of the GERA cohort was funded by a grant from the National Institute on Aging, the National Institute of Mental Health, and the National Institute of Health Common Fund (RC2 AG036607 to Cathy Schaefer and N.R.).	Abuabara K, 2018, J ALLERGY CLIN IMMUN, V141, P778, DOI 10.1016/j.jaci.2017.05.031; Almoguera B, 2019, J ALLERGY CLIN IMMUN, V143, P1229, DOI 10.1016/j.jaci.2018.10.038; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Chaitanya L, 2018, FORENSIC SCI INT-GEN, V35, P123, DOI 10.1016/j.fsigen.2018.04.004; Chang J, 2017, BRIT J DERMATOL, V177, pE114, DOI 10.1111/bjd.15403; Choquet H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04555-4; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Eaaswarkhanth M, 2016, GENOME BIOL EVOL, V8, P3240, DOI 10.1093/gbe/evw242; Eichenfield LF, 2002, J AM ACAD DERMATOL, V46, P495, DOI 10.1067/mjd.2002.122187; Gupta J, 2016, J ALLERGY CLIN IMMUN, V138, P676, DOI 10.1016/j.jaci.2016.02.045; Hanifin IM, 2007, DERMATITIS, V18, P82, DOI 10.2310/6620.2007.06034; Hernandez-Pacheco N, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0635-4; Hoffmann TJ, 2018, GENETICS, V210, P499, DOI 10.1534/genetics.118.301479; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kapoor R, 2009, PEDIATR DERMATOL, V26, P682, DOI 10.1111/j.1525-1470.2009.01013.x; Kapp A, 2002, J ALLERGY CLIN IMMUN, V110, P277, DOI 10.1067/mai.2002.126500; Kramer U, 1998, BRIT J DERMATOL, V139, P1040; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Lin T, 2019, J INVEST DERMATOL, V139, pS137; Mahdavinia M, 2017, J ALLER CL IMM-PRACT, V5, P352, DOI 10.1016/j.jaip.2016.10.006; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Margolis DJ, 2018, J INVEST DERMATOL, V138, P1501, DOI 10.1016/j.jid.2018.01.029; Margolis DJ, 2014, J INVEST DERMATOL, V134, P2272, DOI 10.1038/jid.2014.126; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Paller AS, 2017, J ALLERGY CLIN IMMUN, V140, P633, DOI 10.1016/j.jaci.2017.07.006; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; Polcari I, 2014, PEDIATR DERMATOL, V31, P489, DOI 10.1111/pde.12355; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; R Core Team, 2021, COMPUTER SOFTWARE; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; Sanyal RD, 2019, ANN ALLERG ASTHMA IM, V122, P99, DOI 10.1016/j.anai.2018.08.024; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Silverberg JI, 2017, ALLERGY, V72, P2026, DOI 10.1111/all.13225; Silverberg JI, 2014, DERMATITIS, V25, P107, DOI 10.1097/DER.0000000000000034; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031; Statacorp, 2021, STATA STAT SOFTWARE; Stefflova K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014495; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Uphoff E, 2015, EUR RESPIR J, V46, P364, DOI 10.1183/09031936.00114514; Vakharia PP, 2018, AM J CLIN DERMATOL, V19, P15, DOI 10.1007/s40257-017-0299-4; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Winge MCG, 2011, BRIT J DERMATOL, V165, P1074, DOI 10.1111/j.1365-2133.2011.10475.x	48	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					192	+		10.1016/j.jaci.2019.06.044	http://dx.doi.org/10.1016/j.jaci.2019.06.044			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31369801	Green Accepted, Bronze			2022-12-18	WOS:000505590800026
J	Debeuf, N; Zhakupova, A; Steiner, R; Van Gassen, S; Deswarte, K; Fayazpour, F; Van Moorleghem, J; Vergote, K; Pavie, B; Lemeire, K; Hammad, H; Hornemann, T; Janssens, S; Lambrecht, BN				Debeuf, Nincy; Zhakupova, Assem; Steiner, Regula; Van Gassen, Sofie; Deswarte, Kim; Fayazpour, Farzaneh; Van Moorleghem, Justine; Vergote, Karl; Pavie, Benjamin; Lemeire, Kelly; Hammad, Hamida; Hornemann, Thorsten; Janssens, Sophie; Lambrecht, Bart N.			The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; ORMDL3; house dust mite; Alternaria alternata; sphingolipids; ceramides	SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID BIOSYNTHESIS; AIRWAY RESPONSIVENESS; PROTEINS MEDIATE; EXPRESSION; SPHINGOSINE-1-PHOSPHATE; VARIANTS; ALLERGEN; MODEL; ROLES	Background: Genome-wide association studies in asthma have repeatedly identified single nucleotide polymorphisms in the ORM (yeast)-like protein isoform 3 (ORMDL3) gene across different populations. Although the ORM homologues in yeast are well-known inhibitors of sphingolipid synthesis, it is still unclear whether and how mammalian ORMDL3 regulates sphingolipid metabolism and whether altered sphingolipid synthesis would be causally related to asthma risk. Objective: We sought to examine the in vivo role of ORMDL3 in sphingolipid metabolism and allergic asthma. Methods: Ormdl3-LacZ reporter mice, gene-deficient Ormdl3(-/-) mice, and overexpressing Ormdl3(Tg/wt) mice were exposed to physiologically relevant aeroallergens, such as house dust mite (HDM) or Alternaria alternata, to induce experimental asthma. Mass spectrometry-based sphingolipidomics were performed, and airway eosinophilia, T(H)2 cytokine production, immunoglobulin synthesis, airway remodeling, and bronchial hyperreactivity were measured. Results: HDM challenge significantly increased levels of total sphingolipids in the lungs of HDM-sensitized mice compared with those in control mice. In Ormdl3(Tg/wt) mice the allergen-induced increase in lung ceramide levels was significantly reduced, whereas total sphingolipid levels were not affected. Conversely, in liver and serum, levels of total sphingolipids, including ceramides, were increased in Ormdl3(-/-) mice, whereas they were decreased in Ormdl3(Tg/wt) mice. This difference was independent of allergen exposure. Despite these changes, all features of asthma were identical between wildtype, Ormdl3(Tg/wt), and Ormdl3(-/-) mice across several models of experimental asthma. Conclusion: ORMDL3 regulates systemic ceramide levels, but genetically interfering with Ormdl3 expression does not result in altered experimental asthma.	[Debeuf, Nincy; Deswarte, Kim; Van Moorleghem, Justine; Vergote, Karl; Hammad, Hamida; Lambrecht, Bart N.] VIB Ctr Inflammat Res, Lab Mucosal Immunol & Immunoregulat, Ghent, Belgium; [Debeuf, Nincy; Deswarte, Kim; Fayazpour, Farzaneh; Van Moorleghem, Justine; Vergote, Karl; Hammad, Hamida; Janssens, Sophie; Lambrecht, Bart N.] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium; [Zhakupova, Assem; Steiner, Regula; Hornemann, Thorsten] Univ Zurich, Inst Clin Chem, Zurich, Switzerland; [Zhakupova, Assem; Steiner, Regula; Hornemann, Thorsten] Univ Hosp Zurich, Zurich, Switzerland; [Van Gassen, Sofie] VIB Ctr Inflammat Res, Data Min & Modeling Biomed, Ghent, Belgium; [Van Gassen, Sofie] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium; [Fayazpour, Farzaneh; Janssens, Sophie] VIB Ctr Inflammat Res, Lab ER Stress & Inflammat, Ghent, Belgium; [Pavie, Benjamin] VIB Ctr Inflammat Res, VIB Bioimaging Core, Ghent, Belgium; [Pavie, Benjamin; Lemeire, Kelly] Univ Ghent, Biomed Mol Biol, Ghent, Belgium; [Lemeire, Kelly] VIB Ctr Inflammat Res, Ghent, Belgium; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Zurich; University of Zurich; University Zurich Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium.; Lambrecht, BN (corresponding author), VIB UGent Ctr Inflammat Res, Technologiepark Zwijnaarde 71, B-9052 Zwijnaarde, Belgium.	bart.lambrecht@ugent.be	Janssens, Sophie/HHN-1756-2022; Lambrecht, Bart N/K-2484-2014; Hammad, Hamida/J-9391-2015	Lambrecht, Bart N/0000-0003-4376-6834; Deswarte, Kim/0000-0002-9761-6973; Van Gassen, Sofie/0000-0002-7119-5330; Pavie, Benjamin/0000-0002-0249-3844; Hammad, Hamida/0000-0003-3762-8603	Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO) [11Y8417N]; European Research Council (ERC) [ERC-ADG 789384]; Concerted Research Initiative Grant (GOA) from Ghent University; Excellence of Science (EOS) research grant [30565447]; ERC Consolidator Grant [ERC-CoG 819314]; FWO; UGent MRP grant (Group-ID); Stichting Tegen Kanker Grant	Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); European Research Council (ERC)(European Research Council (ERC)European Commission); Concerted Research Initiative Grant (GOA) from Ghent University; Excellence of Science (EOS) research grant; ERC Consolidator Grant(European Research Council (ERC)); FWO(FWO); UGent MRP grant (Group-ID); Stichting Tegen Kanker Grant	N.D. is supported by a Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO) grant (11Y8417N). B.N.L. is supported by a European Research Council (ERC) advanced grant (ERC-ADG 789384), a Concerted Research Initiative Grant (GOA) from Ghent University, and an Excellence of Science (EOS) research grant (project 30565447). S.J. is a recipient of an ERC Consolidator Grant (ERC-CoG 819314). B.N.L. and S.J. are holders of several FWO program grants, a UGent MRP grant (Group-ID), and a Stichting Tegen Kanker Grant.	Andiappan AK, 2016, J ALLERGY CLIN IMMUN, V137, P758, DOI 10.1016/j.jaci.2015.08.038; Atkinson D, 2017, NEUROLOGY, V88, P533, DOI 10.1212/WNL.0000000000003595; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Bugajev V, 2016, CELL MOL LIFE SCI, V73, P1265, DOI 10.1007/s00018-015-2047-3; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Carreras-Sureda A, 2013, HUM MOL GENET, V22, P519, DOI 10.1093/hmg/dds450; Chakraborty M, 2013, J CLIN INVEST, V123, P1784, DOI 10.1172/JCI60415; Debeuf Nincy, 2016, Curr Protoc Mouse Biol, V6, P169, DOI 10.1002/cpmo.4; Dullaers M, 2017, J ALLERGY CLIN IMMUN, V140, P76, DOI 10.1016/j.jaci.2016.09.020; GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532, DOI 10.1006/cgip.1993.1040; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hsu KJ, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-4; Jolly PS, 2002, MOL IMMUNOL, V38, P1239, DOI 10.1016/S0161-5890(02)00070-6; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Karmouty-Quintana H, 2012, AM J PHYSIOL-LUNG C, V302, pL736, DOI 10.1152/ajplung.00050.2011; Kiefer K, 2015, J BIOL CHEM, V290, P2822, DOI 10.1074/jbc.M114.595116; KleinJan A, 2013, ALLERGY, V68, P204, DOI 10.1111/all.12082; Kothari PH, 2018, J ALLERGY CLIN IMMUN, V141, P2282, DOI 10.1016/j.jaci.2017.11.057; Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829; Levy BD, 2013, NEW ENGL J MED, V369, P976, DOI 10.1056/NEJMcibr1306864; Li ZQ, 2009, BBA-MOL CELL BIOL L, V1791, P297, DOI 10.1016/j.bbalip.2009.01.010; Lluis A, 2011, J ALLERGY CLIN IMMUN, V127, P1587, DOI 10.1016/j.jaci.2011.03.015; Loser S, 2017, J ALLERGY CLIN IMMUN, V139, P1496, DOI 10.1016/j.jaci.2016.07.033; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; Masini E, 2008, J PHARMACOL EXP THER, V324, P548, DOI 10.1124/jpet.107.131565; Miller M, 2017, J IMMUNOL, V198, P3017, DOI 10.4049/jimmunol.1601848; Miller M, 2017, J ALLERGY CLIN IMMUN, V139, P1373, DOI 10.1016/j.jaci.2016.08.053; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Oskeritzian CA, 2015, J ALLERGY CLIN IMMUN, V135, P1008, DOI 10.1016/j.jaci.2014.10.044; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Oyeniran C, 2015, J ALLERGY CLIN IMMUN, V136, P1035, DOI 10.1016/j.jaci.2015.02.031; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Schedel M, 2015, J ALLERGY CLIN IMMUN, V136, P893, DOI 10.1016/j.jaci.2015.03.014; Schmiedel BJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13426; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Stein MM, 2018, J ALLERGY CLIN IMMUN, V142, P749, DOI 10.1016/j.jaci.2017.12.974; Strettoi E, 2010, P NATL ACAD SCI USA, V107, P18706, DOI 10.1073/pnas.1007644107; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Vanheerswynghels M, 2018, METHODS MOL BIOL, V1799, P183, DOI 10.1007/978-1-4939-7896-0_15; Walther TC, 2010, P NATL ACAD SCI USA, V107, P5701, DOI 10.1073/pnas.1001503107; Wang XH, 2017, INT J BIOCHEM CELL B, V87, P8, DOI 10.1016/j.biocel.2017.03.007; Worgall TS, 2017, CURR OPIN CLIN NUTR, V20, P99, DOI 10.1097/MCO.0000000000000349; Worgall TS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005765; Zhakupova A, 2016, FASEB J, V30, P4289, DOI 10.1096/fj.201600639R; Zhang YM, 2019, AM J RESP CRIT CARE, V199, P478, DOI 10.1164/rccm.201803-0438OC; Zhao YF, 2014, HUM IMMUNOL, V75, P960, DOI 10.1016/j.humimm.2014.08.202; Ziv C, 2016, P NATL ACAD SCI USA, V113, pE1907, DOI 10.1073/pnas.1523168113	63	17	18	1	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1648	1659		10.1016/j.jaci.2019.06.041	http://dx.doi.org/10.1016/j.jaci.2019.06.041			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31330218	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000500694900022
J	Lezmi, G; Abou-Taam, R; Garcelon, N; Dietrich, C; Machavoine, F; Delacourt, C; Adel-Patient, K; Leite-de-Moraes, M				Lezmi, Guillaume; Abou-Taam, Rola; Garcelon, Nicolas; Dietrich, Celine; Machavoine, Francois; Delacourt, Christophe; Adel-Patient, Karine; Leite-de-Moraes, Maria			Evidence for a MAIT-17-high phenotype in children with severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							T-CELLS		[Lezmi, Guillaume; Abou-Taam, Rola; Delacourt, Christophe] Hop Necker Enfants Malad, AP HP, Serv Pneumol & Allergol Pediat, Paris, France; [Lezmi, Guillaume; Abou-Taam, Rola; Dietrich, Celine; Machavoine, Francois; Delacourt, Christophe; Leite-de-Moraes, Maria] Univ Paris 05, Paris, France; [Lezmi, Guillaume; Dietrich, Celine; Machavoine, Francois; Leite-de-Moraes, Maria] CNRS UMR8253, INEM, Lab Immunoregulat & Immunopathol, Paris, France; [Lezmi, Guillaume; Dietrich, Celine; Machavoine, Francois; Leite-de-Moraes, Maria] INSERM, UMR1151, Paris, France; [Garcelon, Nicolas] Univ Paris Descartes Sorbonne Paris Cite, Inst Imagine, Paris, France; [Adel-Patient, Karine] Univ Paris Saclay, UMR Serv Pharmacol & Immunoanal, INRA, CEA,Lab Immuno Allergie Alimentaire, Gif Sur Yvette, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Lezmi, G (corresponding author), Hop Necker Enfants Malad, AP HP, Serv Pneumol & Allergol Pediat, Paris, France.; Lezmi, G (corresponding author), Univ Paris 05, Paris, France.; Lezmi, G (corresponding author), CNRS UMR8253, INEM, Lab Immunoregulat & Immunopathol, Paris, France.; Lezmi, G (corresponding author), INSERM, UMR1151, Paris, France.	guillaume.lezmi@aphp.fr; maria.leite-de-moraes@parisdescartes.fr	de Moraes, Maria Leite/AAV-9159-2020; Garcelon, Nicolas/AAB-3080-2022; LEZMI, Guillaume/E-3029-2019	de Moraes, Maria Leite/0000-0002-2891-2269; lezmi, guillaume/0000-0001-7742-5523; Garcelon, Nicolas/0000-0002-3326-2811	Legs Poix, Chancellerie des Universites, Paris, France; ANR (SevAsthma-children), Paris, France [ANR-18-CE14-0011-01]	Legs Poix, Chancellerie des Universites, Paris, France; ANR (SevAsthma-children), Paris, France(French National Research Agency (ANR))	This work was supported by grants from Legs Poix, Chancellerie des Universites, Paris, France, and by ANR (SevAsthma-children; grant no. ANR-18-CE14-0011-01), Paris, France.	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Allali S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219047; Andersson CK, 2017, J ALLERGY CLIN IMMUN, V139, P1819, DOI 10.1016/j.jaci.2016.09.022; Bel EH, 2011, THORAX, V66, P910, DOI 10.1136/thx.2010.153643; Bush A, 2010, LANCET, V376, P814, DOI 10.1016/S0140-6736(10)61054-9; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Fleming L, 2015, EUR RESPIR J, V46, P1322, DOI 10.1183/13993003.00780-2015; Global Strategy for Asthma Management and Prevention, 2016 GINA REP; Hinks TSC, 2015, J ALLERGY CLIN IMMUN, V136, P323, DOI 10.1016/j.jaci.2015.01.014; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Lezmi G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01766; Lezmi G, 2018, CLIN IMMUNOL, V188, P7, DOI 10.1016/j.clim.2017.11.009; Lezmi G, 2016, EUR RESPIR J, V48, P1320, DOI 10.1183/13993003.00947-2016; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6	14	17	17	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1714	+		10.1016/j.jaci.2019.08.003	http://dx.doi.org/10.1016/j.jaci.2019.08.003			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31425779	Bronze			2022-12-18	WOS:000500694900028
J	Stassen, M; Hartmann, AK; Delgado, SJ; Dehmel, S; Braun, A				Stassen, Michael; Hartmann, Ann-Kathrin; Delgado, Sharon Jimenez; Dehmel, Susann; Braun, Armin			Mast cells within cellular networks	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mast cells; neutrophils; eosinophils; T cells; asthma; murine cytomegalovirus infection; vaccination; substance P; sensory nerves; neurogenic inflammation	ALLERGIC AIRWAY INFLAMMATION; TUMOR-NECROSIS-FACTOR; ACTIVATED T-CELLS; COMPLEX-INDUCED PERITONITIS; GENE-RELATED PEPTIDE; SUBSTANCE-P; NEUTROPHIL RECRUITMENT; HISTAMINE-RELEASE; DENDRITIC CELLS; GRANULOCYTE INFILTRATION	Mast cells are highly versatile in terms of their mode of activation by a host of stimuli and their ability to flexibly release a plethora of biologically highly active mediators. Within the immune system, mast cells can best be designated as an active nexus interlinking innate and adaptive immunity. Here we try to draw an arc from initiation of acute inflammatory reactions to microbial pathogens to development of adaptive immunity and allergies. This multifaceted nature of mast cells is made possible by interaction with multiple cell types of immunologic and nonimmunologic origin. Examples for the former include neutrophils, eosinophils, T cells, and professional antigen-presenting cells. These interactions allow mast cells to orchestrate inflammatory innate reactions and complex adaptive immunity, including the pathogenesis of allergies. Important partners of nonimmunologic origin include cells of the sensory neuronal system. The intimate association between mast cells and sensory nerve fibers allows bidirectional communication, leading to neurogenic inflammation. Evidence is accumulating that this mast cell/nerve crosstalk is of pathophysiologic relevance in patients with allergic diseases, such as asthma.	[Stassen, Michael; Hartmann, Ann-Kathrin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, Langenbeckstr 1, D-55131 Mainz, Germany; [Stassen, Michael; Hartmann, Ann-Kathrin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany; [Delgado, Sharon Jimenez; Dehmel, Susann; Braun, Armin] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Delgado, Sharon Jimenez; Dehmel, Susann; Braun, Armin] German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Breath Re, Hannover, Germany; [Delgado, Sharon Jimenez; Dehmel, Susann; Braun, Armin] Cluster Excellence Regenerat Biol Reconstruct The, Hannover, Germany; [Delgado, Sharon Jimenez; Braun, Armin] Hannover Med Sch, Inst Immunol, Hannover, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Fraunhofer Gesellschaft; Hannover Medical School	Stassen, M (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, Langenbeckstr 1, D-55131 Mainz, Germany.	stassenm@uni-mainz.de	Braun, Armin/B-8750-2009	Braun, Armin/0000-0002-1142-1463	Priority Programme of the Deutsche Forschungsgemeinschaft (DFG) SPP 1394: Mast cells - promoters of health and modulators of disease; Deutsche Forschungsgemeinschaft, Priority Programme SPP1394 [STA 984/4-1, BR 212/3-1]	Priority Programme of the Deutsche Forschungsgemeinschaft (DFG) SPP 1394: Mast cells - promoters of health and modulators of disease(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, Priority Programme SPP1394(German Research Foundation (DFG))	This article was published as part of a supplement sponsored by the members of the Priority Programme of the Deutsche Forschungsgemeinschaft (DFG) SPP 1394: Mast cells - promoters of health and modulators of disease.; Part of the work reported here was funded by the Deutsche Forschungsgemeinschaft, Priority Programme SPP1394, individual projects STA 984/4-1 (to M.S.) and BR 212/3-1 (to A.B.).	ADVENIER C, 1992, AM REV RESPIR DIS, V146, P1177, DOI 10.1164/ajrccm/146.5_Pt_1.1177; Al-Afif A, 2015, J ALLERGY CLIN IMMUN, V136, P1346, DOI 10.1016/j.jaci.2015.01.042; Alkanfari I, 2018, J IMMUNOL, V201, P343, DOI 10.4049/jimmunol.1701793; ALVING K, 1991, CELL TISSUE RES, V264, P529, DOI 10.1007/BF00319042; ANAND P, 1983, BRIT J PHARMACOL, V78, P665, DOI 10.1111/j.1476-5381.1983.tb09418.x; Azimi E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89362; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Baram D, 2001, J IMMUNOL, V167, P4008, DOI 10.4049/jimmunol.167.7.4008; Becker M, 2015, CELL MOL IMMUNOL, V12, P192, DOI 10.1038/cmi.2014.73; Becker M, 2011, J IMMUNOL, V186, P7225, DOI 10.4049/jimmunol.1100676; Becker M, 2009, J IMMUNOL, V182, P6136, DOI 10.4049/jimmunol.0802878; Bhattacharyya SP, 1998, J LEUKOCYTE BIOL, V63, P337, DOI 10.1002/jlb.63.3.337; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; BIENENSTOCK J, 1988, AM REV RESPIR DIS, V138, pS31, DOI 10.1164/ajrccm/138.6_Pt_2.S31; Bischoff SC, 2004, NEUROGASTROENT MOTIL, V16, P185, DOI 10.1111/j.1365-2982.2004.00502.x; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Boyce JA, 2003, PROSTAG LEUKOTR ESS, V69, P195, DOI 10.1016/S0952-3278(03)00081-4; BRAIN SD, 1988, NATURE, V335, P73, DOI 10.1038/335073a0; Breedveld A, 2017, J LEUKOCYTE BIOL, V102, P1003, DOI 10.1189/jlb.4MR0217-048RR; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brill A, 2004, CLIN EXP ALLERGY, V34, P1725, DOI 10.1111/j.1365-2222.2004.02093.x; Brown MA, 2012, IMMUNITY, V36, P891, DOI 10.1016/j.immuni.2012.05.004; Bryce PJ, 2016, J ALLERGY CLIN IMMUN, V138, P769, DOI 10.1016/j.jaci.2016.01.049; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Bulfone-Paus S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00394; Carroll NG, 2002, EUR RESPIR J, V19, P879, DOI 10.1183/09031936.02.00275802; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Doener F, 2013, INT IMMUNOL, V25, P553, DOI 10.1093/intimm/dxt019; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Dudeck J, 2017, J EXP MED, V214, P3791, DOI 10.1084/jem.20160783; Dudeck J, 2015, CELL REP, V13, P399, DOI 10.1016/j.celrep.2015.08.078; Ebert S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004100; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Elieh Ali Komi D, 2017, CLIN REV ALLERG IMMU, V54, P1; Elishmereni M, 2013, ALLERGY, V68, P171, DOI 10.1111/all.12059; Elishmereni M, 2011, ALLERGY, V66, P376, DOI 10.1111/j.1398-9995.2010.02494.x; ELLIS JL, 1992, J PHARMACOL EXP THER, V262, P646; Enoksson M, 2013, BLOOD, V121, P530, DOI 10.1182/blood-2012-05-434209; Fajt Merritt L, 2013, Ann Am Thorac Soc, V10 Suppl, pS158, DOI 10.1513/AnnalsATS.201303-064AW; Feng GY, 2010, REGUL PEPTIDES, V160, P121, DOI 10.1016/j.regpep.2009.11.008; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; FINNEY MJB, 1985, BRIT J PHARMACOL, V85, P29, DOI 10.1111/j.1476-5381.1985.tb08827.x; FOREMAN JC, 1987, INT ARCH ALLER A IMM, V82, P366, DOI 10.1159/000234229; Forsythe P, 2000, CLIN EXP ALLERGY, V30, P225; FROSSARD N, 1991, NEUROPEPTIDES, V19, P157, DOI 10.1016/0143-4179(91)90113-W; Fujisawa D, 2014, J ALLERGY CLIN IMMUN, V134, P622, DOI 10.1016/j.jaci.2014.05.004; Galdiero MR, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00103; Galli SJ, 2018, J ALLERGY CLIN IMMUN, V141, P92, DOI 10.1016/j.jaci.2017.05.029; Gangwar RS, 2016, EUR J PHARMACOL, V778, P77, DOI 10.1016/j.ejphar.2015.10.036; Gaudenzio N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01275; Gaudenzio N, 2009, BLOOD, V114, P4979, DOI 10.1182/blood-2009-02-202648; Glaab T, 2003, ALLERGY, V58, P900, DOI 10.1034/j.1398-9995.2003.00208.x; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Gupta K, 2018, IMMUNOL REV, V282, P168, DOI 10.1111/imr.12622; Harvima IT, 2010, GIORN ITAL DERMAT V, V145, P195; HEANEY LG, 1995, CLIN EXP ALLERGY, V25, P179, DOI 10.1111/j.1365-2222.1995.tb01024.x; Heib V, 2007, BLOOD, V110, P946, DOI 10.1182/blood-2006-07-036889; Huang CF, 1998, J IMMUNOL, V160, P1910; Ieni A, 2016, ANAL CELL PATHOL, V2016, DOI 10.1155/2016/6891971; Inamura N, 1998, J IMMUNOL, V160, P4026; Ito Akihiko, 2008, Journal of Smooth Muscle Research, V44, P83, DOI 10.1540/jsmr.44.83; Jawdat DM, 2004, J IMMUNOL, V173, P5275, DOI 10.4049/jimmunol.173.8.5275; JOOS GF, 1994, AM J RESP CRIT CARE, V149, P1160, DOI 10.1164/ajrccm.149.5.7513594; Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180; Khedr MEMS, 2018, CLIN EXP ALLERGY, V48, P555, DOI 10.1111/cea.13108; Kneilling M, 2009, BLOOD, V114, P1696, DOI 10.1182/blood-2008-11-187682; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Lauenstein HD, 2011, CLIN EXP ALLERGY, V41, P592, DOI 10.1111/j.1365-2222.2010.03636.x; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; LILLY CM, 1995, J APPL PHYSIOL, V78, P1234, DOI 10.1152/jappl.1995.78.4.1234; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100109; Lotfi-Emran S, 2018, J ALLERGY CLIN IMMUN, V141, P311, DOI 10.1016/j.jaci.2017.02.048; Malaviya R, 2000, J LEUKOCYTE BIOL, V67, P841, DOI 10.1002/jlb.67.6.841; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Manorak W, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0698-3; MATSUDA H, 1989, J IMMUNOL, V142, P927; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; McAlpine SM, 2012, FASEB J, V26, P1280, DOI 10.1096/fj.11-188979; McGowen AL, 2009, VACCINE, V27, P3544, DOI 10.1016/j.vaccine.2009.03.069; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Mekori YA, 2016, EUR J PHARMACOL, V778, P84, DOI 10.1016/j.ejphar.2015.03.087; Mercer-Jones MA, 1999, J LEUKOCYTE BIOL, V65, P249, DOI 10.1002/jlb.65.2.249; Minai-Fleminger Y, 2010, CELL TISSUE RES, V341, P405, DOI 10.1007/s00441-010-1010-8; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Nakae S, 2005, P NATL ACAD SCI USA, V102, P6467, DOI 10.1073/pnas.0501912102; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; NALINE E, 1989, AM REV RESPIR DIS, V140, P679, DOI 10.1164/ajrccm/140.3.679; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; NIEBER K, 1992, J ALLERGY CLIN IMMUN, V90, P646, DOI 10.1016/0091-6749(92)90138-R; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; Pang X, 1996, UROLOGY, V47, P436, DOI 10.1016/S0090-4295(99)80469-5; Peng WM, 2013, BLOOD, V122, P1779, DOI 10.1182/blood-2012-12-469882; Podlech J, 2015, MED MICROBIOL IMMUN, V204, P295, DOI 10.1007/s00430-015-0405-2; Quartara L, 2009, EXPERT OPIN INV DRUG, V18, P1843, DOI 10.1517/13543780903379530; QURESHI R, 1988, J IMMUNOL, V141, P2090; Raithel M, 1999, SCAND J GASTROENTERO, V34, P496, DOI 10.1080/003655299750026236; RAMOS BF, 1991, J IMMUNOL, V147, P1636; RAMOS BF, 1990, J IMMUNOL, V145, P1868; Reber LL, 2015, MUCOSAL IMMUNOL, V8, P444, DOI 10.1038/mi.2014.131; Reber LL, 2012, TRENDS IMMUNOL, V33, P613, DOI 10.1016/j.it.2012.09.008; Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015; Reuter S, 2010, YONSEI MED J, V51, P797, DOI 10.3349/ymj.2010.51.6.797; Reuter S, 2010, INT ARCH ALLERGY IMM, V151, P214, DOI 10.1159/000242359; Rochlitzer S, 2011, CLIN EXP ALLERGY, V41, P1609, DOI 10.1111/j.1365-2222.2011.03822.x; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Rost Kristin, 2006, Med Monatsschr Pharm, V29, P200; Salamon P, 2005, ALLERGY, V60, P1316, DOI 10.1111/j.1398-9995.2005.00886.x; Salamon P, 2008, J ALLERGY CLIN IMMUN, V121, P448, DOI 10.1016/j.jaci.2007.08.054; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Schubert N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01870; Shefler I, 2010, J IMMUNOL, V185, P4206, DOI 10.4049/jimmunol.1000409; Sibilano R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13696; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Stoyanova II, 2002, ACTA HISTOCHEM, V104, P185, DOI 10.1078/0065-1281-00641; Subramanian H, 2016, J ALLERGY CLIN IMMUN, V138, P700, DOI 10.1016/j.jaci.2016.04.051; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Suzuki A, 2004, BIOL PHARM BULL, V27, P1891, DOI 10.1248/bpb.27.1891; Suzuki R, 1999, J IMMUNOL, V163, P2410; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; TOMAKI M, 1995, AM J RESP CRIT CARE, V151, P613; Toyoda M, 2000, ARCH DERMATOL RES, V292, P418, DOI 10.1007/s004030000149; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Udayanga KGS, 2016, INT IMMUNOL, V28, P611, DOI 10.1093/intimm/dxw047; UNDEM BJ, 1995, INT ARCH ALLERGY IMM, V107, P199, DOI 10.1159/000236976; Undem BJ, 2014, J ALLERGY CLIN IMMUN, V133, P1521, DOI 10.1016/j.jaci.2013.11.027; Veres TZ, 2009, PHARMACOL THERAPEUT, V122, P203, DOI 10.1016/j.pharmthera.2009.02.007; von Stebut E, 2003, BLOOD, V101, P210, DOI 10.1182/blood-2002-03-0921; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062; Weigand LA, 2012, CHEM IMMUNOL ALLERGY, V98, P142, DOI 10.1159/000336508; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; WERSHIL BK, 1988, J IMMUNOL, V140, P2356; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; YANO H, 1989, J CLIN INVEST, V84, P1276, DOI 10.1172/JCI114295; Yu CK, 2003, J IMMUNOL, V171, P3808, DOI 10.4049/jimmunol.171.7.3808; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826; ZHANG Y, 1991, J CLIN INVEST, V88, P841, DOI 10.1172/JCI115385	143	17	19	2	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4		S	SI		S46	S54		10.1016/j.jaci.2019.01.031	http://dx.doi.org/10.1016/j.jaci.2019.01.031			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8GI	30731122	Bronze			2022-12-18	WOS:000488805000005
J	Beaussant-Cohen, S; Jaber, F; Massaad, MJ; Weeks, S; Jones, J; Alosaimi, MF; Wallace, J; Al-Herz, W; Geha, RS; Chou, J				Beaussant-Cohen, Sarah; Jaber, Faris; Massaad, Michel J.; Weeks, Sabrina; Jones, Jennifer; Alosaimi, Mohammed F.; Wallace, Jacqueline; Al-Herz, Waleed; Geha, Raif S.; Chou, Janet			Combined immunodeficiency in a patient with c-Rel deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LYMPHOCYTE-PROLIFERATION; GENERATION; ACTIVATION		[Beaussant-Cohen, Sarah; Jaber, Faris; Massaad, Michel J.; Weeks, Sabrina; Jones, Jennifer; Alosaimi, Mohammed F.; Wallace, Jacqueline; Geha, Raif S.; Chou, Janet] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Alosaimi, Mohammed F.] King Saud Univ, Dept Pediat, Riyadh, Saudi Arabia; [Al-Herz, Waleed] Kuwait Univ, Fac Med, Dept Pediat, Kuwait, Kuwait; [Al-Herz, Waleed] Al Sabah Hosp, Dept Pediat, Allergy & Clin Immunol Unit, Kuwait, Kuwait; [Massaad, Michel J.] Amer Univ Beirut, Fac Med, Beirut, Lebanon	Harvard University; Boston Children's Hospital; Harvard Medical School; King Saud University; Kuwait University; Al Sabah Hospital; American University of Beirut	Chou, J (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	Janet.Chou@childrens.harvard.edu	Alosaimi, Mohammed F/AAY-5814-2021	Alosaimi, Mohammed F/0000-0002-8025-3491; Jaber, Faris/0000-0002-8483-6934; Wallace, Jacqueline/0000-0001-6565-2534; BEAUSSANT COHEN, Sarah/0000-0002-5591-9730	Perkin Fund [5T32AI007512-33, 5K08AI116979-04, 1R01AI139633-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI139633, T32AI007512, K08AI116979] Funding Source: NIH RePORTER	Perkin Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by 5T32AI007512-33 (to S.B.-C.), 5K08AI116979-04 (to J.C.), 1R01AI139633-01 (to R.S.G.), and the Perkin Fund (to R.S.G.).	Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7128, DOI 10.1073/pnas.1521651112; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; Kaltschmidt B, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6020044; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Milanovic M, 2017, IMMUNOL CELL BIOL, V95, P261, DOI 10.1038/icb.2016.95; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Tangye SG, 2015, CURR OPIN IMMUNOL, V34, P107, DOI 10.1016/j.coi.2015.02.010; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949	11	17	18	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					606	+		10.1016/j.jaci.2019.05.003	http://dx.doi.org/10.1016/j.jaci.2019.05.003			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	31103457	Bronze, Green Accepted			2022-12-18	WOS:000478789300030
J	Custovic, A; Henderson, J; Simpson, A				Custovic, Adnan; Henderson, John; Simpson, Angela			Does understanding endotypes translate to better asthma management options for all?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Asthma; childhood; endotypes; data driven; cohorts; integration; team science	IGE RESPONSES; DOUBLE-BLIND; CHILDREN; THERAPY; CLASSIFICATION; FLUTICASONE; MONTELUKAST; SYMPTOMS; INFANTS	Despite the development of novel treatments, improvement in the design of delivery devices, and new technologies for monitoring and improving adherence, the burden of asthma is not decreasing. Predicting an individual patient's response to asthma drugs remains challenging, and the provision of personalized treatment remains elusive. Although biomarkers, such as allergic sensitization and blood eosinophilia, might be important predictors of response to inhaled corticosteroids in preschool children, these relatively cheap and available investigations are seldom used in clinical practice to select patients for corticosteroid prescription. However, for the majority of patients, response to different treatments cannot be accurately predicted. One of the key factors preventing further advances is the reductionist view of asthma as a single disease, which is forcing patients with different asthma subtypes into a single group for empiric treatment. This inevitably results in treatment failures and, for some, an unacceptable risk/benefit ratio. The approach to asthma today is an example of the traditional symptom (diagnosis) based, one size -fits-all approach rather than a stratified approach, and our guidelines-driven management based on a unitary diagnosis might not be the optimal way to deliver care. The only way to deliver stratified medicine and find a cure is through the understanding of asthma endotypes. We propose that the way to discover endotypes, biomarkers, and personalized treatments is through the iterative process based on interpretation of big data analytics from birth and patient cohorts, responses to treatments in randomized controlled trials, and in vitro mechanistic studies using human samples and experimental animal models, with technological and methodological advances at its core.	[Custovic, Adnan] Imperial Coll London, Dept Paediat, London, England; [Custovic, Adnan] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Henderson, John] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Simpson, Angela] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Infect Immun & Resp Med,Sch Biol Sci, Manchester, Lancs, England	Imperial College London; Imperial College London; University of Bristol; University of Manchester	Custovic, A (corresponding author), Imperial Coll London, London W2 1PG, England.	a.custovic@imperial.ac.uk	Custovic, Adnan/A-2435-2012	Custovic, Adnan/0000-0001-5218-7071; Simpson, Angela/0000-0003-2733-6666	MRC [MR/K002449/1, G0601361] Funding Source: UKRI; Medical Research Council [MR/K002449/1, G0601361] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman MC, 2019, NAT IMMUNOL, V20, P637, DOI 10.1038/s41590-019-0347-8; Belgrave D, 2017, J ALLERGY CLIN IMMUN, V139, P400, DOI 10.1016/j.jaci.2016.11.003; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; BROWN HM, 1958, LANCET, V2, P1245; Chang TS, 2014, J ALLERGY CLIN IMMUN, V133, P363, DOI 10.1016/j.jaci.2013.09.002; Christie R, 1956, LANCET, V271, P798, DOI DOI 10.1016/S0140-6736(56)92240-1; Custovic A, 2015, J ALLERGY CLIN IMMUN, V136, P1645, DOI 10.1016/j.jaci.2015.03.041; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Ebmeier S, 2017, LANCET, V390, P935, DOI [10.1016/S0140-6736(17)31448-4, 10.1016/s0140-6736(17)31448-4]; Fitzpatrick AM, 2016, J ALLERGY CLIN IMMUN, V138, P1608, DOI 10.1016/j.jaci.2016.09.028; Fontanella S, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002691; Howard R, 2018, J ALLERGY CLIN IMMUN, V142, P1322, DOI 10.1016/j.jaci.2017.11.064; Howard R, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0542-0; Kola I, 2011, NAT REV DRUG DISCOV, V10, P641, DOI 10.1038/nrd3534; Lawlor DA, 2016, INT J EPIDEMIOL, V45, P1866, DOI 10.1093/ije/dyw314; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Lonergan M, 2017, DRUG DISCOV TODAY, V22, P173, DOI 10.1016/j.drudis.2016.10.016; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Murray C, 2017, LANCET CHILD ADOLESC, V1, P114, DOI 10.1016/S2352-4642(17)30008-1; Murray CS, 2006, LANCET, V368, P754, DOI 10.1016/S0140-6736(06)69285-4; Nwokoro C, 2014, LANCET RESP MED, V2, P796, DOI 10.1016/S2213-2600(14)70186-9; Oksel C, 2019, J ALLERGY CLIN IMMUN, V143, P1783, DOI 10.1016/j.jaci.2018.10.059; Oksel C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00258; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Saglani S, 2019, AM J RESP CRIT CARE, V199, P414, DOI 10.1164/rccm.201810-1956CI; Simpson A, 2015, J ALLERGY CLIN IMMUN, V136, P1224, DOI 10.1016/j.jaci.2015.03.027; Sorkness RL, 2018, J ALLERGY CLIN IMMUN, V142, P1090, DOI 10.1016/j.jaci.2017.09.047; Stokholm J, 2016, LANCET RESP MED, V4, P19, DOI [10.1016/S2213-2600(15)00500-7, 10.1016/S2213-2600(16)00050-3]; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979	32	17	17	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					25	33		10.1016/j.jaci.2019.05.016	http://dx.doi.org/10.1016/j.jaci.2019.05.016			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	31145940	Green Submitted, Bronze			2022-12-18	WOS:000473432800003
J	Altrichter, S; Chuamanochan, M; Knoth, H; Asady, A; Ohanyan, T; Metz, M; Maurer, M				Altrichter, Sabine; Chuamanochan, Mati; Knoth, Henriette; Asady, Aida; Ohanyan, Tatevik; Metz, Martin; Maurer, Marcus			Real-life treatment of cholinergic urticaria with omalizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INDUCIBLE URTICARIA; COLD; IGE		[Altrichter, Sabine; Chuamanochan, Mati; Knoth, Henriette; Asady, Aida; Ohanyan, Tatevik; Metz, Martin; Maurer, Marcus] Charit Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany; [Chuamanochan, Mati] Chiang Mai Univ, Div Dermatol, Dept Internal Med, Fac Med, Chiang Mai, Thailand	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Chiang Mai University	Altrichter, S (corresponding author), Charit Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany.	sabine.altrichter@charite.de	Metz, Martin/B-8799-2009; Maurer, Marcus/ABG-2174-2020	Metz, Martin/0000-0002-4070-9976; Maurer, Marcus/0000-0002-4121-481X; Altrichter, Sabine/0000-0001-9955-385X				Altrichter S, 2014, J DERMATOL SCI, V75, P88, DOI 10.1016/j.jdermsci.2014.04.007; Asady A, 2017, CLIN EXP ALLERGY, V47, P1609, DOI 10.1111/cea.13023; Ertas R, 2017, J ALLERGY CLIN IMMUN, V140, P1749, DOI 10.1016/j.jaci.2017.08.007; Fukunaga A, 2018, CLIN AUTON RES, V28, P103, DOI 10.1007/s10286-017-0418-6; Gericke J, 2017, J ALLERGY CLIN IMMUN, V139, P1059, DOI 10.1016/j.jaci.2016.07.047; Ghazanfar MN, 2016, BRIT J DERMATOL, V175, P404, DOI 10.1111/bjd.14540; Hiragun M, 2014, ALLERGOL INT, V63, P83, DOI 10.2332/allergolint.13-OA-0611; Magerl M, 2015, J EUR ACAD DERMATOL, V29, P2043, DOI 10.1111/jdv.12739; Maurer M, 2018, J ALLERGY CLIN IMMUN, V141, P638, DOI 10.1016/j.jaci.2017.06.032; Metz M, 2008, ALLERGY, V63, P247, DOI 10.1111/j.1398-9995.2007.01591.x; Metz M, 2014, J DERMATOL SCI, V73, P57, DOI 10.1016/j.jdermsci.2013.08.011; Metz M, 2011, INT ARCH ALLERGY IMM, V154, P177, DOI 10.1159/000320233; Gouveia MP, 2017, CLIN EXP DERMATOL, V42, P735, DOI 10.1111/ced.13173; SIGLER RW, 1979, J ALLERGY CLIN IMMUN, V63, P35, DOI 10.1016/0091-6749(79)90159-3; Viswanathan RK, 2013, ALLERGY ASTHMA PROC, V34, P446, DOI 10.2500/aap.2013.34.3694	15	17	18	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					788	+		10.1016/j.jaci.2018.08.050	http://dx.doi.org/10.1016/j.jaci.2018.08.050			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30312709	Bronze			2022-12-18	WOS:000457718700042
J	Bachert, C; Desrosiers, M; Mullol, J; Hellings, PW; Cervin, A; Sher, L; Bosso, JV; Lee, SE; Maspero, JF; Fujieda, S; Matsune, S; Lu, X; Fan, CP; Draikiwicz, S; Amin, N; Kamat, S; Khan, A; Pirozzi, G; Graham, NMH; Ruddy, M; Staudinger, H; Mannent, LP				Bachert, Claus; Desrosiers, Martin; Mullol, Joaquim; Hellings, Peter W.; Cervin, Anders; Sher, Lawrence; Bosso, John V.; Lee, Stella E.; Maspero, Jorge F.; Fujieda, Shigeharu; Matsune, Shoji; Lu, Xin; Fan, Chunpeng; Draikiwicz, Steven; Amin, Nikhil; Kamat, Siddhesh; Khan, Asif; Pirozzi, Gianluca; Graham, Neil M. H.; Ruddy, Marcella; Staudinger, Heribert; Mannent, Leda P.			A Randomized Phase 3 Study, Sinus-52, Evaluating the Efficacy and Safety of Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Bachert, Claus] Upper Airways Res Lab, Fac Med, Ghent, Belgium; [Bachert, Claus] Karolinska Inst, CLINTEC, Stockholm, Sweden; [Desrosiers, Martin] CRCHUM, Montreal, PQ, Canada; [Mullol, Joaquim] Univ Barcelona, CIBERES, IDIBAPS, Hosp Clin, Barcelona, Spain; [Hellings, Peter W.] Univ Hosp Leuven, Dept Otorhinolaryngol Head & Neck Surg, Expt Immunol Lab, Leuven, Belgium; [Cervin, Anders] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Cervin, Anders] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Sher, Lawrence] Peninsula Res Associates, Rolling Hills Estates, CA USA; [Bosso, John V.] Univ Penn, Perelman Sch Med, Div Rhinol, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Lee, Stella E.] Univ Pittsburgh, Med Ctr, Div Sinonasal Disorders & Allergy, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA; [Maspero, Jorge F.] Fdn CIDEA, Allergy & Resp Res Unit, Buenos Aires, DF, Argentina; [Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Fukui, Japan; [Matsune, Shoji] Musashikosugi Hosp, Nippon Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Kawasaki, Kanagawa, Japan; [Lu, Xin; Fan, Chunpeng; Draikiwicz, Steven; Pirozzi, Gianluca; Staudinger, Heribert] Sanofi, Bridgewater, NJ USA; [Amin, Nikhil; Kamat, Siddhesh; Graham, Neil M. H.; Ruddy, Marcella] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Khan, Asif; Mannent, Leda P.] Sanofi, Chilly Mazarin, France	Karolinska Institutet; Universite de Montreal; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; KU Leuven; University Hospital Leuven; University of Queensland; Royal Brisbane & Women's Hospital; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Fukui; Nippon Medical School; Sanofi-Aventis; Regeneron; Sanofi-Aventis; Sanofi France			Khan, Asif H./T-6551-2017; Lee, Stella/AAI-6029-2021; Bachert, Claus/J-8825-2012	Khan, Asif H./0000-0001-9158-0116; 					0	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		L36	AB433	AB433		10.1016/j.jaci.2018.12.980	http://dx.doi.org/10.1016/j.jaci.2018.12.980			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Green Published, Bronze			2022-12-18	WOS:000457771200964
J	Sokol, H; Mahlaoui, N; Aguilar, C; Bach, P; Join-Lambert, O; Garraffo, A; Seksik, P; Danion, F; Jegou, S; Straube, M; Lenoir, C; Neven, B; Moshous, D; Blanche, S; Pigneur, B; Goulet, O; Ruemmele, F; Suarez, F; Beaugerie, L; Pannier, S; Mazingue, F; Lortholary, O; Galicier, L; Picard, C; de Saint Basile, G; Latour, S; Fischer, A				Sokol, Harry; Mahlaoui, Nizar; Aguilar, Claire; Bach, Perrine; Join-Lambert, Olivier; Garraffo, Aurelie; Seksik, Philippe; Danion, Francois; Jegou, Sarah; Straube, Marjolene; Lenoir, Christelle; Neven, Benedicte; Moshous, Despina; Blanche, Stephane; Pigneur, Benedicte; Goulet, Olivier; Ruemmele, Frank; Suarez, Felipe; Beaugerie, Laurent; Pannier, Stephanie; Mazingue, Francoise; Lortholary, Olivier; Galicier, Lionel; Picard, Capucine; de Saint Basile, Genevieve; Latour, Sylvain; Fischer, Alain			Intestinal dysbiosis in inflammatory bowel disease associated with primary immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							BACTERIA		[Sokol, Harry; Seksik, Philippe; Jegou, Sarah; Straube, Marjolene] PSL Res Univ, Sorbonne Univ, UPMC Univ Paris 06, AP HP,Ecole Normale Super,CNRS,INSERM,Lab Biomol, Rue Chaligny, Paris, France; [Sokol, Harry] Micalis & AgroParisTech, INRA, UMR1319, Jouy En Josas, France; [Sokol, Harry; Seksik, Philippe; Beaugerie, Laurent] UPMC Univ Paris 06, St Antoine Hosp, AP HP, Dept Gastroenterol, Paris, France; [Sokol, Harry; Mahlaoui, Nizar; Bach, Perrine; Suarez, Felipe; Lortholary, Olivier; Picard, Capucine; Fischer, Alain] Necker Enfants Malades Univ Hosp, AP HP, French Natl Reference Ctr Primary Immune Deficien, Paris, France; [Mahlaoui, Nizar; Neven, Benedicte; Moshous, Despina; Blanche, Stephane; Fischer, Alain] Hop Necker Enfants Malad, AP HP, Paediat Haematol Immunol & Rheumatol Dept, Paris, France; [Aguilar, Claire; Garraffo, Aurelie; Danion, Francois; Lortholary, Olivier] Paris Descartes Univ, Necker Enfants Malades Hosp, AP HP, Necker Pasteur Infect Dis Ctr,,Infect Dis & Trop, Paris, France; [Aguilar, Claire; Lenoir, Christelle; Neven, Benedicte; Moshous, Despina; Pigneur, Benedicte; Goulet, Olivier; Ruemmele, Frank; Suarez, Felipe; Picard, Capucine; de Saint Basile, Genevieve; Latour, Sylvain; Fischer, Alain] INSERM, UMR 1163, Imagine Inst, Paris, France; [Join-Lambert, Olivier] Paris Descartes Univ, Necker Enfants Malades Hosp, AP HP, Microbiol Dept, Paris, France; [Neven, Benedicte; Moshous, Despina; Blanche, Stephane; Lortholary, Olivier; Picard, Capucine; de Saint Basile, Genevieve; Latour, Sylvain; Fischer, Alain] Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst, Paris, France; [Neven, Benedicte; Moshous, Despina; Blanche, Stephane] Paris Descartes Univ, Hop Necker Enfants Malades, AP HP, Paediat Gastroenterol Hepatol & Nutr Dept, Paris, France; [Suarez, Felipe] Paris Descartes Univ, Necker Enfants Malades Univ Hosp, AP HP, Hematol Dept, Paris, France; [Pannier, Stephanie; Picard, Capucine; de Saint Basile, Genevieve] Necker Enfants Malades Univ Hosp, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France; [Pannier, Stephanie] Necker Enfants Malades Univ Hosp, AP HP, Dept Orthoped Pediat, Paris, France; [Mazingue, Francoise] Univ Hosp Lille, Hop Jeanne Flandre, Dept Pediat, Lille, France; [Galicier, Lionel] St Louis Hosp, AP HP, Dept Clin Immunol, Paris, France; [Fischer, Alain] Coll France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Fischer, A (corresponding author), Necker Enfants Malades Univ Hosp, AP HP, French Natl Reference Ctr Primary Immune Deficien, Paris, France.; Fischer, A (corresponding author), Hop Necker Enfants Malad, AP HP, Paediat Haematol Immunol & Rheumatol Dept, Paris, France.; Fischer, A (corresponding author), INSERM, UMR 1163, Imagine Inst, Paris, France.; Fischer, A (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst, Paris, France.; Fischer, A (corresponding author), Coll France, Paris, France.	alain.fischer@aphp.fr	Moshous, Despina/B-7507-2017; SEKSIK, Philippe/ABE-2962-2020; MAHLAOUI, Nizar/AAH-6103-2020; Join-Lambert, Olivier/AAE-5205-2019; sokol, harry/ABA-8991-2020; Sokol, Harry/E-2290-2019; Danion, François FD/Q-2764-2017; Latour, Sylvain/H-3652-2017; PIGNEUR, Benedicte/I-4742-2017	Moshous, Despina/0000-0001-6719-3693; MAHLAOUI, Nizar/0000-0002-0030-8094; sokol, harry/0000-0002-2914-1822; Sokol, Harry/0000-0002-2914-1822; Danion, François FD/0000-0003-3907-0658; Latour, Sylvain/0000-0001-8238-4391; PIGNEUR, Benedicte/0000-0002-5324-9964; Pannier, Stephanie/0000-0002-5581-4699	patient association Association Francois Aupetit; Agence Nationale de Recherche [ANR-08-MIEN-012-01]	patient association Association Francois Aupetit; Agence Nationale de Recherche(French National Research Agency (ANR))	Financial support by patient association Association Francois Aupetit (S.L., C.A.), and by Agence Nationale de Recherche, ANR-08-MIEN-012-01 (S.L.).	Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Hall AB, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.63; Kummen M, 2017, GUT, V66, P611, DOI 10.1136/gutjnl-2015-310500; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lemoine R, 2014, J ALLERGY CLIN IMMUN, V134, P1354, DOI 10.1016/j.jaci.2014.07.019; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Pigneur B, 2016, MUCOSAL IMMUNOL, V9, P1360, DOI 10.1038/mi.2016.67; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Uhlig HH, 2013, GUT, V62, P1795, DOI 10.1136/gutjnl-2012-303956; Vendrell D, 2006, COMP IMMUNOL MICROB, V29, P177, DOI 10.1016/j.cimid.2006.06.003	14	17	17	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					775	+		10.1016/j.jaci.2018.09.021	http://dx.doi.org/10.1016/j.jaci.2018.09.021			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30312711	Green Submitted			2022-12-18	WOS:000457718700038
J	Hernandez, ML; Dhingra, R; Burbank, AJ; Todorich, K; Loughlin, CE; Frye, M; Duncan, K; Robinette, C; Mills, K; Devlin, RB; Peden, DB; Diaz-Sanchez, D				Hernandez, Michelle L.; Dhingra, Radhika; Burbank, Allison J.; Todorich, Krista; Loughlin, Ceila E.; Frye, Marcia; Duncan, Kelly; Robinette, Carole; Mills, Katherine; Devlin, Robert B.; Peden, David B.; Diaz-Sanchez, David			Low-level ozone has both respiratory and systemic effects in African American adolescents with asthma despite asthma controller therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							AIR-POLLUTION; CHILDREN		[Hernandez, Michelle L.; Burbank, Allison J.; Todorich, Krista; Robinette, Carole; Mills, Katherine; Peden, David B.] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA; [Hernandez, Michelle L.; Burbank, Allison J.; Todorich, Krista; Robinette, Carole; Mills, Katherine; Peden, David B.] Univ N Carolina, Div Allergy Immunol & Rheumatol, Dept Pediat, Chapel Hill, NC 27515 USA; [Loughlin, Ceila E.; Frye, Marcia] Univ N Carolina, Dept Pediat, Div Pulmonol, Chapel Hill, NC 27515 USA; [Dhingra, Radhika; Devlin, Robert B.; Diaz-Sanchez, David] US EPA, Natl Hlth & Environm Effects Res Lab, Chapel Hill, NC USA; [Duncan, Kelly] Merck, Kenilworth, NJ USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Environmental Protection Agency; Merck & Company	Hernandez, ML (corresponding author), Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA.; Hernandez, ML (corresponding author), Univ N Carolina, Div Allergy Immunol & Rheumatol, Dept Pediat, Chapel Hill, NC 27515 USA.	michelle_hernandez@med.unc.edu		Peden, David/0000-0003-4526-4627	US Environmental Protection Agency [5T32GM086330, CR 83578501]; American Academy of Allergy, Asthma & Immunology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM086330] Funding Source: NIH RePORTER	US Environmental Protection Agency(United States Environmental Protection Agency); American Academy of Allergy, Asthma & Immunology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by 5T32GM086330, CR 83578501, and internal funding from the US Environmental Protection Agency and by the American Academy of Allergy, Asthma & Immunology Foundation. The views expressed in this manuscript are those of the authors and do not necessarily reflect the views or policies of the US Environmental Protection Agency.	[Anonymous], 2017, R LANG ENV STAT COMP; Daniels SR, 2011, CIRCULATION, V124, P1673, DOI 10.1161/CIRCULATIONAHA.110.016170; Hernandez ML, 2013, MIDDLETONS ALLERGY P; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Millers DB, 2016, AM J RESP CRIT CARE, V193, P1382, DOI 10.1164/rccm.201508-1599OC; Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012; Schildcrout JS, 2006, AM J EPIDEMIOL, V164, P505, DOI 10.1093/aje/kwj225; Strickland MJ, 2010, AM J RESP CRIT CARE, V182, P307, DOI 10.1164/rccm.200908-1201OC; U.S. EPA, 2013, EPA600R20012	9	17	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1974	+		10.1016/j.jaci.2018.08.003	http://dx.doi.org/10.1016/j.jaci.2018.08.003			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30102937	Bronze, Green Accepted			2022-12-18	WOS:000452315800031
J	Cabral-Marques, O; Franca, TT; Al-Sbiei, A; Schimke, LF; Khan, TA; Feriotti, C; da Costa, TA; Reis, O; Weber, CW; Ferreira, JF; Tavares, FS; Valente, C; Di Gesu, RSW; Lqbal, A; Riemekasten, G; Amarante-Mendes, GP; Barbuto, JAM; Costa-Carvalho, BT; Pereira, PVS; Fernandez-Cabezudo, MJ; Calich, VLG; Notarangelo, LD; Torgerson, TR; al-Ramadi, BK; Ochs, HD; Condino-Neto, A				Cabral-Marques, Otavio; Franca, Tabata Takahashi; Al-Sbiei, Ashraf; Schimke, Lena Friederike; Khan, Taj Ali; Feriotti, Claudia; da Costa, Tania Alves; Reis Junior, Osvaldo; Weber, Cristina Worm; Ferreira, Janaira Fernandes; Tavares, Fabiola Scancetti; Valente, Claudia; Watanabe Di Gesu, Regina Sumiko; Lqbal, Asif; Riemekasten, Gabriela; Amarante-Mendes, Gustavo Pessini; Marzagio Barbuto, Jose Alexandre; Costa-Carvalho, Beatriz Tavares; Soeiro Pereira, Paulo Vitor; Fernandez-Cabezudo, Maria J.; Garcia Calich, Vera Lucia; Notarangelo, Luigi D.; Torgerson, Troy R.; al-Ramadi, Basel K.; Ochs, Hans D.; Condino-Neto, Antonio			CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-gamma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Neutrophils; CD40 ligand; cell development; IFN-gamma	HYPER-IGM SYNDROME; CHRONIC GRANULOMATOUS-DISEASE; DIFFERENTIATED HL-60 CELLS; BONE-MARROW; INTERFERON-GAMMA; IMMUNE-RESPONSE; POLYMORPHONUCLEAR NEUTROPHILS; OXIDATIVE RESPONSE; DENDRITIC CELLS; GLOBAL ANALYSIS	Background: Patients with X-linked hyper-IgM syndrome caused by CD40 ligand (CD40L) deficiency often present with episodic, cyclic, or chronic neutropenia, suggesting abnormal neutrophil development in the absence of CD40L-CD40 interaction. However, even when not neutropenic and despite immunoglobulin replacement therapy, CD40L-deficient patients are susceptible to life-threatening infections caused by opportunistic pathogens, suggesting impaired phagocyte function and the need for novel therapeutic approaches. Objectives: We sought to analyze whether peripheral neutrophils from CD40L-deficient patients display functional defects and to explore the in vitro effects of recombinant human IFN-gamma (rhIFN-gamma) on neutrophil function. Methods: We investigated the microbicidal activity, respiratory burst, and transcriptome profile of neutrophils from CD40L-deficient patients. In addition, we evaluated whether the lack of CD40L in mice also affects neutrophil function. Results: Neutrophils from CD40L-deficient patients exhibited defective respiratory burst and microbicidal activity, which were improved in vitro by rhIFN-gamma but not soluble CD40L. Moreover, neutrophils from patients showed reduced CD16 protein expression and a dysregulated transcriptome suggestive of impaired differentiation. Similar to CD40L-deficient patients, CD40L knockout mice were found to have impaired neutrophil responses. In parallel, we demonstrated that soluble CD40L induces the promyelocytic cell line HL-60 to proliferate and mature by regulating the expression of genes of the same Gene Ontology categories (eg, cell differentiation) when compared with those dysregulated in peripheral blood neutrophils from CD40L-deficient patients. Conclusion: Our data suggest a nonredundant role of CD40L-CD40 interaction in neutrophil development and function that could be improved in vitro by rhIFN-gamma, indicating a potential novel therapeutic application for this cytokine.	[Cabral-Marques, Otavio; Franca, Tabata Takahashi; Schimke, Lena Friederike; Khan, Taj Ali; Feriotti, Claudia; da Costa, Tania Alves; Marzagio Barbuto, Jose Alexandre; Soeiro Pereira, Paulo Vitor; Garcia Calich, Vera Lucia; Condino-Neto, Antonio] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, 1730 Linen Prestes Ave, BR-05508000 Sao Paulo, Brazil; [Lqbal, Asif] Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil; [Amarante-Mendes, Gustavo Pessini] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil; [Marzagio Barbuto, Jose Alexandre] Univ Sao Paulo, NETCEM, Cell & Mol Therapy Ctr, Sao Paulo, Brazil; [Cabral-Marques, Otavio; Schimke, Lena Friederike; Riemekasten, Gabriela] Univ Lubeck, Dept Rheumatol, Lubeck, Germany; [Al-Sbiei, Ashraf; al-Ramadi, Basel K.] UAE Univ, Dept Med Microbiol & Immunol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Fernandez-Cabezudo, Maria J.] UAE Univ, Dept Biochem, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Khan, Taj Ali] Kohat Univ Sci & Technol, Dept Microbiol, Kohat, Pakistan; [Reis Junior, Osvaldo] Univ Estadual Campinas, Cent Lab High Performance Technol LaCTAD, Campinas, SP, Brazil; [Weber, Cristina Worm] Pediat Allergy & Immunol Clin, Caxias Do Sul, Brazil; [Ferreira, Janaira Fernandes] Albert Sabin Hosp, Fortaleza, Ceara, Brazil; [Tavares, Fabiola Scancetti; Valente, Claudia] Hosp Base Dist Fed, Unit Pediat, Pediat Immunol Clin, Asa Sul, Brazil; [Watanabe Di Gesu, Regina Sumiko] Conceicao Children Hosp, Div Allergy & Immunol, Dept Pediat, Porto Alegre, RS, Brazil; [Costa-Carvalho, Beatriz Tavares] Univ Fed Sao Paulo, Div Allergy & Immunol, Dept Pediat, Sao Paulo, Brazil; [Soeiro Pereira, Paulo Vitor] Univ Fed Maranhao, Dept Pathol, Sao Luis, Brazil; [Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Torgerson, Troy R.; Ochs, Hans D.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Torgerson, Troy R.; Ochs, Hans D.] Seattle Childrens Res Inst, Seattle, WA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Lubeck; United Arab Emirates University; United Arab Emirates University; Kohat University of Science & Technology; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Maranhao; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Seattle Children's Hospital	Condino-Neto, A (corresponding author), Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, 1730 Linen Prestes Ave, BR-05508000 Sao Paulo, Brazil.	antoniocondino@gmail.com	Condino-Neto, Antonio/D-4762-2012; Calich, Vera/G-8367-2011; Mendes, Gustavo P Amarante/C-8187-2012; Feriotti, Claudia/AGG-1092-2022; Barbuto, Jose A. M./H-5299-2011	Condino-Neto, Antonio/0000-0002-1069-3117; Calich, Vera/0000-0002-2170-5099; Mendes, Gustavo P Amarante/0000-0002-7851-6205; Barbuto, Jose A. M./0000-0001-9526-6781; Cabral Marques, Otavio/0000-0002-3183-6236; Franca, Tabata Takahashi/0000-0001-8950-0877; Feriotti, Claudia/0000-0002-5184-5359; Watanabe Di Gesu, Regina/0000-0002-2262-1970	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/50515-4, 2012/51745-3, 2016/22158-3]; Jeffrey Modell Foundation; PENSI Institute and Ministerio da Saude do Brasil [PRONAS/PDC2015, 25000.077928/2015-06]; UAEU Program for Advanced Research grant from the Office of Research and Sponsored Projects, UAE University [31M193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001222] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Jeffrey Modell Foundation; PENSI Institute and Ministerio da Saude do Brasil; UAEU Program for Advanced Research grant from the Office of Research and Sponsored Projects, UAE University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant 2012/50515-4 to O.C.-M. and grant 2012/51745-3 and 2016/22158-3 to A.C.-N.), the Jeffrey Modell Foundation (to A.C.-N.), and PENSI Institute and Ministerio da Saude do Brasil (PRONAS/PDC2015 and 25000.077928/2015-06 to A.C.-N.). The animal studies were supported by a UAEU Program for Advanced Research grant (no. 31M193) from the Office of Research and Sponsored Projects, UAE University (to B.K.a.-R.).	Aas V, 1998, J INTERF CYTOK RES, V18, P197, DOI 10.1089/jir.1998.18.197; Al-Ojali SM, 2012, MICROB PATHOGENESIS, V52, P326, DOI 10.1016/j.micpath.2012.03.002; al-Ramadi BK, 2006, J IMMUNOL, V176, P496, DOI 10.4049/jimmunol.176.1.496; al-Ramadi BK, 2003, MOL IMMUNOL, V39, P763, DOI 10.1016/S0161-5890(03)00005-1; al-Ramadi BK, 2002, MOL IMMUNOL, V38, P931, DOI 10.1016/S0161-5890(02)00020-2; Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Anderlini P, 1996, BLOOD, V88, P2819, DOI 10.1182/blood.V88.8.2819.bloodjournal8882819; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Aryappalli P, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00167; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachiega TF, 2016, IMMUNOBIOLOGY, V221, P228, DOI 10.1016/j.imbio.2015.09.003; Battersby AC, 2013, J CLIN IMMUNOL, V33, P1276, DOI 10.1007/s10875-013-9939-5; BERG M, 1990, BLOOD, V76, P2381; Bergthaler A, 2017, NAT IMMUNOL, V18, P481, DOI 10.1038/ni.3727; BIAGIONI LMV, 1986, REV INST MED TROP SP, V28, P281, DOI 10.1590/S0036-46651986000500001; BORREGAARD N, 1983, EUR J CLIN INVEST, V13, P243, DOI 10.1111/j.1365-2362.1983.tb00095.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Cabral-Marques O, 2017, J ALLERGY CLIN IMMUN, V139, P900, DOI 10.1016/j.jaci.2016.07.018; Cabral-Marques O, 2014, J CLIN IMMUNOL, V34, P146, DOI 10.1007/s10875-013-9980-4; Cabral-Marques O, 2012, J CLIN IMMUNOL, V32, P212, DOI 10.1007/s10875-011-9623-6; Canque B, 1998, J LEUKOCYTE BIOL, V64, P235, DOI 10.1002/jlb.64.2.235; Carr R, 2000, BRIT J HAEMATOL, V110, P18, DOI 10.1046/j.1365-2141.2000.01992.x; CARR R, 1990, BLOOD, V76, P607; Carrigan SO, 2005, IMMUNOLOGY, V115, P108, DOI 10.1111/j.1365-2567.2005.02131.x; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Conti F, 2015, J ALLERGY CLIN IMMUN, V135, P1393, DOI 10.1016/j.jaci.2014.11.004; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DANIELS RH, 1994, IMMUNOLOGY, V82, P465; De Kleer I, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00423; de la Morena MT, 2017, J ALLERGY CLIN IMMUN, V139, P1282, DOI 10.1016/j.jaci.2016.07.039; Della Coletta AM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004037; den Dunnen JT, 2000, HUM MUTAT, V15, P7; EGGLETON P, 1995, ANN RHEUM DIS, V54, P916, DOI 10.1136/ard.54.11.916; EGGLETON P, 1992, J LEUKOCYTE BIOL, V51, P617, DOI 10.1002/jlb.51.6.617; Eighetany MT, 2004, J CLIN LAB ANAL, V18, P36, DOI 10.1002/jcla.20001; ELBIM C, 1993, BLOOD, V82, P633; Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x; EZEKOWITZ RAB, 1990, BLOOD, V76, P2443; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Feriotti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054845; Fernandez-Cabezudo MJ, 2009, CLIN IMMUNOL, V130, P51, DOI 10.1016/j.clim.2008.08.017; FLEIT HB, 1984, J CLIN INVEST, V73, P516, DOI 10.1172/JCI111238; FloresRomo L, 1997, J EXP MED, V185, P341, DOI 10.1084/jem.185.2.341; Fontana S, 2003, BLOOD, V102, P4099, DOI 10.1182/blood-2003-04-1244; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; GougerotPodicalo MA, 1996, PATHOL BIOL, V44, P36; Goules A, 2006, J AUTOIMMUN, V26, P165, DOI 10.1016/j.jaut.2006.02.002; Hahn RC, 2003, J CLIN MICROBIOL, V41, P2849, DOI 10.1128/JCM.41.7.2849-2854.2003; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hernandez-Campo PM, 2007, CYTOM PART B-CLIN CY, V72B, P34, DOI 10.1002/cyto.b.20143; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Issac JM, 2013, IMMUNOBIOLOGY, V218, P52, DOI 10.1016/j.imbio.2012.02.001; Jablonska E, 2002, MELANOMA RES, V12, P123; Jain A, 1999, J CLIN INVEST, V103, P1151, DOI 10.1172/JCI5891; Jain A, 2011, BLOOD, V118, P3811, DOI 10.1182/blood-2011-04-351254; Jasinska A, 2013, PEDIATR TRANSPLANT, V17, pE37, DOI 10.1111/j.1399-3046.2012.01786.x; JERNE NK, 1973, SCI AM, V229, P52, DOI 10.1038/scientificamerican0773-52; Jones J, 1995, IMMUNOLOGY, V86, P651; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kotz KT, 2010, NAT MED, V16, P1042, DOI 10.1038/nm.2205; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Leven EA, 2016, J CLIN IMMUNOL, V36, P490, DOI 10.1007/s10875-016-0291-4; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; Lian Z, 2002, BLOOD, V100, P3209, DOI 10.1182/blood-2002-03-0850; MACEY MG, 1995, J IMMUNOL METHODS, V181, P211, DOI 10.1016/0022-1759(95)00003-S; Macoris SAG, 2006, MEM I OSWALDO CRUZ, V101, P331, DOI 10.1590/S0074-02762006000300019; Marigo I, 2016, CANCER CELL, V30, P651, DOI 10.1016/j.ccell.2016.09.009; Marques OC, 2012, J ALLERGY CLIN IMMUN, V129, P778, DOI 10.1016/j.jaci.2011.10.026; Mavroudi I, 2011, J LEUKOCYTE BIOL, V89, P771, DOI 10.1189/jlb.0610330; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Mejia SP, 2015, MICROBIOL-SGM, V161, P1008, DOI 10.1099/mic.0.000059; MeloniBruneri LH, 1996, J LEUKOCYTE BIOL, V59, P526, DOI 10.1002/jlb.59.4.526; Melvan JN, 2010, INT REV IMMUNOL, V29, P315, DOI 10.3109/08830181003792803; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Millius A, 2010, METHODS MOL BIOL, V591, P147, DOI 10.1007/978-1-60761-404-3_9; Miralda I, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00217; Moulding DA, 1999, J LEUKOCYTE BIOL, V65, P875, DOI 10.1002/jlb.65.6.875; Moyerbrailean GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14976; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Newburger PE, 2000, CURR OPIN HEMATOL, V7, P16, DOI 10.1097/00062752-200001000-00004; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; Orr Y, 2007, J LEUKOCYTE BIOL, V82, P1115, DOI 10.1189/jlb.0906545; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Perazzio SF, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1443-5; PERRY FE, 1993, THORAX, V48, P364, DOI 10.1136/thx.48.4.364; Pina A, 2006, J LEUKOCYTE BIOL, V79, P1202, DOI 10.1189/jlb.0106052; PULLEN GR, 1985, CLIN EXP IMMUNOL, V62, P304; Ramadi KB, 2016, NANOTOXICOLOGY, V10, P1061, DOI 10.3109/17435390.2016.1163743; Reinhardt TA, 2013, J PROTEOMICS, V82, P141, DOI 10.1016/j.jprot.2013.02.013; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Sacco MG, 2000, CANCER GENE THER, V7, P1299, DOI 10.1038/sj.cgt.0234; SAELAND S, 1992, EXP HEMATOL, V20, P24; Seijkens T, 2012, ARTERIOSCLER THROMB, V32, P158; Skalnik DG, 2002, GENE, V284, P1, DOI 10.1016/S0378-1119(02)00387-6; Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Soeiro-Pereira PV, 2012, BRIT J PHARMACOL, V166, P1617, DOI 10.1111/j.1476-5381.2011.01764.x; Solanilla A, 2000, BLOOD, V95, P3758; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Subauste CS, 1999, J IMMUNOL, V162, P6690; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taschner PEM, 2011, HUM MUTAT, V32, P507, DOI 10.1002/humu.21427; TENNENBERG SD, 1993, J LEUKOCYTE BIOL, V53, P301, DOI 10.1002/jlb.53.3.301; TERSTAPPEN LWMM, 1990, LEUKEMIA, V4, P657; Uhl B, 2016, BLOOD, V128, P2327, DOI 10.1182/blood-2016-05-718999; VADHANRAJ S, 1988, BLOOD, V72, P134; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; von Bernuth H, 2006, PEDIATRICS, V118, P2498, DOI 10.1542/peds.2006-1845; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Winkelstein JA, 2003, MEDICINE, V82, P373, DOI 10.1097/01.md.0000100046.06009.b0; WOODMAN RC, 1995, BLOOD, V85, P231, DOI 10.1182/blood.V85.1.231.bloodjournal851231; WORKU M, 1994, AM J VET RES, V55, P234; Wright HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058598; Yao Y, 2015, J IMMUNOL, V194, P1211, DOI 10.4049/jimmunol.1402018; Yaseen R, 2017, J NEGAT RESULTS BIOM, V16, DOI 10.1186/s12952-017-0067-2; Zhou Y, 2008, J INTERF CYTOK RES, V28, P65, DOI 10.1089/jir.2007.0025	125	17	17	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1571	+		10.1016/j.jaci.2018.02.026	http://dx.doi.org/10.1016/j.jaci.2018.02.026			27	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	29518426	Bronze, Green Accepted			2022-12-18	WOS:000449429800020
J	Zha, LS; Leoratti, FMS; He, LC; Mohsen, MO; Cragg, M; Storni, F; Vogel, M; Bachmann, MF				Zha, Lisha; Leoratti, Fabiana M. S.; He, Lichun; Mohsen, Mona O.; Cragg, Mark; Storni, Federico; Vogel, Monique; Bachmann, Martin F.			An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor Fc gamma RIIb	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; vaccination; Fc gamma RIIb-mediated inhibition; Fel d 1; low-affinity antibodies	ANTIBODIES; MOUSE	Background: Induction of allergen-specific IgG antibodies is a critical parameter for successful allergen-specific immunotherapy. IgG antibodies can inhibit IgE-mediated mast cell activation through direct allergen neutralization or through the inhibitory receptor Fc gamma RIIb. The affinity of IgE antibodies to the allergen has been shown to be critical for cellular activation. Objective: Here we addressed the question of affinity thresholds of allergen-specific IgG antibodies for inhibition of mast cell activation using 2 different mAbs against the major cat allergen Fel d 1 both in vitro and in vivo in mice. Methods: Sequences of the 2 high-affinity mAbs were back-mutated to germline, resulting in low-affinity (10(-7) mol/L) antibodies of the exact same specificity. Results: Using these newly generated recombinant antibodies, we demonstrate that low-affinity antibodies are still able to inhibit mast cell activation through Fc gamma RIIb but do not neutralize the allergen. Conclusion: Antibody affinity dictates the mechanism of mast cell inhibition, and IgG antibodies triggering the inhibitory Fc gamma RIIb pathway can show a broader cross-reactivity pattern than previously thought. This indicates that allergen-specific immunotherapy generates a larger protective umbrella of inhibitory IgG antibodies than previously appreciated.	[Zha, Lisha; Leoratti, Fabiana M. S.; Storni, Federico; Vogel, Monique; Bachmann, Martin F.] Univ Hosp Bern, Immunol, RIA, Inselspital, CH-3010 Bern, Switzerland; [Mohsen, Mona O.; Bachmann, Martin F.] Univ Oxford, Jenner Inst, Oxford, England; [He, Lichun] Univ Basel, Biozentrum, Basel, Switzerland; [Cragg, Mark] Univ Southampton, Antibody & Vaccine Grp, Canc Sci Unit, Fac Med, Southampton, Hants, England	University of Bern; University Hospital of Bern; University of Oxford; Jenner Institute; University of Basel; University of Southampton	Vogel, M; Bachmann, MF (corresponding author), Univ Hosp Bern, Immunol, RIA, Inselspital, CH-3010 Bern, Switzerland.; Bachmann, MF (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	monique.vogel@dbmr.unibe.ch; martin.bachmann@dbmr.unibe.ch	Cragg, Mark S/E-5965-2010; Storni, Federico/CAH-3483-2022; He, Lichun/AAQ-9058-2021	Cragg, Mark S/0000-0003-2077-089X; He, Lichun/0000-0002-0772-0452	Swiss National Science foundation (SNF) [31003A 149925]	Swiss National Science foundation (SNF)(Swiss National Science Foundation (SNSF))	Supported by funding of the Swiss National Science foundation (SNF grant 31003A 149925 to M.F.B.).	Akdis M, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-23; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Brauweiler AM, 2003, BIOCHEM SOC T, V31, P281, DOI 10.1042/bst0310281; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Buschor P, 2014, INT ARCH ALLERGY IMM, V163, P206, DOI 10.1159/000358487; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; Ejrnaes AM, 2004, MOL IMMUNOL, V41, P471, DOI 10.1016/j.molimm.2004.04.018; Hoh RA, 2016, J ALLERGY CLIN IMMUN, V137, P157, DOI 10.1016/j.jaci.2015.05.029; Jutel M, 2016, ALLERGY ASTHMA IMMUN, V8, P191, DOI 10.4168/aair.2016.8.3.191; Kepley CL, 2000, J ALLERGY CLIN IMMUN, V106, P337, DOI 10.1067/mai.2000.107931; Kundig Thomas M, 2015, Curr Treat Options Allergy, V2, P72; Lee CH, 2017, NAT IMMUNOL, V18, P889, DOI 10.1038/ni.3770; Leynadier F, 1991, Allerg Immunol (Paris), V23, P341; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Strelow J., ASSAY GUIDANCE MANUA; Tasaniyananda N, 2016, BIOCHEM BIOPH RES CO, V470, P593, DOI 10.1016/j.bbrc.2016.01.099; Uermosi C, 2014, ALLERGY, V69, P338, DOI 10.1111/all.12327; Uermosi C, 2010, J ALLERGY CLIN IMMUN, V126, P375, DOI 10.1016/j.jaci.2010.05.040; Williams EL, 2013, J IMMUNOL, V191, P4130, DOI 10.4049/jimmunol.1301430; Yepes-Nunez JJ, 2015, COCHRANE DB SYST REV, V11; Yukselen A, 2014, WORLD J CLIN CASES, V2, P859, DOI 10.12998/wjcc.v2.i12.859; Zellweger F, 2017, ALLERGY, V72, P1174, DOI 10.1111/all.13109; Zhao DY, 2016, INT ARCH ALLERGY IMM, V169, P113, DOI 10.1159/000444391	25	17	17	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1529	+		10.1016/j.jaci.2017.09.054	http://dx.doi.org/10.1016/j.jaci.2017.09.054			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	29391255	Green Accepted, Bronze			2022-12-18	WOS:000449429800016
J	Hajjar, J; Al-Kaabi, A; Kutac, C; Dunn, J; Shearer, WT; Orange, JS				Hajjar, Joud; Al-Kaabi, Aba; Kutac, Carleigh; Dunn, James; Shearer, William T.; Orange, Jordan S.			Questioning the accuracy of currently available pneumococcal antibody testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ANALYTICAL VARIABILITY		[Hajjar, Joud; Al-Kaabi, Aba; Kutac, Carleigh; Shearer, William T.] Baylor Coll Med, Dept Pediat, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Dunn, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Orange, Jordan S.] Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA	Baylor College of Medicine; Baylor College of Medicine; Columbia University	Hajjar, J (corresponding author), Baylor Coll Med, Dept Pediat, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA.	joud.hajjar@bcm.edu	Hajjar, Joud/H-7482-2017	Hajjar, Joud/0000-0003-4633-1043; Dunn, James/0000-0002-7964-281X; orange, jordan/0000-0001-7117-7725	Jeffery Modell Foundation; David Fund	Jeffery Modell Foundation; David Fund	The research is supported by the Jeffery Modell Foundation and the David Fund.	Daly TM, 2014, CLIN VACCINE IMMUNOL, V21, P982, DOI 10.1128/CVI.00235-14; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Zhang XC, 2013, CLIN VACCINE IMMUNOL, V20, P957, DOI 10.1128/CVI.00223-13	3	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1358	1360		10.1016/j.jaci.2018.06.013	http://dx.doi.org/10.1016/j.jaci.2018.06.013			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29936105	Bronze			2022-12-18	WOS:000446327300039
J	Berekmeri, A; Latzko, A; Alase, A; Macleod, T; Ainscough, JS; Laws, P; Goodfield, M; Wright, A; Helliwell, P; Edward, S; Brown, GD; Reid, DM; Wenzel, J; Stacey, M; Wittmann, M				Berekmeri, Anna; Latzko, Anne; Alase, Adewonuola; Macleod, Tom; Ainscough, Joseph S.; Laws, Philip; Goodfield, Mark; Wright, Andrew; Helliwell, Philip; Edward, Sara; Brown, Gordon D.; Reid, Delvth M.; Wenzel, Joerg; Stacey, Martin; Wittmann, Miriam			Detection of IL-36 gamma through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Berekmeri, Anna; Latzko, Anne; Alase, Adewonuola; Wittmann, Miriam] Univ Leeds, Sch Mol & Cellular Biol, LIRMM, Leeds, W Yorkshire, England; [Latzko, Anne; Macleod, Tom; Ainscough, Joseph S.; Stacey, Martin] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Berekmeri, Anna; Latzko, Anne; Laws, Philip; Goodfield, Mark; Helliwell, Philip; Wittmann, Miriam] Leeds Teaching Hosp Leeds, Leeds Biomed Res Ctr BRC, NIHR, Leeds, W Yorkshire, England; [Wright, Andrew; Reid, Delvth M.] Bradford Teaching Hosp Fdn Trust, Bradford, W Yorkshire, England; [Wright, Andrew; Wittmann, Miriam] Univ Bradford, Ctr Skin Sci, Bradford, W Yorkshire, England; [Edward, Sara] St James Univ Hosp, St Jamess Inst Oncol, Leeds, W Yorkshire, England; [Brown, Gordon D.] Univ Aberdeen, Aberdeen Fungal Grp, Inst Med Sci, Med Res Council,Ctr Med Mycol, Aberdeen, Scotland; [Wenzel, Joerg] Univ Hosp Bonn, Dept Dermatol & Allergy, Bonn, Germany	University of Leeds; University of Leeds; Leeds Biomedical Research Centre; University of Bradford; Saint James's University Hospital; University of Aberdeen; University of Bonn	Wittmann, M (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, LIRMM, Leeds, W Yorkshire, England.; Wittmann, M (corresponding author), Leeds Teaching Hosp Leeds, Leeds Biomed Res Ctr BRC, NIHR, Leeds, W Yorkshire, England.; Wittmann, M (corresponding author), Univ Bradford, Ctr Skin Sci, Bradford, W Yorkshire, England.	M.Wittmann@leeds.ac.uk	Wenzel, Jörg/AAX-2644-2020	Wenzel, Jörg/0000-0002-4744-5993; Macleod, Tom/0000-0002-7903-2990; Wittmann, Miriam/0000-0003-2328-4926; Berekmeri, Anna/0000-0001-5894-8812	Pfizer Inflammation Competitive Research Programme (ICRP); MRC [MR/M01942X/1]; Wellcome Trust [102705, 97377]; MRC Centre for Medical Mycology; University of Aberdeen [MR/N006364/1]; National Institute for Health Research (NIHR) [EUDRACT 2014-004741-27]; UK Dermatology Clinical Trials Network (UK DCTN); British Association of Dermatologists; University of Nottingham; NIHR Leeds Biomedical Research Centre; MRC [MR/N006364/1] Funding Source: UKRI	Pfizer Inflammation Competitive Research Programme (ICRP); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Medical Mycology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Aberdeen; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Dermatology Clinical Trials Network (UK DCTN); British Association of Dermatologists; University of Nottingham; NIHR Leeds Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported mainly by a 2014 Pfizer Inflammation Competitive Research Programme (ICRP). In addition, assay development support was received by MRC grant MR/M01942X/1. G.D.B. and D.M.R. were funded by the Wellcome Trust (102705, 97377), the MRC Centre for Medical Mycology, and the University of Aberdeen (MR/N006364/1). Some of the samples included in the AD comparator group were acquired in the context of the National Institute for Health Research (NIHR)-funded ALPHA trial (EUDRACT 2014-004741-27) Explorative Biomarker substudy. The ALPHA trial was developed in collaboration with the Clinical Trials Research Unit at the University of Leeds with support from the UK Dermatology Clinical Trials Network (UK DCTN). The UK DCTN is grateful to the British Association of Dermatologists and the University of Nottingham for financial support of the Network. This research is also supported by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.	D'Erme AM, 2015, J INVEST DERMATOL, V135, P1025, DOI 10.1038/jid.2014.532; Garzorz-Stark N, 2016, EXP DERMATOL, V25, P767, DOI 10.1111/exd.13077; Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Quaranta M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008946; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Riis JL, 2011, EXP DERMATOL, V20, P789, DOI 10.1111/j.1600-0625.2011.01323.x; Yoon SY, 2013, J EUR ACAD DERMATOL, V27, P889, DOI 10.1111/j.1468-3083.2012.04602.x	9	17	17	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					988	991		10.1016/j.jaci.2018.04.031	http://dx.doi.org/10.1016/j.jaci.2018.04.031			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29782895	Green Published, hybrid			2022-12-18	WOS:000443726500034
J	Polivka, L; Hadj-Rabia, S; Bal, E; Leclerc-Mercier, S; Madrange, M; Hamel, Y; Bonnet, D; Mallet, S; Lepidi, H; Ovaert, C; Barbet, P; Dupont, C; Neven, B; Munnich, A; Godsel, LM; Campeotto, F; Weil, R; Laplantine, E; Marchetto, S; Borg, JP; Weis, WI; Casanova, JL; Puel, A; Green, KJ; Bodemer, C; Smahi, A				Polivka, Laura; Hadj-Rabia, Smail; Bal, Elodie; Leclerc-Mercier, Stephanie; Madrange, Marine; Hamel, Yamina; Bonnet, Damien; Mallet, Stephanie; Lepidi, Hubert; Ovaert, Caroline; Barbet, Patrick; Dupont, Christophe; Neven, Benedicte; Munnich, Arnold; Godsel, Lisa M.; Campeotto, Florence; Weil, Robert; Laplantine, Emmanuel; Marchetto, Sylvie; Borg, Jean-Paul; Weis, William I.; Casanova, Jean-Laurent; Puel, Anne; Green, Kathleen J.; Bodemer, Christine; Smahi, Asma			Epithelial barrier dysfunction in desmoglein-1 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HUMAN B-CELLS; MULTIPLE ALLERGIES; SEVERE DERMATITIS; PCR; STANDARDIZATION; IMMUNOGLOBULIN; ACTIVATION; MUTATION; GALAXY; ERBIN		[Polivka, Laura; Hadj-Rabia, Smail; Leclerc-Mercier, Stephanie; Bodemer, Christine] Paris Descartes Univ, Sorbonne Paris Cite, Reference Ctr Genodermatoses MAGEC, Dept Dermatol, Paris, France; [Polivka, Laura; Hadj-Rabia, Smail; Bal, Elodie; Madrange, Marine; Hamel, Yamina; Bodemer, Christine; Smahi, Asma] Paris Descartes Univ, Sorbonne Paris Cite, Lab Genet Monogen Auto Inflammatory Dis, Necker Branch,U1163, Paris, France; [Leclerc-Mercier, Stephanie] Paris Descartes Univ, Sorbonne Paris Cite, Dept Pathol, Paris, France; [Bonnet, Damien] Paris Descartes Univ, Sorbonne Paris Cite, Pediat Reference Ctr Inherited Cardiac Dis, Necker M3C, Paris, France; [Barbet, Patrick] Paris Descartes Univ, Sorbonne Paris Cite, Dept Pediat Gastroenterol Hepatol & Nutr, Paris, France; [Dupont, Christophe] Paris Descartes Univ, Sorbonne Paris Cite, Dept Pediat Immunol & Hematol, Paris, France; [Campeotto, Florence] Paris Descartes Univ, Sorbonne Paris Cite, Necker Enfants Malades Hosp, AP HP,Dept Paediat Gastroenterol, Paris, France; [Mallet, Stephanie] Aix Marseille Univ, La Timone Hosp, AP HM, Dept Dermatol, Marseille, France; [Lepidi, Hubert] Aix Marseille Univ, La Timone Hosp, AP HM, Dept Pathol, Marseille, France; [Ovaert, Caroline] Aix Marseille Univ, La Timone Hosp, AP HM, Dept Pediat Cardiol, Marseille, France; [Neven, Benedicte; Munnich, Arnold] Paris Descartes Univ, Sorbonne Paris Cite, Lab Mol & Pathophysiol Basis Cognit Disorders, Necker Enfants Malades Hosp,Imagine Inst,U1163, Paris, France; [Godsel, Lisa M.; Green, Kathleen J.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Godsel, Lisa M.; Green, Kathleen J.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Weil, Robert; Laplantine, Emmanuel] CNRS, Inst Pasteur, Lab Signaling & Pathogenesis, UMR3691, Paris, France; [Marchetto, Sylvie; Borg, Jean-Paul] Aix Marseille Univ, Inst Paoli Calmettes, CNRS,CRCM, Cell Polar,Cell Signalling,INSERM,UMR7258,UM105,U, Marseille, France; [Marchetto, Sylvie; Borg, Jean-Paul] Canc Equipe Labellisee Ligue Canc, Marseille, France; [Weis, William I.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Casanova, Jean-Laurent; Puel, Anne] INSERM, U1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Casanova, Jean-Laurent; Puel, Anne] Paris Descartes Univ, Imagine Inst, Paris, France; [Casanova, Jean-Laurent; Puel, Anne] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Casanova, Jean-Laurent; Puel, Anne] Howard Hughes Med Inst, New York, NY USA	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Stanford University; Stanford University; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Howard Hughes Medical Institute	Bodemer, C (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Reference Ctr Genodermatoses MAGEC, Dept Dermatol, Paris, France.; Bodemer, C (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Lab Genet Monogen Auto Inflammatory Dis, Necker Branch,U1163, Paris, France.	christine.bodemer@aphp.fr; asma.smahi@inserm.fr	Leclerc-Mercier, Stéphanie/AAP-1057-2021; Puel, Anne/H-7305-2017; Borg, Jean-Paul/AAX-8096-2020; Weis, William/G-1437-2011	Puel, Anne/0000-0003-2603-0323; Borg, Jean-Paul/0000-0001-8418-3382; MARCHETTO, Sylvie/0000-0001-9030-7548; Ovaert, Caroline/0000-0002-2277-2760; Weil, Robert/0000-0001-5235-0932; Weis, William/0000-0002-5583-6150	French Society of Dermatology (SFD); Laboratoires Expanscience; French National Research Agency (ANR) under the "Investments for the Future" program [ANR-10-IAHU-01]; La Ligue Nationale Contre le Cancer (Label Ligue); SIRIC (INCa-DGOS-Inserm) [6038]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041836] Funding Source: NIH RePORTER	French Society of Dermatology (SFD); Laboratoires Expanscience; French National Research Agency (ANR) under the "Investments for the Future" program(French National Research Agency (ANR)); La Ligue Nationale Contre le Cancer (Label Ligue); SIRIC (INCa-DGOS-Inserm); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by grants from the French Society of Dermatology (SFD), Laboratoires Expanscience, and the French National Research Agency (ANR) under the "Investments for the Future" program (reference: ANR-10-IAHU-01). Expanscience Laboratories helped to fund the molecular and immunologic analyses. J.-P.B.'s laboratory is funded by La Ligue Nationale Contre le Cancer (Label Ligue) and SIRIC (INCa-DGOS-Inserm 6038). J.-P.B. is a scholar of Institut Universitaire de France.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Berkowska MA, 2015, J IMMUNOL, V195, P1417, DOI 10.4049/jimmunol.1402708; Broccardo CJ, 2011, J ALLERGY CLIN IMMUN, V127, P186, DOI 10.1016/j.jaci.2010.10.033; Denayer S, 2010, MOL ENDOCRINOL, V24, P898, DOI 10.1210/me.2009-0310; Driessen GJ, 2013, J ALLERGY CLIN IMMUN, V131, P1367, DOI 10.1016/j.jaci.2013.01.053; Fortugno P, 2012, HUM MOL GENET, V21, P4187, DOI 10.1093/hmg/dds243; Guerra L, 2015, ACTA DERM-VENEREOL, V95, P720, DOI 10.2340/00015555-2075; Harmon RM, 2013, J CLIN INVEST, V123, P1556, DOI 10.1172/JCI65220; IJspeert H, 2017, J IMMUNOL, V198, P4156, DOI 10.4049/jimmunol.1601921; IJspeert H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00410; IJspeert H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00157; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Levy C, 2016, J THROMB HAEMOST, V14, P2478, DOI 10.1111/jth.13520; Lyons JJ, 2017, J EXP MED, V214, P669, DOI 10.1084/jem.20161435; McAleer MA, 2015, J ALLERGY CLIN IMMUN, V136, P1268, DOI 10.1016/j.jaci.2015.05.002; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Moorhouse MJ, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0059-7; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Schjerven H, 2017, J EXP MED, V214, P793, DOI 10.1084/jem.20160049; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; van der Burg M, 2011, LEUKEMIA, V25, P1467, DOI 10.1038/leu.2011.118; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110	28	17	17	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					702	706		10.1016/j.jaci.2018.04.007	http://dx.doi.org/10.1016/j.jaci.2018.04.007			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29705242	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000440664400044
J	Keren, A; Shemer, A; Ginzburg, A; Ullmann, Y; Schrum, AG; Paus, R; Gilhar, A				Keren, Aviad; Shemer, Avner; Ginzburg, Alex; Ullmann, Yehuda; Schrum, Adam G.; Paus, Ralf; Gilhar, Amos			Innate lymphoid cells 3 induce psoriasis in xenotransplanted healthy human skin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							T-CELLS		[Keren, Aviad; Shemer, Avner; Ginzburg, Alex; Ullmann, Yehuda; Gilhar, Amos] Technion Israel Inst Technol, Fac Med, Skin Res Lab, Haifa, Israel; [Schrum, Adam G.] Univ Missouri, Dept Mol Microbiol, Columbia, MO USA; [Schrum, Adam G.] Univ Missouri, Dept Immunol Surg & Bioengn, Columbia, MO USA; [Paus, Ralf] Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England; [Paus, Ralf] NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Manchester	Keren, A (corresponding author), Technion Israel Inst Technol, Fac Med, Skin Res Lab, Haifa, Israel.	doritg2000@gmail.com		Schrum, Adam/0000-0001-9276-1859	Technion R&D Foundation Ltd; NIHR Manchester Biomedical Research Centre; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103841] Funding Source: NIH RePORTER	Technion R&D Foundation Ltd; NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded in part by Technion R&D Foundation Ltd (to A.G.). R.P. was supported by the NIHR Manchester Biomedical Research Centre.	Bjorkstrom NK, 2013, IMMUNOLOGY, V139, P416, DOI 10.1111/imm.12098; Di Meglio P, 2016, J ALLERGY CLIN IMMUN, V138, P274, DOI 10.1016/j.jaci.2015.10.046; Eberl G, 2015, NAT IMMUNOL, V16, P1, DOI 10.1038/ni.3059; Konya V, 2018, J ALLERGY CLIN IMMUN, V141, P279, DOI 10.1016/j.jaci.2017.01.045; Melo-Gonzalez F, 2017, IMMUNOLOGY, V150, P265, DOI 10.1111/imm.12697; Nousbeck J, 2011, J INVEST DERMATOL, V131, P1767, DOI 10.1038/jid.2011.108; Paul S, 2015, J LEUKOCYTE BIOL, V97, P259, DOI 10.1189/jlb.3RU0914-443R; Ward NL, 2014, J INVEST DERMATOL, V134, P2305, DOI 10.1038/jid.2014.216; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989	9	17	17	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					305	308		10.1016/j.jaci.2018.02.015	http://dx.doi.org/10.1016/j.jaci.2018.02.015			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29501801				2022-12-18	WOS:000437837500038
J	Tesi, B; Rascon, J; Chiang, SCC; Burnyte, B; Lofstedt, A; Fasth, A; Heizmann, M; Juozapaite, S; Kiudeliene, R; Kvedaraite, E; Miseviciene, V; Muleviciene, A; Muller, ML; Nordenskjold, M; Matuzeviciene, R; Samaitiene, R; Speckmann, C; Stankeviciene, S; Zekas, V; Voss, M; Ehl, S; Vaiciene-Magistris, N; Henter, JI; Meeths, M; Bryceson, YT				Tesi, Bianca; Rascon, Jelena; Chiang, Samuel C. C.; Burnyte, Birute; Lofstedt, Alexandra; Fasth, Anders; Heizmann, Miriam; Juozapaite, Sandra; Kiudeliene, Rosita; Kvedaraite, Egle; Miseviciene, Valdone; Muleviciene, Audrone; Mueller, Martha-Lena; Nordenskjold, Magnus; Matuzeviciene, Reda; Samaitiene, Ruta; Speckmann, Carsten; Stankeviciene, Sigita; Zekas, Vytautas; Voss, Matthias; Ehl, Stephan; Vaiciene-Magistris, Nerija; Henter, Jan-Inge; Meeths, Marie; Bryceson, Yenan T.			A RAB27A 5 ' untranslated region structural variant associated with late-onset hemophagocytic lympho-histiocytosis and normal pigmentation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; GRISCELLI SYNDROME; LUNG-FUNCTION; ASTHMA; LOCI; IDENTIFY; AMERICAN; MUNC13-4		[Tesi, Bianca; Lofstedt, Alexandra; Kvedaraite, Egle; Henter, Jan-Inge; Meeths, Marie] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Tesi, Bianca; Lofstedt, Alexandra; Nordenskjold, Magnus; Meeths, Marie] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Mol Med & Surg, Clin Genet Unit, Stockholm, Sweden; [Tesi, Bianca; Lofstedt, Alexandra; Nordenskjold, Magnus; Meeths, Marie] Karolinska Inst, Karolinska Univ Hosp Solna, Ctr Mol Med, Stockholm, Sweden; [Rascon, Jelena; Muleviciene, Audrone; Stankeviciene, Sigita] Vilnius Univ Hosp, Santariskiu Klin, Childrens Hosp, Ctr Pediat Oncol & Hematol, Vilnius, Lithuania; [Rascon, Jelena; Juozapaite, Sandra; Muleviciene, Audrone; Samaitiene, Ruta; Zekas, Vytautas] Vilnius Univ, Fac Med, Vilnius, Lithuania; [Chiang, Samuel C. C.; Mueller, Martha-Lena; Voss, Matthias; Bryceson, Yenan T.] Karolinska Inst, Dept Med, Ctr Hematol & Regenerat Med HERM, Stockholm, Sweden; [Burnyte, Birute] Vilnius Univ, Fac Med, Dept Human & Med Genet, Vilnius, Lithuania; [Fasth, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden; [Heizmann, Miriam; Speckmann, Carsten; Ehl, Stephan] Univ Freiburg, Fac Med, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Heizmann, Miriam; Speckmann, Carsten; Ehl, Stephan] Univ Freiburg, Fac Med, Med Ctr, Ctr Pediat, Freiburg, Germany; [Heizmann, Miriam] Univ Freiburg, Fac Biol, Freiburg, Germany; [Kiudeliene, Rosita] LUHS, Dept Pediat, Ctr Pediat Oncol & Hematol, Kaunas, Lithuania; [Kiudeliene, Rosita; Miseviciene, Valdone; Samaitiene, Ruta] Hosp LUHS Kauno Klin, Kaunas, Lithuania; [Miseviciene, Valdone] LUHS, Ctr Chron Resp Dis Children, Dept Pediat, Kaunas, Lithuania; [Matuzeviciene, Reda] Vilnius Univ, Dept Physiol Biochem Microbiol & Lab Med, Inst Biomed Sci, Fac Med, Vilnius, Lithuania; [Matuzeviciene, Reda] Vilnius Univ Hosp, Santaros Klin, Ctr Lab Med, Vilnius, Lithuania; [Samaitiene, Ruta] LUHS, Dept Neurol, Kaunas, Lithuania; [Vaiciene-Magistris, Nerija] Vilnius Univ Hosp, Santaros Klin, Childrens Hosp, Child Neurol Dept, Vilnius, Lithuania; [Samaitiene, Ruta] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway; [Chiang, Samuel C. C.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Mueller, Martha-Lena] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Vilnius University Hospital Santariskiu Klinikos; Vilnius University; Karolinska Institutet; Vilnius University; University of Gothenburg; University of Freiburg; University of Freiburg; University of Freiburg; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Vilnius University; Vilnius University Hospital Santariskiu Klinikos; Lithuanian University of Health Sciences; Vilnius University Hospital Santariskiu Klinikos; University of Bergen; Cincinnati Children's Hospital Medical Center; University of Wurzburg	Tesi, B (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden.; Tesi, B (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Dept Mol Med & Surg, Clin Genet Unit, Stockholm, Sweden.; Tesi, B (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Ctr Mol Med, Stockholm, Sweden.	Bianca.Tesi@ki.se; jelena.rascon@vuvl.lt	Žėkas, Vytautas/AAC-2717-2020; Chiang, Samuel CC/O-5960-2019; Kvedaraite, Egle/AAA-5257-2021; Fasth, Anders/I-1109-2019; Matuzeviciene, Reda/GSI-5971-2022; Samaitienė, Rūta/GOK-1072-2022; Rascon, Jelena/AAD-9514-2022; Ehl, Stephan/AAM-6006-2020; Rascon, Jelena/E-5513-2012; Tesi, Bianca/AAH-6304-2021; Bryceson, Yenan/D-2121-2018	Žėkas, Vytautas/0000-0002-4650-2597; Chiang, Samuel CC/0000-0001-6597-6117; Rascon, Jelena/0000-0003-4420-6943; Tesi, Bianca/0000-0002-8253-2507; Nordenskjold, Magnus/0000-0002-4974-425X; Voss, Matthias/0000-0002-4217-3175; Speckmann, Carsten/0000-0002-6217-1556; Henter, Jan-Inge/0000-0002-0629-2126; Ehl, Stephan/0000-0002-9265-2721; Bryceson, Yenan/0000-0002-7783-9934; Samaitiene, Ruta/0000-0001-6503-1578; Fasth, Anders/0000-0002-0033-740X; Kiudeliene, Rosita/0000-0003-3124-9311	European Research Council (ERC) under the European Union's Seventh Framework Programme [FP/2007-2013, 311335]; Norwegian Research Council; Swedish Foundation for Strategic Research; Wallenberg Foundation; Karolinska Institutet Center for Innovative Medicine; Swedish Childhood Cancer Foundation; Stockholm County Council; Swedish Cancer Foundation; Swedish Research Council; Cancer and Allergy Foundation of Sweden; German Ministry of Education and Research [BMBF 01EO1303]; German Research Foundation [SFB1160]; Board of Postgraduate Studies at Karolinska Institutet; Swedish National Infrastructure for Computing (SNIC) through the Uppsala Multidisciplinary Center for Advanced Computational Science [SNIC b2012204, b2015280]	European Research Council (ERC) under the European Union's Seventh Framework Programme(European Research Council (ERC)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wallenberg Foundation(European Commission); Karolinska Institutet Center for Innovative Medicine; Swedish Childhood Cancer Foundation(European Commission); Stockholm County Council(Stockholm County Council); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer and Allergy Foundation of Sweden; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Board of Postgraduate Studies at Karolinska Institutet(Karolinska Institutet); Swedish National Infrastructure for Computing (SNIC) through the Uppsala Multidisciplinary Center for Advanced Computational Science	This work was supported by a grant from the European Research Council (ERC) under the European Union's Seventh Framework Programme (grant no. FP/2007-2013; ERC grant agreement no. 311335), the Norwegian Research Council, the Swedish Foundation for Strategic Research, the Wallenberg Foundation, the Karolinska Institutet Center for Innovative Medicine (Y.T.B.), the Swedish Childhood Cancer Foundation (J.-I.H., Y.T.B., M. M.), as well as the Stockholm County Council, the Swedish Cancer Foundation, and the Swedish Research Council (J.-I.H., Y.T.B.), the Cancer and Allergy Foundation of Sweden (J.-I.H.), the German Ministry of Education and Research (grant no. BMBF 01EO1303), and the German Research Foundation (grant no. SFB1160, TP1; S.E.). B.T. is also supported by a doctoral student scholarship from the Board of Postgraduate Studies at Karolinska Institutet. Computations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) through the Uppsala Multidisciplinary Center for Advanced Computational Science under Project SNIC b2012204 and b2015280.	Aguet F, 2016074450 BIORXIV; Almoguera B, 2017, AM J RESP CRIT CARE, V195, P456, DOI 10.1164/rccm.201604-0861OC; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Brand H, 2015, AM J HUM GENET, V97, P170, DOI 10.1016/j.ajhg.2015.05.012; Cetica V, 2015, J ALLERGY CLIN IMMUN, V135, P1310, DOI 10.1016/j.jaci.2014.08.039; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Ding LL, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-16; Forno E, 2012, J ALLERGY CLIN IMMUN, V130, P83, DOI 10.1016/j.jaci.2012.03.020; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752; Janka GE, 2014, BLOOD REV, V28, P135, DOI 10.1016/j.blre.2014.03.002; Lutz SM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0299-4; Meeths M, 2010, PEDIATR BLOOD CANCER, V54, P563, DOI 10.1002/pbc.22357; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Netter P, 2016, J ALLERGY CLIN IMMUN, V138, P599, DOI 10.1016/j.jaci.2015.12.1337; Nieuwenhuis MA, 2016, ALLERGY, V71, P1712, DOI 10.1111/all.12990; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Ramasamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044008; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Vincent LM, 2010, MOL GENET METAB, V101, P62, DOI 10.1016/j.ymgme.2010.05.015; Wain LV, 2017, NAT GENET, V49, P416, DOI 10.1038/ng.3787; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Yan Q, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01505-2016; Zerah ML, 2015, DERMATOLOGY, V230, P234, DOI 10.1159/000368552	28	17	17	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					317	321		10.1016/j.jaci.2018.02.031	http://dx.doi.org/10.1016/j.jaci.2018.02.031			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29522846	hybrid, Green Published			2022-12-18	WOS:000437837500042
J	Fenoglio, D; Dentone, C; Signori, A; Di Biagio, A; Parodi, A; Kalli, F; Nasi, G; Curto, M; Cenderello, G; De Leo, P; Bartolacci, V; Orofino, G; Nicolini, LA; Taramasso, L; Fiorillo, E; Orru, V; Traverso, P; Bruzzone, B; Ivaldi, F; Mantia, E; Guerra, M; Negrini, S; Giacomini, M; Bhagani, S; Filaci, G				Fenoglio, Daniela; Dentone, Chiara; Signori, Alessio; Di Biagio, Antonio; Parodi, Alessia; Kalli, Francesca; Nasi, Giorgia; Curto, Monica; Cenderello, Giovanni; De Leo, Pasqualina; Bartolacci, Valentina; Orofino, Giancarlo; Nicolini, Laura Ambra; Taramasso, Lucia; Fiorillo, Edoardo; Orru, Valeria; Traverso, Paolo; Bruzzone, Bianca; Ivaldi, Federico; Mantia, Eugenio; Guerra, Michele; Negrini, Simone; Giacomini, Mauro; Bhagani, Sanjay; Filaci, Gilberto			CD8(+)CD28(+)CD127(IO) lo CD39(+) regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HIV; CD8(+) CD28(-) CD12(lo) lo CD39(+) regulatory T cell; antiretroviral therapy	ACTIVATION; LYMPHOCYTES; EXPRESSION; CD4(+); SUPPRESS; CANCER; COUNT	Background: HIV-associated immunodeficiency is related to loss of CD4(+) T cells. This mechanism does not explain certain manifestations of HIV disease, such as immunodeficiency events in patients with greater than 500 CD4(+) T cells/mL. CD8(+) CD28(-) CD127(lo) CD39(+) T cells are regulatory T (Treg) lymphocytes that are highly concentrated within the tumor microenvironment and never analyzed in the circulation of HIV-infected patients. Objectives: We sought to analyze the frequency of CD8(+) CD28(-) CD127(lo) CD39(+) Treg cells in the circulation of HIV-infected patients. Methods: The frequency of circulating CD8(+) CD28(-) CD127(lo) CD39(+) Treg cells was analyzed and correlated with viral load and CD4(+) T-cell counts/percentages in 93 HIV-1-infected patients subdivided as follows: naive (n 5 63), elite controllers (n 5(+)9), long-term nonprogressors (n 5 7), and HIV-infected patients affected by tumor (n 5 4). The same analyses were performed in HIV-negative patients with cancer (n 5 53), hepatitis C virus-infected patients (n 5(+)7), and healthy donors (n 5(+)73). Results: HIV-infected patients had increased circulating levels of functional CD8(+) CD28(-) CD127(lo) CD39(+) Treg cells. These cells showed antigen specificity against HIV proteins. Their frequency after antiretroviral therapy (ART) correlated with HIV viremia, CD4(+) T-cell counts, and immune activation markers, suggesting their pathogenic involvement in AIDS-or non-AIDS-related complications. Their increase after initiation of ART heralded a lack of virologic or clinical response, and hence their monitoring is clinically relevant. Conclusion: HIV infection induces remarkable expansion of CD8(+) CD28(-) CD127(lo) CD39(+) Treg cells, the frequency of which correlates with both clinical disease and signs of chronic immune cell activation. Monitoring their frequency in the circulation is a new marker of response to ARTwhen effects on viremia and clinical response are not met.	[Fenoglio, Daniela; Dentone, Chiara; Parodi, Alessia; Kalli, Francesca; Nasi, Giorgia; Curto, Monica; Traverso, Paolo; Ivaldi, Federico; Negrini, Simone; Giacomini, Mauro; Filaci, Gilberto] Univ Genoa, Ctr Excellence Biomed Res, Viale Benedetto 15 7, I-16132 Genoa, Italy; [Fenoglio, Daniela; Negrini, Simone; Filaci, Gilberto] Univ Genoa, Dept Internal Med, Genoa, Italy; [Signori, Alessio; Nicolini, Laura Ambra] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Traverso, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Giacomini, Mauro] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy; [Fenoglio, Daniela; Traverso, Paolo; Negrini, Simone; Filaci, Gilberto] IRCCS Azienda Osped Univ San Martino, Genoa, Italy; [Di Biagio, Antonio; Nicolini, Laura Ambra; Taramasso, Lucia] IRCCS Azienda Osped Univ San Martino, Infect Dis Unit, Genoa, Italy; [Bruzzone, Bianca] IRCCS Azienda Osped Univ San Martino, Infect Dis Unit, IST Ist Nazl Ric Canc, Genoa, Italy; [Dentone, Chiara] Sanremo Hosp, Infect Dis Dept, Imperia, Italy; [Cenderello, Giovanni] Galliera Hosp, Infect Dis Dept, Genoa, Italy; [De Leo, Pasqualina] San Paolo Hosp, Infect Dis Dept, Savona, Italy; [Bartolacci, Valentina] Osped S Maria Misericordia, Albenga, Italy; [Orofino, Giancarlo] Amedeo di Savoia Hosp, Infect Dis Dept, Turin, Italy; [Fiorillo, Edoardo; Orru, Valeria] Consiglio Nazl Ric CNR, Sede Secondaria IRGB, Ist Ric Genet & Biomed, Lanusei, Italy; [Mantia, Eugenio] Cesare Arrigo Hosp, Infect Dis Dept, Alessandria, Italy; [Guerra, Michele] St Andrea Hosp, Infect Dis Dept, La Spezia, Italy; [Bhagani, Sanjay] Royal Free Hosp, Natl Hlth Serv, Dept Infect Dis HIV Med, London, England	University of Genoa; University of Genoa; University of Genoa; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; Ente Ospedaliero Ospedali Galliera; Hospital Santa Maria della Misericordia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); NHS Blood & Transplant (NHSBT); University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Filaci, G (corresponding author), Univ Genoa, Ctr Excellence Biomed Res, Viale Benedetto 15 7, I-16132 Genoa, Italy.	gfilaci@unige.it	NEGRINI, Simone/AAC-6823-2021; Valeria, Orru/AAY-3805-2020; Fenoglio, Daniela/I-7220-2018; Taramasso, Lucia/J-3358-2019; Signori, Alessio/L-3081-2016; Di Biagio, Antonio/J-4901-2019; Giacomini, Mauro/D-3194-2013; Fiorillo, Edoardo/AAY-3804-2020	NEGRINI, Simone/0000-0003-1267-4320; Fenoglio, Daniela/0000-0001-9532-6473; Taramasso, Lucia/0000-0002-6622-6358; Signori, Alessio/0000-0001-6289-9144; Di Biagio, Antonio/0000-0003-1436-5089; Giacomini, Mauro/0000-0001-5646-2034; Orru, Valeria/0000-0002-6047-4625; Bhagani, Sanjay/0000-0003-2557-4337	Ministero dell'Istruzione, dell'Universita e della Ricerca, PRIN [2008WXF7KK]	Ministero dell'Istruzione, dell'Universita e della Ricerca, PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	Supported by a grant from Ministero dell'Istruzione, dell'Universita e della Ricerca, PRIN no. 2008WXF7KK entitled "Immunoterapia anti-tumorale operata attraverso l'inibizione dei circuiti regolatori citochino-dipendenti.''	Angin M, 2014, J INFECT DIS, V210, P899, DOI 10.1093/infdis/jiu188; Angin M, 2012, AIDS, V26, P2112, DOI 10.1097/QAD.0b013e328358cc75; Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3; Calza L, 2016, CURR HIV RES, V14, P456, DOI 10.2174/1570162X14666160803114651; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Chuang-Stein C., 1992, DRUG INF J, V26, P77, DOI [10.1177/009286159202600108, DOI 10.1177/009286159202600108]; Cockerham LR, 2014, AIDS, V28, P1749, DOI 10.1097/QAD.0000000000000314; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Dentone C, 2014, AIDS, V28, P1071, DOI 10.1097/QAD.0000000000000194; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Fenoglio D, 2008, HUM IMMUNOL, V69, P745, DOI 10.1016/j.humimm.2008.08.282; Filaci G, 2004, HUM IMMUNOL, V65, P142, DOI 10.1016/j.humimm.2003.12.001; Filaci G, 2001, J IMMUNOL, V166, P6452, DOI 10.4049/jimmunol.166.10.6452; Filaci G, 2007, J IMMUNOL, V179, P4323, DOI 10.4049/jimmunol.179.7.4323; Filaci G, 2011, AUTOIMMUNITY, V44, P51, DOI 10.3109/08916931003782171; Fraccaro Paolo, 2013, Med 2 0, V2, pe5, DOI 10.2196/med20.2712; Fraccaro P, 2013, INFORM HEALTH SOC CA, V38, P313, DOI 10.3109/17538157.2013.812648; Freguja R, 2011, CLIN EXP IMMUNOL, V164, P373, DOI 10.1111/j.1365-2249.2011.04383.x; Gazzola L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-51; Guihot A, 2016, AIDS, V30, P327, DOI 10.1097/QAD.0000000000000815; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Jiao YM, 2009, IMMUNOLOGY, V128, pe366, DOI 10.1111/j.1365-2567.2008.02978.x; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Kleijwegt FS, 2011, J IMMUNOL, V187, P6357, DOI 10.4049/jimmunol.1101638; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Lu LR, 2008, P NATL ACAD SCI USA, V105, P19420, DOI 10.1073/pnas.0810383105; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Maggi E, 2005, AUTOIMMUN REV, V4, P579, DOI 10.1016/j.autrev.2005.04.010; Mandalia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029844; Mori S, 2009, INT J STD AIDS, V20, P662, DOI 10.1258/ijsa.2008.008428; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Parodi A, 2016, ONCOTARGET, V7, P6424, DOI 10.18632/oncotarget.7024; Parodi A, 2013, CANCER IMMUNOL IMMUN, V62, P851, DOI 10.1007/s00262-013-1392-z; Phetsouphanh C, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00681; Rey D, 1999, EUR J CLIN MICROBIOL, V18, P137, DOI 10.1007/s100960050242; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085; Vuddamalay Y, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00031; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Whiteside TL, 2015, CANCER MICROENVIRON, V8, P201, DOI 10.1007/s12307-014-0159-1; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	53	17	18	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2220	+		10.1016/j.jaci.2017.08.021	http://dx.doi.org/10.1016/j.jaci.2017.08.021			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29103633	hybrid, Green Published			2022-12-18	WOS:000434701600026
J	Tan, BK; Peters, AT; Schleimer, RP; Hulse, KE				Tan, Bruce K.; Peters, Anju T.; Schleimer, Robert P.; Hulse, Kathryn E.			Pathogenic and protective roles of B cells and antibodies in patients with chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Antibodies; antibody deficiency; autoimmunity; chronic rhinosinusitis; B cells; immunodeficiency; mucosal immunity	COMMON VARIABLE IMMUNODEFICIENCY; INNATE LYMPHOID-CELLS; NASAL POLYPS; ACTIVATING FACTOR; AIRWAY INFLAMMATION; DEFICIENCY SYNDROME; RESPIRATORY SYSTEM; IMMUNOGLOBULIN-D; IGA DEFICIENCY; TNF FAMILY	Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the nose and sinuses that affects up to 12% of the population in Europe and the United States. This complex disease is likely driven by multiple environmental, genetic, and inflammatory mechanisms, and recent studies suggest that B cells might play a critical role in disease pathogenesis. B cells and their antibodies have undisputed roles in health and disease within the airway mucosae. Deficient or inadequate B-cell responses can lead to susceptibility to infectious disease in the nose, whereas excess antibody production, including autoantibodies, can promote damaging inflammation. Thus, patients with B-cell defects often have either chronic or recurrent acute infections, and this can be associated with nonpolypoid CRS. In contrast, many patients with CRS with nasal polyps, which is less likely to be driven by pathogens, have excess production of local immunoglobulins, including autoreactive antibodies. These B-cell responses activate complement in many patients and likely contribute to immunopathogenic responses. A better understanding of the B cell-associated mechanisms that drive disease in patients with CRS should be a high priority in the quest to understand the pathogenesis of this disease.	[Tan, Bruce K.; Schleimer, Robert P.] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, Chicago, IL 60611 USA; [Peters, Anju T.; Schleimer, Robert P.; Hulse, Kathryn E.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Hulse, KE (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, 240 E Huron St,McGaw Rm M-302, Chicago, IL 60611 USA.	k-hulse@northwestern.edu			National Institutes of Health [R56 AI121239, U19 AI106683, R01 AI072570]; Ernest S. Bazley Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137174, U19AI106683, R56AI131239, R01AI072570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernest S. Bazley Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grants R56 AI121239, U19 AI106683, and R01 AI072570 and the Ernest S. Bazley Trust.	Aghamohammadi A, 2011, INT ARCH ALLERGY IMM, V156, P462, DOI 10.1159/000323903; Alachkar H, 2006, CLIN IMMUNOL, V120, P310, DOI 10.1016/j.clim.2006.05.003; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, pe1, DOI DOI 10.1016/J.JACI.2010.07.007; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Bonilla FA, 2016, J ALLER CL IMM-PRACT, V4, P38, DOI 10.1016/j.jaip.2015.07.025; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Calus L, 2017, INT ARCH ALLERGY IMM, V174, P161, DOI 10.1159/000481435; Cameron L, 2000, J ALLERGY CLIN IMMUN, V106, P46; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Carruthers MN, 2015, ANN RHEUM DIS, V74, P1171, DOI 10.1136/annrheumdis-2014-206605; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chan TD, 2010, IMMUNOL REV, V237, P90, DOI 10.1111/j.1600-065X.2010.00942.x; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chen JB, 2017, J ALLERGY CLIN IMMUN, V139, P1195, DOI 10.1016/j.jaci.2016.06.066; COCKS BG, 1993, INT IMMUNOL, V5, P657, DOI 10.1093/intimm/5.6.657; Crestani B, 2005, ALLERGY, V60, P715, DOI 10.1111/j.1398-9995.2005.00761.x; Cunningham-Rundles C, 2001, J CLIN IMMUNOL, V21, P303, DOI 10.1023/A:1012241117984; De Schryver E, 2016, J ALLERGY CLIN IMMUN, V138, P893, DOI 10.1016/j.jaci.2016.03.040; De Schryver E, 2015, ALLERGY ASTHMA IMMUN, V7, P321, DOI 10.4168/aair.2015.7.4.321; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Derycke L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097581; Drolet JP, 2010, CLIN EXP ALLERGY, V40, P841, DOI 10.1111/j.1365-2222.2010.03512.x; Feldman S, 2017, CLIN EXP ALLERGY, V47, P457, DOI 10.1111/cea.12878; Fliegauf M, 2015, AM J HUM GENET, V97, P389, DOI 10.1016/j.ajhg.2015.07.008; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Gatto D, 2013, TRENDS IMMUNOL, V34, P336, DOI 10.1016/j.it.2013.01.007; Germain C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00067; Gevaert P, 2005, ALLERGY, V60, P71, DOI 10.1111/j.1398-9995.2004.00621.x; Gevaert P, 2013, ALLERGY, V68, P55, DOI 10.1111/all.12054; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hulse KE, 2013, J ALLERGY CLIN IMMUN, V131, P1075, DOI 10.1016/j.jaci.2013.01.043; Hulse KE, 2013, J ALLERGY CLIN IMMUN, V131, pe1; Jeffe JS, 2013, LARYNGOSCOPE, V123, P2104, DOI 10.1002/lary.24016; Jennette JC, 2014, SEMIN IMMUNOPATHOL, V36, P327, DOI 10.1007/s00281-014-0431-y; Kanegane H, 2007, GENES IMMUN, V8, P663, DOI 10.1038/sj.gene.6364431; Kashani S, 2015, J ALLER CL IMM-PRACT, V3, P236, DOI 10.1016/j.jaip.2014.09.022; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, pe1; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, P1385, DOI 10.1016/j.jaci.2008.03.002; Kato A, 2013, J ALLERGY CLIN IMMUN, V131, P933, DOI 10.1016/j.jaci.2013.02.023; Keswani A, 2017, J ALLER CL IMM-PRACT, V5, P1105, DOI 10.1016/j.jaip.2016.11.033; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lau A, 2017, J ALLERGY CLIN IMMUN, V139, P1371, DOI 10.1016/j.jaci.2016.08.052; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Losi CG, 2005, J CLIN IMMUNOL, V25, P496, DOI 10.1007/s10875-005-5637-2; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Miljkovic D, 2017, INT FORUM ALLERGY RH, V7, P609, DOI 10.1002/alr.21924; Min JY, 2014, J ALLERGY CLIN IMMUN, V133, pAB236, DOI 10.1016/j.jaci.2013.12.840; Min JY, 2017, J ALLERGY CLIN IMMUN, V140, P1562, DOI 10.1016/j.jaci.2017.05.032; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; Moteki H, 2011, ACTA OTO-LARYNGOL, V131, P518, DOI 10.3109/00016489.2010.533699; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Patadia M, 2010, AM J RHINOL ALLERGY, V24, P11, DOI 10.2500/ajra.2010.24.3386; Pieper K, 2014, J ALLERGY CLIN IMMUN, V133, P1222, DOI 10.1016/j.jaci.2013.11.021; Polosukhin VV, 2011, AM J RESP CRIT CARE, V184, P317, DOI 10.1164/rccm.201010-1629OC; Poposki JA, 2017, IMMUN INFLAMM DIS, V5, P233, DOI 10.1002/iid3.161; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Rothstein TL, 2013, ANN NY ACAD SCI, V1285, P97, DOI 10.1111/nyas.12137; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schipp C, 2016, HAEMATOLOGICA, V101, pE392, DOI 10.3324/haematol.2016.145136; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Schwitzguebel AJP, 2015, J ALLERGY CLIN IMMUN, V136, P1523, DOI 10.1016/j.jaci.2015.07.016; Sokoya M, 2017, ANN ALLERG ASTHMA IM, V119, P317, DOI 10.1016/j.anai.2017.07.024; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; STOOP AE, 1991, J ALLERGY CLIN IMMUN, V87, P470, DOI 10.1016/0091-6749(91)90004-8; Tan BK, 2017, J ALLERGY CLIN IMMUN, V139, P699, DOI 10.1016/j.jaci.2016.06.063; Tan BK, 2011, J ALLERGY CLIN IMMUN, V128, P1198, DOI 10.1016/j.jaci.2011.08.037; Tangye SG, 2013, BLOOD, V121, P5109, DOI 10.1182/blood-2013-05-500074; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Tokunaga T, 2015, ALLERGY, V70, P995, DOI 10.1111/all.12644; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Van Roey GA, 2017, J ALLERGY CLIN IMMUN, V140, P89, DOI 10.1016/j.jaci.2016.11.015; Van Zele T, 2007, CLIN EXP ALLERGY, V37, P1840, DOI 10.1111/j.1365-2222.2007.02838.x; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Walsh JE, 2017, INT FORUM ALLERGY RH, V7, P30, DOI 10.1002/alr.21839; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x; Zhang YN, 2016, J ALLERGY CLIN IMMUN, V137, P462, DOI 10.1016/j.jaci.2015.07.025	90	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1553	1560		10.1016/j.jaci.2018.03.002	http://dx.doi.org/10.1016/j.jaci.2018.03.002			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29731101	Green Accepted, Bronze			2022-12-18	WOS:000432148200002
J	Ali, Z; Nilas, L; Ulrik, CS				Ali, Zarqa; Nilas, Lisbeth; Ulrik, Charlotte Suppli			Excessive gestational weight gain in first trimester is a risk factor for exacerbation of asthma during pregnancy: A prospective study of 1283 pregnancies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; exacerbation; pregnancy; gestational weight gain	LIFE-STYLE INTERVENTION; CHILDHOOD ASTHMA; CORD BLOOD; OBESITY; WOMEN; ASSOCIATION; OUTCOMES; GROWTH; LEPTIN	Background: Acute exacerbation during pregnancy is the most important risk factor for an unfavorable outcome of pregnancy in women with asthma. Objective: We sought to identify pregnancy-related risk factors for acute exacerbations of asthma during pregnancy. Methods: Since 2007, all pregnant women referred to give birth at Hvidovre Hospital, Denmark, have been offered participation in the prospective Management of Asthma during Pregnancy (MAP) program. Women were included in the present analysis if they fulfilled the following criteria: (1) diagnosed with asthma, (2) prescribed at least rescue bronchodilator, and (3) had the first visit to the respiratory outpatient clinic within the first 18 weeks of pregnancy. Data were analyzed using multiple logistic regression models with backward stepwise elimination (Proc Logistic procedure in SAS). Results: Over an 8-year study period, a total of 1283 pregnancies in 1208 women fulfilled the criteria for inclusion in the MAP cohort. Women with asthma exacerbation(s) had larger gestational weight gain (GWG) in the first trimester of pregnancy (P <.001) and increased total GWG (P <.001) compared with women without exacerbation. More than 5 kg first-trimester weight gain was associated with an increased risk of asthma exacerbation (odds ratio, 9.35; 95% CI, 6.39-13.68; P <.001), and the risk increased in a dose-dependent manner with additional weight gain in excess of 5 kg. Conclusions: Excessive GWG in the first trimester is a risk factor for asthma exacerbation during pregnancy and the risk increases in a dose-dependent manner with increasing GWG.	[Ali, Zarqa; Ulrik, Charlotte Suppli] Hvidovre Univ Hosp, Dept Pulm Med, Hvidovre, Denmark; [Nilas, Lisbeth] Hvidovre Univ Hosp, Dept Gynaecol & Obstet, Hvidovre, Denmark; [Nilas, Lisbeth; Ulrik, Charlotte Suppli] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Ali, Z (corresponding author), 253 Hvidovre Hosp, Dept Pulm Med, DK-2650 Hvidovre, Denmark.	zarqa_ali@hotmail.com		Ali, Zarqa/0000-0003-2411-7177	Danish Lung Association; Amager and Hvidovre Hospital Research Foundation; Glaxo Smith Kline; Grosserer L.F. Foght's Foundation; Torben and Alice Frimodt's Foundation; Global Excellence in Health (Capital Region of Denmark)	Danish Lung Association; Amager and Hvidovre Hospital Research Foundation; Glaxo Smith Kline(GlaxoSmithKline); Grosserer L.F. Foght's Foundation; Torben and Alice Frimodt's Foundation; Global Excellence in Health (Capital Region of Denmark)	The Danish Lung Association, Amager and Hvidovre Hospital Research Foundation, Glaxo Smith Kline, Grosserer L.F. Foght's Foundation, Torben and Alice Frimodt's Foundation, and Global Excellence in Health (Capital Region of Denmark) have financially supported this research.	Ali Z, 2016, RESP MED, V120, P124, DOI 10.1016/j.rmed.2016.10.004; Enriquez R, 2007, J ALLERGY CLIN IMMUN, V120, P625, DOI 10.1016/j.jaci.2007.05.044; Ferraro ZM, 2013, INT J WOMENS HEALTH, V5, P657, DOI 10.2147/IJWH.S49594; Ferretti G, 2014, J MATERN-FETAL NEO M, V27, P1353, DOI 10.3109/14767058.2013.858319; Forno E, 2014, PEDIATRICS, V134, pE535, DOI 10.1542/peds.2014-0439; Gesche J, 2014, OBESITY FACTS, V7, P351, DOI 10.1159/000369769; Global Initiative for Asthma (GINA) NHLaBI National Institutes of Health, 2018, GLOB STRAT ASTHM MAN; Halonen M, 2013, AM J RESP CRIT CARE, V188, P35, DOI 10.1164/rccm.201207-1265OC; Hantoushzadeh S, 2016, POSTGRAD MED J, V92, P520, DOI 10.1136/postgradmedj-2015-133816; Helms Eric, 2006, Am J Obstet Gynecol, V194, pe32, DOI 10.1016/j.ajog.2006.01.025; Hendler I, 2006, OBSTET GYNECOL, V108, P77, DOI 10.1097/01.AOG.0000223180.53113.0f; Johnson JL, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.030; Juel CTB, 2012, J ASTHMA ALLERGY, V5, P21, DOI 10.2147/JAA.S32232; Karakosta P, 2013, PAEDIATR PERINAT EP, V27, P461, DOI 10.1111/ppe.12074; Kowal C, 2012, MATERN CHILD HLTH J, V16, P668, DOI 10.1007/s10995-011-0771-3; Liu JH, 2015, MATERN CHILD HLTH J, V19, P840, DOI 10.1007/s10995-014-1582-0; Liu Z, 2014, CHINESE MED J-PEKING, V127, P1255, DOI 10.3760/cma.j.issn.0366-6999.20132772; London SJ, 2015, PLOS ONE, V10; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Murphy VE, 2005, OBSTET GYNECOL, V106, P1046, DOI 10.1097/01.AOG.0000185281.21716.02; Powell H, 2011, LANCET, V378, P983, DOI 10.1016/S0140-6736(11)60971-9; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; SCHATZ M, 1988, Journal of Allergy and Clinical Immunology, V81, P509, DOI 10.1016/0091-6749(88)90187-X; Thomsen SF, 2004, ANN ALLERG ASTHMA IM, V92, P506, DOI 10.1016/S1081-1206(10)61757-7; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Wells CS, 2006, MATERN CHILD HLTH J, V10, P55, DOI 10.1007/s10995-005-0034-2	26	17	21	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					761	767		10.1016/j.jaci.2017.03.040	http://dx.doi.org/10.1016/j.jaci.2017.03.040			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28551030	Bronze			2022-12-18	WOS:000424410800032
J	Wang, H; Do, DC; Liu, JX; Wang, BF; Qu, JJ; Ke, X; Luo, XY; Tang, HM; Tang, HL; Hu, CP; Anderson, ME; Liu, Z; Gao, PS				Wang, Heng; Do, Danh C.; Liu, Jinxin; Wang, Baofeng; Qu, Jingjing; Ke, Xia; Luo, Xiaoyan; Tang, Ho Man; Tang, Ho Lam; Hu, Chengping; Anderson, Mark E.; Liu, Zheng; Gao, Peisong			Functional role of kynurenine and aryl hydrocarbon receptor axis in chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis with nasal polyps; aryl hydrocarbon receptor (AhR); kynurenine; mast cell; calmodulin-dependent protein kinase II (CaMKII)	MAST-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; DENDRITIC CELLS; EOSINOPHILIA; IGE; INFLAMMATION; ACTIVATION; SECRETION; FEATURES; DISEASE	Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with mast cell-mediated inflammation and heightened oxidant stress. Kynurenine (KYN), an endogenous tryptophan metabolite, can promote allergen-induced mast cell activation through the aryl hydrocarbon receptor (AhR). Objectives: We sought to determine the role of the KYN/AhR axis and oxidant stress in mast cell activation and the development of CRSwNP. Methods: We measured the expression of indoleamine 2,3-dioxygenase 1, tryptophan 2,3-dioxygenase, KYN, and oxidized calmodulin-dependent protein kinase II (ox-CaMKII) in nasal polyps and controls. KYN-potentiated ovalbumin (OVA)-induced ROS generation, cell activation, and ox-CaMKII expression were investigated in wild-type and AhR-deficient (AhR(-/-)) mast cells. The role of ox-CaMKII in mast cell activation was further investigated. Results: Nasal polyps in CRSwNP showed an increased expression of indoleamine 2,3-dioxygenase 1, tryptophan2,3-dioxygenase, and KYN compared with controls. AhR was predominantly expressed in mast cells in nasal polyps. Activated mast cells and local IgE levels were substantially increased in eosinophilic polyps compared with noneosinophilic polyps and controls. Furthermore, KYN potentiated OVA-induced ROS generation, intracellular Ca2+ levels, cell activation, and expression of ox-CaMKII in wild-type, but not in AhR(-/-) mast cells. Compared with noneosinophilic polyps and controls, eosinophilic polyps showed increased expression of ox-CaMKII in mast cells. Mast cells from ROS-resistant CaMKII MMVVd mice or pretreated with CaMKII inhibitor showed protection against KYN-promoted OVA-induced mast cell activation. Conclusions: These studies support a potentially critical but previously unidentified function of the KYN/AhR axis in regulating IgE-mediated mast cell activation through ROS and ox-CaMKII in CRSwNP.	[Wang, Heng; Do, Danh C.; Qu, Jingjing; Ke, Xia; Luo, Xiaoyan; Gao, Peisong] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Wang, Heng; Liu, Jinxin; Wang, Baofeng; Liu, Zheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Otolaryngol Head & Neck Surg, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Qu, Jingjing; Hu, Chengping] Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China; [Tang, Ho Man] Johns Hopkins Univ, Sch Med, Inst Basic Biomed Sci, Baltimore, MD USA; [Tang, Ho Lam] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Anderson, Mark E.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA	Johns Hopkins University; Huazhong University of Science & Technology; Central South University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Liu, Z (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Otolaryngol Head & Neck Surg, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.; Gao, PS (corresponding author), Div Allergy & Clin Immunol, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	zhengliuent@hotmail.com; pgao1@jhmi.edu	C, Danh/I-1527-2019	C, Danh/0000-0002-1065-7140	National Institutes of Health [RO1ES021739, R21 AI109062, R21 AI121768]; National Natural Science Foundation of China [81628001, 81325006, 81570899, 81630024, 81200733]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070250, R01HL096652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109062, R21AI121768, R21AI088406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Institutes of Health (grant nos. RO1ES021739, R21 AI109062, and R21 AI121768 to P.G.) and the National Natural Science Foundation of China (grant no. 81628001 to P.G., grant nos. 81325006, 81570899, and 81630024 to Z.L., and grant no. 81200733 to H.W.).	Abdala-Valencia H, 2007, AM J PHYSIOL-LUNG C, V292, pL1111, DOI 10.1152/ajplung.00208.2006; Abonia JP, 2010, J ALLERGY CLIN IMMUN, V126, P140, DOI 10.1016/j.jaci.2010.04.009; Anderson ME, 2015, J MOL CELL CARDIOL, V89, P160, DOI 10.1016/j.yjmcc.2015.10.014; Bowler RR, 2004, CURR ALLERGY ASTHM R, V4, P116, DOI 10.1007/s11882-004-0056-7; Cao PP, 2014, CLIN EXP ALLERGY, V44, P690, DOI 10.1111/cea.12304; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Foger N, 2011, J EXP MED, V208, P1777, DOI 10.1084/jem.20101757; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fordham MT, 2013, OTOLARYNG HEAD NECK, V149, P633, DOI 10.1177/0194599813496377; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Gevaert P, 2013, ALLERGY, V68, P55, DOI 10.1111/all.12054; Hua XY, 2016, ANN OTO RHINOL LARYN, V125, P290, DOI 10.1177/0003489415610775; JARJOUR NN, 1994, J LAB CLIN MED, V123, P131; Joulia R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7174; Kawasaki H, 2014, ALLERGY, V69, P445, DOI 10.1111/all.12346; Kopf PG, 2010, TOXICOL APPL PHARM, V245, P91, DOI 10.1016/j.taap.2010.02.007; Li Ying-Ji, 2010, Inflammation & Allergy Drug Targets, V9, P300; Ma J, 2016, CLIN EXP ALLERGY, V46, P1162, DOI 10.1111/cea.12758; Maaetoft-Udsen K, 2012, J IMMUNOTOXICOL, V9, P327, DOI 10.3109/1547691X.2012.661802; Mahdavinia M, 2016, CLIN EXP ALLERGY, V46, P21, DOI 10.1111/cea.12666; Mahdavinia M, 2015, J ALLERGY CLIN IMMUN, V135, P576, DOI 10.1016/j.jaci.2014.08.031; Mahdavinia M, 2014, J ALLERGY CLIN IMMUN, V133, P1759, DOI 10.1016/j.jaci.2013.12.1092; Manners S, 2014, J ALLERGY CLIN IMMUN, V134, P63, DOI 10.1016/j.jaci.2013.10.047; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mitsuhashi S, 2007, ANAL CHIM ACTA, V584, P315, DOI 10.1016/j.aca.2006.11.040; Morris AS, 2017, MOL PHARMACEUT, V14, P2166, DOI 10.1021/acs.molpharmaceut.7b00114; Nakayama T, 2011, RHINOLOGY, V49, P392, DOI 10.4193/Rhino10.261; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Olze H, 2006, RHINOLOGY, V44, P145; Pezato R, 2014, IMMUNOBIOLOGY, V219, P729, DOI 10.1016/j.imbio.2014.05.004; Poposki JA, 2015, CLIN EXP ALLERGY, V45, P384, DOI 10.1111/cea.12471; Qi SS, 2016, INT ARCH ALLERGY IMM, V171, P234, DOI 10.1159/000452333; Qiu YP, 2014, CLIN CANCER RES, V20, P2136, DOI 10.1158/1078-0432.CCR-13-1939; Qu JJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90139; Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015; Sanders PN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006135; Sebag SC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88297; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Shi LL, 2014, AM J RESP CRIT CARE, V190, P628, DOI 10.1164/rccm.201402-0234OC; Sibilano R, 2012, J IMMUNOL, V189, P120, DOI 10.4049/jimmunol.1200009; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Takabayashi T, 2012, J ALLERGY CLIN IMMUN, V130, P410, DOI 10.1016/j.jaci.2012.02.046; Topal O, 2014, AM J RHINOL ALLERGY, V28, pE1, DOI 10.2500/ajra.2014.28.3963; Totlandsdal AI, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-41; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Zele T, 2014, AM J RHINOL ALLERGY, V28, P192, DOI 10.2500/ajra.2014.28.4033; Wada T, 2013, MOL PHARMACOL, V83, P1133, DOI 10.1124/mol.112.083303; Walford HH, 2014, CLIN IMMUNOL, V155, P126, DOI 10.1016/j.clim.2014.09.007; Wang G, 2016, EUR RESPIR J, V47, P1123, DOI 10.1183/13993003.01098-2015; Wen WP, 2012, J ALLERGY CLIN IMMUN, V129, P1522, DOI 10.1016/j.jaci.2012.01.079; WILHELMS OH, 1980, J IMMUNOL METHODS, V36, P221, DOI 10.1016/0022-1759(80)90127-1; Yeung AWS, 2015, CLIN SCI, V129, P601, DOI 10.1042/CS20140392; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhou YF, 2013, BLOOD, V121, P3195, DOI 10.1182/blood-2012-08-453597	62	17	18	5	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					586	+		10.1016/j.jaci.2017.06.013	http://dx.doi.org/10.1016/j.jaci.2017.06.013			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28689792	Green Accepted, Bronze			2022-12-18	WOS:000424410800015
J	Galli, SJ; Gaudenzio, N				Galli, Stephen J.; Gaudenzio, Nicolas			Human mast cells as antigen-presenting cells: When is this role important in vivo?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Mast cell; HLA class II; HLA-DM; CD80; antigen presentation; structured illumination microscopy; superantigen; CMV antigen			[Galli, Stephen J.; Gaudenzio, Nicolas] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Galli, Stephen J.; Gaudenzio, Nicolas] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Gaudenzio, Nicolas] Univ Toulouse, INSERM, UMR 1056, UDEAR, Toulouse, France	Stanford University; Stanford University; Stanford University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Galli, SJ (corresponding author), Stanford Univ, Med Ctr, 300 Pasteur Dr,L235,Lane Bldg 235, Stanford, CA 94305 USA.; Galli, SJ (corresponding author), SOM, Dept Pathol, 300 Pasteur Dr,L235,Lane Bldg 235, Stanford, CA 94305 USA.	sgalli@stanford.edu		Gaudenzio, Nicolas/0000-0002-5648-509X				Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gaudenzio N, 2013, J ALLERGY CLIN IMMUN, V131, P1400, DOI 10.1016/j.jaci.2013.01.029; Gaudenzio N, 2009, BLOOD, V114, P4979, DOI 10.1182/blood-2009-02-202648; Kambayashi T, 2014, NAT REV IMMUNOL, V14, P719, DOI 10.1038/nri3754; Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180; KOCH N, 1984, J IMMUNOL, V132, P1361; Lotfi-Emran S, 2018, J ALLERGY CLIN IMMUN, V141, P311, DOI 10.1016/j.jaci.2017.02.048; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Nakano N, 2007, BLOOD, V109, P4846, DOI 10.1182/blood-2006-09-045641; Shin JS, 2006, J IMMUNOL, V177, P5791, DOI 10.4049/jimmunol.177.9.5791	10	17	18	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2018	141	1					92	93		10.1016/j.jaci.2017.05.029	http://dx.doi.org/10.1016/j.jaci.2017.05.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR8GH	28624609	Bronze			2022-12-18	WOS:000419312200014
J	Min, JY; Nayak, JV; Hulse, KE; Stevens, WW; Raju, PA; Huang, JH; Suh, LA; Van Roey, GA; Norton, JE; Carter, RG; Price, CPE; Weibman, AR; Rashan, AR; Ghosn, EE; Patel, ZM; Homma, T; Conley, DB; Welch, KC; Shintani-Smith, S; Peters, AT; Grammer, LC; Harris, KE; Kato, A; Hwang, PH; Kern, RC; Herzenberg, LA; Schleimer, RP; Tan, BK				Min, Jin-Young; Nayak, Jayakar V.; Hulse, Kathryn E.; Stevens, Whitney W.; Raju, Paul A.; Huang, Julia H.; Suh, Lydia A.; Van Roey, Griet A.; Norton, James E.; Carter, Roderick G.; Price, Caroline P. E.; Weibman, Ava R.; Rashan, Ali R.; Ghosn, Eliver E.; Patel, Zara M.; Homma, Tetsuya; Conley, David B.; Welch, Kevin C.; Shintani-Smith, Stephanie; Peters, Anju T.; Grammer, Leslie C., III; Harris, Kathleen E.; Kato, Atsushi; Hwang, Peter H.; Kern, Robert C.; Herzenberg, Leonore A.; Schleimer, Robert P.; Tan, Bruce K.			Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis; IgD; B cells; IL-2; bacterial infection; mucosal immunity	IMMUNOGLOBULIN-D; B-CELLS; ACTIVATION; POLYPS; SERUM; PATHOGENESIS; EXPRESSION; BINDING	Background: IgD is an enigmatic antibody isotype best known when coexpressed with IgM on naive B cells. However, increased soluble IgD (sIgD) levels and increased IgD(+)IgM(-) B-cell populations have been described in the human upper respiratory mucosa. Objective: We assessed whether levels of sIgD and IgD(+) B cell counts are altered in nasal tissue from patients with chronic rhinosinusitis (CRS). We further characterized IgD(+) B-cell populations and explored clinical and local inflammatory factors associated with tissue sIgD levels. Methods: sIgD levels were measured by means of ELISA in nasal tissues, nasal lavage fluid, sera, and supernatants of dissociated nasal tissues. IgD(+) cells were identified by using immunofluorescence and flow cytometry. Inflammatory mediator levels in tissues were assessed by using real-time PCR and multiplex immunoassays. Bacterial cultures from the middle meatus were performed. Underlying medical history and medicine use were obtained from medical records. Results: sIgD levels and numbers of IgD(+) cells were significantly increased in uncinate tissue (UT) of patients with chronic rhinosinusitis without nasal polyps (CRSsNP) compared with that of control subjects (4-fold, P < .05). IgD(+) cells were densely scattered in the periglandular regions of UT from patients with CRSsNP. We also found that IgD(+) CD19(+) CD38(bright) plasmablast numbers were significantly increased in tissues from patients with CRSsNP compared with control tissues (P < .05). Among numerous factors tested, IL-2 levels were increased in UT from patients with CRSsNP and were positively correlated with tissue IgD levels. Additionally, supernatants of IL-2-stimulated dissociated tissue from patients with CRSsNP had significantly increased sIgD levels compared with those in IL-2-stimulated dissociated control tissue ex vivo (P < .05). Tissue from patients with CRS with preoperative antibiotic use or those with pathogenic bacteria showed higher IgD levels compared with tissue from patients without these variables (P < .05). Conclusion: sIgD levels and IgD(+)CD19(+)CD38(bright) plasmablast counts were increased in nasal tissue of patients with CRSsNP. IgD levels were associated with increased IL-2 levels and the presence of pathogenic bacteria. These findings suggest that IgD might contribute to enhancement mucosal immunity or inflammation or respond to bacterial infections in patients with CRS, especially CRSsNP.	[Min, Jin-Young; Huang, Julia H.; Van Roey, Griet A.; Price, Caroline P. E.; Weibman, Ava R.; Conley, David B.; Welch, Kevin C.; Shintani-Smith, Stephanie; Kato, Atsushi; Kern, Robert C.; Schleimer, Robert P.; Tan, Bruce K.] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, 676 N St Clair,Suite 1325, Chicago, IL 60611 USA; [Hulse, Kathryn E.; Stevens, Whitney W.; Suh, Lydia A.; Norton, James E.; Carter, Roderick G.; Peters, Anju T.; Grammer, Leslie C., III; Harris, Kathleen E.; Kato, Atsushi; Kern, Robert C.; Schleimer, Robert P.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA; [Nayak, Jayakar V.; Rashan, Ali R.; Patel, Zara M.; Hwang, Peter H.] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Stanford, CA 94305 USA; [Raju, Paul A.; Ghosn, Eliver E.; Herzenberg, Leonore A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Homma, Tetsuya] Showa Univ, Sch Med, Div Resp Med & Allergol, Dept Internal Med, Tokyo, Japan	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Stanford University; Stanford University; Showa University	Tan, BK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, 676 N St Clair,Suite 1325, Chicago, IL 60611 USA.	b-tan@northwestern.edu	Smith, Stephanie Shintani/AAY-4854-2020; Ghosn, Eliver/AAO-5788-2020	Smith, Stephanie Shintani/0000-0002-0605-3993; Ghosn, Eliver/0000-0001-7258-906X; /0000-0002-9590-7419; Patel, Zara/0000-0003-2072-982X; Hwang, Peter/0000-0002-0786-4675; Kato, Atsushi/0000-0001-9144-3138	NIH [K23 DC012067]; Chronic Rhinosinusitis Integrative Studies Program (CRISP) [U19 AI106683, R01 HL078860, R37 HL068546, R01 HL068546, R01 AI072570, R01 AI104733]; Triological Society/American College of Surgeons; Ernest S. Bazley Foundation; Sean N Parker Center for Allergy and Asthma Research at Stanford University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001424] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078860, R01HL068546, R37HL068546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106683, R01AI072570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC012067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chronic Rhinosinusitis Integrative Studies Program (CRISP); Triological Society/American College of Surgeons; Ernest S. Bazley Foundation; Sean N Parker Center for Allergy and Asthma Research at Stanford University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by NIH grants K23 DC012067 (to B.K.T.); Chronic Rhinosinusitis Integrative Studies Program (CRISP) grants U19 AI106683 (to B.K.T., R.C.K., K.E.H., A.K., and R.P.S.), R01 HL078860, R37 HL068546, R01 HL068546, R01 AI072570 and R01 AI104733 (to R.P.S.); the Triological Society/American College of Surgeons (to B.K.T.); the Ernest S. Bazley Foundation (to R.P.S.); and the Sean N Parker Center for Allergy and Asthma Research at Stanford University (to J.V.N.).	Arpin C, 1998, J EXP MED, V187, P1169, DOI 10.1084/jem.187.8.1169; Arpin C, 1997, J EXP MED, V186, P931, DOI 10.1084/jem.186.6.931; Bachert C, 2016, J ALLER CL IMM-PRACT, V4, P621, DOI 10.1016/j.jaip.2016.05.004; Benninger MS, 2006, OTOLARYNG HEAD NECK, V134, P3, DOI 10.1016/j.otohns.2005.10.010; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Chen K, 2011, CURR OPIN IMMUNOL, V23, P345, DOI 10.1016/j.coi.2011.01.006; Chen K, 2010, IMMUNOL REV, V237, P160, DOI 10.1111/j.1600-065X.2010.00929.x; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; De Schryver E, 2015, ALLERGY ASTHMA IMMUN, V7, P321, DOI 10.4168/aair.2015.7.4.321; DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002; DUNNETTE SL, 1977, J IMMUNOL, V119, P1727; Dykewicz MS, 2010, J ALLERGY CLIN IMMUN, V125, pS103, DOI 10.1016/j.jaci.2009.12.989; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Ference EH, 2015, INT FORUM ALLERGY RH, V5, P929, DOI 10.1002/alr.21556; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Hulse KE, 2015, CLIN EXP ALLERGY, V45, P328, DOI 10.1111/cea.12472; Hulse KE, 2013, J ALLERGY CLIN IMMUN, V131, P1075, DOI 10.1016/j.jaci.2013.01.043; Hulse KE, 2013, J ALLERGY CLIN IMMUN, V131, pe1; Jendholm J, 2008, J LEUKOCYTE BIOL, V83, P1370, DOI 10.1189/jlb.1107788; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, pe1; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, P1385, DOI 10.1016/j.jaci.2008.03.002; Kato A, 2013, J ALLERGY CLIN IMMUN, V131, P933, DOI 10.1016/j.jaci.2013.02.023; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; LERTORA JJL, 1975, INT ARCH ALLER A IMM, V49, P597, DOI 10.1159/000231441; Levan-Petit I, 1999, INT IMMUNOL, V11, P1819, DOI 10.1093/intimm/11.11.1819; Lund VJ, 1993, RHINOLOGY, V107, P2; MAKI R, 1981, CELL, V24, P353, DOI 10.1016/0092-8674(81)90325-1; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Min JY, 2017, J ALLERGY CLIN IMMUN, V139, P130, DOI 10.1016/j.jaci.2016.07.020; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI 10.1002/alr.21695; Oyer SL, 2013, LARYNGOSCOPE, V123, pE72, DOI 10.1002/lary.24305; Pearlman AN, 2008, CURR OPIN OTOLARYNGO, V16, P226, DOI 10.1097/MOO.0b013e3282fdcc9a; PLEBANI A, 1984, J IMMUNOL METHODS, V71, P133, DOI 10.1016/0022-1759(84)90059-0; ROSTENBERG I, 1978, CLIN CHIM ACTA, V85, P319, DOI 10.1016/0009-8981(78)90310-8; ROWE DS, 1965, J EXP MED, V121, P171, DOI 10.1084/jem.121.1.171; Seifert M, 2009, MOL IMMUNOL, V46, P630, DOI 10.1016/j.molimm.2008.07.032; Singh K, 2014, J INFECT DIS, V209, P1418, DOI 10.1093/infdis/jit593; SIRISINHA S, 1972, P SOC EXP BIOL MED, V140, P1062; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Tan BK, 2017, J ALLERGY CLIN IMMUN, V139, P699, DOI 10.1016/j.jaci.2016.06.063; Tan BK, 2011, J ALLERGY CLIN IMMUN, V128, P1198, DOI 10.1016/j.jaci.2011.08.037; Thompson CF, 2016, INT FORUM ALLERGY RH, V6, P500, DOI 10.1002/alr.21687; Tomassen Peter, 2011, Proc Am Thorac Soc, V8, P115, DOI 10.1513/pats.201005-036RN; Vladutiu AO, 2000, CLIN DIAGN LAB IMMUN, V7, P131, DOI 10.1128/CDLI.7.2.131-140.2000; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Wingren AG, 2002, J IMMUNOL, V168, P5582, DOI 10.4049/jimmunol.168.11.5582	48	17	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1562	+		10.1016/j.jaci.2017.05.032	http://dx.doi.org/10.1016/j.jaci.2017.05.032			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28625807	Green Accepted, Bronze			2022-12-18	WOS:000417206000010
J	Rowe, JH; Stadinski, BD; Henderson, LA; de Bruin, LO; Delmonte, O; Lee, YN; de la Morena, MT; Goyal, RK; Hayward, A; Huang, CH; Kanariou, M; King, A; Kuijpers, TW; Soh, JY; Neven, B; Walter, JE; Huseby, ES; Notarangelo, LD				Rowe, Jared H.; Stadinski, Brian D.; Henderson, Lauren A.; de Bruin, Lisa Ott; Delmonte, Ottavia; Lee, Yu Nee; de la Morena, M. Teresa; Goyal, Rakesh K.; Hayward, Anthony; Huang, Chiung-Hui; Kanariou, Maria; King, Alejandra; Kuijpers, Taco W.; Soh, Jian Yi; Neven, Benedicte; Walter, Jolan E.; Huseby, Eric S.; Notarangelo, Luigi D.			Abnormalities of T-cell receptor repertoire in CD4(+) regulatory and conventional T cells in patients with RAG mutations: Implications for autoimmunity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							OMENN SYNDROME; DEFECTS; FOXP3		[Rowe, Jared H.; Henderson, Lauren A.; de Bruin, Lisa Ott; Delmonte, Ottavia] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Stadinski, Brian D.; Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Lee, Yu Nee] Edmond & Lily Safra Childrens Hosp, Jeffrey Modell Fdn Ctr, Sheba Med Ctr, Pediat Dept A, Tel Hashomer, Israel; [Lee, Yu Nee] Edmond & Lily Safra Childrens Hosp, Jeffrey Modell Fdn Ctr, Sheba Med Ctr, Serv Immunol, Tel Hashomer, Israel; [Lee, Yu Nee] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [de la Morena, M. Teresa] Univ Texas Southwestern Med Ctr Dallas, Div Allergy & Immunol, Dallas, TX 75390 USA; [Goyal, Rakesh K.] Childrens Mercy Hosp & Clin, Div Hematol Oncol BMT, Kansas City, MO USA; [Hayward, Anthony] Brown Univ, Dept Pediat, Providence, RI 02912 USA; [Huang, Chiung-Hui; Soh, Jian Yi] Natl Univ Singapore, Dept Pediat, Singapore, Singapore; [Kanariou, Maria] Aghia Sophia Childrens Hosp, Dept Immunol Histocompatibil, Athens, Greece; [King, Alejandra] Hosp Ninos Luis Calvo Mackenna, Div Pediat Immunol, Santiago, Chile; [Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, Amsterdam, Netherlands; [Neven, Benedicte] Paris Descartes Univ, Hosp Necker Enfants Malad, AP HP, Pediat Hematol Immunol Dept,Sorbonne Paris Cite,I, Paris, France; [Walter, Jolan E.] Univ S Florida, Johns Hopkins All Childrens Hosp, Div Pediat Allergy Immunol, St Petersburg, FL USA; [Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Mercy Hospital; Brown University; National University of Singapore; The Aghia Sophia Children's Hospital; Universidad de Chile; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Johns Hopkins University; Johns Hopkins Medicine; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Notarangelo, LD (corresponding author), NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	luigi.notarangelo2@nih.gov			National Institute of Allergy and Infectious Diseases, National Institutes of Health [2R01AI100887, 2U54AI082973, 16-I-N139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100887, U54AI082973, R01AI114523, ZIAAI001222, K08AI103035, U19AI109858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095077] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (grant nos. 2R01AI100887 and 2U54AI082973) and by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (protocol 16-I-N139).	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Cassani B, 2010, J ALLERGY CLIN IMMUN, V125, P209, DOI 10.1016/j.jaci.2009.10.023; De Ravin SS, 2010, BLOOD, V116, P1263, DOI 10.1182/blood-2010-02-267583; Golding A, 2017, CLIN EXP IMMUNOL, V188, P12, DOI 10.1111/cei.12904; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; Magurran AE, 2005, CURR BIOL, V15, pR116, DOI 10.1016/j.cub.2005.02.006; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Rechavi E, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0072; Stadinski BD, 2016, NAT IMMUNOL, V17, P946, DOI 10.1038/ni.3491; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81	11	17	17	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1739	+		10.1016/j.jaci.2017.08.001	http://dx.doi.org/10.1016/j.jaci.2017.08.001			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28864286	Green Accepted, Bronze			2022-12-18	WOS:000417206000040
J	Ndika, J; Airaksinen, L; Suojalehto, H; Karisola, P; Fyhrquist, N; Puustinen, A; Alenius, H				Ndika, Joseph; Airaksinen, Liisa; Suojalehto, Hille; Karisola, Piia; Fyhrquist, Nanna; Puustinen, Anne; Alenius, Harri			Epithelial proteome profiling suggests the essential role of interferon-inducible proteins in patients with allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Seasonal allergic rhinitis; nasal epithelia; proteomics; interferon 1 signaling; biomarkers	NASAL MUCUS; BARRIER FUNCTION; ASTHMA; IMPACT; QUANTIFICATION; SENSITIZATION; GENETICS; DISEASES	Background: Seasonal allergic rhinitis (SAR) caused by intermittent exposure to seasonal pollen causes itching, nasal congestion, and repeated sneezing, with profound effects on quality of life, work productivity, and school performance. Although both the genotype and environmental factors can contribute to the immunologic basis of allergic reactions, the molecular underpinnings associated with the pathogenesis of allergic rhinitis are not entirely clear. Methods: To address these questions, nasal epithelial brushings were collected from 29 patients with SAR and 31 control subjects during and after the pollen season. We then implemented an orbitrap-based, bottom-up, label-free quantitative proteomics approach, followed by multivariate analyses to identify differentially abundant (DA) proteins among the 4 sample groups. Results: We identified a total of 133 DA proteins for which the most significantly overrepresented functional category was found to be interferon 1 signaling. Two proteins, cystatin 1 and myeloblastin, the former of which protects against protease activity of allergens and the latter with a role in epithelial barrier function, were DA in patients with SAR and control subjects, irrespective of season. Moreover, interferon-inducible protein with tetratricopeptide repeats 1, cystatin 1, and interferon-inducible protein with tetratricopeptide repeats 3 were found to be differentially regulated between patients with SAR and control subjects, with inverse abundance dynamics during the transition from fall to spring. Conclusion: We identified type 1 interferon-regulated proteins as biomarkers in patients with SAR, potentially playing an important role in its pathogenesis. Moreover, when compared with patients with SAR, healthy subjects exhibit an antagonistic proteomic response across seasons, which might prove to be a therapeutic target for disease prevention.	[Ndika, Joseph; Karisola, Piia; Fyhrquist, Nanna; Alenius, Harri] Univ Helsinki, Medicum, Dept Bacteriol & Immunol, Helsinki, Finland; [Airaksinen, Liisa; Suojalehto, Hille] Finnish Inst Occupat Hlth, Occupat Med, Helsinki, Finland; [Puustinen, Anne] Helsinki Univ Hosp, Dept Clin Chem, Helsinki, Finland; [Puustinen, Anne] Univ Helsinki, Helsinki, Finland; [Alenius, Harri] Karolinska Inst, Inst Environm Med, Stockholm, Sweden	University of Helsinki; Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Karolinska Institutet	Alenius, H (corresponding author), Karolinska Inst, Inst Environm Med IMM, Syst Toxicol, C6,Box 210, S-17177 Stockholm, Sweden.	Harri.Alenius@ki.se	Ndika, Joseph/AAI-1074-2020	Ndika, Joseph/0000-0003-0669-1300; Alenius, Harri/0000-0003-0106-8923; Puustinen, Anne/0000-0002-0262-9975; Fyhrquist, Nanna Theresia/0000-0002-5408-0005; Karisola, Piia/0000-0003-0635-2704	Allergiasaatio (Allergy Research Foundation)	Allergiasaatio (Allergy Research Foundation)	Supported by Allergiasaatio (Allergy Research Foundation: Alenius, H; 2013).	Agache I, 2016, ALLERGOL INT, V65, P243, DOI 10.1016/j.alit.2016.04.011; Barnes KC, 1998, IMMUNOL TODAY, V19, P325, DOI 10.1016/S0167-5699(97)01241-3; BOBEK LA, 1992, CRIT REV ORAL BIOL M, V3, P307, DOI 10.1177/10454411920030040101; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Diz AP, 2009, ELECTROPHORESIS, V30, P2967, DOI 10.1002/elps.200900210; Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14; Fukuoka A, 2016, CLIN EXP ALLERGY, V46, P142, DOI 10.1111/cea.12597; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gern JE, 2015, ANN AM THORAC SOC, V12, pS137, DOI 10.1513/AnnalsATS.201503-153AW; Ghafouri B, 2006, J PROTEOME RES, V5, P330, DOI 10.1021/pr050341h; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Guilbert Theresa W, 2010, Expert Rev Respir Med, V4, P71, DOI 10.1586/ers.09.60; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Hao Z, 2012, QUADRUPOLE ORBITRAP; Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518; Imoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067057; Jeanson L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108671; Joenvaara S, 2009, J ALLERGY CLIN IMMUN, V124, P135, DOI 10.1016/j.jaci.2008.11.048; Kloepfer KM, 2010, IMMUNOL ALLERGY CLIN, V30, P553, DOI 10.1016/j.iac.2010.08.002; Koltes JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1635-9; Kuckleburg CJ, 2013, ARTERIOSCL THROM VAS, V33, P275, DOI 10.1161/ATVBAHA.112.300474; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mattila P, 2010, ALLERGY, V65, P175, DOI 10.1111/j.1398-9995.2009.02181.x; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Passalacqua G, 2001, RESP RES, V2, P320, DOI 10.1186/rr80; Pawankar R, 2011, ASIA PAC ALLERGY, V1, P157, DOI 10.5415/apallergy.2011.1.3.157; Penque D, 2000, LAB INVEST, V80, P857, DOI 10.1038/labinvest.3780090; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Raulf-Heimsoth M, 2000, CLIN EXP ALLERGY, V30, P110; Renkonen J, 2010, ALLERGY, V65, P40, DOI 10.1111/j.1398-9995.2009.02101.x; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; Sibelius U, 1998, J EXP MED, V187, P497, DOI 10.1084/jem.187.4.497; Siebold MA, 2016, United States patent application, Patent No. [US 15/008,094, 15008094]; Simoes T, 2012, J ALLERGY THER, V7, P2; Steelant B, 2016, J ALLERGY CLIN IMMUN, V137, P1043, DOI 10.1016/j.jaci.2015.10.050; Tomazic PV, 2016, J PROTEOMICS, V133, P153, DOI 10.1016/j.jprot.2015.12.021; Tomazic PV, 2015, LARYNGOSCOPE, V125, pE91, DOI 10.1002/lary.25003; Tomazic PV, 2014, J ALLERGY CLIN IMMUN, V133, P741, DOI 10.1016/j.jaci.2013.09.040; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Wang H, 2011, ALLERGY, V66, P132, DOI 10.1111/j.1398-9995.2010.02444.x; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023563; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537	49	17	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1288	1298		10.1016/j.jaci.2017.05.040	http://dx.doi.org/10.1016/j.jaci.2017.05.040			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28633877	Green Published, hybrid			2022-12-18	WOS:000414304300009
J	Song, WJ; Wong, GWK				Song, Woo-Jung; Wong, Gary W. K.			Changing trends and challenges in the management of asthma in Asia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; Asia; epidemiology	ALLERGIC DISEASES; CHILDHOOD ISAAC; PACIFIC REGION; PREVALENCE; WORLD		[Song, Woo-Jung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Wong, Gary W. K.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China	Seoul National University (SNU); Chinese University of Hong Kong; Prince of Wales Hospital	Wong, GWK (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China.	wingkinwong@cuhk.edu.hk	Wong, Gary WK/AAY-9207-2020	Wong, Gary WK/0000-0001-5939-812X; Song, Woo-Jung/0000-0002-4630-9922	Hong Kong Research Grant Council [CUHK4512/06M, CUHK 477110]; TS Lo Foundation	Hong Kong Research Grant Council(Hong Kong Research Grants Council); TS Lo Foundation	G. W. K. Wong has received grants from the Hong Kong Research Grant Council (CUHK4512/06M, CUHK 477110) and the TS Lo Foundation. W.-J. Song declares no relevant conflicts of interest.	Asher MI, 1998, EUR RESPIR J, V12, P315; Bush A., 2017, PEDIAT RESP CRIT CAR, V1, P2; Leung TF, 2012, J ALLERGY CLIN IMMUN, V129, P42, DOI 10.1016/j.jaci.2011.11.031; Ma Y, 2009, PEDIATR PULM, V44, P793, DOI 10.1002/ppul.21061; Nathan RA, 2015, J ALLER CL IMM-PRACT, V3, P734, DOI 10.1016/j.jaip.2015.04.013; Schroder PC, 2015, PEDIAT ALLERG IMM-UK, V26, P95, DOI 10.1111/pai.12341; Song WJ, 2014, CLIN EXP ALLERGY, V44, P553, DOI 10.1111/cea.12239; Song WJ, 2015, ALLERGY ASTHMA IMMUN, V7, P431, DOI 10.4168/aair.2015.7.5.431; Song WJ, 2014, ASIA PAC ALLERGY, V4, P3, DOI [10.5415/apallergy.2014.4.1.3, 10.5415/apallergy.2014.4.2.75]; Wong GWK, 2013, LANCET RESP MED, V1, P386, DOI 10.1016/S2213-2600(13)70073-0; Wong GWK, 2013, ALLERGY ASTHMA IMMUN, V5, P251, DOI 10.4168/aair.2013.5.5.251	11	17	18	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1272	1274		10.1016/j.jaci.2017.09.008	http://dx.doi.org/10.1016/j.jaci.2017.09.008			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28964883				2022-12-18	WOS:000414304300006
J	Gern, JE; Calatroni, A; Jaffee, KF; Lynn, H; Dresen, A; Cruikshank, WW; Lederman, HM; Sampson, HA; Shreffler, W; Bacharier, LB; Gergen, PJ; Gold, DR; Kattan, M; O'Connor, GT; Sandel, MT; Wood, RA; Bloomberg, GR				Gern, James E.; Calatroni, Agustin; Jaffee, Katy F.; Lynn, Henry; Dresen, Amy; Cruikshank, William W.; Lederman, Howard M.; Sampson, Hugh A.; Shreffler, Wayne; Bacharier, Leonard B.; Gergen, Peter J.; Gold, Diane R.; Kattan, Meyer; O'Connor, George T.; Sandel, Megan T.; Wood, Robert A.; Bloomberg, Gordon R.			Patterns of immune development in urban preschoolers with recurrent wheeze and/or atopy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cytokines; cord blood; mononuclear cells; immune development; wheezing; allergy; children	CYTOKINE RESPONSES; CHILDHOOD ASTHMA; UNITED-STATES; EARLY-LIFE; INNATE; EXPOSURE; CHILDREN; INFECTION; 1ST-YEAR; PATHWAYS	Background: Disadvantaged urban children have high rates of allergic diseases and wheezing, which are diseases associated with type 2-biased immunity. Objective: We sought to determine whether environmental exposures in early life influence cytokine responses that affect the development of recurrent wheezing illnesses and allergic sensitization. Methods: A birth cohort of 560 urban families was recruited from neighborhoods with high rates of poverty, and 467 (83%) children were followed until 3 years of age. Cytokine responses were measured in blood cell samples obtained at birth (cord blood) and ages 1 and 3 years. Cytokine responses were examined in relation to personal characteristics and environmental exposures to allergens and endotoxin and to the development of allergic sensitization and recurrent wheeze assessed at age 3 years. Results: Cytokine responses generally increased with age, but responses at birth were poorly predictive for those at ages 1 and 3 years. Exposure to certain allergens (cockroach, mouse, dust mite) was significantly associated with enhanced cytokine responses at age 3 years, including IFN-alpha and IL-10 responses to certain stimulants and responses to phytohemagglutinin. Regarding the clinical outcomes, reduced LPS-induced IL-10 responses at birth were associated with recurrent wheeze. In contrast, reduced respiratory syncytial virus-induced IL-8 responses and increased 59-cytosine -phosphate-guanine-39 (CpG)-induced IL-12p40 and allergen-induced IL-4 responses were associated with atopy. Conclusions: These findings suggest that diverse biologic exposures, including allergens and endotoxin, in urban homes stimulate the development of cytokine responses in early life, and that cytokine responses to specific microbial and viral stimuli are associated with the development of allergic sensitization and recurrent wheeze.	[Gern, James E.; Dresen, Amy] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Calatroni, Agustin; Jaffee, Katy F.; Lynn, Henry] Rho Inc, Chapel Hill, NC USA; [Cruikshank, William W.; O'Connor, George T.; Sandel, Megan T.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lederman, Howard M.; Wood, Robert A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Sampson, Hugh A.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Shreffler, Wayne] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Gold, Diane R.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Bacharier, Leonard B.; Bloomberg, Gordon R.] Washington Univ, Sch Med, St Louis, MO USA; [Bacharier, Leonard B.; Bloomberg, Gordon R.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Gergen, Peter J.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kattan, Meyer] Columbia Univ, Med Ctr, New York, NY USA	University of Wisconsin System; University of Wisconsin Madison; Rho; Boston University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University	Gern, JE (corresponding author), K4-918 CSC,600 Highland Ave, Madison, WI 53792 USA.	gern@medicine.wisc.edu		Shreffler, Wayne/0000-0001-6465-137X; Bacharier, Leonard/0000-0003-0432-2704	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [NO1-AI-25496, NO1-AI-25482, HHSN272200900052C, HHSN272201000052I]; National Center for Research Resources, NIH [RR00052, M01RR00533, 1UL1RR025771, M01RR00071, 1UL1RR024156, 5UL1RR024992-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, M01RR000052, UL1RR025771, UL1RR024156, M01RR000533, M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM2AI117870, N01AI025496, UM1AI114271] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Contract numbers NO1-AI-25496, NO1-AI-25482, HHSN272200900052C, and HHSN272201000052I. Additional support was provided by the National Center for Research Resources, NIH, under grants RR00052, M01RR00533, 1UL1RR025771, M01RR00071, 1UL1RR024156, and 5UL1RR024992-02.	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Alwis KU, 2006, AM J IND MED, V49, P296, DOI 10.1002/ajim.20264; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bousquet J, 2014, J ALLERGY CLIN IMMUN, V133, P1535, DOI 10.1016/j.jaci.2014.01.018; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Bufford JD, 2008, CLIN EXP ALLERGY, V38, P1635, DOI 10.1111/j.1365-2222.2008.03018.x; Cheung DS, 2010, J IMMUNOL, V185, P4983, DOI 10.4049/jimmunol.1002456; Copenhaver CC, 2004, AM J RESP CRIT CARE, V170, P175, DOI 10.1164/rccm.200312-1647OC; de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; Gern JE, 2010, J ALLERGY CLIN IMMUN, V125, P545, DOI 10.1016/j.jaci.2010.01.037; Gern James E, 2009, BMC Pulm Med, V9, P17, DOI 10.1186/1471-2466-9-17; Gern JE, 2006, J ALLERGY CLIN IMMUN, V117, P72, DOI 10.1016/j.jaci.2005.10.002; Gold DR, 2009, J ALLERGY CLIN IMMUN, V124, P1078, DOI 10.1016/j.jaci.2009.08.021; Hoffjan S, 2004, J ALLERGY CLIN IMMUN, V113, P511, DOI 10.1016/j.jaci.2003.10.044; Holt PG, 2015, J ALLERGY CLIN IMMUN, V136, P15, DOI 10.1016/j.jaci.2015.05.011; Hunter D, 2014, J ALLERGY CLIN IMMUN, V133, P901, DOI 10.1016/j.jaci.2013.09.035; Khoo SK, 2004, J ALLERGY CLIN IMMUN, V113, P475, DOI 10.1016/j.jaci.2003.10.043; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Lappalainen MHJ, 2010, CLIN EXP ALLERGY, V40, P1498, DOI 10.1111/j.1365-2222.2010.03566.x; Little R. J., 2019, STAT ANAL MISSING DA, V793; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; RJA L., 2002, STAT ANAL MISSING DA; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Shreffler WG, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-29; Sly PD, 2008, LANCET, V372, P1100, DOI 10.1016/S0140-6736(08)61451-8; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Sumino K, 2012, J ALLERGY CLIN IMMUN, V129, P1267, DOI 10.1016/j.jaci.2012.02.033; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; van Buuren S, 2011, J STAT SOFTW, V45, P1	32	17	18	2	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2017	140	3					836	+		10.1016/j.jaci.2016.10.052	http://dx.doi.org/10.1016/j.jaci.2016.10.052			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FF8CA	28089873	Bronze, Green Accepted			2022-12-18	WOS:000409241500022
J	Davis, BP; Ballas, ZK				Davis, Benjamin P.; Ballas, Zuhair K.			Biologic response modifiers: Indications, implications, and insights	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Biologics; biologic response modifiers; immune dysfunction; infection; autoimmunity; immunodeficiency	PLACEBO-CONTROLLED TRIAL; TUMOR-NECROSIS-FACTOR; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; CYTOKINE-RELEASE-SYNDROME; TO-SEVERE PSORIASIS; INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; CETUXIMAB-INDUCED ANAPHYLAXIS; INFLAMMATORY-BOWEL-DISEASE; SEVERE EOSINOPHILIC ASTHMA; VASCULAR LEAK SYNDROME	The field ofbiologic immunemodulators is currentlymushrooming at a dizzying pace. Although most of these biologics are tested and approved for one or a few indications, their unanticipated side effects and off-label use have contributed significantly to our understanding of basic immune mechanisms, the involvement of cytokines in several apparently nonimmunologic diseases, and the importance of compartmentalized immune responses. In this review we attempt to give a bird's-eye view of the major biologics and to highlight insights and implications derived from their secondary effects and adverse reactions.	[Davis, Benjamin P.] Univ Iowa Hosp & Clin, Dept Internal Med, Div Immunol, 200 Hawkins Dr, Iowa City, IA 52246 USA; [Ballas, Zuhair K.] Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA; [Ballas, Zuhair K.] Iowa City Vet Adm, Iowa City, IA USA	University of Iowa; University of Iowa	Davis, BP (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, Div Immunol, 200 Hawkins Dr, Iowa City, IA 52246 USA.	ben-davis@uiowa.edu		Knaack, Aaron/0000-0001-7712-1415; Ballas, Zuhair/0000-0001-5569-1230; davis, benjamin/0000-0003-2108-8059	Veteran's Administration; Immunodeficiency Foundation; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Veteran's Administration(US Department of Veterans Affairs); Immunodeficiency Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Z. K. Ballas receives grant support from the Veteran's Administration; travel support from the American Academy of Allergy, Asthma & Immunology; and personal fees from the Immunodeficiency Foundation. B. P. Davis declares that he has no relevant conflicts of interest.	Abbas AK, 2014, CELLULAR MOL IMMUNOL, P417; Agache I, 2016, ALLERGOL INT, V65, P243, DOI 10.1016/j.alit.2016.04.011; Arnold DF, 2008, NEW ENGL J MED, V358, P2735, DOI 10.1056/NEJMc080834; Bachert C, 2015, J ALLERGY CLIN IMMUN, V136, P1431, DOI 10.1016/j.jaci.2015.10.010; Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Barmettler S, 2015, J ALLERGY CLIN IMMUN, V136, P1407, DOI 10.1016/j.jaci.2015.06.035; Bek S, 2016, ALIMENT PHARM THER, V44, P554, DOI 10.1111/apt.13736; Berger JR, 2005, NEW ENGL J MED, V353, P414, DOI 10.1056/NEJMe058122; Bessissow T, 2012, ALIMENT PHARM THER, V36, P312, DOI 10.1111/j.1365-2036.2012.05189.x; Blauvelt A, 2015, BRIT J DERMATOL, V172, P484, DOI 10.1111/bjd.13348; Boisson-Dupuis S, 2015, IMMUNOL REV, V264, P103, DOI 10.1111/imr.12272; Brennan FR, 2010, MABS-AUSTIN, V2, P233, DOI 10.4161/mabs.2.3.11782; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Browne SK, 2010, CURR OPIN ALLERGY CL, V10, P534, DOI 10.1097/ACI.0b013e3283402b41; Brunasso AMG, 2014, SCI WORLD J, DOI 10.1155/2014/179180; Bugelski PJ, 2009, EXPERT REV CLIN IMMU, V5, P499, DOI [10.1586/eci.09.31, 10.1586/ECI.09.31]; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Campbell L, 2011, RHEUMATOLOGY, V50, P552, DOI 10.1093/rheumatology/keq343; Cantini F, 2016, SEMIN ARTHRITIS RHEU, V45, P519, DOI 10.1016/j.semarthrit.2015.10.001; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Casulo C, 2013, CL LYMPH MYELOM LEUK, V13, P106, DOI 10.1016/j.clml.2012.11.011; Chinen J, 2016, J ALLERGY CLIN IMMUN, V138, P1531, DOI 10.1016/j.jaci.2016.10.005; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Clarke Janet B, 2010, Handb Exp Pharmacol, P453, DOI 10.1007/978-3-642-00663-0_16; Colombel JF, 2016, GUT; COTRAN RS, 1988, J IMMUNOL, V140, P1883; Czaja AJ, 2011, DIGEST DIS SCI, V56, P958, DOI 10.1007/s10620-011-1611-4; Daien CI, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/386148; DAMLE NK, 1989, J IMMUNOL, V142, P2660; de Golian E, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0434-0; Descotes J, 2007, CYTOKINES HUMAN HLTH, P193; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Donia M, 2016, SEMIN IMMUNOPATHOL; Druey KM, 2016, J ALLERGY CLIN IMMUN; Durrbach A, 2010, AM J TRANSPLANT, V10, P547, DOI 10.1111/j.1600-6143.2010.03016.x; Fine AJ, 2013, CLIN INFECT DIS, V57, P849, DOI 10.1093/cid/cit376; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Fraser G, 2007, Curr Oncol, V14, P96; Fuji Shigeo, 2016, Stem Cell Investig, V3, P70; Galvao VR, 2015, J ALLER CL IMM-PRACT, V3, P175, DOI 10.1016/j.jaip.2014.12.006; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, P2854, DOI 10.1002/art.30463; Ghosh N, 2012, INT REV IMMUNOL, V31, P410, DOI 10.3109/08830185.2012.690794; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Grimbacher Bodo, 2016, J Allergy Clin Immunol, V137, P3, DOI 10.1016/j.jaci.2015.11.004; Her M, 2016, J ALLERGY CLIN IMMUN, V137, P19, DOI 10.1016/j.jaci.2015.10.023; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hunig T, 2007, MANIPULATION REGULAT, P111; Igarashi A, 2012, J DERMATOL, V39, P242, DOI 10.1111/j.1346-8138.2011.01347.x; Isenberg D, 2015, ANN RHEUM DIS, V74, P2006, DOI 10.1136/annrheumdis-2013-205067; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Jones J, 2014, GASTROENTEROL CLIN N, V43, P425, DOI 10.1016/j.gtc.2014.05.004; Kaplan B, 2014, J ALLER CL IMM-PRACT, V2, P594, DOI 10.1016/j.jaip.2014.06.003; Kappos L, 2014, LANCET NEUROL, V13, P353, DOI 10.1016/S1474-4422(14)70028-6; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kerbleski JF, 2009, GUT, V58, P1033, DOI 10.1136/gut.2008.163683; Khasnis AA, 2010, SEMIN ARTHRITIS RHEU, V40, P147, DOI 10.1016/j.semarthrit.2009.09.001; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Kone-Paut I, 2015, EXPERT REV CLIN IMMU, V11, P1083, DOI 10.1586/1744666X.2015.1077702; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Lebrec H, 2015, CURR MED RES OPIN, V31, P557, DOI 10.1185/03007995.2015.1011778; Lee SJ, 2005, J ALLERGY CLIN IMMUN, V116, P900, DOI 10.1016/j.jaci.2005.03.028; Leonard JP, 1997, BLOOD, V90, P2541; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lipson EJ, 2011, CLIN CANCER RES, V17, P6958, DOI 10.1158/1078-0432.CCR-11-1595; Lorenzini T, 2017, J LEUKOCYTE BIOL, V101, P29, DOI [10.1189/jlb.5RI0516-237RR, 10.1189/jlb.5ri0516-237rr]; Lucas CL, 2016, NAT REV IMMUNOL, V16, P702, DOI 10.1038/nri.2016.93; Makatsori M, 2014, QJM-INT J MED, V107, P821, DOI 10.1093/qjmed/hcu094; Malisiewicz B, 2011, DERMATOLOGY, V223, P311, DOI 10.1159/000334805; Maloney DG, 1997, J CLIN ONCOL, V15, P3266, DOI 10.1200/JCO.1997.15.10.3266; Mastellos DC, 2014, EXPERT REV HEMATOL, V7, P583, DOI 10.1586/17474086.2014.953926; Mastroianni CM, 2011, WORLD J GASTROENTERO, V17, P3881, DOI 10.3748/wjg.v17.i34.3881; McInnes IB, 2015, LANCET, V386, P1137, DOI 10.1016/S0140-6736(15)61134-5; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Moiton MP, 2006, CLIN MICROBIOL INFEC, V12, P1151, DOI 10.1111/j.1469-0691.2006.01546.x; Morais SA, 2015, THER ADV MUSCULOSKEL, V7, P122, DOI 10.1177/1759720X15586782; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Papp KA, 2013, BRIT J DERMATOL, V168, P844, DOI 10.1111/bjd.12214; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Perez-Alvarez R, 2013, CURR OPIN RHEUMATOL, V25, P56, DOI 10.1097/BOR.0b013e32835b1366; Perez-Alvarez R, 2011, SEMIN ARTHRITIS RHEU, V41, P256, DOI 10.1016/j.semarthrit.2010.11.002; Quach OL, 2016, JAMA DERMATOL, V152, P486, DOI 10.1001/jamadermatol.2015.4992; Quirce S, 2014, ARCH BRONCONEUMOL, V50, P355, DOI 10.1016/j.arbres.2014.02.002; Rakhit A, 1999, CLIN PHARMACOL THER, V65, P615, DOI 10.1016/S0009-9236(99)90083-8; Ramos-Casals M, 2007, MEDICINE, V86, P242, DOI 10.1097/MD.0b013e3181441a68; Ramos-Casals M, 2011, AM J MED, V124, P386, DOI 10.1016/j.amjmed.2010.11.028; Ramos-Casals M, 2010, AUTOIMMUN REV, V9, P188, DOI 10.1016/j.autrev.2009.10.003; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rossi E, 2016, EXPERT REV CLIN PHAR, V9, P419, DOI 10.1586/17512433.2016.1133289; Rostaing L, 2013, AM J TRANSPLANT, V13, P2875, DOI 10.1111/ajt.12460; Saliu OY, 2006, J INFECT DIS, V194, P486, DOI 10.1086/505430; Schejbel L, 2013, IMMUNOBIOLOGY, V218, P1304, DOI 10.1016/j.imbio.2013.04.021; Schiff M, 2014, ANN RHEUM DIS, V73, P86, DOI 10.1136/annrheumdis-2013-203843; Schiff M, 2011, ANN RHEUM DIS, V70, P2003, DOI 10.1136/annrheumdis-2011-200316; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Schwab N, 2012, NEUROLOGY, V78, P458, DOI 10.1212/WNL.0b013e3182478d4b; Simon D, 2008, J ALLERGY CLIN IMMUN, V121, P122, DOI 10.1016/j.jaci.2007.11.016; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Steinke JW, 2015, J ALLERGY CLIN IMMUN, V135, P589, DOI 10.1016/j.jaci.2014.12.1947; Stuebgen JP, 2008, MUSCLE NERVE, V37, P281, DOI 10.1002/mus.20924; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tanaka T, 2016, IMMUNOTHERAPY-UK, V8, P959, DOI 10.2217/imt-2016-0020; Thaci D, 2015, J AM ACAD DERMATOL, V73, P400, DOI 10.1016/j.jaad.2015.05.013; Toussirot E, 2012, JOINT BONE SPINE, V79, P457, DOI 10.1016/j.jbspin.2011.10.001; Tsai TF, 2011, J DERMATOL SCI, V63, P154, DOI 10.1016/j.jdermsci.2011.05.005; Utsunomiya A, 2015, CANCER SCI, V106, P344, DOI 10.1111/cas.12617; VASQUEZ EM, 1995, TRANSPLANT P, V27, P873; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Vincenti F, 2016, NEW ENGL J MED, V374, P333, DOI 10.1056/NEJMoa1506027; Wallis RS, 2009, CURR OPIN INFECT DIS, V22, P403, DOI 10.1097/QCO.0b013e32832dda55; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Weinblatt M, 2006, ARTHRITIS RHEUM, V54, P2807, DOI 10.1002/art.22070; Weinblatt ME, 2013, J RHEUMATOL, V40, P787, DOI 10.3899/jrheum.120906; Wells AF, 2014, BIOL-TARGETS THER, V8, P41, DOI 10.2147/BTT.S55783; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wing M, 2008, J IMMUNOTOXICOL, V5, P11, DOI 10.1080/15476910801897433; Winkler U, 1999, BLOOD, V94, P2217, DOI 10.1182/blood.V94.7.2217.419k02_2217_2224; Wong EKS, 2015, TRANSL RES, V165, P306, DOI 10.1016/j.trsl.2014.10.010; ZUKIWSKI AA, 1990, CANCER, V65, P1521, DOI 10.1002/1097-0142(19900401)65:7<1521::AID-CNCR2820650712>3.0.CO;2-Y	124	17	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1445	1456		10.1016/j.jaci.2017.02.013	http://dx.doi.org/10.1016/j.jaci.2017.02.013			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28263774	Bronze			2022-12-18	WOS:000400465300004
J	Poposki, JA; Klingler, AI; Stevens, WW; Peters, AT; Hulse, KE; Grammer, LC; Schleimer, RP; Welch, KC; Smith, SS; Sidle, DM; Conley, DB; Tan, BK; Kern, RC; Kato, A				Poposki, Julie A.; Klingler, Aiko I.; Stevens, Whitney W.; Peters, Anju T.; Hulse, Kathryn E.; Grammer, Leslie C.; Schleimer, Robert P.; Welch, Kevin C.; Smith, Stephanie S.; Sidle, Douglas M.; Conley, David B.; Tan, Bruce K.; Kern, Robert C.; Kato, Atsushi			Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Carboxypeptidase; chronic rhinosinusitis; dendritic cells; group 2 innate lymphoid cells; nasal polyps; posttranslational modification; proprotein convertases; thymic stromal lymphopoietin	AIRWAY EPITHELIAL-CELLS; INNATE LYMPHOID-CELLS; CHRONIC RHINOSINUSITIS; NASAL POLYPS; MAST-CELLS; SERINE PROTEASES; DENDRITIC CELLS; T-CELLS; TSLP; EXPRESSION	Rationale: Thymic stromal lymphopoietin (TSLP) is known to be elevated and truncated in nasal polyps (NPs) of patients with chronic rhinosinusitis and might play a significant role in type 2 inflammation in this disease. However, neither the structure nor the role of the truncated products of TSLP has been studied. Objective: We sought to investigate the mechanisms of truncation of TSLP in NPs and the function of the truncated products. Methods: We incubated recombinant human TSLP with NP extracts, and determined the protein sequence of the truncated forms of TSLP using Edman protein sequencing and matrixassisted laser desorption/ionization-time of flight mass spectrometry. We investigated the functional activity of truncated TSLP using a PBMC-based bioassay. Results: Edman sequencing and mass spectrometry results indicated that NP extracts generated 2 major truncated products, TSLP (residues 29-124) and TSLP (131-159). Interestingly, these 2 products remained linked with disulfide bonds and presented as a dimerized form, TSLP (29-124 + 131-159). We identified that members of the proprotein convertase were rate-limiting enzymes in the truncation of TSLP between residues 130 and 131 and generated a heterodimeric unstable metabolite TSLP (29-130 + 131-159). Carboxypeptidase N immediately digested 6 amino acids from the C terminus of the longer subunit of TSLP to generate a stable dimerized form, TSLP (29-124 + 131-159), in NPs. These truncations were homeostatic but primate-specific events. A metabolite TSLP (29-130 + 131-159) strongly activated myeloid dendritic cells and group 2 innate lymphoid cells compared with mature TSLP. Conclusions: Posttranslationalmodifications control the functional activity of TSLP in humans and overproduction of TSLP may be a key trigger for the amplification of type 2 inflammation in diseases.	[Poposki, Julie A.; Klingler, Aiko I.; Stevens, Whitney W.; Peters, Anju T.; Hulse, Kathryn E.; Grammer, Leslie C.; Schleimer, Robert P.; Kern, Robert C.; Kato, Atsushi] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Dept Med, Evanston, IL 60208 USA; [Schleimer, Robert P.; Welch, Kevin C.; Smith, Stephanie S.; Sidle, Douglas M.; Conley, David B.; Tan, Bruce K.; Kern, Robert C.; Kato, Atsushi] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kato, A (corresponding author), Northwestern Univ, Div Allergy Immunol, Feinberg Sch Med, 240 E Huron,Rm M305, Chicago, IL 60611 USA.	a-kato@northwestern.edu	Smith, Stephanie Shintani/AAY-4854-2020	Smith, Stephanie Shintani/0000-0002-0605-3993; Kato, Atsushi/0000-0001-9144-3138	National Institutes of Health [R01 AI104733, R21 HL113913, U19 AI106683, R37 HL068546]; Ernest S. Bazley Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS023011] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055884] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001424] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL113913, R37HL068546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104733, U19AI106683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernest S. Bazley Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the National Institutes of Health (grant nos. R01 AI104733, R21 HL113913, U19 AI106683, and R37 HL068546) and by a grant from the Ernest S. Bazley Foundation.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Bachert C, 2009, ALLERGY, V64, P520, DOI 10.1111/j.1398-9995.2009.01964.x; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Bhattacharyya N, 2011, ANN OTO RHINOL LARYN, V120, P423, DOI 10.1177/000348941112000701; Bhattacharyya N, 2011, OTOLARYNG HEAD NECK, V144, P440, DOI 10.1177/0194599810391852; Comeau MR, 2010, MUCOSAL IMMUNOL, V3, P138, DOI 10.1038/mi.2009.134; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kato A, 2015, ALLERGOL INT, V64, P121, DOI 10.1016/j.alit.2014.12.006; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Matthews KW, 2004, MOL IMMUNOL, V40, P785, DOI 10.1016/j.molimm.2003.10.002; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS133, DOI 10.1016/j.jaci.2004.09.011; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Poposki JA, 2015, CLIN EXP ALLERGY, V45, P384, DOI 10.1111/cea.12471; Poposki JA, 2011, J ALLERGY CLIN IMMUN, V128, P73, DOI 10.1016/j.jaci.2011.03.017; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Takabayashi T, 2013, AM J RESP CRIT CARE, V187, P49, DOI 10.1164/rccm.201207-1292OC; Takabayashi T, 2012, J ALLERGY CLIN IMMUN, V130, P410, DOI 10.1016/j.jaci.2012.02.046; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Verstraete K, 2014, NAT STRUCT MOL BIOL, V21, P375, DOI 10.1038/nsmb.2794; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4	40	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1559	+		10.1016/j.jaci.2016.08.040	http://dx.doi.org/10.1016/j.jaci.2016.08.040			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	27744031	Green Accepted, Bronze			2022-12-18	WOS:000400465300016
J	Staton, TL; Arron, JR; Olsson, J; Holweg, CTJ; Matthews, JG; Choy, DF				Staton, Tracy L.; Arron, Joseph R.; Olsson, Julie; Holweg, Cecile T. J.; Matthews, John G.; Choy, David F.			Seasonal variability of severe asthma exacerbations and clinical benefit from lebrikizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							OMALIZUMAB; DISEASE		[Staton, Tracy L.; Arron, Joseph R.; Olsson, Julie; Holweg, Cecile T. J.; Matthews, John G.; Choy, David F.] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Choy, DF (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	choy.david@gene.com		Arron, Joseph/0000-0001-7677-9979				Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Fajt ML, 2015, J ALLERGY CLIN IMMUN, V135, P299, DOI 10.1016/j.jaci.2014.12.1871; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Hanania NA, 2016, LANCET RESP MED, V4, P781, DOI 10.1016/S2213-2600(16)30265-X; Holtzman MJ, 2012, J CLIN INVEST, V122, P2741, DOI 10.1172/JCI60325; Johnston NW, 2006, THORAX, V61, P722, DOI 10.1136/thx.2005.045161; Mansson A, 2009, J LEUKOCYTE BIOL, V85, P719, DOI 10.1189/jlb.0808494; Monto AS, 2002, CLIN THER, V24, P1987, DOI 10.1016/S0149-2918(02)80093-5; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008	9	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1682	+		10.1016/j.jaci.2017.01.028	http://dx.doi.org/10.1016/j.jaci.2017.01.028			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28238745	Bronze			2022-12-18	WOS:000400465300031
J	Honjo, A; Nakano, N; Yamazaki, S; Hara, M; Uchida, K; Kitaura, J; Nishiyama, C; Yagita, H; Ohtsuka, Y; Ogawa, H; Okumura, K; Shimizu, T				Honjo, Asuka; Nakano, Nobuhiro; Yamazaki, Susumu; Hara, Mutsuko; Uchida, Koichiro; Kitaura, Jiro; Nishiyama, Chiharu; Yagita, Hideo; Ohtsuka, Yoshikazu; Ogawa, Hideoki; Okumura, Ko; Shimizu, Toshiaki			Pharmacologic inhibition of Notch signaling suppresses food antigen-induced mucosal mast cell hyperplasia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Notch signaling; mucosal mast cells; food allergy; mast cell hyperplasia	TRANSFORMING GROWTH FACTOR-BETA(1); CD103(+) DENDRITIC CELLS; TRICHINELLA-SPIRALIS; INDUCED ANAPHYLAXIS; CHYMASE; MOUSE; MICE; ALLERGY; DIFFERENTIATION; HETEROGENEITY	Background: Mucosal mast cells (MMCs) play a central role in the development of symptoms associated with IgE-mediated food allergy. Recently, Notch2-mediated signaling was shown to be involved in proper MMC distribution in the intestinal tract. Objective: This study aimed to clarify the mechanism by which Notch signaling regulates MMC distribution in the intestinal mucosa. Furthermore, pharmacologic inhibition of Notch signaling was evaluated as a treatment for symptoms associated with experimental food allergy. Methods: Bone marrow-derived mast cells generated from mice were cultured with Notch ligands, and then expression of genes associated with MMCs was measured in the cells. In addition, the effect of an inhibitor of Notch signaling on food antigeninduced allergic reactions was examined in a mouse model of food allergy. Results: Notch signaling induced MMC differentiation through upregulation of expression of genes characteristic of MMCs in the presence of IL-3. Some lamina propria cells isolated from the mouse small intestine expressed Notch ligands and were able to upregulate MMC markers in bone marrow-derived mast cells through Notch signaling. In a mouse model of food allergy, administration of a Notch signaling inhibitor led to suppression of food antigen-induced hyperplasia of intestinal MMCs, resulting in alleviation of allergic diarrhea and systemic anaphylaxis. Conclusion: Notch signaling contributes to differentiation and accumulation of MMCs in the intestinal mucosa. Thus inhibition of Notch signaling alleviates symptoms associated with experimental food allergy. These results raise the possibility that Notch signaling in mast cells is a novel target for therapy in patients with food allergy.	[Honjo, Asuka; Yamazaki, Susumu; Ohtsuka, Yoshikazu; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Tokyo, Japan; [Nakano, Nobuhiro; Hara, Mutsuko; Uchida, Koichiro; Kitaura, Jiro; Nishiyama, Chiharu; Ogawa, Hideoki; Okumura, Ko] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo 1138421, Japan; [Nishiyama, Chiharu] Tokyo Univ Sci, Dept Biol Sci & Technol, Fac Ind Sci & Technol, Tokyo 162, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo, Japan	Juntendo University; Juntendo University; Tokyo University of Science; Juntendo University	Nakano, N (corresponding author), Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo 1138421, Japan.	nbnakano@juntendo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022	Yamazaki, Susumu/0000-0003-2327-9297; Nakano, Nobuhiro/0000-0002-5317-5950	MEXT KAKENHI [15K09784]; MEXT from the Ministry of Education, Culture, Sports, Science and Technology, Japan	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT from the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported in part by MEXT KAKENHI grant no. 15K09784 and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015, from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ahrens R, 2012, AM J PATHOL, V180, P1535, DOI 10.1016/j.ajpath.2011.12.036; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Berin MC, 2009, MUCOSAL IMMUNOL, V2, P24, DOI 10.1038/mi.2008.72; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Dahlin JS, 2015, MOL IMMUNOL, V63, P9, DOI 10.1016/j.molimm.2014.01.018; Friend DS, 1998, J IMMUNOL, V160, P5537; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hyde LA, 2006, J PHARMACOL EXP THER, V319, P1133, DOI 10.1124/jpet.106.111716; IRANI AMA, 1987, J IMMUNOL, V138, P4381; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Kashyap M, 2005, EXP HEMATOL, V33, P1281, DOI 10.1016/j.exphem.2005.07.001; Kunisawa J, 2007, J EXP MED, V204, P2335, DOI 10.1084/jem.20062446; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Miller HRP, 1999, BLOOD, V93, P3473, DOI 10.1182/blood.V93.10.3473.410k01_3473_3486; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; Nakamura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8514; Nakano N, 2015, J IMMUNOL, V194, P4535, DOI 10.4049/jimmunol.1301850; Nakano N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.138966; Nakano N, 2009, J ALLERGY CLIN IMMUN, V123, P74, DOI 10.1016/j.jaci.2008.10.040; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; RAZIN E, 1984, J IMMUNOL, V132, P1479; Reber LL, 2015, MUCOSAL IMMUNOL, V8, P444, DOI 10.1038/mi.2014.131; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; RUITENBER EJ, 1976, NATURE, V264, P258, DOI 10.1038/264258a0; Sakata-Yanagimoto M, 2008, P NATL ACAD SCI USA, V105, P7839, DOI 10.1073/pnas.0801074105; Sakata-Yanagimoto M, 2011, BLOOD, V117, P128, DOI 10.1182/blood-2010-07-289611; Saluja R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043547; Schlickum S, 2008, BLOOD, V112, P619, DOI 10.1182/blood-2008-01-134833; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Wright SH, 2002, CLIN EXP ALLERGY, V32, P315, DOI 10.1046/j.1365-2222.2002.01233.x	39	17	18	5	21	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					987	+		10.1016/j.jaci.2016.05.046	http://dx.doi.org/10.1016/j.jaci.2016.05.046			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	27555456	Green Submitted			2022-12-18	WOS:000397295800030
J	Stein, K; Brand, S; Jenckel, A; Sigmund, A; Chen, ZJJ; Kirschning, CJ; Kauth, M; Heine, H				Stein, Karina; Brand, Stephanie; Jenckel, Andre; Sigmund, Anna; Chen, Zhijian James; Kirschning, Carsten J.; Kauth, Marion; Heine, Holger			Endosomal recognition of Lactococcus lactis G121 and its RNA by dendritic cells is key to its allergy-protective effects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy protection; dendritic cells; endosomal acidification; Lactococcus lactis G121; pattern recognition receptor; Toll-like receptor 13; Toll-like receptor 8; bacterial RNA	SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; HUMAN MONOCYTES; IFN-BETA; BORRELIA-BURGDORFERI; CYTOCHALASIN-D; BACTERIAL RNA; IN-VIVO; ASTHMA; TLR8	Background: Bacterial cowshed isolates are allergy protective in mice; however, the underlying mechanisms are largely unknown. We examined the ability of Lactococcus lactis G121 to prevent allergic inflammatory reactions. Objective: We sought to identify the ligands and pattern recognition receptors through which L lactis G121 confers allergy protection. Methods: L lactis G121-induced cytokine release and surface expression of costimulatory molecules by untreated or inhibitortreated (bafilomycin and cytochalasin D) human monocyte-derived dendritic cells (moDCs), bone marrow-derived mouse dendritic cells (BMDCs), and moDC/naive CD4(+) T-cell cocultures were analyzed by using ELISA and flow cytometry. The pathology of ovalbumin-induced acute allergic airway inflammation after adoptive transfer of BMDCs was examined by means of microscopy. Results: L lactis G121-treated murine BMDCs and human moDCs released TH1-polarizing cytokines and induced T(H)1 T cells. Inhibiting phagocytosis and endosomal acidification in BMDCs or moDCs impaired the release of TH1-polarizing cytokines, costimulatory molecule expression, and T-cell activation on L lactis G121 challenge. In vivo allergy protection mediated by L lactis G121 was dependent on endosomal acidification in dendritic cells (DCs). Toll-like receptor (Tlr) 13(-/-) BMDCs showed a weak response to L lactis G121 and were unresponsive to its RNA. The TH1-polarizing activity of L lactis G121-treated human DCs was blocked by TLR8-specific inhibitors, mediated by L lactis G121 RNA, and synergistically enhanced by activation of nucleotide-binding oligomerization domain-containing protein (NOD) 2. Conclusion: Bacterial RNA is the main driver of L lactis G121-mediated protection against experimentally induced allergy and requires both bacterial uptake by DCs and endosomal acidification. In mice L lactis G121 RNA signals through TLR13; however, the most likely intracellular receptor in human subjects is TLR8.	[Stein, Karina; Jenckel, Andre; Heine, Holger] German Ctr Lung Res DZL, Airway Res Ctr North, Div Innate Immun, Res Ctr Borstel, Giessen, Germany; [Brand, Stephanie; Kauth, Marion] Protectimmun GmbH, Gelsenkirchen, Germany; [Sigmund, Anna; Kirschning, Carsten J.] Univ Duisburg Essen, Inst Med Microbiol, Essen, Germany; [Chen, Zhijian James] UT Southwestern Med Sch, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX USA	University of Duisburg Essen; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Heine, H (corresponding author), Res Ctr Borstel, Div Innate Immun, Pk Allee 22, D-23845 Borstel, Germany.	hheine@fz-borstel.de	Chen, Zhijian/C-6039-2012; Heine, Holger/H-4552-2012	Chen, Zhijian/0000-0002-8475-8251; Heine, Holger/0000-0001-8128-5068	Fluorescence Cytometry Core Facility Borstel	Fluorescence Cytometry Core Facility Borstel	We acknowledge the technical help of Ina Goroncy, Katrin Bohnstedt, Suhad Al-Badri, and Sarah Stellbogen. We thank the Fluorescence Cytometry Core Facility Borstel for providing support and access to flow cytometers and the confocal laser scanning microscope.	Almofti MR, 2003, ARCH BIOCHEM BIOPHYS, V410, P246, DOI 10.1016/S0003-9861(02)00725-7; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Bertorelli G, 2000, ALLERGY, V55, P449, DOI 10.1034/j.1398-9995.2000.055005449.x; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0; Bratke K, 2007, THORAX, V62, P168, DOI 10.1136/thx.2006.067793; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Cervantes JL, 2013, J LEUKOCYTE BIOL, V94, P1231, DOI 10.1189/jlb.0413206; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Clausen BE, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23186; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Debarry J, 2010, ALLERGY, V65, P690, DOI 10.1111/j.1398-9995.2009.02253.x; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Douwes J, 2007, ALLERGY, V62, P1158, DOI 10.1111/j.1398-9995.2007.01490.x; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Eigenbrod T, 2015, J IMMUNOL, V195, P1092, DOI 10.4049/jimmunol.1403173; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Gill MA, 2012, J ALLERGY CLIN IMMUN, V129, P889, DOI 10.1016/j.jaci.2012.02.028; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Gorelik L, 2008, INNATE IMMUN-LONDON, V14, P345, DOI 10.1177/1753425908098006; Hagner S, 2013, ALLERGY, V68, P322, DOI 10.1111/all.12094; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Karimi MH, 2010, HYBRIDOMA, V29, P473, DOI 10.1089/hyb.2010.0060; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Li XJ, 2012, INT IMMUNOPHARMACOL, V13, P1, DOI 10.1016/j.intimp.2012.02.011; Lim TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045185; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Muller G, 2002, J INVEST DERMATOL, V119, P836, DOI 10.1046/j.1523-1747.2002.00496.x; Nishibayashi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129806; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Romagnani S, 2004, IMMUNOLOGY, V112, P352, DOI 10.1111/j.1365-2567.2004.01925.x; Schwarz H, 2013, IMMUNOBIOLOGY, V218, P533, DOI 10.1016/j.imbio.2012.06.007; SHINJI H, 1993, J LEUKOCYTE BIOL, V54, P336, DOI 10.1002/jlb.54.4.336; Takagi T, 2011, AM J RESP CRIT CARE, V183, P31, DOI 10.1164/rccm.201001-0107OC; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Turpin J, 1986, J Clin Apher, V3, P111, DOI 10.1002/jca.2920030207; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vissers M, 2012, EUR J IMMUNOL, V42, P2727, DOI 10.1002/eji.201242396; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; Wolf AJ, 2011, J IMMUNOL, V187, P6002, DOI 10.4049/jimmunol.1100232; Yang X, 1999, J IMMUNOL, V162, P1010; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129	47	17	18	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					667	+		10.1016/j.jaci.2016.06.018	http://dx.doi.org/10.1016/j.jaci.2016.06.018			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27544739	Bronze			2022-12-18	WOS:000397002400032
J	Bryant-Stephens, T; Reed-Wells, S; Canales, M; Perez, L; Rogers, M; Localio, AR; Apter, AJ				Bryant-Stephens, Tyra; Reed-Wells, Shakira; Canales, Maryori; Perez, Luzmercy; Rogers, Marisa; Localio, A. Russell; Apter, Andrea J.			Home visits are needed to address asthma health disparities in adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; health disparities; community health worker; patient-centered outcomes research; housing	OUTCOMES	Research on asthma frequently recruits patients from clinics because the ready pool of patients leads to easy access to patients in office waiting areas, emergency departments, or hospital wards. Patients with other chronic conditions, and with mobility problems, face exposures at home that are not easily identified at the clinic. In this article, we describe the perspective of the community health workers and the challenges they encountered when making home visits while implementing a research intervention in a cohort of low-income, minority patients. From their observations, poor housing, often the result of poverty and lack of social resources, is the real elephant in the chronic asthma room. To achieve a goal of reduced asthma morbidity and mortality will require a first-hand understanding of the real-world social and economic barriers to optimal asthma management and the solutions to those barriers.	[Bryant-Stephens, Tyra; Reed-Wells, Shakira; Canales, Maryori] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Bryant-Stephens, Tyra; Perez, Luzmercy; Rogers, Marisa; Localio, A. Russell; Apter, Andrea J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Perez, Luzmercy; Apter, Andrea J.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA; [Localio, A. Russell] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Bryant-Stephens, T (corresponding author), 3535 Market St,Ste 1032, Philadelphia, PA 19104 USA.	stephenst@email.chop.edu		Perez, Luzmercy/0000-0002-1423-7901	Patient-Centered Outcomes Research Institute (PCORI) Program Award [AS-1307-05218]	Patient-Centered Outcomes Research Institute (PCORI) Program Award(Patient-Centered Outcomes Research Institute - PCORI)	Research reported in this Perspective was funded through a Patient-Centered Outcomes Research Institute (PCORI) Program Award (AS-1307-05218). All views in this Perspective are solely those of the authors and do not necessarily represent the views of the PCORI, its Board of Governors, or the Methodology Committee.	Akinbami Lara J, 2012, NCHS Data Brief, P1; Apter AJ, 2015, CONTEMP CLIN TRIALS, V44, P119, DOI 10.1016/j.cct.2015.08.001; Apter AJ, 2013, J ASTHMA, V50, P850, DOI 10.3109/02770903.2013.812655; Apter AJ, 2011, J ALLERGY CLIN IMMUN, V128, P516, DOI 10.1016/j.jaci.2011.05.010; Boyd CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041601; Bryant-Stephens T, 2009, AM J PUBLIC HEALTH, V99, pS657, DOI [DOI 10.2105/AJPH.2009.165423, 10.2105/AJPH.2009.165423]; Bryant-Stephens T, 2008, J NATL MED ASSOC, V100, P306, DOI 10.1016/S0027-9684(15)31243-8; Fargo JD, 2013, AM J PUBLIC HEALTH, V103, pS340, DOI 10.2105/AJPH.2013.301619; Forno E, 2012, AM J RESP CRIT CARE, V185, P1033, DOI 10.1164/rccm.201202-0350ED; Hasegawa K, 2014, J ALLER CL IMM-PRACT, V2, P733, DOI 10.1016/j.jaip.2014.06.012; National Alliance to End Homelessness, 2016, STAT HOM AM 2016; Newcomb PA, 2010, J ASTHMA, V47, P192, DOI 10.3109/02770900903486397; PCORI funding announcement, 2013, PCORI FUNDING ANNOUN; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Samuels-Kalow M, 2016, ACAD EMERG MED, V23, P279, DOI 10.1111/acem.12877	15	17	17	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1526	1530		10.1016/j.jaci.2016.10.006	http://dx.doi.org/10.1016/j.jaci.2016.10.006			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	EF0MK	27777181	hybrid			2022-12-18	WOS:000390019300004
J	Guerra, S; Vasquez, MM; Spangenberg, A; Halonen, M; Martin, RJ				Guerra, Stefano; Vasquez, Monica M.; Spangenberg, Amber; Halonen, Marilyn; Martin, Richard J.			Club cell secretory protein in serum and bronchoalveolar lavage of patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CLARA CELL; LUNG-FUNCTION; BIOMARKER; CC16		[Guerra, Stefano; Vasquez, Monica M.; Spangenberg, Amber; Halonen, Marilyn] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA; [Guerra, Stefano] CREAL Ctr, Barcelona, Spain; [Guerra, Stefano] Univ Pompeu Fabra, Barcelona, Spain; [Vasquez, Monica M.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Martin, Richard J.] Natl Jewish Hlth, Dept Med, Denver, CO USA	University of Arizona; Pompeu Fabra University; Pompeu Fabra University; University of Arizona; National Jewish Health	Guerra, S (corresponding author), Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA.; Guerra, S (corresponding author), CREAL Ctr, Barcelona, Spain.; Guerra, S (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.	stefano@email.arizona.edu		Halonen, Marilyn/0000-0001-9606-935X	NHLBI NIH HHS [R01 HL095021, P50 HL107188] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL107188, R01HL095021] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; Bottai M, 2011, RESPIRATION, V82, P254, DOI 10.1159/000327206; Broeckaert F, 2000, CLIN EXP ALLERGY, V30, P469; Emmanouil P, 2015, ALLERGY, V70, P711, DOI 10.1111/all.12603; Guerra S, 2015, LANCET RESP MED, V3, P613, DOI 10.1016/S2213-2600(15)00196-4; Lakind JS, 2007, BIOMARKERS, V12, P445, DOI 10.1080/13547500701359327; Rava M, 2013, J ALLERGY CLIN IMMUN, V132, P230, DOI 10.1016/j.jaci.2013.01.023; Roth FD, 2007, HISTOCHEM CELL BIOL, V127, P55, DOI 10.1007/s00418-006-0220-3; Schultz ES, 2012, AM J RESP CRIT CARE, V186, P1286, DOI 10.1164/rccm.201206-1045OC; Shijubo N, 1999, LUNG, V177, P45, DOI 10.1007/PL00007626; Shijubo N, 1999, AM J RESP CRIT CARE, V160, P930, DOI 10.1164/ajrccm.160.3.9803113; Thacher JD, 2014, PEDIATRICS, V134, P428, DOI 10.1542/peds.2014-0427; VANVYVE T, 1995, J ALLERGY CLIN IMMUN, V95, P60, DOI 10.1016/S0091-6749(95)70153-2	13	17	19	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					932	+		10.1016/j.jaci.2016.03.047	http://dx.doi.org/10.1016/j.jaci.2016.03.047			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27315766	Bronze, Green Accepted			2022-12-18	WOS:000385496000041
J	Szodoray, P; Stanford, SM; Molberg, O; Munthe, LA; Bottini, N; Nakken, B				Szodoray, Peter; Stanford, Stephanie M.; Molberg, Oyvind; Munthe, Ludvig A.; Bottini, Nunzio; Nakken, Britt			T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						B-cell anergy; break of tolerance; T-cell help; CD45 phosphatase activity; systemic lupus erythematosus	SYSTEMIC-LUPUS-ERYTHEMATOSUS; TYROSINE KINASES; AUTOANTIBODY PRODUCTION; INHIBITORY WEDGE; SELF-TOLERANCE; IMMUNE CELLS; EXPRESSION; LYMPHOCYTES; ACTIVATION; MICE	Background: We recently identified a human B-cell population that is naturally autoreactive and tolerized by functional anergy (BND cells). Objective: We sought to identify the molecular mechanism of how anergic autoreactive BND cells escape functional anergy and whether this process is altered in patients with lupus. Methods: Isolated peripheral blood naive and B-ND cells were cultured with various stimuli, and their activation status was determined by using an intracellular Ca+2 mobilization assay. Lyn kinase and Syk activities were assessed by using phospho-flow analysis. CD45 phosphatase activity was determined by using a novel flow-based assay, which takes advantage of the fluorogenic properties of phosphorylated coumaryl amino propionic acid, an analog of phosphotyrosine, which can be incorporated into peptides. Real-time quantitative PCR was used to quantitate LYN, SYK, and CD45 mRNA. Results: T-helper signals reversed the state of anergy, allowing BND cells to fully respond to antigenic stimulation by restoring signaling through the B-cell receptor (BCR). The mechanism was dependent on increased activity of the tyrosine phosphatase CD45 and CD45-dependent activation of Lyn and Syk. CD45 phosphatase activity was increased by T-cell help both in B-ND and naive B cells. Furthermore, we found that B-ND cells obtained from patients with systemic lupus erythematosus exhibited increased CD45 activity and BCR-signaling capacity, thus being less tolerized than B-ND cells from healthy control subjects. Conclusion: Our findings suggest that CD45 is a key regulator of BCR-signaling thresholds mediated by T-cell help. This raises the possibility that B-ND cells could represent precursors of autoantibody-secreting plasma cells and suggests a role for these autoreactive B cells in contributing to autoimmunity if not properly controlled.	[Szodoray, Peter; Munthe, Ludvig A.; Nakken, Britt] Univ Oslo, Dept Immunol, Ctr Immune Regulat, N-0316 Oslo, Norway; [Szodoray, Peter; Munthe, Ludvig A.; Nakken, Britt] Oslo Univ Hosp, Rikshosp, N-0450 Oslo, Norway; [Stanford, Stephanie M.; Bottini, Nunzio] La Jolla Inst Allergy & Immunol, Div Cellular Biol, La Jolla, CA USA; [Molberg, Oyvind] Oslo Univ Hosp, Rikshosp, Dept Rheumatol, N-0450 Oslo, Norway; [Molberg, Oyvind; Munthe, Ludvig A.] Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; La Jolla Institute for Immunology; University of Oslo; National Hospital Norway; University of Oslo	Szodoray, P (corresponding author), Univ Oslo, Oslo Univ Hosp, Rikshosp, Ctr Immune Regulat,Dept Immunol, NO-0424 Oslo, Norway.	peter.szodoray@medisin.uio.no	Munthe, Ludvig/GRJ-3355-2022; Szodoray, Peter/P-3694-2018; Ingegnoli, Francesca/B-6226-2017	Szodoray, Peter/0000-0003-4443-6159; Munthe, Ludvig A/0000-0002-0344-3654; Ingegnoli, Francesca/0000-0002-6727-1273	Research Council of Norway through its Centres of Excellence funding scheme [179573/V40]; South-Eastern Norway Regional Health Authority [2011018]; UNIFOR funds by the University of Oslo; Norwegian Rheumatism Association; National Institutes of Health [DK080165]	Research Council of Norway through its Centres of Excellence funding scheme; South-Eastern Norway Regional Health Authority; UNIFOR funds by the University of Oslo; Norwegian Rheumatism Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the Research Council of Norway through its Centres of Excellence funding scheme (project no. 179573/V40), the South-Eastern Norway Regional Health Authority (grant no. 2011018), UNIFOR funds by the University of Oslo, Odd Fellow Norway, the Norwegian Rheumatism Association (to P.S. and B.N.), and National Institutes of Health grant DK080165 (to N.B.).	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Chang NH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011691; Cook MC, 1998, EUR J IMMUNOL, V28, P2549, DOI 10.1002/(SICI)1521-4141(199808)28:08<2549::AID-IMMU2549>3.0.CO;2-O; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cox SL, 2010, EUR J IMMUNOL, V40, P3413, DOI 10.1002/eji.201040817; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643; DESAIMEHTA A, 1995, J CLIN INVEST, V95, P531, DOI 10.1172/JCI117695; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; Jolly M, 2010, ANN RHEUM DIS, V69, P29, DOI 10.1136/ard.2008.094763; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Leonardo SM, 2012, EUR J IMMUNOL, V42, P2597, DOI 10.1002/eji.201242616; Leonardo SM, 2012, J IMMUNOL, V188, P5223, DOI 10.4049/jimmunol.1103731; Leonardo SM, 2010, J IMMUNOL, V185, P2147, DOI 10.4049/jimmunol.1000136; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; Mitra S, 2005, BIOORG MED CHEM LETT, V15, P5142, DOI 10.1016/j.bmcl.2005.08.054; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; Rudge EU, 2002, J EXP MED, V195, P1079, DOI 10.1084/jem.20011435; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Seo SJ, 2002, IMMUNITY, V16, P535, DOI 10.1016/S1074-7613(02)00298-4; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103; Stanford SM, 2014, METHODS, V65, P165, DOI 10.1016/j.ymeth.2013.07.022; Stanford SM, 2012, P NATL ACAD SCI USA, V109, P13972, DOI 10.1073/pnas.1205028109; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yurasov S, 2007, CURR OPIN RHEUMATOL, V19, P421, DOI 10.1097/BOR.0b013e328277ef3b; Yurasov S, 2006, J EXP MED, V203, P2255, DOI 10.1084/jem.20061446; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024; Zikherman J, 2013, J IMMUNOL, V190, P2527, DOI 10.4049/jimmunol.1202928; Zikherman J, 2012, P NATL ACAD SCI USA, V109, pE3, DOI 10.1073/pnas.1117374108	48	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					839	+		10.1016/j.jaci.2016.01.035	http://dx.doi.org/10.1016/j.jaci.2016.01.035			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27056269	Bronze			2022-12-18	WOS:000385496000020
J	Netter, P; Chan, SK; Banerjee, PP; Monaco-Shawver, L; Noroski, LM; Hanson, IC; Forbes, LR; Mace, EM; Chinen, J; Gaspar, HB; Sleiman, P; Hakonarson, H; Klein, C; Ehlayel, MS; Orange, JS				Netter, Petra; Chan, Sanny K.; Banerjee, Pinaki P.; Monaco-Shawver, Linda; Noroski, Lenora M.; Hanson, Imelda C.; Forbes, Lisa R.; Mace, Emily M.; Chinen, Javier; Gaspar, H. Bobby; Sleiman, Patrick; Hakonarson, Hakon; Klein, Christoph; Ehlayel, Mohammad S.; Orange, Jordan S.			A novel Rab27a mutation binds melanophilin, but not Munc13-4, causing immunodeficiency without albinism	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FOLLISTATIN-LIKE 1; PROMOTES ARTHRITIS; GRISCELLI-SYNDROME; EXPRESSION; FSTL1; INFLAMMATION; PROTEIN-1; EFFECTOR; LUNG; MICE		[Netter, Petra; Banerjee, Pinaki P.; Noroski, Lenora M.; Hanson, Imelda C.; Forbes, Lisa R.; Mace, Emily M.; Chinen, Javier; Orange, Jordan S.] Baylor Coll Med, Houston, TX 77030 USA; [Netter, Petra; Banerjee, Pinaki P.; Noroski, Lenora M.; Hanson, Imelda C.; Forbes, Lisa R.; Mace, Emily M.; Chinen, Javier; Orange, Jordan S.] Texas Childrens Hosp, Dept Pediat, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Netter, Petra; Banerjee, Pinaki P.; Noroski, Lenora M.; Hanson, Imelda C.; Forbes, Lisa R.; Mace, Emily M.; Chinen, Javier; Orange, Jordan S.] Ctr Human Immunobiol, Houston, TX 77030 USA; [Chan, Sanny K.] Natl Jewish Hlth, Denver, CO USA; [Monaco-Shawver, Linda; Sleiman, Patrick; Hakonarson, Hakon] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Gaspar, H. Bobby] UCL, Pediat & Immunol, London, England; [Klein, Christoph] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [Ehlayel, Mohammad S.] Weill Cornell Med Coll, New York, NY USA; [Ehlayel, Mohammad S.] Hamad Gen Hosp, Doha, Qatar	Baylor College of Medicine; Baylor College of Medicine; National Jewish Health; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; University College London; University of Munich; Cornell University; Hamad Medical Corporation; Hamad General Hospital	Orange, JS (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.; Orange, JS (corresponding author), Texas Childrens Hosp, Dept Pediat, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA.; Orange, JS (corresponding author), Ctr Human Immunobiol, Houston, TX 77030 USA.	orange@bcm.edu		orange, jordan/0000-0001-7117-7725; Mace, Emily/0000-0003-0226-7393	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120989, R01AI067946] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI067946, R01 AI120989] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Cetica V, 2015, J ALLERGY CLIN IMMUN, V135, P1310, DOI 10.1016/j.jaci.2014.08.039; Chaly Y, 2012, ARTHRITIS RHEUM-US, V64, P1082, DOI 10.1002/art.33422; Chan QKY, 2009, CARCINOGENESIS, V30, P114, DOI 10.1093/carcin/bgn215; Clutter SD, 2009, J IMMUNOL, V182, P234, DOI 10.4049/jimmunol.182.1.234; Dong YY, 2015, J EXP MED, V212, P235, DOI 10.1084/jem.20121878; Gavala ML, 2013, CLIN EXP ALLERGY, V43, P187, DOI 10.1111/cea.12032; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Grier JT, 2012, J CLIN INVEST, V122, P3769, DOI 10.1172/JCI64837; Kawabata D, 2004, ARTHRITIS RHEUM-US, V50, P660, DOI 10.1002/art.20023; Le Luduec JB, 2008, AM J TRANSPLANT, V8, P2297, DOI 10.1111/j.1600-6143.2008.02398.x; Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Miller M, 2011, CHEST, V139, P1380, DOI 10.1378/chest.10-0705; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; Murakami K, 2012, FEBS LETT, V586, P319, DOI 10.1016/j.febslet.2012.01.010; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Sundaram GM, 2013, NATURE, V495, P103, DOI 10.1038/nature11890; Sylva M, 2013, BIRTH DEFECTS RES C, V99, P61, DOI 10.1002/bdrc.21030; Tanaka M, 2003, INT IMMUNOL, V15, P71, DOI 10.1093/intimm/dxg005	22	17	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					599	601		10.1016/j.jaci.2015.12.1337	http://dx.doi.org/10.1016/j.jaci.2015.12.1337			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	27016801	Green Accepted, Bronze			2022-12-18	WOS:000380835800036
J	Gepp, B; Lengger, N; Mobs, C; Pfutzner, W; Radauer, C; Bohle, B; Breiteneder, H				Gepp, Barbara; Lengger, Nina; Moebs, Christian; Pfuetzner, Wolfgang; Radauer, Christian; Bohle, Barbara; Breiteneder, Heimo			Monitoring the epitope recognition profiles of IgE, IgG(1), and IgG(4) during birch pollen immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BET V 1; ORAL IMMUNOTHERAPY; ALLERGEN; RESPONSES		[Gepp, Barbara; Lengger, Nina; Radauer, Christian; Bohle, Barbara; Breiteneder, Heimo] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Bohle, Barbara] Med Univ Vienna, Christian Doppler Lab Immunomodulat, Vienna, Austria; [Moebs, Christian; Pfuetzner, Wolfgang] Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany	Medical University of Vienna; Medical University of Vienna; Philipps University Marburg	Bohle, B; Breiteneder, H (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria.; Bohle, B (corresponding author), Med Univ Vienna, Christian Doppler Lab Immunomodulat, Vienna, Austria.	barbara.bohle@meduniwien.ac.at; heimo.breiteneder@meduniwien.ac.at	Radauer, Christian/AAN-6260-2021	Radauer, Christian/0000-0001-9920-4449; Bohle, Barbara/0000-0002-5105-7985; Mobs, Christian/0000-0002-5197-7669; Breiteneder, Heimo/0000-0003-2022-8689				DJURUP R, 1985, ALLERGY, V40, P469, DOI 10.1111/j.1398-9995.1985.tb00253.x; Dodev TS, 2015, ALLERGY, V70, P720, DOI 10.1111/all.12607; Flicker S, 2003, INT ARCH ALLERGY IMM, V132, P13, DOI 10.1159/000073260; Gepp B, 2014, J ALLERGY CLIN IMMUN, V134, P188, DOI 10.1016/j.jaci.2013.12.1073; Mobs C, 2010, J IMMUNOL, V184, P2194, DOI 10.4049/jimmunol.0901379; Savilahti EM, 2014, PEDIAT ALLERG IMM-UK, V25, P227, DOI 10.1111/pai.12186; Subbarayal B, 2015, J ALLERGY CLIN IMMUN; Vickery BP, 2013, J ALLERGY CLIN IMMUN, V131, P128, DOI 10.1016/j.jaci.2012.10.048; Vrtala S, 1997, J CLIN INVEST, V99, P1673, DOI 10.1172/JCI119330	9	17	17	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1600	1603		10.1016/j.jaci.2015.10.022	http://dx.doi.org/10.1016/j.jaci.2015.10.022			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	26686470	hybrid			2022-12-18	WOS:000376180200040
J	Rank, MA; Liesinger, JT; Branda, ME; Gionfriddo, MR; Schatz, M; Zeiger, RS; Shah, ND				Rank, Matthew A.; Liesinger, Juliette T.; Branda, Megan E.; Gionfriddo, Michael R.; Schatz, Michael; Zeiger, Robert S.; Shah, Nilay D.			Comparative safety and costs of stepping down asthma medications in patients with controlled asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; antiasthma agents; anti-inflammatory agents; step down; de-escalate; reduce; taper; withdraw; health services	RANDOMIZED CONTROLLED-TRIALS; LONG-ACTING BETA(2)-AGONIST; INHALED CORTICOSTEROIDS; METAANALYSIS; OUTCOMES; RISK; EXACERBATION	Background: Limited data exist regarding outcomes after stepping down asthma medication. Objective: We sought to compare the safety and costs of stepping down asthma controller medications with maintaining current treatment levels in patients with controlled asthma. Methods: Patients with persistent asthma were identified from the US Medical Expenditure Panel Survey years 2000-2010. Each patient had Medical Expenditure Panel Survey data for 2 years, and measurement was divided into 5 periods of 4 to 5 months each. Eligibility for stepping down asthma controller medications included no hospitalizations or emergency department visits for asthma in periods 1 to 3 and no systemic corticosteroid and 3 or less rescue inhalers dispensed in periods 2 and 3. Steps were defined by type and dose of chronic asthma medication based on current guidelines when comparing period 4 with period 3. The primary outcome of complete asthma control in period 5 was defined as no asthma hospitalizations, emergency department visits, and dispensed systemic corticosteroids and 2 or fewer dispensed rescue inhalers. Multivariable analyses were conducted to assess safety and costs after step down compared with those who maintained the treatment level. Results: Overall, 29.9% of patients meeting the inclusion criteria (n = 4235) were eligible for step down; 89.4% (95% CI, 86.4% to 92.4%) of those who stepped down had preserved asthma control compared with 83.5% (95% CI, 79.9% to 87.0%) of those who were similarly eligible for step down but maintained their treatment level. The average monthly asthma-related cost savings was $34.02/mo (95% CI, $5.42/mo to $61.24/mo) with step down compared with maintenance of the treatment level. Conclusion: Stepping down asthma medications in those whose symptoms were controlled led to similar clinical outcomes at reduced cost compared with those who maintained their current treatment level.	[Rank, Matthew A.] Mayo Clin, Div Allergy Asthma & Clin Immunol, Scottsdale, AZ USA; [Rank, Matthew A.; Branda, Megan E.; Shah, Nilay D.] Robert & Patricia E Kern Ctr Sci Hlth Care Delive, Colorado Springs, CO USA; [Liesinger, Juliette T.; Branda, Megan E.; Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Branda, Megan E.; Gionfriddo, Michael R.; Shah, Nilay D.] Mayo Clin, Knowledge & Evaluat Res KER Unit, Rochester, MN USA; [Gionfriddo, Michael R.] Mayo Grad Sch, Rochester, MN USA; [Schatz, Michael; Zeiger, Robert S.] Kaiser Permanente So Calif, Dept Allergy, San Diego, CA USA; [Schatz, Michael; Zeiger, Robert S.] Kaiser Permanente So Calif, Dept Res & Evaluat, San Diego, CA USA; [Schatz, Michael; Zeiger, Robert S.] Kaiser Permanente So Calif, Dept Allergy, Pasadena, CA USA; [Schatz, Michael; Zeiger, Robert S.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Rank, MA (corresponding author), 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	rank.matthew@mayo.edu	Gionfriddo, Michael R./S-8359-2016	Gionfriddo, Michael R./0000-0003-1391-7072; Zeiger, Robert/0000-0001-5788-5063	Agency for Healthcare Research and Quality [R03 HS-22126]; CTSA from the National Center for Advancing Translational Science (NCATS) [TL1 TR000137]; Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000137] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); CTSA from the National Center for Advancing Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by Agency for Healthcare Research and Quality grant R03 HS-22126. Also supported by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery for additional support. M.R.G. was supported by CTSA grant no. TL1 TR000137 from the National Center for Advancing Translational Science (NCATS). The manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Brozek JL, 2012, ARCH INTERN MED, V172, P1365, DOI 10.1001/archinternmed.2012.3250; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hagan JB, 2014, ALLERGY, V69, P510, DOI 10.1111/all.12368; Hawkins G, 2003, BMJ-BRIT MED J, V326, P1115, DOI 10.1136/bmj.326.7399.1115; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; National Heart Lung and Blood Institute, NAT ASTHM ED PREV PR; Rank MA, 2015, CHEST, V148, P630, DOI 10.1378/chest.15-0301; Rank MA, 2014, J ALLER CL IMM-PRACT, V2, P503, DOI 10.1016/j.jaip.2014.03.004; Rank MA, 2013, J ALLERGY CLIN IMMUN, V131, P724, DOI 10.1016/j.jaci.2012.11.038; Reddel HK, 2010, RESP MED, V104, P1110, DOI 10.1016/j.rmed.2010.04.003; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P995, DOI 10.1016/j.jaci.2006.01.053; Schatz M, 2010, AM J MANAG CARE, V16, pE281; Travers J, 2007, THORAX, V62, P219, DOI 10.1136/thx.2006.066837; Visser MJ, 2001, AM J RESP CRIT CARE, V164, P2073, DOI 10.1164/ajrccm.164.11.2103075; WAALKENS HJ, 1993, AM REV RESPIR DIS, V148, P1252, DOI 10.1164/ajrccm/148.5.1252	17	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1373	+		10.1016/j.jaci.2015.08.035	http://dx.doi.org/10.1016/j.jaci.2015.08.035			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	26506020	Bronze			2022-12-18	WOS:000376180200010
J	Demont, A; Hacini-Rachinel, F; Doucet-Ladeveze, R; Ngom-Bru, C; Mercenier, A; Prioult, G; Blanchard, C				Demont, Audrey; Hacini-Rachinel, Feriel; Doucet-Ladeveze, Remi; Ngom-Bru, Catherine; Mercenier, Annick; Prioult, Guenolee; Blanchard, Carine			Live and heat-treated probiotics differently modulate IL10 mRNA stabilization and microRNA expression	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IL-10		[Demont, Audrey; Hacini-Rachinel, Feriel; Doucet-Ladeveze, Remi; Ngom-Bru, Catherine; Mercenier, Annick; Prioult, Guenolee; Blanchard, Carine] Nestle Res Ctr, Nutr & Hlth Res, CH-1000 Lausanne, Switzerland	Nestle SA	Blanchard, C (corresponding author), Nestle Res Ctr, Nutr & Hlth Res, CH-1000 Lausanne, Switzerland.	Carine.Blanchard@rdls.nestle.com		Blanchard, Carine/0000-0002-3377-290X				de Moreno de LA, 2011, ISRN GASTROENTEROL, V2011; Powell MJ, 2000, J IMMUNOL, V165, P292, DOI 10.4049/jimmunol.165.1.292; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Taverniti V, 2011, GENES NUTR, V6, P261, DOI 10.1007/s12263-011-0218-x; Xie N, 2014, J IMMUNOL, V193, P327, DOI 10.4049/jimmunol.1400203; Yeh CH, 2012, SHOCK, V38, P607, DOI 10.1097/SHK.0b013e318271f944; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158	7	17	19	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2016	137	4					1264	+		10.1016/j.jaci.2015.08.033	http://dx.doi.org/10.1016/j.jaci.2015.08.033			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DI2TG	26478009	Bronze			2022-12-18	WOS:000373351200041
J	Gruber, C; van Stuivenberg, M; Mosca, F; Moro, G; Chirico, G; Braegger, CP; Riedler, J; Yavuz, Y; Boehm, G; Wahn, U				Grueber, Christoph; van Stuivenberg, Margriet; Mosca, Fabio; Moro, Guido; Chirico, Gaetano; Braegger, Christian P.; Riedler, Josef; Yavuz, Yalcin; Boehm, Guenther; Wahn, Ulrich		MIPS II Working Grp	Immunoactive prebiotics transiently prevent occurrence of early atopic dermatitis among low- atopy- risk infants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Grueber, Christoph; Wahn, Ulrich] Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Grueber, Christoph] Klinikum Frankfurt Oder, Dept Pediat, Frankfurt, Germany; [van Stuivenberg, Margriet] Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol, Groningen, Netherlands; [Mosca, Fabio] Univ Milan, Osped Maggiore Policlin, Univ Dept Mother & Infant Sci, NICU,Fdn IRCCS Ca Granda, Milan, Italy; [Moro, Guido] Macedonio Melloni Hosp, Milan, Italy; [Chirico, Gaetano] Spedali Civil Brescia, Dept Neonatol, I-25125 Brescia, Italy; [Braegger, Christian P.] Univ Childrens Hosp, Div Paediat Gastroenterol & Nutr, Zurich, Switzerland; [Riedler, Josef] Schwarzach Hosp, Childrens Hosp, Schwarzach, Austria; [Yavuz, Yalcin] Nutricia Res, Biostat Dept, Utrecht, Netherlands; [Boehm, Guenther] Danone Res Ctr Specialized Nutr, Friedrichshafen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Groningen; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Hospital Spedali Civili Brescia; University Children's Hospital Zurich; Danone Nutricia; Danone Nutricia	Gruber, C (corresponding author), Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany.	christoph.grueber@klinikumffo.de	Braegger, Christian Peter/ABC-9884-2021; Mosca, Fabio/C-5826-2017; riedler, josef/AAQ-4666-2020	Mosca, Fabio/0000-0001-6477-0299; Braegger, Christian/0000-0001-8069-9875				Arslanoglu S, 2012, J Biol Regul Homeost Agents, V26, P49; Arslanoglu S, 2008, J NUTR, V138, P1091, DOI 10.1093/jn/138.6.1091; Bergmann RL, 1998, CLIN EXP ALLERGY, V28, P905; Gruber C, 2010, J ALLERGY CLIN IMMUN, V126, P791, DOI 10.1016/j.jaci.2010.07.022; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Jeurink PV, 2013, AM J CLIN NUTR, V98, p572S, DOI 10.3945/ajcn.112.038596; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; van Stuijvenberg M, 2011, BRIT J NUTR, V106, P1740, DOI 10.1017/S0007114511004053	9	17	18	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1696	1698		10.1016/j.jaci.2015.07.049	http://dx.doi.org/10.1016/j.jaci.2015.07.049			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26412776				2022-12-18	WOS:000366044300037
J	Herberth, G; Offenberg, K; Rolle-Kampczyk, U; Bauer, M; Otto, W; Roder, S; Grutzmann, K; Sack, U; Simon, JC; Borte, M; von Bergen, M; Lehmann, I				Herberth, Gunda; Offenberg, Kirsten; Rolle-Kampczyk, Ulrike; Bauer, Mario; Otto, Wolfgang; Roder, Stefan; Grutzmann, Konrad; Sack, Ulrich; Simon, Jan-Christoph; Borte, Michael; von Bergen, Martin; Lehmann, Irina		LINA Study Grp	Endogenous metabolites and inflammasome activity in early childhood and links to respiratory diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							OXIDATIVE STRESS; ACTIVATION; LYSOPHOSPHATIDYLCHOLINE; EXPRESSION		[Herberth, Gunda; Offenberg, Kirsten; Bauer, Mario; Grutzmann, Konrad; Lehmann, Irina] UFZ Helmholtz Ctr Environm Res Leipzig, Dept Environm Immunol, Leipzig, Germany; [Rolle-Kampczyk, Ulrike] UFZ Helmholtz Ctr Environm Res Leipzig, Dept Metabol, Leipzig, Germany; [Otto, Wolfgang; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res Leipzig, Dept Prote, Leipzig, Germany; [Roder, Stefan] UFZ Helmholtz Ctr Environm Res Leipzig, Core Facil Studies, Leipzig, Germany; [Sack, Ulrich] Univ Leipzig, Inst Clin Immunol, D-04109 Leipzig, Germany; [Simon, Jan-Christoph] Univ Klinikum, Klin Dermatol Venerol & Allergol, Leipzig, Germany; [Borte, Michael] Univ Leipzig, Acad Teaching Hosp, Municipal Hosp St Georg, Childrens Hosp, D-04109 Leipzig, Germany; [von Bergen, Martin] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Leipzig University; Leipzig University; Aalborg University	Herberth, G (corresponding author), UFZ Helmholtz Ctr Environm Res Leipzig, Dept Environm Immunol, Leipzig, Germany.	gunda.herberth@ufz.de; irina.lehmann@ufz.de	Rolle-Kampczyk, Ulrike E./D-4786-2015; von Bergen, Martin/D-7960-2011; Sack, Ulrich/J-6301-2015; Bauer, Mario/AAZ-7540-2021	Rolle-Kampczyk, Ulrike E./0000-0002-7728-6284; von Bergen, Martin/0000-0003-2732-2977; Sack, Ulrich/0000-0002-7813-0492; Herberth, Gunda/0000-0003-0212-3509; Lehmann, Irina/0000-0001-8875-5587				Aihara K, 2014, BRIT J NUTR, V112, P513, DOI 10.1017/S0007114514001147; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Herberth G, 2011, ALLERGY, V66, P1065, DOI 10.1111/j.1398-9995.2011.02587.x; Murch O, 2006, BRIT J PHARMACOL, V148, P769, DOI 10.1038/sj.bjp.0706788; Niu YC, 2012, BRIT J NUTR, V108, P57, DOI 10.1017/S0007114511005289; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	10	17	17	2	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					495	+		10.1016/j.jaci.2015.01.022	http://dx.doi.org/10.1016/j.jaci.2015.01.022			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25754623	hybrid			2022-12-18	WOS:000359004900037
J	Bouchaud, G; Braza, F; Chesne, J; Lair, D; Chen, KW; Rolland-Debord, C; Hassoun, D; Roussey-Bihouee, T; Cheminant, MA; Brouard, S; Bodinier, M; Vrtala, S; Magnan, A				Bouchaud, Gregory; Braza, Faouzi; Chesne, Julie; Lair, David; Chen, Kuan-Wei; Rolland-Debord, Camille; Hassoun, Dorian; Roussey-Bihouee, Tiphaine; Cheminant, Marie-Aude; Brouard, Sophie; Bodinier, Marie; Vrtala, Susanne; Magnan, Antoine			Prevention of allergic asthma through Der p 2 peptide vaccination	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HOUSE-DUST MITE; DERMATOPHAGOIDES-PTERONYSSINUS; SKIN-TESTS; B-CELLS; EXACERBATIONS; IMMUNOTHERAPY; ANTIBODIES; RESPONSES; EXTRACTS; VACCINES		[Bouchaud, Gregory; Braza, Faouzi; Chesne, Julie; Lair, David; Rolland-Debord, Camille; Hassoun, Dorian; Roussey-Bihouee, Tiphaine; Cheminant, Marie-Aude; Magnan, Antoine] INSERM, UMR1087, Inst Thorax, Nantes, France; [Bouchaud, Gregory; Braza, Faouzi; Chesne, Julie; Lair, David; Rolland-Debord, Camille; Hassoun, Dorian; Roussey-Bihouee, Tiphaine; Cheminant, Marie-Aude; Magnan, Antoine] CNRS, UMR 6291, Nantes, France; [Bouchaud, Gregory; Braza, Faouzi; Chesne, Julie; Lair, David; Rolland-Debord, Camille; Hassoun, Dorian; Roussey-Bihouee, Tiphaine; Cheminant, Marie-Aude; Brouard, Sophie; Magnan, Antoine] Univ Nantes, Nantes, France; [Bouchaud, Gregory; Braza, Faouzi; Chesne, Julie; Lair, David; Rolland-Debord, Camille; Hassoun, Dorian; Roussey-Bihouee, Tiphaine; Cheminant, Marie-Aude; Magnan, Antoine] DHU2020 Med Personnalisee Malad Chron, Nantes, France; [Bouchaud, Gregory; Bodinier, Marie] INRA, UR1268, BIA, F-44026 Nantes, France; [Chen, Kuan-Wei; Vrtala, Susanne] Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Brouard, Sophie] INSERM, U1064, Nantes, France; [Brouard, Sophie] CHU Nantes, Hotel Dieu, Inst Transplantat Urol Nephrol, F-44035 Nantes 01, France; [Magnan, Antoine] CHU Nantes, Inst Thorax, Serv Pneumol, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Nantes Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Bouchaud, G (corresponding author), INSERM, UMR1087, Inst Thorax, Nantes, France.	Antoine.Magnan@univ-nantes.fr	MAGNAN, ANTOINE/GVT-4308-2022; Bodinier, Marie/AHA-6349-2022; Bouchaud, Gregory/AAC-4596-2020; bouchaud, gregory/K-9509-2015; brouard, sophie c/Q-1285-2016	Bouchaud, Gregory/0000-0002-3794-7287; bouchaud, gregory/0000-0002-3794-7287; Chen, Kuan-Wei/0000-0001-5899-5766; Braza, Faouzi/0000-0003-1182-1413; Chesne, Julie/0000-0001-8831-4386; Vrtala, Susanne/0000-0003-4250-8243; Hassoun, Dorian/0000-0002-2154-0474	Austrian Science Fund FWF [F 4602] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Botturi K, 2011, PHARMACOL THERAPEUT, V131, P114, DOI 10.1016/j.pharmthera.2011.03.010; Bousquet PJ, 2007, ALLERGY, V62, P301, DOI 10.1111/j.1398-9995.2006.01293.x; Braza F, 2014, ALLERGY, V69, P1454, DOI 10.1111/all.12490; Chen KW, 2012, ALLERGY, V67, P609, DOI 10.1111/j.1398-9995.2012.02794.x; Chen KW, 2012, J ALLERGY CLIN IMMUN, V130, P435, DOI 10.1016/j.jaci.2012.05.035; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; HEYMANN PW, 1989, J ALLERGY CLIN IMMUN, V83, P1055, DOI 10.1016/0091-6749(89)90447-8; Linhart B, 2014, CLIN EXP ALLERGY, V44, P278, DOI 10.1111/cea.12216; MEYER CH, 1994, CLIN EXP ALLERGY, V24, P1041, DOI 10.1111/j.1365-2222.1994.tb02741.x; Pyrc K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032582; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; VANDERZEE JS, 1988, J ALLERGY CLIN IMMUN, V81, P884, DOI 10.1016/0091-6749(88)90946-3	15	17	17	1	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2015	136	1					197	200		10.1016/j.jaci.2014.12.1938	http://dx.doi.org/10.1016/j.jaci.2014.12.1938			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CM2WE	25680456				2022-12-18	WOS:000357542200025
J	Liccardi, G; Meriggi, A; Russo, M; Croce, S; Salzillo, A; Pignatti, P				Liccardi, Gennaro; Meriggi, Antonio; Russo, Maria; Croce, Stefania; Salzillo, Antonello; Pignatti, Patrizia			The risk of sensitization to furry animals in patients already sensitized to cat/dog: An in vitro evaluation using molecular-based allergy diagnostics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Liccardi, Gennaro; Russo, Maria; Salzillo, Antonello] High Special A Cardarelli Hosp, Dept Chest Dis, Div Pneumol & Allergol, Naples, Italy; [Meriggi, Antonio; Croce, Stefania; Pignatti, Patrizia] Fdn Salvatore Maugeri, IRCCS, Allergy & Immunol Unit, Pavia, Italy	Antonio Cardarelli Hospital; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia	Liccardi, G (corresponding author), High Special A Cardarelli Hosp, Dept Chest Dis, Div Pneumol & Allergol, Naples, Italy.	gennaro.liccardi@tin.it	meriggi, antonio/AAC-2870-2020; Croce, Stefania/AAD-2331-2019; Pignatti, Patrizia/K-9595-2016	Croce, Stefania/0000-0001-9176-4257; Pignatti, Patrizia/0000-0001-5283-3897; Meriggi, Antonio/0000-0001-9206-0200				Hentges F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00234; Konradsen JR, 2015, J ALLERGY CLIN IMMUN, V135, P616, DOI 10.1016/j.jaci.2014.08.026; Konradsen JR, 2014, PEDIAT ALLERG IMM-UK, V25, P187, DOI 10.1111/pai.12198; Liccardi G, 2011, ALLERGY, V66, P1500, DOI 10.1111/j.1398-9995.2011.02675.x; Liccardi G, 2011, J INVEST ALLERG CLIN, V21, P137; Liccardi G, 2015, EUR ANN ALL IN PRESS; Phillips JF, 2009, J ALLERGY CLIN IMMUN, V123, P513, DOI 10.1016/j.jaci.2008.09.019	7	17	17	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2015	135	6					1664	1666		10.1016/j.jaci.2015.03.021	http://dx.doi.org/10.1016/j.jaci.2015.03.021			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CK0ZC	26051955	Bronze			2022-12-18	WOS:000355933400041
J	Garbutt, JM; Yan, Y; Highstein, G; Strunk, RC				Garbutt, Jane M.; Yan, Yan; Highstein, Gabrielle; Strunk, Robert C.			A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; randomized controlled trial; self-management; peer training; telephone care	INNER-CITY CHILDREN; AFRICAN-AMERICAN CHILDREN; COMMUNITY-HEALTH WORKERS; RESEARCH-TEAM-II; PEDIATRIC-ASTHMA; PATIENT-OUTCOMES; SELF-MANAGEMENT; PRIMARY-CARE; ORGANIZATIONAL-CHANGE; PHYSICIAN EDUCATION	Childhood asthma morbidity remains significant, especially in low-income children. Most often, asthma management is provided by the child's primary care provider. Objective: We sought to evaluate whether enhancing primary care management for persistent asthma with telephone-based peer coaching for parents reduced asthma impairment and risk in children 3 to 12 years old. Methods: Over 12 months, peer trainers provided parents with asthma management training by telephone (median, 18 calls) and encouraged physician partnership. The interventionwas evaluated in a cluster-randomized trial of 11 intervention and 11 usual care pediatric practices (462 and 486 families, respectively). Patient outcomes were assessed bymeans of telephone interviews at 12 and 24 months conducted by observers blinded to intervention assignment and compared by using mixed-effects models, controlling for baseline values and clustering within practices. In a planned subgroup analysis we examined the heterogeneity of the intervention effect by insurance type (Medicaid vs other). Results: After 12 months, intervention participation resulted in -0.9 (95% CI, 9.1-32.7) more symptom-free days per child than in the control group, and there was no difference in emergency department (ED) visits. After 24 months, ED visits were reduced (difference in mean visits/child, -0.28; 95% CI, -0.5 to -0.02), indicating a delayed intervention effect. In the Medicaid subgroup, after 12 months, intervention participation resulted in 42% fewer ED visits (difference in mean visits/child, -0.50; 95% CI, -0.81 to -0.18) and 62% fewer hospitalizations (difference in mean hospitalizations/child, -0.16; 95% CI, -0.30 to -0.014). Reductions in health care use endured through 24 months. Conclusions: This pragmatic telephone-based peer-training intervention reduced asthma impairment. Asthma risk was reduced in children with Medicaid insurance.	[Garbutt, Jane M.] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Garbutt, Jane M.; Strunk, Robert C.] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Highstein, Gabrielle] Washington Univ, Dept Surg, St Louis, MO 63110 USA; [Highstein, Gabrielle] Winds Change Crosswinds, East Falmouth, MA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Garbutt, JM (corresponding author), Washington Univ, Sch Med, Gen Med Sci, Campus Box 8005,660 S Euclid Ave, St Louis, MO 63110 USA.	jgarbutt@dom.wustl.edu		Yan, Yan/0000-0002-5917-1475	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) [HL072919]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072919] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grant number HL072919 from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).	Akinbami Lara J, 2011, Natl Health Stat Report, P1; Butz AM, 2006, ARCH PEDIAT ADOL MED, V160, P622, DOI 10.1001/archpedi.160.6.622; Cabana MD, 2006, PEDIATRICS, V117, P2149, DOI 10.1542/peds.2005-1055; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Celano MP, 2010, J ASTHMA, V47, P317, DOI 10.3109/02770900903580850; Christakis DA, 2012, ACAD PEDIATR, V12, P302, DOI 10.1016/j.acap.2012.03.006; Clark NM, 2000, BMJ-BRIT MED J, V320, P572, DOI 10.1136/bmj.320.7234.572; Clark NM, 2008, CLIN PEDIATR, V47, P49, DOI 10.1177/0009922807305650; Clark Noreen M, 2003, Paediatr Respir Rev, V4, P325, DOI 10.1016/S1526-0542(03)00091-5; Clark NM, 2012, ANNU REV PUBL HEALTH, V33, P193, DOI 10.1146/annurev-publhealth-031811-124532; Cloutier MM, 2012, ACAD PEDIATR, V12, P312, DOI 10.1016/j.acap.2012.04.004; Diette GB, 2001, J PEDIATR-US, V138, P59, DOI 10.1067/mpd.2001.109600; Eakin MN, 2012, J ALLERGY CLIN IMMUN, V129, P664, DOI 10.1016/j.jaci.2011.10.013; Evans R, 1999, J PEDIATR-US, V135, P332, DOI 10.1016/S0022-3476(99)70130-7; Fisher EB, 2004, PEDIATRICS, V114, P116, DOI 10.1542/peds.114.1.116; Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914; Fisher EB, 2009, ARCH PEDIAT ADOL MED, V163, P225, DOI 10.1001/archpediatrics.2008.577; Flores G, 2009, PEDIATRICS, V124, P1522, DOI 10.1542/peds.2009-0230; Garbutt JM, 2010, ARCH PEDIAT ADOL MED, V164, P625, DOI 10.1001/archpediatrics.2010.91; Glasgow NJ, 2003, BMJ-BRIT MED J, V327, P659, DOI 10.1136/bmj.327.7416.659; Harrell F, 2012, STAT PROBLEMS DOCUME; Hersh AL, 2010, J ASTHMA, V47, P21, DOI 10.3109/02770900903301286; Homer CJ, 2005, ARCH PEDIAT ADOL MED, V159, P464, DOI 10.1001/archpedi.159.5.464; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2002, UNEQUAL TREATMENT CO; Juniper EF, 1996, QUAL LIFE RES, V5, P27, DOI 10.1007/BF00435966; Juniper EF, 1997, PEDIATR PULM, P17; Juniper EF, 2009, CHEST, V136, P951, DOI 10.1378/chest.09-1447; Kattan M, 2006, PEDIATRICS, V117, pE1095, DOI 10.1542/peds.2005-2160; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Krieger J, 2009, ARCH PEDIAT ADOL MED, V163, P141, DOI 10.1001/archpediatrics.2008.532; Krieger JW, 2005, AM J PUBLIC HEALTH, V95, P652, DOI 10.2105/AJPH.2004.042994; Lozano P, 2004, ARCH PEDIAT ADOL MED, V158, P875, DOI 10.1001/archpedi.158.9.875; Lukacs SL, 2002, ARCH PEDIAT ADOL MED, V156, P872, DOI 10.1001/archpedi.156.9.872; Morawska A, 2012, J CHILD HEALTH CARE, V16, P75, DOI 10.1177/1367493511426278; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nelson KA, 2011, ARCH PEDIAT ADOL MED, V165, P520, DOI 10.1001/archpediatrics.2011.57; Otsuki M, 2009, PEDIATRICS, V124, P1513, DOI 10.1542/peds.2008-2961; Partridge MR, 2008, THORAX, V63, P778, DOI 10.1136/thx.2007.084251; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39; Stafford RS, 2003, J ALLERGY CLIN IMMUN, V111, P729, DOI 10.1067/mai.2003.177; Sullivan SD, 2005, ARCH PEDIAT ADOL MED, V159, P428, DOI 10.1001/archpedi.159.5.428; Thyne SM, 2006, J ASTHMA, V43, P667, DOI 10.1080/02770900600925288; Van Gaalen JL, 2012, CURR OPIN ALLERGY CL, V12, P235, DOI 10.1097/ACI.0b013e3283533700; Walders N, 2006, CHEST, V129, P292, DOI 10.1378/chest.129.2.292; Wu AC, 2008, AMBUL PEDIATR, V8, P89, DOI 10.1016/j.ambp.2007.10.007	47	17	17	0	22	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2015	135	5					1163	U534		10.1016/j.jaci.2014.09.033	http://dx.doi.org/10.1016/j.jaci.2014.09.033			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	CH4DA	25445827	Green Accepted, Bronze			2022-12-18	WOS:000353980700008
J	Zheng, PL; Noroski, LM; Hanson, IC; Chen, YH; Lee, ME; Huang, Y; Zhu, MX; Banerjee, PP; Makedonas, G; Orange, JS; Shearer, WT; Liu, DF				Zheng, Peilin; Noroski, Lenora M.; Hanson, Imelda C.; Chen, Yuhui; Lee, Michelle E.; Huang, Yu; Zhu, Michael X.; Banerjee, Pinaki P.; Makedonas, George; Orange, Jordan S.; Shearer, William T.; Liu, Dongfang			Molecular mechanisms of functional natural killer deficiency in patients with partial DiGeorge syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CrkL; beta(2)-integrin; partial DiGeorge syndrome; natural killer cells; functional natural killer deficiency; immunological synapse	ADAPTER PROTEIN CRK; ACTIVATION; COMPENSATION; RECEPTORS; ADHESION; SIGNALS; ALLELE; CELLS; MODEL; GENE	Background: DiGeorge syndrome affects more than 3.5 million persons worldwide. Partial DiGeorge syndrome (pDGS), which is characterized by a number of gene deletions in chromosome 22, including the chicken tumor virus number 10 regulator of kinase (Crk)-like (CrkL) gene, is one of the most common genetic disorders in human subjects. To date, the role of natural killer (NK) cells in patients with pDGS remains unclear. Objective: We sought to define the effect of pDGS-related Crk haploinsufficiency on NK cell activation and cytotoxic immunological synapse (IS) structure and function. Methods: Inducible CrkL-silenced NK cells were used to recapitulate the pDGS, CrkL-haploinsufficient phenotype. Findings were validated by using NK cells from patients with actual pDGS. Ultimately, deficits in the function of NK cells from patients with pDGS were restored by lentiviral transduction of CrkL. Results: Silencing of CrkL expression inhibits NK cell function. Specifically, pDGS haploinsufficiency of CrkL inhibits accumulation of activating receptors, polarization of cytolytic machinery and key signaling molecules, and activation of beta(2)-integrin at the IS. Reintroduction of CrkL protein restores NK cell cytotoxicity. Conclusion: CrkL haploinsufficiency causes functional NK deficits in patients with pDGS by disrupting both b2-integrin activation and activating receptor accumulation at the IS. Our results suggest that NK cell IS quality can directly affect immune status, providing a potential target for diagnosis and therapeutic manipulation in patients with pDGS and in other patients with functional NK cell deficiencies.	[Zheng, Peilin; Chen, Yuhui; Lee, Michelle E.; Huang, Yu; Zhu, Michael X.; Banerjee, Pinaki P.; Makedonas, George; Orange, Jordan S.; Shearer, William T.; Liu, Dongfang] Texas Childrens Hosp, Ctr Human Immunobiol, Houston, TX 77030 USA; [Zheng, Peilin; Chen, Yuhui; Banerjee, Pinaki P.; Makedonas, George; Orange, Jordan S.; Shearer, William T.; Liu, Dongfang] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Noroski, Lenora M.; Hanson, Imelda C.; Lee, Michelle E.; Orange, Jordan S.; Shearer, William T.] Texas Childrens Hosp, Allergy Immunol & Rheumatol, Houston, TX 77030 USA; [Lee, Michelle E.] Rice Univ, Wiess Sch Nat Sci, Houston, TX USA; [Huang, Yu; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Grad Program Cell & Regulatory Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University; University of Texas System; University of Texas Health Science Center Houston	Liu, DF (corresponding author), Baylor Coll Med, Dept Pediat, 1102 Bates St,Suite 330, Houston, TX 77030 USA.	dongfang.liu@bcm.edu	HUANG, YU/U-2835-2019; Zheng, Peilin/B-4360-2015	Liu, Dongfang/0000-0002-7295-8088; HUANG, YU/0000-0002-6982-8485; Zheng, Peilin/0000-0002-4712-4903; Shearer, William/0000-0002-2483-2130; Lee, Michelle/0000-0003-1368-1450; orange, jordan/0000-0001-7117-7725	Baylor-University of Texas at Houston Center for AIDS Research from the National Institute of Allergy and Infectious Diseases [AI36211]; Caroline Wiess Law Fund for Research in Molecular Medicine [2531319101]; Texas Children's Hospital Pediatric Pilot Research Fund [2531319301]; Lymphoma SPORE Developmental Research Program from Baylor College of Medicine; Methodist Research Institute [2531319302, P50 CA126752]; NATIONAL CANCER INSTITUTE [P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL125018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124769, P30AI036211, R56AI130197, R21AI129594] Funding Source: NIH RePORTER	Baylor-University of Texas at Houston Center for AIDS Research from the National Institute of Allergy and Infectious Diseases; Caroline Wiess Law Fund for Research in Molecular Medicine; Texas Children's Hospital Pediatric Pilot Research Fund; Lymphoma SPORE Developmental Research Program from Baylor College of Medicine; Methodist Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by the Baylor-University of Texas at Houston Center for AIDS Research (Core Support Grant AI36211) from the National Institute of Allergy and Infectious Diseases, the Caroline Wiess Law Fund for Research in Molecular Medicine (2531319101), the Texas Children's Hospital Pediatric Pilot Research Fund (2531319301), and the Lymphoma SPORE Developmental Research Program from Baylor College of Medicine and the Methodist Research Institute (2531319302 and P50 CA126752).	Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Ferrando-Martinez S, 2014, J PEDIATR-US, V164, P882, DOI 10.1016/j.jpeds.2013.12.013; Gennery AR, 2013, CURR OPIN PEDIATR, V25, P730, DOI 10.1097/MOP.0000000000000027; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Guidi CJ, 2004, J BIOL CHEM, V279, P4180, DOI 10.1074/jbc.M312043200; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Liu DF, 2014, IMMUNOL CELL BIOL, V92, P80, DOI 10.1038/icb.2013.64; Liu DF, 2012, IMMUNITY, V36, P600, DOI 10.1016/j.immuni.2012.03.007; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; McLean-Tooke A, 2008, J ALLERGY CLIN IMMUN, V122, P362, DOI 10.1016/j.jaci.2008.03.033; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Newbern J, 2008, P NATL ACAD SCI USA, V105, P17115, DOI 10.1073/pnas.0805239105; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Ritter AT, 2013, IMMUNOL REV, V256, P107, DOI 10.1111/imr.12117; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Segovis CM, 2009, J IMMUNOL, V182, P6933, DOI 10.4049/jimmunol.0803840; Song H, 2006, CELL IMMUNOL, V239, P22, DOI 10.1016/j.cellimm.2006.03.002; Theorell J, 2011, J IMMUNOL METHODS, V366, P106, DOI 10.1016/j.jim.2011.01.014; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Zheng PL, 2013, DIABETES, V62, P896, DOI 10.2337/db12-0929	37	17	17	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2015	135	5					1293	1302		10.1016/j.jaci.2015.01.011	http://dx.doi.org/10.1016/j.jaci.2015.01.011			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CH4DA	25748067	Green Accepted			2022-12-18	WOS:000353980700023
J	Lynn, J; Oppenheimer, S; Zimmer, L				Lynn, Jewlya; Oppenheimer, Sophie; Zimmer, Lorena			Using public policy to improve outcomes for asthmatic children in schools Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, and Lorena Zimmer, MA Denver, Colo	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; children; school; public policy	PEDIATRIC ASTHMA; MANAGEMENT	School-based services to improve asthma management need to be accompanied by public policies that can help sustain services, scale effective interventions, create greater equity across schools, and improve outcomes for children. Several national organizations, including the Centers for Disease Control and Prevention, have recommended specific public policies the adoption of which in school settings can improve asthma outcomes for children. Although many states and school districts have adopted some of these policies, adoption is not universal, and implementation is not always successful, leaving inequities in children's access to asthma services and supports. These issues can be addressed by changing public policy. Policy change is a complex process, but it is one that will benefit from greater involvement by asthma experts, including the researchers who generate the knowledge base on what services, supports, and policies have the best outcomes for children. Asthma experts can participate in the policy process by helping to build awareness of the need for school-based asthma policy, estimating the costs associated with policy options and with inaction, advocating for the selection of specific policies, assisting in implementation (including providing feedback), conducting the research that can evaluate the effectiveness of implementation, and ultimately providing information back into the policy process to allow for improvements to the policies.	[Lynn, Jewlya; Oppenheimer, Sophie; Zimmer, Lorena] Spark Policy Inst, Denver, CO 80205 USA		Lynn, J (corresponding author), Spark Policy Inst, 2717 Welton St, Denver, CO 80205 USA.	Jewlya@SparkPolicy.com						Agency for Healthcare Research and Quality, SCH DISTR US POL REL; Allergy & Asthma Network, MOTH ASTHM ASTHM ALL; American Lung Association, 2009, NOMINEEALERT     MAY, P1; [Anonymous], 2013, ASTHM MAN; [Anonymous], 2008, MISS SCH SAF MAN; [Anonymous], 1993, POLICY CHANGE LEARNI; [Anonymous], 2009, WORK ACH ASTHM CONTR; Asthma and Allergy Foundation of America, 2013, STAT HON ROLL 2013 A; Brewer G. D., 1983, FDN POLICY ANAL; Bruzzese JM, 2009, J ALLERGY CLIN IMMUN, V124, P195, DOI 10.1016/j.jaci.2009.05.040; Carpenter LM, 2013, J SCHOOL HEALTH, V83, P859, DOI 10.1111/josh.12104; Centers for Disease Control and Prevention, 2006, STRAT ADDR ASTHM COO, P2; Centers for Disease Control and Prevention CDC's Division of Adolescent and School Health, 2008, CDC HIV AIDS FACTS, P1; Cicutto L, 2009, J ALLERGY CLIN IMMUN, V124, P390, DOI 10.1016/j.jaci.2009.04.042; Clark NM, 2010, AM J PUBLIC HEALTH, V100, P904, DOI 10.2105/AJPH.2009.180869; Clark NM, 2009, PEDIATRICS, V123, pS185, DOI 10.1542/peds.2008-2233I; Coffman JM, 2009, PEDIATRICS, V124, P729, DOI 10.1542/peds.2008-2085; Gerald JK, 2012, PEDIAT ALLER IMM PUL, V25, P11, DOI 10.1089/ped.2011.0118; Gerald LB, 2006, J SCHOOL HEALTH, V76, P291, DOI 10.1111/j.1746-1561.2006.00114.x; GERO JS, 1990, AI MAG, V11, P26; Gilabert P, 2012, POLIT STUD-LONDON, V60, P809, DOI 10.1111/j.1467-9248.2011.00936.x; Gsk-clinicalstudyregister, 2014, 116794 GSK CLIN STUD; Hester LL, 2013, J SCHOOL HEALTH, V83, P833, DOI 10.1111/josh.12101; Hunter LTB., 2003, CHEETAH; Kimball-Stanley A, 2009, LIABILITY RISKS AFTE; Kingdon JohnW., 1995, AGENDAS ALTERNATIVES, V2nd ed.; National Association of School Nurses, CAS ASS; Sabatier P, 1999, THEORIES POLICY PROC, P117; Sabatier PA, 2007, THEORIES POLICY PROC; Szefler S, 2014, J ALLERGY CLIN IMMUN, V131, P36; Szefler SJ, 2014, J ALLERGY CLIN IMMUN, V133, P654, DOI 10.1016/j.jaci.2014.01.012; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, P60, DOI 10.1016/j.jaci.2011.11.011; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V127, P102, DOI 10.1016/j.jaci.2010.11.018; Szefler SJ, 2010, J ALLERGY CLIN IMMUN, V125, P69, DOI 10.1016/j.jaci.2009.11.006	34	17	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2014	134	6					1238	1244		10.1016/j.jaci.2014.09.040	http://dx.doi.org/10.1016/j.jaci.2014.09.040			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	AW1UG	25482868				2022-12-18	WOS:000346075400003
J	Visentini, M; Marrapodi, R; Conti, V; Mitrevski, M; Camponeschi, A; Lazzeri, C; Carbonari, M; Catizone, A; Quinti, I; Fiorilli, M				Visentini, Marcella; Marrapodi, Ramona; Conti, Valentina; Mitrevski, Milica; Camponeschi, Alessandro; Lazzeri, Cristina; Carbonari, Maurizio; Catizone, Angela; Quinti, Isabella; Fiorilli, Massimo			Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Common variable immunodeficiency; B-cell receptor; extracellular signal-regulated kinase; endocytosis	ANTIGEN RECEPTOR; ANERGY; DEFECTS; DISSOCIATION; ACTIVATION; PATHWAYS; SUBSET; VAV	Background: Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by B-cell dysfunction and, in a subgroup, by expansion of CD21(low) B cells. The CD21(low) B cells display defects in early B-cell receptor (BCR) signaling resembling those of anergic B cells. Objective: We sought to investigate whether B cells from patients with CVID, like anergic B cells, have defects in extracellular signal-regulated kinase (ERK) phosphorylation and in endocytic trafficking of the BCR. Methods: Using flow cytometry, we evaluated phosphorylated ERK (pERK) expression and internalization of cross-linked BCR in B-cell subsets. The localization of internalized BCR to lysosome-associated membrane protein 1-positive late endosomes was evaluated with confocal microscopy. Results: Constitutive pERK levels were increased in naive and IgM(+) memory B cells of patients with CVID compared with those of healthy donors, whereas the pERK increment induced by BCR cross-linking was relatively reduced. Intravenous immunoglobulin administration enhanced these anomalies, but they appeared to be intrinsic toBcells from patients with CVID. Cross-linking-induced BCR endocytosis was decreased in the IgM(+) memory B cells, especially in thosewith a CD21 low phenotype, but not in the naive B cells of patients with CVID with CD21(low) expansion. Internalized BCR localized normally to late endosomes. Pharmacologic inhibition of ERK phosphorylation suppressed BCR endocytosis in B cells of healthy patients and those with CVID. Conclusions: The B cells of patients with CVID with CD21(low) B-cell expansion resemble anergic B cells based on high constitutive pERK expression. The IgM(+) memory B cells of these patients, especially those that are CD21(low), have a defect in BCR endocytosis seemingly caused by dysregulated ERK signaling.	[Visentini, Marcella; Marrapodi, Ramona; Mitrevski, Milica; Camponeschi, Alessandro; Lazzeri, Cristina; Carbonari, Maurizio; Fiorilli, Massimo] Univ Roma La Sapienza, Dept Clin Immunol, I-00185 Rome, Italy; [Conti, Valentina; Quinti, Isabella] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Catizone, Angela] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Fiorilli, M (corresponding author), Univ Roma La Sapienza, Dept Clin Immunol, Viale Univ 37, I-00185 Rome, Italy.	massimo.fiorilli@uniroma1.it	; VISENTINI, MARCELLA/K-4161-2016	FIORILLI, MASSIMO/0000-0002-2328-5710; catizone, angela/0000-0002-7836-9495; camponeschi, alessandro/0000-0002-6472-2438; Quinti, Isabella/0000-0002-3328-7584; VISENTINI, MARCELLA/0000-0002-4053-6091	Sapienza University of Rome; Institute Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome	Sapienza University of Rome; Institute Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome	Supported in part by Intramural Research grants from the Sapienza University of Rome (to I. Q. and to M. F.). M.V. was supported by a grant from Institute Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome.	Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Blery M, 2006, J EXP MED, V203, P1773, DOI 10.1084/jem.20060552; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Carsetti R, 2005, J ALLERGY CLIN IMMUN, V115, P412, DOI 10.1016/j.jaci.2004.10.048; Catizone A, 2012, MOL CELL ENDOCRINOL, V348, P135, DOI 10.1016/j.mce.2011.07.050; Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116; Cunningham-Rundles C, 2012, IMMUNOL RES, V54, P227, DOI 10.1007/s12026-012-8318-2; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Eibel H, 2010, CURR OPIN ALLERGY CL, V10, P526, DOI 10.1097/ACI.0b013e32833fea1c; Foerster C, 2010, J IMMUNOL, V184, P7305, DOI 10.4049/jimmunol.1000434; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; Harrison RE, 2004, J CELL SCI, V117, P2151, DOI 10.1242/jcs.00955; Holodick NE, 2009, MOL IMMUNOL, V46, P3029, DOI 10.1016/j.molimm.2009.06.011; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mockridge CI, 2007, BLOOD, V109, P4424, DOI 10.1182/blood-2006-11-056648; Muzio M, 2008, BLOOD, V112, P188, DOI 10.1182/blood-2007-09-111344; O'Neill SK, 2009, P NATL ACAD SCI USA, V106, P6262, DOI 10.1073/pnas.0812922106; Paccani SR, 2005, BLOOD, V106, P626, DOI 10.1182/blood-2004-05-2051; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Seite JF, 2014, J ALLERGY CLIN IMMUN, V133, P181, DOI 10.1016/j.jaci.2013.08.042; Seite JF, 2010, BLOOD, V116, P1698, DOI 10.1182/blood-2009-12-261461; Toapanta FR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00128; van de Ven AAJM, 2012, J ALLERGY CLIN IMMUN, V129, P755, DOI 10.1016/j.jaci.2011.10.020; van de Ven AAJM, 2011, CRIT REV IMMUNOL, V31, P85, DOI 10.1615/CritRevImmunol.v31.i2.10; Visentini M, 2012, EUR J IMMUNOL, V42, P1468, DOI 10.1002/eji.201142313; Visentini M, 2011, EUR J IMMUNOL, V41, P854, DOI 10.1002/eji.201040862; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Yu JE, 2012, J CLIN IMMUNOL, V32, P50, DOI 10.1007/s10875-011-9602-y	32	17	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2014	134	2					401	+		10.1016/j.jaci.2014.03.017	http://dx.doi.org/10.1016/j.jaci.2014.03.017			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GB	24792875				2022-12-18	WOS:000341370800021
J	Martin-Fontecha, M; Eiwegger, T; Jartti, T; Rueda-Zubiaurre, A; Tiringer, K; Stepanow, J; Puhakka, T; Ruckert, B; Ortega-Gutierrez, S; Lopez-Rodriguez, ML; Akdis, M; Akdis, CA; Palomares, O				Martin-Fontecha, Mar; Eiwegger, Thomas; Jartti, Tuomas; Rueda-Zubiaurre, Ainoa; Tiringer, Kerstin; Stepanow, Jefim; Puhakka, Tuomo; Rueckert, Beate; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.; Akdis, Muebeccel; Akdis, Cezmi A.; Palomares, Oscar			The expression of cannabinoid receptor 1 is significantly increased in atopic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HUMAN TONSILS; ALLERGEN; POLLEN; MATURATION; TOLERANCE; FRA-E-1		[Martin-Fontecha, Mar; Rueda-Zubiaurre, Ainoa; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.] Univ Complutense Madrid, Sch Chem, Dept Organ Chem, Madrid, Spain; [Eiwegger, Thomas; Tiringer, Kerstin; Stepanow, Jefim] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Jartti, Tuomas] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Puhakka, Tuomo] Turku Univ Hosp, Dept Otorhinolaryngol, FIN-20520 Turku, Finland; [Puhakka, Tuomo] Satakunta Cent Hosp, Dept Otorhinolaryngol, Pori, Finland; [Rueckert, Beate; Akdis, Muebeccel; Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Palomares, Oscar] Univ Complutense Madrid, Sch Chem, Dept Biochem & Mol Biol, Madrid, Spain	Complutense University of Madrid; Medical University of Vienna; University of Turku; University of Turku; Satakunta Central Hospital; Swiss Institute of Allergy & Asthma Research; University of Zurich; Complutense University of Madrid	Martin-Fontecha, M (corresponding author), Univ Complutense Madrid, Sch Chem, Dept Organ Chem, Madrid, Spain.	oscar.palomares@quim.ucm.es	Martin-Fontecha, Mar/D-3428-2014; Ortega-Gutierrez, Silvia/ABC-7653-2021; Ortega-Gutierrez, Silvia/I-1935-2017; Akdis, Cezmi/AAV-4844-2020; Lopez-Rodriguez, Maria L/S-6342-2016; Palomares, Oscar/ABG-5229-2020	Martin-Fontecha, Mar/0000-0002-4848-0109; Ortega-Gutierrez, Silvia/0000-0002-0257-6754; Akdis, Cezmi/0000-0001-8020-019X; Lopez-Rodriguez, Maria L/0000-0001-8607-1085; Palomares, Oscar/0000-0003-4516-0369; Eiwegger, Thomas/0000-0002-2914-7829				Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barderas R, 2006, ANN ALLERG ASTHMA IM, V96, P557, DOI 10.1016/S1081-1206(10)63550-8; Barderas R, 2005, J ALLERGY CLIN IMMUN, V115, P351, DOI 10.1016/j.jaci.2004.10.001; Barderas R, 2004, INT ARCH ALLERGY IMM, V135, P284, DOI 10.1159/000082321; Benedetti F, 2011, NAT MED, V17, P1228, DOI 10.1038/nm.2435; Braun A, 2011, IMMUNOBIOLOGY, V216, P466, DOI 10.1016/j.imbio.2010.09.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kucuksezer UC, 2013, J ALLERGY CLIN IMMUN, V131, P875, DOI 10.1016/j.jaci.2012.10.051; Martin-Couce L, 2012, ANGEW CHEM INT EDIT, V51, P6896, DOI 10.1002/anie.201200467; Mas S, 2012, FEBS J, V279, P4338, DOI 10.1111/febs.12024; Mimura T, 2012, LIFE SCI, V90, P862, DOI 10.1016/j.lfs.2012.04.005; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Pandey R, 2009, PHARMACOL RES, V60, P85, DOI 10.1016/j.phrs.2009.03.019; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rodriguez R, 2007, J INVEST ALLERG CLIN, V17, P4; Rodriguez R, 2001, INT ARCH ALLERGY IMM, V125, P185, DOI 10.1159/000053815; Sugawara K, 2013, J ALLERGY CLIN IMMUN, V132, P182, DOI 10.1016/j.jaci.2013.01.002; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129, P726, DOI 10.1016/j.jaci.2011.11.009; Wilkins MR, 1999, METH MOL B, V112, P531	19	17	17	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2014	133	3					926	+		10.1016/j.jaci.2013.12.1032	http://dx.doi.org/10.1016/j.jaci.2013.12.1032			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EK	24486070	Bronze			2022-12-18	WOS:000332397600051
J	Wu, AC; Himes, BE; Lasky-Su, J; Litonjua, A; Peters, SP; Lima, J; Kubo, M; Tamari, M; Nakamura, Y; Qiu, WL; Weiss, ST; Tantisira, K				Wu, Ann Chen; Himes, Blanca E.; Lasky-Su, Jessica; Litonjua, Augusto; Peters, Stephen P.; Lima, John; Kubo, Michiaki; Tamari, Mayumi; Nakamura, Yusuke; Qiu, Weiliang; Weiss, Scott T.; Tantisira, Kelan			Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmatics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; bronchodilator response; lung function; inhaled corticosteroids; single nucleotide polymorphisms; zinc finger proteins; ZNF432	GENOME-WIDE ASSOCIATION; MILD ASTHMA; RECEPTOR; AIRWAY; PHARMACOGENETICS; LUNG	Background: Single nucleotide polymorphisms (SNPs) influence a patient's response to inhaled corticosteroids and beta(2)-agonists, and the effect of treatment with inhaled corticosteroids is synergistic with the effect of beta(2)-agonists. We hypothesized that use of inhaled corticosteroids could influence the effect of SNPs associated with a bronchodilator response. Objective: To assess whether, among subjects with asthma, the association of SNPs with bronchodilator response is different between those treated with inhaled corticosteroids versus those on placebo. Methods: A genome-wide association analysis was conducted by using 581 white subjects from the Childhood Asthma Management Program. By using data for 449,540 SNPs, we conducted a gene by environment analysis in PLINK with inhaled corticosteroid treatment as the environmental exposure and bronchodilator response as the outcome measure. We attempted to replicate the top 12 SNPs in the Leukotriene Modifier or Corticosteroid or Corticosteroid-Salmeterol Trial. Results: The combined P value for the Childhood Asthma Management Program and Leukotriene Modifier or Corticosteroid or Corticosteroid-Salmeterol Trial populations was 4.8 x 10(-8) for rs3752120, which is located in the zinc finger protein gene ZNF432 and has an unknown function. Conclusions: Inhaled corticosteroids appear to modulate the association of bronchodilator response with variant(s) in the ZNF432 gene among adults and children with asthma.	[Wu, Ann Chen] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Ctr Child Hlth Care Studies, Boston, MA USA; [Wu, Ann Chen; Himes, Blanca E.; Lasky-Su, Jessica; Litonjua, Augusto; Qiu, Weiliang; Weiss, Scott T.; Tantisira, Kelan] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Wu, Ann Chen] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Himes, Blanca E.; Lasky-Su, Jessica; Litonjua, Augusto; Qiu, Weiliang; Weiss, Scott T.; Tantisira, Kelan] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Himes, Blanca E.; Lasky-Su, Jessica; Litonjua, Augusto; Qiu, Weiliang; Weiss, Scott T.; Tantisira, Kelan] Brigham & Womens Hosp, Dept Med, Ctr Genom Med, Boston, MA 02115 USA; [Peters, Stephen P.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Lima, John] Amer Lung Assoc Asthma Clin Res Ctr, Nemours Childrens Clin, Ctr Clin Pediat Pharmacol, Jacksonville, FL USA; [Lima, John] Amer Lung Assoc Asthma Clin Res Ctr, Nemours Childrens Clin, Ctr Pharmacogenet, Jacksonville, FL USA; [Kubo, Michiaki; Tamari, Mayumi] Riken Ctr Genom Med, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo 1138654, Japan	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Wake Forest University; RIKEN; University of Tokyo	Wu, AC (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	ann.wu@childrens.harvard.edu	Wu, Ann/AAY-4293-2020; Kubo, Michiaki/N-7947-2015; Tamari, Mayumi/N-5378-2015	Wu, Ann/0000-0003-0599-9063; Lasky-Su, Jessica/0000-0001-6236-4705; Qiu, Weiliang/0000-0002-9155-6957	National Heart, Lung, and Blood Institute, National Institutes of Health [K08 HL088046, U01 HL065899, U01 HL076419, U01 HL65899, P01 HL083069, T32 HL07427]; GlaxoSmithKline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL088046, R37HL066289, R00HL105663, R01HL076419, T32HL007427, U01HL065899] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GlaxoSmithKline(GlaxoSmithKline); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Heart, Lung, and Blood Institute, National Institutes of Health, via K08 HL088046 (PI: Wu), U01 HL065899 (PI: Weiss and Tantisira). The LOCCS trial was supported by GlaxoSmithKline (a monetary gift to the ALA-ACRC Data Coordination Center by providing drugs and appropriate placebos) whose employees played no role in the conduction of the trial or its data analysis or interpretation. All work on data collected from the CAMP Genetic Ancillary Study was conducted at Channing Laboratory of the Brigham and Women's Hospital under appropriate CAMP policies and human subject's protections. CAMP is supported by U01 HL076419, U01 HL65899, P01 HL083069, and T32 HL07427 from the National Heart, Lung, and Blood Institute, National Institutes of Health.	Adcock IM, 1996, EUR RESPIR J, V9, P160, DOI 10.1183/09031936.96.09010160; Aksoy MO, 2002, J ALLERGY CLIN IMMUN, V109, P491, DOI 10.1067/mai.2002.122154; Brieva JL, 2000, AM J RESP CRIT CARE, V161, P293, DOI 10.1164/ajrccm.161.1.9905068; Deng Y, 2010, BMB REP, V43, P193, DOI 10.5483/BMBRep.2010.43.3.193; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fisher R., 1950, STAT METHODS RES WOR; Himes BE, PLOS GENET, V8; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Jin Y, 2010, J ALLERGY CLIN IMMUN, V126, P618, DOI 10.1016/j.jaci.2010.06.007; Kitajima M, 2009, J IMMUNOL, V183, P5388, DOI 10.4049/jimmunol.0804155; Litonjua AA, 2008, AM J RESP CRIT CARE, V178, P688, DOI 10.1164/rccm.200709-1363OC; MAK JCW, 1995, AM J PHYSIOL-LUNG C, V268, pL41, DOI 10.1152/ajplung.1995.268.1.L41; Mendes ES, 2008, J ALLERGY CLIN IMMUN, V121, P700, DOI 10.1016/j.jaci.2007.10.038; Mougey EB, 2013, PHARMACOGENOMICS J, V13, P242, DOI 10.1038/tpj.2012.5; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Poon AH, 2008, PHARMACOGENET GENOM, V18, P373, DOI 10.1097/FPC.0b013e3282fa760a; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Silverman EK, 2003, J ALLERGY CLIN IMMUN, V112, P870, DOI 10.1016/S0091-6749(03)02023-2; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; Tantisira KG, 2005, HUM MOL GENET, V14, P1671, DOI 10.1093/hmg/ddi175	22	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2014	133	3					723	+		10.1016/j.jaci.2013.09.037	http://dx.doi.org/10.1016/j.jaci.2013.09.037			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EK	24280104	Green Published, Green Accepted			2022-12-18	WOS:000332397600013
J	Cabana, MD; Kunselman, SJ; Nyenhuis, SM; Wechsler, ME				Cabana, Michael D.; Kunselman, Susan J.; Nyenhuis, Sharmilee M.; Wechsler, Michael E.			Researching asthma across the ages: Insights from the National Heart, Lung, and Blood Institute's Asthma Network	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; clinical trials; study design; outcome measures; participant recruitment; pediatric consent; pediatric assent	SPUTUM INDUCTION; CHILD HEALTH; VITAMIN-D; SAFETY; SPIROMETRY; EXACERBATIONS; REPEATABILITY; FEASIBILITY; RECRUITMENT; CHALLENGES	Clinical asthma studies across different age groups (ie, cross-age studies) can potentially offer insight into the similarities, differences, and relationships between childhood and adult asthma. The National Institutes of Health's Asthma Research Network (AsthmaNet) is unique and innovative in that it has merged pediatric and adult asthma research into a single clinical research network. This combination enhances scientific exchange between pediatric and adult asthma investigators and encourages the application of cross-age studies that involve participants from multiple age groups who are generally not studied together. The experience from AsthmaNet in the development of cross-age protocols highlights some of the issues in the evaluation of cross-age research in asthma. The aim of this review is to summarize these challenges, including the selection of parallel cross-age clinical interventions, identification of appropriate controls, measurement of meaningful clinical outcomes, and various ethical and logistic issues.	[Cabana, Michael D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94118 USA; [Cabana, Michael D.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94118 USA; [Cabana, Michael D.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94118 USA; [Cabana, Michael D.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94118 USA; [Kunselman, Susan J.] Milton S Hershey Coll Med, Hershey, PA USA; [Nyenhuis, Sharmilee M.] Univ Illinois Hosp & Hlth Sci Syst, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Wechsler, Michael E.] Natl Jewish Hlth, Dept Med, Denver, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Jewish Health	Cabana, MD (corresponding author), Univ Calif San Francisco, Laurel Hts Campus,3333 Calif St,Suite 245, San Francisco, CA 94118 USA.	michael.cabana@ucsf.edu	Wechsler, Michael/AAC-5506-2019	Nyenhuis, Sharmilee/0000-0002-7381-9733	National Institutes of Health [HL098115, UL1 TR000004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098090, U10HL098102, U10HL098098, U10HL098115, U10HL098075, U10HL098096, U10HL098107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health (HL098115, UL1 TR000004).	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; [Anonymous], 3 NAT HEART LUNG BLO; Bailey W, 2008, CURR MED RES OPIN, V24, P1669, DOI 10.1185/03007990802119111; Baptist AP, 2011, J ASTHMA, V48, P824, DOI 10.3109/02770903.2011.608460; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Brown RW, 2012, J ALLERGY CLIN IMMUN, V130, P362, DOI 10.1016/j.jaci.2012.03.028; Busse WW, 2011, J ALLERGY CLIN IMMUN, V128, P740, DOI 10.1016/j.jaci.2011.08.014; Busse WW, 2009, J ALLERGY CLIN IMMUN, V124, P445, DOI 10.1016/j.jaci.2009.07.042; Centers for Disease Control and Prevention National Center for Health Statistics, 2001, GROWTH CHARTS; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Clark NM, 2009, PEDIATRICS, V123, pS185, DOI 10.1542/peds.2008-2233I; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Coffey MJ, 2004, PEDIATRICS, V113, P87, DOI 10.1542/peds.113.1.87; Cooper Michael, 2012, NY TIMES; Covar RA, 2006, J ALLERGY CLIN IMMUN, V117, P709, DOI 10.1016/j.jaci.2006.01.010; Covar RA, 2004, J ALLERGY CLIN IMMUN, V114, P575, DOI 10.1016/j.jaci.2004.06.036; Dahl R, 2006, RESP MED, V100, P1307, DOI 10.1016/j.rmed.2005.11.020; Desmond KJ, 1997, AM J RESP CRIT CARE, V156, P542, DOI 10.1164/ajrccm.156.2.9610116; Drotar D, 2004, AMBUL PEDIATR, V4, P353, DOI 10.1367/1539-4409(2004)4<353:MCHSQC>2.0.CO;2; Enright PL, 2000, CHEST, V118, P665, DOI 10.1378/chest.118.3.665; Flores G, 2002, JAMA-J AM MED ASSOC, V288, P82, DOI 10.1001/jama.288.1.82; Fritz GK, 2010, AM J RESP CRIT CARE, V182, P12, DOI 10.1164/rccm.200906-0836OC; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Gaffin JM, 2010, J ASTHMA, V47, P762, DOI 10.3109/02770903.2010.485664; Gibson PG, 2002, EUR RESPIR J, V20, p44S, DOI 10.1183/09031936.02.00004402; Hausner E, 2008, DRUG SAFETY, V31, P1083, DOI 10.2165/0002018-200831120-00005; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Howie SRC, 2011, B WORLD HEALTH ORGAN, V89, P46, DOI 10.2471/BLT.10.080010; Hulley S., 2013, DESIGNING CLIN RES E; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Janson C, 2004, J ASTHMA, V41, P49, DOI 10.1081/JAS-120024593; Jones PD, 2001, AM J RESP CRIT CARE, V164, P1146, DOI 10.1164/ajrccm.164.7.2103015; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; KOHRMAN A, 1995, PEDIATRICS, V95, P314; Krishnan JA, 2012, J ALLERGY CLIN IMMUN, V129, pS124, DOI 10.1016/j.jaci.2011.12.981; Lack JA, 1997, BRIT J ANAESTH, V78, P601, DOI 10.1093/bja/78.5.601; Lex C, 2005, PEDIATR PULM, V39, P318, DOI 10.1002/ppul.20159; Li AM, 2006, PEDIATR PULM, V41, P720, DOI 10.1002/ppul.20371; Loeb JS, 2008, PEDIATR PULM, V43, P1020, DOI 10.1002/ppul.20908; Martin RJ, 2002, AM J RESP CRIT CARE, V165, P1377, DOI 10.1164/rccm.2105013; Martin RJ, 1997, CHEST, V112, P53, DOI 10.1378/chest.112.1.53; Miller FG, 2002, ARCH INTERN MED, V162, P1673, DOI 10.1001/archinte.162.15.1673; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Institutes of Health, REQ APPL RFA NUMB RF; O'Connor A, 2013, J ADV NURS; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Olson LM, 2007, PEDIATRICS, V119, pE93, DOI 10.1542/peds.2005-3211; Quizon A, 2010, CURR OPIN PHARMACOL, V10, P272, DOI 10.1016/j.coph.2010.04.012; Riley AW, 2004, AMBUL PEDIATR, V4, P371, DOI 10.1367/A03-178R.1; Shaddy RE, 2010, PEDIATRICS, V125, P850, DOI 10.1542/peds.2010-0082; Sorkness CA, 2001, CONTROL CLIN TRIALS, V22, p222S, DOI 10.1016/S0197-2456(01)00172-6; Sutherland ER, 2014, J ALLERGY CLIN IMMUN, V133, P34, DOI 10.1016/j.jaci.2013.10.025; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P730, DOI 10.1067/mai.2002.122712; Szefler SJ, 2014, J ALLERGY CLIN IMMUN, V133, P3, DOI 10.1016/j.jaci.2013.10.018; Szefler SJ, 2013, J ALLERGY CLIN IMMUN, V131, P36, DOI 10.1016/j.jaci.2012.11.009; Thomas Mike, 2009, Prim Care Respir J, V18, P83, DOI 10.3132/pcrj.2008.00045; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Weiss ST, 2012, J ALLERGY CLIN IMMUN, V129, P327, DOI 10.1016/j.jaci.2011.12.971; Wilson NM, 2000, THORAX, V55, P768, DOI 10.1136/thorax.55.9.768; Wilson SR, 2012, J ALLERGY CLIN IMMUN, V129, pS88, DOI 10.1016/j.jaci.2011.12.988; Wood PR, 2007, J ALLERGY CLIN IMMUN, V120, P1368, DOI 10.1016/j.jaci.2007.09.025; World Medical Association, DECL HELS ETH PRINC; Yancey AK, 2006, ANNU REV PUBL HEALTH, V27, P1, DOI 10.1146/annurev.publhealth.27.021405.102113; Yoon EY, 2006, CLIN PEDIATR, V45, P75, DOI 10.1177/000992280604500112	64	17	17	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					27	33		10.1016/j.jaci.2013.10.026	http://dx.doi.org/10.1016/j.jaci.2013.10.026			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	24369796	Green Submitted, Green Accepted			2022-12-18	WOS:000329105700003
J	Henmyr, V; Vandeplas, G; Hallden, C; Sall, T; Olze, H; Bachert, C; Cardell, LO				Henmyr, Viktor; Vandeplas, Griet; Hallden, Christer; Sall, Torbjorn; Olze, Heidi; Bachert, Claus; Cardell, Lars Olaf			Replication study of genetic variants associated with chronic rhinosinusitis and nasal polyposis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Henmyr, Viktor; Bachert, Claus; Cardell, Lars Olaf] Karolinska Inst, CLINTEC, Div ENT Dis, Huddinge, Sweden; [Henmyr, Viktor; Hallden, Christer] Kristianstad Univ, Sect Biomed, Kristianstad, Sweden; [Vandeplas, Griet; Bachert, Claus] Univ Hosp Ghent, Upper Airways Res Lab, Ghent, Belgium; [Sall, Torbjorn] Lund Univ, Dept Biol, Lund, Sweden; [Olze, Heidi] Charite, ENT Dept, Berlin, Germany	Karolinska Institutet; Kristianstad University; Ghent University; Ghent University Hospital; Lund University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Henmyr, V (corresponding author), Karolinska Inst, CLINTEC, Div ENT Dis, Huddinge, Sweden.	lars-olaf.cardell@ki.se	Bachert, Claus/J-8825-2012	Olze, Heidi/0000-0001-9987-6392				Barnes KC, 2006, J ALLERGY CLIN IMMUN, V118, P70, DOI 10.1016/j.jaci.2006.03.036; Bosse Y, 2009, HUM GENET, V125, P305, DOI 10.1007/s00439-009-0626-9; Fokkens W, 2007, RHINOLOGY, P1; Hsu J, 2013, J ALLERGY CLIN IMMUN, V131, P977, DOI 10.1016/j.jaci.2013.01.028; Kim SH, 2007, RESP MED, V101, P490, DOI 10.1016/j.rmed.2006.07.002; Nilsson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053975; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039247; Zhang Y, 2011, AM J RHINOL ALLERGY, V25, pE49, DOI 10.2500/ajra.2011.25.3588; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	10	17	19	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					273	275		10.1016/j.jaci.2013.08.011	http://dx.doi.org/10.1016/j.jaci.2013.08.011			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	24074519				2022-12-18	WOS:000329105700041
J	Marcon, A; Cerveri, I; Wjst, M; Anto, J; Heinrich, J; Janson, C; Jarvis, D; Leynaert, B; Probst-Hensch, N; Svanes, C; Toren, K; Burney, P; de Marco, R				Marcon, Alessandro; Cerveri, Isa; Wjst, Matthias; Anto, Josep; Heinrich, Joachim; Janson, Christer; Jarvis, Deborah; Leynaert, Benedicte; Probst-Hensch, Nicole; Svanes, Cecilie; Toren, Kjell; Burney, Peter; de Marco, Roberto			Can an airway challenge test predict respiratory diseases? A population-based international study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Airway hyperresponsiveness; airflow obstruction; allergic rhinitis; asthma; European Community Respiratory Health Survey; chronic obstructive pulmonary disease	OBSTRUCTIVE PULMONARY-DISEASE; DOSE-RESPONSE CURVES; BRONCHIAL HYPERRESPONSIVENESS; RISK-FACTORS; ASTHMA; HISTAMINE; RESPONSIVENESS; DISTINCTION; ADULTS; DEFINITION	Background: Evidence on the longitudinal association of airway responsiveness with respiratory diseases is scarce. The best indicator of responsiveness is still undetermined. Objective: We investigated the association of airway responsiveness with the incidence of asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. Methods: We studied 3851 subjects who underwent spirometry and methacholine challenge tests both at baseline (1991-1993), when they were 20 to 44 years old, and at follow-up (1999-2002) in the European Community Respiratory Health Survey. Airway responsiveness was defined based on the methacholine dose-response slope on both occasions. Incidence rate ratios for the association of airway responsiveness with disease occurrence were computed by using Poisson regression. Results: With respect to reference (slope of the fourth quintile or greater), subjects with the greatest degree of airway responsiveness (slope less than the first quintile) showed the greatest risk of developing asthma, COPD, and allergic rhinitis (incidence rate ratios of 10.82, 5.53, and 4.84, respectively; all P < .01). A low slope predicted disease occurrence, even in subjects who did not reach a 20% decrease in FEV1 at the cumulative dose of 1 mg of methacholine (PD20 > 1 mg). A decrease in slope over time was an independent predictor of disease risk. Conclusion: Airway responsiveness predicted new-onset asthma, COPD, and allergic rhinitis. Our study supports the use of a continuous noncensored indicator of airway responsiveness, such as the slope of the methacholine dose-response curve, in clinical practice and research because it showed clear advantages over PD20.	[Marcon, Alessandro; de Marco, Roberto] Univ Verona, Unit Epidemiol & Med Stat, Dept Publ Hlth & Community Med, I-37134 Verona, Italy; [Cerveri, Isa] Univ Pavia, Ist Ricovero & Cura Carattere Sci, San Matteo Hosp Fdn, I-27100 Pavia, Italy; [Wjst, Matthias] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Muenchen, Comprehens Pneumol Ctr, Inst Lung Biol & Dis iLBD, Munich, Germany; [Wjst, Matthias] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Anto, Josep] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Anto, Josep] IMIM Hosp del Mar Med Res Inst, Barcelona, Spain; [Anto, Josep] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Anto, Josep] CIBER Epidemiol & Salud Publ CIBERES, Barcelona, Spain; [Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Munich, Germany; [Janson, Christer] Uppsala Univ, Akad Sjukhuset, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Jarvis, Deborah; Burney, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol & Publ Hlth Grp, London, England; [Leynaert, Benedicte] Fac Paris Diderot, Inst Natl Sante & Rech Med, Epidemiol U700, Paris, France; [Probst-Hensch, Nicole] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Probst-Hensch, Nicole] Univ Basel, CH-4003 Basel, Switzerland; [Svanes, Cecilie] Univ Bergen, Inst Med, Bergen Resp Res Grp, N-5020 Bergen, Norway; [Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, N-5021 Bergen, Norway; [Toren, Kjell] Gothenburg Univ, Sahlgrenska Acad, Sect Occupat & Environm Med, S-41124 Gothenburg, Sweden	University of Verona; University of Pavia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; Uppsala University Hospital; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Bergen; University of Bergen; Haukeland University Hospital; University of Gothenburg	Marcon, A (corresponding author), Univ Verona, Unit Epidemiol & Med Stat, Dept Publ Hlth & Community Med, Inst Biol 2, Str Le Grazie 8, I-37134 Verona, Italy.	alessandro.marcon@univr.it	Heinrich, Joachim/N-1720-2013; de Marco, Roberto/A-5470-2008; Leynaert, Benedicte/N-5251-2018; Marcon, Alessandro/C-3349-2012; Svanes, Cecilie/N-7556-2017; Anto, J M/H-2676-2014	Heinrich, Joachim/0000-0002-9620-1629; Marcon, Alessandro/0000-0002-2778-658X; Svanes, Cecilie/0000-0001-8512-5192; Anto, J M/0000-0002-4736-8529; Cerveri, Isa/0000-0003-0337-043X; Leynaert, Benedicte/0000-0001-5045-2492; Jarvis, Deborah/0000-0002-1753-3896; Burney, Peter/0000-0001-8635-5678	European Commission as part of their Quality of Life program	European Commission as part of their Quality of Life program	Supported by the European Commission as part of their Quality of Life program. The funding organization had no role in the design of the study; the collection, analysis, and interpretation of data; and the decision to approve publication of the finished manuscript.	ABRAMSON MJ, 1990, THORAX, V45, P924, DOI 10.1136/thx.45.12.924; Anderson SD, 2010, CHEST, V138, p25S, DOI 10.1378/chest.10-0116; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2011, GLOB STRAT ASTHM MAN; Anto JM, 2010, ALLERGY, V65, P1021, DOI 10.1111/j.1398-9995.2009.02301.x; Bakke PS, 2011, EUR RESPIR J, V38, P1261, DOI 10.1183/09031936.00193809; BEAUPRE A, 1981, THORAX, V36, P731, DOI 10.1136/thx.36.10.731; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Cerveri I, 2008, THORAX, V63, P1040, DOI 10.1136/thx.2008.095554; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; CHINN S, 1993, EUR RESPIR J, V6, P670; Chinn S, 1997, EUR RESPIR J, V10, P452, DOI 10.1183/09031936.97.10020452; Chinn S, 1997, EUR RESPIR J, V10, P2495, DOI 10.1183/09031936.97.10112495; Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012; de Marco R, 1998, EUR RESPIR J, V11, P599; de Marco R, 1998, ALLERGY, V53, P673; de Marco R, 2008, THORAX, V63, P756, DOI 10.1136/thx.2008.099895; de Marco R, 2011, AM J RESP CRIT CARE, V184, P486, DOI 10.1164/ajrccm.184.4.486a; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; de Marco R, 2009, AM J RESP CRIT CARE, V180, P956, DOI 10.1164/rccm.200904-0543OC; Guder G, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-13; Guerra S, 2005, CURR OPIN PULM MED, V11, P7; Hospers JJ, 2000, LANCET, V356, P1313, DOI 10.1016/S0140-6736(00)02815-4; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Koh YY, 1998, J ALLERGY CLIN IMMUN, V102, P921, DOI 10.1016/S0091-6749(98)70329-X; Kuster SP, 2008, EUR RESPIR J, V31, P860, DOI 10.1183/09031936.00091407; Leynaert B, 1999, J ALLERGY CLIN IMMUN, V104, P301, DOI 10.1016/S0091-6749(99)70370-2; Lotvall J, 1998, THORAX, V53, P419, DOI 10.1136/thx.53.5.419; Montnemery P, 2001, EUR RESPIR J, V17, P596, DOI 10.1183/09031936.01.17405960; OCONNOR G, 1987, AM REV RESPIR DIS, V136, P1412, DOI 10.1164/ajrccm/136.6.1412; OREHEK J, 1977, AM REV RESPIR DIS, V115, P937; Polosa R, 2000, EUR RESPIR J, V15, P30, DOI 10.1034/j.1399-3003.2000.15a07.x; Rasmussen F, 2002, PEDIATR PULM, V34, P164, DOI 10.1002/ppul.10155; Riiser A, 2012, RESP MED, V106, P215, DOI 10.1016/j.rmed.2011.09.013; RIJCKEN B, 1993, AM REV RESPIR DIS, V148, P944, DOI 10.1164/ajrccm/148.4_Pt_1.944; Scichilone N, 2005, EUR RESPIR J, V25, P364, DOI 10.1183/09031936.05.00080204; Shaaban R, 2007, AM J RESP CRIT CARE, V176, P659, DOI 10.1164/rccm.200703-427OC; STERK PJ, 1989, EUR RESPIR J, V2, P267; Togias A, 2000, J ALLERGY CLIN IMMUN, V105, pS599, DOI 10.1067/mai.2000.106885; van den Berge M, 2012, EUR RESPIR J, V40, P1098, DOI 10.1183/09031936.00169711; Vestbo J, 2006, THORAX, V61, P86, DOI 10.1136/thx.2005.046227	42	17	19	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					104	+		10.1016/j.jaci.2013.03.040	http://dx.doi.org/10.1016/j.jaci.2013.03.040			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	23683511	Bronze			2022-12-18	WOS:000329105700014
J	Pacheco, K; Barker, L; Maier, L; Erb, S; Sills, M; Knight, V				Pacheco, Karin; Barker, Lisa; Maier, Lisa; Erb, Samantha; Sills, Michael; Knight, Vijaya			Development of a validated blood test for nickel sensitization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							T-CELLS		[Pacheco, Karin; Barker, Lisa; Maier, Lisa; Erb, Samantha] Natl Jewish Hlth, Div Environm & Occupat Hlth Sci, Denver, CO USA; [Knight, Vijaya] Natl Jewish Hlth, Div Pathol, Denver, CO USA; [Pacheco, Karin; Maier, Lisa] Univ Colorado, Colorado Sch Publ Hlth, Denver, CO 80202 USA; [Maier, Lisa] Univ Colorado, Sch Med, Denver, CO USA; [Sills, Michael; Knight, Vijaya] Natl Jewish Hlth, Adv Diagnost Labs, Denver, CO USA	National Jewish Health; National Jewish Health; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Pacheco, K (corresponding author), Natl Jewish Hlth, Div Environm & Occupat Hlth Sci, Denver, CO USA.	pachecok@njhealth.org	Maier, Lisa/AAA-4378-2020					Andrews RE, 2011, BONE, V49, P717, DOI 10.1016/j.bone.2011.06.007; Budinger L, 2001, J IMMUNOL, V167, P6038, DOI 10.4049/jimmunol.167.10.6038; Cederbrant K, 2003, INT ARCH ALLERGY IMM, V132, P373, DOI 10.1159/000074905; Fontenot AP, 2002, J IMMUNOL, V168, P3627, DOI 10.4049/jimmunol.168.7.3627; Fransway AF, 2013, DERMATITIS, V24, P10, DOI 10.1097/DER.0b013e318277ca50; Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017; MROZ MM, 1991, J ALLERGY CLIN IMMUN, V88, P54, DOI 10.1016/0091-6749(91)90300-D; Thomas P, 2009, ALLERGY, V64, P1157, DOI 10.1111/j.1398-9995.2009.01966.x; Werfel T, 1997, J IMMUNOL, V158, P2500	9	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2013	132	3					767	769		10.1016/j.jaci.2013.03.023	http://dx.doi.org/10.1016/j.jaci.2013.03.023			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	207OS	23672782				2022-12-18	WOS:000323612000039
J	Tacke, CE; Smits, GP; van der Klis, FRM; Kuipers, IM; Zaaijer, HL; Kuijpers, TW				Tacke, Carline E.; Smits, Gaby. P.; van der Klis, Fiona R. M.; Kuipers, Irene M.; Zaaijer, Hans L.; Kuijpers, Taco W.			Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTIBODY; IMMUNOASSAY		[Tacke, Carline E.; Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Smits, Gaby. P.; van der Klis, Fiona R. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [Kuipers, Irene M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Zaaijer, Hans L.] Univ Amsterdam, Acad Med Ctr, Dept Clin Virol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Tacke, CE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat Hematol Immunol & Infect Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.e.tacke@amc.uva.nl						ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4; Andrews N, 2000, EPIDEMIOL INFECT, V125, P127, DOI 10.1017/S0950268899004173; Kuijpers TW, 1999, J INFECT DIS, V180, P1869, DOI 10.1086/315111; RUDERMAN JW, 1991, AM J DIS CHILD, V145, P425; SIBER GR, 1993, J PEDIATR-US, V122, P204, DOI 10.1016/S0022-3476(06)80114-9; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; Smits GP, 2012, CLIN VACCINE IMMUNOL, V19, P396, DOI 10.1128/CVI.05537-11; Sonobe T., 1994, SHONI NAIKA, V26, P1929; van der Klis FRM, 2009, NETH J MED, V67, P301	9	17	19	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2013	131	6					1701	1703		10.1016/j.jaci.2013.01.045	http://dx.doi.org/10.1016/j.jaci.2013.01.045			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	166CT	23498596				2022-12-18	WOS:000320532800034
J	Leisten, S; Oyoshi, MK; Galand, C; Hornick, JL; Gurish, MF; Geha, RS				Leisten, Sabine; Oyoshi, Michiko K.; Galand, Claire; Hornick, Jason L.; Gurish, Michael F.; Geha, Raif S.			Development of skin lesions in filaggrin-deficient mice is dependent on adaptive immunity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ATOPIC-DERMATITIS; CELLS		[Leisten, Sabine; Oyoshi, Michiko K.; Galand, Claire; Geha, Raif S.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Leisten, Sabine] Univ Hamburg, Dept Biol, Hamburg, Germany; [Galand, Claire] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gurish, Michael F.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; University of Hamburg; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Leisten, S (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA USA.	raif.geha@childrens.harvard.edu		Galand, Claire/0000-0001-8005-4831; Hornick, Jason/0000-0001-6475-8345	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047417] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR047417] Funding Source: Medline; PHS HHS [HHSN272201000020C] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Woodward AL, 2001, J ALLERGY CLIN IMMUN, V107, P359, DOI 10.1067/mai.2001.112695; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503	9	17	19	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1247	+		10.1016/j.jaci.2012.12.1576	http://dx.doi.org/10.1016/j.jaci.2012.12.1576			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23540619				2022-12-18	WOS:000317187200043
J	Lang, PA; Shaabani, N; Borkens, S; Honke, N; Scheu, S; Booth, S; Brenner, D; Meryk, A; Barthuber, C; Recher, M; Mak, TW; Ohashi, PS; Haussinger, D; Griffiths, GM; Thrasher, AJ; Bouma, G; Lang, KS				Lang, Philipp A.; Shaabani, Namir; Borkens, Stephanie; Honke, Nadine; Scheu, Stefanie; Booth, Sarah; Brenner, Dirk; Meryk, Andreas; Barthuber, Carmen; Recher, Mike; Mak, Tak W.; Ohashi, Pamela S.; Haeussinger, Dieter; Griffiths, Gillian M.; Thrasher, Adrian J.; Bouma, Gerben; Lang, Karl S.			Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Type I interferon; dendritic cells; CD8 T cells; virus; Wiskott-Aldrich syndrome protein; Wiskott-Aldrich syndrome; diabetes	LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CD8 T-CELLS; HEPATITIS-C VIRUS; SYNAPSE FORMATION; WASP; ACTIVATION; EXPRESSION; INFECTION; MICE; CYTOTOXICITY	Background: Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency caused by absence of Wiskott-Aldrich syndrome protein (WASP) expression, resulting in defective function of many immune cell lineages and susceptibility to severe bacterial, viral, and fungal infections. Despite a significant proportion of patients with WAS having recurrent viral infections, surprisingly little is known about the effects of WASP deficiency on antiviral immunity. Objective: We sought to evaluate the antiviral immune response in patients with WASP deficiency in vivo. Methods: Viral clearance and associated immunopathology were measured after infection of WASP-deficient (WAS KO) mice with lymphocytic choriomeningitis virus (LCMV). Induction of antiviral CD8(+) T-cell immunity and cytotoxicity was documented in WAS KO mice by means of temporal enumeration of total and antigen-specific T-cell numbers. Type I interferon (IFN-I) production was measured in serum in response to LCMV challenge and characterized in vivo by using IFN-I reporter mice crossed with WAS KO mice. Results: WAS KO mice showed reduced viral clearance and enhanced immunopathology during LCMV infection. This was attributed to both an intrinsic CD8(+) T-cell defect and defective priming of CD8(+) T cells by dendritic cells (DCs). IFN-I production by WAS KODCs was reduced both in vivo and in vitro. Conclusions: These studies use a well-characterized model of persistence-prone viral infection to reveal a critical deficiency of CD8(+) T-cell responses in murine WASP deficiency, in which abrogated production of IFN-I by DCs might play an important contributory role. These findings might help us to understand the immunodeficiency of WAS. (J Allergy Clin Immunol 2013;131:815-24.)	[Lang, Philipp A.; Brenner, Dirk; Mak, Tak W.; Ohashi, Pamela S.] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada; [Lang, Philipp A.; Shaabani, Namir; Honke, Nadine; Meryk, Andreas; Haeussinger, Dieter; Lang, Karl S.] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Borkens, Stephanie; Scheu, Stefanie] Univ Dusseldorf, Inst Med Microbiol, Dusseldorf, Germany; [Borkens, Stephanie; Scheu, Stefanie] Univ Dusseldorf, Hosp Hyg, Dusseldorf, Germany; [Barthuber, Carmen] Univ Dusseldorf, Dept Lab Med, Dusseldorf, Germany; [Shaabani, Namir; Honke, Nadine; Meryk, Andreas; Lang, Karl S.] Univ Essen Gesamthsch, Inst Immunol, Essen, Germany; [Booth, Sarah; Griffiths, Gillian M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Recher, Mike] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Thrasher, Adrian J.; Bouma, Gerben] Univ London, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England; [Thrasher, Adrian J.] Great Ormond St Hosp NHS Fdn Trust, London, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of Oxford; University of Basel; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Bouma, G (corresponding author), Univ London, Inst Child Hlth, Mol Immunol Unit, 30 Guilford St, London WC1N 1EH, England.	g.bouma@ucl.ac.uk	Meryk, Andreas/AAH-5566-2021; Scheu, Stefanie/H-3670-2019; Lang, Karl S/R-2505-2016	Scheu, Stefanie/0000-0002-9707-8191; Thrasher, Adrian/0000-0002-6097-6115; Ohashi, Pamela S./0000-0003-2915-9317; Recher, Mike/0000-0002-9121-6936; Griffiths, Gillian/0000-0003-0434-5842; Bouma, Gerben/0000-0002-1465-9178; Brenner, Dirk/0000-0001-8979-1045; Lang, Karl/0000-0001-9783-7605; Meryk, Andreas/0000-0002-7749-5334; Honke, Nadine/0000-0002-2220-6806	Swiss National Science Foundation [3100A0-100779, 3100A0-100068]; Sonderforschungsbereich [SFB575, SFB974]; Deutsche Forschungsgemeinschaft [SCHE692/3-1, LA1419/3-1]; MOI graduate school (Jurgen Manchot Stiftung); Great Ormond Street Hospital Childrens Charity; Wellcome Trust [057965/Z/99/B, 075880]; European Commission [IEF 040855]; Canadian Institute of Health Research [FRN79434]; Alexander von Humboldt Foundation; German Research Foundation (DFG); Swiss National Science Foundation; Canadian Institutes of Health Research; Terry Fox Foundation; CIHR and Genome Canada; National Institute for Health Research [NF-SI-0611-10001] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1223, V1259] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sonderforschungsbereich(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MOI graduate school (Jurgen Manchot Stiftung); Great Ormond Street Hospital Childrens Charity; Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; CIHR and Genome Canada(Canadian Institutes of Health Research (CIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity	Supported by grants from the Swiss National Science Foundation (3100A0-100779 and 3100A0-100068), the Sonderforschungsbereich (SFB575 and SFB974), the Deutsche Forschungsgemeinschaft (SS, SCHE692/3-1 and LA1419/3-1), the MOI graduate school (Jurgen Manchot Stiftung), the Great Ormond Street Hospital Childrens Charity (to A.J.T.), the Wellcome Trust (057965/Z/99/B to A.J.T. and G.B. and 075880 to G.M.G.), the European Commission (Marie Curie IEF 040855 to G.B.), the Canadian Institute of Health Research (FRN79434 to P.S.O.), and the Alexander von Humboldt Foundation (Sofja Kovalevskaja award to K.S.L. and Feodor Lynen award to D.B.). P.S.O. holds a Canada Research Chair in Autoimmunity and Tumor Immunity, and A.J.T. is an NIHR Senior Investigator.; Disclosure of potential conflict of interest: S. Scheu has received research support from the German Research Foundation (DFG). M. Recher has received grants from the Swiss National Science Foundation. T. W. Mak has received grants from the Canadian Institutes of Health Research and the Terry Fox Foundation. P. S. Ohashi has received research support from CIHR and Genome Canada, is employed by the University Health Network, and has received lecture fees from Drexel University. A. J. Thrasher has received research support from the Wellcome Trust. G. Bouma has received research support from the Wellcome Trust and European Commission and received travel expenses from UCL. The rest of the authors declare they have no relevant conflicts of interest.	Adriani M, 2007, CLIN IMMUNOL, V124, P41, DOI 10.1016/j.clim.2007.02.001; Andreansky S, 2005, EXP HEMATOL, V33, P443, DOI 10.1016/j.exphem.2004.12.006; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Astrakhan A, 2009, J IMMUNOL, V182, P7370, DOI 10.4049/jimmunol.0804256; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Bouma G, 2007, BLOOD, V110, P4278, DOI 10.1182/blood-2007-06-096875; Bouma G, 2011, BLOOD, V118, P2492, DOI 10.1182/blood-2011-03-340265; Bouma G, 2009, IMMUNOBIOLOGY, V214, P778, DOI 10.1016/j.imbio.2009.06.009; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Catucci M, 2011, GENE THER; De Meester J, 2010, J LEUKOCYTE BIOL, V88, P1031, DOI 10.1189/jlb.0410197; de Noronha S, 2005, BLOOD, V105, P1590, DOI 10.1182/blood-2004-06-2332; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; FERRANTINI M, 1994, J IMMUNOL, V153, P4604; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; HENRIQUEZ NV, 1994, J IMMUNOL, V153, P395; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lang PA, 2009, BLOOD, V113, P1045, DOI 10.1182/blood-2007-10-117861; Leverrier Y, 2001, J IMMUNOL, V166, P4831, DOI 10.4049/jimmunol.166.8.4831; Locci M, 2009, J EXP MED, V206, P735, DOI 10.1084/jem.20081773; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Meyer-Bahlburg A, 2008, BLOOD, V112, P4158, DOI 10.1182/blood-2008-02-140814; MOLINA IJ, 1993, J IMMUNOL, V151, P4383; Montoya M, 2005, J IMMUNOL, V174, P1851, DOI 10.4049/jimmunol.174.4.1851; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Orange JS, 2002, P NATL ACAD SCI USA, V99, P11351, DOI 10.1073/pnas.162376099; Pulecio J, 2008, J IMMUNOL, V181, P1135, DOI 10.4049/jimmunol.181.2.1135; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Smit JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001720; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Strom TS, 2003, BLOOD, V102, P3108, DOI 10.1182/blood-2002-11-3489; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Westerberg L, 2005, BLOOD, V105, P1144, DOI 10.1182/blood-2004-03-1003; Westerberg LS, 2008, BLOOD, V112, P4139, DOI 10.1182/blood-2008-02-140715; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075; ZINKERNAGEL RM, 1985, J EXP MED, V162, P2125, DOI 10.1084/jem.162.6.2125	58	17	18	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2013	131	3					815	+		10.1016/j.jaci.2012.08.050	http://dx.doi.org/10.1016/j.jaci.2012.08.050			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	098ZM	23141740	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000315587800025
J	Donohue, KM; Hoffman, EA; Baumhauer, H; Guo, JF; Ahmed, FS; Lovasi, GS; Jacobs, DR; Enright, P; Barr, RG				Donohue, Kathleen M.; Hoffman, Eric A.; Baumhauer, Heather; Guo, Junfeng; Ahmed, Firas S.; Lovasi, Gina S.; Jacobs, David R., Jr.; Enright, Paul; Barr, R. Graham			Asthma and lung structure on computed tomography: The Multi-Ethnic Study of Atherosclerosis Lung Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Airway remodeling; airway structure; asthma; emphysema; epidemiology	OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY WALL THICKNESS; FLOW OBSTRUCTION; MULTIDETECTOR CT; REFERENCE VALUES; MESA LUNG; COPD; DIMENSIONS; EMPHYSEMA; STANDARDIZATION	Background: The potential consequences of asthma in childhood and young adulthood on lung structure in older adults have not been studied in a large, population-based cohort. Objective: The authors hypothesized that a history of asthma onset in childhood (age 18 years or before) or young adulthood (age 19-45 years) was associated with altered lung structure on computed tomography in later life. Methods: The Multi-Ethnic Study of Atherosclerosis Lung Study recruited 3965 participants and assessed asthma history by using standardized questionnaires, guideline-based spirometry, and segmental airway dimensions and percentage of low attenuation area (%LAA) on computed tomographic scans. Results: Asthma with onset in childhood and young adulthood was associated with large decrements in FEV1 among participants with a mean age of 66 years (-365 mL and -343 mL, respectively; P<.001). Asthma with onset in childhood and young adulthood was associated with increased mean airway wall thickness standardized to an internal perimeter of 10 mm (0.1 mm, P<.001 for both), predominantly from narrower segmental airway lumens (-0.39 mm and -0.34 mm, respectively; P<.001). Asthma with onset in childhood and young adulthood also was associated with a greater %LAA (1.69% and 4.30%, respectively; P<.001). Findings were similar among never smokers, except that differential %LAA in childhood-onset asthma were not seen in them. Conclusion: Asthma with onset in childhood or young adulthood was associated with reduced lung function, narrower airways, and among asthmatic patients who smoked, greater %LAA in later life. (J Allergy Clin Immunol 2013;131:361-8.)	[Donohue, Kathleen M.; Ahmed, Firas S.; Lovasi, Gina S.; Barr, R. Graham] Columbia Univ, New York, NY 10032 USA; [Hoffman, Eric A.; Baumhauer, Heather; Guo, Junfeng] Univ Iowa, Iowa City, IA USA; [Jacobs, David R., Jr.] Univ Minnesota, Minneapolis, MN USA; [Enright, Paul] Univ Arizona, Tucson, AZ USA	Columbia University; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities; University of Arizona	Barr, RG (corresponding author), Columbia Univ, Med Ctr, 630 W 168th St,PH 9 E,Room 105, New York, NY 10032 USA.	rgb9@columbia.edu	Lovasi, Gina/C-2781-2009	Lovasi, Gina/0000-0003-2613-9599; Hoffman, Eric/0000-0001-8456-9437; Jacobs, David/0000-0002-7232-0543	National Institutes of Health [R01 HL077612, R01 HL075476, RC1 HL100543, N01-HC95159-169]; National Institutes of Health (NIH); Alpha One Foundation; NIH; University of Iowa; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075476, RC1HL100543, R01HL077612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha One Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health grants R01 HL077612, R01 HL075476, RC1 HL100543, and N01-HC95159-169. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; K. M. Donohue has received grants from the National Institutes of Health (NIH) and the Alpha One Foundation, has received travel support from the NIH, and is employed by Columbia University. E. A. Hoffman has received grants from the NIH and is a founder and shareholder of VIDA Diagnostics, a company commercializing lung image analysis software developed, in part, at the University of Iowa. H. Baumhauer has received grants and travel support from the University of Iowa. J. Guo has received grants from the NIH and is a shareholder in VIDA Diagnostics. D. R. Jacobs and P. Enright have received grants from the NIH. R. G. Barr has received grants from the NIH, has received royalties from UpToDate, and has received travel support from Boehringer Ingelheim. The rest of the authors declare that they have no relevant conflicts of interest.	[Anonymous], 2008, MESA MAN OP FIELD CT; Awadh N, 1998, THORAX, V53, P248, DOI 10.1136/thx.53.4.248; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brown RH, 2001, AM J RESP CRIT CARE, V163, P994, DOI 10.1164/ajrccm.163.4.2007119; Castro M, 2011, J ALLERGY CLIN IMMUN, V128, P467, DOI 10.1016/j.jaci.2011.04.051; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; D'Souza ND, 1996, SPIE MED IMAGING, V2709, P197; de Blic J, 2005, J ALLERGY CLIN IMMUN, V116, P750, DOI 10.1016/j.jaci.2005.07.009; de Lange EE, 2009, RADIOLOGY, V250, P567, DOI 10.1148/radiol.2502080188; Donohue KM, 2012, RESP MED, V106, P1655, DOI 10.1016/j.rmed.2012.08.006; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Gelb AF, 2000, AM J RESP CRIT CARE, V162, P1778, DOI 10.1164/ajrccm.162.5.2001037; Gono H, 2003, EUR RESPIR J, V22, P965, DOI 10.1183/09031936.03.00085302; Grol MH, 1996, ALLERGY, V51, P855; Grydeland TB, 2010, AM J RESP CRIT CARE, V181, P353, DOI 10.1164/rccm.200907-1008OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Hoshino M, 2010, RESP MED, V104, P794, DOI 10.1016/j.rmed.2009.12.005; Kasahara K, 2002, THORAX, V57, P242, DOI 10.1136/thorax.57.3.242; Ketai L, 2001, ACAD RADIOL, V8, P257, DOI 10.1016/S1076-6332(03)80535-4; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lee HM, 2010, EUR RESPIR J, V36, P1002, DOI 10.1183/09031936.00042410; Little SA, 2002, THORAX, V57, P247, DOI 10.1136/thorax.57.3.247; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Minino A., 2010, NATL VITAL STAT REPO; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Mitsunobu F, 2001, THORAX, V56, P851, DOI 10.1136/thorax.56.11.851; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Niimi A, 2000, AM J RESP CRIT CARE, V162, P1518, DOI 10.1164/ajrccm.162.4.9909044; Park SK, 2010, ENVIRON HEALTH PERSP, V118, P1406, DOI 10.1289/ehp.0901778; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Reinhardt JM, 1997, IEEE T MED IMAGING, V16, P820, DOI 10.1109/42.650878; Rodriguez J, 2010, ANN INTERN MED, V152, P201, DOI 10.7326/0003-4819-152-4-201002160-00004; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; Hoffman Eric A, 2006, Proc Am Thorac Soc, V3, P519, DOI 10.1513/pats.200603-086MS; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Tinkelman DG, 2006, J ASTHMA, V43, P75, DOI 10.1080/02770900500448738; Ueda T, 2006, J ALLERGY CLIN IMMUN, V118, P1019, DOI 10.1016/j.jaci.2006.07.032; Van den Toorn LM, 2001, AM J RESP CRIT CARE, V164, P2107, DOI 10.1164/ajrccm.164.11.2006165; Vignola AM, 2004, EUR RESPIR J, V24, P910, DOI 10.1183/09031936.04.00032603	49	17	17	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					361	+		10.1016/j.jaci.2012.11.036	http://dx.doi.org/10.1016/j.jaci.2012.11.036			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23374265	Green Accepted			2022-12-18	WOS:000314661500012
J	Larche, M; Hickey, P; Hebert, J; Hafner, R				Larche, Mark; Hickey, Pascal; Hebert, Jacques; Hafner, Rod			Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Larche, Mark] McMaster Univ, Dept Med, Div Clin Immunol & Allergy, Hamilton, ON, Canada; [Hickey, Pascal] Adiga Life Sci, Hamilton, ON, Canada; [Hebert, Jacques] Ctr Rech Appl Allergie Quebec, Quebec City, PQ, Canada; [Hafner, Rod] Circassia, Oxford, England	McMaster University				Larche, Mark/0000-0002-1439-7593					0	17	18	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB37	AB37		10.1016/j.jaci.2012.12.814	http://dx.doi.org/10.1016/j.jaci.2012.12.814			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800136
J	Szefler, SJ				Szefler, Stanley J.			Advances in pediatric asthma in 2012: Moving toward asthma prevention	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Airway remodeling; asthma; asthma control; asthma exacerbations; asthma impairment; asthma risk; asthma severity; early intervention in asthma; biomarkers; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting beta-adrenergic agonists; omalizumab; personalized medicine; severe asthma; therapeutics; tiotropium	GENOME-WIDE ASSOCIATION; PUBLIC-HEALTH BENEFITS; INNATE IMMUNITY GENES; EXHALED NITRIC-OXIDE; CHILDHOOD ASTHMA; LUNG-FUNCTION; VITAMIN-D; UNITED-STATES; INHALED CORTICOSTEROIDS; NATURAL-HISTORY	Last year's "Advances in pediatric asthma: moving forward'' concluded the following: "Now is also the time to utilize information recorded in electronic medical records to develop innovative disease management plans that will track asthma over time and enable timely decisions on interventions in order to maintain control that can lead to disease remission and prevention.'' This year's summary will focus on recent advances in pediatric asthma on modifying disease activity, preventing asthma exacerbations, managing severe asthma, and risk factors for predicting and managing early asthma, as indicated in Journal of Allergy and Clinical Immunology publications in 2012. Recent reports continue to shed light on methods to improve asthma management through steps to assess disease activity, tools to standardize outcome measures in asthma, genetic markers that predict risk for asthma and appropriate treatment, and interventions that alter the early presentation of asthma to prevent progression. We are well on our way to creating a pathway around wellness in asthma care and also to use new tools to predict the risk for asthma and take steps to not only prevent asthma exacerbations but also to prevent the early manifestations of the disease and thus prevent its evolution to severe asthma. (J Allergy Clin Immunol 2013;131:36-46.)	[Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Szefler, SJ (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Rm J304,Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njhealth.org		Szefler, Stanley/0000-0002-6911-3199	Public Health Services research grants [HL-64288, HL-51834, AI-90052, HL-75416, HL-87811, ES-18181, HL-98075]; Caring for Colorado Foundation; Denver Post Charities; McCormick Foundation; Colorado Cancer; Cardiovascular; Pulmonary Disease Program; Colorado CTSA; NCRR/NIH [UL1 RR025780]; NIH/NCATS [UL1 TR000154]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098075, U10HL064288, R21HL087811, U01HL075416] Funding Source: NIH RePORTER	Public Health Services research grants; Caring for Colorado Foundation; Denver Post Charities; McCormick Foundation; Colorado Cancer; Cardiovascular; Pulmonary Disease Program; Colorado CTSA; NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by Public Health Services research grants HL-64288, HL-51834, AI-90052, HL-75416, HL-87811, ES-18181, and HL-98075; Caring for Colorado Foundation; the Denver Post Charities, a McCormick Foundation; and the Colorado Cancer, Cardiovascular, and Pulmonary Disease Program. Supported in part by Colorado CTSA grant UL1 RR025780 from NCRR/NIH and UL1 TR000154 from NIH/NCATS.	Adamko DJ, 2012, J ALLERGY CLIN IMMUN, V130, P101, DOI 10.1016/j.jaci.2012.05.024; Akdis M, 2012, J ALLERGY CLIN IMMUN, V129, P1438, DOI 10.1016/j.jaci.2012.05.003; Akinbami LJ, 2012, J ALLERGY CLIN IMMUN, V129, pS49, DOI 10.1016/j.jaci.2011.12.984; Alcantara-Neves NM, 2012, J ALLERGY CLIN IMMUN, V129, P359, DOI 10.1016/j.jaci.2011.09.015; Anto JM, 2012, J ALLERGY CLIN IMMUN, V129, P943, DOI 10.1016/j.jaci.2012.01.047; Apter AJ, 2012, J ALLERGY CLIN IMMUN, V129, P69, DOI 10.1016/j.jaci.2011.11.005; Baccarelli A, 2011, AM J RESP CRIT CARE, V184, P1325, DOI 10.1164/rccm.201109-1695ED; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P287, DOI 10.1016/j.jaci.2012.04.025; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Ballow M, 2012, J ALLERGY CLIN IMMUN, V130, P311, DOI 10.1016/j.jaci.2012.04.046; Baraldo S, 2012, J ALLERGY CLIN IMMUN, V130, P1307, DOI 10.1016/j.jaci.2012.08.005; Barnes PJ, 2012, J ALLERGY CLIN IMMUN, V129, P48, DOI 10.1016/j.jaci.2011.11.006; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Bauer RN, 2012, J ALLERGY CLIN IMMUN, V129, P14, DOI 10.1016/j.jaci.2011.11.004; Bisgaard H, 2012, J ALLERGY CLIN IMMUN, V130, P531, DOI 10.1016/j.jaci.2011.10.047; Bisgaard H, 2012, AM J RESP CRIT CARE, V185, P1183, DOI 10.1164/rccm.201110-1922OC; Bosco A, 2012, J ALLERGY CLIN IMMUN, V129, P88, DOI 10.1016/j.jaci.2011.10.038; Bossley CJ, 2012, J ALLERGY CLIN IMMUN, V129, P974, DOI 10.1016/j.jaci.2012.01.059; Boyce JA, 2012, J ALLERGY CLIN IMMUN, V129, P335, DOI 10.1016/j.jaci.2011.12.968; Brehm JM, 2012, J ALLERGY CLIN IMMUN, V129, P1484, DOI 10.1016/j.jaci.2012.03.035; Brown RW, 2012, J ALLERGY CLIN IMMUN, V130, P362, DOI 10.1016/j.jaci.2012.03.028; Brown SD, 2012, J ALLERGY CLIN IMMUN, V129, P388, DOI 10.1016/j.jaci.2011.11.037; Busse W, 2012, J ALLERGY CLIN IMMUN, V129, P983, DOI 10.1016/j.jaci.2012.01.033; Busse WW, 2012, J ALLERGY CLIN IMMUN, V129, pS1, DOI 10.1016/j.jaci.2011.12.985; Busse WW, 2011, J ALLERGY CLIN IMMUN, V128, P740, DOI 10.1016/j.jaci.2011.08.014; Cakmak S, 2012, J ALLERGY CLIN IMMUN, V129, P228, DOI 10.1016/j.jaci.2011.09.025; Capili CR, 2012, J ALLERGY CLIN IMMUN, V129, P957, DOI 10.1016/j.jaci.2011.11.020; Carroll KN, 2012, J ALLERGY CLIN IMMUN, V129, P1236, DOI 10.1016/j.jaci.2012.01.045; Chambers ES, 2012, J ALLERGY CLIN IMMUN, V130, P542, DOI 10.1016/j.jaci.2012.04.022; Chawes BLK, 2012, J ALLERGY CLIN IMMUN, V130, P354, DOI 10.1016/j.jaci.2012.04.045; Chipps BE, 2012, J ALLERGY CLIN IMMUN, V130, P332, DOI 10.1016/j.jaci.2012.04.014; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Colice GL, 2012, ANN ALLERG ASTHMA IM, V108, P157, DOI 10.1016/j.anai.2011.12.017; Cookson W, 2011, J ALLERGY CLIN IMMUN, V128, P266, DOI 10.1016/j.jaci.2011.06.026; Daley D, 2012, J ALLERGY CLIN IMMUN, V130, P1284, DOI 10.1016/j.jaci.2012.07.051; Darrow LA, 2012, J ALLERGY CLIN IMMUN, V130, P630, DOI 10.1016/j.jaci.2012.06.020; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Drazen JM, 2012, J ALLERGY CLIN IMMUN, V129, P1200, DOI 10.1016/j.jaci.2012.03.026; Du R, 2012, J ALLERGY CLIN IMMUN, V129, P368, DOI 10.1016/j.jaci.2011.09.034; Ducharme FM, 2012, THORAX, V67, P102, DOI 10.1136/thoraxjnl-2011-200961; Duong M, 2012, J ALLERGY CLIN IMMUN, V130, P535, DOI 10.1016/j.jaci.2012.02.051; Durrani SR, 2012, J ALLERGY CLIN IMMUN, V130, P489, DOI 10.1016/j.jaci.2012.05.023; Eakin MN, 2012, J ALLERGY CLIN IMMUN, V129, P664, DOI 10.1016/j.jaci.2011.10.013; Forno E, 2012, J ALLERGY CLIN IMMUN, V130, P83, DOI 10.1016/j.jaci.2012.03.020; Fuchs O, 2012, J ALLERGY CLIN IMMUN, V130, P382, DOI 10.1016/j.jaci.2012.04.049; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Gelb AF, 2012, J ALLERGY CLIN IMMUN, V129, P1491, DOI 10.1016/j.jaci.2012.03.036; Gershon A, 2012, J ALLERGY CLIN IMMUN, V129, P679, DOI 10.1016/j.jaci.2011.11.014; Gill MA, 2012, J ALLERGY CLIN IMMUN, V129, P889, DOI 10.1016/j.jaci.2012.02.028; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P1243, DOI 10.1016/j.jaci.2012.01.044; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P687, DOI 10.1016/j.jaci.2011.12.001; Gouvis-Echraghi R, 2012, J ALLERGY CLIN IMMUN, V130; Grad R, 2012, J ALLERGY CLIN IMMUN, V130, P299, DOI 10.1016/j.jaci.2012.05.022; Gupta A, 2012, J ALLERGY CLIN IMMUN, V129, P1669, DOI 10.1016/j.jaci.2012.02.017; Gupta A, 2011, AM J RESP CRIT CARE, V184, P1342, DOI 10.1164/rccm.201107-1239OC; Hawkins GA, 2012, J ALLERGY CLIN IMMUN, V130, P510, DOI 10.1016/j.jaci.2012.03.018; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Hernandez M, 2012, J ALLERGY CLIN IMMUN, V129, P259, DOI 10.1016/j.jaci.2011.11.007; Herr M, 2012, J ALLERGY CLIN IMMUN, V130, P389, DOI 10.1016/j.jaci.2012.05.054; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Ingelsson E, 2012, J ALLERGY CLIN IMMUN, V129, P702, DOI 10.1016/j.jaci.2011.11.052; Ivanova JI, 2012, J ALLERGY CLIN IMMUN, V129, P1229, DOI 10.1016/j.jaci.2012.01.039; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; James KM, 2012, J ALLERGY CLIN IMMUN, V130, P343, DOI 10.1016/j.jaci.2012.05.056; Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP; Ji H, 2012, J ALLERGY CLIN IMMUN, V129, P33, DOI 10.1016/j.jaci.2011.11.008; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Just J, 2012, J ALLERGY CLIN IMMUN, V130, P103, DOI 10.1016/j.jaci.2012.02.041; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Kit BK, 2012, PEDIATRICS, V129, P62, DOI 10.1542/peds.2011-1513; Kreiner-Moller E, 2012, J ALLERGY CLIN IMMUN, V130, P1434, DOI 10.1016/j.jaci.2012.09.017; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Krishnan JA, 2012, J ALLERGY CLIN IMMUN, V129, pS124, DOI 10.1016/j.jaci.2011.12.981; Krishnan JA, 2012, J ALLERGY CLIN IMMUN, V129, P112, DOI 10.1016/j.jaci.2011.10.030; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Ledford DK, 2012, J ALLERGY CLIN IMMUN, V130, P24, DOI 10.1016/j.jaci.2012.02.055; Leung TF, 2012, J ALLERGY CLIN IMMUN, V129, P42, DOI 10.1016/j.jaci.2011.11.031; Li JH, 2012, J ALLERGY CLIN IMMUN, V130, P22, DOI 10.1016/j.jaci.2012.02.047; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; Loss G, 2012, J ALLERGY CLIN IMMUN, V130, P523, DOI 10.1016/j.jaci.2012.05.049; Lotvall J, 2012, J ALLERGY CLIN IMMUN, V129, P904, DOI [10.1097/WOX.0b013e3182504245, 10.1016/j.jaci.2012.02.009]; Manthei DM, 2012, J ALLERGY CLIN IMMUN, V130, P496, DOI 10.1016/j.jaci.2012.05.040; Martinez FD, 2011, J ALLERGY CLIN IMMUN, V128, P939, DOI 10.1016/j.jaci.2011.09.020; Matsui EC, 2012, J ALLERGY CLIN IMMUN, V130, P408, DOI 10.1016/j.jaci.2012.06.008; Matsui EC, 2012, J ALLERGY CLIN IMMUN, V129, P271, DOI 10.1016/j.jaci.2011.10.022; Meltzer EO, 2012, ALLERGY ASTHMA PROC, V33, P36, DOI 10.2500/aap.2011.32.3519; Myers RA, 2012, J ALLERGY CLIN IMMUN, V130, P1294, DOI 10.1016/j.jaci.2012.07.054; Nair P, 2012, J ALLERGY CLIN IMMUN, V130, P655, DOI 10.1016/j.jaci.2012.07.021; O'Brian AL, 2012, J ALLERGY CLIN IMMUN, V129, P1162, DOI 10.1016/j.jaci.2011.11.046; O'Byrne PM, 2012, J ALLERGY CLIN IMMUN, V129, P998, DOI 10.1016/j.jaci.2012.02.030; O'Byrne PM, 2011, J ALLERGY CLIN IMMUN, V128, P257, DOI 10.1016/j.jaci.2011.03.035; Oh SS, 2012, J ALLERGY CLIN IMMUN, V129, P1478, DOI 10.1016/j.jaci.2012.03.017; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Pedersen S, 2012, J ALLERGY CLIN IMMUN, V129, P1280, DOI 10.1016/j.jaci.2012.02.048; Rabinovitch N, 2012, J ALLERGY CLIN IMMUN, V130, P645, DOI 10.1016/j.jaci.2012.07.006; Rabinovitch N, 2011, AM J RESP CRIT CARE, V184, P1350, DOI 10.1164/rccm.201010-1706OC; Rand CS, 2012, J ALLERGY CLIN IMMUN, V129, pS136, DOI 10.1016/j.jaci.2011.12.987; Rank MA, 2012, ANN ALLERG ASTHMA IM, V108, P9, DOI 10.1016/j.anai.2011.09.009; Reponen T, 2012, J ALLERGY CLIN IMMUN, V130, P639, DOI 10.1016/j.jaci.2012.05.030; Rosas-Salazar C, 2012, J ALLERGY CLIN IMMUN, V129, P935, DOI 10.1016/j.jaci.2012.01.040; Rumpel JA, 2012, J ALLERGY CLIN IMMUN; Savenije OEM, 2012, J ALLERGY CLIN IMMUN, V130, P325, DOI 10.1016/j.jaci.2012.05.007; Schatz M, 2011, J ALLERGY CLIN IMMUN, V128, P273, DOI 10.1016/j.jaci.2011.03.027; Schumock GT, 2012, J ALLERGY CLIN IMMUN, V130, P368, DOI 10.1016/j.jaci.2012.04.035; Sevgican U, 2012, J ALLERGY CLIN IMMUN, V129, P567, DOI 10.1016/j.jaci.2011.09.032; Shi YX, 2012, J ALLERGY CLIN IMMUN, V129, P671, DOI 10.1016/j.jaci.2011.11.002; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Skytt N, 2012, J ALLERGY CLIN IMMUN, V130, P403, DOI 10.1016/j.jaci.2012.04.043; Slager RE, 2012, J ALLERGY CLIN IMMUN, V130, P516, DOI 10.1016/j.jaci.2012.03.030; Smyth AR, 2012, AM J RESP CRIT CARE, V185, P238, DOI 10.1164/rccm.201111-1952ED; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040; Spycher BD, 2012, J ALLERGY CLIN IMMUN, V130, P503, DOI 10.1016/j.jaci.2012.06.002; Stephenson ST, 2012, J ALLERGY CLIN IMMUN, V129, P867, DOI 10.1016/j.jaci.2011.10.021; Sumino K, 2012, J ALLERGY CLIN IMMUN, V129, P1267, DOI 10.1016/j.jaci.2012.02.033; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V130, P1256, DOI 10.1016/j.jaci.2012.10.021; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V130, P308, DOI 10.1016/j.jaci.2012.06.004; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, P60, DOI 10.1016/j.jaci.2011.11.011; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V128, P485, DOI 10.1016/j.jaci.2011.07.010; Tantisira KG, 2012, AM J RESP CRIT CARE, V185, P1286, DOI 10.1164/rccm.201111-2061OC; Tepper RS, 2012, J ALLERGY CLIN IMMUN, V129, pS65, DOI 10.1016/j.jaci.2011.12.986; Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P622, DOI 10.1016/j.jaci.2012.03.045; Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P76, DOI 10.1016/j.jaci.2012.02.040; Tsai CL, 2012, J ALLERGY CLIN IMMUN, V129, P1252, DOI 10.1016/j.jaci.2012.01.061; Tse SM, 2012, J ALLERGY CLIN IMMUN, V130, P53, DOI 10.1016/j.jaci.2012.04.005; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Verlaan DJ, 2012, J ALLERGY CLIN IMMUN, V130, P533, DOI 10.1016/j.jaci.2012.03.015; Wahn U, 2012, J ALLERGY CLIN IMMUN, V130, P111, DOI 10.1016/j.jaci.2012.05.025; Weiss ST, 2012, J ALLERGY CLIN IMMUN, V129, P327, DOI 10.1016/j.jaci.2011.12.971; Wells KE, 2012, J ALLERGY CLIN IMMUN, V129, P1274, DOI 10.1016/j.jaci.2011.12.974; Wildfire JJ, 2012, J ALLERGY CLIN IMMUN, V129, P694, DOI 10.1016/j.jaci.2011.12.962; Wilson SR, 2012, J ALLERGY CLIN IMMUN, V129, pS88, DOI 10.1016/j.jaci.2011.12.988; Wu AC, 2012, J ALLERGY CLIN IMMUN, V130, P1065, DOI 10.1016/j.jaci.2012.08.009; Wu PS, 2012, J ALLERGY CLIN IMMUN, V129, P1397, DOI 10.1016/j.jaci.2012.01.029; Yang IV, 2012, J ALLERGY CLIN IMMUN, V130, P1243, DOI 10.1016/j.jaci.2012.07.052; Yang IV, 2011, AM J RESP CRIT CARE, V183, P1295, DOI 10.1164/rccm.201010-1579PP; Zeiger RS, 2012, ANN ALLERG ASTHMA IM, V108, P81, DOI 10.1016/j.anai.2011.12.001; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032	142	17	19	0	48	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2013	131	1					36	46		10.1016/j.jaci.2012.11.009	http://dx.doi.org/10.1016/j.jaci.2012.11.009			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	062YR	23199603				2022-12-18	WOS:000312961200005
J	Brown, RW; O'Brien, CD; Martin, UJ; Uryniak, T; Lampl, KL				Brown, Randall W.; O'Brien, Christopher D.; Martin, Ubaldo J.; Uryniak, Tom; Lampl, Kathy L.			Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: A randomized controlled trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Budesonide; formoterol; asthma; randomized controlled trial; safety; African American	ACTING BETA-AGONISTS; FORMOTEROL; BUDESONIDE; EXACERBATIONS; CORTICOSTEROIDS; ADOLESCENTS; EFFICACY; ADULTS; MULTICENTER; SALMETEROL	Background: Information surrounding the long-term safety of combination inhaled corticosteroid/long-acting beta(2)-adrenergic agonist medications in African American asthmatic patients is limited. Objective: We sought to assess safety and asthma control with a budesonide/formoterol pressurized metered-dose inhaler (pMDI) versus budesonide over 1 year in African American patients. Methods: This 52-week, randomized, double-blind, parallel-group, multicenter, phase 3B safety study (NCT00419952) was conducted in 742 self-reported African American patients 12 years or older with moderate-to-severe asthma previously receiving medium- to high-dose inhaled corticosteroids. After 2 weeks using a 320 mu g twice-daily budesonide pMDI, patients were randomized 1:1 to 320/9 mu g twice-daily budesonide/formoterol pMDI or 320 mu g twice-daily budesonide pMDI. Results: Both treatments were well tolerated. Asthma exacerbation incidence and rate (per patient-treatment year) were lower with budesonide/formoterol versus budesonide (incidence, 7.7% vs 14.0% [P = .006]; rate ratio, 0.615 [P = .002]). Time to first asthma exacerbation was longer (P = .018) with budesonide/formoterol versus budesonide. The most common adverse events, regardless of study drug relationship, were headache (9.5% and 7.7%), nasopharyngitis (6.9% and 8.0%), sinusitis (4.0% and 6.3%), and viral upper respiratory tract infection (5.8% and 4.4%) for budesonide/formoterol and budesonide, respectively. Serious adverse events occurred in 12 and 15 patients, respectively; none were considered drug related. No substantial or unexpected patterns of abnormalities were observed in laboratory, electrocardiographic, or Holter monitoring assessments. Hospitalization caused by asthma exacerbation occurred in 0 and 4 patients in the budesonide/formoterol and budesonide groups, respectively. Pulmonary function and asthma control measures generally favored budesonide/formoterol. Conclusions: In this population budesonide/formoterol pMDI was well tolerated over 12 months, with a safety profile similar to that of budesonide; the asthma exacerbation rate was reduced by 38.5% versus budesonide. (J Allergy Clin Immunol 2012; 130: 362-7.)	[Brown, Randall W.] Univ Michigan, Sch Publ Hlth, Ctr Managing Chron Dis, Ann Arbor, MI 48109 USA; [O'Brien, Christopher D.; Martin, Ubaldo J.; Uryniak, Tom; Lampl, Kathy L.] AstraZeneca LP, Wilmington, DE USA	University of Michigan System; University of Michigan; AstraZeneca	Brown, RW (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Managing Chron Dis, 2790 SPH I,1415 Washington Hts, Ann Arbor, MI 48109 USA.	docrbrown@gmail.com			AstraZeneca, LP, Wilmington, Delaware	AstraZeneca, LP, Wilmington, Delaware(AstraZeneca)	Supported by AstraZeneca, LP, Wilmington, Delaware.	American Lung Association, 2011, TRENDS ASTHM MORB MO; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; [Anonymous], [No title captured]; Bailey W, 2008, CURR MED RES OPIN, V24, P1669, DOI 10.1185/03007990802119111; Chowdhury BA, 2011, NEW ENGL J MED, V364, P2473, DOI 10.1056/NEJMp1104375; Corren J, 2007, CLIN THER, V29, P823, DOI 10.1016/j.clinthera.2007.05.011; Dixon AE, 2011, AM J RESP CRIT CARE, V184, P1220, DOI 10.1164/rccm.201109-1683ED; Federico MJ, 2005, CHEST, V127, P571, DOI 10.1378/chest.127.2.571; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; Gould W, 2010, J ALLERGY CLIN IMMUN, V126, P1131, DOI 10.1016/j.jaci.2010.08.002; Harding G, 2009, CURR MED RES OPIN, V25, P1563, DOI 10.1185/03007990902914403; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1994, INT C HARM HARM TRIP; Jaeschke R, 2008, AM J RESP CRIT CARE, V178, P1009, DOI 10.1164/rccm.200804-494OC; Leidy NK, 2008, ALLERGY ASTHMA PROC, V29, P590, DOI 10.2500/aap.2008.29.3164; Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70; Martin ML, 2009, CURR MED RES OPIN, V25, P2495, DOI 10.1185/03007990903158430; Moorman Jeanne E., 2011, Morbidity and Mortality Weekly Report, V60, P84; Morice AH, 2008, PULM PHARMACOL THER, V21, P32, DOI 10.1016/j.pupt.2006.10.006; Nelson H, 2010, J ALLERGY CLIN IMMUN, V125, P390, DOI 10.1016/j.jaci.2009.11.036; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Noonan M, 2006, DRUGS, V66, P2235, DOI 10.2165/00003495-200666170-00006; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Passalacqua G, 2000, ALLERGY, V55, P16, DOI 10.1034/j.1398-9995.2000.00370.x; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Peters SP, 2008, ALLERGY ASTHMA PROC, V29, P499, DOI 10.2500/aap.2008.29.3147; Sears MR, 2009, EUR RESPIR J, V33, P21, DOI 10.1183/09031936.00145006; Sears Malcolm R., 2002, Journal of Allergy and Clinical Immunology, V110, pS322, DOI 10.1067/mai.2002.129966; Spector SL, 2012, J ASTHMA, V49, P70, DOI 10.3109/02770903.2011.633788; Wechsler ME, 2011, AM J RESP CRIT CARE, V184, P1247, DOI 10.1164/rccm.201103-0514OC; Wolfe J, 2006, CHEST, V129, P27, DOI 10.1378/chest.129.1.27	31	17	17	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2012	130	2					362	+		10.1016/j.jaci.2012.03.028	http://dx.doi.org/10.1016/j.jaci.2012.03.028			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	981WC	22541245				2022-12-18	WOS:000307002200014
J	Ohtsuka, Y; Jimbo, K; Inage, E; Mori, M; Yamakawa, Y; Aoyagi, Y; Suzuki, M; Kudo, T; Suzuki, R; Shimizu, T				Ohtsuka, Yoshikazu; Jimbo, Keisuke; Inage, Eisuke; Mori, Mari; Yamakawa, Yoko; Aoyagi, Yo; Suzuki, Mitsuyoshi; Kudo, Takahiro; Suzuki, Ryuyo; Shimizu, Toshiaki			Microarray analysis of mucosal biopsy specimens in neonates with rectal bleeding: Is it really an allergic disease?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFANCY		[Ohtsuka, Yoshikazu; Jimbo, Keisuke; Inage, Eisuke; Mori, Mari; Yamakawa, Yoko; Aoyagi, Yo; Suzuki, Mitsuyoshi; Kudo, Takahiro; Suzuki, Ryuyo; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescence Med, Tokyo, Japan	Juntendo University	Ohtsuka, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescence Med, Tokyo, Japan.	yohtsuka@juntendo.ac.jp		Jimbo, Keisuke/0000-0001-6317-4305; Suzuki, Mitsuyoshi/0000-0002-9969-3454				Arvola T, 2006, PEDIATRICS, V117, pE760, DOI 10.1542/peds.2005-1069; Bonnelykke K, 2008, J ALLERGY CLIN IMMUN, V121, P646, DOI 10.1016/j.jaci.2007.12.1149; Carlsen HS, 2002, GUT, V51, P364, DOI 10.1136/gut.51.3.364; Juvonen P, 1999, PEDIAT ALLERG IMM-UK, V10, P191, DOI 10.1034/j.1399-3038.1999.00030.x; KAPLAN B, 1984, J PEDIATR GASTR NUTR, V3, P704, DOI 10.1097/00005176-198411000-00012; Kukkonen K, 2010, PEDIAT ALLERG IMM-UK, V21, P67, DOI 10.1111/j.1399-3038.2009.00907.x; Lake AM, 2000, J PEDIATR GASTR NUTR, V30, pS58, DOI 10.1097/00005176-200001001-00009; Ohtsuka Y, 2007, J PEDIATR GASTR NUTR, V44, P501, DOI 10.1097/01.mpg.0000252194.06955.18; POWELL G K, 1986, Comprehensive Therapy, V12, P28; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028	10	17	18	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2012	129	6					1676	1678		10.1016/j.jaci.2012.01.042	http://dx.doi.org/10.1016/j.jaci.2012.01.042			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	952BL	22326485				2022-12-18	WOS:000304764600033
J	Higashi, N; Mita, H; Yamaguchi, H; Fukutomi, Y; Akiyama, K; Taniguchi, M				Higashi, Noritaka; Mita, Haruhisa; Yamaguchi, Hiromichi; Fukutomi, Yuma; Akiyama, Kazuo; Taniguchi, Masami			Urinary tetranor-PGDM concentrations in aspirin-intolerant asthma and anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PROSTAGLANDIN D-2; METABOLITE; CELECOXIB		[Higashi, Noritaka; Mita, Haruhisa; Yamaguchi, Hiromichi; Fukutomi, Yuma; Akiyama, Kazuo; Taniguchi, Masami] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan		Higashi, N (corresponding author), Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan.	n-higashi@sagamihara-hosp.gr.jp	Fukutomi, Yuma/AFQ-4306-2022	Fukutomi, Yuma/0000-0001-9913-4524				Bochenek G, 2003, J ALLERGY CLIN IMMUN, V111, P743, DOI 10.1067/mai.2003.1387; Daham K, 2011, CLIN EXP ALLERGY, V41, P36, DOI 10.1111/j.1365-2222.2010.03617.x; Gyllfors P, 2003, J ALLERGY CLIN IMMUN, V111, P1116, DOI 10.1067/mai.2003.1450; Higashi N, 2002, CLIN EXP ALLERGY, V32, P1484, DOI 10.1046/j.1365-2745.2002.01507.x; Higashi N, 2010, J ALLERGY CLIN IMMUN, V125, P1084, DOI 10.1016/j.jaci.2009.12.977; Mita H, 2001, ALLERGY, V56, P1061; MORROW JD, 1995, J INVEST DERMATOL, V104, P937, DOI 10.1111/1523-1747.ep12606209; Ono E, 2009, CLIN EXP ALLERGY, V39, P72, DOI 10.1111/j.1365-2222.2008.03104.x; Song WL, 2008, J BIOL CHEM, V283, P1179, DOI 10.1074/jbc.M706839200	9	17	18	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2					557	559		10.1016/j.jaci.2011.09.019	http://dx.doi.org/10.1016/j.jaci.2011.09.019			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	887TC	22018904	Bronze			2022-12-18	WOS:000299951700038
J	Mattheij, M; de Vries, E				Mattheij, Marjolein; de Vries, Esther			A suspicion of antibiotic allergy in children is often incorrect	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DIAGNOSIS		[Mattheij, Marjolein; de Vries, Esther] Jeroen Bosch Hosp, Dept Pediat, Shertogenbosch, Netherlands	Jeroen Bosch Ziekenhuis	Mattheij, M (corresponding author), Jeroen Bosch Hosp, Dept Pediat, Shertogenbosch, Netherlands.	e.d.vries@jbz.nl		de Vries, Esther/0000-0003-4311-3550				Aberer W, 2003, ALLERGY, V58, P854, DOI 10.1034/j.1398-9995.2003.00279.x; Caubet JC, 2011, J ALLERGY CLIN IMMUN, V127, P218, DOI 10.1016/j.jaci.2010.08.025; Demoly P, 2002, ALLERGY, V57, P37, DOI 10.1034/j.1398-9995.57.s72.7.x; Macy E, 2010, ANN ALLERG ASTHMA IM, V105, P136, DOI 10.1016/j.anai.2010.06.014; Mattheij MAC, 2011, TIJDSCHR KINDERGENEE, V79, P102; Ponvert C, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e45	6	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2					583	583		10.1016/j.jaci.2011.11.027	http://dx.doi.org/10.1016/j.jaci.2011.11.027			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	887TC	22196770	Bronze			2022-12-18	WOS:000299951700050
J	Boyman, O; Werfel, T; Akdis, CA				Boyman, Onur; Werfel, Thomas; Akdis, Cezmi A.			The suppressive role of IL-10 in contact and atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						IL-10; atopy; dermatitis; contact dermatitis; tolerance; dendritic cells; T cells	STRESS; LYMPHOCYTES; CYTOKINES; CELLS; SKIN		[Boyman, Onur] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, Zurich, Switzerland; [Werfel, Thomas] Hannover Med Sch, Dept Dermatol & Allergy, Div Immunodermatol & Allergy Res, Hannover, Germany; [Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland	University of Zurich; University Zurich Hospital; Hannover Medical School; Swiss Institute of Allergy & Asthma Research; University of Zurich	Akdis, CA (corresponding author), Swiss Inst Allergy & Asthma Res, Dept Immunol, Obere Str 22,Davos Pl, CH-7270 Davos, Switzerland.	akdisac@siaf.unizh.ch	Werfel, Thomas/B-6921-2012; Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X; Boyman, Onur/0000-0001-8279-5545				Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Akdis M, 2009, NAT REV DRUG DISCOV, V8, P645, DOI 10.1038/nrd2653; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; Clausen BE, 2010, IMMUNOL CELL BIOL, V88, P351, DOI 10.1038/icb.2010.40; Girard-Madoux MJH, 2012, J ALLERGY CLIN IMMUN, V129, P143, DOI 10.1016/j.jaci.2011.08.032; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Oh SH, 2012, J ALLERGY CLIN IMMUN, V129, P151, DOI 10.1016/j.jaci.2011.09.008; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Schmid-Ott G, 2001, J ALLERGY CLIN IMMUN, V107, P171, DOI 10.1067/mai.2001.111850; Schmid-Ott G, 2001, J ALLERGY CLIN IMMUN, V108, P455, DOI 10.1067/mai.2001.117800	11	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2012	129	1					160	161		10.1016/j.jaci.2011.10.046	http://dx.doi.org/10.1016/j.jaci.2011.10.046			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	869XT	22196528	Bronze			2022-12-18	WOS:000298634000020
J	Martin, AK; Mack, DG; Falta, MT; Mroz, MM; Newman, LS; Maier, LA; Fontenot, AP				Martin, Allison K.; Mack, Douglas G.; Falta, Michael T.; Mroz, Margaret M.; Newman, Lee S.; Maier, Lisa A.; Fontenot, Andrew P.			Beryllium-specific CD4(+) T cells in blood as a biomarker of disease progression	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Human; lung; CD4(+) T lymphocytes; beryllium; cytokines; granuloma; ELISpot	PROLIFERATIVE RESPONSE; MACHINING PLANT; TARGET ORGAN; CLASS-II; SENSITIZATION; SUSCEPTIBILITY; EXPRESSION; FREQUENCY; EXPOSURE; WORKERS	Background: CD4(+) T cells are responsible for the progressive lung damage seen in patients with chronic beryllium disease (CBD), a granulomatous lung disorder in which antigen-specific, T(H)1-type, cytokine-secreting T cells have been characterized. Compared with those seen in beryllium (Be)-sensitized subjects, increased numbers of Be-responsive T cells are present in the blood of patients with CBD. Objective: The aim of this study was to determine whether the number of Be-specific T cells in blood predicted the development of CBD in a cohort of Be-exposed subjects. Methods: Using IFN-gamma ELISpot and proliferation-based assays, we determined the frequency and proliferative capacity of Be-responsive T cells in blood. Results: Compared with the Be lymphocyte proliferation test, which detected an abnormal Be-induced proliferative response in 11 (4.2%) of 260 workers from a Be-machining facility, the IFN-gamma ELISpot detected a sensitization rate of 10% (chi(2) = 55.7, P < .0001). A significant positive correlation was also noted between the number of Be-responsive CD4(+) T cells in the blood and lung tissue of patients with CBD. Importantly, the transition from Be sensitization to CBD was associated with an increased number of antigen-specific T cells in blood. Conclusion: These findings have important implications for Be-induced disease and potentially other immune-mediated disorders, suggesting that the frequency of antigen-specific T cells in blood can serve as a noninvasive biomarker to predict disease development and severity of the Be-specific CD4(+) T-cell alveolitis. (J Allergy Clin Immunol 2011;128:1100-6.)	[Martin, Allison K.; Mack, Douglas G.; Falta, Michael T.; Newman, Lee S.; Maier, Lisa A.; Fontenot, Andrew P.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Fontenot, Andrew P.] Univ Colorado Denver, Dept Immunol, Aurora, CO 80045 USA; [Newman, Lee S.; Maier, Lisa A.] Univ Colorado Denver, Sch Publ Hlth, Aurora, CO 80045 USA; [Mroz, Margaret M.; Maier, Lisa A.; Fontenot, Andrew P.] Natl Jewish Hlth, Dept Med, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Fontenot, AP (corresponding author), Univ Colorado Denver, Div Clin Immunol B164, 12700 E 19th Ave, Aurora, CO 80045 USA.	andrew.fontenot@ucdenver.edu	Maier, Lisa/AAA-4378-2020	Falta, Michael/0000-0002-0835-6904	National Institutes of Health [HL062410, ES011810, HL102245]; Clinical Translational Research Center from the National Center for Research Resources [UL1 RR025780]; National Institute of Environmental Health Science; US Department of Energy; Centocor; Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062410, K24HL102245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Translational Research Center from the National Center for Research Resources; National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Department of Energy(United States Department of Energy (DOE)); Centocor; Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health grants HL062410, ES011810, and HL102245 (to A.P.F.) and the Clinical Translational Research Center (UL1 RR025780) from the National Center for Research Resources.; Disclosure of potential conflict of interest: L. S. Newman receives research support from the National Institute of Environmental Health Science and the US Department of Energy and has provided legal consultation/expert witness testimony in cases related to medical monitoring for beryllium-exposed individuals. L. A. Maier receives research support from Centocor, the National Institutes of Health, and the Department of Energy and receives honoraria from Up To Date. A. P. Fontenot receives research support from the National Institutes of Health. The rest of the authors declare that they have no relevant conflicts of interest.	Fontenot AP, 1999, J IMMUNOL, V163, P1019; Fontenot AP, 2005, TRENDS IMMUNOL, V26, P543, DOI 10.1016/j.it.2005.08.004; Fontenot AP, 2005, J CLIN INVEST, V115, P2886, DOI 10.1172/JCI24908; Fontenot AP, 1998, AM J RESP CELL MOL, V18, P581, DOI 10.1165/ajrcmb.18.4.2981; Fontenot AP, 2003, J CLIN INVEST, V112, P776, DOI 10.1172/JCI200318317; Fontenot AP, 2002, J CLIN INVEST, V110, P1473, DOI 10.1172/JCI200215846; Henneberger PK, 2001, INT ARCH OCC ENV HEA, V74, P167, DOI 10.1007/s004200100237; Kelleher PC, 2001, J OCCUP ENVIRON MED, V43, P238, DOI 10.1097/00043764-200103000-00012; KREISS K, 1993, AM REV RESPIR DIS, V148, P985, DOI 10.1164/ajrccm/148.4_Pt_1.985; Kreiss K, 1996, AM J IND MED, V30, P16, DOI 10.1002/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q; KREISS K, 1993, J OCCUP ENVIRON MED, V35, P267; Mack DG, 2010, AM J RESP CRIT CARE, V181, P1241, DOI 10.1164/rccm.201001-0025OC; Maier LA, 2003, J IMMUNOL, V171, P6910, DOI 10.4049/jimmunol.171.12.6910; MROZ MM, 1991, J ALLERGY CLIN IMMUN, V88, P54, DOI 10.1016/0091-6749(91)90300-D; Newman LS, 1996, ENVIRON HEALTH PERSP, V104, P953, DOI 10.2307/3433017; Newman LS, 2005, AM J RESP CRIT CARE, V171, P54, DOI 10.1164/rccm.200402-190OC; NEWMAN LS, 1989, AM REV RESPIR DIS, V139, P1479, DOI 10.1164/ajrccm/139.6.1479; Newman LS, 2001, J OCCUP ENVIRON MED, V43, P231, DOI 10.1097/00043764-200103000-00011; Palmer BE, 2008, J IMMUNOL, V180, P2704, DOI 10.4049/jimmunol.180.4.2704; Palmer BE, 2007, J ALLERGY CLIN IMMUN, V120, P184, DOI 10.1016/j.jaci.2007.03.009; Pott GB, 2005, J ALLERGY CLIN IMMUN, V115, P1036, DOI 10.1016/j.jaci.2005.01.019; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; ROSSMAN MD, 1988, ANN INTERN MED, V108, P687, DOI 10.7326/0003-4819-108-5-687; Rossman MD, 2002, AM J RESP CRIT CARE, V165, P788, DOI 10.1164/ajrccm.165.6.2104002; Shearer GM, 1998, IMMUNITY, V9, P587, DOI 10.1016/S1074-7613(00)80656-1	25	17	18	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2011	128	5					1100	U287		10.1016/j.jaci.2011.08.022	http://dx.doi.org/10.1016/j.jaci.2011.08.022			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	842FJ	21943943	Green Accepted			2022-12-18	WOS:000296578200025
J	Brickey, WJ; Alexis, NE; Hernandez, ML; Reed, W; Ting, JPY; Peden, DB				Brickey, Willie June; Alexis, Neil E.; Hernandez, Michelle L.; Reed, William; Ting, Jenny P. Y.; Peden, David B.			Sputum inflammatory cells from patients with allergic rhinitis and asthma have decreased inflammasome gene expression	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PNEUMOCOCCAL DISEASE; RISK		[Brickey, Willie June; Ting, Jenny P. Y.; Peden, David B.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Alexis, Neil E.; Hernandez, Michelle L.; Reed, William; Peden, David B.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC USA; [Alexis, Neil E.; Hernandez, Michelle L.; Reed, William; Peden, David B.] Univ N Carolina, Sch Med, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA; [Ting, Jenny P. Y.] Univ N Carolina, Sch Med, Ctr Translat Immunol, Chapel Hill, NC USA; [Ting, Jenny P. Y.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Peden, David B.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Brickey, WJ (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	peden@med.unc.edu		Peden, David/0000-0003-4526-4627	NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077437] Funding Source: NIH RePORTER; NCRR NIH HHS [KL2 RR025746, KL2RR025746] Funding Source: Medline; NIAID NIH HHS [U19AI077437, U19 AI077437-03, U19 AI077437] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexis NE, 2008, ANN ALLERG ASTHMA IM, V100, P206, DOI 10.1016/S1081-1206(10)60444-9; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Juhn YJ, 2008, J ALLERGY CLIN IMMUN, V122, P719, DOI 10.1016/j.jaci.2008.07.029; Newcomb Dawn C, 2009, Proc Am Thorac Soc, V6, P266, DOI 10.1513/pats.200806-056RM; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113	9	17	18	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2011	128	4					900	+		10.1016/j.jaci.2011.08.012	http://dx.doi.org/10.1016/j.jaci.2011.08.012			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	841UA	21868073	Green Accepted, Green Published			2022-12-18	WOS:000296538100034
J	Papinazath, T; Min, WX; Sujiththa, S; Cohen, A; Ackerley, C; Roifman, CM; Grunebaum, E				Papinazath, Taniya; Min, Wexian; Sujiththa, Suntharalingam; Cohen, Amos; Ackerley, Cameron; Roifman, Chaim M.; Grunebaum, Eyal			Effects of purine nucleoside phosphorylase deficiency on thymocyte development	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Purine nucleoside phosphorylase; thymocytes; apoptosis; proliferation; mice; immune deficiency	CHRONIC LYMPHOCYTIC-LEUKEMIA; DEOXYGUANOSINE KINASE CDNA; DOUBLE-POSITIVE THYMOCYTES; INTRACELLULAR DELIVERY; IN-VITRO; APOPTOSIS; EXPRESSION; DIFFERENTIATION; MICE; BIM	Background: Inherited or acquired defects in purine nucleoside phosphorylase (PNP) impair purine metabolism, as well as the survival and function of T lymphocytes. However, the effects of PNP deficiency on thymocyte development are not well known. Objectives: We sought to study thymocyte development in PNP-deficient (PNP-KO) mice. Methods: Maturation, proliferation, and apoptosis were determined in thymocytes from PNP-KO mice and hematopoietic stem cells from these mice grown ex vivo into thymocyte-like cells. Results: Reduced percentages of CD4(+)CD8(+) double-positive (DP) thymocytes with normal percentages of CD4(-)CD8(+) and CD4(+)CD8(-) single-positive thymocytes were found in the thymi of PNP-KO mice. Similarly, reduced DP-like thymocytes grew ex vivo from hematopoietic stem cells of PNP-KO mice. Thymi of PNP-KO mice contained increased apoptotic DP thymocytes. Increased apoptosis of PNP-deficient DP thymocytes occurred after exposure to deoxyguanosine (dGuo), although not after Fas ligation, and could be prevented by restoring PNP activity within the cells. In DP thymocytes from PNP-KO mice, dGuo caused mitochondrial membrane potential dissipation and induced release of cytochrome c from the mitochondria followed by nuclear DNA fragmentation. Inhibition of the caspase pathway prevented dGuo-induced nuclear DNA fragmentation but not mitochondrial membrane potential dissipation, indicating that PNP deficiency induces apoptosis that is initiated in the mitochondria of DP thymocytes. 5-Bromo-2-deoxyuridine incorporation demonstrated that PNP deficiency does not interfere with DP or single-positive thymocyte proliferation. Conclusions: PNP is important for the survival of DP thymocytes. Accumulation of dGuo in cases of PNP deficiency leads to mitochondria-initiated apoptosis of DP thymocytes, which can be prevented by restoring PNP activity in the cells. (J Allergy Clin Immunol 2011;128:854-63.)	[Grunebaum, Eyal] Hosp Sick Children, Div Immunol & Allergy, Dev & Stem Cell Biol Program, Res Inst, Toronto, ON M5G 1X8, Canada; [Papinazath, Taniya; Grunebaum, Eyal] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Cohen, Amos; Roifman, Chaim M.; Grunebaum, Eyal] Hosp Sick Children, Div Clin Immunol & Allergy, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Ackerley, Cameron] Hosp Sick Children, Div Pathol, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Grunebaum, E (corresponding author), Hosp Sick Children, Div Immunol & Allergy, Dev & Stem Cell Biol Program, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	Eyal.grunebaum@sickkids.ca			March of Dimes [6-FY07 326]; Canadian Centre for Primary Immunodeficiency; Canadian Immunodeficiency Society; Jeffrey Modell Foundation	March of Dimes(March of Dimes); Canadian Centre for Primary Immunodeficiency; Canadian Immunodeficiency Society; Jeffrey Modell Foundation	Supported by grants from the March of Dimes (no. 6-FY07 326), the Canadian Centre for Primary Immunodeficiency, the Canadian Immunodeficiency Society, and the Jeffrey Modell Foundation.	Alonso R, 2009, BLOOD, V114, P1563, DOI 10.1182/blood-2009-02-207654; Apasov SG, 2001, J CLIN INVEST, V108, P131, DOI 10.1172/JCI200110360; Arnoult D, 2008, METHODS, V44, P229, DOI 10.1016/j.ymeth.2007.11.003; Arpaia E, 2000, J EXP MED, V191, P2197, DOI 10.1084/jem.191.12.2197; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Balakrishnan K, 2006, BLOOD, V108, P2392, DOI 10.1182/blood-2006-03-007468; Biswas S, 2010, BLOOD, V116, P5237, DOI 10.1182/blood-2010-04-279687; Cassani B, 2008, BLOOD, V111, P4209, DOI 10.1182/blood-2007-05-092429; COHEN A, 1980, J IMMUNOL, V125, P1578; Cohen A, 2000, IMMUNOL ALLERGY CLIN, V20, P143, DOI 10.1016/S0889-8561(05)70139-9; Dalal I, 2001, CLIN GENET, V59, P430, DOI 10.1034/j.1399-0004.2001.590608.x; Edgar CE, 2010, CELL DEATH DIFFER, V17, P1566, DOI 10.1038/cdd.2010.30; Gangi-Peterson L, 1999, J CLIN INVEST, V103, P833, DOI 10.1172/JCI4320; Hershfield M., 2004, IMMUNOLOGIC DISORDER, P480; Hu MG, 2009, CANCER RES, V69, P810, DOI 10.1158/0008-5472.CAN-08-2473; Hutcheson J, 2007, IMMUNOBIOLOGY, V212, P629, DOI 10.1016/j.imbio.2007.05.003; Iacovelli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007586; Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258; Kicska GA, 2001, P NATL ACAD SCI USA, V98, P4593, DOI 10.1073/pnas.071050798; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; Robak T, 2006, CURR MED CHEM, V13, P3165, DOI 10.2174/092986706778742918; Schmitt TM, 2006, IMMUNOL REV, V209, P95, DOI 10.1111/j.0105-2896.2006.00353.x; SIMMONDS HA, 1987, ARCH DIS CHILD, V62, P385, DOI 10.1136/adc.62.4.385; Snyder FF, 1997, P NATL ACAD SCI USA, V94, P2522, DOI 10.1073/pnas.94.6.2522; Thompson LF, 2003, BIOCHEM PHARMACOL, V66, P1595, DOI 10.1016/S0006-2952(03)00530-6; Toro A, 2006, J CLIN INVEST, V116, P2717, DOI 10.1172/JCI25052; Toro A, 2006, CELL IMMUNOL, V240, P107, DOI 10.1016/j.cellimm.2006.07.003; Van de Wiele CJ, 2006, J IMMUNOL, V176, P5925, DOI 10.4049/jimmunol.176.10.5925; Van de Wiele CJ, 2002, J CLIN INVEST, V110, P395, DOI 10.1172/JCI200215683; Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0; Yu YM, 2009, J IMMUNOL METHODS, V350, P29, DOI 10.1016/j.jim.2009.07.008	33	17	18	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2011	128	4					854	U272		10.1016/j.jaci.2011.07.039	http://dx.doi.org/10.1016/j.jaci.2011.07.039			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	841UA	21868080				2022-12-18	WOS:000296538100024
J	Rachid, R; Castells, M; Cunningham-Rundles, C; Bonilla, FA				Rachid, Rima; Castells, Mariana; Cunningham-Rundles, Charlotte; Bonilla, Francisco A.			Association of anti-IgA antibodies with adverse reactions to gamma-globulin infusion	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INTRAVENOUS IMMUNOGLOBULIN; IMMUNODEFICIENT PATIENTS; SUBSTITUTION THERAPY; HYPOGAMMAGLOBULINEMIA; PATIENT		[Rachid, Rima; Bonilla, Francisco A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Allergy & Immunol, Boston, MA 02115 USA; [Castells, Mariana] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Allergy & Immunol, Boston, MA 02115 USA; [Cunningham-Rundles, Charlotte] Mt Sinai Med Ctr, New York, NY 10029 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Rachid, R (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Div Allergy & Immunol, Boston, MA 02115 USA.	rima.rachid@childrens.harvard.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR02172, M01 RR002172-17, M01 RR002172] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Brennan VM, 2003, CLIN EXP IMMUNOL, V133, P247, DOI 10.1046/j.1365-2249.2003.02199.x; BURKS AW, 1986, NEW ENGL J MED, V314, P560, DOI 10.1056/NEJM198602273140907; Campos RD, 2000, J CLIN IMMUNOL, V20, P77; CUNNINGHAMRUNDLES C, 1986, CLIN IMMUNOL IMMUNOP, V38, P141, DOI 10.1016/0090-1229(86)90133-9; Eijkhout HW, 2003, NETH J MED, V61, P213; FERREIRA A, 1988, CLIN IMMUNOL IMMUNOP, V47, P199, DOI 10.1016/0090-1229(88)90072-4; FERREIRA A, 1989, VOX SANG, V56, P218, DOI 10.1111/j.1423-0410.1989.tb02032.x; HEDDERICH U, 1986, CLIN ALLERGY, V16, P339, DOI 10.1111/j.1365-2222.1986.tb01966.x; SANDLER SG, 1994, BLOOD, V84, P2031	9	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					228	230		10.1016/j.jaci.2011.01.061	http://dx.doi.org/10.1016/j.jaci.2011.01.061			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	785RE	21397310	Green Accepted, Bronze			2022-12-18	WOS:000292245600036
J	Alonzi, C; Campi, P; Gaeta, F; Pineda, F; Romano, A				Alonzi, Cristiana; Campi, Paolo; Gaeta, Francesco; Pineda, Fernando; Romano, Antonino			Diagnosing IgE-mediated hypersensitivity to sesame by an immediate-reading "contact test" with sesame oil	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGY; PEANUT; SEED		[Alonzi, Cristiana; Gaeta, Francesco; Romano, Antonino] Complesso Integrato Columbus, Allergy Unit, Rome, Italy; [Campi, Paolo] Nuovo Osped San Giovanni di Dio, Allergy & Clin Immunol Unit, Florence, Italy; [Pineda, Fernando] DIATER Labs, R&D, Madrid, Spain; [Romano, Antonino] IRCCS Oasi Maria SS, Troina, Italy	IRCCS Oasi Maria SS	Alonzi, C (corresponding author), Complesso Integrato Columbus, Allergy Unit, Rome, Italy.	antoninoromano@h-columbus.it	Romano, Antonino/D-3102-2017; Gaeta, Francesco/AAC-7107-2020	Romano, Antonino/0000-0001-9742-9898; Gaeta, Francesco/0000-0003-2942-7633				Crevel RWR, 2000, FOOD CHEM TOXICOL, V38, P385, DOI 10.1016/S0278-6915(99)00158-1; Gangur V, 2005, ANN ALLERG ASTHMA IM, V95, P4, DOI 10.1016/S1081-1206(10)61181-7; Kanny G, 1996, ALLERGY, V51, P952; Leduc V, 2006, ALLERGY, V61, P349, DOI 10.1111/j.1398-9995.2006.01013.x; Maloney JM, 2008, J ALLERGY CLIN IMMUN, V122, P145, DOI 10.1016/j.jaci.2008.04.014; Morisset M, 2003, CLIN EXP ALLERGY, V33, P1046, DOI 10.1046/j.1365-2222.2003.01734.x; Pecquet C, 1998, CONTACT DERMATITIS, V39, P313, DOI 10.1111/j.1600-0536.1998.tb05948.x; Pons L, 2002, ALLERGY, V57, P88, DOI 10.1034/j.1398-9995.57.s72.16.x; Stern A, 1998, ALLERGY, V53, P325, DOI 10.1111/j.1398-9995.1998.tb03897.x; Zavalkoff S, 2008, J ALLERGY CLIN IMMUN, V121, P1508, DOI 10.1016/j.jaci.2008.04.012	10	17	18	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1627	1629		10.1016/j.jaci.2011.01.050	http://dx.doi.org/10.1016/j.jaci.2011.01.050			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21377720				2022-12-18	WOS:000291048500048
J	Castro-Rodriguez, JA; Cifuentes, L; Rodriguez-Martinez, CE				Castro-Rodriguez, Jose A.; Cifuentes, Lorena; Rodriguez-Martinez, Carlos E.			The asthma predictive index remains a useful tool to predict asthma in young children with recurrent wheeze in clinical practice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EOSINOPHILIA		[Castro-Rodriguez, Jose A.; Cifuentes, Lorena] Pontificia Univ Catolica Chile, Dept Pediat, Sch Med, Santiago, Chile; [Cifuentes, Lorena] Pontificia Univ Catolica Chile, Evidence Based Med Unit, Santiago, Chile; [Rodriguez-Martinez, Carlos E.] Univ El Bosque, Dept Pediat Pulmonol & Pediat Crit Care Med, Bogota, Colombia	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad El Bosque	Castro-Rodriguez, JA (corresponding author), Pontificia Univ Catolica Chile, Dept Pediat, Sch Med, Alameda 340, Santiago, Chile.	jacastro17@hotmail.com	Castro-Rodriguez, Jose A./ABA-2760-2021; Castro-Rodriguez, Jose A./ABA-6591-2021; Cifuentes, Lorena/GXN-3878-2022	Castro-Rodriguez, Jose A./0000-0002-0708-4281; Cifuentes, Lorena/0000-0002-9749-9201				[Anonymous], USERS GUIDE MED LIT; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Brand PLP, 2011, J ALLERGY CLIN IMMUN, V127, P293, DOI 10.1016/j.jaci.2010.10.012; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2010, J ALLERGY CLIN IMMUN, V126, P212, DOI 10.1016/j.jaci.2010.06.032; Cifuentes L, 2010, REV CHIL INFECTOL, V27, P316; Illi S, 2001, J ALLERGY CLIN IMMUN, V108, P709, DOI 10.1067/mai.2001.118786; Just J, 2008, CLIN EXP ALLERGY, V38, P767, DOI 10.1111/j.1365-2222.2008.02966.x; Karakoc F, 2002, CLIN EXP ALLERGY, V32, P51, DOI 10.1046/j.0022-0477.2001.01273.x; Richardson WS, 2008, USERS GUIDES MED LIT, P399	10	17	18	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2011	127	4					1082	1083		10.1016/j.jaci.2011.01.024	http://dx.doi.org/10.1016/j.jaci.2011.01.024			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	743YL	21458660				2022-12-18	WOS:000289055800046
J	Bin, LH; Howell, MD; Kim, BE; Streib, JE; Hall, CF; Leung, DYM				Bin, Lianghua; Howell, Michael D.; Kim, Byung Eui; Streib, Joanne E.; Hall, Clifton F.; Leung, Donald Y. M.			Specificity protein 1 is pivotal in the skin's antiviral response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Specificity protein 1; vaccinia virus; herpes simplex virus 1; double-stranded RNA-dependent protein kinase; 2'5'-oligoadenylate synthetase 2; atopic dermatitis; eczema herpeticum; IFN-gamma	TRANSCRIPTION FACTOR SP1; HERPES-SIMPLEX-VIRUS; INNATE IMMUNE-RESPONSE; HUMAN GASTRIC-CANCER; ATOPIC-DERMATITIS; KINASE PKR; ECZEMA HERPETICUM; VACCINIA VIRUS; SMALLPOX VACCINATION; INCREASED EXPRESSION	Background: Previous studies have found specificity protein (Sp) 1 transcription factor in the viral replication machinery and postulated that Sp1 was required for viral replication in host cells. Objectives: We investigated the role of Sp1 in the skin's antiviral responses from the perspective of host defense and its biological relevance in patients with atopic dermatitis and a history of eczema herpeticum (ADEH(+)). Methods: Small interfering RNA duplexes were used to knock down Sp1 in keratinocytes. The expression of vaccinia virus (VV), herpes simplex virus 1, and other genes were evaluated by real-time PCR, or combined with Western blot and immunohistofluorescence staining. A total of 106 human subjects participated in this study. Results: Both VV and herpes simplex virus 1 replication were enhanced in Sp1 knocked-down keratinocytes. Sp1 gene expression was significantly decreased in ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects (P < .0001) and inversely correlated with VV DNA copy number in human skin explants incubated with VV in vitro (partial correlation r = -0.256; P = .009). Gene profiling revealed that the antiviral genes, double-stranded RNA-dependent protein kinase (PKR) and 2'5'-oligoadenylate synthetase 2 (OAS2), were significantly downregulated in Sp1-silenced keratinocytes. Gene expression of PKR and OAS2 was also significantly decreased in skin biopsies from ADEH(+) subjects compared with patients with atopic dermatitis without a history of eczema herpeticum and nonatopic subjects. IFN-gamma augmented the antiviral capacity of Sp1-silenced keratinocytes. Conclusion: Specificity protein 1 knockdown enhances viral replication in keratinocytes by downregulating gene expression of PKR and OAS2. Sp1 deficiency in ADEH(+) patients may contribute to their increased propensity to disseminated skin viral infections. IFN-gamma augmentation may be a potential treatment for ADEH(+) patients. (J Allergy Clin Immunol 2011;127:430-8.)	[Bin, Lianghua; Howell, Michael D.; Kim, Byung Eui; Streib, Joanne E.; Hall, Clifton F.; Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Howell, Michael D.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Howell, Michael D.; Leung, Donald Y. M.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	National Jewish Health; Boehringer Ingelheim; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leung, DYM (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St,Room K926i, Denver, CO 80206 USA.	leungd@njhealth.org		Kim, Byung Eui/0000-0003-4923-1814	National Institutes of Health/National Institute of Allergy and Infectious Diseases [N01 AI 40029, N01 AI40033]; NIAMS [AR41256]; NCRR/National Institutes of Health [1 UL1 RR025780]; National Jewish Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041256] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Jewish Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases contracts N01 AI 40029 and N01 AI40033 and NIAMS grant AR41256, and in part by Colorado CTSA grant 1 UL1 RR025780 from NCRR/National Institutes of Health. The salary of L. B. was supported in part by the Eugene F. and Easton M. Crawford Pediatric Research Fellowship Fund at National Jewish Health.	Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, P260, DOI 10.1016/j.jaci.2009.05.020; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Boguniewicz M, 2010, J ALLERGY CLIN IMMUN, V125, P4, DOI 10.1016/j.jaci.2009.11.027; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Boyd DA, 2009, EMERG INFECT DIS, V15, P1102, DOI 10.3201/eid1507.090093; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Chiefari E, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-35; Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Drazen JM, 2002, NEW ENGL J MED, V346, P1262, DOI 10.1056/NEJM2e020038; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Fauci AS, 2002, NEW ENGL J MED, V346, P1319, DOI 10.1056/NEJM200204253461711; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Hovanessian AG, 2007, CYTOKINE GROWTH F R, V18, P351, DOI 10.1016/j.cytogfr.2007.06.003; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; Howell MD, 2006, J ALLERGY CLIN IMMUN, V117, P836, DOI 10.1016/j.jaci.2005.12.1345; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Jiang YX, 2004, CLIN EXP METASTAS, V21, P755, DOI 10.1007/s10585-005-1198-2; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KITADAI Y, 1992, BIOCHEM BIOPH RES CO, V189, P1342, DOI 10.1016/0006-291X(92)90221-6; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Oh J, 2005, J VIROL, V79, P12852, DOI 10.1128/JVI.79.20.12852-12860.2005; Peng WM, 2007, J INVEST DERMATOL, V127, P1261, DOI 10.1038/sj.jid.5700657; PROUD CG, 1992, CURR TOP CELL REGUL, V32, P243; Rajcani J, 2004, VIRUS GENES, V28, P293, DOI 10.1023/B:VIRU.0000025777.62826.92; Rebouillat D, 1999, J INTERF CYTOK RES, V19, P295, DOI 10.1089/107999099313992; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Silverman RH, 2007, CYTOKINE GROWTH F R, V18, P381, DOI 10.1016/j.cytogfr.2007.06.012; SUNE C, 1995, J VIROL, V69, P6572; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; WAGNER EK, 1995, PROG NUCLEIC ACID RE, V51, P123, DOI 10.1016/S0079-6603(08)60878-8; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Weidmann M, 2003, J CLIN MICROBIOL, V41, P1565, DOI 10.1128/JCM.41.4.1565-1568.2003; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074	41	17	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2					430	U1668		10.1016/j.jaci.2010.11.013	http://dx.doi.org/10.1016/j.jaci.2010.11.013			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	714KH	21208652	Green Accepted			2022-12-18	WOS:000286808000017
J	Fan, YP; Chen, SL; Qu, XJ; Zuo, KJ; Li, XM; Huang, J; Xu, G; Mi, JP; Li, HB				Fan, Yunping; Chen, Shuli; Qu, Xiujuan; Zuo, Kejun; Li, Xiaomin; Huang, Jin; Xu, Geng; Mi, Jiaoping; Li, Huabin			A lower prevalence of asthma among patients with chronic rhinosinusitis in southern China	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BRONCHIAL HYPERRESPONSIVENESS; MUCOSAL INFLAMMATION		[Fan, Yunping; Zuo, Kejun; Xu, Geng; Li, Huabin] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Fan, Yunping; Chen, Shuli; Qu, Xiujuan; Huang, Jin; Mi, Jiaoping] Sun Yat Sen Univ, Affiliated Hosp 5, Allergy Ctr, Zhuhai, Peoples R China; [Li, Xiaomin] Zhuhai Citys Hosp, Dept Otolaryngol, Zhuhai, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Fan, YP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China.	fanyunping@sohu.com						Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Han DH, 2009, ALLERGY, V64, P118, DOI 10.1111/j.1398-9995.2008.01841.x; Hao J, 2006, OTOLARYNG HEAD NECK, V134, P267, DOI 10.1016/j.otohns.2005.09.026; Jani AL, 2005, J ASTHMA, V42, P1, DOI 10.1081/JAS-200044744; Kountakis SE, 2004, LARYNGOSCOPE, V114, P1895, DOI 10.1097/01.mlg.0000147917.43615.c0; Shi J, 2009, J INVEST ALLERG CLIN, V19, P276; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; ZHONG NS, 1990, THORAX, V45, P860, DOI 10.1136/thx.45.11.860	8	17	24	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2					520	U1909		10.1016/j.jaci.2010.09.023	http://dx.doi.org/10.1016/j.jaci.2010.09.023			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	714KH	21093031				2022-12-18	WOS:000286808000029
J	Wasserman, RL; Sugerman, RW; Mireku-Akomeah, N; Mansfield, L; Baker, JW				Wasserman, Richard L.; Sugerman, Robert W.; Mireku-Akomeah, Nana; Mansfield, Lyndon; Baker, James W.			Office-based oral immunotherapy for food allergy is safe and effective	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Wasserman, Richard L.; Sugerman, Robert W.; Mireku-Akomeah, Nana] DallasAllergyImmunology, Dallas, TX 75231 USA; [Mansfield, Lyndon] Western Sky Med Res, El Paso, TX USA; [Baker, James W.] Baker Allergy Asthma & Dermatol Res Ctr, Lake Oswego, OR USA		Wasserman, RL (corresponding author), DallasAllergyImmunology, Dallas, TX 75231 USA.	drrichwasserman@gmail.com						Atkins D, 2009, CURR ALLERGY ASTHM R, V9, P179, DOI 10.1007/s11882-009-0027-0; Avery NJ, 2003, PEDIAT ALLERG IMM-UK, V14, P378, DOI 10.1034/j.1399-3038.2003.00072.x; Primeau MN, 2000, CLIN EXP ALLERGY, V30, P1135, DOI 10.1046/j.1365-2222.2000.00889.x; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; Thyagarajan A, 2010, J ALLERGY CLIN IMMUN, V126, P31, DOI 10.1016/j.jaci.2010.05.012	5	17	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2011	127	1					290	291		10.1016/j.jaci.2010.08.052	http://dx.doi.org/10.1016/j.jaci.2010.08.052			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	702SY	21040956				2022-12-18	WOS:000285917300055
J	Schneider, L; Weinberg, A; Boguniewicz, M; Taylor, P; Oettgen, H; Heughan, L; Zaccaro, D; Armstrong, B; Holliday, A; Leung, DYM				Schneider, Lynda; Weinberg, Adriana; Boguniewicz, Mark; Taylor, Patricia; Oettgen, Hans; Heughan, Lisa; Zaccaro, Daniel; Armstrong, Brian; Holliday, Aaron; Leung, Donald Y. M.			Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DIPHTHERIA; TETANUS		[Schneider, Lynda; Oettgen, Hans; Heughan, Lisa] Childrens Hosp Boston, Boston, MA USA; [Weinberg, Adriana; Boguniewicz, Mark; Leung, Donald Y. M.] Univ Colorado, Denver, CO 80202 USA; [Boguniewicz, Mark; Taylor, Patricia; Leung, Donald Y. M.] Natl Jewish Hlth, Denver, CO USA; [Zaccaro, Daniel; Armstrong, Brian; Holliday, Aaron] Rho Inc, Chapel Hill, NC USA	Harvard University; Boston Children's Hospital; University of Colorado System; University of Colorado Denver; National Jewish Health; Rho	Schneider, L (corresponding author), Childrens Hosp Boston, Boston, MA USA.	lynda.schneider@childrens.harvard.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040029, R21AI140029] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025758, UL1 RR025780, UL1 RR025758-01] Funding Source: Medline; NIAID NIH HHS [N01AI40033, HHSN266200400029C, N01 AI040029, N01 AI40033, AI40029] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, P260, DOI 10.1016/j.jaci.2009.05.020; Boguniewicz M, 2010, J ALLERGY CLIN IMMUN, V125, P4, DOI 10.1016/j.jaci.2009.11.027; Gao PS, 2010, J ALLERGY CLIN IMMUN, V125, P1403, DOI 10.1016/j.jaci.2010.03.016; Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, P507, DOI 10.1016/j.jaci.2009.07.034; Kreth HW, 2006, EUR J PEDIATR, V165, P677, DOI 10.1007/s00431-006-0103-6; Kumar A, 2009, ANN ALLERG ASTHMA IM, V103, P181, DOI 10.1016/S1081-1206(10)60178-0; MARK A, 1995, VACCINE, V13, P669, DOI 10.1016/0264-410X(94)00017-H; NAGEL JE, 1979, J ALLERGY CLIN IMMUN, V63, P308, DOI 10.1016/0091-6749(79)90124-6; Smith JG, 2001, CLIN DIAGN LAB IMMUN, V8, P871, DOI 10.1128/CDLI.8.5.871-879.2001	9	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2010	126	6					1306	1307		10.1016/j.jaci.2010.08.010	http://dx.doi.org/10.1016/j.jaci.2010.08.010			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	689RZ	20889193	Green Accepted, Bronze			2022-12-18	WOS:000284947800033
J	Atkins, D; Furuta, GT				Atkins, Dan; Furuta, Glenn T.			Mucosal immunology, eosinophilic esophagitis, and other intestinal inflammatory diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mucosal immunity; eosinophilic esophagitis eosinophilic gastrointestinal diseases	REGULATORY T-CELLS; BOWEL-DISEASE; EPITHELIAL-CELLS; GENE-EXPRESSION; CELIAC-DISEASE; SKIN PRICK; CHILDREN; PATHOGENESIS; EOTAXIN-3; SYSTEM	The gastrointestinal mucosa constitutes the largest host-environment interface of the body. It uses both innate and adaptive immune mechanisms to provide protection from the diverse onslaught of foods, microbes, and other ingested products. The innate immune system is genetically encoded and evolutionarily ancient, possesses no memory, and lacks diversity. In contrast, the adaptive immune system is quite diverse, develops memory, and undergoes expansion after stimulation. The gastrointestinal mucosa is charged with the difficult task of mounting protective responses against invading microorganisms while simultaneously maintaining an overall state of nonresponsiveness or tolerance to innocuous substances, such as commensal bacteria and food antigens. Perturbation or malfunction of these complex protective mechanisms results in diseases, such as inflammatory bowel diseases, celiac disease, or eosinophilic gastrointestinal diseases. (J Allergy Clin Immunol 2010;125:S255-61.)	[Furuta, Glenn T.] Childrens Hosp, Gastrointestinal Eosinophil Dis Program, Natl Jewish Hlth, Aurora, CO 80045 USA; [Atkins, Dan; Furuta, Glenn T.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Atkins, Dan; Furuta, Glenn T.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; [Furuta, Glenn T.] Sect Pediat Gastroenterol Hepatol & Nutr, Denver, CO USA	Children's Hospital Colorado; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Furuta, GT (corresponding author), Childrens Hosp, Gastrointestinal Eosinophil Dis Program, Natl Jewish Hlth, 13123 E 16th Ave B290, Aurora, CO 80045 USA.	furuta.glenn@tchden.org			National Institutes of Health Consortium of Food Allergy Research; American Gastroenerological Association; National Institutes of Health	National Institutes of Health Consortium of Food Allergy Research; American Gastroenerological Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Disclosure of potential conflict of interest: D. Atkins has received research support from the National Institutes of Health Consortium of Food Allergy Research. G. T. Furuta is a consultant for Meritage Pharma, has received research support from the American Gastroenerological Association and the National Institutes of Health, and has provided expert witness testimony on the subject of eosinophilic esophagitis.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Aceves SS, 2007, J ALLERGY CLIN IMMUN, V119, P206, DOI 10.1016/j.jaci.2006.10.016; Aceves SS, 2009, ALLERGY; Allez M, 2002, GASTROENTEROLOGY, V123, P1516, DOI 10.1053/gast.2002.36588; Artis D, 2008, MUCOSAL IMMUNOL, V1, P252, DOI 10.1038/mi.2008.21; Atkins D, 2009, NAT REV GASTRO HEPAT, V6, P267, DOI 10.1038/nrgastro.2009.45; Barker Jennifer M, 2008, Adv Pediatr, V55, P349, DOI 10.1016/j.yapd.2008.07.001; Bhattacharya B, 2007, HUM PATHOL, V38, P1744, DOI 10.1016/j.humpath.2007.05.008; Bilsborough J, 2004, GASTROENTEROLOGY, V127, P300, DOI 10.1053/j.gastro.2004.01.028; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2005, INT J BIOCHEM CELL B, V37, P2559, DOI 10.1016/j.biocel.2005.06.010; Blanchard C, 2009, IMMUNOL ALLERGY CLIN, V29, P141, DOI 10.1016/j.iac.2008.10.002; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Boirivant M, 2008, MUCOSAL IMMUNOL, V1, pS47, DOI 10.1038/mi.2008.52; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Cario E, 2008, CURR OPIN GASTROEN, V24, P725, DOI 10.1097/MOG.0b013e32830c4341; Chehade M, 2007, J PEDIATR GASTR NUTR, V45, P319, DOI 10.1097/MPG.0b013e31806ab384; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dahan S, 2007, IMMUNOL REV, V215, P243, DOI 10.1111/j.1600-065X.2006.00484.x; Desai TK, 2005, GASTROINTEST ENDOSC, V61, P795, DOI 10.1016/S0016-5107(05)00313-5; Dotan I, 2007, AM J PHYSIOL-GASTR L, V292, pG1630, DOI 10.1152/ajpgi.00294.2006; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Fagarasan S, 2008, CURR OPIN IMMUNOL, V20, P170, DOI 10.1016/j.coi.2008.04.002; Fleischer DM, 2009, IMMUNOL ALLERGY CLIN, V29, P53, DOI 10.1016/j.iac.2008.09.002; Freeman HJ, 2008, CAN J GASTROENTEROL, V22, P273, DOI 10.1155/2008/905325; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Galli SJ, 2008, J DERMATOL SCI, V49, P7, DOI 10.1016/j.jdermsci.2007.09.009; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; HAAS A, 2009, IMMUNOL ALL IN PRESS; Haines ML, 2008, ALIMENT PHARM THER, V28, P1042, DOI 10.1111/j.1365-2036.2008.03820.x; Himmel ME, 2008, IMMUNOLOGY, V125, P145, DOI 10.1111/j.1365-2567.2008.02939.x; Hogan SP, 2006, CURR ALLERGY ASTHM R, V6, P65, DOI 10.1007/s11882-006-0013-8; Hunt KA, 2009, GUT, V58, P473, DOI 10.1136/gut.2008.155879; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Kagalwalla AF, 2007, J PEDIATR GASTR NUTR, V44, P386, DOI 10.1097/01.mpg.0000243430.32087.5c; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Klinnert MD, 2009, IMMUNOL ALLERGY CLIN, V29, P99, DOI 10.1016/j.iac.2008.09.011; Konikoff MR, 2006, CLIN GASTROENTEROL H, V4, P1328, DOI 10.1016/j.cgh.2006.08.013; Koon HW, 2006, ANN NY ACAD SCI, V1088, P23, DOI 10.1196/annals.1366.024; Leslie C, 2009, J PEDIAT GASTROENTER; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Mason KL, 2008, ADV EXP MED BIOL, V635, P1, DOI 10.1007/978-0-387-09550-9_1; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mishra A, 2002, J IMMUNOL, V168, P2464, DOI 10.4049/jimmunol.168.5.2464; Mishra A, 2008, GASTROENTEROLOGY, V134, P204, DOI 10.1053/j.gastro.2007.10.002; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Ooi CY, 2008, J GASTROEN HEPATOL, V23, P1144, DOI 10.1111/j.1440-1746.2007.05239.x; Protheroe C, 2009, CLIN GASTROENTEROL H, V7, P749, DOI 10.1016/j.cgh.2009.03.022; Regueiro M, 2009, INFLAMM BOWEL DIS, V15, P1583, DOI 10.1002/ibd.20909; Rothenberg ME, 2009, GASTROENTEROLOGY, V137, P1238, DOI 10.1053/j.gastro.2009.07.007; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Shanahan F, 2009, CURR OPIN GASTROEN, V25, P301, DOI 10.1097/MOG.0b013e32832b12ef; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Spergel JM, 2005, ANN ALLERG ASTHMA IM, V95, P336, DOI 10.1016/S1081-1206(10)61151-9; Spergel JM, 2002, J ALLERGY CLIN IMMUN, V109, P363, DOI 10.1067/mai.2002.121458; Spergel JM, 2009, J PEDIATR GASTR NUTR, V48, P30, DOI 10.1097/MPG.0b013e3181788282; Straumann A, 2008, BEST PRACT RES CL GA, V22, P481, DOI 10.1016/j.bpg.2007.09.001; Straumann Alex, 2008, Gastrointest Endosc Clin N Am, V18, P99, DOI 10.1016/j.giec.2007.09.009; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Tantibhaedhyangkul U, 2009, ANN CLIN LAB SCI, V39, P99; van Lierop PPE, 2009, J PEDIATR GASTR NUTR, V48, P142, DOI 10.1097/MPG.0b013e3181821964; Verzegnassi F, 2007, GUT, V56, P1029, DOI 10.1136/gut.2006.117986; VICARIO M, 2009, GUT; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Yamamoto T, 2009, ALIMENT PHARM THER, V30, P99, DOI 10.1111/j.1365-2036.2009.04035.x; Yoshida H, 2009, INFLAMM BOWEL DIS, V15, P1245, DOI 10.1002/ibd.20896; Zhu X, 2009, AM J PHYSIOL-GASTR L, V297, pG550, DOI 10.1152/ajpgi.00148.2009	73	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		2			S255	S261		10.1016/j.jaci.2009.11.037	http://dx.doi.org/10.1016/j.jaci.2009.11.037			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	629CC	20176262	Bronze			2022-12-18	WOS:000280170600023
J	Schatz, M; Rachelefsky, G; Krishnan, JA				Schatz, Michael; Rachelefsky, Gary; Krishnan, Jerry A.			Follow-up after acute asthma episodes: What improves future outcomes?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Acute asthma; asthma exacerbation; emergency department; follow-up care; allergist care; pulmonologist care; asthma specialist care	EMERGENCY-DEPARTMENT VISITS; RANDOMIZED CONTROLLED-TRIAL; INNER-CITY CHILDREN; INTERVENTION PROGRAM; DEPRESSIVE SYMPTOMS; HOSPITAL ADMISSIONS; EDUCATION-PROGRAM; AFTER-DISCHARGE; SPECIALIST CARE; HEALTH OUTCOMES		[Schatz, Michael] Kaiser Permanente Med Ctr, Dept Allergy, San Diego, CA 92111 USA; [Rachelefsky, Gary] Univ Calif Los Angeles, David Geffen Sch Med, Execut Care Ctr Asthma Allergy & Resp Dis, Los Angeles, CA 90095 USA; [Krishnan, Jerry A.] Univ Chicago, Dept Med, Asthma & COPD Ctr, Chicago, IL 60637 USA; [Krishnan, Jerry A.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago; University of Chicago	Schatz, M (corresponding author), Kaiser Permanente Med Ctr, Dept Allergy, 7060 Clairemont Mesa Blvd, San Diego, CA 92111 USA.							Adams RJ, 2000, THORAX, V55, P566, DOI 10.1136/thorax.55.7.566; *AM LUNG ASS EP, 2007, TRENDS ASTHM MORB MO; Baren JM, 2006, CHEST, V129, P257, DOI 10.1378/chest.129.2.257; Baren JM, 2001, ANN EMERG MED, V38, P115, DOI 10.1067/mem.2001.116593; Bartlett SJ, 2001, ARCH PEDIAT ADOL MED, V155, P347, DOI 10.1001/archpedi.155.3.347; BOYCHUK RB, 2001, PEDIATRICS S, V17, P145; Brown MD, 2006, ANN ALLERG ASTHMA IM, V97, P44, DOI 10.1016/S1081-1206(10)61368-3; Castro M, 2003, AM J RESP CRIT CARE, V168, P1095, DOI 10.1164/rccm.200208-877OC; Cowie RL, 1997, CHEST, V112, P1534, DOI 10.1378/chest.112.6.1534; Dalcin PTR, 2004, BRAZ J MED BIOL RES, V37, P1331, DOI 10.1590/S0100-879X2004000900007; Debley JS, 2004, PEDIATR PULM, V38, P443, DOI 10.1002/ppul.20108; Diette GB, 1999, ARCH INTERN MED, V159, P2697, DOI 10.1001/archinte.159.22.2697; Doan T, 1996, ANN ALLERG ASTHMA IM, V76, P513, DOI 10.1016/S1081-1206(10)63270-X; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Eisner MD, 2005, ANN ALLERG ASTHMA IM, V94, P566, DOI 10.1016/S1081-1206(10)61135-0; Erickson S, 2005, HEALTH SERV RES, V40, P1443, DOI 10.1111/j.1475-6773.2005.00410.x; Ford M E, 1997, Ethn Health, V2, P329; Gaspar AP, 2002, ALLERGY ASTHMA PROC, V23, P295; Gorelick MH, 2006, PEDIATRICS, V117, pS127, DOI 10.1542/peds.2005-2000J; HAAS JS, 1994, J GEN INTERN MED, V9, P121, DOI 10.1007/BF02600024; HUGHES DM, 1991, PEDIATRICS, V87, P54; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Kanter LJ, 2002, ANN ALLERG ASTHMA IM, V89, P139, DOI 10.1016/S1081-1206(10)61929-1; Kelly CS, 2000, PEDIATRICS, V105, P1029, DOI 10.1542/peds.105.5.1029; Khan MSR, 2004, J PAEDIATR CHILD H, V40, P674, DOI 10.1111/j.1440-1754.2004.00490.x; Krishnan JA, 2009, J ALLERGY CLIN IMMUN, V124, pS29, DOI 10.1016/j.jaci.2009.05.007; Leickly FE, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.5.e8; Lieu TA, 1997, PEDIATRICS, V100, P334, DOI 10.1542/peds.100.3.334; Macias CG, 2006, PEDIATRICS, V117, pS86, DOI 10.1542/peds.2005-2000F; MAYO PH, 1990, ANN INTERN MED, V112, P864, DOI 10.7326/0003-4819-112-11-864; Maziak W, 2004, PEDIAT ALLERG IMM-UK, V15, P166, DOI 10.1046/j.1399-3038.2003.00105.x; Moore CM, 1997, ANN ALLERG ASTHMA IM, V78, P373, DOI 10.1016/S1081-1206(10)63199-7; Ng DKK, 2006, PEDIATR INT, V48, P158, DOI 10.1111/j.1442-200X.2006.02185.x; Palmer Lyle J, 2004, Aust Fam Physician, V33, P573; RACHELEFSKY GS, 2006, PEDIATRICS S, V17, pS159; Rand CS, 2000, J ALLERGY CLIN IMMUN, V105, P83, DOI 10.1016/S0091-6749(00)90182-9; ROBISON JI, 1992, MED SCI SPORT EXER, V24, P85; Schatz M, 2005, J ALLERGY CLIN IMMUN, V116, P1307, DOI 10.1016/j.jaci.2005.09.027; Schatz M, 2003, J ALLERGY CLIN IMMUN, V111, P503, DOI 10.1067/mai.2003.178; SCHATZ M, 2009, J ALLERGY CLIN IMMUN, V13, P124; Sin DD, 2004, AM J MED, V117, P479, DOI 10.1016/j.amjmed.2004.04.011; Smith SR, 2006, ACAD EMERG MED, V13, P835, DOI 10.1197/j.aem.2006.03.565; Smith SR, 2004, J PEDIATR-US, V145, P772, DOI 10.1016/j.jpeds.2004.08.029; SPERBER K, 1995, J ASTHMA, V32, P335, DOI 10.3109/02770909509082758; Teach SJ, 2006, ARCH PEDIAT ADOL MED, V160, P535, DOI 10.1001/archpedi.160.5.535; ten Brinke A, 2001, AM J RESP CRIT CARE, V163, P1093, DOI 10.1164/ajrccm.163.5.2004020; *US DEP HHS, 3 US DEP HHS NAT I H; Vilar MEB, 2000, ANN ALLERG ASTHMA IM, V84, P299, DOI 10.1016/S1081-1206(10)62777-9; Vollmer WM, 1997, ARCH INTERN MED, V157, P1201, DOI 10.1001/archinte.157.11.1201; Wasilewski Y, 1996, AM J PUBLIC HEALTH, V86, P1410, DOI 10.2105/AJPH.86.10.1410; Westley CR, 1997, ALLERGY ASTHMA PROC, V18, P15, DOI 10.2500/108854197778612835; Wever-Hess J, 2000, PEDIATR PULM, V29, P250, DOI 10.1002/(SICI)1099-0496(200004)29:4<250::AID-PPUL3>3.0.CO;2-4; WISSOW LS, 1988, AM J PUBLIC HEALTH, V78, P777, DOI 10.2105/AJPH.78.7.777; ZEIGER RS, 1991, J ALLERGY CLIN IMMUN, V87, P1160, DOI 10.1016/0091-6749(91)92162-T	54	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2009	124	2		S			S35	S42		10.1016/j.jaci.2009.05.006	http://dx.doi.org/10.1016/j.jaci.2009.05.006			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	482CE	19647134				2022-12-18	WOS:000268860500006
J	Maintz, L; Bussmann, C; Bieber, T; Novak, N				Maintz, Laura; Bussmann, Caroline; Bieber, Thomas; Novak, Natalija			Contribution of histamine metabolism to tachyphylaxis during the buildup phase of rush immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PERIPHERAL-BLOOD LEUKOCYTES; VENOM IMMUNOTHERAPY; HISTIDINE-DECARBOXYLASE; BASOPHILS; EXPRESSION; INDUCTION; ALLERGY; RELEASE; CELLS		[Maintz, Laura; Bussmann, Caroline; Bieber, Thomas; Novak, Natalija] Univ Bonn, Dept Dermatol & Allergy, D-5300 Bonn, Germany	University of Bonn	Maintz, L (corresponding author), Univ Bonn, Dept Dermatol & Allergy, D-5300 Bonn, Germany.	Natalija.Novak@ukb.uni-bonn.de						Bauer C, 2007, ANN ALLERG ASTHMA IM, V98, P281, DOI 10.1016/S1081-1206(10)60719-3; BERNSTEIN DI, 1989, J ALLERGY CLIN IMMUN, V84, P951, DOI 10.1016/0091-6749(89)90394-1; Hirata N, 1999, CLIN EXP ALLERGY, V29, P76; Jutel M, 1996, CLIN EXP ALLERGY, V26, P1112, DOI 10.1111/j.1365-2222.1996.tb00496.x; MACGLASHAN D, 1983, J IMMUNOL, V130, P2337; MAMUNESATO R, 1990, BIOCHEM PHARMACOL, V40, P1125; Muller UR, 2008, J ALLERGY CLIN IMMUN, V122, P1001, DOI 10.1016/j.jaci.2008.08.007; Nakajima T, 2004, J ALLERGY CLIN IMMUN, V113, P528, DOI 10.1016/j.jaci.2003.12.036; Pierkes M, 1999, J ALLERGY CLIN IMMUN, V103, P326, DOI 10.1016/S0091-6749(99)70509-9; RING J, 1977, LANCET, V1, P466; Siegmund R, 2000, J ALLERGY CLIN IMMUN, V106, P1190, DOI 10.1067/mai.2000.110928; STEPHAN V, 1989, ALLERGY, V44, P453, DOI 10.1111/j.1398-9995.1989.tb04182.x; ZEIGER RS, 1976, J ALLERGY CLIN IMMUN, V58, P172, DOI 10.1016/0091-6749(76)90152-4	13	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2009	123	3					701	703		10.1016/j.jaci.2008.11.009	http://dx.doi.org/10.1016/j.jaci.2008.11.009			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	426TQ	19121858	Bronze			2022-12-18	WOS:000264731200034
J	Rand, CS; Apter, AJ				Rand, Cynthia S.; Apter, Andrea J.			Mind the widening gap: Have improvements in asthma care increased asthma disparities?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						asthma morbidity	INNER-CITY ADULTS; HEALTH DISPARITIES; RACIAL DISPARITIES; EMERGENCY-ROOM; PUERTO-RICAN; GUIDELINES; ADHERENCE; PHYSICIAN; CHILDREN; QUALITY		[Rand, Cynthia S.] JHAAC, Johns Hopkins Sch Med, Baltimore, MD 21224 USA; [Apter, Andrea J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania	Rand, CS (corresponding author), JHAAC, Johns Hopkins Sch Med, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	crand@mail.jhmi.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL088469, U01HL072455] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL072455-04S1, HL088469, U01 HL072455-02S1, U01 HL072455-05, U01 HL072455-03, U01 HL072455-03S2, U01 HL072455, U01 HL072455-01, U01 HL072455-04, U01 HL072455-02, HL072455, K02 HL088469] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apter AJ, 2006, J ALLERGY CLIN IMMUN, V117, P345, DOI 10.1016/j.jaci.2005.11.026; Apter AJ, 1998, AM J RESP CRIT CARE, V157, P1810, DOI 10.1164/ajrccm.157.6.9712007; Barnes KC, 2006, J ALLERGY CLIN IMMUN, V117, P243, DOI 10.1016/j.jaci.2005.11.030; Cabana MD, 2007, CHEST, V132, p810S, DOI 10.1378/chest.07-1910; Canino G, 2008, J ALLERGY CLIN IMMUN, V121, P665, DOI 10.1016/j.jaci.2007.10.022; Canino G, 2006, SOC SCI MED, V63, P2926, DOI 10.1016/j.socscimed.2006.07.017; Cohen RT, 2006, CHEST, V130, P463, DOI 10.1016/S0012-3692(15)51862-X; Diette GB, 2007, CHEST, V132, p802S, DOI 10.1378/chest.07-1909; Fredrickson DD, 2004, J AM BOARD FAM PRACT, V17, P96, DOI 10.3122/jabfm.17.2.96; Gelfand EW, 2006, ANN ALLERG ASTHMA IM, V97, P298, DOI 10.1016/S1081-1206(10)60793-4; Gergen PJ, 2007, J ALLERGY CLIN IMMUN, V119, P165, DOI 10.1016/j.jaci.2006.10.032; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; Gupta RS, 2008, J ALLERGY CLIN IMMUN, V121, P639, DOI 10.1016/j.jaci.2007.11.036; Halm EA, 2006, CHEST, V129, P573, DOI 10.1378/chest.129.3.573; Halm EA, 2005, CHEST, V128, P1943, DOI 10.1378/chest.128.4.1943; Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046; Krishnan JA, 2001, ARCH INTERN MED, V161, P1660, DOI 10.1001/archinte.161.13.1660; Le TT, 2008, J ASTHMA, V45, P33, DOI 10.1080/02770900701815552; Mechanic D, 2005, HEALTH AFFAIR, V24, P335, DOI 10.1377/hlthaff.24.2.335; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Navaratnam P, 2008, ANN ALLERG ASTHMA IM, V100, P216, DOI 10.1016/S1081-1206(10)60445-0; Okelo SO, 2007, J GEN INTERN MED, V22, P976, DOI 10.1007/s11606-007-0209-1; Phelan J. C., 2005, Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, V60, pS27; Ressel GW, 2003, AM FAM PHYSICIAN, V68, P169; ShahCanning D, 1996, MED CARE, V34, P1171, DOI 10.1097/00005650-199612000-00002; Singer AJ, 2005, ANN EMERG MED, V45, P295, DOI 10.1016/j.annemergmed.2004.09.024; SMEDLEY BD, 2003, I MEDICINECOMMITTEE; Strunk Robert C., 2002, Journal of Allergy and Clinical Immunology, V109, P229, DOI 10.1067/mai.2002.120950; YAWN BP, 1997, AM FAM PHYSICIAN, V56, P621	30	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2008	122	2					319	321		10.1016/j.jaci.2008.07.004	http://dx.doi.org/10.1016/j.jaci.2008.07.004			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	337HO	18678342	Green Accepted			2022-12-18	WOS:000258426300017
J	Mendes, ES; Horvath, G; Campos, M; Wanner, A				Mendes, Eliana S.; Horvath, Gabor; Campos, Michael; Wanner, Adam			Rapid corticosteroid effect on beta(2)-adrenergic airway and airway vascular reactivity in patients with mild asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; airway blood flow; corticosteroids; fluticasone; nongenomic action; beta(2)-agonists; albuterol; levalbuterol	MUCOSAL BLOOD-FLOW; ORGANIC CATION TRANSPORTERS; HUMAN BRONCHIAL ARTERIAL; SMOOTH-MUSCLE-CELLS; INHALED CORTICOSTEROIDS; FLUTICASONE PROPIONATE; HEALTHY-VOLUNTEERS; GLUCOCORTICOSTEROIDS; PHARMACOKINETICS; RESPONSIVENESS	Background: Long-term glucocorticoid therapy has been suggested to improve airway and airway vascular smooth muscle responsiveness to inhaled beta(2)-agonists in patients with asthma. Objective: We sought to assess whether a single dose of an inhaled glucocorticoid acutely potentiates beta(2)-adrenergic airway and airway vascular smooth muscle reactivity in asthma. Methods: In 10 asthmatic and 10 healthy subjects, airway blood flow and FEV1 were measured before and 30 minutes after fluticasone or placebo inhalation and 15 minutes after the subsequent inhalation of racemic albuterol (0.6 mg or 1.25 mg) or (R)-albuterol (0.3 mg or 0.6 mg). Results: In healthy subjects all albuterol formulations increased airway blood flow equally after placebo or fluticasone pretreatment. In asthmatic subjects airway blood flow response was blunted after placebo and acutely restored after fluticasone pretreatment. Fluticasone pretreatment did not increase FEV1 responses to any albuterol formulation, except 0.6 mg racemic albuterol. Conclusion: A single dose of an inhaled glucocorticoid restores beta(2)-adrenergic airway vasodilator responses in patients with mild asthma. The mechanism of this rapid glucocorticoid effect remains to be clarified.	[Mendes, Eliana S.; Horvath, Gabor; Campos, Michael; Wanner, Adam] Univ Miami, Sch Med, Div Pulm & Crit Care Med, Miami, FL 33101 USA; [Horvath, Gabor] Semmelweis Univ, Sch Med, Dept Pulmonol, Budapest, Hungary	University of Miami; Semmelweis University	Mendes, ES (corresponding author), Univ Miami, Sch Med, Div Pulm & Crit Care Med, POB 016960 R-47, Miami, FL 33101 USA.	emendes@med.miami.edu	Campos, Michael/X-2025-2019	Campos, Michael/0000-0001-5485-9062				Brieva J, 2001, J APPL PHYSIOL, V90, P665, DOI 10.1152/jappl.2001.90.2.665; Brieva JL, 2000, AM J RESP CRIT CARE, V161, P293, DOI 10.1164/ajrccm.161.1.9905068; CARAMORI G, 2006, DRUG DISCOV TODAY, V3, P261; Chetta A, 2003, AM J RESP CRIT CARE, V167, P751, DOI 10.1164/rccm.200207-710OC; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; GEDDES BA, 1974, AM REV RESPIR DIS, V110, P420; Grundemann D, 1998, NAT NEUROSCI, V1, P349, DOI 10.1038/1557; Hayer-Zillgen M, 2002, BRIT J PHARMACOL, V136, P829, DOI 10.1038/sj.bjp.0704785; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; Horvath G, 2006, EUR RESPIR J, V27, P172, DOI 10.1183/09031936.06.00048605; Horvath G., 2003, Archives of Physiology and Biochemistry, V111, P341; Horvath G, 2003, AM J PHYSIOL-LUNG C, V285, pL829, DOI 10.1152/ajplung.00054.2003; Horvath G, 2001, AM J RESP CELL MOL, V25, P500, DOI 10.1165/ajrcmb.25.4.4559; JEFFERY J, 1979, P W PHARMACOL SOC, V22, P149; Ketchell RI, 2002, J ALLERGY CLIN IMMUN, V110, P603, DOI 10.1067/mai.2002.128486; Koepsell H, 2004, TRENDS PHARMACOL SCI, V25, P375, DOI 10.1016/j.tips.2004.05.005; Kumar SD, 2000, AM J RESP CRIT CARE, V161, P918, DOI 10.1164/ajrccm.161.3.9904106; Kumar SD, 1998, AM J RESP CRIT CARE, V158, P153, DOI 10.1164/ajrccm.158.1.9712141; Lipworth BJ, 1997, THORAX, V52, P849, DOI 10.1136/thx.52.10.849; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; MAK JCW, 1995, J CLIN INVEST, V96, P99, DOI 10.1172/JCI118084; MAK JCW, 1995, AM J PHYSIOL-LUNG C, V268, pL41, DOI 10.1152/ajplung.1995.268.1.L41; Mendes ES, 2004, AM J RESP CRIT CARE, V169, P1131, DOI 10.1164/rccm.200311-1544OC; Mendes ES, 2003, EUR RESPIR J, V21, P989, DOI 10.1183/09031936.03.00072402; Miller-Larsson A, 2006, CURR PHARM DESIGN, V12, P3261, DOI 10.2174/138161206778194187; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; ONORATO DJ, 1994, AM J RESP CRIT CARE, V149, P1132, DOI 10.1164/ajrccm.149.5.8173752; Orsida BE, 1999, THORAX, V54, P289, DOI 10.1136/thx.54.4.289; Paredi P, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-15; Pereira A, 2003, LUNG, V181, P201, DOI 10.1007/s00408-003-1022-1; Rodrigo G, 1998, AM J RESP CRIT CARE, V157, P698, DOI 10.1164/ajrccm.157.3.9704022; Rodrigo GJ, 2006, CHEST, V130, P1301, DOI 10.1378/chest.130.5.1301; Schmekel B, 1999, EUR RESPIR J, V13, P1230, DOI 10.1034/j.1399-3003.1999.13f04.x; SCURI M, 1995, J APPL PHYSIOL, V79, P1386, DOI 10.1152/jappl.1995.79.4.1386; Wanner A., 2003, Archives of Physiology and Biochemistry, V111, P319; Wanner Adam, 2004, Proc Am Thorac Soc, V1, P235, DOI 10.1513/pats.200402-013MS	36	17	18	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3					700	704		10.1016/j.jaci.2007.10.038	http://dx.doi.org/10.1016/j.jaci.2007.10.038			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR	18086493				2022-12-18	WOS:000253918900024
J	Lagranderie, M; Abolhassani, M; Vanoirbeek, J; Lefort, J; Nahori, MA; Silva, JRL; Huerre, M; Vargaftig, B; Marchal, G				Lagranderie, Micheline; Abolhassani, Mohammad; Vanoirbeek, Jeroen; Lefort, Jean; Nahori, Marie-Anne; Silva, Jose-Roberto Lapa; Huerre, Michel; Vargaftig, Boris; Marchal, Gilles			Mycobacterium bovis BCG killed by extended freeze-drying reduces airway hyperresponsiveness in 2 animal models	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						BCG killed by extended freeze-drying treatment; allergic asthma; mice; guinea pigs; killed BCG; airway hyperresponsiveness	ALLERGIC RESPONSE; DENDRITIC CELLS; MICE; INFLAMMATION; EOSINOPHILIA; RECRUITMENT; CHALLENGE; OVALBUMIN; VACCAE; ASTHMA	Background: Live BCG administered intranasally to mice inhibits the development of ovalbumin (OVA)-induced eosinophilia and airway hyperresponsiveness (AHR). It is unacceptable to treat human subjects intranasally with live BCG. Objective: We investigated whether BCG killed by extended freeze-drying (EFD) and subcutaneously injected has a protective effect in murine and guinea pig models of allergic airway inflammation. Methods: Mice were OVA sensitized (days 0 and 7), treated subcutaneously (day 14) with EFD and live or heat-killed BCG, and then OVA challenged (day 42). OVA-sensitized mice (days 0 and 7) were challenged (day 14) and EFD treated (day 18) before OVA rechallenge (day 46) to demonstrate the capacity of EFD to reverse the established lung inflammation. Guinea pigs were OVA sensitized (days 0 and 14), treated intradermally (day 35) with EFD, and OVA challenged (days 90-105). Results: In mice and guinea pigs EFD treatment reduced AHR. Among 3 BCG preparations, only EFD efficiently reduced AHR, eosinophilia, and the recruitment of dendritic cells to the lungs after OVA challenge. The protective effect of EFD is associated with production of the immunoregulatory cytokine IL-10. Moreover, EFD treatment did not induce toxic effects or delayed-type hypersensitivity to mycobacterial antigens; that is, it did not interfere with the diagnosis of tuberculosis. Conclusion: EFD administered subcutaneously inhibits the development of allergic airway inflammation and prevents AHR without inducing delayed-type hypersensitivity and side effects associated with live or heat-killed BCG.	[Lagranderie, Micheline; Abolhassani, Mohammad] Inst Pasteur, Lab Immunotherapie, F-75015 Paris, France; [Lefort, Jean; Nahori, Marie-Anne; Vargaftig, Boris] Inst Pasteur, Unite Pharmacol Cellulaire, Paris, France; [Huerre, Michel] Inst Pasteur, Unite Rech Expertise Histotechnol Pathol, Paris, France; [Vanoirbeek, Jeroen; Marchal, Gilles] Katholieke Univ Leuven, Unit Lung Toxicol, Lab Pneumol, Louvain, Belgium; [Silva, Jose-Roberto Lapa] Inst Thorac Dis, Rio De Janeiro, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; KU Leuven	Marchal, G (corresponding author), Inst Pasteur, Lab Immunotherapie, 25 Rue Dr Roux, F-75015 Paris, France.	gmarchal@pasteur.fr	Vargaftig, Bernardo Boris B.B.J./C-3323-2013; Vanoirbeek, Jeroen/D-5183-2016; Lapa e Silva, Jose R./AAS-4793-2020	Vanoirbeek, Jeroen/0000-0001-5508-3518; Lapa e Silva, Jose R./0000-0003-3116-0253; Marie-Anne, Nahori/0000-0002-4066-4528				Aaby P, 2000, CLIN EXP ALLERGY, V30, P644, DOI 10.1046/j.1365-2222.2000.00803.x; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Crater SE, 1999, AM J RESP CRIT CARE, V159, P806, DOI 10.1164/ajrccm.159.3.9805103; Eum SY, 1995, P NATL ACAD SCI USA, V92, P12290, DOI 10.1073/pnas.92.26.12290; Gheorghiu M, 1986, Dev Biol Stand, V58 ( Pt A), P191; Haile S, 1999, AM J RESP CELL MOL, V20, P891, DOI 10.1165/ajrcmb.20.5.3446; Herz U, 2000, CURR OPIN IMMUNOL, V12, P632, DOI 10.1016/S0952-7915(00)00155-2; Hopfenspirger MT, 2002, J IMMUNOL, V168, P2516, DOI 10.4049/jimmunol.168.5.2516; Hubeau C, 2003, CLIN EXP ALLERGY, V33, P386, DOI 10.1046/j.1365-2222.2003.01612.x; Lagranderie M, 2003, IMMUNOLOGY, V108, P352, DOI 10.1046/j.1365-2567.2003.01609.x; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lotte A, 1984, Adv Tuberc Res, V21, P107; Major T, 2002, VACCINE, V20, P1532, DOI 10.1016/S0264-410X(01)00496-0; MARCHAL G, 1986, P NATL ACAD SCI USA, V83, P3977, DOI 10.1073/pnas.83.11.3977; Moller GM, 1996, CLIN EXP ALLERGY, V26, P517, DOI 10.1111/j.1365-2222.1996.tb00571.x; Nahori MA, 2001, VACCINE, V19, P1484, DOI 10.1016/S0264-410X(00)00345-5; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Shirtcliffe PM, 2001, AM J RESP CRIT CARE, V163, P1410, DOI 10.1164/ajrccm.163.6.2003050; Stadler RH, 2002, NATURE, V419, P449, DOI 10.1038/419449a; Tarkowski M, 2007, AM J PHYSIOL-LUNG C, V292, pL207, DOI 10.1152/ajplung.00157.2005; Umetsu DT, 2003, J ALLERGY CLIN IMMUN, V112, P480, DOI 10.1067/mai.2003.1717; Wang CC, 1998, IMMUNOLOGY, V93, P307; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	24	17	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2					471	478		10.1016/j.jaci.2007.09.033	http://dx.doi.org/10.1016/j.jaci.2007.09.033			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	265CX	18037160	Green Published			2022-12-18	WOS:000253337800029
J	Doshi, J; Krawiec, ME				Doshi, Jayna; Krawiec, Marzena E.			Clinical manifestations of airway malacia in young children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						tracheomalacia; persistent wheezing; bronchoscopy	TRACHEOMALACIA; BRONCHOMALACIA; ETIOLOGY	A case of recurrent respiratory distress, wheezing, and "noisy" breathing in a 6-month-old infant with a normal birth history and chest radiographic evaluation is presented. The distinction between primary and secondary tracheomalacia is outlined. This report emphasizes the importance of clinical history in the evaluation of primary tracheomalacia.	[Doshi, Jayna] Natl Jewish Med & Res Ctr, Div Allergy & Immunol, Dept Pediat, Denver, CO 80206 USA; [Krawiec, Marzena E.] Natl Jewish Med & Res Ctr, Div Pediat Pulm Med, Denver, CO 80206 USA	National Jewish Health; National Jewish Health	Krawiec, ME (corresponding author), Natl Jewish Med & Res Ctr, Div Allergy & Immunol, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	krawiecm@njc.org						Austin J, 2003, PAEDIATR ANAESTH, V13, P3, DOI 10.1046/j.1460-9592.2003.00802.x; Boogaard R, 2005, CHEST, V128, P3391, DOI 10.1378/chest.128.5.3391; CLEMENTS BS, 1999, PEDIAT RESP MED, P1113; DURKIN ET, 2007, J PEDIATR SURG, V42, P7; FEIST JH, 1975, CHEST, V68, P340, DOI 10.1378/chest.68.3.340; Holinger Lauren D., 1997, P187; HOLINGER LD, 1980, ANN OTO RHINOL LARYN, V89, P397, DOI 10.1177/000348948008900502; PANITCH HB, 1990, PEDIATR PULM, V9, P170, DOI 10.1002/ppul.1950090309; ROCK MJ, 1988, PEDIATR PULM, V5, P55, DOI 10.1002/ppul.1950050111; Shell R, 2001, PEDIATR PULM, V31, P80, DOI 10.1002/1099-0496(200101)31:1<80::AID-PPUL1011>3.0.CO;2-O; STRAUSS H-J, 1989, Zeitschrift fuer Erkrankungen der Atmungsorgane, V172, P130	11	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2007	120	6					1276	1278		10.1016/j.jaci.2007.09.048	http://dx.doi.org/10.1016/j.jaci.2007.09.048			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241JX	18073123				2022-12-18	WOS:000251653800005
J	Debley, JS; Hallstrand, TS; Monge, T; Ohanian, A; Redding, GI; Zimmerman, J				Debley, Jason S.; Hallstrand, Teal S.; Monge, Tito; Ohanian, Arpy; Redding, Gregory I.; Zimmerman, Jerry			Methods to improve measurement of cysteinyl leukotrienes in exhaled breath condensate from subjects with asthma and healthy controls	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDREN; 8-ISOPROSTANE; MONTELUKAST		Univ Washington, Div Pulm Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Div Crit Care Med, Seattle, WA 98195 USA; Univ Washington, Div Pulm & Crit Care Med, Dept Med, Seattle, WA 98195 USA; Univ New Mexico, Div Crit Care Med, Dept Pediat, Albuquerque, NM 87131 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of New Mexico	Debley, JS (corresponding author), Univ Washington, Div Pulm Med, Dept Pediat, Seattle, WA 98195 USA.	jason.debley@seattlechildrens.org		Hallstrand, Teal/0000-0002-5059-6872	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL077626] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-00037] Funding Source: Medline; NHLBI NIH HHS [K23 HL077626, K23HL077626] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baraldi E, 2003, THORAX, V58, P505, DOI 10.1136/thorax.58.6.505; Biernacki WA, 2005, CHEST, V128, P1958, DOI 10.1378/chest.128.4.1958; Bucchioni E, 2004, RESP MED, V98, P651, DOI 10.1016/j.rmed.2003.12.011; Carraro S, 2005, J ALLERGY CLIN IMMUN, V115, P764, DOI 10.1016/j.jaci.2004.10.043; Csoma Z, 2002, AM J RESP CRIT CARE, V166, P1345, DOI 10.1164/rccm.200203-233OC; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Sandrini A, 2003, CHEST, V124, P1334, DOI 10.1378/chest.124.4.1334; Zanconato S, 2004, J ALLERGY CLIN IMMUN, V113, P257, DOI 10.1016/j.jaci.2003.10.046	9	17	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2007	120	5					1216	1217		10.1016/j.jaci.2007.06.029	http://dx.doi.org/10.1016/j.jaci.2007.06.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	231TZ	17655919	Bronze			2022-12-18	WOS:000250973400035
J	Platts-Mills, TAE; Satinover, SM; Naccara, L; Litonjua, AA; Phipatanakul, W; Carter, MC; Heymann, PW; Woodfolk, JA; Peters, EJ; Gold, DR				Platts-Mills, Thomas A. E.; Satinover, Shama M.; Naccara, Lisa; Litonjua, Augusto A.; Phipatanakul, Wanda; Carter, Melody C.; Heymann, Peter W.; Woodfolk, Judith A.; Peters, Edward J.; Gold, Diane R.			Prevalence and titer of IgE antibodies to mouse allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergy; mouse allergen; Mus m 1; asthma; inner-city; sensitization	INNER-CITY CHILDREN; RAT URINARY ALLERGENS; MODIFIED TH2 RESPONSE; RISK-FACTORS; DUST-MITE; ASTHMA; EXPOSURE; SENSITIZATION; CAT; ASSOCIATION	Background: Positive skin tests to allergens derived from mouse urine have been reported among patients with asthma. Very few data are available detailing the titer of IgE Ab to mouse allergen and how it varies by location and population. Objective: To evaluate further the prevalence and titer of IgE Ab to mouse-derived allergens and their relevance to total IgE and asthma. Methods: IgE Ab to mouse allergens was measured in 1165 sera from diverse populations including children and adults. The results were compared with IgE Ab to other allergens and total serum IgE. Results: Positive results were found in 79 sera, but only 15 had an IgE Ab titer >= 10 IU/mL. Results for IgE Ab to Mus m I showed a close quantitative correlation with IgE Ab to mouse allergen (r = 0.93; P <.001). Cohorts in neither Atlanta nor Virginia contained sera in which IgE Ab to mouse was dominant over other allergens or contributed significantly to total IgE. By contrast, among 319 mothers from minority groups in Boston, 11 sera had >= 10 IU/mL. In these sera, specific IgE Ab to mouse made a significant contribution to the total. Conclusion: Mouse allergen sensitization may contribute significantly to total IgE and allergy in African American and Hispanic populations from some northern cities. Analysis of the significance of an IgE Ab response should include quantitative comparison with other responses and total IgE. Clinical implications: Significance of rodent infestation and IgE Ab varies dramatically in different populations and areas of the United States.	Univ Virginia, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; NIAID, NIH, Bethesda, MD 20892 USA	University of Virginia; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Platts-Mills, TAE (corresponding author), Univ Virginia, Asthma & Allerg Dis Ctr, POB 801355, Charlottesville, VA 22908 USA.	tap2z@Virginia.edu		Platts-Mills, Thomas/0000-0002-1263-329X; Litonjua, Augusto/0000-0003-0422-5875	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020565, R01AI020565, P01AI050989] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20565, AI050989] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bush RK, 1998, J ALLERGY CLIN IMMUN, V102, P99, DOI 10.1016/S0091-6749(98)70060-0; CALL RS, 1992, J PEDIATR-US, V121, P862, DOI 10.1016/S0022-3476(05)80329-4; Carroll WD, 2006, ARCH DIS CHILD, V91, P405, DOI 10.1136/adc.2005.088278; Carter MC, 2001, J ALLERGY CLIN IMMUN, V108, P732, DOI 10.1067/mai.2001.119155; Chew GL, 2003, ENVIRON HEALTH PERSP, V111, P1348, DOI 10.1289/ehp.6124; COCKCROFT A, 1981, LANCET, V1, P827; Crater SE, 1999, AM J RESP CRIT CARE, V159, P806, DOI 10.1164/ajrccm.159.3.9805103; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P74, DOI 10.1016/j.jaci.2004.10.030; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Erwin EA, 2007, J ALLERGY CLIN IMMUN, V119, P359, DOI 10.1016/j.jaci.2006.12.648; Ferrari E, 2004, J ALLERGY CLIN IMMUN, V114, P341, DOI 10.1016/j.jaci.2004.04.028; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; GLEICH GJ, 1975, SCIENCE, V190, P1106, DOI 10.1126/science.1188389; Heederik D, 1999, J ALLERGY CLIN IMMUN, V103, P678, DOI 10.1016/S0091-6749(99)70242-3; Heymann PW, 2004, J ALLERGY CLIN IMMUN, V114, P239, DOI 10.1016/j.jaci.2004.04.006; Jeal H, 2006, AM J RESP CRIT CARE, V174, P21, DOI 10.1164/rccm.200506-964OC; Lewis SA, 2001, J ALLERGY CLIN IMMUN, V107, P615, DOI 10.1067/mai.2001.113523; Litonjua AA, 2005, J ALLERGY CLIN IMMUN, V115, P751, DOI 10.1016/j.jaci.2004.12.1138; Matsui EC, 2005, CLIN EXP ALLERGY, V35, P1347, DOI 10.1111/j.1365-2222.2005.02331.x; Matsui EC, 2005, J ALLERGY CLIN IMMUN, V115, P358, DOI 10.1016/j.jaci.2004.11.007; Matsui EC, 2004, J ALLERGY CLIN IMMUN, V113, P910, DOI 10.1016/j.jaci.2004.02.034; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; OHMAN JL, 1994, J ALLERGY CLIN IMMUN, V94, P810, DOI 10.1016/0091-6749(94)90147-3; Perzanowski MS, 2002, AM J RESP CRIT CARE, V166, P696, DOI 10.1164/rccm.2201035; Phipatanakul W, 2005, ALLERGY, V60, P697, DOI 10.1111/j.1398-9995.2005.00825.x; Phipatanakul W, 2000, J ALLERGY CLIN IMMUN, V106, P1070, DOI 10.1067/mai.2000.110796; Phipatanakul W, 2000, J ALLERGY CLIN IMMUN, V106, P1075, DOI 10.1067/mai.2000.110795; Platts-Mills JA, 2005, CONTEMP TOP LAB ANIM, V44, P12; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V79, P505, DOI 10.1016/0091-6749(87)90369-1; POLLART SM, 1988, J ALLERGY CLIN IMMUN, V82, P224, DOI 10.1016/0091-6749(88)91003-2; Portengen L, 2004, CLIN EXP ALLERGY, V34, P1243, DOI 10.1111/j.1365-2222.2004.02025.x; Reefer AJ, 2004, J IMMUNOL, V172, P2763, DOI 10.4049/jimmunol.172.5.2763; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; SCHUMACHER MJ, 1981, J ALLERGY CLIN IMMUN, V68, P310, DOI 10.1016/0091-6749(81)90157-3; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504	37	17	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2007	120	5					1058	1064		10.1016/j.jaci.2007.06.032	http://dx.doi.org/10.1016/j.jaci.2007.06.032			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	231TZ	17767949				2022-12-18	WOS:000250973400012
J	Crestani, E; Lohman, IC; Guerra, S; Wright, AL; Halonen, M				Crestani, Elena; Lohman, I. Carla; Guerra, Stefano; Wright, Anne L.; Halonen, Marilyn			Association of IL-5 cytokine production and in vivo IgE levels in infants and parents	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IgE; cytokine; eosinophils; allergic diseases	SERUM IMMUNOGLOBULIN-E; HUMAN EOSINOPHILS; INTERLEUKIN-5; ASTHMA; CELLS; CORD; PROLIFERATION; CHILDREN; BIRTH; AGE	Background: Total IgE in human subjects tracks strongly from birth onward through unknown mechanisms. Regulation of IgE might occur in relation to adaptive immune cytokine production. In vitro studies have assessed the role of individual cytokines in regulating IgE production in human subjects. Objective: We sought to investigate the association between IgE levels in vivo and the capacity of the individuals to produce adaptive immune cytokines. Methods: Blood samples from participants in the Tucson Infant Immune Study (children at birth and at 3 and 12 months of age, fathers, and mothers before and after delivery) were assessed for percentage of eosinophils and plasma total IgE levels. IFN-,gamma, IL-4, IL-5, IL-13, and IL-10 levels were measured in supernatants of mitogen-stimulated PBMCs and examined cross-sectionally for relation to cytokine production by using simple regression, multiple regression with cytokines only and with other known predictors of IgE levels, and longitudinally by means of random effects modeling. Results: After adjusting for eosinophils and other predictors, IL-5 production (but not that of other cytokines) was associated directly with total IgE levels in children at 3 months (P =.009) and 12 months (P =.011) of age but not at birth. The IL-5/IgE association was present also in fathers (P =.040) and in mothers, both during pregnancy (P <.001) and after delivery (P =.030). Conclusions: This study indicates that mitogen-stimulated IL-5 production is associated with in vivo total IgE levels, independent of the production of other cytokines and circulating eosinophils. Clinical implications: Understanding the regulation of IgE in vivo might help elucidate the development of allergic responses in individuals.	Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85724 USA; Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85721 USA; Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ 85721 USA; Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Halonen, M (corresponding author), Univ Arizona, Arizona Resp Ctr, 1501 N Campbell Ave,Room 2342A, Tucson, AZ 85724 USA.	mhalonen@arc.arizona.edu		Halonen, Marilyn/0000-0001-9606-935X				Allen JE, 1996, INT ARCH ALLERGY IMM, V109, P3, DOI 10.1159/000237225; AVRECH OM, 1994, INT ARCH ALLERGY IMM, V103, P160, DOI 10.1159/000236622; BARBEE RA, 1987, J ALLERGY CLIN IMMUN, V79, P919, DOI 10.1016/0091-6749(87)90241-7; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504; Ekstrand C, 1998, PREV VET MED, V37, P219, DOI 10.1016/S0167-5877(98)00090-7; Erickson LD, 2001, J IMMUNOL, V166, P1531, DOI 10.4049/jimmunol.166.3.1531; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; HALONEN M, 1991, CLIN EXP ALLERGY, V21, P235, DOI 10.1111/j.1365-2222.1991.tb00836.x; Holberg CJ, 2001, J ALLERGY CLIN IMMUN, V108, P772, DOI 10.1067/mai.2001.119158; Ishihara K, 1999, INT ARCH ALLERGY IMM, V120, P11, DOI 10.1159/000053585; Jacobsen HP, 2001, J ALLERGY CLIN IMMUN, V107, P659; Johnson CC, 1998, AM J EPIDEMIOL, V147, P1145; Lin YC, 2004, CLIN EXP ALLERGY, V34, P548, DOI 10.1111/j.1365-2222.2004.1928.x; Liu Chieh-An, 2003, Chang Gung Med J, V26, P561; LOPEZ AF, 1987, P NATL ACAD SCI USA, V84, P2761; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; Moss WJ, 2002, J INFECT DIS, V186, P879, DOI 10.1086/344230; Oryszczyn MP, 1999, CLIN EXP ALLERGY, V29, P334; PELTONEN L, 1988, ALLERGY, V43, P152, DOI 10.1111/j.1398-9995.1988.tb00410.x; PENE J, 1988, EUR J IMMUNOL, V18, P929, DOI 10.1002/eji.1830180615; PURKERSON JM, 1992, J EXP MED, V175, P973, DOI 10.1084/jem.175.4.973; Rafiq K, 2000, CLIN EXP IMMUNOL, V121, P86, DOI 10.1046/j.1365-2249.2000.01273.x; ROTHENBERG ME, 1989, J IMMUNOL, V143, P2311; SAARINEN UM, 1982, ACTA PAEDIATR SCAND, V71, P489, DOI 10.1111/j.1651-2227.1982.tb09457.x; Schwenger GTF, 2001, J BIOL CHEM, V276, P48502, DOI 10.1074/jbc.M107836200; Scirica CV, 2007, J ALLERGY CLIN IMMUN, V119, P81, DOI 10.1016/j.jaci.2006.09.002; SEHMI R, 1992, BLOOD, V79, P2953; Sewell WA, 1996, IMMUNOL CELL BIOL, V74, P274, DOI 10.1038/icb.1996.48; Soussi-Gounni A, 2001, J ALLERGY CLIN IMMUN, V107, P575, DOI 10.1067/mai.2001.114238; WALSH GM, 1990, IMMUNOLOGY, V71, P258; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190; YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43; YAMAGUCHI Y, 1991, BLOOD, V78, P2542; Yang M, 2003, J ALLERGY CLIN IMMUN, V112, P935, DOI 10.1016/j.jaci.2003.08.010; Zhang DH, 1998, J IMMUNOL, V161, P3817	36	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					820	826		10.1016/j.jaci.2007.05.033	http://dx.doi.org/10.1016/j.jaci.2007.05.033			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	220LH	17628648				2022-12-18	WOS:000250157700015
J	Piacentini, GL; Rigotti, E; Bodini, A; Peroni, D; Boner, AL				Piacentini, Giorgio L.; Rigotti, Erika; Bodini, Alessandro; Peroni, Diego; Boner, Attilio L.			Airway inflammation in elite swimmers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RESPIRATORY HEALTH; SWIMMING POOLS; CHILDREN		Univ Verona, Dept Pediat, I-37100 Verona, Italy	University of Verona	Piacentini, GL (corresponding author), Univ Verona, Dept Pediat, I-37100 Verona, Italy.	giorgio.piacentini@univr.it	Peroni, Diego G/K-4002-2018; Peroni, Diego/K-8795-2016	Peroni, Diego/0000-0002-0234-1373				Bernard A, 2006, ARCH DIS CHILD, V91, P620, DOI 10.1136/adc.2006.097097; Bodini A, 2004, PEDIAT ALLERG IMM-UK, V15, P26, DOI 10.1046/j.0905-6157.2003.00097.x; Bonetto G, 2006, AM J RESP CRIT CARE, V174, P545, DOI 10.1164/rccm.200509-1392OC; Carraro S, 2006, J ALLERGY CLIN IMMUN, V118, P958, DOI 10.1016/j.jaci.2006.07.016; Nemery B, 2002, EUR RESPIR J, V19, P790, DOI 10.1183/09031936.02.00308602; Nickmilder M, 2007, OCCUP ENVIRON MED, V64, P37, DOI 10.1136/oem.2005.025452	6	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2007	119	6					1559	1560		10.1016/j.jaci.2007.01.050	http://dx.doi.org/10.1016/j.jaci.2007.01.050			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	178PO	17399771	Bronze			2022-12-18	WOS:000247232800044
J	Nelson, HS				Nelson, Harold S.			Advances in upper airway diseases and allergen immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						upper airway diseases; allergen immunotherapy	SUBLINGUAL IMMUNOTHERAPY; DOUBLE-BLIND; POLLEN IMMUNOTHERAPY; CONTROLLED-TRIAL; RHINITIS; ASTHMA; EFFICACY; VACCINE; SAFETY; RHINOSINUSITIS	The purpose of this review is to highlight important articles on upper airway diseases and immunotherapy that appeared during 2006. Studies from Europe continue to examine the usefulness of the Allergic Rhinitis and its Impact on Asthma classification of allergic rhinitis as intermittent or persistent and its levels of severity as mild or moderate/severe. A number of physical agents were shown to effect nasal inflammation: sudden temperature changes in patients with allergic rhinitis increased eosinophilic inflammation; in children with allergic asthma, the personal exposure to particles <2.5 mu m air pollution correlated with percent of nasal eosinophils and levels of markers of nasal exudation; and in patients who developed rhinorrhea on exposure to cold and windy weather, nasal challenge with cold dry air caused sloughing of nasal epithelial cells. A 3-month double-blind, placebo-controlled study of nasal washes with amphoteracin B showed no benefit in patients with chronic rhinosinusitis. Studies of immunotherapy with grass and dog dander extracts confirmed the need for doses containing 15 to 20 mu g of the major allergen for optimal effectiveness. The protective effect of immunotherapy on the development of asthma in children with allergic rhinitis was shown to still be present 2 years after completion of a 3-year course of treatment. Injection immunotherapy with a moderate dose of house dust mite extract in house dust-sensitive adults with atopic dermatitis reduced symptoms and use of corticosteroids and antihistamines compared with treatment with about 1/1000 of that dose of the same extract. Pretreatment for 9 weeks with the monoclonal anti-IgE antibody omalizumab reduced systemic reactions during rush immunotherapy 5-fold and allowed further build-up at weekly intervals without systemic reactions. A review of sublingual immunotherapy confirmed both efficacy and safety, but evidence for appropriate dosing and for the effectiveness of sublingual immunotherapy employing multiple allergen mixes was still lacking. Two studies with a sublingual grass pollen extract tablet showed a clear dose response and the ability to initiate sublingual immunotherapy without an up-dosing phase. A pilot study with cytosine phosphorothionate quanosine DNA conjugated to the major allergen of ragweed reported impressive improvement in symptoms the first pollen season that persisted during the second pollen season without any further administration of the. conjugate. In conclusion, studies on rhinitis and sinusitis explored the pathophysiology of the disease more than offering new therapeutic approaches. Studies on immunotherapy addressed optimal dosing, but also a variety of safer and more convenient approaches such as reduction of IgE with omalizumab, conjugating allergen to immunostimulatory DNA sequences, or administration by the sublingual route.	Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	National Jewish Health	Nelson, HS (corresponding author), Natl Jewish Med & Res Ctr, 1400 Jackson St, Denver, CO 80206 USA.	nelsonh@njc.org						Amin HS, 2006, J ALLERGY CLIN IMMUN, V117, P169, DOI 10.1016/j.jaci.2005.10.010; Aoi N, 2006, J ALLERGY CLIN IMMUN, V117, P1359, DOI 10.1016/j.jaci.2006.02.018; Bauer R, 2006, J ALLERGY CLIN IMMUN, V118, P269, DOI 10.1016/j.jaci.2006.03.033; Bordignon V, 2006, ANN ALLERG ASTHMA IM, V97, P158, DOI 10.1016/S1081-1206(10)60006-3; Bousquet J, 2006, J ALLERGY CLIN IMMUN, V117, P158, DOI 10.1016/j.jaci.2005.09.047; Casale TB, 2006, J ALLERGY CLIN IMMUN, V117, P134, DOI 10.1016/j.jaci.2005.09.036; Ciprandi G, 2006, J ALLERGY CLIN IMMUN, V118, P1105, DOI 10.1016/j.jaci.2006.05.010; Colas C, 2006, J ALLERGY CLIN IMMUN, V117, P810, DOI 10.1016/j.jaci.2005.11.039; Cox LS, 2006, J ALLERGY CLIN IMMUN, V117, P1021, DOI 10.1016/j.jaci.2006.02.040; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Cruz AA, 2006, J ALLERGY CLIN IMMUN, V117, P1351, DOI 10.1016/j.jaci.2006.01.054; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; Durham SR, 2006, J ALLERGY CLIN IMMUN, V117, P802, DOI 10.1016/j.jaci.2005.12.1358; Dworetzky M, 2006, J ALLERGY CLIN IMMUN, V118, P1192, DOI 10.1016/j.jaci.2006.05.006; Ebbens FA, 2006, J ALLERGY CLIN IMMUN, V118, P1149, DOI 10.1016/j.jaci.2006.07.058; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; Gabler M, 2006, J ALLERGY CLIN IMMUN, V118, P734, DOI 10.1016/j.jaci.2006.04.048; Garcia-Robaina JC, 2006, J ALLERGY CLIN IMMUN, V118, P1026, DOI 10.1016/j.jaci.2006.07.043; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Graudenz GS, 2006, J ALLERGY CLIN IMMUN, V118, P1126, DOI 10.1016/j.jaci.2006.07.005; Greiner AN, 2006, J ALLERGY CLIN IMMUN, V118, P985, DOI 10.1016/j.jaci.2006.06.029; Higgins D, 2006, J ALLERGY CLIN IMMUN, V118, P504, DOI 10.1016/j.jaci.2006.05.001; Hissaria P, 2006, J ALLERGY CLIN IMMUN, V118, P128, DOI 10.1016/j.jaci.2006.03.012; KleinJan A, 2006, J ALLERGY CLIN IMMUN, V118, P1117, DOI 10.1016/j.jaci.2006.05.030; Kundig TM, 2006, J ALLERGY CLIN IMMUN, V117, P1470, DOI 10.1016/j.jaci.2006.01.040; Lent AM, 2006, J ALLERGY CLIN IMMUN, V118, P1249, DOI 10.1016/j.jaci.2006.07.055; Lockey RF, 2006, J ALLERGY CLIN IMMUN, V118, P1017, DOI 10.1016/j.jaci.2006.06.018; Lombardi C, 2006, J ALLERGY CLIN IMMUN, V117, P468, DOI 10.1016/j.jaci.2005.10.026; Meltzer EO, 2006, J ALLERGY CLIN IMMUN, V118, pS17, DOI 10.1016/j.jaci.2006.09.005; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS133, DOI 10.1016/j.jaci.2004.09.011; Miyahara S, 2006, J ALLERGY CLIN IMMUN, V118, P1110, DOI 10.1016/j.jaci.2006.06.014; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Nelson HS, 2004, J ALLERGY CLIN IMMUN, V113, P635, DOI 10.1016/j.jaci.2004.01.741; Nelson HS, 2006, J ALLERGY CLIN IMMUN, V117, P1047, DOI 10.1016/j.jaci.2005.12.1306; Nelson HS, 2005, J ALLERGY CLIN IMMUN, V115, P676, DOI 10.1016/j.jaci.2005.01.037; Niggemann B, 2006, ALLERGY, V61, P855, DOI 10.1111/j.1398-9995.2006.01068.x; Nikasinovic L, 2006, J ALLERGY CLIN IMMUN, V117, P1382, DOI 10.1016/j.jaci.2006.03.023; Oppenheimer J, 2006, ANN ALLERG ASTHMA IM, V96, P19, DOI 10.1016/S1081-1206(10)61034-4; Passalacqua G, 2006, J ALLERGY CLIN IMMUN, V117, P1054, DOI 10.1016/j.jaci.2005.12.1308; Passlacqua G, 2006, J ALLERGY CLIN IMMUN, V117, P946, DOI 10.1016/j.jaci.2005.12.1312; Ratner PH, 2006, J ALLERGY CLIN IMMUN, V118, P1142, DOI 10.1016/j.jaci.2006.07.050; Roberts G, 2006, J ALLERGY CLIN IMMUN, V117, P263, DOI 10.1016/j.jaci.2005.09.054; Sacchetti M, 2006, J ALLERGY CLIN IMMUN, V118, P872, DOI 10.1016/j.jaci.2006.06.022; Sahin-Yilmaz AA, 2006, J ALLERGY CLIN IMMUN, V118, P1190, DOI 10.1016/j.jaci.2006.04.006; Sarin S, 2006, J ALLERGY CLIN IMMUN, V118, P999, DOI 10.1016/j.jaci.2006.09.013; Van Hoecke H, 2006, J ALLERGY CLIN IMMUN, V118, P758, DOI 10.1016/j.jaci.2006.05.015; Werfel T, 2006, ALLERGY, V61, P202, DOI 10.1111/j.1398-9995.2006.00974.x; Wu XQ, 2006, J ALLERGY CLIN IMMUN, V118, P428, DOI 10.1016/j.jaci.2006.04.037; Ying S, 2006, J ALLERGY CLIN IMMUN, V117, P312, DOI 10.1016/j.jaci.2005.10.037	49	17	18	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2007	119	4					872	880		10.1016/j.jaci.2006.12.613	http://dx.doi.org/10.1016/j.jaci.2006.12.613			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	157OK	17292953				2022-12-18	WOS:000245729500015
J	Fletcher, CV; DeVille, JG; Samson, PM; Moye, JH; Church, JA; Spiegel, HML; Palumbo, P; Fenton, T; Smith, ME; Graham, B; Kraimer, JM; Shearer, WT				Fletcher, Courtney V.; DeVille, Jaime G.; Samson, Pearl M.; Moye, John H., Jr.; Church, Joseph A.; Spiegel, Hans M. L.; Palumbo, Paul; Fenton, Terence; Smith, M. Elizabeth; Graham, Bobbie; Kraimer, Joyce M.; Shearer, William T.			Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG(2) (PRO 542) observed in HIV-1-infected children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTIBODIES		Univ Colorado, Hlth Sci Ctr, Dept Clin Pharm, Denver, CO 80202 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; Harvard Univ, Sch Publ Hlth, Stat & Data Anal Ctr, Boston, MA 02115 USA; NICHHD, Pediat Adolescent & Maternal AIDS Branch, Bethesda, MD 20892 USA; Childrens Hosp, Keck Sch Med, Los Angeles, CA 90027 USA; Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; Childrens Natl Med Ctr, Washington, DC 20010 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; NIAID, Pediat Med Branch, Div Aids, Bethesda, MD 20892 USA; Social & Sci Syst Inc, Silver Spring, MD USA; Frontier Sci Fdn, Amherst, NY USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Children's Hospital Los Angeles; University of Southern California; Children's National Health System; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Social & Scientific Systems; Frontier Science Foundation; Baylor College of Medicine; Baylor College of Medicine	Fletcher, CV (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Clin Pharm, 4200 E 9th Ave, Denver, CO 80202 USA.	wtsheare@TexasChildrensHospital.org	Spiegel, Hans/AAC-4220-2020	Shearer, William/0000-0002-2483-2130	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041983, N01HD033162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071, M01RR000043, M01RR000240, M01RR000865, K01RR000188, M01RR000533, M01RR000188, M01RR000645, M01RR002172, M01RR020359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027551, R43AI048278, U01AI041110, U01AI032921, U01AI027550, R01AI043084, U19AI066329, U01AI041089, R44AI048278, P30AI036211] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000071, M01 RR000188-420393, M01 RR000188, M01 RR002172, M01 RR000533, RR-020359, M01 RR000865, RR-00071, RR-00043, M01 RR000645, K01 RR000188, M01 RR020359, M01 RR000240, RR-00240, RR-00865, M01 RR000043, RR-00645, RR-00533, RR-02172, M01 RR000188-380393, RR-00188] Funding Source: Medline; NIAID NIH HHS [AI-41110, R43 AI048278, R44 AI048278, AI-48278, AI-41089, U01 AI027551, U01 AI027550, AI-27551, U01 AI041089, AI-43084, AI-32921, P30 AI036211, AI-66329, U01 AI041110, U01 AI032921, U19 AI066329, AI-27550] Funding Source: Medline; NICHD NIH HHS [U01 HD041983, HD-3-3162] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ballow M, 2006, J ALLERGY CLIN IMMUN, V118, P1209, DOI 10.1016/j.jaci.2006.09.024; Jacobson JM, 2004, ANTIMICROB AGENTS CH, V48, P423, DOI 10.1128/AAC.48.2.423-429.2004; Jacobson JM, 2000, J INFECT DIS, V182, P326, DOI 10.1086/315698; Junghans RP, 1997, IMMUNOL RES, V16, P29, DOI 10.1007/BF02786322; Liossis SNC, 2005, J ALLERGY CLIN IMMUN, V116, P721, DOI 10.1016/j.jaci.2005.06.035; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Presta LG, 2005, J ALLERGY CLIN IMMUN, V116, P731, DOI 10.1016/j.jaci.2005.08.003; Shearer WT, 2006, J ALLERGY CLIN IMMUN, V118, P518, DOI 10.1016/j.jaci.2006.03.028; Shearer WT, 2000, J INFECT DIS, V182, P1774, DOI 10.1086/317622; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; Waldmann T A, 1972, Ciba Found Symp, V9, P5	11	17	18	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2007	119	3					747	750		10.1016/j.jaci.2006.10.045	http://dx.doi.org/10.1016/j.jaci.2006.10.045			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	146HL	17336619	Bronze, Green Accepted			2022-12-18	WOS:000244925000033
J	Sato, H; Silveira, L; Fingerlin, T; Dockstader, K; Gillespie, M; Lagan, AL; Lympany, P; Sawyer, RT; du Bois, RM; Welsh, KI; Maier, LA				Sato, Hiroe; Silveira, Lori; Fingerlin, Tasha; Dockstader, Karen; Gillespie, May; Lagan, Anna L.; Lympany, Penny; Sawyer, Richard T.; du Bois, Roland M.; Welsh, Kenneth I.; Maier, Lisa A.			TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						TNF-alpha; chronic beryllium disease; beryllium sensitization; berylliosis; genetics; polymorphism; bronchoalveolar lavage	NECROSIS-FACTOR-ALPHA; PROMOTER REGION; GENE POLYMORPHISM; CLASS-II; T-CELLS; SUSCEPTIBILITY; SARCOIDOSIS; HYPERSENSITIVITY; HLA-DPB1; RELEASE	Background: Beryllium stimulates TNF-alpha from chronic beryllium disease (CBD) bronchoalveolar lavage (BAL) cells. Objective: We sought to relate TNF polymorphisms to beryllium-stimulated TNF-a production, to the development of CBD, and to the risk of more severe CBD over time. Methods: We recruited 147 patients with CBD, 112 beryllium-sensitized subjects, and 323 control subjects; genotyped 5 TNF promoter polymorphisms; and measured beryllium-stimulated and unstimulated BAL cell TNF-a production from a subset of subjects. Results: Beryllium-stimulated, but not beryllium-unstimulated, BAL cell TNF-a production was significantly increased in patients with CBD compared with that seen in those only sensitized (P = .0002). Those subjects with the TNF-857T allele and the only haplotype (haplotype 4) containing this allele demonstrated significantly lower unstimulated BAL cell TNF-alpha production compared with that seen in noncarriers (P = .009). Patients with CBD alone and combined with sensitized subjects carrying the TNF haplotype I compared with those without this haplotype had significantly increased beryllium-stimulated BAL cell TNF-a levels (P = .02). We found no significant association between patients with CBD, sensitized subjects, and control subjects with any of the TNF promoter polymorphisms or haplotypes. A greater decrease in PaO2 at maximum exercise was noted in patients with CBD with the -1031C allele (P = .03) and with haplotypes other than the TNF haplotype I (P = .01), 3 (from 5) of which contain the - 1031 C allele. Conclusions: The -857T allele and haplotype I are associated with BAL cell TNF-alpha production, indicating a potential role of TNF promoter variants in regulation of TNF production in sensitized subjects and patients with CBD. Clinical implications: TNF promoter variants are not risk factors for CBD or sensitization.	Natl Jewish Med & Res Ctr, Dept Med, Div Environm & Occupat Hlth Sci, Robert H Hollis Lab Environm & Occupat Hlth, Denver, CO 80206 USA; Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Clin Genom Grp, London, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart Lung Inst, London, England; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80202 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm & Crit Care Sci, Denver, CO 80202 USA	National Jewish Health; Imperial College London; Royal Brompton Hospital; Imperial College London; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Maier, LA (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, Div Environm & Occupat Hlth Sci, Robert H Hollis Lab Environm & Occupat Hlth, 1400 Jackson St, Denver, CO 80206 USA.	maierL@njc.org	Maier, Lisa/AAA-4378-2020		NCRR NIH HHS [M01 RR00051] Funding Source: Medline; NIEHS NIH HHS [P01 ES11810] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011810] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allen RD, 1999, MOL IMMUNOL, V36, P1017, DOI 10.1016/S0161-5890(99)00127-3; Amicosante M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-94; BOST TW, 1993, SEMIN RESPIR MED, V14, P197, DOI 10.1055/s-2007-1006320; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Camarena A, 2001, AM J RESP CRIT CARE, V163, P1528, DOI 10.1164/ajrccm.163.7.2004023; Dotti C, 2004, SARCOIDOSIS VASC DIF, V21, P29; Gaede KJ, 2005, J MOL MED-JMM, V83, P397, DOI 10.1007/s00109-004-0626-0; Gonzalez S, 2003, AM J GASTROENTEROL, V98, P1101, DOI 10.1016/S0002-9270(03)00134-5; Grutters JC, 2002, AM J RESP CRIT CARE, V165, P1119, DOI 10.1164/ajrccm.165.8.200110-0320; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Maier L A, 2001, Appl Occup Environ Hyg, V16, P514, DOI 10.1080/104732201750169570; Maier LA, 2003, J IMMUNOL, V171, P6910, DOI 10.4049/jimmunol.171.12.6910; Maier LA, 2001, AM J RESP CRIT CARE, V164, P1192, DOI 10.1164/ajrccm.164.7.2012123; Maier LA, 2001, EUR RESPIR J, V17, P403, DOI 10.1183/09031936.01.17304030; Maier LA, 1999, AM J RESP CRIT CARE, V159, P1342, DOI 10.1164/ajrccm.159.4.9806106; McCanlies EC, 2003, AM J EPIDEMIOL, V157, P388, DOI 10.1093/aje/kwg001; MROZ MM, 1991, J ALLERGY CLIN IMMUN, V88, P54, DOI 10.1016/0091-6749(91)90300-D; Newman LS, 1996, ENVIRON HEALTH PERSP, V104, P953, DOI 10.2307/3433017; Newman LS, 2005, AM J RESP CRIT CARE, V171, P54, DOI 10.1164/rccm.200402-190OC; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Rossman MD, 2002, AM J RESP CRIT CARE, V165, P788, DOI 10.1164/ajrccm.165.6.2104002; SALTINI C, 1989, NEW ENGL J MED, V320, P1103, DOI 10.1056/NEJM198904273201702; Saltini C, 2001, EUR RESPIR J, V18, P677, DOI 10.1183/09031936.01.00106201; Sawyer R. T., 2004, AM J RESP CELL MOL B, V169, P893; Sawyer RT, 2004, AM J RESP CELL MOL, V31, P122, DOI 10.1165/rcmb.2003-0336OC; Seitzer U, 1997, CYTOKINE, V9, P787, DOI 10.1006/cyto.1997.0224; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Somoskovi A, 1999, CYTOKINE, V11, P882, DOI 10.1006/cyto.1999.0498; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Takashige N, 1999, TISSUE ANTIGENS, V54, P191, DOI 10.1034/j.1399-0039.1999.540211.x; Tinkle SS, 1997, J IMMUNOL, V158, P518; Tinkle SS, 1997, AM J RESP CRIT CARE, V156, P1884, DOI 10.1164/ajrccm.156.6.9610040; Tinkle SS, 1999, J IMMUNOL, V163, P2747; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Welsh K, 1999, Rev Immunogenet, V1, P157	36	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2007	119	3					687	696		10.1016/j.jaci.2006.10.028	http://dx.doi.org/10.1016/j.jaci.2006.10.028			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	146HL	17208287	Bronze			2022-12-18	WOS:000244925000023
J	Vasavda, N; Eichholtz, T; Takahashi, A; Affleck, K; Matthews, JG; Barnes, PJ; Adcock, IM				Vasavda, Nisha; Eichholtz, Thomas; Takahashi, Atsushi; Affleck, Karen; Matthews, John G.; Barnes, Peter J.; Adcock, Ian M.			Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cofilin-1; peripheral blood T cells; glucocorticosteroids; severe asthma; Jurkat T cells	N-TERMINAL KINASE; GLUCOCORTICOID-RECEPTOR; NUCLEAR TRANSLOCATION; C-JUN; INSENSITIVE ASTHMA; RESISTANT ASTHMA; PROTEIN-KINASE; T-LYMPHOCYTE; LIM-KINASE; IN-VIVO	Background: Glucocorticoids are the mainstay of asthma therapy; however, a proportion of patients with asthma has a severe form of the disease that fails to respond to therapy. Understanding the molecular mechanisms behind glucocorticoid-insensitive asthma is therefore of clinical importance. Evidence in glucocorticoid-unresponsive Henrietta Lack (HeLa) cells indicated that cofilin-1 could act as an inhibitor of glucocorticoid function. Objective: To determine whether cofilin-1 expression is abnormally expressed in cells from patients with severe glueocorticoid-insensitive asthma and examine the effect of cofdin-1 overexpression on glucocorticoid function. Methods: Peripheral blood CD4(+) T cells were purified from 16 subjects with severe glucocorticoid-insensitive asthma and 16 subjects with mild glucocorticoid-sensitive asthma, and cofilin1 expression was determined by quantitative real-time RT-PCR and Western blotting. The effect of dexamethasone on cofilin1 expression was determined in Jurkat T cells, and the effect of cofilin-1 overexpression on anti-CD3/CD28-stimulated IL-2 release was measured. Results: Peripheral blood CD4(+) T cells from subjects with severe glucocorticoid-insensitive asthma are less responsive to dexamethasone than cells from subjects with mild glucocorticoid-sensitive asthma. Cells from these patients express significantly (P <.05) higher levels of cofilin-1 than cells from subjects with mild asthma. Dexamethasone did not affect cofilin-1 expression in Jurkat T cells. Functionally, dexamethasone suppression of anti-CD3/CD28-stimulated IL-2 was attenuated in Jurkat cells overexpressing cofilin-1. Conclusion: These results suggest that increased cofilin-1 expression may be important in the regulation of glucocorticoid sensitivity in peripheral blood lymphocytes of patients with severe treatment-insensitive asthma. Clinical implications: Understanding the mechanisms of enhanced cofilin-1 expression may lead to the development of new therapies for severe treatment-insensitive asthma.	GlaxoSmithKline Res & Dev Ltd, Resp & Inflammat Ctr Excellence Drug Discovery, Stevenage, Herts, England	GlaxoSmithKline	Adcock, IM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis Sect, Dovehouse St, London SW3 6LY, England.	ian.adcock@imperial.ac.uk	Adcock, Ian/L-3217-2019	Barnes, Peter/0000-0002-5122-4018; Adcock, Ian/0000-0003-2101-8843	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; [Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bantel H, 2002, FASEB J, V16, P1832, DOI 10.1096/fj.02-0223fje; BARNES PJ, 1995, NEW ENGL J MED, V332, P868, DOI 10.1056/NEJM199503303321307; Barnes PJ, 2001, RESPIR RES, V2, P64, DOI 10.1186/rr39; Barnes PJ, 2003, ANN INTERN MED, V139, P359, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00012; BLIKSTAD I, 1978, CELL, V15, P935, DOI 10.1016/0092-8674(78)90277-5; Caramori G, 2001, EUR RESPIR J, V18, P466, DOI 10.1183/09031936.01.00040701; Chung KF, 1999, EUR RESPIR J, V13, P1198; Farrell RJ, 2003, J ENDOCRINOL, V178, P339, DOI 10.1677/joe.0.1780339; HACZKU A, 1994, J ALLERGY CLIN IMMUN, V93, P510, DOI 10.1016/0091-6749(94)90361-1; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.3.CO;2-L; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; MEUER SC, 1986, J IMMUNOL, V136, P4106; Moore WC, 2006, J ALLERGY CLIN IMMUN, V117, P487, DOI 10.1016/j.jaci.2006.01.033; Nebl G, 1996, J BIOL CHEM, V271, P26276, DOI 10.1074/jbc.271.42.26276; Newton R, 1997, BIOCHEM BIOPH RES CO, V237, P28, DOI 10.1006/bbrc.1997.7064; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Norman M, 2002, CURR OPIN PHARMACOL, V2, P723, DOI 10.1016/S1471-4892(02)00232-1; Oren A, 1999, MOL CELL BIOL, V19, P1742; Robinson DS, 2003, EUR RESPIR J, V22, P478, DOI 10.1183/09031936.03.00017003; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Ruegg J, 2004, MOL CELL BIOL, V24, P9371, DOI 10.1128/MCB.24.21.9371-9382.2004; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Samstag Y, 1996, J IMMUNOL, V156, P4167; SAMSTAG Y, 1988, P NATL ACAD SCI USA, V85, P9689, DOI 10.1073/pnas.85.24.9689; Smith SJ, 2003, AM J PHYSIOL-LUNG C, V284, pL279, DOI 10.1152/ajplung.00170.2002; Sousa AR, 1999, J ALLERGY CLIN IMMUN, V104, P565, DOI 10.1016/S0091-6749(99)70325-8; Syed F, 1998, QJM-MON J ASSOC PHYS, V91, P567, DOI 10.1093/qjmed/91.8.567; Takahashi E, 2002, INT IMMUNOPHARMACOL, V2, P1419, DOI 10.1016/S1567-5769(02)00083-8; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	41	17	19	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2006	118	5					1090	1096		10.1016/j.jaci.2006.07.039	http://dx.doi.org/10.1016/j.jaci.2006.07.039			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	137GY	17088134				2022-12-18	WOS:000244282300014
J	Shearer, WT; DeVille, JG; Samson, PM; Moye, JH; Fletcher, CV; Church, JA; Spiegel, HML; Palumbo, P; Fenton, T; Smith, ME; Graham, B; Kraimer, JM; Olson, WC				Shearer, William T.; DeVille, Jaime G.; Samson, Pearl M.; Moye, John H., Jr.; Fletcher, Courtney V.; Church, Joseph A.; Spiegel, Hans M. L.; Palumbo, Paul; Fenton, Terence; Smith, M. Elizabeth; Graham, Bobbie; Kraimer, Joyce M.; Olson, William C.		Pediat AIDS Clin Trials Grp; Protocol 351 Study Grp	Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG(2) (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNODEFICIENCY-VIRUS TYPE-1; ENTRY INHIBITORS; INFECTION		Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; Harvard Univ, Sch Publ Hlth, Stat & Data Anal Ctr, Boston, MA 02115 USA; NICHHD, Pediat Adolescent & Maternal AIDS Branch, Bethesda, MD 20892 USA; Univ Colorado, Hlth Sci Ctr, Dept Clin Pharmacol, Denver, CO USA; Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA 90027 USA; Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; Childrens Natl Med Ctr, Washington, DC 20010 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; NIAID, Pediat Med Branch, Div AIDS, Bethesda, MD 20892 USA; Frontier Sci Fdn, Amherst, NY USA; Progen Pharmaceut Inc, Tarrytown, NY USA; Social & Sci Syst Inc, Silver Spring, MD USA	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Los Angeles; University of Southern California; Children's National Health System; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Frontier Science Foundation; Social & Scientific Systems	Shearer, WT (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.		Spiegel, Hans/AAC-4220-2020	Shearer, William/0000-0002-2483-2130	NCRR NIH HHS [RR 02172, RR 00865, RR 00645, RR 00533, RR 00240, RR 00188, RR 00071, RR 00043] Funding Source: Medline; NIAID NIH HHS [AI 27550, AI 27551, AI 66239, AI 32921, AI 48278, AI 41089, AI 41110, AI 43084] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172, M01RR000865, M01RR000043, M01RR000645, M01RR000533, M01RR000240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043084, R21AI066239, U01AI027550, U01AI032921, U01AI041089, R43AI048278, R44AI048278, U01AI041110, U01AI027551] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Castagna A, 2005, DRUGS, V65, P879, DOI 10.2165/00003495-200565070-00001; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Hammer SM, 2005, NEW ENGL J MED, V353, P1702, DOI 10.1056/NEJMcp051203; Jacobson JM, 2004, ANTIMICROB AGENTS CH, V48, P423, DOI 10.1128/AAC.48.2.423-429.2004; Kitchen CMR, 2004, J VIROL, V78, P11296, DOI 10.1128/JVI.78.20.11296-11302.2004; Liossis SNC, 2005, J ALLERGY CLIN IMMUN, V116, P721, DOI 10.1016/j.jaci.2005.06.035; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; OLSON WC, 2006, 13 C RETR OPP INF DE; Rusert P, 2005, J VIROL, V79, P8454, DOI 10.1128/JVI.79.13.8454-8469.2005; Shearer WT, 2000, J INFECT DIS, V182, P1774, DOI 10.1086/317622; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001	11	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2006	118	2					518	521		10.1016/j.jaci.2006.03.028	http://dx.doi.org/10.1016/j.jaci.2006.03.028			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	075IH	16890780				2022-12-18	WOS:000239877700031
J	Suzukawa, M; Yamaguchi, M; Komiya, A; Kimura, M; Nito, T; Yamamoto, K				Suzukawa, M; Yamaguchi, M; Komiya, A; Kimura, M; Nito, T; Yamamoto, K			Ortho-phthalaidehyde-induced anaphylaxis after laryngoscopy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GLUTARALDEHYDE; ENDOSCOPY		Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Dept Otolaryngol, Tokyo, Japan	University of Tokyo; University of Tokyo	Suzukawa, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan.			Suzukawa, Maho/0000-0002-2265-1950				Alvarado CJ, 2000, AM J INFECT CONTROL, V28, P138; CALDER IM, 1992, LANCET, V339, P433, DOI 10.1016/0140-6736(92)90124-L; Cooke RPD, 2003, J HOSP INFECT, V54, P226, DOI 10.1016/S0195-6701(03)00040-9; Sokol WN, 2004, J ALLERGY CLIN IMMUN, V114, P392, DOI 10.1016/j.jaci.2004.04.031	4	17	18	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2006	117	6					1500	1501		10.1016/j.jaci.2006.02.015	http://dx.doi.org/10.1016/j.jaci.2006.02.015			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	053UX	16751019				2022-12-18	WOS:000238332300046
J	Fernandez-Nieto, M; Quirce, S; Fraj, J; del Pozo, V; Seoane, C; Sastre, B; Lahoz, C; Sastre, J				Fernandez-Nieto, M; Quirce, S; Fraj, J; del Pozo, V; Seoane, C; Sastre, B; Lahoz, C; Sastre, J			Airway inflammation in occupational asthma caused by styrene	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INDUCED SPUTUM		Fdn Jimenez Diaz, Dept Allergy, E-28040 Madrid, Spain; Hosp Clin, Dept Allergy, Zaragoza, Spain; Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain		Fernandez-Nieto, M (corresponding author), Fdn Jimenez Diaz, Dept Allergy, Av Reyes Catolicos 2, E-28040 Madrid, Spain.		Sastre, Beatriz/F-1715-2015; s, q/AAD-7171-2020	Sastre, Beatriz/0000-0002-2394-6849; 				Fernandez-Caldas E, 1998, J ALLERGY CLIN IMMUN, V101, P554, DOI 10.1016/S0091-6749(98)70364-1; Gauvreau GM, 2000, AM J RESP CRIT CARE, V161, P1473, DOI 10.1164/ajrccm.161.5.9908090; Girard F, 2004, AM J RESP CRIT CARE, V170, P845, DOI 10.1164/rccm.200403-380OC; Hadjicharalambous C, 2004, J ALLERGY CLIN IMMUN, V113, P657, DOI 10.1016/j.jaci.2004.01.757; HAYES JP, 1991, THORAX, V46, P396, DOI 10.1136/thx.46.5.396; Krakowiak Anna, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P27; Lemiere C, 2001, J ALLERGY CLIN IMMUN, V107, P1063, DOI 10.1067/mai.2001.115486; MOSCATO G, 1984, J OCCUP ENVIRON MED, V26, P552, DOI 10.1097/00043764-198408000-00001; MOSCATO G, 1987, J OCCUP ENVIRON MED, V29, P957; Oner F, 2004, RESPIRATION, V71, P336, DOI 10.1159/000079636	10	17	17	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2006	117	4					948	950		10.1016/j.jaci.2005.12.1350	http://dx.doi.org/10.1016/j.jaci.2005.12.1350			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	033QB	16630957				2022-12-18	WOS:000236862800035
J	Raby, BA; Van Steen, K; Lazarus, R; Celedon, JC; Silverman, EK; Weiss, ST				Raby, BA; Van Steen, K; Lazarus, R; Celedon, JC; Silverman, EK; Weiss, ST			Eotaxin polymorphisms and serum total IgE levels in children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eotaxin. CCLII; single nucleotide polymorphism; IgE; genetics; asthma; association	SINGLE-NUCLEOTIDE POLYMORPHISMS; CHEMOKINE RECEPTOR CCR3; EOSINOPHIL CHEMOATTRACTANT; POPULATION STRATIFICATION; LINKAGE DISEQUILIBRIUM; BRONCHOALVEOLAR LAVAGE; INCREASED EXPRESSION; INDUCED SPUTUM; GENE FAMILY; IL-9	Background: Eotaxin (chemokine, CC motif, ligand; CCL11) is a potent eosinophil chemoattractant strongly implicated in the pathobiology of asthma. Genetic variation at the CCL11 locus has been correlated with serum total IgE, blood eosinophil counts, and circulating eotaxin protein levels in several case-control asthma studies. Family-based association studies of CCL11 genetic variants have not been reported to date. Objective: To evaluate 9 common CCL11 single nucleotide polymorphisms (SNPs) in nuclear families ascertained through patients with asthma participating in the Childhood Asthma Management Program study. Methods: Single nucleotide polymorphism genotyping was performed by using minisequencing and probe hybridization platforms. Family-based association analysis for asthma and 4 asthma-related intermediate quantitative phenotypes was performed by using FBAT. Results: One SNP, -384A > G, was associated with asthma among African American families (P = .01). CCL11 SNPs and haplotypes were not associated with asthma among white or Hispanic families. Two low-frequency alleles in strong pairwise linkage disequilibrium, -426C and IVS2+199A, were associated with lower serum total IgE levels (P = .0006 and P = .009, respectively) in white families, whereas 2 more common variants, -576C and g.4438C, were associated with higher IgE levels in African American families (P = .01-.04). Haplotype analysis in the white cohort provided additional evidence of association with serum total IgE, implicating 2 haplotypes. No single SNP or haplotype associations were observed with blood eosinophil levels, FEV1, or airway responsiveness. Conclusion: These findings provide further evidence that genetic variation at the CCL11 locus is an important determinant of serum total IgE levels among patients with asthma.	Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care Med, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Sch Publ Hlth, Dept Biostat, Boston, MA USA; Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA USA; Harvard Partners Ctr Genet & Genom, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University	Raby, BA (corresponding author), Brigham & Womens Hosp, Channing Lab, Dept Med, 75 Francis St, Boston, MA 02115 USA.	raby@channing.harvard.edu	Raby, Benjamin/AAK-3866-2021	lazarus, ross/0000-0003-3939-1961; Van Steen, Kristel/0000-0001-9868-5033	DIVISION OF LUNG DISEASES [N01HR016049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007427, P50HL067664, K08HL074193] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL074193, T32HL07427, P50 HL67664, N01-HR-16049] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARBEE RA, 1987, J ALLERGY CLIN IMMUN, V79, P919, DOI 10.1016/0091-6749(87)90241-7; Barnes KC, 2001, GENOMICS, V71, P246, DOI 10.1006/geno.2000.6430; Brown JR, 1998, CLIN EXP IMMUNOL, V114, P137; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chae SC, 2004, BIOCHEM BIOPH RES CO, V320, P131, DOI 10.1016/j.bbrc.2004.05.136; Chang HS, 2005, J IMMUNOL, V174, P1525, DOI 10.4049/jimmunol.174.3.1525; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; de Paulis A, 2001, INT ARCH ALLERGY IMM, V124, P146, DOI 10.1159/000053694; Devouassoux G, 1999, J IMMUNOL, V163, P2877; DUGAS B, 1993, EUR J IMMUNOL, V23, P1687, DOI 10.1002/eji.1830230743; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Gounni AS, 2000, J ALLERGY CLIN IMMUN, V106, P460, DOI 10.1067/mai.2000.109172; Hakonarson H, 2001, AM J RESP CRIT CARE, V164, P2036, DOI 10.1164/ajrccm.164.11.2101086; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lamkhioued B, 1997, J IMMUNOL, V159, P4593; Lilly CM, 1999, J ALLERGY CLIN IMMUN, V104, P786, DOI 10.1016/S0091-6749(99)70288-5; LOUAHED J, 1995, J IMMUNOL, V154, P5061; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; Miotto D, 2001, J ALLERGY CLIN IMMUN, V107, P664, DOI 10.1067/mai.2001.113524; Miyamasu M, 2001, GENES IMMUN, V2, P461, DOI 10.1038/sj.gene.6363807; Nakamura H, 2001, J ALLERGY CLIN IMMUN, V108, P946, DOI 10.1067/mai.2001.120135; Nakamura H, 1999, AM J RESP CRIT CARE, V160, P1952, DOI 10.1164/ajrccm.160.6.9811089; Nickel R, 1997, GENOMICS, V46, P159, DOI 10.1006/geno.1997.5013; Palmer LJ, 2003, HUM MOL GENET, V12, P1199, DOI 10.1093/hmg/ddg125; Perdow-Hickman S, 2000, J INTERF CYTOK RES, V20, P603, DOI 10.1089/10799900050044804; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rothenberg ME, 1999, AM J RESP CELL MOL, V21, P291, DOI 10.1165/ajrcmb.21.3.f160; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945; Shin HD, 2003, HUM MOL GENET, V12, P1279, DOI 10.1093/hmg/ddg142; Soussi-Gounni A, 2001, J ALLERGY CLIN IMMUN, V107, P575, DOI 10.1067/mai.2001.114238; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taha RA, 2001, CHEST, V120, P595, DOI 10.1378/chest.120.2.595; Tan JQ, 1999, J IMMUNOL, V162, P4285; Tateno H, 2004, RESP MED, V98, P782, DOI 10.1016/j.rmed.2004.01.005; Tsunemi Y, 2002, J DERMATOL SCI, V29, P222, DOI 10.1016/S0923-1811(02)00038-5; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; Yamada H, 2000, ALLERGY, V55, P392, DOI 10.1034/j.1398-9995.2000.00474.x; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	52	17	18	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2					298	305		10.1016/j.jaci.2005.10.041	http://dx.doi.org/10.1016/j.jaci.2005.10.041			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IM	16461130	Green Published			2022-12-18	WOS:000235687300011
J	Sudowe, S; Ludwig-Portugall, I; Montermann, E; Ross, R; Reske-Kunz, AB				Sudowe, S; Ludwig-Portugall, I; Montermann, E; Ross, R; Reske-Kunz, AB			Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						immunoglobulin E; type I allergy; allergen gene transfer; gene gun-mediated DNA vaccination; dendritic cells; fascin; mouse; beta-galactosidase	ACTIN-BUNDLING PROTEIN; IMMUNOGLOBULIN-E SYNTHESIS; DUST MITE ALLERGEN; GENETIC IMMUNIZATION; IMMUNE-RESPONSE; ANTIBODY-FORMATION; POLLEN ALLERGEN; T-CELLS; IN-VIVO; MICE	Background: Allergen gene transfer represents an alternative approach to specific immunotherapy with allergen extracts. Gene gun-mediated DNA immunization with plasmid vectors expressing a transgene under control of the promoter of the fascin gene (pFascin) allows for antigen production predominantly by dendritic cells and resulted in the generation of CD8(+) cytotoxic T lymphocytes as well as in the development of a type I immune response. Objective: We compared the in vivo efficiency of biolistic transfection with pFascin and plasmids containing the cytomegalovirus promoter (pCMV) in a mouse model of type 1 allergy. Methods: BALB/c mice were sensitized with the model allergen beta-galactosidase to induce a distinctive type 2 immune response. The effect of prophylactic as well as therapeutic biolistic transfection with P-galactosidase-encoding plasmids on the development of antibody titers was followed, and anaphylactic potential of sera was determined. Spleen cells were stimulated in vitro to analyze cytokine production and induction of CD8(+) effector T cells. Results: Protective allergen gene transfer with pFascin efficiently prevented specific IgE production accompanied by immune deviation toward a T(H)1-polarized immune response as well as by the induction of IFN-gamma-producing CD8(+) effector T cells, being comparable to vaccination with pCMV. In a therapeutical setting, biolistic DNA vaccination with pFascin or pCMV transiently protected allergen-sensitized mice against the strong increase in specific IgE production caused by subsequent allergen challenge. Conclusion: We demonstrate for the first time that restricting transgene expression primarily to dendritic cells after DNA vaccination suffices to cause inhibition of IgE production prophylactically and therapeutically.	Univ Mainz, Dept Dermatol, Clin Res Unit Allergol, D-55131 Mainz, Germany; Univ Giessen, Giessen, Germany	Johannes Gutenberg University of Mainz; Justus Liebig University Giessen	Sudowe, S (corresponding author), Univ Mainz, Dept Dermatol, Clin Res Unit Allergol, Obere Zahlbacher Str 63, D-55131 Mainz, Germany.	sudowe@mail.uni-mainz.de						Adel-Patient K, 2001, INT ARCH ALLERGY IMM, V126, P59, DOI 10.1159/000049495; Bauer R, 2003, ALLERGY, V58, P1003, DOI 10.1034/j.1398-9995.2003.00170.x; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Chatel JM, 2003, ALLERGY, V58, P641, DOI 10.1034/j.1398-9995.2003.00182.x; Chew JL, 2003, VACCINE, V21, P2720, DOI 10.1016/S0264-410X(03)00228-7; Hochreiter R, 2003, EUR J IMMUNOL, V33, P1667, DOI 10.1002/eji.200323377; Hochreiter R, 2001, INT ARCH ALLERGY IMM, V124, P406, DOI 10.1159/000053772; Hsu CH, 1996, INT IMMUNOL, V8, P1405, DOI 10.1093/intimm/8.9.1405; Hsu CH, 1996, NAT MED, V2, P540, DOI 10.1038/nm0596-540; Jacquet A, 2003, CLIN EXP ALLERGY, V33, P218, DOI 10.1046/j.1365-2222.2003.01584.x; Jilek S, 2001, J IMMUNOL, V166, P3612, DOI 10.4049/jimmunol.166.5.3612; Kwon SS, 2001, ALLERGY, V56, P741, DOI 10.1034/j.1398-9995.2001.056008741.x; Lee DJ, 1997, INT ARCH ALLERGY IMM, V113, P227, DOI 10.1159/000237554; Li XM, 1999, J IMMUNOL, V162, P3045; Ludwig-Portugall I, 2004, J ALLERGY CLIN IMMUN, V114, P951, DOI 10.1016/j.jaci.2004.06.013; Maecker HT, 2001, J IMMUNOL, V166, P959, DOI 10.4049/jimmunol.166.2.959; Mosialos G, 1996, AM J PATHOL, V148, P593; MOSIALOS G, 1994, J VIROL, V68, P7320, DOI 10.1128/JVI.68.11.7320-7328.1994; Payne LG, 2002, CURR OPIN MOL THER, V4, P459; Peng HJ, 2002, VACCINE, V20, P1761, DOI 10.1016/S0264-410X(02)00029-4; Pinkus GS, 1997, AM J PATHOL, V150, P543; Raz E, 1996, P NATL ACAD SCI USA, V93, P5141, DOI 10.1073/pnas.93.10.5141; Ross R, 2003, GENE THER, V10, P1035, DOI 10.1038/sj.gt.3301968; Ross R, 1998, J IMMUNOL, V160, P3776; Ross R, 2000, J INVEST DERMATOL, V115, P658, DOI 10.1046/j.1523-1747.2000.00112.x; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; Slater JE, 1998, J ALLERGY CLIN IMMUN, V102, P469, DOI 10.1016/S0091-6749(98)70137-X; Sudowe S, 2003, MOL THER, V8, P567, DOI 10.1016/S1525-0016(03)00242-9; Sudowe S, 2002, GENE THER, V9, P147, DOI 10.1038/sj.gt.3301625; Takashima A, 1999, J LEUKOCYTE BIOL, V66, P350, DOI 10.1002/jlb.66.2.350; Thomas MJ, 2002, J IMMUNOL, V168, P216, DOI 10.4049/jimmunol.168.1.216; Toda M, 2002, EUR J IMMUNOL, V32, P1631, DOI 10.1002/1521-4141(200206)32:6<1631::AID-IMMU1631>3.0.CO;2-O; Toda M, 2000, IMMUNOLOGY, V99, P179, DOI 10.1046/j.1365-2567.2000.00935.x; Wolfowicz CB, 2003, VACCINE, V21, P1195, DOI 10.1016/S0264-410X(02)00485-1	34	17	22	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2006	117	1					196	203		10.1016/j.jaci.2005.08.058	http://dx.doi.org/10.1016/j.jaci.2005.08.058			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IK	16387606				2022-12-18	WOS:000235687100032
J	Stempel, DA; Fuhlbrigge, AL				Stempel, DA; Fuhlbrigge, AL			Defining the responder in asthma therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						asthma; responder; inhaled corticosteroids; leukotriene receptor antagonists; statistical significance; effect size	PERSISTENT ASTHMA; VARIABILITY; BUDESONIDE; TRIAL		Harvard Univ, Brigham & Womens Hosp, Sch Med, Informed NW & Univ Washington, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Stempel, DA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Informed NW & Univ Washington, Boston, MA 02115 USA.	econmed@msn.com						Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; OSBORNE ML, 2004, AM J RESP CRIT CARE, V169, pA529; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Reddel HK, 2000, EUR RESPIR J, V16, P226, DOI 10.1034/j.1399-3003.2000.16b08.x; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; *US DEP HHS, 1997, GUID DIAGN MAN ASTHM; Zhang J, 2002, EUR RESPIR J, V20, P1102, DOI 10.1183/09031936.02.02402001	11	17	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2005	115	3					466	469		10.1016/j.jaci.2004.12.1113	http://dx.doi.org/10.1016/j.jaci.2004.12.1113			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	907AN	15753889				2022-12-18	WOS:000227687000004
J	Sorkness, RL; Remus, JL; Rosenthal, LA				Sorkness, RL; Remus, JL; Rosenthal, LA			Systemic and pulmonary effects of fluticasone administered through a metered-dose inhaler in rats	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; animal models; aerosols	LUNG-FUNCTION; DEPOSITION; DEXAMETHASONE; INHALATION; DELIVERY; AEROSOLS; AIRWAYS	Background: Metered-dose inhalers (MDIs) are convenient, simple, inexpensive, and reproducible devices for administering acrosolized drugs through the pulmonary route, but methods have not been available for use of these devices in small animals. Objective: We sought to test the efficacy of delivery of fluticasone through an MDI to rats with a rodent-adapted spacer chamber and to compare this treatment with systemic dexamethasone for the acute pulmonary allergic inflammatory response. Methods: Changes in body and thymus weights were used as indicators for systemic steroid effects. Rats were sensitized to ragweed pollen extract 2 weeks before the experiment, and pulmonary allergic responses were evaluated 48 hours after a single aerosolized antigen challenge on the basis of bronchoalveolar leukocytes, lung tissue sections, total lung capacity, and forced expiratory volumes. Results: Inhaled fluticasone caused dose-related systemic effects, indicating successful pulmonary drug delivery. Inhaled fluticasone was more effective than placebo but less effective than systemic dexamethasone in attenuating the increase in lung eosinophils and inflammatory infiltrates and the decrease in total lung capacity associated with the allergic inflammatory response. Inhaled fluticasone prevented airway obstruction and proximal inflammation, as did dexamethasone, but it appeared to have less effect in areas of lung served by the most distal airways. Conclusion: This is an effective method for use of MDIs to deliver inhaled drugs to small laboratory animals, and it should be valuable for investigations of treatment effects, as well as for in vivo testing of delivery devices.	Univ Wisconsin, Morris Inst Resp Res, Madison, WI 53706 USA; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sorkness, RL (corresponding author), 777 Highland Ave, Madison, WI 53705 USA.	rlsorkne@wisc.edu	Rosenthal, Louis/A-8868-2008		NHLBI NIH HHS [HL 56396] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056396] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASKIN MI, 1990, ANN INTERN MED, V113, P677, DOI 10.7326/0003-4819-113-9-677; Boe J, 2001, EUR RESPIR J, V18, P228; Cripps A, 2000, RESP MED, V94, pS3, DOI 10.1016/S0954-6111(00)90147-1; DOLOVICH M, 1981, CHEST, V80, P911; ELWOOD W, 1992, AM REV RESPIR DIS, V145, P1289, DOI 10.1164/ajrccm/145.6.1289; Kumar A, 1997, AM J RESP CRIT CARE, V155, P130, DOI 10.1164/ajrccm.155.1.9001301; Leach CL, 1998, EUR RESPIR J, V12, P1346, DOI 10.1183/09031936.98.12061346; Martin RJ, 2002, J ALLERGY CLIN IMMUN, V109, pS447, DOI 10.1067/mai.2002.121409; NEWMAN SP, 1982, EUR J RESPIR DIS, V63, P57; NEWMAN SP, 1988, THORAX, V43, P318, DOI 10.1136/thx.43.4.318; NEWMAN SP, 1989, THORAX, V44, P706, DOI 10.1136/thx.44.9.706; PAVIA D, 1977, THORAX, V32, P194, DOI 10.1136/thx.32.2.194; RAEBURN D, 1992, J PHARMACOL TOX MET, V27, P143, DOI 10.1016/1056-8719(92)90035-Y; Shen HH, 2002, AM J RESP CRIT CARE, V166, P146, DOI 10.1164/rccm.2008161; Sorkness RL, 2004, J APPL PHYSIOL, V96, P904, DOI 10.1152/japplphysiol.00674.2003; TOMAS FM, 1992, BIOCHEM J, V282, P91, DOI 10.1042/bj2820091; Vanacker NJ, 2002, EUR RESPIR J, V20, P873, DOI 10.1183/09031936.02.02562001; ZAINUDIN BMZ, 1988, THORAX, V43, P987, DOI 10.1136/thx.43.12.987	18	17	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2004	114	5					1027	1032		10.1016/j.jaci.2004.07.015	http://dx.doi.org/10.1016/j.jaci.2004.07.015			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	870HI	15536405				2022-12-18	WOS:000225047800005
J	Chen, CC; Yang, YH; Lin, YT; Hsieh, SL; Chiang, BL				Chen, CC; Yang, YH; Lin, YT; Hsieh, SL; Chiang, BL			Soluble decoy receptor 3: Increased levels in atopic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FAS LIGAND; APOPTOSIS; AMPLIFICATION; EXPRESSION; DCR3; GENE		Far Eastern Mem Hosp, Dept Pediat, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan; Natl Yang Ming Univ, Immunol Res Ctr, Taipei 112, Taiwan; Natl Yang Ming Univ, Dept Microbiol & Immunol, Taipei 112, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, CC (corresponding author), Far Eastern Mem Hosp, Dept Pediat, Taipei 100, Taiwan.		Hsieh, Shie-Liang Edmond/ABA-9184-2021					Akdis M, 2001, ACTA ODONTOL SCAND, V59, P178, DOI 10.1080/000163501750266783; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Brutsche MH, 2001, CLIN EXP IMMUNOL, V123, P181, DOI 10.1046/j.1365-2249.2001.01441.x; Green DR, 1998, NATURE, V396, P629, DOI 10.1038/25248; Hsu TL, 2002, J IMMUNOL, V168, P4846, DOI 10.4049/jimmunol.168.10.4846; Ohshima K, 2000, CANCER LETT, V160, P89, DOI 10.1016/S0304-3835(00)00567-X; Otsuki T, 2000, CLIN EXP IMMUNOL, V119, P323; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Roth W, 2001, CANCER RES, V61, P2759; Yu KY, 1999, J BIOL CHEM, V274, P13733, DOI 10.1074/jbc.274.20.13733	10	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2004	114	1					195	197		10.1016/j.jaci.2004.02.048	http://dx.doi.org/10.1016/j.jaci.2004.02.048			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	836DA	15282937				2022-12-18	WOS:000222534300030
J	De Swert, KO; Tournoy, KG; Joos, GF; Pauwels, RA				De Swert, KO; Tournoy, KG; Joos, GF; Pauwels, RA			The role of the tachykinin NK1 receptor in airway changes in a mouse model of allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Substance P; hyperplasia; goblet cells; knockout mice	SUBSTANCE-P; MUCUS SECRETION; GUINEA-PIGS; ALVEOLAR MACROPHAGES; NEURAL-CONTROL; INFLAMMATION; HYPERRESPONSIVENESS; ANTAGONISTS; MICE; HYPERREACTIVITY	Background: Tachykinins are present in sensory nerves and in nonneuronal cells like macrophages. Human data suggest a role for these peptides in asthma, but the exact role of tachykinins and their receptors in allergic airway inflammation is still a matter of debate. Objective: The aim of this study was to determine the role of the tachykinin NK1 receptor in allergic airway responses in a mouse model. Methods: Tachykinin NK1 receptor wild-type and knockout animals were sensitized intraperitoneally to ovalbumin and subsequently exposed from days 14 to 21 to aerosolized ovalbumin (1%). On day 22, the immunologic and histologic changes were evaluated, and lung function measurements were performed. Results: Mice lacking the tachykinin NK1 receptor and their wild-type litter mates developed inflammatory cell infiltrates in the airways and ovalbumin-specific IgE on sensitization and exposure to ovalbumin compared with saline-exposed controls. No differences were detected between wild-type and knockout mice. The substance P content of alveolar macrophages was not influenced by ovalbumin or by the lack of the NK1 receptor. Ovalbumin-induced hyperresponsiveness was not observed, but at baseline, the knockout mice were more reactive despite similar morphology. Ovalbumin induced more goblet cell hyperplasia in wild-type animals compared with knockout animals. No differences in airway wall thickness were observed. Conclusion: These data suggest that tachykinin NK1 receptors do not affect allergic airway inflammation or endogenous substance P content of alveolar macrophages but influence baseline responsiveness and promote features of remodeling such as goblet cell hyperplasia.	State Univ Ghent Hosp, Dept Resp Dis, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital	De Swert, KO (corresponding author), State Univ Ghent Hosp, Dept Resp Dis, De Pintelaan 185, B-9000 Ghent, Belgium.	Katelijne.Deswert@UGent.be						Advenier C, 1997, EUR RESPIR J, V10, P1892, DOI 10.1183/09031936.97.10081892; BAI A, 1994, J APPL PHYSIOL, V77, P1011, DOI 10.1152/jappl.1994.77.2.1011; Boichot E, 1996, EUR RESPIR J, V9, P1445, DOI 10.1183/09031936.96.09071445; Boichot E, 1998, CLIN EXP ALLERGY, V28, P1299; BOST K L, 1992, Regional Immunology, V4, P105; Bozic CR, 1996, SCIENCE, V273, P1722, DOI 10.1126/science.273.5282.1722; Braun A, 1998, EUR J IMMUNOL, V28, P3240, DOI 10.1002/(SICI)1521-4141(199810)28:10<3240::AID-IMMU3240>3.0.CO;2-U; Chu HW, 2000, J ALLERGY CLIN IMMUN, V106, P713, DOI 10.1067/mai.2000.109829; COOK GA, 1994, J IMMUNOL, V152, P1830; Costello RW, 1998, BRIT J PHARMACOL, V124, P267, DOI 10.1038/sj.bjp.0701822; De Bie JJ, 1998, BRIT J PHARMACOL, V124, P857, DOI 10.1038/sj.bjp.0701901; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; Duguet A, 2000, AM J RESP CRIT CARE, V161, P839, DOI 10.1164/ajrccm.161.3.9906054; Evans CM, 2000, AM J PHYSIOL-LUNG C, V279, pL477, DOI 10.1152/ajplung.2000.279.3.L477; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Folkerts G, 2001, N-S ARCH PHARMACOL, V364, P53, DOI 10.1007/s002100100430; Germonpre PR, 1999, EUR RESPIR J, V14, P776, DOI 10.1034/j.1399-3003.1999.14d08.x; Glaab T, 2001, AM J PHYSIOL-LUNG C, V280, pL565, DOI 10.1152/ajplung.2001.280.3.L565; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Ho WZ, 1998, J NEUROIMMUNOL, V82, P126, DOI 10.1016/S0165-5728(97)00175-6; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Joos GF, 2001, EUR J PHARMACOL, V429, P239, DOI 10.1016/S0014-2999(01)01323-1; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Kaltreider HB, 1997, AM J RESP CELL MOL, V16, P133, DOI 10.1165/ajrcmb.16.2.9032120; Khan S, 2001, BRIT J PHARMACOL, V132, P189, DOI 10.1038/sj.bjp.0703822; KIMBALL ES, 1988, J IMMUNOL, V141, P3564; Lai JP, 2002, J NEUROIMMUNOL, V128, P101, DOI 10.1016/S0165-5728(02)00164-9; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; LUNDBERG JM, 1984, CELL TISSUE RES, V235, P251; LUTS A, 1993, INT ARCH ALLERGY IMM, V101, P52, DOI 10.1159/000236498; Maggi CA, 2000, TRENDS PHARMACOL SCI, V21, P173, DOI 10.1016/S0165-6147(00)01463-2; Maghni K, 2000, AM J RESP CRIT CARE, V162, P1068, DOI 10.1164/ajrccm.162.3.9910089; MURRISESPIN M, 1995, ALLERGY, V50, P334, DOI 10.1111/j.1398-9995.1995.tb01157.x; Palmans E, 2000, AM J RESP CRIT CARE, V161, P627, DOI 10.1164/ajrccm.161.2.9902094; Pare P D, 1997, Monaldi Arch Chest Dis, V52, P589; PASCUAL DW, 1990, IMMUNOLOGY, V71, P52; PAYAN DG, 1984, J CLIN INVEST, V74, P1532, DOI 10.1172/JCI111567; Phillips JE, 2003, BRIT J PHARMACOL, V138, P254, DOI 10.1038/sj.bjp.0705029; RAMNARINE SI, 1994, BRIT J PHARMACOL, V113, P1183, DOI 10.1111/j.1476-5381.1994.tb17122.x; RAMNARINE SI, 1994, PULM PHARMACOL THER, V7, P19, DOI 10.1006/pulp.1994.1002; Rogers DF, 2002, CLIN EXP ALLERGY, V32, P1124, DOI 10.1046/j.1365-2745.2002.01474.x; Schuiling M, 1999, AM J RESP CRIT CARE, V159, P423, DOI 10.1164/ajrccm.159.2.9804125; Tournoy KG, 2003, EUR RESPIR J, V21, P3, DOI 10.1183/09031936.03.00007803; Tournoy KG, 2001, J ALLERGY CLIN IMMUN, V107, P483, DOI 10.1067/mai.2001.112693; TUCK SA, 2002, AM J RESP CRIT CARE, V165, pA802; Wagner U, 1999, NEUROPEPTIDES, V33, P55, DOI 10.1054/npep.1999.0014; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002	48	17	17	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2004	113	6					1093	1099		10.1016/j.jaci.2004.03.015	http://dx.doi.org/10.1016/j.jaci.2004.03.015			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	829ZI	15208590	Green Published, Bronze			2022-12-18	WOS:000222091000014
J	Peeters, KABM; Kunlst, AC; Rynja, FL; Bruijnzeel-Koomen, CAFM; Koppelman, SJ				Peeters, KABM; Kunlst, AC; Rynja, FL; Bruijnzeel-Koomen, CAFM; Koppelman, SJ			Peanut allergy: Sensitization by peanut oil-containing local therapeutics seems unlikely	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Utrecht, Med Ctr, Dept Dermatol Allergol, NL-3584 CX Utrecht, Netherlands; TNO, Nutr & Food Res Zeist, NL-3700 AJ Zeist, Netherlands; Diakonessenhuis Utrecht, Dept Pharm, Utrecht, Netherlands	Utrecht University; Netherlands Organization Applied Science Research; Diakonessenhuis	Peeters, KABM (corresponding author), Univ Utrecht, Med Ctr, Dept Dermatol Allergol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.							Crevel RWR, 2000, FOOD CHEM TOXICOL, V38, P385, DOI 10.1016/S0278-6915(99)00158-1; Hsieh KY, 2003, CLIN EXP ALLERGY, V33, P1067, DOI 10.1046/j.1365-2222.2003.01724.x; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Olszewski A, 1998, CLIN EXP ALLERGY, V28, P850, DOI 10.1046/j.1365-2222.1998.00325.x	4	17	17	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2004	113	5					1000	1001		10.1016/j.jaci.2004.03.005	http://dx.doi.org/10.1016/j.jaci.2004.03.005			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	818UC	15148964				2022-12-18	WOS:000221269000029
J	Xu, BZ; Pekkanen, J; Husman, T; Keski-Nisula, L; Koskela, P				Xu, BZ; Pekkanen, J; Husman, T; Keski-Nisula, L; Koskela, P			Maternal sex hormones in early pregnancy and asthma among offspring: A case-control study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; atopy; allergic disorders; childhood; sex hormones; pregnancy	PROGESTERONE; ESTROGEN; RISK	Background: Sex hormones may be associated with the risk of onset of asthma. Objective: To study the association between maternal sex hormone concentrations during early pregnancy and the risk of asthma among offspring. Methods: A case-control study of 129 asthmatic children and 125 control children 5 to 6 years of age. Maternal sera in early pregnancy were obtained from the Finnish Maternal Cohort serum bank. Results: The means of serum progesterone and estradiol and free estradiol in mothers of asthmatic and control children were 81.0 and 82.8 nmol/L (P = .60), 7.87 nmol/L and 7.65 nmol/L (P = .99), and 149.5 pmoI/L and 148.0 pmol/L (P = .95), respectively. There were also no differences in the mean concentrations of maternal sex hormones according to the presence of allergic rhinitis or atopic eczema among the children. Conclusions: The current results do not support an association between maternal sex hormone concentrations during early pregnancy and onset of allergic disease in early childhood.	Natl Publ Hlth Inst, Environm Epidemiol Unit, Kuopio 70701, Finland; Natl Publ Hlth Inst, Lab Prenatal Serol, Kuopio 70701, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Pekkanen, J (corresponding author), Natl Publ Hlth Inst, Environm Epidemiol Unit, POB 95, Kuopio 70701, Finland.		Putus, Tuula/J-9858-2013	Putus, Tuula/0000-0001-7914-2017				Forbes L, 1999, THORAX, V54, P265, DOI 10.1136/thx.54.3.265; Haggerty CL, 2003, ANN ALLERG ASTHMA IM, V90, P284, DOI 10.1016/S1081-1206(10)61794-2; Holt PG, 1999, NATURE, V402, pB12; Holt PG, 1997, CURR OPIN IMMUNOL, V9, P782, DOI 10.1016/S0952-7915(97)80178-1; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Koskela P, 2000, INT J CANCER, V85, P35, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;35::AID-IJC6&gt;3.0.CO;2-A; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Rangaraj S, 2003, CLIN EXP ALLERGY, V33, P277, DOI 10.1046/j.1365-2745.2003.01619.x; TROISI RJ, 1995, AM J RESP CRIT CARE, V152, P1183, DOI 10.1164/ajrccm.152.4.7551368; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Westergaard T, 2003, CLIN EXP ALLERGY, V33, P301, DOI 10.1046/j.1365-2222.2003.01441.x; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; Wjst M, 1997, PEDIATR ALLERGY IMMU, V8, P200, DOI 10.1111/j.1399-3038.1997.tb00161.x; Xu BZ, 2000, THORAX, V55, P691, DOI 10.1136/thorax.55.8.691	14	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2003	112	6					1101	1104		10.1016/j.jaci.2003.09.027	http://dx.doi.org/10.1016/j.jaci.2003.09.027			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	752HC	14657866	Bronze			2022-12-18	WOS:000187154200011
J	Isogai, S; Rubin, A; Maghni, K; Ramos-Barbon, D; Taha, R; Yoshizawa, Y; Hamid, Q; Martin, JG				Isogai, S; Rubin, A; Maghni, K; Ramos-Barbon, D; Taha, R; Yoshizawa, Y; Hamid, Q; Martin, JG			The effects of CD8+gamma delta T cells on late allergic airway responses and airway inflammation in rats	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CD8(+)gamma delta T cells; TCR-gamma delta; late allergic responses; LAR; BN rat	BROWN-NORWAY RATS; PERIPHERAL LYMPHOID ORGANS; GAMMA-DELTA; IFN-GAMMA; INTERFERON-GAMMA; MESSENGER-RNA; IGE RESPONSES; MURINE MODEL; EXPRESSION; ASTHMA	Background: Gamma-delta (gammadelta) T cells regulate immune responses to foreign protein at mucosal surfaces. Whether they can modify allergen-induced early (EAR) and late airway responses (LAR) is unkown. Objective: We have tested the hypothesis that the CD8(+) sub-type of gammadelta T cells decreases allergen-induced LAR and airway eosinophilia in the rat. Methods: Brown Norway rats were administered, intraperitoneally, 3.5 x 10(4) lymph node CD8(+)gammadelta T cells from naive or sensitized rats. The recipients were sensitized to ovalbumin (OVA) in Al(OH)(3) 3 days after cell transfer and challenged with aerosolized OVA 14 days later. Serum IgE was measured before allergen challenge. After challenge, lung resistance was monitored for 8 hours and then bronchoalveolar lavage (BAL) was analyzed for eosinophil major basic protein (MBP), IL-4, IL-5, IL-13, and IFN-gamma messenger RNA-expressing cells. Results: gammadelta T cells from naive donors significantly decreased LAR in OVA-challenged sensitized rats, whereas MBP+ eosinophils were decreased by both gammadelta T cells from naive and sensitized donors. EAR and serum IgE levels were unchanged. The expression of IL-4, IL-5, and IL-13 by BAL cells of gammadelta T cell recipients was attenuated compared with OVA-challenged controls. This was accompanied by an increase in the expression of IFN-gamma. Conclusions: Our results are consistent with a suppressive role of CD8(+)gammadelta T cells on allergic airway responses. However, only gammadelta T cells from naive donors inhibit LAR.	McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ H2X 2P2, Canada; Tokyo Med & Dent Univ, Dept Pulm Med, Tokyo, Japan	McGill University; Tokyo Medical & Dental University (TMDU)	Martin, JG (corresponding author), McGill Univ, Meakins Christie Labs, Dept Med, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.		RAMOS-BARBON, DAVID/C-6624-2009	RAMOS-BARBON, DAVID/0000-0002-9615-6557; Martin, James/0000-0001-7574-5363				GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; Hirata N, 1998, AM J RESP CELL MOL, V18, P12, DOI 10.1165/ajrcmb.18.1.2704; HOLOSHITZ J, 1992, J CLIN INVEST, V89, P308, DOI 10.1172/JCI115577; Huang TJ, 1999, IMMUNOLOGY, V98, P280; Isogai S, 2000, EUR RESPIR J, V16, P22, DOI 10.1034/j.1399-3003.2000.16a05.x; ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094; KABELITZ D, 1992, CRIT REV IMMUNOL, V11, P281; KOZBOR D, 1989, J EXP MED, V169, P1847, DOI 10.1084/jem.169.5.1847; KUHNLEIN P, 1994, J IMMUNOL, V153, P979; Lahn M, 2002, P NATL ACAD SCI USA, V99, P8850, DOI 10.1073/pnas.132519299; Lahn M, 1999, NAT MED, V5, P1150, DOI 10.1038/13476; Luttmann W, 1998, EUR J IMMUNOL, V28, P2057, DOI 10.1002/(SICI)1521-4141(199807)28:07<2057::AID-IMMU2057>3.0.CO;2-T; MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481; MCMENAMIN C, 1995, J IMMUNOL, V154, P4390; Ochiai K, 1997, CLIN EXP IMMUNOL, V107, P198, DOI 10.1046/j.1365-2249.1997.d01-884.x; Pawankar RU, 1996, AM J RESP CRIT CARE, V153, P1655, DOI 10.1164/ajrccm.153.5.8630617; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Schramm CM, 2000, AM J RESP CELL MOL, V22, P218, DOI 10.1165/ajrcmb.22.2.3620; SORKNESS R, 1988, AM REV RESPIR DIS, V138, P1152, DOI 10.1164/ajrccm/138.5.1152; SPINOZZI F, 1995, MOL MED, V1, P821, DOI 10.1007/BF03401896; Spinozzi F, 1996, ANN INTERN MED, V124, P223, DOI 10.7326/0003-4819-124-2-199601150-00005; Suzuki M, 2002, J ALLERGY CLIN IMMUN, V109, P803, DOI 10.1067/mai.2002.123233; Suzuki M, 1999, J IMMUNOL, V163, P5574; Tang CB, 2001, J IMMUNOL, V166, P1471, DOI 10.4049/jimmunol.166.3.1471; Watanabe A, 1997, AM J RESP CELL MOL, V16, P69, DOI 10.1165/ajrcmb.16.1.8998081; WATANABE A, 1995, J CLIN INVEST, V96, P1303, DOI 10.1172/JCI118165; Wen L, 1998, J IMMUNOL, V160, P1965; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265	31	17	19	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2003	112	3					547	555		10.1067/mai.2003.1682	http://dx.doi.org/10.1067/mai.2003.1682			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	719XW	13679814				2022-12-18	WOS:000185231200014
J	Gagnon, R; Julien, M; Gold, P				Gagnon, R; Julien, M; Gold, P			Selective celecoxib-associated anaphylactoid reaction	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									McGill Univ, Ctr Hlth, Div Clin Immunol & Allergy, Montreal, PQ, Canada; Ungawa Tulattavik Hlth Ctr, Kuujjuaq, PQ, Canada	McGill University	Gagnon, R (corresponding author), McGill Univ, Ctr Hlth, Div Clin Immunol & Allergy, Montreal, PQ, Canada.							Cribb AE, 1996, ADVERSE DRUG REACT T, V15, P9; Grob M, 2002, ALLERGY, V57, P264, DOI 10.1034/j.1398-9995.2002.1n3581.x; Habki R, 2001, ANN MED INTERNE, V152, P355; Levy MB, 2001, ANN ALLERG ASTHMA IM, V87, P72, DOI 10.1016/S1081-1206(10)62327-7; Patterson R, 1999, CLIN THER, V21, P2065, DOI 10.1016/S0149-2918(00)87238-0; Schellenberg RR, 2001, NEW ENGL J MED, V345, P1856, DOI 10.1056/NEJM200112203452518; Stevenson DD, 2001, IMMUNOL ALLERGY CLIN, V21, P745; SULLIVAN TJ, 1991, JAMA-J AM MED ASSOC, V265, P120, DOI 10.1001/jama.265.1.120	8	17	17	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2003	111	6					1404	1405		10.1067/mai.2003.1465	http://dx.doi.org/10.1067/mai.2003.1465			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	688FZ	12789245				2022-12-18	WOS:000183424700033
J	Asero, R; Lorini, M; Tedeschi, A				Asero, R; Lorini, M; Tedeschi, A			Association of chronic urticaria with thyroid autoimmunity and Raynaud phenomenon with anticentromere antibodies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTI-IGE; AUTOANTIBODIES; ANGIOEDEMA; PREVALENCE; BASOPHILS		Clin S Carlo, Allergy Unit, I-20037 Paderno Dugnano, Milano, Italy; IRCCS, Osped Maggiore Policlin, Div Internal Med 1, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico	Asero, R (corresponding author), Clin S Carlo, Allergy Unit, Via Osped 21, I-20037 Paderno Dugnano, Milano, Italy.							Asero R, 2001, CLIN EXP ALLERGY, V31, P1105, DOI 10.1046/j.1365-2222.2001.01131.x; COLLET E, 1995, ANN DERMATOL VENER, V122, P413; Colton T, 1974, STAT MED; Fiebiger E, 1995, J CLIN INVEST, V96, P2606, DOI 10.1172/JCI118325; GRATTAN CEH, 1991, CLIN EXP ALLERGY, V21, P695, DOI 10.1111/j.1365-2222.1991.tb03198.x; GREAVES MW, 1995, NEW ENGL J MED, V332, P1767, DOI 10.1056/NEJM199506293322608; GRUBER BL, 1988, J INVEST DERMATOL, V90, P213, DOI 10.1111/1523-1747.ep12462239; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; Kaplan AP, 1999, CAN J ALLERGY CLIN I, V4, P286; Kikuchi Y, 2001, J ALLERGY CLIN IMMUN, V107, P1056, DOI 10.1067/mai.2001.115484; LANIGAN SW, 1987, CLIN EXP DERMATOL, V12, P335, DOI 10.1111/j.1365-2230.1987.tb02503.x; LEUNG DYM, 2001, CLIN IMMUNOLOGY PRIN; LEZNOFF A, 1989, J ALLERGY CLIN IMMUN, V84, P66, DOI 10.1016/0091-6749(89)90180-2; LEZNOFF A, 1983, ARCH DERMATOL, V119, P636, DOI 10.1001/archderm.119.8.636; MARICQ HR, 1989, ARTHRITIS RHEUM-US, V32, P998, DOI 10.1002/anr.1780320809; MEDSGER TA, 1994, INTERNAL MED, P2443; PRUZANSKY JJ, 1983, J IMMUNOL, V131, P1949; SILVER RM, 1994, INTERNAL MED, P2441; Tong LJ, 1997, J ALLERGY CLIN IMMUN, V99, P461, DOI 10.1016/S0091-6749(97)70071-X; Turktas I, 1997, INT J DERMATOL, V36, P187, DOI 10.1046/j.1365-4362.1997.00187.x; WHITE B, 2001, CLIN IMMUNOLOGY PRIN	21	17	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2003	111	5					1129	1130		10.1067/mai.2003.1389	http://dx.doi.org/10.1067/mai.2003.1389			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	679DA	12743581				2022-12-18	WOS:000182904500031
J	Astwood, JD; Silvanovich, A; Bannon, GA				Astwood, JD; Silvanovich, A; Bannon, GA			Vicilins: A case study in allergen pedigrees	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						cross-reactivity; epitope; biotechnology	MAJOR PEANUT ALLERGEN; CROSS-REACTIVITY; IDENTIFICATION		Monsanto Co, Prod Safety Ctr, St Louis, MO 63167 USA	Monsanto	Astwood, JD (corresponding author), Monsanto Co, Prod Safety Ctr, 800 N Lindbergh Blvd, St Louis, MO 63167 USA.							Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Astwood J. D., 1996, Food allergy: adverse reactions to food and food additives., P65; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; BURKS AW, 1991, J ALLERGY CLIN IMMUN, V88, P172, DOI 10.1016/0091-6749(91)90325-I; *FAO UN WHO, 2001, EV ALL GEN MOD FOODS; *FAO UN WHO, 2000, SAF ASP GEN MOD FOOD; Maleki SJ, 2000, J IMMUNOL, V164, P5844, DOI 10.4049/jimmunol.164.11.5844; Metcalfe DD, 1996, CRIT REV FOOD SCI, V36, pS165, DOI 10.1080/10408399609527763; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shin DS, 1998, J BIOL CHEM, V273, P13753, DOI 10.1074/jbc.273.22.13753; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P128, DOI 10.1067/mai.2001.115755; Teuber SS, 1999, J ALLERGY CLIN IMMUN, V104, P1311, DOI 10.1016/S0091-6749(99)70029-1; United States Food and Drug Administration, 1992, FED REGISTER, V57, P22984; Wang F, 2002, J ALLERGY CLIN IMMUN, V110, P160, DOI 10.1067/mai.2002.125208	16	17	19	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2002	110	1					26	27		10.1067/mai.2002.125690	http://dx.doi.org/10.1067/mai.2002.125690			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	574CF	12110813				2022-12-18	WOS:000176870300005
J	Moylett, EH; Shearer, WT				Moylett, EH; Shearer, WT			HIV: Clinical manifestations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						HIV; AIDS; highly active antiretroviral therapy; opportunistic infections; clinical manifestations	HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; MULTICENTER AIDS COHORT; CYTOMEGALOVIRUS RETINITIS; KAPOSIS-SARCOMA; INTERSTITIAL PNEUMONITIS; PULMONARY-HYPERTENSION; ZIDOVUDINE THERAPY; POSITIVE PATIENTS; INFECTION	HIV infection in the United States appeared early in the 1980s, when previously healthy homosexual men manifested opportunistic infections attributable to apparent underlying immunodeficiency. After these initial isolated reports, there appeared many other groups of patients at risk for development of this devastating disease. From these meager beginnings, the problem has escalated exponentially. HIV infection can affect every system in the human body. Since the era of highly active antiretroviral therapy, however, the prevalence of opportunistic infections and HIV-AIDS clinical manifestations has declined dramatically. In addition to antiretroviral therapy, management of HIV-infected persons requires knowledge of the extent of system involvement, as well as highly active antiretroviral therapy-related adverse effects, so as to recognize complications and initiate appropriate intervention. In the following review we will attempt to comprehensively summarize the clinical manifestations of HIV infection for both pediatric and adult populations.	Texas Childrens Hosp, Dept Allergy & Immunol, Houston, TX 77030 USA; Baylor Coll Med, Dept Allergy & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Moylett, EH (corresponding author), Texas Childrens Hosp, Dept Allergy & Immunol, 6621 Fannin St,MC-3291, Houston, TX 77030 USA.			Shearer, William/0000-0002-2483-2130	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, U01AI027551] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00188] Funding Source: Medline; NIAID NIH HHS [AI-36211, AI-27551] Funding Source: Medline; NICHD NIH HHS [HD-41983] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; BACELLAR H, 1994, NEUROLOGY, V44, P1892, DOI 10.1212/WNL.44.10.1892; Berenguer J, 2002, CLIN INFECT DIS, V34, P394, DOI 10.1086/338401; BESSEN LJ, 1988, NEW ENGL J MED, V318, P708; Biggar RJ, 2000, JAMA-J AM MED ASSOC, V284, P205, DOI 10.1001/jama.284.2.205; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Brinkman K, 2001, J HIV Ther, V6, P13; CALABRESE LH, 1987, ANN INTERN MED, V107, P849, DOI 10.7326/0003-4819-107-6-849; Cheng VCC, 2000, CLIN INFECT DIS, V30, P882, DOI 10.1086/313809; Chetty R, 2000, HUM PATHOL, V31, P374, DOI 10.1016/S0046-8177(00)80253-1; COLEBUNDERS R, 1994, ACTA CLIN BELG, V49, P104, DOI 10.1080/17843286.1994.11718373; CONANT MA, 1994, J AM ACAD DERMATOL, V31, pS47, DOI 10.1016/S0190-9622(08)81267-4; COOPER DA, 1985, LANCET, V1, P537; Cunningham ET, 1998, NEW ENGL J MED, V339, P236, DOI 10.1056/NEJM199807233390406; D'Agati V, 1998, SEMIN NEPHROL, V18, P406; DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602; DENNING DW, 1987, BRIT MED J, V294, P143, DOI 10.1136/bmj.294.6565.143; Elliot B, 1997, LANCET, V349, P850, DOI 10.1016/S0140-6736(05)61753-9; Fantoni M, 2001, ANN NY ACAD SCI, V946, P179, DOI 10.1111/j.1749-6632.2001.tb03912.x; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; GAINES H, 1988, BRIT MED J, V297, P1363, DOI 10.1136/bmj.297.6660.1363; GARDENSWARTZ MH, 1984, CLIN NEPHROL, V21, P197; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; GRIFFITHS MH, 1995, THORAX, V50, P1141, DOI 10.1136/thx.50.11.1141; GRODY WW, 1990, AM J CARDIOL, V66, P203, DOI 10.1016/0002-9149(90)90589-S; HAGBERG L, 1986, SCAND J INFECT DIS, V18, P591, DOI 10.3109/00365548609021668; HELLERSTEIN MK, 1993, J CLIN ENDOCR METAB, V76, P559, DOI 10.1210/jc.76.3.559; Herskowitz A, 1995, EUR HEART J, V16, P50, DOI 10.1093/eurheartj/16.suppl_O.50; HO DD, 1985, ANN INTERN MED, V103, P880, DOI 10.7326/0003-4819-103-6-880; HO DD, 1985, NEW ENGL J MED, V313, P1493, DOI 10.1056/NEJM198512123132401; HOCHBERG MC, 1990, AIDS, V4, P1149, DOI 10.1097/00002030-199011000-00016; Jacobson MA, 1997, LANCET, V349, P1443, DOI 10.1016/S0140-6736(96)11431-8; Jensen BL, 2000, ACTA DERM-VENEREOL, V80, P140; Jones JL, 2000, J ACQ IMMUN DEF SYND, V24, P270; JONES JL, 1999, J ACQ IMMUN DEF SYND, V21, P811; KAPLAN JE, 2000, CLIN INFECT DIS, V1, P85; KAUL S, 1991, AM HEART J, V122, P535, DOI 10.1016/0002-8703(91)91013-D; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Keesler MJ, 2001, ANN NY ACAD SCI, V946, P169, DOI 10.1111/j.1749-6632.2001.tb03911.x; KIEFF ED, 1989, NEW ENGL J MED, V321, P454; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KRANTZ SB, 1994, AM J MED SCI, V307, P353, DOI 10.1097/00000441-199405000-00009; KUPPERMANN BD, 1993, AM J OPHTHALMOL, V115, P575, DOI 10.1016/S0002-9394(14)71453-9; Lai WW, 2001, AM HEART J, V141, P661, DOI 10.1067/mhj.2001.113757; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; LEWIS DA, 1992, INT J STD AIDS, V3, P56, DOI 10.1177/095646249200300115; LOES SKD, 1993, CLIN INFECT DIS, V17, P59, DOI 10.1093/clinids/17.1.59; LOWE FC, 1989, J UROLOGY, V142, P1475, DOI 10.1016/S0022-5347(17)39129-2; Lynch JL, 2001, PEDIATR RADIOL, V31, P299, DOI 10.1007/s002470100440; Macallan DC, 2001, HORM RES, V55, P36, DOI 10.1159/000063461; MAURY CPJ, 1990, J INTERN MED, V227, P253, DOI 10.1111/j.1365-2796.1990.tb00154.x; MAXSON CJ, 1992, AM J GASTROENTEROL, V87, P708; MCCARTHY GM, 1992, ORAL SURG ORAL MED O, V73, P181, DOI 10.1016/0030-4220(92)90192-S; Mehta NJ, 2000, CHEST, V118, P1133, DOI 10.1378/chest.118.4.1133; Parra R, 1998, CLIN INFECT DIS, V26, P218, DOI 10.1086/517029; PATON P, 1990, RES VIROLOGY, V141, P427, DOI 10.1016/0923-2516(90)90043-I; Patton LL, 2000, ORAL SURG ORAL MED O, V90, P182, DOI 10.1067/moe.2000.108799; PEDERSEN C, 1989, BRIT MED J, V299, P154, DOI 10.1136/bmj.299.6692.154; Pellicelli AM, 1998, ANGIOLOGY, V49, P1005, DOI 10.1177/000331979804901206; PELTIER JY, 1991, AIDS, V5, P381, DOI 10.1097/00002030-199104000-00004; Phillips P, 1999, J ACQ IMMUN DEF SYND, V20, P122, DOI 10.1097/00042560-199902010-00003; Pugliese A, 2000, J INFECTION, V40, P282, DOI 10.1053/jinf.2000.0672; RABENECK L, 1990, JAMA-J AM MED ASSOC, V263, P2318, DOI 10.1001/jama.263.17.2318; RODRIGUEZ ER, 1991, AM J CARDIOL, V68, P1511, DOI 10.1016/0002-9149(91)90288-V; RUSTIN MHA, 1986, J INFECTION, V12, P161, DOI 10.1016/S0163-4453(86)93683-2; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Silver B, 1997, ARCH NEUROL-CHICAGO, V54, P647, DOI 10.1001/archneur.1997.00550170115023; Sleasman JW, 1999, J PEDIATR-US, V134, P597, DOI 10.1016/S0022-3476(99)70247-7; SLOAND EM, 1992, EUR J HAEMATOL, V48, P168; Tappuni AR, 2001, ORAL SURG ORAL MED O, V92, P623, DOI 10.1067/moe.2001.118902; TINDALL B, 1988, ARCH INTERN MED, V148, P945, DOI 10.1001/archinte.148.4.945; VALLE SL, 1987, SCAND J INFECT DIS, V19, P13, DOI 10.3109/00365548709032372; Vanhems P, 1997, CLIN INFECT DIS, V24, P965, DOI 10.1093/clinids/24.5.965; WECHSLER AF, 1989, NEUROLOGY, V39, P747, DOI 10.1212/WNL.39.5.747; Weinert M, 1996, ANN INTERN MED, V125, P485, DOI 10.7326/0003-4819-125-6-199609150-00010; Whitcup SM, 2000, JAMA-J AM MED ASSOC, V283, P653, DOI 10.1001/jama.283.5.653; Zampogna JC, 2001, J AM ACAD DERMATOL, V44, P391, DOI 10.1067/mjd.2001.107964	81	17	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2002	110	1					3	16		10.1067/mai.2002.125978	http://dx.doi.org/10.1067/mai.2002.125978			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	574CF	12110810				2022-12-18	WOS:000176870300001
J	Hays, SR; Woodruff, PG; Khashayar, R; Ferrando, RE; Liu, J; Fung, P; Zhao, CQ; Wong, HH; Fahy, JV				Hays, SR; Woodruff, PG; Khashayar, R; Ferrando, RE; Liu, J; Fung, P; Zhao, CQ; Wong, HH; Fahy, JV			Allergen challenge causes inflammation but not goblet cell degranulation in asthmatic subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; goblet cells; allergen; mucin; eosinophils; neutrophils	GLAND SEROUS CELLS; AIRWAY INFLAMMATION; NEUTROPHIL ELASTASE; HEALTHY-SUBJECTS; MUCUS SECRETION; INDUCED SPUTUM; NITRIC-OXIDE; RESPONSES; RESPONSIVENESS; HISTAMINE	Background: An allergen challenge to the airways of sensitized mice causes eosinophilic airway inflammation and degranulation of goblet cells, which lead to airway obstruction. However, whether allergen challenge causes a similar pattern of airway inflammation and goblet cell degranulation in human beings is unknown. Objective: The purpose of this study was to determine whether allergen challenge increases airway inflammatory cells and causes goblet cell degranulation in human subjects with asthma. Methods: In bronchial biopsy specimens taken from 8 asthmatic subjects at 1 and 24 hours after allergen challenge, we measured eosinophil and neutrophil numbers as indicators of inflammation. We also measured goblet cell mucin stores and the amounts of secreted mucin in bronchial lavage as indicators of goblet cell degranulation. Results: Airway eosinophil numbers at both 1 and 24 hours after allergen challenge were twice as high as those after diluent challenge. Changes in neutrophil numbers were smaller and statistically insignificant. Goblet cell mucin stores measured in tissue stained with alcian blue/periodic acid-Schiff did not decrease significantly from baseline to 1 hour and actually tended to increase at 24 hours. This increase was significant in the subgroup of subjects with normal stored mucin levels at baseline. Mucin-like glycoprotein concentrations in bronchial lavage did not change significantly at either time point. Conclusion: Although allergen challenge in asthmatic subjects increases airway eosinophil numbers as early as 1 hour after challenge, this inflammatory response does not cause goblet cell degranulation. In fact, in subjects with normal baseline mucin stores, allergen challenge increases goblet cell mucin stores.	Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fahy, JV (corresponding author), Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, Box 0111,505 Parnassus Ave, San Francisco, CA 94143 USA.				NHLBI NIH HHS [HL-07185, HL-61662, HL56385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061662, P50HL056385, P01HL056385] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAHAM WM, 1994, J CLIN INVEST, V93, P776, DOI 10.1172/JCI117032; ABRAHAM WM, 1997, AM J RESP CRIT CARE, V155, pA878; Agusti C, 1998, AM J RESP CRIT CARE, V158, P1253, DOI 10.1164/ajrccm.158.4.9801041; BLEECKER ER, 1991, J ALLERGY CLIN IMMUN, V88, P808; CARROLL N, 1993, AM REV RESPIR DIS, V147, P405, DOI 10.1164/ajrccm/147.2.405; CLAMAN DM, 1994, J ALLERGY CLIN IMMUN, V94, P861, DOI 10.1016/0091-6749(94)90154-6; COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Deykin A, 1998, AM J RESP CRIT CARE, V157, P769, DOI 10.1164/ajrccm.157.3.9707114; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; FAHY JV, 1995, AM J RESP CRIT CARE, V152, P53, DOI 10.1164/ajrccm.152.1.7599862; FAHY JV, 1993, AM REV RESPIR DIS, V147, P1132, DOI 10.1164/ajrccm/147.5.1132; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; HOUSTON JC, 1953, THORAX, V8, P207, DOI 10.1136/thx.8.3.207; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Louahed J, 2000, AM J RESP CELL MOL, V22, P649, DOI 10.1165/ajrcmb.22.6.3927; LUNDGREN JD, 1991, J ALLERGY CLIN IMMUN, V87, P689, DOI 10.1016/0091-6749(91)90390-A; Ohkawara Y, 1997, AM J RESP CELL MOL, V16, P510, DOI 10.1165/ajrcmb.16.5.9160833; OPENSHAW PJM, 1989, RESP MED, V83, P25, DOI 10.1016/S0954-6111(89)80056-3; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Paredi P, 1999, EUR RESPIR J, V13, P48, DOI 10.1183/09031936.99.13104899; Peebles RS, 1998, J APPL PHYSIOL, V84, P1500, DOI 10.1152/jappl.1998.84.5.1500; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; SHELHAMER JH, 1980, J CLIN INVEST, V66, P1400, DOI 10.1172/JCI109993; Shim JJ, 2001, AM J PHYSIOL-LUNG C, V280, pL134, DOI 10.1152/ajplung.2001.280.1.L134; SOMMERHOFF CP, 1990, J CLIN INVEST, V85, P682, DOI 10.1172/JCI114492; SOMMERHOFF CP, 1989, J IMMUNOL, V142, P2450; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; TABACHNIK E, 1992, J APPL PHYSIOL, V73, P695, DOI 10.1152/jappl.1992.73.2.695; Teran LM, 1996, AM J RESP CRIT CARE, V154, P469, DOI 10.1164/ajrccm.154.2.8756824; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258	34	17	18	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2001	108	5					784	790						7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	498RG	11692105				2022-12-18	WOS:000172523800020
J	Novak, N; Haberstok, J; Kraft, S; Siekmann, L; Allam, JP; Bieber, T				Novak, N; Haberstok, J; Kraft, S; Siekmann, L; Allam, JP; Bieber, T			Standardized extracts from Chinese herbs induce IL-10 production in human monocyte-derived dendritic cells and alter their differentiation in vitro	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						dendritic cells; atopic dermatitis; Chinese herbal therapy; CD23; interleukin 10	EPIDERMAL LANGERHANS CELLS; ATOPIC ECZEMA; FOLLOW-UP; THERAPY; DERMATITIS; SKIN; EFFICACY; EXPRESSION; MEDICINE; ANTIGEN	Background: The efficacy of traditional Chinese medicine (TCM) as a treatment for atopic dermatitis has been evaluated in clinical trials. Until now, the underlying mechanism of this treatment has remained completely elusive; this is particularly true of its putative effects on dendritic cells (DCs), which might play a pivotal role in the disease. Objective: We investigated the influence of a standardized extract from 10 Chinese herbs that was successfully used in clinical trials on the generation of monocyte-derived DCs from atopic donors. Methods: Detailed phenotypic and functional exploration of DCs generated in the presence of IL-4 and GM-CSF and treated with different concentrations of TCM or a placebo control was performed. Results: TCM profoundly affected the morphology and phenotype of the developing DCs. They lost their typical dendritic morphology and decreased their expression of CD1a as well as the low-affinity IgE receptor CD23. Most importantly, TCM-exposed DCs exhibited a diminished stimulatory activity toward autologous antigen-specific and allogeneic T cells while secreting high amounts of IL-10. Conclusion: TCM induces immunopharmacologic alterations on DCs from atopic donors in vitro. These alterations might account, at least in part, for the therapeutic effect of this treatment in AD in vivo.	Univ Bonn, Dept Dermatol, D-53105 Bonn, Germany; Univ Bonn, Dept Clin Biochem, D-53105 Bonn, Germany	University of Bonn; University of Bonn	Bieber, T (corresponding author), Univ Bonn, Dept Dermatol, Sigmund Freud Str 25, D-53105 Bonn, Germany.							Akdis CA, 2000, CURR OPIN IMMUNOL, V12, P641, DOI 10.1016/S0952-7915(00)00156-4; Armstrong NC, 1999, BRIT J CLIN PHARMACO, V48, P262, DOI 10.1046/j.1365-2125.1999.00004.x; ATHERTON DJ, 1992, PEDIATR DERMATOL, V9, P373, DOI 10.1111/j.1525-1470.1992.tb00635.x; ATHERTON DJ, 1991, LANCET, V338, P510, DOI 10.1016/0140-6736(91)90580-I; Banerjee P, 1998, CLIN EXP ALLERGY, V28, P306, DOI 10.1046/j.1365-2222.1998.00233.x; Bieber T, 1996, CURR OPIN IMMUNOL, V8, P773, DOI 10.1016/S0952-7915(96)80003-3; BIEBER T, 1992, RES IMMUNOL, V143, P445, DOI 10.1016/S0923-2494(05)80082-3; Bieber T, 1995, PATHOL BIOL, V43, P871; But P, 1996, CLIN REV ALLERG IMMU, V14, P253; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Dickensheets HL, 1997, J IMMUNOL, V159, P6226; Fung AYP, 1999, INT J DERMATOL, V38, P387, DOI 10.1046/j.1365-4362.1999.00732.x; Gosset P, 2001, J ALLERGY CLIN IMMUN, V107, P114, DOI 10.1067/mai.2001.111126; HANIFIN JM, 1980, ACTA DERM-VENEREOL S, V92, P44, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]; Holgate ST, 1998, ALLERGY, V53, P83, DOI 10.1111/j.1398-9995.1998.tb04946.x; Joss A, 2000, EUR J IMMUNOL, V30, P1683, DOI 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A; Kraft S, 1998, J IMMUNOL, V161, P1000; LATCHMAN Y, 1994, INT ARCH ALLERGY IMM, V104, P222, DOI 10.1159/000236669; Latchman Y, 1996, INT ARCH ALLERGY IMM, V109, P243, DOI 10.1159/000237245; Leung DYM, 2000, J ALLERGY CLIN IMMUN, V105, P860, DOI 10.1067/mai.2000.106484; Morinobu A, 1996, J CLIN IMMUNOL, V16, P326, DOI 10.1007/BF01541668; MULLER K M, 1991, Journal of Dermatological Science, V2, P125, DOI 10.1016/0923-1811(91)90022-P; Novak N, 1999, ALLERGY, V54, P792, DOI 10.1034/j.1398-9995.1999.00101.x; Panhans-Gross A, 2001, J ALLERGY CLIN IMMUN, V107, P345, DOI 10.1067/mai.2001.112600; Park JS, 1997, J IMMUNOL, V158, P5002; Pretolani M, 1997, IMMUNOL TODAY, V18, P277, DOI 10.1016/S0167-5699(97)80023-0; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SHEEHAN MP, 1995, CLIN EXP DERMATOL, V20, P136, DOI 10.1111/j.1365-2230.1995.tb02717.x; SHEEHAN MP, 1994, BRIT J DERMATOL, V130, P488, DOI 10.1111/j.1365-2133.1994.tb03383.x; SHEEHAN MP, 1992, LANCET, V340, P13, DOI 10.1016/0140-6736(92)92424-E; TAKIGAWA M, 1991, CLIN EXP IMMUNOL, V84, P275; TAMAYA T, 1986, AM J OBSTET GYNECOL, V155, P1134, DOI 10.1016/0002-9378(86)90365-0; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Xu XJ, 1997, BRIT J DERMATOL, V136, P54, DOI 10.1111/j.1365-2133.1997.tb08746.x	34	17	17	0	5	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2001	108	4					588	593		10.1067/mai.2001.118597	http://dx.doi.org/10.1067/mai.2001.118597			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	485NK	11590386				2022-12-18	WOS:000171760300019
J	Asero, R; Mistrello, G; Roncarolo, D; Amato, S				Asero, R; Mistrello, G; Roncarolo, D; Amato, S			A case of onion allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Osped Caduti Bollatesi, Ambulatorio Allergol, I-20021 Bollate, MI, Italy; Lofarma, Milan, Italy		Asero, R (corresponding author), Osped Caduti Bollatesi, Ambulatorio Allergol, Via Piave 20, I-20021 Bollate, MI, Italy.		Amato, Sandra/AAH-4430-2021	Amato, Sandra/0000-0002-3277-0662				Asero R, 1999, ANN ALLERG ASTHMA IM, V83, P377, DOI 10.1016/S1081-1206(10)62834-7; Asero R, 2000, INT ARCH ALLERGY IMM, V122, P20, DOI 10.1159/000024355; Asero R, 1998, J ALLERGY CLIN IMMUN, V101, P427, DOI 10.1016/S0091-6749(98)70261-1; BOUSQUET J, 1993, ALLERGY PRINCIPLES P, P573; Perez-Pimiento AJ, 1999, ALLERGY, V54, P626, DOI 10.1034/j.1398-9995.1999.00806.x	5	17	17	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2001	108	2					309	310		10.1067/mai.2001.116983	http://dx.doi.org/10.1067/mai.2001.116983			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	465HY	11496255				2022-12-18	WOS:000170584600027
J	Holm, A; Dijkstra, M; Kleinjan, A; Severijnen, LA; Boks, S; Mulder, P; Fokkens, W				Holm, A; Dijkstra, M; Kleinjan, A; Severijnen, LA; Boks, S; Mulder, P; Fokkens, W			Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						nasal challenge; fluticasone propionate; inflammatory cells; allergic rhinitis; allergic inflammation	INDUCED RHINITIS; ANTIGEN CHALLENGE; PERENNIAL RHINITIS; LANGERHANS CELLS; POLLEN SEASON; LYMPHOCYTES-T; MAST-CELLS; LATE-PHASE; EOSINOPHILS; IMMUNOHISTOLOGY	Background: Topical corticosteroid therapy reduces symptoms and nasal mucosal inflammatory cells in patients with allergic rhinitis. Usually patients are advised to start their medication (1 week) before the beginning of the pollen season. The effect of pretreatment with a topical corticosteroid on unchallenged nasal mucosa is not well documented. Objectives: The purpose of this study was to investigate, in a double-blind, placebo-controlled study, the effect of 6 weeks' pretreatment with 200 mug twice daily fluticasone propionate on nasal symptoms and inflammatory cell numbers after nasal allergen provocation in patients with seasonal allergic rhinitis. Methods: Nineteen patients with grass pollen-induced allergic rhinitis were treated for a 6-week period out of the grass pollen season. After completing the treatment period, patients were challenged with grass pollen. Nasal mucosal biopsy specimens were taken 5 times in every patient. In nasal mucosa changes in numbers of T cells, B cells, mast cells, eosinophils, macrophages, and Langerhans' cells were investigated. Results: After 4 weeks of treatment but before allergen provocation, significantly fewer epithelial Langerhans' cells, macrophages, mast cells, T cells, and eosinophils were found in the fluticasone propionate group compared with those found in the placebo group. In the lamina propria significantly fewer Langerhans' cells and eosinophils were found in the fluticasone propionate group. Cell influx in nasal mucosa after allergen provocation was significantly inhibited in the fluticasone propionate group compared with that in the placebo group for epithelial Langerhans' cells, mast cells, macrophages, and T cells and for lamina propria eosinophils, mast cells, Langerhans' cells, macrophages, and T cells. Conclusions: Fluticasone propionate is effective in reducing early- and late-phase nasal symptoms. Topical corticosteroid treatment reduces inflammatory cells in unchallenged nasal mucosa.	Erasmus Univ, Med Ctr, Dept Otorhinolaryngol, Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Holm, A (corresponding author), Univ Groningen Hosp, POB 30001, NL-9700 RB Groningen, Netherlands.		Fokkens, Wytske WJ/ABF-2185-2020					ANDERSSON M, 1988, J ALLERGY CLIN IMMUN, V82, P1019, DOI 10.1016/0091-6749(88)90139-X; BASCOM R, 1988, AM REV RESPIR DIS, V138, P406, DOI 10.1164/ajrccm/138.2.406; BASCOM R, 1988, J ALLERGY CLIN IMMUN, V81, P570, DOI 10.1016/0091-6749(88)90198-4; BENTLEY AM, 1992, J ALLERGY CLIN IMMUN, V89, P877, DOI 10.1016/0091-6749(92)90444-7; Blom HM, 1997, J ALLERGY CLIN IMMUN, V100, P739, DOI 10.1016/S0091-6749(97)70267-7; BOUSQUET J, 1993, ALLERGY, V48, P327, DOI 10.1111/j.1398-9995.1993.tb02401.x; BRADDING P, 1993, J IMMUNOL, V151, P3853; CALDERON MA, 1994, J ALLERGY CLIN IMMUN, V93, P635, DOI 10.1016/S0091-6749(94)70075-3; Ciprandi G, 1998, CLIN EXP ALLERGY, V28, P293; FOKKENS W J, 1988, Rhinology (Utrecht), V26, P293; FOKKENS WJ, 1989, J ALLERGY CLIN IMMUN, V84, P39, DOI 10.1016/0091-6749(89)90176-0; Godthelp T, 1996, J ALLERGY CLIN IMMUN, V97, P800, DOI 10.1016/S0091-6749(96)80158-8; HOLM AF, 1995, ALLERGY, V50, P204, DOI 10.1111/j.1398-9995.1995.tb01134.x; Holm AF, 1999, CLIN EXP ALLERGY, V29, P1356; IGARASHI Y, 1993, J ALLERGY CLIN IMMUN, V91, P1082, DOI 10.1016/0091-6749(93)90223-3; JULIUSSON S, 1995, ALLERGY, V50, P15, DOI 10.1111/j.1398-9995.1995.tb02478.x; JUNIPER EF, 1993, J ALLERGY CLIN IMMUN, V92, P66, DOI 10.1016/0091-6749(93)90039-I; KONNO A, 1994, INT ARCH ALLERGY IMM, V103, P79, DOI 10.1159/000236609; LOZEWICZ S, 1992, J ALLERGY CLIN IMMUN, V89, P951, DOI 10.1016/0091-6749(92)90217-P; MASUYAMA K, 1994, IMMUNOLOGY, V82, P192; MELTZER EO, 1990, J ALLERGY CLIN IMMUN, V86, P221, DOI 10.1016/S0091-6749(05)80069-7; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; NACLERIO RM, 1988, J ALLERGY CLIN IMMUN, V82, P927; Nielsen LP, 1998, ALLERGY, V53, P778; ORGEL HA, 1991, J ALLERGY CLIN IMMUN, V88, P257, DOI 10.1016/0091-6749(91)90336-M; RAK S, 1994, CLIN EXP ALLERGY, V24, P930, DOI 10.1111/j.1365-2222.1994.tb02724.x; Slater A, 1996, J LARYNGOL OTOL, V110, P929, DOI 10.1017/S0022215100135388; VARNEY VA, 1992, AM REV RESPIR DIS, V146, P170, DOI 10.1164/ajrccm/146.1.170; WIERENGA EA, 1990, J IMMUNOL, V144, P4651; Wright ED, 1999, LARYNGOSCOPE, V109, P551, DOI 10.1097/00005537-199904000-00006	31	17	20	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2001	107	4					627	633		10.1067/mai.2001.113520	http://dx.doi.org/10.1067/mai.2001.113520			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	423RG	11295650	Bronze			2022-12-18	WOS:000168190100013
J	Min, HK; Kambe, N; Schwartz, LB				Min, HK; Kambe, N; Schwartz, LB			Human mouse mast cell protease 7-like tryptase genes are pseudogenes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						mast cell; RT-PCR; pseudogene tryptase	FETAL LIVER-CELLS; FC-EPSILON-RI; RECOMBINANT HUMAN; MONOCLONAL-ANTIBODIES; SYSTEMIC-ANAPHYLAXIS; COMPLEMENTARY-DNA; ACTIVATION; CHYMASE; BLOOD; ALPHA	Background: alpha -Tryptase and beta -tryptase are important clinical markers for mast cell-dependent disorders. A third family of tryptase genes on human chromosome 16 has been identified and called human mouse mast cell protease 7 (hmMCP-7)-like tryptase. Objective: This study was designed to determine whether these tryptase genes are expressed by human mast cells. Methods: A 2842-bp hmMCP-7-like tryptase gene was cloned and sequenced from a human placental genomic library. PCR and RT-PCR procedures, respectively, were used to determine whether this tryptase gene family was present in most genomes and whether it was expressed. Results: The tryptase clone was almost identical to the hmMCP-7-like tryptase II and I genes, and therefore it was called hmMCP-7-like tryptase III. All such genes encode a Gln(-3) like alpha -tryptase. They also terminate translation after amino acid 235, whereas alpha- and beta -tryptase genes each encode a 275-amino acid protein. In this study, cell lines HMC-1, KU812, and Mono-Mac-6; mast cells derived in vitro from cord blood and fetal liver progenitors; and mast cell-enriched preparations of dispersed skin and lung cells contained hmMCP-7-like tryptases in their genomes by PCR with gene-specific primers. To identify whether such genes were transcriptionally active, RT-PCR revealed alpha- or beta -tryptase products in all mast cell preparations and cell lines and in activated skin-derived mast cells, but no hmMCP-7-like tryptase products. Conclusion: These results indicate hmMCP-7-like tryptase (I, II, III) genes are pseudogenes and unlikely to affect measurements of alpha- and beta -tryptases.	Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Schwartz, LB (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, POB 980263, Richmond, VA 23298 USA.		Wilson, Matthew H/K-3193-2013; Kambe, Naotomo/H-3987-2017	Kambe, Naotomo/0000-0001-9610-4952	NIAID NIH HHS [AI27517, AI20487] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI020487, R01AI020487, R01AI027517, R37AI020487] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLOM T, 1993, SCAND J IMMUNOL, V37, P203, DOI 10.1111/j.1365-3083.1993.tb01757.x; CASTELLS MC, 1987, J IMMUNOL, V138, P2184; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CRAIG SS, 1986, AM J PATHOL, V124, P427; HUANG R, 1993, SCAND J IMMUNOL, V38, P359, DOI 10.1111/j.1365-3083.1993.tb01738.x; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; IRANI AMA, 1992, BLOOD, V80, P3009; IRANI AMA, 1989, J HISTOCHEM CYTOCHEM, V37, P1509, DOI 10.1177/37.10.2674273; Jarjour NN, 1997, AM J RESP CRIT CARE, V155, P1515, DOI 10.1164/ajrccm.155.5.9154851; Kambe N, 2000, J IMMUNOL METHODS, V240, P101, DOI 10.1016/S0022-1759(00)00174-5; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; RISKE F, 1991, J BIOL CHEM, V266, P11245; Sakai K, 1996, J CLIN INVEST, V97, P988, DOI 10.1172/JCI118523; Schwartz LB, 1995, J CLIN INVEST, V96, P2702, DOI 10.1172/JCI118337; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; SCHWARTZ LB, 1994, J CLIN IMMUNOL, V14, P190, DOI 10.1007/BF01533368; VANDERLINDEN PWG, 1992, J ALLERGY CLIN IMMUN, V90, P110, DOI 10.1016/S0091-6749(06)80017-5; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; WALLS AF, 1990, J PATHOL, V162, P119, DOI 10.1002/path.1711620204; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002; WILDE CD, 1986, CRIT REV BIOCHEM MOL, V19, P323; Xia HZ, 1997, J IMMUNOL, V159, P2911; XIA HZ, 1995, J IMMUNOL, V154, P5472	26	17	19	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2					315	321		10.1067/mai.2001.112130	http://dx.doi.org/10.1067/mai.2001.112130			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	403YV	11174199				2022-12-18	WOS:000167071400019
J	Rooklin, A; Elkayam, D; Weiler, J; Windom, H; Schoaf, L; Scott, C; House, KW; Payne, JE; Shah, T				Rooklin, A; Elkayam, D; Weiler, J; Windom, H; Schoaf, L; Scott, C; House, KW; Payne, JE; Shah, T			The fluticasone propionate/salmeterol HFA MDI is significantly more efficacious in treating asthma than placebo HFA MDI, fluticasone propionate CFC MDI or salmeterol CFC MDI	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Allergy Res Associates, Upland, PA USA; Bellingham Asthma Allergy & immunol, Bellingham, WA USA; Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; Asthma & Allergy Res Ctr Inc, Sarasota, FL USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA	University of Iowa; GlaxoSmithKline									0	17	17	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		335	S100	S100						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300335
J	Weinstein, SF; Pearlman, DS; Condemi, JJ; Herrle, MR; Scott, CA; Payne, JE; House, KW; Shah, TP				Weinstein, SF; Pearlman, DS; Condemi, JJ; Herrle, MR; Scott, CA; Payne, JE; House, KW; Shah, TP			Superior efficacy of the fluticasone propionate/salmeterol (88/42MCG) HFA-MDI combination product versus the individual components in asthmatics previously treated with either short- or long-acting beta2-agonists or inhaled corticosteroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Asthma & Allergy Specialist Med Grp, Huntington Beach, CA USA; Clin Res Ctr Colorado PC, Aurora, CO USA; Allergy Asthma Immunol Rochester Res Ctr, Rochester, NY USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline									0	17	17	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		339	S102	S102						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300339
J	Roca-Ferrer, J; Mullol, J; Perez, M; Xaubet, A; Molins, L; de Haro, J; Shelhamer, J; Picado, C				Roca-Ferrer, J; Mullol, J; Perez, M; Xaubet, A; Molins, L; de Haro, J; Shelhamer, J; Picado, C			Effects of topical glucocorticoids on in vitro lactoferrin glandular secretion: Comparison between human upper and lower airways	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						nasal mucosa; bronchial mucosa; lactoferrin; glandular secretion; budesonide; beclomethasone dipropionate; lipocortin 1; mucus hypersecretion; methacholine; glucocorticoids	BECLOMETHASONE DIPROPIONATE; ALLERGIC RHINITIS; GLYCOCONJUGATE SECRETION; ANTIINFLAMMATORY DRUGS; EOSINOPHIL SURVIVAL; NASAL SECRETIONS; INVITRO; BUDESONIDE; ASTHMA; LIPOCORTIN-1	Background: Mucus hypersecretion is a hallmark of upper and lower airway diseases, such as rhinitis, asthma, and chronic obstructive pulmonary disease. Although topical glucocorticoids are widely used to treat mucosal inflammation, their effect on mucus hypersecretion remains uncertain. Objective: The aim of this study was to investigate the effect of budesonide and beclomethasone dipropionate on in vitro lactoferrin glandular secretion from both human nasal and bronchial mucosa and the potential mediating role of lipocortin 1. Methods: Nasal and bronchial explants obtained from patients undergoing surgery mere cultured in a controlled atmosphere. Lactoferrin (ELISA) was measured in culture supernatants, and lipocortin 1 (Western blot) was analyzed in explant tissues, Results: Both budesonide and beclomethasone dipropionate (10(-6) mol/L) decreased spontaneous lactoferrin secretion in nasal and bronchial mucosa, The maximum effect of corticosteroids (10(-6) mol/L) was obtained at day 3 in bronchial mucosa (budesonide: -56% +/- 9%, P < .05; beclomethasone dipropionate: 32% +/- 6%, P < .05) and at day 5 in nasal mucosa (budesonide: 34% +/- 10%, P < .05; beclomethasone dipropionate: -37% +/- 10%, P < .05). Methacholine (10(-4) mol/L) increased lactoferrin secretion in both bronchial (248% +/- 72%, P < .05) and nasal (107% +/- 28%, P < .05) explants, with this effect being completely abrogated by atropine, Budesonide caused a dose-related inhibitory effect on methacholine-induced lactoferrin secretion that was similar in both bronchial (down to -86% at 10(-6) mol/L) and nasal (down to -73% at 10(-6) mol/L) mucosa. Budesonide (10(-6) mol/L) did not show any effect on lipocortin 1 expression. Conclusions: These results suggest that glucocorticoid effects on airway inflammation may include a reduction of mucus hypersecretion in both nasal and bronchial mucosa.	Hosp Clin, Inst Clin Pneumol & Cirurgia Torac, Barcelona 08036, Spain; Inst Invest Biomed August Pi Sunyer, IDIBAPS, Barcelona, Spain; Hosp Clin, Serv Otorinolaringol, Barcelona 08036, Spain; Hosp Sargrat Cor, Serv Cirurgia Torac, Barcelona, Spain; Hosp Municipal Badalona, Serv Otorinolaringol, Barcelona, Spain; NIH, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Picado, C (corresponding author), Hosp Clin, Inst Clin Pneumol & Cirurgia Torac, Villarroel 170, Barcelona 08036, Spain.		Roca-Ferrer, Jordi/AFQ-4652-2022; /AAL-7347-2021; /AFX-9519-2022; Gonzalez, Maria Perez/J-5846-2017	Roca-Ferrer, Jordi/0000-0002-9527-2273; Gonzalez, Maria Perez/0000-0001-9013-6785; Perez Gonzalez, Maria/0000-0001-5525-5543				ADAMOPOULOS G, 1995, CLIN OTOLARYNGOL, V20, P340, DOI 10.1111/j.1365-2273.1995.tb00055.x; Ali M, 1996, AM J PHYSIOL-LUNG C, V270, pL595, DOI 10.1152/ajplung.1996.270.4.L595; ALMOHAIMEID H, 1993, J INT MED RES, V21, P67, DOI 10.1177/030006059302100201; AMBROSE MP, 1992, AM J RESP CELL MOL, V6, P17, DOI 10.1165/ajrcmb/6.1.17; BAITON DF, 1999, J IMMUNOL METHODS, V232, P153; BARAN D, 1987, BRIT J DIS CHEST, V81, P170, DOI 10.1016/0007-0971(87)90135-5; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Baroody FM, 1996, ARCH OTOLARYNGOL, V122, P321; BASBAUM CB, 1990, ANNU REV PHYSIOL, V52, P97; BASTIAN BC, 1993, J INVEST DERMATOL, V101, P359, DOI 10.1111/1523-1747.ep12365541; DECATERINA R, 1993, J APPL PHYSIOL, V75, P2368, DOI 10.1152/jappl.1993.75.6.2368; Emala CW, 1997, AM J PHYSIOL-LUNG C, V272, pL745, DOI 10.1152/ajplung.1997.272.4.L745; Fang SY, 1998, AM J RHINOL, V12, P131, DOI 10.2500/105065898781390271; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; HALL SE, 1999, AM J PHYSIOL, V276, P114; JEFFERY PK, 1992, RESPIRATION, V59, P13; JOHNSON CW, 1995, ASTHMA RHINITIS, P584; KLEMENTSSON H, 1991, CLIN EXP ALLERGY, V21, P705, DOI 10.1111/j.1365-2222.1991.tb03199.x; LONNERDAL B, 1995, ANNU REV NUTR, V15, P93, DOI 10.1146/annurev.nu.15.070195.000521; LUNDGREN JD, 1988, AM REV RESPIR DIS, V137, P353, DOI 10.1164/ajrccm/137.2.353; LUNDGREN JD, 1992, PULM PHARMACOL THER, V5, P81, DOI 10.1016/0952-0600(92)90024-B; MALM L, 1981, ALLERGY, V36, P209, DOI 10.1111/j.1398-9995.1981.tb01836.x; MAROM Z, 1981, J CLIN INVEST, V67, P1695, DOI 10.1172/JCI110207; MAROM Z, 1984, AM REV RESPIR DIS, V129, P62; MAROM ZVI, 1982, AM REV RESPIR DIS, V126, P449; MCARTHUR JG, 1994, CLIN OTOLARYNGOL, V19, P537, DOI 10.1111/j.1365-2273.1994.tb01285.x; MCGILL KA, 1995, CLIN IMMUNOTHER, V4, P16, DOI 10.1007/BF03259069; MCGREGOR FB, 1996, CLIN OTOLARYNGOL, V21, P76; Mullol i Miret J, 1997, Arch Bronconeumol, V33 Suppl 2, P3; MULLOL J, 1992, J APPL PHYSIOL, V73, P2069, DOI 10.1152/jappl.1992.73.5.2069; Mullol J, 1997, CLIN EXP ALLERGY, V27, P1432, DOI 10.1111/j.1365-2222.1997.tb02988.x; Mullol J, 1996, Arch Bronconeumol, V32, P527; Mullol J, 1999, LUNG BIOL HEALTH DIS, V134, P3; MULLOL J, 1992, J ALLERGY CLIN IMMUN, V89, P584, DOI 10.1016/0091-6749(92)90326-W; NABISHAH BM, 1991, GEN PHARMACOL-VASC S, V22, P389, DOI 10.1016/0306-3623(91)90469-M; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; RocaFerrer J, 1997, EUR RESPIR J, V10, P1489, DOI 10.1183/09031936.97.10071489; Scherrer D, 1997, FUNDAM CLIN PHARM, V11, P111, DOI 10.1111/j.1472-8206.1997.tb00176.x; SHIMURA S, 1990, AM REV RESPIR DIS, V141, P1044, DOI 10.1164/ajrccm/141.4_Pt_1.1044; SMITH SF, 1995, J APPL PHYSIOL, V79, P121, DOI 10.1152/jappl.1995.79.1.121; SOMMERHOFF CP, 1990, AM J RESP CELL MOL, V2, P41, DOI 10.1165/ajrcmb/2.1.41; TOOGOOD JH, 1989, J ALLERGY CLIN IMMUN, V83, P528, DOI 10.1016/0091-6749(89)90034-1; vanHal PTW, 1996, J APPL PHYSIOL, V81, P548, DOI 10.1152/jappl.1996.81.2.548; VANZIELEGHEM MA, 1987, J ALLERGY CLIN IMMUN, V79, P887, DOI 10.1016/0091-6749(87)90237-5; Vyberg M, 1998, APPL IMMUNOHISTOCHEM, V6, P3, DOI 10.1097/00022744-199803000-00002; WURTHWEIN G, 1990, BIOPHARM DRUG DISPOS, V11, P381, DOI 10.1002/bdd.2510110503	46	17	18	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2000	106	6					1053	1062						10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	384ER	11112886	Bronze			2022-12-18	WOS:000165930300005
J	Knorr, B; Holland, S; Rogers, JD; Nguyen, HH; Reiss, TF				Knorr, B; Holland, S; Rogers, JD; Nguyen, HH; Reiss, TF			Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						leukotrienes; pharmacokinetics; dose selection; montelukast	LEUKOTRIENE-RECEPTOR ANTAGONIST; EXERCISE-INDUCED BRONCHOCONSTRICTION; DOUBLE-BLIND TRIAL; CHRONIC ASTHMA; D-4-RECEPTOR ANTAGONIST; URINARY LEUKOTRIENE-E4; 14-YEAR-OLD CHILDREN; SODIUM MK-0476; PHARMACOKINETICS; BIOAVAILABILITY	Montelukast is a selective leukotriene receptor antagonist that has been shown to be effective in the treatment of chronic asthma. It is approved in more than 70 countries for patients 6 years of age and older. For adults (greater than or equal to 15 years of age), a 10-mg film-coated tablet (FCT) is available, and for children (aged 6 to 14 years), a 5-mg chewable tablet (CT) is available. The adult montelukast dose (10-mg FCT) was selected on the basis of classic dose-ranging studies as the lowest dose that produces maximal improvement in both measures of airway function and patient-reported outcomes in chronic asthma and in the attenuation of exercise-induced bronchoconstriction. The strategy used for the pediatric dose selection for montelukast was based on the determination of a CT dose that would provide an overall systemic exposure to montelukast in children similar to that in adults who receive a IO-mg FCT dose. Because montelukast was to be given chronically for the treatment of asthma, the area under the plasma concentration-time curve was considered to be the pharmacokinetic measurement that best represented systemic exposure to the drug. A 5-mg CT yielded a comparable single-dose area under the plasma concentration-time curve profile to that of the adult 10-mg FCT dose and, therefore, was selected as the pediatric dose for children aged 6 to 14 years with asthma. Subsequently, 2 studies of efficacy and tolerability validated the choice of the 5-mg CT dose.	Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Pulm Immunol, Rahway, NJ 07065 USA; Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Clin Pharmacol, Rahway, NJ 07065 USA; Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Clin Drug Metab, Rahway, NJ 07065 USA; Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Biostat, Rahway, NJ 07065 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Knorr, B (corresponding author), Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Pulm Immunol, POB 2000,RY33-656, Rahway, NJ 07065 USA.							Altman LC, 1998, J ALLERGY CLIN IMMUN, V102, P50, DOI 10.1016/S0091-6749(98)70054-5; AUGSTEIN J, 1973, NATURE-NEW BIOL, V245, P215, DOI 10.1038/newbio245215a0; BARNES NC, 1984, THORAX, V39, P500, DOI 10.1136/thx.39.7.500; BISGAARD H, 1985, J INVEST DERMATOL, V84, P427, DOI 10.1111/1523-1747.ep12265527; Bronsky EA, 1997, CLIN PHARMACOL THER, V62, P556, DOI 10.1016/S0009-9236(97)90051-5; Busse W, 1998, ANN ALLERG ASTHMA IM, V81, P17, DOI 10.1016/S1081-1206(10)63106-7; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; Cheng HY, 1996, PHARM RES-DORDR, V13, P445, DOI 10.1023/A:1016056912698; CHENG JB, 1992, PULM PHARMACOL THER, V5, P77, DOI 10.1016/0952-0600(92)90023-A; CHUNG KF, 1995, EUR RESPIR J, V8, P1203, DOI 10.1183/09031936.95.08071203; Clinton W. J., 1994, FED REG; Fish JE, 1997, CLIN THER, V19, P675, DOI 10.1016/S0149-2918(97)80092-6; HUI KP, 1991, CLIN THER, V19, P675; Kemp JP, 1998, J PEDIATR-US, V133, P424, DOI 10.1016/S0022-3476(98)70281-1; Knorr B, 1998, CLIN PHARMACOL THER, V63, P191; Knorr B, 1999, J CLIN PHARMACOL, V39, P786, DOI 10.1177/00912709922008434; Knorr B, 1998, JAMA-J AM MED ASSOC, V279, P1181, DOI 10.1001/jama.279.15.1181; Laitinen L. A., 1998, European Respiratory Journal, V12, p55s; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Lynch KR, 1999, NATURE, V399, P789; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; MANNING PJ, 1990, J ALLERGY CLIN IMMUN, V86, P211, DOI 10.1016/S0091-6749(05)80068-5; MAROM ZVI, 1982, AM REV RESPIR DIS, V126, P449; *MERCK CO INC, 1999, SING PACK INS; Nguyen H, 1998, CLIN PHARMACOL THER, V63, P195; Noonan MJ, 1998, EUR RESPIR J, V11, P1232, DOI 10.1183/09031936.98.11061232; Pearlman DS, 1999, J PEDIATR-US, V134, P273, DOI 10.1016/S0022-3476(99)70449-X; Reiss TF, 1997, THORAX, V52, P1030, DOI 10.1136/thx.52.12.1030; Reiss TF, 1998, ARCH INTERN MED, V158, P1213, DOI 10.1001/archinte.158.11.1213; SCHOORS DF, 1995, BRIT J CLIN PHARMACO, V40, P277, DOI 10.1111/j.1365-2125.1995.tb05785.x; TAYLOR GW, 1989, LANCET, V1, P584; Zhao JJ, 1997, BIOPHARM DRUG DISPOS, V18, P769, DOI 10.1002/(SICI)1099-081X(199712)18:9<769::AID-BDD60>3.0.CO;2-K	33	17	18	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2000	106	3		S			S171	S178		10.1067/mai.2000.109424	http://dx.doi.org/10.1067/mai.2000.109424			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	357XB	10984399				2022-12-18	WOS:000089525400010
J	Dykewicz, MS; Orfan, NA; Sun, W				Dykewicz, MS; Orfan, NA; Sun, W			In vitro demonstration of IgE antibody to folate-albumin in anaphylaxis from folic acid	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							BINDING-PROTEINS; HOMOCYSTEINE; CANCER; WOMEN	Background: Folic acid (the synthetic form of folate B vitamins in foods) is widely used in vitamin supplements, Anaphylaxis from ingestion or injection of folic acid suggests IgE antibody-mediated mechanisms, but this has not been demonstrated previously in vitro. Objective: This study was conducted to better define the mechanism of folic acid hypersensitivity and cross-reactivity among folic acid congeners, Methods: Skin testing was performed with folic acid congeners in a woman who developed anaphylaxis after ingestion of 2 different multivitamin preparations containing folic acid. In vitro immunologic serum studies were conducted using a Folate-human serum albumin (HSA) conjugate prepared by a novel application of carbodiimide condensation. Results: The patient had positive immediate-type skin test reactions to folic acid and several folate analogues including leucovorin (folinic acid). Urticaria developed during graded oral test dosing with leucovorin, Using a dot immunoblot assay or an ELISA for IgE antibody to folate-HSA, results of the patient's serum testing were positive, whereas results of sera From normal control subjects were negative, the first in vitro demonstration of IgE to a folic acid-protein conjugate, By ELISA, the positive result of the patient's serum was inhibited significantly by serum coincubation with folate-HSA, but not HSA or folic acid. Conclusions: Immediate hypersensitivity to folic acid and possibly other vitamins can be mediated by IgE antibody to conjugates formed between vitamins and self-proteins or polypeptides. Leucovorin can have clinically important immunologic cross-reactivity with folic acid. A diet rich in natural folates (pteroylpolyglutamates) appears useful as a management strategy for providing adequate nutrition to patients with folic acid hypersensitivity.	St Louis Univ, Sch Med, Div Allergy & Immunol, Dept Internal Med, St Louis, MO 63104 USA	Saint Louis University	Dykewicz, MS (corresponding author), St Louis Univ, Sch Med, Div Allergy & Immunol, Dept Internal Med, 1402 S Grand Blvd,R 209, St Louis, MO 63104 USA.							ANTONY AC, 1987, J CLIN INVEST, V80, P711, DOI 10.1172/JCI113126; BRINKLEY M, 1992, BIOCONJUGATE CHEM, V3, P2, DOI 10.1021/bc00013a001; CARMEL R, 1997, TXB INTERNAL MED, P1446; CHANARIN J, 1957, BRIT MED J, V1, P1162; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Hankey GJ, 1999, LANCET, V354, P407, DOI 10.1016/S0140-6736(98)11058-9; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; KAMPSHOLTZAPPLE C, 1993, J IMMUNOL METHODS, V164, P245, DOI 10.1016/0022-1759(93)90317-Z; Kato I, 1999, BRIT J CANCER, V79, P1917, DOI 10.1038/sj.bjc.6690305; LEAMON CP, 1993, BIOCHEM J, V291, P855, DOI 10.1042/bj2910855; LUHRS CA, 1989, J BIOL CHEM, V264, P21446; MITCHELL DC, 1949, ANN INTERN MED, V31, P1102, DOI 10.7326/0003-4819-31-6-1102; Seyoum E, 1998, J NUTR, V128, P1956, DOI 10.1093/jn/128.11.1956; Woodliff H J, 1966, Med J Aust, V1, P351; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632; 1999, PEDIATRICS 1, V104, P325	16	17	18	0	9	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2000	106	2					386	389						4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	343NH	10932085	Bronze			2022-12-18	WOS:000088708100024
J	Schwingshackl, A; Moqbel, R; Duszyk, M				Schwingshackl, A; Moqbel, R; Duszyk, M			Involvement of ion channels in human eosinophil respiratory burst	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophils; Cl- channels; superoxide; patch clamp; phorbol 12-myristate 13-acetate	REGULATED CHLORIDE CHANNEL; HUMAN-NEUTROPHILS; NADPH OXIDASE; K+ CHANNELS; HUMAN BLOOD; INHIBITION; MECHANISM; CONDUCTANCE; EXPRESSION; ACTIVATION	Background: Human eosinophils possess a variety of ion channels that play a crucial role in the regulation of cellular activity. During eosinophil respiratory burst, efflux of H+ ions through H+ channels provides an efficient mechanism of H+ extrusion and charge compensation. Interestingly, recent studies suggest that other ion channels may also be involved in this process. Objective: We sought to investigate the role of ion channels in phorbol 12-myristate 13-acetate-induced superoxide (O-2(.-)) generation by human eosinophils, Methods: O-2(.-) production was measured by using the superoxide dismutase-inhibitable reduction of cytochrome c, Ion channel expression and function were studied by using RT-PCR and the patch clamp technique, respectively. Results: O-2(.-) generation was affected by several ion channel blockers, especially 4,4-diisothio-cyanostilbene-2,2'-disulfonic acid, The involvement of Cl- channels in this process was confirmed by replacement of Cl- with gluconate or other anions, The halide dependence of O-2(.-) production could be described by the sequence Cl(-)greater than or equal to Br->I-, which is similar to the selectivity sequence of several members of the chloride channel (CIC) family. RT-PCR studies performed with primers for CIC-2, CIC-3, CIC-4, CIC-5, CIC-6, and the cystic fibrosis transmembrane conductance regulator showed only the expression of CIC-3, The presence of phorbol 12-myristate 13-acetate-sensitive Cl- channels in human eosinophils with biophysical properties similar to the CIC-3 channel has been studied. Conclusion: Cl- channels play an important role in the regulation of O-2(.-) production by human eosinophils.	Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Med, Pulm Res Grp, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Duszyk, M (corresponding author), Univ Alberta, Dept Physiol, 7-46 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.							Alton EWFW, 1996, J ALLERGY CLIN IMMUN, V98, pS102, DOI 10.1016/S0091-6749(96)80136-9; Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; CHEN JH, 1989, SCIENCE, V243, P657, DOI 10.1126/science.2464852; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; DEMAUREX N, 1993, EUR J HAEMATOL, V51, P309; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Duszyk M, 1999, CAN J PHYSIOL PHARM, V77, P529, DOI 10.1139/cjpp-77-7-529; Ezeamuzie CI, 1998, INT ARCH ALLERGY IMM, V115, P162, DOI 10.1159/000023897; FITZ JG, 1993, AM J PHYSIOL, V265, pG1, DOI 10.1152/ajpgi.1993.265.1.G1; FUKUDA T, 1985, J IMMUNOL, V135, P1349; Giembycz MA, 1999, PHARMACOL REV, V51, P213; Gordienko DV, 1996, J PHYSIOL-LONDON, V496, P299, DOI 10.1113/jphysiol.1996.sp021686; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; Henderson LM, 1996, BBA-BIOENERGETICS, V1273, P87, DOI 10.1016/0005-2728(95)00140-9; Hille B., 1992, IONIC CHANNELS EXCIT; Illek B, 1999, PFLUG ARCH EUR J PHY, V437, P812, DOI 10.1007/s004240050850; Jensen BS, 1999, P NATL ACAD SCI USA, V96, P10917, DOI 10.1073/pnas.96.19.10917; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; KAWASAKI M, 1995, NEURON, V14, P1285, DOI 10.1016/0896-6273(95)90275-9; Mahmudi-Azer S, 1998, J IMMUNOL METHODS, V217, P113, DOI 10.1016/S0022-1759(98)00105-7; OPPENHEIMER EH, 1979, LAB INVEST, V40, P445; SAITO M, 1995, EUR J PHARM-MOLEC PH, V291, P217, DOI 10.1016/0922-4106(95)90147-7; Schrenzel J, 1996, AM J PHYSIOL-CELL PH, V271, pC1861, DOI 10.1152/ajpcell.1996.271.6.C1861; SHEN BQ, 1993, J BIOL CHEM, V268, P19070; SINGH AK, 1991, AM J PHYSIOL, V261, pC51, DOI 10.1152/ajpcell.1991.261.1.C51; Someya A, 1997, ARCH BIOCHEM BIOPHYS, V345, P207, DOI 10.1006/abbi.1997.0252; Timmer RT, 1999, AM J PHYSIOL-CELL PH, V276, pC66, DOI 10.1152/ajpcell.1999.276.1.C66; YATANI A, 1991, J BIOL CHEM, V266, P22872	31	17	17	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2000	106	2					272	279						8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	343NH	10932070				2022-12-18	WOS:000088708100009
J	Chihara, J; Kakazu, T; Higashimoto, I; Saito, N; Honda, K; Sannohe, S; Kayaba, H; Urayama, O				Chihara, J; Kakazu, T; Higashimoto, I; Saito, N; Honda, K; Sannohe, S; Kayaba, H; Urayama, O			Signaling through the beta 2 integrin prolongs eosinophil survival	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on New Trends in Immunopharmacology 1998	JUL 25, 1998	TOKYO, JAPAN			adhesion molecules; integrins; eosinophil survival; cytokines	INTERCELLULAR-ADHESION MOLECULE-1; COLONY-STIMULATING FACTOR; PERIPHERAL-BLOOD EOSINOPHILS; ACTIVATED HUMAN EOSINOPHILS; MESSENGER-RNA EXPRESSION; HYPEREOSINOPHILIC PATIENTS; RECEPTOR EXPRESSION; CELL-DENSITY; HETEROGENEITY; INDUCTION	Background: Recently, adhesion molecules have been suggested to play an important role in allergic inflammatory diseases such as bronchial asthma. It is unclear whether eosinophil activation and paracrine or autocrine synthesis of eosinophilopoietic growth cytokines is mediated through signaling by intercellular adhesion molecule-1 (ICAM-1) and the beta 2 integrin family. Objective: We examined whether signaling by ICAM-1 and its ligands (beta 2 integrins) could prolong eosinophil survival. Methods: Eosinophils were isolated from patients with hypereosinophilia by modified CD16 negative selection. After culture with or without recombinant soluble ICAM-1, eosinophil viability was measured by trypan blue dye exclusion. Results: Eosinophil survival was prolonged in cultures with recombinant soluble ICAM-1 compared with cultures without it (P < .01 on days 2, 4, and 6); this effect was dose-dependent, Eosinophil survival in cultures with recombinant soluble ICAM-1 was significantly inhibited by antibodies against ICAM-1 (P < .01), complement receptor 3 (P < .01), and lymphocyte function-associated antigen-1 beta (P < .01), Anti-IL-3 showed no effect on eosinophil survival, whereas anti-IL-5 caused partial inhibition of survival. Interestingly, anti-granulocyte/macrophage colony-stimulating factor caused the complete inhibition of eosinophil survival in cultures with recombinant soluble ICAM-1. Conclusion: These results suggested the importance of the beta 2 integrins in eosinophil-mediated allergic inflammation.	Akita Univ, Sch Med, Dept Clin & Lab Med, Akita 0108543, Japan; Kinki Univ, Sch Med, Dept Internal Med 4, Osaka 589, Japan	Akita University; Kindai University (Kinki University)	Chihara, J (corresponding author), Akita Univ, Sch Med, Dept Clin & Lab Med, Akita 0108543, Japan.							ANWAR ARF, 1993, J EXP MED, V177, P839, DOI 10.1084/jem.177.3.839; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; CAPRON M, 1989, CLIN EXP ALLERGY, V19, P3; CAPRON M, 1981, J IMMUNOL, V126, P2087; Chihara J, 1999, J ALLERGY CLIN IMMUN, V103, pS452, DOI 10.1016/S0091-6749(99)70161-2; CHIHARA J, 1989, ALLERGY PROC, V10, P27, DOI 10.2500/108854189778968515; CHIHARA J, 1995, ALLERGY, V50, P11, DOI 10.1111/j.1398-9995.1995.tb02477.x; CHIHARA J, 1990, J EXP MED, V172, P1347, DOI 10.1084/jem.172.5.1347; CHIHARA J, 1995, INT ARCH ALLERGY IMM, V108, P45, DOI 10.1159/000237201; Chihara J, 1992, Eur Cytokine Netw, V3, P53; Chihara J, 1997, INT ARCH ALLERGY IMM, V114, P33, DOI 10.1159/000237714; Chihara Junichi, 1993, Biotechnology Therapeutics, V4, P271; DESIMONE C, 1982, CLIN EXP IMMUNOL, V48, P249; DESREUMAUX P, 1992, J EXP MED, V175, P293, DOI 10.1084/jem.175.1.293; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; GRUART V, 1989, J IMMUNOL, V142, P4416; HANSEL TT, 1989, J IMMUNOL METHODS, V122, P97, DOI 10.1016/0022-1759(89)90339-6; KHALIFE J, 1986, J IMMUNOL, V137, P1659; Kita H, 1996, J ALLERGY CLIN IMMUN, V97, P889, DOI 10.1016/S0091-6749(96)80061-3; KITA H, 1991, J EXP MED, V174, P745, DOI 10.1084/jem.174.3.745; MOQBEL R, 1991, J EXP MED, V174, P749, DOI 10.1084/jem.174.3.749; PINCUS SH, 1981, BLOOD, V58, P1175; PRIN L, 1983, INT ARCH ALLER A IMM, V72, P336, DOI 10.1159/000234893; PRIN L, 1989, CLIN EXP IMMUNOL, V78, P383; PRIN L, 1984, CLIN EXP IMMUNOL, V57, P735; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; SHAW RJ, 1985, NATURE, V316, P150, DOI 10.1038/316150a0; TOMASSINI M, 1991, J ALLERGY CLIN IMMUN, V88, P365, DOI 10.1016/0091-6749(91)90099-A; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; WINQVIST I, 1982, IMMUNOLOGY, V47, P531; Yamada H, 1996, INT ARCH ALLERGY IMM, V111, P19, DOI 10.1159/000237408	31	17	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2000	106	1	2	S			S99	S103		10.1067/mai.2000.106884	http://dx.doi.org/10.1067/mai.2000.106884			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	339NF	10887341				2022-12-18	WOS:000088482600014
J	Hirokawa, M; Horiuchi, T; Kitabayashi, A; Kawabata, Y; Matsutani, T; Suzuki, R; Chihara, J; Miura, AB				Hirokawa, M; Horiuchi, T; Kitabayashi, A; Kawabata, Y; Matsutani, T; Suzuki, R; Chihara, J; Miura, AB			Delayed recovery of CDR3 complexity of the T-cell receptor-beta chain in recipients of allogeneic bone marrow transplants who had virus-associated interstitial pneumonia: Monitor of T-cell function by CDR3 spectratyping	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on New Trends in Immunopharmacology 1998	JUL 25, 1998	TOKYO, JAPAN			bone marrow transplantation; T cell; diversity; spectratyping	IMMUNE RECONSTITUTION; HOST-REACTION; GRAFT; REPERTOIRE; HYBRIDIZATION; REGENERATION; INDIVIDUALS; PROPHYLAXIS; DISEASE; REGIONS	Background: In the T-cell receptor (TCR)-beta chain, complementary-determining region 3 (CDR3) contains specific peptide sequences essential for recognition. Diversity of this region is considered to contribute to immunocompetence in humans. Objective: The purpose of this study was to define the process of reconstitution of CDR3 complexity of the TCR-beta chain after allogeneic bone marrow transplantation and to investigate the association between host immunocompetence and CDR3 complexity. Methods: Diversity of the CDR3 region of the TCR-beta chain was examined by CDR3 size distribution analysis with the use of an automated DNA sequencer. Results: Reconstitution of the alpha beta T-cell repertoire and CDR3 diversity was incomplete for at least 2 months after bone marrow transplantation. Delayed reconstitution of T-cell diversity was more marked in immunocompromised hosts. Unlike the situation in patients who received allogeneic bone marrow grafts, the recovery of CDR3 complexity was almost perfect by 2 months after transplantation in patients who received allogeneic blood stem cells. Clonal expansion of alpha beta T cells after allogeneic bone marrow transplantation was readily detected by CDR3 size spectratyping analysis. Conclusion: PCR-based CDR3 size spectratyping may be a useful tool for clinically monitoring immune reconstitution after allogeneic hone marrow transplantation.	Akita Univ, Sch Med, Dept Internal Med 3, Akita 0108543, Japan; Akita Univ, Sch Med, Dept Clin & Lab Med, Akita 0108543, Japan; Shionogi & Co Ltd, Shionogi Res Labs, Div Immunol, Osaka 553, Japan	Akita University; Akita University; Shionogi & Company Limited	Hirokawa, M (corresponding author), Akita Univ, Sch Med, Dept Internal Med 3, 1-1-1 Hondo, Akita 0108543, Japan.							BOECKH M, 1992, BLOOD, V80, P1358; Bomberger C, 1998, BLOOD, V91, P2588, DOI 10.1182/blood.V91.7.2588.2588_2588_2600; COCHET M, 1992, EUR J IMMUNOL, V22, P2639, DOI 10.1002/eji.1830221025; Dumont-Girard F, 1998, BLOOD, V92, P4464, DOI 10.1182/blood.V92.11.4464.423k32_4464_4471; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GORSKI J, 1994, J IMMUNOL, V152, P5109; LUM LG, 1987, BLOOD, V69, P369; Mackall CL, 1997, IMMUNOL TODAY, V18, P245, DOI 10.1016/S0167-5699(97)81664-7; MACKALL CL, 1993, BLOOD, V82, P2585; Matsutani T, 1997, HUM IMMUNOL, V56, P57, DOI 10.1016/S0198-8859(97)00102-X; MEER JW, 1984, SEMIN HEMATOL, V21, P123; MEYERS JD, 1982, REV INFECT DIS, V4, P1119; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; PARKMAN R, 1999, HEMATOPOIETIC CELL T, P704; SEDDIK M, 1980, TRANSPLANTATION, V29, P61, DOI 10.1097/00007890-198001000-00013; SEDDIK M, 1984, TRANSPLANTATION, V37, P281, DOI 10.1097/00007890-198403000-00013; Small TN, 1999, BLOOD, V93, P467, DOI 10.1182/blood.V93.2.467.402k22_467_480; STORB R, 1986, NEW ENGL J MED, V314, P729, DOI 10.1056/NEJM198603203141201; SULLIVAN KM, 1986, INT J CELL CLONING, V4, P107, DOI 10.1002/stem.5530040712; YAU JC, 1991, EUR J HAEMATOL, V47, P371; Yoshioka T, 1997, J IMMUNOL METHODS, V201, P145, DOI 10.1016/S0022-1759(96)00221-9; ZAIA JA, 1983, CLIN BONE MARROW TRA, P131	23	17	20	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2000	106	1	2	S			S32	S39		10.1067/mai.2000.106638	http://dx.doi.org/10.1067/mai.2000.106638			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	339NF	10887331				2022-12-18	WOS:000088482600004
J	Kurtz, KM; Beatty, TL; Adkinson, NF				Kurtz, KM; Beatty, TL; Adkinson, NF			Evidence for familial aggregation of immunologic drug reactions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Johns Hopkins Asthma & Allergy Ctr, Div Clin Immunol & Allergy, Baltimore, MD 21224 USA; Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Adkinson, NF (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Div Clin Immunol & Allergy, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.				PHS HHS [5 UO1 A131876] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ATTAWAY N J, 1991, Journal of Allergy and Clinical Immunology, V87, P227, DOI 10.1016/0091-6749(91)91632-4; BORDA IT, 1968, J AMER MED ASSOC, V205, P645, DOI 10.1001/jama.205.9.645; deShazo RD, 1997, JAMA-J AM MED ASSOC, V278, P1895, DOI 10.1001/jama.278.22.1895; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LIANG KY, 1991, GENET EPIDEMIOL, V8, P361, DOI 10.1002/gepi.1370080602; Romano A, 1998, ANN ALLERG ASTHMA IM, V80, P433, DOI 10.1016/S1081-1206(10)62997-3	6	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	1				184	185		10.1016/S0091-6749(00)90196-9	http://dx.doi.org/10.1016/S0091-6749(00)90196-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	278LW	10629471	Bronze			2022-12-18	WOS:000084992100026
J	Bircher, AJ; Bigliardi, P; Yilmaz, B				Bircher, AJ; Bigliardi, P; Yilmaz, B			Anaphylaxis resulting from selective sensitization to Americana grapes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						anaphylaxis; grapes; sensitization; prick-to-prick test	POLLEN-ALLERGY; FOOD		Univ Basel Hosp, Dept Dermatol, Allergy Unit, CH-4031 Basel, Switzerland	University of Basel	Bircher, AJ (corresponding author), Univ Basel Hosp, Dept Dermatol, Allergy Unit, CH-4031 Basel, Switzerland.			Bigliardi, Paul Lorenz/0000-0003-4567-9080				ANTON E, 1997, ALLERGY S37, V52, P119; DOHI M, 1991, J ALLERGY CLIN IMMUN, V87, P34, DOI 10.1016/0091-6749(91)90210-F; Dreborg S, 1989, ALLERGY S, V44, P22; ERIKSSON NE, 1982, ALLERGY, V37, P437, DOI 10.1111/j.1398-9995.1982.tb02323.x; ERIKSSON NE, 1978, ALLERGY, V33, P189, DOI 10.1111/j.1398-9995.1978.tb01533.x; Giannoccaro F, 1998, ALLERGY, V53, P451, DOI 10.1111/j.1398-9995.1998.tb03923.x; GUINNEPAIN MT, 1997, REV FR ALLERGOL, V37, P400; SENFF H, 1990, Z HAUTKRANKHEITEN, V66, P337; Spiegelberg HL, 1998, ALLERGY, V53, P93, DOI 10.1111/j.1398-9995.1998.tb04948.x; Vaswani SK, 1998, J ALLERGY CLIN IMMUN, V101, pS31	10	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1999	104	5					1111	1113		10.1016/S0091-6749(99)70099-0	http://dx.doi.org/10.1016/S0091-6749(99)70099-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	257JH	10550763				2022-12-18	WOS:000083778400042
J	Demoly, P; Messaad, D; Fabre, J; Reynes, J; Bousquet, J				Demoly, P; Messaad, D; Fabre, J; Reynes, J; Bousquet, J			Nevirapine-induced cutaneous hypersensitivity reactions and successful tolerance induction	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHU Montpellier, Hop Arnaud de Villeneuve, INSERM, U454,IFR3,Dept Malad Resp, F-34295 Montpellier 5, France; CHU Montpellier, Hop Guy de Chauliac, Dept Malad Infect & Trop, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Demoly, P (corresponding author), CHU Montpellier, Hop Arnaud de Villeneuve, INSERM, U454,IFR3,Dept Malad Resp, F-34295 Montpellier 5, France.		Demoly, Pascal/Y-9938-2019; Bousquet, Jean/O-4221-2019	Demoly, Pascal/0000-0001-7827-7964; 				CARR A, 1991, J CLIN IMMUNOL, V11, P52; HARRIS M, 1997, HIV AIDS CURR TRENDS, V3, P6; Schuetz JD, 1996, MOL PHARMACOL, V49, P63; Warren KJ, 1998, LANCET, V351, P567, DOI 10.1016/S0140-6736(98)24008-6	4	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1999	104	2	1				504	505		10.1016/S0091-6749(99)70403-3	http://dx.doi.org/10.1016/S0091-6749(99)70403-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	232HH	10452781				2022-12-18	WOS:000082364800052
J	Parameswaran, K; Leigh, R; Hargreave, FE				Parameswaran, K; Leigh, R; Hargreave, FE			Sputum eosinophil count to assess compliance with corticosteroid therapy in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									St Joseph Hosp, Dept Med, Asthma Res Grp, Hamilton, ON, Canada; McMaster Univ, Hamilton, ON, Canada	McMaster University; McMaster University	Hargreave, FE (corresponding author), McMaster Univ, St Josephs Hosp, Firestone Reg Chest & Allergy Unit, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.							Barnes PJ, 1998, EUR RESPIR J, V12, P1209, DOI 10.1183/09031936.98.12051209; Hargreave FE, 1998, J ALLERGY CLIN IMMUN, V102, pS102, DOI 10.1016/S0091-6749(98)70040-5; Pizzichini MMM, 1999, EUR RESPIR J, V13, P15, DOI 10.1183/09031936.99.13101599; Pizzichini MMM, 1997, AM J RESP CRIT CARE, V155, P1501, DOI 10.1164/ajrccm.155.5.9154849; TOOGOOD JH, 1989, J ALLERGY CLIN IMMUN, V83, P528, DOI 10.1016/0091-6749(89)90034-1	5	17	19	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1999	104	2	1				502	503		10.1016/S0091-6749(99)70402-1	http://dx.doi.org/10.1016/S0091-6749(99)70402-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	232HH	10452780	Bronze			2022-12-18	WOS:000082364800051
J	Todd, GRG; Wright, D; Ryan, M				Todd, GRG; Wright, D; Ryan, M			Acute adrenal insufficiency in a patient with asthma after changing from fluticasone propionate to budesonide	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HEALTHY-VOLUNTEERS; SUPPRESSION; CORTICOSTEROIDS; CHILDREN; SINGLE											BROWN PH, 1991, RESP MED, V85, P501, DOI 10.1016/S0954-6111(06)80268-4; Clark DJ, 1997, THORAX, V52, P55, DOI 10.1136/thx.52.1.55; CORREN J, 1996, CHEST S, V110, P835; Falcoz C., 1997, Journal of Allergy and Clinical Immunology, V99, pS505; GRAHNEN A, 1994, BRIT J CLIN PHARMACO, V38, P521, DOI 10.1111/j.1365-2125.1994.tb04393.x; Lipworth BJ, 1997, THORAX, V52, P686, DOI 10.1136/thx.52.8.686; Lonnebo A, 1996, EUR J CLIN PHARMACOL, V49, P459; Pedersen S, 1997, ALLERGY, V52, P1, DOI 10.1111/j.1398-9995.1997.tb05047.x; Thorsson L, 1997, BRIT J CLIN PHARMACO, V43, P155, DOI 10.1046/j.1365-2125.1997.d01-1425.x; Todd G, 1996, LANCET, V348, P27, DOI 10.1016/S0140-6736(96)03339-9; WONG J, 1992, BRIT MED J, V304, P1415, DOI 10.1136/bmj.304.6839.1415-a; Zimmerman B, 1998, J ALLERGY CLIN IMMUN, V101, P425, DOI 10.1016/S0091-6749(98)70260-X; ZWAAN CM, 1992, LANCET, V340, P1289, DOI 10.1016/0140-6736(92)92991-N; 1997, THORAX S1, V52, pS1	14	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	1				956	957		10.1016/S0091-6749(99)70447-1	http://dx.doi.org/10.1016/S0091-6749(99)70447-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199FP	10329837				2022-12-18	WOS:000080470200038
J	Farkas, H; Csepregi, A; Nemesanszky, E; Par, A; Gyeney, L; Varga, L; Fust, G				Farkas, H; Csepregi, A; Nemesanszky, E; Par, A; Gyeney, L; Varga, L; Fust, G			Acquired angioedema associated with chronic hepatitis C	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CHRONIC ACTIVE HEPATITIS; DISORDERS		Natl Inst Rheumatol & Physiotherapy, Dept Otolaryngol, H-1571 Budapest 114, Hungary; Natl Inst Rheumatol & Physiotherapy, Dept Gastroenterol & Med, H-1571 Budapest, Hungary; Natl Inst Haematol & Immunol, Budapest, Hungary; Univ Med Sch Pecs, Dept Med, Budapest, Hungary; Semmelweis Univ Med, Dept Med 3, H-1085 Budapest, Hungary	National Institute Rheumatology & Physiotherapy; National Institute Rheumatology & Physiotherapy; University of Pecs; Semmelweis University	Farkas, H (corresponding author), Natl Inst Rheumatol & Physiotherapy, Dept Otolaryngol, POB 54, H-1571 Budapest 114, Hungary.		Varga, Lilian/F-2491-2010	Farkas, Henriette/0000-0003-2929-1721; Varga, Lilian/0000-0002-5484-364X				AGOSTONI A, 1992, MEDICINE, V71, P206, DOI 10.1097/00005792-199207000-00003; Cicardi M, 1996, CLIN EXP IMMUNOL, V106, P475, DOI 10.1046/j.1365-2249.1996.d01-866.x; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; NELSON RA, 1966, IMMUNOCHEMISTRY, V3, P111, DOI 10.1016/0019-2791(66)90292-8; PAWLOTSKY JM, 1994, HEPATOLOGY, V19, P841, DOI 10.1016/0270-9139(94)90281-X	5	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1999	103	4					711	712		10.1016/S0091-6749(99)70248-4	http://dx.doi.org/10.1016/S0091-6749(99)70248-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	186HY	10200025	Bronze			2022-12-18	WOS:000079723900029
J	Black, PN				Black, PN			The prevalence of allergic disease and linoleic acid in the diet	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland	Black, PN (corresponding author), Univ Auckland, Dept Med, Private Bag 92024, Auckland, New Zealand.							Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Black PN, 1997, EUR RESPIR J, V10, P6, DOI 10.1183/09031936.97.10010006; *FAO, 1998, FOOD BAL SHEETS; KNUIMAN JT, 1980, ATHEROSCLEROSIS, V37, P617, DOI 10.1016/0021-9150(80)90068-4	4	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1999	103	2	1				351	352		10.1016/S0091-6749(99)70513-0	http://dx.doi.org/10.1016/S0091-6749(99)70513-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	167JW	9949330				2022-12-18	WOS:000078630100026
J	Plotz, SG; Dibbert, B; Abeck, D; Ring, J; Simon, HU				Plotz, SG; Dibbert, B; Abeck, D; Ring, J; Simon, HU			Bcl-2 expression by eosinophils in a patient with hypereosinophilia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CELL-DEATH; APOPTOSIS; RECEPTOR; BLOOD		Univ Zurich, Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland; Tech Univ Munich, Dept Dermatol, Munich, Germany	Swiss Institute of Allergy & Asthma Research; University of Zurich; Technical University of Munich	Simon, HU (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res, Obere Str 22, CH-7270 Davos, Switzerland.		Simon, Hans-Uwe/AAU-7410-2020; Ring, Johannes/GLN-4341-2022	Simon, Hans-Uwe/0000-0002-9404-7736; Ring, Johannes/0000-0001-8236-3152				Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Druilhe A, 1998, AM J RESP CELL MOL, V18, P315, DOI 10.1165/ajrcmb.18.3.3019; Hebestreit H, 1996, EUR J IMMUNOL, V26, P1775, DOI 10.1002/eji.1830260817; IWAI K, 1994, BLOOD, V84, P1201; Ochiai K, 1997, CLIN EXP IMMUNOL, V107, P198, DOI 10.1046/j.1365-2249.1997.d01-884.x; Simon HU, 1996, J EXP MED, V183, P1071, DOI 10.1084/jem.183.3.1071; Simon HU, 1997, J IMMUNOL, V158, P3902; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386	8	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1998	102	6	1				1037	1040		10.1016/S0091-6749(98)70344-6	http://dx.doi.org/10.1016/S0091-6749(98)70344-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	150XE	9847447	Bronze			2022-12-18	WOS:000077690700024
J	Yoshida, S; Sakamoto, H; Yamawaki, Y; Shoji, T; Akahori, K; Onuma, K; Nakagawa, H; Hasegawa, H; Amayasu, H				Yoshida, S; Sakamoto, H; Yamawaki, Y; Shoji, T; Akahori, K; Onuma, K; Nakagawa, H; Hasegawa, H; Amayasu, H			Effect of acyclovir on bronchoconstriction and urinary leukotriene E-4 excretion in aspirin-induced asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						acyclovir; aspirin-induced asthma; cyclooxygenase; leukotriene	MAST-CELL ACTIVATION; EOSINOPHIL ACCUMULATION; SENSITIVE ASTHMATICS; GUINEA-PIGS; CHALLENGE; REAPPRAISAL; DRUGS	Background: Acyclovir (9-[2-hydroxyethoxymethyl] guanine), an inhibitor of the DNA polymerase of the herpes virus, has been reported to exhibit pharmacologic activity other than antiviral activity, including antiasthmatic effects. Objective: This study was designed to investigate the protective effect of acyclovir on airway responsiveness to the sulpyrine provocation test and to investigate whether this protective activity is associated with a reduction in aspirin-induced excretion of urinary leukotriene E-4 (u-LTE4), a marker of cysteinyl leukotriene (LT) overproduction that participates in the pathogenesis of aspirin-induced asthma. Methods: We assessed the effects of pretreatment with acyclovir on bronchoconstriction precipitated by inhalation of sulpyrine in 16 adult patients with mild or moderate aspirin-induced asthma; those who were in stable clinical condition and were hyperresponsive to the sulpyrine provocation test were allocated to this study. A double-blind, randomized, cross-over design was used, u-LTE4 was measured by a combined reverse-phase HPLC enzyme immunoassay. Results: Acyclovir protects against aspirin-induced attacks of asthma through mechanisms unrelated to its bronchodilator property but related to the improvement of bronchial hypersensitivity to sulpyrine; protection was nearly complete in all patients (P < .0001). By contrast, after acyclovir, the maximum Level of u-LTE4 in patients was significantly lower than that in control subjects (P < .01). Conclusion: Our results suggest that acyclovir is not only an antiviral drug but also an inhibitor of analgesic-induced bronchoconstriction, probably acting by inhibiting the release of. cysteinyl LTs.	AOKI Int Med Ctr, Dept Med, Yokohama, Kanagawa, Japan; Fujita Hlth Univ, Sch Med, Inst Comprehens Med Sci, Toyoake, Aichi 47011, Japan; Yokohama Rosai Hosp, Dept Internal Med, Yokohama, Kanagawa, Japan	Fujita Health University; Yokohama Rosai Hospital	Yoshida, S (corresponding author), AOKI Int Med Ctr, Dept Med, 6-56 Kuzugaya Tsuzuki, Yokohama, Kanagawa, Japan.							[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; BACIGALUPO A, 1984, NEW ENGL J MED, V310, P1606; BARNES PJ, 1994, EUR RESPIR J, V7, P579, DOI 10.1183/09031936.94.07030579; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; DELANEY JC, 1976, CLIN ALLERGY, V6, P177, DOI 10.1111/j.1365-2222.1976.tb01896.x; HARRISON WB, 1993, J RHEUMATOL, V20, P761; HOUJOU S, 1994, JPN J CLIN MED, V3, P355; ISRAEL E, 1993, AM REV RESPIR DIS, V148, P1447, DOI 10.1164/ajrccm/148.6_Pt_1.1447; KNAPP HR, 1992, J LAB CLIN MED, V119, P48; LEONI P, 1991, EUR J HAEMATOL, V46, P120; MAKINO S, 1982, JPN J ALLERGOL, V31, P1074; MCDONALD JR, 1972, J ALLERGY CLIN IMMUN, V50, P198, DOI 10.1016/0091-6749(72)90014-0; NASSER SMS, 1994, THORAX, V49, P749, DOI 10.1136/thx.49.8.743; NASUHARA Y, 1996, JPN J THORAC DIS, V33, P728; Okada H, 1997, CLIN EXP ALLERGY, V27, P431; OSullivan S, 1996, J ALLERGY CLIN IMMUN, V98, P421, DOI 10.1016/S0091-6749(96)70167-7; PETERS S P, 1982, Journal of Allergy and Clinical Immunology, V69, P150; POWER I, 1993, BRIT J ANAESTH, V71, P619, DOI 10.1093/bja/71.5.619; SALA A, 1994, PROSTAGLANDINS, V47, P281, DOI 10.1016/0090-6980(94)90023-X; SANJAR S, 1990, BRIT J PHARMACOL, V99, P679, DOI 10.1111/j.1476-5381.1990.tb12989.x; SANJAR S, 1990, BRIT J PHARMACOL, V99, P267, DOI 10.1111/j.1476-5381.1990.tb14692.x; SASA M, 1987, JPN J CLIN PHARM THE, V18, P523; SCHAEFFER HJ, 1978, NATURE, V272, P583, DOI 10.1038/272583a0; SLADEK K, 1993, EUR RESPIR J, V6, P391; SLADEK K, 1994, AM J RESP CRIT CARE, V149, P940, DOI 10.1164/ajrccm.149.4.8143059; SPECTOR SL, 1979, J ALLERGY CLIN IMMUN, V64, P500, DOI 10.1016/0091-6749(79)90059-9; SZCZEKLIK A, 1975, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.5949.67; Szczeklik A, 1996, AM J RESP CRIT CARE, V154, P1608, DOI 10.1164/ajrccm.154.6.8970343; SZCZEKLIK A, 1988, CLIN ALLERGY, V18, P15, DOI 10.1111/j.1365-2222.1988.tb02838.x; Szczeklik A, 1993, Allergol Immunopathol (Madr), V21, P35; Tanigushi M, 1997, AM J RESP CRIT CARE, V155, pA974; WAGSTAFF AJ, 1994, DRUGS, V47, P153, DOI 10.2165/00003495-199447010-00009; WELLMAN S, 1994, BIOCHEMISTRY-US, P489	34	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1998	102	6	1				909	914		10.1016/S0091-6749(98)70327-6	http://dx.doi.org/10.1016/S0091-6749(98)70327-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	150XE	9847430				2022-12-18	WOS:000077690700006
J	Worobec, AS; Akin, C; Scott, LM; Metcalfe, DD				Worobec, AS; Akin, C; Scott, LM; Metcalfe, DD			Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PROTOONCOGENE		NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Worobec, AS (corresponding author), NIAID, Lab Allerg Dis, NIH, Bldg 10,Room 11C-205,10 Ctr Dr,MSC 1881, Bethesda, MD 20892 USA.			Akin, Cem/0000-0001-6301-4520				Lishner M, 1996, J ALLERGY CLIN IMMUN, V98, P199, DOI 10.1016/S0091-6749(96)70243-9; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; SWOLIN B, 1987, BLOOD, V70, P1928; Vliagoftis H, 1997, J ALLERGY CLIN IMMUN, V100, P435, DOI 10.1016/S0091-6749(97)70131-3; WOROBEC AC, IN PRESS CANCER	5	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1998	102	3					523	524		10.1016/S0091-6749(98)70144-7	http://dx.doi.org/10.1016/S0091-6749(98)70144-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	124ZN	9768597				2022-12-18	WOS:000076212800031
J	Rolla, G; Colagrande, P; Magnano, M; Debernardi, V; Dutto, L; Delpiano, L; Cassolino, P; Bucca, C				Rolla, G; Colagrande, P; Magnano, M; Debernardi, V; Dutto, L; Delpiano, L; Cassolino, P; Bucca, C			Extrathoracic airway dysfunction in cough associated with gastroesophageal reflux	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						gastroesophageal reflux; cough; reflux laryngitis; extrathoracic airway dysfunction; laryngospasm	CHRONIC PERSISTENT COUGH; POSTERIOR LARYNGITIS; OTOLARYNGOLOGIC MANIFESTATIONS; ESOPHAGEAL MANOMETRY; PULMONARY-FUNCTION; PH-METRY; ACID; SYMPTOMS; HYPERRESPONSIVENESS; LARYNGOSPASM	Background: Cough associated with gastroesophageal reflux (GER) may originate in extrathoracic airway receptors made hypersensitive by acid-induced mucosal injury. Objective: We investigated the role of laryngeal disease and dysfunction in the pathogenesis of GER-associated cough in nonasthmatic patients. Methods: Seven patients with GER-associated cough were compared with 7 patients with GER but no cough. The patients underwent fiberoptic endoscopy for assessment of laryngitis and esophagitis (expressed by scores); esophageal manometry; 24-hour pH monitoring; lung function tests; and histamine inhalation challenge with assessment of bronchial threshold (concentration provoking 10% fall in FEV1 [PC10]), extrathoracic airway threshold (concentration provoking 25% fall in the maximal midinspiratory flow [PC25MIF50]), and cough threshold (concentration provoking 5 or more coughs PCcough). The patients were reevaluated after 3 months of medical treatment for GER. Results: Patients with cough, compared with those without cough, had significantly higher laryngitis scores (P =.002), lower esophageal sphincter pressures, longer time with pH below 4 (P =.003), greater number of episodes of reflux longer than 5 minutes (P =.016), longer esophageal clearance time (P =.048), and significantly lower PC25MIF50 (P =.005) and PCcough (P =.008) values. Laryngitis score was significantly inversely related to either PCcough (P <.001) or PC25MIF50 (P <.01) but not to PC10. Laryngitis score, PC25MIF50, and PCcough were all closely related to GER severity. After GER treatment, laryngitis, PC25MIF50, and PCcough were all significantly improved. Conclusions: These findings suggest that GER-associated cough is strongly associated with laryngeal disease and dysfunction consequent to acid reflux injury in nonasthmatic patients.	Univ Turin, Dipartimento Sci Biomed & Oncol Umana, I-10126 Turin, Italy; S Giovani Battista Hosp, Dept Med & Surg, Torino, Italy	University of Turin	Bucca, C (corresponding author), Univ Turin, Dipartimento Sci Biomed & Oncol Umana, Via Genova 3, I-10126 Turin, Italy.		Rolla, Giovanni/C-9901-2009; Bucca, Caterina/C-9886-2009	Rolla, Giovanni/0000-0001-5997-7172; Bucca, Caterina/0000-0002-9941-9236				ACRES JC, 1981, CHEST, V80, P207, DOI 10.1378/chest.80.2.207; BORTOLOTTI M, 1989, GUT, V30, P233, DOI 10.1136/gut.30.2.233; BUCCA C, 1995, J ALLERGY CLIN IMMUN, V95, P52, DOI 10.1016/S0091-6749(95)70152-4; BUCCA C, 1991, ALLERGY, V46, P147, DOI 10.1111/j.1398-9995.1991.tb00559.x; BUCCA C, 1995, LANCET, V346, P791, DOI 10.1016/S0140-6736(95)91617-2; BUCCA C, 1990, CHEST, V98, P1133, DOI 10.1378/chest.98.5.1133; CARNEY JK, 1997, AM J RESP CRIT CARE, V156, P211; FULLER RW, 1987, BMJ-BRIT MED J, V295, P1025, DOI 10.1136/bmj.295.6605.1025-a; GASTAL OL, 1994, CHEST, V106, P1793, DOI 10.1378/chest.106.6.1793; GAYNOR EB, 1991, AM J GASTROENTEROL, V86, P801; HARGREAVE FE, 1985, AIRWAY RESPONSIVENES, P122; HENRY RL, 1982, AUST PAEDIATR J, V18, P126; HERBST JJ, 1979, J PEDIATR-US, V95, P763, DOI 10.1016/S0022-3476(79)80733-7; HERVE P, 1986, AM REV RESPIR DIS, V134, P986, DOI 10.1164/arrd.1986.134.5.986; HUNT RH, 1995, DIGEST DIS SCI, V40, pS24, DOI 10.1007/BF02214870; ING AJ, 1994, AM J RESP CRIT CARE, V149, P160, DOI 10.1164/ajrccm.149.1.8111576; ING AJ, 1991, THORAX, V46, P479, DOI 10.1136/thx.46.7.479; IRWIN RS, 1993, CHEST, V104, P1511, DOI 10.1378/chest.104.5.1511; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; JACOB P, 1991, GASTROENTEROLOGY, V100, P305, DOI 10.1016/0016-5085(91)90196-R; KAMBIC V, 1984, J LARYNGOL OTOL, V98, P1237, DOI 10.1017/S0022215100148340; KAMEL PL, 1994, AM J MED, V96, P321, DOI 10.1016/0002-9343(94)90061-2; KOUFMAN JA, 1991, LARYNGOSCOPE, V101, P1; Loughlin CJ, 1996, LARYNGOSCOPE, V106, P1502, DOI 10.1097/00005537-199612000-00011; MALO JL, 1983, AM REV RESPIR DIS, V128, P8, DOI 10.1164/arrd.1983.128.1.8; MANSFIELD LE, 1978, ANN ALLERGY, V41, P224; MILLER RD, 1973, AM REV RESPIR DIS, V108, P475; NIELSON DW, 1982, PEDIATR RES, V16, P358; ORENSTEIN SR, 1983, CHEST, V84, P301, DOI 10.1378/chest.84.3.301; OSSAKOW SJ, 1987, ANN OTO RHINOL LARYN, V96, P387, DOI 10.1177/000348948709600408; PATERSON WG, 1994, DIGEST DIS SCI, V39, P1117, DOI 10.1007/BF02087567; QUANJER PH, 1983, B EUR PHYSIOPATHOL S, V19, P5; RICHTER JE, 1987, DIGEST DIS SCI, V32, P583, DOI 10.1007/BF01296157; Rolla G, 1997, J ALLERGY CLIN IMMUN, V100, P52, DOI 10.1016/S0091-6749(97)70194-5; SAVARY M, 1977, MANUAL ATLAS ENDOSCO; SCHAN CA, 1994, CHEST, V106, P731, DOI 10.1378/chest.106.3.731; SHIM C, 1972, AM REV RESPIR DIS, V106, P233, DOI 10.1164/arrd.1972.106.2.233; SUZUKI M, 1977, ANN OTO RHINOL LARYN, V86, P150, DOI 10.1177/000348947708600203; WARD BW, 1986, J CLIN GASTROENTEROL, V8, P59; WARD PH, 1982, LARYNGOSCOPE, V92, P1377; WILSON JA, 1989, ANN OTO RHINOL LARYN, V98, P405; WRIGHT RA, 1990, GASTROENTEROLOGY, V99, P71, DOI 10.1016/0016-5085(90)91231-T	42	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1998	102	2					204	209		10.1016/S0091-6749(98)70087-9	http://dx.doi.org/10.1016/S0091-6749(98)70087-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	113EH	9723662				2022-12-18	WOS:000075537100009
J	Liccardi, G; Russo, M; Barber, D; Carreira, J; D'Amato, M; D'Amato, G				Liccardi, G; Russo, M; Barber, D; Carreira, J; D'Amato, M; D'Amato, G			Washing the clothes of cat owners is a simple method to prevent cat allergen dispersal	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							FEL-D-I		Hosp A Cardarelli, Dept Chest Dis, Div Pneumol & Allergol, I-80128 Naples, Italy; ALK Abello Grp, Dept Biol Invest, Madrid, Spain	Antonio Cardarelli Hospital; ALK-Abello AS	Liccardi, G (corresponding author), Hosp A Cardarelli, Dept Chest Dis, Div Pneumol & Allergol, Piazza Arenella 7-H, I-80128 Naples, Italy.		D'Amato, Maria/H-3074-2012; Barber, Domingo/Y-9516-2019	D'Amato, Maria/0000-0002-5906-5701; Barber, Domingo/0000-0002-5488-5700				CHARPIN C, 1991, J ALLERGY CLIN IMMUN, V88, P77, DOI 10.1016/0091-6749(91)90303-6; DAmato G, 1997, J ALLERGY CLIN IMMUN, V99, P577, DOI 10.1016/S0091-6749(97)70088-5; ENBERG RN, 1993, ANN ALLERGY, V70, P471; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; LUCZYNSKA CM, 1990, AM REV RESPIR DIS, V141, P361, DOI 10.1164/ajrccm/141.2.361	5	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1998	102	1					143	144		10.1016/S0091-6749(98)70065-X	http://dx.doi.org/10.1016/S0091-6749(98)70065-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	102DX	9679858	Bronze			2022-12-18	WOS:000074909500020
J	Schuurman, J; Perdok, GJ; Mueller, GA; Aalberse, RC				Schuurman, J; Perdok, GJ; Mueller, GA; Aalberse, RC			Complementation of Der p 2 induced histamine release from human basophils sensitized with monoclonal IgE: Not only by IgE, but also by IgG antibodies directed to a nonoverlapping epitope of Der p 2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IgE; IgG1; IgG4; chimeric antibody; Der p 2; basophil histamine release	PERIPHERAL-BLOOD LEUKOCYTES; PASSIVE SENSITIZATION; SEROLOGIC ASPECTS; BLOCKING ACTIVITY; IMMUNOGLOBULIN-E; LEUKEMIA-CELLS; SKIN-TESTS; IMMUNOTHERAPY; EXPRESSION; MEMBRANE	The interaction of free allergen with two (or more) IgE molecules bound to the high-affinity receptor for IgE (Fc epsilon RI) on mast cells and basophilic granulocytes results in the release of inflammatory mediators, The role of allergen-specific IgG antibodies in the allergic reaction in human beings less clear. We produced two chimeric IgE antibodies, hIgE-Dp2A and hIgE-Dp2B, directed to two nonoverlapping epitopes (A and B) of the house dust mite allergen Der p 2, Chimeric IgG1 anti IgG4 variants of these antibodies were produced also. Basophil activation by the house dust mite allergen Der p 2 was induced after sensitization of basophils with a mixture of chimeric hIgE-Dp2A and hIgE-Dp2B antibodies but not after sensitization by the individual IgE antibodies alone. Basophil activation was also shown after sensitization within hIgE-Dp2A and stimulation with Der p 2 incubated with hIgG1-Dp2B or hIgG4-Dp2B antibodies, Both IgE and IgG antibodies directed to the other nonoverlapping epitope complemented the sensitization by the hIgE-Dp2A antibody, Nonsensitized basophils were not activated by the Der p 2/hIgG-Dp2 mixtures. These results indicate that allergen-specific IgG ran complement an IgE-dependent reaction and therefore under certain conditions can act as an anaphylactic antibody.	Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Dept Allergy, NL-1066 CX Amsterdam, Netherlands; Univ Amsterdam, Clin & Expt Immunol Lab, Amsterdam, Netherlands; Univ Virginia, Asthma & Allerg Dis Ctr, Charlottesville, VA 22903 USA	University of Amsterdam; University of Virginia	Aalberse, RC (corresponding author), Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Dept Allergy, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.		Mueller, Geoffrey A/I-2909-2017	Mueller, Geoffrey A/0000-0001-8361-5323				AALBERSE RC, 1983, J IMMUNOL, V130, P722; BAZARAL M, 1972, J ALLERGY CLIN IMMUN, V49, P189, DOI 10.1016/0091-6749(72)90113-3; BRAKENHOFF JPJ, 1987, J IMMUNOL, V139, P4116; BRUEGGEMANN M, 1987, J EXP MED, V166, P1351; CLINTON PM, 1989, INT ARCH ALLER A IMM, V89, P43, DOI 10.1159/000234921; COLLINS AM, 1995, INT ARCH ALLERGY IMM, V107, P547, DOI 10.1159/000237098; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; DEMBO M, 1978, J IMMUNOL, V121, P354; DEMBO M, 1979, J IMMUNOL, V122, P18; FAGAN DL, 1982, J ALLERGY CLIN IMMUN, V70, P399, DOI 10.1016/0091-6749(82)90031-8; FEWTRELL C, 1980, J IMMUNOL, V125, P701; FLANAGAN JG, 1982, EMBO J, V1, P655, DOI 10.1002/j.1460-2075.1982.tb01223.x; HEALICON RM, 1986, IMMUNOLOGY, V57, P611; JIMENO L, 1992, CLIN EXP ALLERGY, V22, P1007, DOI 10.1111/j.1365-2222.1992.tb03029.x; KAGEYSOBOTKA A, 1981, J IMMUNOL, V127, P2285; KEMENY DM, 1988, CLIN ALLERGY, V18, P79, DOI 10.1111/j.1365-2222.1988.tb02846.x; KNOL EF, 1993, J IMMUNOL, V151, P4926; LAMBIN P, 1993, J IMMUNOL METHODS, V165, P99, DOI 10.1016/0022-1759(93)90111-J; LEVY DA, 1966, J IMMUNOL, V97, P203; MACGLASHAN DW, 1983, J IMMUNOL, V130, P4; MAY CD, 1972, J ALLERGY CLIN IMMUN, V49, P54, DOI 10.1016/0091-6749(72)90123-6; MOSSMANN H, 1974, J EXP MED, V140, P1468, DOI 10.1084/jem.140.6.1468; Mueller GA, 1997, J BIOL CHEM, V272, P26893, DOI 10.1074/jbc.272.43.26893; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; MULLIGAN RC, 1981, P NATL ACAD SCI USA, V78, P2972; NEUBERGER MS, 1985, NATURE, V314, P268, DOI 10.1038/314268a0; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; OVSYANNIKOVA IG, 1994, J ALLERGY CLIN IMMUN, V94, P537, DOI 10.1016/0091-6749(94)90211-9; PARREN PWHI, 1991, RES IMMUNOL, V142, P749, DOI 10.1016/0923-2494(91)90121-X; PASMANS SGMA, 1994, INT ARCH ALLERGY IMM, V103, P44, DOI 10.1159/000236604; PHILLIPS ML, 1994, MOL IMMUNOL, V31, P1201, DOI 10.1016/0161-5890(94)90034-5; PRUZANSKY JJ, 1983, J IMMUNOL, V131, P1949; Sambrook J, 1989, MOL CLONING LAB MANU; SCHUMACHER MJ, 1979, INT ARCH ALLER A IMM, V58, P38, DOI 10.1159/000232171; Schuurman J, 1997, INT ARCH ALLERGY IMM, V113, P262, DOI 10.1159/000237566; Schuurman J, 1997, CLIN EXP ALLERGY, V27, P1095, DOI 10.1111/j.1365-2222.1997.tb01262.x; Schuurman J, 1997, J ALLERGY CLIN IMMUN, V99, P545, DOI 10.1016/S0091-6749(97)70083-6; SCHUURMAN J, 1995, INT ARCH ALLERGY IMM, V107, P465, DOI 10.1159/000237085; SEGAL DM, 1977, P NATL ACAD SCI USA, V74, P2993, DOI 10.1073/pnas.74.7.2993; SIRAGANIAN R, 1975, J IMMUNOL METHODS, V7, P282; SIRAGANIAN RP, 1975, IMMUNOCHEMISTRY, V12, P149, DOI 10.1016/0019-2791(75)90111-1; SONNTAGNUSSENZW.R, 1964, J EXP MED, V120, P315; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0; VANDERGIESSEN M, 1976, INT ARCH ALLER A IMM, V50, P625, DOI 10.1159/000231566; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; VANDERZEE JS, 1988, J ALLERGY CLIN IMMUN, V81, P884, DOI 10.1016/0091-6749(88)90946-3; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; VANMETRE TE, 1989, J ALLERGY CLIN IMMUN, V83, P888, DOI 10.1016/0091-6749(89)90102-4; VANTOORENENBERGEN AW, 1982, INT ARCH ALLER A IMM, V67, P117, DOI 10.1159/000233000; VANTOORENENBERGEN AW, 1981, INT ARCH ALLER A IMM, V65, P432, DOI 10.1159/000232784; VIJAY HM, 1977, INT ARCH ALLER A IMM, V53, P78, DOI 10.1159/000231734; WASSERMAN SI, 1983, J ALLERGY CLIN IMMUN, V72, P101, DOI 10.1016/0091-6749(83)90512-2; Witteman AM, 1996, INT ARCH ALLERGY IMM, V109, P369, DOI 10.1159/000237265	55	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1998	101	3					404	409		10.1016/S0091-6749(98)70255-6	http://dx.doi.org/10.1016/S0091-6749(98)70255-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZC570	9525459				2022-12-18	WOS:000072593900020
J	Stone, HD; DiPiro, C; Davis, PC; Meyer, CF; Wray, BB				Stone, HD; DiPiro, C; Davis, PC; Meyer, CF; Wray, BB			Hypersensitivity reactions to Escherichia coli derived polyethylene glycolated asparaginase associated with subsequent immediate skin test reactivity to E-coli-derived granulocyte colony-stimulating factor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Med Coll Georgia, Dept Med, Sect Allergy Immunol, Augusta, GA 30912 USA; Med Coll Georgia, Dept Med, Hematol Oncol Sect, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pediat, Sect Allergy Immunol, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pediat, Hematol Oncol Sect, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Stone, HD (corresponding author), 901 E Cheves St,Suite 440, Florence, SC 29506 USA.							Engler RJM, 1996, ANN ALLERG ASTHMA IM, V76, P531, DOI 10.1016/S1081-1206(10)63273-5; FABRY U, 1985, PEDIATR RES, V19, P400, DOI 10.1203/00006450-198519040-00017; JAYESHIMI I, 1991, NEW ENGL J MED, V325, P587; Munoz RM, 1996, AM J HEALTH-SYST PH, V53, P1607, DOI 10.1093/ajhp/53.13.1607a; SPIEGEL RJ, 1980, MED PEDIATR ONCOL, V8, P123, DOI 10.1002/mpo.2950080204; WEISS RB, 1981, ANN INTERN MED, V94, P66, DOI 10.7326/0003-4819-94-1-66	6	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1998	101	3					429	431		10.1016/S0091-6749(98)70262-3	http://dx.doi.org/10.1016/S0091-6749(98)70262-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZC570	9525466				2022-12-18	WOS:000072593900027
J	Kurosawa, M; Amano, H; Kanbe, N; Akimoto, S; Takeuchi, Y; Yamashita, T; Hashimoto, T; Kurimoto, F; Miyachi, Y				Kurosawa, M; Amano, H; Kanbe, N; Akimoto, S; Takeuchi, Y; Yamashita, T; Hashimoto, T; Kurimoto, F; Miyachi, Y			Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Conference on New Trends in Immunopharmacology	JUL   06, 1996	TOKYO, JAPAN	Novartis Pharma KK, Tokyo, Japan		mast cell; tryptase; chymase; urticaria pigmentosa; systemic mastocytosis	MONOCLONAL-ANTIBODIES; TRYPTASE; RADIOIMMUNOASSAY; RECEPTOR; DISEASE; RELEASE; SKIN	Background: Mastocytosis is a disorder of mast cell proliferation that occurs in both cutaneous and systemic forms. The most frequent site is the skin. Objective: The mast cell subtype of two patients with mastocytosis was investigated. Methods: Immunohistochemical studies were performed on the skin or gastric mucosa or both of the two patients. Blood and urine levels of various mediators were measured for one patient. Results: Mast cells containing tryptase and chymase were the only type seen in the skin lesions of an Ii-month-old boy with urticaria pigmentosa. Mast cells containing tryptase were predominant in lesions of the skin and gastric mucosa of a ill-year-old man with indolent systemic mastocytosis. However, mast cells containing tryptase and chymase were predominant in the nonlesional and the normal skin of this patient. Tryptase-positive cells were more numerous in lesional skin than nonlesional skin and normal skin. Elevated blood and urine levels of various mediators were decreased by means of combination therapy with ketotifen and ranitidine. Conclusion: In indolent systemic mastocytosis, mast cell dynamics involve only cells containing tryptase. Release of mediators from mast cells may be inhibited by means of combination therapy with histamine Hi and H2 receptor antagonists.	Gunma Univ, Sch Med, Dept Dermatol, Maebashi, Gumma 371, Japan; Mitsubishi Kagaku Bioclin Labs Inc, Res & Dev, Tokyo, Japan	Gunma University; Mitsubishi Kagaku Bio-Clinical Laboratories	Kurosawa, M (corresponding author), Gunma Univ, Sch Med, Dept Dermatol, 3-39-22 Showa Machi, Maebashi, Gumma 371, Japan.		Kambe, Naotomo/H-3987-2017	Kambe, Naotomo/0000-0001-9610-4952				Algermissen B, 1994, Exp Dermatol, V3, P290, DOI 10.1111/j.1600-0625.1994.tb00291.x; CAPLAN RM, 1963, ARCH DERMATOL, V87, P146, DOI 10.1001/archderm.1963.01590140008002; CHAGRIN L, 1954, ARCH DERMATOL SYPHIL, V69, P345; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; CRAIG SS, 1986, AM J PATHOL, V124, P427; ENANDER I, 1991, J IMMUNOL METHODS, V138, P39, DOI 10.1016/0022-1759(91)90062-K; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P303, DOI 10.1111/apm.1966.66.3.303; FRIERI M, 1985, AM J MED, V78, P9, DOI 10.1016/0002-9343(85)90454-1; GALLI SJ, 1992, INT ARCH ALLERGY IMM, V99, P234, DOI 10.1159/000236255; GASIORCHRZAN B, 1992, DERMATOLOGY, V184, P149, DOI 10.1159/000247526; HARVIMA IT, 1990, ARCH DERMATOL RES, V282, P428, DOI 10.1007/BF00402617; HARVIMA IT, 1991, ACTA DERM-VENEREOL, V71, P394; HASHIMOT.K, 1966, J INVEST DERMATOL, V46, P139, DOI 10.1038/jid.1966.23; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; IRANI AA, 1990, CLIN EXP ALLERGY, V20, P53, DOI 10.1111/j.1365-2222.1990.tb02775.x; IRANI AMA, 1992, ARTHRITIS RHEUM, V35, P933, DOI 10.1002/art.1780350813; IRANI AMA, 1989, J HISTOCHEM CYTOCHEM, V37, P1509, DOI 10.1177/37.10.2674273; IRANI AMA, 1987, J IMMUNOL, V138, P4381; JARBOE DL, 1989, J IMMUNOL, V142, P2424; KLUINNELEMANS HC, 1992, NEW ENGL J MED, V326, P619, DOI 10.1056/NEJM199202273260907; LINENBERGER ML, 1995, EXP HEMATOL, V23, P1104; LONGLEY J, 1995, J AM ACAD DERMATOL, V32, P545, DOI 10.1016/0190-9622(95)90336-4; MCBRIDE P, 1988, J ALLERGY CLIN IMMUN, V82, P638, DOI 10.1016/0091-6749(88)90977-3; METCALFE DD, 1991, J INVEST DERMATOL, V96, pS2, DOI 10.1111/1523-1747.ep12468882; METCALFE DD, 1991, J INVEST DERMATOL, V96, pS55, DOI 10.1111/1523-1747.ep12469049; NAVEH Y, 1975, ACTA DERM-VENEREOL, V55, P443; OLAFSSON JH, 1986, ACTA DERM-VENEREOL, V66, P16; SCOTER NA, 1992, J INVEST DERMATOL, V96, pS32; STEPHAN V, 1990, J ALLERGY CLIN IMMUN, V86, P862, DOI 10.1016/S0091-6749(05)80147-2; TRAVIS WD, 1988, MEDICINE, V67, P345, DOI 10.1097/00005792-198811000-00001; WELKER P, 1994, J INVEST DERMATOL, V103, P620	31	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1997	100	6	2	S			S25	S32		10.1016/S0091-6749(97)70001-0	http://dx.doi.org/10.1016/S0091-6749(97)70001-0			8	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR026	9440541				2022-12-18	WOS:000071449600001
J	Maiz, L; Cuevas, M; Quirce, S; Pacheco, A; Escobar, H				Maiz, L; Cuevas, M; Quirce, S; Pacheco, A; Escobar, H			Allergic bronchopulmonary aspergillosis with low serum IgE levels in a child with cystic fibrosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MANAGEMENT		HOSP RAMON Y CAJAL,DEPT PULMONOL,E-28034 MADRID,SPAIN; HOSP RAMON Y CAJAL,DEPT IMMUNOL,E-28034 MADRID,SPAIN; HOSP RAMON Y CAJAL,DEPT ALLERGOL,E-28034 MADRID,SPAIN; HOSP RAMON Y CAJAL,DEPT PEDIAT,E-28034 MADRID,SPAIN	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal			s, q/AAD-7171-2020					GREENBERGER PA, 1986, ANN ALLERGY, V56, P444; KAUFFMAN HF, 1984, J ALLERGY CLIN IMMUN, V74, P741, DOI 10.1016/0091-6749(84)90239-2; PATTERSON R, 1982, ANN INTERN MED, V96, P286, DOI 10.7326/0003-4819-96-3-286; PATTERSON R, 1983, ANN INTERN MED, V99, P18, DOI 10.7326/0003-4819-99-1-18; SCHWARTZ RH, 1981, J ALLERGY CLIN IMMUN, V68, P290, DOI 10.1016/0091-6749(81)90154-8	5	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1997	100	3					431	432		10.1016/S0091-6749(97)70262-8	http://dx.doi.org/10.1016/S0091-6749(97)70262-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XX479	9314361	Bronze			2022-12-18	WOS:A1997XX47900026
J	Atkins, PC; Zweiman, B; Moskovitz, A; vonAllmen, C; Ciliberti, M				Atkins, PC; Zweiman, B; Moskovitz, A; vonAllmen, C; Ciliberti, M			Cellular inflammatory responses and mediator release during early developing late-phase allergic cutaneous inflammatory responses: Effects of cetirizine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						late-phase response; cutaneous allergic response neutrophils; eosinophils; lactoferrin; ECP; cetirizine	ANTIGEN-INDUCED HISTAMINE; EOSINOPHIL RECRUITMENT; PAF-ACETHER; INVIVO; CHALLENGE; SKIN; INFILTRATION; REACTIVITY; INHIBITION; EXPRESSION	Background: Events in developing cutaneous late-phase allergic reactions can be characterized by a combination of skin chamber and biopsy approaches. In some previous studies, cetirizine reportedly inhibited mediator release and/or inflammatory cell responses in late-phase reactions. Objective: This study was carried out to determine the effects of cetirizine on early late-phase reactions by using skin chamber and skin biopsy specimens. Methods: Skin chamber responses during a 6-hour challenge with pollen antigens were assessed in 15 sensitive subjects during randomized, crossover treatment with cetirizine (20 mg/day) or placebo for 7-day periods with measurements of humoral and cellular components. Biopsy specimens of the underlying dermis sere obtained. Results: During cetirizine treatment, there was significant (p < 0.01) inhibition of immediate wheal and flare reactions to pollen antigens (34, 46%), codeine (41, 65%), and histamine (35, 68%). However, gross late-phase reactions at 6 hours mere unaffected. During both cetirizine and placebo treatment, there was significantly greater accumulation at antigen sites in: (1) skin chamber levels of histamine, total cells, lactoferrin, and eosinophil cationic protein; (2) eosinophils (total and activated) on appended cover glasses; (3) deposition of lactoferrin and eosinophil cationic protein in the underlying dermis. However, these responses were not significantly differed during cetirizine treatment compared with placebo treatment periods. Conclusion: A persistent pattern of inflammatory cell accumulation with release of granule proteins during early late-phase reactions was unaffected by cetirizine treatment.	UNIV PENN,SCH MED,DEPT MED,ALLERGY & IMMUNOL DIV,PHILADELPHIA,PA 19104	University of Pennsylvania					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 14332] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATKINS PC, 1990, J ALLERGY CLIN IMMUN, V86, P360, DOI 10.1016/S0091-6749(05)80099-5; ATKINS PC, 1995, J ALLERGY CLIN IMMUN, V95, P742, DOI 10.1016/S0091-6749(95)70180-X; ATKINS PC, 1988, ANN ALLERGY, V60, P27; CHARLESWORTH EN, 1992, J PHARMACOL EXP THER, V262, P964; CHARLESWORTH EN, 1989, J ALLERGY CLIN IMMUN, V83, P905, DOI 10.1016/0091-6749(89)90104-8; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; CIPRANDI G, 1995, J ALLERGY CLIN IMMUN, V95, P612, DOI 10.1016/S0091-6749(95)70324-1; FADEL R, 1990, J ALLERGY CLIN IMMUN, V86, P314, DOI 10.1016/S0091-6749(05)80093-4; FADEL R, 1987, CLIN ALLERGY, V17, P373, DOI 10.1111/j.1365-2222.1987.tb02027.x; LEIFERMAN KM, 1990, LAB INVEST, V62, P579; LEPREVOST C, 1988, INT ARCH ALLER A IMM, V87, P9, DOI 10.1159/000234641; MICHEL L, 1988, J ALLERGY CLIN IMMUN, V82, P101, DOI 10.1016/0091-6749(88)90058-9; MOSKOVITZ A, 1993, J ALLERGY CLIN IMMUN, V91, P156; REDIER H, 1992, J ALLERGY CLIN IMMUN, V90, P215, DOI 10.1016/0091-6749(92)90074-C; SUR S, 1991, FASEB J, V5, pA641; TING S, 1985, J ALLERGY CLIN IMMUN, V75, P63, DOI 10.1016/0091-6749(85)90013-2; TSICOPOULOS A, 1994, J ALLERGY CLIN IMMUN, V94, P764, DOI 10.1016/0091-6749(94)90185-6; VARNEY V, 1992, CLIN EXP ALLERGY, V22, P43, DOI 10.1111/j.1365-2222.1992.tb00113.x; WASSERFALLEN JB, 1993, J ALLERGY CLIN IMMUN, V91, P1189, DOI 10.1016/0091-6749(93)90322-7; ZWEIMAN B, 1990, J IMMUNOL, V144, P3953; ZWEIMAN B, 1991, J ALLERGY CLIN IMMUN, V87, P894	21	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1997	99	6	1				806	811		10.1016/S0091-6749(97)80015-2	http://dx.doi.org/10.1016/S0091-6749(97)80015-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XH193	9215249	hybrid			2022-12-18	WOS:A1997XH19300014
J	Pauli, G; deBlay, F; Bessot, JC; Ott, M; Gries, P				Pauli, G; deBlay, F; Bessot, JC; Ott, M; Gries, P			The role of mattress bases in the mite infestation of dwellings	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CONTROLLED TRIAL; HOUSE-DUST; ALLERGENS; ASTHMA				Pauli, G (corresponding author), HOP UNIV STRASBOURG, HOP CIVIL,INSERM,U425,PAVILLON LAENNEC, BP 426, F-67091 STRASBOURG, FRANCE.							COLLOFF MJ, 1992, CLIN EXP ALLERGY, V22, P1, DOI 10.1111/j.1365-2222.1992.tb01763.x; DIETEMANN A, 1993, J ALLERGY CLIN IMMUN, V91, P738, DOI 10.1016/0091-6749(93)90193-J; LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; MARKS GB, 1994, CLIN EXP ALLERGY, V24, P1078, DOI 10.1111/j.1365-2222.1994.tb02746.x; PLATTSMILLS TAE, 1989, J ALLERGY CLIN IMMUN, V83, P416, DOI 10.1016/0091-6749(89)90128-0; TOVEY ER, 1981, AM REV RESPIR DIS, V124, P630; VANSTRIEN RT, 1994, CLIN EXP ALLERGY, V24, P843, DOI 10.1111/j.1365-2222.1994.tb01807.x	7	17	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1997	99	2					261	263		10.1016/S0091-6749(97)70107-6	http://dx.doi.org/10.1016/S0091-6749(97)70107-6			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH831	9042056				2022-12-18	WOS:A1997WH83100019
J	CuestaHerranz, J; delasHeras, M; Sastre, J; Lluch, M; Fernandez, M; Lahoz, C; AlvarezCuesta, E				CuestaHerranz, J; delasHeras, M; Sastre, J; Lluch, M; Fernandez, M; Lahoz, C; AlvarezCuesta, E			Asthma caused by Dermestidae (black carpet beetle): A new allergen in house dust	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HOSP RAMON Y CAJAL,E-28034 MADRID,SPAIN	Hospital Universitario Ramon y Cajal	CuestaHerranz, J (corresponding author), FDN JIMENEZ DIAZ,SERV ALERGIA,C REYES CATOLICOS 2,E-28040 MADRID,SPAIN.							ALVAREZCUESTA E, 1994, J ALLERGY CLIN IMMUN, V93, P556, DOI 10.1016/S0091-6749(94)70067-2; GAMARRA P, 1993, P INT C ARTHR MAN EN, P40; HINOJOSA M, 1984, J ALLERGY CLIN IMMUN, V74, P782, DOI 10.1016/0091-6749(84)90179-9; SHELDON JM, 1941, J ALLERGY, V13, P493	4	17	18	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	1				147	149		10.1016/S0091-6749(97)81055-X	http://dx.doi.org/10.1016/S0091-6749(97)81055-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD061	9003222				2022-12-18	WOS:A1997WD06100019
J	Siebers, RW; Patchett, K; Fitzharris, P; Crane, J				Siebers, RW; Patchett, K; Fitzharris, P; Crane, J			Mite allergen (Der p 1) on children's clothing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											Siebers, RW (corresponding author), WELLINGTON SCH MED, ASTHMA RES GRP, POB 7343, WELLINGTON, NEW ZEALAND.		Siebers, Robert/A-4102-2009	Siebers, Robert/0000-0002-6359-3144				LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; SIEBERS R, 1995, NZ J MED LAB SCI, V49, P197	2	17	19	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1996	98	4					853	854		10.1016/S0091-6749(96)70141-0	http://dx.doi.org/10.1016/S0091-6749(96)70141-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VM665	8876568				2022-12-18	WOS:A1996VM66500025
J	Welch, MJ; Szefler, SJ; Nelson, HS; Apter, AJ; Brandon, ML; Chervinsky, P; Hannaway, PJ; Hendeles, L; Katz, RM; Kemp, JP; Melamed, J; Nicklas, RA; Rowe, MS; Simons, E; Woehler, TR; Ziering, WH				Welch, MJ; Szefler, SJ; Nelson, HS; Apter, AJ; Brandon, ML; Chervinsky, P; Hannaway, PJ; Hendeles, L; Katz, RM; Kemp, JP; Melamed, J; Nicklas, RA; Rowe, MS; Simons, E; Woehler, TR; Ziering, WH			Safety and appropriate use of salmeterol in the treatment of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INHALED SALMETEROL; SALBUTAMOL; ALBUTEROL; SYMPTOMS				Welch, MJ (corresponding author), AAAAI,EXECUT OFF,611 E WELLS ST,MILWAUKEE,WI 53202, USA.							ALLEN, 1995, COMMUNICATION   0616; ARES JG, 1993, AM REV RESPIR DIS, V147, pA61; BOOTH H, 1993, THORAX, V48, P121; BRITTON MG, 1992, EUR RESPIR J, V5, P1062; BUNNEY R, 1993, BRIT MED J, V306, P1610, DOI 10.1136/bmj.306.6892.1610-a; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; CLARK CE, 1993, RESP MED, V87, P227, DOI 10.1016/0954-6111(93)90098-K; CROMPTON G, 1993, BRIT MED J, V306, P1610, DOI 10.1136/bmj.306.6892.1610-b; DALONZO GE, 1994, JAMA-J AM MED ASSOC, V271, P1412, DOI 10.1001/jama.271.18.1412; DEVOY MAB, 1995, CHEST, V107, P1116, DOI 10.1378/chest.107.4.1116; FAURSCHOU P, 1991, EUR RESPIR REV, V1, P282; FINKELSTEIN FN, 1994, NEW ENGL J MED, V331, P1314; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; JOHNSON M, 1993, LIFE SCI, V52, P2131, DOI 10.1016/0024-3205(93)90728-L; KEMP JP, 1994, J RESP DIS S, V15, pS21; LOTVALL J, 1992, ALLERGY, V47, P477, DOI 10.1111/j.1398-9995.1992.tb00668.x; LUNDBACK B, 1993, THORAX, V48, P148, DOI 10.1136/thx.48.2.148; MANN RD, 1994, BRIT MED J, V309, P1018, DOI 10.1136/bmj.309.6960.1018b; MEYER JM, 1993, ANN PHARMACOTHER, V27, P1478, DOI 10.1177/106002809302701214; *NIH, 1995, NAT HEART LUNG BLOOD; PALMER JBD, 1991, EUR RESPIR REV, V1, P297; PEARLMAN DS, 1992, NEW ENGL J MED, V327, P1420, DOI 10.1056/NEJM199211123272004; RAMAGE I, 1994, RESP MED, V888, P363; SEARS MR, 1993, BRIT MED J, V306, P1610, DOI 10.1136/bmj.306.6892.1610-c; ULLMAN A, 1990, AM REV RESPIR DIS, V142, P571, DOI 10.1164/ajrccm/142.3.571; WILKINSON JRW, 1992, BRIT MED J, V305, P931, DOI 10.1136/bmj.305.6859.931; 1993, J ALLERGY CLIN IMMUN, V91, P1234	29	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1996	98	3					475	480						6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VJ428					2022-12-18	WOS:A1996VJ42800001
J	Mundt, C; Becker, WM; Schlaak, M				Mundt, C; Becker, WM; Schlaak, M			Farmer's lung: Patients' IgG(2), antibodies specifically recognize Saccharopolyspora rectivirgula proteins and carbohydrate structures	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Farmer's lung; extrinsic allergic alveolitis; Saccharopolyspora rectivirgula (Micropolyspora faeni); IgG(2); carbohydrate antigens; protein antigens; concanavalin A	MICROPOLYSPORA-FAENI ANTIGENS; TWO-DIMENSIONAL ELECTROPHORESIS; MOLDY HAY DUST; HYPERSENSITIVITY PNEUMONITIS; ALTERNATIVE PATHWAY; IMMUNE-RESPONSE; GLYCOPROTEINS; COMPLEMENT; OLIGOSACCHARIDES; DEGLYCOSYLATION	Farmer's lung is a frequent form of extrinsic allergic alveolitis. In Europe and Northern America the main source of the antigenic components that induce farmer's lung is the bacterium Saccharopolyspora rectivirgula (Micropolyspora faeni). It remains unclear, however, which S. rectivirgula components are responsible for the disease. We approached these problems by investigating the serologic reaction of patients with farmer's lung and demonstrated specific binding of patients' IgG(2) to S. rectivirgula antigens. No such antibodies were found in exposed, unaffected subjects. Thus IgG(2) antibodies reacting with S. rectivirgula antigens are useful for the serologic diagnosis of patients with farmer's lung and for the isolation of disease-causing antigens. After separation of S. rectivirgula extract on concanavalin A-Sepharose (Pharmacia, Uppsala, Sweden), we found that approximately one third of the patients' IgG(2) reactivity occurred with nonglycosylated proteins. Among these, we characterized two major acidic proteins with molecular weights of 12 and 30 kd, respectively, and with identical N-terminal sequences. Approximately two thirds of the patients' IgG(2) reactivity was observed against concanavalin A-binding glycoproteins that contained mainly glucose, mannose, and galactose residues. Deglycosylation of the concanavalin A-bound fraction indicated that most of the IgG(2) reactivity occurred with the carbohydrate components.	FORSCHUNGSINST BORSTEL,INST EXPT BIOL & MED,DIV ALLERGY,D-223845 BORSTEL,GERMANY	Forschungszentrum Borstel								AHMED AEE, 1988, IMMUNOLOGY, V64, P45; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arden-Jones MP, 1979, J GEN MICROBIOL, V115, P343, DOI DOI 10.1099/00221287-115-2-343; AZNAR C, 1988, J CLIN MICROBIOL, V26, P443, DOI 10.1128/JCM.26.3.443-447.1988; BAUR X, 1989, ATEMWEG LUNGENKRANK, V15, P222; BRUMMUND W, 1988, J ALLERGY CLIN IMMUN, V82, P190, DOI 10.1016/0091-6749(88)90998-0; CROSS T, 1968, J GEN MICROBIOL, V50, P351, DOI 10.1099/00221287-50-3-351; DEWAIR M, 1987, RESPIRATION, V51, P146, DOI 10.1159/000195181; DICKIE HA, 1985, JAMA-J AM MED ASSOC, V167, P1069; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; EDWARDS J H, 1974, Clinical Allergy, V4, P379, DOI 10.1111/j.1365-2222.1974.tb01399.x; EDWARDS JH, 1976, CLIN ALLERGY, V6, P19, DOI 10.1111/j.1365-2222.1976.tb01408.x; EGEN NB, 1988, ANAL BIOCHEM, V172, P488, DOI 10.1016/0003-2697(88)90472-1; FLETCHER SM, 1973, J HYG-CAMBRIDGE, V71, P185, DOI 10.1017/S0022172400046350; FLETCHER SM, 1970, J HYG-CAMB, V68, P401, DOI 10.1017/S0022172400042303; GANGWAR M, 1991, ANTON LEEUW INT J G, V59, P167; GERKEN TA, 1992, BIOCHEMISTRY-US, V31, P639, DOI 10.1021/bi00118a002; GORG A, 1988, ELECTROPHORESIS, V9, P57, DOI 10.1002/elps.1150090111; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; HARRIS JO, 1976, AM REV RESPIR DIS, V114, P29; HASELBECK A, 1990, ANAL BIOCHEM, V191, P25, DOI 10.1016/0003-2697(90)90381-I; HOLLICK GE, 1983, LAB MED, V14, P39; HUIZINGA M, 1985, CLIN ALLERGY, V15, P139, DOI 10.1111/j.1365-2222.1985.tb02265.x; IRANITALAB M, 1989, ALLERGY, V44, P314, DOI 10.1111/j.1398-9995.1989.tb00452.x; KAUKONEN K, 1993, CLIN EXP ALLERGY, V23, P21, DOI 10.1111/j.1365-2222.1993.tb02479.x; Kennedy J F, 1973, J Chem Soc Perkin 1, V19, P2041; KHAN ZU, 1984, CLIN ALLERGY, V14, P295, DOI 10.1111/j.1365-2222.1984.tb02209.x; KORNWENDISCH F, 1989, INT J SYST BACTERIOL, V39, P430, DOI 10.1099/00207713-39-4-430; KUMAR A, 1993, INT ARCH ALLERGY IMM, V102, P67, DOI 10.1159/000236552; KURUP VP, 1987, DIAGN CLIN IMMUNOL, V5, P25; KURUP VP, 1975, J CLIN MICROBIOL, V2, P55; KURUP VP, 1977, INFECT IMMUN, V15, P608, DOI 10.1128/IAI.15.2.608-613.1977; KURUP VP, 1979, INT ARCH ALLER A IMM, V60, P140, DOI 10.1159/000232335; KURUP VP, 1981, INFECT IMMUN, V34, P508, DOI 10.1128/IAI.34.2.508-512.1981; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; MANDAL DK, 1992, BIOCHEMISTRY-US, V31, P12602, DOI 10.1021/bi00165a009; MARX JJ, 1978, J ALLERGY CLIN IMMUN, V62, P185, DOI 10.1016/0091-6749(78)90105-7; MARX JJ, 1980, INT ARCH ALLER A IMM, V62, P133, DOI 10.1159/000232505; MARX JJ, 1987, J ALLERGY CLIN IMMUN, V61, P208; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; Neville D M Jr, 1974, Methods Enzymol, V32, P92; PATEL T, 1993, BIOCHEMISTRY-US, V32, P679, DOI 10.1021/bi00053a037; PATTERSON R, 1976, AM REV RESPIR DIS, V114, P315; PEPYS J., 1962, THORAX, V17, P366, DOI 10.1136/thx.17.4.366; REESE G, 1989, IMMUN INFEKT, V17, P59; ROBERTS RC, 1973, J ALLERGY CLIN IMMUN, V52, P297, DOI 10.1016/0091-6749(73)90048-1; SALVAGGIO JE, 1991, EUR RESPIR J, V4, pS47; SALVAGGIO JE, 1979, J ALLERGY CLIN IMMUN, V79, P558; SCHORLEMMER HU, 1977, CLIN EXP IMMUNOL, V27, P198; SCHUR PH, 1987, ANN ALLERGY, V58, P89; SOJAR HT, 1987, ARCH BIOCHEM BIOPHYS, V2591, P52; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; STOKES TC, 1986, MONOGR ALLERGY, V19, P213; STOKES TC, 1981, CLIN ALLERGY, V11, P201, DOI 10.1111/j.1365-2222.1981.tb01585.x; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; TAKASAKI S, 1982, METHOD ENZYMOL, V83, P263	59	17	17	1	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1996	98	2					441	450		10.1016/S0091-6749(96)70169-0	http://dx.doi.org/10.1016/S0091-6749(96)70169-0			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VC995	8757222				2022-12-18	WOS:A1996VC99500024
J	Sais, G; Vidaller, A; Servitje, O; Jucgla, A; Peyri, J				Sais, G; Vidaller, A; Servitje, O; Jucgla, A; Peyri, J			Leukocytoclastic vasculitis and common variable immunodeficiency: Successful treatment with intravenous immune globulin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IMMUNOGLOBULIN		UNIV BARCELONA,HOSP PRINCEPS ESPANYA,DEPT INTERNAL MED,BARCELONA,SPAIN; UNIV BARCELONA,HOSP PRINCEPS ESPANYA,DEPT DERMATOL,BARCELONA,SPAIN	University of Barcelona; University of Barcelona								CUNNINGHAMRUNDLES C, 1989, J CLIN IMMUNOL, V9, P22, DOI 10.1007/BF00917124; DWYER JM, 1992, NEW ENGL J MED, V326, P107; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; HAMILOS DL, 1991, J ALLERGY CLIN IMMUN, V88, P823, DOI 10.1016/0091-6749(91)90195-T; JAYNE DRW, 1991, LANCET, V337, P1137, DOI 10.1016/0140-6736(91)92797-6; Yoshida N, 1990, Ryumachi, V30, P119	6	17	18	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1996	98	1					232	233		10.1016/S0091-6749(96)70247-6	http://dx.doi.org/10.1016/S0091-6749(96)70247-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VA692	8765839				2022-12-18	WOS:A1996VA69200028
J	Nakajima, H; Hachimura, S; Nishiwaki, S; Katsuki, T; Shimojo, N; Ametani, A; Kohno, Y; Kaminogawa, S				Nakajima, H; Hachimura, S; Nishiwaki, S; Katsuki, T; Shimojo, N; Ametani, A; Kohno, Y; Kaminogawa, S			Establishment and characterization of alpha(s1)-casein-specific T-cell lines from patients allergic to cow's milk: Unexpected higher frequency of CD8(+) T-cell lines	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						cow's milk allergy; T-cell line; alpha(s1)-casein; CD8(+) T cell; interferon-gamma	ATOPIC-DERMATITIS; IGE PRODUCTION; LYMPHOCYTES-T; ANTIGEN; CLONES; EPITOPES; RECOGNITION; PROTEIN; PROLIFERATION; SECRETION	To study cow's milk allergy at the cellular level, we assessed the reactivity of peripheral blood mononuclear cells from patients allergic to cow's milk to alpha(s1)-casein, which is one of the major allergens in cow's milk. Proliferation of the cells to alpha(s1)-casein activation showed a rather weak response. Therefore to understand T-cell reactivity to alpha(s1)-casein in more detail we prepared alpha(s1)-casein-specific T-cell lines from patients allergic to cow's milk and established 26 T-cell lines. These T-cell lines could be classified into three groups by analyzing their surface marker expression: those containing predominantly CD4(+)CD8(-) T cells, those containing both CD4(+)CD8(-) and CD4(-)CD8(+) T cells, and those containing predominantly CD4(-)CD8(+) T cells. The CD8(+) T cells were obtained at an unexpectedly higher frequency from the patients. These T-cell lines produced interferon-gamma and IL-4. These results suggest that CD8(+) T cells specific for alpha(s1)-casein and CD4(+) T cells were primed by the stimulation with alpha(s1)-casein in patients allergic to milk and that both T cells may play a key role in the onset, progression of, or recovery from cow's milk allergy.	UNIV TOKYO,DEPT APPL BIOL CHEM,TOKYO,JAPAN; CHIBA UNIV,SCH MED,DEPT PEDIAT,CHIBA 260,JAPAN	University of Tokyo; Chiba University								CARBALLIDO JM, 1992, EUR J IMMUNOL, V22, P1357, DOI 10.1002/eji.1830220605; DHILLON M, 1992, J ALLERGY CLIN IMMUN, V90, P42, DOI 10.1016/S0091-6749(06)80009-6; GROSJEAN I, 1994, EUR J IMMUNOL, V24, P2982, DOI 10.1002/eji.1830241209; HEYMAN M, 1994, GASTROENTEROLOGY, V106, P1514, DOI 10.1016/0016-5085(94)90405-7; HILL DJ, 1993, ALLERGY, V48, P75, DOI 10.1111/j.1398-9995.1993.tb00689.x; HISATSUNE T, 1995, J IMMUNOL, V154, P88; HISATSUNE T, 1990, J IMMUNOL, V145, P2421; KONDO N, 1993, J ALLERGY CLIN IMMUN, V91, P658, DOI 10.1016/0091-6749(93)90272-H; KUMOSINSKI TF, 1991, J DAIRY SCI, V74, P2889, DOI 10.3168/jds.S0022-0302(91)78470-1; LAGOO AS, 1994, EUR J IMMUNOL, V24, P3087, DOI 10.1002/eji.1830241226; MATSUSHITA S, 1987, J IMMUNOL, V138, P109; MCMENAMIN C, 1993, J EXP MED, V178, P889, DOI 10.1084/jem.178.3.889; OKANO M, 1993, INT ARCH ALLERGY IMM, V101, P82, DOI 10.1159/000236502; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; PETTE M, 1990, P NATL ACAD SCI USA, V87, P7968, DOI 10.1073/pnas.87.20.7968; RENZ H, 1994, J IMMUNOL, V152, P351; SAMPSON HA, 1983, J ALLERGY CLIN IMMUN, V71, P473, DOI 10.1016/0091-6749(83)90464-5; SCHIRMBECK R, 1994, EUR J IMMUNOL, V24, P2068, DOI 10.1002/eji.1830240920; SHIMOJO N, 1994, INT ARCH ALLERGY IMM, V105, P155, DOI 10.1159/000236818; SPIEGELBERG HL, 1994, J IMMUNOL, V152, P4706; Suomalainen H, 1993, Pediatr Allergy Immunol, V4, P203, DOI 10.1111/j.1399-3038.1993.tb00092.x; TAYLOR SL, 1986, J FOOD PROTECT, V49, P239, DOI 10.4315/0362-028X-49.3.239; VANNEERVEN RJJ, 1994, J IMMUNOL, V152, P4203; VANNEERVEN RJJ, 1993, J IMMUNOL, V151, P2326; YSSEL H, 1992, J IMMUNOL, V148, P738; ZITTLE CA, 1963, J DAIRY SCI, V46, P1183, DOI 10.3168/jds.S0022-0302(63)89242-5	27	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1342	1349		10.1016/S0091-6749(96)70203-8	http://dx.doi.org/10.1016/S0091-6749(96)70203-8			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607	8648031	Bronze			2022-12-18	WOS:A1996VD60700023
J	Doi, S; Murayama, N; Inoue, T; Takamatsu, I; Kameda, M; Omoto, Y; Toyoshima, K				Doi, S; Murayama, N; Inoue, T; Takamatsu, I; Kameda, M; Omoto, Y; Toyoshima, K			CD4 T-lymphocyte activation is associated with peak expiratory flow variability in childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; children; T-lymphocyte activation; peak expiratory flow; variability	BRONCHIAL BIOPSIES; ATOPIC ASTHMA; INTERLEUKIN-5; EOSINOPHILS; EXPRESSION; POPULATION; RNA	Background: Asthma has been recognized as a chronic inflammatory disorder of the airway. We have investigated the relationships among the activation markers on lymphocytes, eosinophils, their serum products in the peripheral blood, and the variability of airway obstruction in childhood asthma. Methods: Twenty-two patients with atopic asthma (mean age, 12 years) were treated regularly and asked to measure their peak expiratory flow (PEF) twice daily for 7 days. Peripheral venous blood was obtained on day 8. Results: The absolute counts of CD4 T lymphocytes expressing the activation marker CD25 in the peripheral blood or day 8 correlated significantly with the values of the coefficient of variation (CV) of both morning PEF (p < 0.01) and night PEF (p < 0.05) obtained over 7 days, but those of CD8+/CD25+ T lymphocytes, those of CD23+ B lymphocytes, and the serum concentrations of soluble CD25 did not. The absolute counts of peripheral blood eosinophils also demonstrated a significant correlation with the CV values of both morning PEF (p < 0.01) and night PEF (p < 0.05). Conclusion: CD4 T-lymphocyte activation and increased counts of eosinophils in peripheral blood correlate with CV of PEF is patients with asthma, suggesting that CV of PEF is a good marker for assessing not only die variability of airway obstruction but also the degree of airway inflammation.	OTSUKA PHARMACEUT INC, TOKUSHIMA, JAPAN	Otsuka Pharmaceutical	Doi, S (corresponding author), OSAKA PREFECTURAL HABIKINO HOSP, DEPT PEDIAT ALLERGY, 3-7-1 HABIKINO, HABIKINO, OSAKA 583, JAPAN.		Murayama, Norihide/I-2080-2019	Murayama, Norihide/0000-0002-6608-6391				AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; CANTRELL DA, 1983, J EXP MED, V158, P1895, DOI 10.1084/jem.158.6.1895; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; CORRIGAN CJ, 1993, AM REV RESPIR DIS, V147, P540, DOI 10.1164/ajrccm/147.3.540; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; DOI S, 1994, CLIN EXP ALLERGY, V24, P854, DOI 10.1111/j.1365-2222.1994.tb01808.x; GERN JE, 1994, J ALLERGY CLIN IMMUN, V93, P706, DOI 10.1016/0091-6749(94)90250-X; HALLSWORTH MP, 1992, IMMUNOLOGY, V75, P382; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; HIGGINS BG, 1989, AM REV RESPIR DIS, V140, P1368, DOI 10.1164/ajrccm/140.5.1368; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; NICOLAIZIK WH, 1994, AM J RESP CRIT CARE, V150, P624, DOI 10.1164/ajrccm.150.3.8087329; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SULLIVAN P, 1994, LANCET, V343, P1006, DOI 10.1016/S0140-6736(94)90127-9; SYMON FA, 1994, J EXP MED, V180, P371, DOI 10.1084/jem.180.1.371; VIRCHOW JC, 1994, J ALLERGY CLIN IMMUN, V94, P240, DOI 10.1016/0091-6749(94)90046-9; WALKER C, 1991, J IMMUNOL, V146, P1829; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; WILSON JW, 1994, AM J RESP CRIT CARE, V149, P86, DOI 10.1164/ajrccm.149.1.8111605; 1992, EUR RESPIR, V5, P601	22	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1996	97	4					955	962		10.1016/S0091-6749(96)80070-4	http://dx.doi.org/10.1016/S0091-6749(96)80070-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UG086	8655891	Bronze			2022-12-18	WOS:A1996UG08600010
J	Sullivan, S; Broide, DH				Sullivan, S; Broide, DH			Compartmentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophil; GM-CSF; in situ hybridization; asthma	ENDOTHELIAL-CELLS; BRONCHOALVEOLAR LAVAGE; ADHESION MOLECULE-1; BLOOD EOSINOPHILS; BRONCHIAL-ASTHMA; GENE-EXPRESSION; MESSENGER-RNA; CHALLENGE; AIRWAY; INTERLEUKIN-5	Background: In patients with asthma the endobronchial instillation of an allergen induces recruitment of granulocyte-macrophage colony-stimulating factor (GM-CSF) messenger RNA-positive eosinophils into the airway. Objective: The goal of the study was to determine whether peripheral blood (as opposed to bronchoalveolar lavage) eosinophils express GM-CSF mRNA and protein. Methods: We performed in situ hybridization and immunocytochemistry on peripheral blood eosinophils, obtained at 0, 4, and 24 hours after either inhalation of diluent, inhalation of allergen, or endobronchial instillation of allergen. Results: Each study subject (n = 6) had both an immediate and late-phase response to allergen inhalation but not to diluent inhalation. Allergen, but not diluent, challenge induced a significant increase ease in the number. of peripheral blood eosinophils at 24 hours. In situ hybridization of peripheral,nl blood eosinophils with a sulfur 35-labeled GM-CSF RNA riboprobe and immunostaining with a GM-CSF monoclonal antibody revealed that neither pre- nor postchallenge (allergen or diluent) peripheral blood eosinophils expressed GM-CSF mRNA of protein. In contrast, both bronchoalveolar lavage eosinophils and mononuclear cells expressed GM-CSF mRNA and protein. Conclusion: These studies suggest that die expression of GM-CSF by eosinophils after allergen inhalation is compartmentalized ro die lungs.	UNIV CALIF SAN DIEGO,DEPT MED,DIV ALLERGY & IMMUNOL,LA JOLLA,CA 92093	University of California System; University of California San Diego				Broide, David/0000-0001-8405-9090	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI029974, R01AI033977, U01AI031595] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 29974, AI 31595, AI 33977] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AALBERS R, 1993, EUR RESPIR J, V6, P840; ANWAR ARF, 1993, J EXP MED, V177, P839, DOI 10.1084/jem.177.3.839; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOCHNER BS, 1991, J ALLERGY CLIN IMMUN, V88, P629, DOI 10.1016/0091-6749(91)90157-J; BOOIJ-NOORD H, 1972, Clinical Allergy, V2, P43, DOI 10.1111/j.1365-2222.1972.tb01267.x; BROIDE DH, 1991, J ALLERGY CLIN IMMUN, V88, P637, DOI 10.1016/0091-6749(91)90158-K; BROIDE DH, 1992, J CLIN INVEST, V90, P1414, DOI 10.1172/JCI116008; BROIDE DH, 1991, J CLIN INVEST, V88, P1048, DOI 10.1172/JCI115366; DAHL R, 1978, ALLERGY, V33, P211, DOI 10.1111/j.1398-9995.1978.tb01536.x; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DIAZ P, 1989, AM REV RESPIR DIS, V139, P1383, DOI 10.1164/ajrccm/139.6.1383; FIRESTEIN GS, 1991, ARTHRITIS RHEUM, V34, P1094, DOI 10.1002/art.1780340905; GIBSON PG, 1991, AM REV RESPIR DIS, V143, P331, DOI 10.1164/ajrccm/143.2.331; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; HANSEL TT, 1990, J IMMUNOL METHODS, V127, P153, DOI 10.1016/0022-1759(90)90064-3; KAY AB, 1971, J IMMUNOL, V107, P899; KITA H, 1991, J EXP MED, V174, P745, DOI 10.1084/jem.174.3.745; LAMAS AM, 1988, J IMMUNOL, V140, P1500; METZGER WJ, 1986, CHEST, V89, P477, DOI 10.1378/chest.89.4.477; MOQBEL R, 1991, J EXP MED, V174, P749, DOI 10.1084/jem.174.3.749; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; OHNO I, 1991, AM J RESP CELL MOL, V5, P505, DOI 10.1165/ajrcmb/5.6.505; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; OWEN WF, 1987, J EXP MED, V166, P129, DOI 10.1084/jem.166.1.129; OWEN WF, 1990, P NATL ACAD SCI USA, V87, P8647, DOI 10.1073/pnas.87.21.8647; POBER JS, 1986, J IMMUNOL, V137, P1893; ROTHENBERG ME, 1987, SCIENCE, V237, P645, DOI 10.1126/science.3110954; SEDGWICK JB, 1992, J IMMUNOL, V149, P3710; SILBERSTEIN DS, 1986, J IMMUNOL, V137, P3290; SPECTOR SL, 1989, PROVOCATIVE CHALLENG, P293; WELLER PF, 1991, NEW ENGL J MED, V324, P1110	31	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1996	97	4					966	976		10.1016/S0091-6749(96)80072-8	http://dx.doi.org/10.1016/S0091-6749(96)80072-8			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UG086	8655893				2022-12-18	WOS:A1996UG08600012
J	BIEWENGA, J; STOOP, AE; VANDERHEIJDEN, HAMD; VANDERBAAN, S; VANKAMP, GJ				BIEWENGA, J; STOOP, AE; VANDERHEIJDEN, HAMD; VANDERBAAN, S; VANKAMP, GJ			ALBUMIN AND IMMUNOGLOBULIN LEVELS IN NASAL SECRETIONS OF PATIENTS WITH NASAL POLYPS TREATED WITH ENDOSCOPIC SINUS SURGERY AND TOPICAL CORTICOSTEROIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NASAL POLYPS; NASAL SECRETION; IMMUNOGLOBULIN EXCRETION; SECRETORY IGA; CORTICOSTEROIDS; BUDESONIDE	PATHO-PHYSIOLOGY; RHINITIS; PROTEIN; DISEASE; SYSTEM; NOSE; IGA	Background: Nasal polyposis is principally treated by surgery, which may be combined with administration of topical corticosteroids to postpone or prevent recurrences. Objective: In this study endoscopic sinus surgery and subsequent use of topical corticosteroids (budesonide) for I year was evaluated. Methods: Clinical data of 41 patients with nasal polyps were evaluated, and their nasal secretions were compared with those of 26 healthy persons (control subjects). Results: The patients had much higher initial total protein, albumin, IgM, secretory IgA (S-IgA) (p < 0.001 for all), and IgG concentrations (p < 0.05) than the control subjects. Treatment resulted in a significant decrease of S-IgA (p < 0.001) within 6 months. IgM and IgG concentrations decreased more slowly (p < 0.001 and p < 0.05 at 1 year, respectively). IgE levels decreased but we could Plot demonstrate significance. Relative to total protein levels, the albumin and S-IgA levels decreased within 6 months (p < 0.005 and p < 0.001, respectively). The excretion of all proteins remained higher in patients than in the control subjects, even after I year of topical corticosteroid treatment. Clinical evaluation showed slightly higher S-IgA levels in patients with an IgE-mediated allergy than in those without such a condition, and the recurrence rate was highest in the former group (75% vs 48%). Conclusion: The data support the hypothesis that inflammatory reactions in the nasal mucosa play a role in the pathogenesis of nasal polyps but also suggest an additional causative factor.	FREE UNIV AMSTERDAM,FAC MED,DEPT CELL BIOL,1081 HV AMSTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM HOSP,DEPT OTORHINOLARYNGOL HEAD & NECK SURG,AMSTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM HOSP,DEPT CLIN CHEM,AMSTERDAM,NETHERLANDS	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER								BACHERT C, 1989, ARCH OTO-RHINO-LARYN, V246, P173, DOI 10.1007/BF00453657; BIEWENGA J, 1991, ANN CLIN BIOCHEM, V28, P260, DOI 10.1177/000456329102800311; BRANDTZAEG P, 1987, ACTA HISTOCHEM, V34, P9; DONOVAN R, 1970, INT ARCH ALLER A IMM, V37, P154, DOI 10.1159/000230229; ILLUM P, 1987, ACTA OTOLARYNGOL, V86, P135; JENEY EVM, 1990, J ALLERGY CLIN IMMUN, V86, P10, DOI 10.1016/S0091-6749(05)80117-4; KAKOI H, 1987, ACTA OTO-LARYNGOL, V103, P137, DOI 10.3109/00016488709134709; KEITH P, 1991, Journal of Allergy and Clinical Immunology, V87, P139, DOI 10.1016/0091-6749(91)91286-3; LUNDGREN R, 1988, EUR RESPIR J, V1, P883; MIADONNA A, 1983, CLIN ALLERGY, V13, P155, DOI 10.1111/j.1365-2222.1983.tb02583.x; MYGIND N, 1975, INT ARCH ALLER A IMM, V49, P99, DOI 10.1159/000231383; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403; PULIDO V, 1983, Rhinology (Utrecht), V21, P29; RAPHAEL GD, 1988, AM REV RESPIR DIS, V138, P413, DOI 10.1164/ajrccm/138.2.413; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V87, P457, DOI 10.1016/0091-6749(91)90001-5; RAPHAEL GD, 1989, AM REV RESPIR DIS, V139, P791, DOI 10.1164/ajrccm/139.3.791; ROSSEN RD, 1966, J CLIN INVEST, V45, P768, DOI 10.1172/JCI105391; SIEGEL SC, 1988, J ALLERGY CLIN IMMUN, V81, P984, DOI 10.1016/0091-6749(88)90166-2; SORENSEN H, 1976, ACTA OTO-LARYNGOL, V82, P260, DOI 10.3109/00016487609120899; STOOP AE, 1991, J ALLERGY CLIN IMMUN, V87, P470, DOI 10.1016/0091-6749(91)90004-8; STOOP AE, 1993, J ALLERGY CLIN IMMUN, V91, P616, DOI 10.1016/0091-6749(93)90267-J; SWART SJ, 1991, J ALLERGY CLIN IMMUN, V88, P612, DOI 10.1016/0091-6749(91)90155-H; VANKAMP GJ, 1989, CLIN CHIM ACTA, V183, P295, DOI 10.1016/0009-8981(89)90363-X; VLEMING M, 1992, ARCH OTOLARYNGOL, V118, P617; Waller G, 1976, Laryngol Rhinol Otol (Stuttg), V55, P174; WIRA CR, 1990, J IMMUNOL, V144, P142; WLADISLAVOSKYWA.P, 1984, CLIN ALLERGY, V14, P241; YARUMCHUK K, 1991, AM J RHINOL, V5, P19	28	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1995	96	3					334	340		10.1016/S0091-6749(95)70052-8	http://dx.doi.org/10.1016/S0091-6749(95)70052-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RU660	7560635				2022-12-18	WOS:A1995RU66000005
J	VOWELS, BR; ROOK, AH; CASSIN, M; ZWEIMAN, B				VOWELS, BR; ROOK, AH; CASSIN, M; ZWEIMAN, B			EXPRESSION OF INTERLEUKIN-4 AND INTERLEUKIN-5 MESSENGER-RNA IN DEVELOPING CUTANEOUS LATE-PHASE REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						LATE-PHASE REACTIONS; INTERLEUKIN-4; INTERLEUKIN-5; EOSINOPHILS; CYTOKINES	COLONY-STIMULATING FACTOR; T-CELL CLONES; FUNCTIONAL SUBSETS; CD4+ LYMPHOCYTES; MESSENGER-RNA; HUMAN-SKIN; ALLERGEN; EOSINOPHILS; RESPONSES; RELEASE	The stimuli for the accumulation and activation of eosinophils, which ale prominent components of IgE-mediated allergic late-phase reactions (LPRs), are not defined Messenger RNA for interleukin-5 has been found in lymphocytes present in biopsy specimens of skin obtained during LPR 24 hours after antigen challenge. However, it is not known whether interleukin-5 is present to attract or activate the eosinophils that accumulate during the first 6 hours after antigen challenge when cutaneous LPRs are developing. Using reverse transcription-polymerase chain reaction, we have found mRNA for interleukin-5 in biopsy specimens obtained during cutaneous LPR 6 hours after antigen challenge, but not in biopsy specimens obtained from control challenge sites nor in specimens ft om sites of antigen challenge of nonreactive subjects. We also found mRNA for interleukin-4 in these sites developing LPR. This pattern suggests that these cytokines may be important in eosinophil accumulation and activation during developing LPR. These findings are of considerable clinical relevance because the eosinophils in LPR are postulated to play major pathogenic roles in chronic allergic diseases.	UNIV PENN,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT DERMATOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania					NIAID NIH HHS [AI 14332] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATKINS P, 1973, J ALLERGY CLIN IMMUN, V51, P263, DOI 10.1016/0091-6749(73)90128-0; BOS JD, 1987, J INVEST DERMATOL, V88, P569, DOI 10.1111/1523-1747.ep12470172; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; BROIDE DH, 1992, J CLIN INVEST, V90, P1414, DOI 10.1172/JCI116008; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V62, P156; FREW AJ, 1988, J IMMUNOL, V141, P4158; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V86, P422; JOUVINMARCH E, 1984, FED PROC, V43, P924; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; Kelso A, 1990, Adv Immunol, V48, P69, DOI 10.1016/S0065-2776(08)60752-X; LEMANSKE RF, 1988, J CLIN IMMUNOL, V8, P1, DOI 10.1007/BF00915151; LESSIN SR, 1991, J INVEST DERMATOL, V96, P299, DOI 10.1111/1523-1747.ep12465108; LEUNG DYM, 1991, J CLIN INVEST, V87, P1805, DOI 10.1172/JCI115201; LOPEZ AF, 1988, J EXP MED, V219, P219; MOSKOVITZ A, 1993, J ALLERGY CLIN IMMUN, V91, P156; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; SHAW RJ, 1985, NATURE, V316, P150, DOI 10.1038/316150a0; TSICOPOULOS A, 1993, J ALLERGY CLIN IMMUN, V91, P244; ULLMAN KS, 1900, ANNU REV IMMUNOL, V8, P421; VOWELS BR, 1994, J INVEST DERMATOL, V103, P669, DOI 10.1111/1523-1747.ep12398454; WIERENGA EA, 1990, J IMMUNOL, V144, P4651; ZWEIMAN B, 1991, J ALLERGY CLIN IMMUN, V87, P984, DOI 10.1016/0091-6749(91)90421-J	29	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1995	96	1					92	96		10.1016/S0091-6749(95)70037-4	http://dx.doi.org/10.1016/S0091-6749(95)70037-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RK383	7622768				2022-12-18	WOS:A1995RK38300012
J	SAETTA, M; DISTEFANO, A; TURATO, G; DECARO, R; BORDIGNON, D; HOLGATE, ST; FABBRI, LM				SAETTA, M; DISTEFANO, A; TURATO, G; DECARO, R; BORDIGNON, D; HOLGATE, ST; FABBRI, LM			FATAL ASTHMA ATTACK DURING AN INHALATION CHALLENGE WITH ULTRASONICALLY NEBULIZED DISTILLED WATER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							EOSINOPHILS		UNIV FERRARA,INST INFECT & RESP DIS,I-44100 FERRARA,ITALY; UNIV PADUA,INST OCCUPAT MED,I-35100 PADUA,ITALY; UNIV PADUA,INST HUMAN ANAT,I-35100 PADUA,ITALY; UNIV PADUA,INST FORENS MED,I-35100 PADUA,ITALY; UNIV SOUTHAMPTON,GEN HOSP,IMMUNOPHARMACOL GRP,SOUTHAMPTON,HANTS,ENGLAND	University of Ferrara; University of Padua; University of Padua; University of Padua; University of Southampton			Di Stefano, Antonino/AAB-8041-2020; Fabbri, Leonardo M/I-4055-2012	Di Stefano, Antonino/0000-0003-3479-0875; Fabbri, Leonardo M/0000-0001-8894-1689; TURATO, GRAZIELLA/0000-0003-1895-6388; SAETTA, MARINA/0000-0002-1547-2102				ANDERSON SD, 1991, AM REV RESPIR DIS, V143, pS43, DOI 10.1164/ajrccm/143.3_Pt_2.S43; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P863, DOI 10.1164/ajrccm/142.4.863; SAETTA M, 1991, AM REV RESPIR DIS, V143, P138, DOI 10.1164/ajrccm/143.1.138; SUR S, 1993, AM REV RESPIR DIS, V148, P713, DOI 10.1164/ajrccm/148.3.713	4	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1995	95	6					1285	1287		10.1016/S0091-6749(95)70088-9	http://dx.doi.org/10.1016/S0091-6749(95)70088-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RD309	7797798				2022-12-18	WOS:A1995RD30900019
J	BIANCO, S; VAGHI, A; ROBUSCHI, M; REFINI, RM; PIERONI, MG; SESTINI, P				BIANCO, S; VAGHI, A; ROBUSCHI, M; REFINI, RM; PIERONI, MG; SESTINI, P			STEROID-SPARING EFFECT OF INHALED LYSINE ACETYLSALICYLATE AND FUROSEMIDE IN HIGH-DOSE BECLOMETHASONE-DEPENDENT ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						LYSINE ACETYLSALICYLATE; ASPIRIN; FUROSEMIDE; NONSTEROIDAL ANTIINFLAMMATORY DRUG; BECLOMETHASONE; STEROID-DEPENDENT ASTHMA	DRUGS; CORTICOSTEROIDS; FRUSEMIDE; CHILDREN; THERAPY; GROWTH; TRIAL	Background: Inhaled lysine acetylsalicylate and furosemide exert a mutually potentiating protective activity on experimentally induced bronchoconstriction in asthma. Objective: Our purpose was to investigate the clinical effectiveness of combined treatment of asthma with inhaled lysine acetylsalicylate and furosemide. Methods: We performed a randomized, double-blind crossover study in nine patients with chronic asthma requiring a high dose (2 mg/day) of inhaled beclomethasone for clinical control. Patients were treated with a combination of 720 mg inhaled lysine acetylsalicylate and 40 mg furosemide twice daily, or with matched placebo in addition to inhaled steroids. The dose of inhaled steroids was reduced by half every 15 days and eventually suspended unless a patient's respiratory condition worsened. Results: During treatment with placebo all patients had worsening of asthma at dosages of I or 0.5 mg/day beclomethasone (mean +/- SE, 833 +/- 83 mu g/day). During combined treatment complete suspension of inhaled steroids in two patients and reduction to 0.5 to 0.25 mg in the remaining seven patients (mean, 250 +/- 72 mu g/day) was achieved, with a mean reduction of 71% +/- 7%. Forced expiratory volume in 1 second weekly peak expiratory flow rate, symptom score, and bronchodilator intake remained significantly better with combined treatment than with placebo. Conclusions: Treatment with inhaled lysine acetylsalicylate and furosemide allows a considerable sparing of inhaled steroids without significant side effects inpatients with severe asthma.	UNIV SIENA, INST RESP DIS, I-53100 SIENA, ITALY; UNIV MILAN, OSPED SAN RAFFAELE, INST RESP & CARDIOVASC DIS, I-20127 MILAN, ITALY; UNIV MILAN, INST RESP DIS, MILAN, ITALY	University of Siena; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan			Sestini, Piersante/AAF-8570-2019	Sestini, Piersante/0000-0002-8195-0811				ALEXANDER AG, 1992, LANCET, V339, P324, DOI 10.1016/0140-6736(92)91646-P; [Anonymous], 1990, BRIT MED J, V301, P651; BARNES PJ, 1989, NEW ENGL J MED, V321, P1517; BIANCO S, 1992, J ALLERGY CLIN IMMUN, V90, P833, DOI 10.1016/0091-6749(92)90109-F; BIANCO S, 1988, LANCET, V2, P252; BIANCO S, 1977, IRCS (International Research Communications System) Medical Science Library Compendium, V5, P129; BIANCO S, 1993, ALLERGY, V48, P570, DOI 10.1111/j.1398-9995.1993.tb00750.x; BIANCO S, 1993, CHEST, V104, P185, DOI 10.1378/chest.104.1.185; BIANCO S, 1993, INT CONGR SER, V1007, P261; BIANCO S, 1993, EUR RESPIR J, V6, P130; BIANCO S, 1989, NEW ENGL J MED, V321, P1069, DOI 10.1056/NEJM198910193211602; Cochran W.G, 1957, STAT METHODS, V6th ed; ELDERS PJM, 1988, BONE MINER, V5, P11, DOI 10.1016/0169-6009(88)90003-7; GEDDES DM, 1992, THORAX, V47, P404, DOI 10.1136/thx.47.6.404; HIRSH J, 1989, CHEST, V95, pS12; INSEL AP, 1990, GOODMAN GILMAN PHARM; KONIG P, 1988, J ALLERGY CLIN IMMUN, V82, P297, DOI 10.1016/0091-6749(88)91015-9; LITTLEWOOD JM, 1988, LANCET, V1, P115; MULLARKEY MF, 1988, NEW ENGL J MED, V318, P603, DOI 10.1056/NEJM198803103181004; NEWMAN SP, 1985, CHEST, V88, pS152, DOI 10.1378/chest.88.2.152S; NIEROP G, 1992, THORAX, V47, P349, DOI 10.1136/thx.47.5.349; OCONNOR BJ, 1991, AM REV RESPIR DIS, V143, P1329, DOI 10.1164/ajrccm/143.6.1329; PAVORD ID, 1992, THORAX, V47, P797, DOI 10.1136/thx.47.10.797; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; ROBUSCHI M, 1989, Pulmonary Pharmacology, V1, P187, DOI 10.1016/S0952-0600(89)80016-X; ROBUSCHI M, 1992, AM REV RESPIR DIS, V145, P1285, DOI 10.1164/ajrccm/145.6.1285; SESTINI P, 1992, American Review of Respiratory Disease, V145, pA728; SMITH MJ, 1983, LANCET, V1, P265, DOI 10.1016/S0140-6736(83)91686-0; VAGHI A, 1989, EUR RESPIR J S8, V2, P790; WOLTHERS OD, 1991, BMJ-BRIT MED J, V303, P163, DOI 10.1136/bmj.303.6795.163; 1991, J ALLERGY CLIN I 2 3, V88, P425	31	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	1				937	943		10.1016/S0091-6749(95)70092-7	http://dx.doi.org/10.1016/S0091-6749(95)70092-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY917	7751513				2022-12-18	WOS:A1995QY91700003
J	MERRETT, TG; MERRETT, J; BHAMBRI, S; KEKWICK, R				MERRETT, TG; MERRETT, J; BHAMBRI, S; KEKWICK, R			PREVALENCE OF LATEX SPECIFIC IGE ANTIBODIES IN THE UK	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				154	154						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400055
J	KITA, H; KATO, M; GLEICH, GJ; ABRAHAM, RT				KITA, H; KATO, M; GLEICH, GJ; ABRAHAM, RT			TYROSINE PHOSPHORYLATION AND INOSITOL PHOSPHATE PRODUCTION - ARE EARLY EVENTS IN HUMAN EOSINOPHIL ACTIVATION STIMULATED BY IMMOBILIZED SECRETORY IGA AND IGG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PHOSPHOLIPASE-C; PERTUSSIS TOXIN; SIGNAL TRANSDUCTION; G-PROTEINS; RECEPTOR; SUBSTRATE; GRANULE; CELLS; GAMMA; IDENTIFICATION		MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,ROCHESTER,MN 55905	Mayo Clinic	KITA, H (corresponding author), MAYO CLIN & MAYO FDN,DEPT IMMUNOL,200 1ST ST SW,ROCHESTER,MN 55905, USA.							ABDELLATIF AA, 1986, PHARMACOL REV, V38, P227; ABUGHAZALEH RI, 1989, J IMMUNOL, V142, P2393; ACKERMAN SJ, 1983, J IMMUNOL, V131, P2977; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ASMIS R, 1990, EUR J BIOCHEM, V187, P475, DOI 10.1111/j.1432-1033.1990.tb15328.x; BOKOCH GM, 1983, J BIOL CHEM, V258, P2072; BUTTERWORTH AE, 1977, J IMMUNOL, V118, P2230; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COCKCROFT S, 1992, BIOCHIM BIOPHYS ACTA, V1113, P135, DOI 10.1016/0304-4157(92)90036-A; CONNELLY PA, 1991, BIOCHEM BIOPH RES CO, V177, P192, DOI 10.1016/0006-291X(91)91967-H; DOWNES CP, 1981, BIOCHEM J, V198, P133, DOI 10.1042/bj1980133; EINSPAHR KJ, 1991, P NATL ACAD SCI USA, V88, P6279, DOI 10.1073/pnas.88.14.6279; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GLEICH GJ, 1992, INFLAMMATION BASIC P, P663; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; HUANG MM, 1992, J BIOL CHEM, V267, P5467; IDE M, 1994, J IMMUNOL METHODS, V168, P187, DOI 10.1016/0022-1759(94)90054-X; ISHIZAKA T, 1989, CLIN IMMUNOL IMMUNOP, V50, P20, DOI 10.1016/0090-1229(89)90218-3; KITA H, 1991, J IMMUNOL, V147, P3466; KLAUSNER RD, 1991, CELL, V64, P875, DOI 10.1016/0092-8674(91)90310-U; LAPETINA E G, 1986, P271; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MILLIGAN G, 1988, BIOCHEM J, V255, P1; NUSSE O, 1990, J EXP MED, V171, P775, DOI 10.1084/jem.171.3.775; OKAJIMA F, 1985, J BIOL CHEM, V260, P6761; SHAAFI RI, 1988, PROG ALLERGY, V42, P1; SNYDERMAN R, 1990, ADP RIBOSYLATING TOX, P295; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; TOMASSINI M, 1991, J ALLERGY CLIN IMMUN, V88, P365, DOI 10.1016/0091-6749(91)90099-A; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484	30	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1994	94	6	2	S			1272	1281		10.1016/0091-6749(94)90342-5	http://dx.doi.org/10.1016/0091-6749(94)90342-5			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA020	7798568				2022-12-18	WOS:A1994QA02000022
J	DODGE, R; CLINE, MG; LEBOWITZ, MD; BURROWS, B				DODGE, R; CLINE, MG; LEBOWITZ, MD; BURROWS, B			FINDINGS BEFORE THE DIAGNOSIS OF ASTHMA IN YOUNG-ADULTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; ADULTS; ALLERGY; INCIDENCE; SERUM IGE	GENERAL-POPULATION SAMPLE; SKIN-TEST REACTIVITY; COMMUNITY; EPIDEMIOLOGY; PREVALENCE; DISEASE	Background: Asthma is a poorly understood disease. Risk factors are not established, and the natural history of the disease is unknown. Objective: Using subjects of a community-based study, we have prospectively compared young adults destined to develop asthma with control subjects to determine differences between them before diagnosis. Methods: Subjects were participants of the Tucson Epidemiologic Study of Airways Obstructive Disease. They were studied between the ages of 15 and 19 and subsequently every 1 to 2 years until they were at least 21 years old with questionnaires, spirometry, allergy skin testing and serum IgE testing. Results: Logistic regression showed chat ''wheeze'' and ''attacks of shortness of breath with wheeze'' were independently predictive of asthma. Positive allergy skin test results occurred more frequently among subjects who later received a diagnosis of asthma, and initially these subjects had higher serum IgE levels than control subjects (geometric mean IgE = 173.8 IU/ml vs 52.5 IU/ml for control subjects; p < 0.005). Although initial spirometric testing did not distinguish between future asthmatic subjects and control subjects, repeat testing after diagnosis did show significant differences in flows at low lung volumes. Conclusions: These data suggest chat symptoms and findings suggestive of asthma may be present for many years before diagnosis.			DODGE, R (corresponding author), UNIV ARIZONA,COLL MED,CTR RESP SCI,1501 N CAMPBELL AVE,TUCSON,AZ 85724, USA.				NHLBI NIH HHS [HL-14136] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014136] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARBEE RA, 1976, ANN INTERN MED, V84, P129, DOI 10.7326/0003-4819-84-2-129; BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P106, DOI 10.1016/0091-6749(81)90167-6; BRODER I, 1974, J ALLERGY CLIN IMMUN, V53, P127, DOI 10.1016/0091-6749(74)90001-3; BURROWS B, 1991, J ALLERGY CLIN IMMUN, V88, P870, DOI 10.1016/0091-6749(91)90243-H; DODGE R, 1993, J ALLERGY CLIN IMMUN, V92, P744, DOI 10.1016/0091-6749(93)90018-B; DODGE RR, 1980, AM REV RESPIR DIS, V122, P567; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; LEBOWITZ MD, 1975, AM J EPIDEMIOL, V102, P137, DOI 10.1093/oxfordjournals.aje.a112141; LEBOWITZ MD, 1989, AM REV RESPIR DIS, V140, pS35, DOI 10.1164/ajrccm/140.3_Pt_2.S35; SEARS MR, 1991, ASTHMA ITS PATHOLOGY, P15; WILLIAMS H, 1969, BRIT MED J, V4, P321, DOI 10.1136/bmj.4.5679.321; WOOLCOCK A, 1980, Chest, V77, P251, DOI 10.1378/chest.77.2_Supplement.251; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	13	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1994	94	5					831	835		10.1016/0091-6749(94)90150-3	http://dx.doi.org/10.1016/0091-6749(94)90150-3			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PR240	7963152				2022-12-18	WOS:A1994PR24000007
J	FERNANDEZCALDAS, E; TRUDEAU, WL; LEDFORD, DK				FERNANDEZCALDAS, E; TRUDEAU, WL; LEDFORD, DK			ENVIRONMENTAL-CONTROL OF INDOOR BIOLOGIC AGENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Symposium on Building-Related and Home-Related Complaints and Illnesses: Sick Building Syndrome	DEC 03-05, 1992	LAKE BUENA VISTA, FL				HOUSE DUST MITES; FEL-D-I; SEASONAL-VARIATION; CASCADE IMPACTOR; ALLERGEN LEVELS; DOUBLE-BLIND; ASTHMA; CAT; DERMATOPHAGOIDES; REDUCTION		UNIV S FLORIDA,COLL MED,DIV ALLERGY & IMMUNOL,TAMPA,FL	State University System of Florida; University of South Florida	FERNANDEZCALDAS, E (corresponding author), VA HOSP,DIV ALLERGY & IMMUNOL,VAR 111D,13000 BRUCE B DOWNS BLVD,TAMPA,FL 33612, USA.							ARLIAN LG, 1982, J ALLERGY CLIN IMMUN, V69, P527, DOI 10.1016/0091-6749(82)90178-6; ARLIAN LG, 1989, IMMUNOL ALLERGY CLIN, V9, P339; ARLIAN LG, 1983, J MED ENTOMOL, V20, P99, DOI 10.1093/jmedent/20.1.99; BONER AL, 1993, CLIN EXP ALLERGY, V23, P1021, DOI 10.1111/j.1365-2222.1993.tb00294.x; BRUNEKREEF B, 1989, AM REV RESPIR DIS, V140, P1363, DOI 10.1164/ajrccm/140.5.1363; CHANG YC, 1989, ANN ALLERGY, V62, P101; Colloff M. J., 1991, Review of Medical and Veterinary Entomology, V79, P611; COLLOFF MJ, 1986, CLIN ALLERGY, V16, P41, DOI 10.1111/j.1365-2222.1986.tb01952.x; COLLOFF MJ, 1992, CLIN EXP ALLERGY, V2, P1; DEBLAY F, 1991, AM REV RESPIR DIS, V143, P1334, DOI 10.1164/ajrccm/143.6.1334; DEBOER R, 1990, J ALLERGY CLIN IMMUN, V86, P808, DOI 10.1016/S0091-6749(05)80187-3; DIETEMANN A, 1993, J ALLERGY CLIN IMMUN, V91, P738, DOI 10.1016/0091-6749(93)90193-J; DORWARD AJ, 1988, THORAX, V43, P98, DOI 10.1136/thx.43.2.98; DYBENDAL T, 1989, CLIN EXP ALLERGY, V19, P217, DOI 10.1111/j.1365-2222.1989.tb02367.x; GREEN WF, 1989, CLIN EXP ALLERGY, V19, P203, DOI 10.1111/j.1365-2222.1989.tb02365.x; HARVING H, 1988, N ENGL REG ALLERGY P, V9, P283; JALILCOLOME J, 1994, J ALLERGY CLIN IMMUN, V93, P180; KANG BC, 1990, CLIN REV ALLERG, V8, P87; KLUCKA CV, 1994, J ALLERGY CLIN IMMUN, V93, P180; KNIEST FM, 1991, CLIN EXP ALLERGY, V21, P39, DOI 10.1111/j.1365-2222.1991.tb00802.x; KORSGAARD J, 1991, ALLERGY, V46, P14, DOI 10.1111/j.1398-9995.1991.tb00643.x; LANG JD, 1978, ENVIRON ENTOMOL, V7, P281, DOI 10.1093/ee/7.2.281; LASCAUD D, 1978, ANN PARASIT HUM COMP, V53, P675, DOI 10.1051/parasite/1978536675; LUCZYNSKA CM, 1990, AM REV RESPIR DIS, V141, P361, DOI 10.1164/ajrccm/141.2.361; MENZIES R, 1993, NEW ENGL J MED, V328, P321; MILLER J D, 1990, Journal of Allergy and Clinical Immunology, V85, P226; MITCHELL EB, 1985, CLIN ALLERGY, V15, P235, DOI 10.1111/j.1365-2222.1985.tb02280.x; MONTORO A, 1993, J ALLERGY CLIN IMMUN, V91, P251; MURRAY AB, 1980, ANN ALLERGY, V45, P347; MURRAY AB, 1979, J ALLERGY CLIN IMMUN, V64, P266, DOI 10.1016/0091-6749(79)90142-8; NELSON HS, 1988, J ALLERGY CLIN IMMUN, V82, P661, DOI 10.1016/0091-6749(88)90980-3; PLATTSMILLS TAE, 1986, J ALLERGY CLIN IMMUN, V77, P850, DOI 10.1016/0091-6749(86)90383-0; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V79, P781, DOI 10.1016/0091-6749(87)90211-9; PLATTSMILLS TAE, 1982, LANCET, V69, P290; POPE AM, 1993, INDOOR ALLERGENS; PRAHL P, 1992, ALLERGY, V47, P362, DOI 10.1111/j.1398-9995.1992.tb02072.x; REISMAN RE, 1990, J ALLERGY CLIN IMMUN, V85, P1050, DOI 10.1016/0091-6749(90)90050-E; RUSSELL DW, 1991, J ALLERGY CLIN IMMUN, V87, P107, DOI 10.1016/0091-6749(91)90220-I; SAKAGUCHI M, 1989, INT ARCH ALLER A IMM, V90, P190, DOI 10.1159/000235022; SARPONG SB, 1994, J ALLERGY CLIN IMMUN, V93, P179; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; SWANSON MC, 1989, J ALLERGY CLIN IMMUN, V83, P776, DOI 10.1016/0091-6749(89)90014-6; SWANSON MC, 1985, J ALLERGY CLIN IMMUN, V76, P724, DOI 10.1016/0091-6749(85)90678-5; TRUDEAU W, 1989, J ALLERGY CLIN IMMUN, V83, P264; TRUDEAU WL, 1993, CLIN EXP ALLERGY, V23, P377, DOI 10.1111/j.1365-2222.1993.tb00342.x; VANDENHOVE T, 1993, ALLERGY, V48, P264, DOI 10.1111/j.1398-9995.1993.tb00726.x; VERVLOET D, 1991, AM REV RESPI DIS, V143, P505; WARNER JA, 1992, CLIN EXP ALLERGY, V22, P1044, DOI 10.1111/j.1365-2222.1992.tb00127.x; WENTZ PE, 1990, J ALLERGY CLIN IMMUN, V85, P94, DOI 10.1016/0091-6749(90)90228-V; WICKMAN M, 1991, J ALLERGY CLIN IMMUN, V88, P89, DOI 10.1016/0091-6749(91)90305-8; WOOD RA, 1990, J ALLERGY CLIN IMMUN, V85, P328	51	17	17	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2	2				404	412		10.1053/ai.1994.v94.a57115	http://dx.doi.org/10.1053/ai.1994.v94.a57115			9	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG770	8077599				2022-12-18	WOS:A1994PG77000021
J	RENZ, H; BRODIE, C; BRADLEY, K; LEUNG, DYM; GELFAND, EW				RENZ, H; BRODIE, C; BRADLEY, K; LEUNG, DYM; GELFAND, EW			ENHANCEMENT OF IGE PRODUCTION BY ANTI-CD40 ANTIBODY IN ATOPIC-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CD40; B-CELLS; IGE; ATOPIC DERMATITIS; INTERLEUKIN-4	HUMAN B-CELLS; INTERFERON-GAMMA PRODUCTION; SERUM IMMUNOGLOBULIN-E; TUMOR-NECROSIS-FACTOR; T-CELL; INTERLEUKIN-4; RECEPTOR; INDUCTION; CD40; LYMPHOCYTES	It has been recently recognized that the obligate requirement for T cells in the development of IgE responses can be substituted for by anti-CD40 antibody. In this study of patients with atopic dermatitis and high IgE levels, we have analyzed the role of the CD40 molecule in IgE production. Costimulation of peripheral blood mononuclear cells (PBMCs) from normal donors with interleukin-4 (IL-4) and anti-CD40 monoclonal antibody resulted in a selective increase in IgE production, either reagent alone, however, was ineffective. In contrast, addition of anti-CD40 monoclonal antibody alone to PBMCs or B cells from patients with atopic dermatitis markedly increased IgE production, even in the absence of exogenous IL-4. With the use of an ELISA spot assay this increase in IgE production was attributed to an expansion of IgE-secreting B cells. In anti-IgM-stimulated lymphocyte cultures from patients with atopic dermatitis the costimulation with anti-CD40 induced strong lymphocyte proliferation. Similar results were observed with anti-IgM plus IL-4. The augmentation induced by anti-CD40 was inhibited by addition of anti-IL4 to anti-CD40-treated atopic dermatitis cells. In normal subjects the effects of anti-CD40 alone on IgE production could be observed after pretreatment of normal PBMCs with IL-4 for 3 days. The effects of anti-CD40 in atopic dermatitis may be explained in part by differences in CD40 expression. In freshly isolated PBMCs from patients with atopic dermatitis, the mean fluorescence intensity of CD40 expression on B cells was increased when compared with PBMCs from nonatopic donors, and stimulation of normal or atopic dermatitis PBMCs with IL-4 increased the intensity of CD40 staining of cells.	NATL JEWISH CTR IMMUNOL & RESP MED,DIV BASIC SCI,1400 JACKSON ST,DENVER,CO 80206; NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,DIV ALLERGY IMMUNOL,DENVER,CO 80206; RAYMOND & BEVERLY SACKLER FDN,DENVER,CO	National Jewish Health; National Jewish Health					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026490, R01AI029704] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-26490, AI-29704] Funding Source: Medline; PHS HHS [P01-36577] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; CLARK EA, 1989, J IMMUNOL, V143, P3873; CLARK EA, 1990, TISSUE ANTIGENS, V36, P33, DOI 10.1111/j.1399-0039.1990.tb01795.x; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; GAUCHAT JF, 1990, J EXP MED, V172, P463, DOI 10.1084/jem.172.2.463; GERONDAKIS S, 1990, P NATL ACAD SCI USA, V87, P1581, DOI 10.1073/pnas.87.4.1581; GORDON J, 1988, J IMMUNOL, V140, P1425; HANIFIN JM, 1980, ACTA DERM-VENEREOL S, V92, P44, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; JONES HE, 1975, BRIT J DERMATOL, V92, P17; JUHLIN L, 1969, ARCH DERMATOL, V100, P12, DOI 10.1001/archderm.100.1.12; JUJO K, 1992, J ALLERGY CLIN IMMUN, V90, P323, DOI 10.1016/S0091-6749(05)80010-7; LEBMAN DA, 1988, J EXP MED, V168, P8523; LING NR, 1987, LEUCOCYTE TYPING, V3, P302; MAZER BD, 1991, J ALLERGY CLIN IMMUN, V88, P235, DOI 10.1016/0091-6749(91)90334-K; REINHOLD U, 1990, CLIN EXP IMMUNOL, V79, P374; RENZ H, 1990, J IMMUNOL, V145, P3641; ROMAGNANI S, 1989, INT ARCH ALLER A IMM, V88, P111, DOI 10.1159/000234758; ROUSSET F, 1991, J ALLERGY CLIN IMMUN, V87, P58, DOI 10.1016/0091-6749(91)90213-8; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SHAPIRA SK, 1992, J EXP MED, V175, P289, DOI 10.1084/jem.175.1.289; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; STEIN P, 1986, J IMMUNOL, V136, P2080; THYPHRONITIS G, 1989, P NATL ACAD SCI USA, V86, P5580, DOI 10.1073/pnas.86.14.5580; VERCELLI D, 1989, J EXP MED, V169, P1295, DOI 10.1084/jem.169.4.1295; WITTIG HJ, 1980, J ALLERGY CLIN IMMUN, V66, P305, DOI 10.1016/0091-6749(80)90026-3; ZHANG K, 1991, J IMMUNOL, V146, P1836	30	17	19	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1994	93	3					658	668		10.1016/S0091-6749(94)70078-8	http://dx.doi.org/10.1016/S0091-6749(94)70078-8			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ND140	7512104				2022-12-18	WOS:A1994ND14000013
J	FRIEDMAN, BS; GERMANO, P; MILETTI, J; METCALFE, DD				FRIEDMAN, BS; GERMANO, P; MILETTI, J; METCALFE, DD			A CLINICOPATHOLOGICAL STUDY OF 10 PATIENTS WITH RECURRENT UNEXPLAINED FLUSHING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MAST-CELL DISORDERS; SYSTEMIC MASTOCYTOSIS; CARCINOID-SYNDROME; PLASMA HISTAMINE; PROSTAGLANDIN-D2	We describe the clinicopathologic features of 10 patients with recurrent unexplained flushing. These patients were referred to the National Institutes of Health with a diagnosis of mastocytosis or idiopathic anaphylaxis. Both diagnoses were eliminated after evaluation. Patients reported attack of flushing lasting 15 minutes to 2 days and associated with such symptoms as anxiety, chest tightness, paresthesia, slurred speech, weakness, and pruritus. Abdominal pain was a constant feature, often associated with cramping and an increase in stool frequency. Attack witnessed by physicians consisted of an exaggerated blush response of the face and upper part of the chest, and were sometimes associated with tachycardia, mild hypertension, and tachypnea. Hives, angioedema, wheezing, and hypotension were not observed. Routine laboratory studies and 5-hydroxyindoleacetic acid, vanillylmandelic acid, and plasma histamine levels were normal. Plasma histamine levels did not elevate during attacks. When performed, results of bone marrow examinations skin biopsies, and bone scans were normal. Psychiatric examinations frequently revealed somatization disorders. Patients had often been prescribed a wide variety of medications including antihistamines, nonsteroidal anti-inflammatory drugs, and steroids, with little or no benefit Despite the benign nature of the clinical and laboratory findings, patients had undergone repeated, often invasive, examinations for several years. Whether such patients have a prominent flush response exaggerated through a somatization disorder or a relatively benign flushing disorder associated with putative mediator release remains to be determined. Recognition of this category of patients with unexplained flushing will avoid subjecting such patients to unwarranted repeated examinations, procedures, and inappropriate therapy.	NIAID,CLIN INVEST LAB,MAST CELL PHYSIOL SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								ALDRICH LB, 1988, ARCH INTERN MED, V148, P2614, DOI 10.1001/archinte.148.12.2614; DYER J, 1982, J ALLERGY CLIN IMMUN, V70, P82, DOI 10.1016/0091-6749(82)90233-0; FRIEDMAN BS, 1989, AM J MED, V87, P649; GARRIGA MM, 1988, J ALLERGY CLIN IMMUN, V82, P425, DOI 10.1016/0091-6749(88)90015-2; GRAHAMESMITH DG, 1987, GUT, V28, P1413, DOI 10.1136/gut.28.11.1413; GUSTAFSEN J, 1987, GUT, V28, P1417, DOI 10.1136/gut.28.11.1417; MEDLIN IM, 1980, J CLIN GASTROENTEROL, V2, P349; MEGGS WJ, 1984, NEW ENGL J MED, V78, P9; MOONEY E, 1985, INT J DERMATOL, V24, P549, DOI 10.1111/j.1365-4362.1985.tb05565.x; MORROW JD, 1989, PROSTAGLANDINS, V38, P263, DOI 10.1016/0090-6980(89)90088-9; PERNOW B, 1957, AM J MED, V34, P18; ROBERTS LJ, 1980, NEW ENGL J MED, V303, P1400, DOI 10.1056/NEJM198012113032405; ROBERTSON JIS, 1962, Q J MED, V31, P103; ROSENBAUM RC, 1984, J NUCL MED, V25, P859; SHAFF RE, 1979, ANAL BIOCHEM, V94, P425, DOI 10.1016/0003-2697(79)90385-3; TRAVIS WD, 1988, MEDICINE, V67, P345, DOI 10.1097/00005792-198811000-00001; WILKIN JK, 1988, J AM ACAD DERMATOL, V19, P309, DOI 10.1016/S0190-9622(88)70177-2; WILKIN JK, 1981, ANN INTERN MED, V95, P468, DOI 10.7326/0003-4819-95-4-468; WILKIN JK, 1983, RECENT ADV DERMATOLO, V6, P157; 1987, DIAGNOSTIC STATISTIC, P261	20	17	17	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	1				53	60		10.1016/0091-6749(94)90232-1	http://dx.doi.org/10.1016/0091-6749(94)90232-1			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MT781	8308182				2022-12-18	WOS:A1994MT78100006
J	GREALLY, P; COOK, AJ; SAMPSON, AP; COLEMAN, R; CHAMBERS, S; PIPER, PJ; PRICE, JF				GREALLY, P; COOK, AJ; SAMPSON, AP; COLEMAN, R; CHAMBERS, S; PIPER, PJ; PRICE, JF			ATOPIC CHILDREN WITH CYSTIC-FIBROSIS HAVE INCREASED URINARY LEUKOTRIENE E(4) CONCENTRATIONS AND MORE SEVERE PULMONARY-DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CYSTIC FIBROSIS; ATOPY; LEUKOTRIENES; PULMONARY DISEASE; AIRWAY REACTIVITY	NECROSIS-FACTOR-ALPHA; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; COMPLEMENT ACTIVATION; AIRWAYS; SPUTUM; ASSOCIATION; LEUKOCYTES; ANTIBODIES	Background: We investigated the hypothesis that cysteinyl leukotriene (LT) production is altered in atopic patients with cystic fibrosis (CF). Methods: Urinary LTE4 was measured in two groups of children with CF: atopic ACF group, n = 22) and nonatopic (NACF group, n = 13); and in two groups of unaffected children, those with atopic asthma (AA group, n = II) and nonatopic normal control subjects (NN group, n = 12). Results: Atopic groups excreted significantly more urinary LTE, (geometric means [95% confidence intervals] in picomoles per millimole creatinine), ACF group: 104 (73-147) and AA group: 195 (136-282) compared with NACF group: 19 (9-39) and NN group: 27 (15-48). The ACF group had significantly more airflow obstruction than the NACF group, with forced expiratory volume in 1 second (percent predicted, mean +/- SD) in ACF: 58 +/- 21 versus NACF: 81 +/- 23, and forced vital capacity (percent predicted, mean +/- SD) 72 +/- 17 versus 87 +/- 23, respectively. There were significant correlations between the degree of airflow obstruction, bronchodilator responsiveness, and urinary LTE4 concentration within the entire CF group. We used multiple regression analysis to assess the respective influence of age, atopy, sensitization to Aspergillus fumigatus, and colonization with Pseudomonas aeruginosa on urinary LTE4 concentration. The atopic state was the only significant variable associated with urinary LTE4 production in subjects with CF. Conclusions: The similarities in urinary LTE(4) between ACF and AA groups suggest that the atopic state is the prime determinant of urinary LTE(4) excretion. Enhanced cysteinyl LT production associated with atopy in CF may increase the severity of pulmonary disease.	KINGS COLL HOSP,DEPT CHILD HLTH & THORAC MED,LONDON,ENGLAND; ROYAL COLL SURGEONS ENGLAND,HUNTERIAN INST,DEPT PHARMACOL,LONDON WC2A 3PN,ENGLAND; INST CHILD HLTH,DEPT DERMATOL,LONDON,ENGLAND; KINGS COLL HOSP,DEPT CLIN BIOCHEM,LONDON,ENGLAND	King's College Hospital NHS Foundation Trust; King's College Hospital; Royal College of Surgeons of England; University of London; University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital			Sampson, Anthony/C-1112-2011					ARM JP, 1990, AM REV RESPIR DIS, V142, P1112, DOI 10.1164/ajrccm/142.5.1112; BEDROSSIAN CWM, 1976, HUM PATHOL, V7, P195, DOI 10.1016/S0046-8177(76)80023-8; BROCK DJH, 1991, J ROY SOC MED, V84, P2; CLARKE CW, 1981, BRIT J DIS CHEST, V75, P15, DOI 10.1016/S0007-0971(81)80003-4; Cotes J. E., 1979, LUNG FUNCTION ASSESS, P329; CROMWELL O, 1981, LANCET, V2, P164; DAVIES RJ, 1984, RESPIRATORY ALLERGY, P256; DRAZEN JM, 1987, AM REV RESPIR DIS, V136, P985, DOI 10.1164/ajrccm/136.4.985; DUNHILL MS, 1987, PULMONARY PATHOLOGY, P547; FICK RB, 1986, PEDIATR RES, V20, P1258, DOI 10.1203/00006450-198612000-00014; GEALLY P, 1993, ARCH DIS CHILD, V68, P389; GOSSET P, 1992, AM REV RESPIR DIS, V146, P768, DOI 10.1164/ajrccm/146.3.768; JOHANSEN HK, 1991, LANCET, V337, P631, DOI 10.1016/0140-6736(91)92449-C; KOMATSU N, 1991, J HISTOCHEM CYTOCHEM, V39, P655, DOI 10.1177/39.5.2016515; KUBESCH P, 1993, LANCET, V341, P189, DOI 10.1016/0140-6736(93)90062-L; LESKOWITZ S, 1972, Clinical Allergy, V2, P237, DOI 10.1111/j.1365-2222.1972.tb01288.x; MALTBY NH, 1990, J ALLERGY CLIN IMMUN, V85, P3, DOI 10.1016/0091-6749(90)90214-O; MOSS RB, 1981, J PEDIATR-US, V99, P215, DOI 10.1016/S0022-3476(81)80453-2; MOSS RB, 1986, AM REV RESPIR DIS, V133, P648; NADEL JA, 1989, DRUGS, V37, P51, DOI 10.2165/00003495-198900371-00011; NORMAN D, 1991, THORAX, V46, P91, DOI 10.1136/thx.46.2.91; PITCHERWILMOTT RW, 1982, ARCH DIS CHILD, V57, P582, DOI 10.1136/adc.57.8.582; ROUBIN R, 1987, CLIN EXP IMMUNOL, V70, P484; SAMPSON AP, 1992, BRIT J CLIN PHARMACO, V33, P423, DOI 10.1111/j.1365-2125.1992.tb04062.x; SAMPSON AP, 1990, BRIT J CLIN PHARMACO, V30, P861, DOI 10.1111/j.1365-2125.1990.tb05452.x; SCHWARTZ LB, 1987, CLIN RES, V35, P255; SILVERMAN M, 1978, ARCH DIS CHILD, V53, P873, DOI 10.1136/adc.53.11.873; SLAVIN RG, 1988, J ALLERGY CLIN IMMUN, V81, P718, DOI 10.1016/0091-6749(88)91044-5; SMITH AL, 1988, J PEDIATR-US, V112, P547, DOI 10.1016/S0022-3476(88)80165-3; SPENCER DA, 1992, PEDIATR PULM, V12, P90, DOI 10.1002/ppul.1950120206; SUMIMOTO S, 1992, ARCH DIS CHILD, V67, P277, DOI 10.1136/adc.67.3.277; TABOR DR, 1988, P SOC EXP BIOL MED, V187, P408; TURNER MW, 1978, ARCH DIS CHILD, V53, P631, DOI 10.1136/adc.53.8.631; VANASPEREN PP, 1980, AUST PAEDIATR J, V16, P53; WANG JLF, 1979, J PEDIATR-US, V94, P376, DOI 10.1016/S0022-3476(79)80574-0; WARNER JO, 1976, ARCH DIS CHILD, V51, P507, DOI 10.1136/adc.51.7.507; ZAKRZEWSKI JT, 1987, AM REV RESPIR DIS, V136, P779, DOI 10.1164/ajrccm/136.3.779	37	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	1				100	107		10.1016/0091-6749(94)90238-0	http://dx.doi.org/10.1016/0091-6749(94)90238-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MT781	8308175	Bronze			2022-12-18	WOS:A1994MT78100012
J	MOY, JN; THOMAS, LL; WHISLER, LC				MOY, JN; THOMAS, LL; WHISLER, LC			EOSINOPHIL MAJOR BASIC-PROTEIN ENHANCES THE EXPRESSION OF NEUTROPHIL CR3 AND P150,95	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						MAJOR BASIC PROTEIN; EOSINOPHILS; NEUTROPHILS; INTEGRINS; CR3; P150,95; ADHESION	CELL HISTAMINE-RELEASE; GRANULE PROTEINS; COMPLEMENT RECEPTORS; GLYCOPROTEIN FAMILY; SURFACE EXPRESSION; ANTIGEN CHALLENGE; ENDOTHELIAL-CELLS; COUNTER-RECEPTOR; 3RD MEMBER; MAC-1	Background: We examined the effect of major basic protein (MBP) stimulation on the expression of the neutrophil beta2-integrins: LFA-1 (CD11a/CD18), CR3 (CD11b/CD18), and p150,95 (CD11c/CD18). Methods: Incubation of neutrophils with 0.75 to 3.0 mumol/L MBP for 30 minutes at 37-degrees-C resulted in concentration-dependent increases in CR3 expression as detected by staining with the CD11b-specific monoclonal antibody, Leu-15. Results: The expression of CR3 was significantly (p < 0.001) higher when neutrophils were stimulated with 1.5 mumol/L (53% +/- 9% increase) or 3.0 mumol/L (100% +/- 17% increase) MBP as compared with unstimulated neutrophils. The kinetics of MBP-stimulated CR3 expression were rapid and were similar to those of 100 nmol/L. N-formyl-methionyl-leucyl-phenylalanine-stimulated enhancement of CR3 expression. Incubation of neutrophils with reduced and alkylated MBP resulted in significantly lower (p < 0.05) increases in CR3 expression as compared with stimulation with native MBP. In addition, neither eosinophil cationic protein nor eosinophil-derived neurotoxin altered neutrophil CR3 expression. MBP stimulated minimal increases in LFA-1 expression. However, staining with the monoclonal antibody Leu-M5 (anti-CD11c) revealed that MBP stimulated significant increases in the expression of p150,95. Conclusions: These results indicate that MBP stimulates the increased expression of neutrophil adhesion molecules, which in turn may enhance the inflammatory role of neutrophils in the late-phase events of allergic diseases.	RUSH MED COLL,DEPT IMMUNOL MICROBIOL,CHICAGO,IL 60612	Rush University					NIAID NIH HHS [AI 09728, AI 15231] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009728, R01AI009728, R37AI015231, R01AI015231] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARM JP, 1989, J ALLERGY CLIN IMMUN, V83, P649, DOI 10.1016/0091-6749(89)90078-X; ARNAOUT MA, 1984, J CLIN INVEST, V74, P1291, DOI 10.1172/JCI111539; ATKINS P, 1973, J ALLERGY CLIN IMMUN, V51, P263, DOI 10.1016/0091-6749(73)90128-0; BASCOM R, 1989, J ALLERGY CLIN IMMUN, V84, P338, DOI 10.1016/0091-6749(89)90418-1; BASCOM R, 1988, AM REV RESPIR DIS, V138, P406, DOI 10.1164/ajrccm/138.2.406; BOCHNER BS, 1991, J EXP MED, V173, P1553, DOI 10.1084/jem.173.6.1553; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; CARLSON M, 1991, J ALLERGY CLIN IMMUN, V87, P27, DOI 10.1016/0091-6749(91)90209-7; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; FLAVAHAN NA, 1988, AM REV RESPIR DIS, V138, P685, DOI 10.1164/ajrccm/138.3.685; FRIGAS E, 1980, LAB INVEST, V42, P35; FRIGAS E, 1981, MAYO CLIN PROC, V56, P345; GLEICH GJ, 1984, ANNU REV IMMUNOL, V2, P429, DOI 10.1146/annurev.immunol.2.1.429; HASTIE AT, 1987, AM REV RESPIR DIS, V135, P848, DOI 10.1164/arrd.1987.135.4.848; HISAMATSU K, 1990, J ALLERGY CLIN IMMUN, V86, P52, DOI 10.1016/S0091-6749(05)80123-X; JUTLIA MA, 1989, J IMMUNOL, V143, P3318; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; LACAL P, 1988, J BIOL CHEM, V263, P9946; LANIER LL, 1985, EUR J IMMUNOL, V15, P713, DOI 10.1002/eji.1830150714; LEIFERMAN KM, 1990, LAB INVEST, V62, P579; LEIFERMAN KM, 1985, NEW ENGL J MED, V313, P282, DOI 10.1056/NEJM198508013130502; MILLER LJ, 1987, J CLIN INVEST, V80, P535, DOI 10.1172/JCI113102; MOY JN, 1990, J IMMUNOL, V145, P2626; MOY JN, 1993, J ALLERGY CLIN IMMUN, V91, P333; ODONNELL MC, 1983, J EXP MED, V157, P1981, DOI 10.1084/jem.157.6.1981; PELIKAN Z, 1983, J ALLERGY CLIN IMMUN, V72, P657, DOI 10.1016/0091-6749(83)90625-5; PHILIPS MR, 1988, J CLIN INVEST, V82, P495, DOI 10.1172/JCI113623; ROHRBACH MS, 1990, J EXP MED, V172, P1271, DOI 10.1084/jem.172.4.1271; SCHMEICHEL CJ, 1987, J IMMUNOL, V138, P1896; SHALIT M, 1988, J LEUKOCYTE BIOL, V44, P212, DOI 10.1002/jlb.44.3.212; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SPRINGER TA, 1986, J IMMUNOL, V136, P240; STACKER SA, 1991, J IMMUNOL, V146, P648; TONNESEN MG, 1989, J CLIN INVEST, V83, P637, DOI 10.1172/JCI113928; VEDDER NB, 1988, J CLIN INVEST, V81, P676, DOI 10.1172/JCI113372; WASSOM DL, 1981, J CLIN INVEST, V67, P651, DOI 10.1172/JCI110080; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; ZHEUTLIN LM, 1984, J IMMUNOL, V133, P2180; ZWEIMAN B, 1990, J IMMUNOL, V144, P3953	40	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1993	92	4					598	606		10.1016/0091-6749(93)90084-S	http://dx.doi.org/10.1016/0091-6749(93)90084-S			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MC590	8409119				2022-12-18	WOS:A1993MC59000012
J	SANCHEZBORGES, M; OROZCO, A; DIBIAGIO, E; TAMI, I; SUAREZCHACON, R				SANCHEZBORGES, M; OROZCO, A; DIBIAGIO, E; TAMI, I; SUAREZCHACON, R			EOSINOPHILIA IN EARLY-STAGE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							IGE		MINIST SANIDAD & ASISTENCIA SOCIAL,CTR ONCOL & HEMATOL,CARACAS,VENEZUELA									[Anonymous], 1990, Wkly Epidemiol Rec, V65, P221; DESENNE JJ, 1986, AM J MED, V81, P1118, DOI 10.1016/0002-9343(86)90430-4; MURRAY HW, 1984, NEW ENGL J MED, V310, P883, DOI 10.1056/NEJM198404053101404; PAGANELLI R, 1991, J ALLERGY CLIN IMMUN, V88, P416, DOI 10.1016/0091-6749(91)90107-Y; SAMPLE S, 1990, J ALLERGY CLIN IMMUN, V86, P876, DOI 10.1016/S0091-6749(05)80149-6	5	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1993	92	3					494	495		10.1016/0091-6749(93)90130-8	http://dx.doi.org/10.1016/0091-6749(93)90130-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LX309	8360401				2022-12-18	WOS:A1993LX30900017
J	BOUSQUET, J; MICHEL, FB				BOUSQUET, J; MICHEL, FB			PRECISION OF PRICK AND PUNCTURE TESTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							MORROW-BROWN NEEDLE; SKIN PRICK; REPRODUCIBILITY; MULTITEST; ALLERGY; IMMUNOTHERAPY; SENSITIVITY; DIAGNOSIS; EXTRACT; INVIVO				BOUSQUET, J (corresponding author), CHU MONTPELLIER,HOP LAIGUELONGUE,MALAD RESP CLIN,F-34059 MONTPELLIER,FRANCE.		Bousquet, Jean/O-4221-2019					ADINOFF AD, 1989, J ALLERGY CLIN IMMUN, V84, P168, DOI 10.1016/0091-6749(89)90321-7; BASOMBA A, 1985, ALLERGY, V40, P395, DOI 10.1111/j.1398-9995.1985.tb02677.x; BERKOWITZ RB, 1992, J ALLERGY CLIN IMMUN, V90, P979, DOI 10.1016/0091-6749(92)90471-D; BERNSTEIN IL, 1988, J ALLERGY CLIN IMMUN, V82, P487, DOI 10.1016/0091-6749(88)90958-X; BOUSQUET J, 1985, J ALLERGY CLIN IMMUN, V76, P734, DOI 10.1016/0091-6749(85)90680-3; BOUSQUET J, 1988, ALLERGY PRINCIPLES P, P418; BROWN HM, 1981, CLIN ALLERGY, V11, P95, DOI 10.1111/j.1365-2222.1981.tb01571.x; DEMOLY P, 1991, J ALLERGY CLIN IMMUN, V88, P758, DOI 10.1016/0091-6749(91)90183-O; DEMOLY P, 1992, J ALLERGY CLIN IMMUN, V90, P277, DOI 10.1016/0091-6749(92)90089-K; DREBORG S, 1988, ALLERGY S10, V44, P1; ENGLER DB, 1992, J ALLERGY CLIN IMMUN, V90, P985, DOI 10.1016/0091-6749(92)90472-E; GARIBALDI E, 1990, ANN ALLERGY, V65, P481; GARIBALDI E, 1990, J ALLERGY CLIN IMMUN, V86, P137; HAAHTELA T, IN PRESS ALLERGY; Lewis T, 1924, HEART-J STUD CIRC, V11, P209; MAHAN C, 1990, J ALLERGY CLIN IMMUN, V86, P275, DOI 10.1016/S0091-6749(05)80080-6; MALLING HJ, 1982, ALLERGY, V37, P563, DOI 10.1111/j.1398-9995.1982.tb02341.x; MALLING HJ, 1985, ALLERGY, V40, P400, DOI 10.1111/j.1398-9995.1985.tb02678.x; MENARDO JL, 1982, ANN ALLERGY, V48, P235; MURPHREE JT, 1979, ANN ALLERGY, V43, P279; NELSON HS, 1983, ANN ALLERGY, V51, P411; NIEROP G, 1981, ANN ALLERGY, V46, P105; OSTERBALLE O, 1979, ALLERGY, V34, P209, DOI 10.1111/j.1398-9995.1979.tb01700.x; Pepys J., 1975, BR J HOSP MED, V14, P412; PERRIN LF, 1984, CLIN ALLERGY, V14, P581, DOI 10.1111/j.1365-2222.1984.tb02246.x; PIPKORN U, 1988, ALLERGY, V43, P81, DOI 10.1111/j.1398-9995.1988.tb00398.x; TAUDORF E, 1985, ALLERGY, V40, P344, DOI 10.1111/j.1398-9995.1985.tb00245.x; TERHO EO, 1989, ALLERGY, V44, P30, DOI 10.1111/j.1398-9995.1989.tb00442.x; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9; VANMETRE TE, 1990, J ALLERGY CLIN IMMUN, V86, P587, DOI 10.1016/S0091-6749(05)80217-9; VOORHORST R, 1973, ANN ALLERGY, V31, P195; 1983, J ALLERGY CLIN IMMUN, V75, P515; 1989, REGISTRATION ALLERGE	33	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1992	90	6	1				870	872		10.1016/0091-6749(92)90458-E	http://dx.doi.org/10.1016/0091-6749(92)90458-E			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD190	1460194				2022-12-18	WOS:A1992KD19000002
J	VANDERBREMPT, X; LEDENT, C; MAIRESSE, M				VANDERBREMPT, X; LEDENT, C; MAIRESSE, M			RHINITIS AND ASTHMA CAUSED BY OCCUPATIONAL EXPOSURE TO CAROB BEAN FLOUR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							GUAR GUM				VANDERBREMPT, X (corresponding author), CLIN ST LUC,DEPT PNEUMOL & ALLERGOL,SERV PNEUMOL,RUE ST LUC 8,B-5004 BOUGE,BELGIUM.		VAN DER BREMPT, Xavier/GLT-1646-2022					KANERVA L, 1988, CLIN ALLERGY, V18, P245, DOI 10.1111/j.1365-2222.1988.tb02866.x; LEZNOFF A, 1986, AM REV RESPIR DIS, V133, P935; MALO JL, 1990, J ALLERGY CLIN IMMUN, V86, P562, DOI 10.1016/S0091-6749(05)80213-1; REYNOLDS JEF, 1989, EXTRA PHARMACOPOEIA, P1432; Yman L, 1988, ALLERGY, V43	5	17	18	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1992	90	6	1				1008	1010		10.1016/0091-6749(92)90480-P	http://dx.doi.org/10.1016/0091-6749(92)90480-P			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD190	1460192				2022-12-18	WOS:A1992KD19000024
J	EMERY, BE; WHITE, MV; IGARASHI, Y; MULLOL, J; BERKEBILE, C; PEDEN, D; LOTZE, MT; KALINER, MA				EMERY, BE; WHITE, MV; IGARASHI, Y; MULLOL, J; BERKEBILE, C; PEDEN, D; LOTZE, MT; KALINER, MA			THE EFFECT OF IL-4 ON HUMAN NASAL MUCOSAL RESPONSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NASAL CONGESTION; IL-4; CANCER NASAL CHALLENGE	PATHO-PHYSIOLOGY; HISTAMINE TACHYPHYLAXIS; INTERLEUKIN-4 PROMOTES; RHINITIS; SECRETIONS; LYMPHOCYTES; PROTEIN; GROWTH; DOGS	Interleukin (IL)-4 causes the dose limiting sensation of nasal congestion when administered systemically at doses of 3 mug/kg or higher thrice daily to humans. This side effect was observed in a group of patients treated as part of an immunotherapy protocol for cancer management. To determine the source of this congestion, nasal secretions were collected prospectively in a group of patients at baseline and after provocation with normal saline, methacholine (which stimulates glandular secretion), and histamine (which causes increased vascular permeability). Nasal lavages obtained at baseline and after provocation were analyzed for the presence of these glandular and vascular proteins and inflammatory mediators. Washings and provocations were performed before IL-4 administration, after 24 hours of IL-4 treatment, and after 3 days of treatment, at a time when nasal congestion was maximal. Compared with histamine challenge before IL-4 treatment, the secretion of the plasma proteins albumin and IgG were significantly decreased after 3 days of IL-4 treatment. IL-4 treatment had no apparent effect on methacholine-induced responses. Thus systemically administered IL-4 causes the subjective sensation of nasal congestion, increased histamine in nasal lavages, and the development of vascular unresponsiveness to histamine, without affecting parasympathetic responses to histamine. The relationships among increases in nasal lavage histamine, vascular unresponsiveness to histamine, and the sensation of nasal congestion are unclear.	LOUISIANA STATE UNIV,DEPT OTOLARYNGOL HEAD & NECK SURG,SHREVEPORT,LA 71105; NIAID,CLIN INVEST LAB,BETHESDA,MD 20892; NIH,BIOMED ENGN & INSTRUMENTAT BRANCH,CTR CLIN,INTENS CARE UNIT,BETHESDA,MD 20892; UNIV PITTSBURGH,MED CTR,PITTSBURGH CANC INST,PITTSBURGH,PA 15260	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute				Peden, David/0000-0003-4526-4627				ANDERSON WH, 1979, BIOCHEM PHARMACOL, V28, P2223, DOI 10.1016/0006-2952(79)90210-7; ANGGARD A, 1974, ACTA OTO-LARYNGOL, V78, P232, DOI 10.3109/00016487409126349; ANTOL PJ, 1988, J APPL PHYSIOL, V65, P1944, DOI 10.1152/jappl.1988.65.5.1944; ANTOL PJ, 1988, J APPL PHYSIOL, V65, P1938, DOI 10.1152/jappl.1988.65.5.1938; ASAKURA K, 1985, ACTA OTO-LARYNGOL, V100, P450, DOI 10.3109/00016488509126570; BARANIUK JN, 1990, J CLIN INVEST, V86, P825, DOI 10.1172/JCI114780; GANSTROM E, 1978, ADV PROSTAGLANDIN TH, V5, P119; JACKSON RT, 1982, ANN OTO RHINOL LARYN, V91, P216, DOI 10.1177/000348948209100220; JUAN H, 1980, N-S ARCH PHARMACOL, V314, P183, DOI 10.1007/BF00504536; KAWAKAMI Y, 1989, J IMMUNOL, V142, P3452; KAWAKAMI Y, 1988, J EXP MED, V168, P2183, DOI 10.1084/jem.168.6.2183; KAWAKAMI Y, 1989, FASEB J, V2, pA660; KRANE RJ, 1989, NEW ENGL J MED, V321, P1648, DOI 10.1056/NEJM198912143212406; LOTZE MT, IN PRESS INTERLEUKIN, V4; MANNING PJ, 1987, J APPL PHYSIOL, V63, P1572, DOI 10.1152/jappl.1987.63.4.1572; MCBRIDE P, 1988, J ALLERGY CLIN IMMUN, V82, P638, DOI 10.1016/0091-6749(88)90977-3; MEREDITH SD, 1989, J ALLERGY CLIN IMMUN, V84, P920, DOI 10.1016/0091-6749(89)90390-4; MYGIND N, 1982, J ALLERGY CLIN IMMUN, V70, P149, DOI 10.1016/0091-6749(82)90036-7; OKAYAMA M, IN PRESS AM REV RESP; RAPHAEL GD, 1988, AM REV RESPIR DIS, V138, P413, DOI 10.1164/ajrccm/138.2.413; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V87, P457, DOI 10.1016/0091-6749(91)90001-5; RAPHAEL GD, 1989, AM REV RESPIR DIS, V139, P791, DOI 10.1164/ajrccm/139.3.791; RUBIN JT, IN PRESS ANN SURG; SATOH H, 1984, J PHARMACOL EXP THER, V229, P527; SAXENA PN, 1973, JPN J PHARMACOL, V23, P363, DOI 10.1254/jjp.23.363; SHORE S, 1985, J APPL PHYSIOL, V59, P1355, DOI 10.1152/jappl.1985.59.5.1355; SPITS H, 1987, J IMMUNOL, V139, P1142; UDDMAN R, 1981, ACTA OTO-LARYNGOL, V91, P135, DOI 10.3109/00016488109138491; WANG H-W, 1988, Rhinology (Utrecht), V26, P139; WHITE MV, 1992, BLOOD, V79, P1491, DOI 10.1182/blood.V79.6.1491.bloodjournal7961491	31	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1992	90	5					772	781		10.1016/0091-6749(92)90101-7	http://dx.doi.org/10.1016/0091-6749(92)90101-7			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JZ319	1430703				2022-12-18	WOS:A1992JZ31900007
J	STAFFORD, CT; WISE, SL; ROBINSON, DA; CROSBY, BL; HOFFMAN, DR				STAFFORD, CT; WISE, SL; ROBINSON, DA; CROSBY, BL; HOFFMAN, DR			SAFETY AND EFFICACY OF FIRE ANT VENOM IN THE DIAGNOSIS OF FIRE ANT ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SOLENOPSIS-INVICTA; VENOM; WHOLE BODY EXTRACT; DIAGNOSIS; FIRE ANT ALLERGY	HUMAN IMMUNE RESPONSIVENESS; WHOLE-BODY EXTRACTS; HYMENOPTERA VENOM; SOLENOPSIS-INVICTA; INDUSTRIAL-POPULATION; HYPERSENSITIVITY; IMMUNOTHERAPY; SENSITIVITY; INVIVO	Thirty-three adult patients who had had systemic allergic reactions to fire ant stings and 33 insect-nonallergic control subjects were skin tested with single lots of Solenopsis invicta (Sol i) fire ant venom (IFAV) and two commercially available imported fire ant whole body extracts (IFA WBEs). All three extracts were analyzed for protein concentration. Sol i II and Sol i III concentrations were each assayed by means of two ELISAs with complementary monoclonal antibodies, one species specific and one cross-reactive. Radioallergosorbent test (RAST) to IFAV and both IFA WBEs was performed on sera from all study subjects. Both IFA WBEs contained high concentrations of fire ant body proteins. Sol i II and III concentrations each varied twofold between the two IFA WBE preparations. Patients were generally more reactive to IFAV than IFA WBE by skin testing and RAST. IFAV RAST appeared to be a more sensitive assay than IFA WBE RAST. No adverse reactions occurred to skin testing with IFAV, but intradermal testing with higher concentrations of IFA WBE caused delayed large local reactions in 16 of 30 (53%) control subjects. These reactions were attributed to the large amounts of extraneous body proteins in IFA WBE. These results (1) demonstrate that skin testing with IFAV is safe, (2) indicate that IFAV is more potent than IFA WBE, and (3) suggest that IFAV may be the superior reagent for diagnosis of fire ant allergy.	USA, EISENHOWER MED CTR, FT GORDON, GA 30905 USA; E CAROLINA UNIV, SCH MED, GREENVILLE, NC 27834 USA	United States Department of Defense; United States Army; University of North Carolina; East Carolina University	STAFFORD, CT (corresponding author), MED COLL GEORGIA, BG 248, AUGUSTA, GA 30912 USA.							BAHNA SL, 1988, J ALLERGY CLIN IMMUN, V82, P419, DOI 10.1016/0091-6749(88)90014-0; BLOOM FL, 1978, J ALLERGY CLIN IMMUN, V61, P134, DOI 10.1016/0091-6749(78)90256-7; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V81, P33, DOI 10.1016/0091-6749(88)90217-5; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V81, P1096, DOI 10.1016/0091-6749(88)90875-5; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V82, P770, DOI 10.1016/0091-6749(88)90078-4; DESHAZO RD, 1984, J ALLERGY CLIN IMMUN, V74, P841, DOI 10.1016/0091-6749(84)90188-X; DESHAZO RD, 1990, NEW ENGL J MED, V323, P462, DOI 10.1056/NEJM199008163230707; DESHAZO RD, 1991, ANN ALLERGY, V66, P1; FREIDHOFF LR, 1981, AM J MED GENET, V9, P323, DOI 10.1002/ajmg.1320090409; FREIDHOFF LR, 1984, J ALLERGY CLIN IMMUN, V73, P490, DOI 10.1016/0091-6749(84)90360-9; GOLDEN D B K, 1982, Journal of Allergy and Clinical Immunology, V69, P124; HANNAN CJ, 1986, J ALLERGY CLIN IMMUN, V78, P331, DOI 10.1016/S0091-6749(86)80085-9; HOFFMAN DR, 1988, J ALLERGY CLIN IMMUN, V82, P828, DOI 10.1016/0091-6749(88)90085-1; HOFFMAN DR, 1984, ANN ALLERGY, V52, P276; HOFFMAN DR, 1988, J ALLERGY CLIN IMMUN, V82, P818, DOI 10.1016/0091-6749(88)90084-X; HOFFMAN DR, 1987, J ALLERGY CLIN IMMUN, V80, P300, DOI 10.1016/0091-6749(87)90035-2; HOFFMAN DR, 1991, ANN ALLERGY, V66, P29; HOFFMAN DR, 1979, ANN ALLERGY, V42, P224; HYLANDER RD, 1989, J ALLERGY CLIN IMMUN, V83, P232; JACOBSON RS, 1988, J ALLERGY CLIN IMMUN, V81, P203, DOI 10.1016/0091-6749(88)90377-6; LOCKEY RF, 1990, HOSP PRACT, V25, P109; NORDVALL SL, 1988, J ALLERGY CLIN IMMUN, V82, P567, DOI 10.1016/0091-6749(88)90966-9; PAULL BR, 1986, J ALLERGY CLIN IMMUN, V77, P141; PAULL BR, 1983, J ALLERGY CLIN IMMUN, V71, P48; RHOADES R B, 1990, Journal of Allergy and Clinical Immunology, V85, P212; RHOADES RB, 1977, J FLA MED ASSOC, V64, P247; RHOADES RB, 1991, J ALLERGY CLIN IMMUN, V0087, P00237; SMITH AM, 1992, J ALLERGY CLIN IMMUN, V89, P293; STAFFORD CT, 1989, SOUTHERN MED J, V82, P1520, DOI 10.1097/00007611-198912000-00015; STAFFORD CT, 1990, ANN ALLERGY, V64, P368; STROM GB, 1983, J ALLERGY CLIN IMMUN, V72, P46, DOI 10.1016/0091-6749(83)90051-9; TRIPLETT RF, 1973, SOUTHERN MED J, V66, P477, DOI 10.1097/00007611-197304000-00019; ZAR JH, 1984, BIOSTAT ANAL, P378	33	17	18	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1992	90	4	1				653	661		10.1016/0091-6749(92)90139-S	http://dx.doi.org/10.1016/0091-6749(92)90139-S			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT995	1401645	Bronze			2022-12-18	WOS:A1992JT99500012
J	WALD, ER				WALD, ER			ANTIMICROBIAL THERAPY OF PEDIATRIC-PATIENTS WITH SINUSITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	SYMP ON MECHANISMS, DIAGNOSIS, AND TREATMENT OF SINUSITIS IN CHILDREN AND ADULTS	JAN 24-25, 1992	SCOTTSDALE, AZ	ALLEN & HANBURYS		SINUSITIS; ANTIMICROBIAL THERAPY; ANTIBIOTIC THERAPY	ACUTE MAXILLARY SINUSITIS; ACUTE OTITIS-MEDIA; CONTROLLED TRIAL; AMOXICILLIN; CEFACLOR; CHILDREN	The mainstay of medical therapy for acute and subacute sinusitis is the selection of an antimicrobial agent based on an appreciation of the usual bacterial pathogens that include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Amoxicillin is appropriate therapy for patients with uncomplicated sinusitis in geographic areas in which the prevalence of beta-lactamase-producing pathogens is less than 20%. If a patient does not respond to amoxicillin or in areas in which there is a high prevalence of beta-lactamase-producing bacterial species, alternative antimicrobials include amoxicillin-clavulanate, erythromycin-sulfisoxazole, trimethoprim-sulfamethoxazole, cefaclor, cefuroxime axetil, and cefixime. Cefixime, which is less active against S. pneumoniae than most of these antimicrobials, should be reserved for patients who do not improve with amoxicillin. Amoxicillin-potassium clavulanate, cefuroxime axetil, and erythromycin-sulfisoxazole have the most comprehensive antibacterial spectra.			WALD, ER (corresponding author), UNIV PITTSBURGH,CHILDRENS HOSP PITTSBURGH,SCH MED,3705 5TH AVE,PITTSBURGH,PA 15213, USA.							AMBROSINO DM, 1987, NEW ENGL J MED, V316, P790, DOI 10.1056/NEJM198703263161306; CARSON JL, 1988, ADV PEDIATR, V139, P166; COMOCHO AE, 1991, INTERSCIENCE C ANTIM; FARR B, 1983, B NEW YORK ACAD MED, V59, P477; GWALTNEY JM, 1981, ANN OTO RHINOL LARYN, V90, P68, DOI 10.1177/00034894810903S216; HENDERSON FW, 1988, J INFECT DIS, V157, P256, DOI 10.1093/infdis/157.2.256; HOWIE VM, 1987, PEDIATR INFECT DIS J, V6, P989, DOI 10.1097/00006454-198710000-00040; LEVINE LR, 1985, PEDIATR INFECT DIS J, V4, P358, DOI 10.1097/00006454-198507000-00005; MARCHANT CD, 1984, J PEDIATR-US, V105, P633, DOI 10.1016/S0022-3476(84)80438-2; PERRIN JM, 1974, NEW ENGL J MED, V291, P665; RACHELEFSKY GS, 1982, J ALLERGY CLIN IMMUN, V69, P382, DOI 10.1016/0091-6749(82)90150-6; RODRIQUEZ RS, 1988, INTERSCIENCE C ANTIM; SCHELD WM, 1986, ANTIMICROB AGENTS CH, V30, P350, DOI 10.1128/AAC.30.3.350; SYDNOR A, 1989, ARCH OTOLARYNGOL, V115, P1430; SYDNOR TA, 1991, INTERSCIENCE C ANTIM; WALD ER, 1989, J PEDIATR-US, V115, P28, DOI 10.1016/S0022-3476(89)80324-5; WALD ER, 1984, J PEDIATR-US, V104, P297, DOI 10.1016/S0022-3476(84)81018-5; WALD ER, 1986, PEDIATRICS, V77, P795; WALD ER, 1984, POSTGRAD MED     SEP, P133	19	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1992	90	3	2	S			469	473		10.1016/0091-6749(92)90171-W	http://dx.doi.org/10.1016/0091-6749(92)90171-W			5	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JP521	1527339	Bronze			2022-12-18	WOS:A1992JP52100012
J	KOENIG, JQ; DUMLER, K; REBOLLEDO, V; WILLIAMS, PV; PIERSON, WE				KOENIG, JQ; DUMLER, K; REBOLLEDO, V; WILLIAMS, PV; PIERSON, WE			THEOPHYLLINE MITIGATES THE BRONCHOCONSTRICTOR EFFECTS OF SULFUR-DIOXIDE IN SUBJECTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; AIR POLLUTION; SULFUR DIOXIDE; FEV1; THEOPHYLLINE; UNIPHYL; PULMONARY FUNCTION	PULMONARY-FUNCTION; ADOLESCENTS; INHIBITION	The objective of the study was to investigate the ability of a sustained-release (SR) theophylline tablet (Uniphyl; Purdue Frederick Co., Norwalk, Conn.) to block or mitigate sulfur dioxide (SO2)-induced bronchoconstriction in adult subjects with asthma. Eight subjects participated in a double-blind, crossover study with a 400 mg theophylline tablet or placebo once a day for a week before a 10-minute SO2 challenge. FEV1 and total respiratory resistance (R(T)) were measured before and after the SO2 challenge and on a different day before and after an air exposure. After exposure to SO2, average values of FEV1 dropped 16% after placebo treatment and 7% after theophylline treatment. The corresponding percentages for R(T) were a 37% increase after placebo and a 7% increase after theophylline treatment. Analysis of variance demonstrated a significant difference between the SO2-induced decrease in FEV1 and increase in R(T) after SR theophylline treatment compared with that of placebo treatment. Thus, we conclude that SR theophylline tablets, taken at this concentration for 1 week, mitigate SO2-induced bronchoconstriction.	UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	KOENIG, JQ (corresponding author), UNIV WASHINGTON,DEPT ENVIRONM HLTH,SC-34,SEATTLE,WA 98195, USA.			Williams, Paul/0000-0003-3300-1328	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002366] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES 02366] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BIERMAN CW, 1977, PEDIATRICS, V60, P1; DUBOIS AB, 1956, J CLIN INVEST, V35, P322, DOI 10.1172/JCI103281; GOLDMAN M, 1970, J APPL PHYSIOL, V28, P113, DOI 10.1152/jappl.1970.28.1.113; HORSTMAN DH, 1989, ASTM STP, V1024, P195; KOENIG JQ, 1989, ENVIRON HEALTH PERSP, V79, P173, DOI 10.2307/3430546; KOENIG JQ, 1983, J TOXICOL ENV HEALTH, V11, P129, DOI 10.1080/15287398309530327; KOENIG JQ, 1987, J ALLERGY CLIN IMMUN, V79, P54, DOI 10.1016/S0091-6749(87)80016-7; KOENIG JQ, 1980, ENVIRON RES, V22, P145, DOI 10.1016/0013-9351(80)90126-7; KOENIG JQ, 1988, J ALLERGY CLIN IMMUN, V81, P897, DOI 10.1016/0091-6749(88)90947-5; KOENIG JQ, 1985, INHAL TOXICOL, P85; KOENIG JQ, 1989, PEDIATRIC ASTHMA ALL, P147; MCMANUS MS, 1989, J ALLERGY CLIN IMMUN, V83, P619, DOI 10.1016/0091-6749(89)90074-2; ORCOTT JJ, 1977, CLIN CHEM, V23, P599; SHAPIRO GG, 1982, J ALLERGY CLIN IMMUN, V69, P365, DOI 10.1016/0091-6749(82)90147-6; SHEPPARD D, 1981, AM REV RESPIR DIS, V124, P257; SOLDIN SJ, 1977, CLIN BIOCHEM, V10, P71; WEINBERGER M, 1985, BRONCHIAL ASTHMA MEC, P646; WIEBICKE W, 1990, J ALLERGY CLIN IMMUN, V86, P915, DOI 10.1016/S0091-6749(05)80155-1; 1982, EPA600882029B	19	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1992	89	4					789	794		10.1016/0091-6749(92)90432-2	http://dx.doi.org/10.1016/0091-6749(92)90432-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN860	1560163				2022-12-18	WOS:A1992HN86000002
J	HOPPE, M; HARMAN, E; HENDELES, L				HOPPE, M; HARMAN, E; HENDELES, L			THE EFFECT OF INHALED GALLOPAMIL, A POTENT CALCIUM-CHANNEL BLOCKER, ON THE LATE-PHASE RESPONSE IN SUBJECTS WITH ALLERGIC-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						GALLOPAMIL; CALCIUM CHANNEL BLOCKER; LATE PHASE; ALLERGIC ASTHMA	ANTIGEN-INDUCED BRONCHOCONSTRICTION; EXERCISE-INDUCED ASTHMA; BRONCHIAL RESPONSIVENESS; AIRWAY RESPONSIVENESS; CROMOLYN SODIUM; VERAPAMIL; HISTAMINE; ANTAGONISTS; DURATION; METHACHOLINE	The effect of gallopamil on the late-phase response to inhaled allergen was evaluated in six young adults with allergic asthma in a crossover manner. During 2 study days, subjects received 20 mg of inhaled gallopamil or placebo 30 minutes before challenge with the same dose of allergen. In addition, a histamine challenge was performed 1 1/2 hours before and 24 hours after allergen challenge. On 2 additional study days, in the absence of allergen, basal airway responsiveness to histamine was measured before and after gallopamil or placebo administration. During the early phase, the mean +/- SD decrease in FEV1 was 28.0% +/- 11.3% after placebo and 25.1% +/- 8.4% after gallopamil administration (p > 0.05; beta = 0.14). During the late phase, the maximum decrease in FEV1 was 26.9% +/- 11.9% after placebo and 25.3% +/- 10.3% after gallopamil administration (p < 0.05; beta = 0.21). Airway reactivity to histamine 24 hours after allergen challenge could not be measured in three subjects after gallopamil administration and in one subject after placebo administration because of persistent bronchospasm. In contrast, basal responsiveness to histamine in the absence of allergen was modestly decreased by gallopamil. Since gallopamil is one of the most potent calcium channel blockers when it is administered by the inhaled route, it is unlikely that this group of drugs will be clinically useful for allergic asthma.	UNIV FLORIDA,HLTH SCI CTR,COLL PHARM,POB 100486,GAINESVILLE,FL 32610; UNIV FLORIDA,DIV PEDIAT PULM DIS,CYST FIBROSIS,GAINESVILLE,FL 32610; UNIV FLORIDA,DEPT MED,DIV PULM,GAINESVILLE,FL 32611	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida					NCRR NIH HHS [RR05573] Funding Source: Medline; NHLBI NIH HHS [HL 31489] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031489] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHMED T, 1985, CHEST, V88, P176, DOI 10.1378/chest.88.2.176; AHMED T, 1988, J ALLERGY CLIN IMMUN, V81, P852, DOI 10.1016/0091-6749(88)90942-6; AHRENS RC, 1987, J ALLERGY CLIN IMMUN, V79, P876, DOI 10.1016/0091-6749(87)90235-1; CARPENTER N, 1988, J ALLERGY CLIN IMMUN, V81, P859, DOI 10.1016/0091-6749(88)90943-8; COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264; COCKCROFT DW, 1983, LANCET, V2, P253; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; D'BROT J, 1987, American Review of Respiratory Disease, V135, pA312; HOLGATE ST, 1977, LANCET, V2, P375; JAKSCHIK BA, 1980, BIOCHEM BIOPH RES CO, V95, P103, DOI 10.1016/0006-291X(80)90710-X; KONIG P, 1987, J ALLERGY CLIN IMMUN, V79, P64, DOI 10.1016/S0091-6749(87)80018-0; LAI CKW, 1989, AM REV RESPIR DIS, V140, P917, DOI 10.1164/ajrccm/140.4.917; LEE VY, 1983, THORAX, V38, P386, DOI 10.1136/thx.38.5.386; MANNING PJ, 1988, AM REV RESPIR DIS, V137, P1323, DOI 10.1164/ajrccm/137.6.1323; MARKS RG, 1982, ANAL RES DATA BASICS, P43; MASSEY KL, 1988, EUR J CLIN PHARMACOL, V34, P555, DOI 10.1007/BF00615217; MASSEY KL, 1988, J ALLERGY CLIN IMMUN, V81, P912, DOI 10.1016/0091-6749(88)90950-5; MASSEY KL, 1988, PHARMACOTHERAPY, V8, P189; MCCUBBIN M, 1987, AM REV RESPIR DIS, V135, P229; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; PARKS DP, 1989, AM REP RESPIR DIS, V139, P590; PATEL KR, 1985, EUR J RESPIR DIS, V67, P269; PENNINGTON JE, 1986, J LAB CLIN MED, V108, P44; RUSSI EW, 1983, AM REV RESPIR DIS, V127, P675; RUSSI EW, 1985, CHEST, V88, P74, DOI 10.1378/chest.88.1.74; SO SY, 1982, CLIN ALLERGY, V12, P595, DOI 10.1111/j.1365-2222.1982.tb02558.x; WALKER SB, 1986, J ALLERGY CLIN IMMUN, V77, P32, DOI 10.1016/0091-6749(86)90318-0; 1980, ATMS NEWS        SPR, P11	28	17	21	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1992	89	3					688	695		10.1016/0091-6749(92)90375-C	http://dx.doi.org/10.1016/0091-6749(92)90375-C			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HJ340	1545089				2022-12-18	WOS:A1992HJ34000007
J	WEMPE, JB; POSTMA, DS; BREEDERVELD, N; ALTINGHEBING, D; VANDERMARK, TW; KOETER, GH				WEMPE, JB; POSTMA, DS; BREEDERVELD, N; ALTINGHEBING, D; VANDERMARK, TW; KOETER, GH			SEPARATE AND COMBINED EFFECTS OF CORTICOSTEROIDS AND BRONCHODILATORS ON AIR-FLOW OBSTRUCTION AND AIRWAY HYPERRESPONSIVENESS IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						AIRWAY HYPERRESPONSIVENESS; ASTHMA; CORTICOSTEROIDS; BRONCHODILATORS	DOSE-RESPONSE CURVES; BRONCHIAL RESPONSIVENESS; IPRATROPIUM BROMIDE; BECLOMETHASONE DIPROPIONATE; FLOW OBSTRUCTION; BETA-AGONISTS; SALBUTAMOL; HISTAMINE; LUNG; PREDNISOLONE	We have investigated separate and interactive effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness. Twelve allergic subjects with asthma were treated in a double-blind, crossover, randomized study with budesonide, 1.6 mg daily for 3 weeks, prednisone, 40 mg daily, for 8 days, and placebo. After each period, dose-response curves were measured on 4 study days with doubling doses of salbutamol, ipratropium, a combination of salbutamol and ipratropium, and placebo until a plateau in FEV1 was reached. A histamine challenge was then performed, and the provocation concentration causing a 20% fall in FEV1 (PC20) was calculated. The budesonide and prednisone regimens were equipotent. FEV1 was 81.2% of predicted after budesonide, 81.0% predicted after prednisone, and 67.5% predicted after placebo, bronchodilatation thus being 13.7% predicted (budesonide) and 13.5% predicted (prednisone). PC20 improved with 2.17 doubling concentrations (DCs) after budesonide, and 1.86 DCs after prednisone, compared with that of placebo. Salbutamol caused stronger bronchodilatation than ipratropium (26.2% versus 14.7% predicted) and a better protection against histamine challenge (3.95 versus 1.12 DC). The effects of corticosteroids and bronchodilators on FEV1 and PC20 were, in general, additive. This study emphasizes different modes of action on both airflow obstruction and airway hyperresponsiveness by corticosteroids and bronchodilators, and it demonstrates no enhancement of bronchodilator action by corticosteroids.	UNIV GRONINGEN HOSP,DEPT PULMONOL,OOSTERSINGEL 59,9713 EZ GRONINGEN,NETHERLANDS	University of Groningen								BANDOUVAKIS J, 1981, BRIT J DIS CHEST, V75, P295, DOI 10.1016/0007-0971(81)90009-7; BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; BARNES PJ, 1989, THORAX, V44, P161, DOI 10.1136/thx.44.3.161; BEL EH, 1991, AM REV RESPIR DIS, V143, P109, DOI 10.1164/ajrccm/143.1.109; BHAGAT RG, 1985, AM REV RESPIR DIS, V131, P902; BRITTON J, 1984, THORAX, V39, P597, DOI 10.1136/thx.39.8.597; BRITTON J, 1988, THORAX, V43, P300, DOI 10.1136/thx.43.4.300; CHUNG KF, 1990, EUR RESPIR J, V3, P329; CHURCH MK, 1987, BRIT J PHARMACOL, V90, P421, DOI 10.1111/j.1476-5381.1987.tb08972.x; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; COCKCROFT DW, 1977, THORAX, V32, P429, DOI 10.1136/thx.32.4.429; CURZON PGD, 1983, THORAX, V38, P601, DOI 10.1136/thx.38.8.601; EASTON JG, 1981, J ALLERGY CLIN IMMUN, V67, P388, DOI 10.1016/0091-6749(81)90084-1; EASTON PA, 1986, NEW ENGL J MED, V315, P735, DOI 10.1056/NEJM198609183151205; ELLULMICALLEF R, 1975, LANCET, V2, P1269; FRASER J, 1981, J CLIN INVEST, V67, P1777, DOI 10.1172/JCI110217; FRIGAS E, 1986, J ALLERGY CLIN IMMUN, V77, P527, DOI 10.1016/0091-6749(86)90341-6; FUGNER A, 1989, INT ARCH ALLER A IMM, V88, P225, DOI 10.1159/000234792; FULLER RW, 1984, CLIN SCI, V67, P653, DOI 10.1042/cs0670653; GRANDORDY B, 1987, THORAX, V42, P65, DOI 10.1136/thx.42.1.65; GRANDORDY BM, 1988, EUR RESPIR J, V1, P531; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; HOLGATE ST, 1977, LANCET, V2, P375; JAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242; JENKINS CR, 1988, THORAX, V43, P378, DOI 10.1136/thx.43.5.378; JUNIPER EF, 1990, EUR RESPIR J, V3, P1122; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; KRAAN J, 1988, AM REV RESPIR DIS, V137, P44, DOI 10.1164/ajrccm/137.1.44; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; MANO K, 1979, LIFE SCI, V25, P1925, DOI 10.1016/0024-3205(79)90614-3; MATTILA MJ, 1984, BRIT J PHARMACOL, V83, P607, DOI 10.1111/j.1476-5381.1984.tb16214.x; MATTOLI S, 1985, J ALLERGY CLIN IMMUN, V76, P214, DOI 10.1016/0091-6749(85)90704-3; MOLEMA J, 1988, EUR J CLIN PHARMACOL, V34, P577, DOI 10.1007/BF00615220; PERSSON CGA, 1979, ACTA PHARMACOL TOX, V44, P216; PETRIE GR, 1975, BRIT MED J, V1, P430, DOI 10.1136/bmj.1.5955.430; PIERCE RJ, 1979, THORAX, V34, P45, DOI 10.1136/thx.34.1.45; QUANJER PH, 1983, B EUR PHYSIOPATH RES, V19, P1; RIJCKEN B, 1987, AM REV RESPIR DIS, V136, P62, DOI 10.1164/ajrccm/136.1.62; ROSENHALL L, 1982, EUR J REPIR DIS S122, V63, P18; RYAN G, 1985, J ALLERGY CLIN IMMUN, V75, P25, DOI 10.1016/0091-6749(85)90007-7; RYAN G, 1982, THORAX, V37, P423, DOI 10.1136/thx.37.6.423; SALOME CM, 1981, THORAX, V36, P580, DOI 10.1136/thx.36.8.580; SHENFIELD GM, 1975, THORAX, V30, P430, DOI 10.1136/thx.30.4.430; STERK PJ, 1989, EUR RESPIR J, V2, P267; ULLAH MI, 1981, THORAX, V36, P523, DOI 10.1136/thx.36.7.523; WEBB J, 1981, THORAX, V36, P18, DOI 10.1136/thx.36.1.18; 1987, AM REV RESPIR DIS, V130, P225	47	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1992	89	3					679	687		10.1016/0091-6749(92)90374-B	http://dx.doi.org/10.1016/0091-6749(92)90374-B			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HJ340	1531994	Bronze			2022-12-18	WOS:A1992HJ34000006
J	SANDERS, RL; DOCKHORN, RJ; ALDERMAN, JL; MCSORLEY, PA; WENGER, TL; FROSOLONO, MF				SANDERS, RL; DOCKHORN, RJ; ALDERMAN, JL; MCSORLEY, PA; WENGER, TL; FROSOLONO, MF			CARDIAC EFFECTS OF ACRIVASTINE COMPARED TO TERFENADINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				183	183						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000107
J	SWANSON, MC; BUBAK, ME; HUNT, LW; REED, CE				SWANSON, MC; BUBAK, ME; HUNT, LW; REED, CE			OCCUPATIONAL RESPIRATORY ALLERGIC DISEASE FROM LATEX	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905	Mayo Clinic									0	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				227	227						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000281
J	LEE, TH; SMITH, CM; ARM, JP; CHRISTIE, PE				LEE, TH; SMITH, CM; ARM, JP; CHRISTIE, PE			MEDIATOR RELEASE IN ASPIRIN-INDUCED REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							LEUKOTRIENES; HISTAMINE; ASTHMA				LEE, TH (corresponding author), GUYS HOSP,DEPT ALLERGY & ALLIED RESP DISORDERS,4TH FLOOR HUNTS HOUSE,LONDON SE1 9RT,ENGLAND.		Lee, Tak/AAA-9526-2020	Lee, Tak/0000-0002-7554-4059				ARM JP, 1989, AM REV RESPIR DIS, V140, P148, DOI 10.1164/ajrccm/140.1.148; BOSSO JV, 1991, J ALLERGY CLIN IMMUN, V88, P830, DOI 10.1016/0091-6749(91)90238-J; CHAFEE FH, 1974, J ALLERGY CLIN IMMUN, V53, P193, DOI 10.1016/0091-6749(74)90080-3; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; FERRERI NR, 1988, AM REV RESPIR DIS, V137, P847, DOI 10.1164/ajrccm/137.4.847; MAALTBY NH, 1990, J ALLERGY CLIN IMMUN, V85, P3; OATES JA, 1984, ASTHMA PHYSL IMMUNOP, P55; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SMITH C, 1991, Journal of Allergy and Clinical Immunology, V87, P139, DOI 10.1016/0091-6749(91)91285-2; SZCZEKLIK A, 1975, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.5949.67; SZMIDT M, 1987, AGENTS ACTIONS, V11, P105; UNDEM BJ, 1987, AM REV RESPIR DIS, V136, P1183, DOI 10.1164/ajrccm/136.5.1183	13	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1991	88	6					827	829		10.1016/0091-6749(91)90237-I	http://dx.doi.org/10.1016/0091-6749(91)90237-I			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GW262	1744353	Bronze			2022-12-18	WOS:A1991GW26200001
J	BEAUVAIS, F; BIDET, B; DESCOURS, B; HIEBLOT, C; BURTIN, C; BENVENISTE, J				BEAUVAIS, F; BIDET, B; DESCOURS, B; HIEBLOT, C; BURTIN, C; BENVENISTE, J			REGULATION OF HUMAN BASOPHIL ACTIVATION .1. DISSOCIATION OF CATIONIC DYE BINDING FROM HISTAMINE-RELEASE IN ACTIVATED HUMAN BASOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article								Human basophil activation was demonstrated by histamine release (HR) and by the decrease of the toluidine blue-positive basophils (TB+). In four experimental systems, TB+ number decreased in the absence of HR (1) in basophils from atopic subjects stimulated by allergen concentrations below the threshold for HR, (2) in basophils sensitized by anti-2,4-dinitrophenyl IgE stimulated by noncovalently linked 2,4-dinitrobenzene sulfonic acid-human serum albumin (also, the threshold for decrease of TB+ required lower concentrations of sensitizing anti-2,4-dinitrophenyl IgE than for HR), (3) in low Ca++ medium, and (4) in the presence of the Na+/H+ exchanger, monensin. These results suggest that (1) there is a lower threshold for TB+ decrease than for HR in allergen concentration, number of membrane IgE molecules, and number of IgE cross-linkings; moreover, external Ca++ requirement is lower for decrease of TB+ than for HR and (2) TB+ decrease reflects either granule exocytosis or, in the absence of HR, biochemical changes (most probably cation exchanges) altering the interaction of the basic dye with the granules. Thus, monitoring decrease in TB+ allows detection of basophil activation in the absence of HR.			BEAUVAIS, F (corresponding author), UNIV PARIS SUD, INSERM, U 200, 32 RUE CARNETS, F-92140 CLAMART, FRANCE.		BEAUVAIS, Francis/C-7556-2012	BEAUVAIS, Francis/0000-0002-5567-5924				AOKI H, 1986, ANN ALLERGY, V57, P319; BEAUVAIS F, 1990, J IMMUNOL, V144, P3881; BENVENISTE J, 1981, CLIN ALLERGY, V11, P1, DOI 10.1111/j.1365-2222.1981.tb01559.x; BOCHNER BS, 1989, J IMMUNOL, V142, P3180; CAMUSSI G, 1981, LAB INVEST, V44, P241; CAMUSSI G, 1982, INT ARCH ALLER A IMM, V69, P358, DOI 10.1159/000233200; DEROBERTIS E, 1970, CELL BIOL, pCH7; EGIDO J, 1977, LANCET, V2, P712; EISEN H N, 1964, Methods Med Res, V10, P94; GERARD H, 1981, PATHOL BIOL, V29, P137; HOOK WA, 1981, IMMUNOLOGY, V43, P723; IZHIZAKA T, 1972, J IMMUNOL, V108, P1000; LAIWAH ACY, 1984, CLIN ALLERGY, V14, P571, DOI 10.1111/j.1365-2222.1984.tb02245.x; LEVY DA, 1966, J IMMUNOL, V97, P203; LIU FT, 1980, J IMMUNOL, V124, P2728; PEARCE FL, 1985, BRIT J CLIN PHARMACO, V20, pS267, DOI 10.1111/j.1365-2125.1985.tb02812.x; PETIOT JF, 1981, ANN BIOL CLIN-PARIS, V39, P355; PIROTZKY E, 1982, LANCET, V1, P358; PRUZANSKY JJ, 1983, J IMMUNOL, V131, P1949; PRUZANSKY JJ, 1980, IMMUNOLOGY, V40, P411; RENNERT OM, 1967, NATURE, V213, P1133, DOI 10.1038/2131133a0; ROTHENBERG ME, 1987, J IMMUNOL, V138, P2616; RUFF F, 1967, NATURE, V214, P279, DOI 10.1038/214279b0; SIRAGANIAN RP, 1976, J ALLERGY CLIN IMMUN, V57, P525, DOI 10.1016/0091-6749(76)90003-8; TSIEN RY, 1989, METHOD CELL BIOL, V30, P127	25	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1991	87	5					1020	1028		10.1016/0091-6749(91)90426-O	http://dx.doi.org/10.1016/0091-6749(91)90426-O			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FM095	1709184				2022-12-18	WOS:A1991FM09500016
J	RANSOM, JH; LEONARD, J; WASSERSTEIN, RL				RANSOM, JH; LEONARD, J; WASSERSTEIN, RL			ACAREX TEST CORRELATES WITH MONOCLONAL-ANTIBODY TEST FOR DUST MITES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							HOUSE DUST; DERMATOPHAGOIDES-PTERONYSSINUS; ALLERGENS; EXTRACTS	Forty-two dust samples from the homes of patients having positive mite skin tests were tested by both monoclonal antibody and Acarex techniques. A Spearman's correlation coefficient of 0.85 (p = 0.0001) was found. The Acarex test is simple to use and is much less expensive than the monoclonal antibody method. The use of either method may enhance patient compliance with mite-control instructions and may prove crucial to the effective use of miticides in infested homes.			RANSOM, JH (corresponding author), TOPEKA ALLERGY ASTHMA CLIN,FLEMING PL OFF PK,1123 SW GAGE BLVD,TOPEKA,KS 66604, USA.							CHAPMAN MD, 1987, J ALLERGY CLIN IMMUN, V80, P184, DOI 10.1016/0091-6749(87)90128-X; FERNANDEZCALDAS E, 1989, J ALLERGY CLIN IMMUN, V83, P292; GRIFFIN P, 1989, J ALLERGY CLIN IMMUN, V84, P108, DOI 10.1016/0091-6749(89)90184-X; KERSTEN W, 1988, ALLERGOLOGIE, V11, P371; LEMAO J, 1989, J ALLERGY CLIN IMMUN, V83, P926, DOI 10.1016/0091-6749(89)90107-3; MURRAY AB, 1983, PEDIATRICS, V71, P418; PLATTSMILLS TAE, 1989, J ALLERGY CLIN IMMUN, V83, P416, DOI 10.1016/0091-6749(89)90128-0; RANSOM J H, 1990, Journal of Allergy and Clinical Immunology, V85, P239; RANSOM JH, 1990, ANN ALLERGY, V65, P292; SMITH TF, 1985, J ALLERGY CLIN IMMUN, V76, P783; VOORHORS.R, 1967, J ALLERGY, V39, P325, DOI 10.1016/0021-8707(67)90045-7; WOOD RA, 1989, J ALLERGY CLIN IMMUN, V83, P199	12	17	19	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1991	87	4					886	888		10.1016/0091-6749(91)90138-E	http://dx.doi.org/10.1016/0091-6749(91)90138-E			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FG059	2013683				2022-12-18	WOS:A1991FG05900020
J	MANSFIELD, LE				MANSFIELD, LE			THE ROLE OF ANTIHISTAMINE THERAPY IN VASCULAR HEADACHES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MANSFIELD, LE (corresponding author), TEXAS TECH RHSC, DIV IMMUNOL & ALLERGY, SUITE 3100, 1700 CURRIE DR, EL PASO, TX 79902 USA.							AEBELHOLTKRABBE A, 1980, PAIN, V8, P253, DOI 10.1016/0304-3959(88)90012-7; ANTHONY M, 1978, HEADACHE, V18, P261, DOI 10.1111/j.1526-4610.1978.hed1805261.x; ANTHONY M, 1981, CEPHALALGIA, V1, P83, DOI 10.1111/j.1468-2982.1981.tb00014.x; ANTHONY M, 1971, ARCH NEUROL-CHICAGO, V25, P225, DOI 10.1001/archneur.1971.00490030051005; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; ARRANG JM, 1988, J NEUROCHEM, V51, P105, DOI 10.1111/j.1471-4159.1988.tb04841.x; CACABELOS R, 1988, ENDOCRINOLOGY, V122, P1269, DOI 10.1210/endo-122-4-1269; CHAO D, 1963, Headache, V3, P13, DOI 10.1111/j.1526-4610.1963.hed0301013.x; CURZON G, 1969, J NEUROL NEUROSUR PS, V32, P555, DOI 10.1136/jnnp.32.6.555; GROSS PM, 1981, J CEREBR BLOOD F MET, V1, P441, DOI 10.1038/jcbfm.1981.49; HEATLEY RV, 1982, CLIN ALLERGY, V12, P145, DOI 10.1111/j.1365-2222.1982.tb01633.x; KALINER M, 1981, J ALLERGY CLIN IMMUN, V68, P365, DOI 10.1016/0091-6749(81)90134-2; LEE NS, 1988, PHARMACOL BIOCHEM BE, V29, P559, DOI 10.1016/0091-3057(88)90020-2; LIPINSKI JF, 1973, BRAIN RES, V52, P403, DOI 10.1016/0006-8993(73)90681-1; LITTLEWOOD JT, 1988, LANCET, V1, P558, DOI 10.1016/S0140-6736(88)91353-0; MANSFIELD LE, 1985, ANN ALLERGY, V55, P126; MAY CD, 1976, J ALLERGY CLIN IMMUN, V58, P432, DOI 10.1016/0091-6749(76)90124-X; NATH C, 1988, LIFE SCI, V42, P2413, DOI 10.1016/0024-3205(88)90339-6; OLESEN J, 1982, ADV MIGRAINE RES THE, P105; RUSSELL D, 1979, J NEUROL NEUROSUR PS, V42, P668, DOI 10.1136/jnnp.42.7.668; SANDERS WM, 1980, HEADACHE, V20, P307, DOI 10.1111/j.1526-4610.1980.hed2006307.x; SAXENA PR, 1975, NEUROLOGY, V25, P681, DOI 10.1212/WNL.25.7.681; SCHLICKER E, 1988, N-S ARCH PHARMACOL, V337, P588; SICUTERI F, 1963, Headache, V3, P86, DOI 10.1111/j.1526-4610.1963.hed0303086.x; SICUTERI F, 1973, RES CLIN STU HEADACH, V1, P19; SOMERVILLE BW, 1976, MED J AUSTRALIA, V1, P865, DOI 10.5694/j.1326-5377.1976.tb141126.x; VAUGHAN WT, 1948, ALLERGIC DISEASES, P1027; VAUGHN TR, UNPUB FOOD MIGRAINE; YOUNG CS, 1988, BIOCHEM PHARMACOL, V37, P976, DOI 10.1016/0006-2952(88)90194-3; 1982, LANCET, V1, P1138	31	17	20	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	2	S			673	676		10.1016/S0091-6749(05)80239-8	http://dx.doi.org/10.1016/S0091-6749(05)80239-8			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EH093	2229834				2022-12-18	WOS:A1990EH09300020
J	OKUDA, Y; HATTORI, H; TAKASHIMA, T; MIYATAKE, A; YAMATODANI, A; TSUYUGUCHI, I; KISHIMOTO, S				OKUDA, Y; HATTORI, H; TAKASHIMA, T; MIYATAKE, A; YAMATODANI, A; TSUYUGUCHI, I; KISHIMOTO, S			BASOPHIL HISTAMINE-RELEASE BY PLATELET-ACTIVATING-FACTOR IN ASPIRIN-SENSITIVE SUBJECTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									OSAKA UNIV,SCH MED,OSAKA,JAPAN	Osaka University	OKUDA, Y (corresponding author), OSAKA PREFECTURAL HABIKINO HOSP,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN.							AMEISEN JC, 1985, INT ARCH ALLER A IMM, V78, P438, DOI 10.1159/000233927; BARNES PJ, 1988, ASTHMA BASIC MECHANI, P533; COLTEN HR, 1972, J CLIN INVEST, V51, P1927, DOI 10.1172/JCI106998; CONROY MC, 1977, J IMMUNOL, V118, P1317; FARNAM J, 1985, J IMMUNOL, V134, P541; HOLLINGSWORTH HM, 1984, AM REV RESPIR DIS, V130, P373; ISHIZAKA T, 1969, J IMMUNOL, V102, P884; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; LIN S, 1978, P NATL ACAD SCI USA, V75, P329, DOI 10.1073/pnas.75.1.329; MARONE G, 1985, INT ARCH ALLER A IMM, V76, P70, DOI 10.1159/000233737; MARONE G, 1979, J IMMUNOL, V123, P1669; OKUDA Y, 1988, INT ARCH ALLER A IMM, V85, P341, DOI 10.1159/000234529; PAGE CP, 1988, ASTHMA BASIC MECHANI, P283; SCHELLENBERG RR, 1983, J ALLERGY CLIN IMMUN, V71, P145, DOI 10.1016/0091-6749(83)90351-2; SCHLEIMER RP, 1982, J IMMUNOL, V129, P1632; SMITH LJ, 1988, AM REV RESPIR DIS, V137, P1015, DOI 10.1164/ajrccm/137.5.1015; STEVENSON DD, 1976, CLIN ALLERGY, V6, P493, DOI 10.1111/j.1365-2222.1976.tb01934.x; STEVENSON DD, 1987, J ALLERGY CLIN IMMUN, V80, P788, DOI 10.1016/S0091-6749(87)80266-X; SZCZEKLIK A, 1975, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.5949.67; TREVES S, 1987, EXP CELL RES, V168, P285, DOI 10.1016/0014-4827(87)90001-2; VANSELOW NA, 1967, ANN INTERN MED, V66, P568, DOI 10.7326/0003-4819-66-3-568; YAMATODANI A, 1985, J CHROMATOGR, V344, P115, DOI 10.1016/S0378-4347(00)82012-5	22	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	1				548	553		10.1016/S0091-6749(05)80211-8	http://dx.doi.org/10.1016/S0091-6749(05)80211-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EG454	1699986				2022-12-18	WOS:A1990EG45400015
J	WILLIAMS, WR; PAWLOWICZ, A; DAVIES, BH				WILLIAMS, WR; PAWLOWICZ, A; DAVIES, BH			INVITRO TESTS FOR THE DIAGNOSIS OF ASPIRIN-SENSITIVE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											WILLIAMS, WR (corresponding author), SULLY HOSP,ASTHMA & ALLERGY UNIT,CARDIFF CF6 2YA,WALES.							AMEISEN JC, 1985, INT ARCH ALLER A IMM, V78, P438, DOI 10.1159/000233927; ASAD SI, 1983, CLIN ALLERGY, V13, P459, DOI 10.1111/j.1365-2222.1983.tb02622.x; ASAD SI, 1984, BRIT MED J, V288, P745, DOI 10.1136/bmj.288.6419.745; ATTALLAH AA, 1974, PROSTAG OTH LIPID M, V6, P547, DOI 10.1016/S0090-6980(74)80069-9; BIANCO S, 1981, BRIT MED J, V282, P146, DOI 10.1136/bmj.282.6258.146-b; CAPRON A, 1985, INT ARCH ALLER A IMM, V77, P107, DOI 10.1159/000233762; CAPRON A, 1987, INT ARCH ALLER A IMM, V82, P307, DOI 10.1159/000234214; Cooke RA, 1919, J AMER MED ASSOC, V73, P759, DOI 10.1001/jama.1919.02610360029008; DELANEY JC, 1975, POSTGRAD MED J, V51, P15, DOI 10.1136/pgmj.51.591.15; DEMERS LM, 1983, J CLIN ENDOCR METAB, V57, P101, DOI 10.1210/jcem-57-1-101; DURHAM SR, 1985, LANCET, V2, P36; GREER IA, 1984, LANCET, V2, P1479; GRESELE P, 1982, NEW ENGL J MED, V306, P549; HEMMENDINGER S, 1989, J ALLERGY CLIN IMMUN, V83, P990, DOI 10.1016/0091-6749(89)90117-6; KNAUER KA, 1981, NEW ENGL J MED, V304, P1404, DOI 10.1056/NEJM198106043042307; LELLOUCHTUBIANA A, 1987, INT ARCH ALLER A IMM, V83, P198, DOI 10.1159/000234356; LUDLAM CA, 1975, LANCET, V1, P259; MATHE AA, 1973, BRIT MED J, V1, P193, DOI 10.1136/bmj.1.5847.193; Metzger W J, 1987, Agents Actions Suppl, V21, P151; NEMOTO T, 1976, J ALLERGY CLIN IMMUN, V57, P89, DOI 10.1016/0091-6749(76)90028-2; PAGE CP, 1984, INT ARCH ALLER A IMM, V74, P347, DOI 10.1159/000233571; PEARSON DJ, 1990, CLIN EXP ALLERGY, V20, P157, DOI 10.1111/j.1365-2222.1990.tb02661.x; Putnam E., 1975, 3 SERUM ALBUMIN, VSecond, P133, DOI [10.1016/B978-0-12-568401-9.50010-4, DOI 10.1016/B978-0-12-568401-9.50010-4]; STEVENSON DD, 1987, J ALLERGY CLIN IMMUN, V80, P788, DOI 10.1016/S0091-6749(87)80266-X; SZCZEKLIK A, 1975, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.5949.67; UNGER WG, 1972, J PHARM PHARMACOL, V24, P470, DOI 10.1111/j.2042-7158.1972.tb09034.x; WHITEHEAD TP, 1983, NATURE, V305, P158, DOI 10.1038/305158a0	27	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	1				445	451		10.1016/S0091-6749(05)80198-8	http://dx.doi.org/10.1016/S0091-6749(05)80198-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EG454	2146311				2022-12-18	WOS:A1990EG45400002
J	HEMMENDINGER, S; PAULI, G; TENABENE, A; PUJOL, JL; BESSOT, JC; EBER, M; CAZENAVE, JP				HEMMENDINGER, S; PAULI, G; TENABENE, A; PUJOL, JL; BESSOT, JC; EBER, M; CAZENAVE, JP			PLATELET-FUNCTION - AGGREGATION BY PAF OR SEQUESTRATION IN LUNG IS NOT MODIFIED DURING IMMEDIATE OR LATE ALLERGEN-INDUCED BRONCHOSPASM IN MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CTR REG TRANSFUS SANGUINE,SERV HEMOSTASE & THROMBOSE,10 RUE SPIELMANN,F-67085 STRASBOURG,FRANCE; CTR REG LUTTE CONTRE CANC PAUL STRAUSS,SERV MED NUCL,STRASBOURG,FRANCE; CTR REG TRANSFUS SANGUINE,INSERM,U311,STRASBOURG,FRANCE; HOSPICES CIVILS,SERV PNEUMOL 2,STRASBOURG,FRANCE	UNICANCER; Centre Paul Strauss; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg			Cazenave, Jean-Pierre/AAE-2935-2019					BASRAN GS, 1984, CLIN ALLERGY, V14, P75, DOI 10.1111/j.1365-2222.1984.tb02193.x; BENVENISTE J, 1985, NEW TRENDS ALLERGY, V2, P117; BENVENISTE J, 1987, AM REV RESPIR DIS, V195, P52; CAZENAVE JP, 1983, ANN BIOL CLIN-PARIS, V41, P167; CHESNEY CM, 1985, BIOCHEM BIOPH RES CO, V127, P24, DOI 10.1016/S0006-291X(85)80120-0; CHESNEY CM, 1987, PLATELET RESPONSES M, V2, P83; CUSS FM, 1986, LANCET, V2, P189; DENJEAN A, 1983, J APPL PHYSIOL, V55, P799, DOI 10.1152/jappl.1983.55.3.799; DURHAM SR, 1985, LANCET, V2, P36; Farr R S, 1987, Agents Actions Suppl, V21, P129; GATEAU O, 1984, AM REV RESPIR DI SA3, V129, P129; GREER IA, 1985, THROMB HAEMOSTASIS, V3, P348; HARKER LA, 1980, BLOOD, V56, P824; JOHNSON CE, 1986, THORAX, V41, P290, DOI 10.1136/thx.41.4.290; KAPLAN KL, 1981, BLOOD, V57, P199; KNAUER KA, 1981, NEW ENGL J MED, V304, P1404, DOI 10.1056/NEJM198106043042307; KOPFERSCHMITTKUBLER MC, 1987, J ALLERGY CLIN IMMUN, V80, P730, DOI 10.1016/0091-6749(87)90295-8; LANZA F, 1985, THROMB HAEMOSTASIS, V54, P402; LELLOUCHTUBIANA A, 1985, BRIT J EXP PATHOL, V66, P345; MACCIA CA, 1977, J ALLERGY CLIN IMMUN, V59, P101, DOI 10.1016/0091-6749(77)90210-X; MACMANUS LM, 1986, PATHOL IMMUNOPATH R, V5, P104; MALO PE, 1987, PROSTAGLANDINS, V33, P209, DOI 10.1016/0090-6980(87)90007-4; Menz G, 1987, Agents Actions Suppl, V21, P139; Methlin G., 1984, BLOOD CELLS NUCLEA 1, P29; MURPHY EA, 1971, THROMB DIATH HAEMO, V2, P25; NAKAMURA T, 1987, INT ARCH ALLER A IMM, V82, P57, DOI 10.1159/000234290; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; PAGE CP, 1984, INT ARCH ALLER A IMM, V74, P347, DOI 10.1159/000233571; PAGE CP, 1984, TRENDS PHARMACOL SCI, P1; PATTERSON R, 1987, J LAB CLIN MED, V110, P606; PETERS AM, 1985, THORAX, V40, P412; SCHLEIMER RP, 1985, J ALLERGY CLIN IMMUN, V76, P369, DOI 10.1016/0091-6749(85)90656-6; SOLINGER A, 1973, J ALLERGY CLIN IMMUN, V51, P29	33	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1989	83	5					990	996		10.1016/0091-6749(89)90117-6	http://dx.doi.org/10.1016/0091-6749(89)90117-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U7161	2523922				2022-12-18	WOS:A1989U716100023
J	LORIA, RC; FINNERTY, N; WEDNER, HJ				LORIA, RC; FINNERTY, N; WEDNER, HJ			SUCCESSFUL USE OF AZTREONAM IN A PATIENT WHO FAILED ORAL PENICILLIN DESENSITIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WASHINGTON UNIV,SCH MED,DEPT MED,DIV ALLERGY & IMMUNOL,600 S EUCLID,ST LOUIS,MO 63110	Washington University (WUSTL)								ADKINSON NF, 1985, REV INFECT DIS, V7, pS613; ADKINSON NF, 1984, ANTIMICROB AGENTS CH, V25, P93, DOI 10.1128/AAC.25.1.93; ADKINSON NF, 1984, ANTIMICROB AGENTS CH, V25, P933; CHILDS SJ, 1986, PHARMACOTHERAPY, V6, P138; GREENBERG RN, 1986, CLIN THER, V8, P354; HOPEFL AW, 1985, DRUG INTEL CLIN PHAR, V19, P171, DOI 10.1177/106002808501900301; LERNER SA, 1984, REV INFECT DIS, V6, pS678; MOHANTY KC, 1987, CURR MED RES OPIN, V10, P634, DOI 10.1185/03007998709112417; PRINCIPI N, 1987, DRUG EXP CLIN RES, V13, P589; SAXON A, 1984, J INFECT DIS, V149, P16, DOI 10.1093/infdis/149.1.16; SAXON A, 1987, ANN INTERN MED, V107, P204, DOI 10.7326/0003-4819-107-2-204; SAXON A, 1985, AM J MED, V78, P19, DOI 10.1016/0002-9343(85)90198-6; SULLIVAN TJ, 1982, J ALLERGY CLIN IMMUN, V69, P275, DOI 10.1016/S0091-6749(82)80004-3; SYKES RB, 1985, AM J MED, V78, P2, DOI 10.1016/0002-9343(85)90196-2; SYKES RB, 1985, REV INFECT DIS, V7, pS579	15	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1989	83	4					735	737		10.1016/0091-6749(89)90007-9	http://dx.doi.org/10.1016/0091-6749(89)90007-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U3420	2496156				2022-12-18	WOS:A1989U342000004
J	MCBRIDE, P; JACOBS, R; BRADLEY, D; KALINER, M				MCBRIDE, P; JACOBS, R; BRADLEY, D; KALINER, M			USE OF PLASMA HISTAMINE LEVELS TO MONITOR CUTANEOUS MAST-CELL DE-GRANULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,ALLERG DIS SECT,CLIN INVEST LAB,BLDG 10,ROOM 11C205,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								CASALE TB, 1986, JAMA-J AM MED ASSOC, V255, P2049, DOI 10.1001/jama.255.15.2049; CASALE TB, 1984, J ALLERGY CLIN IMMUN, V73, P775, DOI 10.1016/0091-6749(84)90447-0; CASALE TB, 1984, J ALLERGY CLIN IMMUN, V73, P837, DOI 10.1016/0091-6749(84)90456-1; DYER J, 1982, J ALLERGY CLIN IMMUN, V70, P82, DOI 10.1016/0091-6749(82)90233-0; FRIEDMAN MM, 1988, J ALLERGY CLIN IMMUN, V82, P998, DOI 10.1016/0091-6749(88)90136-4; GARAFALO J, 1981, J ALLERGY CLIN IMMUN, V68, P103, DOI 10.1016/0091-6749(81)90166-4; HUSTON DP, 1986, ANN INTERN MED, V104, P507, DOI 10.7326/0003-4819-104-4-507; KALINER M, 1982, J ALLERGY CLIN IMMUN, V69, P283, DOI 10.1016/S0091-6749(82)80005-5; KAPLAN AP, 1975, J ALLERGY CLIN IMMUN, V55, P394, DOI 10.1016/0091-6749(75)90078-0; KEAHEY TM, 1987, J ALLERGY CLIN IMMUN, V80, P831, DOI 10.1016/S0091-6749(87)80273-7; NELSON HS, 1983, ANN ALLERGY, V51, P411; SHEFFER AL, 1984, J ALLERGY CLIN IMMUN, V73, P699, DOI 10.1016/0091-6749(84)90309-9; SOLOMON WR, 1983, PROVOCATIVE CHALLENG, P133; SPECTOR SL, 1983, PROVOCATIVE CHALLENG, P97	14	17	19	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1989	83	2	1				374	380		10.1016/0091-6749(89)90121-8	http://dx.doi.org/10.1016/0091-6749(89)90121-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T4489	2465333				2022-12-18	WOS:A1989T448900002
J	STRUNK, RC; FUKUHARA, JT; LABRECQUE, JF; MRAZEK, DA				STRUNK, RC; FUKUHARA, JT; LABRECQUE, JF; MRAZEK, DA			OUTCOME OF LONG-TERM HOSPITALIZATION FOR ASTHMA IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,DENVER,CO; UNIV COLORADO,SCH MED,DEPT PEDIAT,DENVER,CO 80202; UNIV COLORADO,SCH MED,DEPT PSYCHIAT,DENVER,CO 80202	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K07AI000543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH000430] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BHAGAT RG, 1984, AM REV RESPIR DIS, V129, P221; BRONNIMANN S, 1986, CHEST, V90, P480, DOI 10.1378/chest.90.4.480; CLARK NM, 1986, J ALLERGY CLIN IMMUN, V78, P108, DOI 10.1016/0091-6749(86)90122-3; CLARK NM, 1981, HEALTH EDUC QUART, V8, P166, DOI 10.1177/109019818100800203; CREER TL, 1983, J ASTHMA, V20, P11, DOI 10.3109/02770908309070906; CUMMINGS NP, 1984, ANN ALLERGY, V53, P395; FALLIERS CJ, 1970, ANN ALLERGY, V28, P513; HINDIALEXANDER MC, 1983, J ALLERGY CLIN IMMUN, V72, P555, DOI 10.1016/0091-6749(83)90482-7; LEWIS CE, 1984, PEDIATRICS, V74, P478; MCNICOL KN, 1973, BRIT MED J, V4, P7, DOI 10.1136/bmj.4.5883.7; MRAZEK DA, 1987, SEMIN RESPIR MED, V8, P347, DOI 10.1055/s-2007-1012674; Peshkin MM, 1930, AM J DIS CHILD, V39, P774, DOI 10.1001/archpedi.1930.01930160092010; PESHKIN MM, 1959, INT ARCH ALLER A IMM, V15, P91, DOI 10.1159/000229036; RACKEMANN FM, 1952, NEW ENGL J MED, V246, P815, DOI 10.1056/NEJM195205222462104; ROBBINS SM, 1973, CLIN PEDIATR, V12, P550, DOI 10.1177/000992287301200914; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; STAUDENMAYER H, 1979, PSYCHOSOM MED, V41, P109, DOI 10.1097/00006842-197903000-00004; STRUNK RC, 1987, SEMIN RESPIR MED, V8, P338, DOI 10.1055/s-2007-1012673; UNGER L, 1948, Postgrad Med, V4, P62	19	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					17	25		10.1016/0091-6749(89)90473-9	http://dx.doi.org/10.1016/0091-6749(89)90473-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419	2913136				2022-12-18	WOS:A1989T041900004
J	WOOD, RA; EGGLESTON, PA; MUDD, KE; ADKINSON, NF				WOOD, RA; EGGLESTON, PA; MUDD, KE; ADKINSON, NF			INDOOR ALLERGEN LEVELS AS A RISK FACTOR FOR ALLERGIC SENSITIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					199	199						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900131
J	SHAPIRO, GG				SHAPIRO, GG			THE ROLE OF NASAL AIRWAY-OBSTRUCTION IN SINUS DISEASE AND FACIAL DEVELOPMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHILDRENS ORTHOPED HOSP & MED CTR,SEATTLE,WA 98105		SHAPIRO, GG (corresponding author), UNIV WASHINGTON,SCH MED,NW ASTHMA & ALLERGY CTR,SEATTLE,WA 98195, USA.							BUSINCO L, 1981, INT J PEDIATR OTORHI, V3, P287, DOI 10.1016/0165-5876(81)90053-7; FURUKAWA CT, 1983, PEDIATRICS, V71, P133; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403; RACHELEFSKY GS, 1978, J ALLERGY CLIN IMMUN, V61, P310, DOI 10.1016/0091-6749(78)90052-0; RACHELEFSKY GS, 1984, PEDIATRICS, V73, P526; SHAPIRO GG, 1986, J ALLERGY CLIN IMMUN, V77, P59, DOI 10.1016/0091-6749(86)90324-6; SHAPIRO GG, 1984, CLIN REV ALLERG, V2, P225; SHAPIRO GG, 1985, PEDIATR INFECT DIS J, V4, pS55, DOI 10.1097/00006454-198511001-00003; WALD ER, 1986, PEDIATRICS, V77, P795	9	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1988	82	5	2	S			935	940		10.1016/0091-6749(88)90036-X	http://dx.doi.org/10.1016/0091-6749(88)90036-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R2353	3057046				2022-12-18	WOS:A1988R235300007
J	WYNN, SR; SWANSON, MC; REED, CE; PENNY, ND; SHOWERS, WB; SMITH, JM				WYNN, SR; SWANSON, MC; REED, CE; PENNY, ND; SHOWERS, WB; SMITH, JM			IMMUNOCHEMICAL QUANTITATION, SIZE DISTRIBUTION, AND CROSS-REACTIVITY OF LEPIDOPTERA (MOTH) AEROALLERGENS IN SOUTHEASTERN MINNESOTA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN, DIV ALLERG DIS, ROCHESTER, MN 55905 USA; MAYO GRAD SCH MED, DEPT PEDIAT, DIV ALLERG DIS, ROCHESTER, MN 55901 USA; MAYO GRAD SCH MED, DEPT MED, ROCHESTER, MN 55901 USA; ALLERG DIS RES LAB, ROCHESTER, MN USA; CALIF ACAD SCI, SAN FRANCISCO, CA 94118 USA; IOWA STATE UNIV SCI & TECHNOL, DEPT ENTOMOL, AMES, IA 50011 USA; UNIV IOWA HOSP & CLIN, DEPT ALLERGY, IOWA CITY, IA 52242 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; California Academy of Sciences; Iowa State University; University of Iowa					NIAID NIH HHS [AI 21255] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021255] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGARWAL MK, 1983, J ALLERGY CLIN IMMUN, V72, P40, DOI 10.1016/0091-6749(83)90050-7; AGARWAL MK, 1981, J ALLERGY CLIN IMMUN, V68, P194, DOI 10.1016/0091-6749(81)90183-4; BAKER RR, 1978, NATURE, V276, P818, DOI 10.1038/276818a0; FROST SW, 1954, J ECON ENTOMOL, V47, P275, DOI 10.1093/jee/47.2.275; HOSEN H, 1970, ANN ALLERGY, V28, P596; KINO T, 1978, J ALLERGY CLIN IMMUN, V61, P10, DOI 10.1016/0091-6749(78)90467-0; KINO T, 1987, J ALLERGY CLIN IMMUN, V79, P857, DOI 10.1016/0091-6749(87)90233-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OSTROM NK, 1986, J ALLERGY CLIN IMMUN, V77, P736, DOI 10.1016/0091-6749(86)90420-3; PARLATO SALVATORE J., 1932, JOUR ALLERGY, V3, P459, DOI 10.1016/S0021-8707(32)90181-6; Parlato SJ, 1932, J ALLERGY, V3, P125; PERLMAN F, 1958, J ALLERGY, V29, P302, DOI 10.1016/0021-8707(58)90037-6; SHIVPURI DN, 1971, ANN ALLERGY, V29, P588; SHOWERS WB, 1974, J ECON ENTOMOL, V67, P616, DOI 10.1093/jee/67.5.616; STORMS WW, 1981, CLIN ALLERGY, V11, P55, DOI 10.1111/j.1365-2222.1981.tb01566.x; SWANSON MC, 1985, J ALLERGY CLIN IMMUN, V76, P724, DOI 10.1016/0091-6749(85)90678-5; TEE RD, 1985, J ALLERGY CLIN IMMUN, V76, P826, DOI 10.1016/0091-6749(85)90756-0; TEE RD, 1985, J ALLERGY CLIN IMMUN, V75, P122, DOI 10.1016/0091-6749(85)90204-0; TOVEY ER, 1981, AM REV RESPIR DIS, V124, P630; URBACH ERIC, 1941, JOUR ALLERGY, V12, P485, DOI 10.1016/S0021-8707(41)90227-7; Wirtz R.A., 1980, Bulletin of the Entomological Society of America, V26, P356	21	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1988	82	1					47	54		10.1016/0091-6749(88)90050-4	http://dx.doi.org/10.1016/0091-6749(88)90050-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P4004	2455744	Bronze			2022-12-18	WOS:A1988P400400009
J	BERNSTEIN, JM				BERNSTEIN, JM			RECENT ADVANCES IN IMMUNOLOGICAL REACTIVITY IN OTITIS-MEDIA WITH EFFUSION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY BUFFALO,DEPT SPEECH LANGUAGE PATHOL & AUDIOL,BUFFALO,NY 14260; SUNY BUFFALO,DEPT OTOLARYNGOL,BUFFALO,NY 14260; SUNY BUFFALO,DEPT PEDIAT,BUFFALO,NY 14260	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								BERNSTEIN JM, 1983, AM J OTOL, V5, P66; BLUESTONE CD, 1972, LARYNGOSCOPE, V82, P1654, DOI 10.1288/00005537-197209000-00009; BLUESTONE CD, 1978, PEDIATRICS, V61, P757; BROSTOFF J, 1979, MAST CELL, P380; DAGOO B, 1987, IMMUNOLOGY EAR, P363; DOYLE W J, 1984, Journal of Allergy and Clinical Immunology, V73, P170; FRIEDMAN PA, 1983, J ALLERGY CLIN IMMUN, V71, P442; HEINER DC, 1984, ANN ALLERGY, V53, P657; KAWAUCHI H, 1987, 4TH INT S REC ADV OT; KUIJPERS W, 1987, IMMUNOLOGY EAR, P205; LEARY HL, 1984, J ALLERGY CLIN IMMUN, V74, P190, DOI 10.1016/0091-6749(84)90285-9	11	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	2	S			1004	1009		10.1016/0091-6749(88)90169-8	http://dx.doi.org/10.1016/0091-6749(88)90169-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7037	3286724				2022-12-18	WOS:A1988N703700014
J	BONINI, S; BONINI, S; TODINI, V; ADRIANI, E; ALLANSMITH, MR				BONINI, S; BONINI, S; TODINI, V; ADRIANI, E; ALLANSMITH, MR			LATE-PHASE OCULAR REACTION INDUCED BY CONJUNCTIVAL ALLERGEN CHALLENGE - A DOSE-RESPONSE STUDY IN HUMANS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bonini, Sergio/T-6594-2019; Bonini, Stefano/A-2250-2012	Bonini, Sergio/0000-0003-0079-3031; Bonini, Stefano/0000-0002-7787-2144					0	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					173	173		10.1016/0091-6749(88)90254-0	http://dx.doi.org/10.1016/0091-6749(88)90254-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400041
J	ANDERSON, MC; BAER, H; FRAZIER, DJ; QUINNAN, GV				ANDERSON, MC; BAER, H; FRAZIER, DJ; QUINNAN, GV			THE ROLE OF SPECIFIC IGE AND BETA-PROPIOLACTONE IN REACTIONS RESULTING FROM BOOSTER DOSES OF HUMAN-DIPLOID CELL RABIES VACCINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									US FDA,OFF BIOL RES & REVIEW,8800 ROCKVILLE PIKE,BETHESDA,MD 20892	US Food & Drug Administration (FDA)								DREESEN DW, 1986, VACCINE, V4, P45, DOI 10.1016/0264-410X(86)90096-4; Landsteiner K, 1946, SPECIFICITY SEROLOGI; LEVENBOOK IS, 1986, INT ARCH ALLER A IMM, V80, P110, DOI 10.1159/000234035; PHELAN MA, 1980, J BIOL STAND, V8, P223; REISMAN RE, 1961, JAMA-J AM MED ASSOC, V176, P1004, DOI 10.1001/jama.1961.03040250030010; ROELANDS JF, 1974, VOX SANG, V26, P415, DOI 10.1111/j.1423-0410.1974.tb02716.x; RUSCHMANN E, 1962, Z IMMUNITAETSFORSCH, V124, P326; SEVER JL, 1964, J LAB CLIN MED, V64, P985; WIDE L, 1967, LANCET, V2, P1105; 1984, MMWR, V33, P393	10	17	21	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1987	80	6					861	868		10.1016/S0091-6749(87)80278-6	http://dx.doi.org/10.1016/S0091-6749(87)80278-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5020	3693763	Bronze			2022-12-18	WOS:A1987L502000015
J	BARNETT, D; HOWDEN, MEH				BARNETT, D; HOWDEN, MEH			LECTINS AND THE RADIOALLERGOSORBENT TEST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MACQUARIE UNIV,SCH CHEM,N RYDE,NSW 2113,AUSTRALIA; MACQUARIE UNIV,CSIRO,DIV FOOD RES,N RYDE,NSW 2113,AUSTRALIA	Macquarie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Macquarie University								AALBERSE RC, 1981, INT ARCH ALLER A IMM, V66, P259, DOI 10.1159/000232913; BAENZIGER J, 1974, J BIOL CHEM, V249, P1889; BAENZIGER J, 1974, J BIOL CHEM, V249, P1897; BALDO BA, 1983, ARABINOGALACTAN PROT, P21; BARNETT D, 1983, J ALLERGY CLIN IMMUN, V72, P61, DOI 10.1016/0091-6749(83)90053-2; BARNETT D, 1985, P SYDNEY ALLERGEN GR, P104; BHAVANANDAN VP, 1979, J BIOL CHEM, V254, P4000; FREED DLJ, 1982, LECTINS BIOL BIOCH C, V2, P34; FRIES JH, 1982, ANN ALLERGY, V48, P220; HIGGINS TJV, 1983, J BIOL CHEM, V258, P9544; Lis H., 1977, ANTIGENS, V4, P429; MARCHESI VT, 1972, METHOD ENZYMOL, V28, P354; MIZUOCHI T, 1982, J IMMUNOL, V129, P2016	13	17	17	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1987	80	4					558	561		10.1016/0091-6749(87)90007-8	http://dx.doi.org/10.1016/0091-6749(87)90007-8			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5224	3668119				2022-12-18	WOS:A1987K522400007
J	JAGGI, KS; GANGAL, SV				JAGGI, KS; GANGAL, SV			ISOLATION AND IDENTIFICATION OF POLLEN ALLERGENS OF ARTEMISIA-SCOPARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV DELHI,VALLABHLIHAI PATEL CHEST INST,CSIR,CTR BIOCHEM,DELHI 110007,INDIA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi								Agashe SN, 1982, ASP ALLERGY APPL IMM, VXV, P49; ANDERSON MC, 1985, 4 P INT P EHRL SEM C, P17; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; AXELSEN NH, 1973, SCAND J IMMUNOL S2, V2, P49; BABU CR, 1977, HERBACEOUS FLORA DEH, P240; BALDO BA, 1982, INT ARCH ALLER A IMM, V68, P295, DOI 10.1159/000233117; BERNETT D, 1986, BIOCHIM BIOPHYS ACTA, V882, P97; BJORKSTEN F, 1980, ALLERGY, V35, P671, DOI 10.1111/j.1398-9995.1980.tb02020.x; CHAKRABARTY S, 1981, INT ARCH ALLER A IMM, V65, P377, DOI 10.1159/000232779; COTTAM GP, 1986, BIOCHEM J, V234, P305, DOI 10.1042/bj2340305; COUR P, 1980, REV FR ALLERGOL, V20, P197, DOI 10.1016/S0335-7457(80)80034-7; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUMN JF, 1944, REV ASS MED ARGENTIN, V58, P590; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; Gupta M. C., 1984, ASP ALLERGY APPL IMM, V17, P99; HAAVIK S, 1985, J CHROMATOGR, V321, P199, DOI 10.1016/S0021-9673(01)90436-4; HALMEPURO L, 1985, ALLERGY, V40, P264, DOI 10.1111/j.1398-9995.1985.tb00231.x; HALMEPURO L, 1984, INT ARCH ALLER A IMM, V74, P235, DOI 10.1159/000233550; HARBOE NMG, 1983, SCAND J IMMUNOL S10, V17, P345; INGEMANN L, 1985, ALLERGY, V40, P273, DOI 10.1111/j.1398-9995.1985.tb00232.x; IPSEN H, 1985, ALLERGY, V40, P289, DOI 10.1111/j.1398-9995.1985.tb00234.x; JAGGI KS, 1985, THESIS U DELHI DELHI; JAGGI KS, 1984, ASPECTS ALLERGY APPL, V17, P121; LEIFERMAN KM, 1976, J ALLERGY CLIN IMMUN, V58, P140, DOI 10.1016/0091-6749(76)90149-4; LEWIS WH, 1984, ALLERGY THEORY PRACT, P353; LOWENSTEIN H, 1980, ALLERGY, V35, P198, DOI 10.1111/j.1398-9995.1980.tb01743.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSH DG, 1975, ANTIGENS, V3, P271; NILSEN BM, 1986, INT ARCH ALLERGY APP, V80, P111; PAULI G, 1985, CLIN ALLERGY, V15, P273, DOI 10.1111/j.1365-2222.1985.tb02285.x; PAULSEN BS, 1985, INT ARCH ALLER A IMM, V78, P206; RAO PVS, 1985, ASP ALLERGY APPL IMM, V18, P135; SHIVPURI DN, 1980, ASP ALLERGY APPL IMM, V13, P19; SHIVPURI DN, 1969, INDIAN J CHEST DIS, V4, P102; Singer B, 1969, Prog Nucleic Acid Res Mol Biol, V9, P1, DOI 10.1016/S0079-6603(08)60766-7; SINGH AB, 1982, ANN ALLERGY, V48, P115; SMART IJ, 1980, INT ARCH ALLER A IMM, V62, P179, DOI 10.1159/000232510; STRANDHEDE S-O, 1981, Grana, V20, P187; WOODHOUSE RP, 1948, ANN ALLERGY, V6, P358; YUNGINGER JW, 1972, J ALLERGY CLIN IMMUN, V50, P326, DOI 10.1016/0091-6749(72)90036-X	41	17	18	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1987	80	4					562	572		10.1016/0091-6749(87)90008-X	http://dx.doi.org/10.1016/0091-6749(87)90008-X			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5224	3668120				2022-12-18	WOS:A1987K522400008
J	FLEEKOP, PD; ATKINS, PC; VONALLMEN, C; VALENZANO, MC; SHALIT, M; ZWEIMAN, B				FLEEKOP, PD; ATKINS, PC; VONALLMEN, C; VALENZANO, MC; SHALIT, M; ZWEIMAN, B			CELLULAR INFLAMMATORY RESPONSES IN HUMAN ALLERGIC SKIN REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV PENN,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,510 JOHNSON PAVILION,37TH & HAMILTON WALK,PHILADELPHIA,PA 19104	University of Pennsylvania					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332] Funding Source: NIH RePORTER; NIAID NIH HHS [AI14332] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATKINS PC, 1985, J ALLERGY CLIN IMMUN, V75, P239, DOI 10.1016/0091-6749(85)90052-1; ATKINS PC, 1982, J ALLERGY CLIN IMMUN, V69, P39, DOI 10.1016/0091-6749(82)90085-9; BEDARD PM, 1983, J ALLERGY CLIN IMMUN, V71, P394, DOI 10.1016/0091-6749(83)90068-4; COLDITZ IG, 1984, J IMMUNOL, V133, P2169; COLDITZ IG, 1984, J IMMUNOL, V133, P2163; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; KLINE B. S., 1932, JOUR ALLERGY, V3, P531, DOI 10.1016/S0021-8707(32)90148-8; SCHEJA A, 1985, ACTA PATH MICRO IM C, V93, P25; SCHEJA A, 1985, ACTA PATH MICRO IM C, V93, P31; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; TALBOT SF, 1984, J ALLERGY CLIN IMMUN, V74, P819, DOI 10.1016/0091-6749(84)90185-4; WANDALL JH, 1982, ACTA PATH MICRO IM C, V90, P7; WANDALL JH, 1980, ACTA PATH MICRO IM C, V88, P255; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387; ZWEIMAN B, 1976, J ALLERGY CLIN IMMUN, V58, P657, DOI 10.1016/0091-6749(76)90177-9	15	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1987	80	2					140	146		10.1016/0091-6749(87)90122-9	http://dx.doi.org/10.1016/0091-6749(87)90122-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	J6575	3611535	Bronze			2022-12-18	WOS:A1987J657500004
J	SHALIT, M; CAMPBELL, DE; VONALLMEN, C; ATKINS, PC; DOUGLAS, SD; ZWEIMAN, B				SHALIT, M; CAMPBELL, DE; VONALLMEN, C; ATKINS, PC; DOUGLAS, SD; ZWEIMAN, B			NEUTROPHIL ACTIVATION IN HUMAN INFLAMMATORY SKIN REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHILDRENS HOSP,DIV ALLERGY & IMMUNOL,PHILADELPHIA,PA 19104	University of Pennsylvania; Childrens Hospital of Philadelphia	SHALIT, M (corresponding author), UNIV PENN,SCH MED,DEPT ALLERGY & IMMUNOL,509 JOHNSON PAVIL,37TH & HAMILTON WALK,PHILADELPHIA,PA 19104, USA.							ATKINS PC, 1982, J ALLERGY CLIN IMMUN, V69, P39, DOI 10.1016/0091-6749(82)90085-9; BABIOR BM, 1984, BLOOD, V64, P959; BAGGIOLINI M, 1985, INT ARCH ALLER A IMM, V76, P13, DOI 10.1159/000233730; BASS DA, 1986, J IMMUNOL, V136, P860; BASS DA, 1983, J IMMUNOL, V130, P1910; BEDARD PM, 1983, J ALLERGY CLIN IMMUN, V71, P394, DOI 10.1016/0091-6749(83)90068-4; BEHRENS BL, 1985, CHEST, V87, pS153, DOI 10.1378/chest.87.5_Supplement.153S; CARROLL MP, 1985, J ALLERGY CLIN IMMUN, V75, P290, DOI 10.1016/0091-6749(85)90060-0; DECHATELET LR, 1976, BLOOD, V47, P545; ENGLISH D, 1981, BLOOD, V58, P129; FISH JE, 1980, ALLERGIC DISEASES DI, P204; FLEEKOP P, 1986, J ALLERGY CLIN IMMUN, V77, P243; GALLIN JI, 1984, CLIN RES, V32, P320; GAY JC, 1984, BLOOD, V64, P780; GOLDBERG BS, 1979, J INVEST DERMATOL, V72, P248, DOI 10.1111/1523-1747.ep12531707; HIRABAYASHI Y, 1985, J IMMUNOL METHODS, V82, P253, DOI 10.1016/0022-1759(85)90357-6; KLINE B. S., 1932, JOUR ALLERGY, V3, P531, DOI 10.1016/S0021-8707(32)90148-8; MARTIN WJ, 1984, AM REV RESPIR DIS, V130, P209; SHAW JO, 1981, J IMMUNOL, V127, P1250; SUZUKI Y, 1980, J CLIN INVEST, V66, P1409, DOI 10.1172/JCI109994; TALBOT SF, 1985, J CLIN INVEST, V76, P650, DOI 10.1172/JCI112018; VANEPPS DE, 1980, J CLIN INVEST, V66, P167, DOI 10.1172/JCI109841; WEISSMANN G, 1980, NEW ENGL J MED, V303, P27; WILLIAMS AJ, 1981, IMMUNOLOGY, V43, P733; ZIMMERLI W, 1986, J CLIN INVEST, V77, P925, DOI 10.1172/JCI112391; ZWEIMAN B, 1976, J ALLERGY CLIN IMMUN, V58, P657, DOI 10.1016/0091-6749(76)90177-9	26	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1987	80	1					87	93		10.1016/S0091-6749(87)80196-3	http://dx.doi.org/10.1016/S0091-6749(87)80196-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	J2194	3598032				2022-12-18	WOS:A1987J219400014
J	KOENIG, JQ				KOENIG, JQ			PULMONARY REACTION TO ENVIRONMENTAL-POLLUTANTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											KOENIG, JQ (corresponding author), UNIV WASHINGTON, DEPT ENVIRONM HLTH, SC-34, SEATTLE, WA 98105 USA.							ADAMS WC, 1983, J APPL PHYSIOL, V55, P805, DOI 10.1152/jappl.1983.55.3.805; AVOL EL, 1979, AM REV RESPIR DIS, V120, P319; AVOL EL, 1985, AM REV RESPIR DIS, V132, P619; BATES DV, 1983, CAN J PUBLIC HEALTH, V74, P117; BECKETT WS, 1985, J APPL PHYSIOL, V59, P1879, DOI 10.1152/jappl.1985.59.6.1879; BRAIN JD, 1979, AM REV RESPIR DIS, V120, P1325; BROMBERG PA, 1982, AM REV RESPIR DIS, V125, P489, DOI 10.1164/arrd.1982.125.5.489; BYLIN G, 1985, EUR J RESPIR DIS, V66, P205; DAWSON SV, 1979, AM REV RESPIR DIS, V120, P281; Dickens Charles, 1852, BLEAK HOUSE; ESPOSITO JC, 1970, VANISHING AIR, P5; Finlayson-Pitts B.J., 1986, ATMOSPHERIC CHEM; FISCHER P, 1985, INT J EPIDEMIOL, V14, P221, DOI 10.1093/ije/14.2.221; FOLINSBEE LJ, 1984, J APPL PHYSIOL, V57, P984, DOI 10.1152/jappl.1984.57.4.984; FOLINSBEE LJ, 1983, BIOMEDICAL EFFECTS O, V5, P175; FRANK NR, 1969, ARCH ENVIRON HEALTH, V18, P315, DOI 10.1080/00039896.1969.10665414; HACKNEY JD, 1976, ENVIRON HEALTH PERSP, V18, P141, DOI 10.2307/3428696; HARRIES MG, 1981, LANCET, V1, P5; HAZUCHA MJ, 1983, J APPL PHYSIOL, V54, P730, DOI 10.1152/jappl.1983.54.3.730; HOEK G, 1984, INT ARCH OCC ENV HEA, V55, P79, DOI 10.1007/BF00378070; HOLTZMAN MJ, 1979, AM REV RESPIR DIS, V120, P1059; HONICKY RE, 1985, PEDIATRICS, V75, P587; ISAWA T, 1984, J NUCL MED, V25, P447; JAEGER MJ, 1979, LUNG, V156, P119, DOI 10.1007/BF02714000; KIRKPATRICK MB, 1982, AM REV RESPIR DIS, V125, P627; KLEINMAN MT, 1986, J TOXICOL ENV HLTH, V12, P815; KOENIG JQ, 1983, AM REV RESPIR DIS, V128, P221; KOENIG JQ, 1982, J ALLERGY CLIN IMMUN, V69, P339, DOI 10.1016/0091-6749(82)90143-9; KOENIG JQ, 1983, J TOXICOL ENV HEALTH, V11, P129, DOI 10.1080/15287398309530327; KOENIG JQ, 1987, J ALLERGY CLIN IMMUN, V79, P54, DOI 10.1016/S0091-6749(87)80016-7; KOENIG JQ, 1985, J ALLERGY CLIN IMMUN, V76, P813, DOI 10.1016/0091-6749(85)90754-7; KOENIG JQ, 1982, ARCH ENVIRON HEALTH, V37, P5, DOI 10.1080/00039896.1982.10667525; KOENIG JQ, 1981, ENVIRON RES, V25, P340, DOI 10.1016/0013-9351(81)90036-0; KOENIG JQ, 1985, AM REV RESPIR DIS, V132, P648; LAUBE BL, 1986, AM REV RESPIR DIS, V133, P740; LAURITZEN SK, 1985, J APPL PHYSIOL, V59, P1601, DOI 10.1152/jappl.1985.59.5.1601; LEIKAUF G, 1981, AM IND HYG ASSOC J, V42, P273, DOI 10.1080/15298668191419721; LINN WS, 1984, AM REV RESPIR DIS, V129, P234; LINN WS, 1980, AM REV RESPIR DIS, V121, P243; LINN WS, 1985, ENVIRON RES, V37, P445, DOI 10.1016/0013-9351(85)90126-4; LINN WS, 1982, AM REV RESPIR DIS, V125, P658; LINN WS, 1983, AM REV RESPIR DIS, V127, P278; LINN WS, 1983, ENVIRON RES, V30, P340, DOI 10.1016/0013-9351(83)90219-0; LINN WS, 1983, BIOMEDICAL EFFECTS O, V5; LIOY PJ, 1985, JAPCA J AIR WASTE MA, V35, P1068, DOI 10.1080/00022470.1985.10466008; LIPPMANN M, 1977, HDB PHYSL          9; LOGAN WPD, 1953, LANCET, V264, P336; LOWRY T, 1956, JAMA-J AM MED ASSOC, V162, P153, DOI 10.1001/jama.1956.02970200001001; MCDONNELL WF, 1983, J APPL PHYSIOL, V54, P1345, DOI 10.1152/jappl.1983.54.5.1345; MCDONNELL WF, 1985, AM REV RESPIR DIS, V132, P875; MELIA RJW, 1982, INT J EPIDEMIOL, V11, P164, DOI 10.1093/ije/11.2.164; MENZEL DB, 1984, J TOXICOL ENV HEALTH, V13, P183; MILLER FJ, 1984, FUNDAMENTALS EXTRAPO; MORROW PE, 1984, J TOXICOL ENV HEALTH, V13, P205, DOI 10.1080/15287398409530494; MORROW PE, 1975, ENVIRON RES, V10, P92, DOI 10.1016/0013-9351(75)90076-6; MYERS DJ, 1986, AM REV RESPIR DIS, V133, P1154; MYERS DJ, 1986, AM REV RESPIR DIS, V133, P1150; NELSON N, 1986, AM J IND MED, V10, P7, DOI 10.1002/ajim.4700100104; OGSTON SA, 1985, BRIT MED J, V290, P957, DOI 10.1136/bmj.290.6473.957; OREHEK J, 1976, J CLIN INVEST, V57, P301, DOI 10.1172/JCI108281; Phalen RF, 1984, INHALATION STUDIES F; RONDINELLI RCA, IN PRESS AM IND HYG; Schrenk HH, 1949, PUBLIC HLTH B, V306; SHEPPARD D, 1983, ENVIRON RES, V30, P412, DOI 10.1016/0013-9351(83)90227-X; SHEPPARD D, 1981, AM REV RESPIR DIS, V123, P486; SHEPPARD D, 1981, AM REV RESPIR DIS, V124, P257; SHEPPARD D, 1984, AM REV RESPIR DIS, V130, P52; SHY C M, 1970, Journal of the Air Pollution Control Association, V20, P582; SILVERMAN F, 1979, ENVIRON HEALTH PERSP, V29, P131, DOI 10.2307/3429055; SNASHALL PD, 1982, THORAX, V37, P118, DOI 10.1136/thx.37.2.118; SOLIC JJ, 1982, AM REV RESPIR DIS, V125, P664; SPEIZER FE, 1980, AM REV RESPIR DIS, V121, P3; SPEIZER FE, 1966, ARCH ENVIRON HEALTH, V12, P725, DOI 10.1080/00039896.1966.10664471; SPEKTOR DM, 1985, ENVIRON RES, V37, P174, DOI 10.1016/0013-9351(85)90056-8; SVARTENGREN M, 1984, EXP LUNG RES, V7, P257, DOI 10.3109/01902148409087917; SWIFT DL, 1982, ATMOS ENVIRON, V16, P2279, DOI 10.1016/0004-6981(82)90307-9; TAN WC, 1982, THORAX, V37, P671, DOI 10.1136/thx.37.9.671; UTELL MJ, 1983, AM REV RESPIR DIS, V128, P444, DOI 10.1164/arrd.1983.128.3.444; VANHOUDT JJ, 1986, MUTAT RES, V171, P91, DOI 10.1016/0165-1218(86)90040-6; WARE JH, 1984, AM REV RESPIR DIS, V129, P366; WAYNE WS, 1967, J AMER MED ASSOC, V199, P901, DOI 10.1001/jama.199.12.901; 1982, EPA600882029; 1982, EPA600882026; 1984, FED REG, V49, P10408; 1978, EPA600878004	85	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1987	79	6					833	843		10.1016/0091-6749(87)90226-0	http://dx.doi.org/10.1016/0091-6749(87)90226-0			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	H9044	3294974				2022-12-18	WOS:A1987H904400001
J	PHILLIPS, L; CHAMBERS, C; UNDERDOWN, BJ; ZIMMERMAN, B				PHILLIPS, L; CHAMBERS, C; UNDERDOWN, BJ; ZIMMERMAN, B			LYMPHOCYTE-PROLIFERATION TO ANTIGEN-E - DEMONSTRATION OF THE RESTRICTION OF ANTIGEN E-SPECIFIC T-CELLS TO RAGWEED-ALLERGIC DONORS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV TORONTO,HOSP SICK CHILDREN,RES INST,DIV ALLERGY,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT IMMUNOL,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto								ANDERSON JA, 1974, CELL IMMUNOL, V10, P442, DOI 10.1016/0008-8749(74)90135-X; BLACK PL, 1980, J ALLERGY CLIN IMMUN, V66, P394, DOI 10.1016/0091-6749(80)90119-0; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; BROSTOFF J, 1969, LANCET, V2, P1269; BUCKLEY RH, 1977, J ALLERGY CLIN IMMUN, V59, P70, DOI 10.1016/0091-6749(77)90180-4; DIGUCHI H, 1983, J IMMUNOL, V131, P2751; EISENBREY AB, 1985, J ALLERGY CLIN IMMUN, V75, P84; EVANS R, 1976, J CLIN INVEST, V57, P1378, DOI 10.1172/JCI108406; GATIEN JG, 1975, CLIN IMMUNOL IMMUNOP, V4, P32, DOI 10.1016/0090-1229(75)90036-7; GEHA RS, 1975, J CLIN INVEST, V56, P386, DOI 10.1172/JCI108103; GIRARD JP, 1967, J ALLERGY, V39, P65, DOI 10.1016/0021-8707(67)90113-X; GLEICH GJ, 1977, J ALLERGY CLIN IMMUN, V60, P188, DOI 10.1016/0091-6749(77)90123-3; GO S, 1970, LANCET, V1, P1115; GRAMMER L, 1981, INT ARCH ALLER A IMM, V66, P179, DOI 10.1159/000232817; HENSEN EJ, 1979, NATURE, V277, P223, DOI 10.1038/277223a0; HIRASHIMA M, 1980, J IMMUNOL, V125, P1442; ISHIZAKA K, 1981, J IMMUNOL, V126, P1692; ISHIZAKA K, 1967, J IMMUNOL, V99, P1187; ISHIZAKA K, 1976, ADV IMMUNOL, V23, P1, DOI 10.1016/S0065-2776(08)60318-1; KATZ DH, 1982, PROG ALLERGY, V32, P105; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; KISHIMOTO T, 1982, PROG ALLERGY, V32, P265; KISHIMOTO T, 1973, J IMMUNOL, V111, P720; KISHMOTO T, 1975, J IMMUNOL, V114, P1177; LANZAVECCHIA A, 1983, EUR J IMMUNOL, V13, P820, DOI 10.1002/eji.1830131008; LAPKOFF CB, 1974, INT ARCH ALLER A IMM, V46, P215, DOI 10.1159/000231125; LEUNG DYM, 1986, J EXP MED, V163, P713, DOI 10.1084/jem.163.3.713; LEUNG DYM, 1986, J IMMUNOL, V136, P2851; LOWHAGEN O, 1985, J ALLERGY CLIN IMMUN, V75, P460, DOI 10.1016/S0091-6749(85)80018-X; MAINI RN, 1971, CLIN EXP IMMUNOL, V9, P449; MASSIE FS, 1972, ANN ALLERGY, V30, P676; MEUER SC, 1983, SCIENCE, V222, P1239, DOI 10.1126/science.6606228; RAWLE FC, 1984, J IMMUNOL, V133, P195; RICCI M, 1985, INT ARCH ALLER A IMM, V77, P32, DOI 10.1159/000233749; RICHTER M, 1968, J ALLERGY, V41, P140, DOI 10.1016/0021-8707(68)90054-3; ROCKLIN RE, 1980, NEW ENGL J MED, V302, P1213, DOI 10.1056/NEJM198005293022201; ROCKLIN RE, 1974, J CLIN INVEST, V53, P735, DOI 10.1172/JCI107612; SARAFATI M, 1984, IMMUNOLOGY, V53, P197; SAXON A, 1980, J CLIN INVEST, V65, P1457, DOI 10.1172/JCI109810; SLAVIN RG, 1963, J ALLERGY, V34, P368, DOI 10.1016/0021-8707(63)90055-8; SOTOMAYOR H, 1984, AM REV RESPIR DIS, V130, P56; TSUI F, 1984, CELL IMMUNOL, V85, P33; YODOI J, 1982, J IMMUNOL, V128, P289; YODOI J, 1980, J IMMUNOL, V125, P1436; YOUNG SH, 1968, PEDIATRICS, V42, P976; YUNINGER JW, 1973, J ALLERGY CLIN IMMUN, V51, P174; ZEITZ SJ, 1966, J ALLERGY, V38, P321, DOI 10.1016/0021-8707(66)90030-X; ZIMMERMAN B, 1986, J ALLERGY CLIN IMMUN, V77, P70, DOI 10.1016/0091-6749(86)90326-X; ZURAW BL, 1981, J IMMUNOL, V127, P1169	49	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1987	79	6					933	940		10.1016/0091-6749(87)90243-0	http://dx.doi.org/10.1016/0091-6749(87)90243-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	H9044	3495562				2022-12-18	WOS:A1987H904400015
J	SOGN, DD				SOGN, DD			PREVENTION OF ALLERGIC REACTIONS TO PENICILLIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SOGN, DD (corresponding author), NIAID,ALLERGY & CLIN IMMUNOL BRANCH,WESTWOOD BLDG,ROOM 752,BETHESDA,MD 20892, USA.							ADKINSON NF, 1971, NEW ENGL J MED, V285, P22, DOI 10.1056/NEJM197107012850104; ADKINSON NF, 1984, J ALLERGY CLIN IMMUN, V74, P567, DOI 10.1016/0091-6749(84)90108-8; BROWN BC, 1964, JAMA, V189, P87; FELLNER MJ, 1971, J IMMUNOL, V167, P1440; GREEN GR, 1971, J ALLERGY CLIN IMMUN, V48, P331, DOI 10.1016/0091-6749(71)90079-0; IDSOE O, 1968, B WORLD HEALTH ORGAN, V38, P159; JUHLIN L, 1977, INT ARCH ALLER A IMM, V54, P19, DOI 10.1159/000231804; LEVINE BB, 1969, J ALLERGY, V43, P231, DOI 10.1016/0021-8707(69)90066-5; LEVINE BB, 1965, FED PROC, V24, P45; MENDELSON LM, 1984, J ALLERGY CLIN IMMUN, V73, P76, DOI 10.1016/0091-6749(84)90487-1; PARKER CW, 1975, N ENGL J MED, V292, P735; ROSENBLU.AH, 1968, J ALLERGY, V42, P309, DOI 10.1016/0021-8707(68)90093-2; RYTEL MW, 1963, JAMA-J AM MED ASSOC, V186, P108; SAXON A, 1983, Reviews of Infectious Diseases, V5, pS368; SOGN DD, 1983, J ALLERGY CLIN IMMUN, V71, P147, DOI 10.1016/0091-6749(83)90358-5; SOLLEY GO, 1982, J ALLERGY CLIN IMMUN, V69, P238, DOI 10.1016/0091-6749(82)90105-1; STEMBER RH, 1973, J ALLERGY CLIN IMMUN, V5, P100; SULLIVAN TJ, 1981, J ALLERGY CLIN IMMUN, V68, P171, DOI 10.1016/0091-6749(81)90180-9; WARRINGTON RJ, 1978, CAN MED ASSOC J, V118, P787; WICHER K, 1980, J ALLERGY CLIN IMMUN, V66, P155, DOI 10.1016/0091-6749(80)90063-9	20	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			1051	1052		10.1016/0091-6749(86)90303-9	http://dx.doi.org/10.1016/0091-6749(86)90303-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	3782665	Bronze			2022-12-18	WOS:A1986E971900024
J	ARANDA, JV; CHEMTOB, S; LAUDIGNON, N; SASYNIUK, BI				ARANDA, JV; CHEMTOB, S; LAUDIGNON, N; SASYNIUK, BI			PHARMACOLOGICAL EFFECTS OF THEOPHYLLINE IN THE NEWBORN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT PHARMACOL,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT THERAPEUT,MONTREAL H3A 2T5,QUEBEC,CANADA	McGill University; McGill University; McGill University	ARANDA, JV (corresponding author), MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEV PHARMACOL & PERINATAL RES UNIT,2300 TUPPER AVE,MONTREAL H3H 1P3,QUEBEC,CANADA.							ALLAN WC, 1978, PEDIATR RES, V12, P401, DOI 10.1203/00006450-197804001-00231; ANDERSON J, 1966, METABOLIS, V15, P30, DOI 10.1016/0026-0495(66)90006-0; ARANDA JV, 1976, J PEDIATR-US, V89, P833, DOI 10.1016/S0022-3476(76)80819-0; ARANDA JV, 1979, CLIN PERINATOL, V6, P87, DOI 10.1016/S0095-5108(18)31165-5; ARANDA JV, 1981, PEDIATR CLIN N AM, V28, P113; ARANDA JV, 1979, SCIENCE, V206, P1319, DOI 10.1126/science.515734; ATUK NO, 1967, CIRCULATION, V35, P745, DOI 10.1161/01.CIR.35.4.745; BADA HS, 1979, J PEDIATR-US, V94, P993, DOI 10.1016/S0022-3476(79)80247-4; BARR PA, 1978, ARCH DIS CHILD, V53, P598, DOI 10.1136/adc.53.7.598; BARRETT CT, 1976, PEDIATR RES, V10, P621, DOI 10.1203/00006450-197606000-00011; BARRETT CT, 1978, PEDIATR RES, V12, P38, DOI 10.1203/00006450-197801000-00010; BARRETT CT, 1975, PEDIATR RES, V9, P394; BELFORD J, 1962, BIOCHEM PHARMACOL, V11, P987, DOI 10.1016/0006-2952(62)90157-0; BORY C, 1979, J PEDIATR-US, V94, P988, DOI 10.1016/S0022-3476(79)80246-2; BRADY PG, 1975, JOHNS HOPKINS MED J, V136, P251; CHEMTOB S, 1985, PEDIATR RES, V19, pA337, DOI 10.1203/00006450-198504000-01386; CLOZEL M, 1983, PEDIATR RES, V17, P592, DOI 10.1203/00006450-198307000-00015; CORBET AJ, 1978, PEDIATR RES, V12, P797, DOI 10.1203/00006450-197807000-00012; DAVI MJ, 1978, J PEDIATR-US, V92, P91, DOI 10.1016/S0022-3476(78)80084-5; DEMARQUEZ JL, 1978, ARCH FR PEDIATR, V35, P793; DENENBERG VH, 1982, J PHARMACOL EXP THER, V221, P604; DIETRICH J, 1978, CLIN PHARMACOL THER, V24, P474; DREYFUS-BRISAC C, 1970, Developmental Psychobiology, V3, P91, DOI 10.1002/dev.420030203; ENSINCK JW, 1970, J CLIN ENDOCR METAB, V31, P153, DOI 10.1210/jcem-31-2-153; FESSLOVA V, 1984, ACTA PAEDIATR SCAND, V73, P404, DOI 10.1111/j.1651-2227.1994.tb17757.x; GERHARDT T, 1979, PEDIATRICS, V63, P537; GERHARDT T, 1978, PEDIATRICS, V62, P801; GOLDMAN H, 1976, SCIENCE, V192, P1014, DOI 10.1126/science.775637; GRANATI B, 1984, Pediatric Research, V18, p324A, DOI 10.1203/00006450-198404001-01387; GRASSO S, 1970, DIABETES, V19, P837, DOI 10.2337/diab.19.11.837; GROSFELD JL, 1983, J PEDIATR SURG, V18, P80, DOI 10.1016/S0022-3468(83)80278-4; GROSS I, 1977, BIOCHIM BIOPHYS ACTA, V488, P263, DOI 10.1016/0005-2760(77)90183-7; HADJIGEORGIOU E, 1979, AM J OBSTET GYNECOL, V135, P257, DOI 10.1016/0002-9378(79)90355-7; HARKAVY KL, 1979, BIOL NEONATE, V35, P126; HARRIS MC, 1983, J PEDIATR-US, V103, P303, DOI 10.1016/S0022-3476(83)80372-2; HESS ME, 1958, J PHARMACOL EXP THER, V122, P169; HORROBIN DF, 1977, PROSTAGLANDINS, V13, P33, DOI 10.1016/0090-6980(77)90040-5; JONES RAK, 1982, ARCH DIS CHILD, V57, P761, DOI 10.1136/adc.57.10.761; KAROTKIN EH, 1976, PEDIATR RES, V10, P722, DOI 10.1203/00006450-197610080-00004; KUZEMKO JA, 1973, ARCH DIS CHILD, V48, P404, DOI 10.1136/adc.48.5.404; LARCHER VF, 1978, ARCH DIS CHILD, V53, P757, DOI 10.1136/adc.53.9.757; LEACH FN, 1973, J ENDOCRINOL, V59, P65, DOI 10.1677/joe.0.0590065; LIU DTY, 1973, LANCET, V7825, P378; LOUGHNAN PM, 1978, J PEDIATR, V91, P1016; MILSAP RL, 1980, CLIN PHARMACOL THER, V28, P536, DOI 10.1038/clpt.1980.199; NELSON RM, 1980, DEV PHARMACOL THERAP, V1, P274, DOI 10.1159/000455546; NELSON RM, 1981, SEMIN PERINATOL, V5, P370; NILES RM, 1979, J BIOL CHEM, V254, P4325; NOBEL PA, 1977, J PEDIATR-US, V90, P825, DOI 10.1016/S0022-3476(77)81262-6; PARMELEE AH, 1975, BIOL PSYCHIAT, V10, P501; PATWARDHAN RV, 1980, CLIN PHARMACOL THER, V28, P398, DOI 10.1038/clpt.1980.179; PEABODY JL, 1978, PEDIATRICS, V62, P698; RALL TW, 1985, PHARMACOL BASIS THER, P589; ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403; ROOKLIN AR, 1979, J PEDIATR-US, V95, P882, DOI 10.1016/S0022-3476(79)80459-X; ROSENKRANTZ TS, 1984, AM J DIS CHILD, V138, P489, DOI 10.1001/archpedi.1984.02140430065017; ROTHBERG AD, 1981, PEDIATR PHARMACOL, V1, P181; SANOCHA UM, 1981, PEDIATR RES 2, V15, P4; SEVANIAN A, 1979, PEDIATR RES, V13, P1336, DOI 10.1203/00006450-197912000-00007; SHANNON DC, 1979, J PEDIATR-US, V94, P963, DOI 10.1016/S0022-3476(79)80235-8; SHANNON DC, 1975, PEDIATRICS, V55, P589; SHANNON DC, 1975, PEDIATRICS, V56, P619; SIGURD B, 1978, ACTA MED SCAND, V203, P113; SIMONS FER, 1980, AM J DIS CHILD, V134, P39, DOI 10.1001/archpedi.1980.02130130031009; SOURGENS H, 1983, PEDIATR PHARMACOL, V3, P267; SPINDEL E, 1980, J PHARMACOL EXP THER, V214, P58; SRINIVASAN G, 1981, J PEDIATR-US, V98, P815, DOI 10.1016/S0022-3476(81)80855-4; STEINER AL, 1969, J CLIN INVEST, V48, pA80; STONESTREET BS, 1983, DEV PHARMACOL THERAP, V6, P248, DOI 10.1159/000457311; THOMAN EB, 1985, NEUROPEDIATRICS, V16, P13, DOI 10.1055/s-2008-1052537; TUMEN T, 1981, SEMIN PERINATOL, V5, P326; UAUY R, 1975, PEDIATRICS, V55, P595; WECHSLER RL, 1950, J CLIN INVEST, V29, P28, DOI 10.1172/JCI102230; WELLS DH, 1979, PEDIATRICS, V64, P252; ZAHAUDDIN S, 1976, CLIN RES, V24, P196	75	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	2				773	780		10.1016/0091-6749(86)90060-6	http://dx.doi.org/10.1016/0091-6749(86)90060-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5684	3534058				2022-12-18	WOS:A1986E568400018
J	BERNSTEIN, IL; HARGREAVE, FE; NICKLAS, RA; REED, CE				BERNSTEIN, IL; HARGREAVE, FE; NICKLAS, RA; REED, CE			REPORT OF THE AAAI TASK-FORCE ON GUIDELINES FOR CLINICAL INVESTIGATION OF NONBRONCHODILATOR ANTIASTHMATIC DRUGS - PREFACE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									MCMASTER UNIV,SCH MED,HAMILTON L8S 4L8,ONTARIO,CANADA; US FDA,BETHESDA,MD 20014; MAYO MED SCH,ROCHESTER,MN 55901	McMaster University; US Food & Drug Administration (FDA); Mayo Clinic	BERNSTEIN, IL (corresponding author), UNIV CINCINNATI,MED CTR,CINCINNATI,OH 45267, USA.								0	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	2				489	490		10.1016/0091-6749(86)90093-X	http://dx.doi.org/10.1016/0091-6749(86)90093-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1151		Bronze			2022-12-18	WOS:A1986E115100001
J	CHAPMAN, MD; MARSHALL, NA; SAXON, A				CHAPMAN, MD; MARSHALL, NA; SAXON, A			IDENTIFICATION AND PARTIAL-PURIFICATION OF SPECIES-SPECIFIC ALLERGENS FROM TRIATOMA-PROTRACTA (HETEROPTERA, REDUVIIDAE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV VIRGINIA,DEPT MED,DIV ALLERGY,BOX 225,CHARLOTTESVILLE,VA 22908; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV CLIN IMMUNOL ALLERGY,LOS ANGELES,CA 90024	University of Virginia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA				Chapman, Martin/0000-0002-0845-3632	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015251, P50AI015332, R21AI015251] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-15251, AI-15332] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHAPMAN MD, 1980, J IMMUNOL, V125, P587; Jones JP., 1962, CALIF VECTOR VIEWS, V9, P33; LINDBERG RE, 1981, FED PROC, V40, P970; LINDBERG RE, 1981, J ALLERGY CLIN IMMUN, V67, P25; LYNCH PJ, 1978, CUTIS, V22, P585; MARSHALL N, 1986, J MED ENTOMOL, V23, P117, DOI 10.1093/jmedent/23.2.117; MARSHALL NA, 1986, J ALLERGY CLIN IMMUN, V78, P430, DOI 10.1016/0091-6749(86)90029-1; MARSHALL NA, 1982, J MED ENTOMOL, V19, P248, DOI 10.1093/jmedent/19.3.248; PINNAS JL, 1978, FED PROC, V37, P1555; ROHR AS, 1984, J ALLERGY CLIN IMMUN, V73, P369, DOI 10.1016/0091-6749(84)90410-X; Ryckman R.E., 1979, CALIFORNIA VECTOR VIEWS, V26, P1; SWEZEY RL, 1963, ARCH INTERN MED, V112, P977, DOI 10.1001/archinte.1963.03860060189021	12	17	18	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	1				436	442		10.1016/0091-6749(86)90030-8	http://dx.doi.org/10.1016/0091-6749(86)90030-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1148	3531292				2022-12-18	WOS:A1986E114800011
J	HARGREAVE, FE; FINK, JN				HARGREAVE, FE; FINK, JN			WORKSHOP 4 - THE ROLE OF BRONCHOPROVOCATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL WISCONSIN, MILWAUKEE, WI 53226 USA	Medical College of Wisconsin	HARGREAVE, FE (corresponding author), MCMASTER UNIV, HAMILTON L8S 4L8, ONTARIO, CANADA.							ADELROTH E, N ENGL J MED; BARNES PJ, 1981, J ALLERGY CLIN IMMUN, V68, P411, DOI 10.1016/0091-6749(81)90193-7; BOOIJNOORD H, 1971, J ALLERGY CLIN IMMUN, V48, P344, DOI 10.1016/0091-6749(71)90080-7; CARTIER A, 1983, J APPL PHYSIOL, V54, P821, DOI 10.1152/jappl.1983.54.3.821; CORRIS PA, 1983, AM REV RESPIR DIS, V128, P991; CUSHLEY MJ, 1985, J ALLERGY CLIN IMMUN, V75, P272, DOI 10.1016/0091-6749(85)90057-0; DAVIES RJ, 1984, ALLERGY IMMUNOLOGICA, P83; FAIRFAX AJ, 1983, CLIN EXP IMMUNOL, V52, P393; FISH JE, 1979, J ALLERGY CLIN IMMUN, V64, P592, DOI 10.1016/0091-6749(79)90019-8; GODFREY S, 1976, THORAX, V31, P137, DOI 10.1136/thx.31.2.137; GODFREY S, 1983, ASTHMA, P415; GRIFFIN M, 1983, NEW ENGL J MED, V308, P436, DOI 10.1056/NEJM198302243080807; HARDY CC, 1984, NEW ENGL J MED, V311, P209, DOI 10.1056/NEJM198407263110401; HARGREAVE FE, 1985, CHEST, V87, pS202, DOI 10.1378/chest.87.5_Supplement.202S; HARGREAVE FE, 1983, SEMIN RESPIR MED, V4, P224, DOI 10.1055/s-2007-1012487; HARGREAVE FE, 1985, AIRWAY RESPONSIVENES; HARGREAVE FE, 1980, AIRWAY REACTIVITY ME, P145; HARGREAVE FE, 1984, ASTHMA PHYSL IMMUNOP, P263; JOUBERT JR, 1985, ALLERGY, V40, P202, DOI 10.1111/j.1398-9995.1985.tb00217.x; JUNIPER EF, 1986, J ALLERGY CLIN IMMUN, V78, P387, DOI 10.1016/0091-6749(86)90022-9; LAUBE BL, 1985, J ALLERGY CLIN IMMUN, V76, P708, DOI 10.1016/0091-6749(85)90675-X; LOWHAGEN O, 1985, J ALLERGY CLIN IMMUN, V75, P460, DOI 10.1016/S0091-6749(85)80018-X; OBRYNE PM, 1983, AM REV RESPIR DIS, V128, P611; OBYRNE PM, 1982, THORAX, V37, P913, DOI 10.1136/thx.37.12.913; PEPYS J, 1968, LANCET, V2, P134; PHILLIPS MJ, 1984, THORAX, V39, P345, DOI 10.1136/thx.39.5.345; ROSENTHAL RR, 1984, J ALLERGY CLIN IMMUN, V73, P676, DOI 10.1016/0091-6749(84)90304-X; RUFFIN RE, 1981, J ALLERGY CLIN IMMUN, V67, P285, DOI 10.1016/0091-6749(81)90023-3; RYAN G, 1985, J ALLERGY CLIN IMMUN, V75, P25, DOI 10.1016/0091-6749(85)90007-7; SCOTT GC, 1985, AM REV RESPIR DIS, V132, P268; SOTOMAYOR H, 1984, AM REV RESPIR DIS, V130, P56; THOMSON NC, 1981, J ALLERGY CLIN IMMUN, V68, P392, DOI 10.1016/0091-6749(81)90138-X	32	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	2				517	524		10.1016/0091-6749(86)90098-9	http://dx.doi.org/10.1016/0091-6749(86)90098-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1151		Bronze			2022-12-18	WOS:A1986E115100006
J	RAULS, DO; TING, S; LUND, M				RAULS, DO; TING, S; LUND, M			ANALYSIS OF PLASMA HISTAMINE - A MODIFICATION OF THE ENZYMATIC ISOTOPIC ASSAY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WILLIAM BEAUMONT ARMY MED CTR,DEPT CLIN INVEST,ALLERGY IMMUNOL SERV,EL PASO,TX 79920; WILLIAM BEAUMONT ARMY MED CTR,DEPT MED,DIV ALLERGY IMMUNOL,EL PASO,TX 79920	William Beaumont Army Medical Center; William Beaumont Army Medical Center								BEAVEN MA, 1978, HDB EXPT PHARMACOLOG, V18, P151; BROWN MJ, 1982, J ALLERGY CLIN IMMUN, V69, P20, DOI 10.1016/0091-6749(82)90082-3; DYER J, 1982, J ALLERGY CLIN IMMUN, V70, P82, DOI 10.1016/0091-6749(82)90233-0; SHAFF RE, 1979, ANAL BIOCHEM, V94, P425, DOI 10.1016/0003-2697(79)90385-3; SHORE PA, 1971, METHODS BIOCH ANAL S, V89; VERBURG KM, 1984, LIFE SCI, V35, P241, DOI 10.1016/0024-3205(84)90107-3; VERBURG KM, 1983, LIFE SCI, V32, P2855, DOI 10.1016/0024-3205(83)90322-3	7	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1986	77	5					673	676		10.1016/0091-6749(86)90407-0	http://dx.doi.org/10.1016/0091-6749(86)90407-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	C3903	3700889				2022-12-18	WOS:A1986C390300005
J	POSTMA, DS; KOETER, GH; KEYZER, JJ; MEURS, H				POSTMA, DS; KOETER, GH; KEYZER, JJ; MEURS, H			INFLUENCE OF SLOW-RELEASE TERBUTALINE ON THE CIRCADIAN VARIATION OF CATECHOLAMINES, HISTAMINE, AND LUNG-FUNCTION IN NONALLERGIC PATIENTS WITH PARTLY REVERSIBLE AIR-FLOW OBSTRUCTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									STATE UNIV GRONINGEN HOSP,DEPT ALLERGOL,9713 EZ GRONINGEN,NETHERLANDS; STATE UNIV GRONINGEN HOSP,CENT LAB CLIN CHEM,9713 EZ GRONINGEN,NETHERLANDS; STATE UNIV GRONINGEN HOSP,INTERNAL MED CLIN,9713 EZ GRONINGEN,NETHERLANDS	University of Groningen; University of Groningen; University of Groningen	POSTMA, DS (corresponding author), STATE UNIV GRONINGEN HOSP,DEPT PULMONOL,59 OOSTERSINGEL,9713 EZ GRONINGEN,NETHERLANDS.							BARNES P, 1980, NEW ENGL J MED, V303, P263, DOI 10.1056/NEJM198007313030506; CLARK TJH, 1980, NEW ENGL J MED, V303, P1300; FINDLAY SR, 1980, AM REV RESPIR DIS, V122, P53; HETZEL MR, 1979, THORAX, V34, P749, DOI 10.1136/thx.34.6.749; IND PW, 1983, CLIN ALLERGY, V13, P61, DOI 10.1111/j.1365-2222.1983.tb02568.x; KALES A, 1970, J ALLERGY, V46, P300, DOI 10.1016/0021-8707(70)90070-5; KEYZER JJ, 1983, NEW ENGL J MED, V309, P1603, DOI 10.1056/NEJM198312293092603; KEYZER JJ, 1983, BIOMED MASS SPECTROM, V10, P480, DOI 10.1002/bms.1200100807; KEYZER JJ, 1981, CLIN CHIM ACTA, V113, P165, DOI 10.1016/0009-8981(81)90150-9; KEYZER JJ, 1983, J CHROMATOGR, V275, P261, DOI 10.1016/S0378-4347(00)84373-X; KEYZER JJ, 1984, AGENTS ACTIONS, V5, P189; LEFERINK JG, 1977, J CHROMATOGR, V143, P299, DOI 10.1016/S0378-4347(00)81810-1; PERSSON H, 1970, ACTA MED SCAND S, V512, P11; POSTMA DS, 1985, CLIN SCI, V69, P251, DOI 10.1042/cs0690251; REINBERG A, 1972, B PHYSIO-PATHOL RESP, V8, P663; REINBERG A, 1963, J ALLERGY, V34, P323, DOI 10.1016/0021-8707(63)90049-2; SMEDES F, 1982, J CHROMATOGR, V231, P25, DOI 10.1016/S0378-4347(00)80506-X; SOUTAR CA, 1975, THORAX, V30, P436, DOI 10.1136/thx.30.4.436; TURNERWARWICK M, 1977, BRIT J DIS CHEST, V71, P73, DOI 10.1016/0007-0971(77)90086-9; VANDERHEIJDEN PJC, 1980, BR J PHARM, V68, P152; WESTERINK BHC, 1982, CLIN CHEM, V28, P1745; ZAAGSMA J, 1984, RECEPTORS COLD, P16	22	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1986	77	3					471	477		10.1016/0091-6749(86)90182-X	http://dx.doi.org/10.1016/0091-6749(86)90182-X			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A5367	3512664				2022-12-18	WOS:A1986A536700011
J	KAY, AB; WARDLAW, AJ; COLLINS, JV; DUNNETTE, S; GLEICH, GJ				KAY, AB; WARDLAW, AJ; COLLINS, JV; DUNNETTE, S; GLEICH, GJ			EOSINOPHIL AND MAJOR BASIC-PROTEIN IN BRONCHO ALVEOLAR-LAVAGE IN ASTHMA - RELATIONSHIP TO NONSPECIFIC HYPERREACTIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									BROMPTON HOSP,INST CARDIOTHORAC,LONDON SW3 6HP,ENGLAND; MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905	Royal Brompton Hospital; Mayo Clinic									0	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			236	236						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800458
J	PAULL, BR; COGHLAN, TH				PAULL, BR; COGHLAN, TH			FIRE ANT ALLERGY - WHOLE-BODY EXTRACT TREATMENT FAILURES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			141	141						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800083
J	PIPKORN, U; PROUD, D; SCHLEIMER, RP; PETERS, SP; ADKINSON, NF; KAGEYSOBOTKA, A; NORMAN, PS; LICHTENSTEIN, LM; NACLERIO, RM				PIPKORN, U; PROUD, D; SCHLEIMER, RP; PETERS, SP; ADKINSON, NF; KAGEYSOBOTKA, A; NORMAN, PS; LICHTENSTEIN, LM; NACLERIO, RM			EFFECT OF SYSTEMIC GLUCOCORTICOID TREATMENT ON HUMAN NASAL MEDIATOR RELEASE AFTER ANTIGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			180	180						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800236
J	THOMAS, RHM; BROWNE, PD; KIRBY, JDT				THOMAS, RHM; BROWNE, PD; KIRBY, JDT			THE EFFECT OF RANITIDINE, ALONE AND IN COMBINATION WITH CLEMASTINE, ON ALLERGEN-INDUCED CUTANEOUS WHEAL-AND-FLARE REACTIONS IN HUMAN-SKIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ST BARTHOLOMEWS HOSP,DEPT COMP SERV,LONDON EC1A 7BE,ENGLAND	University of London; Queen Mary University London	THOMAS, RHM (corresponding author), ST BARTHOLOMEWS HOSP,DEPT DERMATOL,LONDON EC1A 7BE,ENGLAND.							BERTACCINI G, 1983, ITAL J GASTROENTEROL, V15, P51; BROOKS CD, 1982, J ALLERGY CLIN IMMUN, V70, P373, DOI 10.1016/0091-6749(82)90027-6; COOK LJ, 1979, BR J DERMATOL S17, V101, P20; HIGHET AS, 1979, BRIT J DERMATOL, V101, P51, DOI 10.1111/j.1365-2133.1979.tb15292.x; JOHNSON CE, 1984, CLIN PHARMACY, V3, P60; LICHTENSTEIN LM, 1973, NATURE, V244, P287, DOI 10.1038/244287a0; MARKS R, 1977, BRIT J CLIN PHARMACO, V4, P367, DOI 10.1111/j.1365-2125.1977.tb00725.x; PEDEN NR, 1979, LANCET, V2, P199; PHILLIPS MJ, 1983, BRIT J CLIN PHARMACO, V15, P277, DOI 10.1111/j.1365-2125.1983.tb01500.x; ROBERTSON I, 1978, BRIT J CLIN PHARMACO, V5, P319, DOI 10.1111/j.1365-2125.1978.tb01714.x; SMITH JA, 1980, J ALLERGY CLIN IMMUN, V65, P118, DOI 10.1016/0091-6749(80)90195-5; SQUIRE JR, 1950, CLINICAL SCIENCE, V9, P129; SUMMERS R, 1981, J ALLERGY CLIN IMMUN, V67, P456, DOI 10.1016/0091-6749(81)90099-3; TING S, 1981, J ALLERGY CLIN IMMUN, V68, P65, DOI 10.1016/0091-6749(81)90125-1; TUNG R, 1982, J IMMUNOL, V129, P2113	15	17	17	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1985	76	6					864	869		10.1016/0091-6749(85)90761-4	http://dx.doi.org/10.1016/0091-6749(85)90761-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AWX93	4067134				2022-12-18	WOS:A1985AWX9300017
J	DVORACEK, JE; HILLIS, A; ROSSING, RG				DVORACEK, JE; HILLIS, A; ROSSING, RG			COMPARISON OF SEQUENTIAL ANTERIOR AND POSTERIOR RHINOMANOMETRY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SCOTT & WHITE MEM HOSP,TEMPLE,TX 76501; SCOTT SHERWOOD & BRINDLEY FDN,TEMPLE,TX; TEXAS A&M UNIV,COLL MED,DEPT MED & MED MICROBIOL,COLLEGE STN,TX 77843; TEXAS A&M UNIV,COLL MED,DEPT IMMUNOL,COLLEGE STN,TX 77843; TEXAS A&M UNIV,COLL MED,DEPT STAT,COLLEGE STN,TX 77843; OLIN TEAGUE VET CTR,TEMPLE,TX	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station								BROMS P, 1982, ACTA OTO-LARYNGOL, V93, P455, DOI 10.3109/00016488209130904; BUTLER J, 1960, CLIN SCI, V19, P55; Cochran WG, 1957, EXPT DESIGNS; CONNELL JT, 1982, ANN ALLERGY, V49, P179; CRAIG AB, 1965, ANN OTO RHINOL LARYN, V74, P589, DOI 10.1177/000348946507400301; DVORACEK JE, 1984, J ALLERGY CLIN IMMUN, V73, P363, DOI 10.1016/0091-6749(84)90409-3; HAIGHT JSJ, 1983, LARYNGOSCOPE, V93, P49; Hamilton L H, 1979, Physiologist, V22, P43; HASEGAWA M, 1979, ANN OTO RHINOL LARYN, V88, P66, DOI 10.1177/000348947908800111; HASEGAWA M, 1977, MAYO CLIN PROC, V52, P28; MCCLEAN JA, 1976, J ALLERGY CLIN IMMUN, V57, P153; NOLTE D, 1973, RESPIRATION, V30, P338; SOLOMON WR, 1965, J ALLERGY, V36, P62, DOI 10.1016/0021-8707(65)90033-X	13	17	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	4					577	582		10.1016/0091-6749(85)90778-X	http://dx.doi.org/10.1016/0091-6749(85)90778-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ATH66	4056245				2022-12-18	WOS:A1985ATH6600009
J	LAUBE, BL; ADAMS, GK; NORMAN, PS; ROSENTHAL, RR				LAUBE, BL; ADAMS, GK; NORMAN, PS; ROSENTHAL, RR			THE EFFECT OF INSPIRATORY FLOW-RATE REGULATION ON NEBULIZER OUTPUT AND ON HUMAN AIRWAY RESPONSE TO METHACHOLINE AEROSOL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									JOHNS HOPKINS UNIV,SCH MED,DIV ALLERGY & CLIN IMMUNOL,BALTIMORE,MD 21205	Johns Hopkins University					NIAID NIH HHS [AI 10304] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CROPP GJA, 1980, ATS NEWS         SPR, P11; DOLOVICH M, 1981, CHEST, V80, P911; DOLOVICH MB, 1977, AM REV RESPIR DIS, V115, P397; LAUBE BL, 1984, AEROSOL SCI TECH, V3, P97, DOI 10.1080/02786828408958997; Mercer T. T., 1970, J AEROSOL SCI, V1, P9; NEWMAN SP, 1981, CHEST, V80, P909; RILEY DJ, 1979, CHEST, V76, P501, DOI 10.1378/chest.76.5.501; RUFFIN RE, 1978, AM REV RESPIR DIS, V117, P485	9	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	5					708	713		10.1016/0091-6749(85)90675-X	http://dx.doi.org/10.1016/0091-6749(85)90675-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AUU34	3902941	Bronze			2022-12-18	WOS:A1985AUU3400009
J	LEVINSON, AI; HOXIE, JA; KORNSTEIN, MJ; ZEMBRYKI, D; MATTHEWS, DM; SCHREIBER, AD				LEVINSON, AI; HOXIE, JA; KORNSTEIN, MJ; ZEMBRYKI, D; MATTHEWS, DM; SCHREIBER, AD			ABSENCE OF THE OKT4 EPITOPE ON BLOOD T-CELLS AND THYMUS-CELLS IN A PATIENT WITH THYMOMA, HYPOGAMMAGLOBULINEMIA, AND RED BLOOD-CELL APLASIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV PENN,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19104; VET ADM MED CTR,CTR RHEUMATOL IMMUNOL,PHILADELPHIA,PA 19104	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA)	LEVINSON, AI (corresponding author), UNIV PENN,SCH MED,515 JOHNSON PAVIL,36TH & HAMILTON WALK,PHILADELPHIA,PA 19104, USA.				NHLBI NIH HHS [HL 28207] Funding Source: Medline; NIAID NIH HHS [AI 22193] Funding Source: Medline; NINDS NIH HHS [NS 19546] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028207, R37HL028207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI022193, R01AI022193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019546] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BACH MA, 1981, J IMMUNOL, V127, P980; BIDDISON WE, 1982, J EXP MED, V156, P1065, DOI 10.1084/jem.156.4.1065; BIDDISON WE, 1983, J IMMUNOL, V131, P152; FULLER TC, 1984, HUM IMMUNOL, V9, P89, DOI 10.1016/0198-8859(84)90031-4; FULLER TC, 1982, HUM IMMUNOL, V5, P151, DOI 10.1016/0198-8859(82)90078-7; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; KAROL RA, 1984, J CLIN IMMUNOL, V4, P71, DOI 10.1007/BF00915290; KORNSTEIN MJ, 1984, LAB INVEST, V50, pA32; KOTZIN BL, 1981, J IMMUNOL, V127, P931; KRENSKY AM, 1982, J IMMUNOL, V129, P2001; KRENSKY AM, 1982, P NATL ACAD SCI-BIOL, V79, P2365, DOI 10.1073/pnas.79.7.2365; LEDBETTER JA, 1981, J EXP MED, V153, P310, DOI 10.1084/jem.153.2.310; LEVINSON AI, 1983, INFECT IMMUN, V39, P290, DOI 10.1128/IAI.39.1.290-296.1983; LISAK RP, 1983, NEUROLOGY, V33, P868, DOI 10.1212/WNL.33.7.868; MEUER SC, 1983, J IMMUNOL, V131, P186; MEUER SC, 1982, P NATL ACAD SCI-BIOL, V79, P4395, DOI 10.1073/pnas.79.14.4395; RAO PE, 1983, CELL IMMUNOL, V80, P310, DOI 10.1016/0008-8749(83)90119-3; REINHERZ EL, 1982, J IMMUNOL, V128, P463; REINHERZ EL, 1979, J IMMUNOL, V123, P2894; REINHERZ EL, 1983, IMMUNOL REV, V74, P83, DOI 10.1111/j.1600-065X.1983.tb01085.x; REINHERZ EL, 1979, P NATL ACAD SCI USA, V76, P4062; ROGOZINSKI L, 1984, J IMMUNOL, V132, P735; RUMKE HC, 1982, J IMMUNOL, V128, P696; SATO M, 1984, J IMMUNOL, V132, P1071; SIEGAL FP, 1977, J IMMUNOL, V118, P642; THOMAS Y, 1980, J IMMUNOL, V125, P2402; ZINKERNAGEL RM, 1978, IMMUNOL REV, V42, P224, DOI 10.1111/j.1600-065X.1978.tb00264.x	27	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	3					433	439		10.1016/0091-6749(85)90723-7	http://dx.doi.org/10.1016/0091-6749(85)90723-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ARC09	2411777				2022-12-18	WOS:A1985ARC0900003
J	MCFADDEN, ER				MCFADDEN, ER			CLINICAL USE OF BETA-ADRENERGIC AGONISTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV HOSP CLEVELAND,DEPT MED,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH 44106	University Hospitals of Cleveland; Case Western Reserve University	MCFADDEN, ER (corresponding author), UNIV HOSP CLEVELAND,CTR ASTHMA & ALLERG DIS,2074 ABINGTON RD,CLEVELAND,OH 44106, USA.							ALHILLAWI AH, 1984, BRIT MED J, V288, P367, DOI 10.1136/bmj.288.6414.367; BANNER AS, 1979, ARCH INTERN MED, V139, P434, DOI 10.1001/archinte.139.4.434; BENGTSSON B, 1982, CLIN PHARMACOL THER, V31, P726, DOI 10.1038/clpt.1982.102; BESWICK K, 1975, PRACTITIONER, V214, P561; BOURDILLON PDV, 1980, BR HEART J, V43, P266; COADY TJ, 1976, PRACTITIONER, V217, P273; CROMPTON GK, 1982, EUR J RESPIR DIS, V63, P101; DAWSON JR, 1980, BRIT HEART J, V43, P523; FANTA CH, 1982, AM J MED, V72, P416, DOI 10.1016/0002-9343(82)90498-3; HARVEY JE, 1982, THORAX, V37, P280, DOI 10.1136/thx.37.4.280; JOSEPHSON GW, 1980, CHEST, V78, P429, DOI 10.1378/chest.78.3.429; KALLENBACH J, 1979, SCAND J RESPIR DIS, V60, P44; KELLING JS, 1983, CHEST, V83, P612, DOI 10.1378/chest.83.4.612; LARSSON S, 1977, AM REV RESPIR DIS, V116, P861; LARSSON S, 1977, J ALLERGY CLIN IMMUN, V59, P93, DOI 10.1016/0091-6749(77)90209-3; LEFERINK JG, 1981, ANAL CLIN PHARM TOXI, P117; LEITCH AG, 1976, BRIT MED J, V1, P365, DOI 10.1136/bmj.1.6006.365; LESLIE D, 1977, BRIT MED J, V3, P768; LOURIDAS G, 1983, RESPIRATION, V44, P439, DOI 10.1159/000194582; MCFADDEN ER, 1981, J ALLERGY CLIN IMMUN, V68, P91, DOI 10.1016/0091-6749(81)90164-0; NELSON HS, 1977, AM REV RESPIR DIS, V116, P871; NOGRADY SG, 1977, THORAX, V32, P559, DOI 10.1136/thx.32.5.559; PRIOR J G, 1981, British Medical Journal, V282, P1932; ROSSING TH, 1983, AM J MED, V75, P781, DOI 10.1016/0002-9343(83)90407-2; ROSSING TH, 1981, AM REV RESPIR DIS, V123, P190; ROSSING TH, 1980, AM REV RESPIR DIS, V122, P365; SHIM C, 1980, AM J MED, V69, P891, DOI 10.1016/S0002-9343(80)80016-7; SHIM C, 1980, ANN INTERN MED, V93, P428; Solis-Cohen S., 1900, J AM MED ASS, V34, P1164, DOI [10.1001/jama.1900.24610190014001c, DOI 10.1001/JAMA.1900.24610190014001C]; SVEDMYR K, 1977, SCAND J RESPIR  S139, V101, P46; TATTERSFIELD AE, 1982, PHARMACOL THERAPEUT, V17, P299, DOI 10.1016/0163-7258(82)90019-5; THIRINGER G, 1976, SCAND J RESPIR DIS, V57, P17; WANG RYC, 1983, J CLIN PHARMACOL, V23, P355, DOI 10.1002/j.1552-4604.1983.tb02748.x; WANG RYC, 1983, J CLIN PHARMACOL, V23, P362, DOI 10.1002/j.1552-4604.1983.tb02749.x; WEBB J, 1982, BRIT J DIS CHEST, V76, P351, DOI 10.1016/0007-0971(82)90069-9; WEBBER RW, 1982, J ALLERGY CLIN IMMUN, V70, P417; WEEKE ER, 1982, EUR J RESPIR DIS, V63, P105; WILLIAMS S, 1977, THORAX, V32, P555, DOI 10.1136/thx.32.5.555; WILLIAMS SJ, 1981, THORAX, V36, P629, DOI 10.1136/thx.36.8.629	39	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	2					352	356		10.1016/0091-6749(85)90653-0	http://dx.doi.org/10.1016/0091-6749(85)90653-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	APE89	2862175	Bronze			2022-12-18	WOS:A1985APE8900017
J	MIDDLETON, E				MIDDLETON, E			CALCIUM-ANTAGONISTS AND ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY BUFFALO,DEPT MED,DIV ALLERGY CLIN IMMUNOL,BUFFALO,NY 14260; SUNY BUFFALO,DEPT PEDIAT,BUFFALO,NY 14260	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								BARNES PJ, 1981, THORAX, V36, P726, DOI 10.1136/thx.36.10.726; BEDARD R M, 1984, Journal of Allergy and Clinical Immunology, V73, P166; BOSTROM SL, 1981, NATURE, V292, P777, DOI 10.1038/292777a0; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; BRUGMAN TM, 1983, AM REV RESPIR DIS, V127, P14, DOI 10.1164/arrd.1983.127.1.14; CARROLL MP, 1985, J ALLERGY CLIN IMMUN, V75, P290, DOI 10.1016/0091-6749(85)90060-0; CERRINA J, 1981, AM REV RESPIR DIS, V123, P156; Cheung W.Y., 1980, CALCIUM CELL FUNCTIO, V1; CORRIS PA, 1983, AM REV RESPIR DIS, V128, P991; CUMELLA J, 1983, J ALLERGY CLIN IMMUN, V71, P94, DOI 10.1016/0091-6749(83)90145-8; CUSS FM, J ALLERGY CLIN IMMUN; DOUGLAS WW, 1981, J PHYSL, V23, P229; DOUGLAS WW, 1978, CIBA F S, V54, P61; ELIRAZ A, 1984, ANN ALLERGY, V52, P125; ENNIS M, 1983, AGENTS ACTIONS, V13, P144, DOI 10.1007/BF01967319; FANTA CH, 1982, AM REV RESPIR DIS, V125, P61; FANTA CH, 1983, BR J PHARM, V78, P687; HARDY CC, 1984, NEW ENGL J MED, V311, P210; HENDERSON AF, 1983, THORAX, V38, P512, DOI 10.1136/thx.38.7.512; HENDERSON AF, 1983, AM REV RESPIR DIS, V127, P549, DOI 10.1164/arrd.1983.127.5.549; HIDAKA H, 1979, MOL PHARMACOL, V15, P49; KNAUER KA, 1981, NEW ENGL J MED, V304, P1404, DOI 10.1056/NEJM198106043042307; MALIK S, 1982, THORAX, V32, P230; MALO PE, 1982, J PHARMACOL EXP THER, V221, P410; MCINTYRE E, 1983, J ALLERGY CLIN IMMUN, V71, P375, DOI 10.1016/0091-6749(83)90065-9; MEARES RA, 1971, MED J AUSTRALIA, V2, P25, DOI 10.5694/j.1326-5377.1971.tb50396.x; MIADONNA A, 1983, ANN ALLERGY, V51, P201; MIDDLETON E, 1981, BIOCHEM PHARMACOL, V30, P2867, DOI 10.1016/0006-2952(81)90428-7; MIDDLETON E, 1980, J PHARM SCI-US, V69, P243, DOI 10.1002/jps.2600690244; MIDDLETON E, 1984, J ALLERGY CLIN IMMUN, V73, P643, DOI 10.1016/0091-6749(84)90298-7; MUELLER E, 1979, NATURE, V281, P682, DOI 10.1038/281682a0; NORN S, 1983, EUR J RESPIR DIS, V64, P394; PATAKAS D, 1983, J ALLERGY CLIN IMMUN, V72, P269, DOI 10.1016/0091-6749(83)90031-3; PATEL KR, 1982, CLIN ALLERGY, V12, P15; PATEL KR, 1983, CLIN ALLERGY, V13, P119, DOI 10.1111/j.1365-2222.1983.tb02578.x; POPA VT, 1983, AM REV RESPIR DIS, V127, P675; RUSSI EW, 1983, AM REV RESPIR DIS, V127, P675; SOLWAY J, 1983, AM REV RESPIR DIS, V127, P92; TANIZAKI Y, 1983, INT ARCH ALLER A IMM, V72, P102, DOI 10.1159/000234850; TRIGGLE DJ, 1980, CHEST, V78, P174, DOI 10.1378/chest.78.1_Supplement.174; WEISS B, 1980, CALMODULIN CELL FUNC, P319; WEISS EB, 1982, ALLERGY, V37, P513, DOI 10.1111/j.1398-9995.1982.tb02334.x; WILLIAMS DO, 1981, BRIT MED J, V283, P348, DOI 10.1136/bmj.283.6287.348	43	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	2					341	346		10.1016/0091-6749(85)90651-7	http://dx.doi.org/10.1016/0091-6749(85)90651-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	APE89	2410477				2022-12-18	WOS:A1985APE8900015
J	DAVIS, KC; MEKORI, YA; KOHLER, PF; SCHOCKET, AL				DAVIS, KC; MEKORI, YA; KOHLER, PF; SCHOCKET, AL			LATE CUTANEOUS REACTIONS IN PATIENTS WITH DELAYED PRESSURE URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO,SCH MED,DEPT MED,DIV CLIN IMMUNOL,DENVER,CO 80202; PRESBYTERIAN ST LUKES MED CTR,ENVIRONM CARE UNIT,DENVER,CO	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NCRR NIH HHS [RR-00051] Funding Source: Medline; NIAID NIH HHS [AI-07166] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ATKINS P, 1973, J ALLERGY CLIN IMMUN, V51, P263, DOI 10.1016/0091-6749(73)90128-0; BLACKLEY C, 1959, EXPT RES CAUSES NATU, P77; DESHAZO RD, 1979, J IMMUNOL, V122, P692; DOLOVICH J, 1972, J ALLERGY CLIN IMMUN, V49, P43, DOI 10.1016/0091-6749(72)90122-4; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; DOR PJ, 1983, J ALLERGY CLIN IMMUN, V71, P363, DOI 10.1016/0091-6749(83)90063-5; DORSCH W, 1981, J ALLERGY CLIN IMMUN, V67, P117, DOI 10.1016/0091-6749(81)90006-3; ESTES SA, 1981, J AM ACAD DERMATOL, V5, P25, DOI 10.1016/S0190-9622(81)70073-2; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P160, DOI 10.1016/0091-6749(82)90037-9; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; POOTHULLIL J, 1976, J ALLERGY CLIN IMMUN, V57, P164, DOI 10.1016/0091-6749(76)90035-X; ROBERTSON DG, 1974, J ALLERGY CLIN IMMUN, V54, P244, DOI 10.1016/0091-6749(74)90067-0; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; SUSSMAN GL, 1982, ANN ALLERGY, V48, P75; SUSSMAN GL, 1982, J ALLERGY CLIN IMMUN, V70, P337, DOI 10.1016/0091-6749(82)90022-7; UMEMOTO L, 1976, J ALLERGY CLIN IMMUN, V58, P60, DOI 10.1016/0091-6749(76)90107-X; Wadsworth A, 1938, J IMMUNOL, V35, P217; WARIN RP, 1974, MAJOR PROBLEMS DERMA, P120; Wilcoxon F, 1964, SOME RAPID APPROXIMA	19	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	6					810	812		10.1016/0091-6749(84)90451-2	http://dx.doi.org/10.1016/0091-6749(84)90451-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SV829	6725792				2022-12-18	WOS:A1984SV82900007
J	ESAU, S; DELCARPIO, J; MARTIN, JG				ESAU, S; DELCARPIO, J; MARTIN, JG			A COMPARISON OF THE EFFECTS OF KETOTIFEN AND CLEMASTINE ON CUTANEOUS AND AIRWAY REACTIVITY TO HISTAMINE AND ALLERGEN IN ATOPIC ASTHMATIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MCGILL UNIV CLIN,ROYAL VICTORIA HOSP,MONTREAL CHEST HOSP CTR,MEAKINS CHRISTIE LABS,MONTREAL H3A 2B4,QUEBEC,CANADA; ROYAL VICTORIA HOSP,DIV ALLERGY & CLIN IMMUNOL,MONTREAL H3A 1A1,QUEBEC,CANADA	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital				Martin, James/0000-0001-7574-5363				ARMOUR C, 1982, AGENTS ACTIONS, V12, P285, DOI 10.1007/BF01965390; AUSTEN KF, 1975, AM REV RESPIR DIS, V112, P423; BEUMER HM, 1979, RESPIRATION, V37, P271, DOI 10.1159/000194038; CASTERLINE CL, 1977, J ALLERGY CLIN IMMUN, V59, P420, DOI 10.1016/0091-6749(77)90004-5; CLARKE CW, 1980, BRIT J CLIN PHARMACO, V10, P473, DOI 10.1111/j.1365-2125.1980.tb01791.x; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAVIES RJ, 1982, RES CLIN FORUMS, V4, P67; GOBEL P, 1979, PHARMATHERAPEUTICA, V2, P153; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; HARTMANN V, 1981, THORAX, V36, P737, DOI 10.1136/thx.36.10.737; LANE DJ, 1980, CLIN ALLERGY, V10, P519, DOI 10.1111/j.1365-2222.1980.tb02132.x; MARTIN U, 1981, N-S ARCH PHARMACOL, V316, P186, DOI 10.1007/BF00505315; MARTIN U, 1978, ARCH PHARM, V316, P186; MATTSON K, 1979, CLIN ALLERGY, V9, P411, DOI 10.1111/j.1365-2222.1979.tb02500.x; NATHAN RA, 1979, AM REV RESPIR DIS, V120, P1251; NOGRADY SG, 1978, THORAX, V33, P700, DOI 10.1136/thx.33.6.700; POPA VT, 1980, CHEST, V78, P442, DOI 10.1378/chest.78.3.442; ROSENTHAL R R, 1981, American Review of Respiratory Disease, V123, P53; STUNGL B, 1980, RESPIRATION S1, V39, P12; SZCZEKLIK A, 1980, RESPIRATION, V39, P3; WUTHRICH B, 1978, INT J CLIN PHARM TH, V16, P424	22	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					270	274		10.1016/0091-6749(84)90257-4	http://dx.doi.org/10.1016/0091-6749(84)90257-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TJ808	6470361				2022-12-18	WOS:A1984TJ80800009
J	KAPLAN, AP				KAPLAN, AP			EXERCISE-INDUCED HIVES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											KAPLAN, AP (corresponding author), SUNY STONY BROOK,HLTH SCI CTR,DIV ALLERGY RHEUMATOL & CLIN IMMUNOL,STONY BROOK,NY 11794, USA.							GRANT RT, 1935, CLIN SCI, V2, P253; HERXHEIMER A, 1956, CLIN SCI, V15, P195; HOUSER DD, 1970, AM J MED, V49, P23, DOI 10.1016/S0002-9343(70)80110-3; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P319, DOI 10.1016/0091-6749(81)90158-5; KAPLAN AP, 1981, NEW ENGL J MED, V305, P1074, DOI 10.1056/NEJM198110293051808; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P438; KAPLAN AP, 1983, CURRENT THERAPY ALLE, P46; LAWRENCE CM, 1981, BRIT J DERMATOL, V105, P543, DOI 10.1111/j.1365-2133.1981.tb00797.x; MOOREROBINSON M, 1968, BRIT J DERMATOL, V80, P794, DOI 10.1111/j.1365-2133.1968.tb11948.x; PETILLO JJ, 1983, ANN ALLERGY, V51, P511; SHELLEY WB, 1983, LANCET, V1, P843; SIGLER RW, 1979, J ALLERGY CLIN IMMUN, V63, P35, DOI 10.1016/0091-6749(79)90159-3; SOTER NA, 1980, NEW ENGL J MED, V302, P604, DOI 10.1056/NEJM198003133021104; SOTER NA, 1976, NEW ENGL J MED, V294, P687, DOI 10.1056/NEJM197603252941302; WANDERER AA, 1977, ARCH DERMATOL, V113, P1375, DOI 10.1001/archderm.113.10.1375; WANDERER AA, 1971, J ALLERGY CLIN IMMUN, V48, P366, DOI 10.1016/0091-6749(71)90083-2; WASSERMAN SI, 1977, J CLIN INVEST, V60, P189, DOI 10.1172/JCI108756; WASSERMAN SI, 1982, CLIN EXP IMMUNOL, V47, P470	18	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					704	707		10.1016/0091-6749(84)90310-5	http://dx.doi.org/10.1016/0091-6749(84)90310-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS046	6371106				2022-12-18	WOS:A1984SS04600017
J	MORITA, Y; NISHIDA, Y; KAMATANI, N; MIYAMOTO, T				MORITA, Y; NISHIDA, Y; KAMATANI, N; MIYAMOTO, T			THEOPHYLLINE INCREASES SERUM URIC-ACID LEVELS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MORITA, Y (corresponding author), UNIV TOKYO,FAC MED,DEPT MED & PHYS THERAPY,BUNKYO KU,TOKYO 113,JAPAN.							ADAMS RF, 1976, CLIN CHEM, V22, P1903; BUCHANAN OH, 1945, J BIOL CHEM, V157, P181; BUCHANAN OH, 1945, J BIOL CHEM, V157, P189; Ellis EF, 1978, ALLERGY PRINCIPLES P, P434; FERRER I, 1982, FEBS LETT, V141, P275, DOI 10.1016/0014-5793(82)80065-3; HARTER JG, 1968, J ALLERGY, V42, P88, DOI 10.1016/0021-8707(68)90138-X; HIGBEE MD, 1982, J ALLERGY CLIN IMMUN, V70, P377, DOI 10.1016/0091-6749(82)90028-8; JENNE JW, 1976, CLIN PHARMACOL THER, V19, P375; KOBAYASHI K, 1981, Japanese Journal of Allergology, V30, P877; LEHNINGER AL, 1977, BIOCHEMISTRY, P729; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; LIDDLE L, 1959, J LAB CLIN MED, V54, P903; NOLAN LL, 1979, BIOCHEM BIOPH RES CO, V91, P253, DOI 10.1016/0006-291X(79)90611-9; RALL TW, 1981, PHARMACOL BASIS THER, P592; STEELE TH, 1969, AM J MED, V47, P564, DOI 10.1016/0002-9343(69)90187-9; SUMI T, 1977, EUR J PHARMACOL, V46, P243, DOI 10.1016/0014-2999(77)90339-9; YOSSELSONSUPERSTINE S, 1980, AM J HOSP PHARM, V37, P1522, DOI 10.1093/ajhp/37.11.1522	17	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	5					707	712		10.1016/0091-6749(84)90234-3	http://dx.doi.org/10.1016/0091-6749(84)90234-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TT169	6501743				2022-12-18	WOS:A1984TT16900009
J	SEAMAN, WE; WOODCOCK, J				SEAMAN, WE; WOODCOCK, J			HUMAN AND MURINE NATURAL-KILLER CELL-ACTIVITY MAY REQUIRE LIPOXYGENATION OF ARACHIDONIC-ACID	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	SEAMAN, WE (corresponding author), VET ADM MED CTR,DEPT MED,SAN FRANCISCO,CA 94121, USA.							AULT KA, 1981, J IMMUNOL, V126, P359; BISHOP GA, 1983, J EXP MED, V157, P1544, DOI 10.1084/jem.157.5.1544; BROOKS CG, 1983, IMMUNOL REV, V72, P43, DOI 10.1111/j.1600-065X.1983.tb01072.x; CUDKOWICZ G, 1979, IMMUNOL REV, V44, P13, DOI 10.1111/j.1600-065X.1979.tb00266.x; DENNERT G, 1981, J EXP MED, V153, P545, DOI 10.1084/jem.153.3.545; DVORAK AM, 1983, J EXP MED, V157, P843, DOI 10.1084/jem.157.3.843; FITZGERALD PA, 1983, J IMMUNOL, V130, P1663; GOETZL EJ, 1980, IMMUNOLOGY, V40, P709; GOETZL EJ, 1981, BIOCHEM BIOPH RES CO, V101, P344, DOI 10.1016/0006-291X(81)91266-3; GOETZL EJ, 1981, MED CLIN N AM, V65, P809, DOI 10.1016/S0025-7125(16)31499-7; GOLDYNE ME, 1983, RECENT ADV CLIN IMMU, P9; HANNA N, 1980, J NATL CANCER I, V65, P801, DOI 10.1093/jnci/65.4.801; HANSSON M, 1979, J IMMUNOL, V123, P765; HATTORI T, 1983, J IMMUNOL, V131, P662; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; HERBERMAN RB, 1982, NK CELLS OTHER NATUR; HIGGS GA, 1979, BIOCHEM PHARMACOL, V28, P1959, DOI 10.1016/0006-2952(79)90651-8; HIRATA F, 1980, SCIENCE, V209, P1082, DOI 10.1126/science.6157192; HISORODT JC, 1982, J IMMUNOL, V129, P1782; HOFFMAN T, 1981, P NATL ACAD SCI-BIOL, V78, P3839, DOI 10.1073/pnas.78.6.3839; KATZ P, 1982, J IMMUNOL, V129, P287; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; KOREN HS, 1981, J IMMUNOL, V127, P2007; LANIER LL, 1983, J IMMUNOL, V131, P1789; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MINATO N, 1981, J EXP MED, V154, P750, DOI 10.1084/jem.154.3.750; QUAN PC, 1982, J IMMUNOL, V128, P1786; RODER JC, 1979, J IMMUNOL, V123, P2785; ROLAPLESZCZYNSKI M, 1983, BIOCHEM BIOPH RES CO, V113, P531, DOI 10.1016/0006-291X(83)91758-8; SEAMAN WE, 1983, J IMMUNOL, V131, P2953; SHAW GM, 1978, CELL IMMUNOL, V41, P122, DOI 10.1016/S0008-8749(78)80032-X; SIRCAR JC, 1983, PROSTAGLANDINS, V25, P393, DOI 10.1016/0090-6980(83)90042-4; STUTMAN O, 1981, FED PROC, V40, P2699; TALMADGE JE, 1980, NATURE, V284, P622, DOI 10.1038/284622a0; TAPPEL AL, 1953, ARCH BIOCHEM BIOPHYS, V42, P293, DOI 10.1016/0003-9861(53)90359-2; TIMONEN T, 1981, J EXP MED, V153, P569, DOI 10.1084/jem.153.3.569; TIMONEN T, 1979, CELL IMMUNOL, V48, P133, DOI 10.1016/0008-8749(79)90106-0; WARNER JF, 1982, NATURE, V300, P31, DOI 10.1038/300031a0	38	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					407	411		10.1016/0091-6749(84)90139-8	http://dx.doi.org/10.1016/0091-6749(84)90139-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ633	6432881				2022-12-18	WOS:A1984TQ63300019
J	BARTLETT, EE				BARTLETT, EE			EDUCATIONAL SELF-HELP APPROACHES IN CHILDHOOD ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV ALABAMA,SCH MED,DEPT FAMILY PRACTICE,BIRMINGHAM,AL 35233	University of Alabama System; University of Alabama Birmingham	BARTLETT, EE (corresponding author), UNIV ALABAMA,SCH FAMILY PRACTICE,DIV HLTH EDUC HLTH BEHAV,BIRMINGHAM,AL 35294, USA.							BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1977, SOCIAL LEARNING THEO; BARTLETT E, 1980, HLTH ED PLANNING DIA; BARTLETT EE, 1982, PATIENT COUNS HEALTH, V4, P29, DOI 10.1016/S0738-3991(82)80032-3; BARTLETT EE, PREV MED; BARTLETT EE, 1981, THESIS J HOPKINS U B; BASHSHUR RL, 1967, AM J PUBLIC HEALTH N, V57, P1991, DOI 10.2105/AJPH.57.11.1991; Becker M H, 1980, J Community Health, V6, P113, DOI 10.1007/BF01318980; Bellin S S, 1972, Med Care, V10, P224, DOI 10.1097/00005650-197205000-00005; BERNSTEIN RA, 1981, MED CARE, V19, P188; BOND BW, 1958, INT J HEALTH EDUC, V1, P41; Brehm J.W., 1972, RESPONSES LOSS FREED; CARROLL JG, 1980, EVALUATION HLTH PROF, V1, P21; Cartwright A., 1964, HUMAN RELATIONS HOSP; CLARK NM, 1980, HLTH ED Q, V7, P88; COOPER BJ, 1976, J ALLERGY CLIN IMMUN, V58, P635, DOI 10.1016/0091-6749(76)90175-5; CREER T, SELF MANAGEMENT CHRO; DAVIS F, 1960, AM J SOCIOL, V66, P41, DOI 10.1086/222821; Davis F., 1963, PASSAGE CRISIS POLIO; DAVIS MS, 1963, J HEALTH HUM BEHAV, V4, P240, DOI 10.2307/2948830; DiMatteo M R, 1979, J Community Health, V4, P280; Duff RS, 1968, SICKNESS SOC; ENEY RD, 1976, PEDIATRICS, V57, P513; ETZWILER DD, 1973, JAMA-J AM MED ASSOC, V224, P1034, DOI 10.1001/jama.224.7.1034; EVANS RI, 1978, J APPL SOC PSYCHOL, V8, P126, DOI 10.1111/j.1559-1816.1978.tb00771.x; FIREMAN P, 1981, PEDIATRICS, V63, P341; Fishbein M., 1975, BELIEF ATTITUDE INTE; FISHER AW, 1971, J MED EDUC, V46, P238; FLYNN B, 1980, PHYSICIANS PATIENT E, V3, P1; FONAROFF A, 1977, HLTH ED MONOGR, V5, P206; FRANKS CM, 1975, ANN REV BEHAVIOR THE, V3; FREEMON B, 1971, PEDIATR RES, V5, P298; Freidson E., 1988, PROFESSION MED STUDY; Glaser BG, 1965, AWARENESS DYING; GREEN LW, 1979, COMPLIANCE HLTH CARE; Haynes RB., 1979, COMPLIANCE HLTH CARE; HEREFORD CF, 1963, CHANGING PARENTAL AT; Houston C S, 1972, Hospitals, V46, P70; HUGHJONES P, 1964, BRIT MED J, V2, P660, DOI 10.1136/bmj.2.5410.660; HULKA BS, 1976, AM J PUBLIC HEALTH, V66, P847, DOI 10.2105/AJPH.66.9.847; Janis I.L., 1977, DECISION MAKING PSYC; JOLLY C, 1971, AM J OBSTET GYNECOL, V110, P291, DOI 10.1016/0002-9378(71)90714-9; KAHN GS, 1979, J MED EDUC, V54, P29; KIRSCHT JP, 1981, HEALTH EDUC QUART, V8, P261, DOI 10.1177/109019818100800303; KORSCH BM, 1968, PEDIATRICS, V42, P855; Lawrence LC, 1955, J APPL PSYCHOL, V39, P334, DOI 10.1037/h0045797; LEVIN LS, 1976, PUBLIC HEALTH REP, V91, P206; LEVIN LS, 1976, SELF CARE LAY INITIA, P11; LEVY RL, 1979, MED CARE, V17, P281, DOI 10.1097/00005650-197903000-00005; LEWIN K, 1953, GROUP DYNAMICS RES T; LEWIS CE, 1977, MEDICATION COMPLIANC; LEY P, 1972, B BRIT PSYCHOL SOC, V25, P115; LEY P, 1976, BRIT J SOC CLIN PSYC, V15, P403, DOI 10.1111/j.2044-8260.1976.tb00052.x; Ley P, 1965, Br J Soc Clin Psychol, V4, P114; LEY P, 1967, COMMUNICATING PATIEN; LIEBERMAN MA, 1975, HELPING PEOPLE CHANG; LINN LS, 1975, MILBANK FUND Q, V53, P531, DOI 10.2307/3349566; LIPTAK GS, 1977, PEDIATRICS, V60, P186; MAIMAN LA, 1979, JAMA-J AM MED ASSOC, V241, P1919; MAZZULLO JM, 1974, JAMA-J AM MED ASSOC, V227, P929, DOI 10.1001/jama.227.8.929; MCALISTER A, 1980, AM J PUBLIC HEALTH, V70, P719, DOI 10.2105/AJPH.70.7.719; McGhee A., 1961, PATIENTS ATTITUDE NU; MICHAEL M, 1982, MED CARE, V20, P432, DOI 10.1097/00005650-198204000-00008; Moore WE, 1949, AM SOCIOL REV, V14, P787, DOI 10.2307/2086681; Parcel G S, 1980, J Dev Behav Pediatr, V1, P128; Parcel G S, 1983, Patient Educ Newsl, V6, P1; PARKIN DM, 1976, PUBLIC HEALTH, V90, P203, DOI 10.1016/S0033-3506(76)80050-9; PERRY C, 1980, AM J PUBLIC HEALTH, V70, P722, DOI 10.2105/AJPH.70.7.722; PRATT L, 1973, J COMP FAM STUD, V4, P13; QUINT J, 1972, MED MEN THEIR WORK; RAPHAEL W, 1969, PATIENTS THEIR HOSPI; REEDER LG, 1957, MOD HOSP, V89, P88; ROTER DL, 1977, HEALTH EDUC QUART, V5, P281, DOI 10.1177/109019817700500402; RUBENSTEIN HS, 1976, LANCET, V1, P1011; SHENKIN BN, 1973, NEW ENGL J MED, V289, P688, DOI 10.1056/NEJM197309272891311; SKIPPER JK, 1964, J HEALTH HUM BEHAV, V5, P34, DOI 10.2307/2948758; SKIPPER JK, 1968, J HEALTH SOC BEHAV, V9, P275, DOI 10.2307/2948536; SQUYERS WD, 1980, PATIENT ED PRIMARY C; STARFIELD B, 1979, JAMA-J AM MED ASSOC, V242, P344, DOI 10.1001/jama.242.4.344; STILES WB, 1979, MED CARE, V17, P667, DOI 10.1097/00005650-197906000-00010; WAITZKIN H, 1972, ADV PSYCHOSOM MED, V8, P180; WAITZKIN H, 1976, SOC SCI MED, V10, P263, DOI 10.1016/0037-7856(76)90070-6; Ware J E Jr, 1978, Health Med Care Serv Rev, V1, P3; WARE JE, 1976, DEV VALIDATION SCALE, V1; WATTS WA, 1967, J PERS SOC PSYCHOL, V5, P4, DOI 10.1037/h0021196; ZIMBARDO PG, 1965, J EXP SOC PSYCHOL, V1, P103, DOI 10.1016/0022-1031(65)90039-9; [No title captured]; [No title captured]	88	17	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	5					545	554		10.1016/0091-6749(83)90481-5	http://dx.doi.org/10.1016/0091-6749(83)90481-5			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	RS163	6358325	Bronze			2022-12-18	WOS:A1983RS16300007
J	BUDD, TW; KUO, CY; YOO, TJ; MCKENNA, WR; CAZIN, J				BUDD, TW; KUO, CY; YOO, TJ; MCKENNA, WR; CAZIN, J			ANTIGENS OF ALTERNARIA .1. ISOLATION AND PARTIAL CHARACTERIZATION OF A BASIC PEPTIDE ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM MED CTR,MEMPHIS,TN 38104; UNIV TENNESSEE,CTR HLTH SCI,DEPT MED,DIV ALLERGY & IMMUNOL,MEMPHIS,TN 38163; UNIV IOWA,DEPT MED & MICROBIOL,IOWA CITY,IA 52242	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Iowa								AAS K, 1967, INT ARCH ALLER A IMM, V32, P1, DOI 10.1159/000229911; AUKRUST L, 1979, INT ARCH ALLER A IMM, V58, P375, DOI 10.1159/000232217; BONIL.O, 1961, J ALLERGY, V32, P246, DOI 10.1016/0021-8707(61)90055-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURROUGHS R, 1976, APPL ENVIRON MICROB, V31, P685, DOI 10.1128/AEM.31.5.685-690.1976; CHAKRABARTY S, 1981, INT ARCH ALLER A IMM, V66, P142, DOI 10.1159/000232813; HOFFMAN DR, 1981, ANN ALLERGY, V46, P310; JOHNSON P, 1965, EUR POLYM J, V1, P63; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; MILES R, 1981, 50TH P AM AC PED ALL; SALVAGGIO J, 1981, J ALLERGY CLIN IMMUN, V68, P327, DOI 10.1016/0091-6749(81)90131-7; SCHUMACHER MJ, 1976, J ALLERGY CLIN IMMUN, V58, P263, DOI 10.1016/0091-6749(76)90131-7; STERNBERGER LA, 1956, J ALLERGY, V27, P16, DOI 10.1016/0021-8707(56)90034-X; VIJAY HM, 1979, INT ARCH ALLER A IMM, V60, P229, DOI 10.1159/000232347; WEEKE B, 1973, SCAND J IMMUNOL, V2, P149, DOI 10.1111/j.1365-3083.1973.tb03796.x; YUNGINGER JW, 1980, J ALLERGY CLIN IMMUN, V66, P138, DOI 10.1016/0091-6749(80)90061-5; YUNGINGER JW, 1976, J ALLERGY CLIN IMMUN, V58, P405, DOI 10.1016/0091-6749(76)90121-4	17	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	3					277	282		10.1016/0091-6749(83)90081-7	http://dx.doi.org/10.1016/0091-6749(83)90081-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QH188	6681826				2022-12-18	WOS:A1983QH18800003
J	FEARON, DT				FEARON, DT			CONTINUING MEDICAL-EDUCATION - COMPLEMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									BRIGHAM & WOMENS HOSP, DEPT RHEUMATOL & IMMUNOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School					NIAID NIH HHS [AI-07722, AI-10356, AI-17917] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Colten H R, 1976, Adv Immunol, V22, P67, DOI 10.1016/S0065-2776(08)60548-9; FEARON DT, 1983, ANNU REV IMMUNOL, V1, P243, DOI 10.1146/annurev.iy.01.040183.001331; FEARON DT, 1980, NEW ENGL J MED, V303, P259, DOI 10.1056/NEJM198007313030505; HUGLI T E, 1981, Critical Reviews in Immunology, V1, P321; LACHMAN PJ, CLIN ASPECTS IMMUNOL; LACHMANN PJ, 1978, SPRINGER SEMIN IMMUN, V1, P339, DOI 10.1007/BF01857311; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; REID KBM, 1981, ANNU REV BIOCHEM, V50, P433, DOI 10.1146/annurev.bi.50.070181.002245	8	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	6					520	529		10.1016/0091-6749(83)90431-1	http://dx.doi.org/10.1016/0091-6749(83)90431-1			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	QV139	6853922				2022-12-18	WOS:A1983QV13900002
J	BUCKLEY, CE; LEE, KL; BURDICK, DS				BUCKLEY, CE; LEE, KL; BURDICK, DS			METHACHOLINE-INDUCED CUTANEOUS FLARE RESPONSE - BIVARIATE ANALYSIS OF RESPONSIVENESS AND SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									DUKE UNIV, MED CTR, DEPT MICROBIOL IMMUNOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT COMMUNITY & FAMILY MED, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT MATH, DURHAM, NC 27710 USA	Duke University; Duke University; Duke University	BUCKLEY, CE (corresponding author), DUKE UNIV, MED CTR, DEPT MED, DURHAM, NC 27710 USA.				NLM NIH HHS [LM 00042] Funding Source: Medline	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		ASCHOFF J, 1976, FED PROC, V35, P2326; Bliss CI, 1941, IND ENG CHEM, V13, P0084, DOI 10.1021/i560090a009; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; BUCKLEY CE, 1976, J AM GERIATR SOC, V24, P241, DOI 10.1111/j.1532-5415.1976.tb03298.x; BUCKLEY CE, 1969, J ALLERGY, V44, P355, DOI 10.1016/0021-8707(69)90027-6; BUCKLEY CE, 1980, ZINSSER MICROBIOLOGY, P476; CURRY JJ, 1947, J CLIN INVEST, V26, P430, DOI 10.1172/JCI101826; Di PALMA JOSEPH R., 1942, AMER HEART JOUR, V23, P377, DOI 10.1016/S0002-8703(42)90616-1; Feinstein A, 1977, CLIN BIOSTATISTICS, P320; FINNEY DJ, 1962, PROBIT ANAL STATISTI; HENDERSON WR, 1979, NEW ENGL J MED, V300, P642, DOI 10.1056/NEJM197903223001203; Hewlett PS, 1978, INTERPRETATION QUANT; IMBER WE, 1977, J ALLERGY CLIN IMMUN, V60, P47, DOI 10.1016/0091-6749(77)90082-3; INDRAJANA T, 1971, ANN ALLERGY, V29, P639; KNAPP MS, 1980, INT J IMMUNOPHARMACO, V2, P91, DOI 10.1016/0192-0561(80)90018-1; KOPKIN IJ, 1980, PSYCHOPHARMACOLOGY B, P221; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; REDDY PM, 1978, J ALLERGY CLIN IMMUN, V61, P36, DOI 10.1016/0091-6749(78)90471-2; ROSENTHAL RR, 1979, J ALLERGY CLIN IMMUN, V64, P564, DOI 10.1016/0091-6749(79)90013-7; SANTILLI J, 1980, J ALLERGY CLIN IMMUN, V65, P406, DOI 10.1016/0091-6749(80)90232-8; SHELHAMER JH, 1980, J ALLERGY CLIN IMMUN, V66, P52, DOI 10.1016/0091-6749(80)90138-4; SMITH LJ, 1980, J ALLERGY CLIN IMMUN, V66, P374, DOI 10.1016/0091-6749(80)90116-5; STARMER CF, 1968, U N CAROLINA I STATI, V560; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; THOMAS GB, 1960, CALCULUS ANAL GEOMET, P510; VOORHORST R, 1973, ANN ALLERGY, V31, P195	26	17	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	1					25	34		10.1016/0091-6749(82)90083-5	http://dx.doi.org/10.1016/0091-6749(82)90083-5			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ377	7054251				2022-12-18	WOS:A1982MZ37700005
J	GEORGITIS, JW; FLESHER, KA; SZEFLER, SJ				GEORGITIS, JW; FLESHER, KA; SZEFLER, SJ			BIOAVAILABILITY ASSESSMENT OF A LIQUID PREDNISONE PREPARATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHILDRENS HOSP,DIV ALLERGY & CLIN IMMUNOL,BUFFALO,NY 14222; SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,BUFFALO,NY 14260; CHILDRENS HOSP,DIV CLIN PHARMACOL & PHARMACOKINET,BUFFALO,NY 14222; SUNY BUFFALO,SCH MED,DEPT PEDIAT,BUFFALO,NY 14260; SUNY BUFFALO,SCH PHARM,DEPT PHARMACOL & THERAPEUT,BUFFALO,NY 14260	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								GIBALDI M, 1975, DRUGS PHARM SCI, P129; LASSEN NA, 1979, TRACER KINETIC METHO, P76; MEIKLE AW, 1975, J CLIN ENDOCR METAB, V41, P717, DOI 10.1210/jcem-41-4-717; MORRIS HG, 1978, ALLERGY PRINCIPLES P, P464; ROSE JQ, 1980, BIOPHARM DRUG DISPOS, V1, P247, DOI 10.1002/bdd.2510010504; ROSE JQ, 1981, J PHARMACOKINET BIOP, V9, P389, DOI 10.1007/BF01060885; ROSE JQ, 1979, J CHROMATOGR, V162, P273, DOI 10.1016/S0378-4347(00)81514-5; SUGITA ET, 1975, J AM PHARMACOLOGY AS, V15, P529; YEH KC, 1978, J PHARMACOKINET BIOP, V6, P79, DOI 10.1007/BF01066064	9	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	4					243	247		10.1016/0091-6749(82)90060-4	http://dx.doi.org/10.1016/0091-6749(82)90060-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PL151	7119300				2022-12-18	WOS:A1982PL15100004
J	HOMBURGER, HA; JACOB, GL				HOMBURGER, HA; JACOB, GL			ANALYTIC ACCURACY OF SPECIFIC IMMUNOGLOBULIN-E ANTIBODY RESULTS DETERMINED BY A BLIND PROFICIENCY SURVEY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											HOMBURGER, HA (corresponding author), MAYO CLIN & MAYO FDN,DEPT LAB MED,HILTON BLDG,ROCHESTER,MN 55905, USA.							ADKINSON NF, 1980, J ALLERGY CLIN IMMUN, V65, P1, DOI 10.1016/0091-6749(80)90169-4; ADKINSON NF, 1981, J ALLERGY CLIN IMMUN, V67, P87, DOI 10.1016/0091-6749(81)90001-4; AXEN R, 1967, NATURE, V214, P1302, DOI 10.1038/2141302a0; DANNAEUS A, 1977, ACTA PAEDIATR SCAND, V66, P31, DOI 10.1111/j.1651-2227.1977.tb07803.x; EVANS R, 1982, J ALLERGY CLIN IMMUN, V69, P245, DOI 10.1016/0091-6749(82)90106-3; GLEICH GJ, 1975, J ALLERGY CLIN IMMUN, V55, P346, DOI 10.1016/0091-6749(75)90006-8; GLEICH GJ, 1975, J ALLERGY CLIN IMMUN, V55, P334, DOI 10.1016/0091-6749(75)90005-6; SANTRACH PJ, 1981, J ALLERGY CLIN IMMUN, V67, P97, DOI 10.1016/0091-6749(81)90003-8; YUNGINGER JW, 1978, J ALLERGY CLIN IMMUN, V61, P93, DOI 10.1016/0091-6749(78)90231-2	9	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	6					474	480		10.1016/0091-6749(82)90011-2	http://dx.doi.org/10.1016/0091-6749(82)90011-2			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PT744	6754791				2022-12-18	WOS:A1982PT74400011
J	REID, MJ; CHEUNG, NKV; LEWISTON, NJ				REID, MJ; CHEUNG, NKV; LEWISTON, NJ			MICROTITER SOLID-PHASE RADIOIMMUNOASSAY FOR SPECIFIC IMMUNOGLOBULIN-E	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									STANFORD UNIV,CHILDRENS HOSP,SCH MED,DEPT PEDIAT,PALO ALTO,CA 94304	Children's Hospital Los Angeles; Stanford University								ADKINSON NF, 1976, MANUAL CLIN IMMUNOLO, P590; AHLSTEDT S, 1974, CLIN ALLERGY, V4, P131, DOI 10.1111/j.1365-2222.1974.tb01370.x; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; FRIEDMAN MG, 1979, J CLIN MICROBIOL, V9, P1; GLEICH GJ, 1975, J ALLERGY CLIN IMMUN, V55, P334, DOI 10.1016/0091-6749(75)90005-6; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; KALIMO KOK, 1977, INFECT IMMUN, V15, P883, DOI 10.1128/IAI.15.3.883-889.1977; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NORMAN PS, 1973, J ALLERGY CLIN IMMUN, V52, P210, DOI 10.1016/0091-6749(73)90059-6; SCHOPFER K, 1979, NEW ENGL J MED, V300, P835, DOI 10.1056/NEJM197904123001506; WIDE L, 1967, LANCET, V2, P1105; ZOLLINGER WD, 1976, J IMMUNOL, V117, P1788	12	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	4					263	271		10.1016/0091-6749(81)90020-8	http://dx.doi.org/10.1016/0091-6749(81)90020-8			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LL697	6162872				2022-12-18	WOS:A1981LL69700003
J	BEALL, GN; ASHMAN, RF; MILLER, ME; EASWARAN, C; RAGHUNATHAN, R; LOUIE, J; YOSHIKAWA, T				BEALL, GN; ASHMAN, RF; MILLER, ME; EASWARAN, C; RAGHUNATHAN, R; LOUIE, J; YOSHIKAWA, T			HYPOGAMMAGLOBULINEMIA IN MOTHER AND SON	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Discussion									UNIV CALIF LOS ANGELES, HARBOR MED CTR, DEPT PEDIAT, TORRANCE, CA 90509 USA; UNIV CALIF LOS ANGELES, CTR HLTH SCI, DEPT MED, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, CTR HLTH SCI, DEPT MED MICROBIOL & IMMUNOL, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	BEALL, GN (corresponding author), UNIV CALIF LOS ANGELES, HARBOR MED CTR, DEPT MED, TORRANCE, CA 90509 USA.							AMMANN AJ, 1977, PEDIATR CLIN N AM, V24, P293; ASHMAN RF, 1980, J ALLERGY CLIN IMMUN, V65, P242, DOI 10.1016/0091-6749(80)90151-7; BARNETT EV, 1970, AM J MED, V48, P40, DOI 10.1016/0002-9343(70)90096-3; BRUTON OC, 1952, PEDIATRICS, V9, P722; DiGeorge A. M., 1968, BIRTH DEFECTS OAS, V4, P116; FISHER DA, 1975, J CLIN ENDOCR METAB, V40, P795, DOI 10.1210/jcem-40-5-795; GATTI RA, 1971, CANCER-AM CANCER SOC, V28, P89, DOI 10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO;2-Q; GRAYZEL AI, 1977, ARTHRITIS RHEUM, V20, P887, DOI 10.1002/art.1780200319; HERMANS PE, 1976, AM J MED, V61, P221, DOI 10.1016/0002-9343(76)90173-X; HITZIG WH, 1973, IMMUNOLOGIC DISORDER, P215; HOLLAND NH, 1966, LANCET, V2, P1152; KYONG CU, 1978, PEDIATR RES, V12, P1024, DOI 10.1203/00006450-197810000-00015; LAWTON AR, 1977, DEV HOST DEFENSES, P43; RAFF MC, 1976, NATURE, V259, P224, DOI 10.1038/259224a0; ROSEN FS, 1978, IMMUNOLOGICAL DISEAS, P472; SIBER GR, 1978, NEW ENGL J MED, V299, P442, DOI 10.1056/NEJM197808312990903; SUHS RH, 1965, ARCH INTERN MED, V116, P29, DOI 10.1001/archinte.1965.03870010031006; TWOMEY JJ, 1970, ANN INTERN MED, V72, P499, DOI 10.7326/0003-4819-72-4-499; WALDMANN TA, 1974, LANCET, V2, P609	19	17	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	6					471	481		10.1016/0091-6749(80)90242-0	http://dx.doi.org/10.1016/0091-6749(80)90242-0			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JV764	6966290				2022-12-18	WOS:A1980JV76400012
J	CHIANG, JL; PATTERSON, R; MCGILLEN, JJ; PHAIR, JP; ROBERTS, M; HARRIS, KE; RIESING, KS				CHIANG, JL; PATTERSON, R; MCGILLEN, JJ; PHAIR, JP; ROBERTS, M; HARRIS, KE; RIESING, KS			LONG-TERM CORTICOSTEROID EFFECT ON LYMPHOCYTE AND POLYMORPHONUCLEAR CELL-FUNCTION IN ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT MED,INFECT DIS SECT,CHICAGO,IL 60611	Northwestern University; Northwestern University								AXELROD L, 1976, MEDICINE, V55, P39, DOI 10.1097/00005792-197601000-00003; BUTLER WT, 1973, J CLIN INVEST, V52, P2629, DOI 10.1172/JCI107455; CHAI H, 1973, J ALLERGY CLIN IMMUN, V51, P65, DOI 10.1016/S0091-6749(73)80001-6; CHIANG J, CLIN ALLERGY; COOPER DA, 1977, CLIN EXP IMMUNOL, V28, P467; FAUCI AS, 1975, J CLIN INVEST, V55, P22, DOI 10.1172/JCI107914; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; JONDAL M, 1972, J EXP MED, V136, P207, DOI 10.1084/jem.136.2.207; MACGREGOR RR, 1974, NEW ENGL J MED, V291, P642, DOI 10.1056/NEJM197409262911302; MACGREGOR RR, 1976, AM J MED, V61, P597, DOI 10.1016/0002-9343(76)90137-6; MCGILLEN JJ, 1979, J INFECT DIS, V139, P69, DOI 10.1093/infdis/139.1.69; PAULY JL, 1973, J LAB CLIN MED, V82, P500; SCHATZ M, 1976, ANN INTERN MED, V84, P261, DOI 10.7326/0003-4819-84-3-261; Snedecor G.W., 1980, STAT METHODS, V7; TAN JS, 1971, J LAB CLIN MED, V78, P316; WYBRAN J, 1973, J CLIN INVEST, V52, P1026, DOI 10.1172/JCI107267; YU DTY, 1974, J CLIN INVEST, V53, P565, DOI 10.1172/JCI107591; ZEMAN GO, 1972, J ALLERGY CLIN IMMUN, V49, P10, DOI 10.1016/0091-6749(72)90118-2	18	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	4					263	268		10.1016/0091-6749(80)90153-0	http://dx.doi.org/10.1016/0091-6749(80)90153-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JN548	7358943				2022-12-18	WOS:A1980JN54800004
J	HENDRIX, S; ZEISS, CR; LEVITZ, D; SUSZKO, IM; PATTERSON, R				HENDRIX, S; ZEISS, CR; LEVITZ, D; SUSZKO, IM; PATTERSON, R			POLYMERIZED WHOLE RAGWEED - 2-YEAR FOLLOW-UP OF PATIENTS TREATED WITH AN IMPROVED METHOD OF IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											ZEISS, CR (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611, USA.							BACAL E, 1978, J ALLERGY CLIN IMMUN, V62, P289, DOI 10.1016/0091-6749(78)90160-4; LIDD D, 1962, J ALLERGY, V33, P45, DOI 10.1016/0021-8707(62)90062-X; METZGER WJ, 1976, NEW ENGL J MED, V295, P1160, DOI 10.1056/NEJM197611182952103; PATTERSON R, 1974, J IMMUNOL, V112, P1855; PATTERSON R, 1973, J IMMUNOL, V110, P1402; PATTERSON R, 1979, J ALLERGY CLIN IMMUN, V63, P47, DOI 10.1016/0091-6749(79)90161-1; WILLIAMS CA, 1968, METHODS IMMUNOLOGY I, V2, P257; ZEISS CR, 1977, CLIN EXP IMMUNOL, V28, P250	8	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	1					57	60		10.1016/0091-6749(80)90177-3	http://dx.doi.org/10.1016/0091-6749(80)90177-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB459	7350204				2022-12-18	WOS:A1980JB45900009
J	KIMELBLATT, BJ; SLAUGHTER, RL				KIMELBLATT, BJ; SLAUGHTER, RL			LACK OF EFFECT OF INTRAVENOUS ERYTHROMYCIN LACTOBIONATE ON THEOPHYLLINE CLEARANCE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									SUNY BUFFALO,SCH PHARM,AMHERST,NY 14260	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	KIMELBLATT, BJ (corresponding author), BUFFALO GEN HOSP,CLIN PHARMACOL LAB,BUFFALO,NY 14203, USA.							CUMMINS LH, 1977, PEDIATRICS, V59, P144; KOZAK PP, 1977, J ALLERGY CLIN IMMUN, V60, P149, DOI 10.1016/0091-6749(77)90042-2; VOZEH S, 1978, JAMA-J AM MED ASSOC, V240, P1882, DOI 10.1001/jama.240.17.1882	3	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	4					313	314		10.1016/0091-6749(80)90162-1	http://dx.doi.org/10.1016/0091-6749(80)90162-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JN548	7358947				2022-12-18	WOS:A1980JN54800013
J	MORRIS, HG				MORRIS, HG			FACTORS THAT INFLUENCE CLINICAL-RESPONSES TO ADMINISTERED CORTICOSTEROIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											MORRIS, HG (corresponding author), NATL JEWISH HOSP & RES CTR,DENVER,CO 80206, USA.				NHLBI NIH HHS [HL-22026] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALLARD PL, 1974, ENDOCRINOLOGY, V94, P998, DOI 10.1210/endo-94-4-998; BALLARD PL, 1975, MONOGR ENDOCRINOL, V12, P25; BAXTER JD, 1979, NEW ENGL J MED, V301, P1149, DOI 10.1056/NEJM197911223012104; BAXTER JD, 1979, GLUCOCORTICOID HORMO, P1; BROOKS SM, 1972, NEW ENGL J MED, V286, P1125, DOI 10.1056/NEJM197205252862103; BROOKS SM, 1977, J CLIN PHARMACOL, V17, P308, DOI 10.1002/j.1552-4604.1977.tb04610.x; Cidlowski J A, 1979, Adv Exp Med Biol, V117, P71; CONNEY AH, 1967, PHARMACOL REV, V19, P317; DWYER J, 1967, AUSTRALAS ANN MED, V16, P297; GILLIAN M, 1974, BRIT J CLIN PHARMACO, V1, P237; GRASSO RJ, 1976, CANCER RES, V36, P2408; Harris A W, 1979, Monogr Endocrinol, V12, P423; Johnson L K, 1979, Monogr Endocrinol, V12, P305; JUBIZ W, 1979, DRUGS, V18, P113, DOI 10.2165/00003495-197918020-00003; LEWIS GP, 1971, LANCET, V2, P778; LIDDLE GW, 1961, CLIN PHARMACOL THER, V2, P615; LIPSETT MB, 1971, ANN NY ACAD SCI, V179, P442, DOI 10.1111/j.1749-6632.1971.tb46921.x; MARTIN LE, 1975, POSTGRAD MED J, V51, P11; MEIKLE AW, 1975, J CLIN ENDOCR METAB, V41, P717, DOI 10.1210/jcem-41-4-717; MORRIS HP, UNPUBLISHED; PARFITT AM, 1964, J CLIN ENDOCR METAB, V24, P560, DOI 10.1210/jcem-24-6-560; POWELL LW, 1972, GUT, V13, P690, DOI 10.1136/gut.13.9.690; ROSE JQ, 1980, J ALLERGY CLIN IMMUN, V66, P366, DOI 10.1016/0091-6749(80)90115-3; ROTH GS, 1975, EXP GERONTOL, V10, P1, DOI 10.1016/0531-5565(75)90009-1; ROTH GS, 1976, ENDOCRINOLOGY, V99, P831, DOI 10.1210/endo-99-3-831; SCHWARTZ HJ, 1968, ANN INTERN MED, V69, P493, DOI 10.7326/0003-4819-69-3-493; Sibley C H, 1979, Monogr Endocrinol, V12, P357; Simons S S Jr, 1979, Monogr Endocrinol, V12, P161; VINGERHOEDS ACM, 1976, J CLIN ENDOCR METAB, V43, P1128, DOI 10.1210/jcem-43-5-1128; WILSON CG, 1975, BRIT J CLIN PHARMACO, V2, P321, DOI 10.1111/j.1365-2125.1975.tb02778.x	30	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	5					343	346		10.1016/0091-6749(80)90112-8	http://dx.doi.org/10.1016/0091-6749(80)90112-8			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KQ965	7002976				2022-12-18	WOS:A1980KQ96500001
J	SELENKE, WM; LEUNG, GW; TOWNLEY, RG				SELENKE, WM; LEUNG, GW; TOWNLEY, RG			NON-ANTIBIOTIC EFFECTS OF MACROLIDE ANTIBIOTICS OF THE OLEANDOMYCIN-ERYTHROMYCIN GROUP WITH SPECIAL REFERENCE TO THEIR STEROID-SPARING EFFECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CREIGHTON UNIV,SCH MED,DEPT MED,DIV ALLERGY,OMAHA,NE 68131	Creighton University								Arcadio F, 1970, Lyon Med, V223, P597; CELMER WD, 1958, ANTIBIOTICS ANNUAL, P476; CLAMAN HN, 1972, NEW ENGL J MED, V287, P388, DOI 10.1056/NEJM197208242870806; DIVORETZKY M, 1950, P SOC EXP BIOL MED, V75, P201; FOLTZ EL, 1959, ANTIBIOTIC THERAPY S, P39; FOX JL, 1961, PENN MED J, V64, P634; GOADBY P, 1964, J PHARM PHARMACOL, V16, P108, DOI 10.1111/j.2042-7158.1964.tb07428.x; GONCHAROVA V. I., 1963, ANTIBIOTIKI, V8, P58; GOOD CH, 1932, J BIOL CHEM, V100, P485; HERXHEIMER H, 1952, J PHYSIOL-LONDON, V118, pP7; HOCHSTEIN FA, 1960, J AM CHEM SOC, V82, P3225, DOI 10.1021/ja01497a066; ISENBERG H, 1959, ANTIBIOTICS ANNUAL 1, P284; ITKIN IH, 1970, J ALLERGY, V45, P146, DOI 10.1016/0021-8707(70)90124-3; KAPLAN MA, 1959, ANTIBIOTICS ANN 1958, P273; LEGER J, 1948, P SOC EXP BIOL MED, V69, P465, DOI 10.3181/00379727-69-16757; LEMING BH, 1959, ANTIBIOTICS ANN 1958, P418; Long CNH, 1940, ENDOCRINOLOGY, V26, P309, DOI 10.1210/endo-26-2-309; MCGUIRE JM, 1952, ANTIBIOT CHEMOTHER, V2, P281; MENZEL ML, 1966, ACADEMY ALLERGY PROG, P55; Nelson N, 1944, J BIOL CHEM, V153, P375; PORTER CC, 1950, J BIOL CHEM, V185, P201; SELENKE AB, 1969, J ALLERGY, V43, P157; SHUBIN H, 1958, ANTIBIOTICS ANNUAL 1, P679; SOBLIN BA, 1955, ANTIBIOTICS ANNUAL 1, P827; SPECTOR SL, 1974, J ALLERGY CLIN IMMUN, V54, P367, DOI 10.1016/0091-6749(74)90027-X; TOWNLEY RG, 1970, J ALLERGY, V45, P71; TOWNLEY RG, 1967, J ALLERGY, V39, P177, DOI 10.1016/0021-8707(67)90036-6; TOWNLEY RG, 1967, EXCERPTA MEDICA  144, P90; WEINBERGER M, 1977, J ALLERGY CLIN IMMUN, V59, P228, DOI 10.1016/0091-6749(77)90154-3; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544	30	17	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	6					454	464		10.1016/0091-6749(80)90239-0	http://dx.doi.org/10.1016/0091-6749(80)90239-0			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JV764	6966289				2022-12-18	WOS:A1980JV76400009
J	BAHNA, SL; HORWITZ, C; HEINER, DC				BAHNA, SL; HORWITZ, C; HEINER, DC			IGE IN CYTOMEGALOVIRUS MONONUCLEOSIS (CMV MONO)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					177	177		10.1016/0091-6749(78)90400-1	http://dx.doi.org/10.1016/0091-6749(78)90400-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300161
J	LANG, P; GOEL, Z; GRIECO, MH				LANG, P; GOEL, Z; GRIECO, MH			SUBSENSITIVITY OF T-LYMPHOCYTES TO SYMPATHOMIMETIC AND CHOLINERGIC STIMULATION IN BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ROOSEVELT HOSP,RA COOKE INST ALLERGY,MED SERV,NEW YORK,NY 10019; COLUMBIA UNIV,COLL PHYS & SURG,NEW YORK,NY 10032	Mount Sinai West; Columbia University								ALSTON WC, 1974, BRIT MED J, V1, P90, DOI 10.1136/bmj.1.5898.90; BACH JF, 1969, TRANSPLANT P, V1, P403; BERNSTEIN RA, 1972, J LAB CLIN MED, V80, P772; BERNSTEIN RA, 1973, J ALLERGY CLIN IMMUN, V51, P89, DOI 10.1016/S0091-6749(73)80025-9; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; CHISARI FV, 1974, J EXP MED, V140, P1122, DOI 10.1084/jem.140.4.1122; CONNOLLY ME, 1976, J CLIN INVEST, V58, P1307; COOKSON DU, 1963, AM REV RESPIR DIS, V88, P636; FALLIERS CJ, 1970, J ALLERGY, V47, P207; FELSBURG PJ, 1977, J IMMUNOL, V118, P62; FIREMAN P, 1970, J ALLERGY, V45, P117; FLAHERTY DK, 1977, J ALLERGY CLIN IMMUN, V59, P48, DOI 10.1016/0091-6749(77)90176-2; FLOREY MJ, 1976, J IMMUNOL METHODS, V13, P201; GALANT SP, 1975, J IMMUNOL, V114, P512; GALANT SP, 1976, J IMMUNOL, V117, P48; GRIECO MH, 1976, J ALLERGY CLIN IMMUN, V58, P149, DOI 10.1016/0091-6749(76)90150-0; GRIECO MH, 1963, AM J MED, V44, P863; GROVE DI, 1975, J ALLERGY CLIN IMMUN, V55, P152, DOI 10.1016/0091-6749(75)90011-1; GUPTA S, 1975, CLIN EXP IMMUNOL, V22, P1; HOROWITZ S, 1975, CLIN IMMUNOL IMMUNOP, V4, P405, DOI 10.1016/0090-1229(75)90009-4; HSIEH KH, 1976, ANN ALLERGY, V37, P383; INOUE S, 1967, J ALLERGY, V40, P337, DOI 10.1016/0021-8707(67)90023-8; JONDAL M, 1972, J EXP MED, V136, P207, DOI 10.1084/jem.136.2.207; KIRKPATRICK CH, 1967, AM REV RESPIR DIS, V96, P692; LEVIN AS, 1975, J CLIN INVEST, V55, P487, DOI 10.1172/JCI107955; LOCKEY SD, 1967, J ALLERGY, V40, P349, DOI 10.1016/0021-8707(67)90024-X; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; LOGSDON PJ, 1973, J ALLERGY CLIN IMMUN, V52, P148, DOI 10.1016/0091-6749(73)90031-6; MASELLI R, 1970, J ALLERGY, V45, P117; MICKEY J, 1975, J BIOL CHEM, V250, P5727; MIDDLETON E, 1968, J ALLERGY, V42, P288, DOI 10.1016/0021-8707(68)90022-1; MJKHERJEE C, 1975, P NATL ACAD SCI US, V72, P1945; MUE S, 1975, TOHOKU J EXP MED, V117, P135, DOI 10.1620/tjem.117.135; NATH I, 1974, CLIN EXP IMMUNOL, V18, P81; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; PARKER CW, 1973, J CLIN INVEST, V52, P1336, DOI 10.1172/JCI107305; PATEL KR, 1974, CLIN ALLERGY, V4, P311, DOI 10.1111/j.1365-2222.1975.tb01868.x; ROBINSON GA, 1966, ANN NY ACAD SCI, V132, P703; SASAKI MT, 1974, J IMMUNOL, V115, P1509; SCHWARTZ HJ, 1973, J ALLERGY CLIN IMMUN, V51, P88, DOI 10.1016/S0091-6749(73)80024-7; SCOTT RE, 1970, BLOOD-J HEMATOL, V35, P514, DOI 10.1182/blood.V35.4.514.514; SMALL P, 1975, ANN ALLERGY, V34, P345; SMITH JW, 1971, J CLIN INVEST, V50, P432, DOI 10.1172/JCI106510; SMITH R, 1975, J IMMUNOL METHODS, V8, P175, DOI 10.1016/0022-1759(75)90094-0; SOKOL WN, 1975, J ALLERGY CLIN IMMUN, V55, P310, DOI 10.1016/0091-6749(75)90003-2; STRANNEGARD IL, 1976, INT ARCH ALLER A IMM, V50, P684, DOI 10.1159/000231547; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; Wybran J, 1971, Trans Assoc Am Physicians, V84, P239; WYBRAN J, 1972, J CLIN INVEST, V51, P2537, DOI 10.1172/JCI107069; WYBRAN J, 1973, NEW ENGL J MED, V288, P710, DOI 10.1056/NEJM197304052881405; YU DTY, 1975, J IMMUNOL, V115, P91; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550	52	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					248	254		10.1016/0091-6749(78)90199-9	http://dx.doi.org/10.1016/0091-6749(78)90199-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	305440				2022-12-18	WOS:A1978EV08000024
J	OKAZAKI, T; ILEA, VS; OKAZAKI, A; WICHER, K; REISMAN, RE; ARBESMAN, CE				OKAZAKI, T; ILEA, VS; OKAZAKI, A; WICHER, K; REISMAN, RE; ARBESMAN, CE			INHIBITION OF ANTIGEN-INDUCED HISTAMINE-RELEASE BY OUABAIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									BUFFALO GEN HOSP,ALLERGY RES LAB,BUFFALO,NY 14203; SUNY BUFFALO,DEPT MED,BUFFALO,NY 14214; SUNY BUFFALO,DEPT MICROBIOL,BUFFALO,NY 14214	Buffalo General Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								AUSTEN KF, 1973, ASTHMA PHYSIOLOGY IM, P111; CHAKRAVARTY N, 1973, ACTA PHYSIOL SCAND, V88, P469, DOI 10.1111/j.1748-1716.1973.tb05476.x; CZERWINSKI A, 1967, AM J PHYSIOL, V213, P786, DOI 10.1152/ajplegacy.1967.213.3.786; EDER M, 1961, Beitr Pathol Anat, V124, P251; GANONG WF, 1971, REV MEDICAL PHYSIOLO, P11; GOLDMAN SS, 1973, J BIOL CHEM, V248, P867; KALINER M, 1974, J IMMUNOL, V112, P664; KATZ AM, 1973, AM J CARDIOL, V31, P193, DOI 10.1016/0002-9149(73)91032-1; LICHTENSTEIN L M, 1973, P91; MOE GK, 1965, PHARMACOL BASIS, P665; MONGAR JL, 1972, BRIT J PHARMACOL, V46, P741, DOI 10.1111/j.1476-5381.1972.tb06899.x; MONGAR JL, 1973, INT ARCH ALLER A IMM, V45, P70, DOI 10.1159/000231004; OKAZAKI T, 1975, J ALLERGY CLIN IMMUN, V56, P243, DOI 10.1016/0091-6749(75)90098-6; PALATINI P, 1972, BIOCHIM BIOPHYS ACTA, V288, P413, DOI 10.1016/0005-2736(72)90262-3; POST RL, 1972, J BIOL CHEM, V247, P6530; SPECHT SC, 1973, ARCH BIOCHEM BIOPHYS, V154, P314, DOI 10.1016/0003-9861(73)90063-5; STAHL WL, 1973, ARCH BIOCHEM BIOPHYS, V154, P56, DOI 10.1016/0003-9861(73)90034-9; STECHSCHULTE DJ, 1974, J IMMUNOL, V112, P970; WHEELER KP, 1970, NATURE, V225, P449, DOI 10.1038/225449a0; YAMASAKI H, 1965, JPN J PHARMACOL, V15, P48, DOI 10.1254/jjp.15.48	20	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	5					454	462		10.1016/0091-6749(76)90061-0	http://dx.doi.org/10.1016/0091-6749(76)90061-0			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BR201	57130				2022-12-18	WOS:A1976BR20100009
J	HIRSCH, SR; RIMM, AA; ZASTROW, JE				HIRSCH, SR; RIMM, AA; ZASTROW, JE			ABSOLUTE PERIPHERAL BASOPHIL COUNT - NEW AND MORE PRECISE METHOD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL WISCONSIN,DEPT MED,ALLERGY SECT,MILWAUKEE,WI; MED COLL WISCONSIN,DEPT BIOSTATISTICS,MILWAUKEE,WI; VET ADM CTR,RES SERV 151,WOOD,WI 53193	Medical College of Wisconsin; Medical College of Wisconsin								BOSEILA AWA, 1959, STAIN TECHNOL, V34, P335, DOI 10.3109/10520295909114701; BOSEILA AWA, 1963, ANN NY ACAD SCI, V103, P394, DOI 10.1111/j.1749-6632.1963.tb53711.x; BOSEILA AWA, 1959, ACTA MED SCAND, V163, P525; BOSEILA AWA, 1959, BASOPHIL LEUKOCYTE R; BRAUNSTEINER H., 1958, ACTA HAEMATOL, V20, P339; BRAUNSTEINER H, 1960, REV HEMATOL, V15, P241; COOPER JR, 1966, J CLIN PATHOL, V19, P402, DOI 10.1136/jcp.19.4.402; HEATH ID, 1961, NATURE, V191, P1370, DOI 10.1038/1911370a0; HIRSCH SR, 1972, J ALLERGY CLIN IMMUN, V50, P338, DOI 10.1016/0091-6749(72)90037-1; JUHLIN L, 1963, ACTA MED SCAND, V174, P249; KOVACS GS, 1966, FOLIA HAEMATOL, V5, P166; MOORE JE, 1953, P SOC EXP BIOL MED, V82, P601; PIETTE M, 1962, Ann Biol Clin (Paris), V20, P197; RORSMAN H, 1957, Acta Derm Venereol, V37, P121; SEYLE H, 1965, MAST CELLS; SHELLEY WB, 1965, J AMER MED ASSOC, V192, P368, DOI 10.1001/jama.1965.03080180026005; TEDESCHI G, 1959, Minerva Med, V50, P1535; THONNARD E, 1963, ACTA HAEMATOL-BASEL, V30, P221, DOI 10.1159/000208127; THONNARDNEUMANN E, 1954, AERZTL FORSCH, V8, P443; THONNARDNEUMANN E, 1951, REV FAC MED, V19, P535; WILLIAMS CS, 1973, J ALLERGY CLIN IMMUN, V51, P80; WINTROBE MM, 1961, CLINICAL HEMATOLOGY	22	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	5					303	310		10.1016/0091-6749(74)90110-9	http://dx.doi.org/10.1016/0091-6749(74)90110-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S9114	4132551				2022-12-18	WOS:A1974S911400008
J	JONES, HE; RINALDI, MG; CHAI, H; KAHN, G				JONES, HE; RINALDI, MG; CHAI, H; KAHN, G			APPARENT CROSS-REACTIVITY OF AIRBORNE MOLDS AND DERMATOPHYTIC FUNGI	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									USA,LETTERMAN GEN HOSP,INST RES,SAN FRANCISCO,CA 94129; CHILDRENS ASTHMA RES INST & HOSP,DENVER,CO	Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)								AJELLO L, 1963, USPHS994 PUB; BARKER SA, 1962, IMMUNOLOGY, V5, P627; BASARAB O., 1968, SABOURAUDIA J INT SOC HUM ANIM MYCOL, V6, P119; BLOCH B, 1909, Z HYG INFEKTIONSKR, V63, P68; CODNER R. C., 1961, SABOURAUDIA JOUR INTERNATL SOC HUMAN AND ANIMAL MYCOL, V1, P116; CRUICKSHANK CND, 1960, J INVEST DERMATOL, V35, P219, DOI 10.1038/jid.1960.107; DURHAM OC, 1954, PRACTICE ALLERGY; JONES HE, 1973, ARCH DERMATOL, V108, P61, DOI 10.1001/archderm.108.1.61; PALMSTIERNA HANS, 1962, SCI TOOLS, V9, P25; PEPYS J, 1959, NATURE, V184, P1328, DOI 10.1038/1841328a0; PRINCE HE, 1959, CURRENT PROBLEMS ALL; REBELL G, 1970, DERMATOPHYTES THEIR; REYES AC, 1966, J INVEST DERMATOL, V47, P27, DOI 10.1038/jid.1966.5; SULZBERGER M, 1940, DERMATOLOGIC ALLERGY; WALZER RA, 1962, J INVEST DERMATOL, V39, P165, DOI 10.1038/jid.1962.98; WOOD SR, 1962, BRIT J DERMATOL, V74, P329, DOI 10.1111/j.1365-2133.1962.tb13521.x	16	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	6					346	351		10.1016/0091-6749(73)90093-6	http://dx.doi.org/10.1016/0091-6749(73)90093-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R5074	4752932				2022-12-18	WOS:A1973R507400004
J	SCHWARTZ, HJ; WHITE, LW				SCHWARTZ, HJ; WHITE, LW			URINARY AND PLASMA CYCLIC-AMP RESPONSES TO EPINEPHRINE IN ASTHMATIC AND NORMAL SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					88	89		10.1016/S0091-6749(73)80024-7	http://dx.doi.org/10.1016/S0091-6749(73)80024-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913		Bronze			2022-12-18	WOS:A1973O791300024
J	ZEMAN, GO; WILLIAMS, GC; BUDRYS, M; JAVOR, H; COHEN, G				ZEMAN, GO; WILLIAMS, GC; BUDRYS, M; JAVOR, H; COHEN, G			EFFECT OF PLASMA CORTISOL LEVELS ON LYMPHOCYTE TRANSFORMATION TEST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		ASTALDI G, 1969, BLUT, V19, P8, DOI 10.1007/BF01632969; CARON GA, 1967, INT ARCH ALLER A IMM, V32, P191, DOI 10.1159/000229927; CARON GA, 1969, 3 P ANN LEUC CULT C, P287; Dougherty TF, 1943, P SOC EXP BIOL MED, V53, P132, DOI 10.3181/00379727-53-14219P; Dougherty Thomas F., 1943, SCIENCE, V98, P367, DOI 10.1126/science.98.2547.367; EURENIUS K, 1969, BIOCHIM BIOPHYS ACTA, V177, P572, DOI 10.1016/0304-4165(69)90321-3; FORBES IJ, 1966, ANN INTERN MED, V65, P69, DOI 10.7326/0003-4819-65-1-69; FORBES IJ, 1967, LANCET, V2, P334; FRANK JA, 1953, P SOC EXP BIOL MED, V82, P17; GANTT CL, 1964, METABOLISM, V13, P1327, DOI 10.1016/0026-0495(64)90152-0; NELSON SD, 1969, ANN RHEUM DIS, V28, P524, DOI 10.1136/ard.28.5.524; NOWELL PC, 1961, CANCER RES, V21, P1518; ROATH S, 1965, CLIN RES, V13, P542; TORMEY DC, 1967, NATURE, V213, P281, DOI 10.1038/213281a0	14	17	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	1					10	&		10.1016/0091-6749(72)90118-2	http://dx.doi.org/10.1016/0091-6749(72)90118-2			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L3388	4331971				2022-12-18	WOS:A1972L338800002
J	Gevaert, P; Saenz, R; Corren, J; Han, JK; Mullol, J; Lee, SE; Ow, RA; Zhao, R; Howard, M; Wong, K; Islam, L; Ligueros-Saylan, M; Omachi, TA; Bachert, C				Gevaert, Philippe; Saenz, Rebecca; Corren, Jonathan; Han, Joseph K.; Mullol, Joaquim; Lee, Stella E.; Ow, Randall A.; Zhao, Rui; Howard, Monet; Wong, Kit; Islam, Lutaf; Ligueros-Saylan, Monica; Omachi, Theodore A.; Bachert, Claus			Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Nasal polyps; rhinosinusitis; omalizumab; quality of life; nasal obstruction; IgE; asthma; nasal corticosteroids; Nasal Polyp Score; Nasal Congestion Score	QUALITY-OF-LIFE; CHRONIC RHINOSINUSITIS; PREVALENCE; OUTCOMES; DISEASE; ASTHMA; IGE	Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) frequently remains uncontrolled despite maximal medical therapy and sinonasal surgery, presenting several unmet needs and challenges. Omalizumab previously demonstrated efficacy in CRSwNP in duplicate phase 3, randomized, placebo-controlled trials (POLYP 1, POLYP 2). Objective: This open-label extension evaluated the continued efficacy, safety, and durability of response of omalizumab in adults with CRSwNP who completed POLYP 1 or 2. Methods: After 24 weeks of omalizumab or placebo in POLYP 1 and 2, patients (n = 249) received open-label omalizumab plus background nasal mometasone therapy for 28 weeks and were subsequently followed for 24 weeks after omalizumab discontinuation. Efficacy end points assessed change from baseline for the coprimary end points, Nasal Polyp Score and Nasal Congestion Score, and the secondary end points of Sino-Nasal Outcome Test 22, Total Nasal Symptom Score and its components, and University of Pennsylvania Smell Identification Test scores. Safety objectives included incidence of adverse events and adverse events leading to omalizumab discontinuation. Results: Patients who continued omalizumab experienced further improvements across coprimary end points and secondary end points through 52 weeks. Patients who switched from placebo to omalizumab experienced favorable responses across end points through week 52 that were similar to POLYP 1 and 2 at week 24. After omalizumab discontinuation, scores gradually worsened over the 24-week follow-up, but remained improved from pretreatment levels for both groups. The safety profile was similar to previous reports. Conclusions: The efficacy and safety profile from this study supports extended omalizumab treatment up to 1 year for CRSwNP with inadequate response to nasal corticosteroids.	[Gevaert, Philippe; Bachert, Claus] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airway Res Lab, Ghent, Belgium; [Saenz, Rebecca; Zhao, Rui; Wong, Kit; Omachi, Theodore A.] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA; [Corren, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Corren, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Han, Joseph K.] Eastern Virginia Med Sch, Norfolk, VA 23501 USA; [Mullol, Joaquim] Univ Barcelona, Hosp Clin, IDIBAPS, Rhinol Unit,CIBERES, Barcelona, Spain; [Mullol, Joaquim] Univ Barcelona, Hosp Clin, IDIBAPS, Smell Clin,ENT Dept,CIBERES, Barcelona, Spain; [Lee, Stella E.] Univ Pittsburgh, Med Ctr, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA; [Ow, Randall A.] Sacramento Ear Nose & Throat Surg & Med Grp Inc, Sacramento, CA USA; [Howard, Monet] Roche, Mississauga, ON, Canada; [Islam, Lutaf] Roche, Welwyn Garden City, Herts, England; [Ligueros-Saylan, Monica] Novartis Pharmaceut, E Hanover, NJ USA; [Bachert, Claus] Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden; [Bachert, Claus] Sun Yat Sen Univ, Int Airway Res Ctr, Affiliated Hosp 1, Guangzhou, Peoples R China	Ghent University; Ghent University Hospital; Roche Holding; Genentech; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Eastern Virginia Medical School; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Roche Holding; Roche Holding; Novartis; Karolinska Institutet; Sun Yat Sen University	Saenz, R (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	saenz.rebecca@gene.com			Genentech, Inc; Novartis Pharma AG; Genentech, Inc.	Genentech, Inc(Roche HoldingGenentech); Novartis Pharma AG; Genentech, Inc.(Roche HoldingGenentech)	This study was funded by Genentech, Inc, a member of the Roche Group, and Novartis Pharma AG. Third-party writing assistance was funded by Genentech, Inc.	Bachert C, 2021, J ALLERGY CLIN IMMUN, V147, P29, DOI 10.1016/j.jaci.2020.11.013; Bachert C, 2015, J ALLERGY CLIN IMMUN, V136, P1431, DOI 10.1016/j.jaci.2015.10.010; Benjamin MR, 2019, J ALLER CL IMM-PRACT, V7, P1010, DOI 10.1016/j.jaip.2018.10.014; Cao PP, 2014, CLIN EXP ALLERGY, V44, P690, DOI 10.1111/cea.12304; de Loos DD, 2019, J ALLERGY CLIN IMMUN, V143, P1207, DOI 10.1016/j.jaci.2018.12.986; De Schryver E, 2015, ALLERGY ASTHMA IMMUN, V7, P321, DOI 10.4168/aair.2015.7.4.321; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Dullaers M, 2012, J ALLERGY CLIN IMMUN, V129, P635, DOI 10.1016/j.jaci.2011.10.029; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens WJ, 2019, ALLERGY, V74, P2312, DOI 10.1111/all.13875; Gasser P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13815-w; Gevaert P, 2020, J ALLERGY CLIN IMMUN, V146, P595, DOI 10.1016/j.jaci.2020.05.032; Hall R, 2020, VALUE HEALTH, V23, P632, DOI 10.1016/j.jval.2019.11.005; Hedman J, 1999, INT J EPIDEMIOL, V28, P717, DOI 10.1093/ije/28.4.717; Hopkins C, 2009, CLIN OTOLARYNGOL, V34, P447, DOI 10.1111/j.1749-4486.2009.01995.x; International Council for Harmonisation, ICH HARM GUID INT AD; Jean T, 2019, ALLERGY ASTHMA PROC, V40, P316, DOI 10.2500/aap.2019.40.4241; Johansson L, 2003, ANN OTO RHINOL LARYN, V112, P625, DOI 10.1177/000348940311200709; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Khusial RJ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00289-2019; Klossek JM, 2005, ALLERGY, V60, P233, DOI 10.1111/j.1398-9995.2005.00688.x; Kowalski ML, 2019, ALLERGY, V74, P28, DOI 10.1111/all.13599; Laidlaw TM, 2019, J ALLER CL IMM-PRACT, V7, P2462, DOI 10.1016/j.jaip.2019.03.044; McCoul ED, 2019, JAMA OTOLARYNGOL, V145, P319, DOI 10.1001/jamaoto.2018.4162; Menzella F, 2017, ALLERGY ASTHMA IMMUN, V9, P368, DOI 10.4168/aair.2017.9.4.368; Newton Jonathan Ray, 2008, Ther Clin Risk Manag, V4, P507; Ohki Y, 2020, RHINOLOGY, V58, P136, DOI 10.4193/Rhin18.225; Pennington LF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11610; Robles-Diaz M, 2014, GASTROENTEROLOGY, V147, P109, DOI 10.1053/j.gastro.2014.03.050; Schneider S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040925; Stevens WW, 2016, J ALLER CL IMM-PRACT, V4, P565, DOI 10.1016/j.jaip.2016.04.012; Vickery TW, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0853-7; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	35	16	16	3	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					957	+		10.1016/j.jaci.2021.07.045	http://dx.doi.org/10.1016/j.jaci.2021.07.045			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34530020	hybrid			2022-12-18	WOS:000765938100025
J	Brown, LAK; Moran, E; Goodman, A; Baxendale, H; Bermingham, W; Buckland, M; AbdulKhaliq, I; Jarvis, H; Hunter, M; Karanam, S; Patel, A; Jenkins, M; Robbins, A; Khan, S; Simpson, T; Jolles, S; Underwood, J; Savic, S; Richter, A; Shields, A; Brown, M; Lowe, DM				Brown, Li-An K.; Moran, Ed; Goodman, Anna; Baxendale, Helen; Bermingham, William; Buckland, Matthew; AbdulKhaliq, Iman; Jarvis, Hannah; Hunter, Michael; Karanam, Surendra; Patel, Aisha; Jenkins, Megan; Robbins, Alexander; Khan, Sujoy; Simpson, Thomas; Jolles, Stephen; Underwood, Jonathan; Savic, Sinisa; Richter, Alex; Shields, Adrian; Brown, Michael; Lowe, David M.			Treatment of chronic or relapsing COVID-19 in immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						COVID-19; SARS-CoV-2; immunodeficiency; therapeutic monoclonal; remdesivir	CORONAVIRUS DISEASE 2019; IMMUNOCOMPROMISED PATIENTS; PATIENT	Background: Patients with some types of immunodeficiency can experience chronic or relapsing infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This leads to morbidity and mortality, infection control challenges, and the risk of evolution of novel viral variants. The optimal treatment for chronic coronavirus disease 2019 (COVID-19) is unknown. Objective: Our aim was to characterize a cohort of patients with chronic or relapsing COVID-19 disease and record treatment response. Methods: We conducted a UK physician survey to collect data on underlying diagnosis and demographics, clinical features, and treatment response of immunodeficient patients with chronic (lasting >= 21 days) or relapsing (>= 2 episodes) of COVID-19. Results: We identified 31 patients (median age 49 years). Their underlying immunodeficiency was most commonly characterized by antibody deficiency with absent or profoundly reduced peripheral B-cell levels; prior anti-CD20 therapy, and X-linked agammaglobulinemia. Their clinical features of COVID-19 were similar to those of the general population, but their median duration of symptomatic disease was 64 days (maximum 300 days) and individual patients experienced up to 5 episodes of illness. Remdesivir monotherapy (including when given for prolonged courses of <= 20 days) was associated with sustained viral clearance in 7 of 23 clinical episodes (30.4%), whereas the combination of remdesivir with convalescent plasma or anti-SARS-CoV-2 mAbs resulted in viral clearance in 13 of 14 episodes (92.8%). Patients receiving no therapy did not clear SARS-CoV-2. Conclusions: COVID-19 can present as a chronic or relapsing disease in patients with antibody deficiency. Remdesivir monotherapy is frequently associated with treatment failure, but the combination of remdesivir with antibody-based therapeutics holds promise.	[Brown, Li-An K.; Lowe, David M.] UCL, Inst Immun & Transplantat, Royal Free Campus,Pond St, London NW3 2QG, England; [Brown, Li-An K.; Patel, Aisha; Brown, Michael] Univ Coll London Hosp NHS Fdn Trust, London, England; [Moran, Ed; Jenkins, Megan] North Bristol NHS Trust, Bristol, Avon, England; [Goodman, Anna] Guys & St Thomas NHS Fdn Trust, London, England; [Baxendale, Helen] Royal Papworth Hosp NHS Fdn Trust, Cambridge, England; [Bermingham, William; Richter, Alex; Shields, Adrian] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Buckland, Matthew] Barts Hlth, London, England; [Buckland, Matthew] UCL, Inst Child Hlth, London, England; [Buckland, Matthew] Great Ormond St Hosp Sick Children, London, England; [AbdulKhaliq, Iman] Mid & South Essex NHS Fdn Trust, Basildon, Essex, England; [Jarvis, Hannah; Lowe, David M.] Royal Free London NHS Fdn Trust, London, England; [Hunter, Michael] Royal Victoria Hosp, Belfast, Antrim, North Ireland; [Karanam, Surendra] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England; [Robbins, Alexander] Imperial Coll Healthcare NHS Trust, London, England; [Khan, Sujoy] Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, N Humberside, England; [Simpson, Thomas] Lewisham & Greenwich NHS Trust, London, England; [Jolles, Stephen] Univ Hosp Wales, Cardiff, Wales; [Underwood, Jonathan] Cardiff & Vale Univ Hlth Board, Dept Infect Dis, Cardiff, Wales; [Underwood, Jonathan] Cardiff Univ, Div Infect & Immun, Cardiff, Wales; [Savic, Sinisa] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Savic, Sinisa] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Richter, Alex; Shields, Adrian] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Brown, Michael] London Sch Hyg & Trop Med, Clin Res Dept, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; North Bristol NHS Trust; Guy's & St Thomas' NHS Foundation Trust; Papworth Hospital; University of Birmingham; Barts Health NHS Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; Imperial College London; Cardiff University; Cardiff University; University of Leeds; University of Leeds; University of Birmingham; University of London; London School of Hygiene & Tropical Medicine	Lowe, DM (corresponding author), UCL, Inst Immun & Transplantat, Royal Free Campus,Pond St, London NW3 2QG, England.	d.lowe@ucl.ac.uk	Buckland, Matthew/H-7049-2019	Buckland, Matthew/0000-0002-5646-4707; Underwood, Jonathan/0000-0001-6963-2821; Savic, Sinisa/0000-0001-7910-0554; Robbins, Alexander/0000-0001-6929-5802				Aljaberi R, 2020, ANN ALLERG ASTHMA IM, V125, P349, DOI 10.1016/j.anai.2020.06.006; Avanzato VA, 2020, CELL, V183, P1901, DOI 10.1016/j.cell.2020.10.049; Brown LAK, 2019, J ALLERGY CLIN IMMUN, V144, P1450, DOI 10.1016/j.jaci.2019.07.036; Buckland MS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19761-2; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Fill Lauren, 2020, Ann Allergy Asthma Immunol, V125, P112, DOI 10.1016/j.anai.2020.04.033; Helleberg M, 2020, J INFECT DIS, V222, P1103, DOI 10.1093/infdis/jiaa446; Hueso T, 2020, BLOOD, V136, P2290, DOI 10.1182/blood.2020008423; Iaboni A, 2021, J CLIN IMMUNOL, V41, P923, DOI 10.1007/s10875-021-00983-y; Jin HL, 2020, J ALLER CL IMM-PRACT, V8, P3594, DOI 10.1016/j.jaip.2020.08.059; Kainulainen L, 2010, J ALLERGY CLIN IMMUN, V126, P120, DOI 10.1016/j.jaci.2010.04.016; London J, 2021, J CLIN IMMUNOL, V41, P356, DOI 10.1007/s10875-020-00904-5; Martinot M, 2021, CLIN INFECT DIS, V73, pE1762, DOI 10.1093/cid/ciaa1474; Meyts I, 2021, J ALLERGY CLIN IMMUN, V147, P520, DOI 10.1016/j.jaci.2020.09.010; Mira E, 2020, J ALLER CL IMM-PRACT, V8, P2793, DOI 10.1016/j.jaip.2020.06.046; Mullur J, 2021, ANN ALLERG ASTHMA IM, V126, P90, DOI 10.1016/j.anai.2020.08.017; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Quinti I, 2020, J ALLERGY CLIN IMMUN, V146, P211, DOI 10.1016/j.jaci.2020.04.013; Rambaut A, PRELIMINARY GENOMIC, P2021; Ribeiro LC, 2021, ALLERGY ASTHMA CL IM, V17, DOI 10.1186/s13223-021-00518-5; Rodionov RN, 2021, LANCET MICROBE, V2, pE138, DOI 10.1016/S2666-5247(21)00030-6; Soresina A, 2020, PEDIAT ALLERG IMM-UK, V31, P565, DOI 10.1111/pai.13263; Tarhini H, 2021, J INFECT DIS, V223, P1522, DOI 10.1093/infdis/jiab075; Van Damme KFA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.596761	25	16	16	6	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					557	+		10.1016/j.jaci.2021.10.031	http://dx.doi.org/10.1016/j.jaci.2021.10.031			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34780850	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000752623200013
J	Kim, J; Lee, J; Kim, HJ; Kameyama, N; Nazarian, R; Der, E; Cohen, S; Guttman-Yassky, E; Putterman, C; Krueger, JG				Kim, Jaehwan; Lee, Jongmi; Kim, Hyun Je; Kameyama, Naoya; Nazarian, Roya; Der, Evan; Cohen, Steven; Guttman-Yassky, Emma; Putterman, Chaim; Krueger, James G.			Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Psoriasis; single-cell RNA sequencing; T cells; dendritic cells; keratinocytes; emigrating cells	T-CELLS; DENDRITIC CELLS; C-MAF; GENE-EXPRESSION; PROMOTE; DIFFERENTIATION; TARGET; IL-10; CD73	Background: In previous human skin single-cell data, inflammatorycells constituted only a small fraction of the overall cell population, such that functional subsets were difficult to ascertain. Objective: Our aims were to overcome the aforesaid limitation by applying single-cell transcriptomics to emigrating cells from skin and elucidate ex vivo gene expression profiles of pathogenic versus regulatory immune cell subsets in the skin of individuals with psoriasis. Methods: We harvested emigrating cells from human psoriasis skin after incubation in culture medium without enzyme digestion or cell sorting and analyzed cells with single-cell RNA sequencing and flow cytometry simultaneously. Results: Unsupervised clustering of harvested cells from psoriasis skin and control skin identified natural killer cells, T-cell subsets, dendritic cell subsets, melanocytes, and keratinocytes in different layers. Comparison between psoriasis cells and control cells within each cluster revealed that (1) cutaneous type 17 T cells display highly differing transcriptome profiles depending on IL-17A versus IL-17F expression and IFN-gamma versus IL-10 expression; (2) semimature dendritic cells are regulatory dendritic cells with high IL-10 expression, but a subset of semimature dendritic cells expresses IL-23A and IL-36G in psoriasis; and (3) CCL27-CCR10 interaction is potentially impaired in psoriasis because of decreased CCL27 expression in basal keratinocytes. Conclusion: We propose that single-cell transcriptomics applied to emigrating cells from human skin provides an innovative study platform to compare gene expression profiles of heterogenous immune cells in various inflammatory skin diseases.	[Kim, Jaehwan; Lee, Jongmi; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10065 USA; [Kim, Jaehwan; Nazarian, Roya; Cohen, Steven] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Dermatol, Bronx, NY 10467 USA; [Kim, Hyun Je; Kameyama, Naoya; Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, Lab Inflammatory Skin Dis, New York, NY 10029 USA; [Kim, Hyun Je; Kameyama, Naoya; Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Kim, Hyun Je] Samsung Med Ctr, Dept Dermatol, Seoul, South Korea; [Der, Evan; Putterman, Chaim] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Rheumatol, Bronx, NY 10467 USA; [Putterman, Chaim] Azrieli Sch Med, Safed, Ramat Gan, Israel; [Putterman, Chaim] Galillee Med Ctr, Res Inst, Nahariyya, Israel	Rockefeller University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Sungkyunkwan University (SKKU); Samsung Medical Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Kim, J (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10065 USA.; Kim, J (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	jkim05@rockefeller.edu	Putterman, Chaim/AFR-0429-2022	Kim, Jaehwan/0000-0002-7586-1425	National Psoriasis Foundation; National Center for Advancing Translational Sciences [UL1TR001866]; National Institutes of Health Clinical and Translational Science Award program	National Psoriasis Foundation; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health Clinical and Translational Science Award program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the National Psoriasis Foundation Discovery Grant 2018 and in part by grant UL1TR001866 from the National Center for Advancing Translational Sciences and the National Institutes of Health Clinical and Translational Science Award program.	Alam MS, 2009, J INFECT DIS, V199, P494, DOI 10.1086/596205; Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Aschenbrenner D, 2018, NAT IMMUNOL, V19, P1126, DOI 10.1038/s41590-018-0200-5; Autengruber A, 2012, EUR J MICROBIOL IMMU, V2, P112, DOI 10.1556/EuJMI.2.2012.2.3; Burns LA, 2020, EUR J IMMUNOL, V50, P568, DOI 10.1002/eji.201948138; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; Der E, 2019, NAT IMMUNOL, V20, P915, DOI 10.1038/s41590-019-0386-1; Der E, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93009; Devitt K, 2019, VIROLOGY, V537, P14, DOI 10.1016/j.virol.2019.08.007; Fujita H, 2009, P NATL ACAD SCI USA, V106, P21795, DOI 10.1073/pnas.0911472106; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Gudjonsson JE, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139930; Gulati Nicholas, 2015, F1000Res, V4, P149, DOI 10.12688/f1000research.6581.1; Harden JL, 2016, J ALLERGY CLIN IMMUN, V137, P1830, DOI 10.1016/j.jaci.2015.09.055; He HL, 2020, J ALLERGY CLIN IMMUN, V145, P1615, DOI 10.1016/j.jaci.2020.01.042; Hu D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01571-8; Kim D, 2020, NAT MED, V26, P236, DOI 10.1038/s41591-019-0733-7; Kim J, 2018, J INVEST DERMATOL, V138, P2669, DOI 10.1016/j.jid.2018.05.021; Kim J, 2017, ANNU REV MED, V68, P255, DOI 10.1146/annurev-med-042915-103905; Klicznik MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav8995; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kulkarni A, 2019, CURR OPIN BIOTECH, V58, P129, DOI 10.1016/j.copbio.2019.03.001; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li C, 2021, J ALLERGY CLIN IMMUN, V147, P759, DOI 10.1016/j.jaci.2020.05.044; Li QS, 2016, J IMMUNOL, V197, P962, DOI 10.4049/jimmunol.1502615; Lowe MM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139932; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller A, 2018, P NATL ACAD SCI USA, V115, P10088, DOI 10.1073/pnas.1801377115; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Riis JL, 2011, EXP DERMATOL, V20, P789, DOI 10.1111/j.1600-0625.2011.01323.x; Rojahn TB, 2020, J ALLERGY CLIN IMMUN, V146, P1056, DOI 10.1016/j.jaci.2020.03.041; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sole-Boldo L, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0922-4; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Takahashi R, 2020, J INVEST DERMATOL, V140, P764, DOI 10.1016/j.jid.2019.07.726; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; WATANABE S, 1991, Journal of Dermatology (Tokyo), V18, P143; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Wu XY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01112; Xia MC, 2014, J ALLERGY CLIN IMMUN, V134, P634, DOI 10.1016/j.jaci.2014.03.010; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Xue D, 2020, J DERMATOL SCI, V97, P41, DOI [10.1016/j.dermsci.2019.11.012, 10.1016/j.jdermsci.2019.11.012]; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194	50	16	17	3	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1281	1292		10.1016/j.jaci.2021.04.021	http://dx.doi.org/10.1016/j.jaci.2021.04.021		NOV 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV7LX	33932468	Green Accepted			2022-12-18	WOS:000717415000026
J	Kulis, MD; Smeekens, JM; Immormino, RM; Moran, TP				Kulis, Michael D.; Smeekens, Johanna M.; Immormino, Robert M.; Moran, Timothy P.			The airway as a route of sensitization to peanut: An update to the dual allergen exposure hypothesis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; peanut allergy; dual allergen exposure hypothesis; airway; cutaneous	FOOD ALLERGY; CONSUMPTION; PROTEIN; DUST; TOLERANCE; INFANTS; RISK; SKIN; ANAPHYLAXIS; PREVALENCE	Food allergies have increased at an alarming rate over the past 2 decades, indicating that environmental factors are driving disease progression. It has been postulated that sensitization to foods, in particular, peanut, occurs through impaired skin. Peanut allergens have been quantified in household dust and may be the culprit source. Indeed, T(H)2 cell-skewing innate cytokines can be driven by application of food antigens on both intact and impaired skin of mice, resulting in antigen-specific IgE production and anaphylaxis following allergen exposure. However, allergy induction through the skin can be prevented by induction of oral tolerance before skin exposure. These observations led to the dual allergen exposure hypothesis, according to which oral exposure to food antigens leads to tolerance and antigen exposure on impaired skin leads to allergy. Here, we propose the airway as an alternative route of sensitization in the dual allergen exposure hypothesis that leads to food allergy. Specifically, we will provide evidence from mouse models and human cell-based studies that together implicate the airway as a plausible route of sensitization.	[Kulis, Michael D.; Smeekens, Johanna M.; Immormino, Robert M.; Moran, Timothy P.] Univ N Carolina, Dept Pediat, Div Allergy & Immunol, Chapel Hill, NC 27515 USA; [Kulis, Michael D.; Smeekens, Johanna M.] Univ N Carolina, Univ North Carolina Food Allergy Initiat, Sch Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kulis, MD (corresponding author), 116 Manning Dr,Room 3310, Chapel Hill, NC 27599 USA.	Mike.kulis@unc.edu			T32 Allergy/Immunology Training Grant through Duke University [AI007062]; T32 Allergy/Immunology Training Grant through University of North Carolina at Chapel Hill [AI007062]; National Institutes of Health/National Institute of Environmental Health Sciences [K08 ES029118]; American Academy of Allergy, Asthma and Immunology Foundation; University of North Carolina Center for Environmental Health and Susceptibility	T32 Allergy/Immunology Training Grant through Duke University; T32 Allergy/Immunology Training Grant through University of North Carolina at Chapel Hill; National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Academy of Allergy, Asthma and Immunology Foundation; University of North Carolina Center for Environmental Health and Susceptibility	Supported by a T32 Allergy/Immunology Training Grant (AI007062 [to J.M.S.] ) through Duke University and the University of North Carolina at Chapel Hill; the National In-stitutes of Health/National Institute of Environmental Health Sciences (grant K08 ES029118 [to T.P.M.] ) ; the American Academy of Allergy, Asthma and Immunology Foundation (to T.P.M.) ; and the University of North Carolina Center for Environmental Health and Susceptibility (to T.P.M. and M.D.K.) .	Blom LH, 2018, J ALLERGY CLIN IMMUN, V141, P1498, DOI 10.1016/j.jaci.2017.10.037; Boralevi F, 2008, ALLERGY, V63, P205, DOI 10.1111/j.1398-9995.2007.01556.x; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Brough HA, 2018, CLIN EXP ALLERGY, V48, P586, DOI 10.1111/cea.13111; Brough HA, 2020, ALLERGY, V75, P2185, DOI 10.1111/all.14304; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P867, DOI 10.1016/j.jaci.2014.08.011; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P630, DOI 10.1016/j.jaci.2013.02.034; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P623, DOI 10.1016/j.jaci.2013.02.035; Chan SMH, 2012, ALLERGY, V67, P336, DOI 10.1111/j.1398-9995.2011.02765.x; Crespo JF, 2001, J ALLERGY CLIN IMMUN, V108, P295, DOI 10.1067/mai.2001.116860; DeLong JH, 2011, J ALLERGY CLIN IMMUN, V127, P1211, DOI 10.1016/j.jaci.2011.02.028; Dioszeghy V, 2011, J IMMUNOL, V186, P5629, DOI 10.4049/jimmunol.1003134; Dolence JJ, 2018, J ALLERGY CLIN IMMUN, V142, P1144, DOI 10.1016/j.jaci.2017.11.020; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; du Toit G, 2016, J ALLERGY CLIN IMMUN, V137, P998, DOI 10.1016/j.jaci.2016.02.005; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Du Toit G, 2013, J ALLERGY CLIN IMMUN, V131, P135, DOI 10.1016/j.jaci.2012.09.015; Gupta RS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.5630; Gupta RS, 2012, CLIN PEDIATR, V51, P856, DOI 10.1177/0009922812448526; Jungewelter S, 2020, AM J IND MED, V63, P1047, DOI 10.1002/ajim.23185; Kotachi M, 2020, ALLERGOL INT, V69, P471, DOI 10.1016/j.alit.2019.12.011; Krempski JW, 2020, J IMMUNOL, V204, P3086, DOI 10.4049/jimmunol.2000029; Kulis MD, 2020, IMMUN INFLAMM DIS, V8, P211, DOI 10.1002/iid3.296; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Leser C, 2001, J INVEST ALLERG CLIN, V11, P89; Leung DYM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav2685; Leyva-Castillo JM, 2019, IMMUNITY, V50, P1262, DOI 10.1016/j.immuni.2019.03.023; Lipp T, 2021, ALLERGY, V76, P3041, DOI 10.1111/all.14742; Makinen-Kiljunen S, 2002, ALLERGY, V57, P1084, DOI 10.1034/j.1398-9995.2002.23836_6.x; McGowan EC, 2015, J ALLERGY CLIN IMMUN, V135, P171, DOI 10.1016/j.jaci.2014.06.033; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Palma-Carlos A G, 2005, Eur Ann Allergy Clin Immunol, V37, P183; Sheehan WJ, 2017, J ALLERGY CLIN IMMUN, V140, P1724, DOI 10.1016/j.jaci.2017.05.042; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Smeekens JM, 2021, J ALLERGY CLIN IMMUN, V147, P387, DOI 10.1016/j.jaci.2020.09.011; Smeekens JM, 2020, IMMUNOL ALLERGY CLIN, V40, P87, DOI 10.1016/j.iac.2019.09.006; Smeekens JM, 2019, CLIN EXP ALLERGY, V49, P1500, DOI 10.1111/cea.13486; Strid J, 2005, CLIN EXP ALLERGY, V35, P757, DOI 10.1111/j.1365-2222.2005.02260.x; Tordesillas L, 2018, CLIN REV ALLERG IMMU, V55, P107, DOI 10.1007/s12016-018-8680-5; Tordesillas L, 2014, J CLIN INVEST, V124, P4965, DOI 10.1172/JCI75660; Trendelenburg V, 2018, ALLERGY, V73, P261, DOI 10.1111/all.13303; Tsitoura DC, 2000, J ALLERGY CLIN IMMUN, V106, P239; Walker MT, 2018, J ALLERGY CLIN IMMUN, V141, P1711, DOI 10.1016/j.jaci.2018.02.003	45	16	16	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					689	693		10.1016/j.jaci.2021.05.035	http://dx.doi.org/10.1016/j.jaci.2021.05.035		SEP 2021	5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	34111450	Green Accepted			2022-12-18	WOS:000695242900008
J	Tay, ASL; Li, CH; Nandi, T; Chng, KR; Andiappan, AK; Mettu, VS; de Cevins, C; Ravikrishnan, A; Dutertre, CA; Wong, XFCC; Ng, AHQ; Matta, SA; Ginhoux, F; Rotzschke, O; Chew, FT; Tang, MBY; Yew, YW; Nagarajan, N; Common, JEA				Tay, Angeline S. L.; Li, Chenhao; Nandi, Tannistha; Chng, Kern Rei; Andiappan, Anand Kumar; Mettu, Vijaya Saradhi; de Cevins, Camille; Ravikrishnan, Aarthi; Dutertre, Charles-Antoine; Wong, X. F. Colin C.; Ng, Amanda Hui Qi; Matta, Sri Anusha; Ginhoux, Florent; Rotzschke, Olaf; Chew, Fook Tim; Tang, Mark B. Y.; Yew, Yik Weng; Nagarajan, Niranjan; Common, John E. A.			Atopic dermatitis microbiomes stratify into ecologic dermotypes enabling microbial virulence and disease severity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; skin; microbiome; nonlesional; stratification; biomarkers	SKIN MICROBIOME; STAPHYLOCOCCUS-AUREUS; FILAGGRIN GENE; CORNEUM; COMORBIDITIES; ASSOCIATION; SERUM	Background: Atopic dermatitis (AD) is a common skin disease affecting up to 20% of the global population, with significant clinical heterogeneity and limited information about molecular subtypes and actionable biomarkers. Although alterations in the skin microbiome have been described in subjects with AD during progression to flare state, the prognostic value of baseline microbiome configurations has not been explored. Objective: Our aim was to identify microbial signatures on AD skin that are predictive of disease fate. Methods: Nonlesional skin of patients with AD and healthy control subjects were sampled at 2 time points separated by at least 4 weeks. Using whole metagenome analysis of skin microbiomes of patients with AD and control subjects (n = 49 and 189 samples), we identified distinct microbiome configurations (dermotypes A and B). Blood was collected for immunophenotyping, and skin surface samples were analyzed for correlations with natural moisturizing factors and antimicrobial peptides. Results: Dermotypes were robust and validated across 2 additional cohorts (63 individuals), with strong enrichment of subjects with AD in dermotype B. Dermotype B was characterized by reduced microbial richness, depletion of Cutibacterium acnes, Dermacoccus and Methylobacterium species, individual-specific outlier abundance of Staphylococcus species (eg, S epidermidis, S capitis, S aureus), and enrichment in metabolic pathways (eg, branched chain amino acids and arginine biosynthesis) and virulence genes (eg, beta-toxin, delta-toxin) that defined a pathogenic ecology. Skin surface and circulating host biomarkers exhibited a distinct microbial-associated signature that was further reflected in more severe itching, frequent flares, and increased disease severity in patients harboring the dermotype B microbiome. Conclusion: We report distinct clusters of microbial profiles that delineate the role of microbiome configurations in AD heterogeneity, highlight a mechanism for ongoing inflammation, and provide prognostic utility toward microbiome-based disease stratification.	[Tay, Angeline S. L.; Wong, X. F. Colin C.; Ginhoux, Florent; Common, John E. A.] Skin Res Inst Singapore, 8A Biomed Grove,06-10 Immunos, Singapore, Singapore; [Li, Chenhao; Nandi, Tannistha; Chng, Kern Rei; de Cevins, Camille; Ravikrishnan, Aarthi; Ng, Amanda Hui Qi; Nagarajan, Niranjan] Genome Inst Singapore, 60 Biopolis,02-01 Genome, Singapore 138672, Singapore; [Andiappan, Anand Kumar; Dutertre, Charles-Antoine; Ginhoux, Florent; Rotzschke, Olaf] Singapore Immunol Network, Singapore, Singapore; [Mettu, Vijaya Saradhi] Agcy Sci Technol & Res Res Inst, Biol Resource Ctr, Singapore, Singapore; [Matta, Sri Anusha; Chew, Fook Tim] Natl Univ Singapore, TheYong Loo Lin Sch Med, Singapore, Singapore; [Tang, Mark B. Y.; Yew, Yik Weng] Natl Healthcare Grp, Natl Skin Ctr, Singapore, Singapore; [Tang, Mark B. Y.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); Skin Research Institute of Singapore (SRIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; National Skin Centre; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Common, JEA (corresponding author), Skin Res Inst Singapore, 8A Biomed Grove,06-10 Immunos, Singapore, Singapore.; Nagarajan, N (corresponding author), Genome Inst Singapore, 60 Biopolis,02-01 Genome, Singapore 138672, Singapore.	nagarajann@gis.a-star.edu.sg; john.common@sris.a-star.edu.sg	Common, John/Q-6412-2018; Mettu, Vijaya Saradhi/GLS-9386-2022; Roetzschke, Olaf/GXH-0012-2022; Andiappan, Anand Kumar/AAT-2336-2021; Chew, Fook Tim/E-7259-2010	Common, John/0000-0002-3280-7365; Mettu, Vijaya Saradhi/0000-0001-8204-1903; Chew, Fook Tim/0000-0003-1337-5146; Andiappan, Anand Kumar/0000-0002-8442-1544; de Cevins, Camille/0000-0002-5370-850X; Dutertre, Charles-Antoine/0000-0001-7950-3652; Ravikrishnan, Aarthi/0000-0003-2391-0202; Nagarajan, Niranjan/0000-0003-0850-5604; Chng, Kern Rei/0000-0003-2746-9880	National Healthcare Group/Agency of Science Technology and Research (A*STAR)/Nanyang Technological University Skin Research Grant [SRG/14032]; A*STAR BMRC EDB IAF-SPF grants [SPF2013/004, SFP2012/005]; A*STAR BMRC EDB IAF-PP grant [H18/01/a0/016]	National Healthcare Group/Agency of Science Technology and Research (A*STAR)/Nanyang Technological University Skin Research Grant(Agency for Science Technology & Research (A*STAR)); A*STAR BMRC EDB IAF-SPF grants; A*STAR BMRC EDB IAF-PP grant	Supported by a National Healthcare Group/Agency of Science Technology and Research (A*STAR)/Nanyang Technological University Skin Research Grant (SRG/14032); A*STAR BMRC EDB IAF-SPF grants (SPF2013/004) titled Skin Biology Basic Research and (SFP2012/005) Genetic Orphan Diseases Adopted: Fostering Innovation Therapy; an A*STAR BMRC EDB IAF-PP grant (H18/01/a0/016) titled the Asian Skin Microbiome Program.	Abuabara K, 2018, ALLERGY, V73, P696, DOI 10.1111/all.13320; Andiappan AK, 2014, ALLERGY, V69, P501, DOI 10.1111/all.12364; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baurecht H, 2018, J ALLERGY CLIN IMMUN, V141, P1668, DOI 10.1016/j.jaci.2018.01.019; Belkaid Y, 2016, NAT REV IMMUNOL, V16, P353, DOI 10.1038/nri.2016.48; Bieber T, 2017, J ALLERGY CLIN IMMUN, V139, pS58, DOI 10.1016/j.jaci.2017.01.008; Boldock E, 2018, NAT MICROBIOL, V3, P881, DOI 10.1038/s41564-018-0198-3; Brunner PM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09207-z; Brunner PM, 2017, J INVEST DERMATOL, V137, P18, DOI 10.1016/j.jid.2016.08.022; Calder PC, 2006, J NUTR, V136, p288S, DOI 10.1093/jn/136.1.288S; Chng KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.106, 10.1038/nmicrobiol.2016.106]; Clausen ML, 2018, JAMA DERMATOL, V154, P293, DOI 10.1001/jamadermatol.2017.5440; Clausen ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20204-8; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Cusumano ZT, 2015, J BACTERIOL, V197, P1288, DOI 10.1128/JB.02517-14; Czarnowicki T, 2019, J ALLERGY CLIN IMMUN, V143, P1, DOI 10.1016/j.jaci.2018.10.032; Danso MO, 2014, J INVEST DERMATOL, V134, P1941, DOI 10.1038/jid.2014.83; Deckert S, 2014, ALLERGY, V69, P37, DOI 10.1111/all.12246; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Geoghegan JA, 2018, TRENDS MICROBIOL, V26, P484, DOI 10.1016/j.tim.2017.11.008; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guttman-Yassky E, 2017, CURR OPIN IMMUNOL, V48, P68, DOI 10.1016/j.coi.2017.08.008; Kim N, 2012, J INVEST DERMATOL, V132, P1169, DOI 10.1038/jid.2011.404; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Leung DYM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav2685; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Li CH, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0729-z; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Nenoff P, 2004, HAUTARZT, V55, P58, DOI 10.1007/s00105-003-0647-6; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oranje AP, 2007, BRIT J DERMATOL, V157, P645, DOI 10.1111/j.1365-2133.2007.08112.x; Paller AS, 2019, J ALLERGY CLIN IMMUN, V143, P26, DOI 10.1016/j.jaci.2018.11.015; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055380; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V135, P1218, DOI 10.1016/j.jaci.2015.03.003; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tang TS, 2014, J ALLERGY CLIN IMMUN, V133, P1615, DOI 10.1016/j.jaci.2013.12.1079; Thijs JL, 2018, J ALLERGY CLIN IMMUN, V141, P1523, DOI 10.1016/j.jaci.2017.12.991; Thijs JL, 2017, J ALLERGY CLIN IMMUN, V140, P730, DOI 10.1016/j.jaci.2017.03.023; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wen HC, 2018, J ALLERGY CLIN IMMUN, V142, P324, DOI 10.1016/j.jaci.2018.02.047; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Williams MR, 2017, CELL HOST MICROBE, V22, P579, DOI 10.1016/j.chom.2017.10.015; Wollenberg A, 2009, ALLERGY, V64, P276, DOI 10.1111/j.1398-9995.2008.01803.x; Wong XFCC, 2018, J ALLERGY CLIN IMMUN, V141, P814, DOI 10.1016/j.jaci.2017.10.001; Yu JL, 2019, J ALLERGY CLIN IMMUN, V143, P2108, DOI 10.1016/j.jaci.2018.11.036; Zeeuwen PLJM, 2017, J ALLERGY CLIN IMMUN, V139, P1368, DOI 10.1016/j.jaci.2016.09.017; Zhang SH, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-016-0139-z	55	16	17	2	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1329	1340		10.1016/j.jaci.2020.09.031	http://dx.doi.org/10.1016/j.jaci.2020.09.031		APR 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	33039480				2022-12-18	WOS:000637368900022
J	Skaarup, SH; Schmid, JM; Skjold, T; Graumann, O; Hoffmann, HJ				Skaarup, Soren Helbo; Schmid, Johannes Martin; Skjold, Tina; Graumann, Ole; Hoffmann, Hans Jurgen			Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergic rhinoconjunctivitis; allergen immunotherapy; intralymphatic immunotherapy; ultrasound-guided injections; com-bined symptom medication score; outcome parameters	SUBLINGUAL IMMUNOTHERAPY; CLINICAL-TRIALS; YOUNG-ADULTS; STANDARDIZATION; RECOMMENDATIONS; SAFE	Background: Allergic rhinoconjunctivitis is a global health problem. Different allergen immunotherapy regimes are marketed but have low adherence because they are expensive, complex, and time-consuming. New allergen immunotherapy forms are needed. Objective: In a 3-year follow-up double-blind randomized placebo-controlled trial, we aimed to investigate the effect of intralymphatic allergen immunotherapy (ILIT). Methods: Patients with grass pollen rhinoconjunctivitis were treated with 3 ILIT injections and an ILIT booster 1 year later, 3 ILIT injections and a placebo booster, or 3 placebo injections and a placebo booster. Primary outcome was improvement in a combined symptom and medication score (cSMS). A novel evaluation tool with a linear regression model of cSMS and grass pollen counts was developed. Secondary outcomes were changes in grass specific immunoglobulins and skin and nasal provocation tests to grass pollen. Results: A total of 36 patients were included. Log10-transformed cSMS was reduced by 0.30 (95% CI, 0.11-0.49; P 5 .002), equaling 48.5% (95% CI, 24.5%-62%), in the entire 3-year follow-up period, significant only in the first follow-up season but not in the second and third seasons. The regression model showed a 37% (P <.001) reduction in cSMS. The booster injection 1 year later had no additional effect. Secondary, repeated measures of IgE and IgG4 to grass showed significant between-group difference and within-group change in the ILIT groups. No change in provocation test results was found. Conclusions: ILIT gives a substantial reduction in grass pollen allergy symptoms and use of rescue medication, significant in the first season after treatment. A booster injection had no additional effect. (J Allergy Clin Immunol 2021;147:1011-9.) <comment>Superscript/Subscript Available</comment	[Skaarup, Soren Helbo; Schmid, Johannes Martin; Skjold, Tina; Hoffmann, Hans Jurgen] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark; [Graumann, Ole] Odense Univ Hosp, Dept Radiol, Odense, Denmark; [Graumann, Ole] Univ Southern Denmark, Res & Innovat Unit Radiol, Odense, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ, Dept Clin Med, Aarhus, Denmark	Aarhus University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Aarhus University	Hoffmann, HJ (corresponding author), Aarhus Univ Hosp, Dept Resp Med & Allergy, Palle Juul Jensens Alle 99, DK-8200 Aarhus N, Denmark.	hjh@clin.au.dk		Skaarup, Soren/0000-0001-7975-7441; Schmid, Johannes/0000-0002-4558-2943; Graumann, Ole/0000-0002-9663-8361	Danish governmental research fund from the Central Denmark Region, Denmark; Toyota Foundation, Copenhagen, Denmark	Danish governmental research fund from the Central Denmark Region, Denmark; Toyota Foundation, Copenhagen, Denmark	The trial was funded by a Danish governmental research fund from the Central Denmark Region, Denmark and by a grant from the Toyota Foundation, Copenhagen, Denmark.	Allam JP, 2018, J ALLERGY CLIN IMMUN, V141, P1898, DOI 10.1016/j.jaci.2017.12.999; Calderon MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001936.pub2; Canonica GW, 2007, ALLERGY, V62, P317, DOI 10.1111/j.1398-9995.2006.01312.x; Durham SR, 2011, ALLERGY, V66, P120, DOI 10.1111/j.1398-9995.2010.02434.x; Durham SR, 2006, J ALLERGY CLIN IMMUN, V117, P802, DOI 10.1016/j.jaci.2005.12.1358; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Hellkvist L, 2018, J ALLERGY CLIN IMMUN, V142, P1338, DOI 10.1016/j.jaci.2018.05.030; Hoffmann HJ, 2017, ALLERGY, V72, P1022, DOI 10.1111/all.13135; Hylander T, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0324-9; Hylander T, 2013, J ALLERGY CLIN IMMUN, V131, P412, DOI 10.1016/j.jaci.2012.10.056; Karatzas K, 2018, ALLERGY, V73, P1851, DOI 10.1111/all.13487; Kiel MA, 2013, J ALLERGY CLIN IMMUN, V132, P353, DOI 10.1016/j.jaci.2013.03.013; Klimek L, 2014, ALLERGY, V69, P1629, DOI 10.1111/all.12513; Konradsen JR, 2020, J ALLERGY CLIN IMMUN, V145, P1005, DOI 10.1016/j.jaci.2019.11.017; Kundig TM, 2014, J ALLERGY CLIN IMMUN, V133, P930, DOI 10.1016/j.jaci.2013.11.036; Patterson AM, 2016, ANN ALLERG ASTHMA IM, V116, P168, DOI 10.1016/j.anai.2015.11.010; Pfaar O, 2017, ALLERGY, V72, P713, DOI 10.1111/all.13092; Pfaar O, 2014, ALLERGY, V69, P854, DOI 10.1111/all.12383; Schmid JM, 2014, J ALLERGY CLIN IMMUN, V134, P741, DOI 10.1016/j.jaci.2014.04.029; Senna G, 2009, CURR OPIN ALLERGY CL, V9, P544, DOI 10.1097/ACI.0b013e328332b8df; Senti G, 2019, INT ARCH ALLERGY IMM, V178, P141, DOI 10.1159/000493647; Senti G, 2012, J ALLERGY CLIN IMMUN, V129, P1290, DOI 10.1016/j.jaci.2012.02.026; Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105; Witten M, 2013, J ALLERGY CLIN IMMUN, V132, P1248, DOI 10.1016/j.jaci.2013.07.033	24	16	17	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1011	1019		10.1016/j.jaci.2020.07.002	http://dx.doi.org/10.1016/j.jaci.2020.07.002		MAR 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	32679209				2022-12-18	WOS:000635524300006
J	Abraham, RS; Marshall, JM; Kuehn, HS; Rueda, CM; Gibbs, A; Guider, W; Stewart, C; Rosenzweig, SD; Wang, HY; Jean, S; Peeples, M; King, T; Hunt, WG; Honegger, JR; Ramilo, O; Mustillo, PJ; Mejias, A; Ardura, MI; Shimamura, M				Abraham, Roshini S.; Marshall, Joanna M.; Kuehn, Hye Sun; Rueda, Cesar M.; Gibbs, Amber; Guider, Will; Stewart, Claire; Rosenzweig, Sergio D.; Wang, Huanyu; Jean, Sophonie; Peeples, Mark; King, Tiffany; Hunt, W. Garrett; Honegger, Jonathan R.; Ramilo, Octavio; Mustillo, Peter J.; Mejias, Asuncion; Ardura, Monica, I; Shimamura, Masako			Severe SARS-CoV-2 disease in the context of a NF-kappa B2 loss-of-function pathogenic variant	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						COVID-19; immunodeficiency; NF-kappa B; NF-kappa B pathway; NF-kappa B2; SARS-CoV-2	NF-KAPPA-B; PRIMARY IMMUNODEFICIENCY; CYTOKINE STORM; MUTATIONS; NFKB2; DEFICIENCY; MECHANISMS; PATHWAY	Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that emerged recently and has created a global pandemic. Symptomatic SARS-CoV-2 infection, termed coronavirus disease 2019 (COVID-19), has been associated with a host of symptoms affecting numerous organ systems, including the lungs, cardiovascular system, kidney, central nervous system, gastrointestinal tract, and skin, among others. Objective: Although several risk factors have been identified as related to complications from and severity of COVID-19, much about the virus remains unknown. The host immune response appears to affect the outcome of disease. It is not surprising that patients with intrinsic or secondary immune compromise might be particularly susceptible to complications from SARS-CoV-2 infection. Pathogenic loss-of-function or gain-of-function heterozygous variants in nuclear factor-kappa B2 have been reported to be associated with either a combined immunodeficiency or common variable immunodeficiency phenotype. Methods: We evaluated the functional consequence and immunologic phenotype of a novel NFKB2 loss of function variant in a 17-year-old male patient and describe the clinical management of SARS-CoV-2 infection in this context. Results: This patient required a 2-week hospitalization for SARS-CoV-2 infection, including 7 days of mechanical ventilation. We used biologic therapies to avert potentially fatal acute respiratory distress syndrome and treat hyperinflammatory responses. The patient had an immunologic phenotype of B-cell dysregulation with decreased switched memory B cells. Despite the underlying immune dysfunction, he recovered from the infection with intense management. Conclusions: This clinical case exemplifies some of the practical challenges in management of patients with SARS-CoV-2 infection, especially in the context of underlying immune dysregulation.	[Abraham, Roshini S.; Marshall, Joanna M.; Rueda, Cesar M.; Gibbs, Amber; Wang, Huanyu; Jean, Sophonie] Nationwide Childrens Hosp, Dept Pathol & Lab Med, 700 Childrens Dr, Columbus, OH 43205 USA; [Kuehn, Hye Sun; Rosenzweig, Sergio D.] NIH, Dept Lab Med, Bethesda, MD USA; [Guider, Will; Stewart, Claire] Nationwide Childrens Hosp, Div Crit Care Med, Columbus, OH 43205 USA; [Guider, Will; Stewart, Claire; Peeples, Mark; King, Tiffany; Hunt, W. Garrett; Honegger, Jonathan R.; Ramilo, Octavio; Mustillo, Peter J.; Mejias, Asuncion; Ardura, Monica, I; Shimamura, Masako] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Guider, Will; Stewart, Claire; Peeples, Mark; King, Tiffany; Hunt, W. Garrett; Honegger, Jonathan R.; Ramilo, Octavio; Mustillo, Peter J.; Mejias, Asuncion; Ardura, Monica, I; Shimamura, Masako] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Hunt, W. Garrett; Honegger, Jonathan R.; Ramilo, Octavio; Mejias, Asuncion; Ardura, Monica, I; Shimamura, Masako] Nationwide Childrens Hosp, Div Infect Dis, Columbus, OH 43205 USA; [Mustillo, Peter J.] Nationwide Childrens Hosp, Div Allergy & Immunol, Columbus, OH 43205 USA; [Peeples, Mark; King, Tiffany; Honegger, Jonathan R.; Ramilo, Octavio; Mejias, Asuncion; Shimamura, Masako] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Abigail Wexner Res Inst, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; National Institutes of Health (NIH) - USA; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Abraham, RS (corresponding author), Nationwide Childrens Hosp, Dept Pathol & Lab Med, 700 Childrens Dr, Columbus, OH 43205 USA.	Roshini.Abraham@nationwidechildrens.org	Peeples, Mark E./AAX-5193-2021; Wang, Huanyu/W-3145-2019	Peeples, Mark E./0000-0002-4582-317X; Wang, Huanyu/0000-0002-5982-6371; Oyeniran, Sophonie Jean/0000-0001-9372-3491; King, Tiffany/0000-0002-9256-6241; Marshall, Joanna/0000-0002-5829-9688	Department of Pathology, Nationwide Children's Hospital, Columbus, Ohio; Department of Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio	Department of Pathology, Nationwide Children's Hospital, Columbus, Ohio; Department of Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio	This study was funded by the Department of Pathology and Department of Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.	Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Brue T, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0139-9; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Casadevall A, 2020, J CLIN INVEST, V130, P1545, DOI 10.1172/JCI138003; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Courtois G, 2005, CELL MOL LIFE SCI, V62, P1682, DOI 10.1007/s00018-005-5031-5; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Joyner MJ, 2020, J CLIN INVEST, V130, P4791, DOI [10.1172/JCI140200, 10.1101/2020.05.12.20099879]; Klemann C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00297; Knight V., ARCH PATHOL LAB MED; Kuehn HS, 2017, BLOOD, V130, P1553, DOI 10.1182/blood-2017-05-782177; Lee CE, 2014, BLOOD, V124, P2964, DOI 10.1182/blood-2014-06-578542; LEE DW, 2014, P NATL ACAD SCI USA, V124, P188; Liang Y., 2020, CLIN INFECT DIS, DOI [DOI 10.1093/CID/CIAA398, 10.1093/cid/ciaa398, 7543314]; Lipworth B, 2020, J ALLER CL IMM-PRACT, V8, P1798, DOI 10.1016/j.jaip.2020.04.014; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lougaris V, 2015, J ALLERGY CLIN IMMUN, V135, P1641, DOI 10.1016/j.jaci.2014.11.038; Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801; Makris S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00259; MARTINS TB, 2004, INT J BIOL SCI, V11, P325; Mazzoni A, 2020, J CLIN INVEST, V130, P4694, DOI [10.1172/JCI138554, 10.1172/JCI138554.]; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Meyts I, 2021, J ALLERGY CLIN IMMUN, V147, P520, DOI 10.1016/j.jaci.2020.09.010; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Quartuccio L, 2020, J MED VIROL, V92, P2852, DOI 10.1002/jmv.26149; Quentien MH, 2012, J CLIN ENDOCR METAB, V97, pE121, DOI 10.1210/jc.2011-0407; Quinti I, 2020, J ALLERGY CLIN IMMUN, V146, P211, DOI 10.1016/j.jaci.2020.04.013; Ramakrishnan KA, 2018, J ALLERGY CLIN IMMUN, V141, P1479, DOI 10.1016/j.jaci.2017.11.014; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Roschewski M, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd0110; ROSEJOHN S, 2012, BLOOD, V8, P1237; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Vandergaast Rianna, 2020, bioRxiv, DOI 10.1101/2020.05.26.117549; Vincent Feng-Sheng Shih, 2011, Cell Research, V21, P86; Vultaggio A, 2020, J ALLER CL IMM-PRACT, V8, P2575, DOI 10.1016/j.jaip.2020.06.013; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Willmann KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6360; Xu X, 2020, CHINAXIV20200300026, DOI [10.1073/pnas.2005615117, DOI 10.1073/PNAS.2005615117]; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; ZHAO PC, 2020, CLIN INFECT DIS, V8, P2585; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2	59	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					532	+		10.1016/j.jaci.2020.09.020	http://dx.doi.org/10.1016/j.jaci.2020.09.020		FEB 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	33007327	Green Published, Bronze			2022-12-18	WOS:000616665800014
J	Haimerl, P; Bernhardt, U; Schindela, S; Henkel, FDR; Lechner, A; Zissler, UM; Pastor, X; Thomas, D; Cecil, A; Ge, Y; Haid, M; Prehn, C; Tokarz, J; Heinig, M; Adamski, J; Schmidt-Weber, CB; Chaker, AM; Esser-von Bieren, J				Haimerl, Pascal; Bernhardt, Ulrike; Schindela, Sonja; Henkel, Fiona D. R.; Lechner, Antonie; Zissler, Ulrich M.; Pastor, Xavier; Thomas, Dominique; Cecil, Alexander; Ge, Yan; Haid, Mark; Prehn, Cornelia; Tokarz, Janina; Heinig, Matthias; Adamski, Jerzy; Schmidt-Weber, Carsten B.; Chaker, Adam M.; Esser-von Bieren, Julia			Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Acylcarnitines; chemokines; eicosanoids; lipid mediator; macrophages; metabolomics; nasal polyps; NSAID-exacerbated respiratory disease; trained immunity; type 2 inflammation	RESIDENT ALVEOLAR MACROPHAGES; ALLERGIC LUNG INFLAMMATION; HOUSE-DUST MITE; CYSTEINYL-LEUKOTRIENES; AIRWAY INFLAMMATION; INTOLERANT ASTHMA; PROSTAGLANDIN E-2; INDUCED SPUTUM; ASPIRIN; CELLS	Background: Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) is a chronic inflammatory condition, which is driven by an aberrant arachidonic acid metabolism. Macrophages are major producers of arachidonic acid metabolites and subject to metabolic reprogramming, but they have been neglected in N-ERD. Objective: This study sought to elucidate a potential metabolic and epigenetic macrophage reprogramming in N-ERD. Methods: Transcriptional, metabolic, and lipid mediator profiles in macrophages from patients with N-ERD and healthy controls were assessed by RNA sequencing, Seahorse assays, and LC-MS/MS. Metabolites in nasal lining fluid, sputum, and plasma from patients with N-ERD (n = 15) and healthy individuals (n = 10) were quantified by targeted metabolomics analyses. Genome-wide methylomics were deployed to define epigenetic mechanisms of macrophage reprogramming in N-ERD. Results: This study shows that N-ERD monocytes/macrophages exhibit an overall reduction in DNA methylation, aberrant metabolic profiles, and an increased expression of chemokines, indicative of a persistent proinflammatory activation. Differentially methylated regions in N-ERD macrophages included genes involved in chemokine signaling and acylcarnitine metabolism. Acylcarnitines were increased in macrophages, sputum, nasal lining fluid, and plasma of patients with N-ERD. On inflammatory challenge, N-ERD macrophages produced increased levels of acylcarnitines, proinflammatory arachidonic acid metabolites, cytokines, and chemokines as compared to healthy macrophages. Conclusions: Together, these findings decipher a proinflammatory metabolic and epigenetic reprogramming of macrophages in N-ERD.	[Haimerl, Pascal; Bernhardt, Ulrike; Schindela, Sonja; Henkel, Fiona D. R.; Lechner, Antonie; Zissler, Ulrich M.; Cecil, Alexander; Schmidt-Weber, Carsten B.; Chaker, Adam M.; Esser-von Bieren, Julia] Tech Univ Munich, Ctr Allergy & Environm, D-80802 Munich, Germany; [Haimerl, Pascal; Bernhardt, Ulrike; Schindela, Sonja; Henkel, Fiona D. R.; Lechner, Antonie; Zissler, Ulrich M.; Cecil, Alexander; Schmidt-Weber, Carsten B.; Chaker, Adam M.; Esser-von Bieren, Julia] Helmholtz Zentrum Munchen, D-80802 Munich, Germany; [Bernhardt, Ulrike; Chaker, Adam M.] Tech Univ Munich, Dept Otolaryngol, Allergy Sect, Klinikum Rechts Isar, Munich, Germany; [Pastor, Xavier; Heinig, Matthias] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Haid, Mark; Prehn, Cornelia; Tokarz, Janina; Adamski, Jerzy] Helmholtz Zentrum Munchen, Genome Anal Ctr, Res Unit Mol Endocrinol & Metab, Neuherberg, Germany; [Thomas, Dominique] Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Inst Clin Pharmacol, Zentrum Arzneimittelforsch Entwicklung & Sicherhe, Frankfurt, Germany; [Ge, Yan] Tech Univ Dresden, Biotechnol Ctr Dresden, Dresden, Germany; [Tokarz, Janina] German Ctr Diabet Res, Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [Adamski, Jerzy] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore, Singapore; [Schmidt-Weber, Carsten B.] German Ctr Lung Res, Giessen, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Goethe University Frankfurt; Technische Universitat Dresden; Technical University of Munich; National University of Singapore	Esser-von Bieren, J (corresponding author), Tech Univ Munich, Ctr Allergy & Environm, D-80802 Munich, Germany.; Esser-von Bieren, J (corresponding author), Helmholtz Zentrum Munchen, D-80802 Munich, Germany.	Julia.esser-von-bieren@tum.de	Zissler, Ulrich Matthias/AAP-2878-2020; Haid, Mark/J-4304-2019; Zissler, Ulrich Matthias/GSD-3514-2022; Zissler, Ulrich/GRO-1107-2022; Schmidt-Weber, Carsten B./AAU-1621-2021	Zissler, Ulrich Matthias/0000-0003-4826-3419; Haid, Mark/0000-0001-6118-1333; Zissler, Ulrich Matthias/0000-0003-4826-3419; Schmidt-Weber, Carsten B./0000-0002-3203-8084; Prehn, Cornelia/0000-0002-1274-4715; Esser-von Bieren, Julia/0000-0003-1898-9382; Pastor, Xavier/0000-0003-2089-3777; Tokarz, Janina/0000-0003-4344-4149; Chaker, Adam/0000-0002-5117-4073	Else Kroner-Fresenius-Stiftung [2015_A195]; German Research Foundation [FOR2599, ES 471/3-1]; Fritz Thyssen Stiftung [Az. 10.17.2.017MN]; Helmholtz Young Investigator grant [VH-NG1331]; German Center for Lung Research [82DZL00302]; German Federal Ministry of Education and Research	Else Kroner-Fresenius-Stiftung; German Research Foundation(German Research Foundation (DFG)); Fritz Thyssen Stiftung; Helmholtz Young Investigator grant; German Center for Lung Research; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by the Else Kroner-Fresenius-Stiftung (grant 2015_A195), the German Research Foundation (FOR2599, ES 471/3-1), the Fritz Thyssen Stiftung (grant Az. 10.17.2.017MN), and a Helmholtz Young Investigator grant (VH-NG1331) to JEvB. CSW receives grant support by the German Center for Lung Research (82DZL00302). This study was supported in part by a grant from the German Federal Ministry of Education and Research to the German Center Diabetes Research.	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Al-Khami AA, 2017, CLIN EXP ALLERGY, V47, P1170, DOI 10.1111/cea.12947; Bomans K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02685; Bordag N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15954; Chawes BLK, 2010, J ALLERGY CLIN IMMUN, V125, P1387, DOI 10.1016/j.jaci.2010.01.039; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cheng X, 2012, J BIOL CHEM, V287, P36896, DOI 10.1074/jbc.M112.409516; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Clarke DL, 2014, MUCOSAL IMMUNOL, V7, P558, DOI 10.1038/mi.2013.74; Daham K, 2011, CLIN EXP ALLERGY, V41, P36, DOI 10.1111/j.1365-2222.2010.03617.x; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; Dhariwal J, 2017, AM J RESP CRIT CARE, V195, P1586, DOI 10.1164/rccm.201609-1846OC; Dietz K, 2017, J ALLERGY CLIN IMMUN, V139, P1343, DOI 10.1016/j.jaci.2016.07.014; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Draijer C, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0681-6; Draijer C, 2016, J LEUKOCYTE BIOL, V100, P95, DOI 10.1189/jlb.3MAB1115-505R; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Erdogan T, 2015, ALLERGOL IMMUNOPATH, V43, P442, DOI 10.1016/j.aller.2014.07.008; Eriksson J, 2015, CLIN EXP ALLERGY, V45, P211, DOI 10.1111/cea.12359; Faith A, 2008, ALLERGY, V63, P168, DOI 10.1111/j.1398-9995.2007.01531.x; Fernandez-Bertolin L, 2013, J ALLERGY CLIN IMMUN, V132, P1243, DOI 10.1016/j.jaci.2013.07.010; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Frankenberger M, 2011, MOL MED, V17, P762, DOI 10.2119/molmed.2010.00202; Gaber F, 2008, THORAX, V63, P1076, DOI 10.1136/thx.2008.101196; Gharib SA, 2019, J ALLERGY CLIN IMMUN, V143, P1536, DOI 10.1016/j.jaci.2018.10.046; Henkel FDR, 2019, ALLERGY, V74, P1090, DOI 10.1111/all.13700; HIDI R, 1992, J LEUKOCYTE BIOL, V51, P425, DOI 10.1002/jlb.51.5.425; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Hulse KE, 2015, CLIN EXP ALLERGY, V45, P328, DOI 10.1111/cea.12472; Koga T, 2006, RESP MED, V100, P273, DOI 10.1016/j.rmed.2005.05.017; Kowalski ML, 2019, ALLERGY, V74, P28, DOI 10.1111/all.13599; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Laidlaw TM, 2016, NEW ENGL J MED, V374, P484, DOI 10.1056/NEJMcibr1514013; Laidlaw TM, 2014, J ALLERGY CLIN IMMUN, V133, P1692, DOI 10.1016/j.jaci.2013.12.1034; Liang ZK, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-72; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Malm L, 1997, ACTA OTO-LARYNGOL, V117, P465, DOI 10.3109/00016489709113422; Mastalerz L, 2014, ALLERGY, V69, P1550, DOI 10.1111/all.12512; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Pastor X., 2018, YAPIMA YET ANOTHER P; Perros F, 2009, ALLERGY, V64, P995, DOI 10.1111/j.1398-9995.2009.02095.x; Peters MC, 2019, J ALLERGY CLIN IMMUN, V143, P104, DOI 10.1016/j.jaci.2017.12.1009; Peters TJ, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-6; Poralla L, 2015, J CELL MOL MED, V19, P2162, DOI 10.1111/jcmm.12595; POWELL WS, 1995, J IMMUNOL, V154, P4123; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; Rajan JP, 2015, J ALLERGY CLIN IMMUN, V135, P676, DOI 10.1016/j.jaci.2014.08.020; RCore Team, 2022, R LANG ENV STAT COMP; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rossi L, 2013, EXP HEMATOL, V41, P102, DOI 10.1016/j.exphem.2012.09.007; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; Saradna A, 2018, TRANSL RES, V191, P1, DOI 10.1016/j.trsl.2017.09.002; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schonrich G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00545; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Stevens WW, 2017, J ALLER CL IMM-PRACT, V5, P1061, DOI 10.1016/j.jaip.2016.12.027; Takabayashi T, 2013, J ALLERGY CLIN IMMUN, V132, P584, DOI 10.1016/j.jaci.2013.02.003; Tang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04100-1; Tian W, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006674; Tomlinson GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040348; Trinh HKT, 2016, SCI REP-UK, V6, DOI 10.1038/srep36599; Varga EM, 1999, EUR RESPIR J, V14, P610, DOI 10.1034/j.1399-3003.1999.14c21.x; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580; Zheng HD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27278-4; Zhu XW, 2019, J LEUKOCYTE BIOL, V105, P215, DOI 10.1002/JLB.3HI0918-373R; Zissler UM, 2018, J ALLERGY CLIN IMMUN, V142, P1980, DOI 10.1016/j.jaci.2018.07.027	74	16	16	4	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					587	599		10.1016/j.jaci.2020.04.064	http://dx.doi.org/10.1016/j.jaci.2020.04.064		FEB 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32540397	Bronze, Green Submitted			2022-12-18	WOS:000616665800021
J	Castiello, MC; Bosticardo, M; Sacchetti, N; Calzoni, E; Fontana, E; Yamazaki, Y; Draghici, E; Corsino, C; Bortolomai, I; Sereni, L; Yu, HH; Uva, P; Palchaudhuri, R; Scadden, DT; Villa, A; Notarangelo, LD				Castiello, Maria Carmina; Bosticardo, Marita; Sacchetti, Nicolo; Calzoni, Enrica; Fontana, Elena; Yamazaki, Yasuhiro; Draghici, Elena; Corsino, Cristina; Bortolomai, Ileana; Sereni, Lucia; Yu, Hsin-Hui; Uva, Paolo; Palchaudhuri, Rahul; Scadden, David T.; Villa, Anna; Notarangelo, Luigi D.			Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						RAG deficiency; conditioning; anti-CD45-saporin; immunotoxin; engraftment; immune reconstitution; hematopoietic stem cell transplantation; thymic epithelial cells	SEVERE COMBINED IMMUNODEFICIENCY; STEM-CELL TRANSPLANTATION; ANTIBODY; MUTATIONS; DISEASE; MICE	Background: Mutations in the recombinase-activating genes cause severe immunodeficiency, with a spectrum of phenotypes ranging from severe combined immunodeficiency to immune dysregulation. Hematopoietic stem cell transplantation is the only curative option, but a high risk of graft failure and poor immune reconstitution have been observed in the absence of myeloablation. Objectives: Our aim was to improve multilineage engraftment; we tested nongenotoxic conditioning with anti-CD45 mAbs conjugated with saporin CD45 (CD45-SAP). Methods: Rag1-KO and Rag1-F971L mice, which represent models of severe combined immune deficiency and combined immune deficiency with immune dysregulation, respectively, were conditioned with CD45-SAP, CD45-SAP plus 2 Gy of total body irradiation (TBI), 2 Gy of TBI, 8 Gy of TBI, or no conditioning and treated by using transplantation with lineage negative bone marrow cells from wild-type mice. Flow cytometry and immunohistochemistry were used to assess engraftment and immune reconstitution. Antibody responses to 2,4,6-trinitrophenyl-conjugated keyhole limpet hemocyanin were measured by ELISA, and presence of autoantibody was detected by microarray. Results: Conditioning with CD45-SAP enabled high levels of multilineage engraftment in both Rag1 mutant models, allowed overcoming of Band T-cell differentiation blocks and thymic epithelial cell defects, and induced robust cellular and humoral immunity in the periphery. Conclusions: Conditioning with CD45-SAP allows multilineage engraftment and robust immune reconstitution in mice with either null or hypomorphic Rag mutations while preserving thymic epithelial cell homeostasis.	[Castiello, Maria Carmina; Sacchetti, Nicolo; Calzoni, Enrica; Draghici, Elena; Bortolomai, Ileana; Sereni, Lucia; Villa, Anna] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy; [Castiello, Maria Carmina; Fontana, Elena; Villa, Anna] CNR, Inst Genet, Milan, Italy; [Castiello, Maria Carmina; Fontana, Elena; Villa, Anna] CNR, Biomed Res Milan Unit, Milan, Italy; [Bosticardo, Marita; Calzoni, Enrica; Yamazaki, Yasuhiro; Corsino, Cristina; Yu, Hsin-Hui; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Yamazaki, Yasuhiro] Humanitas Clin & Res Ctr, Human Genome Lab, Milan, Italy; [Uva, Paolo] Sci & Technol Pk Polaris, CRS4, Pula, Italy; [Palchaudhuri, Rahul; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Palchaudhuri, Rahul; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Palchaudhuri, Rahul] Magenta Therapeut, Cambridge, MA USA	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Harvard University; Massachusetts General Hospital	Villa, A (corresponding author), Via Olgettina 58, I-20127 Milan, Italy.; Notarangelo, LD (corresponding author), NIAID, Immune Deficiency Genet Sect, Lab Clin Immunol & Microbiol, NIH, Bldg 10,Room 5-3950,10 Ctr Dr, Bethesda, MD 20892 USA.	villa.anna@hsr.it; luigi.notarangelo2@nih.gov	Fontana, Elena/K-3845-2016; Uva, Paolo/A-2877-2011; Yu, Hsin-Hui/AAV-2068-2020; Bosticardo, Marita/ABA-2688-2021; Castiello, Maria Carmina/K-9767-2016	Fontana, Elena/0000-0001-8853-3335; Uva, Paolo/0000-0002-9524-8492; Yu, Hsin-Hui/0000-0003-2611-5175; Bosticardo, Marita/0000-0002-1771-4523; Castiello, Maria Carmina/0000-0003-2581-9648; SERENI, LUCIA/0000-0002-8234-3490	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health Bench to Bedside grant RAG Deficiency: From Pathophysiology to Precise Gene Editing; grants Tiget E2; Italian Ministry of Health [PE-2016-02363691]; EU2020 (SCIDNET) [666908]; MIUR [2017-5XHBPN]	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Bench to Bedside grant RAG Deficiency: From Pathophysiology to Precise Gene Editing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); grants Tiget E2; Italian Ministry of Health(Ministry of Health, Italy); EU2020 (SCIDNET); MIUR(Ministry of Education, Universities and Research (MIUR))	Supported by a grant from the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (to L.D.N.); the National Institutes of Health Bench to Bedside grant RAG Deficiency: From Pathophysiology to Precise Gene Editing (to L.D.N. and A.V.); and grants Tiget E2 (to A.V.), Italian Ministry of Health PE-2016-02363691 (to E.F. and L.D.N.), EU2020 (SCIDNET) No. 666908 (to A.V.), and MIUR 2017-5XHBPN (to A.V.).	Bosticardo M, 2019, AM J HUM GENET, V105, P549, DOI 10.1016/j.ajhg.2019.07.014; Burtner CR, 2015, HUM GENE THER, V26, P399, DOI 10.1089/hum.2015.021; Capo V, 2018, J ALLERGY CLIN IMMUN, V142, P928, DOI 10.1016/j.jaci.2017.11.015; Chen Y, 2012, BLOOD, V119, P1130, DOI 10.1182/blood-2011-09-380436; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Czechowicz A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08201-x; Daley SR, 2019, J ALLERGY CLIN IMMUN, V144, P333, DOI 10.1016/j.jaci.2019.03.022; de Bruin LMO, 2018, BLOOD, V132, P281, DOI 10.1182/blood-2017-12-820985; De Ravin SS, 2010, BLOOD, V116, P1263, DOI 10.1182/blood-2010-02-267583; Farmer JR, 2019, J ALLER CL IMM-PRACT, V7, P1970, DOI 10.1016/j.jaip.2019.02.038; Fischer A, 2020, J EXP MED, V217, DOI 10.1084/jem.20190607; Gao CY, 2019, BLOOD ADV, V3, P2700, DOI 10.1182/bloodadvances.2019000516; Haddad E, 2018, BLOOD, V132, P1737, DOI 10.1182/blood-2018-03-840702; Kadouri N, 2020, NAT REV IMMUNOL, V20, P239, DOI 10.1038/s41577-019-0238-0; Krance RA, 2003, BIOL BLOOD MARROW TR, V9, P273, DOI 10.1053/bbmt.2003.50024; Li ZZ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08202-w; Liu A, 2006, BLOOD, V108, P1123, DOI 10.1182/blood-2006-01-0061; Marrella V, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00259; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakamae H, 2009, CANCER RES, V69, P2408, DOI 10.1158/0008-5472.CAN-08-4363; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Palchaudhuri R, 2016, NAT BIOTECHNOL, V34, P738, DOI 10.1038/nbt.3584; Pang WW, 2019, BLOOD, V133, P2069, DOI 10.1182/blood-2018-06-858159; Pearse B.R., 2019, BIOL BLOOD MARROW TR, V25, pS29, DOI [10.1016/j.bbmt.2018.12.101, DOI 10.1016/J.BBMT.2018.12.101]; Picard C, 2018, J CLIN IMMUNOL, V38, P96, DOI 10.1007/s10875-017-0464-9; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Polito L, 2013, TOXINS, V5, P1698, DOI 10.3390/toxins5101698; Puck JM, 2019, IMMUNOL REV, V287, P241, DOI 10.1111/imr.12729; Rowe JH, 2017, J ALLERGY CLIN IMMUN, V140, P1739, DOI 10.1016/j.jaci.2017.08.001; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Schuetz C, 2014, BLOOD, V123, P281, DOI 10.1182/blood-2013-01-476432; Shaw P, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00434; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; Straathof KC, 2009, LANCET, V374, P912, DOI 10.1016/S0140-6736(09)60945-4; Tisdale JF, 2019, BLOOD, V134, DOI 10.1182/blood-2019-125968; Walter JE, 2016, J CLIN INVEST, V126, P4389, DOI 10.1172/JCI91162; Wentink MWJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02680; Xue XK, 2010, BLOOD, V116, P5419, DOI 10.1182/blood-2010-07-295949	38	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					309	+		10.1016/j.jaci.2020.04.033	http://dx.doi.org/10.1016/j.jaci.2020.04.033		JAN 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	32387109	hybrid, Green Accepted			2022-12-18	WOS:000607781700005
J	Brun, P; Tarricone, E; Di Stefano, A; Mattiuzzo, E; Mehrbod, P; Ghavami, S; Leonardi, A				Brun, Paola; Tarricone, Elena; Di Stefano, Antonino; Mattiuzzo, Elena; Mehrbod, Parvaneh; Ghavami, Saeid; Leonardi, Andrea			The regulatory activity of autophagy in conjunctival fibroblasts and its possible role in vernal keratoconjunctivitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PATHOGENESIS; CELLS		[Brun, Paola; Tarricone, Elena; Mattiuzzo, Elena] Univ Padua, Dept Mol Med, Padua, Italy; [Tarricone, Elena; Leonardi, Andrea] Univ Padua, Dept Neurosci, Ophthalmol Unit, Padua, Italy; [Di Stefano, Antonino] IRCCS SpA, Ist Clin Sci Maugeri, Pavia, Italy; [Di Stefano, Antonino] Ist Veruno, Novara, Italy; [Mehrbod, Parvaneh] Pasteur Inst Iran, Influenza & Resp Viruses Dept, Tehran, Iran; [Ghavami, Saeid] Univ Manitoba, Fac Sci, Coll Med, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Ghavami, Saeid] Katowice Sch Technol, Fac Med, Katowice, Poland	University of Padua; University of Padua; Istituti Clinici Scientifici Maugeri IRCCS; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of Manitoba	Leonardi, A (corresponding author), Univ Padua, Dept Neurosci, Ophthalmol Unit, Padua, Italy.	andrea.leonardi@unipd.it	Di Stefano, Antonino/AAB-8041-2020; Ghavami, Saeid/GLT-0606-2022; Mehrbod, Parvaneh/I-4444-2017	Di Stefano, Antonino/0000-0003-3479-0875; Ghavami, Saeid/0000-0001-5948-508X; Mehrbod, Parvaneh/0000-0002-8391-9228; Brun, Paola/0000-0002-4204-3549; LEONARDI, ANDREA/0000-0002-7246-8580; MATTIUZZO, ELENA/0000-0002-8205-412X	Italian Institute of Health [MIUR 60A07-4701/13, 60A06-1891/12]	Italian Institute of Health	Supported in part by grants MIUR 60A07-4701/13 and 60A06-1891/12 from the Italian Institute of Health.	Alizadeh J, 2018, BBA-MOL CELL RES, V1865, P749, DOI 10.1016/j.bbamcr.2018.02.007; Ge Y, 2018, CYTOKINE GROWTH F R, V43, P38, DOI 10.1016/j.cytogfr.2018.07.001; Ghavami S, 2018, AM J PHYSIOL-LUNG C, V314, pL493, DOI 10.1152/ajplung.00372.2017; Gupta SS, 2016, ONCOTARGET, V7, P78516, DOI 10.18632/oncotarget.12392; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kumagai N, 2006, PROG RETIN EYE RES, V25, P165, DOI 10.1016/j.preteyeres.2005.09.002; Leonardi A, 2003, EUR J OPHTHALMOL, V13, P606, DOI 10.1177/112067210301300702; Leonardi A, 2011, CLIN EXP ALLERGY, V41, P52, DOI 10.1111/j.1365-2222.2010.03626.x; Leonardi A, 2002, PROG RETIN EYE RES, V21, P319, DOI 10.1016/S1350-9462(02)00006-X; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Yuan YH, 2018, CELL CYCLE, V17, P1390, DOI 10.1080/15384101.2018.1482150; Zeki AA, 2016, ALLERGY, V71, P5, DOI 10.1111/all.12761	12	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					1210	+		10.1016/j.jaci.2020.03.013	http://dx.doi.org/10.1016/j.jaci.2020.03.013			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	32272130	Bronze, Green Submitted			2022-12-18	WOS:000588153700025
J	Van Nieuwenhove, E; Barber, JS; Neumann, J; Smeets, E; Willemsen, M; Pasciuto, E; Prezzemolo, T; Lagou, V; Seldeslachts, L; Malengier-Devlies, B; Metzemaekers, M; Hassdenteufel, S; Kerstens, A; van der Kant, R; Rousseau, F; Schymkowitz, J; Di Marino, D; Lang, S; Zimmermann, R; Schlenner, S; Munck, S; Proost, P; Matthys, P; Devalck, C; Boeckx, N; Claessens, F; Wouters, C; Humblet-Baron, S; Meyts, I; Liston, A				Van Nieuwenhove, Erika; Barber, John S.; Neumann, Julika; Smeets, Elien; Willemsen, Mathijs; Pasciuto, Emanuela; Prezzemolo, Teresa; Lagou, Vasiliki; Seldeslachts, Laura; Malengier-Devlies, Bert; Metzemaekers, Mieke; Hassdenteufel, Sarah; Kerstens, Axelle; van der Kant, Rob; Rousseau, Frederic; Schymkowitz, Joost; Di Marino, Daniele; Lang, Sven; Zimmermann, Richard; Schlenner, Susan; Munck, Sebastian; Proost, Paul; Matthys, Patrick; Devalck, Christine; Boeckx, Nancy; Claessens, Frank; Wouters, Carine; Humblet-Baron, Stephanie; Meyts, Isabelle; Liston, Adrian			Defective Sec61 alpha 1 underlies a novel cause of autosomal dominant severe congenital neutropenia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Severe congenital neutropenia; SEC61A1; endoplasmic reticulum stress; unfolded protein response; whole exome sequencing	MACROPHAGE DIFFERENTIATION; MUTATIONS; PROTEIN; ELANE; GENE; STRESS; SBDS; HAX1	Background: The molecular cause of severe congenital neutropenia (SCN) is unknown in 30% to 50% of patients. SEC61A1 encodes the alpha subunit of the Sec61 complex, which governs endoplasmic reticulum protein transport and passive calcium leakage. Recently, mutations in SEC61A1 were reported to be pathogenic in common variable immunodeficiency and glomerulocystic kidney disease. Objective: Our aim was to expand the spectrum of SEC61A1-mediated disease to include autosomal dominant SCN. Methods: Whole exome sequencing findings were validated, and reported mutations were compared by Western blotting, Ca2(+) flux assays, differentiation of transduced HL-60 cells, in vitro differentiation of primary CD34 cells, quantitative PCR for unfolded protein response (UPR) genes, and single-cell RNA sequencing on whole bone marrow. Results: We identified a novel de novo missense mutation in SEC61A1 (c.A275G;p.Q92R) in a patient with SCN who was born to nonconsanguineous Belgian parents. The mutation results in diminished protein expression, disturbed protein translocation, and an increase in calcium leakage from the endoplasmic reticulum. In vitro differentiation of CD34(+) cells recapitulated the patient's clinical arrest in granulopoiesis. The impact of Q92R-Sec61 alpha 1 on neutrophil maturation was validated by using HL-60 cells, in which transduction reduced differentiation into CD11b(+)CD16(+) cells. A potential mechanism for this defect is the uncontrolled initiation of the unfolded protein stress response, with single-cell analysis of primary bone marrow revealing perturbed UPR in myeloid precursors and in vitro differentiation of primary CD34(+) cells revealing upregulation of CCAAT/enhancer-binding protein homologous protein and immunoglobulin heavy chain binding protein UPR-response genes. Conclusion: Specific mutations in SEC61A1 cause SCN through dysregulation of the UPR.	[Van Nieuwenhove, Erika; Barber, John S.; Neumann, Julika; Willemsen, Mathijs; Pasciuto, Emanuela; Prezzemolo, Teresa; Lagou, Vasiliki; Seldeslachts, Laura; Schlenner, Susan; Humblet-Baron, Stephanie; Liston, Adrian] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Adapt Immun, Leuven, Belgium; [Smeets, Elien; Claessens, Frank] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Mol Endocrinol, Leuven, Belgium; [Malengier-Devlies, Bert; Matthys, Patrick] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Immunobiol, Rega Inst Med Res, Leuven, Belgium; [Metzemaekers, Mieke; Proost, Paul] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Mol Immunol, Rega Inst Med Res, Leuven, Belgium; [Kerstens, Axelle; Munck, Sebastian] Katholieke Univ Leuven, VIB Bio Imaging Core, Leuven, Belgium; [Kerstens, Axelle; Munck, Sebastian] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium; [van der Kant, Rob; Rousseau, Frederic; Schymkowitz, Joost] Katholieke Univ Leuven, Dept Cellular & Mol Med, Switch Lab, Leuven, Belgium; [Boeckx, Nancy] Katholieke Univ Leuven, Dept Oncol, Leuven, Belgium; [Wouters, Carine] Katholieke Univ Leuven, Dept Microbiol & Immunol, Immunobiol, Leuven, Belgium; [Meyts, Isabelle] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Lab Inborn Errors Immun, Leuven, Belgium; [Van Nieuwenhove, Erika; Barber, John S.; Neumann, Julika; Willemsen, Mathijs; Pasciuto, Emanuela; Prezzemolo, Teresa; Lagou, Vasiliki; Kerstens, Axelle; van der Kant, Rob; Rousseau, Frederic; Schymkowitz, Joost; Munck, Sebastian; Humblet-Baron, Stephanie; Liston, Adrian] VIB KU Leuven Ctr Brain & Dis Res, Leuven, Belgium; [Van Nieuwenhove, Erika] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium; [Boeckx, Nancy] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium; [Wouters, Carine] Univ Hosp Leuven, Dept Pediat, Div Pediat Rheumatol, Leuven, Belgium; [Meyts, Isabelle] Univ Hosp Leuven, Dept Pediat, Div Primary Immunodeficiencies, Leuven, Belgium; [Hassdenteufel, Sarah; Lang, Sven; Zimmermann, Richard] Saarland Univ, Dept Med Biochem & Mol Biol, Homburg, Germany; [Di Marino, Daniele] Polytech Univ Marche, New York Marche Struct Biol Ctr, Dept Life & Environm Sci, Ancona, Italy; [Devalck, Christine] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Hematooncol, Brussels, Belgium; [Wouters, Carine] ERN RITA Execut Board, Leuven, Belgium; [Meyts, Isabelle] ERN RITA Core Ctr, Leuven, Belgium; [Liston, Adrian] Babraham Inst, Lab Lymphocyte Signalling & Dev, Babraham Res Campus, Cambridge, England	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Universitatsklinikum des Saarlandes; Marche Polytechnic University; Universite Libre de Bruxelles; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Liston, A (corresponding author), Babraham Inst, Babraham Hall House, Cambridge CB22 3AT, England.; Meyts, I (corresponding author), Univ Hosp Leuven, Herestr 49, Leuven, Belgium.	isabelle.meyts@uzleuven.be; adrian.liston@babraham.ac.uk	Pasciuto, Emanuela/AAP-2982-2020; Matthys, Patrick/B-4813-2018; Di Marino, Daniele/ABB-2333-2020; Schymkowitz, Joost/AAV-3680-2021; Hassdenteufel, Sarah/AAE-8915-2022; Malengier-Devlies, Bert/Q-8490-2019; Van Nieuwenhove, Erika/H-7445-2018; Metzemaekers, Mieke/U-4989-2017; Neumann, Julika/CAG-6246-2022; Seldeslachts, Laura/ABG-8034-2020; Proost, Paul/V-3052-2017; Claessens, Frank/M-8565-2016; Schlenner, Susan/P-7905-2017; Liston, Adrian/G-8606-2013	Matthys, Patrick/0000-0002-9685-6836; Hassdenteufel, Sarah/0000-0001-7243-6602; Malengier-Devlies, Bert/0000-0003-3527-1145; Van Nieuwenhove, Erika/0000-0001-9584-3198; Metzemaekers, Mieke/0000-0002-8548-0124; Seldeslachts, Laura/0000-0002-9562-2923; Munck, Sebastian/0000-0002-5182-5358; Willemsen, Mathijs/0000-0002-8059-4819; Proost, Paul/0000-0002-0133-5545; Kerstens, Axelle/0000-0003-3364-9589; Humblet-Baron, Stephanie/0000-0003-4684-069X; Claessens, Frank/0000-0002-8676-7709; Pasciuto, Emanuela/0000-0002-5391-9585; Schlenner, Susan/0000-0002-8553-3388; Wouters, Carine/0000-0002-6426-8845; Neumann, Julika/0000-0003-0518-2512; Liston, Adrian/0000-0002-6272-4085; Lagou, Vasiliki/0000-0003-3165-8940	VIB Grand Challenges program; Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek [FWO]) [G0A3218N, G080818N]; KU Leuven [C16/17/010]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0427, BBS/E/B/000C0428]; Biotechnology and Biological Sciences Research Council; European Union [779295]; Hercules type 1 grant [AKUL/09/037]; VIB FlowCore; SB grant [1S22716N]; FWO [1272517N, 12S8918N, 12H3319N]; Jeffrey Modell Foundation; CSL Chair in Primary Immunodeficiencies; European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases [739543]; DFG [IRTG1830]; BBSRC [BBS/E/B/000C0427] Funding Source: UKRI	VIB Grand Challenges program; Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek [FWO])(FWO); KU Leuven(KU Leuven); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Hercules type 1 grant; VIB FlowCore(KU Leuven); SB grant; FWO(FWO); Jeffrey Modell Foundation; CSL Chair in Primary Immunodeficiencies; European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases; DFG(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the VIB Grand Challenges program, the Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek [FWO]) (grants G0A3218N and G080818N), the KU Leuven (C1 grant C16/17/010), the Biotechnology and Biological Sciences Research Council through Institute Strategic Program Grant funding BBS/E/B/000C0427 and BBS/E/B/000C0428, and the Biotechnology and Biological Sciences Research Council Core Capability Grant to the Babraham Institute. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 779295. The Nikon A1R Eclipse Ti Confocal microscope was funded by a Hercules type 1 AKUL/09/037 grant. The VIB FlowCore provided research support in this study. E.V.N. is funded by an SB grant (1S22716N). The following authors are funded by postdoctoral grants from the FWO: S.H.-B. (grant 1272517N), EP (grant 12S8918N), and VL (grant 12H3319N). I.M. is funded by the Jeffrey Modell Foundation and by the CSL Chair in Primary Immunodeficiencies. C.W. and I.M. are members of the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (Project ID No. 739543). S.L. and R.Z. were supported by the DFG via IRTG1830.	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Bellann C, 2019, SYNDROME, V132, P1318; Besse W, 2017, J CLIN INVEST, V127, P3558, DOI 10.1172/JCI96729; Bolar NA, 2016, AM J HUM GENET, V99, P174, DOI 10.1016/j.ajhg.2016.05.028; Boztug K, 2014, NAT GENET, V46, P1021, DOI 10.1038/ng.3069; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Cenci S, 2007, FEBS LETT, V581, P3652, DOI 10.1016/j.febslet.2007.04.031; Cottineau J, 2017, J CLIN INVEST, V127, P1991, DOI 10.1172/JCI90727; Dannenmann B, 2019, EXP HEMATOL, V71, P51, DOI 10.1016/j.exphem.2018.12.006; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; Donadieu J, 2013, HEMATOL ONCOL CLIN N, V27, P1, DOI 10.1016/j.hoc.2012.11.003; Dudek J, 2013, METHODS MOL BIOL, V1033, P285, DOI 10.1007/978-1-62703-487-6_18; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Hauck F, 2013, CURR OPIN ALLERGY CL, V13, P596, DOI 10.1097/ACI.0000000000000014; Hu H, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03083; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krishnaraju K, 1998, BLOOD, V92, P1957, DOI 10.1182/blood.V92.6.1957.418k24_1957_1966; Lang S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00887; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Linxweiler M, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.2; Liston A, 2017, TRENDS MOL MED, V23, P181, DOI 10.1016/j.molmed.2016.12.005; Makaryan V, 2017, J LEUKOCYTE BIOL, V102, P1143, DOI 10.1189/jlb.5A1016-445R; Michel T, 2016, J IMMUNOL, V196, P2923, DOI 10.4049/jimmunol.1502570; Morishima T, 2014, HAEMATOLOGICA, V99, P19, DOI 10.3324/haematol.2013.083873; Nayak RC, 2015, J CLIN INVEST, V125, P3103, DOI 10.1172/JCI80924; Pfeiffer NV, 2013, EMBO J, V32, P1036, DOI 10.1038/emboj.2013.46; Rainbolt TK, 2014, TRENDS ENDOCRIN MET, V25, P528, DOI 10.1016/j.tem.2014.06.007; Rajarathnam K, 2019, CELL SIGNAL, V54, P69, DOI 10.1016/j.cellsig.2018.11.004; Rojas-Rivera D, 2015, ONCOGENE, V34, P269, DOI 10.1038/onc.2014.6; Schaeffer C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48014-6; Schubert D, 2018, J ALLERGY CLIN IMMUN, V141, P1427, DOI 10.1016/j.jaci.2017.06.042; SERRANO L, 1992, NATURE, V356, P453, DOI 10.1038/356453a0; Six E, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.211; Skokowa J, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.32; Stepensky P, 2017, J MED GENET, V54, P558, DOI 10.1136/jmedgenet-2016-104366; Synofzik M, 2014, AM J HUM GENET, V95, P689, DOI 10.1016/j.ajhg.2014.10.013; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Travelli C, 2018, PHARMACOL RES, V135, P25, DOI 10.1016/j.phrs.2018.06.022; Tummala H, 2016, AM J HUM GENET, V99, P115, DOI 10.1016/j.ajhg.2016.05.002; Van Nieuwenhove E, 2018, J ALLERGY CLIN IMMUN, V142, P699, DOI 10.1016/j.jaci.2018.04.008; Vilboux T, 2013, NEW ENGL J MED, V369, P54, DOI 10.1056/NEJMoa1301296; Xia J, 2009, BRIT J HAEMATOL, V147, P535, DOI 10.1111/j.1365-2141.2009.07888.x; Zivna M, 2009, AM J HUM GENET, V85, P204, DOI 10.1016/j.ajhg.2009.07.010	48	16	16	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					1180	1193		10.1016/j.jaci.2020.03.034	http://dx.doi.org/10.1016/j.jaci.2020.03.034			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	32325141	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000588153700020
J	Holt, PG; Strickland, DH; Custovic, A				Holt, Patrick G.; Strickland, Deborah H.; Custovic, Adnan			Targeting maternal immune function during pregnancy for asthma prevention in offspring: Harnessing the "farm effect"?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma prevention; maternal infection; maternal immune training; maternal (fetal) benefit; transplacental effects; OM85-bronchovaxom			[Holt, Patrick G.; Strickland, Deborah H.] Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia; [Custovic, Adnan] Imperial Coll London, Natl Heart & Lung Inst, London, England	Telethon Kids Institute; University of Western Australia; Imperial College London	Holt, PG (corresponding author), Perth Childrens Hosp, Telethon Kids Inst, Northern Entrance, 15 Hosp Ave, Nedlands, WA 6009, Australia.	Patrick.Holt@telethonkids.org.au	Strickland, Deborah/AGV-6937-2022; Custovic, Adnan/A-2435-2012; Holt, Patrick/H-1548-2011	Strickland, Deborah/0000-0003-0114-4201; Custovic, Adnan/0000-0001-5218-7071; Holt, Patrick/0000-0003-1193-0935				de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Kazy Zoltan, 2005, Orv Hetil, V146, P2359; Liu XQ, 2018, J ALLERGY CLIN IMMUN, V141, P886, DOI 10.1016/j.jaci.2017.05.016; Mincham KT, 2018, J CLIN INVEST, V128, P4856, DOI 10.1172/JCI122631; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ober C, 2017, CURR OPIN IMMUNOL, V48, P51, DOI 10.1016/j.coi.2017.08.003; Scott NM, 2017, MUCOSAL IMMUNOL, V10, P789, DOI 10.1038/mi.2016.85; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Strickland DH, 2011, MUCOSAL IMMUNOL, V4, P43, DOI 10.1038/mi.2010.43	10	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					270	272		10.1016/j.jaci.2020.04.008	http://dx.doi.org/10.1016/j.jaci.2020.04.008			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32333916	Green Submitted, Bronze			2022-12-18	WOS:000558835000007
J	Iweala, OI; Choudhary, SK; Addison, CT; Batty, CJ; Kapita, CM; Amelio, C; Schuyler, AJ; Deng, SL; Bachelder, EM; Ainslie, KM; Savage, PB; Brennan, PJ; Commins, SP				Iweala, Onyinye I.; Choudhary, Shailesh K.; Addison, Claire T.; Batty, Cole J.; Kapita, Camille M.; Amelio, Claire; Schuyler, Alexander J.; Deng, Shenglou; Bachelder, Eric M.; Ainslie, Kristy M.; Savage, Paul B.; Brennan, Patrick J.; Commins, Scott P.			Glycolipid-mediated basophil activation in alpha-gal allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							KILLER T-CELLS; IGE		[Iweala, Onyinye I.; Choudhary, Shailesh K.; Addison, Claire T.; Kapita, Camille M.; Amelio, Claire; Commins, Scott P.] Univ N Carolina, Dept Med, Div Rheumatol Allergy & Immunol, Thurston Arthrit Res Ctr, Chapel Hill, NC 27515 USA; [Iweala, Onyinye I.; Commins, Scott P.] Univ N Carolina, Dept Pediat, Food Allergy Initiat, Div Allergy Immunol & Rheumatol, Chapel Hill, NC 27515 USA; [Batty, Cole J.; Bachelder, Eric M.; Ainslie, Kristy M.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, Chapel Hill, NC 27515 USA; [Schuyler, Alexander J.] Univ Virginia, Div Allergy & Clin Immunol, Charlottesville, VA USA; [Deng, Shenglou; Savage, Paul B.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Brennan, Patrick J.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; Brigham Young University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Iweala, OI (corresponding author), Univ N Carolina, Dept Med, Div Rheumatol Allergy & Immunol, Thurston Arthrit Res Ctr, Chapel Hill, NC 27515 USA.; Iweala, OI (corresponding author), Univ N Carolina, Dept Pediat, Food Allergy Initiat, Div Allergy Immunol & Rheumatol, Chapel Hill, NC 27515 USA.	onyinye.iweala@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Iweala, Onyinye/AAZ-2427-2020; Savage, Paul B/HGB-3414-2022	Iweala, Onyinye/0000-0001-7470-7904; Savage, Paul B/0000-0002-4642-6109; Batty, Cole J./0000-0002-5631-2623	National Institutes of Health (NIH) [UM1AI30936, R01AI135049]; NIH [T32AI007062, K08AI102945, P30CA016086, 1UM2AI30836-01]; 2019 Thurston Arthritis Research Center Pilot Award; North Carolina Biotech Center [2017-IDG-1025]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2019 Thurston Arthritis Research Center Pilot Award; North Carolina Biotech Center	Supported by National Institutes of Health (NIH) (grants UM1AI30936 to the University of North Carolina [UNC] Food Allergy Initiative and R01AI135049). O. I. Iweala was supported by NIH grant T32AI007062 and a 2019 Thurston Arthritis Research Center Pilot Award. P. J. Brennan was supported by the NIH (grant K08AI102945) and generous support from the Goodfellow and Karol families. The UNC Flow Cytometry Core Facility is supported in part by the NIH (grant P30CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center). Research reported in this publication was supported in part by the North Carolina Biotech Center (institutional support grant 2017-IDG-1025) and by the NIH (grant 1UM2AI30836-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the letter. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Commins SP, 2014, J ALLERGY CLIN IMMUN, V134, P108, DOI 10.1016/j.jaci.2014.01.024; COOPER AD, 1981, J BIOL CHEM, V256, P9379; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Jyonouchi S, 2011, J ALLERGY CLIN IMMUN, V128, P102, DOI 10.1016/j.jaci.2011.02.026; Steinke JW, 2016, J ALLERGY CLIN IMMUN, V138, P1465, DOI 10.1016/j.jaci.2016.05.021; Tordesillas L, 2017, CLIN EXP ALLERGY, V47, P1398, DOI 10.1111/cea.12962; Yin N, 2009, ACS CHEM BIOL, V4, P191, DOI 10.1021/cb800277n	9	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					450	+		10.1016/j.jaci.2020.02.006	http://dx.doi.org/10.1016/j.jaci.2020.02.006			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32088306	Green Accepted, Bronze			2022-12-18	WOS:000558835000035
J	Liu, SC; Sirohi, K; Verma, M; McKay, J; Michalec, L; Sripada, A; Danhorn, T; Rollins, D; Good, J; Gorska, MM; Martin, RJ; Alam, R				Liu, Sucai; Sirohi, Kapil; Verma, Mukesh; McKay, Jerome; Michalec, Lidia; Sripada, Anand; Danhorn, Tomas; Rollins, Donald; Good, James; Gorska, Magdalena M.; Martin, Richard J.; Alam, Rafeul			Optimal identification of human conventional and nonconventional (CRTH2(-)IL7R alpha(-)) ILC2s using additional surface markers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; type 2 innate lymphoid cells; novel ILC2 population; cytokines	INNATE LYMPHOID-CELLS; T-CELLS; INFLAMMATION; EXPRESSION; PLASTICITY; ASTHMA; CRTH2; DIFFERENTIATION; EXACERBATIONS; ASPERGILLUS	Background: Human type 2 innate lymphoid cells (ILC2s) are identified by coupled detection of CRTH2 and IL7R alpha on lineage negative (Lin(-)) cells. Type 2 cytokine production by CRTH2(-)IL7R alpha(-) innate lymphoid cells (ILCs) is unknown. Objective: We sought to identify CRTH2(-)IL7R alpha(-) type 2 cytokine-producing ILCs and their disease relevance. Methods: We studied human blood and lung ILCs from asthmatic and control subjects by flow cytometry, ELISA, RNA sequencing, quantitative PCR, adoptive transfer to mice, and measurement of airway hyperreactivity by Flexivent. Results: We found that IL-5 and IL-13 were expressed not only by CRTH2(+) but also by CRTH2(-)IL7R alpha(+) and CRTH2(-)IL7R alpha(-) (double-negative [DN]) human blood and lung cells. All 3 ILC populations expressed type 2 genes and induced airway hyperreactivity when adoptively transferred to mice. The frequency of type 2 cytokine-positive IL7Ra and DN ILCs were similar to that of CRTH2 ILCs in the blood and lung. Their frequency was higher in asthmatic patients than in disease controls. Transcriptomic analysis of CRTH2, IL7R alpha, and DN ILCs confirmed the expression of mRNA for type 2 transcription factors in all 3 populations. Unexpectedly, the mRNA for GATA3 and IL-5 correlated better with mRNA for CD30, TNFR2, ICOS, CCR4, and CD200R1 than for CRTH2. By using a combination of these surface markers, especially CD30/TNFR2, we identified a previously unrecognized ILC2 population. Conclusions: The commonly used surface markers for human ILC2s leave a majority of type 2 cytokine-producing ILC2s unaccounted for. We identified top GATA3-correlated cell surface-expressed genes in human ILCs by RNA sequencing. These new surface markers, such as CD30 and TNFR2, identified a previously unrecognized human ILC2 population. This ILC2 population is likely to contribute to asthma.	[Liu, Sucai; Sirohi, Kapil; Verma, Mukesh; McKay, Jerome; Michalec, Lidia; Sripada, Anand; Gorska, Magdalena M.; Alam, Rafeul] Natl Jewish Hlth, Div Allergy & Immunol, Denver, CO USA; [Rollins, Donald; Good, James; Martin, Richard J.] Natl Jewish Hlth, Div Pulm & Crit Care Med, Dept Med, Denver, CO USA; [Danhorn, Tomas] Natl Jewish Hlth, Ctr Genes & Environm, Denver, CO USA; [Rollins, Donald; Good, James; Gorska, Magdalena M.; Martin, Richard J.; Alam, Rafeul] Univ Colorado, Sch Med, Denver, CO USA	National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Alam, R (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	alamr@njhealth.org	Sirohi, Kapil/GVT-2867-2022	Sirohi, Kapil/0000-0001-5039-2848; Danhorn, Thomas/0000-0002-3861-8602	National Institutes of Health [AI102943, AI137970, HL126895]; Cohen Family Foundation; NBL Fellowship Foundation; Colorado Technology; Department of Medicine of National Jewish Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cohen Family Foundation; NBL Fellowship Foundation; Colorado Technology; Department of Medicine of National Jewish Health	Supported by National Institutes of Health grants AI102943, AI137970, and HL126895; grants from the Cohen Family Foundation, the NBL Fellowship Foundation, and Colorado Technology; and the Department of Medicine of National Jewish Health.	Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Beuraud C, 2019, ALLERGY, V74, P933, DOI 10.1111/all.13679; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Cavagnero KJ, 2019, J ALLERGY CLIN IMMUN, V144, P1432, DOI 10.1016/j.jaci.2019.07.018; Cho HY, 2001, AM J PHYSIOL-LUNG C, V280, pL537, DOI 10.1152/ajplung.2001.280.3.L537; Choi JP, 2014, ALLERGY, V69, P186, DOI 10.1111/all.12301; Christianson CA, 2015, J ALLERGY CLIN IMMUN, V136, P59, DOI 10.1016/j.jaci.2014.11.037; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; De Fanis U, 2007, BLOOD, V109, P4343, DOI 10.1182/blood-2006-05-025940; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Faustino L, 2013, J IMMUNOL, V190, P2614, DOI 10.4049/jimmunol.1202354; Fuchiwaki T, 2011, EUR J IMMUNOL, V41, P2947, DOI 10.1002/eji.201141423; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Goplen N, 2009, J ALLERGY CLIN IMMUN, V123, P925, DOI 10.1016/j.jaci.2009.02.009; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Kirkham CL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00214; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Lei AH, 2018, J EXP MED, V215, P2157, DOI 10.1084/jem.20172359; Li N, 2018, J EXP MED, V215, P1383, DOI 10.1084/jem.20171934; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Liu SC, 2018, J ALLERGY CLIN IMMUN, V141, P257, DOI 10.1016/j.jaci.2017.03.032; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Mora-Velandia LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00176; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Nagasawa M, 2019, J EXP MED, V216, P1762, DOI 10.1084/jem.20190490; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata K, 1999, J IMMUNOL, V162, P1278; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Paclik D, 2015, EUR J IMMUNOL, V45, P2766, DOI 10.1002/eji.201545635; Polte T, 2006, J ALLERGY CLIN IMMUN, V118, P942, DOI 10.1016/j.jaci.2006.07.014; Quatromoni JG, 2015, J LEUKOCYTE BIOL, V97, P201, DOI 10.1189/jlb.5TA0814-373; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14601; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rudmann DG, 2000, AM J PHYSIOL-LUNG C, V279, pL1047, DOI 10.1152/ajplung.2000.279.6.L1047; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Schuh JM, 2002, FASEB J, V16, P1313, DOI 10.1096/fj.02-0193fje; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Simoni Y, 2018, IMMUNITY, V48, P1060, DOI 10.1016/j.immuni.2018.04.028; Sun X, 2010, J IMMUNOL, V185, P2222, DOI 10.4049/jimmunol.1000024; Tang C, 2008, J IMMUNOL, V181, P6316, DOI 10.4049/jimmunol.181.9.6316; Verma M, 2018, J ALLERGY CLIN IMMUN, V142, P793, DOI 10.1016/j.jaci.2017.10.020; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wikenheiser DJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00304; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105	55	16	16	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					390	405		10.1016/j.jaci.2020.01.038	http://dx.doi.org/10.1016/j.jaci.2020.01.038			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32032632	Bronze, Green Accepted			2022-12-18	WOS:000558835000029
J	Pepper, AN; Assa'ad, A; Blaiss, M; Brown, E; Chinthrajah, S; Ciaccio, C; Fasano, MB; Gupta, R; Hong, N; Lang, D; Mahr, T; Malawer, E; Roach, A; Shreffler, W; Sicherer, S; Vickers, K; Vickery, BP; Wasserman, R; Yates, K; Casale, TB				Pepper, Amber N.; Assa'ad, Amal; Blaiss, Michael; Brown, Emily; Chinthrajah, Sharon; Ciaccio, Christina; Fasano, Mary Beth; Gupta, Ruchi; Hong, Nurry; Lang, David; Mahr, Todd; Malawer, Erin; Roach, Anita; Shreffler, Wayne; Sicherer, Scott; Vickers, Kathleen; Vickery, Brian P.; Wasserman, Richard; Yates, Kimberley; Casale, Thomas B.			Consensus report from the Food Allergy Research & Education (FARE) 2019 Oral Immunotherapy for Food Allergy Summit	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Oral immunotherapy; Food allergy; Peanut allergy		Food allergy is a major health problem affecting 5% to 10% of the population in developed nations, including an estimated 32 million Americans. Despite the large number of patients suffering from food allergies, up until the end of January 2020, no treatment for food allergies had been approved by the US Food and Drug Administration. The only options were avoidance of food allergen triggers and acute management of allergic reactions. A considerable body of data exists supporting oral immunotherapy (OIT) as a promising, novel treatment option, including that for the now Food and Drug Administration approved peanut OIT product Palforzia (Aimmune Therapeutics, Brisbane, Calif). However, data for long-term quality-of-life improvement with OIT varies, depending on the measures used for analysis. Like many therapies, OIT is not without potential harms, and burdens, and the evaluation of patient-specific risk-benefit ratio of food OIT produces challenges for clinicians and patients alike, with many unanswered questions. Food Allergy Research & Education organized the Oral Immunotherapy for Food Allergy Summit on November 6, 2019, modeled after the PRACTALL sessions between the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology to address these critical issues. Health care providers, patient representatives, researchers, regulators, and food allergy advocates came together to discuss OIT and identify areas of common ground as well as gaps in existing research and areas of uncertainty and disagreement. The purpose of this article was to summarize that discussion and facilitate collaboration among clinicians and patients to help them make better-informed decisions about offering and accepting OIT, respectively, as a therapeutic option.	[Pepper, Amber N.] Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Morsani Coll Med, Tampa, FL 33620 USA; [Assa'ad, Amal] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Blaiss, Michael] Augusta Univ, Med Coll Georgia, Augusta, GA USA; [Brown, Emily] Food Equal Initiat, Kansas City, MO USA; [Chinthrajah, Sharon] Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Ciaccio, Christina] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Fasano, Mary Beth] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Gupta, Ruchi] Northwestern Univ, Ctr Food Allergy & Asthma Res, Feinberg Sch Med, Chicago, IL 60611 USA; [Gupta, Ruchi] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Hong, Nurry; Roach, Anita; Vickers, Kathleen] FARE Food Allergy Res & Educ, Mclean, VA USA; [Lang, David] Cleveland Clin, Dept Allergy & Clin Immunol, Resp Inst, Cleveland, OH 44106 USA; [Mahr, Todd] Gundersen Hlth Syst, La Crosse, WI USA; [Malawer, Erin] MAllergyStrong, Mclean, VA USA; [Shreffler, Wayne] Massachusetts Gen Hosp, Dept Pediat, Food Allergy Ctr, Boston, MA 02114 USA; [Shreffler, Wayne] Massachusetts Gen Hosp, Dept Med, Food Allergy Ctr, Boston, MA 02114 USA; [Sicherer, Scott] Icahn Sch Med Mt Sinai, Dept Pediat, Jaffe Food Allergy Inst, New York, NY 10029 USA; [Vickery, Brian P.] Food Allergy Ctr Emory Childrens, Atlanta, GA USA; [Wasserman, Richard] Allergy Partners North Texas, Dallas, TX USA; [Yates, Kimberley] Latitude Food Allergy Care, Redwood City, CA USA; [Casale, Thomas B.] Univ S Florida, Food Allergy Res & Educ FARE, 12901 Bruce B Downs Blvd,MDC19, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; Cincinnati Children's Hospital Medical Center; University System of Georgia; Augusta University; Stanford University; University of Chicago; University of Iowa; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Cleveland Clinic Foundation; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; State University System of Florida; University of South Florida	Casale, TB (corresponding author), Univ S Florida, Food Allergy Res & Educ FARE, 12901 Bruce B Downs Blvd,MDC19, Tampa, FL 33612 USA.	tbcasale@usf.edu						Assa'ad A, 2018, ANN ALLERG ASTHMA IM, V121, pS53, DOI 10.1016/j.anai.2018.09.170; Berglund JP, 2017, J ALLER CL IMM-PRACT, V5, P1098, DOI 10.1016/j.jaip.2016.11.034; Bilaver LA, 2019, J ALLER CL IMM-PRACT, V7, P22431, DOI 10.1016/j.jaip.2019.03.011; Bilaver LA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3678; Blackman AC, 2020, ANN ALLERG ASTHMA IM, V125, P196, DOI 10.1016/j.anai.2020.03.028; Chinthrajah RS, 2019, LANCET, V394, P1437, DOI 10.1016/S0140-6736(19)31793-3; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; Eiwegger T, 2019, ANN ALLERG ASTHMA IM, V123, P430, DOI 10.1016/j.anai.2019.09.001; Epstein-Rigbi N, 2019, J ALLER CL IMM-PRACT, V7, P429, DOI 10.1016/j.jaip.2018.06.016; Filep S, 2018, J ALLERGY CLIN IMMUN, V141, P626, DOI 10.1016/j.jaci.2017.05.049; Gupta R, 2013, JAMA PEDIATR, V167, P1026, DOI 10.1001/jamapediatrics.2013.2376; Gupta RS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.5630; Gupta RS, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1235; Herbert LJ, 2019, J ALLER CL IMM-PRACT, V7, P2904, DOI 10.1016/j.jaip.2019.04.045; Institute for Clinical and Economic Review, 2019, REV VAL OR IMM EP IM; Jones SM, 2016, J ALLERGY CLIN IMMUN, V137, P1117, DOI 10.1016/j.jaci.2015.12.1316; Nurmatov U, 2017, ALLERGY, V72, P1133, DOI 10.1111/all.13124; Pajno GB, 2018, ALLERGY, V73, P799, DOI 10.1111/all.13319; Roach A, 2020, AM AC ALL ASTH IMM A; */* S   5, 2010, J ALLERGY CLIN IMM S, V126, pS, DOI DOI 10.1016/J.JACI.2010.10.007; Tsai M, 2020, J ALLERGY CLIN IMMUN, V145, P885, DOI 10.1016/j.jaci.2019.10.038; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2013, INV NEW DRUG APPL IN; Vickery BP, 2018, NEW ENGL J MED, V379, P1991, DOI 10.1056/NEJMoa1812856; Wasserman RL, 2019, J ALLER CL IMM-PRACT, V7, P418, DOI 10.1016/j.jaip.2018.05.023	24	16	16	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					244	249		10.1016/j.jaci.2020.05.027	http://dx.doi.org/10.1016/j.jaci.2020.05.027			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32505612				2022-12-18	WOS:000558835000003
J	Hastie, AT; Mauger, DT; Denlinger, LC; Coverstone, A; Castro, M; Erzurum, S; Jarjour, N; Levy, BD; Meyers, DA; Moore, WC; Phillips, B; Wenzel, SE; Fahy, JV; Israel, E; Bleecker, ER				Hastie, Annette T.; Mauger, David T.; Denlinger, Loren C.; Coverstone, Andrea; Castro, Mario; Erzurum, Serpil; Jarjour, Nijar; Levy, Bruce D.; Meyers, Deborah A.; Moore, Wendy C.; Phillips, Brenda; Wenzel, Sally E.; Fahy, John V.; Israel, Elliot; Bleecker, Eugene R.		NHLBI SARP 3 Investigators	Baseline sputum eosinophil 1 neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Hastie, Annette T.; Moore, Wendy C.] Wake Forest Univ, Bowman Gray Sch Med, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA; [Mauger, David T.; Phillips, Brenda] Penn State Coll Med, Hershey, PA USA; [Denlinger, Loren C.; Jarjour, Nijar] Univ Wisconsin, Madison, WI USA; [Coverstone, Andrea; Castro, Mario] Washington Univ, Sch Med, St Louis, MO USA; [Erzurum, Serpil] Cleveland Clin, Cleveland, OH 44106 USA; [Levy, Bruce D.; Israel, Elliot] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Meyers, Deborah A.; Bleecker, Eugene R.] Univ Arizona, Coll Med, Tucson, AZ USA; [Wenzel, Sally E.] Univ Pittsburgh, Pittsburgh, PA USA; [Fahy, John V.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Wake Forest University; Wake Forest Baptist Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	Hastie, AT (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA.	ahastie@wakehealth.edu		Wenzel, Sally/0000-0002-4242-0164	National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) Severe Asthma Research Program [U10 HL109164, U10 HL109257, U10 HL109146, U10 HL109172, U10 HL109250, U10 HL109168, U10 HL109152, U10 HL109086]; AstraZeneca; Boehringer Ingelheim; Genetech; GlaxoSmithKline; MedImmune; Novartis; Regeneron; Sanofi; Teva	National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) Severe Asthma Research Program; AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Genetech; GlaxoSmithKline(GlaxoSmithKline); MedImmune(AstraZenecaMedimmune); Novartis(Novartis); Regeneron(Regeneron); Sanofi; Teva(Teva Pharmaceutical Industries)	The research by the principal and coprincipal investigators was funded by the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) Severe Asthma Research Program: E.R.B. (principal investigator [PI], grant no. U10 HL109164), M.C. (PI, grant no. U10 HL109257), J.V.F. (PI, grant no. U10 HL109146), E.I. and B.D.L. (co-PIs, grant no. U10 HL109172), B. M. Gaston, S.C.E., and W. G. Teague (PI and Co-PIs, grant no. U10 HL109250), N.N.J. (PI, U10 HL109168), S.E.W. (PI, U10 HL109152), and D.T.M. (PI, U10 HL109086). Industry partnerships also provided additional support: AstraZeneca, Boehringer Ingelheim, Genetech, GlaxoSmithKline, MedImmune, Novartis, Regeneron, Sanofi, and Teva. Spirometers used in SARP III were provided by nSpire Health (Longmont, Colo).	Al-Samri MT, 2010, J ALLERGY CLIN IMMUN, V125, P1161, DOI 10.1016/j.jaci.2010.02.005; [Anonymous], 2020, COVID 19 RECOMMENDAT; Ducharme ME, 2011, RESP MED, V105, P1284, DOI 10.1016/j.rmed.2011.04.006; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Luers JC, 2020, LARYNGO RHINO OTOL, V99, P287, DOI 10.1055/a-1095-2344; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Phipatanakul W, 2017, AM J RESP CRIT CARE, V195, P1439, DOI 10.1164/rccm.201607-1453OC; Silkoff PE, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0360-5; van Veen IH, 2009, J ALLERGY CLIN IMMUN, V124, P615, DOI 10.1016/j.jaci.2009.06.029; Walsh CJ, 2016, CLIN EXP ALLERGY, V46, P1291, DOI 10.1111/cea.12762; Zhang JJ, 2020, ALLERGY, V75, P1809, DOI 10.1111/all.14316	12	16	16	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2020	146	1					222	+		10.1016/j.jaci.2020.01.039	http://dx.doi.org/10.1016/j.jaci.2020.01.039			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OC5BB	32032631	Bronze, Green Accepted			2022-12-18	WOS:000579170500037
J	Nahum, A; Sharfe, N; Broides, A; Dadi, H; Naghdi, Z; Mandola, AB; Vong, L; Arbiv, A; Dalal, I; Brami, I; Wormser, O; Levy, J; Roifman, CM				Nahum, Amit; Sharfe, Nigel; Broides, Arnon; Dadi, Harjit; Naghdi, Zahra; Mandola, Amarilla B.; Vong, Linda; Arbiv, Adi; Dalal, Ilan; Brami, Ido; Wormser, Ohad; Levy, Jacov; Roifman, Chaim M.			Defining the biological responses of IL-6 by the study of a novel IL-6 receptor chain immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PHOSPHORYLCHOLINE		[Nahum, Amit; Mandola, Amarilla B.] Soroka Univ, Med Ctr, Pediat Dept A, Beer Sheva, Israel; [Nahum, Amit; Broides, Arnon; Levy, Jacov] Soroka Univ, Med Ctr, Immunol Clin, Beer Sheva, Israel; [Nahum, Amit; Arbiv, Adi] Ben Gurion Univ Negev, Primary Immunodeficiency Res Lab, Fac Hlth Sci, Beer Sheva, Israel; [Brami, Ido] Ben Gurion Univ Negev, Dept Clin Biochem, Fac Hlth Sci, Beer Sheva, Israel; [Wormser, Ohad] Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, Beer Sheva, Israel; [Wormser, Ohad] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Sharfe, Nigel; Dadi, Harjit; Naghdi, Zahra; Mandola, Amarilla B.; Vong, Linda; Roifman, Chaim M.] Univ Toronto, Canadian Ctr Primary Immunodeficiency, Toronto, ON, Canada; [Sharfe, Nigel; Dadi, Harjit; Naghdi, Zahra; Mandola, Amarilla B.; Vong, Linda; Roifman, Chaim M.] Univ Toronto, Jeffrey Modell Res Lab Diag Primary Immunodeficie, Toronto, ON, Canada; [Sharfe, Nigel; Dadi, Harjit; Naghdi, Zahra; Mandola, Amarilla B.; Vong, Linda; Roifman, Chaim M.] Univ Toronto, Dept Paediat, Hosp Sick Children, Div Immunol & Allergy, Toronto, ON, Canada; [Sharfe, Nigel; Dadi, Harjit; Naghdi, Zahra; Mandola, Amarilla B.; Vong, Linda; Roifman, Chaim M.] Univ Toronto, Toronto, ON, Canada; [Dalal, Ilan] E Wolfson Med Ctr, Dept Pediat, Holon, Israel; [Dalal, Ilan] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Tel Aviv University; Sackler Faculty of Medicine	Nahum, A (corresponding author), Soroka Univ, Med Ctr, Pediat Dept A, Beer Sheva, Israel.; Nahum, A (corresponding author), Soroka Univ, Med Ctr, Immunol Clin, Beer Sheva, Israel.; Nahum, A (corresponding author), Ben Gurion Univ Negev, Primary Immunodeficiency Res Lab, Fac Hlth Sci, Beer Sheva, Israel.	amitna@clalit.org.il; chaim.roifman@sickkids.ca	Wormser, Ohad/ABD-7693-2021	Wormser, Ohad/0000-0003-0007-1469; /0000-0003-1774-5423; Mandola, Amarilla/0000-0001-9194-6798	Immunodeficiency Canada's Distinguished Professorship in Immunology; Program for Immunogenomics; Jeffrey Modell Foundation; Immunodeficiency Canada; National Knowledge Center for Rare/Orphan Diseases; Israel ministry of Science, Technology and Space; Ontario Institute for Cancer Research; McEwen Centre for Regenerative Medicine; Canada Foundation for Innovation	Immunodeficiency Canada's Distinguished Professorship in Immunology; Program for Immunogenomics; Jeffrey Modell Foundation; Immunodeficiency Canada; National Knowledge Center for Rare/Orphan Diseases; Israel ministry of Science, Technology and Space(Ministry of Science, Technology and Space (MOST), Israel); Ontario Institute for Cancer Research; McEwen Centre for Regenerative Medicine; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	Supported by Immunodeficiency Canada's Distinguished Professorship in Immunology (to C.M.R.), the Program for Immunogenomics and the Canadian Centre for Primary Immunodeficiency (to C.M.R.), the Jeffrey Modell Foundation, and Immunodeficiency Canada (to C.M.R.). Genetic analysis was completed with support from the National Knowledge Center for Rare/Orphan Diseases sponsored by the Israel ministry of Science, Technology and Space. Flow cytometry performed in Toronto (The SickKids-UHN Flow and Mass Cytometry Facility, Toronto) was supported with funding from the Ontario Institute for Cancer Research, the McEwen Centre for Regenerative Medicine, and the Canada Foundation for Innovation.	Casey R, 2008, INFECT IMMUN, V76, P1298, DOI 10.1128/IAI.00741-07; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Schwerd T, 2017, J EXP MED, V214, P2547, DOI 10.1084/jem.20161810; Spencer S, 2019, J EXP MED, V216, P1986, DOI 10.1084/jem.20190344; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631	9	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					1011	+		10.1016/j.jaci.2019.11.015	http://dx.doi.org/10.1016/j.jaci.2019.11.015			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31778705	Bronze			2022-12-18	WOS:000518756700038
J	Grant, T; Phipatanakul, W; Perzanowski, M; Balcer-Whaley, S; Peng, RD; Curtin-Brosnan, J; Newman, M; Cunningham, A; Divjan, A; Bollinger, ME; Wise, RA; Matsui, EC				Grant, Torie; Phipatanakul, Wanda; Perzanowski, Matthew; Balcer-Whaley, Susan; Peng, Roger D.; Curtin-Brosnan, Jean; Newman, Michelle; Cunningham, Amparito; Divjan, Adnan; Bollinger, Mary E.; Wise, Robert A.; Matsui, Elizabeth C.			Reduction in mouse allergen exposure is associated with greater lung function growth	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergen exposure; allergen exposure reduction; lung function growth; lung function trajectory; mouse allergen exposure; allergen-sensitized and exposed asthmatic children; allergic asthma	TO-MODERATE ASTHMA; AIR-POLLUTION; INHALED CORTICOSTEROIDS; PARTICULATE MATTER; EARLY ADULTHOOD; CHILDREN; CHILDHOOD; DECLINE; LIFE; SENSITIZATION	Background: Current childhood asthma therapies have little effect on lung function trajectory. Objective: We sought to determine whether mouse allergen exposure reduction is associated with lung function growth in mouse-sensitized/exposed asthmatic children. Methods: Three hundred fifty mouse-sensitized/exposed asthmatic children (5-17 years old) were enrolled in a 1-year randomized trial of integrated pest management plus education versus education alone. Prebronchodilator/postbronchodilator spirometry was performed at baseline and 6 and 12 months, and bedroom floor mouse allergen levels were measured every 3 months. Mouse allergen reduction was defined as a 75% or greater decrease in mouse allergen levels from baseline. Treatment groups were combined for analyses because there were no differences in outcomes between groups. Changes in lung function over time were modeled, adjusting for age, sex, race, atopy, group, and bronchodilator reversibility and including an interaction term (allergen reduction*time). Results: The study population was predominantly black (79.4%) and low income (66.3% [<$30,000]). At baseline, the median mouse allergen level was 5.7 ji,g/g (interquartile range, 1.5-22.8 g/g), and the mean (SD) prebronchodilator FEV1/forced vital capacity ratio was 80.2% (9.0%). Ninety-two (26.3%) participants had 75% or greater reduction in mouse allergen levels. For a 10-year-old black boy, 75% or greater allergen reduction was associated with an increase in prebronchodilator FEVi of 238 mL/y (95% CI, 177-299 mL/y), whereas less than 75% allergen reduction was associated with an increase in prebronchodilator FEVi of 131 mL/y (95% CI, 97-166 mL/y). Estimated differences in prebronchodilator and postbronchodilator FEV1 growth were as follows: 107 mL/y (95% CI, 37-177 mL/y; Pint =.003) and 48 mL/y (95% CI, 17 to 113 mL/y; P-int =.15), respectively. Estimated differences in prebronchodilator and postbronchodilator forced expiratory flow at 25% to 75% of vital capacity growth were as follows: 182 mL/y (95% CI, 61-304 mL/y; Pint =.003) and 181 mL/y (95% CI, 48-314 mL/y; P-int =.008), respectively. Conclusion: Mouse allergen reduction is associated with greater increases in prebronchodilator FEVi and prebronchodilator/ postbronchodilator forced expiratory flow at 25% to 75% of vital capacity over 1 year among sensitized/exposed asthmatic children.	[Grant, Torie; Balcer-Whaley, Susan; Curtin-Brosnan, Jean; Newman, Michelle; Matsui, Elizabeth C.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy Immunol, Baltimore, MD USA; [Wise, Robert A.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Phipatanakul, Wanda; Cunningham, Amparito] Harvard Univ, Med Sch, Boston Childrens Hosp, Div Pediat Allergy Immunol, Boston, MA USA; [Perzanowski, Matthew; Divjan, Adnan] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Peng, Roger D.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Bollinger, Mary E.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Matsui, Elizabeth C.] Univ Texas Austin, Dept Populat Hlth, Dell Med Sch, 1701 Trinity St,Stop Z0500, Austin, TX 78712 USA; [Matsui, Elizabeth C.] Univ Texas Austin, Dept Pediat, Dell Med Sch, Austin, TX 78712 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard Medical School; Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Matsui, EC (corresponding author), Univ Texas Austin, Dept Populat Hlth, Dell Med Sch, 1701 Trinity St,Stop Z0500, Austin, TX 78712 USA.	elizabeth.matsui@austin.utexas.edu		Matsui, Elizabeth/0000-0001-8134-5593	National Institutes of Health [U01 Al 083238, K24 AI 106822, K24 AI114769 R01 ES023447, P50ES015903, P01 ES018176]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health grants U01 Al 083238, K24 AI 106822, K24 AI114769 R01 ES023447, P50ES015903, and P01 ES018176.	Agusti A, 2017, LANCET RESP MED, V5, P935, DOI 10.1016/S2213-2600(17)30434-4; Ahluwalia SK, 2013, J ALLERGY CLIN IMMUN, V132, P830, DOI 10.1016/j.jaci.2013.05.005; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Anselmo M, 2011, PEDIATR DRUGS, V13, P11, DOI 10.2165/11533730-000000000-00000; Belgrave DCM, 2018, LANCET RESP MED, V6, P526, DOI 10.1016/S2213-2600(18)30099-7; Breysse PN, 2005, ENVIRON RES, V98, P167, DOI 10.1016/j.envres.2004.07.018; Bryant-Stephens T, 2009, J ALLERGY CLIN IMMUN, V123, P1199, DOI 10.1016/j.jaci.2009.04.030; Bui DS, 2018, LANCET RESP MED, V6, P535, DOI 10.1016/S2213-2600(18)30100-0; Dijkstra A, 2006, THORAX, V61, P105, DOI 10.1136/thx.2004.039271; Flores G, 2009, J ASTHMA, V46, P392, DOI 10.1080/02770900802712971; Foreman MG, 2011, AM J RESP CRIT CARE, V184, P414, DOI 10.1164/rccm.201011-1928OC; Gauderman WJ, 2015, NEW ENGL J MED, V372, P905, DOI 10.1056/NEJMoa1414123; Gauderman WJ, 2000, AM J RESP CRIT CARE, V162, P1383; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gauderman WJ, 2002, AM J RESP CRIT CARE, V166, P76, DOI 10.1164/rccm.2111021; Gershon Andrea S, 2014, Ann Am Thorac Soc, V11, P1195, DOI 10.1513/AnnalsATS.201403-094OC; Gotschi T, 2008, EPIDEMIOLOGY, V19, P690, DOI 10.1097/EDE.0b013e318181650f; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Hamilton RG, 2005, CURR ALLERGY ASTHM R, V5, P394, DOI 10.1007/s11882-005-0013-0; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; He QQ, 2010, RESP MED, V104, P1512, DOI 10.1016/j.rmed.2010.04.016; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Langley SJ, 2003, J ALLERGY CLIN IMMUN, V112, P362, DOI 10.1067/mai.2003.1654; LEBOWITZ MD, 1987, AM REV RESPIR DIS, V136, P69, DOI 10.1164/ajrccm/136.1.69; Limb SL, 2005, J ALLERGY CLIN IMMUN, V116, P1213, DOI 10.1016/j.jaci.2005.09.024; Majewska R, 2018, ENVIRON RES, V166, P150, DOI 10.1016/j.envres.2018.05.037; Matsui EC, 2017, JAMA-J AM MED ASSOC, V317, P1027, DOI 10.1001/jama.2016.21048; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Panizza JA, 2006, INTERN MED J, V36, P773, DOI 10.1111/j.1445-5994.2006.01214.x; PEAT JK, 1987, EUR J RESPIR DIS, V70, P171; Prescott E, 1999, THORAX, V54, P737, DOI 10.1136/thx.54.8.737; Riley CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145476; Roy A, 2012, EPIDEMIOLOGY, V23, P464, DOI 10.1097/EDE.0b013e31824cbd6d; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Shaw RJ, 2002, RESP MED, V96, P67, DOI 10.1053/rmed.2001.1216; Sheehan WJ, 2017, JAMA PEDIATR, V171, P31, DOI 10.1001/jamapediatrics.2016.2543; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; Strunk RC, 2009, J PEDIATR-US, V154, P682, DOI 10.1016/j.jpeds.2008.11.036; Vasquez MM, 2017, AM J RESP CRIT CARE, V195, P1399, DOI 10.1164/rccm.201608-1561LE; WOOD RA, 1988, AM REV RESPIR DIS, V137, P358, DOI 10.1164/ajrccm/137.2.358	42	16	16	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					646	+		10.1016/j.jaci.2019.08.043	http://dx.doi.org/10.1016/j.jaci.2019.08.043			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31866099	Bronze, Green Accepted			2022-12-18	WOS:000512887400026
J	Cui, Y; Keles, S; Charbonnier, LM; Jule, AM; Henderson, L; Celik, SC; Reisli, I; Shen, C; Xie, WJ; Schmitz-Abe, K; Wu, H; Chatila, TA				Cui, Ye; Keles, Sevgi; Charbonnier, Louis-Marie; Jule, Amelie M.; Henderson, Lauren; Celik, Seyma Celikbilek; Reisli, Ismail; Shen, Chen; Xie, Wen Jun; Schmitz-Abe, Klaus; Wu, Hao; Chatila, Talal A.			Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						DNA polymerase delta 1; DNA polymerase delta 1 catalytic subunit; replication factor C; POLD1; primary immunodeficiencywhole-exome sequencing	NUCLEAR ANTIGEN PCNA; CELL-CYCLE; MOLECULAR-DYNAMICS; HUMAN POLD1; REPLICATION; MECHANISMS; SUBUNIT; DAMAGE; P12	Background: Mutations affecting DNA polymerases have been implicated in genomic instability and cancer development, but the mechanisms by which they can affect the immune system remain largely unexplored. Objective: We sought to establish the role of DNA polymerase M catalytic subunit (POLD1) as the cause of a primary immunodeficiency in an extended kindred. Methods: We performed whole-exome and targeted gene sequencing, lymphocyte characterization, molecular and functional analyses of the DNA polymerase delta (Pol delta) complex, and T- and B-cell antigen receptor repertoire analysis. Results: We identified a missense mutation (c. 3178C>T; p.R1060C) in POLD1 in 3 related subjects who presented with recurrent, especially herpetic, infections and T-cell lymphopenia with impaired T-cell but not B-cell proliferation. The mutation destabilizes the Pol delta complex, leading to ineffective recruitment of replication factor C to initiate DNA replication. Molecular dynamics simulation revealed that the R1060C mutation disrupts the intramolecular interaction between the POLD1 CysB motif and the catalytic domain and also between POLD1 and the Pol delta subunit POLD2. The patients exhibited decreased numbers of naive CD4 and especially CD8 T cells in favor of effector memory subpopulations. This skewing was associated with oligoclonality and restricted T-cell receptor beta-chain V-J pairing in CD8(+) but not CD4(+) T cells, suggesting that POLDR1060C differentially affects peripheral CD8(+) T-cell expansion and possibly thymic selection. Conclusion: These results identify gene defects in POLD1 as a novel cause of T-cell immunodeficiency.	[Cui, Ye; Charbonnier, Louis-Marie; Jule, Amelie M.; Henderson, Lauren; Wu, Hao; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Karp Family Bldg,Rm 10-214,1 Blackfan St, Boston, MA 02115 USA; [Cui, Ye; Charbonnier, Louis-Marie; Jule, Amelie M.; Henderson, Lauren; Wu, Hao; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Karp Family Bldg,Rm 10-214,1 Blackfan St, Boston, MA 02115 USA; [Keles, Sevgi; Celik, Seyma Celikbilek; Reisli, Ismail] Necmettin Erbakan Univ, Meram Med Fac, Div Pediat Allergy & Immunol, Konya, Turkey; [Shen, Chen; Wu, Hao] Harvard Med Sch, Dept Pediat, Program Mol & Cellular Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Schmitz-Abe, Klaus] Harvard Med Sch, Div Newborn Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Schmitz-Abe, Klaus] Harvard Med Sch, Boston Childrens Hosp, Neonatal Genom Program, Boston, MA 02115 USA; [Shen, Chen] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Xie, Wen Jun] MIT, Dept Chem, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Necmettin Erbakan University; Selcuk University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Karp Family Bldg,Rm 10-214,1 Blackfan St, Boston, MA 02115 USA.; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Karp Family Bldg,Rm 10-214,1 Blackfan St, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu	Çelik, Şeyma/HHM-9782-2022	Charbonnier, Louis-Marie/0000-0002-4594-7893; M. Jule, Amelie/0000-0003-2605-6726; Schmitz-Abe, Klaus E./0000-0002-7242-8861	National Institutes of Health [5R01AI085090, 5R01AI128976]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants 5R01AI085090 and 5R01AI128976 (to T.A.C.).	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Case DA, 2014, AMBER 14; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; COLEMAN WB, 1995, CLIN CHEM, V41, P644; Daee DL, 2010, P NATL ACAD SCI USA, V107, P157, DOI 10.1073/pnas.0907526106; DOLBEARE F, 1983, P NATL ACAD SCI-BIOL, V80, P5573, DOI 10.1073/pnas.80.18.5573; Doublie S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00444; Elsayed FA, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.603; Garcia-Diaz M, 2007, CRIT REV PLANT SCI, V26, P105, DOI 10.1080/07352680701252817; Greenough L, 2014, EXTREMOPHILES, V18, P653, DOI 10.1007/s00792-014-0646-9; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Henneke G, 2005, J MOL BIOL, V350, P53, DOI 10.1016/j.jmb.2005.04.042; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee MYWT, 2014, CELL CYCLE, V13, P23, DOI 10.4161/cc.27407; Li CJ, 2017, METHODS MOL BIOL, V1524, P149, DOI 10.1007/978-1-4939-6603-5_9; Lieber MR, 2006, IMMUNITY, V25, P7, DOI 10.1016/j.immuni.2006.07.007; Liu DK, 2017, NUCLEIC ACIDS RES, V45, P9427, DOI 10.1093/nar/gkx611; Makarova KS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00354; Murga M, 2016, MOL CELL, V63, P877, DOI 10.1016/j.molcel.2016.07.007; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sasaki H, 2018, ENDOCR J, V65, P227, DOI 10.1507/endocrj.EJ17-0287; Schmitz-Abe K, 2019, EUR J HUM GENET, V27, P1398, DOI 10.1038/s41431-019-0401-x; Song J, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0044-7; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Tumini E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38873; Uchimura A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004184; Weedon MN, 2013, NAT GENET, V45, P947, DOI 10.1038/ng.2670; Zhou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039156	39	16	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					391	+		10.1016/j.jaci.2019.10.004	http://dx.doi.org/10.1016/j.jaci.2019.10.004			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31629014	Bronze, Green Accepted			2022-12-18	WOS:000505590800042
J	Koga, K; Yamagata, R; Kohno, K; Yamane, T; Shiratori-Hayashi, M; Kohro, Y; Tozaki-Saitoh, H; Tsuda, M				Koga, Keisuke; Yamagata, Ryo; Kohno, Keita; Yamane, Takuya; Shiratori-Hayashi, Miho; Kohro, Yuta; Tozaki-Saitoh, Hidetoshi; Tsuda, Makoto			Sensitization of spinal itch transmission neurons in a mouse model of chronic itch requires an astrocytic factor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Contact dermatitis; chronic itch; gastrin-releasing peptide; gastrin-releasing peptide receptor; spinal dorsal horn neurons; astrocytes; lipocalin 2; CRISPR-Cas9; patch-clamp recordings	GASTRIN-RELEASING-PEPTIDE; BRAIN-INJURY; LIPOCALIN-2; RECEPTOR; PAIN; INTERNEURONS; CIRCUITS; SYSTEM	Background: Chronic itch is a highly debilitating symptom among patients with inflammatory skin diseases. Recent studies have revealed that gastrin-releasing peptide (GRP) and its receptor (gastrin-releasing peptide receptor [GRPR]) in the spinal dorsal horn (SDH) play a central role in itch transmission. Objective: We aimed to investigate whether GRP-GRPR signaling is altered in SDH neurons in a mouse model of chronic itch and to determine the potential mechanisms underlying these alterations. Methods: Patch-clamp recordings from enhanced green fluorescent protein (EGFP)-expressing (GRPR(+)) SDH neurons were used to examine GRP-GRPR signaling in spinal cord slices obtained from Grpr-EGFP mice. Immunohistochemical, genetic (gene expression and editing through adeno-associated virus vectors), and behavioral approaches were also used for in vivo experiments. Results: We observed potentiation of GRP-evoked excitation in the GRPR + SDH neurons of mice with contact dermatitis, without concomitant changes in GRPR expression. Interestingly, increases in excitation were attenuated by suppressing the reactive state of SDH astrocytes, which are known to be reactive in patients with chronic itch conditions. Furthermore, CRISPR-Cas9-mediated astrocyte-selective in vivo editing of a gene encoding lipocalin-2 (LCN2), an astrocytic factor implicated in chronic itch, suppressed increases in GRP-induced excitation of GRPR(+) neurons, repetitive scratching, and skin damage in mice with contact dermatitis. Moreover, LCN2 potentiated GRP-induced excitation of GRPR(+) neurons in normal mice. Conclusion: Our findings indicate that, under chronic itch conditions, the GRP-induced excitability of GRPR(+) SDH neurons is enhanced through a non-cell-autonomous mechanism involving LCN2 derived from reactive astrocytes.	[Koga, Keisuke; Yamagata, Ryo; Kohno, Keita; Yamane, Takuya; Shiratori-Hayashi, Miho; Kohro, Yuta; Tozaki-Saitoh, Hidetoshi; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka, Fukuoka, Japan	Kyushu University	Tsuda, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	tsuda@phar.kyushu-u.ac.jp	Tsuda, Makoto/AAE-7256-2020; Kohro, Yuta/GOP-2138-2022; Shiratori-Hayashi, Miho/ABD-6887-2021	Kohro, Yuta/0000-0002-3128-7388; , hidetoshi/0000-0003-0423-2143; Koga, Keisuke/0000-0003-3729-3030	JSPS KAKENHI [JP15H02522, JP19K22500, JP19H05658]; Core Research for Evolutional Science and Technology (CREST) program from Japan Agency for Medical Research and Development (AMED) [JP19gm0910006]; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED [JP18ek0410034]; Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from AMED [JP19am0101091]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology (CREST) program from Japan Agency for Medical Research and Development (AMED)(Core Research for Evolutional Science and Technology (CREST)); Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED; Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from AMED	This work was supported by JSPS KAKENHI grants JP15H02522, JP19K22500, and JP19H05658 (to M.T.), by the Core Research for Evolutional Science and Technology (CREST) program from Japan Agency for Medical Research and Development (AMED) under grant number JP19gm0910006 (to M.T.), by the Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED under grant number JP18ek0410034 (to M.T.), and by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from AMED under grant number JP19am0101091 (to M.T.).	Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dong XT, 2018, NEURON, V98, P482, DOI 10.1016/j.neuron.2018.03.023; Du LX, 2019, GLIA, V67, P1680, DOI 10.1002/glia.23639; Ferreira AC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00122; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Jin M, 2014, J CEREBR BLOOD F MET, V34, P1306, DOI 10.1038/jcbfm.2014.83; Kanehisa K, 2017, J DERMATOL SCI, V88, P251, DOI 10.1016/j.jdermsci.2017.05.017; Kim BW, 2016, J NEUROSCI, V36, P5608, DOI 10.1523/JNEUROSCI.4261-15.2016; Koch SC, 2018, ANNU REV PHYSIOL, V80, P189, DOI 10.1146/annurev-physiol-022516-034303; Koga K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04972-3; Kohro Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14306; Kumar N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00413; Lee H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11676; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mosialou I, 2017, NATURE, V543, P385, DOI 10.1038/nature21697; Mu D, 2017, SCIENCE, V357, P695, DOI 10.1126/science.aaf4918; Mucha M, 2011, P NATL ACAD SCI USA, V108, P18436, DOI 10.1073/pnas.1107936108; Pagani M, 2019, NEURON, V103, P102, DOI 10.1016/j.neuron.2019.04.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Shiratori-Hayashi M, 2015, NAT MED, V21, P927, DOI 10.1038/nm.3912; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Suk K, 2016, PROG NEUROBIOL, V144, P158, DOI 10.1016/j.pneurobio.2016.08.001; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Swartzlander DB, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121109; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; VANDERSTEEN PHM, 1991, J AM ACAD DERMATOL, V24, P253, DOI 10.1016/0190-9622(91)70037-3; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; Yosipovitch G, 2018, J ALLERGY CLIN IMMUN, V142, P1375, DOI 10.1016/j.jaci.2018.09.005; Zhao ZQ, 2014, NEURON, V84, P821, DOI 10.1016/j.neuron.2014.10.003; Zhao ZQ, 2013, J CLIN INVEST, V123, P4769, DOI 10.1172/JCI70528	40	16	16	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					183	+		10.1016/j.jaci.2019.09.034	http://dx.doi.org/10.1016/j.jaci.2019.09.034			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31787267				2022-12-18	WOS:000505590800025
J	Hwang, JW; Lee, KJ; Choi, IH; Han, HM; Kim, TH; Lee, SH				Hwang, Jae Woong; Lee, Ki Jeong; Choi, In Hak; Han, Hye Min; Kim, Tae Hoon; Lee, Sang Hag			Decreased expression of type I (IFN-beta) and type III (IFN-lambda) interferons and interferon-stimulated genes in patients with chronic rhinosinusitis with and without nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Type I interferon; type III interferon; interferon-stimulated gene; chronic rhinosinusitis with nasal polyps; chronic rhinosinusitis without nasal polyps; viperin; oligoadenylate synthetase; myxovirus resistance 1	BRONCHIAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSES; RESPIRATORY VIRUSES; RHINOVIRUS INFECTION; ACUTE EXACERBATION; ANTIVIRAL ACTIONS; VIRAL-INFECTION; COMMON COLD; ASTHMA; INFLAMMATION	Background: Little is known about antiviral responses in the sinonasal mucosal tissue of patients with chronic rhinosinusitis (CRS). Objective: we investigated the presence of virus and the expression of Toll-like receptor (TLR) 3, TLR7, and interferon and interferon-stimulated genes (ISGs) in healthy mucosal tissue of control subjects and the inflammatory sinus mucosal tissue of CRS patients, and evaluated whether levels of interferons and ISGs might be affected by CRS-related cytokines and by treatment with macrolides, dexamethasone, or TLR3 and TLR7 agonists. Methods: The presence of virus in the sinonasal mucosa was evaluated with real-time PCR. The expression of interferons and ISGs in the sinonasal mucosa and in cultured epithelial cells treated with T(H)1 and T(H)2 cytokines, macrolides, dexamethasone, or TLR3 and TLR7 agonists were evaluated with real-time PCR and Western blotting. The expression of TLR3 and TLR7 in the sinonasal mucosa were evaluated with immunohistochemistry. Results: Respiratory viruses were detected in 15% of samples. Interferons and ISGs are expressed in normal mucosa, but their levels were decreased in patients with CRS. Interferon and ISG levels were upregulated in cells treated with macrolides, dexamethasone, or TLR3 agonist, but some were decreased in cytokine-treated cells. TLR3 and TLR7 levels showed no significant difference between normal and inflammatory sinus mucosal tissue. Conclusion: These results suggest that decreased levels of interferons and ISGs in patients with CRS might contribute to impairment of the antiviral innate response in inflammatory sinonasal epithelial cells. Macrolides and glucocorticoids might provide positive effects on the treatment of CRS by upregulating interferon and ISG expression.	[Hwang, Jae Woong; Lee, Ki Jeong; Choi, In Hak; Han, Hye Min; Kim, Tae Hoon; Lee, Sang Hag] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 126-1,5 Ka, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lee, SH (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 126-1,5 Ka, Seoul 136705, South Korea.	sanghag@kumc.or.kr			Basic Science Research Program through the National Research Foundation of Korea [2016R1D1A1A02936927]; Korea University [K1325551]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Korea University	Supported by the Basic Science Research Program through the National Research Foundation of Korea (2016R1D1A1A02936927). This research was also supported by a Korea University grant (K1325551).	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Alfajaro MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200726; Alho OP, 2003, LARYNGOSCOPE, V113, P2163, DOI 10.1097/00005537-200312000-00022; Alobid I, 2012, CURR ALLERGY ASTHM R, V12, P144, DOI 10.1007/s11882-012-0247-6; Baraldo S, 2012, J ALLERGY CLIN IMMUN, V130, P1307, DOI 10.1016/j.jaci.2012.08.005; Beasley V, 2012, INT J CHRONIC OBSTR, V7, P555, DOI 10.2147/COPD.S28286; Bedke N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044580; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Bochkov YA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-98; Brook I, 2006, ARCH OTOLARYNGOL, V132, P1099, DOI 10.1001/archotol.132.10.1099; Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Cho GS, 2013, J CLIN MICROBIOL, V51, P979, DOI 10.1128/JCM.02806-12; Contoli M, 2015, ALLERGY, V70, P910, DOI 10.1111/all.12627; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Costa C, 2014, INTERVIROLOGY, V57, DOI 10.1159/000358880; Djukanovic R, 2014, AM J RESP CRIT CARE, V190, P145, DOI 10.1164/rccm.201312-2235OC; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708; Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809; Gielen V, 2015, J ALLERGY CLIN IMMUN, V136, P177, DOI 10.1016/j.jaci.2014.11.039; Gustafson LM, 1996, J ALLERGY CLIN IMMUN, V97, P1009, DOI 10.1016/S0091-6749(96)80077-7; Hamilos DL, 2015, J ALLERGY CLIN IMMUN, V136, P1454, DOI 10.1016/j.jaci.2015.10.011; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Hilzendeger C, 2016, INT J CHRONIC OBSTR, V11, P1485, DOI 10.2147/COPD.S105948; Hsu ACY, 2016, AM J RESP CELL MOL, V55, P117, DOI 10.1165/rcmb.2015-0306OC; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Klemens JJ, 2006, LARYNGOSCOPE, V116, P1236, DOI 10.1097/01.mlg.0000224526.43698.52; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Lee SMY, 2011, ANTIVIR RES, V91, P330, DOI 10.1016/j.antiviral.2011.07.011; Liao B, 2014, LARYNGOSCOPE, V124, P832, DOI 10.1002/lary.24348; Liao H, 2016, J THORAC DIS, V8, P505, DOI 10.21037/jtd.2016.02.76; Lima JT, 2015, AM J RHINOL ALLERGY, V29, P19, DOI 10.2500/ajra.2015.29.4129; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Machado-Carvalho L, 2019, RESP MED, V150, P136, DOI 10.1016/j.rmed.2019.03.008; Mathur SK, 2013, ANN ALLERG ASTHMA IM, V111, P25, DOI 10.1016/j.anai.2013.05.010; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Moriwaki A, 2011, BIOCHEM BIOPH RES CO, V404, P922, DOI 10.1016/j.bbrc.2010.12.082; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Mullol J, 2009, IMMUNOL ALLERGY CLIN, V29, P657, DOI 10.1016/j.iac.2009.07.001; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; PICADO C, 1992, AM REV RESPIR DIS, V145, P65, DOI 10.1164/ajrccm/145.1.65; Piccirillo JF, 2002, OTOLARYNG HEAD NECK, V126, P41, DOI 10.1067/mhn.2002.121022; Pierzchalska M, 2003, J ALLERGY CLIN IMMUN, V111, P1041, DOI 10.1067/mai.2003.1491; Puhakka T, 1998, J ALLERGY CLIN IMMUN, V101, P726, DOI 10.1016/S0091-6749(98)70301-X; Rank MA, 2010, J ALLERGY CLIN IMMUN, V126, P168, DOI 10.1016/j.jaci.2010.03.041; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Rowan NR, 2015, AM J RHINOL ALLERGY, V29, pE197, DOI 10.2500/ajra.2015.29.4242; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; Schogler A, 2016, J CYST FIBROS, V15, P332, DOI 10.1016/j.jcf.2015.10.013; Schogler A, 2015, EUR RESPIR J, V45, P428, DOI 10.1183/09031936.00102014; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; Shimizu T, 2016, AURIS NASUS LARYNX, V43, P131, DOI 10.1016/j.anl.2015.08.014; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Spann KM, 2014, THORAX, V69, P918, DOI 10.1136/thoraxjnl-2013-204908; Staeheli P, 1990, Adv Virus Res, V38, P147, DOI 10.1016/S0065-3527(08)60862-3; Steinke JW, 2013, J ALLERGY CLIN IMMUN, V132, P856, DOI 10.1016/j.jaci.2013.05.008; Tan KS, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0693-2; Tengroth L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098239; Thomas BJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07176; Tokunaga T, 2015, ALLERGY, V70, P995, DOI 10.1111/all.12644; Wang X-Q., 2012, INT J CLIN MED, V3, P319, DOI DOI 10.4236/IJCM.2012.35063; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Wood AJ, 2011, INT FORUM ALLERGY RH, V1, P95, DOI 10.1002/alr.20030; Xu F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-16; Yamaya M, 2017, ARCH PHARM RES; Yeo NK, 2010, LARYNGOSCOPE, V120, P346, DOI 10.1002/lary.20764; Zaravinos A, 2009, J MED VIROL, V81, P1613, DOI 10.1002/jmv.21534; Zhu J, 2019, J ALLERGY CLIN IMMUN, V143, P114, DOI 10.1016/j.jaci.2018.04.003	74	16	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1551	+		10.1016/j.jaci.2019.08.010	http://dx.doi.org/10.1016/j.jaci.2019.08.010			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31449915	Green Published, Bronze			2022-12-18	WOS:000500694900036
J	Perkin, MR; Bahnson, HT; Logan, K; Marrs, T; Radulovic, S; Knibb, R; Craven, J; Flohr, C; Mills, EN; Versteeg, SA; van Ree, R; Lack, G; Young, L; Offord, V; DeSousa, M; Cullen, J; Taylor, K; Tseng, A; Raji, B; Byrom, S; Regis, G; Bigwood, C; Stedman, C; Tonner, S; Banks, E; Kahnum, Y; Babic, R; Stockwell, B; Thompson, E; Wheatley, L; Richards, K; Pietraszewicz, E; Stephens, A; Sudra, A; Turcanu, V				Perkin, Michael R.; Bahnson, Henry T.; Logan, Kirsty; Marrs, Tom; Radulovic, Suzana; Knibb, Rebecca; Craven, Joanna; Flohr, Carsten; Mills, E. N.; Versteeg, Serge A.; van Ree, Ronald; Lack, Gideon; Young, Louise; Offord, Victoria; DeSousa, Mary; Cullen, Jason; Taylor, Katherine; Tseng, Anna; Raji, Bunmi; Byrom, Sarah; Regis, Gillian; Bigwood, Charlie; Stedman, Charlotte; Tonner, Sharon; Banks, Emily; Kahnum, Yasmin; Babic, Rachel; Stockwell, Ben; Thompson, Erin; Wheatley, Lorna; Richards, Kerry; Pietraszewicz, Ewa; Stephens, Alick; Sudra, Asha; Turcanu, Victor		EAT Study Team	Factors influencing adherence in a trial of early introduction of allergenic food	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; diet; allergens; infancy; breastfeeding; randomized controlled trial; adherence	PEANUT ALLERGY; GUIDELINES; INFANTS; CONSUMPTION; PREVENTION; VALIDATION; GUIDANCE; HEALTH; RISK	Background: The Enquiring About Tolerance (EAT) study examined whether the early introduction of 6 allergenic foods from 3 months of age in exclusively breastfed infants prevented the development of food allergy. The intervention was effective in the per-protocol analysis for allergy to 1 or more foods and for egg and peanut individually, but only 42% of early introduction group (EIG) children met the per-protocol criteria. Objective: We sought to identify which factors were responsible for nonadherence in the EAT study. Methods: Factors influencing adherence within the key early introduction period in the EIG (up to 6 months of age) were divided into enrollment and postenrollment factors, and their association with nonadherence was explored. Results: In an adjusted analysis, at enrollment, increased maternal age, nonwhite ethnicity, and lower maternal quality of life were independently and significantly associated with overall nonadherence in the EIG. Enrollment eczema and enrollment serum allergen-specific IgE sensitization to 1 or more foods (>= 0.1 kU/L) were not related to overall nonadherence. After enrollment, 2 factors were significantly related to EIG overall nonadherence: parent-reported IgE-type symptoms with infant allergenic food consumption by 6 months of age and reported feeding difficulties by 4 months of age. Conclusion: If early introduction of allergenic foods were to be considered a strategy to prevent food allergy, families of nonwhite ethnicity, those with older mothers, and those with infants with reported feeding difficulties or early-onset eczema would benefit from support to promote early and sustained consumption.	[Perkin, Michael R.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Bahnson, Henry T.] Benaroya Res Inst, Seattle, WA USA; [Logan, Kirsty; Marrs, Tom; Radulovic, Suzana; Craven, Joanna; Lack, Gideon] Kings Coll London, Sch Life Course Sci, Dept Women & Childrens Hlth, Paediat Allergy Res Grp, London, England; [Knibb, Rebecca] Aston Univ, Dept Psychol, Birmingham, W Midlands, England; [Flohr, Carsten] Kings Coll London, Fac Life Sci & Med, Unit Populat Based Dermatol Res, Sch Basic & Med Biosci,St Johns Inst Dermatol, London, England; [Mills, E. N.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Infect Immun & Resp Med, Sch Biol Sci, Manchester, Lancs, England; [Mills, E. N.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Versteeg, Serge A.; van Ree, Ronald] Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Versteeg, Serge A.; van Ree, Ronald] Acad Med Ctr, Dept Otorhinolaryngol, Amsterdam, Netherlands	St Georges University London; Benaroya Research Institute; University of London; King's College London; Aston University; University of London; King's College London; University of Manchester; University of Manchester; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Lack, G (corresponding author), Kings Coll London, Clin Acad Paediat Allergy Serv, Guys & St Thomas NHS Fdn Trust,Paediat Allergy, Childrens Allergies Dept,St Thomas Hosp, Westminster Bridge Rd, London SE1 7EH, England.	gideon.lack@kcl.ac.uk	Perkin, Michael/AID-7491-2022	Lack, Gideon/0000-0001-7350-4021; Knibb, Rebecca/0000-0001-5561-0904; Tonner, Sharon/0000-0002-7775-9926; Perkin, Michael/0000-0001-9272-2585	UK Food Standards Agency (FSA) [T07051]; Medical Research Council (MRC) [MC_G1001205]; UK National Institute for Health Research (NIHR); National Institute for Health Research Clinician Scientist Award [NIHRCS/01/2008/009]; FSA [FS101178]; European Union (Integrated Approaches to Food Allergen and Allergy Risk Management [iFAAM]) [312147]; MRC [MC_G1001205] Funding Source: UKRI	UK Food Standards Agency (FSA); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research Clinician Scientist Award; FSA; European Union (Integrated Approaches to Food Allergen and Allergy Risk Management [iFAAM]); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The main components of the Enquiring About Tolerance (EAT) study were jointly funded by the UK Food Standards Agency (FSA; contract code T07051) and the Medical Research Council (MRC; grant MC_G1001205). Additionally, we thank the Davis Foundation. The skin-related aspects of the EAT study were supported by the UK National Institute for Health Research (NIHR). C.F. held a National Institute for Health Research Clinician Scientist Award (NIHRCS/01/2008/009). The analyses presented in this article were supported by a subsequent grant from the FSA (contract code FS101178) and the European Union (Integrated Approaches to Food Allergen and Allergy Risk Management [iFAAM], grant agreement no. 312147). The views expressed in this publication are those of the authors and not necessarily those of the FSA, MRC, the National Health Service, the NIHR, the Wellcome Trust, the European Union, or the UK Department of Health.	[Anonymous], 2011, ETHN CAT 2011 CENS; [Anonymous], 2017, ASS HLTH BEN RISKS I; [Anonymous], 2018, FEED 1 YEAR LIF; Australasian Society of Clinical Immunology and Allergies, 2016, ASCIA GUID INF FEED; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Du Toit G, 2013, J ALLERGY CLIN IMMUN, V131, P135, DOI 10.1016/j.jaci.2012.09.015; Greenhawt M, 2018, ANN ALLERG ASTHMA IM, V120, P620, DOI 10.1016/j.anai.2018.03.001; Johnston GA, 2004, BRIT J DERMATOL, V150, P1186, DOI 10.1111/j.1365-2133.2004.05888.x; Kirkpatrick SI, 2012, J ACAD NUTR DIET, V112, P624, DOI 10.1016/j.jand.2011.11.012; Knibb RC, 2001, APPETITE, V36, P225, DOI 10.1006/appe.2001.0402; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; McAndrew F, 2012, INFANT FEEDING SURVE; Perkin MR, 2019, J ALLERGY CLIN IMMUN, V144, P1606, DOI 10.1016/j.jaci.2019.06.045; Perkin MR, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.0739; Perkin MR, 2016, J ALLERGY CLIN IMMUN, V137, P1477, DOI 10.1016/j.jaci.2015.12.1322; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Sadeh A, 2004, PEDIATRICS, V113, pE570, DOI 10.1542/peds.113.6.e570; Schnabel E, 2010, CLIN EXP ALLERGY, V40, P450, DOI 10.1111/j.1365-2222.2009.03400.x; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Tey D, 2014, J ALLERGY CLIN IMMUN, V133, P476, DOI 10.1016/j.jaci.2013.11.019; Togias A, 2017, PEDIATR DERMATOL, V34, P5, DOI 10.1111/pde.13092; Turner PJ, 2018, CLIN EXP ALLERGY, V48, P912, DOI 10.1111/cea.13218; UK Department of Health, 2003, INF FEED REC; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303	26	16	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1595	1605		10.1016/j.jaci.2019.06.046	http://dx.doi.org/10.1016/j.jaci.2019.06.046			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31812183	hybrid, Green Accepted, Green Published			2022-12-18	WOS:000500694900017
J	Chhatta, AR; Cordes, M; Hanegraaf, MAJ; Vloemans, S; Cupedo, T; Cornelissen, JJ; Carlotti, F; Salvatori, D; Pike-Overzet, K; Fibbe, WE; Hoeben, RC; Mikkers, HMM; Staal, FJT				Chhatta, Amiet R.; Cordes, Martijn; Hanegraaf, Maaike A. J.; Vloemans, Sandra; Cupedo, Tom; Cornelissen, Jan J.; Carlotti, Francoise; Salvatori, Daniela; Pike-Overzet, Karin; Fibbe, Willem E.; Hoeben, Rob C.; Mikkers, Harald M. M.; Staal, Frank J. T.			De novo generation of a functional human thymus from induced pluripotent stem cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Chhatta, Amiet R.; Cordes, Martijn; Vloemans, Sandra; Pike-Overzet, Karin; Fibbe, Willem E.; Staal, Frank J. T.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Hoeben, Rob C.; Mikkers, Harald M. M.] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, Leiden, Netherlands; [Hanegraaf, Maaike A. J.; Carlotti, Francoise] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Mikkers, Harald M. M.] Leiden Univ, Med Ctr, LUMC HiPSC Hotel, Leiden, Netherlands; [Salvatori, Daniela] Leiden Univ, Med Ctr, LUMC Anim Facil, Leiden, Netherlands; [Cupedo, Tom; Cornelissen, Jan J.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Staal, FJT (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	f.j.t.staal@lumc.nl	Cupedo, Tom/GQQ-0614-2022; Hoeben, Rob C./A-5771-2008; Carlotti, Françoise/H-1060-2014; Carlotti, Françoise/AAN-5018-2021; Pike-Overzet, Karin/AAT-3716-2021	Hoeben, Rob C./0000-0001-9443-8377; Carlotti, Françoise/0000-0001-7929-8468; Carlotti, Françoise/0000-0001-7929-8468; Pike-Overzet, Karin/0000-0002-8827-246X; Cordes, Martijn/0000-0001-5643-1676	Dutch government [FES0908]; PON foundation	Dutch government; PON foundation	A.R.C., W.E.F., and F.J.T.S. were in part supported by grant FES0908 from the Dutch government (to the Netherlands Institute for Regenerative Medicine) and the PON foundation (2014).	Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Davies EG, 2017, J ALLERGY CLIN IMMUN, V140, P1660, DOI 10.1016/j.jaci.2017.03.020; Jing LC, 2016, J IMMUNOL, V196, P2205, DOI 10.4049/jimmunol.1502366; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Markert ML, 2004, J ALLERGY CLIN IMMUN, V113, P734, DOI 10.1016/j.jaci.2004.01.766; Parent AV, 2013, CELL STEM CELL, V13, P219, DOI 10.1016/j.stem.2013.04.004; Phillips EJ, 2002, AIDS, V16, P2223, DOI 10.1097/00002030-200211080-00017; Romano R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00187; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Tajima A, 2016, CURR STEM CELL REP, V2, P128, DOI 10.1007/s40778-016-0040-x; Trubiano JA, 2018, J ALLER CL IMM-PRACT, V6, P1287, DOI 10.1016/j.jaip.2017.09.004; Volpi S, 2017, J EXP MED, V214, P623, DOI 10.1084/jem.20161525; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	16	16	16	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1416	+		10.1016/j.jaci.2019.05.042	http://dx.doi.org/10.1016/j.jaci.2019.05.042			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31323248	Bronze			2022-12-18	WOS:000495004700033
J	Daley, SR; Koay, HF; Dobbs, K; Bosticardo, M; Wirasinha, RC; Pala, F; Castagnoli, R; Rowe, JH; de Bruin, LMO; Keles, S; Lee, YN; Somech, R; Holland, SM; Delmonte, OM; Draper, D; Maxwell, S; Niemela, J; Stoddard, J; Rosenzweig, SD; Poliani, PL; Capo, V; Villa, A; Godfrey, DI; Notarangelo, LD				Daley, Stephen R.; Koay, Hui-Fern; Dobbs, Kerry; Bosticardo, Marita; Wirasinha, Rushika C.; Pala, Francesca; Castagnoli, Riccardo; Rowe, Jared H.; de Bruin, Lisa M. Ott; Keles, Sevgi; Lee, Yu Nee; Somech, Raz; Holland, Steven M.; Delmonte, Ottavia M.; Draper, Debbie; Maxwell, Sandra; Niemela, Julie; Stoddard, Jennifer; Rosenzweig, Sergio D.; Poliani, Pietro Luigi; Capo, Valentina; Villa, Anna; Godfrey, Dale I.; Notarangelo, Luigi D.			Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DEFECTS		[Daley, Stephen R.; Wirasinha, Rushika C.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia; [Daley, Stephen R.; Wirasinha, Rushika C.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Koay, Hui-Fern; Godfrey, Dale I.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Koay, Hui-Fern; Godfrey, Dale I.] Univ Melbourne, Australian Res Council Ctr Excellence Adv Mol Ima, Melbourne, Vic, Australia; [Dobbs, Kerry; Bosticardo, Marita; Pala, Francesca; Castagnoli, Riccardo; Holland, Steven M.; Delmonte, Ottavia M.; Draper, Debbie; Maxwell, Sandra; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Niemela, Julie; Stoddard, Jennifer; Rosenzweig, Sergio D.] NIH, Serv Immunol, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Rowe, Jared H.] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Rowe, Jared H.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; [de Bruin, Lisa M. Ott] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Keles, Sevgi] Necmettin Erbakan Univ, Meram Med Fac, Div Pediat Immunol & Allergy, Konya, Turkey; [Lee, Yu Nee; Somech, Raz] Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Immunol Serv, Tel Hashomer, Israel; [Poliani, Pietro Luigi] Univ Brescia, Dept Mol & Translat Med, Pathol Unit, Brescia, Italy; [Capo, Valentina; Villa, Anna] Ist Ricovero & Cura Carattere Sci IRCCS San Raffa, San Raffaele Telethon Inst Gene Therapy, Milan, Italy; [Villa, Anna] CNR, Milan Unit, IRGB, Milan, Italy	Monash University; Monash University; University of Melbourne; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Necmettin Erbakan University; Selcuk University; Chaim Sheba Medical Center; University of Brescia; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Daley, SR (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia.; Daley, SR (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.	stephen.daley@monash.edu; luigi.notarangelo2@nih.gov	Castagnoli, Riccardo/AAF-8555-2019; Capo, Valentina/ABG-3418-2020; Bosticardo, Marita/ABA-2688-2021; Pala, Francesca/AAE-8664-2019	Castagnoli, Riccardo/0000-0003-0029-9383; Capo, Valentina/0000-0002-1851-1429; Bosticardo, Marita/0000-0002-1771-4523; Dobbs, Kerry/0000-0002-3432-3137; Daley, Stephen/0000-0002-5870-644X; Koay, Hui-Fern/0000-0002-3236-9609; Wirasinha, Rushika/0000-0002-2839-2697; Pala, Francesca/0000-0003-4537-9061	Monash Biomedicine Discovery Institute; National Health and Medical Research Council [1107464]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000647, ZIAAI001222, ZIAAI000646, ZIAAI001122] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010304] Funding Source: NIH RePORTER	Monash Biomedicine Discovery Institute(Monash University); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	Supported by the Monash Biomedicine Discovery Institute, the National Health and Medical Research Council (grant 1107464), and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.	Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Ruscher R, 2017, NAT IMMUNOL, V18, P771, DOI 10.1038/ni.3751; Stadinski BD, 2016, NAT IMMUNOL, V17, P946, DOI 10.1038/ni.3491; Tirosh I, 2019, J ALLERGY CLIN IMMUN, V143, P726, DOI 10.1016/j.jaci.2018.04.027; Verstichel G, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah4232; Villa A, 2019, IMMUNOL REV, V287, P73, DOI 10.1111/imr.12713; Wirasinha RC, 2018, IMMUNOL CELL BIOL, V96, P553, DOI 10.1111/imcb.12047	9	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					333	336		10.1016/j.jaci.2019.03.022	http://dx.doi.org/10.1016/j.jaci.2019.03.022			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	31053347	Bronze, Green Accepted			2022-12-18	WOS:000473432800041
J	Damasceno, D; Teodosio, C; van den Bossche, WBL; Perez-Andres, M; Arriba-Mendez, S; Munoz-Bellvis, L; Romero, A; Blanco, JF; Remesal, A; Puig, N; Matarraz, S; Vicente-Villardon, JL; van Dongen, JJM; Almeida, J; Orfao, A				Damasceno, Daniela; Teodosio, Cristina; van den Bossche, Wouter B. L.; Perez-Andres, Martin; Arriba-Mendez, Sonia; Munoz-Bellvis, Luis; Romero, Alfonso; Blanco, Juan F.; Remesal, Ana; Puig, Noemi; Matarraz, Sergio; Luis Vicente-Villardon, Jose; van Dongen, Jacques J. M.; Almeida, Julia; Orfao, Alberto		TiMaScan Study Grp	Distribution of subsets of blood monocytic cells throughout life	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Damasceno, Daniela; Perez-Andres, Martin; Matarraz, Sergio; Almeida, Julia; Orfao, Alberto] Univ Salamanca, Cytometry Serv NUCLEUS, Canc Res Ctr, IBMCC,CSIC, Salamanca, Spain; [Damasceno, Daniela; Perez-Andres, Martin; Matarraz, Sergio; Almeida, Julia; Orfao, Alberto] Univ Salamanca, Dept Med, Salamanca, Spain; [Damasceno, Daniela; Perez-Andres, Martin; Matarraz, Sergio; Almeida, Julia; Orfao, Alberto] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain; [Damasceno, Daniela; Perez-Andres, Martin; Matarraz, Sergio; Almeida, Julia; Orfao, Alberto] CIBERONC, Salamanca, Spain; [Teodosio, Cristina; van den Bossche, Wouter B. L.; van Dongen, Jacques J. M.] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands; [van den Bossche, Wouter B. L.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Arriba-Mendez, Sonia; Remesal, Ana] Complejo Asistencial Univ Salamanca CAUSA, Univ Hosp Salamanca, Serv Pediat, Salamanca, Spain; [Munoz-Bellvis, Luis] Univ Salamanca, Univ Hosp Salamanca CAUSA, Surg Serv, Salamanca, Spain; [Munoz-Bellvis, Luis] Univ Salamanca, Dept Surg, Salamanca, Spain; [Munoz-Bellvis, Luis; Blanco, Juan F.; Puig, Noemi] IBSAL, Salamanca, Spain; [Romero, Alfonso] Sanidad Castilla & Leon SACYL, Primary Hlth Care Ctr Miguel Armijo, Primary Hlth Care Salamanca, Salamanca, Spain; [Blanco, Juan F.] Univ Hosp Salamanca CAUSA, Orthoped Serv, Salamanca, Spain; [Blanco, Juan F.] Univ Salamanca, Dept Surg, Salamanca, Spain; [Puig, Noemi] Univ Hosp Salamanca CAUSA, Hematol Serv, Salamanca, Spain; [Luis Vicente-Villardon, Jose] Univ Salamanca, Dept Stat, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca	Orfao, A (corresponding author), Univ Salamanca, Cytometry Serv NUCLEUS, Canc Res Ctr, IBMCC,CSIC, Salamanca, Spain.; Orfao, A (corresponding author), Univ Salamanca, Dept Med, Salamanca, Spain.; Orfao, A (corresponding author), Inst Biomed Res Salamanca IBSAL, Salamanca, Spain.; Orfao, A (corresponding author), CIBERONC, Salamanca, Spain.	orfao@usal.es	De Arriba Méndez, Sonia/B-4856-2019; Muñoz-Bellvis, Luis/AAU-7364-2021; Muñoz-Bellvis, Luis/A-2245-2016; Perez-Andres, Martin/B-3692-2019; De Arriba Méndez, Sonia/AAC-1234-2020; Matarraz, Sergio/AAE-8249-2019	De Arriba Méndez, Sonia/0000-0003-1990-4125; Muñoz-Bellvis, Luis/0000-0002-7809-5201; Muñoz-Bellvis, Luis/0000-0002-7809-5201; Perez-Andres, Martin/0000-0003-4599-0776; van den Bossche, Wouter/0000-0002-2740-8490; Teodosio, Cristina/0000-0002-2097-7199	Biomedical Research Networking Center Consortium-CIBER-CIBERONC [CB16/12/00400-FEDER]; Instituto de Salud Carlos III (ISCIII), Ministerio de Economia y Competitividad, Madrid, Spain [PI13/01412-FEDER, PI16/00787-FEDER]; European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (grant ERC-2015-AdG) [695655];  [RTICC RD12/0036/0048-FEDER]	Biomedical Research Networking Center Consortium-CIBER-CIBERONC; Instituto de Salud Carlos III (ISCIII), Ministerio de Economia y Competitividad, Madrid, Spain; European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (grant ERC-2015-AdG)(European Research Council (ERC)); 	This work has been partially supported by the following grants: RTICC RD12/0036/0048-FEDER, Biomedical Research Networking Center Consortium-CIBER-CIBERONC (CB16/12/00400-FEDER), PI13/01412-FEDER, PI16/00787-FEDER from the Instituto de Salud Carlos III (ISCIII), Ministerio de Economia y Competitividad, Madrid, Spain, and the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (grant agreement ERC-2015-AdG 695655 [TiMaScan]).	Boyette LB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176460; Faber TJE, 2012, TUMOR BIOL, V33, P435, DOI 10.1007/s13277-011-0269-z; Flores-Montero J, 2017, LEUKEMIA, V31, P2094, DOI 10.1038/leu.2017.29; Lund H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00322; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; PAZBOUZA JI, 1994, PATHOL RES PRACT, V190, P682, DOI 10.1016/S0344-0338(11)80747-8; Prabhu SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162242; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Tak T, 2017, BLOOD, V130, P1474, DOI 10.1182/blood-2017-03-771261; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	11	16	16	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					320	+		10.1016/j.jaci.2019.02.030	http://dx.doi.org/10.1016/j.jaci.2019.02.030			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	30890326	Green Published, hybrid			2022-12-18	WOS:000473432800037
J	Wu, D; Yan, B; Wang, Y; Zhang, L; Wang, CS				Wu, Di; Yan, Bing; Wang, Yang; Zhang, Luo; Wang, Chengshuo			Charcot-Leyden crystal concentration in nasal secretions predicts clinical response to glucocorticoids in patients with chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EOSINOPHILIC CHRONIC RHINOSINUSITIS; CORTICOSTEROIDS		[Wu, Di; Yan, Bing; Wang, Yang; Zhang, Luo; Wang, Chengshuo] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Wu, Di; Yan, Bing; Wang, Yang; Zhang, Luo] Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing, Peoples R China	Capital Medical University	Zhang, L (corresponding author), Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.; Zhang, L (corresponding author), Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing, Peoples R China.	dr.luozhang@139.com; wangcs830@126.com		Zhang, Luo/0000-0002-0910-9884	National Key RAMP;D Program of China [2016YFC20160905200]; Program for Changjiang Scholars and Innovative Research Team [IRT13082]; National Natural Science Foundation of China [81420108009, 81400444, 81470678, 81630023]; Capital Health Development Foundation [2016-1-2052]; Priming Scientific Research Foundation for the Senior Researcher in Beijing TongRen Hospital, Capital Medical University [2017-YJJ-GGL-005]; Beijing Municipal Administration of Hospitals' Mission Plan [SML20150203]; Beijing Advanced Innovation Center for Food Nutrition and Human Health (Beijing Technology and Business University) [20181045]; Beijing Scientific and Technological Overall Plan [Z171100000117002]	National Key RAMP;D Program of China; Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Health Development Foundation; Priming Scientific Research Foundation for the Senior Researcher in Beijing TongRen Hospital, Capital Medical University; Beijing Municipal Administration of Hospitals' Mission Plan; Beijing Advanced Innovation Center for Food Nutrition and Human Health (Beijing Technology and Business University); Beijing Scientific and Technological Overall Plan	Supported by the National Key R&D Program of China (2016YFC20160905200), the Program for Changjiang Scholars and Innovative Research Team (IRT13082), the National Natural Science Foundation of China (81420108009, 81400444, 81470678, and 81630023), the Capital Health Development Foundation (2016-1-2052), the Priming Scientific Research Foundation for the Senior Researcher in Beijing TongRen Hospital, Capital Medical University (2017-YJJ-GGL-005), the Beijing Municipal Administration of Hospitals' Mission Plan (SML20150203), the Beijing Advanced Innovation Center for Food Nutrition and Human Health (Beijing Technology and Business University, 20181045), and the Beijing Scientific and Technological Overall Plan (Z171100000117002).	Asthma G., 2020, GLOB STRAT ASTHM MAN; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; DOR PJ, 1984, AM REV RESPIR DIS, V130, P1072; Fischer AH, 2008, CSHPROTOC, V2008; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Haruna S, 2006, AURIS NASUS LARYNX, V33, P23, DOI 10.1016/j.anl.2005.09.005; Hong HY, 2018, J ALLERGY CLIN IMMUN, V141, P1890, DOI 10.1016/j.jaci.2017.10.050; Lou HF, 2015, AM J RHINOL ALLERGY, V29, P350, DOI 10.2500/ajra.2015.29.4231; Lu HG, 2018, EUR ARCH OTO-RHINO-L, V275, P401, DOI 10.1007/s00405-017-4809-z; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Meng YF, 2016, INT FORUM ALLERGY RH, V6, P812, DOI 10.1002/alr.21749; Milara J, 2017, J ALLERGY CLIN IMMUN, V139, P855, DOI 10.1016/j.jaci.2016.06.064; Milara J, 2015, J ALLERGY CLIN IMMUN, V135, P470, DOI 10.1016/j.jaci.2014.07.011; Wang CS, 2015, J ALLERGY CLIN IMMUN, V135, P922, DOI 10.1016/j.jaci.2014.10.018; Wang H, 2018, J ALLERGY CLIN IMMUN, V141, P1646, DOI 10.1016/j.jaci.2017.12.972; Watelet JB, 2004, EUR ARCH OTO-RHINO-L, V261, P242, DOI 10.1007/s00405-003-0691-y; Wen WP, 2012, J ALLERGY CLIN IMMUN, V129, P1522, DOI 10.1016/j.jaci.2012.01.079; Yao Y, 2017, EUR ARCH OTO-RHINO-L, V274, P3559, DOI 10.1007/s00405-017-4547-2	18	16	21	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					345	+		10.1016/j.jaci.2019.03.029	http://dx.doi.org/10.1016/j.jaci.2019.03.029			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	31002832	Bronze			2022-12-18	WOS:000473432800045
J	Dahlin, A; Sordillo, JE; Ziniti, J; Iribarren, C; Lu, M; Weiss, ST; Tantisira, KG; Lu, Q; Kan, MY; Himes, BE; Jorgenson, E; Wu, AC				Dahlin, Amber; Sordillo, Joanne E.; Ziniti, John; Iribarren, Carlos; Lu, Meng; Weiss, Scott T.; Tantisira, Kelan G.; Lu, Quan; Kan, Mengyuan; Himes, Blanca E.; Jorgenson, Eric; Wu, Ann Chen			Large-scale, multiethnic genome-wide association study identifies novel loci contributing to asthma susceptibility in adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							GENETIC EPIDEMIOLOGY RESEARCH; AMERICAN; HEALTH		[Dahlin, Amber; Ziniti, John; Weiss, Scott T.; Tantisira, Kelan G.; Wu, Ann Chen] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Dahlin, Amber; Ziniti, John; Weiss, Scott T.; Tantisira, Kelan G.; Wu, Ann Chen] Harvard Med Sch, Boston, MA 02115 USA; [Sordillo, Joanne E.; Wu, Ann Chen] Harvard Med Sch, PRecis Med Translat Res PROMoTeR Ctr, Dept Populat Med, Boston, MA 02115 USA; [Sordillo, Joanne E.; Wu, Ann Chen] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; [Iribarren, Carlos; Lu, Meng; Jorgenson, Eric] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Weiss, Scott T.; Tantisira, Kelan G.] Partners Hlth Care, Partners Ctr Personalized Med, Boston, MA USA; [Lu, Quan] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Lu, Quan] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Kan, Mengyuan; Himes, Blanca E.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Kaiser Permanente; Partners Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania	Wu, AC (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Wu, AC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Wu, AC (corresponding author), Harvard Med Sch, PRecis Med Translat Res PROMoTeR Ctr, Dept Populat Med, Boston, MA 02115 USA.; Wu, AC (corresponding author), Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA.	Ann.Wu@childrens.harvard.edu	Wu, Ann/AAY-4293-2020	Wu, Ann/0000-0003-0599-9063	National Institutes of Health [K01 HL130629, R01 HD085993, U01 HL65899];  [RC2 HL101651]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD085993] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133433, K01HL130629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK116738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to acknowledge colleagues and investigators at Kaiser Permanente Northern California, University of California San Francisco, and Harvard Medical School for their support in providing access to the genotype data and study populations. We are grateful to the EVE Consortium, funded by RC2 HL101651, and to Dr Carole Ober, for generously providing us with their primary study results. This work was supported by the following grants from the National Institutes of Health: K01 HL130629, R01 HD085993 and U01 HL65899.	Almoguera B, 2017, AM J RESP CRIT CARE, V195, P456, DOI 10.1164/rccm.201604-0861OC; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Duan QL, 2014, PHARMACOGENOMICS J, V14, P41, DOI 10.1038/tpj.2013.5; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; McGeachie MJ, 2015, J ALLERGY CLIN IMMUN, V136, P1503, DOI 10.1016/j.jaci.2015.04.039; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888	9	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1633	1635		10.1016/j.jaci.2018.11.037	http://dx.doi.org/10.1016/j.jaci.2018.11.037			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30578877	Green Accepted, Bronze			2022-12-18	WOS:000463348900041
J	Cahill, KN; Murphy, K; Singer, J; Israel, E; Boyce, JA; Laidlaw, TM				Cahill, Katherine N.; Murphy, Katherine; Singer, Joseph; Israel, Elliot; Boyce, Joshua A.; Laidlaw, Tanya M.			Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Cahill, Katherine N.; Murphy, Katherine; Singer, Joseph; Israel, Elliot; Boyce, Joshua A.; Laidlaw, Tanya M.] Brigham & Womens Hosp, Jeff & Penny Vinik Ctr Allerg Dis Res, Div Rheumatol Immunol & Allergy, Bldg Transformat Med, Boston, MA 02115 USA; [Cahill, Katherine N.; Israel, Elliot; Boyce, Joshua A.; Laidlaw, Tanya M.] Harvard Med Sch, Boston, MA 02115 USA; [Israel, Elliot] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Cahill, Katherine N.] Vanderbilt Univ, Dept Med, Divi Allergy Pulm & Crit Care Med, Nashville, TN USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Vanderbilt University	Laidlaw, TM (corresponding author), Brigham & Womens Hosp, Jeff & Penny Vinik Ctr Allerg Dis Res, Div Rheumatol Immunol & Allergy, Bldg Transformat Med, Boston, MA 02115 USA.; Laidlaw, TM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	tlaidlaw@bwh.harvard.edu		Cahill, Katherine/0000-0002-8549-1835; Singer, Joseph/0000-0002-5982-9695	National Institutes of Health [K23HL111113, K23AI118804, R01HL128241, U19 AI095219, T32AI007306-32]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128241, K23HL111113, R01HL136209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007306, K23AI118804, U19AI095219, R01AI136041, R01AI078908, R37AI052353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (grants K23HL111113, K23AI118804, R01HL128241, U19 AI095219, and T32AI007306-32), and by generous contributions from the Kaye and Vinik families.	BOSSO JV, 1991, J ALLERGY CLIN IMMUN, V88, P830, DOI 10.1016/0091-6749(91)90238-J; Cahill KN, 2015, J ALLERGY CLIN IMMUN, V135, P245, DOI 10.1016/j.jaci.2014.07.031; FISCHER AR, 1994, J ALLERGY CLIN IMMUN, V94, P1046, DOI 10.1016/0091-6749(94)90123-6; Laidlaw TM, 2019, J ALLERGY CLIN IMMUN, V143, P316, DOI 10.1016/j.jaci.2018.06.001; Liu T, 2018, J IMMUNOL, V200, P915, DOI 10.4049/jimmunol.1700603; SCHWARTZ LB, 1994, J CLIN IMMUNOL, V14, P190, DOI 10.1007/BF01533368; Stevenson DD, 2000, ANN ALLERG ASTHMA IM, V85, P477, DOI 10.1016/S1081-1206(10)62575-6; White A, 2006, ANN ALLERG ASTHMA IM, V97, P688, DOI 10.1016/S1081-1206(10)61101-5	8	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					799	+		10.1016/j.jaci.2018.10.007	http://dx.doi.org/10.1016/j.jaci.2018.10.007			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30339852	Green Accepted, Bronze			2022-12-18	WOS:000457718700046
J	Wang, H; FitzPatrick, M; Wilson, NJ; Anthony, D; Reading, PC; Satzke, C; Dunne, EM; Licciardi, PV; Seow, HJ; Nichol, K; Adcock, IM; Chung, KF; Anderson, GP; Vlahos, R; Wark, P; Bozinovski, S				Wang, Hao; FitzPatrick, Meaghan; Wilson, Nicholas J.; Anthony, Desiree; Reading, Patrick C.; Satzke, Catherine; Dunne, Eileen M.; Licciardi, Paul V.; Seow, Huei Jiunn; Nichol, Kristy; Adcock, Ian M.; Chung, Kian Fan; Anderson, Gary P.; Vlahos, Ross; Wark, Peter; Bozinovski, Steven			CSF3R/CD114 mediates infection-dependent transition to severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INFLAMMATION; AIRWAY		[Wang, Hao; Anthony, Desiree; Seow, Huei Jiunn; Vlahos, Ross; Bozinovski, Steven] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [FitzPatrick, Meaghan; Anderson, Gary P.; Vlahos, Ross; Bozinovski, Steven] Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic, Australia; [FitzPatrick, Meaghan; Wilson, Nicholas J.] CSL Ltd, Parkville, Vic, Australia; [Reading, Patrick C.] Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, WHO Collaborating Ctr Reference & Res Influenza, Parkville, Vic, Australia; [Reading, Patrick C.; Satzke, Catherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia; [Satzke, Catherine; Dunne, Eileen M.; Licciardi, Paul V.] Murdoch Childrens Res Inst, Pneumococcal Res, Parkville, Vic, Australia; [Satzke, Catherine; Dunne, Eileen M.; Licciardi, Paul V.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Nichol, Kristy; Wark, Peter] Hunter Med Res Inst, Prior Res Ctr Healthy Lungs, Newcastle, NSW, Australia; [Nichol, Kristy; Wark, Peter] Univ Newcastle, Newcastle, NSW, Australia; [Nichol, Kristy; Adcock, Ian M.; Wark, Peter] John Hunter Hosp, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Chung, Kian Fan] Imperial Coll London, Natl Heart & Lung Inst, Airways Dis, London, England	Royal Melbourne Institute of Technology (RMIT); University of Melbourne; CSL; Victorian Infectious Diseases Reference Laboratory; World Health Organization; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; John Hunter Hospital; Imperial College London	Bozinovski, S (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia.; Bozinovski, S (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic, Australia.	steven.bozinovski@rmit.edu.au	Dunne, Eileen M/M-3203-2019; Wark, Peter/G-7037-2013; Chung, Kian Fan/B-1872-2012; Vlahos, Ross/AAM-3837-2020; Satzke, Catherine/D-6501-2013	Dunne, Eileen M/0000-0001-5542-0780; Wark, Peter/0000-0001-5676-6126; Chung, Kian Fan/0000-0001-7101-1426; Vlahos, Ross/0000-0001-8443-7071; Bozinovski, Steven/0000-0001-6533-8641; Wang, Hao/0000-0002-0901-5183; Adcock, Ian/0000-0003-2101-8843; Reading, Patrick/0000-0002-8860-5308; Anderson, Gary/0000-0001-6580-3398; Satzke, Catherine/0000-0003-3164-8849; Seow, Huei/0000-0002-4790-4811	National Health and Medical Research Council of Australia [APP1067547]; Australian Research Council [FT130100654]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This study was supported by funding from the National Health and Medical Research Council of Australia (grant no. APP1067547) and the Australian Research Council (grant no. FT130100654).	Anthony D, 2013, AM J RESP CRIT CARE, V188, P179, DOI 10.1164/rccm.201211-2139OC; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; Bozinovski S, 2011, AM J RESP CELL MOL, V45, P229, DOI 10.1165/rcmb.2010-0272OC; Campbell IK, 2016, J IMMUNOL, V197, P4392, DOI 10.4049/jimmunol.1600121; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; FitzPatrick M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22751; Kuo CHS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02135-2016; Rossios C, 2018, J ALLERGY CLIN IMMUN, V141, P560, DOI 10.1016/j.jaci.2017.02.045; Shaw DE, 2015, EUR RESPIR J, V46, P1308, DOI 10.1183/13993003.00779-2015; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sukkar MB, 2012, EUR RESPIR J, V39, P721, DOI 10.1183/09031936.00022011; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Wang H, 2017, CLIN SCI, V131, P2347, DOI 10.1042/CS20171006; Wilkinson TMA, 2006, AM J RESP CRIT CARE, V173, P871, DOI 10.1164/rccm.200509-1489OC; Yuan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010525	16	16	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					785	+		10.1016/j.jaci.2018.10.001	http://dx.doi.org/10.1016/j.jaci.2018.10.001			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30312710	hybrid, Green Published			2022-12-18	WOS:000457718700041
J	Drummond, RA; Zahra, FT; Natarajan, M; Swamydas, M; Hsu, AP; Wheat, LJ; Gavino, C; Vinh, DC; Holland, SM; Mikelis, CM; Lionakis, MS				Drummond, Rebecca A.; Zahra, Fatema Tuz; Natarajan, Mukil; Swamydas, Muthulekha; Hsu, Amy P.; Wheat, L. Joseph; Gavino, Christina; Vinh, Donald C.; Holland, Steven M.; Mikelis, Constantinos M.; Lionakis, Michail S.			GM-CSF therapy in human caspase recruitment domain-containing protein 9 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CARD9 DEFICIENCY		[Drummond, Rebecca A.; Natarajan, Mukil; Swamydas, Muthulekha; Lionakis, Michail S.] NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zahra, Fatema Tuz; Mikelis, Constantinos M.] NIAID, Immunopathogenesis Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hsu, Amy P.; Holland, Steven M.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Sch Pharm, Amarillo, TX USA; [Wheat, L. Joseph] MiraVista Diagnost, Indianapolis, IN USA; [Gavino, Christina; Vinh, Donald C.] MUHC, Infect Dis Susceptibil Program, Montreal, PQ, Canada; [Gavino, Christina; Vinh, Donald C.] MUHC, Res Inst, Montreal, PQ, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Lionakis, MS (corresponding author), NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lionakism@mail.nih.gov	Mikelis, Constantinos/AGF-9423-2022; Drummond, Rebecca/I-3155-2019; Lionakis, Michail/J-8840-2017	Drummond, Rebecca/0000-0001-5424-7074; Lionakis, Michail/0000-0003-4994-9500; Natarajan, Mukil/0000-0001-8908-7306	Division of Intramural Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001175, ZIAAI000646, ZIAAI000647] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health.	Basu S, 2000, BLOOD, V95, P3725; Drummond RA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00039; Drummond RA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005293; Gavino C, 2016, J ALLERGY CLIN IMMUN, V137, P1178, DOI 10.1016/j.jaci.2015.09.016; Gavino C, 2014, CLIN INFECT DIS, V59, P81, DOI 10.1093/cid/ciu215; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Saijo T, 2014, MBIO, V5, DOI 10.1128/mBio.00912-14; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Whitney PG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004276	9	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1334	1338		10.1016/j.jaci.2018.05.025	http://dx.doi.org/10.1016/j.jaci.2018.05.025			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29890237	Bronze			2022-12-18	WOS:000446327300031
J	Lee, SH; Cho, PS; Tonello, R; Lee, HK; Jang, JH; Park, GY; Hwang, SW; Park, CK; Jung, SJ; Berta, T				Lee, Sang Hoon; Cho, Pyung Sun; Tonello, Raquel; Lee, Han Kyu; Jang, Jun Ho; Park, Gi Yeon; Hwang, Sun Wook; Park, Chul-Kyu; Jung, Sung Jun; Berta, Temugin			Peripheral serotonin receptor 2B and transient receptor potential channel 4 mediate pruritus to serotonergic anti-depressants in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LONGEVITY; RESPONSES; HEALTH; ITCH; PAIN		[Lee, Sang Hoon; Tonello, Raquel; Berta, Temugin] Univ Cincinnati, Med Ctr, Dept Anesthesiol, Pain Res Ctr, Cincinnati, OH 45267 USA; [Lee, Sang Hoon; Cho, Pyung Sun; Lee, Han Kyu; Jang, Jun Ho; Jung, Sung Jun] Hanyang Univ, Med Sch, Dept Physiol, Seoul, South Korea; [Park, Gi Yeon; Park, Chul-Kyu] Gachon Univ, Coll Med, Dept Physiol, Incheon, South Korea; [Hwang, Sun Wook] Korea Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	University System of Ohio; University of Cincinnati; Hanyang University; Gachon University; Korea University; Korea University Medicine (KU Medicine)	Berta, T (corresponding author), Univ Cincinnati, Med Ctr, Dept Anesthesiol, Pain Res Ctr, Cincinnati, OH 45267 USA.	temugin.berta@uc.edu	Lee, Hankyu/AAB-5542-2020; Berta, Temugin/AAK-6365-2020; Lee, Han Kyu/K-8388-2015	Berta, Temugin/0000-0002-4486-8288; Tonello, Raquel/0000-0002-2175-9804; Lee, Han Kyu/0000-0002-0949-3345; Hwang, Sun Wook/0000-0001-8460-7480	University of Cincinnati; UC Department of Anesthesiology; National Research Foundation of Korea [NRF-2016R1A2B4013332, NRF-2015R1C1A1A 01054262]	University of Cincinnati; UC Department of Anesthesiology; National Research Foundation of Korea(National Research Foundation of Korea)	Supported by internal funding from the University of Cincinnati and the UC Department of Anesthesiology (to T.B.) and by grants from the National Research Foundation of Korea (NRF-2016R1A2B4013332 to S.J.S. and NRF-2015R1C1A1A 01054262 to C.-K.P.).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chin D, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0397-3; Graeser AC, 2011, J MOL MED, V89, P1027, DOI 10.1007/s00109-011-0771-1; Hasler R, 2017, AGING CELL, V16, P716, DOI 10.1111/acel.12598; Huebbe P, 2015, MOL NUTR FOOD RES, V59, P334, DOI 10.1002/mnfr.201400636; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morita T, 2015, NEURON, V87, P124, DOI 10.1016/j.neuron.2015.05.044; Munsch T, 2003, P NATL ACAD SCI USA, V100, P16065, DOI 10.1073/pnas.2535311100; Nebel A, 2005, P NATL ACAD SCI USA, V102, P7906, DOI 10.1073/pnas.0408670102; Peng L, 2014, CURR NEUROPHARMACOL, V12, P365, DOI 10.2174/1570159X12666140828221720; R Core Team, 2014, LANG ENV STAT COMP; Ross SE, 2011, CURR OPIN NEUROBIOL, V21, P880, DOI 10.1016/j.conb.2011.10.012; Schloesser A, 2015, REJUV RES, V18, P30, DOI 10.1089/rej.2014.1630; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Warnock Julia K, 2002, Am J Clin Dermatol, V3, P329, DOI 10.2165/00128071-200203050-00005	18	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1349	+		10.1016/j.jaci.2018.05.031	http://dx.doi.org/10.1016/j.jaci.2018.05.031			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29920354	Bronze			2022-12-18	WOS:000446327300036
J	Lai, PS; Kolde, R; Franzosa, EA; Gaffin, JM; Baxi, SN; Sheehan, WJ; Gold, DR; Gevers, D; Xavier, RJ; Phipatanakul, W				Lai, Peggy S.; Kolde, Raivo; Franzosa, Eric A.; Gaffin, Jonathan M.; Baxi, Sachin N.; Sheehan, William J.; Gold, Diane R.; Gevers, Dirk; Xavier, Ramnik J.; Phipatanakul, Wanda			The classroom microbiome and asthma morbidity in children attending 3 inner-city schools	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Lai, Peggy S.; Kolde, Raivo; Xavier, Ramnik J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lai, Peggy S.; Franzosa, Eric A.; Gold, Diane R.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Lai, Peggy S.; Gaffin, Jonathan M.; Baxi, Sachin N.; Sheehan, William J.; Gold, Diane R.; Xavier, Ramnik J.; Phipatanakul, Wanda] Harvard Med Sch, Boston, MA 02115 USA; [Gaffin, Jonathan M.; Baxi, Sachin N.; Sheehan, William J.] Boston Childrens Hosp, Boston, MA USA; [Gold, Diane R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Gevers, Dirk; Xavier, Ramnik J.; Phipatanakul, Wanda] Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Phipatanakul, W (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Phipatanakul, W (corresponding author), Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA.	wanda.phipatanakul@childrens.harvard.edu	Kolde, Raivo/AAB-8149-2022; Gevers, Dirk/C-1451-2009	Kolde, Raivo/0000-0003-2886-6298; GAFFIN, JONATHAN/0000-0003-2213-4504; Lai, Peggy/0000-0001-9501-8606	Boston Children's Hospital-Broad Institute Collaboration grant; National Institutes of Health [R01 AI 073964, U01 AI 110397, K24 AI 106822, U01 AI 126614, K23 ES023700, P30 ES000002]; American College of Allergy, Asthma, and Immunology Young Faculty Award; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources, National Institutes of Health Award) [UL1 TR001102]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL1 TR001102]; Harvard University and its affiliated academic health care centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102, UL1TR000170] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI106822, R01AI073964, K23AI106945, T32AI007512, U01AI110397, K23AI104780, U01AI126614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES023700, P30ES000002] Funding Source: NIH RePORTER	Boston Children's Hospital-Broad Institute Collaboration grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Allergy, Asthma, and Immunology Young Faculty Award; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources, National Institutes of Health Award); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award); Harvard University and its affiliated academic health care centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a Boston Children's Hospital-Broad Institute Collaboration grant, as well as in part by the National Institutes of Health (grant nos. R01 AI 073964, U01 AI 110397, K24 AI 106822, and U01 AI 126614 to W.P.; grant no. K23 ES023700 to P.S.L.; grant no. P30 ES000002 to D. Dockery). This work was also supported by the American College of Allergy, Asthma, and Immunology Young Faculty Award. This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic health care centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. Coway, Inc, graciously donated air cleaners and provided support in building the sham cleaners. The funding sources did not contribute to study design; collection, analysis, and interpretation of data; writing of the report; or the decision to submit the article for publication.	Birzele LT, 2017, ALLERGY, V72, P109, DOI 10.1111/all.13002; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Dannemiller KC, 2016, J ALLERGY CLIN IMMUN, V138, P76, DOI 10.1016/j.jaci.2015.11.027; Lai PS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180969; Lai PS, 2015, CHEST, V148, P1251, DOI 10.1378/chest.15-0098; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007	8	16	16	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2311	2313		10.1016/j.jaci.2018.02.022	http://dx.doi.org/10.1016/j.jaci.2018.02.022			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29518428	Green Accepted, Bronze			2022-12-18	WOS:000434701600046
J	Dai, YR; Qiu, H; Sun, SZ; Yang, Y; Lin, HL; Tian, LW				Dai, Yuanrong; Qiu, Hong; Sun, Shengzhi; Yang, Yang; Lin, Hualiang; Tian, Linwei			Age-dependent effect of ambient ozone on emergency asthma hospitalizations in Hong Kong	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASSOCIATION		[Dai, Yuanrong] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Qiu, Hong; Sun, Shengzhi; Yang, Yang; Tian, Linwei] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Lin, Hualiang] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China	Wenzhou Medical University; University of Hong Kong; Sun Yat Sen University	Tian, LW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	linweit@hku.hk	Tian, Linwei/A-9736-2009; Sun, Shengzhi/G-2015-2018	Tian, Linwei/0000-0002-4739-1534; Sun, Shengzhi/0000-0002-3708-1225; Dai, Yuanrong/0000-0002-7146-3374; Tian, Linwei/0000-0003-2240-8886				Hajat S, 1999, THORAX, V54, P597, DOI 10.1136/thx.54.7.597; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Mathews JA, 2017, ENVIRON HEALTH PERSP, V125, P246, DOI 10.1289/EHP272; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Silverman RA, 2010, J ALLERGY CLIN IMMUN, V125, P367, DOI 10.1016/j.jaci.2009.10.061; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; WOLCOTT JA, 1982, APPL ENVIRON MICROB, V44, P723, DOI 10.1128/AEM.44.3.723-731.1982; Yang Q, 2016, J ALLERGY CLIN IMMUN, V137, P571, DOI 10.1016/j.jaci.2015.06.037; Zanobetti A, 2008, AM J RESP CRIT CARE, V177, P184, DOI 10.1164/rccm.200706-823OC	9	16	18	2	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1532	+		10.1016/j.jaci.2018.01.006	http://dx.doi.org/10.1016/j.jaci.2018.01.006			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29382596	Bronze			2022-12-18	WOS:000429197800051
J	Nunes, JOF; Apostolico, JD; Andrade, DAG; Ruiz, FS; Fernandes, ER; Andersen, ML; Keller, AC; Rosa, DS				Nunes, Jethe O. F.; Apostolico, Juliana de Souza; Andrade, David A. G.; Ruiz, Francieli S.; Fernandes, Edgar R.; Andersen, Monica L.; Keller, Alexandre C.; Rosa, Daniela S.			Sleep deprivation predisposes allergic mice to neutrophilic lung inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Sleep deprivation; allergic lung inflammation; airway neutrophilia; IL-17; mouse model	SEVERE ASTHMA; CIRCADIAN CLOCK; TH17 CELLS; T-CELLS; DEXAMETHASONE; RATS; INTERLEUKIN-17; RECRUITMENT; MECHANISMS; CHALLENGE	Background: Although different studies associated sleep deprivation (SD) with systemic inflammatory changes, the effect of sleep duration on the pathology of allergic chronic diseases is poorly understood. Objective: We sought to evaluate the influence of SD on allergen-induced pulmonary inflammation. Methods: Ovalbumin (OVA)-sensitized C57BL/6 mice were exposed to a first set of intranasal OVA challenge under SD or healthy sleep (HS) conditions, followed by a second OVA challenge, 1 week apart. Some groups were subjected to corticosteroid treatment with dexamethasone. Results: OVA-sensitized mice with SD had more severe airway inflammation than the allergic group with HS. Analysis of lung parenchyma revealed that the inflammation in allergic mice with SD was marked by an influx of neutrophils (mainly) and eosinophils and secretion of IL-6, TNF-alpha, and IL-17 in contrast to the eosinophilic inflammation and IL-4 production observed in allergic mice with HS. The same cytokine profile was observed in ex vivo culture of cervical lymph node cells and splenocytes, indicating that in allergic mice SD favors immune responses toward a proinflammatory TH17 profile. This idea is supported by the fact that disruption of IL-17 signaling (IL-17 receptor A(-/-)) prevented airway neutrophilia in allergic mice with SD. Furthermore, allergic mice with SD became refractory to corticosteroid treatment in contrast to the allergic group with HS. Conclusion: Collectively, our data show that sleep quality participates in the progression of allergen-induced eosinophilic lung inflammation to corticosteroid-refractory neutrophilic manifestation.	[Nunes, Jethe O. F.; Apostolico, Juliana de Souza; Andrade, David A. G.; Fernandes, Edgar R.; Keller, Alexandre C.; Rosa, Daniela S.] Fed Univ Sao Paulo UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Rua Botucatu 862,4 Andar, Sao Paulo, Brazil; [Ruiz, Francieli S.; Andersen, Monica L.] Fed Univ Sao Paulo UNIFESP EPM, Dept Psychobiol, Sao Paulo, Brazil; [Keller, Alexandre C.] Fed Univ Sao Paulo UNIFESP EPM, Dept Med, Div Nephrol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Keller, AC; Rosa, DS (corresponding author), Fed Univ Sao Paulo UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Rua Botucatu 862,4 Andar, Sao Paulo, Brazil.	ackeller.unifesp@gmail.com; dsantororosa@gmail.com	Rosa, Daniela S/D-2190-2012; Apostolico, Juliana/W-8804-2018; RUIZ, Francieli Silva/L-3160-2015; Fernandes, Edgar/T-6160-2019; Keller, Alexandre C/E-4621-2012	Rosa, Daniela S/0000-0003-4536-891X; Apostolico, Juliana/0000-0002-3507-3117; RUIZ, Francieli Silva/0000-0001-9975-0298; Fernandes, Edgar/0000-0001-5981-5149; Keller, Alexandre C/0000-0002-7827-0292; Ruiz, Francieli S/0000-0002-9675-4063	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/15061-8, 2012/04692-1]; CNPq/FAPESP; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq/FAPESP(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grants 2014/15061-8, 2012/04692-1). J.S.A., D.A.G.A, and E.R.F received fellowships from CNPq/FAPESP. J.N.O.F received a fellowship from CAPES.	Andersen ML, 2004, EXP GERONTOL, V39, P817, DOI 10.1016/j.exger.2004.02.007; Axelsson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082291; Banuelos J, 2016, ALLERGY, V71, P640, DOI 10.1111/all.12840; Banuelos J, 2016, CYTOKINE GROWTH F R, V31, P27, DOI 10.1016/j.cytogfr.2016.05.002; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Bell MC, 2013, J ALLER CL IMM-PRACT, V1, P110, DOI 10.1016/j.jaip.2013.01.005; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Borges MC, 2013, RESP PHYSIOL NEUROBI, V189, P144, DOI 10.1016/j.resp.2013.07.005; Braido F, 2009, ASIAN PAC J ALLERGY, V27, P27; Brandt EB, 2016, J ALLERGY CLIN IMMUN, V138, P924, DOI 10.1016/j.jaci.2016.03.037; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Carr TF, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0131-2; Cosmi L, 2016, CURR OPIN ALLERGY CL, V16, P1, DOI 10.1097/ACI.0000000000000227; Daniel LC, 2012, ANN ALLERG ASTHMA IM, V109, P41, DOI 10.1016/j.anai.2012.05.015; Day CE, 2009, J IMMUNOL METHODS, V342, P91, DOI 10.1016/j.jim.2008.12.001; Everson CA, 2005, AM J PHYSIOL-REG I, V289, pR1054, DOI 10.1152/ajpregu.00021.2005; Gamaldo CE, 2012, NEUROL CLIN, V30, P1313, DOI 10.1016/j.ncl.2012.08.007; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Global Initiative for Asthma, 2015, GLOB STRAT ASTHM MAN; GOLDE DW, 1976, AM J HEMATOL, V1, P369, DOI 10.1002/ajh.2830010402; Halwani R, 2013, CHEST, V143, P494, DOI 10.1378/chest.12-0598; Ibarra-Coronado EG, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/678164; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Irwin MR, 2015, BRAIN BEHAV IMMUN, V47, P86, DOI 10.1016/j.bbi.2014.09.017; Irwin MR, 2015, ANNU REV PSYCHOL, V66, P143, DOI 10.1146/annurev-psych-010213-115205; Kozyrskyj AL, 2009, EUR RESPIR J, V34, P1288, DOI 10.1183/09031936.00040509; Laan M, 1999, J IMMUNOL, V162, P2347; Lange T, 2006, INT IMMUNOPHARMACOL, V6, P216, DOI 10.1016/j.intimp.2005.08.006; Lange T, 2011, J IMMUNOL, V187, P283, DOI 10.4049/jimmunol.1100015; Lange T, 2011, BRAIN BEHAV IMMUN, V25, P14, DOI 10.1016/j.bbi.2010.08.008; Leander M, 2009, RESP MED, V103, P194, DOI 10.1016/j.rmed.2008.09.015; Li H, 2014, BIOMED CHROMATOGR, V28, P1860, DOI 10.1002/bmc.3232; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Ruiz FS, 2017, BRAIN BEHAV IMMUN, V61, P274, DOI 10.1016/j.bbi.2016.12.027; Schewitz-Bowers LP, 2015, P NATL ACAD SCI USA, V112, P4080, DOI 10.1073/pnas.1418316112; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schramm R, 2003, INFECT IMMUN, V71, P2542, DOI 10.1128/IAI.71.5.2542-2547.2003; Silva RH, 2004, NEUROPHARMACOLOGY, V46, P895, DOI 10.1016/j.neuropharm.2003.11.032; Trevor JL, 2014, ALLERGY, V69, P817, DOI 10.1111/all.12412; ULICH TR, 1988, AM J PATHOL, V133, P630; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Yehuda S, 2009, J INTERF CYTOK RES, V29, P393, DOI 10.1089/jir.2008.0080; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zager A, 2009, EUR NEUROPSYCHOPHARM, V19, P589, DOI 10.1016/j.euroneuro.2009.03.005	49	16	16	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					1018	+		10.1016/j.jaci.2017.06.025	http://dx.doi.org/10.1016/j.jaci.2017.06.025			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	28732645	Bronze			2022-12-18	WOS:000426974800022
J	Geerdink, RJ; Hennus, MP; Westerlaken, GHA; Abrahams, AC; Albers, KI; Walk, J; Wesselink, E; Janssen, R; Bont, L; Meyaard, L				Geerdink, Ruben J.; Hennus, Marije P.; Westerlaken, Geertje H. A.; Abrahams, Alferso C.; Albers, Kim I.; Walk, Jona; Wesselink, Esther; Janssen, Riny; Bont, Louis; Meyaard, Linde			LAIR-1 limits neutrophil extracellular trap formation in viral bronchiolitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; IDENTIFICATION; RECEPTOR; PRIMERS		[Geerdink, Ruben J.; Westerlaken, Geertje H. A.; Albers, Kim I.; Walk, Jona; Wesselink, Esther; Bont, Louis; Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Hennus, Marije P.] Univ Med Ctr Utrecht, Wilhelmina Children Hosp, Dept Pediat Intens Care, Utrecht, Netherlands; [Abrahams, Alferso C.] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands; [Janssen, Riny] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Bont, Louis] Univ Med Ctr Utrecht, Wilhelmina Children Hosp, Dept Pediat, Lab Translat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Meyaard, L (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands.	l.meyaard@umcutrecht.nl	Albers, Kim Iris/B-6341-2018; Walk, Jona/G-2793-2016	Walk, Jona/0000-0002-9420-4578; Meyaard, Linde/0000-0003-0707-4793; Hennus, Marije/0000-0003-1508-0456; Geerdink, Ruben/0000-0003-2976-4015	Netherlands Organization for Scientific Research Graduate Program [022.004.018]; Vici grant from the Netherlands Organization for Scientific Research [91815608]	Netherlands Organization for Scientific Research Graduate Program; Vici grant from the Netherlands Organization for Scientific Research	This work was supported by the Netherlands Organization for Scientific Research Graduate Program (grant no. 022.004.018 to R.J.G.). L.M. is supported by Vici grant number 91815608 from the Netherlands Organization for Scientific Research. L.M. and L.B. have received funding for an investigator-initiated study to validate LAIR-1 as a therapeutic target in an experimental animal model of respiratory syncytial virus infection.	Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DeVincenzo JP, 2015, NEW ENGL J MED, V373, P2048, DOI 10.1056/NEJMoa1413275; Funchal GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124082; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geerdink RJ, 2015, J ALLERGY CLIN IMMUN, V136, P838, DOI 10.1016/j.jaci.2015.06.034; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Sangaletti S, 2014, CANCER DISCOV, V4, P110, DOI 10.1158/2159-8290.CD-13-0276; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Van Avondt K, 2016, J IMMUNOL, V196, P3686, DOI 10.4049/jimmunol.1501650; White T.J., 1990, PCR PROTOCOLS GUIDE, P315	17	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					811	+		10.1016/j.jaci.2017.08.031	http://dx.doi.org/10.1016/j.jaci.2017.08.031			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	29050972	Bronze			2022-12-18	WOS:000424410800048
J	Weber, M; Niespodziana, K; Linhart, B; Neubauer, A; Huber, H; Henning, R; Valenta, R; Focke-Tejkl, M				Weber, Milena; Niespodziana, Katarzyna; Linhart, Birgit; Neubauer, Angela; Huber, Hans; Henning, Rainer; Valenta, Rudolf; Focke-Tejkl, Margarete			Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MONOPHOSPHORYL-LIPID-A; ANTIBODY-RESPONSES; IMMUNOTHERAPY; MECHANISMS; EFFICACY; SAFETY		[Weber, Milena; Niespodziana, Katarzyna; Linhart, Birgit; Valenta, Rudolf; Focke-Tejkl, Margarete] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Neubauer, Angela; Huber, Hans; Henning, Rainer] Biomay AG, Vienna, Austria	Medical University of Vienna	Valenta, R (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria.	rudolf.valenta@meduniwien.ac.at		Valenta, Rudolf/0000-0001-5944-3365; Linhart, Birgit/0000-0001-6857-3049	Christian Doppler Research Association, Vienna, Austria; Biomay AG, Vienna, Austria; Austrian Science Fund (FWF) [F4604, F4605, F4611]; Austrian Research Promotion Agency (FFG) [830432, 835415]	Christian Doppler Research Association, Vienna, Austria; Biomay AG, Vienna, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG)	Supported by research grants from the Christian Doppler Research Association, Vienna, Austria; Biomay AG, Vienna, Austria; the Austrian Science Fund (FWF; projects F4604, F4605, and F4611); and the Austrian Research Promotion Agency (FFG; projects 830432 and 835415).	Casale TB, 2014, J ALLERGY CLIN IMMUN, V133, P612, DOI 10.1016/j.jaci.2014.01.007; Cornelius C, 2016, EBIOMEDICINE, V11, P58, DOI 10.1016/j.ebiom.2016.07.023; Cox L, 2012, IMMUNOTHERAPY-UK, V4, P601, DOI [10.2217/IMT.12.36, 10.2217/imt.12.36]; Drachenberg KJ, 2001, ALLERGY, V56, P498, DOI 10.1034/j.1398-9995.2001.056006498.x; Focke M, 2001, FASEB J, V15, P2042, DOI 10.1096/fj.01-0016fje; Focke-Tejkl M, 2015, J ALLERGY CLIN IMMUN, V135, P1207, DOI 10.1016/j.jaci.2014.09.012; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Kiel MA, 2013, J ALLERGY CLIN IMMUN, V132, P353, DOI 10.1016/j.jaci.2013.03.013; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Marth K, 2004, J ALLERGY CLIN IMMUN, V113, P470, DOI 10.1016/j.jaci.2003.11.042; Mothes N, 2003, CLIN EXP ALLERGY, V33, P1198, DOI 10.1046/j.1365-2222.2003.01699.x; Niederberger V, 2015, J ALLERGY CLIN IMMUN, V136, P1101, DOI 10.1016/j.jaci.2015.03.034; PAUL WE, 1970, J EXP MED, V132, P283, DOI 10.1084/jem.132.2.283; Rosewich M, 2010, CLIN EXP IMMUNOL, V160, P403, DOI 10.1111/j.1365-2249.2010.04106.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; Westritschnig K, 2008, EUR J CLIN INVEST, V38, P260, DOI 10.1111/j.1365-2362.2008.01938.x; Zieglmayer P, 2016, EBIOMEDICINE, V11, P43, DOI 10.1016/j.ebiom.2016.08.022	19	16	16	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1433	+		10.1016/j.jaci.2017.03.048	http://dx.doi.org/10.1016/j.jaci.2017.03.048			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28576673	Green Accepted, hybrid			2022-12-18	WOS:000414304300024
J	Honda, T; Nomura, T; Kabashima, K				Honda, Tetsuya; Nomura, Takashi; Kabashima, Kenji			Advances in atopic dermatitis and urticarial in 2016	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; chronic spontaneous urticaria; biologics; microbiome; biomarker; transcriptome	THYMIC STROMAL LYMPHOPOIETIN; LANGERHANS CELLS; T-CELLS; EPICUTANEOUS SENSITIZATION; SKIN INFLAMMATION; MAJOR DIFFERENCES; DISEASE SEVERITY; RECEPTOR; ECZEMA; T(H)2	This review highlights recent key advances in the pathology and therapies of inflammatory skin diseases, focusing on atopic dermatitis (AD) and chronic spontaneous urticaria (CSU). Regarding AD, transcriptomic analysis with human samples revealed different immune profiles between childhood and adult AD. Phase III clinical trials of dupilumab, an anti-IL-4 receptor a antibody, in the treatment of AD have successfully finished, and dupilumab will appear in clinical practice as the first biologic for AD in 2017. In addition, a novel biologic that targets IL-31 shows promising results in a phase II trial. As for the skin microbiome study, novel insights into the mechanisms of microbial dysbiosis, such as colonization of Staphylococcus aureus, a common feature of AD, were proposed. Regarding CSU, autoreactive CD4(+) T cells that react to Fc epsilon RI were discovered, which might contribute to the development of CSU. These findings provide new insights into the pathogenesis of AD and CSU and will lead to more specific and personalized treatments.	[Honda, Tetsuya; Nomura, Takashi; Kabashima, Kenji] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto, Japan; [Kabashima, Kenji] ASTAR, Singapore Immunol Network SIgN, Biopolis, Singapore; [Kabashima, Kenji] ASTAR, IMB, Biopolis, Singapore	Kyoto University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Kabashima, K (corresponding author), Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hontetsu@kuhp.kyoto-u.ac.jp	Kabashima, Kenji/G-2521-2014	Kabashima, Kenji/0000-0002-0773-0554	Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Andersen YMF, 2017, J ALLERGY CLIN IMMUN, V139, P1057, DOI 10.1016/j.jaci.2016.08.049; Andersen YMF, 2016, J ALLERGY CLIN IMMUN, V138, P310, DOI 10.1016/j.jaci.2016.01.015; [Anonymous], 2016, J ALLERGY CLIN IMMUN; [Anonymous], 2016, J ALLERGY CLIN IMMUN; Auyeung P, 2016, J ALLERGY CLIN IMMUN, V138, P761, DOI 10.1016/j.jaci.2016.04.036; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Boyden SE, 2016, NEW ENGL J MED, V374, P656, DOI 10.1056/NEJMoa1500611; Brunner PM, 2017, J INVEST DERMATOL, V137, P18, DOI 10.1016/j.jid.2016.08.022; Brunner PM, 2016, J ALLERGY CLIN IMMUN, V138, P169, DOI 10.1016/j.jaci.2015.12.1323; Czarnowicki T, 2016, J ALLERGY CLIN IMMUN, V137, P1091, DOI 10.1016/j.jaci.2015.08.013; Czarnowicki T, 2016, J ALLERGY CLIN IMMUN, V137, P118, DOI 10.1016/j.jaci.2015.08.027; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Esaki H, 2016, J ALLERGY CLIN IMMUN, V138, P1639, DOI 10.1016/j.jaci.2016.07.013; Esaki H, 2016, J ALLERGY CLIN IMMUN, V138, P1473, DOI 10.1016/j.jaci.2016.04.052; Ewald DA, 2017, J ALLERGY CLIN IMMUN, V139, P562, DOI 10.1016/j.jaci.2016.08.029; Feld M, 2016, J ALLERGY CLIN IMMUN, V138, P500, DOI 10.1016/j.jaci.2016.02.020; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Gericke J, 2017, J ALLERGY CLIN IMMUN, V139, P1059, DOI 10.1016/j.jaci.2016.07.047; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; GRATTAN CEH, 1991, CLIN EXP ALLERGY, V21, P695, DOI 10.1111/j.1365-2222.1991.tb03198.x; Grattan CEH, 2002, J AM ACAD DERMATOL, V46, P645, DOI 10.1067/mjd.2002.122759; Guttman-Yassky E, 2017, J ALLERGY CLIN IMMUN; Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006; Hamilton JD, 2014, J ALLERGY CLIN IMMUN, V134, P1293, DOI 10.1016/j.jaci.2014.10.013; Heeringa JJ, 2016, J ALLERGY CLIN IMMUN, V138, P317, DOI 10.1016/j.jaci.2016.01.038; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Honda T, 2015, ALLERGOL INT, V64, P11, DOI 10.1016/j.alit.2014.08.002; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Huvenne W, 2010, CLIN EXP ALLERGY, V40, P1079, DOI 10.1111/j.1365-2222.2010.03464.x; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Itoh E, 2017, J ALLERGY CLIN IMMUN, V139, P363, DOI 10.1016/j.jaci.2016.06.049; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kaesler S, 2016, J ALLERGY CLIN IMMUN, V138, P780, DOI 10.1016/j.jaci.2015.11.043; Kaplan A, 2016, J ALLERGY CLIN IMMUN, V137, P474, DOI 10.1016/j.jaci.2015.08.023; Kashem SW, 2017, ANNU REV IMMUNOL, V35, P469, DOI 10.1146/annurev-immunol-051116-052215; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Kennedy EA, 2017, J ALLERGY CLIN IMMUN, V139, P166, DOI 10.1016/j.jaci.2016.07.029; Kim J, 2016, J ALLERGY CLIN IMMUN, V137, P1282, DOI 10.1016/j.jaci.2015.12.1306; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Krause L, 2016, J ALLERGY CLIN IMMUN, V138, P1207, DOI 10.1016/j.jaci.2016.04.018; Laouini D, 2003, J ALLERGY CLIN IMMUN, V112, P981, DOI 10.1016/j.jaci.2003.07.007; Leitch CS, 2016, J ALLERGY CLIN IMMUN, V138, P482, DOI 10.1016/j.jaci.2015.11.040; Li JG, 2016, J ALLERGY CLIN IMMUN, V138, P150, DOI 10.1016/j.jaci.2016.01.013; Li J, 2017, J ALLERGY CLIN IMMUN, V139, P1386, DOI 10.1016/j.jaci.2016.10.017; Malhotra N, 2016, J ALLERGY CLIN IMMUN, V138, P1098, DOI 10.1016/j.jaci.2016.07.001; Mitson-Salazar A, 2016, J ALLERGY CLIN IMMUN, V137, P907, DOI 10.1016/j.jaci.2015.08.007; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Nakamizo S, 2015, SEMIN IMMUNOPATHOL, V37, P73, DOI 10.1007/s00281-014-0452-6; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Noda S, 2015, J ALLERGY CLIN IMMUN, V135, P324, DOI 10.1016/j.jaci.2014.11.015; Nomura T, 2014, J DERMATOL SCI, V76, P3, DOI 10.1016/j.jdermsci.2014.07.010; O'Donovan SM, 2016, J ALLERGY CLIN IMMUN, V137, P108, DOI 10.1016/j.jaci.2015.05.035; Paller AS, 2017, J ALLERGY CLIN IMMUN, V139, P152, DOI 10.1016/j.jaci.2016.07.019; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Prussin C, 2009, J ALLERGY CLIN IMMUN, V124, P1326, DOI 10.1016/j.jaci.2009.09.048; Reich K, 2016, J ALLERGY CLIN IMMUN, V137, P1882, DOI 10.1016/j.jaci.2016.01.016; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Sano Y, 2013, CLIN EXP IMMUNOL, V171, P330, DOI 10.1111/cei.12021; Sasaki T, 2013, J ALLERGY CLIN IMMUN, V132, P1111, DOI 10.1016/j.jaci.2013.08.027; Saunders SP, 2016, J ALLERGY CLIN IMMUN, V137, P482, DOI 10.1016/j.jaci.2015.06.045; Schmitt J, 2016, J ALLERGY CLIN IMMUN, V137, P130, DOI 10.1016/j.jaci.2015.06.029; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Shi BC, 2016, J ALLERGY CLIN IMMUN, V138, P1233, DOI 10.1016/j.jaci.2016.04.053; Shlyankevich J, 2014, AM J MED, V127, P1148, DOI 10.1016/j.amjmed.2014.08.008; Simon D, 2008, J ALLERGY CLIN IMMUN, V121, P122, DOI 10.1016/j.jaci.2007.11.016; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Song H, 2016, J ALLERGY CLIN IMMUN, V137, P852, DOI 10.1016/j.jaci.2015.08.021; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Tauber M, 2016, J ALLERGY CLIN IMMUN, V137, P1272, DOI 10.1016/j.jaci.2015.07.052; Thijs JL, 2015, CLIN EXP ALLERGY, V45, P698, DOI 10.1111/cea.12486; Thijs J, 2015, CURR OPIN ALLERGY CL, V15, P453, DOI 10.1097/ACI.0000000000000198; Thijs JL, 2017, J ALLERGY CLIN IMMUN, V139, P1065, DOI 10.1016/j.jaci.2016.08.023; Ungar B, 2017, J INVEST DERMATOL, V137, P603, DOI 10.1016/j.jid.2016.09.037; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Walterscheid JP, 2006, P NATL ACAD SCI USA, V103, P17420, DOI 10.1073/pnas.0603119103; Wang HH, 2016, J ALLERGY CLIN IMMUN, V138, P1719, DOI 10.1016/j.jaci.2016.05.038; Werfel T, 2016, J ALLERGY CLIN IMMUN, V138, P336, DOI 10.1016/j.jaci.2016.06.010; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Xue LZ, 2005, J IMMUNOL, V175, P6531, DOI 10.4049/jimmunol.175.10.6531; Ying S, 2002, J ALLERGY CLIN IMMUN, V109, P694, DOI 10.1067/mai.2002.123236; Zhao ZT, 2016, J ALLERGY CLIN IMMUN, V137, P1742, DOI 10.1016/j.jaci.2015.12.1342; Zug KA, 2014, DERMATITIS, V25, P345, DOI 10.1097/DER.0000000000000083	86	16	17	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2017	140	2					369	376		10.1016/j.jaci.2017.06.005	http://dx.doi.org/10.1016/j.jaci.2017.06.005			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC5BK	28652155	Bronze			2022-12-18	WOS:000406855500005
J	Butto, LF; Haller, D				Butto, Ludovica F.; Haller, Dirk			Functional relevance of microbiome signatures: The correlation era requires tools for consolidation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Microbiome; metagenomics; inflammatory bowel diseases; allergy; colorectal cancer; diabetes; fecal microbiota transplantation; gnotobiology; synthetic bacterial consortia	HUMAN GUT MICROBIOME; DIET-INDUCED OBESITY; INTESTINAL MICROBIOTA; FECAL MICROBIOTA; MICE; ASSOCIATION; DYSBIOSIS; BACTERIAL; COLITIS; FAT	Compelling research over the past decade identified a fundamental role of the intestinal microbiome on human health. Compositional and functional changes of this microbial ecosystem are correlated with a variety of human pathologies. Metagenomic resolution and bioinformatic tools considerably improved, allowing even strain-level analysis. However, the search for microbial risk patterns in human cohorts is often confounded by environmental factors (eg, medication) and host status (eg, disease relapse), questioning the prognostic and therapeutic value of the currently available information. In addition to a better stratification of human phenotypes, the implementation of standardized protocols for sampling and analysis is needed to improve the reproducibility and comparability of microbiome signatures at a meaningful taxonomic resolution. At the level of mechanistic understanding, the molecular integration of pleiotropic signals coming from this complex and dynamically changing ecosystem is one of the biggest challenges in this field. The first successful attempts to apply reverse genetics based on the available metagenomic information yielded identification of small molecules and metabolites with functional relevance for microbe-host interactions. Further expansion on the isolation of bacteria from the "unculturable biomass" will help characterize microbiome signatures in model systems, finally aiming at the development of clinically relevant synthetic consortia with safe and functionally well-defined strains. In conclusion and beyond reasonable enthusiasm, the mechanistic implementation and clinical relevance of microbiome alterations on disease susceptibility is still in its infancy, but the integration of all the above-mentioned strategies will help overcome the correlation era in microbiome research and lead to a rational evaluation of clinical strategies relevant for targeted microbial intervention.	[Butto, Ludovica F.; Haller, Dirk] Univ Munich, Chair Nutr & Immunol, Freising Weihenstephan, Germany	University of Munich	Haller, D (corresponding author), Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany.	dirk.haller@tum.de	Butto, Ludovica/P-1882-2019	Haller, Dirk/0000-0002-6977-4085	Topfer; Helmsley Charitable Trust	Topfer; Helmsley Charitable Trust	D. Haller serves as a consultant for Gnubiotics, Clasado Bimuno, and Avito; receives grant support from Topfer and the Helmsley Charitable Trust; holds a patent with Lactocepin; and receives royalties from Thieme Verlag. L. F. Butto declares no relevant conflicts of interest.	Arrieta MC, 2016, GUT MICROBES, V7, P342, DOI 10.1080/19490976.2016.1182293; Arrieta MC, 2016, CELL HOST MICROBE, V19, P575, DOI 10.1016/j.chom.2016.04.014; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bashan A, 2016, NATURE, V534, P259, DOI 10.1038/nature18301; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Brugiroux S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.215; Busquets D, 2015, J CROHNS COLITIS, V9, P899, DOI 10.1093/ecco-jcc/jjv119; Butto LF, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00555; Cammarota G, 2017, GUT; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chen YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34055; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Crouzet L, 2013, NEUROGASTROENT MOTIL, V25, pe272, DOI 10.1111/nmo.12103; Dave M, 2012, TRANSL RES, V160, P246, DOI 10.1016/j.trsl.2012.05.003; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Du ZY, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0080-2; Escalona M, 2016, NAT REV GENET, V17, P459, DOI 10.1038/nrg.2016.57; Eun CS, 2014, INFECT IMMUN, V82, P2239, DOI 10.1128/IAI.01513-13; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528; Flemer B, 2016, GUT; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Fujimura KE, 2015, CELL HOST MICROBE, V17, P592, DOI 10.1016/j.chom.2015.04.007; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gronbach K, 2014, GASTROENTEROLOGY, V146, P765, DOI 10.1053/j.gastro.2013.11.033; Guo CJ, 2017, CELL, V168, P517, DOI 10.1016/j.cell.2016.12.021; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hanage WP, 2014, NATURE, V512, P247, DOI 10.1038/512247a; Hiergeist A, 2016, INT J MED MICROBIOL, V306, P334, DOI 10.1016/j.ijmm.2016.03.005; Hormannsperger G, 2015, ILAR J, V56, P179, DOI 10.1093/ilar/ilv019; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jalanka-Tuovinen J, 2014, GUT, V63, P1737, DOI 10.1136/gutjnl-2013-305994; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kubeck R, 2016, MOL METAB, V5, P1162, DOI 10.1016/j.molmet.2016.10.001; Lagkouvardos I, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.131, 10.1038/NMICROBIOL.2016.131]; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee T., 2016, GUT; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Li SS, 2016, SCIENCE, V352, P586, DOI 10.1126/science.aad8852; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Nagao-Kitamoto H, 2016, CELL MOL GASTROENTER, V2, P468, DOI 10.1016/j.jcmgh.2016.02.003; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342; Ott SJ, 2016, GASTROENTEROLOGY; Paramsothy S, 2017, LANCET; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Rabot S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32484; Rausch P, 2016, INT J MED MICROBIOL, V306, P343, DOI 10.1016/j.ijmm.2016.03.004; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rehman A, 2016, GUT, V65, P238, DOI 10.1136/gutjnl-2014-308341; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333; Schwerd T, 2016, J ALLERGY CLIN IMMUN, V138, P592, DOI 10.1016/j.jaci.2015.12.1331; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Serino M, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0540-1; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Steck N, 2011, GASTROENTEROLOGY, V141, P959, DOI 10.1053/j.gastro.2011.05.035; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turpin W, 2016, NAT GENET, V48, P1413, DOI 10.1038/ng.3693; Tyler AD, 2014, AM J GASTROENTEROL, V109, P983, DOI 10.1038/ajg.2014.73; Van de Wiele T, 2016, NAT REV RHEUMATOL, V12, P398, DOI 10.1038/nrrheum.2016.85; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; von Schillde MA, 2012, CELL HOST MICROBE, V11, P387, DOI 10.1016/j.chom.2012.02.006; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Xiao L, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.161, 10.1038/nmicrobiol.2016.161]; Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914	108	16	17	0	23	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2017	139	4					1092	1098		10.1016/j.jaci.2017.02.010	http://dx.doi.org/10.1016/j.jaci.2017.02.010			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ER4LR	28390576				2022-12-18	WOS:000398771800003
J	Al-Kufaidy, R; Vazquez-Tello, A; BaHammam, AS; Al-Muhsen, S; Hamid, Q; Halwani, R				Al-Kufaidy, Roua; Vazquez-Tello, Alejandro; BaHammam, Ahmed S.; Al-Muhsen, Saleh; Hamid, Qutayba; Halwani, Rabih			IL-17 enhances the migration of B cells during asthma by inducing CXCL13 chemokine production in structural lung cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MHC CLASS-II; EPITOPES; BINDING		[Al-Kufaidy, Roua; Vazquez-Tello, Alejandro; BaHammam, Ahmed S.; Al-Muhsen, Saleh; Halwani, Rabih] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh, Saudi Arabia; [Al-Kufaidy, Roua; Vazquez-Tello, Alejandro; BaHammam, Ahmed S.; Al-Muhsen, Saleh; Halwani, Rabih] King Saud Univ, Coll Med, Asthma Res Chair, Dept Pediat, Riyadh, Saudi Arabia; [BaHammam, Ahmed S.] King Saud Univ, Coll Med, Univ Sleep Disorders Ctr, Riyadh, Saudi Arabia; [Hamid, Qutayba] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Hamid, Qutayba] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates	King Saud University; King Saud University; King Saud University; McGill University; University of Sharjah	Halwani, R (corresponding author), King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh, Saudi Arabia.	rhalwani@ksu.edu.sa	Al-muhsen, saleh/E-9315-2014; Halwani, Rabih/AAN-1568-2021; Halwani, Rabih/E-9311-2014; BaHammam, Ahmed S/D-7521-2011; BaHammam, Ahmed Salem/B-9037-2008	Al-muhsen, saleh/0000-0003-3698-9968; Halwani, Rabih/0000-0002-6516-7771; Halwani, Rabih/0000-0002-6516-7771; BaHammam, Ahmed S/0000-0002-1706-6167; BaHammam, Ahmed Salem/0000-0002-1706-6167	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [10-MED1224-02]	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number (10-MED1224-02).	Aly L, 2011, BRAIN, V134, P2687, DOI 10.1093/brain/awr206; Arnaboldi PM, 2005, J IMMUNOL, V175, P1276, DOI 10.4049/jimmunol.175.2.1276; Baena-Cagnani CE, 2015, CURR OPIN ALLERGY CL, V15, P267, DOI 10.1097/ACI.0000000000000161; Chang Y, 2011, J ALLERGY CLIN IMMUN, V127, P1046, DOI 10.1016/j.jaci.2010.12.1117; de Graaf KL, 1999, INT IMMUNOL, V11, P1981, DOI 10.1093/intimm/11.12.1981; Floudas A, 2016, J CLIN IMMUNOL, V36, pS25, DOI 10.1007/s10875-016-0263-8; Gopal R, 2013, MUCOSAL IMMUNOL, V6, P972, DOI 10.1038/mi.2012.135; Goris A, 2008, TISSUE ANTIGENS, V72, P401, DOI 10.1111/j.1399-0039.2008.01101.x; Halwani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114604; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Lenz DC, 2001, J IMMUNOL, V167, P1803, DOI 10.4049/jimmunol.167.3.1803; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Riedhammer C, 2016, METHODS MOL BIOL, V1304, P53, DOI 10.1007/7651_2014_99; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; van der Vlugt LEPM, 2014, CLIN EXP ALLERGY, V44, P517, DOI 10.1111/cea.12238; Wang XH, 2011, CELL MOL IMMUNOL, V8, P462, DOI 10.1038/cmi.2011.38; Yadava K, 2013, THORAX, V68, P597, DOI 10.1136/thoraxjnl-2012-203008	17	16	16	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					696	+		10.1016/j.jaci.2016.07.037	http://dx.doi.org/10.1016/j.jaci.2016.07.037			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27639935	Bronze			2022-12-18	WOS:000397002400040
J	Hysinger, EB; Roizen, JD; Mentch, FD; Vazquez, L; Connolly, JJ; Bradfield, JP; Almoguera, B; Sleiman, PM; Allen, JL; Levine, MA; Hakonarson, H				Hysinger, Erik B.; Roizen, Jeffrey D.; Mentch, Frank D.; Vazquez, Lyam; Connolly, John J.; Bradfield, Jonathan P.; Almoguera, Berta; Sleiman, Patrick M.; Allen, Julian L.; Levine, Michael A.; Hakonarson, Hakon			Mendelian randomization analysis demonstrates that low vitamin D is unlikely causative for pediatric asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SUPPLEMENTATION; ADULTS		[Hysinger, Erik B.; Mentch, Frank D.; Vazquez, Lyam; Connolly, John J.; Bradfield, Jonathan P.; Almoguera, Berta; Sleiman, Patrick M.; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Ctr Appl Genom, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hysinger, Erik B.; Allen, Julian L.; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Div Pulm Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Roizen, Jeffrey D.; Levine, Michael A.] Univ Penn, Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sleiman, Patrick M.; Allen, Julian L.; Levine, Michael A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Hakonarson, H (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Ctr Appl Genom, Perelman Sch Med, Philadelphia, PA 19104 USA.; Hakonarson, H (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Div Pulm Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Hakonarson, H (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	hakonarson@email.chop.edu	; Roizen, Jeffrey/J-5050-2012	Connolly, John/0000-0003-4396-1226; Roizen, Jeffrey/0000-0002-3384-6200; Levine, Michael/0000-0003-0036-7809	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD087964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK094723] Funding Source: NIH RePORTER; NICHD NIH HHS [K08 HD087964] Funding Source: Medline; NIDDK NIH HHS [K12 DK094723] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Castro M, 2014, JAMA-J AM MED ASSOC, V311, P2083, DOI 10.1001/jama.2014.5052; Chinellato I, 2011, J PEDIATR-US, V158, P437, DOI 10.1016/j.jpeds.2010.08.043; Di Filippo P, 2015, INT ARCH ALLERGY IMM, V166, P91, DOI 10.1159/000371350; Kolokotroni O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1385-2; Mansbach JM, 2009, PEDIATRICS, V124, P1404, DOI 10.1542/peds.2008-2041; Martineau AR, 2015, THORAX, V70, P451, DOI 10.1136/thoraxjnl-2014-206449; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94	9	16	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1747	+		10.1016/j.jaci.2016.06.056	http://dx.doi.org/10.1016/j.jaci.2016.06.056			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27554823	Green Accepted, Bronze			2022-12-18	WOS:000390019300043
J	Martin, MA; Press, VG; Nyenhuis, SM; Krishnan, JA; Erwin, K; Mosnaim, G; Margellos-Anast, H; Paik, SM; Ignoffo, S; McDermott, M				Martin, Molly A.; Press, Valerie G.; Nyenhuis, Sharmilee M.; Krishnan, Jerry A.; Erwin, Kim; Mosnaim, Giselle; Margellos-Anast, Helen; Paik, S. Margaret; Ignoffo, Stacy; McDermott, Michael		CHICAGO Plan Consortium	Care transition interventions for children with asthma in the emergency department	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; patient-centered; pediatric; emergency department; care transitions; disparities; care coordination; education	FOLLOW-UP; ENVIRONMENTAL INTERVENTION; RACIAL DISPARITIES; CONTROLLED-TRIAL; MOUSE ALLERGEN; UNITED-STATES; IMPROVE; HOME; EXPOSURE; OUTCOMES	The emergency department (ED) is a critical point of identification and treatment for some of the most high-risk children with asthma. This review summarizes the evidence regarding care transition interventions originating in the ED for children with uncontrolled asthma, with a focus on care coordination and self-management education. Although many interventions on care transition for pediatric asthma have been tested, only a few were actually conducted in the ED setting. Most of these targeted both care coordination and self-management education but ultimately did not improve attendance at follow-up appointments with primary care providers, improve asthma control, or reduce health care utilization. Conducting any ED-based intervention in the current environment is challenging because of the many demands on ED providers and staff, poor communication within and outside of the medical sector, and caregiver/patient burden. The evidence to date suggests that ED care transition interventions should consider expanding beyond the ED to bridge the multiple sectors children with asthma navigate, including health care settings, homes, schools, and community spaces. Patient-centered approaches may also be important to ensure adequate intervention design, enrollment, retention, and evaluation of outcomes important to children and their families.	[Martin, Molly A.; Nyenhuis, Sharmilee M.; Krishnan, Jerry A.] Univ Illinois, Chicago, IL USA; [Press, Valerie G.; Paik, S. Margaret] Univ Chicago, Chicago, IL 60637 USA; [Erwin, Kim] IIT, Inst Design, Chicago, IL 60616 USA; [Mosnaim, Giselle] Rush Univ Hlth Ctr, Chicago, IL USA; [Margellos-Anast, Helen] Sinai Hlth Syst, Chicago, IL USA; [Ignoffo, Stacy] Chicago Asthma Consortium, Chicago, IL USA; CHICAGO Plan Consortium, Illinois Emergency Dept Asthma Surveillance Proj, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; Illinois Institute of Technology; Rush University	Martin, MA (corresponding author), Univ Illinois, Dept Pediat, 840 South Wood St,M C 856, Chicago, IL 60612 USA.	mollyma@uic.edu	McDermott, Michael Francis/GZM-5330-2022	Nyenhuis, Sharmilee/0000-0002-7381-9733; Press, Valerie/0000-0001-9961-4878	Patient-Centered Outcomes Research Institute (PCORI) award [AS-1307-05420]; National Heart, Lung, and Blood Institute/National Institutes of Health [U34 HL130787]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL118151, U34HL130787] Funding Source: NIH RePORTER	Patient-Centered Outcomes Research Institute (PCORI) award(Patient-Centered Outcomes Research Institute - PCORI); National Heart, Lung, and Blood Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this report was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) award (AS-1307-05420, "Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes (CHICAGO) Trial") and a National Heart, Lung, and Blood Institute/National Institutes of Health grant (grant no. U34 HL130787, "Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes (CHICAGO) Collaboration II"). The statements in this report are solely the responsibility of the authors and do not necessarily represent the views of the PCORI, its Board of Governors, or the Methodology Committee, or the National Institutes of Health.	Abraham J, 2009, PEDIATRICS S3, V123, pS185; Akinbami LJ, 2014, J ALLERGY CLIN IMMUN, V134, P547, DOI 10.1016/j.jaci.2014.05.037; Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; AL-Jahdali H, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-80; [Anonymous], 2007, 3 NAT ASTH ED PREV P; Baren JM, 2006, CHEST, V129, P257, DOI 10.1378/chest.129.2.257; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Boyd M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001290.pub2; Bravata DM, 2007, 040700515 AHRQ, V5; Campbell JD, 2015, AM J PUBLIC HEALTH, V105, P2366, DOI 10.2105/AJPH.2015.302685; Centers for Disease Control and Prevention, 2014, NAT CURR ASTHM PREV; Clark NM, 2009, PEDIATRICS, V123, pS185, DOI 10.1542/peds.2008-2233I; Crocker DD, 2011, AM J PREV MED, V41, pS5, DOI [10.1016/j.amepre.2011.04.011, 10.1016/j.amepre.2011.05.012]; DiMango E, 2016, J ALLER CL IMM-PRACT, V4, P671, DOI 10.1016/j.jaip.2016.01.016; Ducharme FM, 2011, AM J RESP CRIT CARE, V183, P195, DOI 10.1164/rccm.201001-0115OC; Erwin K, 2016, J COMP EFFECT RES, V5, P17, DOI 10.2217/cer.15.52; Farber Harold J., 2004, Pediatric Asthma Allergy & Immunology, V17, P107, DOI 10.1089/0883187041269913; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; Gold LS, 2013, J ASTHMA, V50, P783, DOI 10.3109/02770903.2013.795589; Gorelick MH, 2006, PEDIATRICS, V117, pS127, DOI 10.1542/peds.2005-2000J; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Guevara JP, 2003, BMJ-BRIT MED J, V326, P1308, DOI 10.1136/bmj.326.7402.1308; Institute of Medicine, 2001, CROSSING QUALITY CHA, P40; Joseph CLM, 2013, J ADOLESCENT HEALTH, V52, P419, DOI 10.1016/j.jadohealth.2012.07.009; Katz EB, 2012, ANN EMERG MED, V60, P12, DOI 10.1016/j.annemergmed.2012.02.025; Krieger J, 2010, PEDIAT ALLER IMM PUL, V23, P139, DOI 10.1089/ped.2010.0022; Krieger J, 2010, J PUBLIC HEALTH MAN, V16, pS11, DOI 10.1097/PHH.0b013e3181ddcbd9; Kruse LK, 2007, J ASTHMA, V44, P833, DOI 10.1080/02770900701750163; Kyriacou DN, 2005, J GEN INTERN MED, V20, P938, DOI 10.1111/j.1525-1497.2005.0216_1.x; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; McDonald K. M., 2007, CARE COORDINATION, V4, P51; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Nath JB, 2015, ACAD PEDIATR, V15, P225, DOI 10.1016/j.acap.2014.10.011; Ornato JP, 2007, J EMERG MED, V32, P27, DOI 10.1016/j.jemermed.2006.04.016; Parker EA, 2008, HEALTH EDUC BEHAV, V35, P376, DOI 10.1177/1090198106290622; Phipatanakul W, 2000, J ALLERGY CLIN IMMUN, V106, P1070, DOI 10.1067/mai.2000.110796; Phipatanakul W, 2012, ANN ALLERG ASTHMA IM, V109, P375, DOI 10.1016/j.anai.2012.09.019; Pongracic JA, 2008, ANN ALLERG ASTHMA IM, V101, P35, DOI 10.1016/S1081-1206(10)60832-0; Press VG, 2012, J GEN INTERN MED, V27, P1317, DOI 10.1007/s11606-012-2090-9; Press VG, 2011, J GEN INTERN MED, V26, P635, DOI 10.1007/s11606-010-1624-2; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Scarfi CA, 2009, ANN ALLERG ASTHMA IM, V102, P35, DOI 10.1016/S1081-1206(10)60105-6; Smith SR, 2006, ACAD EMERG MED, V13, P835, DOI 10.1197/j.aem.2006.03.565; Sockrider MM, 2006, PEDIATRICS, V117, pS135, DOI 10.1542/peds.2005-2000K; Stanford RH, 2010, J ASTHMA, V47, P257, DOI 10.3109/02770900903584019; The Joint Commission, TRANS CAR NEED MOR E; US Environmental Protection Agency, 2012, COORD FED ACT PLAN R; Wang L, 2015, AM J MED QUAL, V30, P156, DOI 10.1177/1062860614525225; Weiss KB, 2009, CONTEMP CLIN TRIALS, V30, P246, DOI 10.1016/j.cct.2009.01.006; Zorc JJ, 2003, PEDIATRICS, V111, P495, DOI 10.1542/peds.111.3.495; Zorc JJ, 2009, PEDIATRICS, V124, P1135, DOI 10.1542/peds.2008-3352	52	16	16	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1518	1525		10.1016/j.jaci.2016.10.012	http://dx.doi.org/10.1016/j.jaci.2016.10.012			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	EF0MK	27931533	Green Accepted, Bronze			2022-12-18	WOS:000390019300003
J	Nishimura, KK; Iwanaga, K; Oh, SS; Pino-Yanes, M; Eng, C; Keswani, A; Roth, LA; Nguyen, EA; Thyne, SM; Farber, HJ; Serebrisky, D; Meade, K; LeNoir, MA; Rodriguez-Cintron, W; Borrell, LN; Bibbins-Domingo, K; Lurmann, F; Sen, S; Rodriguez-Santana, JR; Brigino-Buenaventura, E; Avila, PC; Balmes, JR; Kumar, R; Burchard, EG				Nishimura, Katherine K.; Iwanaga, Kensho; Oh, Sam S.; Pino-Yanes, Maria; Eng, Celeste; Keswani, Anjeni; Roth, Lindsey A.; Nguyen, Elizabeth A.; Thyne, Shannon M.; Farber, Harold J.; Serebrisky, Denise; Meade, Kelley; LeNoir, Michael A.; Rodriguez-Cintron, William; Borrell, Luisa N.; Bibbins-Domingo, Kirsten; Lurmann, Fred; Sen, Saunak; Rodriguez-Santana, Jose R.; Brigino-Buenaventura, Emerita; Avila, Pedro C.; Balmes, John R.; Kumar, Rajesh; Burchard, Esteban G.			Early-life ozone exposure associated with asthma without sensitization in Latino children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AIR-POLLUTION EXPOSURE; GALA II		[Nishimura, Katherine K.; Sen, Saunak] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Nishimura, Katherine K.; Oh, Sam S.; Pino-Yanes, Maria; Eng, Celeste; Roth, Lindsey A.; Nguyen, Elizabeth A.; Bibbins-Domingo, Kirsten; Balmes, John R.; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Iwanaga, Kensho; Thyne, Shannon M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Pino-Yanes, Maria] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Keswani, Anjeni] Duke Univ, Dept Med, Durham, NC USA; [Farber, Harold J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Serebrisky, Denise] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Meade, Kelley] UCSF, Benioff Childrens Hosp Oakland, Oakland, CA USA; [LeNoir, Michael A.] Bay Area Pediat, Oakland, CA USA; [Rodriguez-Cintron, William] Vet Caribbean Hlth Care Syst, San Juan, PR USA; [Borrell, Luisa N.] CUNY, Lehman Coll, Dept Hlth Sci, Bronx, NY USA; [Lurmann, Fred] Sonoma Technol Inc, Petaluma, CA USA; [Rodriguez-Santana, Jose R.] Ctr Neumol Pediat, San Juan, PR USA; [Brigino-Buenaventura, Emerita] Kaiser Vallejo Med Ctr, Dept Allergy & Immunol, Vallejo, CA USA; [Avila, Pedro C.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Balmes, John R.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Kumar, Rajesh] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Duke University; Baylor College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; City University of New York (CUNY) System; Lehman College (CUNY); Northwestern University; University of California System; University of California Berkeley; Northwestern University; University of California System; University of California San Francisco	Burchard, EG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Burchard, EG (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	esteban.burchard@ucsf.edu	Balmes, John/L-6281-2019; Borrell, Luisa N./G-8753-2018; Pino-Yanes, Maria/C-8498-2017	Borrell, Luisa N./0000-0002-0560-4853; Pino-Yanes, Maria/0000-0003-0332-437X; Kumar, Rajesh/0000-0002-1962-7108; Nguyen, Elizabeth/0000-0002-8070-6382; Nishimura, Katherine/0000-0003-3950-4495	NCI NIH HHS [R25 CA113710] Funding Source: Medline; NHLBI NIH HHS [K23 HL004464, R01 HL088133, K23 HL093023, R01 HL104608, R01 HL078885] Funding Source: Medline; NIAID NIH HHS [U19 AI077439] Funding Source: Medline; NIEHS NIH HHS [R21 ES024844, R01 ES015794] Funding Source: Medline; NIGMS NIH HHS [T32 GM007546] Funding Source: Medline; NIMHD NIH HHS [P60 MD006902] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA113710] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL093023, R01HL088133, R01HL104608, R01HL078885, K23HL004464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794, R21ES024844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007546] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD006902] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		BASHA MA, 1994, CHEST, V106, P1757, DOI 10.1378/chest.106.6.1757; Bowatte G, 2015, ALLERGY, V70, P245, DOI 10.1111/all.12561; Drews AC, 2009, ALLERGY, V64, P1597, DOI 10.1111/j.1398-9995.2009.02057.x; Gruzieva O, 2012, J ALLERGY CLIN IMMUN, V129, P240, DOI 10.1016/j.jaci.2011.11.001; Kumar R, 2013, J ALLERGY CLIN IMMUN, V132, P896, DOI 10.1016/j.jaci.2013.02.046; METZGER R, 1995, ENVIRON HEALTH PERSP, V103, P25, DOI 10.2307/3432340; Miranda ML, 2011, INT J ENV RES PUB HE, V8, P1755, DOI 10.3390/ijerph8061755; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC	8	16	16	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1703	1706		10.1016/j.jaci.2016.03.058	http://dx.doi.org/10.1016/j.jaci.2016.03.058			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27423496	Green Accepted, Bronze			2022-12-18	WOS:000390019300027
J	Kumar, V; Behr, M; Kiritsi, D; Scheffschick, A; Grahnert, A; Homberg, M; Schwieger-Briel, A; Jakob, T; Bruckner-Tuderman, L; Magin, TM				Kumar, Vinod; Behr, Matthias; Kiritsi, Dimitra; Scheffschick, Andrea; Grahnert, Anja; Homberg, Melanie; Schwieger-Briel, Agnes; Jakob, Thilo; Bruckner-Tuderman, Leena; Magin, Thomas M.			Keratin-dependent thymic stromal lymphopoietin expression suggests a link between skin blistering and atopic disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EPIDERMOLYSIS-BULLOSA; DERMATITIS; CELLS; MICE; INFLAMMATION; ASTHMA; MODEL; ITCH		[Kumar, Vinod; Behr, Matthias; Scheffschick, Andrea; Grahnert, Anja; Homberg, Melanie; Magin, Thomas M.] Univ Leipzig, Inst Biol, Leipzig, Germany; [Kumar, Vinod; Behr, Matthias; Scheffschick, Andrea; Grahnert, Anja; Homberg, Melanie; Magin, Thomas M.] Univ Leipzig, Translat Ctr Regenerat Med, Leipzig, Germany; [Kiritsi, Dimitra; Schwieger-Briel, Agnes; Jakob, Thilo; Bruckner-Tuderman, Leena] Med Ctr Univ Freiburg, Dept Dermatol, Freiburg, Germany; [Jakob, Thilo] Justus Liebig Univ, Univ Med Ctr Giessen & Marburg, Dept Dermatol & Allergol, Giessen, Germany	Leipzig University; Leipzig University; Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Magin, TM (corresponding author), Univ Leipzig, Inst Biol, Leipzig, Germany.; Magin, TM (corresponding author), Univ Leipzig, Translat Ctr Regenerat Med, Leipzig, Germany.	thomas.magin@uni-leipzig.de	Behr, Matthias/K-6505-2019; Kumar, Vinod/AAX-9743-2020; Kiritsi, Dimitra/AAL-4762-2020	Behr, Matthias/0000-0001-9869-1257; Kumar, Vinod/0000-0002-7167-0402; Kiritsi, Dimitra/0000-0002-2331-8981; Schwieger-Briel, Agnes/0000-0001-7679-3981				Aratani Y, 1999, INFECT IMMUN, V67, P1828; Bar J, 2014, J INVEST DERMATOL, V134, P1012, DOI 10.1038/jid.2013.416; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Homberg M, 2015, J INVEST DERMATOL, V135, P2437, DOI 10.1038/jid.2015.184; Iijima H, 2013, ALLERGOL INT, V62, P123, DOI 10.2332/allergolint.12-OA-0488; Kumar V, 2015, J CELL BIOL, V211, P1057, DOI 10.1083/jcb.201404147; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Matsushita H, 2010, INT IMMUNOL, V22, P739, DOI 10.1093/intimm/dxq062; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Seltmann K, 2015, J INVEST DERMATOL, V135, P1609, DOI 10.1038/jid.2015.46; Snauwaert JJL, 2014, BRIT J DERMATOL, V171, P73, DOI 10.1111/bjd.12885; Tatsuno K, 2015, J INVEST DERMATOL, V135, P3017, DOI 10.1038/jid.2015.318; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010	18	16	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1461	+		10.1016/j.jaci.2016.04.046	http://dx.doi.org/10.1016/j.jaci.2016.04.046			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27527262	Bronze			2022-12-18	WOS:000389542700033
J	Lomholt, FK; Nielsen, SF; Nordestgaard, BG				Lomholt, Frederikke K.; Nielsen, Sune F.; Nordestgaard, Borge G.			High alcohol consumption causes high IgE levels but not high risk of allergic disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Ethanol; asthma; rhinitis; eczema; IgE; alcohol dehydrogenase; Mendelian randomization; general population	INCREASED SERUM IGE; MENDELIAN RANDOMIZATION; GENERAL-POPULATION; COGNITIVE FUNCTION; HEART-DISEASE; ASTHMA; AGE; DEHYDROGENASE; GENDER; ADULTS	Background: High alcohol consumption is associated with high IgE levels in observational studies; however, whether high alcohol consumption leads to high IgE levels and allergic disease is unclear. Objective: We tested the hypothesis that high alcohol consumption is associated with high IgE levels and allergic disease both observationally and genetically using a Mendelian randomization design free of reverse causation and largely free of confounding. Methods: Among 111,408 subjects aged 20 to 100 years from the general population, 50,019 had plasma IgE measurements, and 102,270 were genotyped for the alcohol-metabolizing enzymes alcohol dehydrogenase 1B (ADH-1B; rs1229984) and alcohol dehydrogenase 1c (ADH-1C; rs698). Observationally, we investigated associations between IgE levels and allergic disease (allergic asthma, rhinitis, and eczema) and between alcohol consumption and IgE levels and allergic disease. Genetically, we explored potential causal relationships between alcohol consumption and IgE levels and allergic disease. Results: The multivariable adjusted odds ratio for IgE levels greater than versus less than 150 kU/L and compared with subjects without allergic disease was 2.3 (95% CI, 2.2-2.5) for 1 allergic disease, 3.9 (95% CI, 3.5-4.4) for 2 allergic diseases, and 7.5 (95% CI, 6.2-9.0) for 3 allergic diseases. High alcohol consumption was associated with high IgE levels but not with high risk of allergic disease. The odds ratio for high versus low IgE levels per 1 alcoholic drink per week higher consumption was 1.12 (95% CI, 1.02-1.23) genetically and 1.01 (95% CI, 1.01-1.02) observationally; for allergic disease, the corresponding odds ratios were 0.96 (95% CI, 0.92-1.00) genetically and 1.00 (95% CI, 1.00-1.00) observationally. Conclusion: High alcohol consumption is associated observationally and geneticallywithhigh IgElevels but not with high risk of allergic disease.	[Lomholt, Frederikke K.; Nielsen, Sune F.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, 54M1,Herlev Ringvej 75, DK-2730 Herlev, Denmark; [Lomholt, Frederikke K.; Nielsen, Sune F.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Lomholt, Frederikke K.; Nielsen, Sune F.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, 54M1,Herlev Ringvej 75, DK-2730 Herlev, Denmark.	Boerge.Nordestgaard@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020	Nordestgaard, Borge/0000-0002-1954-7220	Herlev and Gentofte Hospital, Copenhagen University Hospital	Herlev and Gentofte Hospital, Copenhagen University Hospital	Supported by Herlev and Gentofte Hospital, Copenhagen University Hospital.	Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P106, DOI 10.1016/0091-6749(81)90167-6; Britton A, 2004, AM J EPIDEMIOL, V160, P240, DOI 10.1093/aje/kwh206; Carosso A, 2007, INT ARCH ALLERGY IMM, V142, P230, DOI 10.1159/000097025; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Dominguez-Santalla MJ, 2001, ALCOHOL CLIN EXP RES, V25, P1198, DOI 10.1111/j.1530-0277.2001.tb02336.x; Gonzalez-Quintela A, 1999, ANN ALLERG ASTHMA IM, V83, P61, DOI 10.1016/S1081-1206(10)63514-4; Gonzalez-Quintela A, 2004, ADDICT BIOL, V9, P195, DOI 10.1080/13556210412331292235; GONZALEZQUINTELA A, 1995, CLIN EXP ALLERGY, V25, P756, DOI 10.1111/j.1365-2222.1995.tb00014.x; He L, 2002, J BIOL CHEM, V277, P43572, DOI 10.1074/jbc.M204535200; Helby J, 2015, ANN ONCOL, V26, P1784, DOI 10.1093/annonc/mdv231; Hurley TD, 2012, ALCOHOL RES-CURR REV, V34, P339; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kalmijn S, 2002, AM J EPIDEMIOL, V156, P936, DOI 10.1093/aje/kwf135; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2013, EUR HEART J, V34, P2519, DOI 10.1093/eurheartj/eht081; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; Linneberg A, 2001, CLIN EXP ALLERGY, V31, P1409, DOI 10.1046/j.1365-2222.2001.01178.x; Linneberg A, 2008, ALCOHOL CLIN EXP RES, V32, P553, DOI 10.1111/j.1530-0277.2008.00644.x; Nielsen SF, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5244; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Osman Mustafa, 2007, Prim Care Respir J, V16, P28, DOI 10.3132/pcrj.2007.00006; Panza F, 2009, J ALZHEIMERS DIS, V17, P7, DOI 10.3233/JAD-2009-1009; PASTORELLO EA, 1995, J ALLERGY CLIN IMMUN, V96, P580, DOI 10.1016/S0091-6749(95)70255-5; Pawankar R, 2013, WAO WHITE BOOK ALLER; Platts-Mills TA, 2001, AM J RESP CRIT CAR S, V164, pS1; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Sethi AA, 2004, CLIN CHEM, V50, P443, DOI 10.1373/clinchem.2003.026047; Silverberg JI, 2015, J ALLERGY CLIN IMMUN, V135, P721, DOI 10.1016/j.jaci.2014.11.023; Simpson BM, 2001, CLIN EXP ALLERGY, V31, P391, DOI 10.1046/j.1365-2222.2001.01050.x; Siroux V, 2004, J ALLERGY CLIN IMMUN, V114, P491, DOI 10.1016/j.jaci.2004.05.027; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Starkenburg S, 2001, ALCOHOL CLIN EXP RES, V25, P1221, DOI 10.1097/00000374-200108000-00019; Strachan DP, 2015, CLIN EXP ALLERGY, V45, P126, DOI 10.1111/cea.12349; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Tolstrup JS, 2008, PHARMACOGENOMICS J, V8, P220, DOI 10.1038/sj.tpj.6500471; VIDAL C, 1994, CLIN EXP ALLERGY, V24, P540, DOI 10.1111/j.1365-2222.1994.tb00951.x; Vink NM, 2010, J ALLERGY CLIN IMMUN, V126, P498, DOI 10.1016/j.jaci.2010.06.018; Wium-Andersen MK, 2015, INT J EPIDEMIOL, V44, P526, DOI 10.1093/ije/dyu220; Wolkewitz M, 2007, BRIT J DERMATOL, V156, P693, DOI 10.1111/j.1365-2133.2006.07659.x; Wuthrich B, 1996, INT ARCH ALLERGY IMM, V111, P396, DOI 10.1159/000237398; Zuccala G, 2001, ALCOHOL CLIN EXP RES, V25, P1743, DOI 10.1111/j.1530-0277.2001.tb02185.x	46	16	17	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1404	+		10.1016/j.jaci.2016.05.022	http://dx.doi.org/10.1016/j.jaci.2016.05.022			23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27464961	Bronze			2022-12-18	WOS:000389542700020
J	Steinke, JW; Pochan, SL; James, HR; Platts-Mills, TAE; Commins, SP				Steinke, John W.; Pochan, Shawna L.; James, Hayley R.; Platts-Mills, Thomas A. E.; Commins, Scott P.			Altered metabolic profile in patients with IgE to galactose-alpha-1, 3-galactose following in vivo food challenge	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Steinke, John W.; Pochan, Shawna L.; James, Hayley R.; Platts-Mills, Thomas A. E.] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22903 USA; [Steinke, John W.; Platts-Mills, Thomas A. E.] Univ Virginia Hlth Syst, Carter Immunol Ctr, Charlottesville, VA 22903 USA; [Commins, Scott P.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27514 USA	University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Commins, SP (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27514 USA.	scommins@email.unc.edu		Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI085190, R56AI113095, R01AI020565] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI085190, R01 AI020565, R56 AI113095] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Commins SP, 2014, J ALLERGY CLIN IMMUN, V134, P108, DOI 10.1016/j.jaci.2014.01.024; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Steinke JW, 2015, J ALLERGY CLIN IMMUN, V135, P589, DOI 10.1016/j.jaci.2014.12.1947	5	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1465	1467		10.1016/j.jaci.2016.05.021	http://dx.doi.org/10.1016/j.jaci.2016.05.021			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27448448	Bronze, Green Accepted			2022-12-18	WOS:000389542700034
J	Caucheteux, SM; Jane, HL; Guo, LY; Bhattacharyya, N; Crank, M; Collins, MT; Paul, WE				Caucheteux, Stephan M.; Jane Hu-Li; Guo, Liying; Bhattacharyya, Nisan; Crank, Michelle; Collins, Michael T.; Paul, William E.			IL-1 beta enhances inflammatory T(H)2 differentiation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CD4 T-CELLS; IL-1 ACTS; TH2 CELLS; INDUCTION; GAMMA		[Caucheteux, Stephan M.; Jane Hu-Li; Guo, Liying; Crank, Michelle; Paul, William E.] NIAID, Immunol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Caucheteux, Stephan M.; Jane Hu-Li; Guo, Liying; Crank, Michelle; Paul, William E.] NIH, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA; [Bhattacharyya, Nisan; Collins, Michael T.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Crank, Michelle] NIH, Viral Pathogenesis Lab, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA	Caucheteux, SM (corresponding author), NIAID, Immunol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Caucheteux, SM (corresponding author), NIH, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA.	caucheteuxs@cardiff.ac.uk			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000649] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000493-21] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Khoruts A, 2004, EUR J IMMUNOL, V34, P1085, DOI 10.1002/eji.200324170; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Young N, 2005, J IMMUNOL, V175, P8287, DOI 10.4049/jimmunol.175.12.8287	8	16	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					898	901		10.1016/j.jaci.2016.02.033	http://dx.doi.org/10.1016/j.jaci.2016.02.033			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27212084	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000385496000028
J	Frenz, T; Grabski, E; Buschjager, D; Vaas, LAI; Burgdorf, N; Schmidt, RE; Witte, T; Kalinke, U				Frenz, Theresa; Grabski, Elena; Buschjaeger, Daniela; Vaas, Lea A. I.; Burgdorf, Nina; Schmidt, Reinhold E.; Witte, Torsten; Kalinke, Ulrich			CD4(+) T cells in patients with chronic inflammatory rheumatic disorders show distinct levels of exhaustion	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DISEASE PROGRESSION		[Frenz, Theresa; Grabski, Elena; Buschjaeger, Daniela; Vaas, Lea A. I.; Burgdorf, Nina; Kalinke, Ulrich] TWINCORE, Inst Expt Infect Res, Ctr Expt & Clin Infect Res, Hannover, Germany; [Schmidt, Reinhold E.; Witte, Torsten] Hannover Med Sch, Clin Immunol & Rheumatol, Hannover, Germany; [Vaas, Lea A. I.] Fraunhofer IME SP, Hamburg, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	Kalinke, U (corresponding author), TWINCORE, Inst Expt Infect Res, Ctr Expt & Clin Infect Res, Hannover, Germany.	ulrich.kalinke@twincore.de	Witte, Torsten/B-5783-2016	Kalinke, Ulrich/0000-0003-0503-9564				Bucks CM, 2009, J IMMUNOL, V182, P6697, DOI 10.4049/jimmunol.0800997; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Pauken KE, 2015, J IMMUNOL, V194, P3551, DOI 10.4049/jimmunol.1402262; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740	9	16	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					586	589		10.1016/j.jaci.2016.04.013	http://dx.doi.org/10.1016/j.jaci.2016.04.013			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	27264455	Bronze			2022-12-18	WOS:000380835800032
J	Leitch, CS; Natafji, E; Yu, CJ; Abdul-Ghaffar, S; Madarasingha, N; Venables, ZC; Chu, R; Fitch, PM; Muinonen-Martin, AJ; Campbell, LE; McLean, WHI; Schwarze, J; Howie, SEM; Weller, RB				Leitch, Claire S.; Natafji, Eenass; Yu, Cunjing; Abdul-Ghaffar, Sharizan; Madarasingha, Nayani; Venables, Zoe C.; Chu, Roland; Fitch, Paul M.; Muinonen-Martin, Andrew J.; Campbell, Linda E.; McLean, W. H. Irwin; Schwarze, Juergen; Howie, Sarah E. M.; Weller, Richard B.			Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Filaggrin; atopic dermatitis; Langerhans cells; urocanic acid; costimulatory molecules	UROCANIC ACID; ATOPIC-DERMATITIS; HYPERSENSITIVITY RESPONSE; DENDRITIC CELLS; SKIN-BARRIER; SUPPRESSION; EXPRESSION; INSIGHTS; SUBSETS; CD83	Background: Mutations in the gene encoding filaggrin (FLG), an epidermal structural protein, are the strongest risk factor identified for the development of atopic dermatitis (AD). Up to 50% of patients with moderate-to-severe AD in European populations have FLG-null alleles compared with a general population frequency of 7% to 10%. Objective: This study aimed to investigate the relationship between FLG-null mutations and epidermal antigen-presenting cell (APC) maturation in subjects with and without AD. Additionally, we investigated whether the cis isomer of urocanic acid (UCA), a filaggrin breakdown product, exerts immunomodulatory effects on dendritic cells. Methods: Epidermal APCs from nonlesional skin were assessed by using flow cytometry (n = 27) and confocal microscopy (n = 16). Monocyte-derived dendritic cells from healthy volunteers were used to assess the effects of cis-and trans-UCA on dendritic cell phenotype by using flow cytometry (n = 11). Results: Epidermal APCs from FLG-null subjects had increased CD11c expression. Confocal microscopy confirmed this and additionally revealed an increased number of epidermal CD83(+) Langerhans cells in FLG-null subjects. In vitro differentiation in the presence of cis-UCA significantly reduced costimulatory molecule expression on monocyte-derived dendritic cells from healthy volunteers and increased their ability to induce a regulatory T-cell phenotype in mixed lymphocyte reactions. Conclusions: We show that subjects with FLG-null mutations have more mature Langerhans cells in nonlesional skin irrespective of whether they have AD. We also demonstrate that cis-UCA reduces maturation of dendritic cells and increases their capacity to induce regulatory T cells, suggesting a novel link between filaggrin deficiency and immune dysregulation.	[Leitch, Claire S.; Abdul-Ghaffar, Sharizan; Madarasingha, Nayani; Chu, Roland; Weller, Richard B.] Royal Infirm Edinburgh NHS Trust, Dept Dermatol, Edinburgh, Midlothian, Scotland; [Leitch, Claire S.; Natafji, Eenass; Yu, Cunjing; Madarasingha, Nayani; Venables, Zoe C.; Fitch, Paul M.; Schwarze, Juergen; Howie, Sarah E. M.; Weller, Richard B.] MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Chu, Roland] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland; [Muinonen-Martin, Andrew J.] Southern Gen Hosp, Alan Lyell Ctr Dermatol, Glasgow, Lanark, Scotland; [Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Ctr Dermatol & Genet Med, Dundee, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Dundee	Weller, RB (corresponding author), Univ Edinburgh, Dept Dermatol, Lauriston Bldg,Lauriston Pl, Edinburgh EH3 9HA, Midlothian, Scotland.	r.weller@ed.ac.uk	Schwarze, Jürgen/F-7396-2011; Weller, Richard/B-4954-2010	Weller, Richard/0000-0003-2550-9586; Howie, Sarah/0000-0001-7291-3499	Foundation for Skin Research; British Skin Foundation; University Of Edinburgh; Edinburgh Dermatology Research Fund; Medical Research Council [G0700507]; Commonwealth Scholarship Commission; Wellcome Trust [092530/Z/10/Z, 090066/B/09/Z]; Wellcome Trust Strategic Award [098439/Z/12/Z]; MRC [G0901697, G0700507, G0700314] Funding Source: UKRI; Medical Research Council [G0700314, G0901697] Funding Source: researchfish	Foundation for Skin Research; British Skin Foundation; University Of Edinburgh; Edinburgh Dermatology Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Commonwealth Scholarship Commission; Wellcome Trust(Wellcome Trust); Wellcome Trust Strategic Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Foundation for Skin Research (to R.B.W.), the British Skin Foundation (to C.S.L.), the University Of Edinburgh (to C.S.L.), the Edinburgh Dermatology Research Fund (to C.S.L.), the Medical Research Council (G0700507 to RC.), the Commonwealth Scholarship Commission (to NM.), and the Wellcome Trust (Programme grant 092530/Z/10/Z and Bioresources grant 090066/B/09/Z to W.H.I.M.). The Centre for Dermatology and Genetic Medicine, University of Dundee, is supported by a Wellcome Trust Strategic Award (098439/Z/12/Z to W.H.I.M.).	Angelova-Fischer I, 2011, EXP DERMATOL, V20, P351, DOI 10.1111/j.1600-0625.2011.01259.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bashir SJ, 2001, SKIN RES TECHNOL, V7, P40, DOI 10.1034/j.1600-0846.2001.007001040.x; BerthJones J, 1996, BRIT J DERMATOL, V135, P25, DOI 10.1111/j.1365-2133.1996.tb00706.x; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Chu CC, 2011, SEMIN IMMUNOL, V23, P28, DOI 10.1016/j.smim.2011.01.006; Correale J, 2013, J NEUROIMMUNOL, V261, P134, DOI 10.1016/j.jneuroim.2013.05.014; Dahl MV, 2010, PHOTODERMATOL PHOTO, V26, P303, DOI 10.1111/j.1600-0781.2010.00550.x; Di Gennaro P, 2014, J DERMATOL SCI, V73, P172, DOI 10.1016/j.jdermsci.2013.10.005; Elias PM, 2010, ANN DERMATOL, V22, P245, DOI 10.5021/ad.2010.22.3.245; Gibbs NK, 2008, PHOTOCH PHOTOBIO SCI, V7, P655, DOI 10.1039/b717398a; Gibbs NK, 2011, J INVEST DERMATOL, V131, P14, DOI 10.1038/jid.2010.276; GILMOUR JW, 1993, BRIT J DERMATOL, V129, P28, DOI 10.1111/j.1365-2133.1993.tb03307.x; HARRIOTTSMITH TG, 1988, CLIN EXP IMMUNOL, V72, P174; Kammeyer A, 1997, PHOTOCHEM PHOTOBIOL, V65, P593, DOI 10.1111/j.1751-1097.1997.tb08611.x; Kaneko K, 2011, J INVEST DERMATOL, V131, P1262, DOI 10.1038/jid.2011.37; Kezic S, 2011, ALLERGY, V66, P934, DOI 10.1111/j.1398-9995.2010.02540.x; Laihia JK, 1998, J INVEST DERMATOL, V111, P705, DOI 10.1046/j.1523-1747.1998.00351.x; Leung DYM, 2013, ALLERGOL INT, V62, P151, DOI 10.2332/allergolint.13-RAI-0564; Loffler H, 2004, BRIT J DERMATOL, V151, P746, DOI 10.1111/j.1365-2133.2004.06084.x; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; MEUNIER L, 1994, J INVEST DERMATOL, V103, P775, DOI 10.1111/1523-1747.ep12413014; NORVAL M, 1989, PHOTOCHEM PHOTOBIOL, V49, P633, DOI 10.1111/j.1751-1097.1989.tb08435.x; PINNAGODA J, 1990, CONTACT DERMATITIS, V22, P164, DOI 10.1111/j.1600-0536.1990.tb01553.x; Prechtel AT, 2007, ARCH DERMATOL RES, V299, P59, DOI 10.1007/s00403-007-0743-z; ROMANI N, 1989, J INVEST DERMATOL, V93, P600, DOI 10.1111/1523-1747.ep12319727; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; ROSS JA, 1988, PHOTODERMATOLOGY, V5, P9; Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sergeant A, 2009, J INVEST DERMATOL, V129, P1042, DOI 10.1038/jid.2008.324; SHIBAKI A, 1995, J INVEST DERMATOL, V104, P42, DOI 10.1111/1523-1747.ep12613476; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Williams HC, 1996, BRIT J DERMATOL, V135, P12; Yoshida K, 2014, J ALLERGY CLIN IMMUN, V134, P856, DOI 10.1016/j.jaci.2014.08.001	38	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					482	+		10.1016/j.jaci.2015.11.040	http://dx.doi.org/10.1016/j.jaci.2015.11.040			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	26934939	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000380835800019
J	Berard, A; Sheehy, O; Kurzinger, ML; Juhaeri, J				Berard, Anick; Sheehy, Odile; Kurzinger, Marie-Laure; Juhaeri, Juhaeri			Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Triamcinolone; rhinitis; pregnancy; major congenital malformations; small for gestational age; spontaneous abortions	ALLERGIC RHINITIS; CONGENITAL-MALFORMATIONS; ADMINISTRATIVE DATABASES; FETAL-RAT; ACETONIDE; ASTHMA; IMPACT; QUEBEC; DRUGS; BUDESONIDE	Background: Intranasal corticosteroid use during pregnancy has increased over the past decade. Objective: We aim to estimate the safety of intranasal triamcinolone use during pregnancy, which was introduced for over-the-counter use in October 2013. Methods: We designed a population-based prospective cohort study. From a cohort of 289,723 pregnancies in Montreal, Quebec, Canada, from 1998-2008, intranasal triamcinolone-exposed, other intranasal corticosteroid-exposed, and nonexposed women during the first trimester were studied for major congenital malformations (overall and organ specific) and spontaneous abortions and during the second/third trimesters for small-for-gestational age (SGA) newborns. The first trimester is the time window of interest for malformations and spontaneous abortion (organogenesis), and the second/third trimesters are the time windows of interest for SGA (fetal growth). Logistic regression model-based generalized estimating equations were used. Results: Adjusting for potential confounders, use of intranasal triamcinolone during the first trimester of pregnancy was not significantly associated with the risk of overall congenital malformations (odds ratio [OR], 0.88; 95% CI, 0.60-1.28; 31 exposed cases) compared with nonexposure; however, it was associated with the risk of respiratory defects (OR, 2.71; 95% CI, 1.11-6.64; 5 exposed cases). Pregnancy exposure to intranasal triamcinolone was not significantly associated with the risk of spontaneous abortion (OR, 1.04; 95% CI, 0.76-1.43; 50 exposed cases). No association was found between second-or third-trimester exposure to intranasal triamcinolone and the risk of SGA (OR, 1.06; 95% CI, 0.79-1.43; 50 exposed cases). Conclusions: Maternal exposure to intranasal triamcinolone during pregnancy was not associated with the risk of SGA/spontaneous abortions/overall malformations. However, it has been shown to increase the risk of respiratory system defects. Chance finding cannot be ruled out.	CHU Ste Justine, Res Ctr, Montreal, PQ, Canada; [Berard, Anick] Univ Montreal, Fac Pharm, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada; Sanofi, R&D, Global Pharmacovigilance & Epidemiol, Paris, France; Sanofi, R&D, Global Pharmacovigilance & Epidemiol, Bridgewater, MA USA	Universite de Montreal; Universite de Montreal; Sanofi-Aventis; Sanofi France; Sanofi-Aventis	Berard, A (corresponding author), Univ Montreal, Fac Pharm, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.; Berard, A (corresponding author), CHU Ste Justine, Res Ctr, Res Unit Medicat & Pregnancy, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	anick.berard@umontreal.ca		Juhaeri, Juhaeri/0000-0001-8235-8388	Canadian Institutes of Health Research; Sanofi	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Sanofi(Sanofi-Aventis)	Supported by the Canadian Institutes of Health Research and Sanofi.	Berard A, 2009, J POPUL THER CLIN PH, V16, pE360; Berard A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093870; Blais L, 2013, PHARMACOEPIDEM DR S, V22, P881, DOI 10.1002/pds.3446; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Gervais KJ, 2013, PHARMACOEPIDEM DR S, V22, P155; Gilbert C, 2005, DRUG SAFETY, V28, P707, DOI 10.2165/00002018-200528080-00005; Hamano N, 1998, ALLERGY ASTHMA PROC, V19, P263, DOI 10.2500/108854198778557773; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Jimenez-Solem E, 2013, AM J PSYCHIAT, V170, P299, DOI 10.1176/appi.ajp.2012.11081251; Kallen B, 1999, OBSTET GYNECOL, V93, P392, DOI 10.1016/S0029-7844(98)00454-2; Kallen BAJ, 2003, REPROD TOXICOL, V17, P255, DOI 10.1016/S0890-6238(03)00012-1; Kilic D, 2014, EPILEPSIA, V55, P1714, DOI 10.1111/epi.12758; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Kulaga S, 2009, BJOG-INT J OBSTET GY, V116, P1788, DOI 10.1111/j.1471-0528.2009.02377.x; Laberge AM, 2005, CLIN GENET, V68, P287, DOI 10.1111/j.1399-0004.2005.00497.x; MASSOUD EAS, 1992, PEDIATR PULM, V14, P28, DOI 10.1002/ppul.1950140107; Norjavaara E, 2003, J ALLERGY CLIN IMMUN, V111, P736, DOI 10.1067/mai.2003.1340; Pawankar R, 2007, CURR OPIN ALLERGY CL, V7, P1, DOI 10.1097/ACI.0b013e3280145347; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Rotschild A, 1997, PEDIATR PULM, V23, P76; ROWLAND JM, 1983, TERATOLOGY, V27, P333, DOI 10.1002/tera.1420270307; SCHATZ M, 1988, NEW ENGL REG ALLERGY, V9, P545, DOI 10.2500/108854188778965627; Vilain A, 2008, PHARMACOEPIDEM DR S, V17, P345, DOI 10.1002/pds.1558; Yawn B, 2007, J AM BOARD FAM MED, V20, P289, DOI 10.3122/jabfm.2007.03.060144; Zhao JP, 2015, J POPUL THER CLIN PH, V22, pE198	27	16	17	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					97	+		10.1016/j.jaci.2016.01.021	http://dx.doi.org/10.1016/j.jaci.2016.01.021			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	27045580	Bronze			2022-12-18	WOS:000379659100010
J	Majewska-Szczepanik, M; Askenase, PW; Lobo, FM; Marcinska, K; Wen, L; Szczepanik, M				Majewska-Szczepanik, Monika; Askenase, Philip W.; Lobo, Francis M.; Marcinska, Katarzyna; Wen, Li; Szczepanik, Marian			Epicutaneous immunization with ovalbumin and CpG induces T(H)1/T(H)17 cytokines, which regulate IgE and IgG(2a) production	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Epicutaneous immunization; atopic dermatitis; eosinophil peroxidase; IgE; IgG(2a); Toll-like receptor 9; T(H)1; T(H)17	ALLERGEN-SPECIFIC IMMUNOTHERAPY; CD4(+) T-CELLS; PROTEIN ANTIGEN; CONTACT SENSITIVITY; TH9 CELLS; ASTHMA; MICE; OLIGODEOXYNUCLEOTIDES; HYPERRESPONSIVENESS; SKIN	Background: Subcutaneous allergen-specific immunotherapy is a standard route for the immunotherapy of allergic diseases. It modulates the course of allergy and can generate long-term remission. However, subcutaneous allergen-specific immunotherapy can also induce anaphylaxis in some patients, and therefore additional routes of administration should be investigated to improve the safety and tolerability of immunotherapy. Objective: We sought to determine whether epicutaneous treatment with antigen in the presence of a Toll-like receptor 9 agonist can suppress TH2-mediated responses in an antigen-specific manner. Methods: Epicutaneous immunization was performed by applying a skin patch soaked with ovalbumin (OVA) plus CpG, and its suppressor activity was determined by using the mouse model of atopic dermatitis. Finally, adoptive cell transfers were implemented to characterize the regulatory cells that are induced by epicutaneous immunization. Results: Epicutaneous immunization with OVA and CpG reduces the production of OVA-specific IgE and increases the synthesis of OVA-specific IgG(2a) antibodies in an antigen-specific manner. Moreover, eosinophil peroxidase activity in the skin and production of IL-4, IL-5, IL-10, and IL-13 are suppressed. The observed reduction of IgE synthesis is transferable with T-cell receptor (TCR) alpha beta(+)CD4(+)CD25(-) cells, whereas IgG(2a) production is dependent on both TCR alpha beta(+) and TCR gamma delta(+) T cells. Further experiments show that the described phenomenon is myeloid differentiation primary response 88, IFN-gamma, and IL-17A dependent. Finally, the results suggest that epicutaneous immunization with OVA and CpG decreases the synthesis of OVA-specific IgE and skin eosinophil peroxidase activity in mice with ongoing skin allergy. Conclusion: Epicutaneous application of protein antigen in the presence of adjuvant could be an attractive needle-free and self-administered immunotherapy for allergic diseases.	[Majewska-Szczepanik, Monika; Marcinska, Katarzyna; Szczepanik, Marian] Jagiellonian Univ, Coll Med, Dept Med Biol, Fac Hlth Sci, Krakow, Poland; [Askenase, Philip W.; Lobo, Francis M.] Yale Univ, Sch Med, Dept Internal Med, Sect Allergy & Clin Immunol, New Haven, CT 06510 USA; [Wen, Li] Yale Univ, Sch Med, Dept Internal Med, Endocrinol Sect, New Haven, CT 06510 USA	Jagiellonian University; Collegium Medicum Jagiellonian University; Yale University; Yale University	Szczepanik, M (corresponding author), Jagiellonian Univ, Coll Med, Dept Med Biol, Ul Kopernika 7, PL-31034 Krakow, Poland.	mmszczep@cyf-kr.edu.pl	Szczepanik, Marian/ABA-7001-2021	Wen, Li/0000-0002-8805-2934	Ministry of Science and Higher Education [N N401 3553 33]; National Science Center [2011/03/B/NZ6/00821, UMO-2012/05/B/NZ6/00997]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK092882, R01DK088181, R01DK100500] Funding Source: NIH RePORTER	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Center(National Science Centre, Poland); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by research grants from the Ministry of Science and Higher Education (N N401 3553 33 to M.S.) and the National Science Center (2011/03/B/NZ6/00821 to M.M.-S. and UMO-2012/05/B/NZ6/00997 to M.S.).	Askenase PW, 2004, TRENDS IMMUNOL, V25, P441, DOI 10.1016/j.it.2004.06.003; Broide DH, 2009, ANNU REV MED, V60, P279, DOI 10.1146/annurev.med.60.041807.123524; Cox L, 2013, CURR ALLERGY ASTHM R, V13, P178, DOI 10.1007/s11882-012-0335-7; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gupta GK, 2010, BIODRUGS, V24, P225, DOI 10.2165/11536140-000000000-00000; Hayashida S, 2011, J DERMATOL SCI, V61, P180, DOI 10.1016/j.jdermsci.2010.10.013; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Herrick CA, 2000, J CLIN INVEST, V105, P765, DOI 10.1172/JCI8624; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Johansen P, 2012, HUM VACC IMMUNOTHER, V8, P1525, DOI 10.4161/hv.21948; Kawase Y, 2003, J INVEST DERMATOL, V121, P502, DOI 10.1046/j.1523-1747.2003.12407.x; Kitagaki K, 2006, CLIN EXP IMMUNOL, V143, P249, DOI 10.1111/j.1365-2249.2005.03003.x; Kootiratrakarn T, 2005, EUR J IMMUNOL, V35, P3277, DOI 10.1002/eji.200526274; Krieg AM, 2012, NUCLEIC ACID THER, V22, P77, DOI 10.1089/nat.2012.0340; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Li W, 2014, CURR PHARM DESIGN, V20, P886, DOI 10.2174/13816128113199990051; Lin JY, 2012, J INVEST DERMATOL, V132, P739, DOI 10.1038/jid.2011.382; LITTLE JR, 1966, BIOCHEMISTRY-US, V5, P3385, DOI 10.1021/bi00875a001; Maloy KJ, 1998, P NATL ACAD SCI USA, V95, P1160, DOI 10.1073/pnas.95.3.1160; Marogna M, 2010, J ALLERGY CLIN IMMUN, V126, P969, DOI 10.1016/j.jaci.2010.08.030; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Nakata A, 2001, INT IMMUNOL, V13, P329, DOI 10.1093/intimm/13.3.329; Ptak W, 2006, INT ARCH ALLERGY IMM, V139, P188, DOI 10.1159/000091164; Ptak W, 2002, INT ARCH ALLERGY IMM, V128, P8, DOI 10.1159/000057998; Ptak W, 2009, J IMMUNOL, V182, P837, DOI 10.4049/jimmunol.182.2.837; Santeliz JV, 2002, J ALLERGY CLIN IMMUN, V109, P455, DOI 10.1067/mai.2002.122156; Schmitt E, 2014, TRENDS IMMUNOL, V35, P61, DOI 10.1016/j.it.2013.10.004; Senti G, 2012, J ALLERGY CLIN IMMUN, V129, P128, DOI 10.1016/j.jaci.2011.08.036; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Szczepanik M, 1998, IMMUNOL INVEST, V27, P1, DOI 10.3109/08820139809070886; Szczepanik M, 2005, IMMUNOLOGY, V115, P42, DOI 10.1111/j.1365-2567.2005.02127.x; van Panhuys N, 2008, TISSUE ANTIGENS, V72, P91, DOI 10.1111/j.1399-0039.2008.01068.x; Wang LF, 1996, J IMMUNOL, V156, P4079; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032	37	16	16	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					262	+		10.1016/j.jaci.2015.11.018	http://dx.doi.org/10.1016/j.jaci.2015.11.018			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	26810716	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000379659100028
J	Martorana, D; Bonatti, F; Alberici, F; Gioffredi, A; Reina, M; Urban, ML; Maritati, F; Adorni, A; Radice, A; Pizzolato, S; Gregorini, G; Jeannin, G; Guida, G; Boita, M; Pesci, A; Moroni, G; Neri, TM; Sinico, RA; Vaglio, A				Martorana, Davide; Bonatti, Francesco; Alberici, Federico; Gioffredi, Andrea; Reina, Michele; Urban, Maria L.; Maritati, Federica; Adorni, Alessia; Radice, Antonella; Pizzolato, Silvia; Gregorini, Gina; Jeannin, Guido; Guida, Giuseppe; Boita, Monica; Pesci, Alberto; Moroni, Gabriella; Neri, Tauro M.; Sinico, Renato A.; Vaglio, Augusto			Fc gamma-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHURG-STRAUSS-SYNDROME; EXPRESSION		[Martorana, Davide; Bonatti, Francesco; Reina, Michele; Adorni, Alessia; Neri, Tauro M.] Univ Hosp Parma, Unit Med Genet, Parma, Italy; [Alberici, Federico; Gioffredi, Andrea; Urban, Maria L.; Maritati, Federica; Vaglio, Augusto] Univ Hosp Parma, Nephrol Unit, Parma, Italy; [Alberici, Federico] Univ Cambridge, Sch Med, Cambridge, England; [Radice, Antonella] San Carlo Borromeo Hosp, Inst Microbiol, Milan, Italy; [Pizzolato, Silvia] San Carlo Borromeo Hosp, Pneumol Unit, Milan, Italy; [Sinico, Renato A.] San Carlo Borromeo Hosp, Clin Immunol Unit, Milan, Italy; [Sinico, Renato A.] San Carlo Borromeo Hosp, Renal Unit, Milan, Italy; [Gregorini, Gina; Jeannin, Guido] Spedali Civil Brescia, Nephrol Unit, I-25125 Brescia, Italy; [Guida, Giuseppe] ASL TO2 Birago di Vische Hosp, Dept Med Sci, Immunol & Allergol Outpatient Clin, Internal Med 2, Turin, Italy; [Guida, Giuseppe] Univ Turin, Turin, Italy; [Boita, Monica] Univ Turin, Dept Med Sci, Turin, Italy; [Boita, Monica] S Giovanni Battista Hosp, Allergy & Clin Immunol, Turin, Italy; [Pesci, Alberto] Univ Milano Bicocca, Pneumol Unit, Milan, Italy; [Moroni, Gabriella] Policlin Hosp, Nephrol Unit, Milan, Italy	University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Cambridge; San Carlo Borromeo Hospital; San Carlo Borromeo Hospital; San Carlo Borromeo Hospital; San Carlo Borromeo Hospital; Hospital Spedali Civili Brescia; University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Milano-Bicocca	Vaglio, A (corresponding author), Univ Hosp Parma, Nephrol Unit, Parma, Italy.	augusto.vaglio@virgilio.it	Guida, Giuseppe/AAD-2118-2021; Guida, Giuseppe/B-9713-2008; Maritati, Federica/AFV-5907-2022; Bonatti, Francesco/K-6362-2016; Martorana, Davide/K-6374-2016; Alberici, Federico/AAC-5289-2022; Moroni, Gabriella/J-8183-2015; Vaglio, Augusto/AHE-8117-2022; radice, antonella/M-4279-2018	Guida, Giuseppe/0000-0003-3876-8587; Bonatti, Francesco/0000-0002-5067-5423; Martorana, Davide/0000-0002-7572-7031; Alberici, Federico/0000-0002-1686-5709; Moroni, Gabriella/0000-0003-4955-6061; Vaglio, Augusto/0000-0002-3814-9172; radice, antonella/0000-0002-3886-8812; Urban, Maria Letizia/0000-0003-1334-9538; Adorni, Alessia/0000-0001-8258-8132				Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fernandez Jimenez N, 2011, PLOS ONE, V6; GINA NHLBI, 2009, 3 NHLBI GINA NIH; Haas M, 2004, KIDNEY INT, V65, P2145, DOI 10.1111/j.1523-1755.2004.00632.x; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; McKinney C, 2012, HUM MOL GENET, V21, P2370, DOI 10.1093/hmg/dds039; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Sinico RA, 2005, ARTHRITIS RHEUM, V52, P2926, DOI 10.1002/art.21250; Vaglio A, 2013, ALLERGY, V68, P261, DOI 10.1111/all.12088; Vaglio A, 2007, ARTHRITIS RHEUM-US, V56, P3159, DOI 10.1002/art.22834; Vaglio A, 2012, ANN RHEUM DIS, V71, P390, DOI 10.1136/ard.2011.155382; Wieczorek S, 2008, ARTHRITIS RHEUM-US, V58, P1839, DOI 10.1002/art.23496; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413	15	16	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1597	+		10.1016/j.jaci.2015.09.053	http://dx.doi.org/10.1016/j.jaci.2015.09.053			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	26684293	Bronze			2022-12-18	WOS:000376180200039
J	Huang, WS; Morales, JL; Gazivoda, VP; August, A				Huang, Weishan; Morales, J. Luis; Gazivoda, Victor P.; August, Avery			Nonreceptor tyrosine kinases ITK and BTK negatively regulate mast cell proinflammatory responses to lipopolysaccharide	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Tec; lipopolysaccharide; mast cell; septic hypothermia; TNF-alpha; NF-kappa B; MAPKs; PI3K/Akt	TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; TNF-ALPHA; PHOSPHATIDYLINOSITOL 3-KINASE; T-CELLS; CYTOKINE; PROTEIN; PHOSPHORYLATION; DEGRANULATION; TRANSCRIPTION	Background: Mast cells are indispensable for LPS-induced septic hypothermia, in which TNF-alpha plays an essential role to initiate septic responses. ITK and BTK regulate mast cell responses to allergens, but their roles in mast cell responses in LPS-induced sepsis are unclear. Objective: We sought to investigate the roles of ITK and BTK in mast cell responses during LPS-induced septic inflammation. Methods: Mice (genetically modified or bone marrow-derived mast cell-reconstituted Sash) were given LPS to induce septic hypothermia in the presence or absence of indicated inhibitors. Flow cytometry was used to determine LPS-induced cell influx and TNF-alpha production in peritoneal cells. Microarray was used for genomewide gene expression analysis on bone marrow-derived mast cells. Quantitative PCR and multiplex were used to determine transcribed and secreted proinflammatory cytokines. Microscopy and Western blotting were used to determine activation of signal transduction pathways. Results: The absence of ITK and BTK leads to exacerbation of LPS-induced septic hypothermia and neutrophil influx. Itk(-/-)Btk(-/-) mast cells exhibit hyperactive preformed and LPS-induced TNF-alpha production, and lead to more severe LPS-induced septic hypothermia when reconstituted into mast cell-deficient Sash mice. LPS-induced nuclear factor kappa B, Akt, and p38 activation is enhanced in Itk(-/-)Btk(-/-) mast cells, and blockage of phosphatidylinositol-4,5-bisphosphate 3-kinase, Akt, or p38 downstream mitogen-activated protein kinase interacting serine/threonine kinase 1 activation significantly suppresses TNF-alpha hyperproduction and attenuates septic hypothermia. Conclusions: ITK and BTK regulate thermal homeostasis during septic response through mast cell function in mice. They share regulatory function downstream of Toll-like receptor 4/LPS in mast cells, through regulating the activation of canonical nuclear factor kappa B, phosphatidylinositol-4,5-bisphosphate 3-kinase/Akt, and p38 signaling pathways.	[Huang, Weishan; Gazivoda, Victor P.; August, Avery] Cornell Univ, Dept Microbiol & Immunol, VMC 5171, Ithaca, NY 14853 USA; [Morales, J. Luis] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	August, A (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, VMC 5171, Ithaca, NY 14853 USA.	averyaugust@cornell.edu	; Huang, Weishan/J-3127-2014	Gazivoda, Victor/0000-0002-2923-6573; Huang, Weishan/0000-0002-1330-1131	National Institutes of Health [AI051626, AI065566, AI073955]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065566, R01AI051626, R56AI065566, R01AI073955, R56AI073955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (grant nos. AI051626, AI065566, and AI073955 to A.A.).	Arons MM, 1999, CRIT CARE MED, V27, P699, DOI 10.1097/00003246-199904000-00020; Avila M, 2012, INNATE IMMUN-LONDON, V18, P648, DOI 10.1177/1753425911435265; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; CLEMMER TP, 1992, CRIT CARE MED, V20, P1395, DOI 10.1097/00003246-199210000-00006; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Fairchild KD, 2009, AM J PHYSIOL-REG I, V297, pR1019, DOI 10.1152/ajpregu.00132.2009; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fruman DA, 2004, CURR OPIN IMMUNOL, V16, P314, DOI 10.1016/j.coi.2004.03.014; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hendriks RW, 2011, NAT CHEM BIOL, V7, P4, DOI 10.1038/nchembio.502; Hochdoerfer T, 2013, CELL SIGNAL, V25, P1339, DOI 10.1016/j.cellsig.2013.02.022; Hochdorfer T, 2011, CELL SIGNAL, V23, P866, DOI 10.1016/j.cellsig.2011.01.012; Huang WS, 2013, J IMMUNOL, V190, P2490, DOI 10.4049/jimmunol.1202988; Iyer AS, 2008, J IMMUNOL, V180, P7869, DOI 10.4049/jimmunol.180.12.7869; Iyer AS, 2011, J BIOL CHEM, V286, P9503, DOI 10.1074/jbc.M110.165613; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; KAWAKAMI Y, 1995, J IMMUNOL, V155, P3556; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Keck S, 2011, J IMMUNOL, V186, P5478, DOI 10.4049/jimmunol.1000458; KLUGER MJ, 1978, J PHYSIOL-LONDON, V282, P243, DOI 10.1113/jphysiol.1978.sp012460; Kluger MJ, 1996, INFECT DIS CLIN N AM, V10, P1, DOI 10.1016/S0891-5520(05)70282-8; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lee NA, 1997, J IMMUNOL, V158, P1332; Lu YL, 1998, J IMMUNOL, V161, P5404; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Marron TU, 2012, J ALLERGY CLIN IMMUN, V129, P184, DOI 10.1016/j.jaci.2011.10.009; Masuda A, 2002, J IMMUNOL, V169, P3801, DOI 10.4049/jimmunol.169.7.3801; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; Nautiyal KM, 2009, AM J PHYSIOL-REG I, V296, pR595, DOI 10.1152/ajpregu.90888.2008; Nigo YI, 2006, P NATL ACAD SCI USA, V103, P2286, DOI 10.1073/pnas.0510685103; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Radinger M, 2010, CURR PROTOC IMMUNOL, V90; Sahu N, 2009, CURR TOP MED CHEM, V9, P690, DOI 10.2174/156802609789044443; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Schmidt U, 2009, EUR J IMMUNOL, V39, P3228, DOI 10.1002/eji.200838839; Seeley EJ, 2011, J LEUKOCYTE BIOL, V90, P591, DOI 10.1189/jlb.0910531; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Song C, 2012, SCAND J IMMUNOL, V75, P266, DOI 10.1111/j.1365-3083.2011.02660.x; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Varadaradjalou S, 2003, EUR J IMMUNOL, V33, P899, DOI 10.1002/eji.200323830; Vargas L, 2013, SCAND J IMMUNOL, V78, P130, DOI 10.1111/sji.12069; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Zorn CN, 2009, CELL SIGNAL, V21, P79, DOI 10.1016/j.cellsig.2008.09.010	59	16	17	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2016	137	4					1197	1205		10.1016/j.jaci.2015.08.056	http://dx.doi.org/10.1016/j.jaci.2015.08.056			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DI2TG	26581914	Green Accepted, Bronze			2022-12-18	WOS:000373351200027
J	Butler, MG; Zhou, EH; Zhang, F; Wu, YT; Wu, AC; Levenson, MS; Wu, PS; Seymour, S; Toh, S; Iyer, A; Iyasu, S; Baker, MA				Butler, Melissa G.; Zhou, Esther H.; Zhang, Fang; Wu, Yu-te; Wu, Ann Chen; Levenson, Mark S.; Wu, Pingsheng; Seymour, Sally; Toh, Sengwee; Iyer, Aarthi; Iyasu, Solomon; Baker, Meghan A.			Changing patterns of asthma medication use related to US Food and Drug Administration long-acting beta(2)-agonist regulation from 2005-2011	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Long-acting beta(2)-agonist; asthma; US Food and Drug Administration; medication use; drug safety	INTERRUPTED TIME-SERIES; PERSISTENT ASTHMA; SALMETEROL; CHILDREN; THERAPY; EXACERBATIONS; MONOTHERAPY; CARE	Background: Safety concerns associated with long-acting beta(2)-agonists (LABAs) have led to many US Food and Drug Administration (FDA) regulatory activities for this class of drugs. Little is known about the effect of these regulatory activities on use of LABA-containing agents or other asthma medications. Methods: We created rolling cohorts of pediatric and adult asthmatic patients in the Mini-Sentinel Distributed Database between January 2005 and June 2011. The proportions of asthmatic patients using LABA-containing products, inhaled corticosteroids (ICSs), leukotriene modifiers, short-acting b2-agonists, oral corticosteroids, other bronchodilators, and no medications were measured on a monthly basis, and the changes were evaluated by using interrupted time series with segmented regression analysis. Results: When the 2005 regulatory activity was announced, there were statistically significant decreases in the use of fixed-dose ICS-LABA agents in children (-0.98 percentage points) and adults (-1.24 percentage points). Increased use of ICSs and leukotriene modifiers was observed just after the regulatory activities were announced in both children and adults. Although of smaller magnitude, continued favorable changes in the use of LABA agents were observed after the 2010 FDA regulatory activity. Conclusion: The 2005 and 2010 FDA regulatory activities might have contributed to reduced use of LABA agents, as intended; however, their effect, independent of other factors, cannot be determined. Use of other classes of asthma medications was similarly affected.	[Butler, Melissa G.] Kaiser Permanente Georgia, Ctr Clin & Outcomes Res, Atlanta, GA USA; [Butler, Melissa G.] Evidence Space, Hamilton, Bermuda; [Zhou, Esther H.; Iyasu, Solomon] US FDA, Off Pharmacovigilance & Epidemiol, Off Surveillance & Epidemiol, Silver Spring, MD USA; [Wu, Yu-te; Levenson, Mark S.] US FDA, Off Biostat, Silver Spring, MD USA; [Seymour, Sally] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Zhang, Fang; Wu, Ann Chen; Toh, Sengwee; Iyer, Aarthi; Baker, Meghan A.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Zhang, Fang; Wu, Ann Chen; Toh, Sengwee; Iyer, Aarthi; Baker, Meghan A.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Wu, Pingsheng] Vanderbilt Univ, Sch Med, Dept Med & Biostat, Nashville, TN 37212 USA; [Baker, Meghan A.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA	Kaiser Permanente; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Vanderbilt University; Harvard University; Brigham & Women's Hospital	Baker, MA (corresponding author), Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	meghan_baker@harvardpilgrim.org	Wu, Ann/AAY-4293-2020; Toh, Sengwee/D-7567-2017; Zhang, Fang/HHN-2153-2022	Wu, Ann/0000-0003-0599-9063; Toh, Sengwee/0000-0002-5160-0810; Wu, Pingsheng/0000-0003-4947-3063	US Food and Drug Administration (FDA) through the Department of Health and Human Resources [HHSF223200910006I]; FDA; Sentinel System; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD085993] Funding Source: NIH RePORTER	US Food and Drug Administration (FDA) through the Department of Health and Human Resources; FDA(United States Department of Health & Human Services); Sentinel System; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Mini-Sentinel is funded by the US Food and Drug Administration (FDA) through the Department of Health and Human Resources ( contract HHSF223200910006I). Mini-Sentinel is a pilot project sponsored by the FDA to inform and facilitate development of a fully operational active surveillance system, the Sentinel System, for monitoring the safety of FDA-regulated medical products. Mini-Sentinel is one piece of the Sentinel Initiative, a multifaceted effort by the FDA to develop a national electronic system that will complement existing methods of safety surveillance. Mini-Sentinel Collaborators include Data and Academic Partners that provide access to health care data and ongoing scientific, technical, methodological, and organizational expertise.	Behrman RE, 2011, NEW ENGL J MED, V364, P498, DOI 10.1056/NEJMp1014427; Blackwell Debra L, 2014, Vital Health Stat 10, P1; Blanchette CM, 2009, CLIN THER, V31, P2574, DOI 10.1016/j.clinthera.2009.11.007; Bloom B, 2013, VITAL HLTH STAT, V10, P2013; Bobbitt L., 1990, P BUS EC STAT SECT A, P449; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; Curtis LH, 2012, PHARMACOEPIDEM DR S, V21, P23, DOI 10.1002/pds.2336; DiSantostefano RL, 2013, J ASTHMA, V50, P776, DOI 10.3109/02770903.2013.803116; FDA, 2008, ADV DISK ADV HFA BRO; FDA, 2005, INF HEALTHC PROF SAL; Food and Drug Administration, 2010, FDA DRUG SAF COMM NE; Korelitz JJ, 2008, ANN ALLERG ASTHMA IM, V100, P222, DOI 10.1016/S1081-1206(10)60446-2; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70; McMahon AW, 2011, PEDIATRICS, V128, pE1147, DOI 10.1542/peds.2010-1720; National Heart Lung and Blood Institute. National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; National Heart Lung Blood Institute, 1997, 2 NAT HEART LUNG BLO; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Platt R, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2343; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Shadish WR, 2002, EXPT QUASIEXPERIMENT; The Food and Drug Administration, 2008, EARL COMM ONG SAF RE; Thomas M, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-29; Turner S, 2009, ARCH DIS CHILD, V94, P16, DOI 10.1136/adc.2008.140681; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wasilevich EA, 2011, AM J MANAG CARE, V17, pE91; Zhang F, 2011, J CLIN EPIDEMIOL, V64, P1252, DOI 10.1016/j.jclinepi.2011.02.007; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	29	16	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					710	717		10.1016/j.jaci.2015.09.057	http://dx.doi.org/10.1016/j.jaci.2015.09.057			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26725997	Green Accepted, Bronze			2022-12-18	WOS:000371897500012
J	Heederik, D; Jacobs, J; Samadi, S; van Rooy, F; Portengen, L; Houba, R				Heederik, Dick; Jacobs, Jose; Samadi, Sadegh; van Rooy, Frits; Portengen, Lutzen; Houba, Remko			Exposure-response analyses for platinum salt-exposed workers and sensitization: A retrospective cohort study among newly exposed workers using routinely collected surveillance data	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Sensitization; chloroplatinate salts; exposure response; retrospective cohort study	REFINERY WORKERS; SKIN PRICK; ALLERGY; INDUSTRY; SMOKING; ASTHMA; DUST	Background: Chloroplatinate salts are well-known respiratory sensitizing agents leading to work-related sensitization and allergies in the work environment. No quantitative exposure-response relation has been described for chloroplatinate salts. Objective: We sought to evaluate the quantitative exposure-response relation between occupational chloroplatinate exposure and sensitization. Methods: A retrospective cohort study was conducted using routinely collected health surveillance data and chloroplatinate exposure data. Workers who newly entered work between January 1, 2000, and December 31, 2010, were included, and the relation between measured chloroplatinate exposure and sensitization (as determined by skin prick test responses) was analyzed in more than 1000 refinery workers from 5 refineries for whom a total of more than 1700 personal exposure measurements were available. Results: A clear exposure-response relation was observed, most strongly for more recent platinum salt exposure. Average or cumulative exposure over the follow-up period was less strongly associated with sensitization risk. The exposure-response relation was modified by smoking and atopy. Conclusions: Indications exist that recent exposure explains the risk of platinum salt sensitization most strongly. The precision of the estimate of the exposure-response relation derived from this data set appears superior to previous epidemiologic studies conducted on platinum salt sensitization and as a result, might have possible utility for the development of preventive strategies.	[Heederik, Dick; Jacobs, Jose; Samadi, Sadegh; van Rooy, Frits; Portengen, Lutzen; Houba, Remko] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [van Rooy, Frits] Expert Ctr Chem Risk Management, Arbo Unie, Utrecht, Netherlands; [Houba, Remko] Netherlands Expert Ctr Occupat Resp Dis, Utrecht, Netherlands; [Samadi, Sadegh] Arak Univ Med Sci, Hlth Fac, Dept Occupat Hlth, Arak, Iran	Utrecht University	Heederik, D (corresponding author), Inst Risk Assessment Sci, Div Environm Epidemiol, POB 80178, NL-3508 TD Utrecht, Netherlands.	d.heederik@uu.nl	Samadi, Sadegh/D-3530-2016	Samadi, Sadegh/0000-0002-4834-9418; Heederik, Dick/0000-0002-4550-1437	International Platinum Group Metals Association (IPA); Arbo Unie	International Platinum Group Metals Association (IPA); Arbo Unie	D. Heederik, J. Jacobs, L. Portengen, and R. Houba have received research support from International Platinum Group Metals Association (IPA). F. van Rooy has received research support from Arbo Unie. S. Samadi declares no relevant conflicts of interest.	American Conference of Governmental Industrial Hygienists, 1991, AM C GOV IND HYG; BAKER DB, 1990, AM J IND MED, V18, P653, DOI 10.1002/ajim.4700180604; BERNSTEIN IL, 2006, ASTHMA WORKPLACE; BOLMAUDORFF U, 1992, INT ARCH OCC ENV HEA, V64, P257, DOI 10.1007/BF00378283; BROOKS SM, 1990, CHEST, V97, P1401, DOI 10.1378/chest.97.6.1401; CALVERLEY AE, 1995, OCCUP ENVIRON MED, V52, P661, DOI 10.1136/oem.52.10.661; CLEARE MJ, 1976, CLIN ALLERGY, V6, P183, DOI 10.1111/j.1365-2222.1976.tb01897.x; Cristaudo A, 2005, ALLERGY, V60, P159, DOI 10.1111/j.1398-9995.2004.00521.x; Dutch Expert Committee on Occupational Standards, 2008, 200812OSH DUTCH EXP; Eisen EA, 2004, OCCUP ENVIRON MED, V61, P854, DOI 10.1136/oem.2004.013136; Heederik D, 2012, EUR RESPIR REV, V21, P112, DOI 10.1183/09059180.00005111; Heederik D, 2010, PROG INFLAMM RES SER, P185, DOI 10.1007/978-3-7643-8556-9_11; Houba R, 1998, AM J RESP CRIT CARE, V158, P1499, DOI 10.1164/ajrccm.158.5.9803055; HSL, 1996, PLAT MET SOL PLAT CO; HUNTER D, 1945, BRIT J IND MED, V2, P92; International Platinum Association, 2002, GUID MED SU IN PRESS; Karasek S. R., 1911, REPORT ILLINOIS STAT, P97; Linnett PJ, 1999, OCCUP ENVIRON MED, V56, P191, DOI 10.1136/oem.56.3.191; Lotz A, 2013, GMS MIBE, V9; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; MERGET R, 1988, CLIN ALLERGY, V18, P569, DOI 10.1111/j.1365-2222.1988.tb02908.x; MERGET R, 1991, BRIT J IND MED, V48, P830; Merget R, 2000, J ALLERGY CLIN IMMUN, V105, P364, DOI 10.1016/S0091-6749(00)90089-7; NIEUWENHUIJSEN MJ, 1995, ANN OCCUP HYG, V39, P193, DOI 10.1016/0003-4878(94)00107-C; NIOSH, 1994, NIOSH MAN AN METH NM, P94; OSHA, 1991, MET MET PART WORKPL; OSHA, 1985, PLAT WORKPL ATM; Pepys J, 1972, Clin Allergy, V2, P391, DOI 10.1111/j.1365-2222.1972.tb01303.x; ROBERTS AE, 1951, AMA ARCH IND HYG OCC, V4, P549; RUFF F, 1979, REV FR MAL RESPIR, V7, P206; Thurston SW, 2002, EPIDEMIOLOGY, V13, P685, DOI 10.1097/00001648-200211000-00013; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; Tovey ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069900; VENABLES KM, 1989, BMJ-BRIT MED J, V299, P939, DOI 10.1136/bmj.299.6705.939; Wiseman CLS, 2009, SCI TOTAL ENVIRON, V407, P2493, DOI 10.1016/j.scitotenv.2008.12.057	35	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					922	929		10.1016/j.jaci.2015.07.030	http://dx.doi.org/10.1016/j.jaci.2015.07.030			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26371840	Bronze, Green Published			2022-12-18	WOS:000371897500037
J	Hallstrand, TS; Lai, Y; Hooper, KA; Oslund, RC; Altemeier, WA; Matute-Bello, G; Gelb, MH				Hallstrand, Teal S.; Lai, Ying; Hooper, Kathryn A.; Oslund, Rob C.; Altemeier, William A.; Matute-Bello, Gustavo; Gelb, Michael H.			Endogenous secreted phospholipase A(2) group X regulates cysteinyl leukotrienes synthesis by human eosinophils	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophil; leukotriene; phospholipase A(2); mitogen-activated kinase; asthma; allergy	ARACHIDONIC-ACID RELEASE; GROUP-V; SURFACTANT DYSFUNCTION; AIRWAY INFLAMMATION; POTENT INHIBITORS; PERIPHERAL-BLOOD; MOUSE MODELS; GROUP-IIA; IN-VITRO; GROUP-IV	Background: Phospholipase A(2)s mediate the rate-limiting step in the formation of eicosanoids such as cysteinyl leukotrienes (CysLTs). Group IVA cytosolic PLA(2)alpha (cPLA(2)alpha) is thought to be the dominant PLA(2) in eosinophils; however, eosinophils also have secreted PLA2 (sPLA(2)) activity that has not been fully defined. Objectives: To examine the expression of sPLA(2) group X (sPLA(2)-X) in eosinophils, the participation of sPLA(2)-X in the formation of CysLTs, and the mechanism by which sPLA(2)-X initiates the synthesis of CysLTs in eosinophils. Methods: Peripheral blood eosinophils were obtained from volunteers with asthma and/or allergy. A rabbit polyclonal anti-sPLA(2)-X antibody identified sPLA(2)-X by Western blot. We used confocal microscopy to colocalize the sPLA(2)-X to intracellular structures. Aninhibitor of sPLA(2)-X (ROC-0929) that does not inhibit other mammalian sPLA(2)s, as well as inhibitors of the mitogen-activated kinase cascade (MAPK) and cPLA(2)alpha, was used to examine the mechanism of N-formyl-methionyl-leucyl-phenylalanine (fMLP)-mediated formation of CysLT. Results: Eosinophils express the mammalian sPLA(2)-X gene (PLA2G10). The sPLA(2)-X protein is located in the endoplasmic reticulum, golgi, and granules of eosinophils and moves to the granules and lipid bodies during fMLP-mediated activation. Selective sPLA2-X inhibition attenuated the fMLP-mediated release of arachidonic acid and CysLT formation by eosinophils. Inhibitors of p38, extracellular-signal-regulated kinases 1/2 (p44/42 MAPK), c-Jun N-terminal kinase, and cPLA(2)alpha also attenuated the fMLP-mediated formation of CysLT. The sPLA(2)-X inhibitor reduced the phosphorylation of p38 and extracellular-signal-regulated kinases 1/2 (p44/42 MAPK) as well as cPLA(2)a during cellular activation, indicating that sPLA(2)-X is involved in activating the MAPK cascade leading to the formation of CysLT via cPLA(2)alpha. We further demonstrate that sPLA(2)-X is activated before secretion from the cell during activation. Short-term priming with IL-13 and TNF/IL-1 beta increased the expression of PLA2G10 by eosinophils. Conclusions: These results demonstrate that sPLA(2)-X plays a significant role in the formation of CysLTs by human eosinophils. The predominant role of the enzyme is the regulation of MAPK activation that leads to the phosphorylation of cPLA(2)alpha. The sPLA(2)-X protein is regulated by proteolytic cleavage, suggesting that an inflammatory environment may promote the formation of CysLTs through this mechanism. These results have important implications for the treatment of eosinophilic disorders such as asthma.	[Hallstrand, Teal S.; Lai, Ying; Altemeier, William A.; Matute-Bello, Gustavo] Univ Washington, Div Pulm & Crit Care, Dept Med, Seattle, WA 98195 USA; [Hooper, Kathryn A.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Oslund, Rob C.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hallstrand, TS (corresponding author), Univ Washington, Div Pulm & Crit Care, Box 356522, Seattle, WA 98195 USA.	tealh@uw.edu		Altemeier, William/0000-0001-8860-405X; gelb, michael/0000-0001-7000-5219; Hallstrand, Teal/0000-0002-5059-6872	National Institutes of Health [R21HL111845, R37HL036235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235, R21HL111845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (grant no. R21HL111845 to T.S.H. and grant no. R37HL036235 to M.H.G.).	Ackerman SJ, 2003, CHEST, V123, p355S, DOI 10.1378/chest.123.3_suppl.355S; Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Becker GL, 2010, J MED CHEM, V53, P1067, DOI 10.1021/jm9012455; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blom M, 1998, BLOOD, V91, P3037; Calabrese C, 2000, ALLERGY, V55, P27, DOI 10.1034/j.1398-9995.2000.00504.x; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Curfs DMJ, 2008, J BIOL CHEM, V283, P21640, DOI 10.1074/jbc.M710584200; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gauvreau GM, 2001, AM J RESP CRIT CARE, V164, P1495, DOI 10.1164/ajrccm.164.8.2102033; Geijsen N, 2000, FEBS LETT, V471, P83, DOI 10.1016/S0014-5793(00)01373-9; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; GRIFFIN M, 1983, NEW ENGL J MED, V308, P436, DOI 10.1056/NEJM198302243080807; Hallstrand TS, 2011, CLIN EXP ALLERGY, V41, P801, DOI 10.1111/j.1365-2222.2010.03676.x; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hallstrand TS, 2013, AM J RESP CRIT CARE, V188, P42, DOI 10.1164/rccm.201301-0084OC; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P586, DOI 10.1016/j.jaci.2005.04.035; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2011, J BIOL CHEM, V286, P28049, DOI 10.1074/jbc.M111.235812; Horie S, 1997, INTERNAL MED, V36, P179, DOI 10.2169/internalmedicine.36.179; Jemel I, 2011, J BIOL CHEM, V286, P36509, DOI 10.1074/jbc.M111.268540; Johansson MW, 2008, J IMMUNOL, V180, P7622, DOI 10.4049/jimmunol.180.11.7622; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; Komiyama T, 2009, J BIOL CHEM, V284, P15729, DOI 10.1074/jbc.M901540200; Kwatia MA, 2007, J ALLERGY CLIN IMMUN, V119, P838, DOI 10.1016/j.jaci.2006.12.614; Lai Y, 2010, J BIOL CHEM, V285, P41491, DOI 10.1074/jbc.M110.153338; Lamothe J, 2008, CLIN IMMUNOL, V127, pS89, DOI 10.1016/j.clim.2008.03.250; Liu LY, 2006, ALLERGY, V61, P589, DOI 10.1111/j.1398-9995.2006.01060.x; Liu LY, 2003, J ALLERGY CLIN IMMUN, V112, P556, DOI 10.1067/mai.2003.1700; Luttmann W, 1999, AM J RESP CELL MOL, V20, P474, DOI 10.1165/ajrcmb.20.3.3326; Malm-Erjefalt M, 2001, AM J RESP CELL MOL, V24, P352, DOI 10.1165/ajrcmb.24.3.4357; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Munoz NM, 2006, J IMMUNOL, V177, P574, DOI 10.4049/jimmunol.177.1.574; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; Myou S, 2003, J IMMUNOL, V171, P4399, DOI 10.4049/jimmunol.171.8.4399; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Pavord ID, 1999, AM J RESP CRIT CARE, V160, P1905, DOI 10.1164/ajrccm.160.6.9903114; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Peinado JR, 2004, BIOCHEM BIOPH RES CO, V321, P601, DOI 10.1016/j.bbrc.2004.07.012; Romagnoli M, 2002, EUR RESPIR J, V20, P1370, DOI 10.1183/09031936.02.00029202; Rothenberg ME, 1999, AM J RESP CELL MOL, V21, P291, DOI 10.1165/ajrcmb.21.3.f160; Sarac MS, 2004, INFECT IMMUN, V72, P602, DOI 10.1128/IAI.72.1.602-605.2004; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; SEDGWICK JB, 1995, J ALLERGY CLIN IMMUN, V96, P375, DOI 10.1016/S0091-6749(95)70057-9; SEDGWICK JB, 1992, J IMMUNOL, V149, P3710; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Seno K, 2001, BIOORG MED CHEM LETT, V11, P587, DOI 10.1016/S0960-894X(01)00003-8; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Stolarski B, 2010, J IMMUNOL, V185, P3472, DOI 10.4049/jimmunol.1000730; Svensson L, 2007, EUR J IMMUNOL, V37, P1966, DOI 10.1002/eji.200636936; Touaibia M, 2007, J MED CHEM, V50, P1618, DOI 10.1021/jm060082n; Triggiani M, 2003, J IMMUNOL, V170, P3279, DOI 10.4049/jimmunol.170.6.3279; Vliagoftis H, 2001, J ALLERGY CLIN IMMUN, V107, P679, DOI 10.1067/mai.2001.114245; WEISS J, 1994, J BIOL CHEM, V269, P26331; Wong CK, 2010, AM J RESP CELL MOL, V43, P305, DOI 10.1165/rcmb.2009-0168OC; Zhu XD, 2001, J IMMUNOL, V167, P461, DOI 10.4049/jimmunol.167.1.461	73	16	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2016	137	1					268	+		10.1016/j.jaci.2015.05.026	http://dx.doi.org/10.1016/j.jaci.2015.05.026			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA3UK	26139511	Green Accepted			2022-12-18	WOS:000367724300018
J	Chaigne, B; Watier, H				Chaigne, Benjamin; Watier, Herve			Monoclonal antibodies in excess: A simple way to avoid immunogenicity in patients?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFLIXIMAB; PHARMACOKINETICS; DISEASE		[Chaigne, Benjamin; Watier, Herve] CHRU Tours, Lab Immunol, Tours, France; [Chaigne, Benjamin; Watier, Herve] Univ Tours, Tours, France; [Watier, Herve] UMR 7292, Tours, France; [Watier, Herve] CNRS, UMR 7292, Tours, France	CHU Tours; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Chaigne, B (corresponding author), CHRU Tours, Lab Immunol, Tours, France.	watier@med.univ-tours.fr	Bonnemaison, Marc/AAD-9243-2021; Chaigne, Benjamin/AAH-8709-2020	Chaigne, Benjamin/0000-0001-5448-7860				Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Dostalek M, 2013, CLIN PHARMACOKINET, V52, P83, DOI 10.1007/s40262-012-0027-4; Ducourau E, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3386; JONKER M, 1987, EUR J IMMUNOL, V17, P1519, DOI 10.1002/eji.1830171022; Somerfield J, 2010, J IMMUNOL, V185, P763, DOI 10.4049/jimmunol.1000422; Ternant D, 2008, THER DRUG MONIT, V30, P523, DOI 10.1097/FTD.0b013e318180e300	7	16	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					814	+		10.1016/j.jaci.2015.03.013	http://dx.doi.org/10.1016/j.jaci.2015.03.013			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	25930194				2022-12-18	WOS:000360913300040
J	Chou, J; Massaad, MJ; Cangemi, B; Bainter, W; Platt, C; Badran, YR; Raphael, BP; Kamin, DS; Goldsmith, JD; Pai, SY; Al-Herz, W; Geha, RS				Chou, Janet; Massaad, Michel J.; Cangemi, Brittney; Bainter, Wayne; Platt, Craig; Badran, Yousef R.; Raphael, Bram P.; Kamin, Daniel S.; Goldsmith, Jeffrey D.; Pai, Sung-Yun; Al-Herz, Waleed; Geha, Raif S.			A novel mutation in ICOS presenting as hypogammaglobulinemia with susceptibility to opportunistic pathogens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COMMON VARIABLE IMMUNODEFICIENCY; DEFICIENCY; CELLS; CD4		[Chou, Janet; Massaad, Michel J.; Cangemi, Brittney; Bainter, Wayne; Platt, Craig; Badran, Yousef R.; Geha, Raif S.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Raphael, Bram P.; Kamin, Daniel S.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Raphael, Bram P.; Kamin, Daniel S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Goldsmith, Jeffrey D.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Goldsmith, Jeffrey D.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Pai, Sung-Yun] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Pai, Sung-Yun] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Al-Herz, Waleed] Kuwait Univ, Fac Med, Dept Pediat, Kuwait, Kuwait	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Kuwait University	Chou, J (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	Raif.Geha@childrens.harvard.edu	Pai, Sung-Yun/AAH-7762-2019	Pai, Sung-Yun/0000-0002-0158-8147	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI076210, R03AI094017] Funding Source: NIH RePORTER; NIAID NIH HHS [P01AI-076210, AI-094017] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hedl M, 2014, IMMUNITY, V40, P734, DOI 10.1016/j.immuni.2014.04.011; JOLLIFF CR, 1982, CLIN CHEM, V28, P126; Limper AH, 1997, J CLIN INVEST, V99, P2110, DOI 10.1172/JCI119384; Mellett M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2127; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Takahashi N, 2009, J IMMUNOL, V182, P5515, DOI 10.4049/jimmunol.0803256; Wang YH, 2008, J BIOL CHEM, V283, P9454, DOI 10.1074/jbc.M707962200; Yong PFK, 2011, ADV IMMUNOL, V111, P47, DOI 10.1016/B978-0-12-385991-4.00002-7; Yong PFK, 2009, IMMUNOL REV, V229, P101, DOI 10.1111/j.1600-065X.2009.00764.x	12	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					794	+		10.1016/j.jaci.2014.12.1940	http://dx.doi.org/10.1016/j.jaci.2014.12.1940			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	25678089	Bronze			2022-12-18	WOS:000360913300032
J	Lane, JP; Stewart, CJ; Cummings, SP; Gennery, AR				Lane, Jonathan P.; Stewart, Christopher J.; Cummings, Stephen P.; Gennery, Andrew R.			Gut microbiome variations during hematopoietic stem cell transplant in severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFECTION		[Lane, Jonathan P.; Gennery, Andrew R.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Stewart, Christopher J.; Cummings, Stephen P.] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Newcastle University - UK; Northumbria University	Lane, JP (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jonathan.lane2@ncl.ac.uk	Stewart, Christopher/M-4615-2017; Cummings, Stephen P/S-8336-2018	Stewart, Christopher/0000-0002-6033-338X; Cummings, Stephen P/0000-0001-5298-2075; Lane, Jonathan/0000-0002-1572-471X	National Institute for Health Research [ACF-2013-01-007] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Berrington JE, 2014, CURR OPIN INFECT DIS, V27, P236, DOI 10.1097/QCO.0000000000000061; Holler E, 2014, BIOL BLOOD MARROW TR, V20, P640, DOI 10.1016/j.bbmt.2014.01.030; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Valles Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004406; van der Burg M, 2011, EUR J PEDIATR, V170, P561, DOI 10.1007/s00431-011-1452-3	9	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2015	135	6					1654	1656		10.1016/j.jaci.2015.01.024	http://dx.doi.org/10.1016/j.jaci.2015.01.024			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CK0ZC	25769913				2022-12-18	WOS:000355933400034
J	Whyatt, RM; Rundle, AG; Perzanowski, MS; Just, AC; Donohue, KM; Calafat, AM; Hoepner, L; Perera, FP; Miller, RL				Whyatt, Robin M.; Rundle, Andrew G.; Perzanowski, Matthew S.; Just, Allan C.; Donohue, Kathleen M.; Calafat, Antonia M.; Hoepner, Lori; Perera, Frederica P.; Miller, Rachel L.			Prenatal phthalate and early childhood bisphenol A exposures increase asthma risk in inner-city children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							URINE		[Whyatt, Robin M.; Rundle, Andrew G.; Perzanowski, Matthew S.; Donohue, Kathleen M.; Hoepner, Lori; Perera, Frederica P.; Miller, Rachel L.] Columbia Univ, Columbia Ctr Childrens Environm Hlth, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Rundle, Andrew G.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Just, Allan C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Donohue, Kathleen M.; Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care, New York, NY USA; [Calafat, Antonia M.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Rheumatol Allergy & Immunol, New York, NY USA	Columbia University; Columbia University; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; Centers for Disease Control & Prevention - USA; Columbia University	Whyatt, RM (corresponding author), Columbia Univ, Columbia Ctr Childrens Environm Hlth, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	rmw5@columbia.edu	Rundle, Andrew G/A-5282-2009; Calafat, Antonia/N-1183-2019; Calafat, Antonia/GOP-1115-2022	Rundle, Andrew G/0000-0003-0211-7707; Calafat, Antonia/0000-0002-9796-7482; Perera, Frederica/0000-0002-1364-9250; Just, Allan/0000-0003-4312-5957	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, RC2ES018784, R01ES013163, P01ES009600, R01ES014393, R01ES008977] Funding Source: NIH RePORTER; NIEHS NIH HHS [RC2 ES018784, P01 ES009600, P01 ES09600, P30ES009089, R01ES13163, R01 ES014393, RC2ES018784, R01 ES013163, P30 ES009089, R01ES014393, R01ES08977] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248; Perera F, 2006, ANN NY ACAD SCI, V1076, P15, DOI 10.1196/annals.1371.018; Whyatt R.M., 2014, ENV HLTH PERSPECT; Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	7	16	16	1	18	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2014	134	5					1195	1197		10.1016/j.jaci.2014.07.027	http://dx.doi.org/10.1016/j.jaci.2014.07.027			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AT4UN	25174861	Green Accepted, Green Submitted			2022-12-18	WOS:000344938900028
J	Ghosh, D; Bernstein, JA				Ghosh, Debajyoti; Bernstein, Jonathan A.			Systemic and localized seminal plasma hypersensitivity patients exhibit divergent immunologic characteristics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							POLLEN MAJOR ALLERGEN; MONOCLONAL-ANTIBODIES; EPITOPES; RECEPTOR; JUN-A-1; JUN		[Ghosh, Debajyoti; Bernstein, Jonathan A.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Immunol Allergy Sect, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati	Ghosh, D (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Immunol Allergy Sect, Cincinnati, OH 45220 USA.	Jonathan.Bernstein@uc.edu		Bernstein, Jonathan/0000-0002-3476-1196				BERNSTEIN IL, 1981, ANN INTERN MED, V94, P459, DOI 10.7326/0003-4819-94-4-459; Bernstein JA, 1997, ANN ALLERG ASTHMA IM, V78, P54, DOI 10.1016/S1081-1206(10)63372-8; BERNSTEIN JA, 1993, OBSTET GYNECOL, V82, P667; BOSE R, 1986, IMMUNOLOGY, V59, P309; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Dibbern DA, 2003, J IMMUNOL METHODS, V274, P37, DOI 10.1016/S0022-1759(02)00369-1; ESTES DM, 1990, VET IMMUNOL IMMUNOP, V25, P61, DOI 10.1016/0165-2427(90)90110-E; Fuller S.A., 2001, CURR PROTOC MOL BIOL; HESTERBERG LK, 1981, J BIOL CHEM, V256, P9724; HINO K, 1995, J BIOCHEM-TOKYO, V117, P289, DOI 10.1093/jb/117.2.289; Jeon SK, 2008, J INVEST DERMATOL, V128, P1930, DOI 10.1038/jid.2008.13; KROON S, 1980, ACTA DERM-VENEREOL, V60, P436; KUNTZ ID, 1971, J AM CHEM SOC, V93, P516, DOI 10.1021/ja00731a037; Larsen AK, 2008, TOXICOL APPL PHARM, V230, P276, DOI 10.1016/j.taap.2008.02.019; Ludman B G, 1999, J Obstet Gynecol Neonatal Nurs, V28, P359, DOI 10.1111/j.1552-6909.1999.tb02003.x; Midoro-Horiuti T, 1999, J ALLERGY CLIN IMMUN, V104, P613, DOI 10.1016/S0091-6749(99)70332-5; Midoro-Horiuti T, 1999, J ALLERGY CLIN IMMUN, V104, P608, DOI 10.1016/S0091-6749(99)70331-3; Midoro-Horiuti T, 2003, MOL IMMUNOL, V40, P555, DOI 10.1016/S0161-5890(03)00168-8; Narita S, 2007, ENVIRON HEALTH PERSP, V115, P48, DOI 10.1289/ehp.9378; Pilch B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r40; Sublett JW, 2011, ALLERGY ASTHMA PROC, V32, P467, DOI 10.2500/aap.2011.32.3495; Varshney S, 2007, MOL IMMUNOL, V44, P2781, DOI 10.1016/j.molimm.2005.12.001; Wiegand TW, 1996, J IMMUNOL, V157, P221; Zaitsu M, 2007, MOL IMMUNOL, V44, P1977, DOI 10.1016/j.molimm.2006.09.030; Zitta K, 2007, ASIAN J ANDROL, V9, P690, DOI 10.1111/j.1745-7262.2007.00289.x	25	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2014	134	4					969	972		10.1016/j.jaci.2014.05.016	http://dx.doi.org/10.1016/j.jaci.2014.05.016			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AQ9GC	24997637				2022-12-18	WOS:000343155700031
J	Pascual, M; Roa, S; Garcia-Sanchez, A; Sanz, C; Hernandez-Hernandez, L; Greally, JM; Lorente, F; Davila, I; Isidoro-Garcia, M				Pascual, Marien; Roa, Sergio; Garcia-Sanchez, Asuncion; Sanz, Catalina; Hernandez-Hernandez, Laura; Greally, John M.; Lorente, Felix; Davila, Ignacio; Isidoro-Garcia, Maria			Genome-wide expression profiling of B lymphocytes reveals IL4R increase in allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SEMINAL PLASMA; CELLS; IGE; HYPERSENSITIVITY		[Pascual, Marien; Roa, Sergio] Univ Navarra, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Garcia-Sanchez, Asuncion; Lorente, Felix; Davila, Ignacio] Univ Salamanca, Dept Pediat, E-37008 Salamanca, Spain; [Garcia-Sanchez, Asuncion; Sanz, Catalina; Hernandez-Hernandez, Laura; Lorente, Felix; Davila, Ignacio; Isidoro-Garcia, Maria] Inst Biosanitario Salamanca IBSAL, Salamanca, Spain; [Sanz, Catalina] Univ Salamanca, Dept Genet & Microbiol, E-37008 Salamanca, Spain; [Greally, John M.] Albert Einstein Coll Med, Ctr Epigen, Dept Genet, Div Computat Genet, Bronx, NY 10467 USA; [Lorente, Felix] Hosp Univ Salamanca, Serv Pediat, Salamanca, Spain; [Davila, Ignacio] Hosp Univ Salamanca, Serv Inmunoalergia, Salamanca, Spain; [Isidoro-Garcia, Maria] Hosp Univ Salamanca, Serv Bioquim Clin, Salamanca, Spain; [Isidoro-Garcia, Maria] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain	University of Navarra; University of Salamanca; University of Salamanca; Yeshiva University; Albert Einstein College of Medicine; University of Salamanca	Pascual, M (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain.	marienpdp@unav.es; sroa@unav.es	Garcia-Sanchez, Asuncion/AAE-8611-2019; Sanz, Catalina/H-6759-2015; Dávila, Ignacio/K-4453-2012; Roa, Sergio/H-9293-2015; Pascual, Marién/F-6661-2013; Greally, John/AAF-9540-2019	Garcia-Sanchez, Asuncion/0000-0002-9655-4918; Sanz, Catalina/0000-0003-2974-0873; Dávila, Ignacio/0000-0001-8485-5513; Roa, Sergio/0000-0003-1095-0715; Pascual, Marién/0000-0002-1678-1054; Greally, John/0000-0001-6069-7960; ISIDORO-GARCIA, MARIA/0000-0002-9013-9422				Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Bernstein I L, 1985, Contrib Gynecol Obstet, V14, P151; BERNSTEIN IL, 1981, ANN INTERN MED, V94, P459, DOI 10.7326/0003-4819-94-4-459; BERNSTEIN JA, 1993, OBSTET GYNECOL, V82, P667; Chan MA, 2011, INT J IMMUNOGENET, V38, P533, DOI 10.1111/j.1744-313X.2011.01043.x; Chan Marcia A, 2013, Clin Transl Allergy, V3, P29, DOI 10.1186/2045-7022-3-29; Dibbern DA, 2003, J IMMUNOL METHODS, V274, P37, DOI 10.1016/S0022-1759(02)00369-1; Isidoro-Garcia M, 2005, MED CLIN-BARCELONA, V124, P211, DOI 10.1157/13071760; Isidoro-Garcia Maria, 2005, Clin Mol Allergy, V3, P15, DOI 10.1186/1476-7961-3-15; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Loza MJ, 2007, J ALLERGY CLIN IMMUN, V120, P578, DOI 10.1016/j.jaci.2007.05.019; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; MITTMAN RJ, 1990, J ALLERGY CLIN IMMUN, V86, P954, DOI 10.1016/S0091-6749(05)80159-9; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Pascual M, 2011, EPIGENETICS-US, V6, P1131, DOI 10.4161/epi.6.9.16061; Pascual Marien, 2010, Front Biosci (Schol Ed), V2, P815	16	16	18	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2014	134	4					972	975		10.1016/j.jaci.2014.05.015	http://dx.doi.org/10.1016/j.jaci.2014.05.015			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AQ9GC	24975796				2022-12-18	WOS:000343155700032
J	Bauer, CS; Rank, MA				Bauer, Cindy S.; Rank, Matthew A.			Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							ALLERGEN-SPECIFIC IMMUNOTHERAPY; HOUSE-DUST MITE; DOUBLE-DUMMY; DOUBLE-BLIND; INFLAMMATION PARAMETERS; CLINICAL-EFFICACY; POLLEN EXTRACT; RHINITIS; CHILDREN; ASTHMA		[Bauer, Cindy S.] Phoenix Childrens Hosp, Div Allergy & Immunol, Scottsdale, AZ USA; [Rank, Matthew A.] Mayo Clin, Div Allergy Asthma & Clin Immunol, Scottsdale, AZ USA	Phoenix Children's Hospital; Mayo Clinic; Mayo Clinic Phoenix	Bauer, CS (corresponding author), Dept Pediat Pulmonol, Div Allergy & Immunol, 1919 East Thomas Rd, Phoenix, AZ 85016 USA.	cindysbauer@gmail.com						Abramson MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001186.pub2; Amar SM, 2009, J ALLERGY CLIN IMMUN, V124, P150, DOI 10.1016/j.jaci.2009.04.037; Calderon MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001936.pub2; Calderon MA, 2011, J ALLERGY CLIN IMMUN, V127, P30, DOI 10.1016/j.jaci.2010.08.024; Cox LS, 2014, J ALLER CL IMM-PRACT, V2, P156, DOI 10.1016/j.jaip.2014.01.010; Eifan AO, 2010, CLIN EXP ALLERGY, V40, P922, DOI 10.1111/j.1365-2222.2009.03448.x; Keles S, 2011, J ALLERGY CLIN IMMUN, V128, P808, DOI 10.1016/j.jaci.2011.04.033; Khinchi MS, 2004, ALLERGY, V59, P45, DOI 10.1046/j.1398-9995.2003.00387.x; Lin SY, 2013, JAMA-J AM MED ASSOC, V309, P1278, DOI 10.1001/jama.2013.2049; Malling HJ, 2009, CLIN EXP ALLERGY, V39, P387, DOI 10.1111/j.1365-2222.2008.03152.x; Mauro M, 2007, Eur Ann Allergy Clin Immunol, V39, P119; Mungan D, 1999, ANN ALLERG ASTHMA IM, V82, P485, DOI 10.1016/S1081-1206(10)62726-3; Noon L, 1911, LANCET, V1, P1572; Pfaar O, 2013, ALLERGY, V68, P1306, DOI 10.1111/all.12219; Quirino T, 1996, CLIN EXP ALLERGY, V26, P1253, DOI 10.1046/j.1365-2222.1996.d01-280.x; SCADDING GK, 1986, CLIN ALLERGY, V16, P483, DOI 10.1111/j.1365-2222.1986.tb01983.x; Tahamiler R, 2008, ORL-J OTO-RHIN-LARYN, V70, P144, DOI 10.1159/000124286; Ventura MT, 2009, INT J IMMUNOPATH PH, V22, P403, DOI 10.1177/039463200902200217; Yukselen A, 2013, ASIAN PAC J ALLERGY, V31, P233, DOI 10.12932/AP0276.31.3.2013; Yukselen A, 2012, INT ARCH ALLERGY IMM, V157, P288, DOI 10.1159/000327566	20	16	17	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2014	134	3					765	+		10.1016/j.jaci.2014.07.024	http://dx.doi.org/10.1016/j.jaci.2014.07.024			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GR	25171871				2022-12-18	WOS:000341372400046
J	Lapin, B; Piorkowski, J; Ownby, D; Wagner-Cassanova, C; Freels, S; Chavez, N; Hernandez, E; Pelzel, D; Vergara, C; Hayes, RM; Persky, V				Lapin, Brittany; Piorkowski, Julie; Ownby, Dennis; Wagner-Cassanova, Cynthia; Freels, Sally; Chavez, Noel; Hernandez, Eva; Pelzel, Darlene; Vergara, Carmen; Hayes, Rachel M.; Persky, Victoria			The relationship of early-life antibiotic use with asthma in at-risk children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDHOOD ASTHMA; EXPOSURE		[Lapin, Brittany; Piorkowski, Julie; Wagner-Cassanova, Cynthia; Freels, Sally; Chavez, Noel; Persky, Victoria] Univ Illinois, Chicago, IL 60607 USA; [Ownby, Dennis] Georgia Regents Univ, Augusta, GA USA; [Hernandez, Eva] Healthcare Alternative Syst Inc, Chicago, IL USA; [Pelzel, Darlene] Mayo Clin, Scottsdale, AZ USA; [Vergara, Carmen] Esperanza Hlth Ctr, Chicago, IL USA; [Hayes, Rachel M.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Georgia; Augusta University; Mayo Clinic; Mayo Clinic Phoenix; Vanderbilt University	Lapin, B (corresponding author), Univ Illinois, Chicago, IL 60607 USA.	blapin@uic.edu	HERNÁNDEZ, EVA/HDO-7002-2022		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011377, R21ES008716] Funding Source: NIH RePORTER; NIEHS NIH HHS [R21ES08716, R01ES011377, R01 ES011377] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Celedon JC, 2004, CLIN EXP ALLERGY, V34, P1011, DOI 10.1111/j.1365-2222.2004.01994.x; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Heintze K, 2013, EUR J CLIN PHARMACOL, V69, P1197, DOI 10.1007/s00228-012-1463-7; Jedrychowski W, 2011, J PHYSIOL PHARMACOL, V62, P189; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Marra F, 2006, CHEST, V129, P610, DOI 10.1378/chest.129.3.610; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; Rosenthal LA, 2010, J ALLERGY CLIN IMMUN, V125, P1212, DOI 10.1016/j.jaci.2010.04.002; Wickens K, 2008, CLIN EXP ALLERGY, V38, P1318, DOI 10.1111/j.1365-2222.2008.03024.x	9	16	21	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2014	134	3					728	729		10.1016/j.jaci.2014.05.006	http://dx.doi.org/10.1016/j.jaci.2014.05.006			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GR	24954277	Bronze, Green Accepted			2022-12-18	WOS:000341372400028
J	Gadermaier, G; Eichhorn, S; Vejvar, E; Weilnbock, L; Lang, R; Briza, P; Huber, CG; Ferreira, F; Hawranek, T				Gadermaier, Gabriele; Eichhorn, Stephanie; Vejvar, Eva; Weilnboeck, Lisa; Lang, Roland; Briza, Peter; Huber, Christian G.; Ferreira, Fatima; Hawranek, Thomas			Plantago lanceolata: An important trigger of summer pollinosis with limited IgE cross-reactivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							POLLEN; ALLERGENS; BATTERY		[Gadermaier, Gabriele; Huber, Christian G.] Salzburg Univ, Christian Doppler Lab Biosimilar Characterizat, A-5020 Salzburg, Austria; [Gadermaier, Gabriele; Eichhorn, Stephanie; Vejvar, Eva; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Weilnboeck, Lisa; Huber, Christian G.] Salzburg Univ, Dept Mol Biol, Div Chem, A-5020 Salzburg, Austria; [Lang, Roland; Hawranek, Thomas] Paracelsus Med Univ Salzburg, Dept Dermatol, Salzburg, Austria	Salzburg University; Salzburg University; Salzburg University; Paracelsus Private Medical University	Gadermaier, G (corresponding author), Salzburg Univ, Christian Doppler Lab Biosimilar Characterizat, A-5020 Salzburg, Austria.	Gabriele.Gadermaier@sbg.ac.at	Gadermaier, Gabriele/L-5997-2015; Ferreira, Fatima/E-4889-2011; Huber, Christian G./E-5445-2011; Briza, Peter/D-7309-2012; Ferreira, Fatima/AAB-4321-2019	Gadermaier, Gabriele/0000-0002-4886-417X; Ferreira, Fatima/0000-0003-0989-2335; Huber, Christian G./0000-0001-8358-1880; Briza, Peter/0000-0002-4941-6782; Ferreira, Fatima/0000-0003-0989-2335; Miranda, Mario/0000-0001-7989-4550				Asero R, 2000, ALLERGY, V55, P1059, DOI 10.1034/j.1398-9995.2000.00675.x; Asero R, 2011, EUR ANN ALLERGY CLIN, V43, P77; Bousquet PJ, 2009, ALLERGY, V64, P1656, DOI 10.1111/j.1398-9995.2009.02169.x; Calabozo B., 2002, Clinical and Experimental Allergy, V32, P1628, DOI 10.1046/j.1365-2222.2002.01530.x; Calabozo B, 2001, CLIN EXP ALLERGY, V31, P322, DOI 10.1046/j.1365-2222.2001.00985.x; Couto M, 2011, J INVEST ALLERG CLIN, V21, P491; Gadermaier G, 2004, CURR ALLERGY ASTHM R, V4, P391, DOI 10.1007/s11882-004-0090-5; Marazuela EG, 2012, MOL IMMUNOL, V50, P83, DOI 10.1016/j.molimm.2011.12.006; Ortiz JCG, 1996, J INVEST ALLERG CLIN, V6, P378	9	16	16	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2014	134	2					472	475		10.1016/j.jaci.2014.02.016	http://dx.doi.org/10.1016/j.jaci.2014.02.016			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GB	24698322				2022-12-18	WOS:000341370800029
J	Rafei-Shamsabadi, D; Muller, S; Pfutzner, W; Spillner, E; Rueff, F; Jakob, T				Rafei-Shamsabadi, David; Mueller, Sabine; Pfuetzner, Wolfgang; Spillner, Edzard; Rueff, Franziska; Jakob, Thilo			Recombinant allergens rarely allow identification of Hymenoptera venom-allergic patients with negative specific IgE to whole venom preparations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Rafei-Shamsabadi, David; Mueller, Sabine; Jakob, Thilo] Univ Freiburg, Med Ctr, Allergy Res Grp, Dept Dermatol, D-79106 Freiburg, Germany; [Pfuetzner, Wolfgang] Univ Med Ctr, Dept Dermatol & Allergol, Marburg, Germany; [Spillner, Edzard] Aarhus Univ, Dept Engn, Aarhus, Denmark; [Rueff, Franziska] Univ Munich, Dept Dermatol & Allergol, Munich, Germany	University of Freiburg; Aarhus University; University of Munich	Rafei-Shamsabadi, D (corresponding author), Univ Freiburg, Med Ctr, Allergy Res Grp, Dept Dermatol, Hugstetter Str 55, D-79106 Freiburg, Germany.	thilo.jakob@uniklinik-freiburg.de		spillner, edzard/0000-0003-0999-5254				Blank S, 2010, J IMMUNOL, V184, P5403, DOI 10.4049/jimmunol.0803709; Cifuentes L, 2014, J ALLERGY CLIN IMMUN, V133, P909, DOI 10.1016/j.jaci.2013.09.047; Eberlein B, 2012, J ALLERGY CLIN IMMUN, V130, P155, DOI 10.1016/j.jaci.2012.02.008; Hofmann SC, 2011, J ALLERGY CLIN IMMUN, V127, P265, DOI 10.1016/j.jaci.2010.06.042; Kohler J, 2014, J ALLERGY CLIN IMMUN, V133, P1383, DOI 10.1016/j.jaci.2013.10.060; Muller U, 2012, ALLERGY, V67, P1069, DOI 10.1111/j.1398-9995.2012.02847.x; Vos B, 2013, J ALLERGY CLIN IMMUN, V131, P1225, DOI 10.1016/j.jaci.2012.07.041	7	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2014	134	2					493	494		10.1016/j.jaci.2014.05.035	http://dx.doi.org/10.1016/j.jaci.2014.05.035			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GB	25087228	Bronze			2022-12-18	WOS:000341370800037
J	Kim, BJ; Lee, SY; Kwon, JW; Jung, YH; Lee, E; Yang, SI; Kim, HY; Seo, JH; Kim, HB; Kim, HC; Leem, JH; Kwon, HJ; Hong, SJ				Kim, Byoung-Ju; Lee, So-Yeon; Kwon, Ji-Won; Jung, Young-Ho; Lee, Eun; Yang, Song I.; Kim, Hyung-Young; Seo, Ju-Hee; Kim, Hyo-Bin; Kim, Hwan-Cheol; Leem, Jong-Han; Kwon, Ho-Jang; Hong, Soo-Jong			Traffic-related air pollution is associated with airway hyperresponsiveness	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGIC SENSITIZATION; ASTHMA		[Kim, Byoung-Ju] Inje Univ Haeundae Paik Hosp, Dept Pediat, Pusan, South Korea; [Lee, So-Yeon] Hallym Univ Coll Med, Hallym Sacred Heart Hosp, Dept Pediat, Anyang, South Korea; [Kwon, Ji-Won] Seoul Natl Univ Bundang Hosp, Dept Pediat, Songnam, South Korea; [Jung, Young-Ho; Lee, Eun; Yang, Song I.; Hong, Soo-Jong] Univ Ulsan Coll Med, Dept Pediat, Asan Med Ctr, Seoul, South Korea; [Kim, Hyung-Young] Pusan Natl Univ Childrens Hosp, Dept Pediat, Yangsan, South Korea; [Seo, Ju-Hee] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea; [Kim, Hyo-Bin] Inje Univ Sanggye Paik Hosp, Dept Pediat, Seoul, South Korea; [Kim, Hwan-Cheol; Leem, Jong-Han] Inha Univ Coll Med, Dept Occupat & Environm Med, Inchon, South Korea; [Kwon, Ho-Jang] Dankook Univ Coll Med, Dept Prevent Med, Cheonan, South Korea	Inje University; Hallym University; Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Pusan National University; Pusan National University Hospital; National Cancer Center - Korea (NCC); Inje University; Inha University; Dankook University	Kim, BJ (corresponding author), Inje Univ Haeundae Paik Hosp, Dept Pediat, Pusan, South Korea.	sjhong@amc.seoul.kr	Hong, Soo-Jong/AAR-1788-2020; Kim, Hwan-Cheol/GYR-0244-2022	Hong, Soo-Jong/0000-0003-1409-2113; Kim, Byoung-Ju/0000-0003-0271-9417				Auerbach A, 2012, CURR OPIN ALLERGY CL, V12, P133, DOI 10.1097/ACI.0b013e32835113d6; Braback L, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-17; Carlsten C, 2012, CURR OPIN ALLERGY CL, V12, P455, DOI 10.1097/ACI.0b013e328357cc55; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; Kim BJ, 2013, ALLERGY, V68, P517, DOI 10.1111/all.12104; Kim Byoung-Ju, 2012, Korean J Pediatr, V55, P185, DOI 10.3345/kjp.2012.55.6.185; Kim BJ, 2011, ANN ALLERG ASTHMA IM, V107, P214, DOI 10.1016/j.anai.2011.05.025; Liao DP, 2006, ENVIRON HEALTH PERSP, V114, P1374, DOI 10.1289/ehp.9169; Pujades-Rodriguez Mar, 2009, BMC Pulm Med, V9, P42, DOI 10.1186/1471-2466-9-42	9	16	16	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2014	133	6					1763	1765		10.1016/j.jaci.2014.01.020	http://dx.doi.org/10.1016/j.jaci.2014.01.020			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AI2FI	24636097				2022-12-18	WOS:000336672500034
J	Gao, YF; Workman, S; Gadola, S; Elliott, T; Grimbacher, B; Williams, AP				Gao, Yifang; Workman, Sarita; Gadola, Stephan; Elliott, Tim; Grimbacher, Bodo; Williams, Anthony P.			Common variable immunodeficiency is associated with a functional deficiency of invariant natural killer T cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						iNKT; CVID; XLA; cytokine; proliferation	RECEPTOR-ALPHA-CHAIN; B-CELLS; LIPID ANTIGEN; CUTTING EDGE; RESPONSES; HELP; SAP; CLASSIFICATION; ACTIVATION; EXPRESSION	Background: Common variable immunodeficiency (CVID) is the commonest symptomatic primary antibody disorder, with monogenic causes identified in less than 10% of all cases. X-linked proliferative disease is a monogenic disorder that is associated with hypogammaglobulinemia and characterized by a deficiency of invariant NKT (iNKT) cells. We sought to evaluate whether a defect in iNKT cell number or function was associated with CVID. Objective: An evaluation of the function and number of iNKT cells in CVID. Methods: Six-color flow cytometry enumerated iNKT cells in 36 patients with CVID and 50 healthy controls. Their proliferative capacity and cytokine production (IFN-g, IL-13, IL-17) was then investigated following activation with CD1d ligand alpha-galactosylceramide. Results: A reduction in the number of iNKT cells ( 31 iNKT cells/10(5) T cells) in patients with CVID compared with healthy controls (100 iNKT cells/10(5) T cells) was observed (P <.0001). Two cohorts could be discerned within the CVID group: group 1 with an abnormal number of iNKT cells (n = 28) and group 2 with a normal number of iNKT cells (n = 8). This segregation coassociated with the proliferative capacity of iNKT cells between the 2 groups. However, differences in the function of iNKT cells were noted in group 2, in which an increase in IFN-gamma (P =.0016) and a decrease in IL-17 (P =.0002) production was observed between patients with CVID and controls. Finally, a significant association was seen between the number of iNKT cells and the percentage of class-switched memory B cells and propensity to lymphoproliferation (P =.002) in patients with CVID. Conclusion: iNKT cells are deficient and/or functionally impaired in most of the patients with CVID.	[Gao, Yifang; Elliott, Tim; Williams, Anthony P.] Univ Southampton, Fac Med, Canc Sci Div, Southampton SO16 6YD, Hants, England; [Workman, Sarita; Grimbacher, Bodo] Royal Free Hosp, Dept Clin Immunol & Mol Pathol, London NW3 2QG, England; [Workman, Sarita; Grimbacher, Bodo] UCL, London, England; [Gadola, Stephan] Univ Southampton, Fac Med, Clin & Expt Sci Div, Southampton SO16 6YD, Hants, England	University of Southampton; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of Southampton	Williams, AP (corresponding author), Univ Southampton, Fac Med, Canc Sci Div, Mailpoint 824, Southampton SO16 6YD, Hants, England.	apw2@soton.ac.uk		Gao, Yifang/0000-0003-2817-9391; Elliott, Tim/0000-0003-1097-0222	Cancer Research UK; Experimental Cancer Medicine Centre, Southampton; European Community's 6th and 7th Framework Programmes [HEALTH-F2-2008-201549, Health-F5-2008-2223292]; Marie Curie Excellence Grant [MEXT-CT-2006-042316, MC-PIAID]; BBSRC [BB/J017302/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017302/1] Funding Source: researchfish; Cancer Research UK [16997] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Experimental Cancer Medicine Centre, Southampton; European Community's 6th and 7th Framework Programmes; Marie Curie Excellence Grant(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	Y.G., T.E., and A.P.W. were supported by Cancer Research UK and the Experimental Cancer Medicine Centre, Southampton. B. G. was funded by the European Community's 6th and 7th Framework Programmes FP7/2007-2013 under grant agreements HEALTH-F2-2008-201549 (EURO-PADnet) and Health-F5-2008-2223292 (Euro Gene Scan) and a Marie Curie Excellence Grant to B. G. (MEXT-CT-2006-042316, MC-PIAID).	Balato A, 2009, J INVEST DERMATOL, V129, P1628, DOI 10.1038/jid.2009.30; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; BRYANT A, 1990, CLIN IMMUNOL IMMUNOP, V56, P239, DOI 10.1016/0090-1229(90)90145-G; Carvalho KI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012652; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2007, J ALLERGY CLIN IMMUN, V120, P885, DOI 10.1016/j.jaci.2007.06.012; Castigli E, 2007, NAT GENET, V39, P430, DOI 10.1038/ng0407-430; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Fulcher DA, 2009, CLIN EXP IMMUNOL, V157, P365, DOI 10.1111/j.1365-2249.2009.03973.x; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; IMAI K, 1986, P NATL ACAD SCI USA, V83, P8708, DOI 10.1073/pnas.83.22.8708; JANEWAY CA, 1953, T ASSOC AM PHYSICIAN, V66, P200; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Losi CG, 2005, J CLIN IMMUNOL, V25, P496, DOI 10.1007/s10875-005-5637-2; Marrella V, 2007, J CLIN INVEST, V117, P1260, DOI 10.1172/JCI30928; Matangkasombut P, 2008, BLOOD, V111, P271, DOI 10.1182/blood-2007-06-096487; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Salzer U, 2004, CLIN IMMUNOL, V113, P234, DOI 10.1016/j.clim.2004.07.002; Schuster V, 2000, IMMUNOL REV, V178, P21, DOI 10.1034/j.1600-065X.2000.17819.x; Spickett GP, 1997, IMMUNOL TODAY, V18, P325, DOI 10.1016/S0167-5699(97)01086-4; SUMIDA T, 1985, J IMMUNOL, V134, P3675; SUMIDA T, 1984, J IMMUNOL, V133, P1131; Tonti E, 2009, BLOOD, V113, P370, DOI 10.1182/blood-2008-06-166249; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; Veillette A, 2008, P NATL ACAD SCI USA, V105, P1273, DOI 10.1073/pnas.0710698105; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744	38	16	16	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2014	133	5					1420	U316		10.1016/j.jaci.2013.10.059	http://dx.doi.org/10.1016/j.jaci.2013.10.059			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AG5HS	24582167				2022-12-18	WOS:000335450700025
J	Beigelman, A; Bacharier, LB				Beigelman, Avraham; Bacharier, Leonard B.			Infection-induced wheezing in young children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							RESPIRATORY SYNCYTIAL VIRUS; PRESCHOOL-CHILDREN; CONTROLLED-TRIAL; EARLY-LIFE; BRONCHIOLITIS; ASTHMA; DEXAMETHASONE; PREDNISOLONE; MANAGEMENT; DIAGNOSIS		Washington Univ, Dept Pediat, St Louis, MO 63110 USA; St Louis Childrens Hosp, St Louis, MO 63178 USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Bacharier, LB (corresponding author), Washington Univ, Sch Med, Div Allergy Immunol & Pulm Med, Dept Pediat, 660 S Euclid Ave,Campus Box 8116, St Louis, MO 63110 USA.	bacharier_l@kids.wustl.edu		Bacharier, Leonard/0000-0003-0432-2704	NCATS NIH HHS [KL2 TR000450, UL1 TR000448] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450, UL1TR000448] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P287, DOI 10.1016/j.jaci.2012.04.025; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Bacharier LB, 2010, CURR OPIN PULM MED, V16, P31, DOI 10.1097/MCP.0b013e32833303e6; Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Beigelman A, 2013, J ALLERGY CLIN IMMUN, V131, P1518, DOI 10.1016/j.jaci.2013.01.034; Beigelman A, 2013, CURR OPIN ALLERGY CL, V13, P211, DOI 10.1097/ACI.0b013e32835eb6ef; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Bush A, 2007, BMJ-BRIT MED J, V335, P1037, DOI 10.1136/bmj.39374.600081.AD; Bush A, 2009, NEW ENGL J MED, V360, P409, DOI 10.1056/NEJMe0808951; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Carroll KN, 2009, J ALLERGY CLIN IMMUN, V123, p[1055, 61e1]; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Escobar GJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-97; Gadomski AM, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001266.pub2, 10.1002/14651858.CD001266.pub3]; Grigg J, 2010, ARCH DIS CHILD, V95, P491, DOI 10.1136/adc.2009.160994; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Lehtinen P, 2007, J ALLERGY CLIN IMMUN, V119, P570, DOI 10.1016/j.jaci.2006.11.003; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; National Asthma Education and Prevention Program, 2007, HYPERLIPIDAEMIA; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Robertson CF, 2007, AM J RESP CRIT CARE, V175, P323, DOI 10.1164/rccm.200510-1546OC; Wainwright C, 2010, PAEDIATR RESPIR REV, V11, P39, DOI 10.1016/j.prrv.2009.10.001; Zeiger RS, 2011, NEW ENGL J MED, V365, P1990, DOI 10.1056/NEJMoa1104647; Zhang LJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006458.pub3	28	16	20	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2					603	+		10.1016/j.jaci.2013.12.001	http://dx.doi.org/10.1016/j.jaci.2013.12.001			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EF	24636478	Green Accepted			2022-12-18	WOS:000332397100050
J	Slifka, MK; Leung, DYM; Hammarlund, E; Raue, HP; Simpson, EL; Tofte, S; Baig-Lewis, S; David, G; Lynn, H; Woolson, R; Hata, T; Milgrom, H; Hanifin, J				Slifka, Mark K.; Leung, Donald Y. M.; Hammarlund, Erika; Raue, Hans-Peter; Simpson, Eric L.; Tofte, Susan; Baig-Lewis, Shahana; David, Gloria; Lynn, Henry; Woolson, Rob; Hata, Tissa; Milgrom, Henry; Hanifin, Jon			Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Yellow fever virus; antibody; T-cell memory; IgE; atopic dermatitis	SMALLPOX VACCINATION; DELIVERY; VACCINES; 17D; IMMUNOGENICITY; RESPONSES; IMMUNITY; ECZEMA; COST	Background: Atopic dermatitis (AD) is a common inflammatory skin disease with a global prevalence ranging from 3% to 20%. Patients with AD have an increased risk for complications after viral infection (eg, herpes simplex virus), and vaccination of patients with AD with live vaccinia virus is contraindicated because of a heightened risk of eczema vaccinatum, a rare but potentially lethal complication associated with smallpox vaccination. Objective: We sought to develop a better understanding of immunity to cutaneous viral infection in patients with AD. Methods: In a double-blind randomized study we investigated the safety and immunogenicity of live attenuated yellow fever virus (YFV) vaccination of nonatopic subjects and patients with AD after standard subcutaneous inoculation or transcutaneous vaccination administered with a bifurcated needle. Viremia, neutralizing antibody, and antiviral T-cell responses were analyzed for up to 30 days after vaccination. Results: YFV vaccination administered through either route was well tolerated. Subcutaneous vaccination resulted in higher seroconversion rates than transcutaneous vaccination but elicited similar antiviral antibody levels and T-cell responses in both the nonatopic and AD groups. After transcutaneous vaccination, both groups mounted similar neutralizing antibody responses, but patients with AD demonstrated lower antiviral T-cell responses by 30 days after vaccination. Among transcutaneously vaccinated subjects, a significant inverse correlation between baseline IgE levels and the magnitude of antiviral antibody and CD4(+) T-cell responses was observed. Conclusions: YFV vaccination of patients with AD through the transcutaneous route revealed that high baseline IgE levels provide a potential biomarker for predicting reduced virus-specific immune memory after transcutaneous infection with a live virus.	[Slifka, Mark K.; Hammarlund, Erika; Raue, Hans-Peter] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Simpson, Eric L.; Tofte, Susan; Baig-Lewis, Shahana; Hanifin, Jon] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [David, Gloria; Lynn, Henry; Woolson, Rob] Rho Inc, Chapel Hill, NC USA; [Hata, Tissa] Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA; [Leung, Donald Y. M.; Milgrom, Henry] Natl Jewish Hlth, Dept Pediat, Denver, CO USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Rho; University of California System; University of California San Diego; National Jewish Health	Slifka, MK (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	slifkam@ohsu.edu			National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200400029C, HHSN26620400033C]; Oregon National Primate Research Center [8P51 OD011092-53]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040029] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oregon National Primate Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services contract no. HHSN266200400029C (to D.Y.M.L., T.H., J.H., and M.K.S.) and HHSN26620400033C and Oregon National Primate Research Center grant 8P51 OD011092-53 (to M.K.S.).	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Al-Zahrani S, 2012, EXPERT OPIN DRUG DEL, V9, P541, DOI 10.1517/17425247.2012.676038; Amanna IJ, 2008, HUM VACCINES, V4, P316, DOI 10.4161/hv.4.4.5751; Barrett ADT, 2007, VACCINE, V25, P2758, DOI 10.1016/j.vaccine.2006.12.015; Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, P260, DOI 10.1016/j.jaci.2009.05.020; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; CANNON D A, 1957, Ann Trop Med Parasitol, V51, P256; Dean CH, 2005, HUM VACCINES, V1, P106, DOI 10.4161/hv.1.3.1797; Ellis CN, 2002, J AM ACAD DERMATOL, V46, P361, DOI 10.1067/mjd.2002.120528; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hickling JK, 2011, B WORLD HEALTH ORGAN, V89, P221, DOI 10.2471/BLT.10.079426; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; Laske N, 2004, PEDIAT ALLERG IMM-UK, V15, P86, DOI 10.1046/j.0905-6157.2003.00106.x; Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009; Marra F, 2013, INFLUENZA OTHER RESP, V7, P584, DOI 10.1111/irv.12000; MEERS P. D., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P338, DOI 10.1016/0035-9203(57)90125-6; MEERS P. D., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P493, DOI 10.1016/0035-9203(60)90099-7; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Monath T. P., 2008, VACCINES, P959; Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; Pettis RJ, 2012, THER DELIV, V3, P357, DOI 10.4155/TDE.12.13; REDFIELD RR, 1985, JAMA-J AM MED ASSOC, V254, P3203, DOI 10.1001/jama.254.22.3203; Reed JL, 2012, CLIN INFECT DIS, V54, P832, DOI 10.1093/cid/cir952; Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B; Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993; Sun JG, 2005, SCAND J STAT, V32, P49, DOI 10.1111/j.1467-9469.2005.00414.x	30	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2					439	447		10.1016/j.jaci.2013.10.037	http://dx.doi.org/10.1016/j.jaci.2013.10.037			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EF	24331381	Bronze, Green Accepted			2022-12-18	WOS:000332397100019
J	Sutherland, ER; Busse, WW				Sutherland, E. Rand; Busse, William W.		Natl Heart Lung Blood Inst AsthmaN	Designing clinical trials to address the needs of childhood and adult asthma: The National Heart, Lung, and Blood Institute's AsthmaNet	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						AsthmaNet; asthma; treatment; clinical trials; proof of concept; mechanistic studies; asthma management	RANDOMIZED CONTROLLED-TRIAL; MILD PERSISTENT ASTHMA; STEP-UP THERAPY; INHALED CORTICOSTEROIDS; PRESCHOOL-CHILDREN; UNCONTROLLED ASTHMA; RESEARCH NETWORK; MODERATE ASTHMA; MONTELUKAST; SALMETEROL	In 2008, the National Heart, Lung, and Blood Institute announced its intent to support a new asthma network known as AsthmaNet. This clinical trials consortium, now in its fifth year, has been charged with developing and executing clinical trials to address the most important asthma management questions and identify new treatment approaches in pediatric and adult patients. This review will discuss the organization of AsthmaNet and the scientific context in which the network was developed and began its work, report the results of an internal priority-setting exercise designed to guide the network's scientific strategy, and highlight the portfolio of clinical trials, proof-of-concept studies, and mechanistic studies planned for the 7-year period of the network to update the global asthma community regarding the progress and processes of the network.	[Sutherland, E. Rand] Univ Colorado, Sch Med, Dept Med, Natl Jewish Hlth, Denver, CO USA; [Busse, William W.] Univ Wisconsin, Dept Med, Madison, WI USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Wisconsin System; University of Wisconsin Madison	Sutherland, ER (corresponding author), 1400 Jackson St, Denver, CO 80206 USA.	sutherlande@njhealth.org			National Institutes of Health [HL098075, HL098098, HL098102, HL098107, HL098090, HL098112, HL098103, HL098096, HL098177, HL098115]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098107, U10HL098112, U10HL098090, U10HL098096, U10HL098075, U10HL098115, U10HL098177, U10HL098103, U10HL098102, U10HL098098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health grants HL098075, HL098098, HL098102, HL098107, HL098090, HL098112, HL098103, HL098096, HL098177, and HL098115.	Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Busse WW, 2012, J ALLERGY CLIN IMMUN, V129, pS1, DOI 10.1016/j.jaci.2011.12.985; Calhoun WJ, 2012, JAMA-J AM MED ASSOC, V308, P987, DOI 10.1001/2012.jama.10893; Clinical Centers for the NHLBI Asthma Network (AsthmaNet), RFAHL08010 CLIN CTR; Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet), RFAHL08011 DAT COORD; Denlinger LC, 2007, J ALLERGY CLIN IMMUN, V119, P3, DOI 10.1016/j.jaci.2006.10.015; Deykin A, 2007, AM J RESP CRIT CARE, V175, P228, DOI 10.1164/rccm.200601-112OC; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Ducharme FM, 2008, J PEDIATR-US, V152, P476, DOI 10.1016/j.jpeds.2007.08.034; Fish JE, 1997, AM J RESP CRIT CARE, V156, P1165, DOI 10.1164/ajrccm.156.4.9703012; Guidelines for the diagnosis and management of asthma, 1997, NIH PUBLICATION; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Martin RJ, 2007, J ALLERGY CLIN IMMUN, V119, P73, DOI 10.1016/j.jaci.2006.10.035; Martin RJ, 2002, AM J RESP CRIT CARE, V165, P1377, DOI 10.1164/rccm.2105013; Martinez FD, 2011, LANCET, V377, P650, DOI 10.1016/S0140-6736(10)62145-9; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Strunk RC, 2008, J ALLERGY CLIN IMMUN, V122, P1138, DOI 10.1016/j.jaci.2008.09.028; Sutherland ER, 2010, J ALLERGY CLIN IMMUN, V126, P747, DOI 10.1016/j.jaci.2010.07.024; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Szefler SJ, 2012, THORAX, V67, P450, DOI 10.1136/thoraxjnl-2012-201876; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC; Wechsler ME, 2009, LANCET, V374, P1754, DOI 10.1016/S0140-6736(09)61492-6; Zeiger RS, 2011, NEW ENGL J MED, V365, P1990, DOI 10.1056/NEJMoa1104647	31	16	16	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					34	+		10.1016/j.jaci.2013.10.025	http://dx.doi.org/10.1016/j.jaci.2013.10.025			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	24369797	Bronze, Green Accepted			2022-12-18	WOS:000329105700004
J	Noel, N; Mahlaoui, N; Blanche, S; Suarez, F; Coignard-Biehler, H; Durieu, I; Godeberge, P; Sokol, H; Catherinot, E; Poiree, S; Chapdelaine, H; Dunogue, B; Bodemer, C; Lecuit, M; Fischer, A; Lortholary, O; Hermine, O				Noel, Nicolas; Mahlaoui, Nizar; Blanche, Stephane; Suarez, Felipe; Coignard-Biehler, Helene; Durieu, Isabelle; Godeberge, Philippe; Sokol, Harry; Catherinot, Emilie; Poiree, Sylvain; Chapdelaine, Hugo; Dunogue, Bertrand; Bodemer, Christine; Lecuit, Marc; Fischer, Alain; Lortholary, Olivier; Hermine, Olivier			Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: A retrospective case series	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BOWEL-DISEASE; COLITIS		[Noel, Nicolas; Mahlaoui, Nizar; Blanche, Stephane; Suarez, Felipe; Coignard-Biehler, Helene; Durieu, Isabelle; Godeberge, Philippe; Sokol, Harry; Catherinot, Emilie; Poiree, Sylvain; Chapdelaine, Hugo; Dunogue, Bertrand; Bodemer, Christine; Lecuit, Marc; Fischer, Alain; Lortholary, Olivier; Hermine, Olivier] Hop Necker Enfants Malad, AP HP, CEREDIH, Ctr Reference Deficits Immunitaires Hereditaires, Paris, France; [Noel, Nicolas; Dunogue, Bertrand; Lecuit, Marc; Lortholary, Olivier] AP HP, Serv Malad Infect & Trop, Ctr Infectiol Necker Pasteur, Paris, France; [Noel, Nicolas; Mahlaoui, Nizar; Blanche, Stephane; Suarez, Felipe; Coignard-Biehler, Helene; Dunogue, Bertrand; Fischer, Alain; Lortholary, Olivier; Hermine, Olivier] Univ Paris 04, Inst Imagine, Paris, France; [Mahlaoui, Nizar; Blanche, Stephane; Fischer, Alain] Hop Necker Enfants Malad, AP HP, Serv Immuno Hematol Pediat, Paris, France; [Suarez, Felipe; Chapdelaine, Hugo; Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Serv Hematol Adultes, Paris, France; [Durieu, Isabelle] CHU Lyon, Serv Med Interne, Lyon, France; [Godeberge, Philippe] Inst Mutualiste Montsouris, Serv Gastroenterol, Paris, France; [Sokol, Harry] Hop St Antoine, AP HP, Serv Gastroenterol, F-75571 Paris, France; [Catherinot, Emilie] Hop Foch, Serv Pneumol, Suresnes, France; [Poiree, Sylvain] Hop Necker Enfants Malad, AP HP, Serv Radiol, Paris, France; [Bodemer, Christine] Hop Necker Enfants Malad, AP HP, Serv Dermatol, Paris, France; [Lecuit, Marc] Inst Pasteur, INSERM, Grp Microorganismes & Barrieres Hote, F-75724 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Noel, N (corresponding author), Hop Bicetre, AP HP, Serv Med Interne, Paris, France.	olivier.lortholary@nck.aphp.fr; olivier.hermine@nck.aphp.fr	Sokol, Harry/E-2290-2019; Noel, Nicolas/AAK-3911-2021; Mahlaoui, Nizar/J-7928-2017; sokol, harry/ABA-8991-2020; Lecuit, Marc/J-4073-2013; MAHLAOUI, Nizar/AAH-6103-2020; Hermine, Olivier/Q-7072-2018; Lecuit, Marc/M-4126-2019	Sokol, Harry/0000-0002-2914-1822; Mahlaoui, Nizar/0000-0002-0030-8094; sokol, harry/0000-0002-2914-1822; Lecuit, Marc/0000-0002-4491-1063; MAHLAOUI, Nizar/0000-0002-0030-8094; Lecuit, Marc/0000-0002-4491-1063; Chapdelaine, Hugo/0000-0001-6256-0271; Hermine, Olivier/0000-0003-2574-3874; Noel, Nicolas/0000-0003-4055-617X				CEREDIH: The French PID study group, 2010, CLIN IMMUNOL, V135, P264, DOI [10.1016/j.clim.2010.02.021, DOI 10.1016/J.CLIM.2010.02.021]; Fidanboylu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025212; Freudenberg F, 2010, J ALLERGY CLIN IMMUN, V125, P943, DOI 10.1016/j.jaci.2010.01.035; Horwitz ME, 2001, NEW ENGL J MED, V344, P881, DOI 10.1056/NEJM200103223441203; Marks DJB, 2009, AM J GASTROENTEROL, V104, P117, DOI 10.1038/ajg.2008.72; Palumbo A, 2008, BLOOD, V111, P3968, DOI 10.1182/blood-2007-10-117457; Seger RA, 2008, BRIT J HAEMATOL, V140, P255, DOI 10.1111/j.1365-2141.2007.06880.x; Sokol H, 2009, AM J GASTROENTEROL, V104, P1069, DOI 10.1038/ajg.2009.56; Uzel G, 2010, CLIN INFECT DIS, V51, P1429, DOI 10.1086/657308	9	16	16	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2013	132	4					997	1000		10.1016/j.jaci.2013.04.059	http://dx.doi.org/10.1016/j.jaci.2013.04.059			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	227FR	23791514				2022-12-18	WOS:000325096500037
J	Guan, WJ; Zheng, JP; Gao, Y; Jiang, CY; Xie, YQ; An, JY; Yu, XX; Liu, WT; Zhong, NS				Guan, Weijie; Zheng, Jinping; Gao, Yi; Jiang, Caiyu; Xie, Yanqing; An, Jiaying; Yu, Xinxin; Liu, Wenting; Zhong, Nanshan			Leukotriene D-4 and methacholine bronchial provocation tests for identifying leukotriene-responsiveness subtypes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Leukotriene D-4; methacholine; bronchial provocation test; asthma; leukotriene responsive; leukotriene unresponsive; control status	AIRWAY HYPERRESPONSIVENESS; ASTHMA; BRONCHOCONSTRICTION; INFLAMMATION; ZAFIRLUKAST	Background: Both leukotriene D-4 (LTD4) and methacholine bronchial provocation tests are measurements of airway responsiveness; however, their correlation and distinction remain unexplored. Objectives: We sought to compare the 2 tests and classify leukotriene-responsiveness subtypes in asthmatic patients. Methods: In this randomized cross-over study we enrolled healthy subjects and asthmatic patients with different control statuses. All subjects underwent both tests with a 2- to 14-day interval. Distribution and correlation of cumulative doses inducing a 20% decrease in FEV1, LTD4/methacholine potency ratio, diagnostic value, and adverse events were recorded and analyzed. Asthmatic patients with a lower cumulative dose for LTD4 and a higher leukotriene/methacholine potency ratio than geometric means were regarded as leukotriene responsive. Results: Twenty patients with uncontrolled, 22 with partly controlled, and 20 with controlled asthma and 21 healthy subjects were enrolled. Geometric means of cumulative doses for LTD4 and methacholine (0.272 nmol vs 0.945 mu mol) were lowest in patients with uncontrolled asthma, followed by those with partly controlled (0.387 nmol vs 1.933 mu mol) and controlled (1.484 nmol vs 3.946 mu mol) asthma. The average potency ratio was highest in those with partly controlled asthma (5000.2), followed by those with uncontrolled (3477.7) and controlled (2702.6) asthma. Eighteen leukotriene-responsive asthmatic patients (29.03%) with a cumulative dose of LTD4 of 0.533 nmol or less and a potency ratio of 3647 or greater were identified. Adverse events, including tachypnea and chest tightness, were similar and mild. No serious adverse event was reported. Conclusion: Diagnostic value and safety were ideal in both tests. The combination of cumulative dose for LTD4 and potency ratio might be useful to identify leukotriene-responsive asthmatic patients. (J Allergy Clin Immunol 2013;131:332-8.)	[Guan, Weijie; Zheng, Jinping; Gao, Yi; Jiang, Caiyu; Xie, Yanqing; An, Jiaying; Yu, Xinxin; Liu, Wenting; Zhong, Nanshan] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zheng, JP (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, 151 Yanjiang Rd, Guangzhou, Guangdong, Peoples R China.	jpzhenggy@163.com	Gao, Yi/AAS-9165-2020; Guan, Wei-jie/K-8257-2019		Provincial Nature Science Foundation of Guangdong [915280000100019]; Municipal Science and Technology Plan of Guangzhou [2009J1-C321-1]; Guangzhou Leading Project for Medicine and Health [2009-YB-143]; Scientific Project of Guangzhou Medical College [2008A02]; Changjiang Scholars and Innovative Research Team in University [ITR0961]; National Key Technology R&D Program of the 12th National Five-year Development Plan [2012BAI05B01]; Provincial Nature Science Foundation of Guangdong; Changjiang Scholars and Innovative Research Team in University; National Key Technology R&D Program of the 12th National Five-year Development Plan; Municipal Science and Technology Plan of Guangzhou; Guangzhou Leading Project for Medicine and Health; Scientific Project of Guangzhou Medical College	Provincial Nature Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Municipal Science and Technology Plan of Guangzhou; Guangzhou Leading Project for Medicine and Health; Scientific Project of Guangzhou Medical College; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology R&D Program of the 12th National Five-year Development Plan(National Key Technology R&D Program); Provincial Nature Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology R&D Program of the 12th National Five-year Development Plan(National Key Technology R&D Program); Municipal Science and Technology Plan of Guangzhou; Guangzhou Leading Project for Medicine and Health; Scientific Project of Guangzhou Medical College	Supported by the Provincial Nature Science Foundation of Guangdong 915280000100019 (to J.Z.), the Municipal Science and Technology Plan of Guangzhou 2009J1-C321-1 (to Y.G.), the Guangzhou Leading Project for Medicine and Health 2009-YB-143 (to Y.G.), the Scientific Project of Guangzhou Medical College 2008A02 (to Y.G.), Changjiang Scholars and Innovative Research Team in University ITR0961 (to J.Z.), and the National Key Technology R&D Program of the 12th National Five-year Development Plan 2012BAI05B01 (to J.Z.).; J. Zheng has received grants from the Provincial Nature Science Foundation of Guangdong, the Changjiang Scholars and Innovative Research Team in University, and the National Key Technology R&D Program of the 12th National Five-year Development Plan. Y. Gao has received grants from the Municipal Science and Technology Plan of Guangzhou, the Guangzhou Leading Project for Medicine and Health, and the Scientific Project of Guangzhou Medical College. The rest of the authors declare that they have no relevant conflicts of interest.	ADELROTH E, 1986, NEW ENGL J MED, V315, P480, DOI 10.1056/NEJM198608213150803; BOULET LP, 1994, CHEST, V105, P1024, DOI 10.1378/chest.105.4.1024; Casas A, 2005, EUR RESPIR J, V26, P442, DOI 10.1183/09031936.05.00147504; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; Deykin A, 2000, AM J RESP CRIT CARE, V162, P1685, DOI 10.1164/ajrccm.162.5.9911081; Drazen JM, 1998, AM J RESP CRIT CARE, V158, pS193, DOI 10.1164/ajrccm.158.supplement_2.13tac180; Echazarreta AL, 2001, AM J RESP CRIT CARE, V164, P202, DOI 10.1164/ajrccm.164.2.2101105; Guan WJ, 2012, CURR MED RES OPIN, V28, P797, DOI 10.1185/03007995.2012.678936; Gyllfors P, 2005, THORAX, V60, P902, DOI 10.1136/thx.2005.041913; Hanania NA, 2008, CHEST, V133, P989, DOI 10.1378/chest.07-0829; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mulder A, 1999, AM J RESP CRIT CARE, V159, P1562, DOI 10.1164/ajrccm.159.5.9810095; O'Byrne P, 2006, GLOBAL STRATEGY ASTH; O'Byrne PM, 2003, CHEST, V123, p411S, DOI 10.1378/chest.123.3_suppl.411S; OByrne PM, 1997, CHEST, V111, pS27, DOI 10.1378/chest.111.2_Supplement.27S; Schelfhout V, 2008, PULM PHARMACOL THER, V21, P276, DOI 10.1016/j.pupt.2007.05.003; Smith LJ, 1998, ANN ALLERG ASTHMA IM, V81, P43, DOI 10.1016/S1081-1206(10)63108-0; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Taggart SCO, 1996, EUR RESPIR J, V9, P1146, DOI 10.1183/09031936.96.09061146; WOODBAKER R, 1995, BRIT J CLIN PHARMACO, V39, P119, DOI 10.1111/j.1365-2125.1995.tb04417.x; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50	22	16	18	1	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					332	+		10.1016/j.jaci.2012.08.020	http://dx.doi.org/10.1016/j.jaci.2012.08.020			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23040886				2022-12-18	WOS:000314661500008
J	Paquet, B; Begin, P; Paradis, L; Drouin, E; Des Roches, A				Paquet, Brenda; Begin, Philippe; Paradis, Louis; Drouin, Eric; Des Roches, Anne			Variable yield of allergy patch testing in children with eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ELIMINATION DIET		[Paquet, Brenda; Begin, Philippe; Paradis, Louis; Des Roches, Anne] Ctr Hosp Univ Ste Justine, Div Allergy & Immunol, Montreal, PQ, Canada; [Drouin, Eric] Ctr Hosp Univ Ste Justine, Div Gastroenterol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Paquet, B (corresponding author), Ctr Hosp Univ Ste Justine, Div Allergy & Immunol, Montreal, PQ, Canada.	a.des.roches@umontreal.ca	Bégin, Philippe/AAU-9126-2021					Assa'ad AH, 2007, J ALLERGY CLIN IMMUN, V119, P731, DOI 10.1016/j.jaci.2006.10.044; Henderson CJ, 2012, J ALLERGY CLIN IMMUN, V129, P1570, DOI 10.1016/j.jaci.2012.03.023; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Molina-Infante J, 2012, J ALLERGY CLIN IMMUN, V130, P1200, DOI 10.1016/j.jaci.2012.06.027; Pascual JMR, 2011, J INVEST ALLERG CLIN, V21, P59; Spergel JM, 2005, ANN ALLERG ASTHMA IM, V95, P336, DOI 10.1016/S1081-1206(10)61151-9; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V130, P461, DOI 10.1016/j.jaci.2012.05.021	7	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					613	613		10.1016/j.jaci.2012.10.053	http://dx.doi.org/10.1016/j.jaci.2012.10.053			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23260753				2022-12-18	WOS:000314661500052
J	Apter, AJ				Apter, Andrea J.			Advances in adult asthma diagnosis and treatment in 2012: Potential therapeutics and gene-environment interactions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; adults; inhaled corticosteroids; biomarkers; long-acting beta-agonist; gene-environment interaction	THYMIC STROMAL LYMPHOPOIETIN; PUBLIC-HEALTH BENEFITS; VITAMIN-D; OUTCOMES; POLLUTION; CORTICOSTEROIDS; EXPRESSION; DIVERSITY; EXPOSURE; CHILDREN	In the Journal of Allergy and Clinical Immunology in 2012, research reports related to asthma in adults clustered around mechanisms of disease, with a special focus on their potential for informing new therapies. There was also consideration of the effect of the environment on health from pollution, climate change, and epigenetic influences, underlining the importance of understanding gene-environment interactions in the pathogenesis of asthma and response to treatment. (J Allergy Clin Immunol 2013;131:47-54.)	[Apter, Andrea J.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Apter, AJ (corresponding author), Hosp Univ Penn, 829 Gates Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	apter@mail.med.upenn.edu						Akinbami LJ, 2012, J ALLERGY CLIN IMMUN, V129, pS49, DOI 10.1016/j.jaci.2011.12.984; Apter AJ, 2012, J ALLERGY CLIN IMMUN, V129, P69, DOI 10.1016/j.jaci.2011.11.005; Arbes SJ, 2012, J ALLERGY CLIN IMMUN, V130, P1202, DOI 10.1016/j.jaci.2012.06.040; Barnes PJ, 2012, J ALLERGY CLIN IMMUN, V129, P48, DOI 10.1016/j.jaci.2011.11.006; Bauer RN, 2012, J ALLERGY CLIN IMMUN, V129, P14, DOI 10.1016/j.jaci.2011.11.004; Bauer RN, 2012, J ALLERGY CLIN IMMUN, V130; Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Bime C, 2012, J ALLERGY CLIN IMMUN, V130, P1078, DOI 10.1016/j.jaci.2012.07.058; Bougault V, 2012, J ALLERGY CLIN IMMUN, V129, P351, DOI 10.1016/j.jaci.2011.11.010; Brozek JL, 2012, ARCH INTERN MED; Busse W, 2012, J ALLERGY CLIN IMMUN, V129, P983, DOI 10.1016/j.jaci.2012.01.033; Busse WW, 2012, J ALLERGY CLIN IMMUN, V129, pS1, DOI 10.1016/j.jaci.2011.12.985; Calhoun WJ, 2012, JAMA-J AM MED ASSOC, V308, P987, DOI 10.1001/2012.jama.10893; Chang PJ, 2012, J ALLERGY CLIN IMMUN, V130, P877, DOI 10.1016/j.jaci.2012.07.017; Chaudhuri R, 2012, J ALLERGY CLIN IMMUN, V129, P655, DOI 10.1016/j.jaci.2011.12.996; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Daley D, 2012, J ALLERGY CLIN IMMUN; Du R, 2012, J ALLERGY CLIN IMMUN, V129, P368, DOI 10.1016/j.jaci.2011.09.034; Farah CS, 2012, J ALLERGY CLIN IMMUN, V129, P381, DOI 10.1016/j.jaci.2011.11.017; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Gershon A, 2012, J ALLERGY CLIN IMMUN, V129, P679, DOI 10.1016/j.jaci.2011.11.014; Gingo MR, 2012, J ALLERGY CLIN IMMUN, V129, P708, DOI 10.1016/j.jaci.2011.11.015; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P1243, DOI 10.1016/j.jaci.2012.01.044; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P687, DOI 10.1016/j.jaci.2011.12.001; Greenberg S, 2012, J ALLERGY CLIN IMMUN, V130, P1071, DOI 10.1016/j.jaci.2012.07.057; Hashimoto S, 2012, LANCET, V380, P626, DOI 10.1016/S0140-6736(12)61132-5; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Hernandez ML, 2012, J ALLERGY CLIN IMMUN, V130, P869, DOI 10.1016/j.jaci.2012.05.026; Ingelsson E, 2012, J ALLERGY CLIN IMMUN, V129, P702, DOI 10.1016/j.jaci.2011.11.052; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Ji H, 2012, J ALLERGY CLIN IMMUN, V129, P33, DOI 10.1016/j.jaci.2011.11.008; Jia G, 2012, J ALLERGY CLIN IMMUN, V130; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Kauffmann F, 2012, J ALLERGY CLIN IMMUN; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Koinis-Mitchell D, 2012, J ALLERGY CLIN IMMUN; Krishnan JA, 2012, J ALLERGY CLIN IMMUN, V129, pS124, DOI 10.1016/j.jaci.2011.12.981; Kumar R, 2012, J ALLERGY CLIN IMMUN, V130, P996, DOI 10.1016/j.jaci.2012.04.047; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Ledford DK, 2012, J ALLERGY CLIN IMMUN, V130, P24, DOI 10.1016/j.jaci.2012.02.055; Leung TF, 2012, J ALLERGY CLIN IMMUN, V129, P42, DOI 10.1016/j.jaci.2011.11.031; Li JH, 2012, J ALLERGY CLIN IMMUN, V130, P22, DOI 10.1016/j.jaci.2012.02.047; Li XN, 2012, J ALLERGY CLIN IMMUN, V130, P861, DOI 10.1016/j.jaci.2012.04.041; Meyer N, 2012, J ALLERGY CLIN IMMUN, V129, P964, DOI 10.1016/j.jaci.2011.12.1002; Munitz A, 2012, J ALLERGY CLIN IMMUN, V129, P1011, DOI 10.1016/j.jaci.2012.02.016; Myers RA, 2012, J ALLERGY CLIN IMMUN; Nair P, 2012, J ALLERGY CLIN IMMUN, V130, P655, DOI 10.1016/j.jaci.2012.07.021; Nelsen LM, 2012, J ALLERGY CLIN IMMUN, V129, P251, DOI 10.1016/j.jaci.2011.09.003; Patel M, 2012, J ALLERGY CLIN IMMUN; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Rand CS, 2012, J ALLERGY CLIN IMMUN, V129, pS136, DOI 10.1016/j.jaci.2011.12.987; Rosas-Salazar C, 2012, J ALLERGY CLIN IMMUN, V129, P935, DOI 10.1016/j.jaci.2012.01.040; Rumpel JA, 2012, J ALLERGY CLIN IMMUN; Schwartz DA, 2012, J ALLERGY CLIN IMMUN; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Sumino K, 2012, J ALLERGY CLIN IMMUN, V130, DOI [10.1016/j.jaci.2012.02.025, DOI 10.1016/J.JACI.2012.02.025]; Szefler S, 2012, J ALLERGY CLIN IMMUN; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, P60, DOI 10.1016/j.jaci.2011.11.011; Tepper RS, 2012, J ALLERGY CLIN IMMUN, V129, pS65, DOI 10.1016/j.jaci.2011.12.986; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; von Mutius E, 2012, J ALLERGY CLIN IMMUN, V129, P1202, DOI 10.1016/j.jaci.2011.12.994; Wegienka G, 2012, J ALLERGY CLIN IMMUN, V130, P657, DOI 10.1016/j.jaci.2012.06.024; Weiss ST, 2012, J ALLERGY CLIN IMMUN, V129, P327, DOI 10.1016/j.jaci.2011.12.971; Wildfire JJ, 2012, J ALLERGY CLIN IMMUN, V129, P694, DOI 10.1016/j.jaci.2011.12.962; Wilson SR, 2012, J ALLERGY CLIN IMMUN, V130, P1085, DOI 10.1016/j.jaci.2012.09.002; Wilson SR, 2012, J ALLERGY CLIN IMMUN, V129, pS88, DOI 10.1016/j.jaci.2011.12.988; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032	72	16	17	0	18	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2013	131	1					47	54		10.1016/j.jaci.2012.11.020	http://dx.doi.org/10.1016/j.jaci.2012.11.020			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	062YR	23265695				2022-12-18	WOS:000312961200006
J	Konstantinou, GN; Xepapadaki, P; Manousakis, E; Makrinioti, H; Kouloufakou-Gratsia, K; Saxoni-Papageorgiou, P; Papadopoulos, NG				Konstantinou, George N.; Xepapadaki, Paraskevi; Manousakis, Emmanuel; Makrinioti, Heidi; Kouloufakou-Gratsia, Kalliopi; Saxoni-Papageorgiou, Photini; Papadopoulos, Nikolaos G.			Assessment of airflow limitation, airway inflammation, and symptoms during virus-induced wheezing episodes in 4-to 6-year-old children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Airflow limitation; airway inflammation; spirometry; reversibility; exhaled nitric oxide; forced expiratory volume at 0.5 seconds; longitudinal study	EXHALED NITRIC-OXIDE; PRESCHOOL-CHILDREN; EPITHELIAL-CELLS; LUNG-FUNCTION; INHALED CORTICOSTEROIDS; RHINOVIRUS INFECTION; HIGH-RISK; ASTHMA; SYNTHASE; HYPERRESPONSIVENESS	Background: It is disputed whether recurrent episodes of wheeze in preschool-aged children comprise a distinct asthma phenotype. Objective: We sought to prospectively assess airflow limitation and airway inflammation in children 4 to 6 years old with episodic virus-induced wheeze. Methods: Ninety-three children 4 to 6 years old with a history of mild, virus-induced episodes of wheeze who were able to perform acceptable fraction of exhaled nitric oxide (FENO) maneuvers and spirometry (with forced expiratory time >= 0.5 seconds) were followed prospectively. Lung function and FENO values were measured every 6 weeks (baseline) within the first 48 hours of an acute wheezing episode (day 0) and 10 and 30 days later. Symptom scores and peak flow measurement were recorded daily. Results: Forty-three children experienced a wheezing episode. At day 0, FENO values were significantly increased, whereas forced expiratory volume at 0.5 seconds (FEV0.5) significantly decreased compared with baseline (16 ppb [interquartile range {IQR}, 13-20 ppb] vs 9 ppb IQR, 7-11 ppb] and 0.84 L [IQR, 0.75-0.99 L] vs 0.99 L [IQR, 0.9-1.07 L], respectively; both P < .001). Airflow limitation at day 0 was reversible after bronchodilation. FEV0.5 and FENO values were significantly associated with each other and with lower and upper respiratory tract symptoms when assessed longitudinally but not cross-sectionally at all time points independently of atopy. FENO and FEV0.5 values returned to baseline levels within 10 days. Conclusions: Mild episodes of wheeze in preschoolers are characterized by enhanced airway inflammation, reversible airflow limitation, and asthma-related symptoms. FENO values increase significantly during the first 48 hours and return to personal baseline within 10 days from the initiation of the episode. Longitudinal follow-up suggests that symptoms, inflammation, and lung function correlate well in this phenotype of asthma. (J Allergy Clin Immunol 2013;131:87-93.)	[Konstantinou, George N.] 424 Gen Mil Training Hosp, Dept Allergy & Clin Immunol, Thessaloniki, Greece; [Konstantinou, George N.; Xepapadaki, Paraskevi; Manousakis, Emmanuel; Makrinioti, Heidi; Kouloufakou-Gratsia, Kalliopi; Saxoni-Papageorgiou, Photini; Papadopoulos, Nikolaos G.] Univ Athens, Pediat Clin 2, Allergy Res Ctr, Athens, Greece	National & Kapodistrian University of Athens	Konstantinou, GN (corresponding author), 21 Sirou St, Thessaloniki 54453, Greece.	gnkonstantinou@gmail.com	N.G., Papadopoulos/L-8670-2013; Papadopoulos, Nikolaos/ABE-1774-2021	N.G., Papadopoulos/0000-0002-4448-3468; Papadopoulos, Nikolaos/0000-0002-4448-3468; Papadopoulos, Nikolaos/0000-0002-2508-3872; Konstantinou, George/0000-0003-1371-6764	National and Kapodistrian University of Athens, Greece; Nestle; Merck Sharp Dohme; Deviblis (EBT)	National and Kapodistrian University of Athens, Greece; Nestle(Nestle SA); Merck Sharp Dohme(Merck & Company); Deviblis (EBT)	Supported by resources of the National and Kapodistrian University of Athens, Greece (Special Account for Research Grants/ELKE Account).; N. G. Papadopoulos has consultant arrangements with Abbott; has received grants from Nestle, Merck Sharp & Dohme, and Deviblis (EBT); has received payment for lectures from Merck Sharp & Dohme, Allergopharma, Uriach, and GlaxoSmithKline; and has received payment for development of educational presentations from Merck Sharp & Dohme and Uriach. The rest of the authors declare that they have no relevant conflicts of interest.	Alving K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-67; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Aurora P, 2004, AM J RESP CRIT CARE, V169, P1152, DOI 10.1164/rccm.200310-1453OC; Bacharier LB, 2008, ALLERGY, V63, P5, DOI 10.1111/j.1398-9995.2007.01586.x; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Brussee JE, 2005, EUR RESPIR J, V25, P455, DOI 10.1183/09031936.05.00079604; Covar RA, 2003, J PEDIATR-US, V142, P469, DOI 10.1067/mpd.2003.187; de Gouw HWFM, 1998, EUR RESPIR J, V11, P126, DOI 10.1183/09031936.98.11010126; Debley JS, 2010, J ALLERGY CLIN IMMUN, V125, P1228, DOI 10.1016/j.jaci.2010.03.023; DeMore JP, 2009, J ALLERGY CLIN IMMUN, V124, P245, DOI 10.1016/j.jaci.2009.05.030; Franklin PJ, 1999, AM J RESP CRIT CARE, V159, P69, DOI 10.1164/ajrccm.159.1.9804134; Global Strategy for Asthma Management and Prevention (2021), GLOB STRAT ASTHM MAN; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kao YJ, 2001, AM J RESP CRIT CARE, V163, P532, DOI 10.1164/ajrccm.163.2.9912068; Kaul P, 1999, AM J RESP CRIT CARE, V159, P1193, DOI 10.1164/ajrccm.159.4.9808043; KHARITONOV SA, 1995, EUR RESPIR J, V8, P295, DOI 10.1183/09031936.95.08020295; Kharitonov SA, 1996, AM J RESP CRIT CARE, V153, P1773, DOI 10.1164/ajrccm.153.6.8665033; Lands LC, 2005, AM J RESP CRIT CARE, V172, P776, DOI 10.1164/rccm.200405-661ST; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; Malmberg LP, 2003, THORAX, V58, P494, DOI 10.1136/thorax.58.6.494; Marteus H, 2004, NITRIC OXIDE-BIOL CH, V11, P247, DOI 10.1016/j.niox.2004.09.006; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moeller A, 2008, J ALLERGY CLIN IMMUN, V121, P705, DOI 10.1016/j.jaci.2007.11.008; Murphy AW, 1998, CHEST, V114, P452, DOI 10.1378/chest.114.2.452; National Asthma Education and Prevention Program, 2007, HYPERLIPIDAEMIA; Nystad W, 2002, THORAX, V57, P1021, DOI 10.1136/thorax.57.12.1021; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Saito J, 2006, PEDIATR PULM, V41, P709, DOI 10.1002/ppul.20387; Sanders SP, 2001, J ALLERGY CLIN IMMUN, V107, P235, DOI 10.1067/mai.2001.112028; Silkoff PE, 1998, RESP PHYSIOL, V113, P33, DOI 10.1016/S0034-5687(98)00033-4; Silkoff PE, 1997, AM J RESP CRIT CARE, V155, P260, DOI 10.1164/ajrccm.155.1.9001322; Sonnappa S, 2010, J ALLERGY CLIN IMMUN, V126, P519, DOI 10.1016/j.jaci.2010.04.018; Spyridaki IS, 2009, J VIROL METHODS, V156, P102, DOI 10.1016/j.jviromet.2008.10.027; Steerenberg PA, 2003, THORAX, V58, P242, DOI 10.1136/thorax.58.3.242; Strunk RC, 2003, J ALLERGY CLIN IMMUN, V112, P883, DOI 10.1016/j.jaci.2003.08.014; Tepper RS, 1999, AM J RESP CRIT CARE, V160, P835, DOI 10.1164/ajrccm.160.3.9811025; Uetani K, 2000, J IMMUNOL, V165, P988, DOI 10.4049/jimmunol.165.2.988; van de Kant KDG, 2011, CLIN EXP ALLERGY, V41, P1076, DOI 10.1111/j.1365-2222.2011.03774.x; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Vints AM, 2005, CHEST, V128, P2465, DOI 10.1378/chest.128.4.2465; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Xepapadaki P, 2005, J ALLERGY CLIN IMMUN, V116, P299, DOI 10.1016/j.jaci.2005.04.007; Zetterquist W, 1999, EUR RESPIR J, V13, P327, DOI 10.1034/j.1399-3003.1999.13b18.x	53	16	21	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2013	131	1					87	U135		10.1016/j.jaci.2012.10.033	http://dx.doi.org/10.1016/j.jaci.2012.10.033			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	062YR	23199600	Bronze, Green Published			2022-12-18	WOS:000312961200010
J	Rouleau, I; De Serres, G; Drolet, JP; Banerjee, D; Lemire, C; Moore, A; Paradis, L; Alizadhefar, R; Roches, AD; Chan, ES; Stark, D; Benoit, M; Skowronski, DM				Rouleau, Isabelle; De Serres, Gaston; Drolet, Jean Philippe; Banerjee, Devi; Lemire, Chantal; Moore, Andrew; Paradis, Louis; Alizadhefar, Reza; Roches, Anne Des; Chan, Edmond S.; Stark, Donald; Benoit, Melanie; Skowronski, Danuta M.		PCIRN Public Hlth Agcy Canada-Cana	Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Rouleau, Isabelle; De Serres, Gaston; Drolet, Jean Philippe; Benoit, Melanie] Univ Laval, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [De Serres, Gaston] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Banerjee, Devi; Alizadhefar, Reza] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Lemire, Chantal] Univ Sherbrooke, CHU Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Moore, Andrew] Ctr Affilie Univ Hop Charles Lemoyne, Quebec City, PQ, Canada; [Paradis, Louis] Univ Montreal, CHU Montreal, Montreal, PQ, Canada; [Roches, Anne Des] Univ Montreal, Hop St Justine, Montreal, PQ H3T 1C5, Canada; [Chan, Edmond S.] Univ British Columbia, BC Childrens Hosp, Vancouver, BC V5Z 1M9, Canada; [Skowronski, Danuta M.] BC Ctr Dis Control, Vancouver, BC, Canada	Laval University; Institut national de sante publique du Quebec (INSPQ); McGill University; University of Sherbrooke; Universite de Montreal; Universite de Montreal; BC Childrens Hospital; University of British Columbia	Rouleau, I (corresponding author), Univ Laval, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada.	gaston.deserres@ssss.gouv.qc.ca		Chan, Edmond/0000-0003-2947-1175	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Groupe Central ESPRI, 2010, SURV MAN CLIN INH SU; Kelso JM, 2009, MIDDLETONS ALLERGY P; Kurz X, 2011, VACCINE, V29, P4378, DOI 10.1016/j.vaccine.2011.04.005; Lafleche J, 2010, CAN J INFECT DIS MED, V21, P223; Liew KW, 2008, BRIT MED J, V337, pa2642; Seitz CS, 2009, VACCINE, V27, P3885, DOI 10.1016/j.vaccine.2009.04.020; Sugai K, 2007, VACCINE, V25, P3454, DOI 10.1016/j.vaccine.2006.12.057; Wood RA, 2008, PEDIATRICS, V122, pE771, DOI 10.1542/peds.2008-1002; Wood RA, 2007, J ALLERGY CLIN IMMUN, V120, P478, DOI 10.1016/j.jaci.2007.04.035	9	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2012	130	6					1423	1426		10.1016/j.jaci.2012.07.019	http://dx.doi.org/10.1016/j.jaci.2012.07.019			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	044RP	22958947				2022-12-18	WOS:000311641100029
J	Lee, JJ; Fried, AJ; Hait, E; Yen, EH; Perkins, JM; Rubinstein, E				Lee, John J.; Fried, Ari J.; Hait, Elizabeth; Yen, Elizabeth H.; Perkins, Julia M.; Rubinstein, Eitan			Topical inhaled ciclesonide for treatment of eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MODERATE PERSISTENT ASTHMA; FLUTICASONE PROPIONATE		[Lee, John J.; Fried, Ari J.; Hait, Elizabeth; Yen, Elizabeth H.; Perkins, Julia M.; Rubinstein, Eitan] Boston Childrens Hosp, Eosinophil Gastrointestinal Dis Program, Boston, MA USA; [Lee, John J.; Fried, Ari J.; Rubinstein, Eitan] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Hait, Elizabeth; Yen, Elizabeth H.; Perkins, Julia M.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Lee, JJ (corresponding author), Boston Childrens Hosp, Eosinophil Gastrointestinal Dis Program, Boston, MA USA.	john.lee@childrens.harvard.edu		Yen, Elizabeth/0000-0002-7172-8723	NIDDK NIH HHS [T32 DK067009] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067009] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boulet LP, 2007, RESP MED, V101, P1677, DOI 10.1016/j.rmed.2007.03.001; Konikoff MR, 2006, GASTROENTEROLOGY, V131, P1381, DOI 10.1053/j.gastro.2006.08.033; Pearlman DS, 2005, J ALLERGY CLIN IMMUN, V116, P1206, DOI 10.1016/j.jaci.2005.08.037; Schroeder S, 2012, J ALLERGY CLIN IMMUN, V129, P1419, DOI 10.1016/j.jaci.2012.03.007	4	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2012	130	4					1011	1011		10.1016/j.jaci.2012.06.053	http://dx.doi.org/10.1016/j.jaci.2012.06.053			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017MT	23021144	Green Accepted			2022-12-18	WOS:000309594800033
J	Bernstein, JA				Bernstein, Jonathan A.			Correlation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: Early evidence supporting a paradigm shift in drug investigation?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Pollen challenge chamber; environmental exposure unit; allergic rhinitis; ragweed; natural season; endotypes	ONSET; EFFICACY; PLACEBO; LORATADINE; CETIRIZINE; RHINITIS; RELIEF; SPRAY; UNIT		Univ Cincinnati, Div Immunol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Bernstein, JA (corresponding author), Univ Cincinnati, Div Immunol, 231 Bethesda Ave, Cincinnati, OH 45267 USA.	jonathan.bernstein@uc.edu		Bernstein, Jonathan/0000-0002-3476-1196				Bernstein JA, 2012, ALLERGY ASTHMA PROC, V33, P1; Corren J, 2011, J ALLERGY CLIN IMMUN, V127, P398, DOI 10.1016/j.jaci.2010.09.043; Day JH, 2000, J ALLERGY CLIN IMMUN, V105, P489, DOI 10.1067/mai.2000.104550; Day JH, 2006, ANN ALLERG ASTHMA IM, V96, P263, DOI 10.1016/S1081-1206(10)61235-5; Day JH, 1997, ANN ALLERG ASTHMA IM, V79, P163, DOI 10.1016/S1081-1206(10)63104-3; Day JH, 1996, J ALLERGY CLIN IMMUN, V97, P1050, DOI 10.1016/S0091-6749(96)70257-9; Day JH, 1998, J ALLERGY CLIN IMMUN, V101, P638, DOI 10.1016/S0091-6749(98)70172-1; Day JH, 1997, ANN ALLERG ASTHMA IM, V79, P533, DOI 10.1016/S1081-1206(10)63062-1; Day JH, 2001, ANN ALLERG ASTHMA IM, V87, P474, DOI 10.1016/S1081-1206(10)62260-0; Donovan JP, 1996, ANN ALLERG ASTHMA IM, V77, P74, DOI 10.1016/S1081-1206(10)63483-7; Ellis AK, 2010, ANN ALLERG ASTHMA IM, V104, P293, DOI 10.1016/j.anai.2010.01.012; Jacobs RL, 2012, J ALLERGY CLIN IMMUN, V130, P122, DOI 10.1016/j.jaci.2012.03.031; Salapatek AM, 2010, AM J RHINOL ALLERGY, V24, P433, DOI 10.2500/ajra.2010.24.3548; Stubner P, 2004, CURR MED RES OPIN, V20, P891, DOI 10.1185/030079904125003700; Togias A, 2010, ENV EXPOSURE UNITS C, P1	15	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2012	130	1					128	129		10.1016/j.jaci.2012.05.032	http://dx.doi.org/10.1016/j.jaci.2012.05.032			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	977GN	22742840				2022-12-18	WOS:000306644800018
J	Filep, S; Tsay, A; Vailes, LD; Gadermaier, G; Ferreira, F; Matsui, E; King, EM; Chapman, MD				Filep, Stephanie; Tsay, Amy; Vailes, Lisa D.; Gadermaier, Gabriele; Ferreira, Fatima; Matsui, Elizabeth; King, Eva M.; Chapman, Martin D.			Specific allergen concentration of WHO and FDA reference preparations measured using a multiple allergen standard	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DERMATOPHAGOIDES-PTERONYSSINUS; EXTRACTS; MITE		[Filep, Stephanie; Tsay, Amy; Vailes, Lisa D.; King, Eva M.; Chapman, Martin D.] Indoor Biotechnol Inc, Charlottesville, VA USA; [Gadermaier, Gabriele; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Matsui, Elizabeth] Johns Hopkins Univ Hosp, Dept Pediat Allergy & Immunol, Baltimore, MD 21287 USA	INDOOR Biotechnologies; Salzburg University; Johns Hopkins University; Johns Hopkins Medicine	Filep, S (corresponding author), Indoor Biotechnol Inc, Charlottesville, VA USA.	mdc@inbio.com	Ferreira, Fatima/E-4889-2011; Gadermaier, Gabriele/L-5997-2015; Ferreira, Fatima/AAB-4321-2019	Ferreira, Fatima/0000-0003-0989-2335; Gadermaier, Gabriele/0000-0002-4886-417X; Ferreira, Fatima/0000-0003-0989-2335; Filep, Stephanie/0000-0003-2135-5161; Matsui, Elizabeth/0000-0001-8134-5593; Chapman, Martin/0000-0002-0845-3632	NIAID NIH HHS [R01AI081845, R01 AI081845, R01AI070630, R01 AI070630] Funding Source: Medline; NIEHS NIH HHS [P50ES015903, P01 ES018176, HHSN273201000008C, P50 ES015903, N44ES55545, P01ES018176] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081845, R01AI070630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018176, P50ES015903] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Chapman MD, 2008, J ALLERGY CLIN IMMUN, V122, P882, DOI 10.1016/j.jaci.2008.07.030; Chapman MD, 2008, ALLERGY, V63, P310; Earle CD, 2007, J ALLERGY CLIN IMMUN, V119, P428, DOI 10.1016/j.jaci.2006.11.004; Filep S, 2011, ALLERGY         1118, DOI [10.1111/j.1398-9995.2011.02750.x, DOI 10.1111/J.1398-9995.2011.02750.X]; FORD AW, 1985, INT ARCH ALLER A IMM, V76, P58, DOI 10.1159/000233662; MEYER CH, 1994, CLIN EXP ALLERGY, V24, P1041, DOI 10.1111/j.1365-2222.1994.tb02741.x; Nelson HS, 2007, J ALLERGY CLIN IMMUN, V119, P769, DOI 10.1016/j.jaci.2007.01.036; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Turkeltaub PC, 1997, ARB P EHRLICH I BUND, V91, P145; YASUEDA H, 1994, CLIN EXP ALLERGY, V24, P1030, DOI 10.1111/j.1365-2222.1994.tb02739.x	10	16	16	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2012	129	5					1408	1410		10.1016/j.jaci.2011.12.978	http://dx.doi.org/10.1016/j.jaci.2011.12.978			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	934CG	22277198	Green Accepted			2022-12-18	WOS:000303418000036
J	Hafner, RP; Efthimiou, J; Salapatek, A; Patel, D; Larche, M				Hafner, R. P.; Efthimiou, J.; Salapatek, A.; Patel, D.; Larche, M.			Persistent Treatment Effect Achieved at One Year After 4 Doses of Fel d 1-Derived Peptide Immunotherapy in an Environmental Exposure Chamber (EEC) Model of Cat Allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Hafner, R. P.; Efthimiou, J.] Circassia Ltd, Oxford, England; [Salapatek, A.; Patel, D.] Cetero Res, Mississauga, ON, Canada; [Larche, M.] McMaster Univ, Hamilton, ON, Canada	McMaster University				Larche, Mark/0000-0002-1439-7593					0	16	18	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB144	AB144		10.1016/j.jaci.2011.12.485	http://dx.doi.org/10.1016/j.jaci.2011.12.485			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133400545
J	Chinn, IK; Markert, ML				Chinn, Ivan K.; Markert, M. Louise			Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						DiGeorge anomaly; parathyroid; thymus; tolerance induction; transplantation	ALLOGRAFT SURVIVAL; CLASS-I; TRANSPLANTATION; HISTOCOMPATIBILITY; ALLOTRANSPLANTATION; CELLS	DiGeorge anomaly can affect both thymic and parathyroid function. Although athymia is corrected by allogeneic thymus transplantation, treatment options for hypoparathyroidism have been unsatisfactory. Parathyroid transplantation offers the potential for definitive cure but remains challenging because of graft rejection. Some allogeneic parathyroid grafts have functioned in adult recipients in the context of immunosuppression for renal transplantation. Other efforts have attempted to reduce the allogenicity of the parathyroid grafts through manipulation of the parathyroid tissues before transplantation (by using encapsulation or special culture techniques). Recently, we demonstrated the efficacy of parental parathyroid transplantation when combined with allogeneic thymus transplantation in an infant with complete DiGeorge anomaly. The recipient developed tolerance toward the parathyroid donor. The parathyroid graft has functioned for 5 years after transplantation without the need for continued immunosuppression or calcium supplementation. We observed that matching of the allogeneic thymus graft to the parathyroid donor HLA class II alleles that are unshared with the recipient appears to be associated with the induction of tolerance toward the parathyroid graft. Further work is needed to determine the optimal means for using combined allogeneic thymus and parental parathyroid transplantation to correct hypoparathyroidism in patients with both complete and partial DiGeorge anomaly. (J Allergy Clin Immunol 2011;127:1351-5.)	[Chinn, Ivan K.; Markert, M. Louise] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA; [Markert, M. Louise] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University	Chinn, IK (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Box 3068, Durham, NC 27710 USA.	chinn001@mc.duke.edu		Chinn, Ivan/0000-0001-5684-5457	American Academy of Allergy; National Institutes of Health [R01 AI 047040, R21 AI 060967, M03 RR 30, T32 AI 007062-28A2, 2 K12 HD043494 06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007062, R21AI060967, R01AI047040] Funding Source: NIH RePORTER	American Academy of Allergy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the American Academy of Allergy, Asthma & Immunology 2006 Third-Year Fellow-in-Training Research and 2008 Senior Allergy/Immunology Fellow Transition Awards and National Institutes of Health grants R01 AI 047040, R21 AI 060967, M03 RR 30 (General Clinical Research Center, National Center for Research Resources), T32 AI 007062-28A2, and 2 K12 HD043494 06. M. L. M. is a member of the Duke Comprehensive Cancer Center.	BACH FH, 1967, SCIENCE, V156, P1506, DOI 10.1126/science.156.3781.1506; BJERNEROTH G, 1993, TRANSPLANTATION, V56, P717, DOI 10.1097/00007890-199309000-00040; Chinn IK, 2008, CLIN IMMUNOL, V126, P277, DOI 10.1016/j.clim.2007.11.009; Chinn IK, 2010, J ALLERGY CLIN IMMUN, V126, P814, DOI 10.1016/j.jaci.2010.07.016; FIREMAN P, 1965, J PEDIATR-US, V67, P907; GOSS JA, 1994, TRANSPLANT P, V26, P3374; Griesemer AD, 2010, TRANSPLANTATION, V90, P465, DOI 10.1097/TP.0b013e3181e7e54f; JACOB SW, 1963, AM J SURG, V105, P196, DOI 10.1016/0002-9610(63)90291-5; Jeras M, 2002, TRANSPL IMMUNOL, V10, P205, DOI 10.1016/S0966-3274(02)00067-9; Kaczmarek I, 2006, J HEART LUNG TRANSPL, V25, P1057, DOI 10.1016/j.healun.2006.05.004; Li XAC, 2010, CURR OPIN ORGAN TRAN, V15, P499, DOI 10.1097/MOT.0b013e32833bfb33; Liu WT, 2010, CURR OPIN ORGAN TRAN, V15, P422, DOI 10.1097/MOT.0b013e32833b7903; Markert ML, 2007, BLOOD, V109, P4539, DOI 10.1182/blood-2006-10-048652; MULLER W, 1988, EUR J PEDIATR, V147, P496; NAJI A, 1976, J SURG RES, V20, P261, DOI 10.1016/0022-4804(76)90012-3; Nawrot I, 2007, TRANSPLANTATION, V83, P734, DOI 10.1097/01.tp.0000258601.17505.9d; Safinia N, 2010, CURR OPIN ORGAN TRAN, V15, P427, DOI 10.1097/MOT.0b013e32833bfadc; Seyfert-Margolis V, 2010, PEDIATR CLIN N AM, V57, P523, DOI 10.1016/j.pcl.2010.01.015; Sullivan KE, 2008, IMMUNOL ALLERGY CLIN, V28, P353, DOI 10.1016/j.iac.2008.01.003; Tibell A, 2001, CELL TRANSPLANT, V10, P591; Torregrosa NM, 2005, THYROID, V15, P1299, DOI 10.1089/thy.2005.15.1299; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882	22	16	17	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1351	1355		10.1016/j.jaci.2011.03.033	http://dx.doi.org/10.1016/j.jaci.2011.03.033			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21513969	Green Accepted			2022-12-18	WOS:000291048500004
J	Andregnette-Roscigno, V; Fernandez-Nieto, M; Del Potro, MG; Aguado, E; Sastre, J				Andregnette-Roscigno, Victoria; Fernandez-Nieto, Mar; Garcia Del Potro, Manuela; Aguado, Erika; Sastre, Joaquin			Methacholine is more sensitive than mannitol for evaluation of bronchial hyperresponsiveness in children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHALLENGE		[Fernandez-Nieto, Mar; Sastre, Joaquin] CIBER Enfermedades Resp CIBERES Madrid, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES		jsastre@fjd.es						Anderson SD, 1997, AM J RESP CRIT CARE, V156, P758, DOI 10.1164/ajrccm.156.3.9701113; Joos GF, 2003, EUR RESPIR J, V21, P1050, DOI 10.1183/09031936.03.00008403; Porsbjerg C, 2009, CLIN RESPIR J, V3, P189, DOI 10.1111/j.1752-699X.2009.00161.x; Sastre J, 2003, CHEST, V123, P1276, DOI 10.1378/chest.123.4.1276; Sverrild A, 2009, J ALLERGY CLIN IMMUN, V124, P928, DOI 10.1016/j.jaci.2009.06.028	5	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2010	126	4					869	871		10.1016/j.jaci.2010.07.025	http://dx.doi.org/10.1016/j.jaci.2010.07.025			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	658SP	20920775				2022-12-18	WOS:000282510000028
J	Tcheurekdjian, H; Via, M; De Giacomo, A; Corvol, H; Eng, C; Thyne, S; Chapela, R; Rodriguez-Cintron, W; Rodriguez-Santana, JR; Avila, PC; Burchard, EG				Tcheurekdjian, Haig; Via, Marc; De Giacomo, Anthony; Corvol, Harriet; Eng, Celeste; Thyne, Shannon; Chapela, Rocio; Rodriguez-Cintron, William; Rodriguez-Santana, Jose R.; Avila, Pedro C.; Burchard, Esteban Gonzalez		Genetics Asthma Latino Amer Study	ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; leukotriene; leukotriene modifier; Latino; albuterol; drug responsiveness; association study; genetic polymorphism	PUERTO-RICAN; GENETIC ANCESTRY; UNITED-STATES; ASTHMA; MEXICAN; US; REPLICATION	Background: Understanding the effects of interactions between multiple genes and asthma medications may aid in the understanding of the heterogeneous response to asthma therapies. Objective: To identify modulating effects of arachidonate 5-lipoxygenase- activating protein (ALOX5AP) and leukotriene A(4) hydrolase (LTA4H) gene polymorphisms on the drug-drug interaction between leukotriene modifiers and albuterol in Mexicans and Puerto Ricans. Methods: In a cross-sectional study of 293 Mexicans and 356 Puerto Ricans with asthma, ALOX5AP and LTA4H genes were sequenced, and interactions between gene polymorphisms and bronchodilator responsiveness to albuterol were compared between leukotriene modifier users and nonusers. Results: In heterozygotes and homozygotes for the minor allele at LTA4H single nucleotide polymorphism (SNP) rs2540491 and heterozygotes for the major allele at LTA4H SNP rs2540487, leukotriene modifier use was associated with a clinically significant increase in percent change in FEV(1) after albuterol administration of 7.10% (P = .002), 10.06% (P = .001), and 10.03% (P < .001), respectively. Presence of the major allele at ALOX5AP SNP rs10507391 or the minor allele at ALOX5AP SNP rs9551963 augmented this response. When stratified by ethnicity, these findings held true for Puerto Ricans but not Mexicans. Conclusion: LTA4H and ALOX5AP gene polymorphisms modify the augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Ricans but not Mexicans with asthma. (J Allergy Clin Immunol 2010;126:853-8.)	[Tcheurekdjian, Haig; Burchard, Esteban Gonzalez] Allergy Immunol Associates Inc, Cleveland, OH USA; [Tcheurekdjian, Haig; Burchard, Esteban Gonzalez] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Via, Marc; De Giacomo, Anthony; Corvol, Harriet; Eng, Celeste; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Via, Marc; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Thyne, Shannon] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Corvol, Harriet] UPMC INSERM U893, Dept Pediat Pulm, Paris, France; [Chapela, Rocio] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Rodriguez-Cintron, William] Vet Caribbean Hlth Care Syst, San Juan, PR USA; [Rodriguez-Santana, Jose R.] CSP, Ctr Neumol Pediat, San Juan, PR USA; [Avila, Pedro C.] Northwestern Univ, Div Allergy Immunol, Chicago, IL 60611 USA	Case Western Reserve University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Northwestern University	Tcheurekdjian, H (corresponding author), 1611 S Green Rd,231, Cleveland, OH 44121 USA.	haig.tcheurekdjian@gmail.com	Corvol, Harriet/N-5922-2018; Via, Marc/L-6511-2014	Corvol, Harriet/0000-0002-7026-7523; Via, Marc/0000-0002-9966-9921	National Institutes of Health [HL078885, AI077439, HL088133]; Flight Attendant Medical Research Institute; RWJF Amos Medical Faculty Development Award; Beatriu de Pinos Postdoctoral Grant [2006 BP-A 10144]; Sandler Center for Basic Research in Asthma; Sandler Family Supporting Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088133, R01HL078885, K23HL004464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; RWJF Amos Medical Faculty Development Award; Beatriu de Pinos Postdoctoral Grant; Sandler Center for Basic Research in Asthma; Sandler Family Supporting Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the National Institutes of Health (HL078885, AI077439, HL088133), the Flight Attendant Medical Research Institute and RWJF Amos Medical Faculty Development Award to E.G.B., the Ernest S. Bazley Trust to P.C.A., the Beatriu de Pinos Postdoctoral Grant (2006 BP-A 10144) to M.V., and the Sandler Center for Basic Research in Asthma and the Sandler Family Supporting Foundation.; Disclosure of potential conflict of interest: S. Thyne has received research support from the National Institutes of Health. The rest of the authors have declared that they have no conflict of interest.	American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P1107; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Choudhry S, 2005, AM J RESP CRIT CARE, V171, P563, DOI 10.1164/rccm.200409-1286OC; Corvol H, 2009, PHARMACOGENET GENOM, V19, P489, DOI 10.1097/FPC.0b013e32832c440e; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Holloway JW, 2008, ALLERGY, V63, P1046, DOI 10.1111/j.1398-9995.2008.01667.x; Homa DM, 2000, AM J RESP CRIT CARE, V161, P504, DOI 10.1164/ajrccm.161.2.9906025; Lima JJ, 2009, CURR OPIN PULM MED, V15, P57, DOI 10.1097/MCP.0b013e32831da8be; Litonjua AA, 2008, AM J RESP CRIT CARE, V178, P688, DOI 10.1164/rccm.200709-1363OC; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Ranganathan M, 2006, PLOS MED, V3, P329, DOI 10.1371/journal.pmed.0030044; Sheikh A, 2004, BMJ-BRIT MED J, V329, P87, DOI 10.1136/bmj.38061.593935.F7; Tcheurekdjian H, 2009, ANN ALLERG ASTHMA IM, V102, P510, DOI 10.1016/S1081-1206(10)60126-3; Via M, 2010, CLIN EXP ALLERGY, V40, P582, DOI 10.1111/j.1365-2222.2009.03438.x; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; 2004, JAMA, V291, P1435	20	16	21	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2010	126	4					853	858		10.1016/j.jaci.2010.06.048	http://dx.doi.org/10.1016/j.jaci.2010.06.048			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	658SP	20810156	Green Accepted			2022-12-18	WOS:000282510000025
J	van de Kant, KDG; Klaassen, EMM; Jobsis, Q; Koers, K; Rijkers, GT; van der Grinten, CP; van Schayck, OCP; Passos, VL; Dompeling, E				van de Kant, Kim D. G.; Klaassen, Ester M. M.; Jobsis, Quirijn; Koers, Karlijn; Rijkers, Ger T.; van der Grinten, Chris P.; van Schayck, Onno C. P.; Passos, Valeria Lima; Dompeling, Edward			Wheezing in preschool children is associated with increased levels of cytokines/chemokines in exhaled breath condensate	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AIRWAY INFLAMMATION; ASTHMA; CELLS		[van de Kant, Kim D. G.; Klaassen, Ester M. M.; Jobsis, Quirijn; Koers, Karlijn; Dompeling, Edward] Maastricht Univ, Med Ctr, Dept Pediat Pulmonol, Maastricht, Netherlands; [van Schayck, Onno C. P.] Maastricht Univ, Med Ctr, Dept Gen Practice, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands; [van der Grinten, Chris P.] Maastricht Univ, Med Ctr, Dept Resp Med, Maastricht, Netherlands; [Passos, Valeria Lima] Maastricht Univ, Med Ctr, Dept Methodol & Stat, Maastricht, Netherlands; [Rijkers, Ger T.] Univ Med Ctr, Dept Surg, Utrecht, Netherlands; [Rijkers, Ger T.; Passos, Valeria Lima] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht	van de Kant, KDG (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat Pulmonol, Maastricht, Netherlands.	kim.vande.kant@mumc.nl	Lima Passos, Valeria/AFT-1000-2022; Rijkers, Ger/R-7236-2019; Rijkers, Ger/AAW-6143-2020	Rijkers, Ger/0000-0001-6948-6123; Lima Passos, Valeria/0000-0003-0580-6639				Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Drews AC, 2009, ALLERGY, V64, P1597, DOI 10.1111/j.1398-9995.2009.02057.x; Le Bourgeois M, 2002, CHEST, V122, P791, DOI 10.1378/chest.122.3.791; Marguet C, 1999, AM J RESP CRIT CARE, V159, P1533, DOI 10.1164/ajrccm.159.5.9805028; Martinez FD, 2003, IMMUNOLOGY WHEEZING; McDougall CM, 2006, THORAX, V61, P739, DOI 10.1136/thx.2005.057984; McNamara PS, 2004, LANCET, V363, P1031, DOI 10.1016/S0140-6736(04)15838-8; Rosias PPR, 2010, PEDIAT ALLERG IMM-UK, V21, pE235, DOI 10.1111/j.1399-3038.2009.00909.x; van de Kant KDG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-210	10	16	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2010	126	3					669	671		10.1016/j.jaci.2010.07.013	http://dx.doi.org/10.1016/j.jaci.2010.07.013			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	646CF	20816200	Bronze			2022-12-18	WOS:000281512500042
J	Parviainen, S; Taivainen, A; Liukko, A; Nieminen, A; Rytkonen-Nissinen, M; Kinnunen, T; Virtanen, T				Parviainen, Suvi; Taivainen, Antti; Liukko, Aino; Nieminen, Anssi; Rytkonen-Nissinen, Marja; Kinnunen, Tuure; Virtanen, Tuomas			Comparison of the allergic and nonallergic CD4(+) T-cell responses to the major dog allergen Can f 1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNE DEVIATION; INDIVIDUALS; ACTIVATION		[Parviainen, Suvi; Liukko, Aino; Nieminen, Anssi; Rytkonen-Nissinen, Marja; Kinnunen, Tuure; Virtanen, Tuomas] Univ Eastern, Dept Clin Microbiol, Inst Clin Med & Bioctr Kuopio, Kuopio, Finland; [Taivainen, Antti] Kuopio Univ Hosp, Dept Pulm Dis, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Parviainen, S (corresponding author), Univ Eastern, Dept Clin Microbiol, Inst Clin Med & Bioctr Kuopio, Kuopio, Finland.	Tuure.Kinnunen@uef.fi	Kinnunen, Tuure/D-4898-2011	Kinnunen, Tuure/0000-0003-1595-5371; Rytkonen-Nissinen, Marja/0000-0002-2014-8315; Ronka, Aino/0000-0001-6007-3648; Kailaanmaki, Anssi/0000-0002-4737-980X				Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Bateman EAL, 2006, J ALLERGY CLIN IMMUN, V118, P1350, DOI 10.1016/j.jaci.2006.07.040; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Macaubas C, 2006, J IMMUNOL, V176, P5069, DOI 10.4049/jimmunol.176.8.5069; Mobs C, 2010, J IMMUNOL, V184, P2194, DOI 10.4049/jimmunol.0901379; Romagnani S, 2007, J ALLERGY CLIN IMMUN, V119, P1511, DOI 10.1016/j.jaci.2007.04.005; Skrindo I, 2008, CLIN EXP ALLERGY, V38, P1752, DOI 10.1111/j.1365-2222.2008.03081.x; Van Overtvelt L, 2008, J IMMUNOL, V180, P4514, DOI 10.4049/jimmunol.180.7.4514; Yamanaka K, 2009, J ALLERGY CLIN IMMUN, V124, P842, DOI 10.1016/j.jaci.2009.06.020	10	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2010	126	2								10.1016/j.jaci.2010.06.005	http://dx.doi.org/10.1016/j.jaci.2010.06.005			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	642IL	20624643	Bronze			2022-12-18	WOS:000281203800036
J	Gerald, JK; Grad, R; Bailey, WC; Gerald, LB				Gerald, Joe K.; Grad, Roni; Bailey, William C.; Gerald, Lynn B.			Cost-effectiveness of school-based asthma screening in an urban setting	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; screening; case detection; childhood asthma; cost-effectiveness; quality of life; economic analysis; Markov modeling	HEALTH-CARE SERVICES; QUALITY-OF-LIFE; ELEMENTARY-SCHOOL; CHILDHOOD ASTHMA; CHILDREN; PREVALENCE; MEDICAID; THERAPY; EMERGENCY; SEVERITY	Background: Much has been done to promote population-based childhood asthma screening; however, concerns remain regarding its cost-effectiveness. Objectives: To conduct a cost-effectiveness analysis of school-based asthma screening strategies. Methods: A 5 health state Markov approach (symptom-free, symptom, exacerbation recovery, emergency department, and hospitalization day) was used to evaluate school-based screening in a simulated population of urban elementary-age school children. Two questionnaire and 2 multistage strategies incorporating spirometry or spirometry with exercise testing were evaluated from the societal perspective by using 365 daily cycles. The outcome was 2006 dollars per quality-adjusted life year (QALY). Results: The most efficient strategy identified children with previously diagnosed but poorly controlled asthma at a cost of $150,000 per QALY (95% CI, $65,800-$318,000). Uncertainty surrounding the cost-effectiveness estimate was primarily a result of the symptom day preference weight estimate (44%), the probability of confirmation after screening (17%), the adequacy of asthma control in the population (9%), and the estimated treatment effect on symptoms (6%). Screening generated an additional 21 symptom-free day equivalents per child identified with previously diagnosed but not well controlled asthma and led to $85.55, $12.36, and $2.58 in additional screening, daily treatment, and indirect costs and $5.01 less in emergency department and hospitalization costs. Conclusion: Population-based asthma screening is not cost-effective at $50,000 per QALY and has only a 20% chance of being cost-effective at $100,000 per QALY. The most efficient approach is to screen for previously diagnosed but poorly controlled asthma. Linking screening with better treatment, and long-term adherence strategies might yield future cost-effective approaches. (J Allergy Clin Immunol 2010;125:643-50.)	[Gerald, Joe K.] Univ Arizona, Div Community Environm & Policy, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85724 USA; [Gerald, Lynn B.] Univ Arizona, Div Hlth Promot Sci, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85724 USA; [Grad, Roni; Gerald, Lynn B.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85724 USA; [Bailey, William C.] Univ Alabama Birmingham, Sch Med, Lung Hlth Ctr, Birmingham, AL USA	University of Arizona; University of Arizona; University of Arizona; University of Alabama System; University of Alabama Birmingham	Gerald, JK (corresponding author), Univ Arizona, Div Community Environm & Policy, Mel & Enid Zuckerman Coll Publ Hlth, 1295 N Martin Ave,POB 245210, Tucson, AZ 85724 USA.	geraldj@email.arizona.edu	Praena-Crespo, Manuel/E-7172-2010	Praena-Crespo, Manuel/0000-0002-1928-9663	National Heart, Lung, and Blood Institute [NHLB1 1R01HL65529]; drug companies as sponsors of investigational drug research projects; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065529] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); drug companies as sponsors of investigational drug research projects; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a grant NHLB1 1R01HL65529 from the National Heart, Lung, and Blood Institute.; Disclosure of potential conflict of interest: W. C. Bailey has received research contracts front drug companies as sponsors of investigational drug research projects; receives honoraria from pharmaceutical companies for delivering lectures as part of continuing medical education programs for physicians with appropriate disclosure; and works on grants as an investigator with the National Institutes of Health, which may occasionally use a therapy/drug from pharmaceutical companies. Some of the pharmaceutical companies are GlaxoSmithKline, Schering Plough, Merck, Inspire, Rhone Poulenc Rorer, Pfizer, Pharmaceutical Product Dev, Aventis, Boehringer Ingelheim, Altana, and Novartis. The authors have declared that they have no conflict of interest.	Adams RJ, 2001, PEDIATRICS, V107, P706, DOI 10.1542/peds.107.4.706; Akinbami, 2006, STATE CHILDHOOD ASTH, V381; *AL BOARD ED, 2006, 2005 2006 REP CARD S; *AL MED AG, 2006, FEE SCHED PHYS COD; *AL MED AG, 2007, PREF DRUG LIST; *AL MED AG, 2007, ANN REP FY 2006; *AM COLL ALL ASTHM, 2007, NAT ASTHM SCREEN PRO; Antonicelli L, 2004, EUR RESPIR J, V23, P723, DOI 10.1183/09031936.04.00004904; *ASTHM ALL FDN AM, 2009, ASTHM SCREEN PROGR; *ASTHM ALL NETW MO, 2009, STOP ASTHM DEATHS NO; Bauer EJ, 1999, J SCHOOL HEALTH, V69, P12, DOI 10.1111/j.1746-1561.1999.tb02335.x; Bauman LJ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e6; Bravata DM, 2009, ARCH PEDIAT ADOL MED, V163, P572, DOI 10.1001/archpediatrics.2009.63; Camargo CA, 2007, AM J HEALTH-SYST PH, V64, P1054, DOI 10.2146/ajhp060256; Chen YZ, 2006, PEDIAT ALLERG IMM-UK, V17, P7, DOI 10.1111/j.1600-5562.2006.00379.x; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Chiou CF, 2005, INT J QUAL HEALTH C, V17, P23, DOI 10.1093/intqhc/mzh086; Clark NM, 2002, J CLIN EPIDEMIOL, V55, P870, DOI 10.1016/S0895-4356(02)00451-1; David C, 2004, J ASTHMA, V41, P655, DOI 10.1081/JAS-200026432; de Jongste JC, 2009, AM J RESP CRIT CARE, V179, P93, DOI 10.1164/rccm.200807-1010OC; Diette GB, 2004, ANN ALLERG ASTHMA IM, V93, P546, DOI 10.1016/S1081-1206(10)61261-6; Dolan CM, 2004, ANN ALLERG ASTHMA IM, V92, P32, DOI 10.1016/S1081-1206(10)61707-3; Finkelstein JA, 2000, PEDIATRICS, V106, P886; Finkelstein JA, 2002, ARCH PEDIAT ADOL MED, V156, P562, DOI 10.1001/archpedi.156.6.562; FLEMING T, 2007, RED BOOK PHARM FUND; Gencarelli Dawn M, 2002, NHPF Issue Brief, P1; Gerald JK, 2009, AM J RESP CRIT CARE, V179; Gerald JK, 2009, PEDIATRICS, V124, pE927, DOI 10.1542/peds.2008-2798; Gerald LB, 2004, PEDIATRICS, V114, pE459, DOI 10.1542/peds.2004-0455; Gerald LB, 2002, J ASTHMA, V39, P29, DOI 10.1081/JAS-120000804; Gerald Lynn B, 2007, Proc Am Thorac Soc, V4, P133, DOI 10.1513/pats.200604-103ST; Grant EN, 1999, CHEST, V116, p145S, DOI 10.1378/chest.116.suppl_2.145S; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; Gupta RS, 2006, AMBUL PEDIATR, V6, P15, DOI 10.1016/j.ambp.2005.07.001; Halterman JS, 2001, AMBUL PEDIATR, V1, P275, DOI 10.1367/1539-4409(2001)001<0275:MUAHCC>2.0.CO;2; HAYWARD JA, 2003, RITE STATS, V2; Internal Review Service, 2006, IRS ANN 2007 STAND M; Joseph CLM, 2005, J PEDIATR-US, V146, P96, DOI 10.1016/j.jpeds.2004.09.001; Joseph CLM, 1996, J PEDIATR-US, V129, P735, DOI 10.1016/S0022-3476(96)70158-0; Lieu TA, 2002, PEDIATRICS, V109, P857, DOI 10.1542/peds.109.5.857; Maier WC, 1998, J CLIN EPIDEMIOL, V51, P557, DOI 10.1016/S0895-4356(98)00027-4; MANDELBLATT F, 1996, COST EFFECTIVENESS H; Meurer JR, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.6.e70; Moonie SA, 2006, J SCHOOL HEALTH, V76, P18, DOI 10.1111/j.1746-1561.2006.00062.x; Mvula M, 2005, J ASTHMA, V42, P9, DOI 10.1081/JAS-200044746; *NAT HEART LUNG BL, 2009, EPR 3 NAT HEART LUNG; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Nicholas SW, 2005, AM J PUBLIC HEALTH, V95, P245, DOI 10.2105/AJPH.2004.042705; Nuijsink M, 2007, EUR RESPIR J, V30, P457, DOI 10.1183/09031936.00111806; Pawar V, 2006, RESP MED, V100, P1579, DOI 10.1016/j.rmed.2005.12.009; Piecoro LT, 2001, HEALTH SERV RES, V36, P357; Price MJ, 2002, PHARMACOECONOMICS, V20, P183, DOI 10.2165/00019053-200220030-00004; Riekert KA, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e214; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Schmier JK, 2007, ANN ALLERG ASTHMA IM, V98, P245, DOI 10.1016/S1081-1206(10)60713-2; Schneider D, 2004, ARCH ENVIRON HEALTH, V59, P4, DOI 10.3200/AEOH.59.1.4-13; Sin DD, 2002, ARCH INTERN MED, V162, P1591, DOI 10.1001/archinte.162.14.1591; Smith MJ, 2004, ANN ALLERG ASTHMA IM, V92, P40, DOI 10.1016/S1081-1206(10)61708-5; Stevens MW, 2001, PEDIATRICS, V107, P1357, DOI 10.1542/peds.107.6.1357; *TREEAGE SOFTW INC, 2009, TREEAGE PRO SUIT 200; *US DEP LAB, 2005, 2005 CURR POP SURV; van Gent R, 2007, EUR J PEDIATR, V166, P843, DOI 10.1007/s00431-006-0358-y; Wang Li Yan, 2005, Prev Chronic Dis, V2, pA11; Webber MP, 2002, PEDIATR PULM, V34, P105, DOI 10.1002/ppul.10146; Yawn BP, 2003, ANN ALLERG ASTHMA IM, V90, P508, DOI 10.1016/S1081-1206(10)61844-3; Yawn BP, 2002, ARCH PEDIAT ADOL MED, V156, P1256, DOI 10.1001/archpedi.156.12.1256	66	16	16	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2010	125	3					643	650		10.1016/j.jaci.2009.12.984	http://dx.doi.org/10.1016/j.jaci.2009.12.984			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	573BK	20226298				2022-12-18	WOS:000275883200020
J	Zeiger, RS; Chipps, BE; Haselkorn, T; Rasouliyan, L; Simons, FER; Fish, JE				Zeiger, Robert S.; Chipps, Bradley E.; Haselkorn, Tmirah; Rasouliyan, Lawrence; Simons, F. Estelle R.; Fish, James E.			Comparison of asthma exacerbations in pediatric and adult patients with severe or difficult-to-treat asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDREN		[Zeiger, Robert S.] Kaiser Permanente So Calif, San Diego, CA USA; [Chipps, Bradley E.] Capital Allergy & Resp Dis Ctr, Sacramento, CA USA; [Haselkorn, Tmirah; Fish, James E.] Genentech Inc, San Francisco, CA 94080 USA; [Rasouliyan, Lawrence] ICON Clin Res, San Francisco, CA USA; [Simons, F. Estelle R.] Univ Manitoba, Winnipeg, MB, Canada	Kaiser Permanente; Roche Holding; Genentech; ICON plc; University of Manitoba	Zeiger, RS (corresponding author), Kaiser Permanente So Calif, San Diego, CA USA.	Robert.S.Zeiger@kp.org		Zeiger, Robert/0000-0001-5788-5063				Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Dolan CM, 2004, ANN ALLERG ASTHMA IM, V92, P32, DOI 10.1016/S1081-1206(10)61707-3; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Jenkins HA, 2003, CHEST, V124, P1318, DOI 10.1378/chest.124.4.1318; Kelly HW, 2008, PEDIATRICS, V122, pE53, DOI 10.1542/peds.2007-3381; Leone FT, 2003, CHEST, V124, P2329, DOI 10.1378/chest.124.6.2329; Paul EF, 2002, SOCIETY, V39, P7, DOI 10.1007/s12115-002-1000-x; Randler C, 2007, WILSON J ORNITHOL, V119, P23, DOI 10.1676/04-014.1; Skinner Elizabeth A, 2004, Dis Manag, V7, P305, DOI 10.1089/dis.2004.7.305; Strunk RC, 2008, J ALLERGY CLIN IMMUN, V122, P1138, DOI 10.1016/j.jaci.2008.09.028; Zollner EW, 2007, PEDIATR ALLERGY IMMU, V18, P469, DOI 10.1111/j.1399-3038.2007.00539.x	12	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2009	124	5					1106	1108		10.1016/j.jaci.2009.07.052	http://dx.doi.org/10.1016/j.jaci.2009.07.052			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	523XI	19800677				2022-12-18	WOS:000272108000034
J	Spina, MF; Miadonna, A				Spina, Maria Francesca; Miadonna, Antonio			Role of omalizumab and steroids in Churg-Strauss syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA		[Spina, Maria Francesca; Miadonna, Antonio] Osped Fatebenefratelli & Oftalm, Div Med Interna & Pneumol, Milan, Italy		Spina, MF (corresponding author), Osped Fatebenefratelli & Oftalm, Div Med Interna & Pneumol, Milan, Italy.	mfdocj@hotmail.com						Bargagli E, 2008, J ASTHMA, V45, P115, DOI 10.1080/02770900701767704; Giavina-Bianchi P, 2008, J ALLERGY CLIN IMMUN, V122, P217, DOI 10.1016/j.jaci.2008.05.024; Grau Rafael G, 2008, Curr Rheumatol Rep, V10, P453; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Puechal X, 2008, EUR J INTERN MED, V19, P364, DOI 10.1016/j.ejim.2007.09.001; Ruppert AA, 2008, J ALLERGY CLIN IMMUN, V121, P253, DOI 10.1016/j.jaci.2007.10.040; Winchester DE, 2006, NEW ENGL J MED, V355, P1281	7	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2009	124	3					600	601		10.1016/j.jaci.2009.05.023	http://dx.doi.org/10.1016/j.jaci.2009.05.023			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	552TG	19631973				2022-12-18	WOS:000274315900030
J	Akdis, CA				Akdis, Cezmi A.			T cells in health and disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						T cells; T regulatory cells; T helper 17 cells; immune regulation; immune tolerance; immune deficiency	T(H)17 CELLS		Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, CH-7270 Davos, Switzerland	Swiss Institute of Allergy & Asthma Research; University of Zurich	Akdis, CA (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Obere Str 22, CH-7270 Davos, Switzerland.	akdisac@siaf.unizh.ch	Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X				Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; Miyara M, 2009, J ALLERGY CLIN IMMUN, V123, P749, DOI 10.1016/j.jaci.2009.03.001; Mucida D, 2009, J ALLERGY CLIN IMMUN, V123, P997, DOI 10.1016/j.jaci.2009.03.016; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Nguyen KD, 2009, J ALLERGY CLIN IMMUN, V123, P933, DOI 10.1016/j.jaci.2008.11.037; Ochs HD, 2009, J ALLERGY CLIN IMMUN, V123, P977, DOI 10.1016/j.jaci.2009.03.030; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056	9	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2009	123	5					1022	1023		10.1016/j.jaci.2009.03.034	http://dx.doi.org/10.1016/j.jaci.2009.03.034			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	449CW	19410690	Bronze			2022-12-18	WOS:000266309400006
J	Casale, TB; Stokes, J				Casale, Thomas B.; Stokes, Jeffrey			Anti-IgE therapy: Clinical utility beyond asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Omalizumab; Anti-IgE; immunotherapy; rhinitis; urticaria; allergy; food allergy	ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; SYSTEMIC MASTOCYTOSIS; OMALIZUMAB; URTICARIA; IMMUNOTHERAPY; ANAPHYLAXIS		[Casale, Thomas B.; Stokes, Jeffrey] Creighton Univ, Dept Med, Div Allergy Immunol, Omaha, NE 68131 USA	Creighton University	Casale, TB (corresponding author), Creighton Univ, Dept Med, Div Allergy Immunol, 601 N 30th St,Suite 5850, Omaha, NE 68131 USA.	tbcasale@creighton.edu	Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377				Belloni B, 2007, J ALLERGY CLIN IMMUN, V120, P1223, DOI 10.1016/j.jaci.2007.08.060; Carter MC, 2007, J ALLERGY CLIN IMMUN, V119, P1550, DOI 10.1016/j.jaci.2007.03.032; Foroughi S, 2007, J ALLERGY CLIN IMMUN, V120, P594, DOI 10.1016/j.jaci.2007.06.015; Grunstein RR, 2008, SLEEP MED REV, V12, P1, DOI 10.1016/j.smrv.2007.11.001; Kaplan AP, 2008, J ALLERGY CLIN IMMUN, V122, P569, DOI 10.1016/j.jaci.2008.07.006; Kontou-Fili K, 2008, ALLERGY, V63, P376, DOI 10.1111/j.1398-9995.2007.01604.x; MASSANARI M, 2009, ANN ALLERGY S, V102, pA7; Matheu V, 2007, J ALLERGY CLIN IMMUN, V120, P1471, DOI 10.1016/j.jaci.2007.07.037; Metz M, 2008, ALLERGY, V63, P247, DOI 10.1111/j.1398-9995.2007.01591.x; Nagakura T, 2008, CLIN EXP ALLERGY, V38, P329, DOI 10.1111/j.1365-2222.2007.02894.x; Penn R, 2007, AM J RHINOL, V21, P428, DOI 10.2500/ajr.2007.21.3060; Sands MF, 2007, J ALLERGY CLIN IMMUN, V120, P979, DOI 10.1016/j.jaci.2007.07.041; Schulze J, 2007, ALLERGY, V62, P963, DOI 10.1111/j.1398-9995.2007.01388.x; Siebenhaar F, 2007, J ALLERGY CLIN IMMUN, V120, P213, DOI 10.1016/j.jaci.2007.05.011; Spector SL, 2007, ANN ALLERG ASTHMA IM, V99, P190, DOI 10.1016/S1081-1206(10)60644-8; STOKES J, 2008, MIDDLETONS ALLERGY P, P1679; van der Ent CK, 2007, THORAX, V62, P276, DOI 10.1136/thx.2004.035519; Zirbes JM, 2008, PEDIATR PULM, V43, P607, DOI 10.1002/ppul.20804	18	16	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2009	123	4					770	771		10.1016/j.jaci.2009.02.016	http://dx.doi.org/10.1016/j.jaci.2009.02.016			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	431JW	19348915				2022-12-18	WOS:000265058600005
J	Khan, FI; Reddy, RC; Baptist, AP				Khan, Farah I.; Reddy, Raju C.; Baptist, Alan P.			Pediatric Dyspnea Scale for use in hospitalized patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; discharge; dyspnea; hospitalized; outcome; pediatric; scale; spirometry; symptoms; exhaled nitric oxide	EXHALED NITRIC-OXIDE; BRONCHOCONSTRICTION; PERFORMANCE; EXERCISE; OUTCOMES; CHILDREN	Background: Asthma is a leading cause of pediatric hospitalizations across the country, yet no clinical instrument exists that incorporates the child's perception of dyspnea in determining discharge readiness. Objective: We sought to develop the Pediatric Dyspnea Scale (PDS) to support discharge decision making in hospitalized asthmatic patients and to compare the performance of the PDS with traditional markers of asthma control in predicting outcomes after discharge. Methods: Asthmatic children aged 6 to 18 years hospitalized for an exacerbation were included in the study. The PDS score, demographics, asthma severity, spirometric results, peak expiratory How rate, and fraction of exhaled nitric oxide were assessed at the time of discharge. A telephone call 14 days after discharge determined relapse, activity limitation, asthma control, and asthma-related quality-of-life outcomes. Results: Eighty-nine patients were enrolled, of whom 70 completed the telephone follow-up. Eight patients had a relapse, and 29 complained of limited activity. A PDS score of greater than 2 on the 7-point scale was a significant predictor of these poor outcomes, with each additional point of the PDS doubling the risk. A higher score on the PDS also correlated with worse asthma control and poor asthma-specific quality of life. The PDS performed better than FEV1, peak expiratory flow rate, or fraction of exhaled nitric oxide in predicting the outcomes of interest. Conclusion: The PDS, which is easy to use in children as young as 6 years of age, might be able to predict adverse outcomes after hospitalization for an asthma exacerbation and should be used as a tool to help guide inpatient discharge decisions. (J Allergy Clin Immunol 2009;123:660-4.)	[Khan, Farah I.] Wayne State Univ, Childrens Hosp Michigan, Carman & Ann Adams Dept Pediat, Div Rheumatol Allergy & Immunol, Detroit, MI USA; [Reddy, Raju C.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Baptist, Alan P.] Univ Michigan, Dept Internal Med, Div Clin Immunol & Allergy, Ann Arbor, MI 48109 USA	Children's Hospital of Michigan; Wayne State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Baptist, AP (corresponding author), 24 Frank Lloyd Wright Dr,Box 442,Suite H-2100, Ann Arbor, MI 48106 USA.	abaptist@med.umich.edu			National Institutes of Health (NIH) [HL070068]; NIH Loan Repayment Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL070068] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health (NIH) grant HL070068 (R.C.R.) and the NIH Loan Repayment Program (A.P.B.).	*AER AB, 2005, NIOX MINO US MAN; Akinbami, 2006, STATE CHILDHOOD ASTH, V381; Alving K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-67; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Baptist AP, 2008, J ASTHMA, V45, P670, DOI 10.1080/02770900802140207; Benito-Fernandez J, 2005, CURR OPIN ALLERGY CL, V5, P241, DOI 10.1097/01.all.0000168788.97453.02; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; *CDCP, 2006, ASTHM PREV HLTH CAR; Gorelick MH, 2004, ANN ALLERG ASTHMA IM, V92, P47, DOI 10.1016/S1081-1206(10)61709-7; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Karras DJ, 2000, ACAD EMERG MED, V7, P327, DOI 10.1111/j.1553-2712.2000.tb02231.x; Kelly AM, 2004, RESP MED, V98, P777, DOI 10.1016/j.rmed.2004.01.008; Kendrick K R, 2000, J Emerg Nurs, V26, P216; KESTEN S, 1990, CHEST, V97, P58, DOI 10.1378/chest.97.1.58; Khasnis A, 2002, J Postgrad Med, V48, P46; KILLIAN KJ, 1993, EUR RESPIR J, V6, P1004; Markoff BA, 2001, CLIN REV ALLERG IMMU, V20, P341, DOI 10.1385/CRIAI:20:3:341; McCarren M, 2000, ACAD EMERG MED, V7, P28, DOI 10.1111/j.1553-2712.2000.tb01887.x; McGrath Patrick J, 2005, BMC Pediatr, V5, P33, DOI 10.1186/1471-2431-5-33; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; *NAEPP, 2007, NIH PUBL; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Newacheck PW, 2000, ARCH PEDIAT ADOL MED, V154, P287, DOI 10.1001/archpedi.154.3.287; Pianosi P, 2006, PEDIATR PULM, V41, P1182, DOI 10.1002/ppul.20512; Silverman RA, 2007, CHEST, V131, P164, DOI 10.1378/chest.06-0530; Stevens MW, 2001, PEDIATRICS, V107, P1357, DOI 10.1542/peds.107.6.1357; Strunk RC, 2003, J ALLERGY CLIN IMMUN, V112, P883, DOI 10.1016/j.jaci.2003.08.014; TURCOTTE H, 1990, THORAX, V45, P914, DOI 10.1136/thx.45.12.914; Wang Li Yan, 2005, Prev Chronic Dis, V2, pA11; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Wilson Mark M, 2003, J Intensive Care Med, V18, P275, DOI 10.1177/0885066603256044; Wong DL, 2001, PAIN, V89, P295, DOI 10.1016/S0304-3959(00)00375-4	32	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2009	123	3					660	664		10.1016/j.jaci.2008.12.018	http://dx.doi.org/10.1016/j.jaci.2008.12.018			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	426TQ	19181371	Green Accepted			2022-12-18	WOS:000264731200027
J	Barnes, KC; Gao, P; Rafaels, NM; Hand, T; Boguniewicz, M; Hata, TR; Schneider, L; Hanifin, JM; Gallo, RL; Gao, L; Yang, M; Beaty, TH; Beck, LA; Leung, DY				Barnes, K. C.; Gao, P.; Rafaels, N. M.; Hand, T.; Boguniewicz, M.; Hata, T. R.; Schneider, L.; Hanifin, J. M.; Gallo, R. L.; Gao, L.; Yang, M.; Beaty, T. H.; Beck, L. A.; Leung, D. Y.			Filaggrin R501X Mutation is Associated with an Increased Susceptibility to Atopic Dermatitis and Eczema Herpeticum, and Associated Phenotypes in a European Population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Barnes, K. C.; Gao, P.; Rafaels, N. M.; Hand, T.; Gao, L.; Yang, M.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Boguniewicz, M.; Leung, D. Y.] Natl Jewish Hlth, Denver, CO USA; [Hata, T. R.; Gallo, R. L.] Univ Calif San Diego, Dept Dermatol, San Diego, CA 92103 USA; [Schneider, L.] Boston Childrens Hosp, Boston, MA USA; [Hanifin, J. M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Beaty, T. H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Beck, L. A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Johns Hopkins University; National Jewish Health; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Oregon Health & Science University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Rochester			Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861					0	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				119	S34	S34		10.1016/j.jaci.2008.12.1074	http://dx.doi.org/10.1016/j.jaci.2008.12.1074			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596300130
J	Bonadonna, P; Perbellini, O; Passalacqua, G; Caruso, B; Colarossi, S; Dal Fior, D; Castellani, L; Bonetto, C; Frattini, F; Dama, A; Martinelli, G; Chilosi, M; Senna, G; Pizzolo, G; Zanotti, R				Bonadonna, P.; Perbellini, O.; Passalacqua, G.; Caruso, B.; Colarossi, S.; Dal Fior, D.; Castellani, L.; Bonetto, C.; Frattini, F.; Dama, A.; Martinelli, G.; Chilosi, M.; Senna, G.; Pizzolo, G.; Zanotti, R.			Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Bonadonna, P.; Dama, A.; Senna, G.] Verona Gen Hosp, Allergy Unit, Verona, Italy; [Perbellini, O.; Frattini, F.; Pizzolo, G.; Zanotti, R.] Univ Verona, Dept Clin & Expt Med, Sect Haematol, I-37100 Verona, Italy; [Passalacqua, G.] Univ Genoa, Allergy & Resp Dis DIMI, Genoa, Italy; [Caruso, B.] Verona Gen Hosp, Lab Clin Chem & Haematol, Verona, Italy; [Colarossi, S.; Martinelli, G.] Univ Bologna, Dept Haematol Oncol L & A Seragnoli, Rete Italiana Mastocitosi RIMA, Bologna, Italy; [Dal Fior, D.; Chilosi, M.] Univ Verona, Dept Pathol, I-37100 Verona, Italy; [Castellani, L.] Santa Maria Del Carmine Hosp, Dept Dermatol, Rovereto, Italy; [Bonetto, C.] Univ Verona, Sect Psychiat & Clin Psycol, Dept Med & Publ Hlth, I-37100 Verona, Italy	University of Verona; University of Genoa; University of Bologna; University of Verona; University of Verona			CHILOSI, MARCO/ABB-8028-2021; Martinelli, Giovanni/AAK-9211-2020; Bonetto, Chiara/B-4199-2010	Martinelli, Giovanni/0000-0002-1025-4210; 					0	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				938	S242	S242		10.1016/j.jaci.2008.12.935	http://dx.doi.org/10.1016/j.jaci.2008.12.935			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596301410
J	Conus, S; Straumann, A; Simon, HU				Conus, Sebastien; Straumann, Alex; Simon, Hans-Uwe			Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Conus, Sebastien; Simon, Hans-Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Straumann, Alex] Kantonsspital, Dept Gastroenterol, Olten, Switzerland	University of Bern; Kantonsspital Aarau AG (KSA); Kantonsspital Olten	Conus, S (corresponding author), Univ Bern, Inst Pharmacol, Bern, Switzerland.	hus@pki.unibe.ch	Simon, Hans-Uwe/AAU-7410-2020	Simon, Hans-Uwe/0000-0002-9404-7736				Stein ML, 2008, J ALLERGY CLIN IMMUN, V121, P1473, DOI 10.1016/j.jaci.2008.02.033	1	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					269	269		10.1016/j.jaci.2008.09.031	http://dx.doi.org/10.1016/j.jaci.2008.09.031			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	399IP	18951621				2022-12-18	WOS:000262793900049
J	Nahum, A; Bates, A; Sharfe, N; Roifman, CM				Nahum, Amit; Bates, Andrea; Sharfe, Nigel; Roifman, Chaim M.			Association of the lymphoid protein tyrosine phosphatase, R620W variant, with chronic mucocutaneous candidiasis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PTPN22; POLYMORPHISM; DISEASE		[Nahum, Amit] Hosp Sick Children, Canadian Ctr Primary Immunodeficiency, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pediat, Div Immunol & Allergy, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Nahum, A (corresponding author), Hosp Sick Children, Canadian Ctr Primary Immunodeficiency, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	chaim.roifman@sickkids.ca						AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Chapman SJ, 2006, NAT GENET, V38, P499, DOI 10.1038/ng0506-499; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Wu H, 2005, ARTHRITIS RHEUM-US, V52, P2396, DOI 10.1002/art.21223	9	16	18	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2008	122	6					1220	1222		10.1016/j.jaci.2008.10.027	http://dx.doi.org/10.1016/j.jaci.2008.10.027			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	383ZA	19084113				2022-12-18	WOS:000261711800024
J	Akdis, CA				Akdis, Cezmi A.			New insights into mechanisms of immunoregulation in 2007	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						immune regulation; regulatory T cells; effector T-cell responses	ALLERGIC AIRWAY INFLAMMATION; CLASS-SWITCH RECOMBINATION; T-REGULATORY CELLS; HUMAN MAST-CELLS; CYTOKINE PRODUCTION; LUNG INFLAMMATION; ATOPIC-DERMATITIS; IGE LEVELS; BRONCHODILATOR RESPONSE; ASTHMA EXACERBATIONS	Substantial progress in understanding the mechanisms of immune regulation in allergic diseases and asthma has been made during the last year. In asthma, rhinitis, and atopic dermatitis the immune system is activated by allergens, autoantigens, and components of superimposed infectious agents. Immune regulation in the lymphatic organs and in the tissue has an important role in the control and suppression of allergic disease in all stages of the inflammatory process, such as cell migration to tissues, cells gaining an inflammatory and tissue-destructive phenotype in the tissues, and their interaction with resident tissue cells to augment the inflammation. After the discovery of regulatory T cells, the importance of their unique suppressive capacity was strongly emphasized for the suppression of effector T-cell responses. However, it seems that all 3 subsets of effector T(H)1, T(H)2, and T(H)17 cells, as well as regulatory T cells, regulate each other at the level of transcription, major cytokines, and surface molecules. This review highlights key advances in immune regulation that were published in the Journal of Allergy and Clinical Immunology.	Swiss Inst Allergy & Asthma Res SIAF, CH-7270 Davos, Switzerland	Swiss Institute of Allergy & Asthma Research	Akdis, CA (corresponding author), Swiss Inst Allergy & Asthma Res SIAF, Obere Str 22, CH-7270 Davos, Switzerland.	akdisac@siaf.uzh.ch	Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X				Adedoyin J, 2007, J ALLERGY CLIN IMMUN, V119, P640, DOI 10.1016/j.jaci.2006.11.637; Admyre C, 2007, J ALLERGY CLIN IMMUN, V120, P1418, DOI 10.1016/j.jaci.2007.06.040; Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P152, DOI 10.1016/j.jaci.2006.03.045; Akdis M, 2007, J ALLERGY CLIN IMMUN, V119, P780, DOI 10.1016/j.jaci.2007.01.022; Akkoc T, 2008, J ALLERGY CLIN IMMUN, V121, P652, DOI 10.1016/j.jaci.2007.12.1171; Allam JP, 2008, J ALLERGY CLIN IMMUN, V121, P368, DOI 10.1016/j.jaci.2007.09.045; Allen LC, 2007, J ALLERGY CLIN IMMUN, V120, P462, DOI 10.1016/j.jaci.2007.04.019; Ando T, 2007, J ALLERGY CLIN IMMUN, V120, P916, DOI 10.1016/j.jaci.2007.05.023; Andrews AL, 2007, J ALLERGY CLIN IMMUN, V120, P91, DOI 10.1016/j.jaci.2007.04.026; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Balzar S, 2007, J ALLERGY CLIN IMMUN, V119, P855, DOI 10.1016/j.jaci.2006.12.642; Bieli C, 2007, J ALLERGY CLIN IMMUN, V120, P1308, DOI 10.1016/j.jaci.2007.07.034; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Bree A, 2007, J ALLERGY CLIN IMMUN, V119, P1251, DOI 10.1016/j.jaci.2007.02.009; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Casale TB, 2008, J ALLERGY CLIN IMMUN, V121, P288, DOI 10.1016/j.jaci.2007.11.040; Casolaro V, 2008, J ALLERGY CLIN IMMUN, V121, P853, DOI 10.1016/j.jaci.2007.12.1166; Castigli E, 2007, J ALLERGY CLIN IMMUN, V120, P885, DOI 10.1016/j.jaci.2007.06.012; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Chatila TA, 2008, J ALLERGY CLIN IMMUN, V121, P812, DOI 10.1016/j.jaci.2008.02.025; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Crestani E, 2007, J ALLERGY CLIN IMMUN, V120, P820, DOI 10.1016/j.jaci.2007.05.033; Daines MO, 2007, J ALLERGY CLIN IMMUN, V119, P375, DOI 10.1016/j.jaci.2006.09.039; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Dharajiya N, 2007, J ALLERGY CLIN IMMUN, V119, P646, DOI 10.1016/j.jaci.2006.11.634; Dijkstra D, 2007, J ALLERGY CLIN IMMUN, V120, P300, DOI 10.1016/j.jaci.2007.03.024; Ebner S, 2007, J ALLERGY CLIN IMMUN, V119, P982, DOI 10.1016/j.jaci.2007.01.003; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Erwin EA, 2007, J ALLERGY CLIN IMMUN, V119, P359, DOI 10.1016/j.jaci.2006.12.648; Esnault S, 2007, J ALLERGY CLIN IMMUN, V120, P1082, DOI 10.1016/j.jaci.2007.06.024; Fawaz LM, 2007, J ALLERGY CLIN IMMUN, V120, P1208, DOI 10.1016/j.jaci.2007.08.022; Foroughi S, 2007, J ALLERGY CLIN IMMUN, V120, P594, DOI 10.1016/j.jaci.2007.06.015; Fujiwara M, 2007, J ALLERGY CLIN IMMUN, V119, P662, DOI 10.1016/j.jaci.2006.12.643; Gernez Y, 2007, J ALLERGY CLIN IMMUN, V120, P1441, DOI 10.1016/j.jaci.2007.08.012; Gieras A, 2007, J ALLERGY CLIN IMMUN, V119, P384, DOI 10.1016/j.jaci.2006.09.034; Gilmour J, 2007, J ALLERGY CLIN IMMUN, V120, P56, DOI 10.1016/j.jaci.2007.03.033; Godot V, 2007, J ALLERGY CLIN IMMUN, V120, P827, DOI 10.1016/j.jaci.2007.05.046; Goleva E, 2007, J ALLERGY CLIN IMMUN, V120, P1065, DOI 10.1016/j.jaci.2007.07.042; Gutermuth J, 2007, J ALLERGY CLIN IMMUN, V120, P293, DOI 10.1016/j.jaci.2007.03.017; Hajoui O, 2007, J ALLERGY CLIN IMMUN, V120, P1425, DOI 10.1016/j.jaci.2007.07.011; Hallstrand TS, 2007, J ALLERGY CLIN IMMUN, V119, P1092, DOI 10.1016/j.jaci.2007.01.005; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hasannejad H, 2007, J ALLERGY CLIN IMMUN, V120, P69, DOI 10.1016/j.jaci.2007.04.010; Horvath G, 2007, J ALLERGY CLIN IMMUN, V120, P1103, DOI 10.1016/j.jaci.2007.08.034; Hsu SC, 2007, J ALLERGY CLIN IMMUN, V119, P1522, DOI 10.1016/j.jaci.2007.01.034; Hulse KE, 2008, J ALLERGY CLIN IMMUN, V121, P756, DOI 10.1016/j.jaci.2007.10.016; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V120, P84, DOI 10.1016/j.jaci.2007.04.032; Jabara HH, 2008, J ALLERGY CLIN IMMUN, V121, P191, DOI 10.1016/j.jaci.2007.08.008; Jartti T, 2007, J ALLERGY CLIN IMMUN, V120, P177, DOI 10.1016/j.jaci.2007.03.008; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V120, P803, DOI 10.1016/j.jaci.2007.05.030; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V119, P831, DOI 10.1016/j.jaci.2006.12.653; Johansson S, 2007, J ALLERGY CLIN IMMUN, V120, P308, DOI 10.1016/j.jaci.2007.03.021; Kanters D, 2007, J ALLERGY CLIN IMMUN, V120, P1073, DOI 10.1016/j.jaci.2007.06.021; Kawaguchi M, 2007, J ALLERGY CLIN IMMUN, V119, P1408, DOI 10.1016/j.jaci.2007.02.036; Kim HJ, 2007, J ALLERGY CLIN IMMUN, V119, P1225, DOI 10.1016/j.jaci.2007.01.016; Kinnunen T, 2007, J ALLERGY CLIN IMMUN, V119, P965, DOI 10.1016/j.jaci.2007.01.011; Kino T, 2007, J ALLERGY CLIN IMMUN, V120, P437, DOI 10.1016/j.jaci.2007.03.018; Kiss A, 2007, J ALLERGY CLIN IMMUN, V120, P334, DOI 10.1016/j.jaci.2007.04.025; Klunker S, 2007, J ALLERGY CLIN IMMUN, V120, P688, DOI 10.1016/j.jaci.2007.05.034; Knisz J, 2007, J ALLERGY CLIN IMMUN, V119, P739, DOI 10.1016/j.jaci.2006.12.620; Koya T, 2007, J ALLERGY CLIN IMMUN, V119, P1241, DOI 10.1016/j.jaci.2007.01.039; Kunzmann S, 2007, J ALLERGY CLIN IMMUN, V119, P1398, DOI 10.1016/j.jaci.2007.02.018; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Kwatia MA, 2007, J ALLERGY CLIN IMMUN, V119, P838, DOI 10.1016/j.jaci.2006.12.614; Leb VM, 2008, J ALLERGY CLIN IMMUN, V121, P64, DOI 10.1016/j.jaci.2007.10.006; Lee KS, 2007, J ALLERGY CLIN IMMUN, V119, P141, DOI 10.1016/j.jaci.2006.09.001; Lerch M, 2007, J ALLERGY CLIN IMMUN, V119, P1529, DOI 10.1016/j.jaci.2007.02.007; Lim A, 2007, J ALLERGY CLIN IMMUN, V120, P696, DOI 10.1016/j.jaci.2007.05.035; Liotta F, 2008, J ALLERGY CLIN IMMUN, V121, P1000, DOI 10.1016/j.jaci.2008.01.004; Love TM, 2008, J ALLERGY CLIN IMMUN, V121, P309, DOI 10.1016/j.jaci.2007.12.1167; Loza MJ, 2008, J ALLERGY CLIN IMMUN, V121, P750, DOI 10.1016/j.jaci.2007.10.036; Loza MJ, 2007, J ALLERGY CLIN IMMUN, V119, P235, DOI 10.1016/j.jaci.2006.09.019; Maggi L, 2007, J ALLERGY CLIN IMMUN, V120, P429, DOI 10.1016/j.jaci.2007.05.002; Meliton AY, 2007, J ALLERGY CLIN IMMUN, V120, P1316, DOI 10.1016/j.jaci.2007.07.038; Metz-Favre C, 2007, J ALLERGY CLIN IMMUN, V120, P315, DOI 10.1016/j.jaci.2007.03.046; Miller M, 2007, J ALLERGY CLIN IMMUN, V120, P1118, DOI 10.1016/j.jaci.2007.08.045; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Munitz A, 2007, J ALLERGY CLIN IMMUN, V119, P1382, DOI 10.1016/j.jaci.2007.01.031; Munthe-Kaas MC, 2008, J ALLERGY CLIN IMMUN, V121, P51, DOI 10.1016/j.jaci.2007.07.068; Nakae S, 2007, J ALLERGY CLIN IMMUN, V120, P48, DOI 10.1016/j.jaci.2007.02.046; Nakae S, 2007, J ALLERGY CLIN IMMUN, V119, P680, DOI 10.1016/j.jaci.2006.11.701; Nassenstein C, 2007, J ALLERGY CLIN IMMUN, V120, P1089, DOI 10.1016/j.jaci.2007.07.007; Nie ZY, 2007, J ALLERGY CLIN IMMUN, V119, P1415, DOI 10.1016/j.jaci.2007.03.005; Oh SY, 2007, J ALLERGY CLIN IMMUN, V119, P123, DOI 10.1016/j.jaci.2006.08.029; Orihara K, 2007, J ALLERGY CLIN IMMUN, V120, P960, DOI 10.1016/j.jaci.2007.05.036; Palmer BE, 2007, J ALLERGY CLIN IMMUN, V120, P184, DOI 10.1016/j.jaci.2007.03.009; Pegorier S, 2007, J ALLERGY CLIN IMMUN, V120, P1301, DOI 10.1016/j.jaci.2007.09.023; Persson H, 2007, J ALLERGY CLIN IMMUN, V120, P1186, DOI 10.1016/j.jaci.2007.06.041; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Prescott SL, 2007, J ALLERGY CLIN IMMUN, V120, P200, DOI 10.1016/j.jaci.2007.03.045; Raby BA, 2007, J ALLERGY CLIN IMMUN, V120, P351, DOI 10.1016/j.jaci.2007.05.029; Ramsey CD, 2007, J ALLERGY CLIN IMMUN, V119, P150, DOI 10.1016/j.jaci.2006.09.012; Romagnani S, 2007, J ALLERGY CLIN IMMUN, V119, P1511, DOI 10.1016/j.jaci.2007.04.005; Rothers J, 2007, J ALLERGY CLIN IMMUN, V120, P1201, DOI 10.1016/j.jaci.2007.07.036; Salamon P, 2008, J ALLERGY CLIN IMMUN, V121, P448, DOI 10.1016/j.jaci.2007.08.054; Saxon A, 2008, J ALLERGY CLIN IMMUN, V121, P320, DOI 10.1016/j.jaci.2007.10.017; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Siddiqui S, 2007, J ALLERGY CLIN IMMUN, V120, P813, DOI 10.1016/j.jaci.2007.05.028; Soeria-Atmadja D, 2007, J ALLERGY CLIN IMMUN, V120, P1433, DOI 10.1016/j.jaci.2007.07.021; Southam DS, 2007, J ALLERGY CLIN IMMUN, V119, P848, DOI 10.1016/j.jaci.2006.12.623; Stern DA, 2007, J ALLERGY CLIN IMMUN, V120, P835, DOI 10.1016/j.jaci.2007.05.050; Stern DA, 2007, J ALLERGY CLIN IMMUN, V119, P351, DOI 10.1016/j.jaci.2006.10.013; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Taylor A, 2007, J ALLERGY CLIN IMMUN, V120, P76, DOI 10.1016/j.jaci.2007.04.004; Triggiani M, 2007, J ALLERGY CLIN IMMUN, V119, P472, DOI 10.1016/j.jaci.2006.09.027; Valenta R, 2007, J ALLERGY CLIN IMMUN, V119, P826, DOI 10.1016/j.jaci.2007.01.025; Verhagen J, 2006, J ALLERGY CLIN IMMUN, V117, P176, DOI 10.1016/j.jaci.2005.10.040; Wang L, 2007, J ALLERGY CLIN IMMUN, V120, P445, DOI 10.1016/j.jaci.2007.03.028; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Weber-Chrysochoou C, 2007, J ALLERGY CLIN IMMUN, V120, P286, DOI 10.1016/j.jaci.2007.06.034; Wells JW, 2007, J ALLERGY CLIN IMMUN, V119, P226, DOI 10.1016/j.jaci.2006.09.004; Williams MA, 2007, J ALLERGY CLIN IMMUN, V119, P488, DOI 10.1016/j.jaci.2006.10.022; Wu Y, 2007, J ALLERGY CLIN IMMUN, V119, P973, DOI 10.1016/j.jaci.2006.12.617; Yang KD, 2007, J ALLERGY CLIN IMMUN, V120, P842, DOI 10.1016/j.jaci.2007.07.009; Yoshioka M, 2007, J ALLERGY CLIN IMMUN, V120, P452, DOI 10.1016/j.jaci.2007.03.027; Yoshisue H, 2007, J ALLERGY CLIN IMMUN, V119, P132, DOI 10.1016/j.jaci.2006.08.028; Zanini A, 2007, J ALLERGY CLIN IMMUN, V120, P329, DOI 10.1016/j.jaci.2007.04.021; Zhou XX, 2007, J ALLERGY CLIN IMMUN, V119, P1388, DOI 10.1016/j.jaci.2007.02.011	118	16	18	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					700	709		10.1016/j.jaci.2008.07.048	http://dx.doi.org/10.1016/j.jaci.2008.07.048			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	19014761				2022-12-18	WOS:000259989000011
J	Rice, NE; Patel, BD; Lang, IA; Kumari, M; Frayling, TM; Murray, A; Melzer, D				Rice, Neil E.; Patel, Bipen D.; Lang, Iain A.; Kumari, Meena; Frayling, Timothy M.; Murray, Anno; Melzer, David			Filaggrin gene mutations are associated with asthma and eczema in later life	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DISEASE; BURDEN		[Rice, Neil E.; Lang, Iain A.; Frayling, Timothy M.; Murray, Anno; Melzer, David] Peninsula Med Sch, Exeter, Devon, England; [Patel, Bipen D.] Royal Devon & Exeter Fdn Trust, Dept Resp Med, Exeter, Devon, England; [Kumari, Meena] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Exeter; University of London; University College London	Rice, NE (corresponding author), Peninsula Med Sch, RD&E Wonford Site, Exeter, Devon, England.	david.melzer@pms.ac.uk	Lang, Iain A/B-8255-2008	Lang, Iain/0000-0002-8473-2350; Melzer, David/0000-0002-0170-3838; Murray, Anna/0000-0002-2351-2522; Kumari, Meena/0000-0001-9716-1035	NATIONAL INSTITUTE ON AGING [R01AG017644, R01AG024233] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG1764406 S1, R01 AG24233, R01 AG024233-04, R01 AG024233] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission)		Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Hudson TJ, 2006, NAT GENET, V38, P399, DOI 10.1038/ng0406-399; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; Novak N, 2008, J INVEST DERMATOL, V128, P1430, DOI 10.1038/sj.jid.5701190; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014	9	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					834	836		10.1016/j.jaci.2008.07.027	http://dx.doi.org/10.1016/j.jaci.2008.07.027			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	18760831	Green Accepted			2022-12-18	WOS:000259989000035
J	Hamilton, RG; Saito, H				Hamilton, Robert G.; Saito, Hirohisa			IgE antibody concentration, specific activity, clonality, and affinity measures from future diagnostic confirmatory tests	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						human; IgE; antibodies; concentration; affinity; clonality; specificity; effector cell activation; basophils; chimeric; diagnostic tests	HISTAMINE-RELEASE; HUMAN BASOPHILS; ALLERGY		[Hamilton, Robert G.] Johns Hopkins Univ, Sch Med, Dept Med Clin Immunol & Pathol, Baltimore, MD 21224 USA; [Saito, Hirohisa] Natl Res Inst, Tokyo, Japan	Johns Hopkins University	Hamilton, RG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med Clin Immunol & Pathol, 5501 Hopkins Bayview Circle,Room 1A20, Baltimore, MD 21224 USA.	rhamilto@jhmi.edu		Saito, Hirohisa/0000-0002-6630-8337				Celik-Bilgili S, 2005, CLIN EXP ALLERGY, V35, P268, DOI 10.1111/j.1365-2222.2005.02150.x; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Erwin EA, 2007, J ALLERGY CLIN IMMUN, V119, P359, DOI 10.1016/j.jaci.2006.12.648; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Kleine-Tebbe J, 2006, INT ARCH ALLERGY IMM, V141, P79, DOI 10.1159/000094495; Kober A, 2006, J ALLERGY CLIN IMMUN, V117, pS219, DOI 10.1016/j.jaci.2005.12.865; Kohno M, 2005, BLOOD, V105, P2059, DOI 10.1182/blood-2004-07-2639; LICHTENSTEIN LM, 1992, J IMMUNOL, V148, P3929; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; MATSSON PNJ, 2008, ANAL PERFORMANCE CHA; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Semic-Jusufagic A, 2007, J ALLERGY CLIN IMMUN, V119, P930, DOI 10.1016/j.jaci.2006.12.639; Simpson A, 2005, J ALLERGY CLIN IMMUN, V116, P744, DOI 10.1016/j.jaci.2005.06.032; Soderstrom L, 2003, ALLERGY, V58, P921, DOI 10.1034/j.1398-9995.2003.00227.x; Valenta R, 2007, J INVEST ALLERG CLIN, V17, P36	15	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2008	122	2					305	306		10.1016/j.jaci.2008.05.009	http://dx.doi.org/10.1016/j.jaci.2008.05.009			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	337HO	18571709				2022-12-18	WOS:000258426300014
J	Yin, L; Rodriguez, CA; Hou, W; Potter, O; Caplan, MJ; Goodenow, MM; Sleasman, JW				Yin, Li; Rodriguez, Carina A.; Hou, Wei; Potter, Olivia; Caplan, Margaret J.; Goodenow, Maureen M.; Sleasman, John W.			Antiretroviral therapy corrects HIV-1-induced expansion of CD8(+)CD45RA(+)CD27(-)CD11a(bright) activated T cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HIV-1; children; T-cell receptor; T-cell receptor rearrangement excision circles; immune reconstitution; flow cytometry; T cells	HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTION; THYMIC OUTPUT; HIV-1-INFECTED CHILDREN; 1-INFECTED CHILDREN; PERIPHERAL-BLOOD; SUBSETS; IDENTIFICATION; LYMPHOCYTES; POPULATIONS	Background: HIV infection decreases thymic output and induces chronic T-cell activation. Objective: To examine the reconstitution of naive and activated T cells. Methods: Extended immune phenotyping of CD4(+) and CD8(+) T-cell subsets was combined with T-cell receptor rearrangement excision circle (TREC) levels and measures of T-cell receptor repertoire perturbations in CD8(+) T-cell subpopulation to define the global effect of HIV-1 on T-cell dynamics. Evaluations before and after therapy were performed in HIV-infected children and compared with those in healthy individuals. Results: Ten HIV-infected children and adolescents with a broad range of pretherapy CD4(+) T-cell counts were compared with healthy individuals. Pretherapy late activated CD8(+) T cells (CD3(+)CD8(+)CD45RA(+)CD27(-)CD11a(bright) cells) were expanded among HIV-infected subjects. Successful antiretroviral therapy increased the proportion of naive T cells (CD3(+)CD4(+)CD45RA(+)CD27(+)CD28(+) and CD3(+) CD8(+)CD45RA(+)CD27(+)CD11a(dim) cells), with a significant decrease in late activated CD8(+) T cells. The proportion of naive CD4(+) and CD8(+) T cells significantly predicted log(10) TREC copies/10(6) PBMCs in infected children and healthy control subjects, with a negative correlation in late activated CD8(+) T cells and activated CD4(+) T cells. Treatment re-established Gaussian distributions and decreased oligoclonal expansion within the V beta repertoire of CD8(+)CD45RA(+) T cells, but compared with that seen in healthy children, the proportion of late activated CD8(+) T cells remained increased. Conclusion: HIV infection strikingly shifts the proportion of naive and late activated CD45RA(+)CD8(+) T cells. Homeostasis within this T-cell population reflects TREC levels and the extent of T-cell receptor V beta perturbations.	[Sleasman, John W.] Univ S Florida, Coll Med, Dept Pediat, Div Allergy Immunol & Rheumatol, St Petersburg, FL 33701 USA; [Yin, Li; Goodenow, Maureen M.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Dept Pediat, Gainesville, FL USA; [Hou, Wei] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Rodriguez, Carina A.; Caplan, Margaret J.] Univ S Florida, Dept Pediat, Div Infect Dis, St Petersburg, FL 33701 USA	State University System of Florida; University of South Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida	Sleasman, JW (corresponding author), Univ S Florida, Coll Med, Dept Pediat, Div Allergy Immunol & Rheumatol, St Petersburg, FL 33701 USA.	jsleasma@health.usf.edu	hou, wei/GWM-4800-2022		NIAID NIH HHS [R37 AI028571, R01 AI065265, R01 AI047723, R01 AI028571] Funding Source: Medline; NICHD NIH HHS [R01 HD032259] Funding Source: Medline; PHS HHS [R60 MC 00003-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065265, R01AI028571, R01AI047723] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alves NL, 2007, J IMMUNOL, V179, P221, DOI 10.4049/jimmunol.179.1.221; Appay V, 2004, SEMIN IMMUNOL, V16, P205, DOI 10.1016/j.smim.2004.02.007; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Chavan S, 2001, J INFECT DIS, V183, P1445, DOI 10.1086/320197; Chinen J, 2002, J ALLERGY CLIN IMMUN, V110, P189, DOI 10.1067/mai.2002.126226; De Rossi A, 2002, J INFECT DIS, V186, P312, DOI 10.1086/341657; Donnelly CA, 2005, HIV MED, V6, P170, DOI 10.1111/j.1468-1293.2005.00285.x; Douek Daniel, 2007, Top HIV Med, V15, P114; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2000, J INFECT DIS, V181, P1479, DOI 10.1086/315398; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Douglas SD, 2000, ARCH PEDIAT ADOL MED, V154, P375, DOI 10.1001/archpedi.154.4.375; Ganusov VV, 2007, J IMMUNOL, V179, P950, DOI 10.4049/jimmunol.179.2.950; GHAFFARI G, 1914, PEDIATRICS, V114, pE604; Hayes PJ, 1999, CLIN EXP IMMUNOL, V117, P331; Hoflich C, 1998, INT IMMUNOL, V10, P1837, DOI 10.1093/intimm/10.12.1837; Kou ZC, 2003, J INFECT DIS, V187, P385, DOI 10.1086/367674; Kou ZC, 2000, CLIN DIAGN LAB IMMUN, V7, P953, DOI 10.1128/CDLI.7.6.953-959.2000; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; McFarland EJ, 2002, J INFECT DIS, V186, P477, DOI 10.1086/341939; McFarland RD, 2000, P NATL ACAD SCI USA, V97, P4215, DOI 10.1073/pnas.070061597; McGhee SA, 2005, MOL GENET METAB, V86, P427, DOI 10.1016/j.ymgme.2005.09.005; Ometto L, 2002, AIDS, V16, P839, DOI 10.1097/00002030-200204120-00003; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Paul ME, 2001, J ALLERGY CLIN IMMUN, V108, P258, DOI 10.1067/mai.2001.117179; Resino S, 2003, J CLIN IMMUNOL, V23, P279, DOI 10.1023/A:1024536816684; Roederer M, 2004, CLIN IMMUNOL, V110, P199, DOI 10.1016/j.clim.2003.11.015; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sleasman JW, 1999, J PEDIATR-US, V134, P597, DOI 10.1016/S0022-3476(99)70247-7; Sleasman JW, 1997, CLIN DIAGN LAB IMMUN, V4, P653, DOI 10.1128/CDLI.4.6.653-658.1997; Wilson JDK, 1998, J EXP MED, V188, P785, DOI 10.1084/jem.188.4.785	32	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2008	122	1					166	172		10.1016/j.jaci.2008.04.029	http://dx.doi.org/10.1016/j.jaci.2008.04.029			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	325RD	18538835	Green Accepted, hybrid			2022-12-18	WOS:000257605100027
J	Gonzalez-Mancebo, E; Fernandez-Rivas, M				Gonzalez-Mancebo, Eloina; Fernandez-Rivas, Montserrat			Outcome and safety of double-blind, placebo-controlled food challenges in 111 patients sensitized to lipid transfer proteins	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							POSITIVE DOUBLE-BLIND; ALLERGY; POPULATION; EUROPE		[Gonzalez-Mancebo, Eloina] Hosp Fuenlabrada, Unidad Alergia, Madrid, Spain; [Fernandez-Rivas, Montserrat] Hosp Clin San Carlos, Serv Alergia, Madrid, Spain	Hospital Universitario Fuenlabrada; Hospital Clinico San Carlos	Gonzalez-Mancebo, E (corresponding author), Hosp Fuenlabrada, Unidad Alergia, Madrid, Spain.	egonzaiez.hflr@salud.madrid.org						Asero R, 2002, ALLERGY, V57, P900, DOI 10.1034/j.1398-9995.2002.t01-1-23541.x; Fernandez-Rivas M, 2003, J ALLERGY CLIN IMMUN, V112, P789, DOI 10.1016/S0091-6749(03)02016-5; Fernandez-Rivas M, 2006, ALERGOLOGICA 2005 FA, P227; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Kanny G, 2001, J ALLERGY CLIN IMMUN, V108, P133, DOI 10.1067/mai.2001.116427; Pastorello EA, 2002, J ALLERGY CLIN IMMUN, V109, P563, DOI 10.1067/mai.2002.121946; Pastorello EA, 2003, J ALLERGY CLIN IMMUN, V112, P775, DOI 10.1016/S0091-6749(03)01942-0; Reuter A, 2006, CLIN EXP ALLERGY, V36, P815, DOI 10.1111/j.1365-2222.2006.2492.x; Salcedo G, 2007, BBA-MOL CELL BIOL L, V1771, P781, DOI 10.1016/j.bbalip.2007.01.001	9	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2008	121	6					1507	1508		10.1016/j.jaci.2008.01.029	http://dx.doi.org/10.1016/j.jaci.2008.01.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	313WW	18325569				2022-12-18	WOS:000256771700030
J	Godkin, A; Ng, WF; Gallagher, K; Betts, G; Thomas, HC; Lechler, RI				Godkin, Andrew; Ng, Wan Fai; Gallagher, Kathleen; Betts, Gareth; Thomas, Howard C.; Lechler, Robert I.			Expansion of hepatitis C-specific CD4(+)CD25(+) regulatory T cells after viral clearance: A mechanism to limit collateral damage?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						hepatitis C infection; regulatory T cells; autoimmunity; viral clearance; viral persistence	IMMUNOLOGICAL SELF-TOLERANCE; IN-VITRO PROLIFERATION; PERIPHERAL GENERATION; IMMUNE-RESPONSES; EX-VIVO; VIRUS; AUTOIMMUNITY	Background: Data from rodent models suggest that a subpopulation of CD4(+) T cells, characterized by the constitutive expression of CD25, play a key role in regulating many immune responses. Human CD4(+)CD25(+) T cells also appear to possess a regulatory function, but their role in infections is not fully defined. Objectives: We sought to explore the possibility of a role for CD4(+)CD25(+) T cells in controlling immunity to hepatitis C virus (HCV). We hypothesized that CD4(+)CD25(+) T cells might account for the paucity of immune responses measurable in chronically viremic patients by suppressing the immune responses to HCV antigens. Methods: We compared the responses of PBMCs to 3 different recombinant HCV antigens before and after depletion of CD25(+) cells in 15 chronically viremic patients, 14 nonviremic HCV antibody-positive subjects, and 14 healthy control subjects. We also tested the ability of CD4(+)CD25(+) T cells purified from HLA-matched viremic or nonviremic blood to suppress the responses of HCV epitope-specific T-cell clones. Results: To our surprise, depletion of peripheral blood CD25(+) cells led to a pronounced increase in proliferation of and IFN-gamma production by PBMCs only in nonviremic patients. Furthermore, the CD4(+)CD25(+) T cells purified from HLA-matched nonviremic blood (in contrast to CD4(+)CD25(+) T cells isolated from chronically viremic blood) inhibited the responses of HCV epitope-specific T-cell clones. Conclusion: HCV-specific CD4(+)CD25(+) regulatory T cells appear to accompany successful viral clearance.	[Godkin, Andrew; Thomas, Howard C.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Ng, Wan Fai; Lechler, Robert I.] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Godkin, Andrew; Gallagher, Kathleen; Betts, Gareth] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff, S Glam, Wales; [Lechler, Robert I.] Kings Coll London, Sch Med, London, England; [Lechler, Robert I.] Kings Coll London, Guys Hosp, Inst Dent, London, England; [Lechler, Robert I.] Kings Coll London, Kings Hosp, Inst Dent, London, England; [Lechler, Robert I.] Kings Coll London, St Thomas Hosp, Inst Dent, London, England	Imperial College London; Imperial College London; Cardiff University; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Ng, WF (corresponding author), Univ Newcastle, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Wan-fai.Ng@ncl.ac.uk	; Ng, Wan-Fai/R-8083-2016	Godkin, Andrew/0000-0002-1910-7567; Ng, Wan-Fai/0000-0002-5539-388X	Medical Research Council [G0600698B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Akbar AN, 2003, IMMUNOLOGY, V109, P319, DOI 10.1046/j.1365-2567.2003.01678.x; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Boyer O, 2004, BLOOD, V103, P3428, DOI 10.1182/blood-2003-07-2598; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Cohen J, 1999, SCIENCE, V285, P26, DOI 10.1126/science.285.5424.26; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Godkin A, 2001, EUR J IMMUNOL, V31, P1438, DOI 10.1002/1521-4141(200105)31:5<1438::AID-IMMU1438>3.0.CO;2-2; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Itoh M, 1999, J IMMUNOL, V162, P5317; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kakumu S, 1997, CLIN EXP IMMUNOL, V108, P138, DOI 10.1046/j.1365-2249.1997.d01-987.x; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Manigold T, 2006, BLOOD, V107, P4424, DOI 10.1182/blood-2005-09-3903; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; Nishikawa H, 2005, J EXP MED, V201, P681, DOI 10.1084/jem.20041959; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Rushbrook SM, 2005, J VIROL, V79, P7852, DOI 10.1128/JVI.79.12.7852-7859.2005; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M; Sugimoto K, 2003, HEPATOLOGY, V38, P1437, DOI 10.1016/j.hep.2003.09.026; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Taams LS, 2005, CURR TOP MICROBIOL, V293, P115, DOI 10.1007/3-540-27702-1_6; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; TAURUS LS, 2001, EUR J IMMUNOL, V31, P1122; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Yang GL, 2007, INT IMMUNOL, V19, P133, DOI 10.1093/intimm/dxl130	40	16	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2008	121	5					1277	1284		10.1016/j.jaci.2008.01.070	http://dx.doi.org/10.1016/j.jaci.2008.01.070			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	302IJ	18355912	Bronze			2022-12-18	WOS:000255961700030
J	Rabito, FA; Iqbal, S; Kiernan, MP; Holt, E; Chew, GL				Rabito, Felicia A.; Iqbal, Shahed; Kiernan, Michael P.; Holt, Elizabeth; Chew, Ginger L.			Children's respiratory health and model levels in New Orleans after Katrina: A preliminary look	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						mold; fungi; pulmonary function; children; allergens; cough; Hurricane Katrina; indoor air; wheezing	HURRICANE-KATRINA; HOME DAMPNESS; MOLD; SYMPTOMS	Background: When the federal levee system broke after Hurricane Katrina, 80 percent of New Orleans, approximately 134,000 homes, flooded. As repopulation and revitalization activities continue, exposure to mold and other respiratory irritants has emerged as a major health concern; however, there has been no study examining children's respiratory health and indoor mold levels in the post-Katrina environment. Objective: The Children's Respiratory Health Study was designed as a preliminary examination of indoor air levels of mold, children's lung function, and common indices of respiratory health in a select sample of children returning to live in New Orleans immediately after Hurricane Katrina. Methods: Children were recruited from a private primary school in the Garden District of New Orleans. Respiratory health questionnaire and spirometric data were collected on children 7 to 14 years of age, and mold air sampling was conducted at baseline and again after 2 months. Conclusions: There was an overall decrease in mold levels and respiratory symptoms over the study period, and indoor mold levels were low despite reported hurricane damage.	[Rabito, Felicia A.; Iqbal, Shahed; Holt, Elizabeth] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [Kiernan, Michael P.] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Chew, Ginger L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA	Tulane University; Tulane University; Columbia University	Rabito, FA (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St,SL18, New Orleans, LA 70112 USA.	rabito@tulane.edu		Iqbal, Shahed/0000-0002-3013-4750				*AM AC OT, HEAD NECK SURG FACT; Andriessen JW, 1998, CLIN EXP ALLERGY, V28, P1191, DOI 10.1046/j.1365-2222.1998.00322.x; Belanger K, 2003, AM J EPIDEMIOL, V158, P195, DOI 10.1093/aje/kwg148; BRUNEKREEF B, 1989, AM REV RESPIR DIS, V140, P1363, DOI 10.1164/ajrccm/140.5.1363; Chew GL, 2006, ENVIRON HEALTH PERSP, V114, P1883, DOI 10.1289/ehp.9258; DiazSanchez D, 1997, ALLERGY, V52, P52; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; *IOM NAT AC COMM D, 2004, DAMP IND SP HLTH; LUTHER L, DISASTER DEBRIS REMO; Manuel J, 2006, ENVIRON HEALTH PERSP, V114, pA32, DOI 10.1289/ehp.114-a32; *OFF FED COORD GUL, 2006, CURR HOUS UN DAM EST; Parnia S, 2002, ALLERGY, V57, P1111, DOI 10.1034/j.1398-9995.2002.02167.x; Peat JK, 1998, ALLERGY, V53, P120, DOI 10.1111/j.1398-9995.1998.tb03859.x; Rao CY, 2007, APPL ENVIRON MICROB, V73, P1630, DOI 10.1128/AEM.01973-06; Ratard R., 2006, Morbidity and Mortality Weekly Report, V55, P41; Ross MA, 2000, ALLERGY, V55, P705, DOI 10.1034/j.1398-9995.2000.00551.x; Solomon GM, 2006, ENVIRON HEALTH PERSP, V114, P1381, DOI 10.1289/ehp.9198	17	16	17	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3					622	625		10.1016/j.jaci.2007.11.022	http://dx.doi.org/10.1016/j.jaci.2007.11.022			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR	18179814	Bronze			2022-12-18	WOS:000253918900012
J	Virtanen, H; Remitz, A; Malmlierg, P; Rytila, P; Metso, T; Haahtela, T; Reitanio, S				Virtanen, Hannele; Remitz, Anita; Malmlierg, Pekka; Rytilae, Paula; Metso, Tuula; Haahtela, Tari; Reitanio, Sakari			Topical tacrolimus in the treatment of atopic dermatitis - does it benefit the airways? A 4-year open follow-up	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Virtanen, Hannele; Remitz, Anita; Malmlierg, Pekka; Rytilae, Paula; Metso, Tuula; Haahtela, Tari; Reitanio, Sakari] Univ Helsinki, Ctr Hosp, Skin & Allergy Hosp, Helsinki, Finland	University of Helsinki	Virtanen, H (corresponding author), Univ Helsinki, Ctr Hosp, Skin & Allergy Hosp, Helsinki, Finland.	hannele.virtanen@finmet.fi						Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; RAJKA G, 1989, ACTA DERM-VENEREOL, P13; Reitamo Sakari, 2002, Am J Clin Dermatol, V3, P381, DOI 10.2165/00128071-200203060-00002; SOVIJARVI ARA, 1993, CHEST, V104, P164, DOI 10.1378/chest.104.1.164; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; 2002, J ALLERGY CLIN IMM S, V110, P141	9	16	17	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2007	120	6					1464	1466		10.1016/j.jaci.2007.08.021	http://dx.doi.org/10.1016/j.jaci.2007.08.021			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241JX	17910892				2022-12-18	WOS:000251653800034
J	Federico, MJ; Wamboldt, FS; Carter, R; Mansell, A; Wamboldt, MZ				Federico, Monica J.; Wamboldt, Frederick S.; Carter, Rick; Mansell, Anthony; Wamboldt, Marianne Z.			History of serious asthma exacerbations should be included asthma severity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; severity; pulmonary function tests; clinical guidelines	EXHALED NITRIC-OXIDE; CHILDHOOD ASTHMA; RISK-FACTORS; AIRWAY HYPERRESPONSIVENESS; CHILDREN; RESPONSIVENESS; CARE; METHACHOLINE; SYMPTOMS; ATOPY		Univ Colorado, Dept Pediat, Hlth Sci Ctr, Sect Pediat Pulmonol,Childrens Hosp, Denver, CO 80218 USA; Univ Colorado, Dept Psychiat, Hlth Sci Ctr,Div Child Psychiat, Sect Pediat Pulmonol,Childrens Hosp, Denver, CO 80218 USA; Natl Jewish Med & Res Ctr, Div Psychosocial Med, Dept Med, Denver, CO USA; Texas Tech Univ, Dept Hlth Exercise & Sport Sci, Lubbock, TX 79409 USA; Hasbro Childrens Hosp, Rhode Isl Hosp, Dept Pediat, Sect Pediat Pulmonol,Brown Med Sch, Providence, RI USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; Texas Tech University System; Texas Tech University; Brown University; Hasbro Children's Hospital; Lifespan Health Rhode Island; Rhode Island Hospital	Federico, MJ (corresponding author), Univ Colorado, Dept Pediat, Hlth Sci Ctr, Sect Pediat Pulmonol,Childrens Hosp, 1056 E 19th Ave,Suite B395, Denver, CO 80218 USA.	Federico.monica@tchden.org			NCRR NIH HHS [MO1-RR00051] Funding Source: Medline; NHLBI NIH HHS [R01 HL07670, R01 HL64938] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064938] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Belessis Y, 2004, PEDIATR PULM, V37, P201, DOI 10.1002/ppul.10443; Castro M, 2003, AM J RESP CRIT CARE, V168, P1095, DOI 10.1164/rccm.200208-877OC; Colice GL, 1999, AM J RESP CRIT CARE, V160, P1962, DOI 10.1164/ajrccm.160.6.9902112; Covar RA, 2003, J PEDIATR-US, V142, P469, DOI 10.1067/mpd.2003.187; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Delgado-Corcoran Claudia, 2004, Pediatr Crit Care Med, V5, P48, DOI 10.1097/01.CCM.0000105310.00799.51; Djukanovic R, 2002, J ALLERGY CLIN IMMUN, V109, pS539, DOI 10.1067/mai.2002.124568; Franklin PJ, 2003, THORAX, V58, P1048, DOI 10.1136/thorax.58.12.1048; Fuhlbrigge AL, 2002, AM J RESP CRIT CARE, V166, P1044, DOI 10.1164/rccm.2107057; Jatakanon A, 1998, THORAX, V53, P91, DOI 10.1136/thx.53.2.91; Jones SL, 2001, AM J RESP CRIT CARE, V164, P738, DOI 10.1164/ajrccm.164.5.2012125; Joseph-Bowen J, 2004, J ALLERGY CLIN IMMUN, V114, P1040, DOI 10.1016/j.jaci.2004.07.051; Klein RB, 1995, PEDIATR PULM, V20, P372, DOI 10.1002/ppul.1950200607; La Grutta S, 2003, AM J RESP CRIT CARE, V167, P1490, DOI 10.1164/rccm.200206-549OC; Lafata JE, 2002, AMBUL PEDIATR, V2, P268, DOI 10.1367/1539-4409(2002)002<0268:RFFEDU>2.0.CO;2; Leuppi JD, 2001, AM J RESP CRIT CARE, V163, P406, DOI 10.1164/ajrccm.163.2.9912091; McFadden ER, 2003, AM J RESP CRIT CARE, V168, P740, DOI 10.1164/rccm.200208-902SO; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V104, P775, DOI 10.1016/S0091-6749(99)70287-3; Nogami H, 2003, J ASTHMA, V40, P653, DOI 10.1081/JAS-120019036; Ramsey CD, 2005, PEDIATR PULM, V39, P268, DOI 10.1002/ppul.20177; ROSIER MJ, 1994, AM J RESP CRIT CARE, V149, P1434, DOI 10.1164/ajrccm.149.6.8004295; Silvestri M, 2000, THORAX, V55, P484, DOI 10.1136/thorax.55.6.484; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Spahn JD, 2004, AM J RESP CRIT CARE, V169, P784, DOI 10.1164/rccm.200309-1234OE; Turner MO, 1998, AM J RESP CRIT CARE, V157, P1804, DOI 10.1164/ajrccm.157.6.9708092; Weiss ST, 2000, AM J RESP CRIT CARE, V162, P50, DOI 10.1164/ajrccm.162.1.9811005; WOOLCOCK A, 1989, MED J AUSTRALIA, V151, P650, DOI 10.5694/j.1326-5377.1989.tb139640.x; [No title captured]	30	16	17	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1					50	56		10.1016/j.jaci.2006.10.019	http://dx.doi.org/10.1016/j.jaci.2006.10.019			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	127YL	17141850				2022-12-18	WOS:000243622200009
J	Radon, K; Schulze, A				Radon, Katja; Schulze, Anja			Adult obesity, farm childhood, and their effect on allergic sensitization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						leptin; hygiene hypothesis; inhalant allergens; specific IgE	BODY-MASS INDEX; ASTHMA; ATOPY; ASSOCIATION; PREVALENCE; EXPOSURE; LEPTIN	Background: Obesity as well as a reduced microbial exposure, 2 markers of Western lifestyle, might be associated with an increased risk of allergic sensitization. Objective: We aimed to analyze the interplay of these markers of Western lifestyle on allergic sensitization. Methods: A questionnaire survey was completed by rural adults (18-45 years). Clinical assessments included those of sensitization (specific IgE) against inhalant allergens and body mass index (BMI). Subjects were grouped on the basis of their recent BMI (obesity: BMI >= 30 kg/m(2)) and whether they had regular farm contact during the first 3 years of life (farm subjects). Nonobese nonfarm subjects served as the reference group. Overall, 1861 subjects were included in the analyses. Results: Compared with nonobese nonfarm subjects, nonobese farm subjects showed a decreased odds ratio for sensitization (odds ratio, 0.6; 95% CI, 0.5-0.8). This decrease was not observed in obese subjects (obese nonfarm subjects: 1.2, 0.8-1.9; obese farm subjects: 1.0, 0.6-1.6). Associations were similar for symptoms of allergic rhinitis. Conclusion: Obesity, as a risk factor for respiratory allergies per se, might diminish or even cancel the protective effect of a farm childhood. Clinical implications: The high prevalence of respiratory allergies in inner-city societies despite lower levels of hygiene might be explained by obesity.	Univ Munich, Inst Occupat & Environm Med, Unit Occupat & Environm Epidemiol & Net Teaching, D-80336 Munich, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Radon, K (corresponding author), Univ Munich, Inst Occupat & Environm Med, Unit Occupat & Environm Epidemiol & Net Teaching, Ziemssenstr 1, D-80336 Munich, Germany.	Katja.Radon@med.uni-muenchen.de						Calvert J, 2005, J ALLERGY CLIN IMMUN, V116, P773, DOI 10.1016/j.jaci.2005.05.025; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Guarner F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/ncpgasthep0471; Huang SL, 1999, CLIN EXP ALLERGY, V29, P323, DOI 10.1046/j.1365-2222.1999.00455.x; Kilpelainen M, 2006, RESP MED, V100, P1518, DOI 10.1016/j.rmed.2006.01.011; Mai XM, 2003, PEDIATR ALLERGY IMMU, V14, P184, DOI 10.1034/j.1399-3038.2003.00045.x; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Naleway Allison L, 2004, Clin Med Res, V2, P5; Nowak D, 1996, EUR RESPIR J, V9, P2541, DOI 10.1183/09031936.96.09122541; Perzanowski MS, 2006, J ALLERGY CLIN IMMUN, V117, P1082, DOI 10.1016/j.jaci.2005.12.1348; Peters M, 2006, THORAX, V61, P134, DOI 10.1136/thx.2005.049403; Platts-Mills TAE, 2005, ALLERGY, V60, P25, DOI 10.1111/j.1398-9995.2005.00854.x; Praml G, 2005, CHEST, V128, P3585, DOI 10.1378/chest.128.5.3585; Radon K, 2006, ALLERGY, V61, P443, DOI 10.1111/j.1398-9995.2006.00995.x; Renz H, 2006, CHEM IMMUNOL ALLERGY, V91, P30; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Schachter LM, 2003, THORAX, V58, P1031, DOI 10.1136/thorax.58.12.1031; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P103, DOI 10.1016/j.jaci.2004.10.007; von Mutius E, 2001, THORAX, V56, P835, DOI 10.1136/thorax.56.11.835; von Mutius E, 2006, ALLERGY, V61, P407, DOI 10.1111/j.1398-9995.2006.01009.x	21	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2006	118	6					1279	1283		10.1016/j.jaci.2006.08.033	http://dx.doi.org/10.1016/j.jaci.2006.08.033			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	117NP	17157657	Bronze			2022-12-18	WOS:000242880300011
J	Blumchen, K; Gerhold, K; Schwede, M; Niggemann, B; Avagyan, A; Dittrich, AM; Wagner, B; Breiteneder, H; Hamelmann, E				Blumchen, Katharina; Gerhold, Kerstin; Schwede, Marcus; Niggemann, Bodo; Avagyan, Anzhela; Dittrich, Anna-Maria; Wagner, Birgit; Breiteneder, Heimo; Hamelmann, Eckard			Effects of established allergen sensitization on immune and airway responses after secondary allergen sensitization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						sensitization; mice; T(H)1/T(H)2 cytokines; airway reactivity; airway inflammation	T-CELL RESPONSES; LATEX ALLERGY; EARLY-LIFE; MICE; DIFFERENTIATION; IMMUNOTHERAPY; CHILDREN; PREVENTION; ASTHMA; HYPERRESPONSIVENESS	Background: Spreading of sensitization with clinical manifestation of allergy is often observed in atopic individuals. Objective: To investigate the effects of an established primary allergen sensitization on immune responses and airway inflammation/reactivity on secondary allergen sensitization and airway challenges in a murine model. Methods: Balb/c mice were primarily sensitized intraperitoneally with ovalbumin or PBS, followed by systemic sensitization and airway challenges with latex extract as a secondary, unrelated allergen. Purely sham-sensitized animals were included as controls. In a second set of experiments, the primary and secondary allergens were switched. Results: Sensitization With ovalbumin before sensitization with latex resulted in increased production of total and latex-specific (Hev b 3-specific) IgE and IgG(1), and enhanced secretion of T(H)2-cytokines by spleen mononuclear cells cultured with mitogen compared with single latex-sensitized mice. Furthermore, airway challenges of double-sensitized mice (ovalbumin + latex) with latex caused a significant increase in airway reactivity compared with purely latex-sensitized and challenged animals. These effects were dependent on dosing and timing of the primary sensitization in relation to the secondary sensitization and independent of the primary allergen used. Conclusion: Primary sensitization boosted systemic T(H)2 immune responses and enhanced the development of airway reactivity after sensitization and airway challenges with a secondary, unrelated allergen. This effect of consecutive priming was dependent on the strength of the primary sensitization but independent of the allergen used. The results explain the increased susceptibility toward sensitization spreading in atopic individuals. Clinical implications: Because sensitization spreading is facilitated by primary sensitization, early prevention measurements or immunotherapy should be considered at this stage of monosensitization.	Univ Hosp Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; Med Univ Vienna, Ctr Physiol & Pathophysiol, Vienna, Austria	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Vienna	Blumchen, K (corresponding author), Univ Hosp Charite, Dept Pediat Pneumol & Immunol, Augustenburger Pl 1, D-13353 Berlin, Germany.	nina.bluemchen@charite.de	Dittrich, Anna/GRY-6738-2022; Dittrich, Anna Maria/M-5640-2013; Hamelmann, Eckard/AAJ-9124-2021					Alam R, 2004, J ALLERGY CLIN IMMUN, V113, P38, DOI 10.1016/j.jaci.2003.10.054; Blumchen K, 2004, CLIN EXP ALLERGY, V34, P1124, DOI 10.1111/j.1365-2222.2004.01974.x; Bochner BS, 2004, J ALLERGY CLIN IMMUN, V113, P3, DOI 10.1016/j.jaci.2003.09.046; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P450, DOI 10.1016/S0091-6749(97)70069-1; Eisenbarth SC, 2004, J IMMUNOL, V172, P4527, DOI 10.4049/jimmunol.172.7.4527; Gerhold K, 2003, J ALLERGY CLIN IMMUN, V112, P389, DOI 10.1067/mai.2003.1646; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Hamelmann E, 1997, AM J RESP CRIT CARE, V155, P819, DOI 10.1164/ajrccm.155.3.9117011; Hufnagl K, 2003, CLIN EXP IMMUNOL, V133, P170, DOI 10.1046/j.1365-2249.2003.02210.x; Illi S, 2001, J ALLERGY CLIN IMMUN, V108, P709, DOI 10.1067/mai.2001.118786; KURUP VP, 1994, INT ARCH ALLERGY IMM, V103, P370, DOI 10.1159/000236656; Liebke C, 1996, PEDIATR ALLERGY IMMU, V7, P103, DOI 10.1111/j.1399-3038.1996.tb00115.x; MANTEL RZ, 2006, SWISS MED WEEKLY, V136, P149; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; Nickel R, 1997, J ALLERGY CLIN IMMUN, V99, P613, DOI 10.1016/S0091-6749(97)70021-6; Niggemann B, 1998, J ALLERGY CLIN IMMUN, V102, P665, DOI 10.1016/S0091-6749(98)70285-4; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Pajno GB, 2001, CLIN EXP ALLERGY, V31, P1392, DOI 10.1046/j.1365-2222.2001.01161.x; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Purello-D'Ambrosio F, 2001, CLIN EXP ALLERGY, V31, P1295, DOI 10.1046/j.1365-2222.2001.01027.x; Rhodes HL, 2001, J ALLERGY CLIN IMMUN, V108, P720, DOI 10.1067/mai.2001.119151; Schipf A, 2003, EUR J IMMUNOL, V33, P1697, DOI 10.1002/eji.200323809; Sherrill D, 1999, CLIN EXP ALLERGY, V29, P905; Takeda K, 2001, AM J PHYSIOL-LUNG C, V281, pL394, DOI 10.1152/ajplung.2001.281.2.L394; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Wagner B, 1999, J ALLERGY CLIN IMMUN, V104, P1084, DOI 10.1016/S0091-6749(99)70093-X; Woolhiser MR, 2000, TOXICOL SCI, V55, P343, DOI 10.1093/toxsci/55.2.343	29	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					615	621		10.1016/j.jaci.2006.04.054	http://dx.doi.org/10.1016/j.jaci.2006.04.054			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950279				2022-12-18	WOS:000240649000013
J	Kraft, M; Hamid, Q				Kraft, Monica; Hamid, Qutayba			Mycoplasma in severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							PNEUMONIAE INFECTION; CHILDREN		McGill Univ, Meakins Christie Labs, Dept Pathol & Med, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada; Duke Univ, Med Ctr, Allergy & Airway Ctr, Durham, NC USA	McGill University; Duke University	Hamid, Q (corresponding author), McGill Univ, Meakins Christie Labs, Dept Pathol & Med, Meakins Christie Labs, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	qutayba.hamid@mcgill.ca						Chu HW, 2003, INFECT IMMUN, V71, P1520, DOI 10.1128/IAI.71.3.1520-1526.2003; Esposito S, 2002, PEDIATR PULM, V34, P122, DOI 10.1002/ppul.10139; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Waris ME, 1998, J CLIN MICROBIOL, V36, P3155, DOI 10.1128/JCM.36.11.3155-3159.1998	5	16	18	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2006	117	5					1197	1198		10.1016/j.jaci.2006.03.001	http://dx.doi.org/10.1016/j.jaci.2006.03.001			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	041EM	16675358				2022-12-18	WOS:000237436300042
J	Cho, JY; Miller, M; McElwain, K; McElwain, S; Broide, DH				Cho, JY; Miller, M; McElwain, K; McElwain, S; Broide, DH			Combination of corticosteroid therapy and allergen avoidance reverses allergen-induced airway remodeling in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; remodeling; corticosteroids; allergen; eosinophil; fibrosis; smooth muscle	SUBEPITHELIAL COLLAGEN DEPOSITION; BASEMENT-MEMBRANE; BRONCHIAL HYPERRESPONSIVENESS; INHALED CORTICOSTEROIDS; MILD ASTHMA; INFLAMMATION; CHILDREN; EXPRESSION; INHALATION; DECREASE	Background: Allergen avoidance and anti-inflammatory therapy are standard therapeutic approaches guidelines advocate to control asthma symptoms. Currently, it is not known whether such strategies reduce airway remodeling. Objective: We have therefore used a mouse model of allergen-induced airway remodeling to determine whether allergen avoidance combined with corticosteroid therapy can reverse established airway remodeling. Methods: Mice were sensitized to ovalbumin and then repetitively challenged with intranasal ovalbumin for 3 months to develop structural features of airway remodeling including peribronchial fibrosis and increased thickness of the peribronchial smooth muscle layer. At this time point, mice were treated with allergen avoidance, allergen avoidance and corticosteroids, or corticosteroids for 1 month to determine whether either strategy could reverse established airway remodeling. Results: Mice repetitively challenged with ovalbumin developed peribronchial fibrosis (increased total lung collagen and increased peribronchial trichrome staining) as well as increased thickness of the peribronchial smooth muscle layer. Allergen avoidance significantly reduced airway inflammation and mucus expression, slightly reduced peribronchial fibrosis, and had no effect on the thickness of the peribronchial smooth muscle layer. Addition of corticosteroids to allergen avoidance significantly reduced levels of peribronchial fibrosis as well as the thickness of the peribronchial smooth muscle layer. Conclusion: Allergen avoidance reduces airway inflammation and mucus expression but has more limited immediate effects on reducing structural features of established airway remodeling. The combination of allergen avoidance and corticosteroid therapy is effective in reversing established features of airway remodeling including peribronchial fibrosis and the increased thickness of the smooth muscle layer.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Broide, DH (corresponding author), Univ Calif San Diego, Dept Med, Basic Sci Bldg,Room 5090,9500 Gilman Dr, La Jolla, CA 92093 USA.	dbroide@ucsd.edu		Broide, David/0000-0001-8405-9090	NIAID NIH HHS [AI 38425] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038425, R37AI038425] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blyth DI, 2000, AM J RESP CELL MOL, V23, P241, DOI 10.1165/ajrcmb.23.2.3999; Bodini A, 2004, PEDIAT ALLERG IMM-UK, V15, P26, DOI 10.1046/j.0905-6157.2003.00097.x; Boulet LP, 2000, AM J RESP CRIT CARE, V162, P1308, DOI 10.1164/ajrccm.162.4.9910051; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Cho JY, 2004, AM J RESP CELL MOL, V30, P651, DOI 10.1165/rcmb.2003-0066OC; CHO JY, 2004, J IMMUNOL, V173, P7556; Christie PE, 2004, EUR RESPIR J, V24, P107, DOI 10.1183/09031936.04.00013303; DJUKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669, DOI 10.1164/ajrccm/145.3.669; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Hoshino M, 1999, J ALLERGY CLIN IMMUN, V104, P356, DOI 10.1016/S0091-6749(99)70379-9; Ikeda RK, 2003, AM J RESP CELL MOL, V28, P655, DOI 10.1165/rcmb.4853; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; Milanese M, 2004, J ALLERGY CLIN IMMUN, V114, P505, DOI 10.1016/j.jaci.2004.05.041; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; National Asthma Education and Prevention Program, 2003, J ALLERGY CLIN IMMUN, V111, P466, DOI DOI 10.1542/PEDS.2007-3825; *NINLBI, 1995, NIH PUBL; Olivieri D, 1997, AM J RESP CRIT CARE, V155, P1864, DOI 10.1164/ajrccm.155.6.9196087; Peroni DG, 2002, CLIN EXP ALLERGY, V32, P850, DOI 10.1046/j.1365-2222.2002.01372.x; Piacentini GL, 1996, J ALLERGY CLIN IMMUN, V97, P1079, DOI 10.1016/S0091-6749(96)70261-0; Platts-Mills TAE, 2003, NEW ENGL J MED, V349, P207, DOI 10.1056/NEJMp030082; TRIGG CJ, 1994, AM J RESP CRIT CARE, V150, P17, DOI 10.1164/ajrccm.150.1.8025745; Vanacker NJ, 2001, AM J RESP CRIT CARE, V163, P674, DOI 10.1164/ajrccm.163.3.2004160; vanVelzen E, 1996, THORAX, V51, P582, DOI 10.1136/thx.51.6.582; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Woodcock A, 2003, NEW ENGL J MED, V349, P225, DOI 10.1056/NEJMoa023175; [No title captured]	28	16	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2005	116	5					1116	1122		10.1016/j.jaci.2005.08.015	http://dx.doi.org/10.1016/j.jaci.2005.08.015			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IG	16275385	Bronze			2022-12-18	WOS:000235686700026
J	Sedgwick, JB; Jansen, KJ; Kennedy, JD; Kita, H; Busse, WW				Sedgwick, JB; Jansen, KJ; Kennedy, JD; Kita, H; Busse, WW			Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophil; very late adhesion molecule 4 antagonists; degranulation; respiratory burst; adhesion; transendothelial migration; vascular cell adhesion molecule 1; endothelial cells	COLONY-STIMULATING FACTOR; SUPEROXIDE ANION GENERATION; ENDOTHELIAL-CELLS; AIRWAY HYPERRESPONSIVENESS; TRANSENDOTHELIAL MIGRATION; MONOCLONAL-ANTIBODY; ALPHA(4) INTEGRIN; GM-CSF; ACTIVATION; VCAM-1	Background: Eosinophil infiltration to the lung in allergic inflammation can be initiated by the tethering of circulating cells through very late adhesion molecule 4 (VLA-4; alpha 4 beta 1, CD49d/CD29) to vascular cell adhesion molecule 1 (VCAM-1) expressed on pulmonary vascular endothelium. Small-molecule VLA-4 antagonists have been proposed as a therapeutic mechanism to prevent eosinophil infiltration in asthma; however, they might affect other eosinophil functions. Objective: The small-molecule VLA-4 antagonist (2S)-3(4-Dimethylcarbamoyloxyphenyl)-2-{[(4R)-5,5-dimethyl-3-(1-methyl-IH-pyrazole-4 sulfonyl)thiazolidine-4-carbonyl]amino}propionic acid (WAY103) was assessed for its effects on eosinophil VLA-4-dependent functions, including adhesion, migration, respiratory burst, and degranulation. Methods: Human peripheral blood eosinophils were preincubated with WAY103, anti-alpha 4, and/or anti-beta 2 integrin mAbs and then assessed for adhesion to recombinant VCAM-I, intercellular adhesion molecule 1, and endothelial cell monolayers. Transmigration was measured by using human pulmonary microvascular endothelial cell monolayers and Transwell filters. Superoxide anion generation was determined by means of cytochrome C reduction and degranulation by means of eosinophil-derived neurotoxin release. Results: WAY103 inhibition of eosinophil adhesion to recombinant VCAM-I was dose dependent (63% inhibition with 100 nM WAY103, P < .04) and comparable with inhibition caused by anti-alpha 4 mAb (60.1% inhibition). Although pretreatment with WAY103 also decreased eosinophil adhesion to TNF-alpha plus IL-4-activated human pulmonary microvascular endothelial cell monolayers, it did not prevent eosinophil transendothelial migration in response to RANTES. Finally, WAY103 inhibited VCAM-1-stimulated superoxide generation but enhanced cytokine-activated eosinophil-derived neurotoxin degranulation. Conclusion: Although small-molecule VLA-4 antagonists, such as WAY103, might reduce eosinophil adhesion, this approach might not be sufficient to eliminate this cell from in vivo allergic airway inflammatory participation and could even promote specific cell activation.	Univ Wisconsin, Dept Med, Allergy & Immunol Unit, Madison, WI 53706 USA; Wyeth Ayerst Res, Princeton, NJ 08543 USA; Mayo Clin, Rochester, MN 55905 USA	University of Wisconsin System; University of Wisconsin Madison; Pfizer; Mayo Clinic	Sedgwick, JB (corresponding author), CSC-3244 H6-355,600 Highland Ave, Madison, WI 53792 USA.	jxs@medicine.wisc.edu						Abraham WM, 2000, AM J RESP CRIT CARE, V162, P603, DOI 10.1164/ajrccm.162.2.9911061; ABRAHAM WM, 1994, J CLIN INVEST, V93, P776, DOI 10.1172/JCI117032; CARLSON M, 1993, ALLERGY, V48, P437; Chiba R, 1999, BLOOD, V94, P1319, DOI 10.1182/blood.V94.4.1319.416k28_1319_1329; Fujiu T, 2002, ANN ALLERG ASTHMA IM, V89, P90, DOI 10.1016/S1081-1206(10)61917-5; Grayson MH, 1998, J EXP MED, V188, P2187, DOI 10.1084/jem.188.11.2187; HORIE S, 1994, J IMMUNOL, V152, P5457; Huryn DM, 2004, CURR TOP MED CHEM, V4, P1473, DOI 10.2174/1568026043387467; Jackson DY, 2002, CURR PHARM DESIGN, V8, P1229, DOI 10.2174/1381612023394737; Jia GQ, 1999, INT IMMUNOL, V11, P1, DOI 10.1093/intimm/11.1.1; Kanehiro A, 2000, AM J RESP CRIT CARE, V162, P1132, DOI 10.1164/ajrccm.162.3.9910100; Kita H, 1996, J IMMUNOL, V156, P1174; Kitayama J, 1997, J IMMUNOL, V159, P3929; Koo GC, 2003, AM J RESP CRIT CARE, V167, P1400, DOI 10.1164/rccm.200207-696OC; Kraneveld AD, 1997, J ALLERGY CLIN IMMUN, V100, P242, DOI 10.1016/S0091-6749(97)70231-8; Liu LY, 2002, J IMMUNOL, V169, P6452, DOI 10.4049/jimmunol.169.11.6452; Matsui T, 2000, ACTA OTO-LARYNGOL, V120, P761; May AE, 2000, BLOOD, V96, P506; Nagata M, 1998, AM J RESP CELL MOL, V19, P158, DOI 10.1165/ajrcmb.19.1.3001; Nagata M, 1997, INT ARCH ALLERGY IMM, V114, P78, DOI 10.1159/000237725; NAGATA M, 1995, J IMMUNOL, V155, P2194; Nagata M, 1999, CLIN EXP ALLERGY, V29, P550; Ramos-Barbon D, 2001, AM J RESP CRIT CARE, V163, P101, DOI 10.1164/ajrccm.163.1.2001093; Sagara H, 1997, INT ARCH ALLERGY IMM, V112, P287, DOI 10.1159/000237468; SEDGWICK JB, 1992, J IMMUNOL, V149, P3710; Sung KLP, 1997, J IMMUNOL, V158, P919; Teixeira MM, 2001, BRIT J PHARMACOL, V132, P596, DOI 10.1038/sj.bjp.0703857; Van der Vieren M, 1999, J IMMUNOL, V163, P1984; Xu X, 2000, CLIN EXP ALLERGY, V30, P794; Yamamoto H, 2000, AM J RESP CELL MOL, V23, P379, DOI 10.1165/ajrcmb.23.3.3707; Yamamoto H, 1998, J IMMUNOL, V161, P971; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001	32	16	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2005	116	4					812	819		10.1016/j.jaci.2005.07.003	http://dx.doi.org/10.1016/j.jaci.2005.07.003			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IF	16210055				2022-12-18	WOS:000235686600015
J	Win, PH; Brown, H; Zankar, A; Ballas, ZK; Hussain, I				Win, PH; Brown, H; Zankar, A; Ballas, ZK; Hussain, I			Rapid intravenous cephalosporin desensitization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PENICILLIN ALLERGY; ANTIBIOTICS; RISK		Washington Univ, Sch Med, Div Allergy & Immunol, St Louis, MO 63110 USA; Univ Iowa Hosp & Clin Program, Dept Internal Med, Iowa City, IA USA	Washington University (WUSTL); University of Iowa	Win, PH (corresponding author), Washington Univ, Sch Med, Div Allergy & Immunol, 660 S Euclid Ave,Campus Box 8122, St Louis, MO 63110 USA.			Ballas, Zuhair/0000-0001-5569-1230; Knaack, Aaron/0000-0001-7712-1415				ANNE S, 1995, ANN ALLERG ASTHMA IM, V74, P167; Baldo BA, 1999, CLIN EXP ALLERGY, V29, P744; Clarke H. T., 1949, CHEM PENICILLIN; Empedrad R, 2003, J ALLERGY CLIN IMMUN, V112, P629, DOI 10.1067/mai.2003.1690; Ghosal S, 1997, J ANTIMICROB CHEMOTH, V39, P556, DOI 10.1093/jac/39.4.556; MENDELSON LM, 1984, J ALLERGY CLIN IMMUN, V73, P76, DOI 10.1016/0091-6749(84)90487-1; PAPAKONSTANTINOU G, 1993, CLIN INVESTIGATOR, V71, P165; Pumphrey RSH, 1999, LANCET, V353, P1157, DOI 10.1016/S0140-6736(99)00449-3; Romano A, 2004, ANN INTERN MED, V141, P16, DOI 10.7326/0003-4819-141-1-200407060-00010	9	16	19	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2005	116	1					225	228		10.1016/j.jaci.2005.03.037	http://dx.doi.org/10.1016/j.jaci.2005.03.037			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IC	15990801				2022-12-18	WOS:000235686300036
J	Liu, J; Zhu, XD; Myo, S; Lambertino, AT; Xu, C; Boetticher, E; Munoz, NM; Sano, M; Cordoba, M; Learoyd, J; Meliton, A; Johnson, M; Leff, AR				Liu, J; Zhu, XD; Myo, S; Lambertino, AT; Xu, C; Boetticher, E; Munoz, NM; Sano, M; Cordoba, M; Learoyd, J; Meliton, A; Johnson, M; Leff, AR			Glucocorticoid-induced surface expression of annexin 1 blocks beta(2)-integrin adhesion of human eosinophils to intercellular adhesion molecule 1 surrogate protein	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophils; adhesion molecules; glucocorticoids; annexin 1; cPLA(2) translocation	CYTOSOLIC PHOSPHOLIPASE A(2); FLUTICASONE PROPIONATE; AIRWAY HYPERRESPONSIVENESS; LIPOXIN A(4); LIPOCORTIN-1; INHIBITION; DEXAMETHASONE; ACTIVATION; RECEPTOR; BUDESONIDE	Background: Glucocorticoids attenuate the population of eosinophils and T lymphocytes in asthmatic airways. The decrease in airway eosinophilia is caused both by accelerated cell death and by induction of blockade of integrin adhesion. In this study, we examined the hypothesis that annexin 1 surface expression, which is upregulated by the glucocorticoid receptor, prevents integrin adhesion essential to cell migration by blocking intracellular translocation of cytosolic group TV phospholipase A(2) (cPLA(2)). Objective: To examine the relationship of the glucocorticoid on annexin 1 expression and the effect of blockade of annexin 1 activity on adhesion of human eosinophils in vitro. To determine the relationship between annexin 1surface expression and nuclear membrane translocation of cPLA(2). Methods: Eosinophils isolated from human peripheral blood were pretreated with fluticasone propionate (FP), and beta(2)-integrin adhesion was measured after stimulation with IL-5 or eotaxin. Effects of FP on cPLA(2) expression, phosphorylation, and translocation were determined. The role of annexin 1 was examined by using annexin 1 blocking antibody and/or mimetic peptides. Results: Fluticasone propionate decreased stimulated eosinophil adhesion and caused 4-fold increase in annexin 1 expression on the plasma membrane. Inhibition of adhesion by FP was blocked with annexin 1 blocking antibody. Annexin 1 N-terminal mimetic peptide also blocked beta(2)-integrin adhesion. Translocation of cPLA(2) to the nuclear membrane was significantly blocked by incubation with FP. Blockade was reversed with annexin 1 blocking antibody. Conclusion: Blockade of beta(2)-integrin adhesion by glucocorticoid is regulated by annexin 1, which blocks cPLA(2) translocation to nuclear membrane.	Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; Univ Chicago, Dept Pharmacol, Chicago, IL 60637 USA; Univ Chicago, Dept Physiol, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; Univ Chicago, Committees Clin Pharmacol & Pharmacogenom Cell Ph, Div Biol Sci, Chicago, IL 60637 USA; GlaxoSmithKline, Uxbridge, Middx, England	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; GlaxoSmithKline	Leff, AR (corresponding author), Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, MC6076,5841 S Maryland Ave, Chicago, IL 60637 USA.	aleff@medicine.bsd.uchicago.edu		zhu, xiangdong/0000-0002-5627-8082	NHLBI NIH HHS [HL-56399] Funding Source: Medline; NIAID NIH HHS [AI52109] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI052109] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CROXTALL JD, 1995, BIOCHEM PHARMACOL, V50, P465, DOI 10.1016/0006-2952(95)00156-T; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Hagan JB, 1998, CLIN EXP ALLERGY, V28, P999; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; HARTNELL A, 1992, IMMUNOLOGY, V77, P488; Johnson M, 1998, J ALLERGY CLIN IMMUN, V101, pS434, DOI 10.1016/S0091-6749(98)70155-1; KAISER J, 1993, J PHARMACOL EXP THER, V267, P245; Kim SW, 2001, FEBS LETT, V489, P243, DOI 10.1016/S0014-5793(00)02326-7; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Lim LHK, 2000, AM J RESP CELL MOL, V22, P693, DOI 10.1165/ajrcmb.22.6.3890; Myo S, 2004, EUR RESPIR J, V23, P511, DOI 10.1183/09031936.04.00065904; Myou S, 2001, NAT IMMUNOL, V2, P145, DOI 10.1038/84244; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; NAGATA M, 1995, J IMMUNOL, V155, P2194; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; PERRETTI M, 1995, BIOCHEM PHARMACOL, V50, P1037, DOI 10.1016/0006-2952(95)00238-U; PERRETTI M, 1993, J IMMUNOL, V151, P4306; PERRETTI M, 1993, J IMMUNOL, V150, P992; Roviezzo F, 2002, J PHYSIOL PHARMACOL, V53, P541; Sano A, 1999, AM J RESP CRIT CARE, V159, P1903, DOI 10.1164/ajrccm.159.6.9810005; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Walsh GM, 1997, J ALLERGY CLIN IMMUN, V100, P208, DOI 10.1016/S0091-6749(97)70226-4; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wong CK, 2002, IMMUNOPHARM IMMUNOT, V24, P165, DOI 10.1081/IPH-120003748; Zhang XZ, 2000, EUR J PHARMACOL, V406, P325, DOI 10.1016/S0014-2999(00)00690-7; Zhu XD, 1999, J IMMUNOL, V163, P3423; Zhu XD, 2000, J IMMUNOL METHODS, V240, P157, DOI 10.1016/S0022-1759(00)00192-7	27	16	21	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2005	115	3					493	500		10.1016/j.jaci.2004.11.010	http://dx.doi.org/10.1016/j.jaci.2004.11.010			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	907AN	15753895				2022-12-18	WOS:000227687000010
J	Augustin, MT; Kokkonen, J; Karttunen, R; Karttunen, TJ				Augustin, MT; Kokkonen, J; Karttunen, R; Karttunen, TJ			Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						children; food allergy; enteropathy; coeliac disease; serum; granzyme; CD30; Fas; cytotoxic lymphocytes; duodenum	FOOD ALLERGY; INTRAEPITHELIAL LYMPHOCYTES; T-CELLS; SOLUBLE GRANZYME; EXPRESSION; APOPTOSIS; FAS; CYTOTOXICITY; HYPERPLASIA; DIAGNOSIS	Background: Cow's milk protein sensitive enteropathy (CMSE) and celiac disease (CD) associate with upregulation of local intestinal immune responses, including activation of cytotoxic lymphocytes. Objective: We investigated whether this upregulation can be detected at the systemic level by analyzing serum concentrations of granzymes A (GrA) and B (GrB), soluble Fas, and CD30. Methods: Fifty-seven children with a final diagnosis of CMSE in 23 subjects (18 untreated and 5 on a diet), 20 untreated CD patients, and 14 control subjects with no gastrointestinal disease were examined by endoscopy for gastrointestinal complaints. Duodenal biopsies were studied for basic histology, CD3, alphabeta and gammadelta T-cell receptors (TCRs), and serum samples by commercial ELISA assays. Results: Concentrations of GrA and GrB were significantly higher in untreated CMSE and in CD as compared with the control subjects. Measurable GrB was present in only 20% of the control subjects but in 100% of patients with CMSE. CD30 was similarly increased in both untreated CMSE and CD cases, whereas in treated CMSE cases the concentrations were equal to the control subjects. All groups showed similar soluble Fas. The numbers of duodenal CD3(+), alphabeta- and gammadelta-TCRs correlated with the serum granzyme and CD30 levels. Conclusion: The intestinal immune response in CMSE and CD is manifested by the increase in serum GrA, GrB, and CD30; the measurement of these markers provides a new practical and objective complementary means for diagnosis and assessment of treatment response. However, this has to be confirmed by more studies before routine use.	Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland; Univ Oulu, Dept Med Microbiol, FIN-90014 Oulu, Finland; Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Karttunen, TJ (corresponding author), Univ Oulu, Dept Pathol, POB 5000, FIN-90014 Oulu, Finland.	tuomo.karttunen@oulu.fi		Karttunen, Tuomo/0000-0002-8843-7957				Augustin M, 2001, J PEDIATR GASTR NUTR, V32, P11, DOI 10.1097/00005176-200101000-00008; Bock SA, 2003, PEDIATRICS, V111, P1638; Ciccocioppo R, 2000, CLIN EXP IMMUNOL, V120, P235, DOI 10.1046/j.1365-2249.2000.01200.x; DELPRETE G, 1995, FASEB J, V9, P81, DOI 10.1096/fasebj.9.1.7821763; Di Sabatino A, 2001, GUT, V49, P380, DOI 10.1136/gut.49.3.380; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hankard GF, 1997, J PEDIATR GASTR NUTR, V25, P79, DOI 10.1097/00005176-199707000-00013; Hermsen CC, 2003, CLIN EXP IMMUNOL, V132, P467, DOI 10.1046/j.1365-2249.2003.02160.x; Ho CY, 2002, CHEST, V122, P1751, DOI 10.1378/chest.122.5.1751; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Kahaleh MB, 1997, CLIN IMMUNOL IMMUNOP, V83, P32, DOI 10.1006/clin.1996.4322; Kato M, 1999, ALLERGY, V54, P1299, DOI 10.1034/j.1398-9995.1999.00303.x; Kokkonen J, 1999, J PEDIATR GASTR NUTR, V29, P57, DOI 10.1097/00005176-199907000-00015; Kokkonen J, 2004, ACTA PAEDIATR, V93, P880, DOI [10.1080/08035250410024907, 10.1111/j.1651-2227.2004.tb02684.x]; Kokkonen J, 2001, J PEDIATR-US, V139, P797, DOI 10.1067/mpd.2001.118882; Kokkonen J, 2001, J PEDIATR GASTR NUTR, V32, P156, DOI 10.1097/00005176-200102000-00012; Kokkonen J, 2001, ACTA PAEDIATR, V90, P16, DOI 10.1080/080352501750064824; Kokkonen J, 2000, SCAND J GASTROENTERO, V35, P1137, DOI 10.1080/003655200750056592; Lauw FN, 2000, J INFECT DIS, V182, P206, DOI 10.1086/315642; Li XM, 2003, J ALLERGY CLIN IMMUN, V111, P1140, DOI 10.1067/mai.2003.1494; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; Moss SF, 1996, GUT, V39, P811, DOI 10.1136/gut.39.6.811; Oberhuber G, 1996, AM J PATHOL, V148, P1351; Quiros AB, 1999, PEDIAT ALLERG IMM-UK, V10, P235, DOI 10.1034/j.1399-3038.1999.00039.x; Schade RR, 2002, J ALLERGY CLIN IMMUN, V109, P357, DOI 10.1067/mai.2002.121457; Sicherer SH, 2002, LANCET, V360, P701, DOI 10.1016/S0140-6736(02)09831-8; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Tak PP, 1999, CLIN EXP IMMUNOL, V116, P366; Talley NJ, 2002, LANCET, V360, P555, DOI 10.1016/S0140-6736(02)09712-X; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	32	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2005	115	1					157	162		10.1016/j.jaci.2004.10.009	http://dx.doi.org/10.1016/j.jaci.2004.10.009			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	886XS	15637563				2022-12-18	WOS:000226267000023
J	Ying, S; O'Connor, BJ; Meng, Q; Woodman, N; Greenaway, S; Wong, H; Mallett, K; Lee, TH; Corrigan, C				Ying, S; O'Connor, BJ; Meng, Q; Woodman, N; Greenaway, S; Wong, H; Mallett, K; Lee, TH; Corrigan, C			Expression of prostaglandin E-2 receptor subtypes on cells in sputum from patients with asthma and controls: Effect of allergen inhalational challenge	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						prostaglandin E-2; EP receptor; immunocytochemistry; asthma; allergen challenge; sputum	CYCLOOXYGENASE-2 EXPRESSION; PROSTANOID RECEPTORS; TNF-ALPHA; LIPOPOLYSACCHARIDE; ASPIRIN; PGE(2); EP4; MACROPHAGES	Background: Prostaglandin (PG) E-2 binds to 4 G-protein-coupled receptors designated EP1 through EP4. Although PGE(2) plays an immunomodulatory role in asthma, there is little information on the expression of PGE(2) receptors in this disease. Objective: We hypothesized that profiles of E-prostanoid (EP) receptor expression are altered on asthmatic bronchial inflammatory cells in vivo and further altered by allergen challenge in vivo and proinflammatory mediators in vitro. Methods: The numbers and phenotypes of EP1-4 immunoreactive induced sputum cells from atopic asthmatics (n = 13; before and 24 hours after allergen inhalational challenge) and normal controls (n = 9; 3 after saline challenge) and EP1-4 expression on purified blood eosinophils from both groups (n = 4 for each) before and after stimulation with LPS and/or IL-5 in vitro were measured by using single and double immunocytochemistry. Results: Subsets of sputum cells of all phenotypes expressed all 4 EP receptors in both patients with asthma and controls. There were significantly greater numbers of macrophages expressing all 4 EP receptors and increased percentages of macrophages expressing EP2 and EP4 in patients with asthma compared with controls. Allergen bronchial challenge of patients with asthma was associated with a selective influx of eosinophils, but the percentages of these and other leukocytes expressing all 4 EP receptors were unchanged. Compared with sputum, only small percentages of peripheral blood eosinophils expressed each receptor, but this was increased by culture with exogenous IL-5 or LPS. Conclusion: E-prostanoid receptor expression is increased on airway macrophages of patients with asthma at baseline and may be altered on eosinophils after allergen challenge in vivo in response to inflammatory stimuli.	Guy Kings & St Thomas Sch Med, Dept Asthma Allergy & Resp Sci, London, England	University of London; King's College London	Ying, S (corresponding author), Guys Hosp, Guy Kings & St Thomas Sch Med, Dept Asthma Allergy & Resp Sci, 5th Floor,Thomas Guy House, London SE1 9RT, England.	ying.sun@kcl.ac.uk	Lee, Tak/AAA-9526-2020	Lee, Tak/0000-0002-7554-4059; Corrigan, Chris/0000-0002-0706-6534				BETZ M, 1991, J IMMUNOL, V146, P108; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Burgess JK, 2004, J ALLERGY CLIN IMMUN, V113, P876, DOI 10.1016/j.jaci.2004.02.029; DAMON M, 1983, BIOCHEM BIOPH RES CO, V111, P518, DOI 10.1016/0006-291X(83)90337-6; Fedyk ER, 1996, CLIN IMMUNOL IMMUNOP, V81, P101, DOI 10.1006/clin.1996.0165; GAUREAU GM, 1999, AM J RESP CRIT CARE, V159, P31; GODARD P, 1982, J ALLERGY CLIN IMMUN, V70, P88, DOI 10.1016/0091-6749(82)90234-2; Hinz B, 2000, BIOCHEM BIOPH RES CO, V272, P744, DOI 10.1006/bbrc.2000.2859; Hubbard NE, 2001, PROSTAG LEUKOTR ESS, V65, P287, DOI 10.1054/plef.2001.0327; Ikegami R, 2001, J IMMUNOL, V166, P4689, DOI 10.4049/jimmunol.166.7.4689; Liu JJ, 2000, J LEUKOCYTE BIOL, V68, P187; Macfarlane AJ, 2000, AM J RESP CRIT CARE, V161, P1553, DOI 10.1164/ajrccm.161.5.9906068; Martin JG, 2002, J IMMUNOL, V169, P3963, DOI 10.4049/jimmunol.169.7.3963; MCCOLL SR, 1993, J IMMUNOL, V150, P4550; Meng Q, 1997, ALLERGY, V52, P1095, DOI 10.1111/j.1398-9995.1997.tb00181.x; Mita H, 2002, J ALLERGY CLIN IMMUN, V110, P457, DOI 10.1067/mai.2002.127001; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Peacock CD, 1999, J ALLERGY CLIN IMMUN, V104, P153, DOI 10.1016/S0091-6749(99)70127-2; Pierzchalska M, 2003, J ALLERGY CLIN IMMUN, V111, P1041, DOI 10.1067/mai.2003.1491; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Profita M, 2003, J ALLERGY CLIN IMMUN, V112, P709, DOI 10.1016/S0091-6749(03)01889-X; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Sousa AR, 2002, NEW ENGL J MED, V347, P1493, DOI 10.1056/NEJMoa013508; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Teixeira MM, 1997, BRIT J PHARMACOL, V121, P77, DOI 10.1038/sj.bjp.0701107; Tilley SL, 2003, AM J PHYSIOL-LUNG C, V284, pL599, DOI 10.1152/ajplung.00324.2002; Varner AE, 1998, ANN ALLERG ASTHMA IM, V81, P347, DOI 10.1016/S1081-1206(10)63127-4; Yamane H, 2000, BIOCHEM BIOPH RES CO, V278, P224, DOI 10.1006/bbrc.2000.3779; Ying S, 1999, J IMMUNOL, V163, P6321	29	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2004	114	6					1309	1316		10.1016/j.jaci.2004.08.034	http://dx.doi.org/10.1016/j.jaci.2004.08.034			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	877NN	15577828				2022-12-18	WOS:000225577400009
J	Wittmann, M; Alter, M; Stunkel, T; Kapp, A; Werfel, T				Wittmann, M; Alter, M; Stunkel, T; Kapp, A; Werfel, T			Cell-to-cell contact between activated CD4(+) T lymphocytes and unprimed monocytes interferes with a T(H)1 response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						monocytes/macrophages; T-lymphocytes; skin; transcription factors; human	INDUCED INTERLEUKIN-12 PRODUCTION; ANTIGEN-PRESENTING CELLS; HUMAN DENDRITIC CELLS; IL-12 PRODUCTION; ATOPIC-DERMATITIS; TH2 CELLS; TRANSCRIPTION FACTOR; SUBUNIT EXPRESSION; IN-VITRO; CD40	Background: The production of IL-12 by monocytes and dendritic cells is tightly regulated and critically dependent on signals from surrounding cells in the micromilieu. Objective: We studied the capacity of T cells to regulate directly the production of IL-12 by human monocytes. Methods: Human isolated CD4(+) T cells from peripheral blood and T cells from acute patch test lesions were cocultured with autologous monocytes. IL-12 expression and production were measured, and intracellular signal transduction pathways were studied. Monocytes, which had been cocultured with activated T cells, were further investigated for their capacity to induce T(H)1-directed responses. Results: A marked inhibition of IL-12 production was observable on coculture of monocytes with isolated CD4(+) activated autologous T lymphocytes derived from blood or from acute eczematous skin lesions. The inhibiting effect of activated T lymphocytes on IL-12 production was dependent on cell-to-cell contact to monocytes but not on their ability to secrete soluble mediators. Experiments performed in the presence of mitogen-activated protein kinase kinase 1/2 inhibitors provided evidence that activation of the p44/42 pathway plays an important role for the inhibition of IL-12 production in monocytes (here referred to as IL-12(low) monocytes). In addition, T cells cocultured with IL-12(low) monocytes showed a markedly lower expression of the T(H)1 specific transcription factor T-bet, IFN-gamma, and IL-12Rbeta2 cell surface expression. Conclusion: Activated T lymphocytes may directly contribute to the T(H)2-like cytokine milieu found at sites of allergic inflammation (eg, in acute eczematous skin lesions) by inhibiting IL-12 production of unprimed antigen-presenting cells.	Hannover Med Univ, Dept Dermatol & Allergol, D-30449 Hannover, Germany	Hannover Medical School	Wittmann, M (corresponding author), Hannover Med Univ, Dept Dermatol & Allergol, Ricklinger Str 5, D-30449 Hannover, Germany.	Wittmann.Miriam@MH-Hannover.de	Wittmann, Miriam/F-9006-2010; Werfel, Thomas/B-6921-2012	Wittmann, Miriam/0000-0003-2328-4926; Kapp, Alexander/0000-0002-1748-6276				Avice MN, 1999, J IMMUNOL, V162, P2748; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Delespesse G, 1999, INT ARCH ALLERGY IMM, V118, P384, DOI 10.1159/000024143; Feng GJ, 1999, J IMMUNOL, V163, P6403; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hamid Q, 1996, J ALLERGY CLIN IMMUN, V98, P225, DOI 10.1016/S0091-6749(96)70246-4; HAYES MP, 1995, BLOOD, V86, P646, DOI 10.1182/blood.V86.2.646.bloodjournal862646; Hodge-Dufour J, 1998, P NATL ACAD SCI USA, V95, P13806, DOI 10.1073/pnas.95.23.13806; Josien R, 1999, J IMMUNOL, V162, P2562; Karp CL, 1998, EUR J IMMUNOL, V28, P3128, DOI 10.1002/(SICI)1521-4141(199810)28:10<3128::AID-IMMU3128>3.0.CO;2-T; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; Peng XH, 1996, EUR J IMMUNOL, V26, P1621, DOI 10.1002/eji.1830260732; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Rogge L, 1999, J IMMUNOL, V162, P3926; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Rowe A, 1998, CONTACT DERMATITIS, V38, P36, DOI 10.1111/j.1600-0536.1998.tb05634.x; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; SHU U, 1995, EUR J IMMUNOL, V25, P1125, DOI 10.1002/eji.1830250442; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szepietowski JC, 1997, BRIT J DERMATOL, V137, P195, DOI 10.1046/j.1365-2133.1997.18051888.x; Thepen T, 1996, J ALLERGY CLIN IMMUN, V97, P828, DOI 10.1016/S0091-6749(96)80161-8; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Werfel T, 1997, J IMMUNOL, V158, P2500; Werfel T, 1996, J IMMUNOL, V157, P1729; Wittmann M, 1999, BLOOD, V94, P1717, DOI 10.1182/blood.V94.5.1717.417k21_1717_1726; Wittmann M, 2002, J IMMUNOL, V168, P3793, DOI 10.4049/jimmunol.168.8.3793; Yang SH, 2002, MOL CELL BIOL, V22, P5036, DOI 10.1128/MCB.22.14.5036-5046.2002	36	16	17	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2004	114	4					965	973		10.1016/j.jaci.2004.06.033	http://dx.doi.org/10.1016/j.jaci.2004.06.033			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	861SO	15480343	Bronze			2022-12-18	WOS:000224439100037
J	Magi, M; Garcia, L; Vandenbranden, M; Palmantier, R; Jacquet, A				Magi, M; Garcia, L; Vandenbranden, M; Palmantier, R; Jacquet, A			Heat denaturation affects the ProDer p 1 IgE reactivity and downregulates the development of the specific allergic response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergy; T(H)1-T(H)2 polarization; vaccination; ProDer p 1; denaturation	HOUSE-DUST-MITE; DER-P-I; CYSTEINE PROTEASE ACTIVITY; T-CELL RESPONSES; DERMATOPHAGOIDES-PTERONYSSINUS; SEQUENCE POLYMORPHISMS; PROTEOLYTIC ACTIVITY; AIRWAY EOSINOPHILIA; ANTIBODY-RESPONSE; DOSE-RESPONSE	Background: Modified allergens with reduced IgE-binding activity represent an elegant approach to circumvent the risk of anaphylactic reactions in allergen-specific immunotherapy. Objective: The current work investigated the effect of heat denaturation on the allergenic properties of recombinant ProDer p 1, a precursor form of the major house dust mite allergen Der p 1. Methods: The IgE reactivity was estimated by direct and competition ELISA. The immunogenicity of heat-denatured ProDer p 1 was evaluated in naive and Der p 1-allergic mice. Results: Heat denaturation in reducing conditions drastically reduced the in vitro ProDer p 1 IgE reactivity toward human allergic sera. In naive mice, heat-denatured ProDer p 1 generated mixed T(H)1-T(H)2 responses characterized by the absence of specific IgE with concomitant rise in specific IgG2a titers and the presence of IL-5 and IFN-gamma in splenocyte cultures. In contrast, natural Der p 1 or native ProDer p 1 induced typical strict T(H)2-biased allergic responses with strong IgG1 and IgE titers, whereas spleen cells exhibited only high IL-5 secretion. Moreover, native or beat-denatured ProDer p 1 vaccinations prevented airway eosinophil infiltrations after challenge. Although native or heat-treated ProDer p 1 adjuvanted with SBAS1b induced mixed T(H)1-T(H)2 responses in allergic mice, heat-denatured ProDer p 1, compared with native ProDer p 1, proved to be more effective in redirecting the T(H)2-allergic response toward T(H)1. Conclusion: Taken together, our results suggest that variants of Der p 1 with reduced IgE-binding reactivity could represent hypoallergenic molecules suitable for allergen-specific immunotherapy.	Free Univ Brussels, Inst Biol & Med Mol, Serv Genet Appl, Gosselies, Belgium; Free Univ Brussels, Lab Struct & Fonct Membranes Biol, Brussels, Belgium; GlaxoSmithKline, Rixensart, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; GlaxoSmithKline	Jacquet, A (corresponding author), Rue Professeurs Jeener & Brachet,12, B-6041 Gosselies, Belgium.	alain.jacquet@ulb.ac.be	Jacquet, Alain/GQI-0546-2022; Jacquet, Alain/T-8611-2019	Jacquet, Alain/0000-0002-0980-9741; Jacquet, Alain/0000-0002-0980-9741				Akdis CA, 2000, INT ARCH ALLERGY IMM, V121, P261, DOI 10.1159/000024352; Akdis CA, 1998, EUR J IMMUNOL, V28, P914, DOI 10.1002/(SICI)1521-4141(199803)28:03<914::AID-IMMU914>3.0.CO;2-C; Akdis CA, 2001, TRENDS IMMUNOL, V22, P175, DOI 10.1016/S1471-4906(01)01862-2; Akoum H, 1996, IMMUNOLOGY, V87, P593, DOI 10.1046/j.1365-2567.1996.506585.x; Andre C, 2003, INT ARCH ALLERGY IMM, V131, P111, DOI 10.1159/000070926; Chapman MD, 2002, ALLERGY ASTHMA PROC, V23, P5; CHUA KY, 1993, INT ARCH ALLERGY IMM, V101, P364, DOI 10.1159/000236478; Collins SP, 1996, CLIN EXP ALLERGY, V26, P36, DOI 10.1111/j.1365-2222.1996.tb00054.x; DJURUP R, 1985, ALLERGY, V40, P469, DOI 10.1111/j.1398-9995.1985.tb00253.x; Draghi M, 2002, EUR J IMMUNOL, V32, P3720, DOI 10.1002/1521-4141(200212)32:12<3720::AID-IMMU3720>3.0.CO;2-J; Ebner C, 1997, CLIN EXP ALLERGY, V27, P1007, DOI 10.1111/j.1365-2222.1997.tb01252.x; Ewbank PA, 2003, J ALLERGY CLIN IMMUN, V111, P155, DOI 10.1067/mai.2003.41; Ferreira F, 2002, INT ARCH ALLERGY IMM, V128, P171, DOI 10.1159/000064249; Gardner LM, 2004, INT ARCH ALLERGY IMM, V133, P1, DOI 10.1159/000075248; Ghaemmaghami AM, 2001, EUR J IMMUNOL, V31, P1211, DOI 10.1002/1521-4141(200104)31:4&lt;1211::AID-IMMU1211&gt;3.0.CO;2-R; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; GREENE WK, 1992, MOL IMMUNOL, V29, P257, DOI 10.1016/0161-5890(92)90107-9; Gregoire C, 2001, CLIN REV ALLERG IMMU, V21, P215; GUSTAFSON GL, 1992, BIOCHEM BIOPH RES CO, V182, P269, DOI 10.1016/S0006-291X(05)80140-8; Harris SJ, 1997, INT IMMUNOL, V9, P273, DOI 10.1093/intimm/9.2.273; HIGGINS JA, 1994, J ALLERGY CLIN IMMUN, V93, P891, DOI 10.1016/0091-6749(94)90383-2; Jacquet A, 2000, CLIN EXP ALLERGY, V30, P677, DOI 10.1046/j.1365-2222.2000.00823.x; Jacquet A, 2003, CLIN EXP ALLERGY, V33, P218, DOI 10.1046/j.1365-2222.2003.01584.x; Jarnicki AG, 2002, CLIN EXP ALLERGY, V32, P942, DOI 10.1046/j.1365-2745.2002.01407.x; JUTEL M, 1995, J IMMUNOL, V154, P4187; KEMENY DM, 1995, ALLERGY, V50, P9, DOI 10.1111/j.1398-9995.1995.tb04268.x; Kim MJ, 2002, J FOOD PROTECT, V65, P1192, DOI 10.4315/0362-028X-65.7.1192; King C, 1998, J IMMUNOL, V161, P3645; Koch C, 1996, APMIS, V104, P115, DOI 10.1111/j.1699-0463.1996.tb00696.x; Koppelman SJ, 1999, J BIOL CHEM, V274, P4770, DOI 10.1074/jbc.274.8.4770; Koppelman SJ, 2002, J AGR FOOD CHEM, V50, P1562, DOI 10.1021/jf0106998; Korematsu S, 2000, J IMMUNOL, V165, P2895, DOI 10.4049/jimmunol.165.5.2895; KRILIS S, 1984, J ALLERGY CLIN IMMUN, V74, P132, DOI 10.1016/0091-6749(84)90275-6; LOMBARDERO M, 1990, J IMMUNOL, V144, P1353; Massaer M, 2001, INT ARCH ALLERGY IMM, V125, P32, DOI 10.1159/000053794; Moore A, 1999, VACCINE, V17, P2517, DOI 10.1016/S0264-410X(99)00062-6; OBRIEN RM, 1994, J ALLERGY CLIN IMMUN, V93, P628, DOI 10.1016/S0091-6749(94)70074-5; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V80, P755, DOI 10.1016/S0091-6749(87)80261-0; Salgado J, 1996, IMMUNOBIOLOGY, V196, P375, DOI 10.1016/S0171-2985(96)80060-X; Sanchez-Monge R, 2000, J ALLERGY CLIN IMMUN, V106, P190, DOI 10.1067/mai.2000.107599; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Shakib F, 2000, CLIN EXP ALLERGY, V30, P751, DOI 10.1046/j.1365-2222.2000.00865.x; Smith WA, 2001, J ALLERGY CLIN IMMUN, V107, P985, DOI 10.1067/mai.2001.114652; Speidel K, 1997, EUR J IMMUNOL, V27, P2391, DOI 10.1002/eji.1830270938; Van Oosterhout AJM, 1998, AM J RESP CELL MOL, V19, P622, DOI 10.1165/ajrcmb.19.4.3112m; VANSTOKKUM IHM, 1995, BIOCHEMISTRY-US, V34, P10508, DOI 10.1021/bi00033a024; Wan H, 2000, CLIN EXP ALLERGY, V30, P685, DOI 10.1046/j.1365-2222.2000.00820.x; Wheeler AW, 2001, INT ARCH ALLERGY IMM, V126, P135, DOI 10.1159/000049504; YANG X, 1993, J EXP MED, V178, P349, DOI 10.1084/jem.178.1.349; YSSEL H, 1992, J IMMUNOL, V148, P738	50	16	20	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2004	114	3					545	552		10.1016/j.jaci.2004.04.014	http://dx.doi.org/10.1016/j.jaci.2004.04.014			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	853AX	15356555				2022-12-18	WOS:000223799600012
J	Saeki, S; Matsuse, H; Kondo, Y; Machida, I; Kawano, T; Tomari, S; Obase, Y; Fukushima, C; Kohno, S				Saeki, S; Matsuse, H; Kondo, Y; Machida, I; Kawano, T; Tomari, S; Obase, Y; Fukushima, C; Kohno, S			Effects of antiasthmatic agents on the functions of peripheral blood monocyte-derived dendritic cells from atopic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						monocyte-derived dendritic cell; cysteinyl leukotriene; cytokine; cysteinyl leukotriene 1 receptor antagonist; dexamethasone; tacrolimus	EPIDERMAL LANGERHANS CELLS; TUMOR-NECROSIS-FACTOR; 5-LIPOXYGENASE EXPRESSION; RESPONSES; RECEPTOR; LIPOPOLYSACCHARIDE; PROGENITORS; INDUCTION; INHIBIT; ASTHMA	Background: Dendritic cells (DCs), the antigen-presenting cells in the airway, play a critical role in asthma. Nevertheless, there is little information on the effects of antiasthmatic agents on DCs. Objectives: The purpose of the present study was to determine the effects of representative antiasthmatic agents, including cysteinyl leukotriene (cysLT) 1 receptor antagonists, corticosteroid, and tacrolimus, on DCs in inducing allergy. Methods: Human peripheral blood monocyte-derived DCs (MoDCs) generated from atopic and healthy subjects were pulsed with Dermatophagoides farinae allergen in the presence of medium alone, pranlukast, montelukast, dexamethasone, or tacrolimus. The mRNA expressions of cysLT receptor, cysLTs producing enzymes, and various surface markers on MoDCs, as well as the concentrations of cysLTs, IL-10, and IL-12 in cultured supernatants, were determined. MoDCs were also cocultured in vitro with autologous CD4(+) T cells, and IL-5 and IFN-gamma production was measured. Results: MoDCs of atopic patients expressed mRNAs of cysLT1 receptor and cysLT-producing enzymes, and allergen pulsing significantly increased cysLT production. MoDCs of atopic patients showed a T(H)2-favoring phenotype and induced T(H)2-skewed cytokine production from autologous CD4(+) T cells. Dexamethasone and tacrolimus inhibited allergen-pulsed MoDC-induced cytokine production by autologous CD4(+) T cells without and with IL-10 inhibition, respectively. CysLT1 receptor antagonists had no effect on MoDC functions. Conclusion: Our results indicate that MoDCs of atopic patients induce a T(H)2 reaction. Corticosteroid and tacrolimus, but not cysLT1 receptor antagonists, inhibit T(H)2 reactions, and this effect is probably mediated through different pathways.	Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan	Nagasaki University	Matsuse, H (corresponding author), Nagasaki Univ, Sch Med, Dept Internal Med 2, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	hmatsuse@net.nagasaki-u.ac.jp						Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bellinghausen I, 2000, J ALLERGY CLIN IMMUN, V105, P988, DOI 10.1067/mai.2000.105526; BEULANS C, 1997, EUR J IMMUNOL, V27, P756; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; De Wit D, 2000, J ALLERGY CLIN IMMUN, V105, P346, DOI 10.1016/S0091-6749(00)90086-1; Figueroa DJ, 2001, AM J RESP CRIT CARE, V163, P226, DOI 10.1164/ajrccm.163.1.2003101; Girolomoni G, 1997, IMMUNOL TODAY, V18, P102, DOI 10.1016/S0167-5699(97)01030-X; Holloway JA, 2001, J ALLERGY CLIN IMMUN, V107, P1009, DOI 10.1067/mai.2001.115039; Idzko M, 2002, J ALLERGY CLIN IMMUN, V109, P839, DOI 10.1067/mai.2002.124044; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Lambrecht BN, 2001, CLIN EXP ALLERGY, V31, P206, DOI 10.1046/j.1365-2222.2001.01061.x; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Machida I, 2004, J IMMUNOL, V172, P1833, DOI 10.4049/jimmunol.172.3.1833; Matsue H, 2002, J IMMUNOL, V169, P3555, DOI 10.4049/jimmunol.169.7.3555; Panhans-Gross A, 2001, J ALLERGY CLIN IMMUN, V107, P345, DOI 10.1067/mai.2001.112600; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Seiffert K, 2002, J IMMUNOL, V168, P6128, DOI 10.4049/jimmunol.168.12.6128; Spanbroek R, 2000, BLOOD, V96, P3857, DOI 10.1182/blood.V96.12.3857.h8003857_3857_3865; Spanbroek R, 1998, P NATL ACAD SCI USA, V95, P663, DOI 10.1073/pnas.95.2.663; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Tomari S, 2003, CLIN EXP ALLERGY, V33, P795, DOI 10.1046/j.1365-2222.2003.01656.x; TunonDeLara JM, 1996, CLIN EXP ALLERGY, V26, P648, DOI 10.1046/j.1365-2222.1996.1095481.x; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Vieira PL, 1998, J IMMUNOL, V161, P5245; Woltman AM, 2000, EUR J IMMUNOL, V30, P1807, DOI 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N; Woltman AM, 2003, J LEUKOCYTE BIOL, V73, P428, DOI 10.1189/jlb.0902431	28	16	18	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2004	114	3					538	544		10.1016/j.jaci.2004.05.053	http://dx.doi.org/10.1016/j.jaci.2004.05.053			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	853AX	15356554	Bronze			2022-12-18	WOS:000223799600011
J	Yu, XH; Sperling, A; Blair, C; Thompson, K; Naclerio, R				Yu, XH; Sperling, A; Blair, C; Thompson, K; Naclerio, R			Antigen stimulation of T(H)2 cells augments acute bacterial sinusitis in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergic rhinitis; acute sinusitis; bacterial infection; allergy; T(H)2	ALLERGIC AIRWAY INFLAMMATION; MUCUS PRODUCTION; MESSENGER-RNA; NASAL-MUCOSA; RHINOSINUSITIS; EOSINOPHILIA; EXPRESSION; RESPONSES; MODEL; IL-4	Background: Previously, we showed that an ongoing nasal allergic response augmented bacterial sinusitis in mice. In those experiments mice were sensitized to ovalbumin (OVA) by means of intraperitoneal injections of OVA-alum and then exposed to OVA intranasally before being infected with Streptococcus pneamoniae. Objective: We sought to study the importance of T(H)2 cells and to eliminate potential alum effects. Methods: In this study we sensitized mice by adoptively transferring OVA-specific T(H)2- or T(H)1-skewed cells. Results: T(H)2 passive sensitization followed by intranasal OVA showed a robust local eosinophilic response (5-fold increase) compared with that seen in mice with only T(H)2 passive sensitization alone (P < .001). Mice with T(H)2 passive sensitization and intranasal OVA exposure followed by infection showed an increase in the number of recovered S pneumoniae (P < .05) and an increase in sinus inflammation compared with that seen in those with infection alone (P < .01). In contrast, mice passively sensitized with T(H)1 followed by intranasal OVA exposure and infection showed no significant increase in the recovery of S pneumoniae and sinus inflammation compared with those with infection alone. Conclusions: These data support the importance of antigen-stimulated T(H)2 cells in the augmented response to infection in allergic mice. Whether the increased infection is related to the direct effect of T(H)2 cells and their cytokines; or subsequent recruitment of other cells, such as eosinophils, will be determined in further studies.	Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Naclerio, R (corresponding author), Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, 5841 S Maryland Ave,MC 1035, Chicago, IL 60637 USA.	rnacleri@surgery.bsd.uchicago.edu	Sperling, Anne/ACZ-2351-2022	Sperling, Anne I./0000-0002-4265-9212				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ABRAMS P, 1995, WORLD J UROL, V13, P1; BINDER E, 1984, Rhinology (Utrecht), V22, P255; Blair C, 2001, J ALLERGY CLIN IMMUN, V108, P424, DOI 10.1067/mai.2001.117793; Bomer K, 1998, ARCH OTOLARYNGOL, V124, P1227, DOI 10.1001/archotol.124.11.1227; Brewer JM, 1998, IMMUNOLOGY, V93, P41; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Cohn L, 2001, J IMMUNOL, V166, P2760, DOI 10.4049/jimmunol.166.4.2760; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Conrad DA, 2002, CURR OPIN PEDIATR, V14, P86, DOI 10.1097/00008480-200202000-00015; DURHAM SR, 1992, J IMMUNOL, V148, P2390; Durham SR, 1998, CLIN EXP ALLERGY, V28, P11; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Holzmann D, 2001, AM J RHINOL, V15, P387, DOI 10.1177/194589240101500606; Iwens P., 1994, Rhinology (Utrecht), V32, P65; Janssen EM, 2000, J IMMUNOL, V164, P580, DOI 10.4049/jimmunol.164.2.580; Kaliner MA, 1997, OTOLARYNG HEAD NECK, V116, pS1; Kaminuma O, 1997, AM J RESP CELL MOL, V16, P448, DOI 10.1165/ajrcmb.16.4.9115756; Kanaizumi E, 2002, SCAND J IMMUNOL, V56, P376, DOI 10.1046/j.1365-3083.2002.01136.x; KARLSSON G, 1994, ACTA OTO-LARYNGOL, P26; Lavigne F, 2000, J ALLERGY CLIN IMMUN, V105, P746, DOI 10.1067/mai.2000.105218; Li L, 1998, J IMMUNOL, V161, P3128; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; MARRACK P, 1983, J EXP MED, V158, P1635, DOI 10.1084/jem.158.5.1635; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nouri-Aria KT, 2000, CLIN EXP ALLERGY, V30, P1709, DOI 10.1046/j.1365-2222.2000.00998.x; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SAVOLAINEN S, 1989, ALLERGY, V44, P116, DOI 10.1111/j.1398-9995.1989.tb02234.x; Settipane RA, 1999, ALLERGY ASTHMA PROC, V20, P209, DOI 10.2500/108854199778339053; SHAPIRO GG, 1985, PEDIATR INFECT DIS J, V4, pS55, DOI 10.1097/00006454-198511001-00003; SPECTOR SL, 1992, J ALLERGY CLIN IMMUN, V90, P518, DOI 10.1016/0091-6749(92)90178-5; WALDEN SM, 1991, AM REV RESPIR DIS, V144, P642, DOI 10.1164/ajrccm/144.3_Pt_1.642	32	16	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2004	114	2					328	334		10.1016/j.jaci.2004.04.051	http://dx.doi.org/10.1016/j.jaci.2004.04.051			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	847OU	15316511				2022-12-18	WOS:000223405600018
J	Spieksma, FTM; Dieges, PH				Spieksma, FTM; Dieges, PH			The history of the finding of the house dust mite	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; Erasmus Med Ctr, Dept Allergol, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Spieksma, FTM (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands.								0	16	18	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2004	113	3					573	576		10.1016/j.jaci.2003.10.064	http://dx.doi.org/10.1016/j.jaci.2003.10.064			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	802DM	15007368	Bronze			2022-12-18	WOS:000220144200040
J	Pramod, SN; Venkatesh, YP				Pramod, SN; Venkatesh, YP			Allergy to eggplant (Solanum melongena)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IDENTIFICATION; POTATO; POLLEN		Cent Food Technol Res Inst, Dept Biochem & Nutr, Mysore 570013, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Pramod, SN (corresponding author), Cent Food Technol Res Inst, Dept Biochem & Nutr, Mysore 570013, Karnataka, India.		Pramod, Siddanakoppalu N/R-2573-2019; Pramod, Siddanakoppalu N./AAX-9916-2020; Venkatesh, Yeldur/E-9644-2010	Pramod, Siddanakoppalu N./0000-0001-9917-1069; Venkatesh, Yeldur/0000-0001-6842-1344				BERNSTEIN IL, 1995, ANN ALLERG ASTHMA IM, V75, P553; Foetisch K, 2001, EUR FOOD RES TECHNOL, V213, P259, DOI 10.1007/s002170100343; Gil M, 2002, ALLERGY, V57, P652, DOI 10.1034/j.1398-9995.2002.23749.x; Jensen-Jarolim E, 1998, INT ARCH ALLERGY IMM, V116, P103, DOI 10.1159/000023932; Lawande K.F., 1998, HDB VEGETABLE SCI TE, P225; Muthiah R., 1996, Journal of Allergy and Clinical Immunology, V97, P334, DOI 10.1016/S0091-6749(96)80825-6; PUCCI S, 2001, 8 INT S PROBL FOOD A; Seppala U, 1999, J ALLERGY CLIN IMMUN, V103, P165, DOI 10.1016/S0091-6749(99)70541-5; Seppala U, 2001, ALLERGY, V56, P619, DOI 10.1034/j.1398-9995.2001.00058.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	10	16	17	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2004	113	1					171	173		10.1016/j.jaci.2003.10.037	http://dx.doi.org/10.1016/j.jaci.2003.10.037			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	760MP	14713925	Green Submitted			2022-12-18	WOS:000187837900024
J	Suh, YJ; Lee, YM; Choi, JH; Suh, CH; Nahm, DH; Park, HS				Suh, YJ; Lee, YM; Choi, JH; Suh, CH; Nahm, DH; Park, HS			Heterogeneity of IgE response to cefteram pivoxil was noted in 2 patients with cefteram-induced occupational asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Ajou Univ, Sch Med, Dept Allergy Rheumatol, Suwon 442721, South Korea	Ajou University	Suh, YJ (corresponding author), Ajou Univ, Sch Med, Dept Allergy Rheumatol, Paldalgu Wonchondong San 5, Suwon 442721, South Korea.		Park, Hae-Sim/S-7974-2019	Park, Hae-Sim/0000-0003-2614-0303; Lee, Young Mok/0000-0003-4039-0456; Suh, Chang-Hee/0000-0001-6156-393X				ROSE BG, 1995, BIOCONJUGATE CHEM, V6, P529, DOI 10.1021/bc00035a005; Sastre J, 1999, EUR RESPIR J, V13, P1189, DOI 10.1034/j.1399-3003.1999.13e40.x; STENTON SC, 1995, EUR RESPIR J, V8, P1421, DOI 10.1183/09031936.95.08081421; WASS U, 1989, J ALLERGY CLIN IMMUN, V83, P126, DOI 10.1016/0091-6749(89)90487-9	4	16	16	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2003	112	1					209	210		10.1067/mai.2003.1525	http://dx.doi.org/10.1067/mai.2003.1525			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	698QQ	12847502				2022-12-18	WOS:000184010600033
J	Liu, LY; Swenson, CA; Kelly, EA; Kita, H; Jarjour, NN; Busse, WW				Liu, LY; Swenson, CA; Kelly, EA; Kita, H; Jarjour, NN; Busse, WW			Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergen; low-dose provocation; sputum induction; eosinophils	ALLERGEN EXPOSURE; INDUCED SPUTUM; BRONCHIAL HYPERRESPONSIVENESS; BRONCHOALVEOLAR LAVAGE; REPEATED INHALATION; PERIPHERAL-BLOOD; ASTHMA; CELL; EOSINOPHIL; INCREASES	Background: Airway allergen provocation provides a model to study allergic inflammation in relationship to pulmonary physiology. Allergen provocation is usually administered as a relatively large single-dose challenge that might not reflect a chronic, natural, low-dose airborne allergen exposure. Objective: We sought to compare the magnitude, characteristic features, and kinetics of airway inflammation induced by means of repetitive low-dose antigen challenges with those factors induced by means of an equivalent single-dose allergen challenge in allergic asthma. Methods: This was a 2-period crossover study. During separate phases, each subject was administered either a predetermined single-dose antigen challenge or 25% of that dose on each of 4 consecutive days. The airway response to allergen challenge was determined by means of measurement of pulmonary function and sputum features of inflammation, including eosinophil, eosinophil derived neurotoxin, and fibronectin levels. Results: Both models of antigen challenge caused significant and equivalent sputum eosinophilia. The immediate decrease in FEV1 and the FEV1/forced vital capacity ratio and the increase in sputum eosinophilia, eosinophil-derived neurotoxin, and fibronectin levels occurred gradually over the first 3 low doses and then reached a plateau or tended to decrease with the fourth antigen exposure. Conclusion: Our data suggest that although the 2 challenge models had similar quantitative effects on lung function and sputum eosinophilia, the qualitative responses and kinetics of these changes were distinct. Repetitive low doses of antigen, as might mimic natural allergy exposure, produced an equivalent inflammatory response to the large single-dose challenge but with a smaller amount of antigen, suggesting that priming and accumulative effects might have occurred. Moreover, our limited data also suggest that immunologic tolerance might be induced by frequent challenges.	Univ Wisconsin Hosp, Sect Allergy & Immunol, Dept Med, Madison, WI 53792 USA; Univ Wisconsin Hosp, Pulm & Crit Care Sect, Dept Med, Madison, WI 53792 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic	Busse, WW (corresponding author), Univ Wisconsin Hosp, Sect Allergy & Immunol, Dept Med, K4-910-9988,600 Highland Ave, Madison, WI 53792 USA.			Kelly, Elizabeth/0000-0001-7335-6698	NCRR NIH HHS [M01 RR03186] Funding Source: Medline; NHLBI NIH HHS [HL56396] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056396] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABUGHAZALEH RI, 1989, J IMMUNOL, V142, P2393; Arshad SH, 1998, AM J RESP CRIT CARE, V157, P1900, DOI 10.1164/ajrccm.157.6.9603034; de Blay F, 1999, INT ARCH ALLERGY IMM, V120, P158, DOI 10.1159/000024234; de Bruin-Weller MS, 1999, CLIN EXP ALLERGY, V29, P159; de Kluijver J, 2002, AM J RESP CRIT CARE, V166, P294, DOI 10.1164/rccm.2112097; Esnault S, 2001, J IMMUNOL, V166, P4658, DOI 10.4049/jimmunol.166.7.4658; Gauvreau GM, 1999, AM J RESP CRIT CARE, V160, P640, DOI 10.1164/ajrccm.160.2.9809130; GIBSON PG, 1989, THORAX, V44, P693, DOI 10.1136/thx.44.9.693; IHRE E, 1993, CLIN EXP ALLERGY, V23, P298, DOI 10.1111/j.1365-2222.1993.tb00326.x; Jarjour NN, 1997, AM J RESP CRIT CARE, V155, P1515, DOI 10.1164/ajrccm.155.5.9154851; Kelly EAB, 1997, AM J RESP CRIT CARE, V156, P1421, DOI 10.1164/ajrccm.156.5.9703054; Kuo HP, 2001, BRIT J PHARMACOL, V134, P1539, DOI 10.1038/sj.bjp.0704389; Lensmar C, 1999, CLIN EXP ALLERGY, V29, P1632, DOI 10.1046/j.1365-2222.1999.00757.x; LEVITZKY MG, 1999, PULMONARY PHYSL; Liu LY, 2000, J ALLERGY CLIN IMMUN, V106, P1063; MATTOLI S, 1991, J ALLERGY CLIN IMMUN, V87, P764; Meerschaert J, 1999, J IMMUNOL, V163, P6217; Meerschaert J, 1999, AM J RESP CRIT CARE, V159, P619, DOI 10.1164/ajrccm.159.2.9806053; Palmqvist M, 2001, EUR RESPIR J, V17, P872, DOI 10.1183/09031936.01.17508720; Palmqvist M, 1998, RESP MED, V92, P1223, DOI 10.1016/S0954-6111(98)90425-5; PIN I, 1992, AM REV RESPIR DIS, V145, P1265, DOI 10.1164/ajrccm/145.6.1265; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; Pizzichini E, 1998, EUR RESPIR J, V11, P828, DOI 10.1183/09031936.98.11040828; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; RASMUSSEN JB, 1991, ALLERGY, V46, P419, DOI 10.1111/j.1398-9995.1991.tb04220.x; Ronchi MC, 1996, THORAX, V51, P1000, DOI 10.1136/thx.51.10.1000; Roquet A, 1998, APMIS, V106, P293, DOI 10.1111/j.1699-0463.1998.tb01349.x; Rosi E, 1999, J ALLERGY CLIN IMMUN, V103, P232, DOI 10.1016/S0091-6749(99)70496-3; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; Sterk PJ, 1998, EUR RESPIR J, V11, P798, DOI 10.1183/09031936.98.11040798; Sulakvelidze I, 1998, EUR RESPIR J, V11, P821, DOI 10.1183/09031936.98.11040821; VIRCHOW JC, 1992, AM REV RESPIR DIS, V146, P604, DOI 10.1164/ajrccm/146.3.604	32	16	16	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2003	111	4					818	825		10.1067/mai.2003.1346	http://dx.doi.org/10.1067/mai.2003.1346			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	667WW	12704364	Bronze			2022-12-18	WOS:000182258500024
J	Dent, G; Hosking, LA; Lordan, JL; Steel, MD; Cruikshank, WW; Center, DM; Ellis, JH; Holgate, ST; Davies, DE; Djukanovic, R				Dent, G; Hosking, LA; Lordan, JL; Steel, MD; Cruikshank, WW; Center, DM; Ellis, JH; Holgate, ST; Davies, DE; Djukanovic, R			Differential roles of IL-16 and CD28/B7 costimulation in the generation of T-lymphocyte chemotactic activity in the bronchial mucosa of mild and moderate asthmatic individuals	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergen; asthma; bronchial explant; B7; CD28; chemotaxis; costimulation; induced sputum; interleukin 16; T lymphocytes	BRONCHOALVEOLAR LAVAGE FLUID; ALLERGEN CHALLENGE; INCREASED EXPRESSION; INFLAMMATORY CELLS; INTERLEUKIN-16; BIOPSY; IDENTIFICATION; INFILTRATION; TISSUE; CD80	Background: IL-16 is an important T-cell chemotactic cytokine in asthmatic airways; its release from allergen-stimulated bronchial mucosa in mild asthma has been shown to be dependent on CD28/B7 costimulation. Objective: We have extended our previous studies to investigate the role of IL-16 and CD28/B7 costimulation in T-lymphocyte chemotactic activity (TLCA) released from the bronchial mucosa in more severe asthma. Methods: TLCA was determined in the supernatants of induced sputum and allergen-stimulated bronchial mucosal explants from healthy volunteers and volunteers with mild and moderately severe asthma by means of a Boyden chamber technique. The contribution of IL-16 to the activity was evaluated through use of a neutralizing monoclonal antibody; the contribution of CD28/B7 costimulation to allergen-induced release of TLCA was determined through use of CTLA4-Ig fusion protein and neutralizing monoclonal antibodies to CD80 (B7.1) and CD86 (B7.2). Results: Induced sputum and unstimulated explants from asthmatic subjects generated significant spontaneous TLCA (P < .05). Both mild and moderate asthmatic explants showed significantly elevated Dermatophagoides pteronyssinus-induced release of TLCA, but only in mild asthma could sputum and allergen-stimulated explant TLCA be inhibited by anti-IL-16 (median inhibition, 39% and 59%; P < .05). In addition, allergen released significant quantities of IL-16 from mild asthmatic explants (P < .05) but not from moderate asthmatic explants. Antibodies to the CD28 counter-ligands CD80 and CD86 inhibited allergen-induced release of TLCA in mild asthmatic explants by 94% (P < .05) and 62%, but TLCA release from moderate asthmatic explants was unaffected by CTLA4-Ig. Conclusion: These results show that TLCA release in moderate asthmatic airways, in contrast to mild asthmatic airways, is not dependent on CD28/B7 costimulation and does not involve IL-16.	Univ Southampton, Sch Med, Resp Cell & Mol Biol Sect, Div Infect Inflammat & Repair, Southampton SO9 5NH, Hants, England; Boston Univ, Sch Med, Boston, MA 02118 USA; Glaxo SmithKline, R&D, Stevenage, Herts, England	University of Southampton; Boston University; GlaxoSmithKline	Dent, G (corresponding author), Southampton Gen Hosp, Mail Point 810,Tremona Rd, Southampton SO16 6YD, Hants, England.		Davies, Donna E/H-2993-2012; Dent, Gordon/O-3197-2013	Dent, Gordon/0000-0001-9419-2952; Davies, Donna/0000-0002-5117-2991; Center, David/0000-0002-5879-7978; Djukanovic, Ratko/0000-0001-6039-5612				[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Arima M, 1999, AM J RESP CELL MOL, V21, P684, DOI 10.1165/ajrcmb.21.6.3671; BENTLEY AM, 1993, AM J RESP CELL MOL, V8, P35, DOI 10.1165/ajrcmb/8.1.35; CENTER DM, 1982, J IMMUNOL, V128, P2563; CRUIKSHANK W, 1982, J IMMUNOL, V128, P2569; CRUIKSHANK WW, 1995, AM J RESP CELL MOL, V13, P738, DOI 10.1165/ajrcmb.13.6.7576712; Deurloo DT, 2001, AM J RESP CELL MOL, V25, P751, DOI 10.1165/ajrcmb.25.6.4607; Djukanovic R, 1996, THORAX, V51, P575, DOI 10.1136/thx.51.6.575; DJUKANOVIC R, 1991, AM REV RESPIR DIS, V143, P772, DOI 10.1164/ajrccm/143.4_Pt_1.772; Ellis JH, 1996, J IMMUNOL, V156, P2700; Hidi R, 2000, J IMMUNOL, V164, P412, DOI 10.4049/jimmunol.164.1.412; HIDI R, 1997, AM J RESP CRIT CARE, V155, pA542; Jaffar Z, 1999, AM J RESP CELL MOL, V20, P153, DOI 10.1165/ajrcmb.20.1.3255; Jaffar ZH, 1999, J IMMUNOL, V163, P6283; Krug N, 2000, AM J RESP CRIT CARE, V162, P105, DOI 10.1164/ajrccm.162.1.9908055; Laberge S, 2000, J ALLERGY CLIN IMMUN, V106, P293; Laberge S, 1997, AM J RESP CELL MOL, V17, P193, DOI 10.1165/ajrcmb.17.2.2750; Lordan JL, 2001, J ALLERGY CLIN IMMUN, V108, P976, DOI 10.1067/mai.2001.119740; LORDAN JL, 2000, AM J RESP CRIT CARE, V161, pA207; Louis R, 1997, AM J RESP CRIT CARE, V155, P466, DOI 10.1164/ajrccm.155.2.9032180; Mashikian MV, 1998, J ALLERGY CLIN IMMUN, V101, P786, DOI 10.1016/S0091-6749(98)70403-8; MONTEFORT S, 1994, J CLIN INVEST, V93, P1411, DOI 10.1172/JCI117118; Ohshima Y, 1998, BLOOD, V92, P3338, DOI 10.1182/blood.V92.9.3338.421k19_3338_3345; Pizzichini E, 1998, EUR RESPIR J, V11, P828, DOI 10.1183/09031936.98.11040828; Ray A, 2000, Curr Opin Investig Drugs, V1, P442; Vrugt B, 1999, EUR RESPIR J, V13, P1245, DOI 10.1183/09031936.99.13612539; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046	27	16	18	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2002	110	6					906	914		10.1067/mai.2002.130049	http://dx.doi.org/10.1067/mai.2002.130049			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	624TL	12464958				2022-12-18	WOS:000179777400014
J	Kumar, M; Behera, AK; Lockey, RF; Vesely, DL; Mohapatra, SS				Kumar, M; Behera, AK; Lockey, RF; Vesely, DL; Mohapatra, SS			Atrial natriuretic peptide gene transfer by means of intranasal administration attenuates airway reactivity in a mouse model of allergic sensitization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						atrial natriuretic peptide; gene therapy; allergic asthma	ASTHMA; MICE	Atrial natriuretic peptide (ANP) is a bronchodilator; however, the short half-life of ANP in vivo limited its therapeutic utility to treat asthma. The efficacy of intranasally administered plasmid DNA-expressing ANP (pANP; amino acid 99-126; Acc. No. XM131840) on the prevention of allergen-induced airway hyperresponsiveness (AHR) was examined in this study by using a mouse model of asthma. Ovalbumin-sensitized mice were treated with pANP versus control plasmids, and AHR was monitored after ovalbumin challenge for 5 weeks on 10-day intervals starting 4 days after gene transfer. Mice administered pANP demonstrated significantly less AHR for 20 days after treatment. The results demonstrate that pANP gene transfer protects against AHR and might be useful in the treatment of asthma.	Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Joy McCann Culverhouse Airway Dis Ctr, Tampa, FL 33612 USA; VA Hosp, Tampa, FL 33612 USA; Univ S Florida, Dept Internal Med, Div Endocrinol, Tampa, FL 33612 USA; James A Haley Vet Hosp, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Mohapatra, SS (corresponding author), Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Joy McCann Culverhouse Airway Dis Ctr, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.		Mohapatra, Shyam/C-2500-2012					ANGUS RM, 1994, CLIN EXP ALLERGY, V24, P784, DOI 10.1111/j.1365-2222.1994.tb00991.x; BOITEAU R, 1988, AM REV RESPIR DIS, V137, pA484; CHANEZ P, 1990, J ALLERGY CLIN IMMUN, V86, P321, DOI 10.1016/S0091-6749(05)80094-6; HULKS G, 1992, BRIT MED J, V304, P1156, DOI 10.1136/bmj.304.6835.1156; HULKS G, 1990, CLIN SCI, V79, P51, DOI 10.1042/cs0790051; ISHII Y, 1989, J ANAT, V166, P85; Kumar M, 1999, VACCINE, V18, P558, DOI 10.1016/S0264-410X(99)00185-1; Matsuse H, 2000, J IMMUNOL, V164, P6583, DOI 10.4049/jimmunol.164.12.6583; NEEDLEMAN P, 1986, NEW ENGL J MED, V314, P828; Ohbayashi H, 1998, EUR J PHARMACOL, V346, P55, DOI 10.1016/S0014-2999(98)00014-4; Vesely DL, 2001, CARDIOVASC RES, V51, P647, DOI 10.1016/S0008-6363(01)00256-5; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661	12	16	24	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2002	110	6					879	882		10.1067/mai.2002.129699	http://dx.doi.org/10.1067/mai.2002.129699			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	624TL	12464954				2022-12-18	WOS:000179777400010
J	Tulic, MK; Manoukian, JJ; Eidelman, DH; Hamid, Q				Tulic, MK; Manoukian, JJ; Eidelman, DH; Hamid, Q			T-cell proliferation induced by local application of LPS in the nasal mucosa of nonatopic children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immunomodulation; lipopolysaccharide; nasal mucosa; T cell proliferation; children; explants	MESSENGER-RNA; ALLERGEN; EXPOSURE; ASTHMA; LIPOPOLYSACCHARIDE; INTERLEUKIN-10; ENDOTOXIN	Background: Recently, there has been a great deal of interest in the role of bacterial products in altering the allergic immune response in early life. Objective: We sought to develop a model of bacterial inflammation in human subjects to characterize the ex vivo response to LPS in the nasal mucosa of young nonatopic children. Methods: Using the explant technique, we cultured nasal mucosa in the presence or absence of increasing concentrations of LPS (0.001-1 mug LPS/mL) for 24 hours. Immunocytochemistry and in situ hybridization were used to phenotype the cells and cytokines in the explant, and immunofluorescence was used to study proliferation of T cells in explants cultured with LPS and 5-bromo-2'-deoxyuridine (BrdU). Results: CD68, CD3, tryptase, elastase, IFN-gamma IL-12, and IL-10 inummoreactivity was detected in unstimulated tissue. LPS stimulation caused a dose-dependent increase in the number of CD3(+) (n = 7, P < .05), CD68(+) (n = 7, P < .01), elastase-positive (n = 7, P < .01), tryptase-positive (n = 7, P < .05), IL-2-positive (n = 6, P < .05), IL-12-positive (n = 6, P < .05), and IFN-gamma-positive (n = 6, P < .05) cells compared with media alone. LPS had no effect on major basic protein, IL-4, IL-5, or IL-13 immunoreactivity. LPS (0.1 mug/mL) caused an increase in the number of BrdU-positive cells as early as 2 hours after incubation (n = 8, P < .001). The maximal BrdU immunoreactivity was seen 24 hours after incubation with LPS, at which time approximately 70% of BrdU-positive cells were CD3(+) T cells. Conclusions: Our results suggest that LPS is capable of inducing local inflammation, TO cytokine inummoreactivity, and proliferation of CD3(+) activated T cells in the absence of de novo cell recruitment. This model holds promise for future studies investigating the importance of bacterial products in regulating local immune function in young atopic children.	McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada; Montreal Childrens Hosp, Dept Otolaryngol, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University	Tulic, MK (corresponding author), McGill Univ, Meakins Christie Labs, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.		Tulic, Meri/P-6613-2016; Tulic, Meri K/ABB-5138-2020	Tulic, Meri/0000-0002-2661-2369; Tulic, Meri K/0000-0002-2661-2369				Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Cameron L, 2000, J ALLERGY CLIN IMMUN, V106, P46; Cameron L, 2000, J IMMUNOL, V164, P1538, DOI 10.4049/jimmunol.164.3.1538; FREW AJ, 1988, J IMMUNOL, V141, P4158; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; HAMID Q, 1987, P NATL ACAD SCI USA, V84, P6760, DOI 10.1073/pnas.84.19.6760; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; Liu AH, 2002, J ALLERGY CLIN IMMUN, V109, P379, DOI 10.1067/mai.2002.122157; Malaviya R, 2002, CLIN REV ALLERG IMMU, V22, P189, DOI 10.1385/CRIAI:22:2:189; MARTINEZ FD, 1994, THORAX, V49, P1189, DOI 10.1136/thx.49.12.1189; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; Tulic MK, 2001, AM J RESP CELL MOL, V24, P640, DOI 10.1165/ajrcmb.24.5.4265; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P365	17	16	16	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2002	110	5					771	776		10.1067/mai.2002.128857	http://dx.doi.org/10.1067/mai.2002.128857			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	612NN	12417887				2022-12-18	WOS:000179082500013
J	Altschul, A; Cunningham-Rundles, C				Altschul, A; Cunningham-Rundles, C			Chronic urticaria and angioedema as the first presentations of common variable immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IVIG		CUNY Mt Sinai Sch Med, Dept Clin Immunol, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Altschul, A (corresponding author), CUNY Mt Sinai Sch Med, Dept Clin Immunol, New York, NY 10029 USA.							Asero R, 2000, ALLERGY, V55, P1099, DOI 10.1034/j.1398-9995.2000.00829.x; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Greaves M, 2000, J ALLERGY CLIN IMMUN, V105, P664, DOI 10.1067/mai.2000.105706; HUSTON DP, 1992, MED CLIN N AM, V76, P805, DOI 10.1016/S0025-7125(16)30327-3; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Supanaranond Wichai, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P171; VOLONAKIS M, 1992, ANN ALLERGY, V69, P61	7	16	18	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2002	110	4					664	665		10.1067/mai.2002.127002	http://dx.doi.org/10.1067/mai.2002.127002			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	602JJ	12373278				2022-12-18	WOS:000178501900020
J	Asero, R				Asero, R			Multiple intolerance to food additives	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							URTICARIA		Osped Caduti Bollatesi, I-20021 Bollate, MI, Italy		Asero, R (corresponding author), Osped Caduti Bollatesi, Via Piave 20, I-20021 Bollate, MI, Italy.							Asero R, 2001, Curr Allergy Rep, V1, P18, DOI 10.1007/s11882-001-0092-5; Asero R, 2002, ANN ALLERG ASTHMA IM, V88, P468, DOI 10.1016/S1081-1206(10)62384-8; Asero R, 2001, J ALLERGY CLIN IMMUN, V107, P197, DOI 10.1067/mai.2001.112132; Bush R.K., 1998, ALLERGY PRINCIPLES P, VII, P1183; GREAVES MW, 1995, NEW ENGL J MED, V332, P1767, DOI 10.1056/NEJM199506293322608; Sabroe RA, 1999, BRIT J DERMATOL, V140, P446; Simon RA, 1993, ALLERGY PRINCIPLES P, P1687; SQUIRE EN, 1987, LANCET, V1, P988	8	16	18	0	5	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2002	110	3					531	532		10.1067/mai.2002.126463	http://dx.doi.org/10.1067/mai.2002.126463			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	592KM	12209108				2022-12-18	WOS:000177936900031
J	Stempel, DA; Pinto, L; Stanford, RH				Stempel, DA; Pinto, L; Stanford, RH			The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						fluticasone propionate; retrospective analysis; leukotriene modifier; leukotriene receptor antagonist; inhaled corticosteroid; asthma; claims data; asthma costs; single-controller therapy	FLUTICASONE PROPIONATE; PERSISTENT ASTHMA; CONTROLLED TRIAL; MONTELUKAST; ZAFIRLUKAST; BECLOMETHASONE; PLACEBO; IMPACT	Asthma-related hospitalization rates were compared over a 2-year period between a cohort of patients with asthma who switched from an inhaled corticosteroid in year I to a leukotriene modifier in year 2 (n = 285) and a matched cohort continuously treated with an inhaled corticosteroid (n = 570). During year 1, patients were well maintained, with a hospitalization rate of 1.1% to 1.4%. During year 2, 2.5% of the patients switched to a leukotriene modifier had one or more asthma-related hospitalizations compared with 0.6% of the patients continuously receiving an inhaled corticosteroid. Patients treated with a leukotriene modifier were at 7 times greater risk for an asthma-related hospitalization compared with patients who continued to receive an inhaled corticosteroid (risk-adjusted odds ratio, 7.1; 95% CI, 2.79-17.95). These data are consistent with the results of well-controlled clinical trials showing that leukotriene modifiers may be associated with deterioration of asthma control relative to inhaled corticosteroids. Considered in aggregate, the data support the conclusion that leukotriene modifiers should not be substituted for inhaled corticosteroids as a single-controller therapy for asthma.	GlaxoSmithKline, Res Triangle Pk, NC USA; Hlth Benchmarks Inc, Woodland Hills, CA USA; Univ Washington, Seattle, WA 98195 USA	GlaxoSmithKline; University of Washington; University of Washington Seattle	Stempel, DA (corresponding author), 9121 NE 16th St, Bellevue, WA 98004 USA.							Busse W, 2001, J FAM PRACTICE, V50, P595; Busse W, 2001, J ALLERGY CLIN IMMUN, V107, P461, DOI 10.1067/mai.2001.114657; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Creticos P, 2002, ANN ALLERG ASTHMA IM, V88, P401, DOI 10.1016/S1081-1206(10)62372-1; Fuhlbrigge AL, 2001, J ALLERGY CLIN IMMUN, V107, P61, DOI 10.1067/mai.2001.111590; Kim KT, 2000, ANN ALLERG ASTHMA IM, V85, P398, DOI 10.1016/S1081-1206(10)62555-0; Laviolette M, 1999, AM J RESP CRIT CARE, V160, P1862, DOI 10.1164/ajrccm.160.6.9803042; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; *NAT ASTHM ED PREV, 1997, NIH PUBL NAT ASTHM E; Stempel DA, 2001, J ALLERGY CLIN IMMUN, V107, P94, DOI 10.1067/mai.2001.112029; Suissa S, 2001, J ALLERGY CLIN IMMUN, V107, P937, DOI 10.1067/mai.2001.115653; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; 2001, ASTHMA AM ASTHMA STA	13	16	18	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2002	110	1					39	41		10.1067/mai.2002.125263	http://dx.doi.org/10.1067/mai.2002.125263			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	574CF	12110816				2022-12-18	WOS:000176870300008
J	Simons, FER; Chad, ZH; Gold, M				Simons, FER; Chad, ZH; Gold, M			Real-time reporting of anaphylaxis in infants, children and adolescents by physicians involved in the Canadian Pediatric Surveillance Program	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Manitoba, Winnipeg, MB R3T 2N2, Canada; Univ Toronto, Toronto, ON, Canada	University of Manitoba; University of Toronto									0	16	16	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		536	S181	S181						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800535
J	Marks, GB				Marks, GB			What should we tell allergic families about pets?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							SKIN-TEST REACTIVITY; HOUSE-DUST MITE; HAY-FEVER; BRONCHIAL HYPERRESPONSIVENESS; RESPIRATORY SYMPTOMS; CHILDHOOD ASTHMA; EARLY EXPOSURE; CHILDREN; SENSITIZATION; CAT		Inst Resp Med, Sydney, NSW 2050, Australia		Marks, GB (corresponding author), Inst Resp Med, POB M77,Missenden Rd PO, Sydney, NSW 2050, Australia.		Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053				Almqvist C, 2001, AM J RESP CRIT CARE, V163, P694, DOI 10.1164/ajrccm.163.3.2006114; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; BURROWS B, 1995, J ALLERGY CLIN IMMUN, V95, P548, DOI 10.1016/S0091-6749(95)70317-9; Chinn S, 1999, EUR RESPIR J, V14, P876, DOI 10.1034/j.1399-3003.1999.14d25.x; Custovic A, 2001, LANCET, V358, P188, DOI 10.1016/S0140-6736(01)05406-X; Downs SH, 2001, CLIN EXP ALLERGY, V31, P570, DOI 10.1046/j.1365-2222.2001.01070.x; Ernst P, 2000, AM J RESP CRIT CARE, V161, P1563, DOI 10.1164/ajrccm.161.5.9908119; Haby MM, 2000, PEDIATR PULM, V30, P377, DOI 10.1002/1099-0496(200011)30:5<377::AID-PPUL3>3.0.CO;2-3; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; INGRAM JM, 1995, J ALLERGY CLIN IMMUN, V96, P449, DOI 10.1016/S0091-6749(95)70286-5; Jarvis D, 1997, CLIN EXP ALLERGY, V27, P240; Kilpelainen M, 2000, CLIN EXP ALLERGY, V30, P201, DOI 10.1046/j.1365-2222.2000.00800.x; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Matricardi PM, 1998, J ALLERGY CLIN IMMUN, V101, P439, DOI 10.1016/S0091-6749(98)70350-1; Nafstad P, 2001, ALLERGY, V56, P307, DOI 10.1034/j.1398-9995.2001.00881.x; *NAT HEART LUNG BL, 1998, ASTHM MAN PREV POCK; PEAT JK, 1993, CLIN EXP ALLERGY, V23, P812, DOI 10.1111/j.1365-2222.1993.tb00258.x; PEAT JK, 1991, CLIN EXP ALLERGY, V21, P573, DOI 10.1111/j.1365-2222.1991.tb00849.x; Plaschke P, 1999, ALLERGY, V54, P843, DOI 10.1034/j.1398-9995.1999.00162.x; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Sicherer SH, 1997, J ALLERGY CLIN IMMUN, V99, P798, DOI 10.1016/S0091-6749(97)80014-0; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Svanes C, 1999, J ALLERGY CLIN IMMUN, V103, P415, DOI 10.1016/S0091-6749(99)70465-3; Tunnicliffe WS, 1999, EUR RESPIR J, V13, P654, DOI 10.1183/09031936.99.13365499; van der Heide S, 1999, J ALLERGY CLIN IMMUN, V104, P447, DOI 10.1016/S0091-6749(99)70391-X; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; VONMUTIUS E, 1994, BRIT MED J, V308, P692, DOI 10.1136/bmj.308.6930.692; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7	33	16	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2001	108	4					500	502		10.1067/mai.2001.119383	http://dx.doi.org/10.1067/mai.2001.119383			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	485NK	11590371				2022-12-18	WOS:000171760300004
J	Pastorello, EA; Farioli, L; Robino, AM; Trambaioli, C; Conti, A; Pravettoni, V				Pastorello, EA; Farioli, L; Robino, AM; Trambaioli, C; Conti, A; Pravettoni, V			A lipid transfer protein involved in occupational sensitization to spelt	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MAJOR ALLERGEN		IRCCS, Osped Maggiore, Div Gen Med 3, Allergy Ctr, Milan, Italy; ICP Hosp, CEMOC, Milan, Italy; CNR, Turin, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Consiglio Nazionale delle Ricerche (CNR)	Pastorello, EA (corresponding author), IRCCS, Osped Maggiore, Div Gen Med 3, Allergy Ctr, Milan, Italy.		PASTORELLO, ELIDE ANNA/E-3897-2017	PASTORELLO, ELIDE ANNA/0000-0002-3753-1783				Pastorello EA, 1999, J ALLERGY CLIN IMMUN, V103, P520, DOI 10.1016/S0091-6749(99)70480-X; Pastorello EA, 2000, J ALLERGY CLIN IMMUN, V106, P744, DOI 10.1067/mai.2000.108712; Romagnani S, 2000, J ALLERGY CLIN IMMUN, V105, P399, DOI 10.1067/mai.2000.104575	3	16	16	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2001	108	1					145	146		10.1067/jmai.2001.114988	http://dx.doi.org/10.1067/jmai.2001.114988			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	458AN	11447401				2022-12-18	WOS:000170171200026
J	Roca-Ferrer, J; Mullol, J; Xaubet, A; Benitez, P; Bernal-Sprekelsen, M; Shelhamer, J; Picado, C				Roca-Ferrer, J; Mullol, J; Xaubet, A; Benitez, P; Bernal-Sprekelsen, M; Shelhamer, J; Picado, C			Proinflammatory cytokines and eosinophil cationic protein on glandular secretion from human nasal mucosa: Regulation by corticosteroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						nasal mucosa; glandular secretion; lactoferrin; budesonide; eosinophil cationic protein; IL-1 beta; TNF-alpha; GM-CSF; IL-10	OBSTRUCTIVE PULMONARY-DISEASE; TOPICAL ANTIINFLAMMATORY DRUGS; NECROSIS-FACTOR-ALPHA; HUMAN AIRWAYS INVITRO; GM-CSF SECRETION; EPITHELIAL-CELLS; ALLERGIC RHINITIS; TNF-ALPHA; GLYCOCONJUGATE SECRETION; GLYCOPROTEIN-SECRETION	Background: Airway hypersecretion is a common finding in rhinitis and asthma in which proinflammatory cytokines are upregulated. The effect of inflammation on glandular secretion remains unclear. Objective: We sought to investigate the effect of proinflammatory cytokines and eosinophil products in in vitro lactoferrin glandular secretion from human nasal mucosa and the role of corticosteroids and IL-10 in modulating this effect. Methods: Nasal explants from patients undergoing turbinectomies were incubated in a controlled atmosphere (50% N-2, 5% CO2, and 45% O-2) at 37 degreesC. Nasal explants were incubated with or without IL-1 beta, IL-4, IL-5, IL-8, eotaxin, GM-CSF, TNF-alpha, eosinophil cationic protein (ECP), IL-10, and budesonide in a time-course and dose-response fashion. Lactoferrin concentrations in culture supernatants were measured by means of ELISA. Results: ECP (up to 30%) caused a dose-related stimulation of lactoferrin secretion. TNF-alpha (20 ng/mL) induced a significant increase of lactoferrin release from 8 hours (27.7 % +/- 17.8 %, P < .05) to 24 hours (40.8% +/- 17.2%, P < .01) compared with that found in media-treated explants. At 24 hours, TNF-alpha caused a dose-related stimulation of lactoferrin secretion (up to 35%). IL-1 beta (65.3% +/- 15.2%, P < .05) and GM-CSF (15.7% +/- 6.7%, P < .05), both at 20 ng/mL, exerted a stimulatory effect only at 24 hours, and IL-4, IL-5, IL-8, and eotaxin had no significant effect. Budesonide caused a dose-related inhibition of lactoferrin secretion induced by IL-1 beta (down to -76%) and TNF-alpha (down to -70%), whereas IL-10 had no effect. Conclusions: ECP and some proinflammatory cytokines (IL-1 beta, TNF-alpha, and GM-CSF) may contribute to glandular hypersecretion in the inflamed nose. Corticosteroids may reduce nasal hypersecretion by blocking the direct effect of proinflammatory cytokines on glandular output.	Univ Barcelona, Hosp Clin, Dept Med, Serv Pneumol, E-08036 Barcelona, Catalonia, Spain; IDIBAPS, Fundacio Clin Recerca Biomed, Barcelona, Catalonia, Spain; Gen Hosp, Serv Otorinolaringol, Barcelona, Catalonia, Spain; NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Picado, C (corresponding author), Univ Barcelona, Hosp Clin, Dept Med, Serv Pneumol, Villarroel 170, E-08036 Barcelona, Catalonia, Spain.		Roca-Ferrer, Jordi/AFQ-4652-2022; /AFX-9519-2022; /AAL-7347-2021; Bernal-Sprekelsen, Manuel/AAJ-7568-2021; Bernal-Sprekelsen, Manuel/AAG-4299-2021	Roca-Ferrer, Jordi/0000-0002-9527-2273; Bernal-Sprekelsen, Manuel/0000-0001-8191-9833				ALI M, 1996, AM J PHYSIOL, V270, pL95; BARANIUK JN, 1994, INT ARCH ALLERGY IMM, V103, P202, DOI 10.1159/000236628; BARNES PJ, 1997, LUNG BIOL HEALTH DIS, V97, P651; Benson M, 1999, PEDIATR ALLERGY IMMU, V10, P178; Benson M, 2000, PEDIAT ALLERG IMM-UK, V11, P20, DOI 10.1034/j.1399-3038.2000.00051.x; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q; Calderon MA, 1997, J ALLERGY CLIN IMMUN, V99, P65, DOI 10.1016/S0091-6749(97)70302-6; Chung KF, 1999, BRIT J PHARMACOL, V127, P1145, DOI 10.1038/sj.bjp.0702660; Dabbagh K, 1999, J IMMUNOL, V162, P6233; EMERY BE, 1992, J ALLERGY CLIN IMMUN, V90, P772, DOI 10.1016/0091-6749(92)90101-7; Ennis M, 1999, CLIN EXP ALLERGY, V29, P362; Fernandez-Morata JC, 2000, CLIN EXP ALLERGY, V30, P1275; FISCHER BM, 1995, CHEST, V107, pS133, DOI 10.1378/chest.107.3_Supplement.133S; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; HOSHI H, 1995, CLIN EXP ALLERGY, V25, P720, DOI 10.1111/j.1365-2222.1995.tb00009.x; HOWARTH PH, 1997, LUNG BIOL HEALTH DIS, V97, P521; Jeffery PK, 1998, THORAX, V53, P129, DOI 10.1136/thx.53.2.129; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P449, DOI 10.1164/ajrccm.155.2.9032177; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; KleinJan A, 1999, J ALLERGY CLIN IMMUN, V103, P441, DOI 10.1016/S0091-6749(99)70469-0; LEVINE SJ, 1993, AM REV RESPIR DIS, V147, pA437; LEVINE SJ, 1995, AM J RESP CELL MOL, V12, P196, DOI 10.1165/ajrcmb.12.2.7865217; LUNDGREN JD, 1991, J ALLERGY CLIN IMMUN, V87, P689, DOI 10.1016/0091-6749(91)90390-A; LUNDGREN JD, 1988, AM REV RESPIR DIS, V137, P353, DOI 10.1164/ajrccm/137.2.353; LUNDGREN JD, 1990, AM REV RESPIR DIS, V141, pS52; LUNDGREN JD, 1994, RESP MED, V88, P511, DOI 10.1016/S0954-6111(05)80333-6; MAROM Z, 1984, AM REV RESPIR DIS, V129, P62; MCGREGOR FB, 1996, CLIN OTOLARYNGOL, V21, P76; Minshall EM, 1997, AM J RESP CELL MOL, V17, P683, DOI 10.1165/ajrcmb.17.6.2865; MOTOJIMA S, 1989, AM REV RESPIR DIS, V139, P801, DOI 10.1164/ajrccm/139.3.801; Mullol J, 2000, RESP MED, V94, P428, DOI 10.1053/rmed.1999.0756; MULLOL J, 1992, NEUROPEPTIDES, V21, P231, DOI 10.1016/0143-4179(92)90027-T; MULLOL J, 1993, AM J RESP CELL MOL, V8, P393, DOI 10.1165/ajrcmb/8.4.393; MULLOL J, 1995, CLIN EXP ALLERGY, V25, P607, DOI 10.1111/j.1365-2222.1995.tb01108.x; Mullol J, 1997, CLIN EXP ALLERGY, V27, P1432, DOI 10.1111/j.1365-2222.1997.tb02988.x; MULLOL J, 1992, J ALLERGY CLIN IMMUN, V89, P584, DOI 10.1016/0091-6749(92)90326-W; NOAH TL, 1995, AM J RESP CRIT CARE, V152, P1290, DOI 10.1164/ajrccm.152.4.7551384; Nonaka M, 1996, AM J RESP CRIT CARE, V153, P1675, DOI 10.1164/ajrccm.153.5.8630619; Ogata N, 1997, Auris Nasus Larynx, V24, P279, DOI 10.1016/S0385-8146(96)00034-X; Pesci A, 1998, EUR RESPIR J, V12, P380, DOI 10.1183/09031936.98.12020380; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V88, P33, DOI 10.1016/0091-6749(91)90298-3; ROBINSON DS, 1995, CLIN EXP ALLERGY, V25, P1118, DOI 10.1111/j.1365-2222.1995.tb03259.x; Robinson DS, 1996, AM J RESP CELL MOL, V14, P113, DOI 10.1165/ajrcmb.14.2.8630259; Roca-Ferrer J, 2000, J ALLERGY CLIN IMMUN, V106, P1053, DOI 10.1067/mai.2000.110476; RocaFerrer J, 1997, EUR RESPIR J, V10, P1489, DOI 10.1183/09031936.97.10071489; SHIMURA S, 1990, AM REV RESPIR DIS, V141, P1044, DOI 10.1164/ajrccm/141.4_Pt_1.1044; SIM TC, 1995, AM J RESP CRIT CARE, V152, P927, DOI 10.1164/ajrccm.152.3.7545059; SIM TC, 1994, AM J RESP CRIT CARE, V149, P339, DOI 10.1164/ajrccm.149.2.8306027; STERN M, 1992, J IMMUNOL, V148, P3543; STOOP AE, 1993, J ALLERGY CLIN IMMUN, V91, P616, DOI 10.1016/0091-6749(93)90267-J; SUN S, 1991, CHIN J OTORHINOLARYN, V26, P144; Takanashi S, 1999, EUR RESPIR J, V14, P309, DOI 10.1034/j.1399-3003.1999.14b12.x; WANG DY, 1995, INT ARCH ALLERGY IMM, V106, P278, DOI 10.1159/000236855; Yang X, 2000, EUR J IMMUNOL, V30, P382, DOI 10.1002/1521-4141(200002)30:2<382::AID-IMMU382>3.0.CO;2-L	55	16	16	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2001	108	1					87	93		10.1067/mai.2001.115485	http://dx.doi.org/10.1067/mai.2001.115485			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	458AN	11447387				2022-12-18	WOS:000170171200012
J	Rueff, F; Przybilla, B				Rueff, F; Przybilla, B			Ultrarush immunotherapy in patients with Hymenoptera venom allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Munich, Klin & Poliklin Dermatol & Allergol, D-890337 Munich, Germany	University of Munich	Rueff, F (corresponding author), Univ Munich, Klin & Poliklin Dermatol & Allergol, Frauenlobstr 9-11, D-890337 Munich, Germany.							Brehler R, 2000, J ALLERGY CLIN IMMUN, V105, P1231, DOI 10.1067/mai.2000.105708; Rueff F, 1996, ALLERGY, V51, P216, DOI 10.1111/j.1398-9995.1996.tb04596.x; Rueff F, 1997, ALLERGO J S1, V6, P59	3	16	16	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2001	107	5					928	928						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	434JX	11344369				2022-12-18	WOS:000168812300030
J	Malerba, G; Patuzzo, C; Trabetti, E; Lauciello, MC; Galavotti, R; Pescollderungg, L; Whalen, MB; Zanoni, G; Martinati, LC; Boner, AL; Pignatti, PF				Malerba, G; Patuzzo, C; Trabetti, E; Lauciello, MC; Galavotti, R; Pescollderungg, L; Whalen, MB; Zanoni, G; Martinati, LC; Boner, AL; Pignatti, PF			Chromosome 14 linkage analysis and mutation study of 2 serpin genes in allergic asthmatic families	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						a(1)-antichymotrypsin; alpha(1)-antitrypsin; allergic asthma; bronchial hyperresponsiveness; transmission disequilibrium test; chromosome 14; linkage; association	GENOME-WIDE SEARCH; ALPHA(1)-ANTITRYPSIN; SUSCEPTIBILITY; ASSOCIATION; ALPHA(1)-ANTICHYMOTRYPSIN; POLYMORPHISM; PHENOTYPES; INHIBITOR; GENETICS; TRAITS	Background: Genome and chromosome screens reported DNA markers on chromosome 14 linked to allergic asthma or intermediate phenotypes in several populations. Objective: We sought to perform a linkage study on chromosome 14 and a further association study on candidate genes mapped in the region found to be linked to allergic asthma or intermediate phenotypes. Methods: The study consisted of a sample of 189 families (847 genotyped individuals) from a restricted geographic area in northeastern Italy. The subjects were characterized for the following phenotypes: allergic asthma, total serum IgE levels. skin prick test responses, and bronchial hyperresponsiveness (BHR) to methacholine. Genotyping was done with 14 DNA markers and 4 polymorphisms in the genes encoding alpha (1)-antitrypsin and alpha (1)-antichymotrypsin (ACT). Results: Multipoint analysis indicated a potential linkage of BHR with marker D14S617 (nonparametric linkage z score = 2.32, P = .01). Transmission disequilibrium of Thr -15Ala in the gene encoding ACT was observed with all the phenotypes investigated: allergic asthma, BHR. total IgE levels, or skin prick test responses (P = .041,.02,.0053, or .026, respectively). Conclusion: Chromosome 14 screening and transmission disequilibrium testing on the gene encoding ACT suggest that it or a closely located gene may be involved in susceptibility to allergic asthma in the Italian population.	Univ Verona, DMIBG, Sect Biol & Genet, I-37134 Verona, Italy; Univ Verona, Dept Pathol, I-37100 Verona, Italy; Hosp Bolzano, Inst Paediat, Bolzano, Italy	University of Verona; University of Verona; Krankenhaus Bozen	Pignatti, PF (corresponding author), Univ Verona, DMIBG, Sect Biol & Genet, Strada Grazie 8, I-37134 Verona, Italy.		Malerba, Giovanni/T-3278-2019; Patuzzo, Cristina/G-4816-2011	WHALEN, MICHAELBERNARD/0000-0001-7300-8511; Malerba, Giovanni/0000-0001-8705-8560	Telethon [E.0837] Funding Source: Medline	Telethon(Fondazione Telethon)		[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Benetazzo MG, 1999, RESP MED, V93, P648, DOI 10.1016/S0954-6111(99)90105-1; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; GAILLARD MC, 1992, AM REV RESPIR DIS, V145, P1311, DOI 10.1164/ajrccm/145.6.1311; Hall IP, 1999, THORAX, V54, P65, DOI 10.1136/thx.54.1.65; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hinds DA, 1996, ASPEX PACKAGE AFFECT; Ishii T, 2000, EUR J CLIN INVEST, V30, P543; JANOFF A, 1985, AM REV RESPIR DIS, V132, P417; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LINDMARK B, 1990, J INTERN MED, V227, P115, DOI 10.1111/j.1365-2796.1990.tb00128.x; Mansur AH, 1999, AM J RESP CRIT CARE, V159, P1796, DOI 10.1164/ajrccm.159.6.9804036; Marsh DG, 1997, NAT GENET, V15, P389; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Martinez FD, 1999, ALLERGY, V54, P24, DOI 10.1111/j.1398-9995.1999.tb04384.x; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MOFFATT F, 1994, LANCET, V343, P1597, DOI 10.1016/S0140-6736(94)93057-0; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; PERONI DG, 1994, AM J RESP CRIT CARE, V149, P1442, DOI 10.1164/ajrccm.149.6.8004296; POLLER W, 1990, EUR J CLIN INVEST, V20, P1; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Rollini P, 1997, GENOMICS, V46, P409, DOI 10.1006/geno.1997.5077; Sandford A, 1996, AM J RESP CRIT CARE, V153, P1749, DOI 10.1164/ajrccm.153.6.8665031; Sandford AJ, 1999, AM J RESP CRIT CARE, V159, P1624, DOI 10.1164/ajrccm.159.5.9711004; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TOWNLEY RG, 1990, CHEST, V98, P594, DOI 10.1378/chest.98.3.594; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806	32	16	18	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2001	107	4					654	658		10.1067/mai.2001.113865	http://dx.doi.org/10.1067/mai.2001.113865			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	423RG	11295654				2022-12-18	WOS:000168190100017
J	Niggemann, B; Buck, D; Michael, T; Haberl, H; Wahn, U				Niggemann, B; Buck, D; Michael, T; Haberl, H; Wahn, U			Latex allergy in spina bifida: At the turning point?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SENSITIZATION; CHILDREN; RISK		Humboldt Univ, Charite, Childrens Hosp, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Niggemann, B (corresponding author), Humboldt Univ, Charite, Childrens Hosp, Augustenburger Pl 1, D-13353 Berlin, Germany.							Cremer R, 1998, PEDIATR ALLERGY IMMU, V9, P40, DOI 10.1111/j.1399-3038.1998.tb00299.x; Cremer R, 1998, ALLERGY, V53, P709, DOI 10.1111/j.1398-9995.1998.tb03958.x; Michael T, 1996, CLIN EXP ALLERGY, V26, P934; Niggemann B, 1998, J ALLERGY CLIN IMMUN, V102, P665, DOI 10.1016/S0091-6749(98)70285-4; Shah S, 1998, J ALLERGY CLIN IMMUN, V101, P741, DOI 10.1016/S0091-6749(98)70303-3	5	16	16	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2000	106	6					1201	1201						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	384ER	11112908				2022-12-18	WOS:000165930300027
J	Zeiger, RS; Schatz, M				Zeiger, RS; Schatz, M			Effect of allergist intervention on patient-centered and societal outcomes: Allergists as leaders, innovators, and educators	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						allergist interventions; allergic rhinitis; anaphylaxis; asthma; clinical trials; drug allergy; education; food allergy	INNER-CITY CHILDREN; QUALITY-OF-LIFE; ASTHMA MANAGEMENT GUIDELINES; TOBACCO-SMOKE EXPOSURE; FOOD ALLERGY; COST-EFFECTIVENESS; ATOPIC-DERMATITIS; CONTROLLED-TRIAL; SELF-MANAGEMENT; METHACHOLINE CHALLENGE	Atopic disorders, which afflict millions of Americans and hundreds of millions worldwide, are at epidemic levels with concomitant increases in morbidity and mortality, Environmental and lifestyle changes over the past three to five decades are proposed causes for this pandemic and as such present major burdens to reverse, The scope of allergy practice bridges directly on this challenge. Allergy as a specialty is a major leader in developing effective strategies to confront this epidemic, Allergists have made major contributions to the understanding of the risk factors, immunology, pathophysiology, immunomodulation, and prevention of atopic and immunologic disorders, Allergist epidemiologists and clinicians have helped develop and implement national and international guidelines in the recognition, management, and prevention of asthma and rhinitis, Allergist clinical researchers are active in (1) outcomes research that demonstrates convincingly the value of allergy as a specialty in asthma, allergic rhinitis, anaphylaxis, drug and food allergy, and other atopic disorders, (2) National Institutes of Health clinical trials that will form the basis for the future treatment of asthma and allergic disease, and (3) pharmaceutical trials that evaluate new, effective, and safe medication to treat atopic disease, Allergist educators, comprising academic and practicing allergists, supported by allied health professionals, national associations, and affiliated lay organizations, provide comprehensive education to fellows, residents, colleague physicians, media, the public, and patients, Documentation of the value of allergists in improving patient-centered and societal outcomes in their core domain, allergy, is the appropriate final topic contribution in the important series "New millennium: The conquest of allergy.".	Kaiser Permanente Med Ctr, Dept Allergy Immunol, San Diego, CA 92111 USA; Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	Kaiser Permanente; University of California System; University of California San Diego; University of California System; University of California San Diego	Zeiger, RS (corresponding author), Kaiser Permanente Med Ctr, Dept Allergy Immunol, 7060 Clairemont Mesa Blvd, San Diego, CA 92111 USA.			Zeiger, Robert/0000-0001-5788-5063				ABRAMSON MJ, 1995, AM J RESP CRIT CARE, V151, P969; ABRAMSON MJ, 1998, COCHRANE LIB REV; Adkinson NF, 1997, NEW ENGL J MED, V336, P324, DOI 10.1056/NEJM199701303360502; Alvarez-Cuesta E, 2000, Curr Opin Pulm Med, V6, P50, DOI 10.1097/00063198-200001000-00010; *AM COLL ALL ASTHM, 1998, EXP CAR IMM ASTHM RE; Armstrong D, 1994, Int J Qual Health Care, V6, P199; *ASTHM AM SURV PRO, 1998, ASTHM AM LANDM SURV; Bagenstose SE, 1999, ANN ALLERG ASTHMA IM, V83, P524, DOI 10.1016/S1081-1206(10)62863-3; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; BELL D, 1991, BRIT MED J, V302, P1440, DOI 10.1136/bmj.302.6790.1440; BJORKSTEN B, 1998, ALLERGY PRINCIPLES P, P816; Blanc PD, 1997, WESTERN J MED, V167, P398; BLUMENTHAL MN, 1988, J ALLERGY CLIN IMMUN, V81, P681, DOI 10.1016/0091-6749(88)91038-X; Boguniewicz M, 1998, J ALLERGY CLIN IMMUN, V102, P637, DOI 10.1016/S0091-6749(98)70281-7; Bonifazi F, 1997, ALLERGY, V52, P698, DOI 10.1111/j.1398-9995.1997.tb01226.x; Bousquet J, 1998, ANN ALLERG ASTHMA IM, V81, P401, DOI 10.1016/S1081-1206(10)63136-5; BUCKNALL CE, 1988, LANCET, V1, P748; Burks AW, 1999, IMMUNOL ALLERGY CLIN, V19, P533, DOI 10.1016/S0889-8561(05)70106-5; BUSTOS GJ, 1995, CLIN EXP ALLERGY, V25, P568, DOI 10.1111/j.1365-2222.1995.tb01096.x; CHARPIN D, 1990, ALLERGY PROC, V11, P29, DOI 10.2500/108854190778999447; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Corren J, 1998, J ALLERGY CLIN IMMUN, V101, pS352, DOI 10.1016/S0091-6749(98)70218-0; Crain EF, 1999, J ASTHMA, V36, P129, DOI 10.3109/02770909909065156; CRETICOS P, 1995, J ALLERGY CLIN IMMUN, V95, P829, DOI 10.1016/S0091-6749(95)70126-5; Creticos PS, 2000, J ALLERGY CLIN IMMUN, V105, pS559, DOI 10.1016/S0091-6749(00)90060-5; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; Dakin CJ, 2000, J PAEDIATR CHILD H, V36, P23, DOI 10.1046/j.1440-1754.2000.00437.x; Diette GB, 1999, ARCH INTERN MED, V159, P2697, DOI 10.1001/archinte.159.22.2697; Doan T, 1996, ANN ALLERG ASTHMA IM, V76, P513, DOI 10.1016/S1081-1206(10)63270-X; Doerschug KC, 1999, AM J RESP CRIT CARE, V159, P1735, DOI 10.1164/ajrccm.159.6.9809051; Donahue JG, 1999, ANN ALLERG ASTHMA IM, V82, P339, DOI 10.1016/S1081-1206(10)63282-6; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Eggleston PA, 1998, J ALLERGY CLIN IMMUN, V102, P563, DOI 10.1016/S0091-6749(98)70272-6; Eisner MD, 1998, MED CARE, V36, P1567, DOI 10.1097/00005650-199811000-00006; Eisner MD, 1999, ARCH INTERN MED, V159, P196, DOI 10.1001/archinte.159.2.196-a; ENGEL W, 1989, MED CARE, V27, P306, DOI 10.1097/00005650-198903000-00009; ESSAYAN DM, 1994, ANN ALLERGY, V73, P297; Evans R, 1999, J PEDIATR-US, V135, P332, DOI 10.1016/S0022-3476(99)70130-7; Fish JE, 1997, AM J RESP CRIT CARE, V156, P1165, DOI 10.1164/ajrccm.156.4.9703012; Flores G, 2000, PEDIATRICS, V105, P496, DOI 10.1542/peds.105.3.496; Francillon C, 1995, ALLERGY, V50, P959, DOI 10.1111/j.1398-9995.1995.tb02507.x; FREUND DA, 1989, J ALLERGY CLIN IMMUN, V84, P401, DOI 10.1016/0091-6749(89)90428-4; FRIED RA, 1995, J FAM PRACTICE, V41, P139; Galant D, 1998, J ALLERGY CLIN IMMUN, V101, pS44; Gergen PJ, 1999, J ALLERGY CLIN IMMUN, V103, P501, DOI 10.1016/S0091-6749(99)70477-X; Goodman DC, 1998, PEDIATRICS, V101, P208, DOI 10.1542/peds.101.2.208; Graft DF, 2000, ALLERGY ASTHMA PROC, V21, P113, DOI 10.2500/108854100778250897; GREINEDER DK, 1995, ARCH PEDIAT ADOL MED, V149, P415, DOI 10.1001/archpedi.1995.02170160069010; Greineder DK, 1996, J ALLERGY CLIN IMMUN, V98, pS330, DOI 10.1016/S0091-6749(96)80119-9; Gruchalla R. S., 1998, Clinical and Experimental Allergy, V28, P63; Hide DW, 1996, ALLERGY, V51, P89, DOI 10.1111/j.1398-9995.1996.tb04563.x; HOLT PG, 1995, PEDIAT ALLERG IMM-UK, V6, P1, DOI 10.1111/j.1399-3038.1995.tb00250.x; Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518; Hourihane JO, 1996, BRIT MED J, V313, P1046; HOVELL MF, 1994, CHEST, V106, P440, DOI 10.1378/chest.106.2.440; HUGHES DM, 1991, PEDIATRICS, V87, P54; Hunt LW, 1996, J OCCUP ENVIRON MED, V38, P765, DOI 10.1097/00043764-199608000-00011; IIKURA Y, 1992, ANN ALLERGY, V68, P233; Jacobsen L, 1997, J INVEST ALLERG CLIN, V7, P367; JAMES JM, 1995, NEW ENGL J MED, V332, P1262, DOI 10.1056/NEJM199505113321904; James JM, 1999, IMMUNOL ALLERGY CLIN, V19, P519, DOI 10.1016/S0889-8561(05)70105-3; James JM, 1998, J PEDIATR-US, V133, P624, DOI 10.1016/S0022-3476(98)70101-5; Jatulis DE, 1998, ANN ALLERG ASTHMA IM, V81, P82, DOI 10.1016/S1081-1206(10)63113-4; JOHNSTONE DE, 1968, PEDIATRICS, V42, P793; Jorgensen AF, 1999, SCAND J PRIM HEALTH, V17, P221; Joyce DP, 1996, CHEST, V109, P697, DOI 10.1378/chest.109.3.697; Kahan E, 1997, OCCUP MED-OXFORD, V47, P273, DOI 10.1093/occmed/47.5.273; Kaliner MA, 1997, OTOLARYNG HEAD NECK, V116, pS1; Kattan M, 1997, PEDIATR PULM, V24, P253, DOI 10.1002/(SICI)1099-0496(199710)24:4<253::AID-PPUL4>3.0.CO;2-L; Kelly CS, 2000, PEDIATRICS, V105, P1029, DOI 10.1542/peds.105.5.1029; Kemp JP, 1998, J ASTHMA, V35, P601, DOI 10.3109/02770909809048963; KOTSES H, 1995, J ALLERGY CLIN IMMUN, V95, P529, DOI 10.1016/S0091-6749(95)70315-2; Kozma CM, 1996, PHARMACOECONOMICS, V10, P4, DOI 10.2165/00019053-199610010-00002; Lahdensuo A, 1996, BRIT MED J, V312, P748; LANTNER RR, 1995, ANN ALLERG ASTHMA IM, V74, P188; Legorreta AP, 1998, ARCH INTERN MED, V158, P457, DOI 10.1001/archinte.158.5.457; Lehrer SB, 1999, IMMUNOL ALLERGY CLIN, V19, P563, DOI 10.1016/S0889-8561(05)70108-9; Leung DYM, 1999, J ALLERGY CLIN IMMUN, V104, pS99, DOI 10.1016/S0091-6749(99)70051-5; LINNA O, 1992, ACTA PAEDIATR, V81, P1013, DOI 10.1111/j.1651-2227.1992.tb12165.x; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Macy E, 1998, J ALLERGY CLIN IMMUN, V102, P281, DOI 10.1016/S0091-6749(98)70097-1; MAHR TA, 1993, ANN ALLERGY, V71, P115; Malone DC, 1997, J ALLERGY CLIN IMMUN, V99, P22, DOI 10.1016/S0091-6749(97)81040-8; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Martin RJ, 1999, J ALLERGY CLIN IMMUN, V103, P535, DOI 10.1016/S0091-6749(99)70484-7; Martin RJ, 1997, CHEST, V112, P53, DOI 10.1378/chest.112.1.53; MAYO PH, 1990, ANN INTERN MED, V112, P864, DOI 10.7326/0003-4819-112-11-864; MCMENAMIN P, 1994, ANN ALLERGY, V73, P35; McNally PA, 1997, ALLERGY ASTHMA PROC, V18, P169, DOI 10.2500/108854197778984374; Meng YY, 1999, J EVAL CLIN PRACT, V5, P213, DOI 10.1046/j.1365-2753.1999.00177.x; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; Milks CJ, 1999, ANN ALLERG ASTHMA IM, V83, P208, DOI 10.1016/S1081-1206(10)62641-5; Mitchell H, 1997, PEDIATR PULM, V24, P237; Moore CM, 1997, ANN ALLERG ASTHMA IM, V78, P373, DOI 10.1016/S1081-1206(10)63199-7; Moy JN, 1999, CHEST, V116, p154S, DOI 10.1378/chest.116.suppl_2.154S; *NAT ASTHM ED PREV, 1997, NIH PUBL; *NAT ASTHM ED PREV, 1996, NIH PUBL; *NAT ASTHM ED PROG, 1993, NIH PUBL; *NAT ASTHM ED PROG, 1991, US DEP HHS PUBL; *NAT I ALL INF DIS, 1997, ASTHM CONC MIN POP; Nathan RA, 1997, J ALLERGY CLIN IMMUN, V99, pS808, DOI 10.1016/S0091-6749(97)80040-1; Nestor A, 1998, ANN ALLERG ASTHMA IM, V81, P327, DOI 10.1016/S1081-1206(10)63124-9; *NIH NAT HEART LUN, 1995, NIH PUBL; Nyman JA, 1997, ANN ALLERG ASTHMA IM, V79, P496, DOI 10.1016/S1081-1206(10)63055-4; OSMAN J, 1987, BRIT J DIS CHEST, V81, P232, DOI 10.1016/0007-0971(87)90155-0; Patterson R, 1999, ANN ALLERG ASTHMA IM, V82, P315, DOI 10.1016/S1081-1206(10)63280-2; PEARLMAN DS, 1992, NEW ENGL J MED, V327, P1420, DOI 10.1056/NEJM199211123272004; Peat JK, 1999, J ALLERGY CLIN IMMUN, V103, P1, DOI 10.1016/S0091-6749(99)70517-8; PEAT JK, 1994, BMJ-BRIT MED J, V308, P1591, DOI 10.1136/bmj.308.6944.1591; PEAT JK, 1994, CLIN EXP ALLERGY, V24, P797, DOI 10.1111/j.1365-2222.1994.tb01802.x; Picken HA, 1998, J GEN INTERN MED, V13, P659, DOI 10.1046/j.1525-1497.1998.00200.x; Premaratne UN, 1999, BRIT MED J, V318, P1251; Ray NF, 1999, J ALLERGY CLIN IMMUN, V103, P408, DOI 10.1016/S0091-6749(99)70464-1; Revicki DA, 1998, QUAL LIFE RES, V7, P693, DOI 10.1023/A:1008860113818; Roghmann MC, 1999, J ASTHMA, V36, P381, DOI 10.3109/02770909909068231; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sampson HA, 2000, HOSP PRACT, V35, P67, DOI 10.3810/hp.2000.05.196; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P981, DOI 10.1016/S0091-6749(99)70167-3; SAMPSON HA, 1985, J PEDIATR-US, V107, P669, DOI 10.1016/S0022-3476(85)80390-5; Sampson HA, 1999, IMMUNOL ALLERGY CLIN, V19, P495, DOI 10.1016/S0889-8561(05)70104-1; Sampson HA, 2000, J PEDIATR GASTR NUTR, V30, pS87, DOI 10.1097/00005176-200001001-00013; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Schadlich PK, 2000, PHARMACOECONOMICS, V17, P37, DOI 10.2165/00019053-200017010-00003; SCHATZ M, 1995, AM J RESP CRIT CARE, V151, P1170; SIMONS FER, 1994, CLIN EXP ALLERGY, V24, P707, DOI 10.1111/j.1365-2222.1994.tb00981.x; Sly RM, 1999, ANN ALLERG ASTHMA IM, V82, P233, DOI 10.1016/S1081-1206(10)62603-8; Smith JM, 1996, JAMA-J AM MED ASSOC, V276, P1180, DOI 10.1001/jama.276.14.1180; SOGN DD, 1992, ARCH INTERN MED, V152, P1025, DOI 10.1001/archinte.152.5.1025; Solomon DH, 1997, ANN INTERN MED, V127, P52, DOI 10.7326/0003-4819-127-1-199707010-00009; SPECTOR SL, 1994, AM J RESP CRIT CARE, V150, P618, DOI 10.1164/ajrccm.150.3.8087328; SPERBER K, 1995, J ASTHMA, V32, P335, DOI 10.3109/02770909509082758; Spiegelberg HL, 1997, ALLERGY, V52, P964, DOI 10.1111/j.1398-9995.1997.tb02415.x; Stempel DA, 1997, ANN ALLERG ASTHMA IM, V79, P517, DOI 10.1016/S1081-1206(10)63059-1; Storms B, 1995, ANN ALLERG ASTHMA IM, V75, P491; Storms W, 1997, J ALLERGY CLIN IMMUN, V99, pS820, DOI 10.1016/S0091-6749(97)80042-5; Sugiura H, 1998, ACTA DERM-VENEREOL, V78, P293; TAITEL MS, 1995, J ALLERGY CLIN IMMUN, V95, P672, DOI 10.1016/S0091-6749(95)70171-0; THOMPSON R, 1993, NEW ZEAL MED J, V106, P81; TINKELMAN DG, 1993, PEDIATRICS, V92, P64; *US DEP HHS, 2000, HHS TARG EFF ASTHM; *US DEP HHS PHS NA, 1994, VIT HLTH STAT; VENGE P, 1994, ALLERGY, V49, P1, DOI 10.1111/j.1398-9995.1994.tb00765.x; Vilar MEB, 2000, ANN ALLERG ASTHMA IM, V84, P299, DOI 10.1016/S1081-1206(10)62777-9; Vollmer WM, 1998, AM J RESP CRIT CARE, V157, P1079, DOI 10.1164/ajrccm.157.4.9704140; Vollmer WM, 1997, ARCH INTERN MED, V157, P1201, DOI 10.1001/archinte.157.11.1201; Wade S, 1997, PEDIATR PULM, V24, P263, DOI 10.1002/(SICI)1099-0496(199710)24:4<263::AID-PPUL5>3.0.CO;2-L; Wahlgren DR, 1997, CHEST, V111, P81, DOI 10.1378/chest.111.1.81; Warner JO, 1998, PEDIATR ALLERGY IMMU, V9, P116; Webb L Z, 1992, QRB Qual Rev Bull, V18, P471; Weinberger M, 1996, NEW ENGL J MED, V334, P1380, DOI 10.1056/NEJM199605233342107; Weinstein AG, 1996, J ALLERGY CLIN IMMUN, V98, P264, DOI 10.1016/S0091-6749(96)70149-5; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Westley CR, 1997, ALLERGY ASTHMA PROC, V18, P15, DOI 10.2500/108854197778612835; WILLERT C, 1985, J PEDIATR-US, V106, P707, DOI 10.1016/S0022-3476(85)80340-1; Williams LW, 1999, IMMUNOL ALLERGY CLIN, V19, P479, DOI 10.1016/S0889-8561(05)70103-X; WOLLE JM, 1995, J ASTHMA, V32, P309, DOI 10.3109/02770909509044839; WONG S, 1990, ARCH INTERN MED, V150, P1323, DOI 10.1001/archinte.150.6.1323; Yocum MW, 1999, J ALLERGY CLIN IMMUN, V104, P452, DOI 10.1016/S0091-6749(99)70392-1; YUNGINGER JW, 1988, JAMA-J AM MED ASSOC, V260, P1450, DOI 10.1001/jama.260.10.1450; Zeiger RS, 1997, J ROY SOC MED, V90, P21, DOI 10.1177/0141076897090030S05; ZEIGER RS, 1991, J ALLERGY CLIN IMMUN, V87, P1160, DOI 10.1016/0091-6749(91)92162-T; ZEIGER RS, 1995, J ALLERGY CLIN IMMUN, V95, P1179, DOI 10.1016/S0091-6749(95)70074-9; Zeiger RS, 2000, J PEDIATR GASTR NUTR, V30, pS77, DOI 10.1097/00005176-200001001-00012; 1997, MON VITAL STAT REP, V46, P1	165	16	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2000	106	6					995	1018		10.1067/mai.2000.110921	http://dx.doi.org/10.1067/mai.2000.110921			24	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	384ER	11112881				2022-12-18	WOS:000165930300001
J	Fan, GK; Itoh, T; Imanaka, M; Fujieda, S; Takenaka, H				Fan, GK; Itoh, T; Imanaka, M; Fujieda, S; Takenaka, H			Eosinophilic apoptosis in sinus mucosa: Relationship to tissue eosinophilia and its resolution in allergic sinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophil; apoptosis; IL-5; allergic sinusitis; sinus mucosa; EG2; Fas; Bax	PROGRAMMED CELL-DEATH; AIRWAY INFLAMMATION; IN-VITRO; EXPRESSION; INTERLEUKIN-5; PHAGOCYTOSIS; ASTHMA; IL-5; GLUCOCORTICOIDS; GRANULOCYTES	Background: Apoptosis, which is regulated by both cell survival and death signals, is important for the swift clearance of unwanted cells. Objective: We sought to elucidate whether eosinophilic apoptosis is associated with tissue eosinophilia and to determine its resolution in allergic sinusitis (AS). Methods: Numbers of eosinophils, numbers of IL-5(+) cells, and the apoptosis index of eosinophils were calculated in the submucosa (both superficial and deep layers) of patients with AS by using histochemical methods before and after prednisolone treatment. Patients without AS were used for control groups. Anti-EG2 antibody was used to identify eosinophils. IL-5, Fas, or Bax expression of eosinophils was evaluated to elucidate the role of the factors affecting eosinophilic apoptosis. Results: EG2 and IL-5(+) cells were abundant in the submucosa of patients with AS, especially in the superficial layer. About 50% to 60% of the IL-5-producing cells were eosinophils. Apoptotic eosinophils were less numerous in the superficial layer than the deep layer in these diseases. After prednisolone treatment, an induction of eosinophilic apoptosis was accompanied by a significant decrease in the number of EG2(+) and IL-5+ cells. No remarkable difference was observed in the Pas or Bax expression of eosinophils after prednisolone treatment. Conclusion: Autocrine secretion of IL-5 from eosinophils may be one reason why eosinophilic disease is difficult to manage. Induction of eosinophilic apoptosis is critical for reversing tissue eosinophilia in patients with AS.	Osaka Med Coll, Dept Otorhinolaryngol, Osaka 05698686, Japan; Fukui Med Univ, Dept Otorhinolaryngol, Fukui, Japan	University of Fukui	Takenaka, H (corresponding author), Osaka Med Coll, Dept Otorhinolaryngol, Daigaku Cho 2-7, Osaka 05698686, Japan.							Adachi T, 1996, J ALLERGY CLIN IMMUN, V98, pS207, DOI 10.1016/S0091-6749(96)70068-4; ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102; AYERS GH, 1985, J ALLERGY CLIN IMMUN, V76, P595; Bratton DL, 1999, J ALLERGY CLIN IMMUN, V103, P555, DOI 10.1016/S0091-6749(99)70223-X; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; DEMOLY P, 1994, J ALLERGY CLIN IMMUN, V94, P95, DOI 10.1016/0091-6749(94)90076-0; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P863, DOI 10.1164/ajrccm/142.4.863; Fadok VA, 1998, BIOCHEM SOC T, V26, P653, DOI 10.1042/bst0260653; Fujieda S, 1999, INT J CANCER, V84, P315, DOI 10.1002/(SICI)1097-0215(19990621)84:3<315::AID-IJC20>3.0.CO;2-U; HAMILOS DL, 1995, J ALLERGY CLIN IMMUN, V96, P537, DOI 10.1016/S0091-6749(95)70298-9; HARLIN SL, 1988, J ALLERGY CLIN IMMUN, V81, P867, DOI 10.1016/0091-6749(88)90944-X; HASLETT C, 1992, CLIN SCI, V83, P639, DOI 10.1042/cs0830639; Jankowski R, 1996, ACTA OTO-LARYNGOL, V116, P160, DOI 10.3109/00016489609137813; Kodama T, 1998, CLIN EXP ALLERGY, V28, P1435; Lane SJ, 1997, INT ARCH ALLERGY IMM, V113, P193, DOI 10.1159/000237544; Luttmann W, 1998, EUR J IMMUNOL, V28, P2057, DOI 10.1002/(SICI)1521-4141(199807)28:07<2057::AID-IMMU2057>3.0.CO;2-T; Meagher LC, 1996, J IMMUNOL, V156, P4422; Minshall EM, 1997, AM J RESP CELL MOL, V17, P683, DOI 10.1165/ajrcmb.17.6.2865; MIYASHITA T, 1995, CELL, V80, P293; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; Okada S, 1998, J IMMUNOL, V160, P4010; Okudaira H, 1998, INT ARCH ALLERGY IMM, V117, P11, DOI 10.1159/000023985; SIMON HU, 1995, IMMUNOL TODAY, V16, P53, DOI 10.1016/0167-5699(95)80086-7; Simon HU, 1997, J IMMUNOL, V158, P3902; Sousa AR, 1997, AM J RESP CRIT CARE, V156, P1384, DOI 10.1164/ajrccm.156.5.9702072; Stern M, 1996, AM J PATHOL, V149, P911; STERN M, 1992, J IMMUNOL, V148, P3543; Strasser A, 1998, NAT MED, V4, P21, DOI 10.1038/nm0198-021; Sugimoto C, 1999, INT J CANCER, V82, P860, DOI 10.1002/(SICI)1097-0215(19990909)82:6<860::AID-IJC15>3.0.CO;2-6; Tsuyuki S, 1995, J CLIN INVEST, V96, P2924, DOI 10.1172/JCI118364; Vignola AM, 1999, J ALLERGY CLIN IMMUN, V103, P563, DOI 10.1016/S0091-6749(99)70225-3; Walsh GM, 1997, CLIN EXP ALLERGY, V27, P482, DOI 10.1111/j.1365-2222.1997.tb00735.x; Wedi B, 1997, J ALLERGY CLIN IMMUN, V100, P536, DOI 10.1016/S0091-6749(97)70147-7; Woolley KL, 1996, AM J RESP CRIT CARE, V154, P237, DOI 10.1164/ajrccm.154.1.8680686	34	16	18	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2000	106	3					551	558						8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	356YN	10984377				2022-12-18	WOS:000089471900020
J	Hirsch, T; Neumeister, V; Weiland, SK; von Mutius, E; Hirsch, D; Grafe, H; Duhme, H; Leupold, W				Hirsch, T; Neumeister, V; Weiland, SK; von Mutius, E; Hirsch, D; Grafe, H; Duhme, H; Leupold, W			Traffic exposure and allergic sensitization against latex in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						traffic; road dust; rubber tires; wheels; latex particles; allergic sensitization; children; International Study of Asthma and Allergies in Childhood	CHRONIC RESPIRATORY SYMPTOMS; AIR-POLLUTION; AIRBORNE PARTICLES; PREVALENCE; HEALTH; IGE; EXHAUST; ASTHMA; DENSITY; GERMANY	Background: Latex antigens have been found in urban air samples and in debris deposited near freeways. Objective: We investigated whether exposure to road traffic in a large city is associated with allergic sensitization against latex in children. Methods: A population-based sample of 2505 children aged 5 to 11 years was examined in a cross-sectional study in the city of Dresden, Germany. Specific IgE levels against latex and a panel of common aeroallergens (timothy grass, rye, birch, mugwort, Cladosporium herbarum, Dermatophagoides pteronyssinus, cat dander, and dog dander) was determined by using a fluorescence immunoassay (CAP Pharmacia). Traffic exposure was assessed by (1) parental self-report on traffic frequency and truck traffic in the street of residence, (2) traffic counts, and (3) measurements of benzene at 182 points on a 1-km(2) grid for 1 year, which were used to estimate the children's individual exposure at the home address. Results: Eight hundred fifty-four (34.1%) of the children were sensitized against any of the allergens, and 150 (6.0%) had specific IgE (>0.35 kU/L) against latex. The prevalence of latex sensitization was not positively associated with self-reported traffic exposure, traffic counts in the street of residence (adjusted prevalence odds ratio for >5000 vs less than or equal to 5000 cars/d, 0.7; 95% confidence interval, 0.4-1.3), or benzene exposure (adjust ed prevalence odds ratio for an increase of 1 mu g/m(3) air, 0.8; 95% confidence interval, 0.7-1.05). Conclusion: The data suggest that exposure to road traffic is not associated with allergic sensitization to latex in children.	Tech Univ Dresden, Univ Childrens Hosp, D-8027 Dresden, Germany; Tech Univ Dresden, Inst Clin Chem, D-8027 Dresden, Germany; Tech Univ Dresden, Lab Med, D-8027 Dresden, Germany; Univ Munster, Inst Epidemiol & Social Med, D-4400 Munster, Germany; Univ Childrens Hosp Munich, Munich, Germany; Saxon State Author Environm & Geol, Radebeul, Germany	Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technische Universitat Dresden; Technische Universitat Dresden; University of Munster; University of Munich	Hirsch, T (corresponding author), Tech Univ Dresden, Kinderklin, Klinikum Carl Gustav Carus, D-01307 Dresden, Germany.							BAUR X, 1990, LANCET, V335, P912, DOI 10.1016/0140-6736(90)90508-3; Bernardini R, 1998, J ALLERGY CLIN IMMUN, V101, P621, DOI 10.1016/S0091-6749(98)70169-1; Blanco C, 1998, CLIN EXP ALLERGY, V28, P971; BraunFahrlander C, 1997, AM J RESP CRIT CARE, V155, P1042, DOI 10.1164/ajrccm.155.3.9116984; BRAUNFAHRLANDER C, 1992, AM REV RESPIR DIS, V145, P42, DOI 10.1164/ajrccm/145.1.42; BRAUNFAHRLANDER CH, 1998, EPIDEMIOLOGY, V9, pS104; Briggs DJ, 1997, INT J GEOGR INF SCI, V11, P699, DOI 10.1080/136588197242158; Ciccone G, 1998, OCCUP ENVIRON MED, V55, P771, DOI 10.1136/oem.55.11.771; Diaz-Sanchez D, 1999, J ALLERGY CLIN IMMUN, V104, P1183, DOI 10.1016/S0091-6749(99)70011-4; DOCKERY DW, 1989, AM REV RESPIR DIS, V139, P587, DOI 10.1164/ajrccm/139.3.587; Duhme H, 1996, EPIDEMIOLOGY, V7, P578, DOI 10.1097/00001648-199611000-00003; English P, 1999, ENVIRON HEALTH PERSP, V107, P761, DOI 10.2307/3434663; Fuchs T, 1997, J ALLERGY CLIN IMMUN, V100, P356, DOI 10.1016/S0091-6749(97)70249-5; *GES UMW UMW MBH, 1995, 31795 GES UM UMW MBH; *HEUSCH BOES GMBH, EM QUELL VERK, P13; Hirsch T, 1999, EUR RESPIR J, V14, P669, DOI 10.1034/j.1399-3003.1999.14c29.x; *I TROP EV, 1998, FORSCH AUFN ERG OZ D; ISHIZAKI T, 1987, ANN ALLERGY, V58, P265; Kabesch M, 1999, EUR RESPIR J, V13, P577, DOI 10.1183/09031936.99.13357799; Kim KT, 1999, J ALLERGY CLIN IMMUN, V103, P671, DOI 10.1016/S0091-6749(99)70241-1; Liebke C, 1996, PEDIATR ALLERGY IMMU, V7, P103, DOI 10.1111/j.1399-3038.1996.tb00115.x; Miguel AG, 1999, ENVIRON SCI TECHNOL, V33, P4159, DOI 10.1021/es9904890; Miguel AG, 1996, ENVIRON HEALTH PERSP, V104, P1180, DOI 10.2307/3432911; Monn C, 1997, ATMOS ENVIRON, V31, P2243, DOI 10.1016/S1352-2310(97)00030-7; Niggemann B, 1998, J ALLERGY CLIN IMMUN, V102, P665, DOI 10.1016/S0091-6749(98)70285-4; NITTA H, 1993, ARCH ENVIRON HEALTH, V48, P53, DOI 10.1080/00039896.1993.9938393; Oosterlee A, 1996, OCCUP ENVIRON MED, V53, P241, DOI 10.1136/oem.53.4.241; Porri F, 1997, CLIN EXP ALLERGY, V27, P413; Salvi SS, 1999, CLIN EXP ALLERGY, V29, P4; Senna GE, 1999, ALLERGY, V54, P80, DOI 10.1034/j.1398-9995.1999.00982.x; SLATER JE, 1994, J ALLERGY CLIN IMMUN, V94, P139, DOI 10.1016/0091-6749(94)90031-0; SWANSON MC, 1994, J ALLERGY CLIN IMMUN, V94, P445, DOI 10.1016/0091-6749(94)90199-6; vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757; Venuta A, 1999, ALLERGY, V54, P1007, DOI 10.1034/j.1398-9995.1999.00304.x; *VER DURCHF BUND, 1996, VERORDNUNG FESTLEG 1; Vermeulen R, 2000, EPIDEMIOLOGY, V11, P92, DOI 10.1097/00001648-200001000-00020; Weiland SK, 1999, EUR RESPIR J, V14, P862, DOI 10.1034/j.1399-3003.1999.14d23.x; Weiland Stephan K., 1994, Annals of Epidemiology, V4, P243; WILLIAMS PB, 1995, J ALLERGY CLIN IMMUN, V95, P88, DOI 10.1016/S0091-6749(95)70156-7; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596	40	16	17	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2000	106	3					573	578		10.1067/mai.2000.109430	http://dx.doi.org/10.1067/mai.2000.109430			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	356YN	10984380				2022-12-18	WOS:000089471900023
J	Laitinen, LA; Altraja, A; Karjalainen, EM; Laitinen, A				Laitinen, LA; Altraja, A; Karjalainen, EM; Laitinen, A			Early interventions in asthma with inhaled corticosteroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; airways inflammation; inhaled corticosteroid; basement membrane; tenascin; laminin remodelling	BUDESONIDE; BETA-2-AGONIST; TERBUTALINE	We have earlier shown epithelial damage in the airway mucosa in patients with asthma, Later other structural changes have been recognized in asthma, such as deposition of collagen and tenascin in the subepithelial basement membrane and changes in the laminin subchain composition, These processes are modified by an inflammatory process in the airways. Both the United States National Institutes of Health and the British Thoracic Society guidelines on the management of asthma emphasize the need for early use of anti-inflammatory drugs. Many clinical studies that used airway biopsy specimens have shown a decrease in airway inflammatory cell numbers after inhaled corticosteroid therapy. However, there is very little information on the effects of asthma medication on the structural components of the airways. Both the synthesis and degradation of many extracellular matrix components may he affected by the disease process and the drugs resulting in altered remodeling and gene expression in the airways, Because there are only a few studies that try to identify early changes in asthma, it is not known whether the anti-inflammatory treatment of asthma proposed by the guidelines is started early enough.	Univ Helsinki, Cent Hosp, Dept Med, FIN-00029 Helsinki, Finland; Univ Helsinki, Dept Anat, Inst Biomed, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Laitinen, LA (corresponding author), Univ Helsinki, Cent Hosp, Dept Med, POB 341, FIN-00029 Helsinki, Finland.							Altraja A, 1996, AM J RESP CELL MOL, V15, P482, DOI 10.1165/ajrcmb.15.4.8879182; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; Holgate ST, 1996, CLIN EXP ALLERGY, V26, P1; Karjalainen E.-M, 1997, AM J RESP CRIT CARE, V155, pA962; KARJALAINEN EM, 1998, AM J RESP CRIT CAR S, V157, pA98; LAITINEN A, 1997, AM J RESP CRIT CARE, V156, P1; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P696; LOWHAGEN O, 1994, EUR J RESP DIS S, V6, P33; *NIH, 1997, NIH PUBL; *WOODH P ASS LTD, 1996, EARL INT ASTHM START; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	14	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2000	105	2	2	S			S582	S585		10.1016/S0091-6749(00)90062-9	http://dx.doi.org/10.1016/S0091-6749(00)90062-9			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	286JG	10669543				2022-12-18	WOS:000085439600021
J	Kemp, JP; DeGraff, AC; Pearlman, DS; Wang, YH; Arledge, TE; Welch, MB; O'Riordan, TG; Herrle, MR; Stahl, EG				Kemp, JP; DeGraff, AC; Pearlman, DS; Wang, YH; Arledge, TE; Welch, MB; O'Riordan, TG; Herrle, MR; Stahl, EG		Salmeterol Res Grp	A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						salmeterol xinafoate powder; pulmonary function; bronchial hyperresponsiveness; methacholine; placebo; asthma therapy	AIRWAY RESPONSIVENESS; INHALED ALBUTEROL; MODERATE ASTHMA; TOLERANCE; AGONIST; SALBUTAMOL; REACTIVITY; CHILDREN; THERAPY	Background: Long-acting beta(2)-sympathomimetic agonists such as salmeterol have been proved safe and effective for the treatment of asthma, However controversy still exists as to the appropriateness of scheduled long-term therapy with these agents. Objective: This study assessed the degree of bronchodilation provided by treatment with salmeterol for a period of 52 weeks and evaluated bronchial hyperresponsiveness to methacholine during and after the treatment period. Methods: Three hundred fifty-two patients with mild to moderate asthma were assessed by 12-hour serial spirometry and serial methacholine challenge tests. Results: The mean area under the FEV1 curve above baseline over 12 hours after drug at day 1 was significantly greater with salmeterol powder compared with placebo (5.06 liter hours vs 0.77 L/h) and did not change significantly over 1 year. The mean increase in the log(2) of the provocative cumulative methacholine dose producing a 20% decrease in FEV1 (PD20FEV1) during treatment was significantly higher in the salmeterol-treated patients than in the placebo group (1.02 doubling doses vs 0.43 doubling doses at week 4, 1.06 doubling doses vs 0.41 doubling doses at week 24), At week 52 the increase from baseline in log(2)PD(20)FEV(1) was not significantly different between salmeterol and placebo (1.08 vs 0.69 doubling doses), Seven days after treatment the log(2)PD(20)FEV(1) was -0.60 doubling doses lower than baseline for salmeterol compared with 0.10 doubling doses for placebo (P = .031), Longterm salmeterol use was not associated with a deleterious effect on asthma control during and after treatment. Conclusion: This study demonstrates that the bronchodilator properties of salmeterol are sustained over 52 weeks and that bronchial hyperresponsiveness to methacholine is decreased to a modest degree during treatment. Clinically significant increases in hyperresponsiveness did not develop after discontinuation of salmeterol treatment.	Allergy & Asthma Med Grp & Res Ctr, San Diego, CA 92123 USA; Hartford Lung Phys, Hartford, CT USA; Colorado Allergy & Asthma Clin, Aurora, CO USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline	Kemp, JP (corresponding author), Allergy & Asthma Med Grp & Res Ctr, 9610 Granite Ridge Dr,Suite B, San Diego, CA 92123 USA.							BARNES PJ, 1995, AM J RESP CRIT CARE, V152, P838, DOI 10.1164/ajrccm.152.3.7663795; BRINDLEY A, 1995, PHARM TECH EUR, V7, P14; BRITTON MG, 1992, EUR RESPIR J, V5, P1062; BURROWS B, 1992, NEW ENGL J MED, V326, P560, DOI 10.1056/NEJM199202203260809; CHEUNG D, 1992, NEW ENGL J MED, V327, P198; COCKCROFT DW, 1995, AM J RESP CRIT CARE, V152, P1485, DOI 10.1164/ajrccm.152.5.7582281; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; DALONZO GE, 1994, JAMA-J AM MED ASSOC, V271, P1412, DOI 10.1001/jama.271.18.1412; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; GONGORA HC, 1991, AM REV RESPIR DIS, V144, P626, DOI 10.1164/ajrccm/144.3_Pt_1.626; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; JUNIPER EF, 1990, EUR RESPIR J, V3, P1122; MEYER JM, 1993, ANN PHARMACOTHER, V27, P1478, DOI 10.1177/106002809302701214; *NAT ASTHM ED PREV, 1997, GUID DIAGN MAN ASTHM; NATHAN RA, 1995, ANN ALLERG ASTHMA IM, V75, P243; OByrne PM, 1996, NEW ENGL J MED, V335, P886, DOI 10.1056/NEJM199609193351211; OCONNOR BJ, 1992, NEW ENGL J MED, V327, P1204, DOI 10.1056/NEJM199210223271704; PEARLMAN DS, 1992, NEW ENGL J MED, V327, P1420, DOI 10.1056/NEJM199211123272004; PEAT JK, 1994, J CLIN EPIDEMIOL, V47, P1099, DOI 10.1016/0895-4356(94)90096-5; REPSHER LH, 1984, CHEST, V85, P34, DOI 10.1378/chest.85.1.34; ROSENTHAL RR, 1989, ALLERGY PROC, V10, P301, DOI 10.2500/108854189778959867; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; Simons FER, 1997, PEDIATRICS, V99, P655, DOI 10.1542/peds.99.5.655; Simons FER, 1997, NEW ENGL J MED, V337, P1659, DOI 10.1056/NEJM199712043372304; SPIZER W, 1992, NEW ENGL J MED, V326, P501; TATTERSFIELD AE, 1981, THORAX, V36, P561, DOI 10.1136/thx.36.8.561; *UN ENV PROGR, 1997, 1997 MONTR PROT SUBS; VANSCHAYCK CP, 1990, J ALLERGY CLIN IMMUN, V86, P793, DOI 10.1016/S0091-6749(05)80185-X; VANSCHAYCK CP, 1991, BRIT MED J, V303, P1426, DOI 10.1136/bmj.303.6815.1426; VATHENEN AS, 1988, LANCET, V1, P55; VERBERNE AAPH, 1993, J ALLERGY CLIN IMMUN, V91, P127, DOI 10.1016/0091-6749(93)90305-Y; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067; WANNER A, 1995, AM J RESP CRIT CARE, V151, P597; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590; Yates DH, 1996, AM J RESP CRIT CARE, V154, P1603, DOI 10.1164/ajrccm.154.6.8970342	35	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1999	104	6					1189	1197		10.1016/S0091-6749(99)70012-6	http://dx.doi.org/10.1016/S0091-6749(99)70012-6			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266FD	10589000	Bronze			2022-12-18	WOS:000084289200012
J	Loebstein, R; Lalkin, A; Addis, A; Costa, A; Lalkin, I; Bonati, M; Koren, G				Loebstein, R; Lalkin, A; Addis, A; Costa, A; Lalkin, I; Bonati, M; Koren, G			Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						terfenadine; pregnancy outcome; malformations	DIPHENHYDRAMINE; ANTIHISTAMINES; EFFICACY; SAFETY	Background: Terfenadine is a selective, nonsedative, H-1-blocker antihistamine used for a variety of allergic conditions, The widespread popularity of terfenadine and its use by many women in their reproductive age raises concerns regarding its safety during pregnancy. Presently, no prospective controlled study has addressed its safety during gestation, Objective: We sought to determine whether terfenadine use during pregnancy is associated with an increased risk of major malformations, decreased birth weight, perinatal complications, or developmental delays, Methods: A multicenter, prospective controlled study was per formed. Pregnant women exposed to terfenadine during gestation were matched with control subjects exposed to drugs not known to adversely affect pregnancy outcome, The primary end point was the incidence of major malformations. Secondary outcomes of interest were pregnancy outcome, rates of preterm delivery, birth weight, and developmental milestones. Results: One hundred eighteen women were exposed to terfenadine during pregnancy, Among those exposed during the first trimester (n = 65), rates of major malformations in the terfenadine group did not differ from rates in their matched control subjects (0% vs 2%; relative risk, 0.57; 95% confidence interval, 0.06-5.39; P = .53), The birth weight in the terfenadine-exposed newborns was significantly lower compared with that in their matched control subjects (3335 +/- 582 vs 3499 +/- 617 g; P = .04), However, the rates of birth weight below 2500 g and birth weight below the 10th percentile for gestational age were not different between the groups. Univariate and multiple regression analysis revealed that none of the terfenadine therapy-related factors (daily dose, duration of therapy, and trimester of exposure) had a significant predictive effect on birth weight, Gestational age at delivery, rates of preterm deliveries, and developmental milestones sere comparable between the groups. Conclusions: On the basis of the limited sample size of this study, it appears that terfenadine is not associated with a 6-fold or greater increased incidence of major malformations. Terfenadine use during gestation was not associated with increased rates of prematurity or developmental delays. Further studies n ill be needed to confirm the finding of lower birth weight in newborns exposed to terfenadine.	Motherisk Program, Toronto, ON, Canada; Inst Ric Farmacol Mario Negri, Ctr Reg Informaz Farm, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Koren, G (corresponding author), Hosp Sick Children, Div Clin Pharmacol & Toxicol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Addis, Antonio/J-7894-2016; Koren, Gideon/AAG-7726-2019; Addis, Antonio/K-1865-2019; Bonati, Maurizio/K-8980-2016	Addis, Antonio/0000-0003-0962-9959; Koren, Gideon/0000-0002-9234-0875; Addis, Antonio/0000-0003-0962-9959; Bonati, Maurizio/0000-0003-3997-3726				BRIGGS GG, 1994, DRUGS PREGNANCY LACT, P807; Einarson A, 1997, ANN ALLERG ASTHMA IM, V78, P183, DOI 10.1016/S1081-1206(10)63385-6; ESTELLE F, 1994, DRUG SAFETY, V10, P350, DOI 10.2165/00002018-199410050-00002; *HOESCHT MAR ROUSS, 1992, SELD PROD MON; HONIG PK, 1993, CLIN PHARMACOL THER, V53, P630, DOI 10.1038/clpt.1993.83; KALINER MA, 1992, AM FAM PHYSICIAN, V45, P1337; MABRY RL, 1986, SOUTHERN MED J, V79, P965, DOI 10.1097/00007611-198608000-00012; MARDEN PM, 1964, J PEDIATR-US, V64, P357, DOI 10.1016/S0022-3476(64)80188-8; *MM DOW INC, 1990, IMP DRUG WARM; MONAHAN BP, 1990, JAMA-J AM MED ASSOC, V264, P2788, DOI 10.1001/jama.264.21.2788; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Pastuszak A, 1996, J ALLERGY CLIN IMMUN, V98, P748, DOI 10.1016/S0091-6749(96)70122-7; PASTUSZAK A, 1994, MATERNAL FETAL TOXIC, P683; RURAK DW, 1988, J PHARMACOL EXP THER, V247, P271; SAXEN I, 1974, LANCET, V1, P407; Schatz M, 1997, CLIN PERINATOL, V24, P407, DOI 10.1016/S0095-5108(18)30173-8; Schatz M, 1997, ANN ALLERG ASTHMA IM, V78, P157, DOI 10.1016/S1081-1206(10)63382-0; Schick B., 1994, Teratology, V49, P417; SORKIN EM, 1985, DRUGS, V29, P34, DOI 10.2165/00003495-198529010-00002; 1992, PHARM J, V249, P87; 1992, LANCET, V339, P1600	21	16	16	0	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1999	104	5					953	956		10.1016/S0091-6749(99)70074-6	http://dx.doi.org/10.1016/S0091-6749(99)70074-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	257JH	10550738				2022-12-18	WOS:000083778400016
J	Mason, K; Riley, G; Siebers, R; Crane, J; Fitzharris, P				Mason, K; Riley, G; Siebers, R; Crane, J; Fitzharris, P			Hot tumble drying and mite survival in duvets	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Wellington Sch Med, Dept Med, Wellington, New Zealand	University of Otago	Fitzharris, P (corresponding author), Wellington Sch Med, Dept Med, POB 7343, Wellington, New Zealand.		Siebers, Robert/A-4102-2009	Siebers, Robert/0000-0002-6359-3144				BISCHOFF ERC, 1992, EXP APPL ACAROL, V16, P1, DOI 10.1007/BF01201489; KINNAIRD C H, 1974, Acarologia (Paris), V16, P340; Miller J. D., 1996, Journal of Allergy and Clinical Immunology, V97, P423, DOI 10.1016/S0091-6749(96)81180-8; Siebers RW, 1996, CLIN EXP ALLERGY, V26, P1225, DOI 10.1046/j.1365-2222.1996.d01-287.x; Wickens K, 1997, CLIN EXP ALLERGY, V27, P1077, DOI 10.1111/j.1365-2222.1997.tb01260.x	5	16	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1999	104	2	1				499	500		10.1016/S0091-6749(99)70400-8	http://dx.doi.org/10.1016/S0091-6749(99)70400-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	232HH	10452778	Bronze			2022-12-18	WOS:000082364800049
J	Nelson, HS				Nelson, HS			Clinical experience with levalbuterol	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						racemic albuterol; levalbuterol; isomers; bronchodilation; nebulization; asthma; pediatric asthma	STEREOSELECTIVE SULFATE CONJUGATION; BETA-ADRENERGIC RECEPTORS; AIRWAY RESPONSIVENESS; INHALED ALBUTEROL; GUINEA-PIGS; ASTHMA; SALBUTAMOL; HYPERRESPONSIVENESS; BRONCHODILATORS; SUBSENSITIVITY	Although racemic albuterol is an effective bronchodilator, regular use has been associated with some loss of bronchodilator potency, decreased protection against bronchoprovocation, increased sensitivity to allergen challenge, and increased sensitivity to some bronchoconstrictor stimuli. In experimental animals racemic albuterol has produced bronchial hyperresponsiveness, which could also be induced by administration of (S)-albuterol, These findings suggest that the pure or homochiral formulation of (R)-albuterol (levalbuterol) might be more effective as a bronchodilator than the racemic form. Single doses of levalbuterol provided more prolonged protection against methacholine challenge than the racemate, whereas (S)-albuterol significantly increased sensitivity to methacholine, In a l-week study in adults, equivalent amounts of pure levalbuterol provided greater bronchodilation than did similar amounts of levalbuterol given as racemic mixtures. Furthermore, after 4 weeks, the baseline morning FEV1 was lower in those receiving the racemate than in those receiving placebo or levalbuterol. In a single-dose study in children, the same conclusion regarding greater bronchodilation with pure levalbuterol compared with the same amount of levalbuterol in a racemic mixture was confirmed. These studies appear to confirm the greater efficacy of pure levalbuterol over a similar amount in a racemic mixture. This implies a deleterious effect of (S)-albuterol on both the acute bronchodilator response and baseline airway caliber, the exact mechanism of which will require further investigation.	Natl Med & Res Ctr, Dept Med, Denver, CO 80206 USA		Nelson, HS (corresponding author), Natl Med & Res Ctr, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.							AHRENS RC, 1984, AM REV RESPIR DIS, V129, P903; BARNES PJ, 1995, AM J RESP CRIT CARE, V152, P838, DOI 10.1164/ajrccm.152.3.7663795; BRANDON ML, 1978, ANN ALLERGY, V40, P86; Busse WW, 1998, J ALLERGY CLIN IMMUN, V101, P457, DOI 10.1016/S0091-6749(98)70353-7; CHERVINSKY P, 1969, ANN ALLERGY, V27, P611; COCKCROFT DW, 1993, LANCET, V342, P833, DOI 10.1016/0140-6736(93)92695-P; Cockcroft DW, 1996, THORAX, V51, P1051, DOI 10.1136/thx.51.10.1051; CONOLLY ME, 1976, J CLIN INVEST, V58, P1307, DOI 10.1172/JCI108586; Crowther SD, 1997, LANCET, V350, P1450, DOI 10.1016/S0140-6736(05)64212-2; Crowther SD, 1998, INHAL TOXICOL, V10, P923; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Eaton EA, 1996, BRIT J CLIN PHARMACO, V41, P201, DOI 10.1111/j.1365-2125.1996.tb00183.x; Evans DJ, 1997, NEW ENGL J MED, V337, P1412, DOI 10.1056/NEJM199711133372002; Fried KM, 1998, CHIRALITY, V10, P484, DOI 10.1002/(SICI)1520-636X(1998)10:5<484::AID-CHIR11>3.0.CO;2-W; Gauvreau GM, 1997, AM J RESP CRIT CARE, V156, P1738, DOI 10.1164/ajrccm.156.6.96-08042; Gawchik SM, 1999, J ALLERGY CLIN IMMUN, V103, P615, DOI 10.1016/S0091-6749(99)70233-2; Handley D A, 1998, Expert Opin Investig Drugs, V7, P2027, DOI 10.1517/13543784.7.12.2027; Handley D A, 1998, Expert Opin Investig Drugs, V7, P1601, DOI 10.1517/13543784.7.10.1601; HANDLEY DA, 1997, BETA 2 AGONIST ISOME, P61; HOSHIKO K, 1993, JPN J PHARMACOL, V63, P159, DOI 10.1254/jjp.63.159; JENNE JW, 1993, BRONCHIAL ASTHMA MEC, P700; JONES B, 1990, DESIGN ANAL 3 MORE T, P189; Keir SD, 1999, AM J RESP CRIT CARE, V159, pA875; Keir SD, 1999, J ALLERGY CLIN IMMUN, V103, pS10; Leff AR, 1997, PULM PHARMACOL THER, V10, P97, DOI 10.1006/pupt.1997.0082; MAZZONI L, 1994, PULM PHARMACOL, V7, P367, DOI 10.1006/pulp.1994.1043; Nelson HS, 1998, J ALLERGY CLIN IMMUN, V102, P943, DOI 10.1016/S0091-6749(98)70332-X; NELSON HS, 1977, AM REV RESPIR DIS, V116, P871; PERRINFAYOLLE M, 1995, LANCET, V346, P1101, DOI 10.1016/S0140-6736(95)91775-6; Pizzichini MMM, 1997, AM J RESP CRIT CARE, V155, P1501, DOI 10.1164/ajrccm.155.5.9154849; POLGAR G, 1971, PULMONARY FUNCTION T, P272; REPSHER LH, 1984, CHEST, V85, P34, DOI 10.1378/chest.85.1.34; ROWLAND JM, 1981, CURR EYE RES, V1, P25, DOI 10.3109/02713688109019969; SANJAR S, 1990, J PHYSIOL-LONDON, V425, P43, DOI 10.1113/jphysiol.1990.sp018091; SPEIZER FE, 1968, BRIT MED J, V1, P339, DOI 10.1136/bmj.1.5588.339; SUISSA S, 1994, AM J RESP CRIT CARE, V149, P604, DOI 10.1164/ajrccm.149.3.8118625; SUISSA S, 1994, EUR RESPIR J, V7, P1602, DOI 10.1183/09031936.94.07091602; SVEDMYR N, 1982, EUR J RESPIR DIS, V63, P81; SVEDMYR NLV, 1976, CHEST, V69, P479, DOI 10.1378/chest.69.4.479; TAYLOR DR, 1994, THORAX, V49, P190, DOI 10.1136/thx.49.2.190; Templeton AGB, 1998, PULM PHARMACOL THER, V11, P1, DOI 10.1006/pupt.1998.0110; Volcheck GW, 1998, J ALLERGY CLIN IMMUN, V101, pS35; WALLE UK, 1993, BRIT J CLIN PHARMACO, V35, P413, DOI 10.1111/j.1365-2125.1993.tb04159.x; WEBER RW, 1982, J ALLERGY CLIN IMMUN, V70, P417, DOI 10.1016/0091-6749(82)90003-3	44	16	16	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1999	104	2	2	S			S77	S84		10.1016/S0091-6749(99)70277-0	http://dx.doi.org/10.1016/S0091-6749(99)70277-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	233GX	10452792				2022-12-18	WOS:000082419400010
J	Rohrbach, M; Frey, U; Kraemer, R; Liechti-Gallati, S				Rohrbach, M; Frey, U; Kraemer, R; Liechti-Gallati, S			A variant in the gene for GM-CSF, I117T, is associated with atopic asthma in a Swiss population of asthmatic children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; EOSINOPHILS		Univ Bern, Inselspital, Dept Clin Res, CH-3010 Bern, Switzerland; Univ Bern, Inselspital, Dept Pediat, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Rohrbach, M (corresponding author), Univ Bern, Inselspital, Dept Clin Res, CH-3010 Bern, Switzerland.			Rohrbach, Marianne/0000-0002-4013-6012				Gauvreau GM, 1998, AM J RESP CELL MOL, V19, P55, DOI 10.1165/ajrcmb.19.1.2871; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Nagata M, 1998, AM J RESP CELL MOL, V19, P158, DOI 10.1165/ajrcmb.19.1.3001; Park CS, 1998, EUR RESPIR J, V12, P872, DOI 10.1183/09031936.98.12040872; SOMMER CW, 1993, PEDIATR RES, V34, P478, DOI 10.1203/00006450-199310000-00018	5	16	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1999	104	1					247	248		10.1016/S0091-6749(99)70147-8	http://dx.doi.org/10.1016/S0091-6749(99)70147-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	221QZ	10400873				2022-12-18	WOS:000081738900043
J	Fox, RA; Sabo, BMT; Williams, TPW; Joffres, MR				Fox, RA; Sabo, BMT; Williams, TPW; Joffres, MR			Intradermal testing for food and chemical sensitivities: A double-blind controlled study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						diagnostic techniques and procedures; double-blind method; environmental illness; intradermal tests; multiple chemical sensitivity; placebos; provocation neutralization; skin tests		Background: Confirming adverse reactions to foods and chemicals is fundamental in providing a basis for diagnosis and treatment of patients with reported environmental sensitivities. Provocation-neutralization testing is widely used in this respect but has not been thoroughly evaluated, therefore remaining a controversial and unproven technique. Objective: This study investigated the validity of intradermal testing for evaluation of reported adverse reactions to a variety of incidents within the patient population at the Nova Scotia Environmental Health Centre, Methods: A total of 132 people who were referred to the Nova Scotia Environmental Health Centre, a dedicated government-funded research and treatment facility for suspected environmental sensitivities, were tested by the technique of provocation-neutralization by the guidelines set out by the American Academy of Environmental Medicine. A panel of 13 foods, 9 chemicals, and 4 placebos (normal saline solution) was evaluated in a double-blind, randomized study. Symptoms and skin reactions were recorded, and response rates were determined for all substances, including saline solution injections. Results: Seventy percent of the patients reported symptoms to 1 or more of the 4 saline solution injections. In comparison, 15% of patients experienced a skin reaction (wheal) to 1 or more injections of saline solution. Only 5% of individuals experienced a wheal to more than 1 saline solution injection, although 40% of the patients reported symptoms to more than 1 saline injection. Patients who experienced 1 or more reactions (wheal or symptoms) to saline solution were more reactive to injected allergens, on average reacting to 67% of active substances. Patients who experienced no reaction to the saline solution did experience a reaction to 48% of injected substances on average. Reaction by symptoms to foods, chemicals, and normal saline solution showed a random pattern, although wheal reactions showed a distinct pattern. Subsequent observations hare indicated that experiencing no reaction to previous saline solution injections does not accurately predict response to saline solution in later testing. Some individuals who did not experience a reaction to saline solution in an initial screening later experienced a reaction to saline solution during further testing. Conclusions: Provocation of symptoms in usual testing conditions is not a useful tool for discriminating between reactions to saline solution and reactions to specific chemicals or foods. Skin response alone may be a more reliable indicator and will require cross-validation with other tests, such as oral and inhalation challenges and comparison with a control population. Heightened sensitivity and chaotic responses may be a feature of chemical sensitivity. Meanwhile, the results of provocation-neutralization testing, using symptoms alone as an indicator of neutralization, should not be used as a basis for clinical intervention.	Nova Scotia Environm Hlth Ctr, Fall River, NS B2T 1K6, Canada		Fox, RA (corresponding author), Nova Scotia Environm Hlth Ctr, POB 2130, Fall River, NS B2T 1K6, Canada.			Sabo, Brenda/0000-0001-5455-6686				*AAAI TRAIN PROGR, 1994, J ALLERGY CLIN IMMUN, V93, P955; HENNEE WR, 1987, JAMA-J AM MED ASSOC, V258, P1363; JEWETT DL, 1990, NEW ENGL J MED, V323, P429, DOI 10.1056/NEJM199008163230701; KING WP, 1988, OTOLARYNG HEAD NECK, V99, P263, DOI 10.1177/019459988809900301; LEE CH, 1969, ARCH OTOLARYNGOL, V90, P87; Lee CH, 1961, BUCHANAN CO MED B, V25, P9; Meggs WJ, 1996, ARCH ENVIRON HEALTH, V51, P275, DOI 10.1080/00039896.1996.9936026; Miller JB, 1972, FOOD ALLERGY PROVOCA; Missal S C, 1971, Otolaryngol Clin North Am, V4, P479; Nova Scotia Department of Health, 1996, NOV SCOT HLTH SURV 1; REST KM, 1992, P ASS OCC ENV CLIN W; Rietschel R L, 1996, Am J Contact Dermat, V7, P152, DOI 10.1016/S1046-199X(96)90003-2; RINKEL HJ, 1964, ARCHIV OTOLARYNGOL, V79, P71, DOI 10.1001/archotol.79.1.87; vanderVeen MJ, 1996, J ALLERGY CLIN IMMUN, V98, P1028, DOI 10.1016/S0091-6749(96)80187-4; WILLIAMS PB, 1992, J ALLERGY CLIN IMMUN, V89, P738, DOI 10.1016/0091-6749(92)90382-C	15	16	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	1				907	911		10.1016/S0091-6749(99)70437-9	http://dx.doi.org/10.1016/S0091-6749(99)70437-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199FP	10329827				2022-12-18	WOS:000080470200028
J	Spector, S				Spector, S			Ideal pharmacotherapy for allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CROMOGLYCATE; THERAPY	The characteristics of the "ideal" pharmacotherapeutic agent for managing the symptoms of seasonal allergic rhinitis and the advantages and disadvantages of the pharmacotherapeutic agents that are currently available are reviewed. Decongestants, mast cell stabilizers. anticholinergics, intranasal steroids, and oral antihistamines and their place in the therapeutic armamentarium of the clinician are discussed.	Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Spector, S (corresponding author), Calif Allergy & Asthma, 11645 Wilshire Blvd,Suite 1090, Los Angeles, CA 90025 USA.							BJERRUM P, 1985, ALLERGY, V40, P65, DOI 10.1111/j.1398-9995.1985.tb04156.x; BORUM P, 1978, Rhinology (Utrecht), V16, P225; BOUSQUET J, 1990, INSIGHTS ALLERGY, V4, P1; Brown J.H., 1996, GOODMAN GILMANS PHAR, V9th, P141; DRUCE HM, 1988, JAMA-J AM MED ASSOC, V259, P260, DOI 10.1001/jama.259.2.260; DUSHAY ME, 1989, PHARMACOTHERAPY, V9, P338; HILLAS J, 1980, CLIN ALLERGY, V10, P253, DOI 10.1111/j.1365-2222.1980.tb02104.x; KNUTSSON U, 1995, J ENDOCRINOL, V144, P301, DOI 10.1677/joe.0.1440301; LIEBERMAN P, 1988, HOSP PRACT, V23, P117; MELTZER EO, 1987, IMMUNOL ALLERGY CLIN, V7, P57; MYGIND N, 1975, POSTGRAD MED J, V51, P107; Naclerio R, 1997, JAMA-J AM MED ASSOC, V278, P1842, DOI 10.1001/jama.278.22.1842; NACLERIO RM, 1991, NEW ENGL J MED, V325, P860; Nathan RA, 1996, ANN ALLERG ASTHMA IM, V77, P255, DOI 10.1016/S1081-1206(10)63315-7; PHILIP G, 1995, J RESP DIS, V16, P367; Rachelefsky GS, 1998, J ALLERGY CLIN IMMUN, V101, pS236; SPECTOR SL, 1995, J ALLERGY CLIN IMMUN, V95, P1133, DOI 10.1016/S0091-6749(95)70218-0; Wilson AM, 1998, J ALLERGY CLIN IMMUN, V101, P470, DOI 10.1016/S0091-6749(98)70354-9	18	16	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1999	103	3	2	S			S386	S387		10.1016/S0091-6749(99)70217-4	http://dx.doi.org/10.1016/S0091-6749(99)70217-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	179CL	10069898				2022-12-18	WOS:000079305900004
J	Castellazzi, AM; Maccario, R; Moretta, A; De Amici, M; Gasparoni, A; Chirico, G; Rondini, G				Castellazzi, AM; Maccario, R; Moretta, A; De Amici, M; Gasparoni, A; Chirico, G; Rondini, G			Effect of active and passive smoking during pregnancy on natural killer-cell activity in infants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CORD-BLOOD		Univ Pavia, Dept Pediat, I-27100 Pavia, Italy; Policlin San Matteo, IRCCS, Div Neonatal Intens Care, Pavia, Italy; Policlin San Matteo, IRCCS, Lab Bone Marrow Transplantat & Pediat Oncol & Hem, Pavia, Italy	University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia	Castellazzi, AM (corresponding author), Univ Pavia, IRCCS, Policlin San Matteo, Lab Immunol,Clin Pediat, Ple Golgi, I-27100 Pavia, Italy.		De Amici, Mara/AAC-2746-2020	De Amici, Mara/0000-0003-1055-8123; Moretta, Antonia/0000-0001-7040-9715; castellazzi, annamaria/0000-0002-3617-2168				CEDERQVIST LL, 1984, AM J OBSTET GYNECOL, V148, P1123, DOI 10.1016/0002-9378(84)90639-2; CHIRICO G, 1990, J PEDIATR-US, V117, P465, DOI 10.1016/S0022-3476(05)81099-6; MercelinaRoumans PEAM, 1996, J CLIN EPIDEMIOL, V49, P449, DOI 10.1016/0895-4356(95)00542-0; MONTAGNA D, 1988, CLIN EXP IMMUNOL, V71, P177; PAGANELLI R, 1979, CLIN EXP IMMUNOL, V36, P256	5	16	17	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	1				172	173		10.1016/S0091-6749(99)70542-7	http://dx.doi.org/10.1016/S0091-6749(99)70542-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	158JM	9893202	Bronze			2022-12-18	WOS:000078112300026
J	Duplantier, JE; Nelson, RP; Morelli, AR; Good, RA; Kornfeld, SJ				Duplantier, JE; Nelson, RP; Morelli, AR; Good, RA; Kornfeld, SJ			Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Univ S Florida, All Childrens Hosp, Div Allergy & Immunol, St Petersburg, FL 33701 USA; Diagnost Clin, Clearwater, FL USA	State University System of Florida; University of South Florida	Kornfeld, SJ (corresponding author), Univ S Florida, All Childrens Hosp, Div Allergy & Immunol, 801 6th St S, St Petersburg, FL 33701 USA.							AYRES JG, 1995, EUR RESPIR J, V8, P579; HOLLMAN GA, 1988, PEDIATRICS, V81, P452; Tan KS, 1996, CHEST, V109, P343, DOI 10.1378/chest.109.2.343; Thorsson L, 1997, BRIT J CLIN PHARMACO, V43, P155, DOI 10.1046/j.1365-2125.1997.d01-1425.x; Todd G, 1996, LANCET, V348, P27, DOI 10.1016/S0140-6736(96)03339-9	5	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1998	102	4	1				699	700		10.1016/S0091-6749(98)70292-1	http://dx.doi.org/10.1016/S0091-6749(98)70292-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	131XK	9802384				2022-12-18	WOS:000076600400026
J	Zhou, DH; Chen, G; Kim, JT; Lee, LY; Kang, BC				Zhou, DH; Chen, G; Kim, JT; Lee, LY; Kang, BC			A dose-response relationship between exposure to cockroach allergens and induction of sensitization in an experimental asthma in Hartley guinea pigs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	AAAAI/AAI/CIS Joint Meeting	FEB 21-26, 1997	SAN FRANCISCO, CALIFORNIA	AAAAI, AAI, CIS		cockroach allergens; dose-response relationship; passive cutaneous anaphylaxis; bronchoalveolar lavage; airway resistance; airway; smooth muscle contraction; asthma; guinea pig	BRONCHIAL-ASTHMA; ANTIGEN CHALLENGE; INDOOR ALLERGENS; RISK-FACTORS; EPIDEMIOLOGY; INFLAMMATION; PREVALENCE; PROFILE; AIRWAYS; AGENT	Objective: An indoor allergen, cockroach allergen (CRa) has bi?en partly implicated in the rising prevalence of inner-city asthma. This study investigates a dose-response relationship of exposure to CRa with the degree of sensitization and with airway inflammation through the use of our established guinea pig asthma model. Methods: Four groups of Hartley guinea pigs were exposed to aerosolized saline (control) and three dose levels of CRa: low-dose, 0.5 mg (LD); medium-dose, 5 mg (MD); or high-dose, 25 mg (HD), nebulized twice a day, 5 days per week, for 4 weeks. The development of anaphylactic antibodies was measured by both allergy skin test and passive cutaneous anaphylaxis assay. Animals were challenged with CRa 5 days after the last sensitization, and specific airway resistance was measured continuously by a double-chamber plethysmograph while animals were in the conscious state. The inflammatory cells in bronchoalveolar lavage fluid (BALF) and the contractile responses of tracheal rings were analyzed in vitro at 24 hours after CRa challenge. Results: The anaphylactic antibodies to CRa were detected in the CRa-sensitized animals by allergy skin test. Passive cutaneous anaphylaxis titers of IgG(ln)-like antibody were zero in control, 1:2 in LD, 1:40 in MD, and 1:160 in HD. Total leukocytes in BALF were increased by CRa challenge in all three CRa-sensitized groups compared with control (p < 0.0001). The tracheal rings from CRa-sensitized guinea pigs constricted upon addition of incremental doses of CRa challenge in vitro in a dose-responsive manner (p < 0.0001): The leukocytosis in BALF and the anaphylactic contractile responses of the tracheal rings in CRa-sensitized groups were correlated to the levels of CRa to which the groups had been exposed during sensitization (p < 0.001). CRa-provoked increase in SRaw was noted in all three groups of the CRa-sensitized guinea pigs compared with control (p < 0.01). Yet, among CRa-sensitized groups, a greater increase in specific airway resistance was noted in the LD group but not in the HD CRa group. Conclusions: The development of anaphylactic cockroach sensitivity in guinea pigs was dependent on the levels of CRa exposure during sensitization, and the CRa-sensitized animals showed antigen-specific airway inflammation along with airway smooth muscle contractions. However, the severity of bronchospasm in conscious animals,vas not in agreement with the degree of CRa sensitivity.	Univ Kentucky, Dept Internal Med, Div Allergy & Immunol, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Zhou, DH (corresponding author), Univ Kentucky, Dept Internal Med, Div Allergy & Immunol, 800 Rose St, Lexington, KY 40536 USA.							ABE T, 1995, INT ARCH ALLERGY IMM, V106, P78, DOI 10.1159/000236893; ANDERSSON P, 1980, ALLERGY, V35, P65, DOI 10.1111/j.1398-9995.1980.tb01718.x; ANDERSSON SE, 1995, ALLERGY, V50, P349, DOI 10.1111/j.1398-9995.1995.tb01159.x; BERNTON HS, 1967, SOUTH MED J, V60, P852, DOI 10.1097/00007611-196708000-00012; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; CHAND N, 1978, AGENTS ACTIONS, V8, P171, DOI 10.1007/BF01966600; DUPUIS R, 1992, J ALLERGY CLIN IMMUN, V89, P850, DOI 10.1016/0091-6749(92)90441-4; EPPEL G, 1991, DESIGN ANAL RES HDB; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; ISHII A, 1989, INT ARCH ALLER A IMM, V89, P400, DOI 10.1159/000234982; KANG B, 1978, ANN ALLERGY, V41, P333; KANG B, 1976, J ALLERGY CLIN IMMUN, V58, P357, DOI 10.1016/0091-6749(76)90115-9; KANG B, 1979, J ALLERGY CLIN IMMUN, V63, P80, DOI 10.1016/0091-6749(79)90196-9; KANG B, 1989, ANN ALLERGY, V62, P30; KANG BC, 1992, ANN ALLERGY, V68, P237; Kang BC, 1996, INT ARCH ALLERGY IMM, V111, P299, DOI 10.1159/000237381; KANG BC, 1995, INT ARCH ALLERGY IMM, V107, P569, DOI 10.1159/000237101; PERINI A, 1973, IMMUNOLOGY, V25, P297; PLATTSMILLS TAE, 1991, INT ARCH ALLER A IMM, V94, P339, DOI 10.1159/000235398; POLLART SM, 1989, J ALLERGY CLIN IMMUN, V83, P875, DOI 10.1016/0091-6749(89)90100-0; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; SANTING RE, 1994, CLIN EXP ALLERGY, V24, P1157, DOI 10.1111/j.1365-2222.1994.tb03322.x; Sarpong SB, 1996, J ALLERGY CLIN IMMUN, V97, P1393, DOI 10.1016/S0091-6749(96)70209-9; SASAKI H, 1987, AM REV RESPIR DIS, V136, P1459, DOI 10.1164/ajrccm/136.6.1459; SHAVER JR, 1995, AM J RESP CRIT CARE, V152, P1189, DOI 10.1164/ajrccm.152.4.7551369; SPERBER K, 1993, MT SINAI J MED, V60, P227; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; STRETTON D, 1991, CLIN EXP PHARMACOL P, V18, P675, DOI 10.1111/j.1440-1681.1991.tb01380.x; SUGIYAMA H, 1992, J ALLERGY CLIN IMMUN, V89, P858, DOI 10.1016/0091-6749(92)90442-5; UNDERWOOD DC, 1992, AGENTS ACTIONS, V37, P191, DOI 10.1007/BF02028106; WENZEL SE, 1994, ANN ALLERGY, V72, P261	31	16	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1998	101	5					653	659		10.1016/S0091-6749(98)70174-5	http://dx.doi.org/10.1016/S0091-6749(98)70174-5			7	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZN926	9600503	Bronze			2022-12-18	WOS:000073697400014
J	Tashkin, DP				Tashkin, DP			New devices for asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	21st Century Management of Upper Respiratory Allergic Diseases - a Focus on Allergy and Asthma	JAN 13-14, 1997	CHICAGO, IL				METERED-DOSE INHALER; BREATH-ACTUATED INHALER; SPACER DEVICE; MULTIPLE ACTUATIONS; CLINICAL-TRIAL; DRUG-DELIVERY; DEPOSITION; AEROSOL; FLOW; BRONCHODILATOR		Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tashkin, DP (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Pulm & Crit Care Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.							AGERTOFT L, 1994, ARCH DIS CHILD, V71, P217, DOI 10.1136/adc.71.3.217; AHRENS R, 1995, J ALLERGY CLIN IMMUN, V96, P288, DOI 10.1016/S0091-6749(95)70208-3; ARTHUR V, 1992, CLIN TRIAL META-ANAL, V28, P23; BARRY PW, 1994, EUR RESPIR J, V7, P1707, DOI 10.1183/09031936.94.07091707; BENTON G, 1989, AM J DIS CHILD, V143, P678, DOI 10.1001/archpedi.1989.02150180056020; BISGAARD H, 1995, ARCH DIS CHILD, V73, P226, DOI 10.1136/adc.73.3.226; CROMPTON G, 1989, PRACTITIONER, V233, P268; DIGGORY P, 1991, AGE AGEING, V20, P379, DOI 10.1093/ageing/20.5.379; FARR SJ, 1995, THORAX, V50, P639, DOI 10.1136/thx.50.6.639; FERGUSSON RJ, 1991, EUR RESPIR J, V4, P172; GROSSMAN J, 1994, J ASTHMA, V31, P55, DOI 10.3109/02770909409056770; HAYMAN G, 1995, BRIT J CLIN PRACT, P2; Hess D, 1996, CHEST, V110, P498, DOI 10.1378/chest.110.2.498; HILL M, 1996, RESP DRUG DELIVERY, V5, P197; NEWMAN S P, 1991, Respiratory Care, V36, P939; NEWMAN SP, 1981, EUR J RESPIR DIS, V62, P3; NEWMAN SP, 1991, THORAX, V46, P712, DOI 10.1136/thx.46.10.712; NEWMAN SP, 1991, INT J PHARM, V74, P209, DOI 10.1016/0378-5173(91)90239-K; NIDES MA, 1993, CHEST, V104, P501, DOI 10.1378/chest.104.2.501; OCALLAGHAN C, 1993, THORAX, V48, P603, DOI 10.1136/thx.48.6.603; RAND CS, 1992, AM REV RESPIR DIS, V146, P1559, DOI 10.1164/ajrccm/146.6.1559; TASHKIN D, 1995, BRIT J CLIN PRACT, P33; TASHKIN D P, 1991, Respiratory Care, V36, P977; TASHKIN DP, 1995, CHEST, V107, pS176, DOI 10.1378/chest.107.5_Supplement.176S; THORSSON L, 1994, EUR RESPIR J, V7, P1839, DOI 10.1183/09031936.94.07101839	25	16	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	2	S			S409	S416		10.1016/S0091-6749(98)70233-7	http://dx.doi.org/10.1016/S0091-6749(98)70233-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	ZA245	9500741				2022-12-18	WOS:000072343900017
J	Malmstrom, K; Meltzer, E; Prenner, B; Lu, S; Weinstein, S; Wolfe, J; Wei, LX; Reiss, TF				Malmstrom, K; Meltzer, E; Prenner, B; Lu, S; Weinstein, S; Wolfe, J; Wei, LX; Reiss, TF			Effects of montelukast (a leukotriene receptor antagonist), loratadine, montelukast plus loratadine and placebo in seasonal allergic rhinitis and conjunctivitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Merck Res Labs, Rahway, NJ USA	Merck & Company									0	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			406	S97	S97						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800406
J	Moneret-Vautrin, DA; Beaudouin, E; Kanny, G; Guerin, L; Roche, JF				Moneret-Vautrin, DA; Beaudouin, E; Kanny, G; Guerin, L; Roche, JF			Anaphylactic shock caused by ticks (Ixodes ricinus)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AUSTRALIAN PARALYSIS TICK; HOLOCYCLUS; IGE		Ctr Hosp Univ Nancy, Serv Med Med Interne Immun Clin & Allergol, Cent Hosp, F-54035 Nancy, France	CHU de Nancy	Moneret-Vautrin, DA (corresponding author), Ctr Hosp Univ Nancy, Serv Med Med Interne Immun Clin & Allergol, Cent Hosp, 29 Ave De Lattre De Tassigny, F-54035 Nancy, France.		Kanny, Gisèle/AHA-8910-2022					GAUCI M, 1989, CLIN EXP ALLERGY, V19, P279, DOI 10.1111/j.1365-2222.1989.tb02384.x; GAUCI M, 1988, INT ARCH ALLER A IMM, V85, P190, DOI 10.1159/000234501; GRASSI J, 1986, J ALLERGY CLIN IMMUN, V77, P808, DOI 10.1016/0091-6749(86)90378-7; SOLLEY GO, 1990, MED J AUSTRALIA, V153, P650, DOI 10.5694/j.1326-5377.1990.tb126312.x; SPACH DH, 1993, NEW ENGL J MED, V329, P936, DOI 10.1056/NEJM199309233291308	5	16	19	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	1				144	145						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR872	9449522				2022-12-18	WOS:000071539800030
J	Park, HS; Nahm, DH; Suh, CH; Lee, SM; Choi, SY; Jung, KS; Lee, SY; Park, K				Park, HS; Nahm, DH; Suh, CH; Lee, SM; Choi, SY; Jung, KS; Lee, SY; Park, K			Evidence of Hop Japanese pollinosis in Korea: IgE sensitization and identification of allergenic components	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hop Japanese pollen; asthma; specific IgE; immunoblotting		Background: Hop Japanese (Hop J) pollens are abundant in the air of Korea during the autumn season. Their significance as a source of allergic sensitization is still unclear. Objectives: We sought to detect the sensitization rate to Hop J pollen as an inhalant allergen and to identify its allergenic components, Method: We carried out skin prick tests with Hop J pollen extract in 1287 patients with respiratory allergy who visited pur hospital over the course of 1 year. The serum-specific IgE antibody to Hop J pollen antigen was detected by ELISA, and its binding specificity was confirmed by the ELISA inhibition test. To confirm the respiratory sensitization, bronchoprovocation tests were performed in 16 asthmatic patients sensitive to this pollen, To characterize allergenic components, Hop J pollen extract was analyzed by means of sodium dodecylsulfate-polyacrylamide gel electrophoresis followed by IgE immunoblotting. Results: A positive result on the skin prick test (greater than or equal to 2+ of the antigen to histamine ratio) was noted in 79 (6.1%) patients. The serum-specific IgE antibody was detected in 18 (41.9%) patients among 43 positive reactors tested. The ELISA inhibition test with the addition of Hop J pollen extract showed a dose-dependent response. Minimal inhibitions were noted with addition of ragweed and mugwort pollen extracts. Nine asthmatic patients showed significant bronchoconstriction after inhalation of the Hop J pollen extract (five early and four dual asthmatic responders), and all of them had high specific IgE binding. Immunoblot analysis revealed 12 IgE-binding components ranging from 13 to 89 kd. Three bands (13 kd, 74 kd, and 80 kd) were bound to the IgE among the sera tested from more than 50% of the patients. Conclusion: We believe that the Hop J pollen should be considered as a relevant allergen during the autumn season and thus included in skin test batteries in Korea. Some patients diagnosed as having ''intrinsic'' asthma or rhinitis might be sensitized to this pollen and other previously unknown allergens.	AJOU UNIV,SCH MED,DEPT PEDIAT,SUWON 442749,SOUTH KOREA; AJOU UNIV,SCH MED,DEPT OTOLARYNGOL,SUWON 442749,SOUTH KOREA; HALLYM UNIV,SCH MED,DEPT MED,DIV RESP & CRIT CARE,SEOUL,SOUTH KOREA	Ajou University; Ajou University; Hallym University	Park, HS (corresponding author), AJOU UNIV,SCH MED,DEPT ALLERGY & CLIN IMMUNOL,PALDALGU WONCHONDONG SAN 5,SUWON 442749,SOUTH KOREA.		Park, Hae-Sim/S-7974-2019; Jung, Ki-Suck/AAN-2473-2021; Suh, Chang-Hee/H-9723-2019	Suh, Chang-Hee/0000-0001-6156-393X; Park, Hae-Sim/0000-0003-2614-0303				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; KIM SK, 1987, KOREAN J ALLERGY, V9, P224; LEE CB, 1985, ATLAS PLANTS KOREA, P288; NAHM DK, 1988, KOREAN J INTERN MED, V35, P213; *NO SOC ALL, 1972, ACTA ALLERGOL, V27, P439; Park Hae Sim, 1994, Journal of Korean Medical Science, V9, P42; Park HS, 1997, ANN ALLERG ASTHMA IM, V78, P225, DOI 10.1016/S1081-1206(10)63392-3; Park HS, 1996, CLIN EXP ALLERGY, V26, P423, DOI 10.1046/j.1365-2222.1996.d01-331.x	9	16	18	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1997	100	4					475	479		10.1016/S0091-6749(97)70138-6	http://dx.doi.org/10.1016/S0091-6749(97)70138-6			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YA529	9338540				2022-12-18	WOS:A1997YA52900008
J	Hammann, C; Kammerer, R; Gerber, M; Spertini, F				Hammann, C; Kammerer, R; Gerber, M; Spertini, F			Comparison of effects of topical levocabastine and nedocromil sodium on the early response in a conjunctival provocation test with allergen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						levocabastine; nedocromil sodium; allergic conjunctivitis; allergen challenge; provocation test	HISTAMINE-INDUCED CONJUNCTIVITIS; 1-PERCENT NASAL SOLUTION; 0.05-PERCENT LEVOCABASTINE; CHALLENGE MODEL; EYE-DROPS; PLACEBO; ANTIHISTAMINE; CROMOGLYCATE; RHINITIS; CROMOLYN	Background: Multiple ocular challenges or seasonal trials have demonstrated the efficacy of levocabastine and nedocromil sodium in the treatment of allergic conjunctivitis. Objective: This study was designed to compare the protective effect of levocabastine eye drops with that of nedocromil in a conjunctival provocation test with allergen. Methods: Twenty-four patients with allergic conjunctivitis to grass pollen were recruited. After a preliminary provocation to determine conjunctival reaction threshold (erythema of at least 50% of the conjunctiva with ocular itching), patients were randomized to receive either topical levocabastine (0.05%) or nedocromil (2%) 15 minutes before provocation. Erythema and pruritus intensity were recorded at each concentration of allergen lip to the reaction threshold. Results: The allergen concentration level necessary to reach reaction threshold was increased (p < 0.001) after treatment with both drugs. Comparison between screening and each treatment indicated that the shift in allergen concentration was significantly greater after levocabastine treatment than after nedocromil treatment (p = 0.019). Conjunctival itching (symptom score) and erythema (percent conjunctival surface) were also better controlled by levocabastine than by nedocromil during provocation (p < 0.05). Conclusion: In a provocation test with allergen, levocabastine and nedocromil were both effective in increasing the conjunctival tolerance to allergen, with better protection provided by levocabastine.	CHU VAUDOIS,DEPT MED,DIV IMMUNOL & ALLERGOL,CH-1011 LAUSANNE,SWITZERLAND; JANSSEN RES FDN,BAAR,SWITZERLAND	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)								AALBERS R, 1991, J ALLERGY CLIN IMMUN, V87, P993, DOI 10.1016/0091-6749(91)90422-K; ABELSON MB, 1995, OPHTHALMOLOGY, V102, P310; ABELSON MB, 1994, J ALLERGY CLIN IMMUN, V94, P458, DOI 10.1016/0091-6749(94)90201-1; ABRAHAM WM, 1993, J ALLERGY CLIN IMMUN, V92, P171, DOI 10.1016/0091-6749(93)90101-K; AZEVEDO M, 1991, CLIN EXP ALLERGY, V21, P689, DOI 10.1111/j.1365-2222.1991.tb03197.x; BARNES PJ, 1995, CLIN EXP ALLERGY, V25, P71; CHURCH MK, 1993, J ALLERGY CLIN IMMUN, V92, P177, DOI 10.1016/0091-6749(93)90102-L; CIPRANDI G, 1995, J ALLERGY CLIN IMMUN, V95, P612, DOI 10.1016/S0091-6749(95)70324-1; CIPRANDI G, 1993, INT ARCH ALLERGY IMM, V100, P185, DOI 10.1159/000236407; DAVIES BH, 1993, ALLERGY, V48, P519, DOI 10.1111/j.1398-9995.1993.tb01108.x; DECHANT KL, 1991, DRUGS, V41, P202, DOI 10.2165/00003495-199141020-00006; DRUCE HM, 1990, ANN ALLERGY, V65, P212; FEINBERG G, 1987, INT ARCH ALLER A IMM, V82, P537, DOI 10.1159/000234272; KJELLMAN NIM, 1995, ALLERGY, V50, P14, DOI 10.1111/j.1398-9995.1995.tb04252.x; KNIGHT A, 1994, BRIT J CLIN PRACT, V48, P139; LEINO M, 1992, CLIN EXP ALLERGY, V22, P929, DOI 10.1111/j.1365-2222.1992.tb02066.x; MELAMED J, 1994, ANN ALLERGY, V73, P57; MOLLER C, 1984, ALLERGY, V39, P37, DOI 10.1111/j.1398-9995.1984.tb01931.x; RIMAS M, 1990, ALLERGY, V45, P18, DOI 10.1111/j.1398-9995.1990.tb01079.x; SCHULLER DE, 1990, J ALLERGY CLIN IMMUN, V86, P554, DOI 10.1016/S0091-6749(05)80212-X; STOKES TC, 1993, CLIN EXP ALLERGY, V23, P791, DOI 10.1111/j.1365-2222.1993.tb00368.x; VANWAUWE JP, 1989, RHINOCONJUNCTIVITIS, P27; ZUBER P, 1988, J ALLERGY CLIN IMMUN, V82, P590, DOI 10.1016/0091-6749(88)90969-4	23	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	1				1045	1050		10.1016/S0091-6749(96)80189-8	http://dx.doi.org/10.1016/S0091-6749(96)80189-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WB378	8977503				2022-12-18	WOS:A1996WB37800007
J	Holgate, ST				Holgate, ST			The immunopharmacology of mild asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergic inflammation cytokines; mart cell; mild asthma	INHALED ADENOSINE 5'-MONOPHOSPHATE; LOCAL ALLERGEN CHALLENGE; HUMAN MAST-CELLS; BRONCHOALVEOLAR LAVAGE; SODIUM CROMOGLYCATE; TNF-ALPHA; INDUCED BRONCHOCONSTRICTION; ATOPIC ASTHMATICS; NEDOCROMIL SODIUM; RELEASE	If cell numbers, activation state, or mediators, fbr example, can be correlated with some clinical measure of disease severity, a major effector role in the disease may be postulated. Mast cells, along with eosinophils and lymphocytes, are present in inn eased numbers in the airways of patients with asthma. Mast cell mediators are also increased in persons with allergies, with the concentrations of histamine, tryptase, and prostaglandin D-2 being proportional to the degree of airway obstruction and bronchial hyperresponsiveness. Increased numbers of activated mart cells and eosinophils (but not T cells or macrophages) were also found in bronchoalveolar lavage fluid in children. The mast cell is also known to release a range of cytokines (e.g., tumor necrosis factor-alpha and IL-4) that have various important functions, including upregulation of the endothelial adhesion molecules that are responsible for eosinophil recruitment from the microvascular circulation into the airways and subsequent activation. Mast cell staining for secreted IL-4 was found to be proportional to the infiltration of eosinophils and lower airway symptoms in patients with seasonal asthma, which is compatible with the concept that mast cells alone can sustain a continuing allergic inflammatory response. The mart cell proteases chymase and tryptase are also important for eosinophil recruitment and activation and for increasing mucus secretion and microvascular permeability. The evidence that the human mast cell is capable of releasing proteases and cytokines that have the capacity to initiate and maintain a chronic inflammatory response provides a mechanism whereby the clinical efficacy of nedocromil sodium in patients with chronic mild to moderate asthma can be explained.			Holgate, ST (corresponding author), SOUTHAMPTON GEN HOSP,LEVEL D,CTR BLOCK,TREMONA RD,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND.							AVITAL A, 1995, THORAX, V50, P511, DOI 10.1136/thx.50.5.511; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BISSONNETTE EY, 1995, CLIN EXP IMMUNOL, V102, P78; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BRADDING P, 1995, CLIN EXP ALLERGY, V25, P406, DOI 10.1111/j.1365-2222.1995.tb01071.x; BRADDING P, 1995, J IMMUNOL, V155, P297; BRADDING P, 1994, AM J RESP CELL MOL, V10, P471, DOI 10.1165/ajrcmb.10.5.8179909; BRADDING P, 1993, J IMMUNOL, V151, P3853; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; CAIRNS JA, IN PRESS J IMMUNOL; Calhoun WJ, 1996, J ALLERGY CLIN IMMUN, V98, pS46, DOI 10.1016/S0091-6749(96)80128-X; CUSHLEY MJ, 1983, BRIT J CLIN PHARMACO, V15, P161, DOI 10.1111/j.1365-2125.1983.tb01481.x; CUSHLEY MJ, 1985, J ALLERGY CLIN IMMUN, V75, P272, DOI 10.1016/0091-6749(85)90057-0; DELARA JMT, 1994, ANN NY ACAD SCI, V725, P50, DOI 10.1111/j.1749-6632.1994.tb39789.x; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P863, DOI 10.1164/ajrccm/142.4.863; DJUKANOVIC R, 1992, EUR RESPIR J, V5, P538; DJUKANOVIC R, 1991, AM REV RESPIR DIS, V143, P772, DOI 10.1164/ajrccm/143.4_Pt_1.772; DJUKANOVIC R, IN PRESS EUR RESPIR; DJUKANOVIC R, IN PRESS THORAX; DOULL IJM, UNPUB J ALLERGY CLIN; EDWARDS AM, 1994, CLIN EXP ALLERGY, V24, P612, DOI 10.1111/j.1365-2222.1994.tb00964.x; FEOKTISTOV I, IN PRESS J CLIN INVE; FRANKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; GALLI SJ, 1990, LAB INVEST, V62, P5; GORDON JR, 1991, J EXP MED, V174, P103, DOI 10.1084/jem.174.1.103; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; GRATZIOU C, 1992, AM REV RESPIR DIS, V145, P1259, DOI 10.1164/ajrccm/145.6.1259; GRATZIOU C, IN PRESS AM J RESPIR; HEANEY LG, 1994, CLIN EXP ALLERGY, V24, P1991; HUDON C, IN PRESS AM J RESPIR; JAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242; JONES CA, 1995, BIOL REPROD, V52, P839, DOI 10.1095/biolreprod52.4.839; KAY AB, 1994, NEW ENGL J MED, V330, P567, DOI 10.1056/NEJM199402243300811; LIU MC, 1990, AM REV RESPIR DIS, V142, P126, DOI 10.1164/ajrccm/142.1.126; MANNING AM, 1994, ANNU REP MED CHEM, V29, P235; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; MONTEFORT S, 1994, J CLIN INVEST, V93, P1411, DOI 10.1172/JCI117118; OKAYAMA Y, 1994, J IMMUNOL METHODS, V169, P153, DOI 10.1016/0022-1759(94)90259-3; OKAYAMA Y, 1995, J IMMUNOL, V155, P1796; PARE PD, 1995, THORAX, V50, P328, DOI 10.1136/thx.50.4.328; PARK HS, 1995, AM J RESP CRIT CARE, V151, pA240; PHILLIPS GD, 1989, AM REV RESPIR DIS, V139, P463, DOI 10.1164/ajrccm/139.2.463; PHILLIPS GD, 1990, AM REV RESPIR DIS, V141, P9, DOI 10.1164/ajrccm/141.1.9; PHILLIPS GD, 1989, CLIN EXP ALLERGY, V19, P405, DOI 10.1111/j.1365-2222.1989.tb02406.x; PHILLIPS GD, 1989, EUR RESPIR J, V2, P210; POLOSA R, 1995, AM J RESP CRIT CARE, V151, P624; REDINGTON AE, 1995, AM J RESP CRIT CARE, V151, P1034; REDINGTON AE, 1995, J ALLERGY CLIN IMMUN, V95, P377; REDINGTON AE, IN PRESS AM J RESPIR; REDINGTON AE, 1996, AM J RESP CRIT CARE, V151, pA702; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SOMMERHOFF CP, 1989, J IMMUNOL, V142, P2450; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; TERAN LM, IN PRESS AM J RESP C; VICHOW JC, 1995, AM J RESP CRIT CARE, V151, P960; VRUGT B, 1996, J ALLERGY CLIN IMMUN, V98, pA22; WALLS AF, 1993, J ALLERGY CLIN IMMUN, V91, P256; WALLS AF, IN PRESS INT ARCH AL; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; YING S, IN PRESS AM J RESP C; ZHANG S, IN PRESS EUR RESPIR; ZHANG S, IN PRESS J PATHOL	64	16	17	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S7	S16		10.1016/S0091-6749(96)80123-0	http://dx.doi.org/10.1016/S0091-6749(96)80123-0			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939171				2022-12-18	WOS:A1996VW14000003
J	Astarita, C; DiMartino, P; Scala, G; Franzese, A; Sproviero, S				Astarita, C; DiMartino, P; Scala, G; Franzese, A; Sproviero, S			Contact allergy: Another occupational risk to Tetranychus urticae	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Tetranychus urticae; contact urticaria; allergic contact dermatitis; protein contact dermatitis; patch test; open test; allergy	ATOPIC-DERMATITIS; IMMEDIATE; HYPERSENSITIVITY	Background: Tetranychus urticae is a phytophagous, macroscopic mite ubiquitous to warm climates, which causes occupational allergic symptoms in farm workers. Objective: This study was designed to investigate the cause-and mechanisms of an otherwise ''undetermined'' recurrent and occupational dermatitis on the hands of farm workers and to obtain a better diagnostic profile of the urticaria that many farm workers who are allergic to T. urticae experience. Methods: Fifty-six farm workers with occupational cutaneous and/or respiratory symptoms and 10 healthy farm workers underwent in vivo and in vitro diagnostic trials by skin prick testing, serum-specific IgE determination, and three different types of epicutaneous tests. Results: Four of the 10 patients with recurrent dermatitis had a positive IgE reaction to T. urticae, and five of the 10 had a positive patch test response. The percentage of positive patch test responses between subjects with positive T. urticae IgE and those with negative T. urticae IgE was similar. The diagnostic trial allowed the diagnosis of immune-mediated contact dermatitis in seven of the 10 patients with recurrent occupational dermatitis on the hands. The result of the epicutaneous open test on healthy skin with no history of eczema was positive in almost all patients with IgE to T. urticae and episodes of occupational urticaria. Conclusions: Urticaria frequently occurring in farm workers allergic to T. urticae is an allergic contact urticaria. T. urticae is also directly responsible for recurrent dermatitis, caused by a different immune-mediated mechanism, in farm workers.	CTR STUDI PATOL & AMBIENTE,NAPLES,ITALY; UNIV NAPLES 2,SCH MED,DIPARTIMENTO INTERNIST CLIN & SPERIMENTALE F MAGR,MED CLIN,LAB IMMUNOPATOL,NAPLES,ITALY	Universita della Campania Vanvitelli				Astarita, Corrado/0000-0002-6972-466X				ADAMS RM, 1993, DERMATOLOGY GEN MED, P1767; ADAMS RM, 1990, OCCUPATIONAL SKIN DI, P240; ADINOFF AD, 1988, J ALLERGY CLIN IMMUN, V81, P736, DOI 10.1016/0091-6749(88)91047-0; ASTARITA C, 1994, ALLERGY, V49, P466, DOI 10.1111/j.1398-9995.1994.tb00841.x; BARKER JNWN, 1988, J INVEST DERMATOL, V90, P117, DOI 10.1111/1523-1747.ep12462074; BIEBER T, 1990, ANN DERMATOL VENER, V117, P185; BOONK WJ, 1981, DERMATOLOGICA, V163, P151, DOI 10.1159/000250152; BRUJNZEELKOOMEN C, 1986, ARCH DERMATOL RES, V78, P199; CAMPOLMI P, 1982, CONTACT DERMATITIS, V8, P352, DOI 10.1111/j.1600-0536.1982.tb04256.x; DEGROOT AC, 1989, CONTACT DERMATITIS, V21, P209, DOI 10.1111/j.1600-0536.1989.tb03197.x; Gell PGH., 1975, CLIN ASPECTS IMMUNOL, V3; HJORTH N, 1980, CONTACT DERMATITIS, V6, P27, DOI 10.1111/j.1600-0536.1980.tb03885.x; Hjorth N, 1976, Contact Dermatitis, V2, P28, DOI 10.1111/j.1600-0536.1976.tb02975.x; KROOK G, 1977, CONTACT DERMATITIS, V3, P27, DOI 10.1111/j.1600-0536.1977.tb03583.x; LAHTI A, 1978, ALLERGY, V33, P143, DOI 10.1111/j.1398-9995.1978.tb01524.x; MAIBACH HI, 1975, ARCH DERMATOL, V111, P726, DOI 10.1001/archderm.111.6.726; MATHIAS CGT, 1989, J AM ACAD DERMATOL, V20, P842; MITCHELL EB, 1982, LANCET, V1, P27; MUDDE GC, 1990, IMMUNOL TODAY, V11, P440, DOI 10.1016/0167-5699(90)90172-6; PLATTSMILLS TAE, 1983, CLIN EXP DERMATOL, V8, P233, DOI 10.1111/j.1365-2230.1983.tb01776.x; REITAMO S, 1986, BRIT J DERMATOL, V114, P303, DOI 10.1111/j.1365-2133.1986.tb02821.x; SAUDER DN, 1986, PATHOGENESIS SKIN DI, P3; SEIDENARI S, 1992, ANN ALLERGY, V69, P201; von Krogh G, 1982, SEMIN DERMATOL, V1, P59; VONKROGH G, 1982, DERMATOLOGY, P323	25	16	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1996	98	4					732	738		10.1016/S0091-6749(96)70120-3	http://dx.doi.org/10.1016/S0091-6749(96)70120-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VM665	8876547				2022-12-18	WOS:A1996VM66500004
J	Duque, S; delaPuente, J; Rodriguez, F; Pellon, LF; Maquiera, E; Jerez, J				Duque, S; delaPuente, J; Rodriguez, F; Pellon, LF; Maquiera, E; Jerez, J			Zidovudine-related erythroderma and successful desensitization: A case report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME		HOSP SIERRALLANA,ALLERGY UNIT,TORRELAVEGA,SPAIN; UNIV SANTANDER,HOSP MARQUES DE VALDECILLA,ALLERGY UNIT,SANTANDER,SPAIN	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria								CARR A, 1993, J ALLERGY CLIN IMMUN, V91, P683, DOI 10.1016/0091-6749(93)90276-L; JACOBSON MA, 1989, J ACQ IMMUN DEF SYND, V2, P382; LEE MH, 1990, P 6 INT C AIDS SAN F, P2026; MCKINLEY GF, 1990, LANCET, V336, P384, DOI 10.1016/0140-6736(90)91933-2; MORENO JN, 1995, ANN ALLERG ASTHMA IM, V74, P140	5	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1996	98	1					234	235		10.1016/S0091-6749(96)70248-8	http://dx.doi.org/10.1016/S0091-6749(96)70248-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VA692	8765840				2022-12-18	WOS:A1996VA69200029
J	DeCuyper, C; Bogaerts, Y; Vandekerckhove, F; Gunst, J				DeCuyper, C; Bogaerts, Y; Vandekerckhove, F; Gunst, J			Intravaginal desensitization and successful pregnancy in a woman with seminal fluid allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PLASMA		AZ ST JAN BRUGGE,DEPT PNEUMOL,B-8000 RUDDERSHOVE,BRUGGE,BELGIUM; AZ ST JAN BRUGGE,FERTIL CLIN,B-8000 RUDDERSHOVE,BRUGGE,BELGIUM		DeCuyper, C (corresponding author), AZ ST JAN BRUGGE,DEPT DERMATOL,B-8000 RUDDERSHOVE,BRUGGE,BELGIUM.							FRISCH C, 1984, LANCET, V1, P1073; MATLOFF SM, 1993, J ALLERGY CLIN IMMUN, V91, P1230, DOI 10.1016/0091-6749(93)90328-D; OHMAN JL, 1990, J ALLERGY CLIN IMMUN, V85, P103, DOI 10.1016/0091-6749(90)90230-2; SHAPIRO SS, 1981, FERTIL STERIL, V36, P405; SPECKEN, 1958, Ned Tijdschr Verloskd Gynaecol, V58, P314	5	16	19	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1427	1428		10.1016/S0091-6749(96)70219-1	http://dx.doi.org/10.1016/S0091-6749(96)70219-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607	8648047				2022-12-18	WOS:A1996VD60700039
J	Seggev, JS; Lagstein, Z				Seggev, JS; Lagstein, Z			Photosensitivity skin reactions to calcium channel blockers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NIFEDIPINE; DILTIAZEM		UNIV NEVADA,SCH MED,DEPT INTERNAL MED,DIV CARDIOL,LAS VEGAS,NV 89102	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Seggev, JS (corresponding author), UNIV NEVADA,SCH MED,DEPT INTERNAL MED,DIV ALLERGY CLIN IMMUNOL,2040 W CHARLESTON BLVD,SUITE 503,LAS VEGAS,NV 89102, USA.							BARBAUD A, 1993, THERAPIE, V48, P499; BREATHNACH SM, 1992, ADVERSE DRUG REACT, P215; COLLINS P, 1993, BRIT J DERMATOL, V129, P630, DOI 10.1111/j.1365-2133.1993.tb00501.x; GUARRERA M, 1990, PHOTODERMATOL PHOTO, V7, P25; HASHIMOTO M, 1979, ACTA DERMATOL KYOTO, V74, P181; ROMANO A, 1992, ANN ALLERGY, V69, P31; SOUSABASTO A, 1993, CONTACT DERMATITIS, V29, P44, DOI 10.1111/j.1600-0536.1993.tb04541.x; STERN R, 1989, ARCH INTERN MED, V149, P829, DOI 10.1001/archinte.149.4.829; THOMAS SE, 1986, BRIT MED J, V292, P992; VARGAS F, 1991, PHOTODERMATOL PHOTO, V8, P218; ZENAROLA P, 1991, DERMATOLOGICA, V182, P196, DOI 10.1159/000247783	11	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1996	97	3					852	855		10.1016/S0091-6749(96)80164-3	http://dx.doi.org/10.1016/S0091-6749(96)80164-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UA975	8613643				2022-12-18	WOS:A1996UA97500017
J	KORNFELD, SJ; KRATZ, J; HAIRE, RN; LITMAN, GW; GOOD, RA				KORNFELD, SJ; KRATZ, J; HAIRE, RN; LITMAN, GW; GOOD, RA			X-LINKED AGAMMAGLOBULINEMIA PRESENTING AS TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									UNIV S FLORIDA,ALL CHILDRENS HOSP,COLL MED,DEPT PEDIAT,ST PETERSBURG,FL 33701	State University System of Florida; University of South Florida					NIA NIH HHS [AG5628-10] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG005628, R01AG005628] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRUTON OC, 1952, PEDIATRICS, V9, P722; LEICKLEY FE, 1986, CLIN EXP IMMUNOL, V68, P90; OHTA Y, 1994, P NATL ACAD SCI USA, V91, P9062, DOI 10.1073/pnas.91.19.9062; ROSE NR, 1992, MANUAL CLIN LABORATO; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0	5	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1995	95	4					915	917		10.1016/S0091-6749(95)70138-9	http://dx.doi.org/10.1016/S0091-6749(95)70138-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QT468	7722175				2022-12-18	WOS:A1995QT46800020
J	WASSERMAN, SI; FURUKAWA, CT; HENOCHOWICZ, SI; MARCOUX, JP; PRENNER, BM; FINDLAY, SR; GROSS, GN; HUDSON, LD; MYERS, DJ; STEINBERG, P				WASSERMAN, SI; FURUKAWA, CT; HENOCHOWICZ, SI; MARCOUX, JP; PRENNER, BM; FINDLAY, SR; GROSS, GN; HUDSON, LD; MYERS, DJ; STEINBERG, P			ASTHMA SYMPTOMS AND AIRWAY HYPERRESPONSIVENESS ARE LOWER DURING TREATMENT WITH NEDOCROMIL SODIUM THAN DURING TREATMENT WITH REGULAR INHALED ALBUTEROL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NEDOCROMIL SODIUM; ANTIINFLAMMATORY; ALBUTEROL; ASTHMA	BRONCHIAL RESPONSIVENESS; BETA-AGONISTS; TERBUTALINE; MANAGEMENT; INHALATION; SALBUTAMOL; THERAPY	In a double-blind, double-dummy, multicenter study, 212 patients with asthma whose symptoms were not controlled by as-needed use of inhaled bronchodilators were randomized to receive either 4 mg of nedocromil sodium or 180 mu g of albuterol four times daily for 12 weeks. Asthma symptom scores (daytime asthma, nighttime asthma, morning chest tightness, and cough) and peak expiratory flow rate were recorded daily on diary cards. Bronchial hyperresponsiveness was assessed by changes in diurnal variation in peak expiratory flow rate and by methacholine inhalation challenge. Statistically significant differences were found between groups favoring nedocromil sodium for relief of day and nighttime asthma and morning chest tightness. Patients treated with nedocromil sodium also had significantly lower diurnal variation in peak expiratory flow rate compared with patients treated with albuterol. Compared with patients treated with albuterol, patients treated with nedocromil sodium showed a greater improvement in cough and a decreased sensitivity to methacholine challenge. Patients in both groups reduced their as-needed albuterol use. Regular treatment with nedocromil sodium therefore led to greater asthma symptom control and reduced bronchial responsiveness compared with regular treatment with albuterol. The study also showed that more frequent we of a beta(2)-agonist (for symptom relief or not) did nor improve asthma central. Both drugs were well tolerated.	MAYO CLIN & MAYO FDN,DEPT INTERNAL MED ALLERG DIS,ROCHESTER,MN 55905; HARBORVIEW MED CTR,SEATTLE,WA; HENNEPIN CTY MED CTR,MINNEAPOLIS,MN	Mayo Clinic; Harborview Medical Center; Hennepin County Medical Center	WASSERMAN, SI (corresponding author), UNIV CALIF SAN DIEGO,MED CTR,DEPT MED,DIV ALLERGY,402 W DICKINSON ST,SAN DIEGO,CA 92103, USA.							BEL EH, 1990, AM REV RESPIR DIS, V141, P21, DOI 10.1164/ajrccm/141.1.21; BUSSE W W, 1989, Drugs, V37, P1; CALLAGHAN B, 1992, CHEST, V101, P787, DOI 10.1378/chest.101.3.787; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHERNIACK R M, 1990, Chest, V97, P1299; DOWARD AJ, 1986, CLIN ALLERGY, V16, P309; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; KOCH GG, 1990, STATISTICAL METHODOL, P201; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; PATAKAS D, 1988, RESPIRATION, V54, P174, DOI 10.1159/000195518; REBUCK AS, 1990, J ALLERGY CLIN IMMUN, V85, P612, DOI 10.1016/0091-6749(90)90101-9; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; TAYLOR DR, 1993, THORAX, V48, P134, DOI 10.1136/thx.48.2.134; VANSCHAYCK CP, 1990, J ALLERGY CLIN IMMUN, V86, P793, DOI 10.1016/S0091-6749(05)80185-X; VATHENEN AS, 1988, LANCET, V1, P554; WILLIAMS AJ, 1986, EUR J RESPIR DIS, V69, P340; 1992, NIH923091 NAT HEART	19	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1995	95	2					541	547		10.1016/S0091-6749(95)70316-0	http://dx.doi.org/10.1016/S0091-6749(95)70316-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QH697	7852670	Bronze			2022-12-18	WOS:A1995QH69700006
J	OKAYAMA, M; YAMAUCHI, K; SEKIZAWA, K; OKAYAMA, H; SASAKI, H; INAMURA, N; MAEYAMA, K; WATANABE, T; TAKISHIMA, T; SHIRATO, K				OKAYAMA, M; YAMAUCHI, K; SEKIZAWA, K; OKAYAMA, H; SASAKI, H; INAMURA, N; MAEYAMA, K; WATANABE, T; TAKISHIMA, T; SHIRATO, K			LOCALIZATION OF HISTAMINE N-METHYLTRANSFERASE MESSENGER-RNA IN HUMAN NASAL-MUCOSA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HISTAMINE N-METHYLTRANSFERASE; IN SITU HYBRIDIZATION; NASAL MUCOSA	INSITU HYBRIDIZATION; METHYL TRANSFERASE; CELLS; RECEPTORS; EMBRYOS	Background: Histamine is metabolized mainly by histamine N-methyltransferase (HMT) to N-tau-methylhistamine in human nasal mucosa. Human HMT cDNA has been cloned and expressed in COS cells. The purpose of this study was to determine the localization of HMT mRNA in human nasal mucosa. Methods: The fragment (nucleotide residues 430-1055) of human HMT cDNA was subcloned in a Bluescript vector (Stratagene, La Jolla, Calif.), and HMT sense and anti-sense RNA probes were made with T-7 and T-3 RNA polymerases. In situ hybridization with digoxigenin-labeled RNA probes was performed on surgical specimens of human nasal turbinates. Results: HMT mRNA was localized in cells in the epithelium and submucosa, and densely in endothelial cells of vessels. No HMT mRNA was identified in the submucosal glands. The presence of HMT mRNA was confirmed by Northern blot analysis, and HMT activities were also detected in nasal mucosa. Conclusion: Our study indicates that endothelium expresses HMT mRNA, whereas cells in the epithelium and submucosa, which remain unidentified, are on additional source of HMT mRNA.	TOHOKU UNIV,SCH MED,DEPT INTERNAL MED 1,AOBA KU,SENDAI,MIYAGI 980,JAPAN; TOHOKU UNIV,SCH MED,DEPT GERIATR MED,SENDAI,MIYAGI 980,JAPAN; TOHOKU UNIV,SCH MED,DEPT OTORHINOLARYNGOL,SENDAI,MIYAGI 980,JAPAN; TOHOKU UNIV,SCH MED,DEPT PHARMACOL 1,SENDAI,MIYAGI 980,JAPAN	Tohoku University; Tohoku University; Tohoku University; Tohoku University			Yamauchi, Kohei/N-2749-2016					ABE Y, 1993, CLIN EXP ALLERGY, V23, P132, DOI 10.1111/j.1365-2222.1993.tb00308.x; BENSON JR, 1975, P NATL ACAD SCI USA, V72, P619, DOI 10.1073/pnas.72.2.619; BROWN DD, 1959, J BIOL CHEM, V234, P2948; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; FRANCIS D, 1977, BRIT J PHARMACOL, V60, P583, DOI 10.1111/j.1476-5381.1977.tb07538.x; FUKUDA H, 1991, J CHROMATOGR-BIOMED, V567, P459, DOI 10.1016/0378-4347(91)80152-3; FUKUDA T, 1987, BLOOD, V70, P612; GARRISON JC, 1990, PHARMACOL BASIS THER, P575; HADDOCK RC, 1987, J BIOL CHEM, V262, P10220; HESTERBERG R, 1984, AGENTS ACTIONS, V14, P325; HUKKANEN V, 1990, Methods in Molecular and Cellular Biology, V2, P70; IGARASHI Y, 1993, J ALLERGY CLIN IMMUN, V91, P1082, DOI 10.1016/0091-6749(93)90223-3; KALINER M, 1981, J ALLERGY CLIN IMMUN, V68, P365, DOI 10.1016/0091-6749(81)90134-2; KONNO A, 1979, ANN OTO RHINOL LARYN, V88, P258, DOI 10.1177/000348947908800219; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OHRUI T, 1992, J PHARMACOL EXP THER, V261, P1268; OHTANI H, 1992, J HISTOCHEM CYTOCHEM, V40, P1139, DOI 10.1177/40.8.1619278; OKAYAMA M, 1992, J ALLERGY CLIN IMMUN, V89, P1144, DOI 10.1016/0091-6749(92)90298-G; PACIFICI GM, 1992, BRIT J CLIN PHARMACO, V34, P322, DOI 10.1111/j.1365-2125.1992.tb05637.x; RAPHAEL GD, 1989, AM REV RESPIR DIS, V139, P791, DOI 10.1164/ajrccm/139.3.791; SCHAYER RW, 1959, PHYSIOL REV, V39, P116, DOI 10.1152/physrev.1959.39.1.116; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TECOTT LH, 1987, IN SITU HYBRIDIZATIO, P3; TOGIAS A, 1987, J ALLERGY CLIN IMMUN, V79, P599, DOI 10.1016/S0091-6749(87)80155-0; WATANABE T, 1991, HISTAMINERGIC NEURON, P11; YAMATODANI A, 1982, BIOCHEM PHARMACOL, V31, P305; YAMAUCHI K, 1994, AM J PHYSIOL, V127, P342; ZEIGER RS, 1976, J ALLERGY CLIN IMMUN, V58, P172, DOI 10.1016/0091-6749(76)90152-4	30	16	18	1	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	1				96	102		10.1016/S0091-6749(95)70157-5	http://dx.doi.org/10.1016/S0091-6749(95)70157-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QC312	7822670				2022-12-18	WOS:A1995QC31200013
J	FUKUDA, T; NAKAJIMA, H; FUKUSHIMA, Y; AKUTSU, I; NUMAO, T; MAJIMA, K; MOTOJIMA, S; SATO, Y; TAKATSU, K; MAKINO, S				FUKUDA, T; NAKAJIMA, H; FUKUSHIMA, Y; AKUTSU, I; NUMAO, T; MAJIMA, K; MOTOJIMA, S; SATO, Y; TAKATSU, K; MAKINO, S			DETECTION OF INTERLEUKIN-5 MESSENGER-RNA AND INTERLEUKIN-5 PROTEIN IN BRONCHIAL BIOPSIES FROM ASTHMA BY NONRADIOACTIVE IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	New Trends in Immunopharmacology 1993 Conference	JUL   17, 1993	TOKYO, JAPAN			ASTHMA; BRONCHIAL BIOPSY; INTERLEUKIN-5; MESSENGER RNA; EOSINOPHIL; IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY	RECOMBINANT HUMAN INTERLEUKIN-5; COLONY-STIMULATING FACTOR; ALLERGEN INHALATION CHALLENGE; HUMAN EOSINOPHILS; ATOPIC ASTHMA; BRONCHOALVEOLAR LAVAGE; MAST-CELLS; T-CELLS; EXPRESSION; INFLAMMATION	Recently direct evidence for the role of interleukin-5 (IL-5) in eosinophilic inflammation in the radioisotope-labeled IL-5 complementary RNA probes. Radioisotope-labeled probes, although we attempted to detect IL-5 messenger RNA in the bronchial biopsy specimens from patients with asthma using nonradioactive in situ hybridization, which gives rapid results. Bronchial biopsy specimens were obtained from eight patients with asthma and seven diseased control subjects. IL-5 complementary DNA probes were labeled with digoxigenin-deoxyuridine an immunohistochemistry technique. Positive hybridization signals were observed in sir of the eight biopsy specimens fi om patients with asthma. Pretreatment with ribonuclease or hybridization with an unrelated probe produced negative results. Immunohistochemical staining of serial sections with a monoclonal antibody to IL-5 revealed that a few cells within the mucosa positively stained, suggesting active synthesis of IL-5. Biopsy results from the seven diseased control subjects did not show any hybridization signal. These results confirm and asthma, and suggest that digoxigenin-labeled IL-5 complementary DNA probes would be a powerful research tool.	KITASATO UNIV,SCH MED,DEPT PATHOL,SAGAMIHARA,KANAGAWA,JAPAN; UNIV TOKYO,INST MED SCI,DEPT IMMUNOL,TOKYO,JAPAN	Kitasato University; University of Tokyo	FUKUDA, T (corresponding author), DOKKYO UNIV,SCH MED,DEPT INTERNAL MED & CLIN IMMUNOL,MIBU,TOCHIGI 32102,JAPAN.							AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; BENTLEY AM, 1993, AM J RESP CELL MOL, V8, P35, DOI 10.1165/ajrcmb/8.1.35; BRADDING P, 1994, AM J RESP CELL MOL, V10, P471, DOI 10.1165/ajrcmb.10.5.8179909; BROIDE DH, 1992, J CLIN INVEST, V90, P1414, DOI 10.1172/JCI116008; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; CHIHARA J, 1990, J EXP MED, V172, P1347, DOI 10.1084/jem.172.5.1347; CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504; DESREUMAUX P, 1992, J EXP MED, V175, P293, DOI 10.1084/jem.175.1.293; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P863, DOI 10.1164/ajrccm/142.4.863; ENOKIHARA H, 1989, BLOOD, V73, P1809; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUJISAWA T, 1990, J IMMUNOL, V144, P642; GLEICH GJ, 1991, J ALLERGY CLIN IMMUN, V87, P893; HAMID O, 1991, J CLIN INVEST, V87, P1541; HARADA N, 1987, P NATL ACAD SCI USA, V84, P4581, DOI 10.1073/pnas.84.13.4581; HIRASHIMA M, 1992, LYMPHOKINE CYTOK RES, V11, P331; HOEFLER H, 1986, HISTOCHEM J, V18, P597, DOI 10.1007/BF01675295; HOFLER H, 1990, IN SITU HYBRIDIZATIO, P15; HOLTKE HJ, 1990, NUCLEIC ACIDS RES, V18, P5843, DOI 10.1093/nar/18.19.5843; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; MIGITA M, 1991, CELL IMMUNOL, V133, P484, DOI 10.1016/0008-8749(91)90120-Z; MOSER R, 1992, J IMMUNOL, V149, P1432; POSTON RN, 1992, AM REV RESPIR DIS, V145, P918, DOI 10.1164/ajrccm/145.4_Pt_1.918; ROBINSON D, 1993, J ALLERGY CLIN IMMUN, V92, P313, DOI 10.1016/0091-6749(93)90175-F; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; ROTHENBERG ME, 1989, J IMMUNOL, V143, P2311; TSUJIMOTO M, 1989, J BIOCHEM-TOKYO, V106, P23, DOI 10.1093/oxfordjournals.jbchem.a122812; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; WALSH GM, 1990, IMMUNOLOGY, V71, P258; WANG JM, 1989, EUR J IMMUNOL, V19, P701, DOI 10.1002/eji.1830190420	32	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1994	94	3	2	S			584	593		10.1016/0091-6749(94)90134-1	http://dx.doi.org/10.1016/0091-6749(94)90134-1			10	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PH235	8083466				2022-12-18	WOS:A1994PH23500003
J	IKIZAWA, K; KAJIWARA, K; KOSHIO, T; YANAGIHARA, Y				IKIZAWA, K; KAJIWARA, K; KOSHIO, T; YANAGIHARA, Y			POSSIBLE ROLE OF TYROSINE KINASE-ACTIVITY IN INTERLEUKIN 4-INDUCED EXPRESSION OF GERM-LINE C-EPSILON TRANSCRIPTS IN A HUMAN BURKITT-LYMPHOMA B-CELL LINE, DND39	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	New Trends in Immunopharmacology 1993 Conference	JUL   17, 1993	TOKYO, JAPAN			INTERLEUKIN-4; GERM-LINE C-EPSILON TRANSCRIPTS; DND39 CELLS; PHOSPHOLIPASE C-GAMMA-1; TYROSINE KINASE; FYN KINASE; PROTEIN KINASE C	HUMAN LYMPHOCYTES-B; HEAVY-CHAIN; IFN-GAMMA; IL-4; RECEPTOR; CD23; PHOSPHORYLATION; ASSOCIATION; HYDROLYSIS; INDUCTION	Despite the recent advances in knowledge of the molecular mechanism by which interleukin-4 (IL-4) induces IgE production, little is known about the signal transduction pathway that leads to this event. This study investigated the signal transduction mechanism responsible for. IL-4-induced expression of germ-line C epsilon transcripts with use of a human Burkitt lymphoma B-cell line, DND39, which is known to express gem-line C epsilon transcripts in response to IL-4. On stimulation with IL-4, the generation of inositol triphosphate was observed in the cells. In addition, this generation was associated with activation of phospholipase C-gamma 1 (PLC-gamma 1). Although herbimycin A, a potent inhibitor of tryosine kinase, inhibited IL-4-induced activation of PLC-gamma 1 and generation of inositol triphosphate, direct phosphorylation of PCL-gamma 1 was not determined. Nevertheless, IL-4 stimulation Could induce activation of FYN but not LYN kinase, suggesting that additional molecule(s) might link FYN kinase to PLC-gamma 1. Interestingly, herbimycin A almost completely inhibited IL-4-induced expression of germ-line C epsilon transcripts when present during the entire culture period. These results indicate that the induction of germ-line C epsilon transcripts in IL-4-stimulated DND39 cells is essentially dependent on the activation of tyrosine kinase, possibly FYN kinase.	NATL SAGAMIHARA HOSP & RES CTR RHEUMATOL ALLERGY,CLIN RES CTR ALLERGY,SAGAMIHARA,KANAGAWA 228,JAPAN									DELESPESSE G, 1989, J IMMUNOL, V142, P134; FINNEY M, 1990, EUR J IMMUNOL, V20, P151, DOI 10.1002/eji.1830200122; GAUCHAT JF, 1990, J EXP MED, V172, P463, DOI 10.1084/jem.172.2.463; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; ICHIKI T, 1992, INT IMMUNOL, V4, P747, DOI 10.1093/intimm/4.7.747; IZUHARA K, 1993, J BIOL CHEM, V268, P13097; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; ROUSSET F, 1988, J IMMUNOL, V140, P2625; SHIMIZU A, 1993, FASEB J, V7, P149, DOI 10.1096/fasebj.7.1.7916698; SHOKETT P, 1991, J IMMUNOL, V147, P4374; Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631; STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704; VALLE A, 1989, EUR J IMMUNOL, V19, P1463, DOI 10.1002/eji.1830190818; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; YANAGIHARA Y, 1992, INT ARCH ALLERGY IMM, V98, P189, DOI 10.1159/000236184; ZUBER CE, 1990, EUR J IMMUNOL, V20, P551, DOI 10.1002/eji.1830200314	18	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1994	94	3	2	S			620	624		10.1016/0091-6749(94)90138-4	http://dx.doi.org/10.1016/0091-6749(94)90138-4			5	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PH235	8083470				2022-12-18	WOS:A1994PH23500007
J	SALVAGGIO, JE				SALVAGGIO, JE			PSYCHOLOGICAL-ASPECTS OF ENVIRONMENTAL ILLNESS, MULTIPLE CHEMICAL-SENSITIVITY, AND BUILDING-RELATED ILLNESS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Symposium on Building-Related and Home-Related Complaints and Illnesses: Sick Building Syndrome	DEC 03-05, 1992	LAKE BUENA VISTA, FL								SALVAGGIO, JE (corresponding author), TULANE UNIV,MED CTR,1430 TULANE AVE,NEW ORLEANS,LA 70112, USA.							ALEXANDER RW, 1986, J OCCUP ENVIRON MED, V28, P42, DOI 10.1097/00043764-198601000-00011; BARDANA EJ, 1986, SCIENCES, V26, P39; BARDANA JE, 1988, CLIN REV ALLERG, V6, P75; BELL IR, 1992, NEUROPSYCHIATRIC BIO, P89; BOXER PA, 1985, J OCCUP ENVIRON MED, V27, P867; BRODSKY CM, 1987, STATE ART REV OCCUP, V2, P695; CULLEN MR, 1987, OCCUP MED, V2, P655; GUIDOTTI TL, 1987, J OCCUP ENVIRON MED, V29, P148; LETZ GA, 1990, ALLERGY PROC, V3, P109; MEGGS WJ, 1992, INT MED NEWS CARDIOL, V26; OLKINUORA M, 1984, SCAND J WORK ENV HEA, V10, P501, DOI 10.5271/sjweh.2294; RANDOLPH TG, 1976, CLIN ECOLOGY, P9; SCHOUTEN JC, 1987, 9TH P INT C FLUID BE, V2, P749; SIMON GE, 1990, AM J PSYCHIAT, V147, P901; TERR AI, 1986, ARCH INTERN MED, V146, P145	15	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2	2				366	370		10.1016/0091-6749(94)90098-1	http://dx.doi.org/10.1016/0091-6749(94)90098-1			5	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	PG770	8077591				2022-12-18	WOS:A1994PG77000013
J	VEGA, A; CABANAS, R; CONTRERAS, J; CAZANA, JL; SERRANO, CL; PASCUAL, C; ALZAMORA, FM				VEGA, A; CABANAS, R; CONTRERAS, J; CAZANA, JL; SERRANO, CL; PASCUAL, C; ALZAMORA, FM			ANAPHYLAXIS TO METHOTREXATE - A POSSIBLE IGE-MEDIATED MECHANISM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note											VEGA, A (corresponding author), HOSP LA PAZ,ALLERGY UNIT,SANTA GENOVEVA 6-4 1,E-28017 MADRID,SPAIN.							COHN JR, 1993, ANN ALLERGY, V70, P384; DACOSTA M, 1980, CANCER-AM CANCER SOC, V46, P471; GLUCKKUYT I, 1979, CANCER TREAT REP, V63, P797; GOLDBERG NH, 1978, CANCER, V41, P52, DOI 10.1002/1097-0142(197801)41:1<52::AID-CNCR2820410109>3.0.CO;2-P; KLIMO P, 1981, CANCER TREAT REP, V65, P725	5	16	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2					268	270		10.1016/0091-6749(94)90053-1	http://dx.doi.org/10.1016/0091-6749(94)90053-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC926	8064083				2022-12-18	WOS:A1994PC92600022
J	ROLLA, G; BUCCA, C; BRUSSINO, L				ROLLA, G; BUCCA, C; BRUSSINO, L			SYSTEMIC REACTIONS TO INTRAVENOUS IRON THERAPY IN PATIENTS RECEIVING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note											ROLLA, G (corresponding author), UNIV TURIN,DIPARTIMENTO SCI BIOMED & ONCOL UMANA,VIA GENOVA 3,I-10126 TURIN,ITALY.		brussino, luisa/J-2486-2012; Rolla, Giovanni/C-9901-2009; Bucca, Caterina/C-9886-2009	brussino, luisa/0000-0001-7249-7616; Rolla, Giovanni/0000-0001-5997-7172; Bucca, Caterina/0000-0002-9941-9236				CASCIERI MA, 1984, MOL PHARMACOL, V25, P287; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; HAMSTRA RD, 1980, JAMA-J AM MED ASSOC, V243, P1726, DOI 10.1001/jama.243.17.1726; LINDGREN BR, 1989, CHEST, V95, P1225, DOI 10.1378/chest.95.6.1225; SWARTZ SL, 1982, AM J CARDIOL, V49, P1405, DOI 10.1016/0002-9149(82)90351-4	5	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1994	93	6					1074	1075		10.1016/S0091-6749(94)70059-1	http://dx.doi.org/10.1016/S0091-6749(94)70059-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NT172	8006314	Bronze			2022-12-18	WOS:A1994NT17200019
J	BOXER, MB; GRAMMER, LC; ORFAN, N				BOXER, MB; GRAMMER, LC; ORFAN, N			GUTTA-PERCHA ALLERGY IN A HEALTH-CARE WORKER WITH LATEX ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									LONG ISL JEWISH MED CTR,GREAT NECK,NY; NORTHWESTERN UNIV,SCH MED,DEPT ALLERGY & IMMUNOL,CHICAGO,IL; COLUMBIA UNIV,MARY IMOGENE BASSETT HOSP,SCH MED,COOPERSTOWN,NY	Northwell Health; Northwestern University; Columbia University				Grammer, Leslie/0000-0001-6860-2014				DECORRES LF, 1993, ANN ALLERGY, V70, P35; MRAIHI L, 1991, J ALLERGY CLIN IMMUN, V87, P129, DOI 10.1016/0091-6749(91)90224-C; SLATER JE, 1992, ANN ALLERGY, V68, P203; WEINE FS, 1982, ENDODONTIC THERAPY, P345	4	16	17	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1994	93	5					943	944		10.1016/0091-6749(94)90389-1	http://dx.doi.org/10.1016/0091-6749(94)90389-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NL919	8182237				2022-12-18	WOS:A1994NL91900020
J	YLONEN, J; VIRTANEN, T; HORSMANHEIMO, L; PARKKINEN, S; PELKONEN, J; MANTYJARVI, R				YLONEN, J; VIRTANEN, T; HORSMANHEIMO, L; PARKKINEN, S; PELKONEN, J; MANTYJARVI, R			AFFINITY PURIFICATION OF THE MAJOR BOVINE ALLERGEN BY A NOVEL MONOCLONAL-ANTIBODY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CROSSED RADIO-IMMUNOELECTROPHORESIS; IDENTIFICATION; EXTRACTS; URINE; DOG; STANDARDIZATION; IMMUNOASSAY; INHIBITION; RESPONSES; ANTIGENS	A monoclonal antibody was developed to the 20 kd major allergen of cow by immunizing mice with crude dander extract. The monoclonal antibody did not exhibit cross-reactivity to cat, dog, and horse dander extracts when studied by ELISA inhibition. The antibody was used in affinity chromatography for the purification of the 20 kd allergen from cow dander extract. Purity of the allergen was estimated to be 88%, and allergenic reactivity was verified by IgE immunoblotting and skin prick tests. After further purification with size-exclusion chromatography, the allergen was almost 100% pure. The isoelectric point of the double-purified allergen was determined to be 4.1. The amino acid composition was characterized by the predominance of acidic amino acids.	UNIV KUOPIO,DEPT DERMATOL,KUOPIO,FINLAND	University of Eastern Finland	YLONEN, J (corresponding author), UNIV KUOPIO,DEPT CLIN MICROBIOL,POB 1627,SF-70211 KUOPIO,FINLAND.							AAS K, 1972, ACTA ALLERGOL, V27, P439; BLANDS J, 1977, ACTA ALLERGOL, V32, P147, DOI 10.1111/j.1398-9995.1977.tb01346.x; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; DREBORG S, 1992, ALLERGY, V47, P418, DOI 10.1111/j.1398-9995.1992.tb02082.x; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; FORD AW, 1989, CLIN EXP ALLERGY, V19, P183, DOI 10.1111/j.1365-2222.1989.tb02362.x; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; HOIBY N, 1984, SCAND J IMMUNOL, V17, P125; JAROLIM E, 1989, INT ARCH ALLER A IMM, V90, P54, DOI 10.1159/000235000; KRILIS S, 1983, J ALLERGY CLIN IMMUN, V71, P261, DOI 10.1016/0091-6749(83)90079-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMAO J, 1992, MOL IMMUNOL, V29, P205, DOI 10.1016/0161-5890(92)90101-3; LIN ZW, 1990, INT ARCH ALLER A IMM, V91, P217, DOI 10.1159/000235120; LOMBARDERO M, 1992, J ALLERGY CLIN IMMUN, V89, P884, DOI 10.1016/0091-6749(92)90445-8; LOWENSTEIN H, 1976, INT ARCH ALLER A IMM, V51, P48, DOI 10.1159/000231578; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MUELLER UW, 1986, J IMMUNOL METHODS, V87, P193, DOI 10.1016/0022-1759(86)90530-2; PRAHL P, 1982, INT ARCH ALLER A IMM, V67, P293, DOI 10.1159/000233036; RAUTALAHTI M, 1987, EUR J RESPIR DIS, V71, P155; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIANDER M, 1983, INT ARCH ALLER A IMM, V71, P252, DOI 10.1159/000233399; YLONEN J, 1992, CLIN EXP ALLERGY, V22, P83, DOI 10.1111/j.1365-2222.1992.tb00118.x; YLONEN J, 1990, ALLERGY, V45, P30, DOI 10.1111/j.1398-9995.1990.tb01081.x	23	16	16	0	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1994	93	5					851	858		10.1016/0091-6749(94)90377-8	http://dx.doi.org/10.1016/0091-6749(94)90377-8			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NL919	8182227	Bronze			2022-12-18	WOS:A1994NL91900008
J	ANIBARRO, B; GARCIAARA, C; OJEDA, JA				ANIBARRO, B; GARCIAARA, C; OJEDA, JA			BIRD-EGG SYNDROME IN CHILDHOOD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									LA PAZ HOSP, ALLERGOL SERV, MADRID, SPAIN	Hospital Universitario La Paz								BAUSELA BA, 1991, ALLERGY, V46, P614, DOI 10.1111/j.1398-9995.1991.tb00632.x; CARMONA JGB, 1992, ALLERGY, V47, P190, DOI 10.1111/j.1398-9995.1992.tb00964.x; MAATBLEEKER F, 1985, ANN ALLERGY, V54, P245; MANDALLAZ MM, 1988, INT ARCH ALLER A IMM, V87, P143, DOI 10.1159/000234664; PAULI G, 1992, ACI NEWS, V4, P43	5	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1993	92	4					628	630		10.1016/0091-6749(93)90089-X	http://dx.doi.org/10.1016/0091-6749(93)90089-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MC590	8409123				2022-12-18	WOS:A1993MC59000017
J	PELIKAN, Z; KNOTTNERUS, I				PELIKAN, Z; KNOTTNERUS, I			INHIBITION OF THE LATE ASTHMATIC RESPONSE BY NEDOCROMIL SODIUM ADMINISTERED MORE THAN 2 HOURS AFTER ALLERGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						LATE ASTHMATIC RESPONSE; EFFECTS OF NEDOCROMIL SODIUM	BRONCHIAL ANTIGEN CHALLENGE; BECLOMETHASONE DIPROPIONATE; DISODIUM-CROMOGLYCATE; INDUCED BRONCHOCONSTRICTION; AIRWAY INFLAMMATION; HOUSE DUST; MAST-CELLS; RESPONSIVENESS; PROVOCATION; IMMEDIATE	Fourteen adult patients with bronchial asthma who were known late responders to bronchial allergen challenge were entered into a double-blind crossover study to compare the protective effects of nedocromil sodium (3 x 4 mg) and placebo aerosols on the late asthmatic response (LAR). After screening for development of an LAR (fall in forced expiratory volume in 1 second [FEV1] greater-than-or-equal-to 20% at at least 3 consecutive time points, 4 to 10 hours after challenge), patients were randomized to test treatment on 2 study days, with an interval of at least 3 days. Nine of the patients had a dual late response, which is a combination of an immediate and a late response, and five other patients had an isolated late response only. On each study day the concentration of allergen that previously elicited a response was inhaled for 10 minutes. FEV1 was recorded every 10 or 15 minutes for up to 1 hour after challenge, and then at hourly intervals for 12 hours and every second hour on the next 2 days. Test treatments were administered in three doses at 30-minute intervals, with the first dose given 90 minutes before the expected onset of the LAR for each patient. Compared with placebo, nedocromil sodium significantly inhibited the LAR (p < 0.05) at each time point measured from 6 to 10 hours after challenge and reduced the maximum fall in FEV1 by 21.0% overall (p = 0.003).			PELIKAN, Z (corresponding author), INST MED SCI DE KLOKKENBERG,DEPT ALLERGOL & IMMUNOL,GALDERSEWEG 81,4836 AE BREDA,NETHERLANDS.							AUTY RM, 1986, EUR J RESPIR DIS, V69, P120; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BOOIJNOORD H, 1971, J ALLERGY CLIN IMMUN, V48, P344, DOI 10.1016/0091-6749(71)90080-7; BOULET LP, 1990, 1990 ASTHM S MONTR, P91; BRYANT DH, 1977, ASTHMA PHYSL IMMUNOP, P315; CAIRNS H, 1987, INT ARCH ALLER A IMM, V82, P513, DOI 10.1159/000234267; CARTIER A, 1982, J ALLERGY CLIN IMMUN, V70, P170, DOI 10.1016/0091-6749(82)90038-0; CHURCH MK, 1989, DRUGS, V37, P101, DOI 10.2165/00003495-198900371-00018; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; CRIMI E, 1989, J ALLERGY CLIN IMMUN, V83, P985, DOI 10.1016/0091-6749(89)90116-4; CRIMI E, 1986, EUR J RESPIR DIS, V69, P255; DAHL R, 1986, EUR J RESPIR DIS, V69, P263; DEMONCHY JGR, 1990, LATE PHASE ALLERGIC, P257; DURHAM SR, 1986, 12TH P INT C ALL CLI, P229; DURHAM SR, 1990, LATE PHASE ALLERGIC, P185; EADY RP, 1986, EUR J RESPIR DIS, V69, P113; FRIGAS E, 1986, J ALLERGY CLIN IMMUN, V77, P527, DOI 10.1016/0091-6749(86)90341-6; HOLGATE ST, 1986, EUR J RESPIR DIS, V69, P149; HOWARTH PH, 1985, AM REV RESPIR DIS, V132, P986; JOHNSON HG, 1983, ALLERGY PRINCIPLES P, P613; JOSEPH M, 1989, DRUGS, V37, P32, DOI 10.2165/00003495-198900371-00008; KAY AB, 1986, EUR J RESPIR DIS, V69, P38; KAY AB, 1983, 11 P INT C ALL CLIN, P245; KNOTTNERUS I G, 1990, Journal of Allergy and Clinical Immunology, V85, P145; KOCH GG, 1972, BIOMETRICS, V28, P577, DOI 10.2307/2556170; LAM S, 1983, J ALLERGY CLIN IMMUN, V72, P134, DOI 10.1016/0091-6749(83)90520-1; LEIFERMAN KM, 1990, LATE PHASE ALLERGIC, P101; LEUNG KBP, 1986, EUR J RESPIR DIS, V69, P223; MATTOLI S, 1987, J ALLERGY CLIN IMMUN, V79, P747, DOI 10.1016/0091-6749(87)90206-5; METZGER WJ, 1990, LATE PHASE ALLERGIC, P197; MOQBEL R, 1986, EUR J RESPIR DIS, V69, P227; MORRIS HG, 1985, J ALLERGY CLIN IMMUN, V75, P1, DOI 10.1016/0091-6749(85)90002-8; PEARCE FL, 1989, DRUGS, V37, P37, DOI 10.2165/00003495-198900371-00009; PELIKAN Z, 1986, ANN ALLERGY, V56, P421; PELIKAN Z, 1983, CLIN ALLERGY, V13, P203, DOI 10.1111/j.1365-2222.1983.tb02589.x; PELIKAN Z, 1986, ANN ALLERGY, V56, P252; PELIKAN Z, 1988, ANN ALLERGY, V60, P211; PELIKAN Z, 1986, ANN ALLERGY, V56, P414; PELIKAN Z, 1988, ANN ALLERGY, V60, P217; PELIKAN Z, 1991, Journal of Allergy and Clinical Immunology, V87, P249, DOI 10.1016/0091-6749(91)91720-E; PELIKAN Z, 1991, ALLERGY CLIN IMMU S1, P180; PELIKAN Z, 1990, 1990 P ASTHM S MONTR, P40; Pelikan Z, 1990, LATE PHASE ALLERGIC, P499; PELIKAN Z, 1988, N ENGL REGIONAL ALLE, V9, P382; PELIKAN Z, 1990, MEDIATORS AIRWAY HYP, P39; PELIKAN Z, 1992, EUR J ALLERGY CLIN S, V47, P129; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; RAK S, 1986, EUR J RESPIR DIS, V69, P280; RAMSDALE E H, 1984, Journal of Allergy and Clinical Immunology, V73, P123; ROBUSCHI M, 1986, EUR J RESPIR DIS, V69, P286; SPREAFICO F, 1977, COMPREHENSIVE IMMUNO, V3, P245; SPRY CJF, 1986, EUR J RESPIR DIS, V69, P241; WALSH G, 1984, Journal of Allergy and Clinical Immunology, V73, P171; WARNER JO, 1976, ARCH DIS CHILD, V51, P905, DOI 10.1136/adc.51.12.905; YOUNGCHAIYUD P, 1986, EUR J RESPIR DI S147, V69, P30	55	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	1				19	28		10.1016/0091-6749(93)90032-B	http://dx.doi.org/10.1016/0091-6749(93)90032-B			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ353	8393019				2022-12-18	WOS:A1993LQ35300004
J	REISMAN, RE				REISMAN, RE			INTENTIONAL DIAGNOSTIC INSECT STING CHALLENGES - A MEDICAL AND ETHICAL ISSUE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HYMENOPTERA				REISMAN, RE (corresponding author), BUFFALO MED GRP PC,85 HIGH ST,BUFFALO,NY 14203, USA.							BARNARD JH, 1973, J ALLERGY CLIN IMMUN, V52, P259, DOI 10.1016/0091-6749(73)90044-4; BLAAUW PK, 1985, J ALLERGY CLIN IMMUN, V75, P566; PARKER JL, 1982, J ALLERGY CLIN IMMUN, V69, P200, DOI 10.1016/0091-6749(82)90100-2; REISMAN RE, 1992, J ALLERGY CLIN IMMUN, V90, P335, DOI 10.1016/S0091-6749(05)80012-0; SMITH PL, 1980, J CLIN INVEST, V66, P1072, DOI 10.1172/JCI109936	5	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1993	91	5					1100	1100		10.1016/0091-6749(93)90227-7	http://dx.doi.org/10.1016/0091-6749(93)90227-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LC978	8491944	Bronze			2022-12-18	WOS:A1993LC97800021
J	HOSHIKO, K; KRISTERSSON, A; MORLEY, J				HOSHIKO, K; KRISTERSSON, A; MORLEY, J			KETOTIFEN INHIBITS EXACERBATION OF ALLERGIC AIRWAY HYPERREACTIVITY BY RACEMIC SALBUTAMOL IN THE GUINEA-PIG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						KETOTIFEN, HYDROCORTISONE; HYPERREACTIVITY; SALBUTAMOL; LEUKOTRIENE-C(4); BRONCHOSPASM	BRONCHIAL RESPONSIVENESS; ASTHMA; TERBUTALINE	In passively sensitized anesthetized guinea pigs, intravenous infusion of low doses of antigen ovalbumin induced a marked increased responsivity of the airways to intravenous injection of leukotriene C4. Sustained infusion of racemic salbutamol intensified responses to leukotriene C4 both before and after infusion of ovalbumin. Hyperreactivity as a result of infusion of ovalbumin was inhibited by intraduodenal injection of either hydrocortisone or ketotifen at doses that did not diminish responses to leukotriene C4 in animals not exposed to antigen. Ketotifen, but not hydrocortisone, inhibited the enhanced hyperreactivity associated with infusion of racemic salbutamol.	SANDOZ PHARM LTD,DEPT PRECLIN RES,CH-4002 BASEL,SWITZERLAND	Novartis; Sandoz								ANDERSSON P, 1980, BRIT J PHARMACOL, V69, P467, DOI 10.1111/j.1476-5381.1980.tb07036.x; BOUBEKEUR K, 1991, Fundamental and Clinical Pharmacology, V5, P402; BRODDE OE, 1985, J CLIN INVEST, V76, P1096, DOI 10.1172/JCI112063; BRODDE OE, 1992, IN PRESS J CARDIOVAS; CHAPMAN I, 1992, UNPUB ANOMALOUS EFFE; CHAPMAN ID, 1990, BRIT J PHARMACOL, V99, pP66; CONOLLY ME, 1971, BRIT J PHARMACOL, V43, P389; CONOLLY ME, 1987, DRUG THERAPY ASTHMA, P259; CRAPS LP, 1985, BRONCHIAL ASTHMA MEC, P734; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; KOETER GH, 1984, RESPIRATION, V45, P139, DOI 10.1159/000194610; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; MORLEY J, 1989, AGENTS ACTIONS, V26, P31, DOI 10.1007/BF02126555; MORLEY J, 1992, J PHYSIOL-LONDON, V446, pP117; MORLEY J, 1991, BRIT J PHARMACOL, V104, pP295; MORLEY J, 1992, BETA AGONISTS TREATM; PAUWELS R, 1988, J ALLERGY CLIN IMMUN, V81, P674, DOI 10.1016/0091-6749(88)91037-8; REISMAN RE, 1970, J ALLERGY, V46, P162, DOI 10.1016/0021-8707(70)90095-X; SANJAR S, 1990, J PHYSIOL-LONDON, V425, P43, DOI 10.1113/jphysiol.1990.sp018091; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SPEIZER FE, 1968, BRIT MED J, V1, P339, DOI 10.1136/bmj.1.5588.339; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; VATHENEN AS, 1988, LANCET, V1, P554	23	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1993	91	4					909	916		10.1016/0091-6749(93)90349-K	http://dx.doi.org/10.1016/0091-6749(93)90349-K			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KY251	8473680	Bronze			2022-12-18	WOS:A1993KY25100012
J	ESSAYAN, DM; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; HUANG, SK				ESSAYAN, DM; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; HUANG, SK			MODULATION OF ALLERGEN-INDUCED CYTOKINE GENE-EXPRESSION AND PROLIFERATION BY PHOSPHODIESTERASE (PDE) INHIBITORS INVITRO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	16	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				254	254						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100454
J	MAESTRELLI, P; DELPRETE, GF; DECARLI, M; SAETTA, M; DISTEFANO, A; RICCI, M; ROMAGNANI, S; FABBRI, LM				MAESTRELLI, P; DELPRETE, GF; DECARLI, M; SAETTA, M; DISTEFANO, A; RICCI, M; ROMAGNANI, S; FABBRI, LM			ACTIVATED CD8 LYMPHOCYTES-T PRODUCING INTERFERON-GAMMA (IFN-GAMMA) AND INTERLEUKIN-5 (IL-5) IN BRONCHIAL-MUCOSA OF SUBJECTS SENSITIZED TO TOLUENE DIISOCYANATE (TDI)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Fabbri, Leonardo M/I-4055-2012; Di Stefano, Antonino/AAB-8041-2020	Fabbri, Leonardo M/0000-0001-8894-1689; Di Stefano, Antonino/0000-0003-3479-0875					0	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				220	220						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100319
J	MARSHALL, GD; GIBBONS, AS; PARNELL, LS				MARSHALL, GD; GIBBONS, AS; PARNELL, LS			HUMAN CYTOKINES INDUCED BY ACEMANNAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Marshall, Gailen D./R-7459-2019						0	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				295	295						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100619
J	SHELTON, D; URCH, B; TARLO, SM				SHELTON, D; URCH, B; TARLO, SM			OCCUPATIONAL ASTHMA INDUCED BY A CARPET FUNGICIDE - TRIBUTYL TIN OXIDE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									TORONTO HOSP,WESTERN DIV,OCCUPAT LUNG DIS CLIN,ECW 4-008,399 BATHURST ST,TORONTO M5T 2S8,ONTARIO,CANADA; GAGE RES INST,TORONTO,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto			Urch, R. Bruce/C-9162-2014	Tarlo, Susan/0000-0002-4746-5310				Gammeltoft M, 1978, Contact Dermatitis, V4, P238, DOI 10.1111/j.1600-0536.1978.tb03801.x; GOH CL, 1985, CONTACT DERMATITIS, V12, P161, DOI 10.1111/j.1600-0536.1985.tb01086.x; LEWIS PG, 1987, CONTACT DERMATITIS, V7, P129; LYLE W H, 1958, Br J Ind Med, V15, P193; 1976, DHEW NIOSH77115 PUBL	5	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1992	90	2					274	275		10.1016/0091-6749(92)90085-G	http://dx.doi.org/10.1016/0091-6749(92)90085-G			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ423	1500633				2022-12-18	WOS:A1992JJ42300022
J	ANIBARRO, B; CABALLERO, T; GARCIAARA, MC; DIAZPENA, JM; OJEDA, JA				ANIBARRO, B; CABALLERO, T; GARCIAARA, MC; DIAZPENA, JM; OJEDA, JA			ASTHMA WITH SULFITE INTOLERANCE IN CHILDREN - A BLOCKING STUDY WITH CYANOCOBALAMIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						METABISULFITE INTOLERANCE; CYANOCOBALAMIN; ASTHMA; CHILDREN	SODIUM METABISULFITE; SENSITIVITY	Sulfites have been implicated as the cause of bronchospasm in some subjects with asthma. However, there is still no universally accepted explanation of the pathogenesis of these reactions. We have studied five children with asthma with metabisulfite intolerance confirmed by oral challenge testing. The challenge test with metabisulfite was repeated after premedication of all the patients with 1.5 mg of oral cyanocobalamin. In four of the five patients treated with cyanocobalamin, bronchospasm did not develop in the second metabisulfite challenge. The possible mechanisms are discussed.	LA PAZ HOSP,ALLERGOL SERV,MADRID,SPAIN	Hospital Universitario La Paz			Caballero, Teresa/AAU-3982-2020; Caballero, Teresa/H-6454-2014	Caballero, Teresa/0000-0003-3005-9858; Caballero, Teresa/0000-0003-3005-9858				BAKER GJ, 1982, AUST NZ J MED, V12, P213; BOXER MB, 1988, J ALLERGY CLIN IMMUN, V82, P622, DOI 10.1016/0091-6749(88)90974-8; BUSH RK, 1986, J ALLERGY CLIN IMMUN, V78, P191, DOI 10.1016/0091-6749(86)90012-6; BUSH RK, 1986, AM J MED, V81, P816, DOI 10.1016/0002-9343(86)90351-7; FINE JM, 1987, AM REV RESPIR DIS, V136, P1122, DOI 10.1164/ajrccm/136.5.1122; FREDDMAN BJ, 1977, CLIN ALLERGY, V7, P407; JACOBSEN D W, 1984, Journal of Allergy and Clinical Immunology, V73, P135; JAMIESON DM, 1985, ANN ALLERGY, V54, P115; KOEPKE JW, 1985, ANN ALLERGY, V54, P213; NICHOL GM, 1989, THORAX, V44, P1009, DOI 10.1136/thx.44.12.1009; PRENNER BM, 1976, ANN ALLERGY, V37, P180; SIMON R, 1984, Journal of Allergy and Clinical Immunology, V73, P136; SIMON RA, 1986, ANN ALLERGY, V56, P281; SIMON RA, 1987, ANN ALLERGY, V59, P100; SIMON RA, 1988, ALLERGY PRINCIPLES P, P1555; SOKOL WN, 1990, ANN ALLERGY, V65, P233; STEVENSON DD, 1981, J ALLERGY CLIN IMMUN, V68, P26, DOI 10.1016/0091-6749(81)90119-6; STEVENSON DD, 1984, J ALLERGY CLIN IMMUN, V74, P469, DOI 10.1016/0091-6749(84)90380-4; TOWNS SJ, 1984, PEDIATRICS, V73, P631; WOLF SI, 1985, ANN ALLERGY, V54, P420; YANG WH, 1986, J ALLERGY CLIN IMMUN, V78, P443, DOI 10.1016/0091-6749(86)90031-X; 1989, MARTINDALE EXTRA PHA, P1250	22	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1992	90	1					103	109		10.1016/S0091-6749(06)80016-3	http://dx.doi.org/10.1016/S0091-6749(06)80016-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JE255	1629495				2022-12-18	WOS:A1992JE25500012
J	BAROODY, FM; MAJCHEL, AM; ROECKER, MM; ROSZKO, PJ; ZEGARELLI, EC; WOOD, CC; NACLERIO, RM				BAROODY, FM; MAJCHEL, AM; ROECKER, MM; ROSZKO, PJ; ZEGARELLI, EC; WOOD, CC; NACLERIO, RM			IPRATROPIUM BROMIDE (ATROVENT NASAL SPRAY) REDUCES THE NASAL RESPONSE TO METHACHOLINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IPRATROPIUM; METHACHOLINE; NASAL MUCOSA; PERENNIAL RHINITIS	VASOMOTOR RHINITIS; CHRONIC-BRONCHITIS; ELDERLY PATIENTS; TRIAL; RHINORRHEA; PLACEBO; MUCOSA	We investigated the efficacy of local ipratropium bromide on methacholine-induced nasal secretions in a double-blind, placebo-controlled experiment. Twenty subjects with perennial rhinitis received a total intranasal dose of 21, 42, 84, and 168-mu-g of ipratropium bromide or placebo in each nostril. One hour later, filter paper disks were used to deliver increasing doses of methacholine and to collect secretions from the left septum. Concomitantly, symptoms of rhinorrhea and nasal congestion were scored. Compared with doses of placebo, all doses of ipratropium bromide significantly reduced the methacholine-induced increase in nasal secretion weights and symptoms of rhinorrhea (p < 0.01). The highest dose was significantly more effective than the lower doses in reducing secretion weights (p = 0.01). We speculate that ipratropium bromide may prove beneficial for the treatment of rhinorrhea in perennial rhinitis. Furthermore, increasing the delivered dose to 168-mu-g may increase efficacy without augmenting side effects.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV CLIN IMMUNOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,BALTIMORE,MD 21205; BOEHRINGER INGELHEIM PHARMACEUT INC,RIDGEFIELD,CT	Johns Hopkins University; Johns Hopkins University; Boehringer Ingelheim					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL037119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031335] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 37119] Funding Source: Medline; NIAID NIH HHS [AI 31335] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen, 1982, NOSE UPPER AIRWAY PH, P45; ANGGARD A, 1974, ACTA OTO-LARYNGOL, V78, P98, DOI 10.3109/00016487409126332; ANGGARD A, 1977, ACTA OTO-LARYNGOL, V83, P22, DOI 10.3109/00016487709128806; BAROODY F, 1990, AM REV RESPIR DIS, V141, P176; BOK HE, 1983, EUR J RESPIR DIS, V64, P486; Borum P, 1979, Acta Otorhinolaryngol Belg, V33, P528; BORUM P, 1979, CLIN OTOLARYNGOL, V4, P407, DOI 10.1111/j.1365-2273.1979.tb01773.x; BORUM P, 1979, J ALLERGY CLIN IMMUN, V63, P253, DOI 10.1016/0091-6749(79)90109-X; BORUM P, 1979, ACTA OTOLARYNGOL S S, V360, P35; CAUNA N, 1972, J NEUROCYTOL, V1, P49, DOI 10.1007/BF01098645; DOLOVICH J, 1987, J ALLERGY CLIN IMMUN, V80, P274, DOI 10.1016/0091-6749(87)90031-5; FOWLER BP, 1949, ARCH OTOLARYNGOL, V37, P710; GOLDING-WOOD P H, 1961, J Laryngol Otol, V75, P232, DOI 10.1017/S0022215100057716; GOLDINGWOOD PH, 1973, LARYNGOSCOPE, V83, P1673, DOI 10.1288/00005537-197310000-00008; GOLDINGWOOD PH, 1970, LARYNGOSCOPE, V80, P1179, DOI 10.1288/00005537-197008000-00001; GROTH S, 1983, EUR J RESPIR DIS, V64, P490; JOKINEN K, 1983, Rhinology (Utrecht), V21, P341; KNIGHT A, 1986, ANN ALLERGY, V57, P348; KRAJINA Z, 1970, ANN OTO RHINOL LARYN, V79, P1068; MALMBERG H, 1983, CLIN OTOLARYNGOL, V8, P273, DOI 10.1111/j.1365-2273.1983.tb01441.x; OKUDA M, 1977, ORL DIGEST, V39, P22; PAKES GE, 1980, DRUGS, V20, P237, DOI 10.2165/00003495-198020040-00001; POPPIUS H, 1973, BMJ-BRIT MED J, V4, P134, DOI 10.1136/bmj.4.5885.134; SJOGREN I, 1988, ACTA OTO-LARYNGOL, V106, P453, DOI 10.3109/00016488809122270; SPEKTOR S, 1975, CHEST, V68, P426; Starr I, 1933, AM J MED SCI, V186, P313, DOI 10.1097/00000441-193309000-00001; UDDMAN R, 1981, Rhinology (Utrecht), V19, P75; VANMEGEN YJB, 1991, J ALLERGY CLIN IMMUN, V87, P521, DOI 10.1016/0091-6749(91)90011-C; VONHAACKE NP, 1983, BRIT MED J, V287, P1258, DOI 10.1136/bmj.287.6401.1258-a; WIESER O, 1975, POSTGRAD MED J, V51, P125	30	16	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1992	89	6					1065	1075		10.1016/0091-6749(92)90290-I	http://dx.doi.org/10.1016/0091-6749(92)90290-I			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HZ748	1535082				2022-12-18	WOS:A1992HZ74800001
J	BRITTON, J				BRITTON, J			AIRWAY HYPERRESPONSIVENESS AND THE CLINICAL-DIAGNOSIS OF ASTHMA - HISTAMINE OR HISTORY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							BRONCHIAL SYMPTOMS QUESTIONNAIRE; RANDOM-POPULATION SAMPLE; RESPIRATORY SYMPTOMS; INHALED HISTAMINE; PULMONARY-FUNCTION; NEW-ZEALAND; AUSTRALIAN SCHOOLCHILDREN; ADULT-POPULATION; NORMAL INFANTS; LUNG-FUNCTION				BRITTON, J (corresponding author), CITY HOSP,RESP MED UNIT,HUCKNALL RD,NOTTINGHAM NG5 1PB,ENGLAND.		Britton, John R/G-9705-2011					BAKKE PS, 1991, AM REV RESPIR DIS, V143, P317, DOI 10.1164/ajrccm/143.2.317; BARTER CE, 1976, AM REV RESPIR DIS, V113, P305; BRAND PLP, 1991, AM REV RESPIR DIS, V143, P916, DOI 10.1164/ajrccm/143.5_Pt_1.916; BRITTON J, 1986, EUR J RESPIR DIS, V68, P233; BRITTON J, 1988, EUR RESPIR J, V1, P478; BRITTON J, 1986, THORAX, V41, P128, DOI 10.1136/thx.41.2.128; BURNEY P, 1991, CHEST, V6, P79; BURNEY PGJ, 1989, EUR RESPIR J, V2, P940; BURNEY PGJ, 1987, THORAX, V42, P38, DOI 10.1136/thx.42.1.38; BURNEY PGJ, 1989, INT J EPIDEMIOL, V18, P165, DOI 10.1093/ije/18.1.165; CERVERI I, 1989, AM REV RESPIR DIS, V140, P191, DOI 10.1164/ajrccm/140.1.191; CLARK TJH, 1990, RESPIRATORY MED; CLIFFORD RD, 1989, ARCH DIS CHILD, V64, P1133, DOI 10.1136/adc.64.8.1133; COCKCROFT DW, 1983, CHEST, V83, P751, DOI 10.1378/chest.83.5.751; COCKCROFT DW, 1983, EUR J RESPIR DIS, V64, P207; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; COCKCROFT DW, 1992, J ALLERGY CLIN IMMUN, V89, P23, DOI 10.1016/S0091-6749(05)80037-5; COCKCROFT DW, 1990, AM REV RESPIR DIS, V142, P497, DOI 10.1164/ajrccm/142.3.497; COCKCROFT DW, 1984, ANN ALLERGY, V53, P26; CRANE J, 1989, J ALLERGY CLIN IMMUN, V84, P768, DOI 10.1016/0091-6749(89)90307-2; ENARSON DA, 1987, AM REV RESPIR DIS, V136, P613, DOI 10.1164/ajrccm/136.3.613; GERRARD JW, 1980, AM REV RESPIR DIS, V122, P577; HIGGINS BG, 1989, AM REV RESPIR DIS, V140, P1368, DOI 10.1164/ajrccm/140.5.1368; HIGGINS BG, 1988, THORAX, V43, P605, DOI 10.1136/thx.43.8.605; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; KLEIN RC, 1966, J ALLERGY, V37, P158, DOI 10.1016/0021-8707(66)90090-6; LEE DA, 1983, BRIT MED J, V286, P1256, DOI 10.1136/bmj.286.6373.1256; LESOUEF PN, 1989, AM REV RESPIR DIS, V139, P62, DOI 10.1164/ajrccm/139.1.62; MONTGOMERY GL, 1990, AM REV RESPIR DIS, V142, P1372, DOI 10.1164/ajrccm/142.6_Pt_1.1372; MORTAGY AK, 1986, BRIT MED J, V293, P525, DOI 10.1136/bmj.293.6546.525; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; OCONNOR GT, 1989, AM REV RESPIR DIS, V140, P1540; PARKER DR, 1990, AM REV RESPIR DIS, V141, P589, DOI 10.1164/ajrccm/141.3.589; PATTEMORE PK, 1990, AM REV RESPIR DIS, V142, P549, DOI 10.1164/ajrccm/142.3.549; PATTEMORE PK, 1989, THORAX, V44, P168, DOI 10.1136/thx.44.3.168; PEAT JK, 1989, CLIN EXP ALLERGY, V19, P299, DOI 10.1111/j.1365-2222.1989.tb02387.x; QUACKENBOSS JJ, 1991, AM REV RESPIR DIS, V143, P323, DOI 10.1164/ajrccm/143.2.323; RAMSDALE EH, 1984, THORAX, V39, P912, DOI 10.1136/thx.39.12.912; RAMSDELL JW, 1982, AM REV RESPIR DIS, V126, P829; RIJCKEN B, 1988, AM REV RESPIR DIS, V137, P826, DOI 10.1164/ajrccm/137.4.826; RIJCKEN B, 1987, B EUR PHYSIOPATH RES, V23, P391; RIJCKEN B, 1989, AM REV RESPIR DIS, V140, P615, DOI 10.1164/ajrccm/140.3.615; SALOME CM, 1987, CLIN ALLERGY, V17, P271, DOI 10.1111/j.1365-2222.1987.tb02015.x; SCADDING JG, 1983, ASTHMA; SEARS MR, 1986, THORAX, V41, P283, DOI 10.1136/thx.41.4.283; SPARROW D, 1987, AM REV RESPIR DIS, V135, P1255; SPARROW D, 1991, AM REV RESPIR DIS, V143, P978, DOI 10.1164/ajrccm/143.5_Pt_1.978; STEVENS WJ, 1980, EUR J RESPIR DIS, V61, P203; TAYLOR RG, 1985, THORAX, V40, P9, DOI 10.1136/thx.40.1.9; TOWNLEY RG, 1965, J ALLERGY, V36, P121, DOI 10.1016/0021-8707(65)90161-9; VANASPEREN P, 1981, AM J DIS CHILD, V135, P815, DOI 10.1001/archpedi.1981.02130330027009; VARPELA E, 1978, CLIN ALLERGY, V8, P273, DOI 10.1111/j.1365-2222.1978.tb03224.x; WOOLCOCK AJ, 1987, THORAX, V42, P361, DOI 10.1136/thx.42.5.361; YAN K, 1985, AM REV RESPIR DIS, V132, P25; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760; 1962, AM REV RESPIR DIS, V85, P762	56	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	1				19	22		10.1016/S0091-6749(05)80036-3	http://dx.doi.org/10.1016/S0091-6749(05)80036-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ908	1730836				2022-12-18	WOS:A1992GZ90800002
J	MATTHIESEN, F; OLSEN, M; LOWENSTEIN, H				MATTHIESEN, F; OLSEN, M; LOWENSTEIN, H			PURIFICATION AND PARTIAL SEQUENZATION OF THE MAJOR ALLERGEN OF ALTERNARIA-ALTERNATA, ALT-ALPHA-I	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				241	241						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000338
J	LEHRER, SB; HORNER, WE; MENON, PK; OLIVER, J; HAUCK, P				LEHRER, SB; HORNER, WE; MENON, PK; OLIVER, J; HAUCK, P			COCKROACH ALLERGENIC ACTIVITY - ANALYSIS OF COMMERCIAL COCKROACH AND DUST EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						COCKROACH; ALLERGENS; COMMERCIAL EXTRACTS; DUST; SKIN TEST; RAST	HOUSE DUST; BRONCHIAL-ASTHMA; MITE; ANTIGENS; CHILDREN; PURIFICATION; AMERICAN	Previous investigations demonstrated that cockroach whole bodies and feces are important sources of allergens in the induction/exacerbation of bronchial asthma. The current study investigated different cockroach source materials, commercial extracts, and house dust extracts for cockroach allergenic activity. In general, extracts from four different sources of either American or German cockroaches contained similar amounts of allergenic activity by RAST inhibition. Three commercial American cockroach extracts compared by RAST inhibition had similar allergenic activity on an equal protein basis. Skin test results correlated house dust reactivity to both commercial and inhouse cockroach wholebody extracts and to fecal extracts. Six different samples of house dust obtained from vacuum cleaners in the New Orleans area and three commercially obtained house dust extracts contained varying quantities of cockroach allergenic activity by RAST inhibition. These studies demonstrate that commercial cockroach extracts vary in allergenic activity and that all house dust extracts tested contain cockroach allergens.	CTR LABS, PORT WASHINGTON, NY USA		LEHRER, SB (corresponding author), TULANE UNIV, SCH MED, DEPT MED, ALLERGY & CLIN IMMUNOL SECT, NEW ORLEANS, LA 70112 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022918] Funding Source: NIH RePORTER; NIAID NIH HHS [AI22918] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERNTON H S, 1972, British Journal of Diseases of the Chest, V66, P61, DOI 10.1016/S0007-0971(72)80008-1; BERNTON HS, 1970, ANN ALLERGY, V28, P543; CHAPMAN MD, 1988, CHEST, V94, P185, DOI 10.1378/chest.94.1.185; CHOOVIVATHANAVA.P, 1970, LANCET, P1362; CHOOVIVATHANAVANICH P, 1974, J MED ASSOC THAILAND, V57, P237; COLLINSWILLIAMS C, 1976, ANN ALLERGY, V37, P12; DHORRANINTRA B, 1977, ANN ALLERGY, V39, P201; FEINBERG AR, 1956, J ALLERGY, V27, P437, DOI 10.1016/0021-8707(56)90103-4; HALE R, 1987, ANN ALLERGY, V59, P1; HORNER WE, 1990, INT ARCH ALLER A IMM, V93, P256; HULETT AC, 1979, ANN ALLERGY, V42, P160; KABASAWA Y, 1976, ACTA ALLERGOL, V31, P442, DOI 10.1111/j.1398-9995.1976.tb01494.x; KANG B, 1976, J ALLERGY CLIN IMMUN, V58, P357, DOI 10.1016/0091-6749(76)90115-9; KANG BC, 1989, ANN ALLERGY, V63, P207; LEHRER SB, 1991, J ALLERGY CLIN IMMUN, V87, P574, DOI 10.1016/0091-6749(91)90017-I; MANSFIELD LE, 1982, ANN ALLERGY, V48, P205; MENDOZA J, 1970, ANN ALLERGY, V28, P159; MENON V, 1989, J ALLERGY CLIN IMMUN, V83, P265; MORRIS EC, 1986, J ALLERGY CLIN IMMUN, V77, P206; POLLART SM, 1991, J ALLERGY CLIN IMMUN, V87, P511, DOI 10.1016/0091-6749(91)90010-L; SANDERS G, 1985, J ALLERGY CLIN IMMUN, V75, P146, DOI 10.1016/0091-6749(85)90302-1; STANKUS RP, 1988, J ALLERGY CLIN IMMUN, V81, P548, DOI 10.1016/0091-6749(88)90195-9; SWANSON MC, 1985, J ALLERGY CLIN IMMUN, V76, P724, DOI 10.1016/0091-6749(85)90678-5; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; TWAROG FJ, 1977, J ALLERGY CLIN IMMUN, V59, P154, DOI 10.1016/0091-6749(77)90218-4; VOORHORS.R, 1967, J ALLERGY, V39, P325, DOI 10.1016/0021-8707(67)90045-7; WAHL R, 1989, ANN ALLERGY, V63, P137; SUMMARY MINUTES ALLE	28	16	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1991	88	6					895	901		10.1016/0091-6749(91)90246-K	http://dx.doi.org/10.1016/0091-6749(91)90246-K			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GW262	1744360				2022-12-18	WOS:A1991GW26200010
J	HOYET, C; BESSOT, JC; LEMAO, J; QUOIX, E; PAULI, G				HOYET, C; BESSOT, JC; LEMAO, J; QUOIX, E; PAULI, G			COMPARISON BETWEEN DER-P-I PLUS DER-F-I CONTENT DETERMINATIONS AND GUANINE MEASUREMENTS IN 239 HOUSE DUST SAMPLES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							DERMATOPHAGOIDES; QUANTIFICATION; ALLERGENICITY		CTR HOSP REG & UNIV, SERV PNEUMOL 2, PAVILLON LAENNEC, BP 426, F-67091 STRASBOURG, FRANCE; INST PASTEUR, F-75724 PARIS 15, FRANCE	CHU Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris								BISCHOFF E, 1984, ALLERGOLOGIE, V7, P446; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; LAU S, 1990, ALLERGOLOGIE, V13, P12; LEMAO J, 1989, J ALLERGY CLIN IMMUN, V83, P926, DOI 10.1016/0091-6749(89)90107-3; LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; PAULI G, 1988, CLIN ALLERGY, V18, P383, DOI 10.1111/j.1365-2222.1988.tb02886.x; VANBRONSWIJK JEMH, 1989, J MED ENTOMOL, V26, P55, DOI 10.1093/jmedent/26.1.55; VERVLOET D, 1989, J ALLERGY CLIN IMMUN, V83, P486	8	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1991	88	4					678	680		10.1016/0091-6749(91)90162-H	http://dx.doi.org/10.1016/0091-6749(91)90162-H			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GL049	1918733	Bronze			2022-12-18	WOS:A1991GL04900017
J	BARKER, AF; HIRSHMAN, CA; DSILVA, R; HANIFIN, JM				BARKER, AF; HIRSHMAN, CA; DSILVA, R; HANIFIN, JM			AIRWAY RESPONSIVENESS IN ATOPIC-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							METHACHOLINE INHALATION CHALLENGE; SENSITIVITY; HISTAMINE; CHILDREN; IGE	Twelve of 123 patients with atopic dermatitis (AD) were screened by questionnaire and spirometry for the absence of smoking, hay fever, and respiratory disorders. Seven of these 12 patients had a positive methacholine challenge test. None of eight patients with another skin disorder, psoriasis, screened in a similar fashion, had a positive methacholine challenge. We conclude that hyperresponsive airways are a frequent finding in patients with AD and that similar mechanisms may account for the cutaneous physiologic and pharmacologic abnormalities that have been observed in AD.	OREGON HLTH SCI UNIV,DEPT ANESTHESIOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT DERMATOL,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University	BARKER, AF (corresponding author), OREGON HLTH SCI UNIV,DEPT INTERNAL MED,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201, USA.				NHLBI NIH HHS [HL 25831] Funding Source: Medline; NIAID NIH HHS [AI 15557, AI 18615] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018615, R01AI015557] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGOSTI JM, 1988, NEW ENGL J MED, V319, P1623, DOI 10.1056/NEJM198812223192502; BRYANT DH, 1976, CLIN ALLERGY, V6, P373, DOI 10.1111/j.1365-2222.1976.tb01919.x; COCKCROFT DW, 1984, ANN ALLERGY, V53, P26; COOKSON WOCM, 1986, CLIN ALLERGY, V16, P425, DOI 10.1111/j.1365-2222.1986.tb01977.x; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P11; FISH JE, 1985, CHEST S, V87, P206; HANIFIN JM, 1977, ARCH DERMATOL, V113, P663, DOI 10.1001/archderm.113.5.663; HANIFIN JM, 1986, CLIN REV ALLERG, V4, P43; HOPP RJ, 1984, J ALLERGY CLIN IMMUN, V74, P154, DOI 10.1016/0091-6749(84)90279-3; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; LUTZ E, 1958, Arch Klin Exp Dermatol, V205, P597, DOI 10.1007/BF00482535; MALO JL, 1983, AM REV RESPIR DIS, V128, P8, DOI 10.1164/arrd.1983.128.1.8; MASUDA T, 1967, J ALLERGY, V40, P193, DOI 10.1016/0021-8707(67)90081-0; PRICE JF, 1976, ARCH DIS CHILD, V51, P912, DOI 10.1136/adc.51.12.912; RAJKA G, 1989, ESSENTIAL ASPECTS AT, P36; RYAN G, 1981, AM REV RESPIR DIS, V123, P195; TOWNLEY RG, 1979, J ALLERGY CLIN IMMUN, V64, P569, DOI 10.1016/0091-6749(79)90014-9; 1980, ATS NEWS, V6, P11	18	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1991	87	4					780	783		10.1016/0091-6749(91)90122-5	http://dx.doi.org/10.1016/0091-6749(91)90122-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FG059	2013672				2022-12-18	WOS:A1991FG05900005
J	VANMEGEN, YJB; KLAASSEN, ABM; DEMIRANDA, JFR; VANGINNEKEN, CAM; WENTGES, BTR				VANMEGEN, YJB; KLAASSEN, ABM; DEMIRANDA, JFR; VANGINNEKEN, CAM; WENTGES, BTR			ALTERATIONS OF ADRENOCEPTORS IN THE NASAL-MUCOSA OF ALLERGIC PATIENTS IN COMPARISON WITH NONALLERGIC INDIVIDUALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							BETA-ADRENERGIC RECEPTORS; CHOLINERGIC RECEPTORS; STATISTICAL-ANALYSIS; ADENYLATE-CYCLASE; SMOOTH-MUSCLE; BINDING; SUBTYPES; LUNG; TERBUTALINE; LYMPHOCYTES	Nasal hyperreactivity in nasal allergy may be due to changes of the characteristics in adrenergic receptors. Radioligand receptor-binding studies with the antagonists, H-3-prazosin (alpha-1-adrenoceptor), H-3-rauwolscine (alpha-adrenoceptor), and I-125-(-)-Cyanopindolol (beta-adrenoceptor) were performed in homogenates of nasal mucosa of allergic and nonallergic (NA) patients to investigate this hypothesis. The heterogeneous NA group was subdivided into control individuals and patients with chronic sinusitis and vasomotor rhinitis. No significant differences in affinities or densities of alpha-1- and alpha-2-adrenoceptors could be demonstrated in allergic patients in comparison with NA and control individuals. The beta-adrenoceptor density was significantly reduced in allergic patients in comparison with that of control individuals. Neither changes in agonist binding or in the effect of Gpp(NH)p on the agonist binding to beta-adrenoceptors could be observed in allergic patients. The subtype selective antagonist, LK203-030, demonstrated the presence of a homogeneous population of beta-2-adrenoceptors in human nasal mucosa of both NA and allergic patients. In vitro, autoradiography demonstrated specific I-125-(-)-Cyanopindolol labeling of the epithelium in NA and allergic patients. In conclusion, no changes in characteristics of alpha-1- or alpha-2-adrenoceptors in the nasal mucosa could be demonstrated in nasal allergy. However, a decreased number of beta-adrenoceptors may reflect a beta-adrenergic abnormality in nasal allergy.	CATHOLIC UNIV NIJMEGEN,DEPT OTORHINOLARYNGOL,NIJMEGEN,NETHERLANDS; CATHOLIC UNIV NIJMEGEN,DEPT PHARMACOL,NIJMEGEN,NETHERLANDS	Radboud University Nijmegen; Radboud University Nijmegen								BARNES PJ, 1980, NATURE, V285, P569, DOI 10.1038/285569a0; BARNES PJ, 1988, TRENDS PHARMACOL SCI, V9, P412, DOI 10.1016/0165-6147(88)90069-7; BENDE M, 1986, ORL J OTO-RHINO-LARY, V48, P238, DOI 10.1159/000275875; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS C D, 1988, Rhinology (Utrecht), V26, P51; CARSTAIRS JR, 1985, AM REV RESPIR DIS, V132, P541; CHEUNG AH, 1989, MOL PHARMACOL, V34, P132; CHRIST GJ, 1988, BIOCHEM PHARMACOL, V37, P1281, DOI 10.1016/0006-2952(88)90783-6; DAVIS B, 1979, AM REV RESPIR DIS, V120, P547; DELEAN A, 1982, MOL PHARMACOL, V21, P5; FLETCHER R, 1963, COMPUT J, V6, P163, DOI 10.1093/comjnl/6.2.163; HALL LJ, 1968, ANN OTO RHINOL LARYN, V77, P1120, DOI 10.1177/000348946807700610; HANCOCK AA, 1988, TRENDS PHARMACOL SCI, V9, P29, DOI 10.1016/0165-6147(88)90239-8; ISHIBE T, 1983, ARCH OTO-RHINO-LARYN, V238, P167, DOI 10.1007/BF00454309; KALINER M, 1975, ANNU REV PHARMACOL, V15, P177, DOI 10.1146/annurev.pa.15.040175.001141; KALINER M, 1982, ANN INTERN MED, V96, P349, DOI 10.7326/0003-4819-96-3-349; KONNO A, 1987, ORL J OTO-RHINO-LARY, V49, P103, DOI 10.1159/000275915; LEVITZKI A, 1986, PHYSIOL REV, V66, P819, DOI 10.1152/physrev.1986.66.3.819; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALM L, 1977, ACTA OTO-LARYNGOL, V83, P20, DOI 10.3109/00016487709128805; MEURS H, 1987, J ALLERGY CLIN IMMUN, V80, P326, DOI 10.1016/0091-6749(87)90039-X; MULLER A, 1988, LIFE SCI, V42, P667, DOI 10.1016/0024-3205(88)90458-4; MYGIND N, 1982, J ALLERGY CLIN IMMUN, V70, P149, DOI 10.1016/0091-6749(82)90036-7; Mygind N, 1978, NASAL ALLERGY; PASSALI D, 1983, Rhinology (Utrecht), V21, P321; RAAIJMAKERS JAM, 1987, CELL MOL BIOL, V33, P515; ROGERS AW, 1973, TECHNIQUES AUTORADIO; SHELHAMER JH, 1983, J ALLERGY CLIN IMMUN, V71, P57, DOI 10.1016/0091-6749(83)90547-X; STILES GL, 1984, PHYSIOL REV, V64, P661, DOI 10.1152/physrev.1984.64.2.661; SVENSSON G, 1980, ACTA OTO-LARYNGOL, V90, P297, DOI 10.3109/00016488009131729; Szentivanyi A, 1979, Ann N Y Acad Sci, V332, P295, DOI 10.1111/j.1749-6632.1979.tb47123.x; VANKOPPEN CJ, 1987, LIFE SCI, V40, P2561, DOI 10.1016/0024-3205(87)90079-8; VANKOPPEN CJ, 1989, THORAX, V44, P28, DOI 10.1136/thx.44.1.28; VANMEGEN YJB, 1988, NEUROSCI LETT, V90, P75, DOI 10.1016/0304-3940(88)90789-6; VANMEGEN YJB, 1989, J RECEPTOR RES, V9, P221, DOI 10.3109/10799898909066056; VANMEGEN YJB, 1990, EUR J PHARMACOL, V182, P561, DOI 10.1016/0014-2999(90)90056-C; VANMEGEN YJB, 1990, EUR J PHARMACOL, V182, P515, DOI 10.1016/0014-2999(90)90050-G; VECERINA S, 1983, Rhinology (Utrecht), V21, P73; WELSH MJ, 1987, PHYSIOL REV, V67, P1143, DOI 10.1152/physrev.1987.67.4.1143; YAMADA S, 1987, J PHARMACOL EXP THER, V242, P326	40	16	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1991	87	2					530	540		10.1016/0091-6749(91)90012-D	http://dx.doi.org/10.1016/0091-6749(91)90012-D			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EX987	1847157				2022-12-18	WOS:A1991EX98700011
J	PIERSON, WE; LAFORCE, CF; BELL, TD; MACCOSBE, PE; SYKES, RS; TINKELMAN, D				PIERSON, WE; LAFORCE, CF; BELL, TD; MACCOSBE, PE; SYKES, RS; TINKELMAN, D			LONG-TERM, DOUBLE-BLIND COMPARISON OF CONTROLLED-RELEASE ALBUTEROL VERSUS SUSTAINED-RELEASE THEOPHYLLINE IN ADOLESCENTS AND ADULTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CAROLINA ALLERGY & ASTHMA CONSULTANTS,RALEIGH,NC; ALLERGY & ASTHMA CTR,WESTERN MONTANA,W MISSOULA,MT; ATLANTA ALLERGY CLIN,ATLANTA,GA; GLAXO INC,RES TRIANGLE PK,NC	GlaxoSmithKline	PIERSON, WE (corresponding author), ASTHMA INC,4540 SAND POINT WAY NE,SEATTLE,WA 98105, USA.							BRITTON M, 1988, EUR RESPIR J, V1, P147; CLARK TJH, 1983, PRACT CARDIOL, V9, P104; Cochrane G M, 1973, Curr Med Res Opin, V1, P517, DOI 10.1185/03007997309111715; CONOLLY ME, 1982, J ALLERGY CLIN IMMUN, V70, P423, DOI 10.1016/0091-6749(82)90004-5; HENDELES L, 1984, CLIN PHARMACOKINET, V9, P95, DOI 10.2165/00003088-198409020-00001; HENDELES L, 1983, PHARMACOTHERAPY, V3, P2; LAITINEN LA, 1981, CURR THER RES, V31, P727; LARSSON S, 1977, J ALLERGY CLIN IMMUN, V59, P93, DOI 10.1016/0091-6749(77)90209-3; POWELL ML, 1987, BIOPHARM DRUG DISPOS, V8, P461, DOI 10.1002/bdd.2510080506; REPSHER LH, 1984, CHEST, V85, P34, DOI 10.1378/chest.85.1.34; SAHAY JN, 1979, J INT MED RES, V7, P56; SYKES RS, 1988, BIOPHARM DRUG DISPOS, V9, P551, DOI 10.1002/bod.2510090605; TANSER AR, 1982, PRACTITIONER, V226, P569; THEEUWES F, 1975, J PHARM SCI, V64, P1987, DOI 10.1002/jps.2600641218; TILLES DS, 1987, CHEST, V91, P370, DOI 10.1378/chest.91.3.370; TSANAKAS JN, 1988, EUR RESPIR J, V1, P356; TSANAKAS JN, 1988, EUR RESPIR J, V1, P202; WILLIAMS MH, 1984, N ENGL REG ALLERGY P, V5, P34; WOLFE JD, 1985, JAMA-J AM MED ASSOC, V253, P2068, DOI 10.1001/jama.253.14.2068; WRIGHT BM, 1959, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.5159.1041; ZEITLIN S, 1988, EUR RESPIR J, V1, P202; 1962, AM REV RESPIR DIS, V85, P762	22	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1990	85	3					618	626		10.1016/0091-6749(90)90102-A	http://dx.doi.org/10.1016/0091-6749(90)90102-A			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CU668	2179367	Bronze			2022-12-18	WOS:A1990CU66800013
J	WASS, U; NILSSON, R; NORDLINDER, R; BELIN, L				WASS, U; NILSSON, R; NORDLINDER, R; BELIN, L			AN OPTIMIZED ASSAY OF SPECIFIC IGE ANTIBODIES TO REACTIVE DYES AND STUDIES OF IMMUNOLOGICAL RESPONSES IN EXPOSED WORKERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SAHLGRENS UNIV HOSP,DEPT MED 1,OCCUPAT MED SECT,S-41345 GOTHENBURG,SWEDEN	Sahlgrenska University Hospital	WASS, U (corresponding author), SAHLGRENS UNIV HOSP,DEPT MED 1,ASTHMA & ALLERGY RES CTR,S-41345 GOTHENBURG,SWEDEN.							ALANKO K, 1978, CLIN ALLERGY, V8, P25, DOI 10.1111/j.1365-2222.1978.tb00444.x; BARNETT RN, 1979, CLIN LABORATORY STAT, P105; BIRKENMEIER G, 1984, FEBS LETT, V174, P162, DOI 10.1016/0014-5793(84)81097-2; BYFIELD PGH, 1984, MOL IMMUNOL, V21, P647, DOI 10.1016/0161-5890(84)90050-6; CARLSON R, 1983, NOUV J CHIM, V7, P315; CARLSON R, 1986, ACTA CHEM SCAND B, V40, P444, DOI 10.3891/acta.chem.scand.40b-0444; DOCKER A, 1987, BRIT J IND MED, V44, P534; HAGMAR L, 1986, SCAND J WORK ENV HEA, V12, P221, DOI 10.5271/sjweh.2154; KALAS D, 1980, PRAC LEK, V32, P103; KOPPERSCHLAGER G, 1986, J CHROMATOGR, V376, P141, DOI 10.1016/S0378-4347(00)80831-2; LUCZYNSKA CM, 1986, J IMMUNOL METHODS, V95, P177, DOI 10.1016/0022-1759(86)90404-7; STERN MA, 1985, ANN ALLERGY, V55, P264; THOREN K, 1986, CONTACT DERMATITIS, V15, P186, DOI 10.1111/j.1600-0536.1986.tb01323.x; WASS U, 1988, J ALLERGY CLIN IMMUN, V82, P679, DOI 10.1016/0091-6749(88)90983-9; WASS U, 1989, J ALLERGY CLIN IMMUN, V83, P126, DOI 10.1016/0091-6749(89)90487-9; WASS U, 1990, CLIN EXP ALLERGY, V19, P463; 1985, SAS USERS GUIDE STAT, P725	17	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1990	85	3					642	648		10.1016/0091-6749(90)90105-D	http://dx.doi.org/10.1016/0091-6749(90)90105-D			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CU668	2312995	Bronze			2022-12-18	WOS:A1990CU66800016
J	CANO, F; MAYO, DR; BALLOW, M				CANO, F; MAYO, DR; BALLOW, M			ABSENT SPECIFIC VIRAL ANTIBODIES IN PATIENTS WITH TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									STATE CONNECTICUT,VIROL LAB,DEPT HLTH SERV,HARTFORD,CT; UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06032	University of Connecticut								GITLIN D, 1956, PROG HEMATOL, V1, P318; HAYAKAWA H, 1981, J CLIN IMMUNOL, V1, P31, DOI 10.1007/BF00915474; MCGEADY SJ, 1987, J PEDIATR-US, V110, P47, DOI 10.1016/S0022-3476(87)80286-X; TILLER TL, 1978, J PEDIATR-US, V92, P347, DOI 10.1016/S0022-3476(78)80417-X	4	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1990	85	2					510	513		10.1016/0091-6749(90)90163-X	http://dx.doi.org/10.1016/0091-6749(90)90163-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CP511	2303650				2022-12-18	WOS:A1990CP51100014
J	CASALE, TB; BALLAS, ZK; KALINER, MA; KEAHEY, TM				CASALE, TB; BALLAS, ZK; KALINER, MA; KEAHEY, TM			THE EFFECTS OF INTRAVENOUS ENDOTOXIN ON VARIOUS HOST-EFFECTOR MOLECULES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM MED CTR,DEPT INTERNAL MED,IOWA CITY,IA 52240; UNIV IOWA,COLL MED,IOWA CITY,IA 52242; NIAID,CLIN INVEST LAB,BETHESDA,MD 20205	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377; Knaack, Aaron/0000-0001-7712-1415; Ballas, Zuhair/0000-0001-5569-1230				AURON PE, 1987, J IMMUNOL, V138, P1447; BALLAS ZK, 1983, CELL IMMUNOL, V76, P81, DOI 10.1016/0008-8749(83)90350-7; BAUMGARTNER JD, 1985, LANCET, V2, P59; BERKENBOSCH F, 1987, SCIENCE, V238, P524, DOI 10.1126/science.2443979; BERNTON EW, 1987, SCIENCE, V238, P519, DOI 10.1126/science.2821620; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; BRACKETT DJ, 1985, CIRC SHOCK, V16, P141; BROUCKAERT P, 1989, J EXP MED, V169, P2257, DOI 10.1084/jem.169.6.2257; CARR DB, 1982, SCIENCE, V217, P845, DOI 10.1126/science.6285473; CASALE TB, 1984, J ALLERGY CLIN IMMUN, V73, P775, DOI 10.1016/0091-6749(84)90447-0; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; COOK JA, 1980, J CLIN INVEST, V65, P227, DOI 10.1172/JCI109655; DEMLING RH, 1981, AM J PHYSIOL, V240, pH348, DOI 10.1152/ajpheart.1981.240.3.H348; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; DUNCOMBE AS, 1988, NEW ENGL J MED, V319, P1227; DYER J, 1982, J ALLERGY CLIN IMMUN, V70, P82, DOI 10.1016/0091-6749(82)90233-0; EGDAHL RH, 1959, J CLIN INVEST, V38, P1120, DOI 10.1172/JCI103888; EMAU P, 1984, CIRC SHOCK, V12, P47; GIRARDIN E, 1988, NEW ENGL J MED, V319, P397, DOI 10.1056/NEJM198808183190703; GOEKEN NE, 1986, HUM IMMUNOL, V16, P234, DOI 10.1016/0198-8859(86)90051-0; HAGMANN W, 1985, FEBS LETT, V180, P309, DOI 10.1016/0014-5793(85)81092-9; HARBOURMCMENAMIN D, 1985, INFECT IMMUN, V48, P813, DOI 10.1128/IAI.48.3.813-817.1985; HELLE M, 1989, J IMMUNOL, V142, P4335; HENNEY CS, 1989, IMMUNOL TODAY, V10, P170, DOI 10.1016/0167-5699(89)90175-8; HOOK WA, 1972, INFECT IMMUN, V5, P909, DOI 10.1128/IAI.5.6.909-914.1972; JACOBS R, 1989, CRIT CARE MED, V17, P30, DOI 10.1097/00003246-198901000-00008; LAWRENCE ID, 1987, J IMMUNOL, V139, P3062; LE JM, 1988, P NATL ACAD SCI USA, V85, P8643, DOI 10.1073/pnas.85.22.8643; LIAO ZH, 1985, J IMMUNOL, V134, P3882; LISI PJ, 1987, LYMPHOKINE RES, V6, P229; LOTZE MT, 1984, J IMMUNOL, V134, P1157; LUGER TA, 1983, FED PROC, V42, P2772; MAINS RE, 1977, P NATL ACAD SCI USA, V74, P3014, DOI 10.1073/pnas.74.7.3014; MATHISON JC, 1988, J CLIN INVEST, V81, P1925, DOI 10.1172/JCI113540; MATSUSHIMA K, 1985, J IMMUNOL, V135, P1132; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; NEUGEBAUER E, 1987, REV INFECT DIS, V9, pS585; NORN S, 1986, AGENTS ACTIONS, V18, P149, DOI 10.1007/BF01988007; OKUSAWA S, 1988, J CLIN INVEST, V81, P1162, DOI 10.1172/JCI113431; Oyama T, 1983, Prog Clin Biol Res, V111, P185; RANGES GE, 1988, J EXP MED, V167, P1472, DOI 10.1084/jem.167.4.1472; SAPOLSKY R, 1987, SCIENCE, V238, P522, DOI 10.1126/science.2821621; SUBRAMANIAN N, 1987, J IMMUNOL, V138, P271; TENG NNH, 1985, P NATL ACAD SCI USA, V82, P1790, DOI 10.1073/pnas.82.6.1790; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; VICK JA, 1971, P SOC EXP BIOL MED, V137, P902; WAAGE A, 1988, J EXP MED, V167, P1987, DOI 10.1084/jem.167.6.1987; WAAGE A, 1987, LANCET, V1, P355; WONG GG, 1988, IMMUNOL TODAY, V9, P137, DOI 10.1016/0167-5699(88)91200-5	51	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1990	85	1	1				45	51		10.1016/0091-6749(90)90219-T	http://dx.doi.org/10.1016/0091-6749(90)90219-T			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CM378	2137152				2022-12-18	WOS:A1990CM37800007
J	MILLER, J; NELSON, HS				MILLER, J; NELSON, HS			SUPPRESSION OF IMMEDIATE SKIN-TESTS BY RANITIDINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,1400 JACKSON ST,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								BLACK JW, 1972, NATURE, V236, P385, DOI 10.1038/236385a0; BROGDEN RN, 1982, DRUGS, V24, P267, DOI 10.2165/00003495-198224040-00002; COOK TJ, 1973, J ALLERGY CLIN IMMUN, V51, P71, DOI 10.1016/S0091-6749(73)80002-8; DREBORG S, 1989, THESIS U LINKOPING L; GALANT S, 1972, ANN ALLERGY, V30, P53; HAGERMARK O, 1979, ACTA DERM-VENEREOL, V59, P297; HARVEY RP, 1980, J ALLERGY CLIN IMMUN, V65, P136, DOI 10.1016/0091-6749(80)90198-0; JOHNSON CE, 1984, CLIN PHARMACY, V3, P60; KALINER M, 1981, J ALLERGY CLIN IMMUN, V68, P365, DOI 10.1016/0091-6749(81)90134-2; MARKS R, 1977, BRIT J CLIN PHARMACO, V4, P367, DOI 10.1111/j.1365-2125.1977.tb00725.x; MOSKO MM, 1950, J ALLERGY, V21, P242, DOI 10.1016/0021-8707(50)90132-8; NATHAN RA, 1981, J ALLERGY CLIN IMMUN, V67, P171, DOI 10.1016/0091-6749(81)90057-9; PULVER K, 1986, ANN ALLERGY, V56, P520; SMITH JA, 1979, ANN ALLERGY, V42, P353; SUMMERS R, 1981, J ALLERGY CLIN IMMUN, V67, P456, DOI 10.1016/0091-6749(81)90099-3; THOMAS RHM, 1985, BRIT J CLIN PHARMACO, V20, P377, DOI 10.1111/j.1365-2125.1985.tb05080.x; THOMAS RHM, 1985, J ALLERGY CLIN IMMUN, V76, P864, DOI 10.1016/0091-6749(85)90761-4; VANTO T, 1982, ANN ALLERGY, V49, P340; VOORHORST R, 1973, ANN ALLERGY, V31, P195; VOORHORST R, 1980, ALLERGY, V35, P247, DOI 10.1111/j.1398-9995.1980.tb01762.x	20	16	16	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1989	84	6	1				895	899		10.1016/0091-6749(89)90386-2	http://dx.doi.org/10.1016/0091-6749(89)90386-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CG293	2600323	Bronze			2022-12-18	WOS:A1989CG29300007
J	RAPHAEL, GD; DAVIS, JL; FOX, PC; MALECH, HL; GALLIN, JI; BARANIUK, JN; KALINER, MA				RAPHAEL, GD; DAVIS, JL; FOX, PC; MALECH, HL; GALLIN, JI; BARANIUK, JN; KALINER, MA			GLANDULAR SECRETION OF LACTOFERRIN IN A PATIENT WITH NEUTROPHIL LACTOFERRIN DEFICIENCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,CLIN INVEST LAB,BACTERIAL DIS SECT,BETHESDA,MD 20205; NIDR,CLIN INVEST & PATIENT CARE BRANCH,CLIN STUDIES UNIT,BETHESDA,MD 20205; NEI,IMMUNOL LAB,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	RAPHAEL, GD (corresponding author), NIAID,CLIN INVEST LAB,ALLERG DIS SECT,9000 ROCKVILLE PIKE,BLDG 10,11C207,BETHESDA,MD 20892, USA.		Abrams, William R/A-5782-2008	Davis, Janet/0000-0001-6395-5881; Baraniuk, James Nicholas/0000-0002-1866-4177; Malech, Harry/0000-0001-5874-5775				AMBRUSO DR, 1984, J CLIN IMMUNOL, V4, P23, DOI 10.1007/BF00915283; ARNOLD RR, 1982, INFECT IMMUN, V35, P792, DOI 10.1128/IAI.35.3.792-799.1982; BOWES D, 1981, THORAX, V36, P108, DOI 10.1136/thx.36.2.108; BRANDTZAEG P, 1981, J HISTOCHEM CYTOCHEM, V29, P1302, DOI 10.1177/29.11.7033362; Brandtzaeg P., 1984, IMMUNOLOGY LUNG UPPE, P28; BRETONGORIUS J, 1980, AM J PATHOL, V99, P413; BULLEN JJ, 1979, IMMUNOLOGY, V36, P781; Carlson AJ, 1910, AM J PHYSIOL, V26, P169, DOI 10.1152/ajplegacy.1910.26.1.169; FALLOON J, 1986, J ALLERGY CLIN IMMUN, V77, P653, DOI 10.1016/0091-6749(86)90404-5; FOX PC, 1985, J AM DENT ASSOC, V110, P519, DOI 10.14219/jada.archive.1985.0384; GALLIN JI, 1982, BLOOD, V59, P1317; GANZ T, 1988, J CLIN INVEST, V82, P552, DOI 10.1172/JCI113631; JANSSEN PT, 1983, INVEST OPHTH VIS SCI, V24, P623; JEFFERY P K, 1987, European Journal of Respiratory Diseases Supplement, V71, P34; KIJLSTRA A, 1983, BRIT J OPHTHALMOL, V67, P199, DOI 10.1136/bjo.67.3.199; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; KORSRUD FR, 1982, J HISTOCHEM CYTOCHEM, V30, P657, DOI 10.1177/30.7.6179983; LEHTONEN OPJ, 1987, ACTA PATH MICRO IM C, V95, P35; LOMAX KJ, 1989, J CLIN INVEST, V83, P514, DOI 10.1172/JCI113912; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0; PALESTINE AG, 1983, AM J OPHTHALMOL, V95, P598, DOI 10.1016/0002-9394(83)90377-X; RAPHAEL GD, 1988, AM REV RESPIR DIS, V138, P413, DOI 10.1164/ajrccm/138.2.413; RAPHAEL GD, IN PRESS J CLIN INVE; RAPHAEL GD, 1989, J ALLERGY CLIN IMMUN, V84, P110; Schirmer O., 1903, ALBRECH GRAEFES ARCH, V56, P197, DOI 10.1007/BF01946264; WHITE MV, 1987, J IMMUNOL, V139, P1624	27	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1989	84	6	1				914	919		10.1016/0091-6749(89)90389-8	http://dx.doi.org/10.1016/0091-6749(89)90389-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CG293	2600325				2022-12-18	WOS:A1989CG29300010
J	BUTCHER, BT; BERNSTEIN, IL; SCHWARTZ, HJ				BUTCHER, BT; BERNSTEIN, IL; SCHWARTZ, HJ			GUIDELINES FOR THE CLINICAL-EVALUATION OF OCCUPATIONAL ASTHMA DUE TO SMALL MOLECULAR-WEIGHT CHEMICALS - REPORT OF THE SUBCOMMITTEE-ON-THE-CLINICAL-EVALUATION-OF-OCCUPATIONAL-ASTHMA-DUE-TO-SMALL-MOLECULAR-WEIGHT-CHEMICALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											BUTCHER, BT (corresponding author), ARTHRITIS FDN, 1314 SPRING ST NW, ATLANTA, GA 30309 USA.							BANKS DE, 1986, CHEST, V89, P389, DOI 10.1378/chest.89.3.389; BERNSTEIN DI, 1982, J ALLERGY CLIN IMMUN, V69, P311, DOI 10.1016/S0091-6749(82)80009-2; BROOKS SM, 1985, BRONCHIAL ASTHMA, P461; BURGE PS, 1982, EUR J RESPIR DIS, V63, P47; BURNEY P, 1987, CHEST, V91, pS79, DOI 10.1378/chest.91.6.79S; BUTCHER BT, 1986, J ALLERGY CLIN IMMUN, V78, P547, DOI 10.1016/0091-6749(86)90068-0; BUTCHER BT, 1980, J ALLERGY CLIN IMMUN, V66, P213, DOI 10.1016/0091-6749(80)90041-X; BUTCHER BT, 1979, J ALLERGY CLIN IMMUN, V64, P146, DOI 10.1016/0091-6749(79)90049-6; BUTCHER BT, 1982, J ALLERGY CLIN IMMUN, V70, P231, DOI 10.1016/0091-6749(82)90058-6; BUTCHER BT, 1984, OCCUPATIONAL LUNG DI, P111; CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P823, DOI 10.1016/0091-6749(89)90346-1; CORRIGAN CJ, 1988, LANCET, V1, P1129; CROMWELL O, 1979, CLIN ALLERGY, V9, P109, DOI 10.1111/j.1365-2222.1979.tb01529.x; DAVIES RJ, 1977, J ALLERGY CLIN IMMUN, V60, P223, DOI 10.1016/0091-6749(77)90134-8; GALLAGHER JS, 1981, J OCCUP ENVIRON MED, V23, P610, DOI 10.1097/00043764-198109000-00009; LISS GM, 1988, J ALLERGY CLIN IMMUN, V82, P55, DOI 10.1016/0091-6749(88)90051-6; MACCIA CA, 1976, AM REV RESPIR DIS, V113, P701; MOLLER DR, 1985, J ALLERGY CLIN IMMUN, V75, P663, DOI 10.1016/0091-6749(85)90091-0; NIELSEN J, 1988, J ALLERGY CLIN IMMUN, V82, P126, DOI 10.1016/0091-6749(88)90062-0; PEPYS J, 1978, ALLERGY PRINCIPLES P, P812; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; 1979, ASTHMA OTHER ALLERGI, P387	22	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1989	84	5	2	S			834	838		10.1016/0091-6749(89)90348-5	http://dx.doi.org/10.1016/0091-6749(89)90348-5			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CC527	2809033	Bronze			2022-12-18	WOS:A1989CC52700008
J	NOVEY, HS; BERNSTEIN, IL; MIHALAS, LS; TERR, AI; YUNGINGER, JW				NOVEY, HS; BERNSTEIN, IL; MIHALAS, LS; TERR, AI; YUNGINGER, JW			GUIDELINES FOR THE CLINICAL-EVALUATION OF OCCUPATIONAL ASTHMA DUE TO HIGH MOLECULAR-WEIGHT (HMW) ALLERGENS - REPORT OF THE SUBCOMMITTEE-ON-THE-CLINICAL-EVALUATION-OF-OCCUPATIONAL-ASTHMA-DUE-TO-HMW-ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											NOVEY, HS (corresponding author), UNIV CALIF IRVINE,DEPT MED,DIV BASIC & CLIN IMMUNOL,101 CITY DR S,ORANGE,CA 92668, USA.							Adkinson NF, 1986, MANUAL CLIN LABORATO, P664; AGRUP G, 1986, BRIT J IND MED, V43, P192; ARMENTIA A, 1988, ANN ALLERGY, V60, P209; AXELSSON IGK, 1987, ALLERGY, V42, P161, DOI 10.1111/j.1398-9995.1987.tb02193.x; BAGANSTOSE AH, 1980, J ALLERGY CLIN IMMUN, V65, P71; BALDO BA, 1982, CLIN ALLERGY, V12, P179, DOI 10.1111/j.1365-2222.1982.tb01637.x; BALDO BA, 1980, ALLERGY, V35, P45, DOI 10.1111/j.1398-9995.1980.tb01716.x; BAUR X, 1982, CLIN ALLERGY, V12, P9, DOI 10.1111/j.1365-2222.1982.tb03121.x; BAUR X, 1979, CLIN ALLERGY, V9, P443, DOI 10.1111/j.1365-2222.1979.tb02507.x; BERNSTEIN DI, 1983, J ALLERGY CLIN IMMUN, V72, P475, DOI 10.1016/0091-6749(83)90584-5; BERNSTEIN DI, 1986, J ALLERGY CLIN IMMUN, V77, P173; BJORKSTEN F, 1977, CLIN ALLERGY, V7, P473, DOI 10.1111/j.1365-2222.1977.tb01478.x; BLOCK G, 1983, CLIN ALLERGY, V13, P359, DOI 10.1111/j.1365-2222.1983.tb02610.x; BOHNER CB, 1940, J ALLERGY, V12, P290; BOUSQUET J, 1985, J ALLERGY CLIN IMMUN, V75, P70, DOI 10.1016/0091-6749(85)90015-6; BROOKS SM, 1982, J ALLERGY CLIN IMMUN, V70, P56, DOI 10.1016/0091-6749(82)90202-0; BURGE PS, 1982, EUR J RESPIR DIS, V63, P47; BURGE PS, 1987, BRIT J DIS CHEST, V81, P105; BURGE PS, 1979, CLIN ALLERGY, V9, P185, DOI 10.1111/j.1365-2222.1979.tb01540.x; BUSSE WW, 1975, ANN INTERN MED, V83, P361, DOI 10.7326/0003-4819-83-3-361; CARITER A, 1984, J ALLERGY CLIN IMMUN, V73, P574; CARTIER A, 1986, J ALLERGY CLIN IMMUN, V78, P344, DOI 10.1016/S0091-6749(86)80087-2; CHANYEUNG M, 1973, AM REV RESPIR DIS, V108, P1094; CHANYEUNG M, 1986, AM REV RESPIR DIS, V133, P666; COCKCROFT A, 1981, LANCET, V1, P827; COLTEN HR, 1975, NEW ENGL J MED, V292, P1050, DOI 10.1056/NEJM197505152922003; CUTHBERT OD, 1979, CLIN ALLERGY, V9, P229, DOI 10.1111/j.1365-2222.1979.tb01547.x; DAVIES GE, 1983, J IMMUNOASSAY, V4, P113, DOI 10.1080/15321818308057004; DAVIES RJ, 1974, CLIN ALLERGY, V4, P227; DAVIES RJ, 1984, SEMIN RESPIR MED, V5, P229, DOI 10.1055/s-2007-1011457; DAVIES RJ, 1983, ALLERGY PRINCIPLES P, P1037; DAVIES RJ, 1975, CLIN ALLERGY, V1, P99; DOPICO GA, 1987, CHEST, V73, P3; EDWARDS RG, 1983, LAB ANIM, V17, P235, DOI 10.1258/002367783781070696; ENARSON DA, 1987, AM REV RESPIR DIS, V136, P613, DOI 10.1164/ajrccm/136.3.613; FAIRSHTER RD, 1982, RESPIRATION, V43, P142, DOI 10.1159/000194477; FALLERONI AE, 1981, J ALLERGY CLIN IMMUN, V68, P156, DOI 10.1016/0091-6749(81)90173-1; Figley KD, 1928, J AMER MED ASSOC, V90, P79, DOI 10.1001/jama.1928.02690290009003; FLOOD DFS, 1985, BR J IND MED, V42, P45; FRANKLAND AW, 1965, BRIT J IND MED, V22, P157; GADDIE J, 1980, LANCET, V2, P1350; GARDNER RM, 1981, OCCUPATIONAL LUNG DI, P61; GOLD BL, 1985, AM REV RESPIR DIS, V131, P949; GRAMMER LC, ALLERGIC DISEASES DI, P691; GREENBERG M, 1970, BMJ-BRIT MED J, V2, P629, DOI 10.1136/bmj.2.5710.629; HARGREAVE FE, 1983, SEMIN RESPIR MED, V4, P224, DOI 10.1055/s-2007-1012487; HARINDRANATH N, 1985, ANN ALLERGY, V55, P511; HARRIES MG, 1982, BRIT MED J, V284, P867, DOI 10.1136/bmj.284.6319.867; HENDRICK DJ, 1983, ANN ALLERGY, V51, P179; HILL D, 1975, MED J AUSTRALIA, V2, P553, DOI 10.5694/j.1326-5377.1975.tb106057.x; Hosey A., 1973, IND ENV ITS EVALUATI, P95; INGRAM CG, 1979, LANCET, V2, P1130; JAPPINEN P, 1987, ALLERGY, V42, P545, DOI 10.1111/j.1398-9995.1987.tb00380.x; JONES RN, 1982, AM REV RESPIR DIS, V125, P199; Jyo T, 1974, Allerg Immunol (Leipz), V20-21, P435; KARR RM, 1978, J ALLERGY CLIN IMMUN, V62, P143, DOI 10.1016/0091-6749(78)90098-2; LONGBOTTOM JL, 1987, J ALLERGY CLIN IMMUN, V80, P243, DOI 10.1016/0091-6749(87)90026-1; LUCZYNSKA CM, 1984, CLIN ALLERGY, V14, P169, DOI 10.1111/j.1365-2222.1984.tb02649.x; LUTSKY I, 1984, J ALLERGY CLIN IMMUN, V73, P56, DOI 10.1016/0091-6749(84)90484-6; LUTSKY I, 1982, LANCET, V2, P874; MAESTRELLI P, 1987, ANN ALLERGY, V5959, P347; MILNE J, 1975, BRIT J IND MED, V32, P302; NOVEY HS, 1980, CLIN ALLERGY, V10, P721, DOI 10.1111/j.1365-2222.1980.tb02157.x; OBRIEN D, 1987, ECTB15603 NAT I OCC; PEPYS J, 1973, Clinical Allergy, V3, P143, DOI 10.1111/j.1365-2222.1973.tb01318.x; PERLMAN F, 1976, ANN ALLERGY, V36, P302; PLATTSMILLS TAE, 1986, J ALLERGY CLIN IMMUN, V77, P850, DOI 10.1016/0091-6749(86)90383-0; REVSBECH P, 1987, ALLERGY, V42, P423, DOI 10.1111/j.1398-9995.1987.tb00357.x; ROSENBERG S, 1982, ANN ALLERGY, V48, P294; SCHLUETER DP, 1976, ANN INTERN MED, V70, P457; SCHOENWETTER WF, 1985, ANN INTERN MED, V103, P642, DOI 10.7326/0003-4819-103-4-642; SCHUMACHER MJ, 1980, MOL IMMUNOL, V17, P1087, DOI 10.1016/0161-5890(80)90105-4; SLOVAK AJM, 1981, BRIT J IND MED, V38, P38; SMITH AB, 1987, AM J IND MED, V12, P205, DOI 10.1002/ajim.4700120209; STEVENSON DD, 1967, J ALLERGY, V39, P274, DOI 10.1016/0021-8707(67)90091-3; SUTTON R, 1984, CLIN ALLERGY, V14, P93, DOI 10.1111/j.1365-2222.1984.tb02196.x; SUZUKI S, 1975, INT ARCH ALLER A IMM, V48, P800, DOI 10.1159/000231368; SWANSON MC, 1985, J ALLERGY CLIN IMMUN, V76, P724, DOI 10.1016/0091-6749(85)90678-5; SWANSON MC, 1984, AM REV RESPIR DIS, V129, P844, DOI 10.1164/arrd.1984.129.5.844; SYMINGTON IS, 1981, CLIN ALLERGY, V11, P43, DOI 10.1111/j.1365-2222.1981.tb01564.x; TAYLOR AN, 1977, LANCET, V2, P847; TWAROG FJ, 1977, J ALLERGY CLIN IMMUN, V59, P35, DOI 10.1016/0091-6749(77)90174-9; TWIGGS JT, 1982, J ALLERGY CLIN IMMUN, V69, P522, DOI 10.1016/0091-6749(82)90177-4; VIRTANEN T, 1986, INT ARCH ALLER A IMM, V81, P253, DOI 10.1159/000234143; WAHN U, 1980, J ALLERGY CLIN IMMUN, V65, P413, DOI 10.1016/0091-6749(80)90233-X	85	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1989	84	5	2	S			829	833		10.1016/0091-6749(89)90347-3	http://dx.doi.org/10.1016/0091-6749(89)90347-3			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CC527	2809032				2022-12-18	WOS:A1989CC52700007
J	APTER, AJ; GREENBERGER, PA; LIOTTA, JL; ROBERTS, M				APTER, AJ; GREENBERGER, PA; LIOTTA, JL; ROBERTS, M			FLUCTUATIONS OF SERUM IGA AND ITS SUBCLASSES IN ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,303 E CHICAGO AVE,CHICAGO,IL 60611	Northwestern University			Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403, R01AI023071] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403, AI 23071] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brown T A, 1987, Adv Exp Med Biol, V216B, P1691; BROWN TA, 1985, J CLIN MICROBIOL, V22, P259, DOI 10.1128/JCM.22.2.259-264.1985; CONLEY ME, 1987, ANN INTERN MED, V106, P892, DOI 10.7326/0003-4819-106-6-892; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; GREENBERGER PA, 1988, J ALLERGY CLIN IMMUN, V82, P164, DOI 10.1016/0091-6749(88)90995-5; GREENBERGER PA, 1982, J LAB CLIN MED, V99, P288; GUTT L, 1986, J ALLERGY CLIN IMMUN, V78, P98, DOI 10.1016/0091-6749(86)90120-X; JOHNSON KJ, 1984, J CLIN INVEST, V74, P358, DOI 10.1172/JCI111431; PATTERSON R, 1980, CLIN EXP IMMUNOL, V42, P395; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; ROSENBERG M, 1977, J PEDIATR-US, V91, P914, DOI 10.1016/S0022-3476(77)80889-5; WANG JLF, 1978, AM REV RESPIR DIS, V117, P917	12	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1989	84	3					367	372		10.1016/0091-6749(89)90422-3	http://dx.doi.org/10.1016/0091-6749(89)90422-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AR199	2778243				2022-12-18	WOS:A1989AR19900015
J	GURKA, G; OHMAN, J; ROSENWASSER, LJ				GURKA, G; OHMAN, J; ROSENWASSER, LJ			ALLERGEN-SPECIFIC HUMAN T-CELL CLONES - DERIVATION, SPECIFICITY, AND ACTIVATION REQUIREMENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TUFTS UNIV,NEW ENGLAND MED CTR,SCH MED,DEPT MED,DIV ALLERGY,750 WASHINGTON ST,BOX 71,BOSTON,MA 02111	Tufts Medical Center; Tufts University					NHLBI NIH HHS [HL 33961] Funding Source: Medline; NIAID NIH HHS [AI00595, AI25173] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025173, K07AI000595] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN PM, 1984, J IMMUNOL, V132, P1077; ASANO Y, 1983, J EXP MED, V158, P1178, DOI 10.1084/jem.158.4.1178; CELIS E, 1984, J IMMUNOL, V132, P1511; CHIZZOLINI C, 1986, J IMMUNOL, V137, P1022; CORTE G, 1981, EUR J IMMUNOL, V11, P162, DOI 10.1002/eji.1830110220; EVANS R, 1976, J CLIN INVEST, V57, P1378, DOI 10.1172/JCI108406; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; FRIEDMAN SM, 1986, J EXP MED, V164, P1773, DOI 10.1084/jem.164.5.1773; GILLIS S, 1978, J IMMUNOL, V120, P2027; GUILLET J, 1987, SCIENCE, V235, P1353; LAMB J, 1982, J IMMUNOL, V129, P146; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LAPERCHE Y, 1983, CELL, V32, P453, DOI 10.1016/0092-8674(83)90465-8; LORUSSO JR, 1986, J ALLERGY CLIN IMMUN, V78, P928, DOI 10.1016/0091-6749(86)90242-3; MALYNN BA, 1985, J IMMUNOL, V135, P980; MARGALIT H, 1987, J IMMUNOL, V138, P2213; MATIS LA, 1983, J IMMUNOL, V130, P1527; MEUER S, 1983, SCIENCE, V222, P129; MUSTAFA AS, 1986, NATURE, V319, P63, DOI 10.1038/319063a0; NELL LJ, 1985, J CLIN INVEST, V76, P2070, DOI 10.1172/JCI112210; PARMELY MJ, 1986, J IMMUNOL, V137, P988; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V79, P505, DOI 10.1016/0091-6749(87)90369-1; ROSENWASSER LJ, 1981, J EXP MED, V153, P1113, DOI 10.1084/jem.153.5.1113; ROSENWASSER LJ, 1979, J IMMUNOL, V123, P471; ROSENWASSER LJ, 1979, J EXP MED, V150, P709, DOI 10.1084/jem.150.3.709; SCHUMACHER MJ, 1981, J ALLERGY CLIN IMMUN, V68, P310, DOI 10.1016/0091-6749(81)90157-3; SHAW PH, 1983, CELL, V32, P755, DOI 10.1016/0092-8674(83)90061-2; UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650; WANG F, 1987, J CLIN INVEST, V79, P7, DOI 10.1172/JCI112810	29	16	20	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1989	83	5					945	954		10.1016/0091-6749(89)90110-3	http://dx.doi.org/10.1016/0091-6749(89)90110-3			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U7161	2469709				2022-12-18	WOS:A1989U716100016
J	BAHNA, SL; STRIMAS, JH; REED, MA; BUTCHER, BT				BAHNA, SL; STRIMAS, JH; REED, MA; BUTCHER, BT			IMPORTED FIRE ANT ALLERGY IN YOUNG-CHILDREN - SKIN REACTIVITY AND SERUM IGE ANTIBODIES TO VENOM AND WHOLE-BODY EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									LOUISIANA STATE UNIV,MED CTR,SCH MED,DEPT PEDIAT,ALLERGY & IMMUNOL SECT,NEW ORLEANS,LA 70112; TULANE UNIV,MED CTR,DEPT MED,CLIN IMMUNOL SECT,NEW ORLEANS,LA 70118	Louisiana State University System; Tulane University					NIAID NIH HHS [AI 21551] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS CT, 1981, J MED ENTOMOL, V18, P378, DOI 10.1093/jmedent/18.5.378; BUTCHER BT, 1988, INT ARCH ALLER A IMM, V85, P458, DOI 10.1159/000234551; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V81, P33, DOI 10.1016/0091-6749(88)90217-5; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V81, P1096, DOI 10.1016/0091-6749(88)90875-5; BUTCHER BT, IN PRESS J ALLERGY C; DESHAZO RD, 1984, J ALLERGY CLIN IMMUN, V74, P841, DOI 10.1016/0091-6749(84)90188-X; ELSTON RC, 1987, ESSENTIAL BIOSTATIST, P141; GINSBURG CM, 1984, PEDIATRICS, V73, P689; HANNAN CJ, 1986, J ALLERGY CLIN IMMUN, V78, P331, DOI 10.1016/S0091-6749(86)80085-9; LICHTENSTEIN LM, 1979, J ALLERGY CLIN IMMUN, V64, P5, DOI 10.1016/0091-6749(79)90075-7; LOCKEY RF, 1974, J ALLERGY CLIN IMMUN, V54, P132, DOI 10.1016/0091-6749(74)90050-5; PAULL BR, 1983, J ALLERGY CLIN IMMUN, V71, P448, DOI 10.1016/0091-6749(83)90460-8; Rhoades R.B., 1977, MED ASPECTS IMPORTED; RHOADES RB, 1975, J ALLERGY CLIN IMMUN, V56, P84, DOI 10.1016/0091-6749(75)90112-8; RHOADES RB, 1977, J FLA MED ASSOC, V64, P247; STABLEIN JJ, 1987, CLIN REV ALLERG, V5, P161; STROM GB, 1983, J ALLERGY CLIN IMMUN, V72, P46, DOI 10.1016/0091-6749(83)90051-9; TRIPLETT RF, 1976, SOUTHERN MED J, V69, P258, DOI 10.1097/00007611-197603000-00002; TRIPLETT RF, 1973, SOUTHERN MED J, V66, P477, DOI 10.1097/00007611-197304000-00019; Yeager W, 1978, J Med Assoc Ga, V67, P101	20	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1988	82	3	1				419	424		10.1016/0091-6749(88)90014-0	http://dx.doi.org/10.1016/0091-6749(88)90014-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q3229	3170990				2022-12-18	WOS:A1988Q322900015
J	SLY, RM; KEMP, JP				SLY, RM; KEMP, JP			THE USE OF ANTIHISTAMINES IN PATIENTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material																		BRIK A, 1987, J ALLERGY CLIN IMMUN, V80, P51, DOI 10.1016/S0091-6749(87)80190-2; CHAI H, 1980, CHEST, V78, P420, DOI 10.1378/chest.78.3.420; CHAN TB, 1986, BRIT J DIS CHEST, V80, P375, DOI 10.1016/0007-0971(86)90091-4; CLEE MD, 1984, BRIT J DIS CHEST, V78, P180, DOI 10.1016/0007-0971(84)90120-7; COOKSON WOCM, 1987, BRIT J CLIN PHARMACO, V24, P120, DOI 10.1111/j.1365-2125.1987.tb03150.x; GROGGINS RC, 1979, BRIT J DIS CHEST, V73, P297, DOI 10.1016/0007-0971(79)90056-1; HARTLEY JPR, 1980, THORAX, V35, P675, DOI 10.1136/thx.35.9.675; HARTMANN V, 1981, THORAX, V36, P737, DOI 10.1136/thx.36.10.737; HEURICH A, 1972, RESPIRATION, V29, P135, DOI 10.1159/000192865; HOLGATE ST, 1985, J ALLERGY CLIN IMMUN, V76, P375, DOI 10.1016/0091-6749(85)90657-8; KARLIN JM, 1972, ANN ALLERGY, V30, P342; KARLIN JM, 1975, PEDIATR CLIN N AM, V22, P157; LEWISTON NJ, 1982, J PEDIATR-US, V101, P458, DOI 10.1016/S0022-3476(82)80087-5; MICHELSON AL, 1958, NEW ENGL J MED, V258, P994, DOI 10.1056/NEJM195805152582006; PATEL KR, 1984, BRIT MED J, V288, P1496, DOI 10.1136/bmj.288.6429.1496; PATEL KR, 1987, J ALLERGY CLIN IMMUN, V79, P355, DOI 10.1016/0091-6749(87)90155-2; POPA VT, 1980, CHEST, V78, P442, DOI 10.1378/chest.78.3.442; POPA VT, 1977, J ALLERGY CLIN IMMUN, V59, P54, DOI 10.1016/0091-6749(77)90177-4; RAFFERTY P, 1987, AM REV RESPIR DIS, V135, P181; SCHULLER DE, 1983, J ALLERGY CLIN IMMUN, V71, P147, DOI 10.1016/0091-6749(83)90359-7; SCHULLER DE, 1983, J ALLERGY CLIN IMMUN, V72, P175, DOI 10.1016/0091-6749(83)90526-2; SECHER C, 1982, J ALLERGY CLIN IMMUN, V70, P211, DOI 10.1016/0091-6749(82)90044-6; 1986, PHYSICIANS DESK REFE	23	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1988	82	3	1				481	482		10.1016/0091-6749(88)90022-X	http://dx.doi.org/10.1016/0091-6749(88)90022-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q3229					2022-12-18	WOS:A1988Q322900023
J	KEAHEY, TM; INDRISANO, J; KALINER, MA				KEAHEY, TM; INDRISANO, J; KALINER, MA			A CASE-STUDY ON THE INDUCTION OF CLINICAL TOLERANCE IN COLD URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,CLIN INVEST LAB,ALLERG DIS SECT,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								AKIYAMA T, 1981, Journal of Dermatology (Tokyo), V8, P139; BENTLEYPHILLIPS CB, 1976, LANCET, V2, P63; DYER J, 1982, J ALLERGY CLIN IMMUN, V70, P82, DOI 10.1016/0091-6749(82)90233-0; GRANDEL KE, 1985, NEW ENGL J MED, V313, P405, DOI 10.1056/NEJM198508153130702; Horton BT, 1936, J AMER MED ASSOC, V107, P1263, DOI 10.1001/jama.1936.02770420001001; HOUSER DD, 1970, AM J MED, V49, P23, DOI 10.1016/S0002-9343(70)80110-3; INOUE S, 1980, J ALLERGY CLIN IMMUN, V66, P299, DOI 10.1016/0091-6749(80)90025-1; KAPLAN AP, 1981, NEW ENGL J MED, V305, P1074, DOI 10.1056/NEJM198110293051808; KAPLAN AP, 1975, J ALLERGY CLIN IMMUN, V55, P394, DOI 10.1016/0091-6749(75)90078-0; KEAHEY TM, 1984, BRIT J DERMATOL, V110, P327, DOI 10.1111/j.1365-2133.1984.tb04639.x; KEAHEY TM, 1980, ARCH DERMATOL, V116, P174, DOI 10.1001/archderm.116.2.174; KELLY FJ, 1953, AM J MED, V15, P431, DOI 10.1016/0002-9343(53)90132-6; LAVKER RM, 1979, J INVEST DERMATOL, V73, P59, DOI 10.1111/1523-1747.ep12532763; LEIGH IM, 1975, BRIT J DERMATOL, V92, P191, DOI 10.1111/j.1365-2133.1975.tb03057.x; RAMSAY CA, 1977, ARCH DERMATOL, V113, P1222, DOI 10.1001/archderm.113.9.1222; SIGLER RW, 1980, J ALLERGY CLIN IMMUN, V65, P309, DOI 10.1016/0091-6749(80)90161-X; SOTER NA, 1976, NEW ENGL J MED, V294, P687, DOI 10.1056/NEJM197603252941302; WANDERER AA, 1986, J ALLERGY CLIN IMMUN, V78, P417, DOI 10.1016/0091-6749(86)90027-8; WANDERER AA, 1971, J ALLERGY CLIN IMMUN, V48, P13, DOI 10.1016/0091-6749(71)90050-9; WASSERMAN SI, 1982, CLIN EXP IMMUNOL, V47, P570; WASSERMAN SI, 1977, J CLIN INVEST, V60, P189, DOI 10.1172/JCI108756	21	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1988	82	2					256	261		10.1016/0091-6749(88)91008-1	http://dx.doi.org/10.1016/0091-6749(88)91008-1			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P8741	3403865	Bronze			2022-12-18	WOS:A1988P874100018
J	BUTCHER, BT; DESHAZO, RD; ORTIZ, AA; REED, MA				BUTCHER, BT; DESHAZO, RD; ORTIZ, AA; REED, MA			RAST-INHIBITION STUDIES OF THE IMPORTED FIRE ANT SOLENOPSIS-INVICTA WITH WHOLE-BODY EXTRACTS AND VENOM PREPARATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TULANE UNIV,MED CTR,DEPT MED,CLIN IMMUNOL SECT,NEW ORLEANS,LA 70118; BROOKE ARMY MED CTR,ALLERGY IMMUNOL SERV,FT SAM HOUSTON,TX 78234	Tulane University; San Antonio Military Medical Center; United States Department of Defense; United States Army					NIAID NIH HHS [AI 21552-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021552] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADROUNEY GA, 1959, SCIENCE, V128, P306; BRAND JM, 1976, TOXICON, V14, P69; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V81, P33, DOI 10.1016/0091-6749(88)90217-5; BUTCHER BT, 1983, CLIN ALLERGY, V13, P31, DOI 10.1111/j.1365-2222.1983.tb02563.x; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1021, DOI 10.1016/0019-2791(72)90112-7; DESHAZO RD, 1984, J ALLERGY CLIN IMMUN, V74, P841, DOI 10.1016/0091-6749(84)90188-X; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HANNAN CJ, 1986, J ALLERGY CLIN IMMUN, V78, P331, DOI 10.1016/S0091-6749(86)80085-9; JONES TH, 1984, J CHEM ECOL, V10, P1233, DOI 10.1007/BF00988551; KLEINBAUM DG, 1978, APPLIED REGRESSION A, P99; MACCONNELL JG, 1970, SCIENCE, V168, P840, DOI 10.1126/science.168.3933.840; RHOADES RB, 1975, J ALLERGY CLIN IMMUN, V56, P84, DOI 10.1016/0091-6749(75)90112-8; RHOADES RB, 1977, J FLA MED ASSOC, V64, P247; STROM GB, 1983, J ALLERGY CLIN IMMUN, V72, P46, DOI 10.1016/0091-6749(83)90051-9; Tallarida RJ, 1981, MANUAL PHARM CALCULA; TRIPLETT RF, 1976, SOUTHERN MED J, V69, P258, DOI 10.1097/00007611-197603000-00002; TRIPLETT RF, 1973, SOUTHERN MED J, V66, P477, DOI 10.1097/00007611-197304000-00019; VALENTINE M, 1982, CURRENT PERSPECTIVES, P122; Yaeger W, 1978, J MED ASS GA, V67, P101; 1983, STATPRO STATISTICS G	20	16	16	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1988	81	6					1096	1100		10.1016/0091-6749(88)90875-5	http://dx.doi.org/10.1016/0091-6749(88)90875-5			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P0023	3379222	Bronze			2022-12-18	WOS:A1988P002300005
J	BERMAN, BA				BERMAN, BA			ALLERGIC RHINITIS - MECHANISMS AND MANAGEMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		ALLANSMITH MR, 1986, SURV OPHTHALMOL, V30, P229, DOI 10.1016/0039-6257(86)90119-0; BAUMGARTEN CR, 1986, J IMMUNOL, V137, P977; BERMAN BA, 1983, CLIN REV ALLERGY, V1, P1; BIERMAN CW, 1980, ALLERGIC DISEASES IN; CHANDRA RK, 1982, ANN ALLERGY, V49, P131; DAVIES HJ, 1985, CLIN ALLERGY, V15, P419, DOI 10.1111/j.1365-2222.1985.tb02291.x; DVORACEK JE, 1984, J ALLERGY CLIN IMMUN, V73, P363, DOI 10.1016/0091-6749(84)90409-3; ESTELLE F, 1984, CLIN REV ALLERG, V2, P237; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P160, DOI 10.1016/0091-6749(82)90037-9; HANDELMAN NI, 1977, J ALLERGY CLIN IMMUN, V59, P237, DOI 10.1016/0091-6749(77)90156-7; LINDSAYMILLER ACM, 1987, ANN ALLERGY, V58, P28; MALM L, 1980, ACTA OTO-LARYNGOL, V90, P304, DOI 10.3109/00016488009131730; Mygind N., 1979, NASAL ALLERGY; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; ORIE NGM, 1970, DISODIUM CROMOGLYCAT; PELIKAN Z, 1978, ANN ALLERGY, V41, P37; PELIKAN Z, 1982, ANN ALLERGY, V49, P200; PELIKAN Z, 1982, ANN ALLERGY, V49, P283; SANWIKARJA S, 1986, ANN ALLERGY, V56, P162; Schwartz H J, 1986, Ear Nose Throat J, V65, P449; SCHWARTZ HJ, 1987, J ALLERGY CLIN IMMUN, V79, P186; SHAPIRO GG, 1985, PHARMACOTHERAPY, V5, P156; SHORE SC, 1981, S AFR MED J, V59, P252; STAFFORD CT, 1987, POSTGRAD MED, V81, P147, DOI 10.1080/00325481.1987.11699668; UDDMAN R, 1979, ORL J OTO-RHINO-LARY, V41, P221, DOI 10.1159/000275461; VINER AS, 1976, CLIN ALLERGY, V6, P251, DOI 10.1111/j.1365-2222.1976.tb01904.x; WANNER A, 1983, J ALLERGY CLIN IMMUN, V72, P347, DOI 10.1016/0091-6749(83)90498-0; WASSERMAN SI, 1983, J ALLERGY CLIN IMMUN, V72, P101, DOI 10.1016/0091-6749(83)90512-2; WELSH PW, 1987, MAYO CLIN PROC, V62, P125, DOI 10.1016/S0025-6196(12)61882-5; WELSH PW, 1977, J ALLERGY CLIN IMMUN, V60, P104, DOI 10.1016/0091-6749(77)90034-3; 1983, NCHS ADV DATA, V88	31	16	16	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	2	S			980	984		10.1016/0091-6749(88)90165-0	http://dx.doi.org/10.1016/0091-6749(88)90165-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7037	2453545				2022-12-18	WOS:A1988N703700010
J	KIRKPATRICK, CH				KIRKPATRICK, CH			TRANSFER-FACTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											KIRKPATRICK, CH (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,CONRAD D STEPHENSON LAB RES IMMUNOL,1400 JACKSON ST,DENVER,CO 80206, USA.				NIAID NIH HHS [AI-18487] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BORKOWSKY W, 1981, J IMMUNOL, V126, P486; BURGER DR, 1979, J IMMUNOL, V122, P1091; BURGER DR, 1977, CELL IMMUNOL, V29, P4; BURGER DR, 1979, IMMUNE REGULATORS TR, P377; BURGER DR, 1976, J RETICULOENDOTHEL S, V24, P385; BUUS S, 1986, CELL, V47, P1071, DOI 10.1016/0092-8674(86)90822-6; CATANZARO A, 1974, J CLIN INVEST, V54, P690, DOI 10.1172/JCI107807; CHASE MW, 1945, P SOC EXP BIOL MED, V59, P134, DOI 10.3181/00379727-59-15006P; Dwyer J. M., 1983, IMMUNOBIOLOGY TRANSF, P233; EMODI G, 1973, LANCET, V2, P1382; GUILLET JG, 1987, SCIENCE, V235, P865, DOI 10.1126/science.2433769; HEBERKATZ E, 1983, J MOL CELL IMMUNOL, V1, P3; KHAN A, 1981, DERMATOLOGICA, V163, P177, DOI 10.1159/000250157; KHAN A, 1978, LANCET, V1, P328; Kirkpatrick C. H., 1979, IMMUNE REGULATORS TR, P547; KIRKPATRICK CH, 1985, J IMMUNOL, V134, P1723; KIRKPATRICK CH, 1985, J IMMUNOL, V135, P4027; KIRKPATRICK CH, 1972, J CLIN INVEST, V51, P2948, DOI 10.1172/JCI107119; KIRKPATRICK CH, IN PRESS J EXP PATHO; KIRKPATRICK CH, 1983, LYMPHOKINES, V8, P1; Landsteiner K, 1942, P SOC EXP BIOL MED, V49, P688, DOI 10.3181/00379727-49-13670; LAWRENCE HS, 1956, J EXP MED, V104, P321, DOI 10.1084/jem.104.3.321; LAWRENCE HS, 1983, CELL IMMUNOL, V82, P102, DOI 10.1016/0008-8749(83)90145-4; LAWRENCE HS, 1955, J CLIN INVEST, V34, P219, DOI 10.1172/JCI103075; LAWRENCE HS, 1963, T ASSOC AM PHYSICIAN, V76, P84; LEVIN AS, 1975, J CLIN INVEST, V55, P487, DOI 10.1172/JCI107955; LIEW FY, 1982, IMMUNOL TODAY, V3, P18, DOI 10.1016/0167-5699(82)90119-0; NASH AA, 1983, CELL IMMUNOL, V75, P348, DOI 10.1016/0008-8749(83)90332-5; PADDOCK GV, 1979, IMMUNE REGULATORS TR, P419; PETERSEN EA, 1981, J IMMUNOL, V126, P2480; PETERSEN EA, 1983, IMMUNOBIOLOGY TRANSF, P65; RAPAPORT FT, 1960, J IMMUNOL, V84, P358; RIFKIND D, 1977, INFECT IMMUN, V16, P258, DOI 10.1128/IAI.16.1.258-262.1977; SPITLER LE, 1972, J CLIN INVEST, V51, P3216, DOI 10.1172/JCI107148; SPITLER LE, 1973, J CLIN INVEST, V52, pA80; Steele R. W., 1976, TRANSFER FACTOR BASI, P381; STEELE RW, 1980, NEW ENGL J MED, V303, P355, DOI 10.1056/NEJM198008143030702; TSANG KY, 1986, SPRINGER SEMIN IMMUN, V9, P19; VIZA D, 1985, LYMPHOKINE RES, V4, P27; Viza D., 1983, IMMUNOBIOLOGY TRANSF, P245; WILSON GB, 1981, LYMPHOKINES, V4, P107	42	16	19	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	1				803	813		10.1016/0091-6749(88)90935-9	http://dx.doi.org/10.1016/0091-6749(88)90935-9			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7036	3286720				2022-12-18	WOS:A1988N703600007
J	VOLOVITZ, B; VARSANO, I; CUMELLA, JC; JABER, L				VOLOVITZ, B; VARSANO, I; CUMELLA, JC; JABER, L			EFFICACY AND SAFETY OF KETOTIFEN IN YOUNG-CHILDREN WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TEL AVIV UNIV, BEILINSON MED CTR, SACKLER SCH MED, DEPT PEDIAT, PETACH TIKVA, ISRAEL; SUNY BUFFALO, DEPT PEDIAT, DIV ALLERGY & IMMUNOL, BUFFALO, NY 14260 USA	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								CLARKE CW, 1980, BRIT J CLIN PHARMACO, V10, P473, DOI 10.1111/j.1365-2125.1980.tb01791.x; CRAPS L, 1978, CLIN ALLERGY, V8, P373, DOI 10.1111/j.1365-2222.1978.tb00472.x; CRAPS L, 1983, PHARMATHERAPEUTICA, V3, P314; CRAPS L, 1981, PHARMATHERAPEUTICA, V3, P18; CRAPS L, 1981, INT ARCH ALLER A IMM, V66, P272, DOI 10.1159/000232917; GRAFFLONNEVIG V, 1985, J ALLERGY CLIN IMMUN, V76, P59, DOI 10.1016/0091-6749(85)90805-X; GREENWOOD C, 1982, CHEST, V82, pS45, DOI 10.1378/chest.82.1.45S; GROGGINS RC, 1981, ARCH DIS CHILD, V56, P304, DOI 10.1136/adc.56.4.304; JAKSCHIK BA, 1977, J IMMUNOL, V119, P618; KUMAGAI A, 1980, SCHWEIZ MED WSCHR, V110, P197; LAMARRE A, 1980, RESPIRATION, V39, P16, DOI 10.1159/000195031; LOWE DA, 1980, RESPIRATION, V39, P44, DOI 10.1159/000195038; MARTIN U, 1978, ARZNEIMITTELFORSCH, V28-1, P770; MARTIN U, 1977, ALLERGOL IMMUNOPA S5, V5, P5; SIMONS FER, 1982, ANN ALLERGY, V48, P145; SPICAK V, 1980, RESPIRATION, V39, P18, DOI 10.1159/000195032; SZCZEKLIK A, 1980, RESPIRATION, V39, P3; TINKELMAN DG, 1985, J ALLERGY CLIN IMMUN, V76, P487, DOI 10.1016/0091-6749(85)90732-8	18	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1988	81	3					509	517		10.1016/0091-6749(88)90189-3	http://dx.doi.org/10.1016/0091-6749(88)90189-3			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M6181		Bronze			2022-12-18	WOS:A1988M618100005
J	BANERJI, D; FOX, R; SELEZNICK, M; LOCKEY, R				BANERJI, D; FOX, R; SELEZNICK, M; LOCKEY, R			CONTROLLED ANTIPRURITIC TRIAL OF NALMEFENE (N) IN CHRONIC URTICARIA (CU) AND ATOPIC-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	16	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					252	252		10.1016/0091-6749(88)90571-4	http://dx.doi.org/10.1016/0091-6749(88)90571-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400358
J	MEDIRATTA, PK; DAS, N; GUPTA, VS; SEN, P				MEDIRATTA, PK; DAS, N; GUPTA, VS; SEN, P			MODULATION OF HUMORAL IMMUNE-RESPONSES BY ENDOGENOUS OPIOIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLL MED SCI,DEPT PHARMACOL,RING ROAD,NEW DELHI 110029,INDIA	University of Delhi; University College of Medical Sciences								AMIR S, 1982, EUR J PHARMACOL, V80, P161, DOI 10.1016/0014-2999(82)90194-7; BESEDOVSKY H, 1977, CLIN EXP IMMUNOL, V27, P1; CASALE TB, 1984, J ALLERGY CLIN IMMUN, V73, P775, DOI 10.1016/0091-6749(84)90447-0; CHAKRAVARTY N, 1965, J CELL BIOL, V25, P113, DOI 10.1083/jcb.25.2.113; CHAKRAVARTY N, 1968, ACTA PHYSIOL SCAND, V72, P425, DOI 10.1111/j.1748-1716.1968.tb03867.x; ELLIS HV, 1970, J PHARMACOL EXP THER, V175, P627; FERRANTE A, 1979, CLIN EXP IMMUNOL, V38, P70; GOPALAKRISHNAN C, 1980, INDIAN J MED RES, V71, P940; GROSMAN N, 1982, AGENTS ACTIONS, V12, P417, DOI 10.1007/BF01965920; HOLADAY JW, 1983, ANNU REV PHARMACOL, V23, P541, DOI 10.1146/annurev.pa.23.040183.002545; HOLADAY JW, 1982, LIFE SCI, V31, P2359, DOI 10.1016/0024-3205(82)90156-4; HOLADAY JW, 1982, FED PROC, V41, P1468; HUGES J, 1983, OPIOID PEPTIDES; SOLOMON GF, 1981, ANNU REV MICROBIOL, V35, P155, DOI 10.1146/annurev.mi.35.100181.001103; STEIN M, 1976, SCIENCE, V191, P435; WILLIAM CA, 1976, METHODS IMMUNOLOGY I, V5, P1; 1984, LANCET, V1, P774	17	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					27	32		10.1016/0091-6749(88)90216-3	http://dx.doi.org/10.1016/0091-6749(88)90216-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274	2448356				2022-12-18	WOS:A1988M027400005
J	MAZUR, G; BECKER, WM; BAUR, X				MAZUR, G; BECKER, WM; BAUR, X			EPITOPE MAPPING OF MAJOR INSECT ALLERGENS (CHIRONOMID HEMOGLOBINS) WITH MONOCLONAL-ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FORSCHUNGSINST BORSTEL,D-2061 BORSTEL,FED REP GER	Forschungszentrum Borstel	MAZUR, G (corresponding author), UNIV MUNICH,KLINIKUM GROSSHADERN,MED KLIN 1,PNEUMOL ABT,MARCHIONINISTR 15,D-8000 MUNICH 70,FED REP GER.							ALTSCHUH D, 1985, MOL IMMUNOL, V22, P329, DOI 10.1016/0161-5890(85)90169-5; BAUR X, 1982, J ALLERGY CLIN IMMUN, V69, P66, DOI 10.1016/0091-6749(82)90090-2; BAUR X, 1983, CLIN EXP IMMUNOL, V54, P599; BAUR X, 1986, SCIENCE, V233, P351, DOI 10.1126/science.2425431; BAUR X, 1982, INT C ALLERGY CLIN I; BERZOFSKY JA, 1982, J BIOL CHEM, V257, P3189; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; GEYSEN HM, 1985, IMMUNOL TODAY, V6, P364, DOI 10.1016/0167-5699(85)90096-9; GOODMAN M, 1983, H-S Z PHYSIOL CHEM, V364, P205, DOI 10.1515/bchm2.1983.364.1.205; HAAS H, 1986, INT ARCH ALLER A IMM, V79, P434, DOI 10.1159/000234014; IGARASHI T, 1985, ANN ALLERGY 2, V55, P596; KAY AB, 1978, CLIN EXP IMMUNOL, V34, P106; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045; METZGER DW, 1984, EUR J IMMUNOL, V14, P87, DOI 10.1002/eji.1830140116; OLSON JR, 1986, J IMMUNOL, V136, P2109; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; RETEGUI LA, 1986, MOL IMMUNOL, V23, P119, DOI 10.1016/0161-5890(86)90032-5; SINGH MB, 1985, INT ARCH ALLER A IMM, V78, P300, DOI 10.1159/000233901; STEER W, 1981, H-S Z PHYSIOL CHEM, V362, P73, DOI 10.1515/bchm2.1981.362.1.73; STEIGEMANN W, 1979, J MOL BIOL, V127, P309, DOI 10.1016/0022-2836(79)90332-2; TEE RD, 1985, CLIN ALLERGY, V15, P335, DOI 10.1111/j.1365-2222.1985.tb03001.x	22	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1987	80	6					876	883		10.1016/S0091-6749(87)80280-4	http://dx.doi.org/10.1016/S0091-6749(87)80280-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5020	2447145	Bronze			2022-12-18	WOS:A1987L502000017
J	MILAVETZ, G; VAUGHAN, LM; WEINBERGER, MM; HARRIS, JB; MULLENIX, TA				MILAVETZ, G; VAUGHAN, LM; WEINBERGER, MM; HARRIS, JB; MULLENIX, TA			RELATIONSHIP BETWEEN RATE AND EXTENT OF ABSORPTION OF ORAL THEOPHYLLINE FROM UNIPHYL BRAND OF SLOW-RELEASE THEOPHYLLINE AND RESULTING SERUM CONCENTRATIONS DURING MULTIPLE DOSING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV IOWA,COLL MED,DEPT PEDIAT,DIV ALLERGY & PULM,IOWA CITY,IA 52242	University of Iowa	MILAVETZ, G (corresponding author), UNIV IOWA,COLL PHARM,IOWA CITY,IA 52242, USA.				NCRR NIH HHS [RR-59] Funding Source: Medline; NIAID NIH HHS [AI-16151] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DUSDIEKER L, 1982, J PEDIATR-US, V101, P281; FINK JN, 1985, AM J MED, V79, P58, DOI 10.1016/0002-9343(85)90090-7; GINCHANSKY E, 1977, J PEDIATR-US, V91, P655, DOI 10.1016/S0022-3476(77)80527-1; HAMBLETON G, 1977, LANCET, V1, P381; HENDELES L, 1978, AM J DIS CHILD, V132, P876; HENDELES L, 1985, CHEST, V87, P758, DOI 10.1378/chest.87.6.758; HENDELES L, 1984, CLIN PHARMACOKINET, V9, P95, DOI 10.2165/00003088-198409020-00001; HENDELES L, 1977, AM J HOSP PHARM, V34, P525, DOI 10.1093/ajhp/34.5.525; HENDELES L, 1986, J ALLERGY CLIN IMMUN, V78, P743, DOI 10.1016/0091-6749(86)90055-2; HENDELES L, 1983, PHARMACOTHERAPY, V3, P2; JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349; JOAD JP, 1987, J ALLERGY CLIN IMMUN, V79, P78, DOI 10.1016/S0091-6749(87)80020-9; KARIM A, 1985, CLIN PHARMACOL THER, V38, P77, DOI 10.1038/clpt.1985.138; Karim A, 1985, Am Pharm, VNS25, P4; MANGURA BT, 1986, CHEST, V90, P566, DOI 10.1378/chest.90.4.566; MILAVETZ G, 1987, CLIN PHARMACOL THER, V41, P388, DOI 10.1038/clpt.1987.46; MILAVETZ G, 1984, PHARMACOTHERAPY, V4, P216; MILAVETZ G, 1986, J PEDIATR-US, V109, P351, DOI 10.1016/S0022-3476(86)80403-6; NASSIF EG, 1981, NEW ENGL J MED, V304, P71, DOI 10.1056/NEJM198101083040202; NEIJENS HJ, 1985, J PEDIATR-US, V107, P811, DOI 10.1016/S0022-3476(85)80426-1; PECK CC, 1985, J ALLERGY CLIN IMMUN, V76, P292, DOI 10.1016/0091-6749(85)90644-X; PEDERSEN S, 1987, J PEDIATR-US, V110, P953, DOI 10.1016/S0022-3476(87)80424-9; PEDERSEN S, 1984, PEDIATRICS, V74, P534; PETTY TL, 1984, NEW PERSPECTIVES THE; POLLOCK J, 1977, PEDIATRICS, V60, P840; RICHER C, 1982, CLIN PHARMACOL THER, V31, P579, DOI 10.1038/clpt.1982.81; SARRAZIN E, 1980, J PEDIATR-US, V97, P825, DOI 10.1016/S0022-3476(80)80280-0; SIMONS FER, 1982, AM J DIS CHILD, V136, P790, DOI 10.1001/archpedi.1982.03970450032008; SKELLY JP, 1983, SUMMARY BASIS APPROV; VAUGHAN LM, 1986, LANCET, V1, P184; VAUGHAN LM, 1986, DRUG INTEL CLIN PHAR, V20, P118, DOI 10.1177/106002808602000204; WEINBERG.MM, 1974, J PEDIATR-US, V84, P421; WEINBERGER M, 1981, J PEDIATR-US, V99, P145, DOI 10.1016/S0022-3476(81)80982-1; WEINBERGER M, 1986, ANN ALLERGY, V56, P2; WEINBERGER M, 1975, CLIN PHARMACOL THER, V17, P585; WEINBERGER M, 1983, NEW ENGL J MED, V308, P760, DOI 10.1056/NEJM198303313081306; WEINBERGER M, 1977, J PEDIATR-US, V91, P820, DOI 10.1016/S0022-3476(77)81051-2; WEINBERGER M, 1978, NEW ENGL J MED, V299, P852, DOI 10.1056/NEJM197810192991603; WEINBERGER M, 1986, IOWA MED, V76, P24; WEINBERGER MM, 1984, PHARMACOTHERAPY, V4, P181; WELSH PW, 1986, AM J MED, V80, P1098, DOI 10.1016/0002-9343(86)90671-6; 1984, FDA PUBLICATION, V14; 1985, WASHINGTON DRUG LETT, V17	43	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1987	80	5					723	729		10.1016/0091-6749(87)90294-6	http://dx.doi.org/10.1016/0091-6749(87)90294-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K9930	3680816				2022-12-18	WOS:A1987K993000014
J	ASAI, S; SHIMODA, T; HARA, K; FUJIWARA, K				ASAI, S; SHIMODA, T; HARA, K; FUJIWARA, K			OCCUPATIONAL ASTHMA CAUSED BY ISONICOTINIC-ACID HYDRAZIDE (INH) INHALATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NAGASAKI UNIV,FAC PHARMACEUT SCI,NAGASAKI 852,JAPAN	Nagasaki University	ASAI, S (corresponding author), NAGASAKI UNIV,SCH MED,DEPT INTERNAL MED 2,SAKAMOTO MACH 7-1,NAGASAKI 852,JAPAN.							DASTA JF, 1979, CHEST, V75, P196, DOI 10.1378/chest.75.2.196; ERGSTROM I, 1980, ALLERGY, V35, P256; FUJIWARA K, 1987, J ALLERGY CLIN IMMUN, V80, P582, DOI 10.1016/0091-6749(87)90011-X; MANDELL GL, 1980, PHARMACOL BASIS THER, P1200; TSE KS, 1976, J IMMUNOL, V116, P965; VOORHORST R, 1980, ALLERGY, V35, P247, DOI 10.1111/j.1398-9995.1980.tb01762.x; Wang I, 1974, Z Hautkr, V49, P803; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1	8	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1987	80	4					578	582		10.1016/0091-6749(87)90010-8	http://dx.doi.org/10.1016/0091-6749(87)90010-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5224	3668121				2022-12-18	WOS:A1987K522400010
J	HOGG, JC				HOGG, JC			VARIETIES OF AIRWAY NARROWING IN SEVERE AND FATAL ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV BRITISH COLUMBIA,DEPT PATHOL,VANCOUVER V6T 1W5,BC,CANADA	University of British Columbia	HOGG, JC (corresponding author), ST PAULS HOSP,PULM RES LAB,1081 BURRARD ST,VANCOUVER V6Z 1Y6,BC,CANADA.							ADAMS GK, 1979, J IMMUNOL, V122, P555; ARMOUR CL, 1984, AM REV RESPIR DIS, V129, P907; BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; Dunnill M S, 1971, Ciba Found Study Group, V38, P35; DUNNILL MS, 1969, THORAX, V24, P176, DOI 10.1136/thx.24.2.176; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; FREEDMAN BJ, 1972, B PHYSL PATHOL RESPI, V85, P45; HEARD BE, 1973, J PATHOL, V110, P319, DOI 10.1002/path.1711100406; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; JAMES AL, 1986, AM REV RESPIR DIS, V133, pA113; MACKLEM PT, 1970, RESP PHYSIOL, V8, P191, DOI 10.1016/0034-5687(70)90015-0; MARTIN JG, 1986, AM REV RESPIR DIS, V133, pA15; MCCARTER JH, 1966, ARCH PATHOL, V82, P328; MORENO RH, 1986, AM REV RESPIR DIS, V133, P1171; MORENO RH, 1985, AM REV RESPIR DIS, V131, P288; NAYLOR BERNARD, 1962, THORAX, V17, P69, DOI 10.1136/thx.17.1.69; PATTERSON JW, 1982, BRONCHIAL HYPERRACTI, P19; Rigler LG, 1938, AM J ROENTGENOL RADI, V39, P353; SANERKIN NG, 1965, J PATHOL BACTERIOL, V89, P535, DOI 10.1002/path.1700890211; SCHELLENBERG RR, 1984, INT ARCH ALLER A IMM, V75, P237, DOI 10.1159/000233622; SOBONYA RE, 1984, AM REV RESPIR DIS, V130, P289; TAYLOR SM, 1985, AM REV RESPIR DIS, V132, P32; VINCENC KS, 1983, AM REV RESPIR DIS, V128, P875	23	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	2	S			417	419		10.1016/0091-6749(87)90065-0	http://dx.doi.org/10.1016/0091-6749(87)90065-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1037	3624696				2022-12-18	WOS:A1987K103700016
J	PATAKAS, D; MANIKI, E; TSARA, V; DASCALOPOULOU, E				PATAKAS, D; MANIKI, E; TSARA, V; DASCALOPOULOU, E			NIFEDIPINE TREATMENT OF PATIENTS WITH BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PATAKAS, D (corresponding author), ARISTOTELIAN UNIV SALONIKA,DEPT INTERNAL MED,PULM CLIN,1 PATRIARCHOU IOAKIM ST,SALONIKA,GREECE.							ANTMAN E, 1980, NEW ENGL J MED, V302, P1269, DOI 10.1056/NEJM198006053022301; BARNES PJ, 1981, THORAX, V36, P726, DOI 10.1136/thx.36.10.726; CERRINA J, 1981, AM REV RESPIR DIS, V123, P156; Cotes JE, 1975, LUNG FUNCTION; GONZALEZ JM, 1983, AM REV RESPIR DIS, V127, P155; HENDERSON AF, 1983, THORAX, V38, P512, DOI 10.1136/thx.38.7.512; HENDERSON AF, 1983, AM REV RESPIR DIS, V127, P549, DOI 10.1164/arrd.1983.127.5.549; Hills E A, 1970, Br J Clin Pract, V24, P116; HIMORI N, 1980, BRIT J PHARMACOL, V68, P595, DOI 10.1111/j.1476-5381.1980.tb10848.x; JAIPRAKASH SS, 1980, POSTGRAD MED J, V56, P624, DOI 10.1136/pgmj.56.659.624; LORELL BH, 1980, CIRCULATION, V62, P317; NAIR N, 1984, CHEST, V86, P515, DOI 10.1378/chest.86.4.515; OLIVARI MT, 1979, CIRCULATION, V59, P1056, DOI 10.1161/01.CIR.59.5.1056; PATAKAS D, 1983, THORAX, V38, P108, DOI 10.1136/thx.38.2.108; PATAKAS D, 1983, J ALLERGY CLIN IMMUN, V72, P269, DOI 10.1016/0091-6749(83)90031-3; RODHEFFER RJ, 1983, NEW ENGL J MED, V308, P880; RUSSI EW, 1984, CHEST, V86, P475, DOI 10.1378/chest.86.3.475; WEISER HF, 1977, Z GASTROENTEROL, V15, P691; WILLIAMS DO, 1981, BR MED J, P283	19	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1987	79	6					959	963		10.1016/0091-6749(87)90247-8	http://dx.doi.org/10.1016/0091-6749(87)90247-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	H9044	3294978				2022-12-18	WOS:A1987H904400019
J	BOSSE, J; BOILEAU, R; BEGIN, R; GEOFFROY, M; MARTEL, M; DESMARAIS, Y				BOSSE, J; BOILEAU, R; BEGIN, R; GEOFFROY, M; MARTEL, M; DESMARAIS, Y			CHRONIC ALLERGIC AIRWAY DISEASE IN THE SHEEP MODEL - FUNCTIONAL AND LUNG-LAVAGE FEATURES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHU SHERBROOKE,PULM RES UNIT,SHERBROOKE J1H 5N4,QUEBEC,CANADA	University of Sherbrooke								ABRAHAM WM, 1983, AM REV RESPIR DIS, V128, P839; ATKINS PC, 1980, J ALLERGY CLIN IMMUN, V66, P478, DOI 10.1016/0091-6749(80)90009-3; AUBAS P, 1984, AM REV RESPIR DIS, V130, P875; BEGIN R, 1981, J APPL PHYSIOL, V50, P665, DOI 10.1152/jappl.1981.50.3.665; BEGIN R, 1985, ENVIRON RES, V36, P389, DOI 10.1016/0013-9351(85)90033-7; BEGIN R, 1982, AM REV RESPIR DIS, V126, P870; BEGIN R, 1986, CHEST, V89, P237, DOI 10.1378/chest.89.2.237; DAHLEN SE, 1983, P NATL ACAD SCI-BIOL, V80, P1712, DOI 10.1073/pnas.80.6.1712; DANIELE RP, 1985, ANN INTERN MED, V102, P93, DOI 10.7326/0003-4819-102-1-93; DERKSEN FJ, 1985, AM REV RESPIR DIS, V132, P1066; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; FRANDSEN EK, 1976, LIFE SCI, V18, P529, DOI 10.1016/0024-3205(76)90331-3; GODARD P, 1981, NOUV PRESSE MED, V10, P3141; GODARD P, 1983, REV FR MAL RESPIR, V11, P275; GODARD P, 1982, BRONCHES ASTHMATIQUE, P49; GRIFFIN M, 1983, NEW ENGL J MED, V308, P436, DOI 10.1056/NEJM198302243080807; HIRSHMAN CA, 1986, AM REV RESPIR DIS, V133, P482; KILLINGSWORTH LM, 1972, CLIN CHEM, V18, P335; KRELL RD, 1976, J ALLERGY CLIN IMMUN, V58, P664, DOI 10.1016/0091-6749(76)90178-0; MCFADDEN ER, 1975, J ALLERGY CLIN IMMUN, V56, P18, DOI 10.1016/0091-6749(75)90030-5; MICHEL FB, 1982, B ACAD NAT MED PARIS, V166, P1019; MORGENSTERN S, 1965, CLIN CHEM, V11, P876; NADEL JA, 1985, CHEST, V87, pS171, DOI 10.1378/chest.87.5_Supplement.171S; RENNARD SI, 1980, ANAL BIOCHEM, V104, P205, DOI 10.1016/0003-2697(80)90300-0; SCHULMAN ES, 1981, AM REV RESPIR DIS, V124, P402; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; Snedecor G.W., 1980, STAT METHODS, V7; WANNER A, 1982, LUNG, V160, P231, DOI 10.1007/BF02719297; 1985, AM REV RESPIR DIS, V132, P180	29	16	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1987	79	2					339	344		10.1016/0091-6749(87)90152-7	http://dx.doi.org/10.1016/0091-6749(87)90152-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G1791	3819218	Bronze			2022-12-18	WOS:A1987G179100007
J	DELPRETE, GF; VERCELLI, D; TIRI, A; MAGGI, E; ROSSI, O; ROMAGNANI, S; RICCI, M				DELPRETE, GF; VERCELLI, D; TIRI, A; MAGGI, E; ROSSI, O; ROMAGNANI, S; RICCI, M			EFFECT OF INVITRO IRRADIATION AND CELL-CYCLE INHIBITORY DRUGS ON THE SPONTANEOUS HUMAN IGE SYNTHESIS INVITRO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV FLORENCE,DEPT ALLERGOL,I-50121 FLORENCE,ITALY; UNIV FLORENCE,DEPT CLIN IMMUNOL,I-50121 FLORENCE,ITALY	University of Florence; University of Florence			Maggi, Enrico/AAA-8045-2019	Maggi, Enrico/0000-0002-1824-3583				COOPER DA, 1979, CLIN EXP IMMUNOL, V37, P145; CUPPS TR, 1985, J CLIN INVEST, V75, P754, DOI 10.1172/JCI111757; FAUCI AS, 1977, J IMMUNOL, V119, P598; FISER PM, 1979, J IMMUNOL, V123, P1788; GRAYSON J, 1981, J CLIN INVEST, V68, P1539, DOI 10.1172/JCI110408; HEMADY Z, 1985, J ALLERGY CLIN IMMUN, V75, P304, DOI 10.1016/0091-6749(85)90062-4; ISHIZAKA K, 1983, IMMUNOL TODAY, V4, P192, DOI 10.1016/0167-5699(83)90080-4; KATZ DH, 1983, PROG IMMUNOL P INT C, V5, P465; MURAGUCHI A, 1984, J IMMUNOL, V133, P1283; OHTA K, 1980, INT ARCH ALLER A IMM, V63, P129, DOI 10.1159/000232618; OKUDAIRA H, 1981, CELL IMMUNOL, V58, P188, DOI 10.1016/0008-8749(81)90160-X; OKUDAIRA H, 1981, INT ARCH ALLER A IMM, V65, P162, DOI 10.1159/000232752; OKUDAIRA H, 1979, FED PROC, V38, P1081; POSEY WC, 1978, J ALLERGY CLIN IMMUN, V62, P340, DOI 10.1016/0091-6749(78)90134-3; RICCI M, 1985, INT ARCH ALLER A IMM, V77, P32, DOI 10.1159/000233749; RICCI M, 1983, 11 P INT C ALL CLIN, P471; ROMAGNANI S, 1983, J CLIN INVEST, V71, P1375, DOI 10.1172/JCI110890; ROMAGNANI S, 1982, CLIN EXP IMMUNOL, V49, P176; ROMAGNANI S, 1980, INT ARCH ALLER A IMM, V63, P64, DOI 10.1159/000232610; ROMAGNANI S, 1978, IMMUNOLOGY, V35, P471; ROMAGNANI S, 1982, CLIN EXP IMMUNOL, V49, P185; ROMAGNANI S, 1980, CLIN EXP IMMUNOL, V42, P579; ROMAGNANI S, 1980, CLIN EXP IMMUNOL, V42, P167; SAMPSON HA, 1981, J IMMUNOL, V127, P829; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SHIRLEY L R, 1982, Journal of Allergy and Clinical Immunology, V69, P157; SMITH RS, 1972, INT ARCH ALLER A IMM, V43, P859, DOI 10.1159/000230903; SPIEGELBERG HL, 1983, J IMMUNOL, V131, P3001; TURNER KJ, 1983, CLIN EXP IMMUNOL, V51, P387; YANAGIHARA Y, 1981, INT ARCH ALLER A IMM, V66, P251, DOI 10.1159/000232828; ZURAW BL, 1981, J IMMUNOL, V127, P1169	31	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					69	77						9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810	3492525				2022-12-18	WOS:A1987F881000015
J	ROSENSTREICH, DL				ROSENSTREICH, DL			CHRONIC URTICARIA, ACTIVATED T-CELLS, AND MAST-CELL RELEASABILITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											ROSENSTREICH, DL (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,1300 MORRIS PK AVE,BRONX,NY 10461, USA.							BEDARD PM, 1986, J ALLERGY CLIN IMMUN, V78, P1121, DOI 10.1016/0091-6749(86)90260-5; BOONK WJ, 1981, DERMATOLOGICA, V163, P151, DOI 10.1159/000250152; CENTER DM, 1983, J ALLERGY CLIN IMMUN, V71, P29, DOI 10.1016/0091-6749(83)90543-2; COHEN RW, 1986, J ALLERGY CLIN IMMUN, V77, P802, DOI 10.1016/0091-6749(86)90377-5; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; EZEUMUZIE IC, 1983, AGENTS ACTIONS, V13, P222; FINDLAY SR, 1980, AM REV RESPIR DIS, V122, P53; FOON KA, 1976, J IMMUNOL, V117, P1545; GOETZL EJ, 1984, IMMUNOLOGY, V53, P227; GREAVES MW, 1974, CLIN ALLERGY, V4, P265, DOI 10.1111/j.1365-2222.1974.tb01384.x; IDA S, 1980, CLIN EXP IMMUNOL, V41, P380; JUHLIN L, 1967, ACTA DERM-VENEREOL, V47, P383; KAPLAN AP, 1981, AM J MED, V70, P755, DOI 10.1016/0002-9343(81)90528-3; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; KAPLAN AP, 1978, J ALLERGY CLIN IMMUN, V61, P350, DOI 10.1016/0091-6749(78)90113-6; KERN F, 1976, J CLIN INVEST, V57, P1369, DOI 10.1172/JCI108405; LETTBROWN MA, 1984, CELL IMMUNOL, V87, P445, DOI 10.1016/0008-8749(84)90013-3; MATHEWS KP, 1980, J ALLERGY CLIN IMMUN, V6, P347; MAY CD, 1976, J ALLERGY CLIN IMMUN, V58, P432, DOI 10.1016/0091-6749(76)90124-X; MEKORI YA, 1983, J ALLERGY CLIN IMMUN, V72, P681, DOI 10.1016/0091-6749(83)90629-2; NATBONY SF, 1983, J ALLERGY CLIN IMMUN, V71, P177, DOI 10.1016/0091-6749(83)90096-9; NUMATA T, 1979, ANN ALLERGY, V43, P356; PHANUPHAK P, 1980, J ALLERGY CLIN IMMUN, V65, P436, DOI 10.1016/0091-6749(80)90237-7; PHANUPHAK P, 1980, J ALLERGY CLIN IMMUN, V65, P371, DOI 10.1016/0091-6749(80)90215-8; RAZIN E, 1984, J IMMUNOL, V132, P1479; SCHULMAN ES, 1985, AM REV RESPIR DIS, V131, P230; SOBOTKA AK, 1979, J IMMUNOL, V122, P511; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; THUESON DO, 1979, J IMMUNOL, V123, P626; TUDOKORO K, 1983, J EXP MED, V158, P857; TUNG R, 1982, J IMMUNOL, V128, P2067; ZACHARIAE H, 1963, ACTA DERM VENEREOL S, V47, P383	32	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1986	78	6					1099	1102		10.1016/0091-6749(86)90256-3	http://dx.doi.org/10.1016/0091-6749(86)90256-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F3026	2431026				2022-12-18	WOS:A1986F302600002
J	HENTGES, F; HUMBEL, R; DICATO, M; HEMMER, R; KUNTZIGER, H				HENTGES, F; HUMBEL, R; DICATO, M; HEMMER, R; KUNTZIGER, H			ACQUIRED-C1 ESTERASE-INHIBITOR DEFICIENCY - CASE-REPORT WITH EMPHASIS ON COMPLEMENT AND KALLIKREIN ACTIVATION DURING 2 PATTERNS OF CLINICAL MANIFESTATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CTR HOSP LUXEMBOURG,BIOCHEM LAB,L-1210 LUXEMBOURG,LUXEMBOURG	Luxembourg Hospital Center	HENTGES, F (corresponding author), CTR HOSP LUXEMBOURG,DEPT IMMUNOALLERGOL,4 BARBLE ST,L-1210 LUXEMBOURG,LUXEMBOURG.							BURDON KL, 1965, J ALLERGY, V36, P546, DOI 10.1016/0021-8707(65)90192-9; Caldwell JR, 1972, CLIN IMMUNOL IMMUNOP, V1, P39; CASALI P, 1978, ACTA HAEMATOL-BASEL, V59, P277, DOI 10.1159/000207773; COHEN SH, 1978, J ALLERGY CLIN IMMUN, V62, P217, DOI 10.1016/0091-6749(78)90210-5; COSTANZI JJ, 1969, J LAB CLIN MED, V74, P902; CULLMANN W, 1982, CLIN EXP IMMUNOL, V49, P618; CULLMANN W, 1982, CLIN CHIM ACTA, V119, P237, DOI 10.1016/0009-8981(82)90335-7; DAY NK, 1976, CLIN EXP IMMUNOL, V26, P189; DEATON CD, 1976, CLIN CHEM, V22, P1465; DENNEHY JJ, 1970, ANN INTERN MED, V73, P55, DOI 10.7326/0003-4819-73-1-55; DONALDSON VH, 1969, J CLIN INVEST, V48, P642, DOI 10.1172/JCI106022; DOR PJ, 1983, J ALLERGY CLIN IMMUN, V71, P363, DOI 10.1016/0091-6749(83)90063-5; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; FIELDS T, 1983, J ALLERGY CLIN IMMUN, V72, P54, DOI 10.1016/0091-6749(83)90052-0; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; GEHA RS, 1985, NEW ENGL J MED, V312, P534, DOI 10.1056/NEJM198502283120902; GELFAND JA, 1979, MEDICINE, V58, P321, DOI 10.1097/00005792-197907000-00004; HADJIYANNAKI K, 1971, Clinical Allergy, V1, P221, DOI 10.1111/j.1365-2222.1971.tb03021.x; HAUPTMANN G, 1979, CLIN EXP IMMUNOL, V37, P523; HAUPTMANN G, 1975, SCAND J HAEMATOL, V15, P22; HAUPTMANN G, 1976, BLUT, V32, P195, DOI 10.1007/BF00995913; Henry T.J., 1974, CLIN CHEM, V2nd; JORDON RE, 1974, CLIN EXP IMMUNOL, V18, P407; KARGES HE, 1982, HAEMOSTASE THROMBOPH, P690; KLEMPERER MR, 1968, J CLIN INVEST, V47, P604, DOI 10.1172/JCI105756; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MCDUFFIE FC, 1973, MAYO CLIN PROC, V48, P340; NILSEN A, 1980, ACTA MED SCAND, V207, P123; OBERLING F, 1975, NOUV PRESSE MED, V4, P2705; PARKER RE, 1979, I BIOL STUDIES BIOL, V43; SCHAPIRA M, 1983, NEW ENGL J MED, V308, P1050, DOI 10.1056/NEJM198305053081802; SCHREIBER AD, 1976, BLOOD, V48, P567; SHAPIRA M, 1982, J CLIN INVEST, V96, P462; SHEFFER AL, 1985, J ALLERGY CLIN IMMUN, V75, P640, DOI 10.1016/0091-6749(85)90087-9; WITT I, 1977, PLASMA KALLIKREIN AK, P6; WONG PY, 1974, ANN INTERN MED, V80, P577, DOI 10.7326/0003-4819-80-5-577	36	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	1				860	867		10.1016/0091-6749(86)90231-9	http://dx.doi.org/10.1016/0091-6749(86)90231-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9713	3640782				2022-12-18	WOS:A1986E971300006
J	NICKLAS, RA; BALAZS, T				NICKLAS, RA; BALAZS, T			ADVERSE-EFFECTS OF THEOPHYLLINE BETA-AGONIST INTERACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									US FDA,DRUG TOX BRANCH,DIV DRUG BIOL,WASHINGTON,DC 20204	US Food & Drug Administration (FDA)	NICKLAS, RA (corresponding author), US FDA,CTR DRUGS & BIOL,OFF DRUG RES & REVIEW,HFN-160,ROCKVILLE,MD 20857, USA.							ALHILLAWI AH, 1984, BRIT MED J, V288, P367, DOI 10.1136/bmj.288.6414.367; AUSTEN KF, 1975, NEW DIRECTIONS ASTHM, P187; BAKER BJ, 1984, CLIN PHARMACOL THER, V35, P226; BALAZS T, 1976, Annals of Clinical and Laboratory Science, V6, P467; BALAZS T, 1972, RECENT ADV STUDIES C, P770; BALAZS T, 1981, CARDIAC TOXICOLOGY, P61; BALAZS T, 1982, CARDIOVASCULAR TOXIC, P199; BANNER AS, 1979, ARCH INTERN MED, V139, P434, DOI 10.1001/archinte.139.4.434; BARCLAY J, 1981, BRIT J CLIN PHARMACO, V11, P203, DOI 10.1111/j.1365-2125.1981.tb01125.x; BARKMAN RP, 1981, MED J AUSTRALIA, V1, P316; BAUGHMAN RP, 1984, ANN ALLERGY, V53, P131; BECK PD, 1981, S AFR MED J, V59, P252; BENEDETTI TJ, 1983, AM J OBSTAT GYNECOL, V141, P1; BOHM N, 1981, EUR J PEDIATR, V136, P1499; BUCH J, 1984, ACTA PHARMACOL TOX, V54, P183; CAMPBELL AH, 1976, MED J AUSTRALIA, V1, P386, DOI 10.5694/j.1326-5377.1976.tb140697.x; CANEPAANSON R, 1982, EUR HEART J, V3, P129; CHAPMAN KR, 1984, CLIN PHARMACOL THER, V35, P762, DOI 10.1038/clpt.1984.108; CHEW WC, 1978, LANCET, V2, P1383; COLEMAN J J, 1985, American Review of Respiratory Disease, V131, pA52; CONRADSON TB, 1984, EUR J CLIN PHARMACOL, V27, P319, DOI 10.1007/BF00542168; COREA L, 1981, BRIT MED J, V283, P500; COTTON DB, 1981, AM J OBSTET GYNECOL, V141, P617, DOI 10.1016/S0002-9378(15)33300-7; CURTIUS JM, 1980, DEUT MED WOCHENSCHR, V105, P1320, DOI 10.1055/s-2008-1070864; DANZIGER Y, 1985, CLIN PHARMACOL THER, V37, P469, DOI 10.1038/clpt.1985.73; DAWSON KP, 1982, ARCH DIS CHILD, V57, P674, DOI 10.1136/adc.57.9.674; DEACON J, 1980, MED J AUSTRALIA, V2, P572, DOI 10.5694/j.1326-5377.1980.tb100773.x; GALANT SP, 1983, PEDIATR CLIN N AM, V30, P931; Gent P N, 1968, Br J Clin Pract, V22, P479; GODFREY S, 1981, THORAX, V36, P534; GRANT IWB, 1983, BRIT MED J, V286, P374, DOI 10.1136/bmj.286.6362.374; GREEFHORST APM, 1983, EUR J CLIN PHARMACOL, V24, P173, DOI 10.1007/BF00613813; GREENBERG A, 1984, AM J MED, V76, P854, DOI 10.1016/0002-9343(84)90997-5; GROGGINS RC, 1980, ARCH DIS CHILD, V55, P204, DOI 10.1136/adc.55.3.204; HAMBLETON G, 1970, ARCH DIS CHILD, V45, P766, DOI 10.1136/adc.45.244.766; HEITZ A, 1983, BRIT J PHARMACOL, V80, P711, DOI 10.1111/j.1476-5381.1983.tb10062.x; HELLIWELL M, 1979, BRIT MED J, V2, P1114, DOI 10.1136/bmj.2.6198.1114; HENDELES L, 1977, DRUG INTEL CLIN PHAR, V11, P12, DOI 10.1177/106002807701100101; HIGBEE MD, 1982, J ALLERGY CLIN IMMUN, V70, P377, DOI 10.1016/0091-6749(82)90028-8; HOOPER WW, 1982, AM HEART J, V104, P1027, DOI 10.1016/0002-8703(82)90436-7; HUDSON LD, 1977, CHEST, V72, P401; INGRAM RH, 1970, AM REV RESPIR DIS, V101, P364; INMAN WHW, 1969, LANCET, V2, P279; JACKSON RT, 1982, BRIT MED J, V285, P771, DOI 10.1136/bmj.285.6344.771; JOSEPH X, 1981, FUNDAM APPL TOXICOL, V2, P147; JOSEPHSON GW, 1980, CHEST, V78, P429, DOI 10.1378/chest.78.3.429; JOSEPHSON GW, 1981, AM REV RESPIR DIS, V124, P765; JOSEPHSON GW, 1979, JAMA, V242, P629; KATZ M, 1981, AM J OBSTET GYNECOL, V139, P605, DOI 10.1016/0002-9378(81)90524-X; KEARNEY TE, 1985, ANN INTERN MED, V102, P766, DOI 10.7326/0003-4819-102-6-766; KELLY HW, 1985, ANN ALLERGY, V54, P405; KELLY HW, 1984, CLIN PHARMACY, V3, P386; KEMP JP, 1984, J ALLERGY CLIN IMMUN, V73, P32, DOI 10.1016/0091-6749(84)90481-0; KENDALL MJ, 1982, J CLIN HOSP PHARM, V7, P31, DOI 10.1111/j.1365-2710.1982.tb00905.x; KENDALL MJ, 1982, BRIT J CLIN PHARMACO, V14, P821, DOI 10.1111/j.1365-2125.1982.tb02043.x; KINNEY EL, 1978, JAMA-J AM MED ASSOC, V240, P2247, DOI 10.1001/jama.1978.03290210029010; KOLSKI G B, 1985, American Review of Respiratory Disease, V131, pA39; KRAVITZ S, 1982, ANN ALLERGY, V48, P261; KUNG M, 1984, AM REV RESPIR DIS, V129, P329; KURLAND G, 1979, J ALLERGY CLIN IMMUN, V63, P407, DOI 10.1016/0091-6749(79)90214-8; LANDS AM, 1964, P SOC EXP BIOL MED, V116, P331; LANDS AM, 1967, NATURE, V214, P597, DOI 10.1038/214597a0; LAURSEN LC, 1985, EUR J RESPIR DIS, V66, P82; LEENEN FHH, 1985, CLIN PHARMACOL THER, V37, P208; LEVINE JH, 1985, LANCET, V1, P12; LITTNER MR, 1983, ANN ALLERGY, V50, P309; LONNERHOLM G, 1981, BRIT MED J, V282, P1029, DOI 10.1136/bmj.282.6269.1029; MANN JS, 1985, AM REV RESPIR DIS, V132, P1; MATSON JR, 1978, J PEDIATR-US, V92, P776, DOI 10.1016/S0022-3476(78)80150-4; MCFADDEN ER, 1981, J ALLERGY CLIN IMMUN, V68, P91, DOI 10.1016/0091-6749(81)90164-0; METTAUER B, 1985, AM HEART J, V109, P840, DOI 10.1016/0002-8703(85)90648-9; MOOSS A, 1985, CHEST, V88, pS52; MORAVEC MA, 1980, ANESTH ANALG, V59, P917; NELSON HS, 1977, AM REV RESPIR DIS, V116, P871; NEVILLE E, 1982, BRIT MED J, V285, P796, DOI 10.1136/bmj.285.6344.796; OROURKE PP, 1984, CRIT CARE MED, V12, P373, DOI 10.1097/00003246-198404000-00007; PATEL AK, 1981, CHEST, V80, P661, DOI 10.1378/chest.80.6.661; PERSSON CGA, 1983, J CARDIOVASC PHARM, V5, P778, DOI 10.1097/00005344-198309000-00012; PIHLAJAMAKI K, 1979, INT J CLIN PHARM BI, V17, P435; PINNAS JL, 1984, CHEST, V86, P896, DOI 10.1378/chest.86.6.896; ROBBERECHT P, 1983, MOL PHARMACOL, V24, P169; RONA G, 1959, ARCH PATHOL, V67, P443; SACKNER MA, 1975, CHEST, V68, P616, DOI 10.1378/chest.68.5.616; SANTO M, 1980, S AFR MED J, V58, P394; SCHOLZ H, 1984, J AM COLL CARDIOL, V4, P389, DOI 10.1016/S0735-1097(84)80231-4; SHIM CS, 1983, AM J MED, V75, P697, DOI 10.1016/0002-9343(83)90459-X; SMITH JA, 1980, CHEST, V78, P816, DOI 10.1378/chest.78.6.816; SMITH SR, 1984, J ROY COLL PHYS LOND, V18, P190; SMYTHE AR, 1981, OBSTET GYNECOL, V57, P566; SNIDER GL, 1972, J AMER MED ASSOC, V221, P682, DOI 10.1001/jama.221.7.682; SVEDMYR K, 1982, ALLERGY, V37, P119, DOI 10.1111/j.1398-9995.1982.tb01885.x; SWENSON E R, 1985, American Review of Respiratory Disease, V131, pA99; TAI E, 1967, THORAX, V22, P543, DOI 10.1136/thx.22.6.543; TANDON MK, 1980, CHEST, V77, P429, DOI 10.1378/chest.77.3.429; TATTERSFIELD A, 1981, THORAX, V36, P320, DOI 10.1136/thx.36.4.320; THOMAS DJB, 1977, BRIT MED J, V2, P438, DOI 10.1136/bmj.2.6084.438; Tsien R W, 1977, Adv Cyclic Nucleotide Res, V8, P363; TYE KH, 1980, JAMA-J AM MED ASSOC, V244, P692, DOI 10.1001/jama.244.7.692; UEDA I, 1961, ANESTHESIOLOGY, V22, P926, DOI 10.1097/00000542-196111000-00010; URTHALER F, 1976, CHEST, V70, P24, DOI 10.1378/chest.70.1.24; VARGAS G, 1975, AM HEART J, V90, P25, DOI 10.1016/0002-8703(75)90253-7; VESTAL RE, 1983, CIRCULATION, V67, P162, DOI 10.1161/01.CIR.67.1.162; VICK J, UNPUB EFFECT CAFFEIN; VINCENT HH, 1984, J CARDIOVASC PHARM, V6, P107; WAELBROECK M, 1983, MOL PHARMACOL, V24, P174; WEBER RW, 1982, J ALLERGY CLIN IMMUN, V70, P417, DOI 10.1016/0091-6749(82)90003-3; WESTLING H, 1979, ACTA PHARMACOL TOX, V44, P36; WHITEHURST VE, 1983, J AM COLL TOXICOL, V2, P147, DOI 10.3109/10915818309140676; WHITEHURST VE, 1983, TOXICOLOGIST, V3, P53; WHITSETT TL, 1981, BRIT J CLIN PHARMACO, V12, P195; WINSOR T, 1975, MICROVASC RES, V9, P261, DOI 10.1016/0026-2862(75)90063-1; YOSSEF A, 1975, CHEST, V68, P107	112	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	2				806	811		10.1016/0091-6749(86)90065-5	http://dx.doi.org/10.1016/0091-6749(86)90065-5			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5684	2877018				2022-12-18	WOS:A1986E568400023
J	SHARP, JT				SHARP, JT			THEOPHYLLINE IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM HOSP,RES SERV,HINES,IL 60141		SHARP, JT (corresponding author), VET ADM HOSP,DEPT MED,DIV PULM,PULM DIS SECT,POB 7,HINES,IL 60141, USA.				NHLBI NIH HHS [HL-31558] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031558] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDER MR, 1980, JAMA-J AM MED ASSOC, V244, P2286, DOI 10.1001/jama.244.20.2286; AUBIER M, 1983, J APPL PHYSIOL, V54, P460, DOI 10.1152/jappl.1983.54.2.460; AUBIER M, 1981, NEW ENGL J MED, V305, P249, DOI 10.1056/NEJM198107303050503; BELLAMY D, 1981, BRIT J DIS CHEST, V75, P190, DOI 10.1016/0007-0971(81)90052-8; BELLEMARE F, 1982, J APPL PHYSIOL, V53, P1190, DOI 10.1152/jappl.1982.53.5.1190; BELMAN MJ, 1985, AM REV RESPIR DIS, V131, P226; COLUCCI WS, 1981, NEW ENGL J MED, V305, P185, DOI 10.1056/NEJM198107233050402; DRUZ WS, 1982, AM REV RESPIR DIS, V125, P275; EATON ML, 1980, ANN INTERN MED, V92, P758, DOI 10.7326/0003-4819-92-6-758; EATON ML, 1982, CHEST, V82, P538, DOI 10.1378/chest.82.5.538; GALDSTON M, 1962, AM J MED, V33, P852, DOI 10.1016/0002-9343(62)90217-6; GOTTFRIED SB, 1978, CHEST, V73, P286, DOI 10.1378/chest.73.2.286; HENDELES L, 1983, PHARMACOTHERAPY, V3, P2; ISHIZAKA T, 1982, ANN ALLERGY, V48, P313; JENNE JW, 1984, AM REV RESPIR DIS, V130, P600; JONES DA, 1982, CLIN SCI, V63, P161, DOI 10.1042/cs0630161; KILLIAN KJ, 1985, CHEST, V88, pS84, DOI 10.1378/chest.88.2_Supplement.84S; LAKSHMINARAYAN S, 1978, AM REV RESPIR DIS, V117, P33; LEE HS, 1982, J PEDIATR-US, V101, P632, DOI 10.1016/S0022-3476(82)80728-2; MAHLER DA, 1985, AM REV RESPIR DIS, V131, P22; MATTHAY RA, 1982, AM HEART J, V104, P1022, DOI 10.1016/0002-8703(82)90435-5; MATTHAY RA, 1978, AM J MED, V65, P903, DOI 10.1016/0002-9343(78)90741-6; MURCIANO D, 1984, NEW ENGL J MED, V311, P349, DOI 10.1056/NEJM198408093110601; PARKER JO, 1967, CIRCULATION, V35, P365, DOI 10.1161/01.CIR.35.2.365; PARKER JO, 1966, CIRCULATION, V33, P17, DOI 10.1161/01.CIR.33.1.17; PAVIA D, 1983, EUR J RESPIR DIS, V64, P304; RAMSDELL JW, 1982, AM REV RESPIR DIS, V126, P829; SHARP JT, 1977, AM REV RESPIR DIS, V115, P47; SHARP JT, 1980, AM REV RESPIR DIS, V122, P201; SHARP JT, 1968, AM J MED, V44, P30; SMITH JA, 1980, CHEST, V78, P816, DOI 10.1378/chest.78.6.816; SUPINSKI GS, 1984, AM REV RESPIR DIS 2, V129, P270; SUTTON PP, 1981, CHEST, V80, P889; TAYLOR DR, 1985, AM REV RESPIR DIS, V131, P747; VIIRES N, 1984, AM REV RESPIR DIS, V129, P396	35	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	2				800	805		10.1016/0091-6749(86)90064-3	http://dx.doi.org/10.1016/0091-6749(86)90064-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5684	2877017				2022-12-18	WOS:A1986E568400022
J	MALO, JL; CARTIER, A; BOULET, LP				MALO, JL; CARTIER, A; BOULET, LP			OCCUPATIONAL ASTHMA IN SAWMILLS OF EASTERN CANADA AND UNITED-STATES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HOP LAVAL, CTR PNEUMOL, QUEBEC CITY, QUEBEC, CANADA	Laval University	MALO, JL (corresponding author), HOP SACRE COEUR, DEPT CHEST MED, 5400 W GOUIN BLVD, MONTREAL H4J 1C5, QUEBEC, CANADA.							[Anonymous], 1979, AM REV RESPIR DIS, V119, P831; BLACK JL, 1985, THORAX, V40, P427, DOI 10.1136/thx.40.6.427; BOOTH BH, 1976, J ALLERGY CLIN IMMUN, V57, P352, DOI 10.1016/0091-6749(76)90092-0; BURGE PS, 1979, THORAX, V34, P308, DOI 10.1136/thx.34.3.308; BURGE PS, 1982, THORAX, V37, P348, DOI 10.1136/thx.37.5.348; BUSH RK, 1978, AM REV RESPIR DIS, V117, P601; CARTIER A, 1984, CLIN ALLERGY, V14, P193, DOI 10.1111/j.1365-2222.1984.tb02652.x; CARTIER A, 1982, J ALLERGY CLIN IMMUN, V70, P170, DOI 10.1016/0091-6749(82)90038-0; CHANYEUNG M, 1976, AM REV RESPIR DIS, V114, P1027; CHANYEUNG M, 1982, AM J MED, V72, P411, DOI 10.1016/0002-9343(82)90497-1; CHANYEUNG M, 1973, AM REV RESPIR DIS, V108, P1094; CHARPIN J, 1974, ALLERGOLOGIE, P120; COCKCROFT DW, 1980, J ALLERGY CLIN IMMUN, V66, P458, DOI 10.1016/0091-6749(80)90006-8; COCKCROFT DW, 1979, CAN MED ASSOC J, V121, P602; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; DEHAUT P, 1983, THORAX, V38, P516, DOI 10.1136/thx.38.7.516; HARGREAVE FE, 1984, AM REV RESPIR DIS, V130, P513; HETZEL MR, 1980, THORAX, V35, P732, DOI 10.1136/thx.35.10.732; HUDSON P, 1985, J ALLERGY CLIN IMMUN, V76, P682, DOI 10.1016/0091-6749(85)90671-2; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; LEMIRE I, 1984, J ALLERGY CLIN IMMUN, V73, P234, DOI 10.1016/S0091-6749(84)80013-5; MALO JL, 1983, J ALLERGY CLIN IMMUN, V72, P413, DOI 10.1016/0091-6749(83)90508-0; MALO JL, 1983, AM REV RESPIR DIS, V128, P8, DOI 10.1164/arrd.1983.128.1.8; ORDMAN D, 1949, Ann Allergy, V7, P492; PAGGIARO PL, 1984, CLIN ALLERGY, V14, P463, DOI 10.1111/j.1365-2222.1984.tb02230.x; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; PICKERING C A C, 1972, Clinical Allergy, V2, P213, DOI 10.1111/j.1365-2222.1972.tb01285.x; ROSENTHAL RR, 1984, J ALLERGY CLIN IMMUN, V73, P676, DOI 10.1016/0091-6749(84)90304-X; RUFFIN RE, 1981, J ALLERGY CLIN IMMUN, V67, P285, DOI 10.1016/0091-6749(81)90023-3; RYAN G, 1981, AM REV RESPIR DIS, V123, P195; SOSMAN AJ, 1969, NEW ENGL J MED, V281, P977, DOI 10.1056/NEJM196910302811802	31	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	1				392	398		10.1016/0091-6749(86)90023-0	http://dx.doi.org/10.1016/0091-6749(86)90023-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1148	3760398				2022-12-18	WOS:A1986E114800004
J	MARSHALL, NA; CHAPMAN, MD; SAXON, A				MARSHALL, NA; CHAPMAN, MD; SAXON, A			SPECIES-SPECIFIC ALLERGENS FROM THE SALIVARY-GLANDS OF TRIATOMINAE (HETEROPTERA, REDUVIIDAE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV CLIN IMMUNOL ALLERGY,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV CLIN IMMUNOL & ALLERGY,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH PUBL HLTH,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles				Chapman, Martin/0000-0002-0845-3632	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015251, R21AI015251, P50AI015332] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-15251, AI-15332] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAUR X, 1983, CLIN EXP IMMUNOL, V54, P599; CHAPMAN MD, 1986, J ALLERGY CLIN IMMUN, V78; HOFFMAN DR, 1985, J ALLERGY CLIN IMMUN, V75, P611, DOI 10.1016/0091-6749(85)90038-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDBERG RE, 1981, J ALLERGY CLIN IMMUN, V67, P25; MARSHALL N, 1986, J MED ENTOMOL, V23, P117, DOI 10.1093/jmedent/23.2.117; MARSHALL NA, 1982, J MED ENTOMOL, V19, P248, DOI 10.1093/jmedent/19.3.248; REISMAN RE, 1982, J ALLERGY CLIN IMMUN, V69, P268, DOI 10.1016/S0091-6749(82)80003-1; RICHMAN PG, 1984, J ALLERGY CLIN IMMUN, V73, P590, DOI 10.1016/0091-6749(84)90516-5; ROHR AS, 1984, J ALLERGY CLIN IMMUN, V73, P369, DOI 10.1016/0091-6749(84)90410-X; Ryckman R.E., 1979, CALIFORNIA VECTOR VIEWS, V26, P1	11	16	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	1				430	435		10.1016/0091-6749(86)90029-1	http://dx.doi.org/10.1016/0091-6749(86)90029-1			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1148	3531291				2022-12-18	WOS:A1986E114800010
J	LEAVENGOOD, DC; RENARD, RL; MARTIN, BG; NELSON, HS				LEAVENGOOD, DC; RENARD, RL; MARTIN, BG; NELSON, HS			CROSS ALLERGENICITY AMONG GRASSES DETERMINED BY TISSUE THRESHOLD CHANGES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FITZSIMONS ARMY MED CTR,ALLERGY IMMUNOL SERV,AURORA,CO 80045									AUGUSTIN R, 1959, IMMUNOLOGY, V2, P148; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1021, DOI 10.1016/0019-2791(72)90112-7; Coca AF, 1925, J IMMUNOL, V10, P445; Cooke RA, 1916, J IMMUNOL, V1, P201; DANTZLER BS, 1980, ANN ALLERGY, V45, P213; FEINBERG JG, 1960, INT ARCH ALLER A IMM, V16, P1; Freeman J, 1911, LANCET, V2, P814; LEIFERMAN KM, 1976, J ALLERGY CLIN IMMUN, V58, P129, DOI 10.1016/0091-6749(76)90148-2; MARSH DG, 1970, J ALLERGY, V46, P107, DOI 10.1016/0021-8707(70)90078-X; MARTIN BG, 1985, ANN ALLERGY, V54, P99; SOBOTKA AK, 1976, J IMMUNOL, V117, P84; STULL ARTHUR, 1932, JOUR ALLERGY, V3, P352, DOI 10.1016/S0021-8707(32)90231-7; TIPTON WR, 1982, J ALLERGY CLIN IMMUN, V69, P194, DOI 10.1016/0091-6749(82)90099-9; WATSON SH, 1922, JAMA-J AM MED ASSOC, V78, P719; WODEHOUSE RP, 1955, INT ARCH ALLER A IMM, V6, P65, DOI 10.1159/000228150	15	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1985	76	6					789	794		10.1016/0091-6749(85)90749-3	http://dx.doi.org/10.1016/0091-6749(85)90749-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AWX93	4067128	Bronze			2022-12-18	WOS:A1985AWX9300005
J	CASIMIR, G; GOSSART, B; VIS, HL; DUCHATEAU, J				CASIMIR, G; GOSSART, B; VIS, HL; DUCHATEAU, J			ANTIBODY AGAINST BETALACTOGLOBULIN (IGG) AND COWS MILK ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	16	16	0	6	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					206	206		10.1016/0091-6749(85)90541-X	http://dx.doi.org/10.1016/0091-6749(85)90541-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200406
J	FRIEDLAENDER, MH				FRIEDLAENDER, MH			OCULAR ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article															NEI NIH HHS [EY 02502] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002502] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABELSON MB, 1983, ARCH OPHTHALMOL-CHIC, V101, P555; ABELSON MB, 1980, AM J OPHTHALMOL, V90, P254, DOI 10.1016/S0002-9394(14)74864-0; ALLANSMITH M, 1967, IMMUNOLOGY, V12, P225; ALLANSMITH MR, 1973, ARCH OPHTHALMOL-CHIC, V89, P36, DOI 10.1001/archopht.1973.01000040038010; ALLANSMITH MR, 1976, AM J OPHTHALMOL, V81, P506, DOI 10.1016/0002-9394(76)90310-X; ALLANSMITH MR, 1977, AM J OPHTHALMOL, V83, P697, DOI 10.1016/0002-9394(77)90137-4; AXELROD AJ, 1978, INVEST OPHTHALMOL  S, V17, P182; Beetham WP, 1940, ARCH OPHTHALMOL-CHIC, V24, P21; BELFORT R, 1978, INVEST OPHTHALMOL  S, V17, P182; BLUESTONE R, 1975, BRIT J OPHTHALMOL, V59, P279, DOI 10.1136/bjo.59.5.279; BRAUNINGER GE, 1971, AM J OPHTHALMOL, V72, P558, DOI 10.1016/0002-9394(71)90853-1; BUCKLEY RJ, 1981, T OPHTHAL SOC UK, V101, P234; CHANDLER JW, 1974, INVEST OPHTH VISUAL, V13, P151; COLES RS, 1952, AMA ARCH OPHTHALMOL, V48, P30; COLLIN HB, 1977, INVEST OPHTH VIS SCI, V16, P858; COPEMAN PWM, 1965, BRIT MED J, V2, P977, DOI 10.1136/bmj.2.5468.977; DONNELLY JJ, 1977, INVEST OPHTH VIS SCI, V16, P976; Dwyer R S, 1976, Mod Probl Ophthalmol, V16, P186; DWYER RSC, 1974, INT ARCH ALLER A IMM, V46, P910, DOI 10.1159/000231192; Easty D, 1971, Trans Ophthalmol Soc U K, V91, P491; ELLIOTT JH, 1966, ARCH OPHTHALMOL-CHIC, V76, P104, DOI 10.1001/archopht.1966.03850010106019; Frankland A W, 1971, Trans Ophthalmol Soc U K, V91, P479; FRANKLIN RM, 1973, J IMMUNOL, V110, P984; FRIDAY GA, 1983, AM J OPHTHALMOL, V95, P169, DOI 10.1016/0002-9394(83)90010-7; Friedlaender M H, 1983, Int Ophthalmol Clin, V23, P175, DOI 10.1097/00004397-198302310-00014; FRIEDLAENDER MH, 1980, ARCH OPHTHALMOL-CHIC, V98, P1211; FRIEDLAENDER MH, 1984, ARCH OPHTHALMOL-CHIC, V102, P1198; FRIEDLAENDER MH, 1977, J IMMUNOL, V118, P1558; FRIEDLAENDER MH, 1979, INVEST OPHTHALMOL  S, V18, P95; FRIEDLANDER MH, 1979, ALLERGY IMMUNOLOGY E, P80; FROMER CH, 1976, AM J PATHOL, V82, P157; FUNAISHI S, 1923, KLIN MONATSBL AUGENH, V71, P141; GREENBAUM J, 1977, J ALLERGY CLIN IMMUN, V59, P437, DOI 10.1016/0091-6749(77)90006-9; GREINER JV, 1977, AM J OPHTHALMOL, V83, P892, DOI 10.1016/0002-9394(77)90921-7; HALL JM, 1984, INVEST OPHTH VIS SCI, V25, P212; INGRAM RM, 1965, BRIT J OPHTHALMOL, V49, P96, DOI 10.1136/bjo.49.2.96; INOMATA H, 1971, INVEST OPHTH VISUAL, V10, P840; KIMURA SJ, 1955, AM J OPHTHALMOL, V39, P137, DOI 10.1016/0002-9394(55)90017-9; KLINTWORTH GK, 1977, INVEST OPHTH VIS SCI, V16, P281; MARKS MB, 1977, STIGMATA RESPIRATORY, P12; MATHIAS CGT, 1979, ARCH OPHTHALMOL-CHIC, V97, P286; MCCLELLAN BH, 1973, AM J OPHTHALMOL, V76, P89, DOI 10.1016/0002-9394(73)90015-9; MCMASTER PR, 1967, ARCH OPHTHALMOL-CHIC, V77, P392; MEISLER DM, 1982, ARCH OPHTHALMOL-CHIC, V100, P1608; MEISLER DM, 1981, AM J OPHTHALMOL, V92, P368, DOI 10.1016/0002-9394(81)90526-2; MEISLER DM, 1980, AM J OPHTHALMOL, V89, P66, DOI 10.1016/0002-9394(80)90231-7; OSTLER HB, 1982, ARCH OPHTHALMOL-CHIC, V100, P412; OSTLER HB, 1982, LANCET, V1, P1287; Rahi A H, 1976, Mod Probl Ophthalmol, V16, P155; SETTIPANE GA, 1979, JAMA-J AM MED ASSOC, V241, P811, DOI 10.1001/jama.241.8.811; STEGMAN R, 1975, ARCH OPHTHALMOL-CHIC, V93, P1354; TABBARA KF, 1977, ARCH OPHTHALMOL-CHIC, V95, P2184; THYGESON P, 1954, Trans Am Acad Ophthalmol Otolaryngol, V58, P128; WALTON KW, 1973, J PATHOL, V111, P263, DOI 10.1002/path.1711110407; WEEKERS L, 1909, ARCH OPHTHALMOL-CHIC, V29, P294; Wessely K., 1911, MUNCHEN MED WOCHEN, V58, P1713; ZIMIANSKI MC, 1974, INVEST OPHTH VISUAL, V13, P623	57	16	19	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	5					645	657		10.1016/0091-6749(85)90664-5	http://dx.doi.org/10.1016/0091-6749(85)90664-5			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AUU34	3902939	Bronze			2022-12-18	WOS:A1985AUU3400001
J	GEORGITIS, JW				GEORGITIS, JW			THE APPLICABILITY OF RHINOMANOMETRY IN NONATOPIC CHILDREN - COMPARISON OF 3 TECHNIQUES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											GEORGITIS, JW (corresponding author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PEDIAT,WINSTON SALEM,NC 27103, USA.				PHS HHS [2859] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; CHO YW, 1978, INT J CLIN PHARM BI, V16, P63; COLE P, 1980, Rhinology (Utrecht), V18, P3; COLE P, 1981, NOSE UPPER AIRWAY PH, P163; CONNELL JT, 1966, J ALLERGY, V37, P127, DOI 10.1016/0021-8707(66)90087-6; DIXON W, 1981, BMDP STATISTICAL SOF, P94; Hamilton L H, 1979, Physiologist, V22, P43; HASEGAWA M, 1977, MAYO CLIN PROC, V52, P28; MCLEAN JA, 1976, J ALLERGY CLIN IMMUN, V58, P563, DOI 10.1016/0091-6749(76)90202-5; PELIKAN Z, 1977, ANN ALLERGY, V38, P263; PIPKORN U, 1982, ACTA OTOLARYNGOL S, V386, P276; SAITO A, 1981, Rhinology (Utrecht), V19, P149; SALMAN SD, 1971, ANN OTO RHINOL LARYN, V80, P736, DOI 10.1177/000348947108000516; SECHER C, 1982, J ALLERGY CLIN IMMUN, V70, P211, DOI 10.1016/0091-6749(82)90044-6; Siegel S, 1956, NONPARAMETRIC STAT, P104; SOLOMON WR, 1965, J ALLERGY, V36, P62, DOI 10.1016/0021-8707(65)90033-X; SOLOW B, 1980, Rhinology (Utrecht), V18, P31	17	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	5					614	620		10.1016/0091-6749(85)90039-9	http://dx.doi.org/10.1016/0091-6749(85)90039-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AHV07	3989147				2022-12-18	WOS:A1985AHV0700013
J	JENKINS, C; BRESLIN, ABX; MARLIN, GE				JENKINS, C; BRESLIN, ABX; MARLIN, GE			THE ROLE OF ALPHA-ADRENOCEPTORS AND BETA-ADRENOCEPTORS IN AIRWAY HYPERRESPONSIVENESS TO HISTAMINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											JENKINS, C (corresponding author), CONCORD HOSP,RESP INVEST UNIT,CONCORD,NSW 2139,AUSTRALIA.			Jenkins, Christine/0000-0003-2717-5647				ANDERSON SD, 1976, AM REV RESPIR DIS, V114, P493; BARNES PJ, 1983, J APPL PHYSIOL, V54, P1469, DOI 10.1152/jappl.1983.54.6.1469; BARNES PJ, 1981, THORAX, V36, P378, DOI 10.1136/thx.36.5.378; BARNES PJ, 1980, NATURE, V285, P569, DOI 10.1038/285569a0; BARNES PJ, 1982, NATURE, V299, P444, DOI 10.1038/299444a0; BARNES PJ, 1981, J ALLERGY CLIN IMMUN, V68, P411, DOI 10.1016/0091-6749(81)90193-7; BEAUPRE A, 1981, THORAX, V36, P731, DOI 10.1136/thx.36.10.731; BEIL M, 1978, RESPIRATION, V35, P78, DOI 10.1159/000193863; BIANCO S, 1972, British Journal of Diseases of the Chest, V66, P27, DOI 10.1016/S0007-0971(72)80004-4; BROWN JK, 1983, J APPL PHYSIOL, V54, P1558, DOI 10.1152/jappl.1983.54.6.1558; BROWN JK, 1982, AM REV RESPIR DIS, V126, P842; BRUYNZEEL PL, 1982, EUR J RESP DIS S, V121, P64; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; GADDIE J, 1972, British Journal of Diseases of the Chest, V66, P141, DOI 10.1016/S0007-0971(72)80036-6; GAYRARD P, 1979, THORAX, V34, P234, DOI 10.1136/thx.34.2.234; HENDERSON WR, 1979, NEW ENGL J MED, V300, P642, DOI 10.1056/NEJM197903223001203; HOFFMAN BB, 1980, NEW ENGL J MED, V302, P1390, DOI 10.1056/NEJM198006193022504; KALINER M, 1972, J EXP MED, V136, P556, DOI 10.1084/jem.136.3.556; KNEUSSL MP, 1978, J APPL PHYSIOL, V45, P307, DOI 10.1152/jappl.1978.45.2.307; Marlin G E, 1982, Br J Clin Pharmacol, V13, P445; MEURS H, 1982, J ALLERGY CLIN IMMUN, V70, P272, DOI 10.1016/0091-6749(82)90063-X; MILLS JE, 1969, J PHYSIOL-LONDON, V203, P337, DOI 10.1113/jphysiol.1969.sp008867; OBYRNE PM, 1982, THORAX, V37, P913, DOI 10.1136/thx.37.12.913; ORANGE RP, 1971, FED PROC, V30, P1725; OREHEK J, 1981, AM REV RESPIR DIS, V123, P269; OREHEK J, 1977, AM REV RESPIR DIS, V115, P937; PATEL KR, 1973, CLIN ALLERGY, V3, P439, DOI 10.1111/j.1365-2222.1973.tb01351.x; PEEL ET, 1980, AM REV RESPIR DIS, V121, P973; SALOME CM, 1981, THORAX, V36, P580, DOI 10.1136/thx.36.8.580; SIMMONSON BG, 1972, SAND J RESPIR DIS, V53, P227; SNASHALL PD, 1978, CLIN SCI MOL MED, V54, P283, DOI 10.1042/cs0540283; TASHKIN DP, 1982, AM REV RESPIR DIS, V125, P185; TAYLOR SH, 1965, CLIN SCI, V28, P265; THOMSON NC, 1982, AM REV RESPIR DIS, V126, P521; 1962, AM REV RESPIR DIS, V85, P762	36	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	3					364	372		10.1016/0091-6749(85)90073-9	http://dx.doi.org/10.1016/0091-6749(85)90073-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AEB46	2857739				2022-12-18	WOS:A1985AEB4600007
J	SIMONS, FER; BECKER, AB; SIMONS, KJ; GILLESPIE, CA				SIMONS, FER; BECKER, AB; SIMONS, KJ; GILLESPIE, CA			THE BRONCHODILATOR EFFECT AND PHARMACOKINETICS OF THEOBROMINE IN YOUNG-PATIENTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MANITOBA,FAC MED,DEPT VET SURG,ALLERGY & CLIN IMMUNOL SECT,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,FAC PHARM,WINNIPEG R3T 2N2,MANITOBA,CANADA	University of Manitoba; University of Manitoba								BECKER AB, 1984, NEW ENGL J MED, V310, P743, DOI 10.1056/NEJM198403223101202; CORNISH HH, 1957, J BIOL CHEM, V228, P315; CZOK G, 1974, Z ERNAHRUNGSWISS, V13, P165, DOI 10.1007/BF02021187; DORFMAN LJ, 1970, CLIN PHARMACOL THER, V11, P869; DROUILLARD DD, 1978, CLIN PHARMACOL THER, V23, P296; GIBALDI M, 1982, PHARMACOKINETICS, P1; HENDELES L, 1977, AM J HOSP PHARM, V34, P525, DOI 10.1093/ajhp/34.5.525; HENDELES L, 1983, PHARMACOTHERAPY, V3, P2; HIRSCH S, 1922, KLIN WOCHENSCHR, V13, P615; HUDSON LD, 1973, CURR THER RES CLIN E, V15, P367; KARLSSON JA, 1982, J PHARM PHARMACOL, V34, P788, DOI 10.1111/j.2042-7158.1982.tb06226.x; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; KREISER WR, 1980, J ASSOC OFF ANA CHEM, V63, P591; LAURSEN LC, 1983, EUR J CLIN PHARMACOL, V24, P323, DOI 10.1007/BF00610048; LUNELL E, 1983, ACTA PHARMACOL TOX, V53, P205; LUNELL E, 1982, EUR J CLIN PHARMACOL, V22, P395, DOI 10.1007/BF00542541; Macht DI, 1921, J PHARMACOL EXP THER, V18, P373; MINERS JO, 1982, DRUG METAB DISPOS, V10, P672; PERSSON CGA, 1977, ACTA PHARMACOL TOX, V40, P529; PERSSON CGA, 1982, LIFE SCI, V30, P2181, DOI 10.1016/0024-3205(82)90292-2; RESMAN BH, 1977, J PEDIATR-US, V91, P477, DOI 10.1016/S0022-3476(77)81329-2; RITCHIE JM, 1970, PHARMACOL BASIS, P358; SIMONS FER, 1975, PEDIATRICS, V56, P916; SIMONS KJ, 1982, J PHARM SCI, V71, P505, DOI 10.1002/jps.2600710507; Steel R.G.D., 1980, PRINCIPLES STAT	25	16	18	0	6	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	5					703	707		10.1016/0091-6749(85)90674-8	http://dx.doi.org/10.1016/0091-6749(85)90674-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AUU34	4056254				2022-12-18	WOS:A1985AUU3400008
J	HAMRICK, HJ; JENNETTE, JC; LAFORCE, CF				HAMRICK, HJ; JENNETTE, JC; LAFORCE, CF			KIMURAS DISEASE - REPORT OF A PEDIATRIC CASE IN THE UNITED-STATES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV N CAROLINA,SCH MED,DEPT PATHOL,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	HAMRICK, HJ (corresponding author), UNIV N CAROLINA,SCH MED,DEPT PEDIAT,CHAPEL HILL,NC 27514, USA.			Jennette, John Charles/0000-0002-8081-6565				BERGLUND G, 1968, ACTA PAEDIATR SCAND, V57, P89, DOI 10.1111/j.1651-2227.1968.tb04658.x; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; CHANG T L, 1962, Chin Med J, V81, P384; FUJITA K, 1963, JAP J DERM, V73, P367; Iizuka S, 1959, NIHON U MED J, V18, P900; JOHANSSON SG, 1968, LANCET, V1, P1118; JUHLIN L, 1969, ARCH DERMATOL, V100, P12, DOI 10.1001/archderm.100.1.12; KAWADA AKIHIRO, 1966, JAP J DERMATOL, V76, P61; Kimura T., 1948, T SOC PATH JAP, V37, P179; KITABATAKE T, 1972, STRAHLENTHER ONKOL, V144, P407; MATSUMOTO T, 1981, ANN ALLERGY, V47, P47; MEHREGAN AH, 1971, ARCH DERMATOL, V103, P50, DOI 10.1001/archderm.103.1.50; NELSON RD, 1975, J IMMUNOL, V115, P1650; REED RJ, 1972, CANCER-AM CANCER SOC, V29, P489, DOI 10.1002/1097-0142(197202)29:2<489::AID-CNCR2820290239>3.0.CO;2-X; ROSAI J, 1979, HUM PATHOL, V10, P707, DOI 10.1016/S0046-8177(79)80114-8; TAKENAKA T, 1976, CLIN ALLERGY, V6, P27, DOI 10.1111/j.1365-2222.1976.tb01409.x; THOMPSON JW, 1981, ARCH OTOLARYNGOL, V107, P316; WELLS GC, 1969, BRIT J DERMATOL, V81, P1, DOI 10.1111/j.1365-2133.1969.tb15914.x	18	16	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					561	566		10.1016/0091-6749(84)90511-6	http://dx.doi.org/10.1016/0091-6749(84)90511-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS045	6609182				2022-12-18	WOS:A1984SS04500004
J	VANDERHEIDE, S; KAUFFMAN, HF; DEVRIES, K				VANDERHEIDE, S; KAUFFMAN, HF; DEVRIES, K			MEASUREMENT OF SPECIFIC IGE AND IGG ANTIBODIES AGAINST ASPERGILLUS-FUMIGATUS ANTIGEN IN PATIENT SERA BY USE OF ENZYME IMMUNOASSAYS - INFLUENCE OF DIFFERENT PROCEDURES OF ANTIGEN IMMOBILIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											VANDERHEIDE, S (corresponding author), STATE UNIV GRONINGEN HOSP, DEPT ALLERGOL, INTERNAL MED CLIN, 9713 EZ GRONINGEN, NETHERLANDS.							CANTARERO LA, 1980, ANAL BIOCHEM, V105, P375, DOI 10.1016/0003-2697(80)90473-X; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1021, DOI 10.1016/0019-2791(72)90112-7; GIALLONGO A, 1982, J IMMUNOL METHODS, V52, P379, DOI 10.1016/0022-1759(82)90009-6; GREENBERGER PA, 1982, J LAB CLIN MED, V99, P288; HAMILTON RG, 1981, J IMMUNOL METHODS, V44, P101, DOI 10.1016/0022-1759(81)90111-3; HILL PN, 1981, J IMMUNOL METHODS, V45, P51, DOI 10.1016/0022-1759(81)90093-4; KARR RM, 1981, J ALLERGY CLIN IMMUN, V67, P194, DOI 10.1016/0091-6749(81)90061-0; KAUFFMAN HF, 1983, J ALLERGY CLIN IMMUN, V72, P255, DOI 10.1016/0091-6749(83)90029-5; KAUFFMAN HF, 1980, INT ARCH ALLER A IMM, V62, P252, DOI 10.1159/000232521; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCKELVY JF, 1969, ARCH BIOCHEM BIOPHYS, V132, P99, DOI 10.1016/0003-9861(69)90341-5; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x; WIDE L, 1967, LANCET, V2, P1105	13	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	6					813	818						6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SV829	6373891	Bronze			2022-12-18	WOS:A1984SV82900008
J	BOCK, SA; MARTIN, M				BOCK, SA; MARTIN, M			THE INCIDENCE OF ADVERSE REACTIONS TO FOODS - A CONTINUING STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					98	98		10.1016/0091-6749(83)90162-8	http://dx.doi.org/10.1016/0091-6749(83)90162-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200039
J	MILES, RM; PARKER, JL; JONES, RT; DAHLBERG, MJE; YUNGINGER, JW				MILES, RM; PARKER, JL; JONES, RT; DAHLBERG, MJE; YUNGINGER, JW			STUDIES ON ALTERNARIA ALLERGENS .4. BIOLOGIC ACTIVITY OF A PURIFIED ALTERNARIA FRACTION (ALT-L)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN,ALLERG DIS RES LAB,406 GUGGENHEIM BLDG,ROCHESTER,MN 55905; MAYO MED SCH,DEPT PEDIAT,ROCHESTER,MN 55901; MAYO MED SCH,DEPT INTERNAL MED,ROCHESTER,MN 55901	Mayo Clinic; Mayo Clinic; Mayo Clinic					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016791, P50AI011483] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-16791, AI-11483] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AUKRUST L, 1979, INT ARCH ALLER A IMM, V60, P68, DOI 10.1159/000232324; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; GLEICH GJ, 1980, J ALLERGY CLIN IMMUN, V65, P20, DOI 10.1016/0091-6749(80)90172-4; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; NORMAN PS, 1980, MANUAL CLIN IMMUNOLO, P789; SOLOMON WR, 1978, ALLERGY PRINCIPLES P, P899; Yunginger J. W., 1980, MANUAL CLIN IMMUNOLO, P778; YUNGINGER JW, 1980, J ALLERGY CLIN IMMUN, V66, P138, DOI 10.1016/0091-6749(80)90061-5	8	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					36	39		10.1016/0091-6749(83)90544-4	http://dx.doi.org/10.1016/0091-6749(83)90544-4			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ461	6185555	Bronze			2022-12-18	WOS:A1983PZ46100006
J	NORMAN, PS				NORMAN, PS			THE SHELDON,JOHN MEMORIAL LECTURE - REVIEW OF NASAL THERAPY - UPDATE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT MED, DIV CLIN IMMUNOL, BALTIMORE, MD 21205 USA	Johns Hopkins University	NORMAN, PS (corresponding author), GOOD SAMARITAN HOSP, DIV CLIN IMMUNOL, BALTIMORE, MD 21239 USA.				NIAID NIH HHS [AI-04866, AI-10304] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI004866, R37AI004866] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHATTERJEE S S, 1974, Clinical Allergy, V4, P343, DOI 10.1111/j.1365-2222.1974.tb01395.x; COHAN RH, 1976, J ALLERGY CLIN IMMUN, V58, P121, DOI 10.1016/0091-6749(76)90147-0; HARRIS DM, 1974, CLIN ALLERGY, V4, P291, DOI 10.1111/j.1365-2222.1974.tb01387.x; JOHANSSON AG, 1978, IMMEDIATE HYPERSENSI, P533; LICHTENSTEIN LM, 1971, J IMMUNOL, V107, P1131; MYGIND N, 1975, Clinical Allergy, V5, P159, DOI 10.1111/j.1365-2222.1975.tb01848.x; NACLERIO RM, 1983, EUR J RESPIR DIS, V64, P26; NACLERIO RM, AM REV RESPIR DIS; NORMAN PS, 1967, J ALLERGY, V40, P57, DOI 10.1016/0021-8707(67)90060-3; NORMAN PS, 1965, J ALLERGY, V36, P284, DOI 10.1016/0021-8707(65)90087-0; NORMAN PS, 1983, RHINITIS TOPICAL PHA, P35; PELIKAN Z, 1982, ANN ALLERGY, V49, P200; PELIKAN Z, 1982, ANN ALLERGY, V49, P283; PROUD D, J CLIN INVEST; SCHLEIMER RP, 1983, J CLIN INVEST, V71, P1830, DOI 10.1172/JCI110938; SCHLEIMER RP, 1982, J IMMUNOL, V129, P1632; TARLO SM, 1977, J ALLERGY CLIN IMMUN, V59, P232, DOI 10.1016/0091-6749(77)90155-5; TOOGOOD JH, 1982, CLIN ALLERGY, V12, P95, DOI 10.1111/j.1365-2222.1982.tb03131.x; TURKELTAUB PC, 1982, ALLERGY, V37, P303, DOI 10.1111/j.1398-9995.1982.tb01916.x; TURKELTAUB PC, 1976, J ALLERGY CLIN IMMUN, V58, P597, DOI 10.1016/0091-6749(76)90206-2	20	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	5					421	432		10.1016/0091-6749(83)90577-8	http://dx.doi.org/10.1016/0091-6749(83)90577-8			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RR916	6195204				2022-12-18	WOS:A1983RR91600001
J	TWIGGS, JT; YUNGINGER, JW; AGARWAL, MK; REED, CE				TWIGGS, JT; YUNGINGER, JW; AGARWAL, MK; REED, CE			OCCUPATIONAL ASTHMA IN A FLORIST CAUSED BY THE DRIED PLANT, BABYS BREATH	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN,ALLERG DIS RES LAB,ROCHESTER,MN 55905; MAYO MED SCH,DEPT PEDIAT,ROCHESTER,MN 55901; MAYO MED SCH,DEPT MED,ROCHESTER,MN 55901	Mayo Clinic; Mayo Clinic; Mayo Clinic					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011483] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11483] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; FERNALD ML, 1950, GRAYS MANUAL BOTANY, P635; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; NORMAN PS, 1980, MANUAL CLIN IMMUNOLO, P789; PEPYS J, 1978, ALLERGY PRINCIPLES P, V2, P812; Yunginger J. W., 1980, MANUAL CLIN IMMUNOLO, P778	6	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	5					474	477		10.1016/0091-6749(82)90124-5	http://dx.doi.org/10.1016/0091-6749(82)90124-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NP934	7076987				2022-12-18	WOS:A1982NP93400011
J	SNAPPER, JR; BRAASCH, PS; INGRAM, RH; LORING, SH; DRAZEN, JM				SNAPPER, JR; BRAASCH, PS; INGRAM, RH; LORING, SH; DRAZEN, JM			EFFECTS OF BETA-ADRENERGIC-BLOCKADE ON HISTAMINE AND PROSTAGLANDIN-F2-ALPHA RESPONSIVENESS IN THE DOG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									PETER BENT BRIGHAM HOSP,DEPT MED,DIV RESP,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT PHYSIOL,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health					NHLBI NIH HHS [HL-00549, HL-19170, HL-5337] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL019170] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		DOUGLAS JS, 1973, J PHARMACOL EXP THER, V184, P169; DRAZEN JM, 1976, J APPL PHYSIOL, V41, P388, DOI 10.1152/jappl.1976.41.3.388; DRAZEN JM, 1978, J APPL PHYSIOL, V44, P340, DOI 10.1152/jappl.1978.44.3.340; EVANS GH, 1973, J PHARMACOL EXP THER, V186, P114; HABIB MP, 1977, CLIN RES, V25, pA713; LORING SH, 1977, J APPL PHYSIOL, V42, P946, DOI 10.1152/jappl.1977.42.6.946; LORING SH, 1978, J APPL PHYSIOL, V45, P40, DOI 10.1152/jappl.1978.45.1.40; OREHEK J, 1975, J ALLERGY CLIN IMMUN, V55, P164, DOI 10.1016/0091-6749(75)90012-3; PLOYSONGSANG Y, 1978, J APPL PHYSIOL, V44, P690, DOI 10.1152/jappl.1978.44.5.690; RICHARDSON PS, 1969, BMJ-BRIT MED J, V3, P143, DOI 10.1136/bmj.3.5663.143; SNAPPER JR, 1978, J APPL PHYSIOL, V44, P738, DOI 10.1152/jappl.1978.44.5.738; SNAPPER JR, 1979, J APPL PHYSIOL, V47, P13, DOI 10.1152/jappl.1979.47.1.13; SNAPPER JR, 1979, CLIN RES, V27, pA404; SNAPPER JR, 1980, AM REV RESPIR DIS, V122, P775, DOI 10.1164/arrd.1980.122.5.775; STASZEWS.J, 1965, BRIT J PHARM CHEMOTH, V25, P728, DOI 10.1111/j.1476-5381.1965.tb01795.x; TATTERSFIELD AE, 1973, J APPL PHYSIOL, V35, P613, DOI 10.1152/jappl.1973.35.5.613; VONNEERGAARD K, 1927, Z KLIN MED, V105, P51; WOOLCOCK AJ, 1969, J APPL PHYSIOL, V26, P814, DOI 10.1152/jappl.1969.26.6.814; ZAID G, 1966, NEW ENGL J MED, V275, P580, DOI 10.1056/NEJM196609152751103; ZUSKIN E, 1974, J APPL PHYSIOL, V36, P449, DOI 10.1152/jappl.1974.36.4.449	20	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	3					199	205		10.1016/0091-6749(81)90062-2	http://dx.doi.org/10.1016/0091-6749(81)90062-2			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LG778	6109742				2022-12-18	WOS:A1981LG77800007
J	BUSSE, WW; ANDERSON, CL; HANSON, PG; FOLTS, JD				BUSSE, WW; ANDERSON, CL; HANSON, PG; FOLTS, JD			THE EFFECT OF EXERCISE ON THE GRANULOCYTE RESPONSE TO ISOPROTERENOL IN THE TRAINED ATHLETE AND UNCONDITIONED INDIVIDUAL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,SCH MED,DEPT MED,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison								Aragno R, 1975, J Sports Med Phys Fitness, V15, P282; BACH MA, 1975, J CLIN INVEST, V55, P1074, DOI 10.1172/JCI108008; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BUSH RK, 1978, J ALLERGY CLIN IMMUN, V61, P80, DOI 10.1016/0091-6749(78)90229-4; BUSSE WW, 1977, J CLIN INVEST, V59, P1080, DOI 10.1172/JCI108731; BUSSE WW, 1976, SCIENCE, V194, P737, DOI 10.1126/science.185696; BUSSE WW, 1977, AM REV RESPIR DIS, V115, P783; BUSSE WW, 1979, AM REV RESPIR DIS, V120, P377; FISHMAN WH, 1967, CLIN CHIM ACTA, V15, P435, DOI 10.1016/0009-8981(67)90008-3; HAWKINS D, 1971, LAB INVEST, V24, P483; HENSON PM, 1971, J IMMUNOL, V107, P1535; HOWLEY ET, 1976, MED SCI SPORT EXER, V8, P219; IGNARRO LJ, 1974, J EXP MED, V139, P1395, DOI 10.1084/jem.139.6.1395; LEFKOWITZ RJ, 1976, NEW ENGL J MED, V295, P323, DOI 10.1056/NEJM197608052950607; LEFKOWITZ RJ, 1978, FED PROC, V37, P123; PASSON PG, 1973, ANAL BIOCHEM, V51, P618, DOI 10.1016/0003-2697(73)90517-4; SCHEUER J, 1977, ANNU REV PHYSIOL, V39, P221, DOI 10.1146/annurev.ph.39.030177.001253; SHEAR M, 1976, J BIOL CHEM, V251, P7572; WEISSMANN G, 1971, J EXP MED, V134, pS149; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550; ZURIER RB, 1973, P NATL ACAD SCI USA, V70, P844, DOI 10.1073/pnas.70.3.844	22	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	5					358	364		10.1016/0091-6749(80)90213-4	http://dx.doi.org/10.1016/0091-6749(80)90213-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JV955	7372954	Bronze			2022-12-18	WOS:A1980JV95500007
J	GUERCIO, JP; BIRCH, S; FERNANDEZ, RJ; SACKNER, MA				GUERCIO, JP; BIRCH, S; FERNANDEZ, RJ; SACKNER, MA			DEPOSITION OF RAGWEED POLLEN AND EXTRACT ON NASAL-MUCOSA OF PATIENTS WITH ALLERGIC RHINITIS - EFFECT ON NASAL AIR-FLOW RESISTANCE AND NASAL MUCUS VELOCITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MT SINAI MED CTR,DIV PULM DIS,4300 ALTON RD,MIAMI BEACH,FL 33140	Mount Sinai Medical Center								CHEVANCE L G, 1957, Acta Otolaryngol, V47, P480, DOI 10.3109/00016485709130372; CHEVANCE LG, 1971, ACTA OTO-LARYNGOL, V72, P121, DOI 10.3109/00016487109122464; CONNELL JT, 1970, NEW YORK STATE J MED, V70, P1751; CONNELL JT, 1968, J ALLERGY, V41, P123, DOI 10.1016/0021-8707(68)90053-1; CONNELL JT, 1969, J ALLERGY, V43, P33, DOI 10.1016/0021-8707(69)90018-5; CONNELL JT, 1967, J ALLERGY, V39, P358, DOI 10.1016/0021-8707(67)90048-2; KALINER M, 1973, NEW ENGL J MED, V289, P277, DOI 10.1056/NEJM197308092890601; MCLEAN JA, 1976, J ALLERGY CLIN IMMUN, V58, P563, DOI 10.1016/0091-6749(76)90202-5; MENDENHALL W, 1977, STATISTICS PSYCHOL, P246; MEZEY RJ, 1978, AM REV RESPIR DIS, V118, P677, DOI 10.1164/arrd.1978.118.4.677; SAKETKHOO K, 1978, CHEST, V74, P408, DOI 10.1378/chest.74.4.408; TAYLOR G, 1971, Clinical Allergy, V1, P63, DOI 10.1111/j.1365-2222.1971.tb02448.x; TOS M, 1977, ACTA OTO-LARYNGOL, V83, P498, DOI 10.3109/00016487709128878; WANNER A, 1975, J APPL PHYSIOL, V39, P950, DOI 10.1152/jappl.1975.39.6.950; WIHL JA, 1977, ACTA OTO-LARYNGOL, V84, P281, DOI 10.3109/00016487709123968; YERGIN BM, 1978, J APPL PHYSIOL, V44, P964, DOI 10.1152/jappl.1978.44.6.964	16	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	1					61	69		10.1016/0091-6749(80)90139-6	http://dx.doi.org/10.1016/0091-6749(80)90139-6			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	JZ541	7381124				2022-12-18	WOS:A1980JZ54100009
J	KOOISTRA, JB; YUNGINGER, JW; SANTRACH, PJ; CLARK, JW				KOOISTRA, JB; YUNGINGER, JW; SANTRACH, PJ; CLARK, JW			INVITRO STUDIES OF HUMAN SEMINAL PLASMA ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,DEPT MED ALLERGY,MADISON,WI 53706; MAYO CLIN & MAYO FDN,ALLERG DIS RES LAB,ROCHESTER,MN 55901; MAYO CLIN & MAYO FDN,DEPT INTERNAL MED ALLERGY,ROCHESTER,MN 55901; MAYO CLIN & MAYO FDN,DEPT PEDIAT,ROCHESTER,MN 55901	University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Mayo Clinic; Mayo Clinic								AWDEH ZL, 1968, NATURE, V219, P66, DOI 10.1038/219066a0; CHANG TW, 1976, AM J OBSTET GYNECOL, V126, P442, DOI 10.1016/0002-9378(76)90634-7; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DIXON WJ, 1969, INTRO STATISTICAL AN, P222; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FRANKLAND AW, 1974, CLIN ALLERGY, V4, P249, DOI 10.1111/j.1365-2222.1974.tb01382.x; GLEICH GJ, 1976, MANUAL CLIN IMMUNOLO, P575; HALPERN BN, 1967, IMMUNOLOGY, V12, P247; LEVINE BB, 1973, NEW ENGL J MED, V288, P894, DOI 10.1056/NEJM197304262881707; LEVINE BB, 1974, NEW ENGL J MED, V290, P916; MATHIAS CG, 1979, J ALLERGY CLIN IMMUN, V63, P173; MIKKELSEN FJ, 1975, ANN ALLERGY, V34, P239; MUMFORD DM, 1978, ANN ALLERGY, V40, P40; PANYIM S, 1969, ARCH BIOCHEM BIOPHYS, V130, P337, DOI 10.1016/0003-9861(69)90042-3; REUNALA T, 1977, FERTIL STERIL, V28, P832; SCHULZ KH, 1974, NEW ENGL J MED, V290, P916; SIRAGANIAN RP, 1975, CLIN IMMUNOL IMMUNOP, V4, P59, DOI 10.1016/0090-1229(75)90040-9; SPECKEN, 1958, Ned Tijdschr Verloskd Gynaecol, V58, P314; WINTER A, 1975, LKB198 LKB PROD AB A	19	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	2					148	154		10.1016/0091-6749(80)90062-7	http://dx.doi.org/10.1016/0091-6749(80)90062-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD119	7400478				2022-12-18	WOS:A1980KD11900009
J	PEPYS, J				PEPYS, J			OCCUPATIONAL ASTHMA - REVIEW OF PRESENT CLINICAL AND IMMUNOLOGICAL STATUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review																		ALANKO K, 1978, CLIN ALLERGY, V8, P25, DOI 10.1111/j.1365-2222.1978.tb00444.x; BARIANA DS, 1965, NATURE, V207, P1155, DOI 10.1038/2071155a0; BOURNE MD, 1979, BRIT MED J, V3, P10; BRYANT DH, 1973, BRIT MED J, V4, P589, DOI 10.1136/bmj.4.5892.589; BURGE PS, 1980, CLIN ALLERGY, V10, P137, DOI 10.1111/j.1365-2222.1980.tb02091.x; BUTCHER BT, 1977, J ALLERGY CLIN IMMUN, V59, P223, DOI 10.1016/0091-6749(77)90153-1; CHANYEUNG M, 1971, CAN MED ASSOC J, V105, P56; CHANYEUNG M, 1973, AM REV RESPIR DIS, V108, P1094; CLEARE MJ, 1976, CLIN ALLERGY, V6, P183, DOI 10.1111/j.1365-2222.1976.tb01897.x; CROMWELL O, 1979, CLIN ALLERGY, V9, P109, DOI 10.1111/j.1365-2222.1979.tb01529.x; CROMWELL O, CLIN ALLERGY; DAVIES R, 1976, J ALLERGY CLIN IMMUN, V57, P373, DOI 10.1016/0091-6749(76)90095-6; DAVIES RJ, 1977, J ALLERGY CLIN IMMUN, V60, P223, DOI 10.1016/0091-6749(77)90134-8; EDGE G, 1980, CLIN ALLERGY, V10, P47, DOI 10.1111/j.1365-2222.1980.tb02079.x; FAWCETT IW, 1977, CLIN ALLERGY, V7, P1, DOI 10.1111/j.1365-2222.1977.tb01418.x; FAWCETT IW, 1976, CLIN ALLERGY, V6, P577, DOI 10.1111/j.1365-2222.1976.tb01944.x; FREEDMAN SO, 1968, J ALLERGY, V42, P233, DOI 10.1016/S0021-8707(68)90118-4; GREENE SA, 1976, CLIN ALLERGY, V6, P105, DOI 10.1111/j.1365-2222.1976.tb01887.x; HARRIES MG, 1979, THORAX, V34, P762, DOI 10.1136/thx.34.6.762; KAROL MH, 1980, CLIN ALLERGY, V10, P101, DOI 10.1111/j.1365-2222.1980.tb02086.x; MACCIA CA, 1976, AM REV RESPIR DIS, V113, P701; MCCONNELL LH, 1973, ANN INTERN MED, V78, P888, DOI 10.7326/0003-4819-78-6-888; NEWMANTAYLOR AJ, 1979, CLIN ALLERGY, V9, P213; OBRIEN IM, 1979, CLIN ALLERGY, V9, P7, DOI 10.1111/j.1365-2222.1979.tb01517.x; PARISH WE, 1970, LANCET, V2, P591; PARROT JL, 1969, ARCH ENVIRON HEALTH, V19, P685, DOI 10.1080/00039896.1969.10666910; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; PEPYS J, 1973, Clinical Allergy, V3, P143, DOI 10.1111/j.1365-2222.1973.tb01318.x; PEPYS J, 1979, CLIN ALLERGY, V9, P99, DOI 10.1111/j.1365-2222.1979.tb01528.x; PEPYS J, 1976, CLIN ALLERGY, V6, P399, DOI 10.1111/j.1365-2222.1976.tb01922.x; PEPYS J, 1977, MED BIOL EFFECTS ENV, P105; PEPYS J, 1978, ALLERGY PRINCIPLES P, P812; POPA V, 1969, DIS CHEST, V56, P395, DOI 10.1378/chest.56.5.395; ROBERTS AE, 1951, AMA ARCH IND HYG OCC, V4, P549; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; STANWORTH D R, 1973, Clinical Allergy, V3, P37, DOI 10.1111/j.1365-2222.1973.tb01307.x; TSE CST, 1979, AM REV RESPIR DIS, V120, P829; WARREN CPW, 1977, CLIN ALLERGY, V7, P303, DOI 10.1111/j.1365-2222.1977.tb01458.x; WEILL H, 1975, NEW DIRECTIONS ASTHM, P325; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZEISS CR, 1979, J ALLERGY CLIN IMMUN, V63, P150; [No title captured]	42	16	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	3					179	185		10.1016/0091-6749(80)90036-6	http://dx.doi.org/10.1016/0091-6749(80)90036-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KH358	6251125	Bronze			2022-12-18	WOS:A1980KH35800002
J	SMITH, SM; SNYDER, IS; BURRELL, R				SMITH, SM; SNYDER, IS; BURRELL, R			MITOGENIC RESPONSE TO MICROPOLYSPORA-FAENI CELL-WALLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									W VIRGINIA UNIV,SCH MED,DEPT MICROBIOL,MORGANTOWN,WV 26506	West Virginia University								BICE DE, 1977, INT ARCH ALLER A IMM, V55, P267; BONA C, 1975, J IMMUNOL, V114, P348; BONA C, 1974, P NATL ACAD SCI USA, V71, P1602, DOI 10.1073/pnas.71.5.1602; BONA C, 1974, J IMMUNOL, V112, P2028; CIORBARU R, 1975, INFECT IMMUN, V11, P257, DOI 10.1128/IAI.11.2.257-264.1975; COHEN JJ, 1975, J IMMUNOL, V114, P1132; DAMAIS C, 1975, J IMMUNOL, V115, P268; DZIARSKI R, 1974, CURR TOP MICROBIOL I, V74, P113; ENGEL D, 1977, J IMMUNOL, V118, P1466; GREENBLATT J, 1978, INFECT IMMUN, V19, P296, DOI 10.1128/IAI.19.1.296-303.1978; Guthrie RD, 1962, METHODS CARBOHYDRATE, V1, P432; HANDWERGER BS, 1974, TRANSPLANTATION, V18, P544, DOI 10.1097/00007890-197412000-00013; HOLLINGDALE MR, 1975, J GEN MICROBIOL, V86, P250, DOI 10.1099/00221287-86-2-250; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KAZMIEROWSKI JA, 1976, J IMMUNOL, V116, P615; LACEY J, 1974, ASPERGILLOSIS FARMER, P16; LIPSKY PE, 1976, J IMMUNOL, V117, P1594; MATSUBARA H, 1971, ENZYMES, V3, P721; Pepys J, 1969, Monogr Allergy, V4, P1; ROBERTS RC, 1977, AM REV RESPIR DIS, V116, P1075; SAKANE T, 1978, J IMMUNOL, V120, P302; SCHLEIFER KH, 1975, Z IMMUNITATSFORSCH, V149, P104; SCHMIDT G, 1957, METHOD ENZYMOL, V3, P671, DOI 10.1016/S0076-6879(57)03441-2; SCHORLEMMER HU, 1977, CLIN EXP IMMUNOL, V27, P198; SMITH SM, 1978, INFECT IMMUN, V22, P568, DOI 10.1128/IAI.22.2.568-574.1978; SMITH SM, 1978, ANN ALLERGY, V40, P12; STADECKER MJ, 1973, J IMMUNOL, V111, P1834	27	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	4					298	304		10.1016/0091-6749(80)90159-1	http://dx.doi.org/10.1016/0091-6749(80)90159-1			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JN548	6965682	Bronze			2022-12-18	WOS:A1980JN54800010
J	DATTWYLER, RJ; GOLDMAN, MA; BLOCH, KJ				DATTWYLER, RJ; GOLDMAN, MA; BLOCH, KJ			PNEUMOMEDIASTINUM AS A COMPLICATION OF ASTHMA IN TEENAGE AND YOUNG-ADULTS PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MASSACHUSETTS GEN HOSP,CLIN IMMUNOL UNIT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,ALLERGY UNITS,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital			Dattwyler, Raymond/ABH-2292-2021	Dattwyler, Raymond/0000-0002-1983-1301				BIERMAN CW, 1967, AM J DIS CHILD, V114, P42, DOI 10.1001/archpedi.1967.02090220048008; EGGLESTON PA, 1974, PEDIATRICS, V54, P442; JORGENSEN JR, 1963, PEDIATRICS, V31, P824; KARETZKY, 1975, LANCET, V1, P828; KNOTT GA, 1850, LANCET, V1, P16; LEGRAND M, 1975, SEM HOP PARIS, V51, P31; Macklin CC, 1939, ARCH INTERN MED, V64, P913, DOI 10.1001/archinte.1939.00190050019003; Macklin MT, 1944, MEDICINE, V23, P281, DOI 10.1097/00005792-194412000-00001; MCGOVERN JP, 1961, PEDIATRICS, V27, P951; Munsell W. P., 1967, JAMA-J AM MED ASSOC, V202, P129	10	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	6					412	416		10.1016/0091-6749(79)90215-X	http://dx.doi.org/10.1016/0091-6749(79)90215-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GY514	447943	Bronze			2022-12-18	WOS:A1979GY51400008
J	GERBLICH, AA; HOROWITZ, J; CHESTER, EH; SCHWARTZ, HJ; FLEMING, GM				GERBLICH, AA; HOROWITZ, J; CHESTER, EH; SCHWARTZ, HJ; FLEMING, GM			PROPOSED STANDARDIZED METHOD FOR BRONCHOPROVOCATION TESTS IN TOLUENE DIISOCYANATE-INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM HOSP,MED CTR,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,DIV PULM,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,DEPT MED,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University								ALTSHULLER AP, 1960, ANAL CHEM, V32, P802, DOI 10.1021/ac60163a021; BUTCHER BT, 1976, J ALLERGY CLIN IMMUN, V58, P89, DOI 10.1016/0091-6749(76)90110-X; CHARLES J, 1976, THORAX, V31, P127, DOI 10.1136/thx.31.2.127; CHESTER EH, 1979, CHEST, V75, P229, DOI 10.1378/chest.75.2_Supplement.229; HOROWITZ JG, 1978, J LAB CLIN MED, V92, P634; PEPYS J, 1972, Clinical Allergy, V2, P225, DOI 10.1111/j.1365-2222.1972.tb01287.x; PRATT C, ADSORPTION TOLUENE D; REILLY DA, 1968, ANALYST, V93, P178, DOI 10.1039/an9689300178; ZEDDA S, 1976, RESPIRATION, V33, P14, DOI 10.1159/000193684	9	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					658	661		10.1016/0091-6749(79)90032-0	http://dx.doi.org/10.1016/0091-6749(79)90032-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX843	229145				2022-12-18	WOS:A1979HX84300020
J	GREENBERGER, P; HARRIS, K; PATTERSON, R				GREENBERGER, P; HARRIS, K; PATTERSON, R			EFFECT OF HISTAMINE-1 AND HISTAMINE-2 ANTAGONISTS ON AIRWAY RESPONSES TO HISTAMINE IN THE RHESUS-MONKEY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,CHICAGO,IL 60611	Northwestern University			Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498				AMDUR MO, 1958, AM J PHYSIOL, V192, P364, DOI 10.1152/ajplegacy.1958.192.2.364; BLACK JW, 1972, NATURE, V236, P385, DOI 10.1038/236385a0; BLACK JW, 1973, INT S HISTAMINE H2 R, P23; BOURNE HR, 1971, SCIENCE, V173, P743, DOI 10.1126/science.173.3998.743; BUSSE WW, 1977, J CLIN INVEST, V59, P1080, DOI 10.1172/JCI108731; CASTERLINE CL, 1977, J ALLERGY CLIN IMMUN, V59, P420, DOI 10.1016/0091-6749(77)90004-5; CURRY JJ, 1946, J CLIN INVEST, V25, P785, DOI 10.1172/JCI101764; DRAZEN JM, 1978, AM REV RESPIR DIS, V117, P479; EDMONDS JF, 1969, BRIT J SURG, V56, P622; GOODMAN LSL, 1975, PHARMACOLOGIC BASIS, P605; KALINER M, 1978, AM ACADEMY ALLERGY; KRELL RD, 1977, EUR J PHARMACOL, V44, P35, DOI 10.1016/0014-2999(77)90113-3; LICHTENSTEIN LM, 1973, NATURE, V244, P287, DOI 10.1038/244287a0; MARTIN G, 1978, FED PROC, V37, P393; MATHE AA, 1977, NEW ENGL J MED, V296, P910, DOI 10.1056/NEJM197704212961605; MATHE AA, 1974, RES COMMUN CHEM PATH, V8, P635; ORANGE RP, 1971, J EXP MED, V134, pS136; PATTERSON R, 1978, J ALLERGY CLIN IMMUN, V61, P261, DOI 10.1016/0091-6749(78)90201-4; PATTERSON R, 1976, J CLIN INVEST, V57, P586, DOI 10.1172/JCI108314; PATTERSON R, 1976, J LAB CLIN MED, V87, P65; SNEDECOR GW, 1973, STATISTICAL METHODS, P59; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P71, DOI 10.1113/jphysiol.1954.sp005034	22	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	3					189	196		10.1016/0091-6749(79)90094-0	http://dx.doi.org/10.1016/0091-6749(79)90094-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HL221	38270				2022-12-18	WOS:A1979HL22100006
J	HENDELES, L; WYATT, R; WEINBERGER, M; SCHOTTELIUS, D; FINCHAM, R				HENDELES, L; WYATT, R; WEINBERGER, M; SCHOTTELIUS, D; FINCHAM, R			DECREASED ORAL PHENYTOIN ABSORPTION FOLLOWING CONCURRENT THEOPHYLLINE ADMINISTRATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					156	156						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400073
J	WOLFE, JD; PLAUT, M; NORMAN, PS; LICHTENSTEIN, LM				WOLFE, JD; PLAUT, M; NORMAN, PS; LICHTENSTEIN, LM			EFFECT OF AN H-2 RECEPTOR ANTAGONIST ON IMMEDIATE AND DELAYED SKIN-TEST REACTIVITY IN MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					208	208						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400252
J	PATTERSON, R; FINK, JN; ROBERTS, M; KELLY, JF; SOMMERS, HM				PATTERSON, R; FINK, JN; ROBERTS, M; KELLY, JF; SOMMERS, HM			ANTIBODY ACTIVITY IN SERA OF PATIENTS WITH HUMIDIFIER DISEASE - STUDIES OF WATER-SUPPLY AS A SOURCE OF ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT PATHOL,CHICAGO,IL 60611; MED COLL WISCONSIN,MILWAUKEE,WI 53233	Northwestern University; Medical College of Wisconsin	PATTERSON, R (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611, USA.							BANASZAK EF, 1970, NEW ENGL J MED, V283, P271, DOI 10.1056/NEJM197008062830601; EDWARDS JH, 1976, NATURE, V264, P438, DOI 10.1038/264438a0; FINK JN, 1971, ANN INTERN MED, V74, P80, DOI 10.7326/0003-4819-74-1-80; HODGES GR, 1974, ANN INTERN MED, V80, P501, DOI 10.7326/0003-4819-80-4-501; MILLER MM, 1976, CLIN ALLERGY, V6, P451, DOI 10.1111/j.1365-2222.1976.tb01929.x; PATTERSON R, 1974, INT ARCH ALLER A IMM, V46, P150, DOI 10.1159/000231119; SCHATZ M, 1977, J ALLERGY CLIN IMMUN, V60, P27, DOI 10.1016/0091-6749(77)90079-3; SWEET LC, 1971, J ALLERGY CLIN IMMUN, V48, P171, DOI 10.1016/0091-6749(71)90013-3	8	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	62	2					103	108		10.1016/0091-6749(78)90086-6	http://dx.doi.org/10.1016/0091-6749(78)90086-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL835	566775				2022-12-18	WOS:A1978FL83500006
J	FINK, JN; BARBORIAK, JJ; KURUP, VP; SCRIBNER, GH				FINK, JN; BARBORIAK, JJ; KURUP, VP; SCRIBNER, GH			VARIABILITY OF EXTRACTS USED IN IMMUNOPRECIPITIN TESTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM CTR,RES SERV,WOOD,WI 53193; MED COLL WISCONSIN,DEPT PATHOL,MILWAUKEE,WI 53233; VET ADM CTR,MED SERV,WOOD,WI 53193; VET ADM CTR,LAB SERV,WOOD,WI 53193; MED COLL WISCONSIN,DEPT MED,ALLERGY SECT,MILWAUKEE,WI 53233; MED COLL WISCONSIN,DEPT PHARMACOL,MILWAUKEE,WI 53233	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin								BANASZAK EF, 1974, GERIATRICS, V29, P65; BARBORIAK JJ, 1965, J LAB CLIN MED, V65, P600; BARBORIAK JJ, 1973, J LAB CLIN MED, V82, P372; EMANUEL DA, 1964, AM J MED, V37, P392, DOI 10.1016/0002-9343(64)90195-0; FINK JN, 1971, J ALLERGY CLIN IMMUN, V48, P179, DOI 10.1016/0091-6749(71)90014-5; FINK JN, 1973, J ALLERGY CLIN IMMUN, V52, P309, DOI 10.1016/0091-6749(73)90051-1; HARGREAVE FE, 1973, CAN MED ASSOC J, V108, P1150; HOEHNE JH, 1973, CHEST, V63, P177, DOI 10.1378/chest.63.2.177; LONGBOTTOM JL, 1964, J PATHOL BACTERIOL, V88, P141, DOI 10.1002/path.1700880119; LOPEZ M, 1976, ANNU REV MED, V27, P453, DOI 10.1146/annurev.me.27.020176.002321; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PEPYS J, 1969, MONOGRAPHS ALLERGY, V4; SALVAGGIO JE, 1966, ANN INTERN MED, V64, P748, DOI 10.7326/0003-4819-64-4-748	13	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	60	4					238	241		10.1016/0091-6749(77)90137-3	http://dx.doi.org/10.1016/0091-6749(77)90137-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DX458	409751	Bronze			2022-12-18	WOS:A1977DX45800007
J	NOVEY, HS; ROTH, M; WELLS, ID				NOVEY, HS; ROTH, M; WELLS, ID			MESQUITE POLLEN - AEROALLERGEN IN ASTHMA AND ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF IRVINE,IRVINE MED CTR,DEPT MED,DIV ALLERGY & IMMUNOL,ORANGE,CA 92668	University of California System; University of California Irvine								BENSON L, 1954, TREES SHRUBS SW DESE, P172; SELLERS ED, 1929, TEX STATE J MED, V25, P297; 1975, CALIFORNIA AIR QUALI, V7, P70; 1975, LOCAL CLIMATOLOGICAL; 1969, STATISTICAL REPORT P; 1971, COMMON WEEDS US, P234	6	16	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	5					359	363		10.1016/0091-6749(77)90018-5	http://dx.doi.org/10.1016/0091-6749(77)90018-5			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DF215	853175				2022-12-18	WOS:A1977DF21500004
J	FIELD, J; ALLEGRA, J; TRAUTLEIN, J; DEMERS, L; GILLIN, M; ZELIS, R				FIELD, J; ALLEGRA, J; TRAUTLEIN, J; DEMERS, L; GILLIN, M; ZELIS, R			MEASUREMENT OF PLASMA PROSTAGLANDINS DURING EXERCISE-INDUCED BRONCHOSPASM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									PENN STATE UNIV,MILTON S HERSHEY MED CTR,DIV INTERN MED,HERSHEY,PA 17033; PENN STATE UNIV,MILTON S HERSHEY MED CTR,DIV CARDIOL,HERSHEY,PA 17033; PENN STATE UNIV,MILTON S HERSHEY MED CTR,DIV CLIN PATHOL,HERSHEY,PA 17033	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health								ALLEGRA J, 1976, J ALLERGY CLIN IMMUN, V58, P546, DOI 10.1016/0091-6749(76)90200-1; ANDERSON SD, 1971, THORAX, V26, P396, DOI 10.1136/thx.26.4.396; DEMERS LM, 1974, PROSTAG OTH LIPID M, V5, P513, DOI 10.1016/S0090-6980(74)80026-2; FIELD J, 1975, CLIN RES         DEC; FISHER HK, 1968, CLIN RES, V16, P162; FITCH KD, 1971, BRIT MED J, V4, P577, DOI 10.1136/bmj.4.5787.577; GODFREY S, 1975, J ALLERGY CLIN IMMUN, V56, P1, DOI 10.1016/0091-6749(75)90029-9; MATHE AA, 1973, BRIT MED J, V1, P193, DOI 10.1136/bmj.1.5847.193; MCNEILL RS, 1968, LANCET, V2, P678; PARKER CW, 1973, ANN INTERN MED, V78, P963, DOI 10.7326/0003-4819-78-6-963; PIERSON WE, 1969, J ALLERGY, V43, P136, DOI 10.1016/S0021-8707(69)80004-3; SHAW JO, 1975, CHEST, V68, P75, DOI 10.1378/chest.68.1.75; SILVERMAN M, 1972, BMJ-BRIT MED J, V1, P207, DOI 10.1136/bmj.1.5794.207; ZAID G, 1966, NEW ENGL J MED, V275, P580, DOI 10.1056/NEJM196609152751103	14	16	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	5					581	585		10.1016/0091-6749(76)90204-9	http://dx.doi.org/10.1016/0091-6749(76)90204-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CL088	977865				2022-12-18	WOS:A1976CL08800006
J	WINTERS, WD; HEINER, DC				WINTERS, WD; HEINER, DC			IGE LEVELS IN SERA OF CANCER-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HARBOR GEN HOSP, LOS ANGELES, CA USA; UNIV CALIF, SCH MED, DEPT SURG, DIV ONCOL, LOS ANGELES, CA 90024 USA; UNIV CALIF, SCH MED, DEPT PEDIAT, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles								AUGUSTIN R, 1972, INT ARCH ALLERGY, V41, P1414; BAZARAL M, 1974, J ALLERGY CLIN IMMUN, V54, P288, DOI 10.1016/0091-6749(74)90015-3; FISHERMAN EW, 1960, J ALLERGY, V31, P74, DOI 10.1016/0021-8707(60)90026-5; Gabriel R, 1972, Br J Clin Pract, V26, P202; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; HEINER DC, 1970, J ALLERGY, V45, P30, DOI 10.1016/0021-8707(70)90014-6; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; ISHIZAKA K, 1967, J IMMUNOL, V99, P1187; JACOBS D, 1972, LANCET, V2, P1059; JOHANSSON SG, 1968, LANCET, V1, P1118; LOGAN J, 1953, N Z Med J, V52, P210; MACKAY WD, 1966, BRIT J CANCER, V20, P434, DOI 10.1038/bjc.1966.52; MCKEE WD, 1967, J ALLERGY, V39, P294, DOI 10.1016/0021-8707(67)90093-7; NORDBRING F, 1969, SCAND J INFECT DIS, V1; ORGEL HA, 1974, J ALLERGY CLIN IMMUN, V53, P213, DOI 10.1016/0091-6749(74)90083-9; POLMAR SH, 1973, J IMMUNOL, V110, P1253; URE D M J, 1969, Scottish Medical Journal, V14, P51; WALDMANN TA, 1974, J IMMUNOL, V113, P379; WALDMANN TA, 1972, J IMMUNOL, V109, P304	19	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	2					181	186		10.1016/0091-6749(76)90039-7	http://dx.doi.org/10.1016/0091-6749(76)90039-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BE952	1249352				2022-12-18	WOS:A1976BE95200012
J	LEVINE, MI				LEVINE, MI			CHRONIC URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV PITTSBURGH,PRESBYTERIAN HOSP,FALK CLIN,ALLERGY CLIN,PITTSBURGH,PA; UNIV PITTSBURGH,SCH MED,DEPT MED,PITTSBURGH,PA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh								ASEL ND, 1964, J INVEST DERMATOL, V43, P535, DOI 10.1038/jid.1964.195; BAUSCHARD FD, 1966, J ALLERGY, V37, P105; CAUNA N, UNPUBLISHED OBSERVAT; COHEN S G, 1950, Am Pract Dig Treat, V1, P246; EISENBERG B C, 1959, J Am Med Assoc, V169, P14; FROMER JL, 1967, DERMATOLOGIC ALLERGY, P279; GREEN GR, 1965, ANN ALLERGY, V23, P30; HALPERN SR, 1965, ANN ALLERGY, V23, P589; James J, 1970, Br J Dermatol, V82, P204, DOI 10.1111/j.1365-2133.1970.tb15015.x; LEVER WF, 1961, HISTOPATHOLOGY SKIN, P114; LEVINE MJ, UNPUBLISHED OBSERVAT; MATHEWS KP, 1974, MED CLIN N AM, V58, P185, DOI 10.1016/S0025-7125(16)32187-3; MILLER DA, 1968, AM J MED, V44, P68, DOI 10.1016/0002-9343(68)90238-6; MITCHELL JOHN H., 1957, ANN ALLERGY, V15, P128; MONTGOMERY H, 1967, DERMATOPATHOLOGY, P177; REES L, 1957, J PSYCHOSOM RES, V2, P172, DOI 10.1016/0022-3999(57)90002-8; SHELDON JM, 1954, J ALLERGY, V25, P525, DOI 10.1016/S0021-8707(54)90034-9; SHOEMAKER ROBERT J., 1962, AMER JOUR PSYCHIAT, V119, P358; STEINHARDT MILTON J., 1954, ANN ALLERGY, V12, P659; TAS J, 1967, DERMATOLOGICA, V135, P90, DOI 10.1159/000254166; UNGER A H, 1960, Tex State J Med, V56, P347	21	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	4					276	283		10.1016/0091-6749(75)90147-5	http://dx.doi.org/10.1016/0091-6749(75)90147-5			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	W1385	1123497				2022-12-18	WOS:A1975W138500009
J	MILLER, JFAP				MILLER, JFAP			SIGNIFICANCE OF CELLULAR INTERACTIONS IN IMMUNE-RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ROY MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,MELBOURNE 3050,VICTORIA,AUSTRALIA	Royal Melbourne Hospital; Walter & Eliza Hall Institute								BASTEN A, 1974, J EXP MED, V140, P199, DOI 10.1084/jem.140.1.199; DUKOR P, 1973, CELL IMMUNOL, V7, P349, DOI 10.1016/0008-8749(73)90199-8; DWYER JM, 1971, NATURE-NEW BIOL, V234, P252, DOI 10.1038/newbio234252a0; FELDMANN M, 1972, TRANSPLANT REV, V13, P3; Gershon R K, 1974, Contemp Top Immunobiol, V3, P1; HAMILTON JA, 1973, J EXP MED, V138, P1009, DOI 10.1084/jem.138.4.1009; HAMILTON JA, 1973, EUR J IMMUNOL, V3, P457, DOI 10.1002/eji.1830030716; HAMILTON JA, 1974, EUR J IMMUNOL, V4, P268, DOI 10.1002/eji.1830040408; HAMILTON JA, 1974, EUR J IMMUNOL, V4, P261, DOI 10.1002/eji.1830040407; HAMMERLING G, 1974, J EXP MED, V137, P1180; HUDSON L, 1974, NATURE, V251, P60, DOI 10.1038/251060a0; HUNT SV, 1974, J EXP MED, V139, P479, DOI 10.1084/jem.139.3.479; Katz D H, 1972, Transplant Rev, V12, P141; KATZ DH, 1973, J EXP MED, V137, P1405, DOI 10.1084/jem.137.6.1405; KLINMAN NR, 1973, J EXP MED, V138, P473, DOI 10.1084/jem.138.2.473; MILLER GW, 1973, J EXP MED, V138, P495, DOI 10.1084/jem.138.3.495; MILLER JFAP, 1972, INT REV CYTOL, V33, P77, DOI 10.1016/S0074-7696(08)61449-7; MITCHELL G F, 1974, Scandinavian Journal of Immunology, V3, P39, DOI 10.1111/j.1365-3083.1974.tb01231.x; MITCHELL GF, 1972, EUR J IMMUNOL, V2, P460, DOI 10.1002/eji.1830020516; OSBORNE DP, 1973, J EXP MED, V137, P991, DOI 10.1084/jem.137.4.991; SHEARER GM, 1972, J EXP MED, V136, P1302, DOI 10.1084/jem.136.5.1302; Siskind G W, 1969, Adv Immunol, V10, P1, DOI 10.1016/S0065-2776(08)60414-9; ZEMBALA M, 1973, NATURE, V244, P227, DOI 10.1038/244227a0	23	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	1					1	9		10.1016/S0091-6749(75)80002-9	http://dx.doi.org/10.1016/S0091-6749(75)80002-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V2344	45924				2022-12-18	WOS:A1975V234400001
J	SOKOL, WN; BEALL, GN				SOKOL, WN; BEALL, GN			LEUKOCYTIC EPINEPHRINE RECEPTORS OF NORMAL AND ASTHMATIC INDIVIDUALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF,SCH MED,LOS ANGELES,CA; HARBOR GEN HOSP,DEPT MED,TORRANCE,CA 90509	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center								AHLQUIST RP, 1948, AM J PHYSIOL, V153, P1586; ALLAN D, 1970, BIOCHEM J, V120, P133, DOI 10.1042/bj1200133; BILEZIKIAN J P, 1973, Journal of Biological Chemistry, V248, P5577; BIRNBAUM.L, 1973, J BIOL CHEM, V248, P2056; COOKSON DU, 1963, AM REV RESPIR DIS, V88, P636; CUATRECA.P, 1971, J BIOL CHEM, V246, P6522; FREYCHET P, 1972, FEBS LETT, V25, P339, DOI 10.1016/0014-5793(72)80519-2; GRIECO MH, 1968, AM J MED, V44, P863, DOI 10.1016/0002-9343(68)90086-7; INOUE S, 1967, J ALLERGY, V40, P337, DOI 10.1016/0021-8707(67)90023-8; KAHN CR, 1973, J BIOL CHEM, V248, P244; KONO T, 1971, J BIOL CHEM, V246, P6210; LEFKOWITZ RJ, 1971, P NATL ACAD SCI USA, V68, P1773, DOI 10.1073/pnas.68.8.1773; LOCKEY SD, 1967, J ALLERGY, V40, P349, DOI 10.1016/0021-8707(67)90024-X; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCNEILL RS, 1964, LANCET, V2, P1101; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; PARKER CW, 1973, J CLIN INVEST, V52, P1336, DOI 10.1172/JCI107305; ROBINSON GA, 1966, ANN NY ACAD SCI, V132, P703; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHRAMM M, 1972, P NATL ACAD SCI USA, V69, P523, DOI 10.1073/pnas.69.2.523; STEINER AL, 1969, P NATL ACAD SCI USA, V64, P367, DOI 10.1073/pnas.64.1.367; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; WEDNER H, 1972, Clinical Research, V20, P798	24	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	5					310	324		10.1016/0091-6749(75)90003-2	http://dx.doi.org/10.1016/0091-6749(75)90003-2			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AB754	164491				2022-12-18	WOS:A1975AB75400003
J	BUCKLEY, RH; ROWLANDS, DT				BUCKLEY, RH; ROWLANDS, DT			AGAMMAGLOBULINEMIA, NEUTROPENIA, FEVER, AND ABDOMINAL PAIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									DUKE UNIV,SCH MED,DEPT MICROBIOL,DURHAM,NC 27710; DUKE UNIV,SCH MED,DEPT PEDIAT,DURHAM,NC 27710; UNIV PENN,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19104; DUKE UNIV,MED CTR,DURHAM,NC 27710; DUKE UNIV,SCH MED,DEPT IMMUNOL,DURHAM,NC 27710	Duke University; Duke University; University of Pennsylvania; Duke University; Duke University			Buckley, Rebecca/AAB-1578-2019					BIANCO C, 1970, J EXP MED, V132, P702, DOI 10.1084/jem.132.4.702; BUCKLEY RA, TO BE PUBLISHED; BUCKLEY RH, 1972, ZINSSER MICROBIOLOGY; COOPER MD, 1971, LANCET, V2, P791; FROLAND S S, 1972, Scandinavian Journal of Immunology, V1, P1, DOI 10.1111/j.1365-3083.1972.tb03730.x; GITLIN D, 1959, CELLULAR HUMORAL ASP; GOLDFARB AA, 1961, NEW YORK STATE J MED, V61, P2721; GOOD RA, 1962, PROGRESS ALLERGY, V6; GREY HM, 1971, J CLIN INVEST, V50, P2368, DOI 10.1172/JCI106735; HUNTLEY CC, 1957, PEDIATRICS, V19, P351; KINCADE PW, 1971, J IMMUNOL, V106, P1421; LAY WH, 1971, NATURE, V230, P531, DOI 10.1038/230531a0; MENDES NT, TO BE PUBLISHED; NAOR D, 1969, AUST J EXP BIOL MED, V47, P759, DOI 10.1038/icb.1969.173; PAPAMICH.M, 1972, LANCET, V2, P64; PERNIS G, 1970, J EXP MED, V132, P1001; PETERSON RD, 1962, J ALLERGY, V33, P406, DOI 10.1016/0021-8707(62)90045-X; RABELLINO E, 1971, J EXP MED, V133, P156, DOI 10.1084/jem.133.1.156; SCHIFF RI, 1973, J ALLERGY CLIN IMMUN, V51, P125, DOI 10.1016/S0091-6749(73)80100-9; SILVEIRA NP, 1972, J IMMUNOL, V108, P1456; 1971, PEDIATRICS, V47, P927	21	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	5					308	318		10.1016/0091-6749(73)90133-4	http://dx.doi.org/10.1016/0091-6749(73)90133-4			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P5931	4697357	Bronze			2022-12-18	WOS:A1973P593100007
J	TOOGOOD, JH; MCCOURTIE, DR; JENNINGS, BH; LEFCOE, NM; MULLIN, JK				TOOGOOD, JH; MCCOURTIE, DR; JENNINGS, BH; LEFCOE, NM; MULLIN, JK			CHANGES IN CORTICOSTEROID USAGE BY CHRONIC ASTHMA PATIENTS DURING A YEAR OF CROMOGLYCATE TREATMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WESTERN ONTARIO, DEPT MED, LONDON, ONTARIO, CANADA; UNIV WESTERN ONTARIO, DEPT COMP SCI, LONDON, ONTARIO, CANADA	Western University (University of Western Ontario); Western University (University of Western Ontario)								ARNER B, 1971, ACTA ALLERGOL, V26, P383, DOI 10.1111/j.1398-9995.1971.tb01311.x; BLACK R L, 1957, J Chronic Dis, V5, P751, DOI 10.1016/0021-9681(57)90082-6; BROOKS SM, 1972, NEW ENGL J MED, V286, P1125, DOI 10.1056/NEJM197205252862103; CAPEL LH, 1964, BRIT J DIS CHEST, V58, P174, DOI 10.1016/S0007-0971(64)80004-8; CHAI H, PERSONAL COMMUNICATI; CHAI H, 1971, EXCERPTA MEDICA  232, P385; COLLINSWILLIAMS C, 1971, ANN ALLERGY, V29, P613; COX JSG, 1970, ADV DRUG RESEARCH, V5; DEARAUJO G, 1972, J ALLERGY CLIN IMMUN, V50, P257, DOI 10.1016/0091-6749(72)90024-3; DICKSON W, 1970, DISODIUM CROMOGLYCAT; EASTON JG, 1971, J ALLERGY CLIN IMMUN, V48, P355, DOI 10.1016/0091-6749(71)90081-9; FALLIERS CJ, 1972, J ALLERGY CLIN IMMUN, V49, P156, DOI 10.1016/0091-6749(72)90109-1; Gelbard C, 1971, Harefuah, V81, P124; GREGG I, 1970, DISODIUM CROMOGLYCAT; HOLMES TH, 1972, AM REV RESPIR DIS, V106, P610, DOI 10.1164/arrd.1972.106.4.610; HONIGFELD G, 1964, DIS NERV SYST, V25, P145; HYDE JS, 1971, ANN ALLERGY, V29, P483; LIEBERMAN P, 1972, J ALLERGY CLIN IMMUN, V49, P329, DOI 10.1016/0091-6749(72)90131-5; MATHISON DA, 1971, J AMER MED ASSOC, V216, P1454, DOI 10.1001/jama.216.9.1454; MAUNSELL K, 1968, BMJ-BRIT MED J, V1, P661, DOI 10.1136/bmj.1.5593.661; MILNE JF, 1972, BRIT MED J, V4, P383; MOLDOFSKY H, 1970, ARTHRITIS RHEUM-US, V13, P338; MORAN F, 1968, LANCET, V2, P137; MORRISONSMITH J, 1968, BRIT MED J, V2, P340; PATEL K R, 1971, Clinical Allergy, V1, P199, DOI 10.1111/j.1365-2222.1971.tb03019.x; PORTNER MM, 1972, J ALLERGY CLIN IMMUN, V49, P16, DOI 10.1016/0091-6749(72)90119-4; READ J, 1969, MED J AUSTRALIA, V1, P566, DOI 10.5694/j.1326-5377.1969.tb92293.x; REES HA, 1962, BMJ-BRIT MED J, P1575, DOI 10.1136/bmj.1.5292.1575; SAVILLE PD, 1970, ANN INTERN MED, V73, P1038, DOI 10.7326/0003-4819-73-6-1038_1; SMYLLIE HC, 1968, THORAX, V23, P571, DOI 10.1136/thx.23.6.571; Spitzer S A, 1971, Harefuah, V81, P130; TOOGOOD JH, 1973, CHEST, V63, P881, DOI 10.1378/chest.63.6.881; TOOGOOD JH, 1971, AM REV RESPIR DIS, V104, P323, DOI 10.1164/arrd.1971.104.3.323; TOOGOOD JH, 1971, DISODIUM CROMOGLYCAT, P65; TOOGOOD JH, UNPUBLISHED DATA; WESTERHOF L, 1970, BMJ-BRIT MED J, V4, P534, DOI 10.1136/bmj.4.5734.534; 1969, STANDARDS EPIDEMIOLO	37	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	6					334	345		10.1016/0091-6749(73)90092-4	http://dx.doi.org/10.1016/0091-6749(73)90092-4			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R5074	4201770				2022-12-18	WOS:A1973R507400003
J	BERNSTEIN, RA; FACKTOR, MA; FIREMAN, P; DRASH, A; LINARELLI, L; FRIDAY, GA				BERNSTEIN, RA; FACKTOR, MA; FIREMAN, P; DRASH, A; LINARELLI, L; FRIDAY, GA			DECREASED URINARY CYCLIC 3',5'-ADENOSINE MONOPHOSPHATE (CAMP) AFTER EPINEPHRINE IN ASTHMATIC PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					86	+		10.1016/0091-6749(72)90060-7	http://dx.doi.org/10.1016/0091-6749(72)90060-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997		Green Accepted, Bronze			2022-12-18	WOS:A1972L599700004
J	COFFEY, RG; LOGSDON, PJ; MIDDLETON, E				COFFEY, RG; LOGSDON, PJ; MIDDLETON, E			EFFECTS OF GLUCOCORTICOSTEROIDS ON LEUKOCYTE ADENYL-CYCLASE AND ATPASE OF ASTHMATIC AND NORMAL CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		1969, ANAL BIOCHEM, V32, P210	1	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					87	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700006
J	MICHIE, DD; WOMBOLT, DG; CARRETTA, RF; ZENCKA, AE; EGAN, JD				MICHIE, DD; WOMBOLT, DG; CARRETTA, RF; ZENCKA, AE; EGAN, JD			ADVERSE REACTIONS ASSOCIATED WITH ADMINISTRATION OF A TRICARBOCYANINE DYE (CARDIO-GREEN) TO UREMIC PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; FISCHIL EE, 1961, INFLAMMATION DISEASE; FOX IJ, 1956, CIRCULATION, V14, P937; GOSS JE, 1967, T AM SOC ART INT ORG, V13, P68; HAMPERS CL, 1967, CIRCULATION, V35, P272, DOI 10.1161/01.CIR.35.2.272; Hawking F., 1941, ANN TROP MED AND PARASITOL, V35, P45; KOHEN M, 1970, J ALLERGY, V46, P309, DOI 10.1016/0021-8707(70)90071-7; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; MERRILL JP, 1968, CANCER RES, V28, P1449; OPDYKE DF, 1959, P SOC EXP BIOL MED, V102, P725; OUCHTERLONY O, 1949, ACTA PATHOL MIC SC, V26, P507; PATON WDM, 1957, PHARMACOL REV, V9, P269; SALVATO D, 1959, EXPERIENTIA, V15, P308; SHERMAN WB, 1957, ALLERGY PEDIATRIC PR; WILSON WEC, 1965, ANN INTERN MED, V62, P1	15	16	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	4					235	&		10.1016/0091-6749(71)90071-6	http://dx.doi.org/10.1016/0091-6749(71)90071-6			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5566	4106084				2022-12-18	WOS:A1971K556600007
J	Leem, G; Cheon, S; Lee, H; Choi, SJ; Jeong, S; Kim, ES; Jeong, HW; Jeong, H; Park, SH; Kim, YS; Shin, EC				Leem, Galam; Cheon, Shinhye; Lee, Hoyoung; Choi, Seong Jin; Jeong, Seongju; Kim, Eui-Soon; Jeong, Hye Won; Jeong, Hyeongseok; Park, Su-Hyung; Kim, Yeon-Sook; Shin, Eui-Cheol			Abnormality in the NK-cell population is prolonged in severe COVID-19 patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SARS-CoV-2; COVID-19; innate immunity; NK cells; cytotoxicity; unconventional CD56(dim)CD16(neg) (uCD56(dim)) NK cell	NATURAL-KILLER-CELLS; CYTOTOXICITY	Background: Our understanding of adaptive immune responses in patients with coronavirus disease 2019 (COVID-19) is rapidly evolving, but information on the innate immune responses by natural killer (NK) cells is still insufficient. Objective: We aimed to examine the phenotypic and functional status of NK cells and their changes during the course of mild and severe COVID-19. Methods: We performed RNA sequencing and flow cytometric analysis of NK cells from patients with mild and severe COVID-19 at multiple time points in the course of the disease using cryopreserved PBMCs. Results: In RNA-sequencing analysis, the NK cells exhibited distinctive features compared with healthy donors, with significant enrichment of proinflammatory cytokine-mediated signaling pathways. Intriguingly, we found that the unconventional CD56(dim) CD16(neg) NK-cell population expanded in cryopreserved PBMCs from patients with COVID-19 regardless of disease severity, accompanied by decreased NK cell cytotoxicity. The NK-cell population was rapidly normalized alongside the disappearance of unconventional CD56(dim)CD16(neg) NK cells and the recovery of NK-cell cytotoxicity in patients with mild COVID-19, but this occurred slowly in patients with severe COVID-19. Conclusions: The current longitudinal study provides a deep understanding of the NK-cell biology in COVID-19.	[Leem, Galam] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Gastroenterol,Coll Med, Seoul, South Korea; [Cheon, Shinhye; Jeong, Hyeongseok; Kim, Yeon-Sook] Chungnam Natl Univ, Dept Internal Med, Div Infect Dis, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea; [Lee, Hoyoung; Choi, Seong Jin; Jeong, Seongju; Kim, Eui-Soon; Park, Su-Hyung; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ, Dept Internal Med, Coll Med, Cheongju, South Korea	Yonsei University; Yonsei University Health System; Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST); Chungbuk National University	Kim, YS (corresponding author), Chungnam Natl Univ, Dept Internal Med, Div Infect Dis, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.; Shin, EC (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea.	alice@cnuh.co.kr; ecshin@kaist.ac.kr	Park, Su-Hyung/N-3514-2014	Park, Su-Hyung/0000-0001-6363-7736; Jeong, Hyeongseok/0000-0002-4539-079X	2020 Joint Research Project of Institutes of Science and Technology	2020 Joint Research Project of Institutes of Science and Technology	This research was supported by the 2020 Joint Research Project of Institutes of Science and Technology.	Abel AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01869; Amand M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00699; Andoniou CE, 2006, IMMUNOL REV, V214, P239, DOI 10.1111/j.1600-065X.2006.00465.x; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Azzi T, 2014, BLOOD, V124, P2533, DOI 10.1182/blood-2014-01-553024; Benjamini Y., 1995, J R STAT SOC B, V57, P289; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Clark KEN, 2021, CLIN INFECT DIS, V73, pE3110, DOI 10.1093/cid/ciaa1463; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fan YY, 2008, CELL BIOL INT, V32, P188, DOI 10.1016/j.cellbi.2007.08.025; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grom AA, 2004, ARTHRITIS RHEUM, V50, P689, DOI 10.1002/art.20198; Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203; Hayden A, 2016, BLOOD REV, V30, P411, DOI 10.1016/j.blre.2016.05.001; Herman TE, 2010, J PERINATOL, V30, P363, DOI 10.1038/jp.2010.25; Hust MA, 2017, J MED CASE REP, V11, P172; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liu B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73955-8; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mark C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19094-0; Maucourant C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6832; Mazzoni A, 2020, J CLIN INVEST, V130, P4694, DOI [10.1172/JCI138554, 10.1172/JCI138554.]; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Moller MJ, 1998, INT J CANCER, V78, P533, DOI 10.1002/(SICI)1097-0215(19981123)78:5<533::AID-IJC1>3.0.CO;2-2; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Osman M, 2020, BLOOD ADV, V4, P5035, DOI 10.1182/bloodadvances.2020002650; Penack O, 2005, LEUKEMIA, V19, P835, DOI 10.1038/sj.leu.2403704; PEREZ N, 1984, J PEDIATR-US, V104, P569, DOI 10.1016/S0022-3476(84)80549-1; Ramos-Casals M, 2014, LANCET, V383, P1503, DOI 10.1016/S0140-6736(13)61048-X; Roberto A, 2018, HAEMATOLOGICA, V103, P1390, DOI 10.3324/haematol.2017.186619; Romee R, 2013, BLOOD, V121, P3599, DOI 10.1182/blood-2012-04-425397; Stabile H, 2015, HAEMATOLOGICA, V100, P492, DOI 10.3324/haematol.2014.116053; STARK B, 1987, CANCER, V60, P2629, DOI 10.1002/1097-0142(19871201)60:11<2629::AID-CNCR2820601110>3.0.CO;2-Q; Takahashi E, 2007, SCAND J IMMUNOL, V65, P126, DOI 10.1111/j.1365-3083.2006.01883.x; Tholin B, 2020, J MED CASE REP, V14, DOI 10.1186/s13256-020-02503-9; Varchetta S, 2021, CELL MOL IMMUNOL, V18, P604, DOI 10.1038/s41423-020-00557-9; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vujanovic L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00014; White K, 2020, CHEST, V158, p1007A, DOI 10.1016/j.chest.2020.08.937; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Wu JM, 2019, J LEUKOCYTE BIOL, V105, P1297, DOI 10.1002/JLB.2MR1218-501R; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	46	15	15	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					996	+		10.1016/j.jaci.2021.07.022	http://dx.doi.org/10.1016/j.jaci.2021.07.022		OCT 2021	29	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	34339730	Bronze, Green Published			2022-12-18	WOS:000705023300010
